PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Saenz, SA; Siracusa, MC; Perrigoue, JG; Spencer, SP; Urban, JF; Tocker, JE; Budelsky, AL; Kleinschek, MA; Kastelein, RA; Kambayashi, T; Bhandoola, A; Artis, D				Saenz, Steven A.; Siracusa, Mark C.; Perrigoue, Jacqueline G.; Spencer, Sean P.; Urban, Joseph F., Jr.; Tocker, Joel E.; Budelsky, Alison L.; Kleinschek, Melanie A.; Kastelein, Robert A.; Kambayashi, Taku; Bhandoola, Avinash; Artis, David			IL25 elicits a multipotent progenitor cell population that promotes T(H)2 cytokine responses	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; TYPE-2 IMMUNITY; IN-VIVO; IL-4; INNATE; INFLAMMATION; EXPRESSION; BASOPHILS	CD4(+) T helper 2 (T(H)2) cells secrete interleukin (IL)4, IL5 and IL13, and are required for immunity to gastrointestinal helminth infections(1). However, T(H)2 cells also promote chronic inflammation associated with asthma and allergic disorders(2). The nonhaematopoietic-cell-derived cytokines thymic stromal lymphopoietin, IL33 and IL25 (also known as IL17E) have been implicated in inducing T(H)2 cell-dependent inflammation at mucosal sites(3-6), but how these cytokines influence innate immune responses remains poorly defined. Here we show that IL25, a member of the IL17 cytokine family, promotes the accumulation of a lineage-negative (Lin(-)) multipotent progenitor (MPP) cell population in the gut-associated lymphoid tissue that promotes T(H)2 cytokine responses. The IL25-elicited cell population, termed MPPtype2 cells, was defined by the expression of Sca-1 (also known as Ly6a) and intermediate expression of c-Kit (c-Kit(int)), and exhibited multipotent capacity, giving rise to cells of monocyte/macrophage and granulocyte lineages both in vitro and in vivo. Progeny of MPPtype2 cells were competent antigen presenting cells, and adoptive transfer of MPPtype2 cells could promote T(H)2 cytokine responses and confer protective immunity to helminth infection in normally susceptible Il25(-/-) mice. The ability of IL25 to induce the emergence of an MPPtype2 cell population identifies a link between the IL17 cytokine family and extramedullary haematopoiesis, and suggests a previously unrecognized innate immune pathway that promotes T(H)2 cytokine responses at mucosal sites.	[Saenz, Steven A.; Siracusa, Mark C.; Perrigoue, Jacqueline G.; Spencer, Sean P.; Artis, David] Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA; [Kambayashi, Taku; Bhandoola, Avinash] Univ Penn, Dept Pathol & Lab Med, Philadelphia, PA 19104 USA; [Urban, Joseph F., Jr.] USDA, Diet Genom & Immunol Lab, Beltsville Human Nutr Res Ctr, Beltsville, MD 20705 USA; [Tocker, Joel E.; Budelsky, Alison L.] Amgen Inc, Dept Inflammat Res, Seattle, WA 98119 USA; [Kleinschek, Melanie A.; Kastelein, Robert A.] Schering Plough Biopharma, Discovery Res, Palo Alto, CA 94304 USA	University of Pennsylvania; University of Pennsylvania; United States Department of Agriculture (USDA); Amgen; Merck & Company	Artis, D (corresponding author), Univ Penn, Dept Pathobiol, Philadelphia, PA 19104 USA.	dartis@vet.upenn.edu		Urban, Joseph/0000-0002-1590-8869; Artis, David/0000-0002-1753-4100; Spencer, Sean/0000-0002-7328-5399	National Institutes of Health [AI61570, AI074878, AI083480, GM082187, AI007532-08]; Burroughs Wellcome Fund; National Institute of Diabetes and Digestive Kidney Disease Center [P30 DK50306]; University of Pennsylvania (URF, VCID and PGI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007775] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI102942, R21AI083480, T32AI007532, R01AI074878, R01AI061570, R01AI095466] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK050306] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F31GM082187] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Burroughs Wellcome Fund(Burroughs Wellcome Fund); National Institute of Diabetes and Digestive Kidney Disease Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); University of Pennsylvania (URF, VCID and PGI); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Artis laboratory for constructive discussions, M. Abt, D. Hill, G. Sonnenberg, P. Giacomin, M. Nair and K. Walsh for critical reading of the manuscript, and T. Chi and J. J. Bell for invaluable assistance with reagents and experimental design. Work in the Artis laboratory is supported by the National Institutes of Health (AI61570, AI074878 and AI083480 to D. A., F31 training grant GM082187 to S. A. S., and T32 training grant AI007532-08 to J. G. P.), the Burroughs Wellcome Fund (to D. A.), a National Institute of Diabetes and Digestive Kidney Disease Center Grant (P30 DK50306) and pilot grants from the University of Pennsylvania (URF, VCID and PGI) (to D. A.).	Anthony RM, 2007, NAT REV IMMUNOL, V7, P975, DOI 10.1038/nri2199; Bell JJ, 2008, NATURE, V452, P764, DOI 10.1038/nature06840; Cardier JE, 1997, HEPATOLOGY, V26, P165; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fort MM, 2001, IMMUNITY, V15, P985, DOI 10.1016/S1074-7613(01)00243-6; Gessner A, 2005, J IMMUNOL, V174, P1063, DOI 10.4049/jimmunol.174.2.1063; GOODMAN JOAN WRIGHT, 1962, BLOOD JOUR HEMATOL, V19, P702; Hurst SD, 2002, J IMMUNOL, V169, P443, DOI 10.4049/jimmunol.169.1.443; Kondo Y, 2008, INT IMMUNOL, V20, P791, DOI 10.1093/intimm/dxn037; LYON MF, 1982, GENET RES, V39, P315, DOI 10.1017/S001667230002098X; Massberg S, 2007, CELL, V131, P994, DOI 10.1016/j.cell.2007.09.047; McKinney-Freeman SL, 2002, P NATL ACAD SCI USA, V99, P1341, DOI 10.1073/pnas.032438799; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Mohrs M, 2001, IMMUNITY, V15, P303, DOI 10.1016/S1074-7613(01)00186-8; Moro K, 2010, NATURE, V463, P540, DOI 10.1038/nature08636; Nagai Y, 2006, IMMUNITY, V24, P801, DOI 10.1016/j.immuni.2006.04.008; NAKANO T, 1994, SCIENCE, V265, P1098, DOI 10.1126/science.8066449; Owyang AM, 2006, J EXP MED, V203, P843, DOI 10.1084/jem.20051496; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; Reya T, 2001, NATURE, V414, P105, DOI 10.1038/35102167; Saenz SA, 2008, IMMUNOL REV, V226, P172, DOI 10.1111/j.1600-065X.2008.00713.x; Schmitz J, 2005, IMMUNITY, V23, P479, DOI 10.1016/j.immuni.2005.09.015; Sokol CL, 2008, NAT IMMUNOL, V9, P310, DOI 10.1038/ni1558; Soumelis V, 2002, NAT IMMUNOL, V3, P673, DOI 10.1038/ni805; Terashima A, 2008, J EXP MED, V205, P2727, DOI 10.1084/jem.20080698; Umetsu DT, 2002, NAT IMMUNOL, V3, P715, DOI 10.1038/ni0802-715; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Wilson A, 2008, CELL, V135, P1118, DOI 10.1016/j.cell.2008.10.048; Wright DE, 2001, SCIENCE, V294, P1933, DOI 10.1126/science.1064081; Zaph C, 2007, NATURE, V446, P552, DOI 10.1038/nature05590	30	441	463	1	68	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1362	U8		10.1038/nature08901	http://dx.doi.org/10.1038/nature08901			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20200520	Green Accepted			2022-12-01	WOS:000277149000049
J	Gapstur, SM; Thun, MJ				Gapstur, Susan M.; Thun, Michael J.			Progress in the War on Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Gapstur, Susan M.] Amer Canc Soc, Natl Home Off, Atlanta, GA 30303 USA	American Cancer Society	Gapstur, SM (corresponding author), Amer Canc Soc, Natl Home Off, 250 Williams St NW, Atlanta, GA 30303 USA.	susan.gapstur@cancer.org						American Cancer Society, 2009, CANC FACTS FIG 2009; Bailar JC, 1997, NEW ENGL J MED, V336, P1569, DOI 10.1056/NEJM199705293362206; Jemal A, 2009, CA-CANCER J CLIN, V59, P225, DOI 10.3322/caac.20006; LEAF C, WHY WERE LOSING WAR; *NAT CANC I, SEER CANC STAT 1975; *US BUR CENS, POP EST PROGR; *WHO, WORLD HLTH STAT 2007; World Cancer Research Fund/American Institute for Cancer Research, 2007, FOOD NUTR PHYS ACT P	8	14	15	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1084	1085		10.1001/jama.2010.284	http://dx.doi.org/10.1001/jama.2010.284			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233827				2022-12-01	WOS:000275594100022
J	Iess, L; Rappaport, NJ; Jacobson, RA; Racioppa, P; Stevenson, DJ; Tortora, P; Armstrong, JW; Asmar, SW				Iess, Luciano; Rappaport, Nicole J.; Jacobson, Robert A.; Racioppa, Paolo; Stevenson, David J.; Tortora, Paolo; Armstrong, John W.; Asmar, Sami W.			Gravity Field, Shape, and Moment of Inertia of Titan	SCIENCE			English	Article							AMMONIUM-SULFATE; SATELLITES	Precise radio tracking of the spacecraft Cassini has provided a determination of Titan's mass and gravity harmonics to degree 3. The quadrupole field is consistent with a hydrostatically relaxed body shaped by tidal and rotational effects. The inferred moment of inertia factor is about 0.34, implying incomplete differentiation, either in the sense of imperfect separation of rock from ice or a core in which a large amount of water remains chemically bound in silicates. The equilibrium figure is a triaxial ellipsoid whose semi-axes a, b, and c differ by 410 meters (a - c) and 103 meters (b - c). The nonhydrostatic geoid height variations (up to 19 meters) are small compared to the observed topographic anomalies of hundreds of meters, suggesting a high degree of compensation appropriate to a body that has warm ice at depth.	[Iess, Luciano; Racioppa, Paolo] Univ Roma La Sapienza, Dipartimento Ingn Aerospaziale & Astronaut, I-00184 Rome, Italy; [Rappaport, Nicole J.; Jacobson, Robert A.; Armstrong, John W.; Asmar, Sami W.] CALTECH, Jet Prop Lab, Pasadena, CA 91109 USA; [Stevenson, David J.] CALTECH, Pasadena, CA 91125 USA; [Tortora, Paolo] Univ Bologna, DIEM II Fac Ingn, I-47100 Forli, Italy	Sapienza University Rome; California Institute of Technology; National Aeronautics & Space Administration (NASA); NASA Jet Propulsion Laboratory (JPL); California Institute of Technology; University of Bologna	Iess, L (corresponding author), Univ Roma La Sapienza, Dipartimento Ingn Aerospaziale & Astronaut, Via Eudossiana 18, I-00184 Rome, Italy.	luciano.iess@uniroma1.it	Tortora, Paolo/J-6191-2012; IESS, Luciano/F-4902-2011	Tortora, Paolo/0000-0001-9259-7673; IESS, Luciano/0000-0002-6230-5825	Italian Space Agency; NASA	Italian Space Agency(Agenzia Spaziale Italiana (ASI)); NASA(National Aeronautics & Space Administration (NASA))	The work of L. I., P. R., and P. T. was funded in part by the Italian Space Agency. The work of N. J. R., R. A. J., J. W. A., and S. W. A. was carried out at the Jet Propulsion Laboratory, California Institute of Technology, under a contract with NASA. D. J. S. acknowledges support from NASA's planetary geology and geophysics program.	Barr AC, 2008, ICARUS, V198, P163, DOI 10.1016/j.icarus.2008.07.004; Fortes AD, 2007, ICARUS, V188, P139, DOI 10.1016/j.icarus.2006.11.002; Grindrod PM, 2008, ICARUS, V197, P137, DOI 10.1016/j.icarus.2008.04.006; Heiskanen W., 1979, PHYS GEODESY; Jacobson RA, 2006, ASTRON J, V132, P2520, DOI 10.1086/508812; Kaula W. M., 1966, THEORY SATELLITE GEO; Lunine JI, 2009, ANNU REV EARTH PL SC, V37, P299, DOI 10.1146/annurev.earth.031208.100142; Murray C. D., 1999, SOLAR SYSTEM DYNAMIC; Rappaport N, 1997, ICARUS, V126, P313, DOI 10.1006/icar.1996.5661; Showman AP, 1999, SCIENCE, V286, P77, DOI 10.1126/science.286.5437.77; Sotin C, 2009, TITAN FROM CASSINI-HUYGENS, P61, DOI 10.1007/978-1-4020-9215-2_4; Zebker HA, 2009, SCIENCE, V324, P921, DOI 10.1126/science.1168905	12	149	149	1	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1367	1369		10.1126/science.1182583	http://dx.doi.org/10.1126/science.1182583			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223984				2022-12-01	WOS:000275418700038
J	Chen, DD; Xiao, H; Zhang, K; Wang, B; Gao, ZY; Jian, YL; Qi, XY; Sun, JW; Miao, L; Yang, CL				Chen, Didi; Xiao, Hui; Zhang, Kai; Wang, Bin; Gao, Zhiyang; Jian, Youli; Qi, Xiaying; Sun, Jianwei; Miao, Long; Yang, Chonglin			Retromer Is Required for Apoptotic Cell Clearance by Phagocytic Receptor Recycling	SCIENCE			English	Article							GOLGI RETROGRADE TRANSPORT; WNT-PRODUCING CELLS; CAENORHABDITIS-ELEGANS; C-ELEGANS; MAMMALIAN RETROMER; COMPLEX; ENGULFMENT; SECRETION; ENDOSOME; MIG-14/WNTLESS	The cell surface receptor CED-1 mediates apoptotic cell recognition by phagocytic cells, enabling cell corpse clearance in Caenorhabditis elegans. Here, we found that the C. elegans intracellular protein sorting complex, retromer, was required for cell corpse clearance by mediating the recycling of CED-1. Retromer was recruited to the surfaces of phagosomes containing cell corpses, and its loss of function caused defective cell corpse removal. The retromer probably acted through direct interaction with CED-1 in the cell corpse recognition pathway. In the absence of retromer function, CED-1 associated with lysosomes and failed to recycle from phagosomes and cytosol to the plasma membrane. Thus, retromer is an essential mediator of apoptotic cell clearance by regulating phagocytic receptor(s) during cell corpse engulfment.	[Chen, Didi; Xiao, Hui; Gao, Zhiyang; Jian, Youli; Qi, Xiaying; Sun, Jianwei; Yang, Chonglin] Chinese Acad Sci, Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Beijing 100101, Peoples R China; [Chen, Didi; Xiao, Hui; Sun, Jianwei] Chinese Acad Sci, Grad Sch, Beijing 100039, Peoples R China; [Zhang, Kai; Wang, Bin; Miao, Long] Chinese Acad Sci, Inst Biophys, Natl Lab Biomacromol, Beijing 100101, Peoples R China	Chinese Academy of Sciences; Institute of Genetics & Developmental Biology, CAS; Chinese Academy of Sciences; University of Chinese Academy of Sciences, CAS; Chinese Academy of Sciences; Institute of Biophysics, CAS	Yang, CL (corresponding author), Chinese Acad Sci, Key Lab Mol & Dev Biol, Inst Genet & Dev Biol, Datun Rd, Beijing 100101, Peoples R China.	clyang@genetics.ac.cn	chen, didi/P-7934-2015; xiao, hui/O-8437-2014; Qi, Xiaying/D-2640-2017; XIAO, HUI/H-2342-2013; Zhang, Kai/M-9831-2017	chen, didi/0000-0002-1453-6899; xiao, hui/0000-0001-5709-3365; Qi, Xiaying/0000-0002-1793-1974; Zhang, Kai/0000-0003-2962-3976; Miao, Long/0000-0002-0562-6681	Chinese government [2007CB947201, 30871266, KSCX1-YW-R-70]; Chinese Academy of Sciences 100-Talents Program	Chinese government; Chinese Academy of Sciences 100-Talents Program(Chinese Academy of Sciences)	We thank S. Mitani, X. Wang, D. Xue, H. Fares, and C. elegans Genetic Center (CGC) for strains; X. Wang and H. Zhang for critically reading the manuscript; and I. Hanson for proofreading services. This research was supported by grants 2007CB947201, 30871266, and KSCX1-YW-R-70 from the Chinese government. C.Y. is supported by the Chinese Academy of Sciences 100-Talents Program.	Arighi CN, 2004, J CELL BIOL, V165, P123, DOI 10.1083/jcb.200312055; Belenkaya TY, 2008, DEV CELL, V14, P120, DOI 10.1016/j.devcel.2007.12.003; Bonifacino JS, 2008, CURR OPIN CELL BIOL, V20, P427, DOI 10.1016/j.ceb.2008.03.009; Collins BM, 2008, TRAFFIC, V9, P1811, DOI 10.1111/j.1600-0854.2008.00777.x; Coudreuse DYM, 2006, SCIENCE, V312, P921, DOI 10.1126/science.1124856; Cullen PJ, 2008, NAT REV MOL CELL BIO, V9, P574, DOI 10.1038/nrm2427; Franch-Marro X, 2008, NAT CELL BIOL, V10, P170, DOI 10.1038/ncb1678; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; Kamath RS, 2003, METHODS, V30, P313, DOI 10.1016/S1046-2023(03)00050-1; Kritikou EA, 2006, GENE DEV, V20, P2279, DOI 10.1101/gad.384506; Pan CL, 2008, DEV CELL, V14, P132, DOI 10.1016/j.devcel.2007.12.001; Port F, 2008, NAT CELL BIOL, V10, P178, DOI 10.1038/ncb1687; Prasad BC, 2006, DEVELOPMENT, V133, P1757, DOI 10.1242/dev.02357; Reddien PW, 2004, ANNU REV CELL DEV BI, V20, P193, DOI 10.1146/annurev.cellbio.20.022003.114619; Seaman MNJ, 1998, J CELL BIOL, V142, P665, DOI 10.1083/jcb.142.3.665; Shi AB, 2009, EMBO J, V28, P3290, DOI 10.1038/emboj.2009.272; Strochlic TI, 2007, J CELL BIOL, V177, P115, DOI 10.1083/jcb.200609161; Verges M, 2004, NAT CELL BIOL, V6, P763, DOI 10.1038/ncb1153; Wassmer T, 2009, DEV CELL, V17, P110, DOI 10.1016/j.devcel.2009.04.016; Yang PT, 2008, DEV CELL, V14, P140, DOI 10.1016/j.devcel.2007.12.004; Yu XM, 2006, DEV CELL, V10, P743, DOI 10.1016/j.devcel.2006.04.007; Zhou Z, 2001, CELL, V104, P43, DOI 10.1016/S0092-8674(01)00190-8	22	93	116	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1261	1264		10.1126/science.1184840	http://dx.doi.org/10.1126/science.1184840			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20133524				2022-12-01	WOS:000275162100041
J	Davenport, A; Farrington, K				Davenport, Andrew; Farrington, Ken			Dialysis dose in acute kidney injury and chronic dialysis	LANCET			English	Editorial Material							NATIONAL COOPERATIVE DIALYSIS; CRITICALLY-ILL PATIENTS; HEMODIALYSIS-PATIENTS; MORTALITY; INTENSITY; MORBIDITY; SURVIVAL		[Davenport, Andrew] UCL, Sch Med, Ctr Nephrol, London NW3 2PF, England; [Farrington, Ken] Lister Hosp, Renal Unit, Stevenage, Herts, England	University of London; University College London; UCL Medical School; Lister Hospital	Davenport, A (corresponding author), UCL, Sch Med, Ctr Nephrol, Royal Free Campus, London NW3 2PF, England.	andrew.davenport@royalfree.nhs.uk	Farrington, Ken/V-1531-2019					Bellomo R, 2009, NEW ENGL J MED, V361, P1627, DOI 10.1056/NEJMoa0902413; Cheung AK, 2006, J AM SOC NEPHROL, V17, P546, DOI 10.1681/ASN.2005020132; DAVENPORT A, 1993, LANCET, V341, P1614, DOI 10.1016/0140-6736(93)90757-8; Eknoyan G, 2002, NEW ENGL J MED, V347, P2010, DOI 10.1056/NEJMoa021583; GOTCH FA, 1985, KIDNEY INT, V28, P526, DOI 10.1038/ki.1985.160; Held PJ, 1996, KIDNEY INT, V50, P550, DOI 10.1038/ki.1996.348; Locatelli F, 2009, J AM SOC NEPHROL, V20, P645, DOI 10.1681/ASN.2008060590; LOWRIE EG, 1981, NEW ENGL J MED, V305, P1176, DOI 10.1056/NEJM198111123052003; Palevsky PM, 2008, NEW ENGL J MED, V359, P7, DOI 10.1056/NEJMoa0802639; PARKER TF, 1994, AM J KIDNEY DIS, V23, P670, DOI 10.1016/S0272-6386(12)70277-9; Spalding EM, 2008, KIDNEY INT, V74, P348, DOI 10.1038/ki.2008.185; TISHER CC, 1994, ANN INTERN MED, V121, P62	12	27	28	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					705	706		10.1016/S0140-6736(09)62062-6	http://dx.doi.org/10.1016/S0140-6736(09)62062-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20167358				2022-12-01	WOS:000275211200008
J	Lo, B; Parham, L; Cedars, M; Fisher, S; Gates, E; Giudice, L; Halme, DG; Hershon, W; Kriegstein, A; Rao, R; Roberts, C; Wagner, R				Lo, Bernard; Parham, Lindsay; Cedars, Marcelle; Fisher, Susan; Gates, Elena; Giudice, Linda; Halme, Dina Gould; Hershon, William; Kriegstein, Arnold; Rao, Radhika; Roberts, Clifford; Wagner, Richard			NIH Guidelines for Stem Cell Research and Gamete Donors	SCIENCE			English	Editorial Material							CONSENT; DONATION; OOCYTES; EMBRYO		[Lo, Bernard; Parham, Lindsay] Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA; [Lo, Bernard] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Lo, Bernard; Fisher, Susan; Gates, Elena; Giudice, Linda; Kriegstein, Arnold] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Cedars, Marcelle; Gates, Elena; Giudice, Linda] Univ Calif San Francisco, Dept Obstet Gynecol & Reprod Sci, San Francisco, CA 94143 USA; [Fisher, Susan] Univ Calif San Francisco, Dept Anat, San Francisco, CA 94143 USA; [Halme, Dina Gould] Univ Calif San Francisco, Sch Med, Off Dean, San Francisco, CA 94143 USA; [Hershon, William] Disabil Rights Calif, Oakland, CA 94612 USA; [Kriegstein, Arnold] Univ Calif San Francisco, Program Dev & Stem Cell Biol, San Francisco, CA 94143 USA; [Rao, Radhika] Univ Calif San Francisco, Hastings Coll Law, San Francisco, CA 94102 USA; [Roberts, Clifford] Univ Calif San Francisco, Off Vice Chancellor Res, San Francisco, CA 94143 USA; [Wagner, Richard] Univ Calif San Francisco, Human Res Protect Program, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Lo, B (corresponding author), Univ Calif San Francisco, Program Med Eth, San Francisco, CA 94143 USA.	bernie@medicine.ucsf.edu			NCRR NIH HHS [UL1 RR024131, UL1 RR024131-04] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Adsuar N, 2005, FERTIL STERIL, V84, P1513, DOI 10.1016/j.fertnstert.2005.05.042; *AUSTR GOV NAT HLT, 2002, PROH HUM CLON REPR A; BERG JW, 2001, INFORMED CONSENT LEG; *EUR GROUP ETH SCI, 2007, ETH REV HESC FP7 RES; *HFEA, 1991, GUID CONS US STOR GA; Kalfoglou AL, 2000, FERTIL STERIL, V74, P660, DOI 10.1016/S0015-0282(00)01489-8; Klitzman R, 2009, REPROD BIOMED ONLINE, V18, P603, DOI 10.1016/S1472-6483(10)60002-8; KOROBKIN R, 2007, STEM CELL CENTURY LO; Lo B, 2003, SCIENCE, V301, P921, DOI 10.1126/science.1087038; Lo B, 2009, CELL STEM CELL, V4, P115, DOI 10.1016/j.stem.2009.01.013; Lomax GP, 2007, PLOS MED, V4, P803, DOI 10.1371/journal.pmed.0040114; National Commission for the Protection of Human Subjects of Biomedical and Behavioral Research, 1979, BELM REP ETH PRINC G; National Research Council and Institute of Medicine of the National Academies, 2007, 2007 AM NAT AC GUID; *NEBAC, 1999, ETH ISS HUM STEM CEL; *NIH, 2009, NAT I HLTH GUID HUM; Streiffer R, 2008, HASTINGS CENT REP, V38, P40; Sugarman J, 2008, SCIENCE, V322, P379, DOI 10.1126/science.1164441; The International Society for Stem Cell Research (ISSCR), 2006, GUID COND HUM EMBR S	18	10	10	1	3	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					962	963		10.1126/science.1180725	http://dx.doi.org/10.1126/science.1180725			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	556XE	20167773	Green Accepted, Green Published			2022-12-01	WOS:000274625800025
J	Olsen, SK; Capili, AD; Lu, XQ; Tan, DS; Lima, CD				Olsen, Shaun K.; Capili, Allan D.; Lu, Xuequan; Tan, Derek S.; Lima, Christopher D.			Active site remodelling accompanies thioester bond formation in the SUMO E1	NATURE			English	Article							UBIQUITIN-ACTIVATING ENZYME; MECHANISTIC INSIGHTS; PROTEIN MODIFICATION	E1 enzymes activate ubiquitin (Ub) and ubiquitin-like (Ubl) proteins in two steps by carboxy-terminal adenylation and thioester bond formation to a conserved catalytic cysteine in the E1 Cys domain. The structural basis for these intermediates remains unknown. Here we report crystal structures for human SUMO E1 in complex with SUMO adenylate and tetrahedral intermediate analogues at 2.45 and 2.6 angstrom, respectively. These structures show that side chain contacts to ATP.Mg are released after adenylation to facilitate a 130 degree rotation of the Cys domain during thioester bond formation that is accompanied by remodelling of key structural elements including the helix that contains the E1 catalytic cysteine, the crossover and re-entry loops, and refolding of two helices that are required for adenylation. These changes displace side chains required for adenylation with side chains required for thioester bond formation. Mutational and biochemical analyses indicate these mechanisms are conserved in other E1s.	[Lu, Xuequan; Tan, Derek S.] Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA; [Olsen, Shaun K.; Capili, Allan D.; Lima, Christopher D.] Sloan Kettering Inst, Struct Biol Program, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Tan, DS (corresponding author), Sloan Kettering Inst, Mol Pharmacol & Chem Program, New York, NY 10065 USA.	tand@mskcc.org; limac@mskcc.org		Olsen, Shaun/0000-0002-1265-7101; Lima, Christopher/0000-0002-9163-6092	NCRR at the NIH [RR-15301]; US Department of Energy, Office of Basic Energy Sciences [DE-AC02-06CH11357]; NIH [R01 AI068038, R01 GM065872, F32 GM075695]; NYSTAR Watson Investigator Program; Rita Allen Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR015301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI068038] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM065872, F32GM075695] Funding Source: NIH RePORTER	NCRR at the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); US Department of Energy, Office of Basic Energy Sciences(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NYSTAR Watson Investigator Program; Rita Allen Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank A. Armstrong for Ub and Ub E1 clones and N. Takeda for assistance in graphic art preparation. This work is based on research conducted at the NE-CAT beamlines of the Advanced Photon Source, supported by RR-15301 from the NCRR at the NIH. Use of the APS is supported by the US Department of Energy, Office of Basic Energy Sciences, under Contract No. DE-AC02-06CH11357. D. S. T. is an Alfred P. Sloan Research Fellow. X. L. and D. S. T. were supported by NIH R01 AI068038 and the NYSTAR Watson Investigator Program. S.K.O., A. D. C. and C. D. L. were supported by NIH R01 GM065872, F32 GM075695 (A. D. C.), and the Rita Allen Foundation (C. D. L.).	BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Capili AD, 2007, CURR OPIN STRUC BIOL, V17, P726, DOI 10.1016/j.sbi.2007.08.018; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Dye BT, 2007, ANNU REV BIOPH BIOM, V36, P131, DOI 10.1146/annurev.biophys.36.040306.132820; Gulick AM, 2009, ACS CHEM BIOL, V4, P811, DOI 10.1021/cb900156h; HAAS AL, 1982, J BIOL CHEM, V257, P329; Hayward S, 1998, PROTEINS, V30, P144, DOI 10.1002/(SICI)1097-0134(19980201)30:2<144::AID-PROT4>3.3.CO;2-I; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Huang DT, 2007, NATURE, V445, P394, DOI 10.1038/nature05490; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Knuesel M, 2005, MOL CELL PROTEOMICS, V4, P1626, DOI 10.1074/mcp.T500011-MCP200; Lake MW, 2001, NATURE, V414, P325, DOI 10.1038/35104586; Laney JD, 1999, CELL, V97, P427, DOI 10.1016/S0092-8674(00)80752-7; LASKOWSKI RA, 1993, J MOL BIOL, V231, P1049, DOI 10.1006/jmbi.1993.1351; Lee I, 2008, CELL, V134, P268, DOI 10.1016/j.cell.2008.05.046; Lois LM, 2005, EMBO J, V24, P439, DOI 10.1038/sj.emboj.7600552; Lu XQ, 2010, J AM CHEM SOC, V132, P1748, DOI 10.1021/ja9088549; Melchior F, 2000, ANNU REV CELL DEV BI, V16, P591, DOI 10.1146/annurev.cellbio.16.1.591; Mossessova E, 2000, MOL CELL, V5, P865, DOI 10.1016/S1097-2765(00)80326-3; Muir TW, 2003, ANNU REV BIOCHEM, V72, P249, DOI 10.1146/annurev.biochem.72.121801.161900; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PICKART CM, 1994, J BIOL CHEM, V269, P7115; Reverter D, 2005, NATURE, V435, P687, DOI 10.1038/nature03588; Reverter D, 2004, STRUCTURE, V12, P1519, DOI 10.1016/j.str.2004.05.023; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Soucy TA, 2009, NATURE, V458, P732, DOI 10.1038/nature07884; Storoni LC, 2004, ACTA CRYSTALLOGR D, V60, P432, DOI 10.1107/S0907444903028956; Verdecia MA, 2003, MOL CELL, V11, P249, DOI 10.1016/S1097-2765(02)00774-8; Walden H, 2003, MOL CELL, V12, P1427, DOI 10.1016/S1097-2765(03)00452-0; Wu PY, 2003, EMBO J, V22, P5241, DOI 10.1093/emboj/cdg501; Yunus AA, 2006, NAT STRUCT MOL BIOL, V13, P491, DOI 10.1038/nsmb1104	33	146	151	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					906	U77		10.1038/nature08765	http://dx.doi.org/10.1038/nature08765			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164921	Green Accepted			2022-12-01	WOS:000274582700037
J	Lumbiganon, P; Laopaiboon, M; Gulmezoglu, AM; Souza, JP; Taneepanichskul, S; Pang, RY; Attygalle, DE; Shrestha, N; Mori, R; Hinh, ND; Bang, HT; Rathavy, T; Kang, CY; Cheang, K; Festin, M; Udomprasertgul, V; Germar, MJV; Gao, YQ; Roy, M; Carroli, G; Ba-Thike, K; Filatova, E; Villar, J				Lumbiganon, Pisake; Laopaiboon, Malinee; Guelmezoglu, A. Metin; Souza, Joao Paulo; Taneepanichskul, Surasak; Pang Ruyan; Attygalle, Deepika Eranjanie; Shrestha, Naveen; Mori, Rintaro; Hinh, Nguyen Duc; Bang, Hoang Thi; Rathavy, Tung; Kang Chuyun; Cheang, Kannitha; Festin, Mario; Udomprasertgul, Venus; Germar, Maria Julieta V.; Gao Yanqiu; Roy, Malabika; Carroli, Guillermo; Ba-Thike, Katherine; Filatova, Ekaterina; Villar, Jose		World Hlth Org Global Survey	Method of delivery and pregnancy outcomes in Asia: the WHO global survey on maternal and perinatal health 2007-08	LANCET			English	Article							CESAREAN DELIVERY; LATIN-AMERICA; RATES; OBSTETRICIANS; MORTALITY; SECTIONS	Background There has been concern about rising rates of Caesarean section worldwide. This Article reports the third phase of the WHO global survey, which aimed to estimate the rate of different methods of delivery and to examine the relation between method of delivery and maternal and perinatal outcomes in selected facilities in Africa and Latin America in 2004-05, and in Asia in 2007-08. Methods Nine countries participated in the Asia global survey: Cambodia, China, India, Japan, Nepal, Philippines, Sri Lanka, Thailand, and Vietnam. in each country, the capital city and two other regions or provinces were randomly selected. We studied all women admitted for delivery during 3 months in institutions with 6000 or fewer expected deliveries per year and during 2 months in those with more than 6000 deliveries. We gathered data for institutions to obtain a detailed description of the health facility and its resources for obstetric care. We obtained data from women's medical records to summarise obstetric and perinatal events. Findings We obtained data for 109101 of 112152 deliveries reported in 122 recruited facilities (97% coverage), and analysed 107 950 deliveries. The overall rate of Caesarean section was 27.3% (n=29 428) and of operative vaginal delivery was 3.2% (n=3465). Risk of maternal mortality and morbidity index (at least one of maternal mortality, admission to intensive care unit [ICU], blood transfusion, hysterectomy, or internal iliac artery ligation) was increased for operative vaginal delivery (adjusted odds ratio 2.1, 95% CI 1.7-2.6) and all types of Caesarean section (antepartum without indication 2.7, 1.4-5.5; antepartum with indication 10.6, 9.3-12.0; intrapartum without indication 14.2, 9.8-20.7; intrapartum. with indication 14.5, 13.2-16.0). For breech presentation, Caesarean section, either antepartum (0.2, 0.1-0.3) or intrapartum (0.3, 0.2-0.4), was associated with improved perinatal outcomes, but also with increased risk of stay in neonatal ICU (2.0, 1.1-3.6; and 2.1, 1.2-3.7, respectively). Interpretation To improve maternal and perinatal outcomes, Caesarean section should be done only when there is a medical indication.	[Guelmezoglu, A. Metin] WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA, CH-1211 Geneva 27, Switzerland; [Lumbiganon, Pisake] Khon Kaen Univ, Fac Med, Dept Obstet & Gynaecol, Khon Kaen, Thailand; [Laopaiboon, Malinee] Khon Kaen Univ, Fac Publ Hlth, Dept Biostat & Demog, Khon Kaen, Thailand; [Taneepanichskul, Surasak; Udomprasertgul, Venus] Chulalongkorn Univ, Coll Publ Hlth Sci, Bangkok, Thailand; [Pang Ruyan; Kang Chuyun; Gao Yanqiu] Peking Univ, Sch Publ Hlth, Dept Maternal & Child Hlth, Beijing 100871, Peoples R China; [Attygalle, Deepika Eranjanie] Minist Hlth, Family Hlth Bur, Colombo, Sri Lanka; [Shrestha, Naveen] Pokhara Univ, Fac Sci & Technol, Sch Pharmaceut & Biomed Sci, Kaski, Nepal; [Mori, Rintaro] Osaka Med Ctr & Res Inst Maternal & Child Hlth, Osaka, Japan; [Hinh, Nguyen Duc] Natl Obstet & Gynaecol Hosp, Hanoi, Vietnam; [Bang, Hoang Thi] WHO Country Off, Hanoi, Vietnam; [Rathavy, Tung] Natl Maternal & Child Hlth Ctr, Phnom Penh, Cambodia; [Cheang, Kannitha] WHO Country Off, Phnom Penh, Cambodia; [Festin, Mario; Germar, Maria Julieta V.] Univ Philippines, Coll Med, Manila, Philippines; [Roy, Malabika] Indian Council Med Res, New Delhi, India; [Carroli, Guillermo] Ctr Rosarino Estudios Perinatales Rosario, Rosario, Santa Fe, Argentina	The World Bank; United Nations Population Fund; World Health Organization; Khon Kaen University; Khon Kaen University; Chulalongkorn University; Peking University; University of the Philippines System; University of the Philippines Manila; Indian Council of Medical Research (ICMR)	Gulmezoglu, AM (corresponding author), WHO, Dept Reprod Hlth & Res, World Bank Special Programme Res Dev & Res Traini, UNDP,UNFPA, Ave Appia 20, CH-1211 Geneva 27, Switzerland.	gulmezoglum@who.int	Souza, João Paulo/G-1982-2010; Lumbiganon, Pisake/E-8634-2010; Withinunthakit, Siriporn/E-6131-2010; Festin, Mario Philip/GQQ-9749-2022	Souza, João Paulo/0000-0002-2288-4244; Lumbiganon, Pisake/0000-0001-9372-0071; Mori, Rintaro/0000-0001-7656-6156; Shrestha, Naveen/0000-0002-9325-598X	United States Agency for International Development (USAID); UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), WHO, Geneva, Switzerland; Ministry of Health, Labour and Welfare of Japan; Ministry of Public Health, Beijing, China; Indian Council of Medical Research, Delhi, India	United States Agency for International Development (USAID)(United States Agency for International Development (USAID)); UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), WHO, Geneva, Switzerland; Ministry of Health, Labour and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); Ministry of Public Health, Beijing, China; Indian Council of Medical Research, Delhi, India(Indian Council of Medical Research (ICMR))	We thank Nirun Intarut for support during the data monitoring and analysis; Mary Ellen Stanton of USAID for her support and technical input to the project: Mai Fujii who assisted the implementation of the survey; S Marthinsson who developed the online data entry system and assisted in the training of country personnel; Leiv Bakketeig who assisted die first training meeting; Daniel Wojdyla and Liana Campodonico at Centro Rosarino de Estudios Perinatales, Rosario, Argentina for providing relevant information from the earlier surveys and methodological support; the WHO South-East Asia and Western Pacific Regional Office Staff at Delhi and Manila for their support to the operationalisation of the survey: and WHO country office staff and the Counterparts at die ministries of health for providing permissions and administrative Support to the project. The study was financially supported by the United States Agency for International Development (USAID); UNDP/UNFPA/WHO/World Bank Special Programme of Research, Development and Research Training in Human Reproduction (HRP), WHO, Geneva, Switzerland; Ministry of Health, Labour and Welfare of Japan; Ministry of Public Health, Beijing, China; and Indian Council of Medical Research, Delhi, India.	AlMufti R, 1997, EUR J OBSTET GYN R B, V73, P1, DOI 10.1016/S0301-2115(96)02692-9; Althabe F, 2002, BRIT MED J, V324, P945, DOI 10.1136/bmj.324.7343.945; Behague DP, 2002, BMJ-BRIT MED J, V324, P942, DOI 10.1136/bmj.324.7343.942; Belizan JM, 1999, BMJ-BRIT MED J, V319, P1397, DOI 10.1136/bmj.319.7222.1397; Deneux-Tharaux C, 2006, OBSTET GYNECOL, V108, P541, DOI 10.1097/01.AOG.0000233154.62729.24; Hofmeyr GJ, 2000, COCHRANE DB SYST REV, V2; HOFMEYR GJ, 2003, COCHRANE DB SYST REV, V3, DOI DOI 10.1002/14651858.CD000166; Langer A, 2002, BRIT MED J, V324, P928, DOI 10.1136/bmj.324.7343.928; Lavender T, 2005, BMJ-BRIT MED J, V331, P490, DOI 10.1136/bmj.38560.572639.3A; Maine D, 2007, LANCET, V370, P1380, DOI 10.1016/S0140-6736(07)61580-3; National Collaborating Centre for Women's and Children's Health, 2004, CAES SECT CLIN GUID; Shah A, 2008, B WORLD HEALTH ORGAN, V86, P126, DOI 10.2471/BLT.06.039842; Tita ATN, 2009, NEW ENGL J MED, V360, P111, DOI 10.1056/NEJMoa0803267; Villar J, 2007, BRIT MED J, V335, P1025, DOI 10.1136/bmj.39363.706956.55; Villar J, 2006, LANCET, V367, P1819, DOI 10.1016/S0140-6736(06)68704-7	15	616	785	1	116	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					490	499		10.1016/S0140-6736(09)61870-5	http://dx.doi.org/10.1016/S0140-6736(09)61870-5			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20071021				2022-12-01	WOS:000274757900032
J	Temperley, R; Richter, R; Dennerlein, S; Lightowlers, RN; Chrzanowska-Lightowlers, ZM				Temperley, Richard; Richter, Ricarda; Dennerlein, Sven; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M.			Hungry Codons Promote Frameshifting in Human Mitochondrial Ribosomes	SCIENCE			English	Article							TRANSLATION		[Temperley, Richard; Richter, Ricarda; Dennerlein, Sven; Lightowlers, Robert N.; Chrzanowska-Lightowlers, Zofia M.] Univ Newcastle, Inst Ageing & Hlth, Mitochondrial Res Grp, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England	Newcastle University - UK	Chrzanowska-Lightowlers, ZM (corresponding author), Univ Newcastle, Inst Ageing & Hlth, Mitochondrial Res Grp, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	Z.Chrzanowska-Lightowlers@ncl.ac.uk		Chrzanowska-Lightowlers, Zofia/0000-0002-0045-3152	Wellcome Trust [074454/Z/04/Z]; Biotechnology and Biological Sciences Research Council [BB/F011520/1]; BBSRC [BB/F011520/1] Funding Source: UKRI; Medical Research Council [G0700718B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (074454/Z/04/Z) and Biotechnology and Biological Sciences Research Council (BB/F011520/1). We thank K. Gerdes for kindly providing the clone and antibodies to bacterial RelE.	GESTELAND RF, 1992, SCIENCE, V257, P1640, DOI 10.1126/science.1529352; Russell RD, 2008, J MOL EVOL, V67, P682, DOI 10.1007/s00239-008-9179-0; Soleimanpour-Lichaei HR, 2007, MOL CELL, V27, P745, DOI 10.1016/j.molcel.2007.06.031	3	114	119	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					301	301		10.1126/science.1180674	http://dx.doi.org/10.1126/science.1180674			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075246				2022-12-01	WOS:000273629700033
J	Murphy, AM				Murphy, Anne M.			Mammography Screening for Breast Cancer A View From 2 Worlds	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									Johns Hopkins Univ, Sch Med, Dept Pediat, Div Cardiol, Baltimore, MD 21205 USA	Johns Hopkins University	Murphy, AM (corresponding author), Johns Hopkins Univ, Sch Med, Dept Pediat, Div Cardiol, 720 Rutland Ave,Ross Bldg 1144, Baltimore, MD 21205 USA.	amurphy2@jhmi.edu						Burke W, 2009, AM J MED GENET A, V149A, P349, DOI 10.1002/ajmg.a.32643; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Nelson HD, 2009, ANN INTERN MED, V151, pW237, DOI DOI 10.7326/0003-4819-151-10-200911170-00009; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Pisano ED, 2005, NEW ENGL J MED, V353, P1773, DOI 10.1056/NEJMoa052911; Qaseem A, 2007, ANN INTERN MED, V146, P511, DOI 10.7326/0003-4819-146-7-200704030-00007; Smith-Bindman R, 2003, JAMA-J AM MED ASSOC, V290, P2129, DOI 10.1001/jama.290.16.2129; Taplin S, 2008, J NATL CANCER I, V100, P876, DOI 10.1093/jnci/djn172; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; US Cancer Statistics Working Group, 2016, US CANC STAT 1999 20; Weitzel JN, 2007, JAMA-J AM MED ASSOC, V297, P2587, DOI 10.1001/jama.297.23.2587	11	22	22	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					166	167		10.1001/jama.2009.1991	http://dx.doi.org/10.1001/jama.2009.1991			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068212				2022-12-01	WOS:000273522600029
J	Grosset, DG; Macphee, GJA; Nairn, M				Grosset, D. G.; Macphee, G. J. A.; Nairn, M.		Guideline Dev Grp	Guidelines Diagnosis and pharmacological management of Parkinson's disease: summary of SIGN guidelines	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							EXCESSIVE DAYTIME SLEEPINESS; CHOLINESTERASE-INHIBITORS; DEPRESSION; DEMENTIA; COMMUNITY; SCALE		[Nairn, M.] Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland; [Grosset, D. G.; Macphee, G. J. A.] So Gen Hosp, Dept Neurol, Glasgow G51 4TF, Lanark, Scotland	University of Glasgow	Nairn, M (corresponding author), Scottish Intercollegiate Guidelines Network, Edinburgh EH7 5EA, Midlothian, Scotland.	moray.nairn@nhs.net		Nairn, Moray/0000-0001-6474-4410; Grosset, Donald/0000-0002-2757-8203	BI; UCB Pharma	BI; UCB Pharma(UCB Pharma SA)	All authors have completed the Unified Competing Interest form at www.icmje.org/coi_disclosure.pdf (available on request from the corresponding author) and declare that (1) No authors have support from any company for the submitted work; (2) DGG has received honorariums for talks from Boehringer-Ingelheim (BI), GE Healthcare, GlaxoSmithKline (GSK), Teva, and Union Chimique Belge (UCB); has been reimbursed for conference attendance from Teva and UCB; and has received grant support for research staff from GSK and GE Healthcare. GM has participated in advisory boards for BI, GSK, Teva, and Solvay Pharmaceuticals; has received speaker fees from BI, GSK, Orion, and Solvay; and has received travel grants from BI and UCB Pharma. MN has no relationships with any company that might have an interest in the submitted work in the previous three years; (3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and (4) DGG chaired the SIGN guideline development group on diagnosis and pharmacological management of Parkinson's disease. GM and MN have no non-financial interests that may be relevant to the submitted work.	Aarsland D, 2004, J GERIATR PSYCH NEUR, V17, P164, DOI 10.1177/0891988704267463; Aarsland D, 2005, MOVEMENT DISORD, V20, P1255, DOI 10.1002/mds.20527; Ahlskog JE, 2001, MOVEMENT DISORD, V16, P448, DOI 10.1002/mds.1090; Chaudhuri KR, 2006, MOVEMENT DISORD, V21, P916, DOI 10.1002/mds.20844; Devos D, 2008, MOVEMENT DISORD, V23, P850, DOI 10.1002/mds.21966; General Register Office for Scotland, 2009, PROJ POP SCOTL 2008; GIBB WRG, 1988, J NEUROL NEUROSUR PS, V51, P745, DOI 10.1136/jnnp.51.6.745; Gjerstad MD, 2006, NEUROLOGY, V67, P853, DOI 10.1212/01.wnl.0000233980.25978.9d; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Lang AE, 2009, NEUROLOGY, V72, pS39, DOI 10.1212/WNL.0b013e318198e177; Leroi I, 2006, J NEUROL SCI, V248, P104, DOI 10.1016/j.jns.2006.05.021; Maidment ID, 2005, ACTA PSYCHIAT SCAND, V111, P403, DOI 10.1111/j.1600-0447.2005.00516.x; Miyasaki JM, 2006, NEUROLOGY, V66, P996, DOI 10.1212/01.wnl.0000215428.46057.3d; MONTGOMERY SA, 1979, BRIT J PSYCHIAT, V134, P382, DOI 10.1192/bjp.134.4.382; Schrag A, 2002, J NEUROL NEUROSUR PS, V73, P529, DOI 10.1136/jnnp.73.5.529; Schrag A, 2007, MOVEMENT DISORD, V22, P1077, DOI 10.1002/mds.21333; *SCOTT INT GUID NE, 2010, SIGN PUBL, V113; Sellbach AN, 2006, PARKINSONISM RELAT D, V12, P399, DOI 10.1016/j.parkreldis.2006.03.002; Starkstein SE, 2008, MOVEMENT DISORD, V23, P538, DOI 10.1002/mds.21866; Tan EK, 2002, NEUROLOGY, V58, P465, DOI 10.1212/WNL.58.3.465; Tandberg E, 1999, MOVEMENT DISORD, V14, P922, DOI 10.1002/1531-8257(199911)14:6<922::AID-MDS1003>3.0.CO;2-7; Weintraub D, 2005, MOVEMENT DISORD, V20, P1161, DOI 10.1002/mds.20555	22	21	21	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2010	340								b5614	10.1136/bmj.b5614	http://dx.doi.org/10.1136/bmj.b5614			12	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545CZ	20068048				2022-12-01	WOS:000273711400007
J	Jha, AK; Orav, EJ; Epstein, AM				Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.			Public Reporting of Discharge Planning and Rates of Readmissions	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							CONGESTIVE-HEART-FAILURE; QUALITY-OF-CARE; MEDICARE BENEFICIARIES; RANDOMIZED-TRIALS; MORTALITY-RATES; UNITED-STATES; PERFORMANCE; SYSTEM	BACKGROUND A reduction in hospital readmissions may improve quality and reduce costs. The Centers for Medicare and Medicaid Services has initiated a national effort to measure and publicly report on the conduct of discharge planning. We know little about how U. S. hospitals perform on the current discharge metrics, the factors that underlie better performance, and whether better performance is related to lower readmission rates. METHODS We examined hospital performance on the basis of two measures of discharge planning: the adequacy of documentation in the chart that discharge instructions were provided to patients with congestive heart failure, and patient-reported experiences with discharge planning. We examined the association between performance on these measures and rates of readmission for congestive heart failure and pneumonia. RESULTS We found a weak correlation in performance between the two discharge measures (r = 0.05, P<0.001). Although larger hospitals performed better on the chart-based measure, smaller hospitals and those with higher nurse-staffing levels performed better on the patient-reported measure. We found no association between performance on the chart-based measure and readmission rates among patients with congestive heart failure ( readmission rates among hospitals performing in the highest quartile vs. the lowest quartile, 23.7% vs. 23.5%; P = 0.54) and only a very modest association between performance on the patient-reported measure and readmission rates for congestive heart failure ( readmission rates among hospitals performing in the highest quartile vs. the lowest quartile, 22.4% vs. 24.7%; P<0.001) and pneumonia (17.5% vs. 19.5%, P<0.001). CONCLUSIONS Our findings suggest that current efforts to collect and publicly report data on discharge planning are unlikely to yield large reductions in unnecessary readmissions.	[Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.] Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, Boston, MA 02115 USA; [Jha, Ashish K.; Orav, E. John; Epstein, Arnold M.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Jha, Ashish K.] Vet Affairs Boston Healthcare Syst, Boston, MA USA	Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Brigham & Women's Hospital; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System	Jha, AK (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Hlth Policy & Management, 677 Huntington Ave, Boston, MA 02115 USA.	ajha@hsph.harvard.edu			Commonwealth Fund	Commonwealth Fund	Supported by the Commonwealth Fund.	[Anonymous], 2007, MPA COMMITTEE REPORT; Bodenheimer T, 2008, NEW ENGL J MED, V358, P1064, DOI 10.1056/NEJMhpr0706165; Coleman EA, 2004, ANN INTERN MED, V141, P533, DOI 10.7326/0003-4819-141-7-200410050-00009; Elixhauser A, 1998, MED CARE, V36, P8, DOI 10.1097/00005650-199801000-00004; Epstein AM, 2009, NEW ENGL J MED, V360, P1457, DOI 10.1056/NEJMe0901006; FISHER ES, 1994, NEW ENGL J MED, V331, P989, DOI 10.1056/NEJM199410133311506; Fung CH, 2008, ANN INTERN MED, V148, P111, DOI 10.7326/0003-4819-148-2-200801150-00006; Jencks SF, 2009, NEW ENGL J MED, V360, P1418, DOI 10.1056/NEJMsa0803563; Jha AK, 2008, NEW ENGL J MED, V359, P1921, DOI 10.1056/NEJMsa0804116; Jha AK, 2007, HEALTH AFFAIR, V26, P1104, DOI 10.1377/hlthaff.26.4.1104; Krumholz HM, 2006, CIRCULATION, V113, P1693, DOI 10.1161/CIRCULATIONAHA.105.611194; McAlister FA, 2001, AM J MED, V110, P378, DOI 10.1016/S0002-9343(00)00743-9; McGlynn EA, 2003, NEW ENGL J MED, V348, P2635, DOI 10.1056/NEJMsa022615; Peikes D, 2009, JAMA-J AM MED ASSOC, V301, P603, DOI 10.1001/jama.2009.126; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; *QUALITYNET, 2009, SPEC MAN NAT HOSP IN; RICH MW, 1995, NEW ENGL J MED, V333, P1190, DOI 10.1056/NEJM199511023331806; Schoen C, 2006, HEALTH AFFAIR, V25, pW457, DOI 10.1377/hlthaff.25.w457; Wennberg J.E., 1998, DARTMOUTH ATLAS HLTH	19	185	186	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2637	2645		10.1056/NEJMsa0904859	http://dx.doi.org/10.1056/NEJMsa0904859			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042755	Bronze			2022-12-01	WOS:000273181300011
J	Klumpp, S; Zhang, ZG; Hwa, T				Klumpp, Stefan; Zhang, Zhongge; Hwa, Terence			Growth Rate-Dependent Global Effects on Gene Expression in Bacteria	CELL			English	Article							ESCHERICHIA-COLI K-12; MESSENGER-RNA; TRANSCRIPTIONAL REGULATION; TOGGLE SWITCH; LAC OPERON; REPLICATION; DNA; PERSISTER; TOLERANCE; PROMOTER	Bacterial gene expression depends not only on specific regulatory mechanisms, but also on bacterial growth, because important global parameters such as the abundance of RNA polymerases and ribosomes are all growth-rate dependent. Understanding of these global effects is necessary for a quantitative understanding of gene regulation and for the design of synthetic genetic circuits. We find that the observed growth-rate dependence of constitutive gene expression can be explained by a simple model using the measured growth-rate dependence of the relevant cellular parameters. More complex growth dependencies for genetic circuits involving activators, repressors, and feedback control were analyzed and verified experimentally with synthetic circuits. Additional results suggest a feedback mechanism mediated by general growth-dependent effects that does not require explicit gene regulation if the expressed protein affects cell growth. This mechanism can lead to growth bistability and promote the acquisition of important physiological functions such as antibiotic resistance and tolerance (persistence).	[Klumpp, Stefan; Hwa, Terence] Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA; [Klumpp, Stefan; Hwa, Terence] Univ Calif San Diego, Dept Phys, La Jolla, CA 92093 USA; [Zhang, Zhongge; Hwa, Terence] Univ Calif San Diego, Div Biol Sci, La Jolla, CA 92093 USA; [Klumpp, Stefan] Max Planck Inst Colloids & Interfaces, D-14424 Potsdam, Germany	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Max Planck Society	Klumpp, S (corresponding author), Univ Calif San Diego, Ctr Theoret Biol Phys, La Jolla, CA 92093 USA.	klumpp@ctbp.ucsd.edu; hwa@ucsd.edu	Hwa, Terence/J-4012-2013; Klumpp, Stefan/C-2966-2008; Klumpp, Stefan/AAC-3936-2019; Hwa, Terry/GOJ-9904-2022	Hwa, Terence/0000-0003-1837-6842; Klumpp, Stefan/0000-0003-0584-2146; Klumpp, Stefan/0000-0003-0584-2146; 	National Science Foundation through the Center for Theoretical Biological Physics [PHY-0822283]; National Institutes of Health [RO1GM77298]; Deutsche Forschungsgemeinschaft [KL818/1-1, 1-2];  [MCB0746581]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077298] Funding Source: NIH RePORTER	National Science Foundation through the Center for Theoretical Biological Physics; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); ; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to Hans Bremer, Patrick Dennis, Mans Ehrenberg, Peter Geiduschek, Richard Gourse, Carl Gunderson, Po-han Lee, Eduard Mateescu, Atul Narang, Moselio Schaechter, Matthew Scott, Arbel Tadmor, and Lingchong You for discussions during the course of this work. This work was supported by the National Science Foundation through the Center for Theoretical Biological Physics (grant PHY-0822283) and through grant MCB0746581, by the National Institutes of Health through grant RO1GM77298, and by a fellowship from Deutsche Forschungsgemeinschaft (grants KL818/1-1 and 1-2, to S.K.).	Andrianantoandro E, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100073; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Bintu L, 2005, CURR OPIN GENET DEV, V15, P116, DOI 10.1016/j.gde.2005.02.007; Bremer H, 1996, ESCHERICHIA COLI SAL, P1553; Cayley S, 2004, J MOL RECOGNIT, V17, P488, DOI 10.1002/jmr.695; CHIARAMELLO AE, 1989, J BACTERIOL, V171, P4272, DOI 10.1128/JB.171.8.4272-4280.1989; COFFMAN RL, 1971, J MOL BIOL, V60, P1, DOI 10.1016/0022-2836(71)90442-6; COOPER S, 1968, J MOL BIOL, V31, P519, DOI 10.1016/0022-2836(68)90425-7; Donachie W. D., 1987, ESCHERICHIA COLI SAL, P1578; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; ENGBERG B, 1975, J BACTERIOL, V123, P179, DOI 10.1128/JB.123.1.179-186.1975; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Guido NJ, 2006, NATURE, V439, P856, DOI 10.1038/nature04473; HARVEY RJ, 1980, ANTIMICROB AGENTS CH, V18, P323, DOI 10.1128/AAC.18.2.323; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Haugen SP, 2008, NAT REV MICROBIOL, V6, P507, DOI 10.1038/nrmicro1912; Husnain SI, 2008, J BACTERIOL, V190, P2450, DOI 10.1128/JB.01732-07; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Jain C, 2002, MOL MICROBIOL, V43, P1053, DOI 10.1046/j.1365-2958.2002.02808.x; Kaplan S, 2008, MOL CELL, V29, P786, DOI 10.1016/j.molcel.2008.01.021; Keener J, 1996, ESCHERICHIA COLI SAL, V2, P1417; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Klumpp S, 2008, P NATL ACAD SCI USA, V105, P20245, DOI 10.1073/pnas.0804953105; Korch SB, 2006, J BACTERIOL, V188, P3826, DOI 10.1128/JB.01740-05; Kuhlman T, 2007, P NATL ACAD SCI USA, V104, P6043, DOI 10.1073/pnas.0606717104; Liang ST, 1999, J MOL BIOL, V288, P521, DOI 10.1006/jmbi.1999.2710; Liang ST, 1999, J MOL BIOL, V292, P19, DOI 10.1006/jmbi.1999.3056; Liang ST, 2000, J BACTERIOL, V182, P3037, DOI 10.1128/JB.182.11.3037-3044.2000; LINCHAO S, 1986, MOL GEN GENET, V203, P143, DOI 10.1007/BF00330395; Lou CB, 2008, J THEOR BIOL, V255, P205, DOI 10.1016/j.jtbi.2008.07.035; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Maaloe O., 1979, BIOL REGUL DEV, V1, P487; Miller JH., 1972, EXPT MOL GENETICS; Nanninga N, 1985, MOL CYTOLOGY ESCHERI, P259; Narang A, 2008, B MATH BIOL, V70, P1032, DOI 10.1007/s11538-007-9289-7; Neidhardt F.C., 1990, PHYSL BACTERIAL CELL; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; NILSSON G, 1984, NATURE, V312, P75, DOI 10.1038/312075a0; PATO ML, 1970, COLD SPRING HARB SYM, V35, P497, DOI 10.1101/SQB.1970.035.01.065; PEDERSEN S, 1978, CELL, V14, P179, DOI 10.1016/0092-8674(78)90312-4; PerezMartin J, 1996, J MOL BIOL, V258, P575, DOI 10.1006/jmbi.1996.0270; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; SAVAGEAU MA, 1974, NATURE, V252, P546, DOI 10.1038/252546a0; SCHAECHTER M, 1958, J GEN MICROBIOL, V19, P592, DOI 10.1099/00221287-19-3-592; Shen-Orr SS, 2002, NAT GENET, V31, P64, DOI 10.1038/ng881; SOMPAYRAC L, 1973, NATURE-NEW BIOL, V241, P133, DOI 10.1038/newbio241133a0; Thieffry D, 1998, BIOESSAYS, V20, P433, DOI 10.1002/(SICI)1521-1878(199805)20:5<433::AID-BIES10>3.0.CO;2-2; Walsh C, 2000, NATURE, V406, P775, DOI 10.1038/35021219; WANNER BL, 1977, J BACTERIOL, V130, P212, DOI 10.1128/JB.130.1.212-222.1977; WILLUMSEN BM, 1975, THESIS U COPENHAGEN	54	397	402	6	89	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1366	1375		10.1016/j.cell.2009.12.001	http://dx.doi.org/10.1016/j.cell.2009.12.001			10	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064380	Bronze, Green Accepted			2022-12-01	WOS:000273048700023
J	Smith-Spangler, CM; Juusola, JL; Enns, EA; Owens, DK; Garber, AM				Smith-Spangler, Crystal M.; Juusola, Jessie L.; Enns, Eva A.; Owens, Douglas K.; Garber, Alan M.			Population Strategies to Decrease Sodium Intake and the Burden of Cardiovascular Disease A Cost-Effectiveness Analysis	ANNALS OF INTERNAL MEDICINE			English	Article							DIETARY-SODIUM; BLOOD-PRESSURE; MYOCARDIAL-INFARCTION; STOP HYPERTENSION; SALT; HEALTH; CONSUMPTION; REDUCTION; STROKE; RECOMMENDATIONS	Background: Sodium consumption raises blood pressure, increasing the risk for heart attack and stroke. Several countries, including the United States, are considering strategies to decrease population sodium intake. Objective: To assess the cost-effectiveness of 2 population strategies to reduce sodium intake: government collaboration with food manufacturers to voluntarily cut sodium in processed foods, modeled on the United Kingdom experience, and a sodium tax. Design: A Markov model was constructed with 4 health states: well, acute myocardial infarction (MI), acute stroke, and history of MI or stroke. Data Sources: Medical Panel Expenditure Survey (2006), Framingham Heart Study ( 1980 to 2003), Dietary Approaches to Stop Hypertension trial, and other published data. Target Population: U.S. adults aged 40 to 85 years. Time Horizon: Lifetime. Perspective: Societal. Outcome Measures: Incremental costs ( 2008 U. S. dollars), quality-adjusted life-years (QALYs), and MIs and strokes averted. Results of Base-Case Analysis: Collaboration with industry that decreases mean population sodium intake by 9.5% averts 513 885 strokes and 480 358 MIs over the lifetime of adults aged 40 to 85 years who are alive today compared with the status quo, increasing QALYs by 2.1 million and saving $32.1 billion in medical costs. A tax on sodium that decreases population sodium intake by 6% increases QALYs by 1.3 million and saves $22.4 billion over the same period. Results of Sensitivity Analysis: Results are sensitive to the assumption that consumers have no disutility with modest reductions in sodium intake. Limitation: Efforts to reduce population sodium intake could result in other dietary changes that are difficult to predict. Conclusion: Strategies to reduce sodium intake on a population level in the United States are likely to substantially reduce stroke and MI incidence, which would save billions of dollars in medical expenses.	[Smith-Spangler, Crystal M.] Stanford Univ, Ctr Hlth Policy, Stanford, CA 94305 USA; Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Smith-Spangler, CM (corresponding author), Stanford Univ, Ctr Hlth Policy, 117 Encina Commons, Stanford, CA 94305 USA.	smith-spangler@stanford.edu	Garber, Alan M/F-1476-2010	Juusola, Jessie/0000-0002-2885-2008	Department of Veterans Affairs; Stanford University; National Science Foundation	Department of Veterans Affairs(US Department of Veterans Affairs); Stanford University(Stanford University); National Science Foundation(National Science Foundation (NSF))	Primary Funding Source: Department of Veterans Affairs, Stanford University, and National Science Foundation.	*AG HEALTHC RES QU, 2006, HC105 AG HEALTHC RES; Angeletos GM, 2001, J ECON PERSPECT, V15, P47, DOI 10.1257/jep.15.3.47; [Anonymous], 2005, DIET GUID AM; Ayala C., 2009, Morbidity and Mortality Weekly Report, V58, P281; BEAUCHAMP GK, 1987, JAMA-J AM MED ASSOC, V258, P3275, DOI 10.1001/jama.258.22.3275; BERTINO M, 1982, AM J CLIN NUTR, V36, P1134, DOI 10.1093/ajcn/36.6.1134; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; Brown DL, 2006, NEUROLOGY, V67, P1390, DOI 10.1212/01.wnl.0000237024.16438.20; Brownell KD, 2009, NEW ENGL J MED, V360, P1805, DOI 10.1056/NEJMp0902392; Chaloupka FJ, 2002, ALCOHOL RES HEALTH, V26, P22; CUPPLES LA, 1993, AM HEART J, V125, P863, DOI 10.1016/0002-8703(93)90182-9; Dall TM, 2009, AM J HEALTH PROMOT, V23, P412, DOI 10.4278/ajhp.080930-QUAN-226; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Dasgupta PK, 2008, ENVIRON SCI TECHNOL, V42, P1315, DOI 10.1021/es0719071; *FOOD STAND AG, 2008, SALT LEV CONT FALL; Food Standards Agency, 2009, IMP ASS REV SALT RED; Girgis S, 2003, EUR J CLIN NUTR, V57, P616, DOI 10.1038/sj.ejcn.1601583; Havas S, 2004, AM J PUBLIC HEALTH, V94, P19, DOI 10.2105/AJPH.94.1.19; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD004937; Henderson L, 2003, NATL DIET NUTR SURVE, V3; Hopkins DP, 2001, AM J PREV MED, V20, P67, DOI 10.1016/S0749-3797(00)00298-1; *I MED, STRAT RED SOD INT; Kannel WB, 1998, CLIN THER, V20, pB2, DOI 10.1016/S0149-2918(98)80027-1; Karanja N, 2007, J AM DIET ASSOC, V107, P1530, DOI 10.1016/j.jada.2007.06.013; Karppanen H, 2006, PROG CARDIOVASC DIS, V49, P59, DOI 10.1016/j.pcad.2006.07.001; Kauf TL, 2006, AM HEART J, V151, P206, DOI 10.1016/j.ahj.2005.02.028; Lakdawalla D, 2005, AM ECON REV, V95, P253, DOI 10.1257/000282805774670266; Lenfant C, 2003, HYPERTENSION, V41, P1178, DOI 10.1161/01.HYP.0000075790.33892.AE; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; Mathias SD, 1997, STROKE, V28, P1888, DOI 10.1161/01.STR.28.10.1888; MATTES RD, 1991, J AM COLL NUTR, V10, P383; *MIN STAT DEP HLTH, 2008, DEP EXP LIM 2008 200; Mitchell M, 2009, J SENS STUD, V24, P133, DOI 10.1111/j.1745-459X.2008.00199.x; Mytton O, 2007, J EPIDEMIOL COMMUN H, V61, P689, DOI 10.1136/jech.2006.047746; *NAT CTR HLTH STAT, MORT DAT ALL AG NAT; *NAT CTR SOC RES H, 2008, ASS DIET SOD LEV AD; *NAT HEART LUNG BL, 2006, NHLBI INC PREV CHART; ORZECHOWKI W, 2006, TAX BURDEN TOBACCO; Pagoulatos E., 1986, INT J IND ORGAN, V4, P237; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; PIGGOTT N, 2003, AM J AGR ECON, V4, P237; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; THALER BI, 1982, NEW ZEAL MED J, V95, P839; TSEVAT J, 1993, MED DECIS MAKING, V13, P161, DOI 10.1177/0272989X9301300210; *US BUR CENS, 2007, NAT POP EST 200S MON; US Bureau of Labor Statistics, CONS PRIC IND; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wilson N, 2004, BRIT MED J, V329, P918, DOI 10.1136/bmj.329.7471.918-c; Witt BJ, 2005, ANN INTERN MED, V143, P785, DOI 10.7326/0003-4819-143-11-200512060-00006; World Bank, INT COMP PROGR; Wright Jacqueline D, 2003, Adv Data, P1; WROTH C, 2009, POPULATION VITAL STA	53	183	191	2	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	APR 20	2010	152	8					481	U21		10.7326/0003-4819-152-8-201004200-00212	http://dx.doi.org/10.7326/0003-4819-152-8-201004200-00212			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	588FV	20194225				2022-12-01	WOS:000277054400001
J	Li, C; Love, GD; Lyons, TW; Fike, DA; Sessions, AL; Chu, XL				Li, Chao; Love, Gordon D.; Lyons, Timothy W.; Fike, David A.; Sessions, Alex L.; Chu, Xuelei			A Stratified Redox Model for the Ediacaran Ocean	SCIENCE			English	Article							SOUTH CHINA; DOUSHANTUO FORMATION; YANGTZE PLATFORM; SULFATE; OXYGENATION; EVOLUTION; OXIDATION; ANIMALS; EMBRYOS; ROCKS	The Ediacaran Period (635 to 542 million years ago) was a time of fundamental environmental and evolutionary change, culminating in the first appearance of macroscopic animals. Here, we present a detailed spatial and temporal record of Ediacaran ocean chemistry for the Doushantuo Formation in the Nanhua Basin, South China. We find evidence for a metastable zone of euxinic (anoxic and sulfidic) waters impinging on the continental shelf and sandwiched within ferruginous [Fe(II)-enriched] deep waters. A stratified ocean with coeval oxic, sulfidic, and ferruginous zones, favored by overall low oceanic sulfate concentrations, was maintained dynamically throughout the Ediacaran Period. Our model reconciles seemingly conflicting geochemical redox conditions proposed previously for Ediacaran deep oceans and helps to explain the patchy temporal record of early metazoan fossils.	[Li, Chao; Love, Gordon D.; Lyons, Timothy W.] Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA; [Fike, David A.] Washington Univ, Dept Earth & Planetary Sci, St Louis, MO 63130 USA; [Sessions, Alex L.] CALTECH, Dept Geol & Planetary Sci, Pasadena, CA 91125 USA; [Chu, Xuelei] Chinese Acad Sci, Inst Geol & Geophys, State Key Lab Lithospher Evolut, Beijing 100029, Peoples R China	University of California System; University of California Riverside; Washington University (WUSTL); California Institute of Technology; Chinese Academy of Sciences; Institute of Geology & Geophysics, CAS	Li, C (corresponding author), Univ Calif Riverside, Dept Earth Sci, Riverside, CA 92521 USA.	chaoli@ucr.edu	Fike, David A/D-3634-2011; Sessions, Alex/ABC-9207-2020; Sessions, Alex L/C-2752-2008; Chu, Xuelei/AAE-6623-2022	Fike, David A/0000-0003-2848-0328; Sessions, Alex/0000-0001-6120-2763; Sessions, Alex L/0000-0001-6120-2763; Chu, Xuelei/0000-0002-2155-7081; Li, Chao/0000-0001-9861-661X	NSF of China [EAR-0720362, EAR-0719493, 40532012]; Chinese Academy of Sciences [KZCX3-SW-141]; NASA Astrobiology Institute; Agouron Institute	NSF of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); NASA Astrobiology Institute; Agouron Institute(Pfizer)	We are extremely grateful to R. Raiswell, S. Bates, W. Gilhooly, B. Gill, J. Owens, A. Khong, P. Marenco, N. Planavsky, C. Reinhard, M. Rohrssen, C. Scott, S. Severmann, J. Huang, L. Feng, H. Chang, and Q. Zhang for laboratory and field assistance and helpful discussions. The NSF Earth Sciences program (grant EAR-0720362 to G. D. L. and T. W. L. and grant EAR-0719493 to A. L. S.), National Science Foundation of China Fund (grant 40532012 to X. C.), the Chinese Academy of Sciences Fund (grant KZCX3-SW-141 to X. C.), the NASA Astrobiology Institute, and the Agouron Institute provided funding.	BERNER RA, 1984, GEOLOGY, V12, P365, DOI 10.1130/0091-7613(1984)12<365:CMFDFF>2.0.CO;2; Canfield DE, 2004, AM J SCI, V304, P839, DOI 10.2475/ajs.304.10.839; Canfield DE, 2007, SCIENCE, V315, P92, DOI 10.1126/science.1135013; Canfield DE, 2008, SCIENCE, V321, P949, DOI 10.1126/science.1154499; Cohen PA, 2009, P NATL ACAD SCI USA, V106, P6519, DOI 10.1073/pnas.0902322106; Condon D, 2005, SCIENCE, V308, P95, DOI 10.1126/science.1107765; Fike DA, 2006, NATURE, V444, P744, DOI 10.1038/nature05345; Gorjan P, 2000, PRECAMBRIAN RES, V100, P151, DOI 10.1016/S0301-9268(99)00073-X; Habicht KS, 2002, SCIENCE, V298, P2372, DOI 10.1126/science.1078265; Hurtgen MT, 2002, EARTH PLANET SC LETT, V203, P413, DOI 10.1016/S0012-821X(02)00804-X; Jiang GQ, 2007, EARTH PLANET SC LETT, V261, P303, DOI 10.1016/j.epsl.2007.07.009; Kirschvink J.L., 1992, PROTEROZOIC BIOSPHER, P51; Kump LR, 2005, EARTH PLANET SC LETT, V235, P654, DOI 10.1016/j.epsl.2005.04.040; LOGAN GA, 1995, NATURE, V376, P53, DOI 10.1038/376053a0; Love GD, 2009, NATURE, V457, P718, DOI 10.1038/nature07673; MARAIS DJD, 1992, NATURE, V359, P605, DOI 10.1038/359605a0; McFadden KA, 2008, P NATL ACAD SCI USA, V105, P3197, DOI 10.1073/pnas.0708336105; Poulton SW, 2004, NATURE, V431, P173, DOI 10.1038/nature02912; Raiswell R, 1998, AM J SCI, V298, P219, DOI 10.2475/ajs.298.3.219; Raiswell R, 2008, AM J SCI, V308, P105, DOI 10.2475/02.2008.01; Rothman DH, 2003, P NATL ACAD SCI USA, V100, P8124, DOI 10.1073/pnas.0832439100; Scott C, 2008, NATURE, V452, P456, DOI 10.1038/nature06811; Shen Y, 2003, NATURE, V423, P632, DOI 10.1038/nature01651; Shen YN, 2008, P NATL ACAD SCI USA, V105, P7376, DOI 10.1073/pnas.0802168105; Vernhet E, 2006, PRECAMBRIAN RES, V148, P32, DOI 10.1016/j.precamres.2006.03.009; Wang J, 2003, PRECAMBRIAN RES, V122, P141, DOI 10.1016/S0301-9268(02)00209-7; Xiao SH, 1998, NATURE, V391, P553, DOI 10.1038/35318; Yin LM, 2007, NATURE, V446, P661, DOI 10.1038/nature05682; Zhu MY, 2007, PALAEOGEOGR PALAEOCL, V254, P7, DOI 10.1016/j.palaeo.2007.03.025	29	428	496	18	226	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 2	2010	328	5974					80	83		10.1126/science.1182369	http://dx.doi.org/10.1126/science.1182369			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20150442				2022-12-01	WOS:000276202200038
J	Moisander, PH; Beinart, RA; Hewson, I; White, AE; Johnson, KS; Carlson, CA; Montoya, JP; Zehr, JP				Moisander, Pia H.; Beinart, Roxanne A.; Hewson, Ian; White, Angelicque E.; Johnson, Kenneth S.; Carlson, Craig A.; Montoya, Joseph P.; Zehr, Jonathan P.			Unicellular Cyanobacterial Distributions Broaden the Oceanic N-2 Fixation Domain	SCIENCE			English	Article							NORTH PACIFIC-OCEAN; NITROGEN-FIXATION; ATLANTIC-OCEAN; DIAZOTROPHIC CYANOBACTERIA; N-2-FIXING CYANOBACTERIA; TRICHODESMIUM; PHYLOTYPES; PHOSPHORUS	Nitrogen (N-2)-fixing microorganisms (diazotrophs) are an important source of biologically available fixed N in terrestrial and aquatic ecosystems and control the productivity of oligotrophic ocean ecosystems. We found that two major groups of unicellular N-2-fixing cyanobacteria (UCYN) have distinct spatial distributions that differ from those of Trichodesmium, the N-2-fixing cyanobacterium previously considered to be the most important contributor to open-ocean N-2 fixation. The distributions and activity of the two UCYN groups were separated as a function of depth, temperature, and water column density structure along an 8000-kilometer transect in the South Pacific Ocean. UCYN group A can be found at high abundances at substantially higher latitudes and deeper in subsurface ocean waters than Trichodesmium. These findings have implications for the geographic extent and magnitude of basin-scale oceanic N-2 fixation rates.	[Moisander, Pia H.; Beinart, Roxanne A.; Hewson, Ian; Zehr, Jonathan P.] Univ Calif Santa Cruz, Dept Ocean Sci, Santa Cruz, CA 95064 USA; [White, Angelicque E.] Oregon State Univ, Coll Ocean & Atmospher Sci, Corvallis, OR 97331 USA; [Johnson, Kenneth S.] Monterey Bay Aquarium Res Inst, Moss Landing, CA 95039 USA; [Carlson, Craig A.] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Montoya, Joseph P.] Georgia Inst Technol, Sch Biol, Atlanta, GA 30332 USA	University of California System; University of California Santa Cruz; Oregon State University; Monterey Bay Aquarium Research Institute; University of California System; University of California Santa Barbara; University System of Georgia; Georgia Institute of Technology	Moisander, PH (corresponding author), Univ Calif Santa Cruz, Dept Ocean Sci, 1156 High St, Santa Cruz, CA 95064 USA.	pmoisand@ucsc.edu	Montoya, Joseph/C-3115-2013; Johnson, Kenneth S/F-9742-2011; Zehr, Jonathan P/B-3513-2014; Hewson, Ian/B-4871-2013	Montoya, Joseph/0000-0001-7197-4660; Johnson, Kenneth S/0000-0001-5513-5584; Zehr, Jonathan P/0000-0002-5691-5408; Moisander, Pia/0000-0002-3262-3662; White, angelicque/0000-0002-0938-7948	NSF-Division of Ocean Sciences (OCE) [0425363, 0425583, 0623596]; NSF (Center for Microbial Oceanography: Research and Education) [0424599]	NSF-Division of Ocean Sciences (OCE)(National Science Foundation (NSF)); NSF (Center for Microbial Oceanography: Research and Education)(National Science Foundation (NSF))	We thank R. Paerl, C. Sakamoto, T. Cote, N. Pereira, M. Furnas, B. Carter, M. Ochiai, K. London, E. Preston, M. Hogan, and personnel onboard R/V Kilo Moana for technical assistance and C. Edwards for helpful discussions. This study was supported by NSF-Division of Ocean Sciences (OCE) (grant 0425363), NSF Emerging Frontiers Program (Center for Microbial Oceanography: Research and Education) (grant 0424599), and the Gordon and Betty Moore Foundation for J.P.Z., and NSF-OCE (grant 0425583) for J.P.M. A. E. W. was supported by NSF-OCE (grant 0623596, R. Letelier, principal investigator).	Baird ME, 2008, DEEP-SEA RES PT I, V55, P1438, DOI 10.1016/j.dsr.2008.06.011; Capone DG, 1997, SCIENCE, V276, P1221, DOI 10.1126/science.276.5316.1221; Church MJ, 2008, LIMNOL OCEANOGR, V53, P63, DOI 10.4319/lo.2008.53.1.0063; Church MJ, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003418; Church MJ, 2005, AQUAT MICROB ECOL, V38, P3, DOI 10.3354/ame038003; Deutsch C, 2007, NATURE, V445, P163, DOI 10.1038/nature05392; Falkowski PG, 1997, NATURE, V387, P272, DOI 10.1038/387272a0; Galloway JN, 2004, BIOGEOCHEMISTRY, V70, P153, DOI 10.1007/s10533-004-0370-0; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Gruber N, 2008, NITROGEN IN THE MARINE ENVIRONMENT, 2ND EDITION, P1, DOI 10.1016/B978-0-12-372522-6.00001-3; Hansell DA, 2009, OCEANOGRAPHY, V22, P202, DOI 10.5670/oceanog.2009.109; Hood RR, 2004, J GEOPHYS RES-OCEANS, V109, DOI 10.1029/2002JC001753; Johnson ZI, 2006, SCIENCE, V311, P1737, DOI 10.1126/science.1118052; Karl D, 1997, NATURE, V388, P533, DOI 10.1038/41474; Langlois RJ, 2008, APPL ENVIRON MICROB, V74, P1922, DOI 10.1128/AEM.01720-07; Montoya JP, 2004, NATURE, V430, P1027, DOI 10.1038/nature02824; Needoba JA, 2007, LIMNOL OCEANOGR, V52, P1317, DOI 10.4319/lo.2007.52.4.1317; Rees AP, 2009, MAR ECOL PROG SER, V374, P7, DOI 10.3354/meps07771; Sanudo-Wilhelmy SA, 2001, NATURE, V411, P66, DOI 10.1038/35075041; Short SM, 2007, ENVIRON MICROBIOL, V9, P1591, DOI 10.1111/j.1462-2920.2007.01258.x; Tripp HJ, 2010, NATURE, V464, P90, DOI 10.1038/nature08786; Tyrrell T, 1999, NATURE, V400, P525, DOI 10.1038/22941; Webb EA, 2009, ENVIRON MICROBIOL, V11, P338, DOI 10.1111/j.1462-2920.2008.01771.x; White AE, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2007JC004129; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	27	315	327	1	95	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 19	2010	327	5972					1512	1514		10.1126/science.1185468	http://dx.doi.org/10.1126/science.1185468			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20185682				2022-12-01	WOS:000275715200049
J	Levesque, LE; Hanley, JA; Kezouh, A; Suissa, S				Levesque, Linda E.; Hanley, James A.; Kezouh, Abbas; Suissa, Samy			Problem of immortal time bias in cohort studies: example using statins for preventing progression of diabetes	BRITISH MEDICAL JOURNAL			English	Article							OBSTRUCTIVE PULMONARY-DISEASE; MYOCARDIAL-INFARCTION; ELDERLY PATIENTS; INHALED CORTICOSTEROIDS; RISK; MORTALITY; INHIBITORS; ADHERENCE; SURVIVAL; USERS		[Levesque, Linda E.; Hanley, James A.; Suissa, Samy] McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada; [Levesque, Linda E.] Queens Univ, Dept Community Hlth & Epidemiol, Kingston, ON, Canada; [Levesque, Linda E.] Kingston Frontenac Lennox & Addington Publ Hlth, Kingston, ON, Canada; [Hanley, James A.; Kezouh, Abbas; Suissa, Samy] McGill Univ, Jewish Gen Hosp, Ctr Clin Epidemiol, Montreal, PQ H3T 1E2, Canada	McGill University; Queens University - Canada; McGill University	Levesque, LE (corresponding author), McGill Univ, Dept Epidemiol Biostat & Occupat Hlth, Montreal, PQ, Canada.	linda.levesque@queensu.ca	brophy, james/H-6673-2019	brophy, james/0000-0001-8049-6875	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Breslow NL, 1987, STAT METHODS CANC RE, VII, P178; COX DR, 1972, J R STAT SOC B, V187, P220; Downey W, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P295; Ellis JJ, 2004, J GEN INTERN MED, V19, P638, DOI 10.1111/j.1525-1497.2004.30516.x; GUYATT GH, 1995, JAMA-J AM MED ASSOC, V274, P1800, DOI 10.1001/jama.274.22.1800; Hippisley-Cox J, 2005, BMJ-BRIT MED J, V330, P1366, DOI 10.1136/bmj.330.7504.1366; Jackevicius CA, 2002, JAMA-J AM MED ASSOC, V288, P462, DOI 10.1001/jama.288.4.462; Jackevicius CA, 2008, CIRCULATION, V117, P1028, DOI 10.1161/CIRCULATIONAHA.107.706820; KLEINBAUM DG, 1998, APPL REGRESSION ANAL, P687; Levesque LE, 2005, ANN INTERN MED, V142, P481, DOI 10.7326/0003-4819-142-7-200504050-00113; Levesque LE, 2006, CAN MED ASSOC J, V174, P1563, DOI 10.1503/cmaj.051679; LIDDELL FDK, 1977, J R STAT SOC A STAT, V140, P469, DOI 10.2307/2345280; Nichol KL, 2007, NEW ENGL J MED, V357, P1373, DOI 10.1056/NEJMoa070844; Rothman K., 1998, MODERN EPIDEMIOLOGY, P79; Schade R, 2007, NEW ENGL J MED, V356, P29, DOI 10.1056/NEJMoa062222; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; Sheehy O, 2008, CAN MED ASSOC J, V178, P413, DOI 10.1503/cmaj.070586; Sin DD, 2002, AM J MED, V113, P650, DOI 10.1016/S0002-9343(02)01346-3; Sin DD, 2001, AM J RESP CRIT CARE, V164, P580, DOI 10.1164/ajrccm.164.4.2009033; Soriano JB, 2002, EUR RESPIR J, V20, P819, DOI 10.1183/09031936.02.00301302; Strom BL, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P17; Suissa S, 2004, EUR RESPIR J, V23, P391, DOI 10.1183/09031936.04.00062504; Suissa S, 2003, AM J RESP CRIT CARE, V168, P49, DOI 10.1164/rccm.200210-1231OC; Suissa S, 2008, AM J EPIDEMIOL, V167, P492, DOI 10.1093/aje/kwm324; Suissa S, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P811; Suissa S, 2007, PHARMACOEPIDEM DR S, V16, P241, DOI 10.1002/pds.1357; Trojano M, 2007, ANN NEUROL, V61, P300, DOI 10.1002/ana.21102; VONKORFF M, 1992, J CLIN EPIDEMIOL, V45, P197, DOI 10.1016/0895-4356(92)90016-G; Yee A, 2004, DIABETIC MED, V21, P962, DOI 10.1111/j.1464-5491.2004.01263.x; Zhou Z, 2005, AM J EPIDEMIOL, V162, P1016, DOI 10.1093/aje/kwi307; 2004, DIABETES CARE S1, V27, pS15	31	572	572	2	32	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2010	340								b5087	10.1136/bmj.b5087	http://dx.doi.org/10.1136/bmj.b5087			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FF	20228141				2022-12-01	WOS:000275657000001
J	Rowland, LP				Rowland, Lewis P.			Ameliorating Amyotrophic Lateral Sclerosis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							MICRORNAS; TARGETS		Columbia Univ, Med Ctr, Neurol Inst, New York, NY 10027 USA	Columbia University	Rowland, LP (corresponding author), Columbia Univ, Med Ctr, Neurol Inst, New York, NY 10027 USA.							Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Ferrer I, 2008, CELL TISSUE BANK, V9, P181, DOI 10.1007/s10561-008-9077-0; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Rothstein JD, 2009, ANN NEUROL, V65, pS3, DOI 10.1002/ana.21543; Van Rooij E, 2007, J CLIN INVEST, V117, P2369, DOI 10.1172/JCI33099; Williams AH, 2009, SCIENCE, V326, P1549, DOI 10.1126/science.1181046	6	4	4	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					953	954		10.1056/NEJMcibr0912229	http://dx.doi.org/10.1056/NEJMcibr0912229			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220193				2022-12-01	WOS:000275365900020
J	Goldberg, AD; Banaszynski, LA; Noh, KM; Lewis, PW; Elsaesser, SJ; Stadler, S; Dewell, S; Law, M; Guo, XY; Li, X; Wen, DC; Chapgier, A; DeKelver, RC; Miller, JC; Lee, YL; Boydston, EA; Holmes, MC; Gregory, PD; Greally, JM; Rafii, S; Yang, CW; Scambler, PJ; Garrick, D; Gibbons, RJ; Higgs, DR; Cristea, IM; Urnov, FD; Zheng, DY; Allis, CD				Goldberg, Aaron D.; Banaszynski, Laura A.; Noh, Kyung-Min; Lewis, Peter W.; Elsaesser, Simon J.; Stadler, Sonja; Dewell, Scott; Law, Martin; Guo, Xingyi; Li, Xuan; Wen, Duancheng; Chapgier, Ariane; DeKelver, Russell C.; Miller, Jeffrey C.; Lee, Ya-Li; Boydston, Elizabeth A.; Holmes, Michael C.; Gregory, Philip D.; Greally, John M.; Rafii, Shahin; Yang, Chingwen; Scambler, Peter J.; Garrick, David; Gibbons, Richard J.; Higgs, Douglas R.; Cristea, Ileana M.; Urnov, Fyodor D.; Zheng, Deyou; Allis, C. David			Distinct Factors Control Histone Variant H3.3 Localization at Specific Genomic Regions	CELL			English	Article							ZINC-FINGER NUCLEASES; EMBRYONIC STEM-CELLS; REPEAT-CONTAINING RNA; ATR-X SYNDROME; MAMMALIAN TELOMERES; SYNDROME PROTEIN; GENE-EXPRESSION; POLYMERASE-II; DNA-SYNTHESIS; ES CELLS	The incorporation of histone H3 variants has been implicated in the epigenetic memory of cellular state. Using genome editing with zinc-finger nucleases to tag endogenous H3.3, we report genome-wide profiles of H3 variants in mammalian embryonic stem cells and neuronal precursor cells. Genome-wide patterns of H3.3 are dependent on amino acid sequence and change with cellular differentiation at developmentally regulated loci. The H3.3 chaperone Hira is required for H3.3 enrichment at active and repressed genes. Strikingly, Hira is not essential for localization of H3.3 at telomeres and many transcription factor binding sites. Immunoaffinity purification and mass spectrometry reveal that the proteins Atrx and Daxx associate with H3.3 in a Hira-independent manner. Atrx is required for Hira-independent localization of H3.3 at telomeres and for the repression of telomeric RNA. Our data demonstrate that multiple and distinct factors are responsible for H3.3 localization at specific genomic locations in mammalian cells.	[Guo, Xingyi; Zheng, Deyou] Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Greally, John M.] Albert Einstein Coll Med, Dept Med, Bronx, NY 10461 USA; [Greally, John M.; Zheng, Deyou] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10461 USA; [Zheng, Deyou] Albert Einstein Coll Med, Dept Neurosci, Bronx, NY 10461 USA; [Goldberg, Aaron D.; Banaszynski, Laura A.; Noh, Kyung-Min; Lewis, Peter W.; Elsaesser, Simon J.; Stadler, Sonja; Allis, C. David] Rockefeller Univ, Lab Chromatin Biol & Epigenet, New York, NY 10065 USA; [Dewell, Scott] Rockefeller Univ, Genom Resource Ctr, New York, NY 10065 USA; [Li, Xuan; Yang, Chingwen] Rockefeller Univ, Gene Targeting Resource Ctr, New York, NY 10065 USA; [Law, Martin; Garrick, David; Gibbons, Richard J.; Higgs, Douglas R.] John Radcliffe Hosp, Weatherall Inst Mol Med, MRC Mol Haematol Unit, Oxford OX3 9DS, England; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Howard Hughes Med Inst, New York, NY 10065 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Ansary Stem Cell Inst, New York, NY 10065 USA; [Wen, Duancheng; Rafii, Shahin] Weill Cornell Med Coll, Dept Med Genet, New York, NY 10065 USA; [Chapgier, Ariane; Scambler, Peter J.] Inst Child Hlth, Mol Med Unit, London WC1N 1EH, England; [DeKelver, Russell C.; Miller, Jeffrey C.; Lee, Ya-Li; Boydston, Elizabeth A.; Holmes, Michael C.; Gregory, Philip D.; Urnov, Fyodor D.] Sangamo BioSci, Point Richmond Tech Ctr, Richmond, CA 94804 USA; [Cristea, Ileana M.] Princeton Univ, Dept Mol Biol, Princeton, NJ 08544 USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Rockefeller University; Rockefeller University; Rockefeller University; University of Oxford; Cornell University; Howard Hughes Medical Institute; Cornell University; Cornell University; University of London; University College London; Sangamo Therapeutics, Inc.; Princeton University	Zheng, DY (corresponding author), Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA.	deyou.zheng@einstein.yu.edu; alliscd@rockefeller.edu	Lewis, Peter/C-4348-2008; Elsässer, Simon/B-8911-2014; Goldberg, Aaron/C-6565-2009; Garrick, David/F-1728-2017; Greally, John/AAF-9540-2019; GARRICK, David/O-5734-2019; Scambler, Peter/AAZ-6026-2020; Elsässer, Simon/AAM-3986-2020; Gibbons, Richard/E-6937-2011	Elsässer, Simon/0000-0001-8724-4849; Garrick, David/0000-0001-7422-7986; Greally, John/0000-0001-6069-7960; GARRICK, David/0000-0001-7422-7986; Scambler, Peter/0000-0002-1487-4628; Elsässer, Simon/0000-0001-8724-4849; Goldberg, Aaron/0000-0002-2892-2643; Gibbons, Richard/0000-0002-7680-9311; Noh, Kyung-Min/0000-0002-0708-787X; Gregory, Philip/0000-0001-9249-2468; Chapgier, Ariane/0000-0002-1734-0744; Costa, Elizabeth/0000-0001-8365-0436; Wen, Duancheng/0000-0002-3160-6289; Zheng, Deyou/0000-0003-4354-5337; Higgs, Douglas/0000-0003-3579-8705; Lewis, Peter/0000-0002-9816-7823	National Institutes of Health (NIH) [GM07739, RR00862, RR022220, DP1DA026192, GM53122, GM53512]; Damon Runyon Cancer Research Foundation; Rockefeller University; Starr Foundation; New York State Department of Health [C023046]; Howard Hughes Medical Institute; Biotechnology and Biological Sciences Research Council UK; British Heart Foundation; Albert Einstein College of Medicine of Yeshiva University; BBSRC [BB/E009603/1] Funding Source: UKRI; MRC [MC_U137961147] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E009603/1] Funding Source: researchfish; Medical Research Council [G1000801b, MC_U137961147, G1000801j] Funding Source: researchfish; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR000862, U54RR022220] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM053512, R01GM053512, T32GM007739] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [DP1DA026192] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Damon Runyon Cancer Research Foundation; Rockefeller University; Starr Foundation; New York State Department of Health; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Biotechnology and Biological Sciences Research Council UK(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); British Heart Foundation(British Heart Foundation); Albert Einstein College of Medicine of Yeshiva University; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank L. Baker, E.M. Duncan, G.G. Wang for critical reading of the manuscript, P. Wu, A. Sfeir, and T. de Lange for telomere reagents and helpful discussion, P.D. Adams for Hira antibodies, R. Jaenisch for F1 hybrid male 129SVJae x M. m. castaneus ESCs, G. Almouzni for H3.1 and H3.3-FLAG-HA HeLa cells, K. Zhao for sharing his native ChIP-seq protocol, E. Moehle for drawing the gene editing schemes, N. Jina of the University College London Genomics Core, K.R. Molloy for assistance with mass spectrometric analysis, and S. Mazel and A. North of the Rockefeller University Flow Cytometry and Bio-Imaging Resource Centers. A. D. G. is supported by National Institutes of Health (NIH) Medical Scientist Training Program grant GM07739. L. A. B. is a Damon Runyon Cancer Research Foundation fellow. This work was funded by institutional support from The Rockefeller University and grants from the Tri-Institutional Stem Cell Initiative (funded by the Starr Foundation), Empire State Stem Cell fund through New York State Department of Health contract #C023046, the Howard Hughes Medical Institute (S.R.), Biotechnology and Biological Sciences Research Council UK and the British Heart Foundation (P.J.S.), startup funds from the Albert Einstein College of Medicine of Yeshiva University (D.Z.), and NIH grants RR00862, RR022220, DP1DA026192 (I.M.C.), GM53122, and GM53512 (C.D.A.). J.C.M., M.C.H., Y.L.L., P.D.G., and F.D.U. are full-time employees of Sangamo BioSciences, Inc.	Ahmad K, 2002, MOL CELL, V9, P1191, DOI 10.1016/S1097-2765(02)00542-7; Azzalin CM, 2007, SCIENCE, V318, P798, DOI 10.1126/science.1147182; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; Bonnefoy E, 2007, PLOS GENET, V3, P1991, DOI 10.1371/journal.pgen.0030182; Burdon T, 2002, TRENDS CELL BIOL, V12, P432, DOI 10.1016/S0962-8924(02)02352-8; Carroll D, 2008, GENE THER, V15, P1463, DOI 10.1038/gt.2008.145; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Conti L, 2005, PLOS BIOL, V3, P1594, DOI 10.1371/journal.pbio.0030283; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Cristea IM, 2005, MOL CELL PROTEOMICS, V4, P1933, DOI 10.1074/mcp.M500227-MCP200; Daury L, 2006, EMBO REP, V7, P66, DOI 10.1038/sj.embor.7400561; De Koning L, 2007, NAT STRUCT MOL BIOL, V14, P997, DOI 10.1038/nsmb1318; Doyon Y, 2008, NAT BIOTECHNOL, V26, P702, DOI 10.1038/nbt1409; Garrick D, 2006, PLOS GENET, V2, P438, DOI 10.1371/journal.pgen.0020058; Gaspar-Maia A, 2009, NATURE, V460, P863, DOI 10.1038/nature08212; Gibbons RJ, 2008, HUM MUTAT, V29, P796, DOI 10.1002/humu.20734; Goldberg AD, 2007, CELL, V128, P635, DOI 10.1016/j.cell.2007.02.006; Guenther MG, 2007, CELL, V130, P77, DOI 10.1016/j.cell.2007.05.042; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hake SB, 2006, P NATL ACAD SCI USA, V103, P6428, DOI 10.1073/pnas.0600803103; Hake SB, 2006, J BIOL CHEM, V281, P559, DOI 10.1074/jbc.M509266200; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Henikoff S, 2008, NAT REV GENET, V9, P15, DOI 10.1038/nrg2206; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Hodl M, 2009, CURR BIOL, V19, P1221, DOI 10.1016/j.cub.2009.05.048; Janicki SM, 2004, CELL, V116, P683, DOI 10.1016/S0092-8674(04)00171-0; Jin C, 2006, P NATL ACAD SCI USA, V103, P574, DOI 10.1073/pnas.0509974103; Jin CY, 2009, NAT GENET, V41, P941, DOI 10.1038/ng.409; Konev AY, 2007, SCIENCE, V317, P1087, DOI 10.1126/science.1145339; Lee TI, 2006, NAT PROTOC, V1, P729, DOI 10.1038/nprot.2006.98; Loppin B, 2005, NATURE, V437, P1386, DOI 10.1038/nature04059; Loyola A, 2007, TRENDS BIOCHEM SCI, V32, P425, DOI 10.1016/j.tibs.2007.08.004; Luke B, 2009, EMBO J, V28, P2503, DOI 10.1038/emboj.2009.166; Luo Y, 2010, J AM SOC MASS SPECTR, V21, P34, DOI 10.1016/j.jasms.2009.08.026; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; Meshorer E, 2006, DEV CELL, V10, P105, DOI 10.1016/j.devcel.2005.10.017; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Moehle EA, 2007, P NATL ACAD SCI USA, V104, P3055, DOI 10.1073/pnas.0611478104; Nakayama T, 2007, GENE DEV, V21, P552, DOI 10.1101/gad.1503407; Picketts DJ, 1996, HUM MOL GENET, V5, P1899, DOI 10.1093/hmg/5.12.1899; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ray-Gallet D, 2002, MOL CELL, V9, P1091, DOI 10.1016/S1097-2765(02)00526-9; Roberts C, 2002, MOL CELL BIOL, V22, P2318, DOI 10.1128/MCB.22.7.2318-2328.2002; Sakai A, 2009, CURR BIOL, V19, P1816, DOI 10.1016/j.cub.2009.09.021; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Schneiderman JI, 2009, P NATL ACAD SCI USA, V106, P14472, DOI 10.1073/pnas.0905816106; Schoeftner S, 2008, NAT CELL BIOL, V10, P228, DOI 10.1038/ncb1685; Schones DE, 2008, CELL, V132, P887, DOI 10.1016/j.cell.2008.02.022; Schwartz BE, 2005, GENE DEV, V19, P804, DOI 10.1101/gad.1259805; Sfeir A, 2009, CELL, V138, P90, DOI 10.1016/j.cell.2009.06.021; Siegel TN, 2009, GENE DEV, V23, P1063, DOI 10.1101/gad.1790409; SMITH S, 1989, CELL, V58, P15, DOI 10.1016/0092-8674(89)90398-X; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Sutcliffe EL, 2009, MOL CELL BIOL, V29, P1972, DOI 10.1128/MCB.01590-08; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Talbert PB, 2009, GENE DEV, V23, P1037, DOI 10.1101/gad.1806409; Tamura T, 2009, J BIOL CHEM, V284, P12217, DOI 10.1074/jbc.M805651200; Tang J, 2004, J BIOL CHEM, V279, P20369, DOI 10.1074/jbc.M401321200; Urnov FD, 2005, NATURE, V435, P646, DOI 10.1038/nature03556; Wang ZB, 2008, NAT GENET, V40, P897, DOI 10.1038/ng.154; Wong LH, 2009, GENOME RES, V19, P404, DOI 10.1101/gr.084947.108; Xue YT, 2003, P NATL ACAD SCI USA, V100, P10635, DOI 10.1073/pnas.1937626100	69	846	867	5	86	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					678	691		10.1016/j.cell.2010.01.003	http://dx.doi.org/10.1016/j.cell.2010.01.003			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211137	Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000275197400017
J	Regier, JC; Shultz, JW; Zwick, A; Hussey, A; Ball, B; Wetzer, R; Martin, JW; Cunningham, CW				Regier, Jerome C.; Shultz, Jeffrey W.; Zwick, Andreas; Hussey, April; Ball, Bernard; Wetzer, Regina; Martin, Joel W.; Cunningham, Clifford W.			Arthropod relationships revealed by phylogenomic analysis of nuclear protein-coding sequences	NATURE			English	Article							BAYESIAN-INFERENCE; COMPLETE 28S; MITOCHONDRIAL; GENE; HYPOTHESIS; CRUSTACEA; MYRIAPODS; ECDYSOZOA; EVOLUTION; HEXAPODA	The remarkable antiquity, diversity and ecological significance of arthropods have inspired numerous attempts to resolve their deep phylogenetic history, but the results of two decades of intensive molecular phylogenetics have been mixed(1-7). The discovery that terrestrial insects (Hexapoda) are more closely related to aquatic Crustacea than to the terrestrial centipedes and millipedes(2,8) (Myriapoda) was an early, if exceptional, success. More typically, analyses based on limited samples of taxa and genes have generated results that are inconsistent, weakly supported and highly sensitive to analytical conditions(7,9,10). Here we present strongly supported results from likelihood, Bayesian and parsimony analyses of over 41 kilobases of aligned DNA sequence from 62 single-copy nuclear protein-coding genes from 75 arthropod species. These species represent every major arthropod lineage, plus five species of tardigrades and onychophorans as outgroups. Our results strongly support Pancrustacea (Hexapoda plus Crustacea) but also strongly favour the traditional morphology-based Mandibulata(11) (Myriapoda plus Pancrustacea) over the molecule-based Paradoxopoda (Myriapoda plus Chelicerata)(2,5,12). In addition to Hexapoda, Pancrustacea includes three major extant lineages of 'crustaceans', each spanning a significant range of morphological disparity. These are Oligostraca (ostracods, mystacocarids, branchiurans and pentastomids), Vericrustacea (malacostracans, thecostracans, copepods and branchiopods) and Xenocarida (cephalocarids and remipedes). Finally, within Pancrustacea we identify Xenocarida as the long-sought sister group to the Hexapoda, a result confirming that 'crustaceans' are not monophyletic. These results provide a statistically well-supported phylogenetic framework for the largest animal phylum and represent a step towards ending the often-heated, century-long debate on arthropod relationships.	[Ball, Bernard; Cunningham, Clifford W.] Duke Univ, Dept Biol, Durham, NC 27708 USA; [Regier, Jerome C.; Shultz, Jeffrey W.; Zwick, Andreas; Hussey, April] Univ Maryland, Inst Biotechnol, Ctr Biosyst Res, College Pk, MD 20742 USA; [Shultz, Jeffrey W.] Univ Maryland, Dept Entomol, College Pk, MD 20742 USA; [Shultz, Jeffrey W.] Univ Maryland, Inst Biosci & Biotechnol Res, College Pk, MD 20742 USA; [Wetzer, Regina; Martin, Joel W.] Nat Hist Museum Los Angeles Cty, Los Angeles, CA 90007 USA	Duke University; University System of Maryland; University of Maryland Baltimore; University of Maryland College Park; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Cunningham, CW (corresponding author), Duke Univ, Dept Biol, Durham, NC 27708 USA.	cliff@duke.edu	Zwick, Andreas/A-5735-2015; Cunningham, Clifford/B-9807-2014	Zwick, Andreas/0000-0002-7532-1752; Ball, Bernard/0000-0002-9817-0993; Cunningham, Clifford/0000-0002-5434-5122	Maryland Agricultural Experiment Station; Whiteley Center; US National Science Foundation; Direct For Biological Sciences [1042845] Funding Source: National Science Foundation	Maryland Agricultural Experiment Station; Whiteley Center; US National Science Foundation(National Science Foundation (NSF)); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	C. W. C. thanks W. Hartman for early insight into questions of arthropod phylogeny and D. Percy for sequencing. J.W.M. and R. W. thank N. Tait, G. Hampson and R. Hessler for help collecting samples. J.C.R. and A.Z. thank M. Cummings and A. Bazinet for making available grid computing, and the DNA Sequencing Facility at the Center for Biosystems Research, University of Maryland Biotechnology Institute. J.W.S. was supported by the Maryland Agricultural Experiment Station. C. W. C. was supported by the Whiteley Center. This work was funded by two programmes at the US National Science Foundation, namely Biocomplexity in the Environment: Genome-Enabled Environmental Science and Engineering, and Assembling the Tree of Life.	ABELE LG, 1989, MOL BIOL EVOL, V6, P685; Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Bazinet A. L, 2009, DISTRIBUTED GRID COM; Boore JL, 1998, NATURE, V392, P667, DOI 10.1038/33577; Boxshall GA, 2007, ZOOTAXA, P313, DOI 10.11646/zootaxa.1668.1.16; Budd GE, 2009, NATURE, V457, P812, DOI 10.1038/nature07890; Carapelli A, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-S2-S8; Cummings M. P, 2005, EDUCAUSE REV, V40, P116; Dunn CW, 2008, NATURE, V452, P745, DOI 10.1038/nature06614; Fanenbruck M, 2004, P NATL ACAD SCI USA, V101, P3868, DOI 10.1073/pnas.0306212101; FRIEDRICH M, 1995, NATURE, V376, P165, DOI 10.1038/376165a0; Gai YH, 2006, ZOOL SCI, V23, P1101, DOI 10.2108/zsj.23.1101; Giribet G, 2001, NATURE, V413, P157, DOI 10.1038/35093097; Goldman N, 1996, J MOL BIOL, V263, P196, DOI 10.1006/jmbi.1996.0569; Harzsch S, 2006, INTEGR COMP BIOL, V46, P162, DOI 10.1093/icb/icj011; Hennig W., 1981, INSECT PHYLOGENY; Holder MT, 2008, PHILOS T R SOC B, V363, P4013, DOI 10.1098/rstb.2008.0162; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hwang UW, 2001, NATURE, V413, P154, DOI 10.1038/35093090; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; Mallatt JM, 2004, MOL PHYLOGENET EVOL, V31, P178, DOI 10.1016/j.ympev.2003.07.013; Mallatt J, 2006, MOL PHYLOGENET EVOL, V40, P772, DOI 10.1016/j.ympev.2006.04.021; Philippe H, 2009, CURR BIOL, V19, P706, DOI 10.1016/j.cub.2009.02.052; Phillips MJ, 2004, MOL BIOL EVOL, V21, P1455, DOI 10.1093/molbev/msh137; Podsiadlowski L, 2008, MOL BIOL EVOL, V25, P42, DOI 10.1093/molbev/msm223; Regier JC, 2005, BIOTECHNIQUES, V38, P34, DOI 10.2144/05381BM02; Regier JC, 1997, MOL BIOL EVOL, V14, P902, DOI 10.1093/oxfordjournals.molbev.a025833; Regier JC, 2001, MOL PHYLOGENET EVOL, V20, P136, DOI 10.1006/mpev.2001.0956; Regier JC, 2008, SYST BIOL, V57, P920, DOI 10.1080/10635150802570791; Remm M, 2001, J MOL BIOL, V314, P1041, DOI 10.1006/jmbi.2000.5197; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rota-Stabelli O, 2008, MOL PHYLOGENET EVOL, V48, P103, DOI 10.1016/j.ympev.2008.03.033; SCHRAM FR, 1983, CRUSTACEAN PHYLOGENY; Seo TK, 2009, SYST BIOL, V58, P199, DOI 10.1093/sysbio/syp015; Shultz JW, 2007, ZOOL J LINN SOC-LOND, V150, P221, DOI 10.1111/j.1096-3642.2007.00284.x; *SIN ASS, 2002, PAUP V 4 0; SMITH SW, 1994, COMPUT APPL BIOSCI, V10, P671; Snodgrass RE, 1938, EVOLUTION ANNELIDA O; Staden R, 2001, Methods Biochem Anal, V43, P303; Timmermans MJTN, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-83; *UPPS U EV BIOL CT, 2004, MRMODELTEST V 2; ZRZAVY J, 1997, ARTHROPOD RELATIONSH, P97; Zwickl D.J., 2006, GARLI GENETIC ALGORI	43	702	724	4	391	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1079	U98		10.1038/nature08742	http://dx.doi.org/10.1038/nature08742			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20147900				2022-12-01	WOS:000275108400036
J	Liu, XD; Yang, PS; Yang, WJ; Yue, DT				Liu, Xiaodong; Yang, Philemon S.; Yang, Wanjun; Yue, David T.			Enzyme-inhibitor-like tuning of Ca2+ channel connectivity with calmodulin	NATURE			English	Article							CA2+-DEPENDENT INACTIVATION; CALCIUM-CHANNELS; MECHANISMS; PROTEINS; MICE	Ca2+ channels and calmodulin (CaM) are two prominent signalling hubs(1) that synergistically affect functions as diverse as cardiac excitability(2), synaptic plasticity(3) and gene transcription(4). It is therefore fitting that these hubs are in some sense coordinated, as the opening of Ca(V)1-2 Ca2+ channels are regulated by a single CaM constitutively complexed with channels(5). The Ca2+-free form of CaM (apoCaM) is already pre-associated with the isoleucine-glutamine (IQ) domain on the channel carboxy terminus, and subsequent Ca2+ binding to this 'resident' CaM drives conformational changes that then trigger regulation of channel opening(6). Another potential avenue for channel-CaM coordination could arise from the absence of Ca2+ regulation in channels lacking a pre-associated CaM6,7. Natural fluctuations in CaM concentrations might then influence the fraction of regulable channels and, thereby, the overall strength of Ca2+ feedback. However, the prevailing view has been that the ultrastrong affinity of channels for apoCaM ensures their saturation with CaM8, yielding a significant form of concentration independence between Ca2+ channels and CaM. Here we show that significant exceptions to this autonomy exist, by combining electrophysiology (to characterize channel regulation) with optical fluorescence resonance energy transfer (FRET) sensor determination of free-apoCaM concentration in live cells(9). This approach translates quantitative CaM biochemistry from the traditional test-tube context into the realm of functioning holochannels within intact cells. From this perspective, we find that long splice forms of Ca(V)1.3 and Ca(V)1.4 channels include a distal carboxy tail(10-12) that resembles an enzyme competitive inhibitor that retunes channel affinity for apoCaM such that natural CaM variations affect the strength of Ca2+ feedback modulation. Given the ubiquity of these channels(13,14), the connection between ambient CaM levels and Ca2+ entry through channels is broadly significant for Ca2+ homeostasis. Strategies such as ours promise key advances for the in situ analysis of signalling molecules resistant to in vitro reconstitution, such as Ca2+ channels.	[Liu, Xiaodong; Yang, Philemon S.; Yang, Wanjun; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Baltimore, MD 21205 USA; [Liu, Xiaodong; Yang, Philemon S.; Yang, Wanjun; Yue, David T.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins University	Yue, DT (corresponding author), Johns Hopkins Univ, Sch Med, Dept Biomed Engn, Calcium Signals Lab, Ross Bldg,Room 713,720 Rutland Ave, Baltimore, MD 21205 USA.	dyue@jhmi.edu	Liu, Xiaodong/B-1839-2008; Liu, Xiaodong/N-3373-2019	Liu, Xiaodong/0000-0002-3171-9611; Liu, Xiaodong/0000-0002-3171-9611	US National Institute of Mental Health; US National Heart, Lung, and Blood Institute; US National Institute of Neurological Disorders and Stroke; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC000276, P30DC005211] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); US National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); US National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Tadross, I. Dick and members of the Calcium Signals Laboratory for comments; M. Tadross for data-acquisition software; D. J. Black and A. Persechini for BSCaM<INF>IQ</INF> and neuromodulin complementary DNA; J. McRory and T. Snutch for human alpha<INF>1F</INF> cDNA; J. Streissnig for human alpha<INF>1D</INF> cDNA; and V. Wu for earlier foundational experiments. This work is supported by grants from the US National Institute of Mental Health, the US National Heart, Lung, and Blood Institute and the US National Institute of Neurological Disorders and Stroke.	Alseikhan BA, 2002, P NATL ACAD SCI USA, V99, P17185, DOI 10.1073/pnas.262372999; Bezprozvanny I, 2009, TRENDS MOL MED, V15, P89, DOI 10.1016/j.molmed.2009.01.001; Black DJ, 2006, BIOCHEMISTRY-US, V45, P6987, DOI 10.1021/bi052533w; Black DJ, 2004, CELL CALCIUM, V35, P415, DOI 10.1016/j.ceca.2003.10.005; CANTOR CR, 1980, BIOPHYSICAL CHEM, P887; Chambers JS, 2005, PROG NEURO-PSYCHOPH, V29, P283, DOI 10.1016/j.pnpbp.2004.11.013; Chan CS, 2007, NATURE, V447, P1081, DOI 10.1038/nature05865; Dick IE, 2008, NATURE, V451, P830, DOI 10.1038/nature06529; Doering CJ, 2005, BIOPHYS J, V89, P3042, DOI 10.1529/biophysj.105.067124; Erickson MG, 2003, NEURON, V39, P97, DOI 10.1016/S0896-6273(03)00395-7; Griessmeier K, 2009, J BIOL CHEM, V284, P29809, DOI 10.1074/jbc.M109.048082; Ikeda S, 2009, MOL CELL BIOL, V29, P2193, DOI 10.1128/MCB.01222-08; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kim J, 2004, NEURON, V41, P745, DOI 10.1016/S0896-6273(04)00081-9; Krey JF, 2007, CURR OPIN NEUROBIOL, V17, P112, DOI 10.1016/j.conb.2007.01.010; Lee D, 2002, J NEUROCHEM, V82, P1007, DOI 10.1046/j.1471-4159.2002.01024.x; Liang HY, 2003, NEURON, V39, P951, DOI 10.1016/S0896-6273(03)00560-9; Masliah E, 2000, SCIENCE, V287, P1265, DOI 10.1126/science.287.5456.1265; Namkung Y, 2001, J CLIN INVEST, V108, P1015, DOI 10.1172/JCI200113310; Peterson BZ, 2000, BIOPHYS J, V78, P1906, DOI 10.1016/S0006-3495(00)76739-7; Platzer J, 2000, CELL, V102, P89, DOI 10.1016/S0092-8674(00)00013-1; Singh A, 2008, J BIOL CHEM, V283, P20733, DOI 10.1074/jbc.M802254200; Singh A, 2006, NAT NEUROSCI, V9, P1108, DOI 10.1038/nn1751; Slemmon JR, 2000, MOL NEUROBIOL, V22, P99, DOI 10.1385/MN:22:1-3:099; Strom TM, 1998, NAT GENET, V19, P260, DOI 10.1038/940; Wahl-Schott C, 2006, P NATL ACAD SCI USA, V103, P15657, DOI 10.1073/pnas.0604621103; Xiong LW, 2005, J BIOL CHEM, V280, P7070, DOI 10.1074/jbc.M410558200; Xu JH, 2005, NEURON, V46, P633, DOI 10.1016/j.neuron.2005.03.024; Yang PS, 2006, J NEUROSCI, V26, P10677, DOI 10.1523/JNEUROSCI.3236-06.2006; YANG PS, 2007, BIOPHYS J S	30	73	73	0	23	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					968	U149		10.1038/nature08766	http://dx.doi.org/10.1038/nature08766			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20139964	Green Accepted			2022-12-01	WOS:000274582700050
J	Veselka, N; McErlain, DD; Holdsworth, DW; Eger, JL; Chhem, RK; Mason, MJ; Brain, KL; Faure, PA; Fenton, MB				Veselka, Nina; McErlain, David D.; Holdsworth, David W.; Eger, Judith L.; Chhem, Rethy K.; Mason, Matthew J.; Brain, Kirsty L.; Faure, Paul A.; Fenton, M. Brock			A bony connection signals laryngeal echolocation in bats	NATURE			English	Article							COMPUTED-TOMOGRAPHY; MIDDLE-EAR; EVOLUTION; MAMMALS; APPARATUS; REGION; FLIGHT	Echolocation is an active form of orientation in which animals emit sounds and then listen to reflected echoes of those sounds to form images of their surroundings in their brains(1). Although echolocation is usually associated with bats, it is not characteristic of all bats(2,3). Most echolocating bats produce signals in the larynx, but within one family of mainly non-echolocating species (Pteropodidae), a few species use echolocation sounds produced by tongue clicks(4,5). Here we demonstrate, using data obtained from micro-computed tomography scans of 26 species (n = 35 fluid-preserved bats), that proximal articulation of the stylohyal bone (part of the mammalian hyoid apparatus) with the tympanic bone always distinguishes laryngeally echolocating bats from all other bats (that is, non-echolocating pteropodids and those that echo-locate with tongue clicks). In laryngeally echolocating bats, the proximal end of the stylohyal bone directly articulates with the tympanic bone and is often fused with it. Previous research on the morphology of the stylohyal bone in the oldest known fossil bat (Onychonycteris finneyi) suggested that it did not echolocate(6), but our findings suggest that O. finneyi may have used laryngeal echolocation because its stylohyal bones may have articulated with its tympanic bones. The present findings reopen basic questions about the timing and the origin of flight and echolocation in the early evolution of bats. Our data also provide an independent anatomical character by which to distinguish laryngeally echolocating bats from other bats.	[Veselka, Nina; Fenton, M. Brock] Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada; [McErlain, David D.; Holdsworth, David W.] Univ Western Ontario, Robarts Res Inst, Imaging Res Labs, London, ON N6A 5B7, Canada; [McErlain, David D.] Univ Western Ontario, Dept Med Biophys, London, ON N6A 5B7, Canada; [Holdsworth, David W.] Univ Western Ontario, Schulich Sch Med & Dent, Dept Surg, London, ON N6A 5K8, Canada; [Eger, Judith L.] Royal Ontario Museum, Dept Nat Hist, Toronto, ON M5S 2C6, Canada; [Chhem, Rethy K.] Med Univ Vienna, Div Human Hlth, Dept Radiol, A-1090 Vienna, Austria; [Chhem, Rethy K.] IAEA, Div Human Hlth, A-1400 Vienna, Austria; [Mason, Matthew J.; Brain, Kirsty L.] Univ Cambridge, Dept Physiol Dev & Neurosci, Cambridge CB2 3EG, England; [Faure, Paul A.] McMaster Univ, Dept Psychol Neurosci & Behav, Hamilton, ON L8S 4K1, Canada	Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Western University (University of Western Ontario); Royal Ontario Museum; Medical University of Vienna; International Atomic Energy Agency; University of Cambridge; McMaster University	Fenton, MB (corresponding author), Univ Western Ontario, Dept Biol, London, ON N6A 5B7, Canada.	bfenton@uwo.ca	Mason, Matthew James/AAX-9783-2021; Holdsworth, David W/F-6315-2012	Mason, Matthew James/0000-0001-7845-0720; Holdsworth, David W/0000-0002-0603-5322	Canadian Institutes of Health Research [CIHR MOP-89852]; Natural Sciences and Engineering Research Council of Canada; Canada Foundation for Innovation; Ontario Innovation Trust	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Canada Foundation for Innovation(Canada Foundation for InnovationCGIAR); Ontario Innovation Trust	We thank B. Clare, E. Fraser, B. Galef, L. Jakobsen, D. S. Johnston, L. Lazure, J. McNeil, S. Peters, J. Ratcliffe, D. Riskin, K. Seymour, J. A. Simmons, N. Simmons, J. Szewczak and H. The wissen for comments on earlier versions of the manuscript, and K. Seymour, who arranged access to the O. finneyi specimen. We are particularly grateful to S. I. Pollmann, who assisted in the preparation of the Supplementary Movies. Our research was supported by an Operating Grant from the Canadian Institutes of Health Research (CIHR MOP-89852), and by Discovery Grants from the Natural Sciences and Engineering Research Council of Canada. The McMaster Bat Lab is also supported by grants from the Canada Foundation for Innovation and the Ontario Innovation Trust.	Cranford TW, 1996, J MORPHOL, V228, P223; FELDKAMP LA, 1989, J BONE MINER RES, V4, P3, DOI 10.1002/jbmr.5650040103; FENTON MB, 1995, PALEOBIOLOGY, V21, P229, DOI 10.1017/S0094837300013221; GOULD E, 1988, J MAMMAL, V69, P378, DOI 10.2307/1381392; Griffin D.R., 1958, LISTENING DARK; HABERSETZER J, 1992, NATURWISSENSCHAFTEN, V79, P462, DOI 10.1007/BF01139198; HOFFMEISTER RG, 1991, AN I BIOL U NAC AU Z, V52, P219; Holderied MW, 2005, J EXP BIOL, V208, P1321, DOI 10.1242/jeb.01528; Holland RA, 2005, ACTA CHIROPTEROL, V7, P83, DOI 10.3161/1733-5329(2005)7[83:ESAPMI]2.0.CO;2; JEN PHS, 1976, SCIENCE, V191, P950, DOI 10.1126/science.1251206; Jones G, 2006, TRENDS ECOL EVOL, V21, P149, DOI 10.1016/j.tree.2006.01.001; Mason MJ, 2006, J MORPHOL, V267, P678, DOI 10.1002/jmor.10430; McErlain DD, 2008, OSTEOARTHR CARTILAGE, V16, P458, DOI 10.1016/j.joca.2007.08.006; Moss CF, 2001, J ACOUST SOC AM, V110, P2207, DOI 10.1121/1.1398051; Muller R, 2004, J ACOUST SOC AM, V116, P3701, DOI 10.1121/1.1815133; Nickel R., 1984, LEHRBUCH ANATOMIE HA; REIDENBERG JS, 1994, ANAT RECORD, V240, P598, DOI 10.1002/ar.1092400417; Schnitzler HU, 2001, BIOSCIENCE, V51, P557, DOI 10.1641/0006-3568(2001)051[0557:EBIEB]2.0.CO;2; Siemers BM, 2009, BIOL LETTERS, V5, P593, DOI 10.1098/rsbl.2009.0378; Simmons NB, 2008, NATURE, V451, P818, DOI 10.1038/nature06549; Simmons NB, 1998, B AM MUS NAT HIST, P1; SPEAKMAN JR, 1991, NATURE, V350, P421, DOI 10.1038/350421a0; SPRAGUE JAMES M., 1941, JOUR MAMMAL, V22, P296, DOI 10.2307/1374956; Sprague JM, 1943, AM J ANAT, V72, P385, DOI 10.1002/aja.1000720304; Springer MS, 2004, TRENDS ECOL EVOL, V19, P430, DOI 10.1016/j.tree.2004.05.006; SUTHERS RA, 1988, J COMP PHYSIOL A, V162, P799, DOI 10.1007/BF00610969; Teeling EC, 2009, TRENDS ECOL EVOL, V24, P351, DOI 10.1016/j.tree.2009.02.012; Thomas J.A., 2004, ECHOLOCATION BATS DO; van der Klaauw CJ, 1931, B AM MUS NAT HIST, V62, P1; Wible JR, 2008, ANN CARNEGIE MUS, V77, P321, DOI 10.2992/0097-4463-77.3.321	30	83	85	1	78	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					939	942		10.1038/nature08737	http://dx.doi.org/10.1038/nature08737			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20098413				2022-12-01	WOS:000274582700044
J	Vilhais-Neto, GC; Maruhashi, M; Smith, KT; Vasseur-Cognet, M; Peterson, AS; Workman, JL; Pourquie, O				Vilhais-Neto, Goncalo C.; Maruhashi, Mitsuji; Smith, Karen T.; Vasseur-Cognet, Mireille; Peterson, Andrew S.; Workman, Jerry L.; Pourquie, Olivier			Rere controls retinoic acid signalling and somite bilateral symmetry	NATURE			English	Article							LEFT-RIGHT AXIS; HISTONE DEACETYLASE; MOUSE GENE; EXPRESSION; FGF8; SOMITOGENESIS; MESODERM; NOTCH; CHICK	One of the most notable features of the vertebrate body plan organization is its bilateral symmetry, evident at the level of vertebrae and skeletal muscles. Here we show that a mutation in Rere (also known as atrophin2) leads to the formation of asymmetrical somites in mouse embryos, similar to embryos deprived of retinoic acid(1-4). Furthermore, we also demonstrate that Rere controls retinoic acid signalling, which is required to maintain somite symmetry by interacting with Fgf8 in the left-right signalling pathway. Rere forms a complex with Nr2f2, p300 (also known as Ep300) and a retinoic acid receptor, which is recruited to the retinoic acid regulatory element of retinoic acid targets, such as the Rarb promoter. Furthermore, the knockdown of Nr2f2 and/or Rere decreases retinoic acid signalling, suggesting that this complex is required to promote transcriptional activation of retinoic acid targets. The asymmetrical expression of Nr2f2 in the pre-somitic mesoderm overlaps with the asymmetry of the retinoic acid signalling response, supporting its implication in the control of somitic symmetry. Misregulation of this mechanism could be involved in symmetry defects of the human spine, such as those observed in patients with scoliosis.	[Vilhais-Neto, Goncalo C.; Maruhashi, Mitsuji; Smith, Karen T.; Workman, Jerry L.; Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Maruhashi, Mitsuji; Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Vasseur-Cognet, Mireille] Univ Paris 05, Inst Cochin, CNRS,UMR 8104, Dept Endocrinol Metab & Canc,Inserm,U567, Paris, France; [Peterson, Andrew S.] Genentech Inc, San Francisco, CA 94080 USA; [Pourquie, Olivier] Univ Kansas, Med Ctr, Kansas City, KS 66160 USA	Stowers Institute for Medical Research; Howard Hughes Medical Institute; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Cochin - APHP; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Roche Holding; Genentech; University of Kansas; University of Kansas Medical Center	Pourquie, O (corresponding author), Univ Strasbourg, INSERM, U964, Inst Genet & Biol Mol & Cellulaire,CNRS,UMR 7104, F-67400 Illkirch Graffenstaden, France.	pourquie@igbmc.fr	Vasseur, Mireille/L-6958-2017; Pourquié, Olivier/CAJ-5443-2022	Vasseur, Mireille/0000-0001-6963-4114; Pourquié, Olivier/0000-0001-5189-1227	Portuguese Fundacao para a Ciencia e Tecnologia (FCT); American Cancer Society; ALFEDIAM-GlaxoSmithKline; Bonus Qualite Recherche, Universite Paris Descartes; Howard Hughes Medical Institute; Stowers Institute for Medical Research; Muscular Dystrophy Association; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047867] Funding Source: NIH RePORTER	Portuguese Fundacao para a Ciencia e Tecnologia (FCT)(Portuguese Foundation for Science and Technology); American Cancer Society(American Cancer Society); ALFEDIAM-GlaxoSmithKline(GlaxoSmithKline); Bonus Qualite Recherche, Universite Paris Descartes; Howard Hughes Medical Institute(Howard Hughes Medical Institute); Stowers Institute for Medical Research; Muscular Dystrophy Association(Muscular Dystrophy Association); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Pourquie laboratory for discussions and comments on the manuscript, H. Li for help with the statistics, J. Chatfield for editorial assistance and S. Esteban for artwork. We are grateful to D. Henrique for critical reading of the manuscript. We thank J. Rossant, G. Martin and P. Dolle for providing mouse lines. We thank the Stowers Institute Core Facilities, especially D. Dukes and B. Lewis in the Laboratory Animal Service Facility. G.C.V.-N. was funded by the Portuguese Fundacao para a Ciencia e Tecnologia (FCT). K. T. S. is funded by the American Cancer Society. M. V.-C. was supported by l'Association de Langue Francaise pour l'Etude du Diabete et des Maladies Metaboliques (grant from ALFEDIAM-GlaxoSmithKline) and Bonus Qualite Recherche, Universite Paris Descartes. This research was supported by the Howard Hughes Medical Institute, the Stowers Institute for Medical Research and the Muscular Dystrophy Association.	Aulehla A, 2003, DEV CELL, V4, P395, DOI 10.1016/S1534-5807(03)00055-8; Aulehla A, 1999, DEV BIOL, V207, P49, DOI 10.1006/dbio.1998.9164; Bardoux P, 2005, DIABETES, V54, P1357, DOI 10.2337/diabetes.54.5.1357; Bessho Y, 2001, GENES CELLS, V6, P175, DOI 10.1046/j.1365-2443.2001.00409.x; Boettger T, 1999, CURR BIOL, V9, P277, DOI 10.1016/S0960-9822(99)80119-5; BRUECKNER M, 1989, P NATL ACAD SCI USA, V86, P5035, DOI 10.1073/pnas.86.13.5035; Dale JK, 2006, DEV CELL, V10, P355, DOI 10.1016/j.devcel.2006.02.011; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; Forsberg H, 1998, CURR BIOL, V8, P1027, DOI 10.1016/S0960-9822(07)00424-1; Gillespie RF, 2007, J MOL BIOL, V372, P298, DOI 10.1016/j.jmb.2007.06.079; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; Kawakami Y, 2005, NATURE, V435, P165, DOI 10.1038/nature03512; Lin BZ, 2000, MOL CELL BIOL, V20, P957, DOI 10.1128/MCB.20.3.957-970.2000; Meyers EN, 1999, SCIENCE, V285, P403, DOI 10.1126/science.285.5426.403; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; Plaster N, 2007, DEV DYNAM, V236, P1891, DOI 10.1002/dvdy.21196; ROSSANT J, 1991, GENE DEV, V5, P1333, DOI 10.1101/gad.5.8.1333; Saga Y, 1997, GENE DEV, V11, P1827, DOI 10.1101/gad.11.14.1827; Shen S, 1991, DNA Seq, V2, P111, DOI 10.3109/10425179109039679; Shen Y, 2009, CELL MOL LIFE SCI, V66, P437, DOI 10.1007/s00018-008-8403-9; Shen YG, 2007, J BIOL CHEM, V282, P5037, DOI 10.1074/jbc.M610274200; Shiratori H, 2006, DEVELOPMENT, V133, P2095, DOI 10.1242/dev.02384; Sirbu IO, 2006, NAT CELL BIOL, V8, P271, DOI 10.1038/ncb1374; Tsai SY, 1997, ENDOCR REV, V18, P229, DOI 10.1210/er.18.2.229; Vermot J, 2005, SCIENCE, V308, P563, DOI 10.1126/science.1108363; Vermot J, 2005, NATURE, V435, P215, DOI 10.1038/nature03488; Wang L, 2006, GENE DEV, V20, P525, DOI 10.1101/gad.1393506; Wang Lei, 2008, Nucl Recept Signal, V6, pe009, DOI 10.1621/nrs.06009; Zoltewicz JS, 2004, DEVELOPMENT, V131, P3, DOI 10.1242/dev.00908	30	82	83	3	17	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					953	957		10.1038/nature08763	http://dx.doi.org/10.1038/nature08763			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164929				2022-12-01	WOS:000274582700047
J	Boddey, JA; Hodder, AN; Gunther, S; Gilson, PR; Patsiouras, H; Kapp, EA; Pearce, JA; de Koning-Ward, TF; Simpson, RJ; Crabb, BS; Cowman, AF				Boddey, Justin A.; Hodder, Anthony N.; Guenther, Svenja; Gilson, Paul R.; Patsiouras, Heather; Kapp, Eugene A.; Pearce, J. Andrew; de Koning-Ward, Tania F.; Simpson, Richard J.; Crabb, Brendan S.; Cowman, Alan F.			An aspartyl protease directs malaria effector proteins to the host cell	NATURE			English	Article							FALCIPARUM-INFECTED ERYTHROCYTES; PLASMODIUM EXPORT ELEMENT; ENDOPLASMIC-RETICULUM; PARASITE PROTEINS; HIV-1 PROTEASE; TRAFFICKING; EXPRESSION; VIRULENCE; CYTOADHERENCE; INVASION	Plasmodium falciparum causes the virulent form of malaria and disease manifestations are linked to growth inside infected erythrocytes. To survive and evade host responses the parasite remodels the erythrocyte by exporting several hundred effector proteins beyond the surrounding parasitophorous vacuole membrane. A feature of exported proteins is a pentameric motif (RxLxE/Q/D) that is a substrate for an unknown protease. Here we show that the protein responsible for cleavage of this motif is plasmepsin V (PMV), an aspartic acid protease located in the endoplasmic reticulum. PMV cleavage reveals the export signal (xE/Q/D) at the amino terminus of cargo proteins. Expression of an identical mature protein with xQ at the N terminus generated by signal peptidase was not exported, demonstrating that PMV activity is essential and linked with other key export events. Identification of the protease responsible for export into erythrocytes provides a novel target for therapeutic intervention against this devastating disease.	[Boddey, Justin A.; Hodder, Anthony N.; Guenther, Svenja; Pearce, J. Andrew; Simpson, Richard J.; Cowman, Alan F.] Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia; [Gilson, Paul R.; Crabb, Brendan S.] Macfarlane Burnet Inst Med Res & Publ Hlth, Melbourne, Vic 3004, Australia; [Patsiouras, Heather; Kapp, Eugene A.; Simpson, Richard J.] Ludwig Inst Canc Res, Joint Prote Facil, Melbourne, Vic 3050, Australia; [de Koning-Ward, Tania F.] Deakin Univ, Waurn Ponds 3217, Australia	Walter & Eliza Hall Institute; Burnet Institute; Ludwig Institute for Cancer Research; Deakin University	Cowman, AF (corresponding author), Walter & Eliza Hall Inst Med Res, Melbourne, Vic 3052, Australia.	cowman@wehi.edu.au	Crabb, Brendan/F-5287-2013; Simpson, Richard/A-6947-2012; Cowman, Alan F/C-7642-2013; de Koning-Ward, Tania F/N-3572-2017	Cowman, Alan F/0000-0001-5145-9004; de Koning-Ward, Tania F/0000-0001-5810-8063; Boddey, Justin/0000-0001-7322-2040; Simpson, Richard/0000-0002-9834-0796	National Health and Medical Research Council; National Institutes of Health [RO1 AI44008]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044008] Funding Source: NIH RePORTER	National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank the Australian Red Cross Blood Bank for the provision of human blood and serum, the AIDS Research and Reference Reagent Program, Division of AIDS, NIAID, NIH for providing HIV protease inhibitors and MR4 (ATCC) for plasmepsin V antibodies, contributed by D. Goldberg. This work was supported by the National Health and Medical Research Council, and a grant from the National Institutes of Health (RO1 AI44008). J.A.B. is an NHMRC Peter Doherty postdoctoral Fellow and A. F. C. is an International Research Scholar of the Howard Hughes Medical Institute and an Australia Fellow.	BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; BARUCH DI, 1995, CELL, V82, P77, DOI 10.1016/0092-8674(95)90054-3; Baum J, 2008, CELL HOST MICROBE, V3, P188, DOI 10.1016/j.chom.2008.02.006; Bendtsen JD, 2004, J MOL BIOL, V340, P783, DOI 10.1016/j.jmb.2004.05.028; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Bozdech Z, 2003, PLOS BIOL, V1, P85, DOI 10.1371/journal.pbio.0000005; Carlton JM, 2008, NATURE, V455, P757, DOI 10.1038/nature07327; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Duraisingh MT, 2002, INT J PARASITOL, V32, P81, DOI 10.1016/S0020-7519(01)00345-9; Gilson PR, 2008, MOL MICROBIOL, V68, P124, DOI 10.1111/j.1365-2958.2008.06140.x; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Hodder AN, 2009, J MOL BIOL, V392, P154, DOI 10.1016/j.jmb.2009.07.007; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Knuepfer E, 2005, MOL BIOCHEM PARASIT, V142, P258, DOI 10.1016/j.molbiopara.2005.04.005; LaGreca N, 1997, MOL BIOCHEM PARASIT, V89, P283, DOI 10.1016/S0166-6851(97)00134-5; Le Roch KG, 2003, SCIENCE, V301, P1503, DOI 10.1126/science.1087025; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Meissner M, 2005, P NATL ACAD SCI USA, V102, P2980, DOI 10.1073/pnas.0500112102; MILLER LH, 1994, SCIENCE, V264, P1878, DOI 10.1126/science.8009217; MILLER M, 1989, SCIENCE, V246, P1149, DOI 10.1126/science.2686029; Pain A, 2008, NATURE, V455, P799, DOI 10.1038/nature07306; Pei XH, 2005, J BIOL CHEM, V280, P31166, DOI 10.1074/jbc.M505298200; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; RAVENTOSSUAREZ C, 1985, P NATL ACAD SCI USA, V82, P3829, DOI 10.1073/pnas.82.11.3829; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; SMITH JD, 1995, CELL, V82, P101, DOI 10.1016/0092-8674(95)90056-X; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; SU XZ, 1995, CELL, V82, P89, DOI 10.1016/0092-8674(95)90055-1; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084; Waller RF, 2000, EMBO J, V19, P1794, DOI 10.1093/emboj/19.8.1794; WEBER IT, 1989, SCIENCE, V243, P928, DOI 10.1126/science.2537531	34	227	232	0	34	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					627	U52		10.1038/nature08728	http://dx.doi.org/10.1038/nature08728			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130643	Green Accepted			2022-12-01	WOS:000274193900028
J	Specchia, V; Piacentini, L; Tritto, P; Fanti, L; D'Alessandro, R; Palumbo, G; Pimpinelli, S; Bozzetti, MP				Specchia, Valeria; Piacentini, Lucia; Tritto, Patrizia; Fanti, Laura; D'Alessandro, Rosalba; Palumbo, Gioacchino; Pimpinelli, Sergio; Bozzetti, Maria P.			Hsp90 prevents phenotypic variation by suppressing the mutagenic activity of transposons	NATURE			English	Article							DROSOPHILA-MELANOGASTER; GENETIC-ANALYSIS; Y-CHROMOSOME; STELLATE; SPERMATOGENESIS; EVOLUTION; PROTEIN; HSP83; ORGANIZATION; CAPACITOR	The canalization concept(1) describes the resistance of a developmental process to phenotypic variation, regardless of genetic and environmental perturbations, owing to the existence of buffering mechanisms. Severe perturbations, which overcome such buffering mechanisms, produce altered phenotypes that can be heritable and can themselves be canalized by a genetic assimilation process. An important implication of this concept is that the buffering mechanism could be genetically controlled. Recent studies on Hsp90, a protein involved in several cellular processes and development pathways(2-5), indicate that it is a possible molecular mechanism for canalization and genetic assimilation. In both flies and plants, mutations in the Hsp90-encoding gene induce a wide range of phenotypic abnormalities, which have been interpreted as an increased sensitivity of different developmental pathways to hidden genetic variability(6,7.) Thus, Hsp90 chaperone machinery may be an evolutionarily conserved buffering mechanism of phenotypic variance, which provides the genetic material for natural selection. Here we offer an additional, perhaps alternative, explanation for proposals of a concrete mechanism underlying canalization. We show that, in Drosophila, functional alterations of Hsp90 affect the Piwi-interacting RNA (piRNA; a class of germ-line-specific small RNAs) silencing mechanism leading to transposon activation and the induction of morphological mutants. This indicates that Hsp90 mutations can generate new variation by transposon-mediated 'canonical' mutagenesis.	[Specchia, Valeria; Bozzetti, Maria P.] Univ Salento, DiSTeBA, I-73100 Lecce, Italy; [Piacentini, Lucia; Fanti, Laura; Pimpinelli, Sergio] Univ Roma La Sapienza, Ist Pasteur, Fdn Cenci Bolognetti, I-00185 Rome, Italy; [Piacentini, Lucia; Fanti, Laura; Pimpinelli, Sergio] Univ Roma La Sapienza, Dipartimento Genet & Biol Mol, I-00185 Rome, Italy; [Tritto, Patrizia; D'Alessandro, Rosalba; Palumbo, Gioacchino] Univ Bari, DIGEMI, I-70126 Bari, Italy	University of Salento; Fondazione Cenci Bolognetti; Sapienza University Rome; Sapienza University Rome; Universita degli Studi di Bari Aldo Moro	Bozzetti, MP (corresponding author), Univ Salento, DiSTeBA, I-73100 Lecce, Italy.	maria.bozzetti@unisalento.it	D'Alessandro, Rosalba/J-2351-2018; Bozzetti, Maria/C-4694-2013; Piacentini, Lucia/A-5391-2016; Specchia, Valeria/AAS-8179-2020	Piacentini, Lucia/0000-0002-3656-5068; Specchia, Valeria/0000-0002-1051-6014; FANTI, Laura/0000-0003-4380-997X	Ministero dell'Universita e della Ricerca (MIUR)	Ministero dell'Universita e della Ricerca (MIUR)(Ministry of Education, Universities and Research (MIUR))	This study was supported by a grant from the Ministero dell'Universita e della Ricerca (MIUR) project: RNAi, heterochromatin and epigenetic control of gene expression and chromosome behaviour. V. S. was supported by a grant provided by MIUR for the same project.	Aravin AA, 2003, DEV CELL, V5, P337, DOI 10.1016/S1534-5807(03)00228-4; Aravin AA, 2001, CURR BIOL, V11, P1017, DOI 10.1016/S0960-9822(01)00299-8; BOZZETTI MP, 1995, P NATL ACAD SCI USA, V92, P6067, DOI 10.1073/pnas.92.13.6067; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; CAIZZI R, 1993, GENETICS, V133, P335; CASTRILLON DH, 1993, GENETICS, V135, P489; CUTFORTH T, 1994, CELL, V77, P1027, DOI 10.1016/0092-8674(94)90442-1; DING D, 1993, MOL CELL BIOL, V13, P3773, DOI 10.1128/MCB.13.6.3773; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gvozdev VA, 2000, GENETICA, V109, P131, DOI 10.1023/A:1026596419250; HARDY RW, 1984, GENETICS, V107, P591; Hartl FU, 1996, NATURE, V381, P571, DOI 10.1038/381571a0; Li CJ, 2009, CELL, V137, P509, DOI 10.1016/j.cell.2009.04.027; LIVAK KJ, 1990, GENETICS, V124, P303; LIVAK KJ, 1984, GENETICS, V107, P611; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Malone CD, 2009, CELL, V137, P522, DOI 10.1016/j.cell.2009.03.040; MCCLINTOCK B, 1984, SCIENCE, V226, P792, DOI 10.1126/science.15739260; Nishida KM, 2007, RNA, V13, P1911, DOI 10.1261/rna.744307; PALUMBO G, 1994, GENETICA, V94, P267, DOI 10.1007/BF01443440; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sambrook J., 1989, MOL CLONING LAB MANU; Schmidt A, 1999, GENETICS, V151, P749; Soriano S, 2002, J MOL EVOL, V55, P606, DOI 10.1007/s00239-002-2356-7; Stapleton W, 2001, CHROMOSOMA, V110, P228, DOI 10.1007/s004120100136; Tritto P, 2003, GENETICA, V117, P247, DOI 10.1023/A:1022960632306; vanderStraten A, 1997, EMBO J, V16, P1961, DOI 10.1093/emboj/16.8.1961; Waddington CH, 1942, NATURE, V150, P563, DOI 10.1038/150563a0; Yue L, 1999, GENETICS, V151, P1065	30	193	195	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					662	U92		10.1038/nature08739	http://dx.doi.org/10.1038/nature08739			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20062045				2022-12-01	WOS:000274193900036
J	Marraffini, LA; Sontheimer, EJ				Marraffini, Luciano A.; Sontheimer, Erik J.			Self versus non-self discrimination during CRISPR RNA-directed immunity	NATURE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; PROVIDES ACQUIRED-RESISTANCE; IDENTIFICATION; PROKARYOTES; REPEATS; SYSTEM; PLASMID; DEFENSE; GENE; DNA	All immune systems must distinguish self from non-self to repel invaders without inducing autoimmunity. Clustered, regularly interspaced, short palindromic repeat (CRISPR) loci protect bacteria and archaea from invasion by phage and plasmid DNA through a genetic interference pathway(1-9). CRISPR loci are present in similar to 40% and similar to 90% of sequenced bacterial and archaeal genomes, respectively(10), and evolve rapidly, acquiring new spacer sequences to adapt to highly dynamic viral populations(1,11-13). Immunity requires a sequence match between the invasive DNA and the spacers that lie between CRISPR repeats(1-9). Each cluster is genetically linked to a subset of the cas (CRISPR-associated) genes(14-16) that collectively encode >40 families of proteins involved in adaptation and interference. CRISPR loci encode small CRISPR RNAs (crRNAs) that contain a full spacer flanked by partial repeat sequences(2,17-19). CrRNA spacers are thought to identify targets by direct Watson-Crick pairing with invasive 'protospacer' DNA(2,3), but how they avoid targeting the spacer DNA within the encoding CRISPR locus itself is unknown. Here we have defined the mechanism of CRISPR self/non-self discrimination. In Staphylococcus epidermidis, target/crRNA mismatches at specific positions outside of the spacer sequence license foreign DNA for interference, whereas extended pairing between crRNA and CRISPR DNA repeats prevents autoimmunity. Hence, this CRISPR system uses the base-pairing potential of crRNAs not only to specify a target, but also to spare the bacterial chromosome from interference. Differential complementarity outside of the spacer sequence is a built-in feature of all CRISPR systems, indicating that this mechanism is a broadly applicable solution to the self/non-self dilemma that confronts all immune pathways.	[Marraffini, Luciano A.; Sontheimer, Erik J.] Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, Evanston, IL 60208 USA	Northwestern University	Marraffini, LA (corresponding author), Northwestern Univ, Dept Biochem Mol Biol & Cell Biol, 2205 Tech Dr, Evanston, IL 60208 USA.	l-marraffini@northwestern.edu; erik@northwestern.edu		Sontheimer, Erik/0000-0002-0881-0310	National Institutes of Health, USA; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R03AI079722] Funding Source: NIH RePORTER	National Institutes of Health, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank N. Fang for cloning assistance and members of our laboratory for critical reading of the manuscript. We thank V. Gerbasi and J. Marques for experimental advice. L. A. M. is a Fellow of The Jane Coffin Childs Memorial Fund for Medical Research. This work was supported by a grant from the National Institutes of Health, USA, to E. J. S.	Andersson AF, 2008, SCIENCE, V320, P1047, DOI 10.1126/science.1157358; Bae T, 2006, PLASMID, V55, P58, DOI 10.1016/j.plasmid.2005.05.005; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Bolotin A, 2005, MICROBIOL-SGM, V151, P2551, DOI 10.1099/mic.0.28048-0; Brouns SJJ, 2008, SCIENCE, V321, P960, DOI 10.1126/science.1159689; Climo MW, 1996, J BACTERIOL, V178, P4975, DOI 10.1128/jb.178.16.4975-4983.1996; Deveau H, 2008, J BACTERIOL, V190, P1390, DOI 10.1128/JB.01412-07; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Grissa I, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-172; Haft DH, 2005, PLOS COMPUT BIOL, V1, P474, DOI 10.1371/journal.pcbi.0010060; Hale C, 2008, RNA, V14, P2572, DOI 10.1261/rna.1246808; HORINOUCHI S, 1982, J BACTERIOL, V150, P815, DOI 10.1128/JB.150.2.815-825.1982; Jansen R, 2002, MOL MICROBIOL, V43, P1565, DOI 10.1046/j.1365-2958.2002.02839.x; KREISWIRTH BN, 1983, NATURE, V305, P709, DOI 10.1038/305709a0; Lillestol Reidun K., 2006, Archaea, V2, P59, DOI 10.1155/2006/542818; Lillestol RK, 2009, MOL MICROBIOL, V72, P259, DOI 10.1111/j.1365-2958.2009.06641.x; Makarova KS, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-7; Marraffini LA, 2008, SCIENCE, V322, P1843, DOI 10.1126/science.1165771; Mojica FJM, 2009, MICROBIOL-SGM, V155, P733, DOI 10.1099/mic.0.023960-0; Mojica FJM, 2005, J MOL EVOL, V60, P174, DOI 10.1007/s00239-004-0046-3; MORTON TM, 1995, ANTIMICROB AGENTS CH, V39, P1272, DOI 10.1128/AAC.39.6.1272; Pall GS, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm112; Pourcel C, 2005, MICROBIOL-SGM, V151, P653, DOI 10.1099/mic.0.27437-0; SCHNEEWIND O, 1992, CELL, V70, P267, DOI 10.1016/0092-8674(92)90101-H; Semenova E, 2009, FEMS MICROBIOL LETT, V296, P110, DOI 10.1111/j.1574-6968.2009.01626.x; Shah SA, 2009, BIOCHEM SOC T, V37, P23, DOI 10.1042/BST0370023; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sugimoto N, 2000, BIOCHEMISTRY-US, V39, P11270, DOI 10.1021/bi000819p; Tang TH, 2005, MOL MICROBIOL, V55, P469, DOI 10.1111/j.1365-2958.2004.04428.x; Tang TH, 2002, P NATL ACAD SCI USA, V99, P7536, DOI 10.1073/pnas.112047299; van der Oost J, 2009, TRENDS BIOCHEM SCI, V34, P401, DOI 10.1016/j.tibs.2009.05.002; van der Ploeg JR, 2009, MICROBIOL-SGM, V155, P1966, DOI 10.1099/mic.0.027508-0; Weigel LM, 2003, SCIENCE, V302, P1569, DOI 10.1126/science.1090956	34	415	487	5	171	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					568	U194		10.1038/nature08703	http://dx.doi.org/10.1038/nature08703			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20072129	Green Accepted			2022-12-01	WOS:000273981100057
J	Zhang, JM; Adrian, FJ; Jahnke, W; Cowan-Jacob, SW; Li, AG; Iacob, RE; Sim, T; Powers, J; Dierks, C; Sun, FX; Guo, GR; Ding, Q; Okram, B; Choi, Y; Wojciechowski, A; Deng, XM; Liu, GX; Fendrich, G; Strauss, A; Vajpai, N; Grzesiek, S; Tuntland, T; Liu, Y; Bursulaya, B; Azam, M; Manley, PW; Engen, JR; Daley, GQ; Warmuth, M; Gray, NS				Zhang, Jianming; Adrian, Francisco J.; Jahnke, Wolfgang; Cowan-Jacob, Sandra W.; Li, Allen G.; Iacob, Roxana E.; Sim, Taebo; Powers, John; Dierks, Christine; Sun, Fangxian; Guo, Gui-Rong; Ding, Qiang; Okram, Barun; Choi, Yongmun; Wojciechowski, Amy; Deng, Xianming; Liu, Guoxun; Fendrich, Gabriele; Strauss, Andre; Vajpai, Navratna; Grzesiek, Stephan; Tuntland, Tove; Liu, Yi; Bursulaya, Badry; Azam, Mohammad; Manley, Paul W.; Engen, John R.; Daley, George Q.; Warmuth, Markus; Gray, Nathanael S.			Targeting Bcr-Abl by combining allosteric with ATP-binding-site inhibitors	NATURE			English	Article							CHRONIC MYELOID-LEUKEMIA; CELL LUNG-CANCER; KINASE-INHIBITOR; C-ABL; TYROSINE KINASE; LYMPHOBLASTIC-LEUKEMIA; IMATINIB RESISTANCE; SELECTIVE INHIBITOR; MUTATIONS; DYNAMICS	In an effort to find new pharmacological modalities to overcome resistance to ATP-binding-site inhibitors of Bcr-Abl, we recently reported the discovery of GNF-2, a selective allosteric Bcr-Abl inhibitor. Here, using solution NMR, X-ray crystallography, mutagenesis and hydrogen exchange mass spectrometry, we show that GNF-2 binds to the myristate-binding site of Abl, leading to changes in the structural dynamics of the ATP-binding site. GNF-5, an analogue of GNF-2 with improved pharmacokinetic properties, when used in combination with the ATP-competitive inhibitors imatinib or nilotinib, suppressed the emergence of resistance mutations in vitro, displayed additive inhibitory activity in biochemical and cellular assays against T315I mutant human Bcr-Abl and displayed in vivo efficacy against this recalcitrant mutant in a murine bone-marrow transplantation model. These results show that therapeutically relevant inhibition of Bcr-Abl activity can be achieved with inhibitors that bind to the myristate-binding site and that combining allosteric and ATP-competitive inhibitors can overcome resistance to either agent alone.	[Adrian, Francisco J.; Li, Allen G.; Dierks, Christine; Sun, Fangxian; Guo, Gui-Rong; Ding, Qiang; Liu, Guoxun; Tuntland, Tove; Liu, Yi; Bursulaya, Badry] Novartis Res Fdn, Dept Chem, Genom Inst, San Diego, CA 92121 USA; [Zhang, Jianming; Sim, Taebo; Choi, Yongmun; Wojciechowski, Amy; Deng, Xianming; Gray, Nathanael S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhang, Jianming; Sim, Taebo; Powers, John; Choi, Yongmun; Wojciechowski, Amy; Deng, Xianming; Azam, Mohammad; Daley, George Q.; Gray, Nathanael S.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Jahnke, Wolfgang; Cowan-Jacob, Sandra W.; Fendrich, Gabriele; Strauss, Andre; Manley, Paul W.] Novartis Inst Biomed Res, CH-4056 Basel, Switzerland; [Iacob, Roxana E.; Engen, John R.] Northwestern Univ, Dept Chem & Chem Biol, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northwestern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Sim, Taebo] Korea Inst Sci & Technol, Life Sci Res Div, Seoul 136791, South Korea; [Powers, John; Azam, Mohammad; Daley, George Q.] Childrens Hosp, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Powers, John; Azam, Mohammad; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Powers, John; Azam, Mohammad; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Okram, Barun] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Okram, Barun] Scripps Res Inst, Dept Chem, La Jolla, CA 92037 USA; [Vajpai, Navratna; Grzesiek, Stephan] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [Warmuth, Markus] Novartis Inst BioMed Res Inc, Cambridge, MA 02139 USA	Novartis; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Novartis; Northwestern University; Northwestern University; Korea Institute of Science & Technology (KIST); Harvard University; Boston Children's Hospital; Harvard University; Brigham & Women's Hospital; Howard Hughes Medical Institute; Scripps Research Institute; Scripps Research Institute; University of Basel; Novartis	Adrian, FJ (corresponding author), Novartis Res Fdn, Dept Chem, Genom Inst, 10675 John Jay Hopkins Dr, San Diego, CA 92121 USA.	fadrian@gnf.org; markus.warmuth@novartis.com; nathanael_gray@dfci.harvard.edu	Powers, John/AAO-1018-2020; manley, paul william/GVT-9482-2022; Dierks, Christine/L-4358-2013	Deng, Xianming/0000-0002-9354-5864; Zhang, Jianming/0000-0001-6326-3906; Manley, Paul William/0000-0002-9722-7863; Grzesiek, Stephan/0000-0003-1998-4225; Engen, John R./0000-0002-6918-9476	NCI NIH HHS [R01 CA130876, R01 CA130876-03] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA130876] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adrian FJ, 2006, NAT CHEM BIOL, V2, P95, DOI 10.1038/nchembio760; Azam M, 2003, CELL, V112, P831, DOI 10.1016/S0092-8674(03)00190-9; Azam M, 2006, P NATL ACAD SCI USA, V103, P9244, DOI 10.1073/pnas.0600001103; Barnett SF, 2005, BIOCHEM J, V385, P399, DOI 10.1042/BJ20041140; Blencke S, 2004, CHEM BIOL, V11, P691, DOI 10.1016/j.chembiol.2004.02.029; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Branford S, 2002, BLOOD, V99, P3472, DOI 10.1182/blood.V99.9.3472; BROWN EJ, 1994, NATURE, V369, P756, DOI 10.1038/369756a0; Burke JR, 2003, J BIOL CHEM, V278, P1450, DOI 10.1074/jbc.M209677200; Choi Y, 2009, J BIOL CHEM, V284, P29005, DOI 10.1074/jbc.M109.026633; CHOU TC, 1984, ADV ENZYME REGUL, V22, P27, DOI 10.1016/0065-2571(84)90007-4; Converso A, 2009, BIOORG MED CHEM LETT, V19, P1240, DOI 10.1016/j.bmcl.2008.12.076; Cools J, 2004, CANCER RES, V64, P6385, DOI 10.1158/0008-5472.CAN-04-2148; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7689; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hantschel O, 2003, CELL, V112, P845, DOI 10.1016/S0092-8674(03)00191-0; Iacob RE, 2009, P NATL ACAD SCI USA, V106, P1386, DOI 10.1073/pnas.0811912106; Jahnke W, 2004, CELL MOL LIFE SCI, V61, P580, DOI 10.1007/s00018-003-3382-3; Joensuu H, 2001, NEW ENGL J MED, V344, P1052, DOI 10.1056/NEJM200104053441404; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; KORNBERG A, 1951, J BIOL CHEM, V189, P123; Lee TS, 2008, CANCER-AM CANCER SOC, V112, P1744, DOI 10.1002/cncr.23355; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Mishra S, 2006, CANCER RES, V66, P5387, DOI 10.1158/0008-5472.CAN-05-3058; Nagar B, 2002, CANCER RES, V62, P4236; Nagar B, 2003, CELL, V112, P859, DOI 10.1016/S0092-8674(03)00194-6; OPPI C, 1987, P NATL ACAD SCI USA, V84, P8200, DOI 10.1073/pnas.84.23.8200; Quintas-Cardama A, 2007, NAT REV DRUG DISCOV, V6, P834, DOI 10.1038/nrd2324; Ray A, 2007, BLOOD, V109, P5011, DOI 10.1182/blood-2006-01-015347; Seeliger MA, 2005, PROTEIN SCI, V14, P3135, DOI 10.1110/ps.051750905; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shah NP, 2004, SCIENCE, V305, P399, DOI 10.1126/science.1099480; Strauss A, 2005, J BIOMOL NMR, V31, P343, DOI 10.1007/s10858-005-2451-3; TOKUMITSU H, 1990, J BIOL CHEM, V265, P4315; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; VANETTEN RA, 1993, LEUKEMIA LYMPHOMA, V11, P239, DOI 10.3109/10428199309047893; von Bubnoff N, 2005, BLOOD, V105, P1652, DOI 10.1182/blood-2004-06-2445; Wales TE, 2006, MASS SPECTROM REV, V25, P158, DOI 10.1002/mas.20064; Wales TE, 2008, ANAL CHEM, V80, P6815, DOI 10.1021/ac8008862; Weis DD, 2006, J AM SOC MASS SPECTR, V17, P1700, DOI 10.1016/j.jasms.2006.07.025; Weisberg E, 2005, CANCER CELL, V7, P129, DOI 10.1016/j.ccr.2005.01.007	41	442	459	4	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					501	U116		10.1038/nature08675	http://dx.doi.org/10.1038/nature08675			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20072125	Green Accepted			2022-12-01	WOS:000273981100042
J	Epshtein, V; Dutta, D; Wade, J; Nudler, E				Epshtein, Vitaly; Dutta, Dipak; Wade, Joseph; Nudler, Evgeny			An allosteric mechanism of Rho-dependent transcription termination	NATURE			English	Article							RNA-POLYMERASE-II; ESCHERICHIA-COLI; ELONGATION COMPLEX; STRUCTURAL BASIS; TRIGGER LOOP; DNA HYBRID; IN-VITRO; SUBUNITS	Rho is the essential RNA helicase that sets the borders between transcription units and adjusts transcriptional yield to translational needs in bacteria(1-3). Although Rho was the first termination factor to be discovered(4), the actual mechanism by which it reaches and disrupts the elongation complex (EC) is unknown. Here we show that the termination-committed Rho molecule associates with RNA polymerase (RNAP) throughout the transcription cycle; that is, it does not require the nascent transcript for initial binding. Moreover, the formation of the RNAP-Rho complex is crucial for termination. We show further that Rho-dependent termination is a two-step process that involves rapid EC inactivation (trap) and a relatively slow dissociation. Inactivation is the critical rate-limiting step that establishes the position of the termination site. The trap mechanism depends on the allosterically induced rearrangement of the RNAP catalytic centre by means of the evolutionarily conserved mobile trigger-loop domain, which is also required for EC dissociation. The key structural and functional similarities, which we found between Rho-dependent and intrinsic (Rho-independent) termination pathways, argue that the allosteric mechanism of termination is general and likely to be preserved for all cellular RNAPs throughout evolution.	[Epshtein, Vitaly; Dutta, Dipak; Nudler, Evgeny] NYU, Sch Med, Dept Biochem, New York, NY 10016 USA; [Wade, Joseph] SUNY Albany, Sch Publ Hlth, Dept Biomed Sci, Albany, NY 12201 USA	New York University; State University of New York (SUNY) System; State University of New York (SUNY) Albany	Nudler, E (corresponding author), NYU, Sch Med, Dept Biochem, New York, NY 10016 USA.	evgeny.nudler@nyumc.org		Wade, Joseph/0000-0002-9779-3160; Nudler, Evgeny/0000-0002-8811-3071	National Institutes of Health [R01GM58750]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM058750, R01GM072814] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank I. Artsimovitch, S. Borukhov, K. Severinov, B. Stitt, D. Vassylyev and R. Weisberg for materials and discussions. This work was supported by a grant from the National Institutes of Health (R01GM58750, to E. N.).	Adelman JL, 2006, MOL CELL, V22, P611, DOI 10.1016/j.molcel.2006.04.022; ADHYA S, 1978, ANNU REV BIOCHEM, V47, P967, DOI 10.1146/annurev.bi.47.070178.004535; Banerjee S, 2006, J MICROBIOL, V44, P11; Bar-Nahum G, 2005, CELL, V120, P183, DOI 10.1016/j.cell.2004.11.045; BORUKHOV S, 1993, PROTEIN EXPRES PURIF, V4, P503, DOI 10.1006/prep.1993.1066; BRENNAN CA, 1987, CELL, V48, P945, DOI 10.1016/0092-8674(87)90703-3; Browne RJ, 2005, J BIOL CHEM, V280, P13292, DOI 10.1074/jbc.M500221200; Cardinale CJ, 2008, SCIENCE, V320, P935, DOI 10.1126/science.1152763; Chalissery J, 2007, J MOL BIOL, V371, P855, DOI 10.1016/j.jmb.2007.06.013; Epshtein V, 2007, MOL CELL, V28, P991, DOI 10.1016/j.molcel.2007.10.011; GEISELMANN J, 1992, BIOCHEMISTRY-US, V31, P111, DOI 10.1021/bi00116a017; Guerin M, 1998, NUCLEIC ACIDS RES, V26, P4895, DOI 10.1093/nar/26.21.4895; Gusarov I, 1999, MOL CELL, V3, P495, DOI 10.1016/S1097-2765(00)80477-3; JIN DJ, 1992, P NATL ACAD SCI USA, V89, P1453, DOI 10.1073/pnas.89.4.1453; Kettenberger H, 2004, MOL CELL, V16, P955, DOI 10.1016/j.molcel.2004.11.040; Kim DE, 2001, J BIOL CHEM, V276, P13902, DOI 10.1074/jbc.M011043200; Komissarova N, 2002, MOL CELL, V10, P1151, DOI 10.1016/S1097-2765(02)00738-4; Mentesana PE, 2000, J MOL BIOL, V302, P1049, DOI 10.1006/jmbi.2000.4114; Naryshkina T, 2006, J MOL BIOL, V361, P634, DOI 10.1016/j.jmb.2006.05.034; Nudler E, 2003, METHOD ENZYMOL, V371, P160; Nudler E, 1998, SCIENCE, V281, P424, DOI 10.1126/science.281.5375.424; PLATT T, 1994, MOL MICROBIOL, V11, P983, DOI 10.1111/j.1365-2958.1994.tb00376.x; RICHARDSON JP, 1991, CELL, V64, P1047, DOI 10.1016/0092-8674(91)90257-Y; Roberts JW, 2008, ANNU REV MICROBIOL, V62, P211, DOI 10.1146/annurev.micro.61.080706.093422; ROBERTS JW, 1969, NATURE, V224, P1168, DOI 10.1038/2241168a0; Schwartz A, 2007, J BIOL CHEM, V282, P31469, DOI 10.1074/jbc.M706935200; Skordalakes E, 2006, CELL, V127, P553, DOI 10.1016/j.cell.2006.08.051; Toulokhonov I, 2007, MOL CELL, V27, P406, DOI 10.1016/j.molcel.2007.06.008; Vassylyev DG, 2005, NAT STRUCT MOL BIOL, V12, P1086, DOI 10.1038/nsmb1015; Vassylyev DG, 2007, NATURE, V448, P157, DOI 10.1038/nature05932; Wang D, 2006, CELL, V127, P941, DOI 10.1016/j.cell.2006.11.023; Westover KD, 2004, SCIENCE, V303, P1014, DOI 10.1126/science.1090839; WRIGHT DJ, 1989, J BIOL CHEM, V264, P11816; Zhu AQ, 1998, BIOCHEMISTRY-US, V37, P11215, DOI 10.1021/bi972912s	34	126	128	1	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					245	U136		10.1038/nature08669	http://dx.doi.org/10.1038/nature08669			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075920	Green Accepted			2022-12-01	WOS:000273582700039
J	Schmutz, J; Cannon, SB; Schlueter, J; Ma, JX; Mitros, T; Nelson, W; Hyten, DL; Song, QJ; Thelen, JJ; Cheng, JL; Xu, D; Hellsten, U; May, GD; Yu, Y; Sakurai, T; Umezawa, T; Bhattacharyya, MK; Sandhu, D; Valliyodan, B; Lindquist, E; Peto, M; Grant, D; Shu, SQ; Goodstein, D; Barry, K; Futrell-Griggs, M; Abernathy, B; Du, JC; Tian, ZX; Zhu, LC; Gill, N; Joshi, T; Libault, M; Sethuraman, A; Zhang, XC; Shinozaki, K; Nguyen, HT; Wing, RA; Cregan, P; Specht, J; Grimwood, J; Rokhsar, D; Stacey, G; Shoemaker, RC; Jackson, SA				Schmutz, Jeremy; Cannon, Steven B.; Schlueter, Jessica; Ma, Jianxin; Mitros, Therese; Nelson, William; Hyten, David L.; Song, Qijian; Thelen, Jay J.; Cheng, Jianlin; Xu, Dong; Hellsten, Uffe; May, Gregory D.; Yu, Yeisoo; Sakurai, Tetsuya; Umezawa, Taishi; Bhattacharyya, Madan K.; Sandhu, Devinder; Valliyodan, Babu; Lindquist, Erika; Peto, Myron; Grant, David; Shu, Shengqiang; Goodstein, David; Barry, Kerrie; Futrell-Griggs, Montona; Abernathy, Brian; Du, Jianchang; Tian, Zhixi; Zhu, Liucun; Gill, Navdeep; Joshi, Trupti; Libault, Marc; Sethuraman, Anand; Zhang, Xue-Cheng; Shinozaki, Kazuo; Nguyen, Henry T.; Wing, Rod A.; Cregan, Perry; Specht, James; Grimwood, Jane; Rokhsar, Dan; Stacey, Gary; Shoemaker, Randy C.; Jackson, Scott A.			Genome sequence of the palaeopolyploid soybean	NATURE			English	Article							PHYLOGENETIC ANALYSIS; GLYCINE-MAX; GENES; EVOLUTION; IDENTIFICATION; PROTEIN; PLANTS; DNA; DIVERSIFICATION; RESISTANCE	Soybean (Glycine max) is one of the most important crop plants for seed protein and oil content, and for its capacity to fix atmospheric nitrogen through symbioses with soil-borne microorganisms. We sequenced the 1.1-gigabase genome by a whole-genome shotgun approach and integrated it with physical and high-density genetic maps to create a chromosome-scale draft sequence assembly. We predict 46,430 protein-coding genes, 70% more than Arabidopsis and similar to the poplar genome which, like soybean, is an ancient polyploid (palaeopolyploid). About 78% of the predicted genes occur in chromosome ends, which comprise less than one-half of the genome but account for nearly all of the genetic recombination. Genome duplications occurred at approximately 59 and 13 million years ago, resulting in a highly duplicated genome with nearly 75% of the genes present in multiple copies. The two duplication events were followed by gene diversification and loss, and numerous chromosome rearrangements. An accurate soybean genome sequence will facilitate the identification of the genetic basis of many soybean traits, and accelerate the creation of improved soybean varieties.	[Schlueter, Jessica; Ma, Jianxin; Futrell-Griggs, Montona; Abernathy, Brian; Du, Jianchang; Tian, Zhixi; Zhu, Liucun; Gill, Navdeep; Jackson, Scott A.] Purdue Univ, Dept Agron, W Lafayette, IN 47906 USA; [Schmutz, Jeremy; Sethuraman, Anand; Grimwood, Jane] HudsonAlpha Genome Sequencing Ctr, Huntsville, AL 35806 USA; [Schmutz, Jeremy; Hellsten, Uffe; Lindquist, Erika; Shu, Shengqiang; Goodstein, David; Barry, Kerrie; Grimwood, Jane; Rokhsar, Dan] Joint Genome Inst, Walnut Creek, CA 94598 USA; [Cannon, Steven B.; Peto, Myron; Grant, David; Shoemaker, Randy C.] ARS, USDA, Corn Insects & Crop Genet Res Unit, Ames, IA 50011 USA; [Schlueter, Jessica] Univ N Carolina, Dept Bioinformat & Genom, Charlotte, NC 28223 USA; [Mitros, Therese] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Nelson, William] Univ Arizona, Inst BIO5, Arizona Genom Computat Lab, Tucson, AZ 85721 USA; [Hyten, David L.; Song, Qijian; Cregan, Perry] ARS, USDA, Soybean Genom & Improvement Lab, Beltsville, MD 20705 USA; [Song, Qijian] Univ Maryland, Dept Plant Sci & Landscape Architecture, College Pk, MD 20742 USA; [Thelen, Jay J.; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr 109, Div Biochem, Columbia, MO 65211 USA; [Thelen, Jay J.; Stacey, Gary] Univ Missouri, Christopher S Bond Life Sci Ctr 109, Interdisciplinary Plant Grp, Columbia, MO 65211 USA; [Cheng, Jianlin; Xu, Dong; Joshi, Trupti] Univ Missouri, Dept Comp Sci, Columbia, MO 65211 USA; [May, Gregory D.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Yu, Yeisoo; Wing, Rod A.] Univ Arizona, Sch Plant Sci, Arizona Genom Inst, Tucson, AZ 85721 USA; [Sakurai, Tetsuya; Umezawa, Taishi; Shinozaki, Kazuo] RIKEN, Plant Sci Ctr, Yokohama, Kanagawa 2300045, Japan; [Bhattacharyya, Madan K.] Iowa State Univ, Dept Agron, Ames, IA 50011 USA; [Sandhu, Devinder] Univ Wisconsin, Dept Biol, Stevens Point, WI 54481 USA; [Valliyodan, Babu; Libault, Marc; Zhang, Xue-Cheng; Nguyen, Henry T.; Stacey, Gary] Univ Missouri, Div Plant Sci, Natl Ctr Soybean Biotechnol, Columbia, MO 65211 USA; [Specht, James] Univ Nebraska, Dept Agron & Hort, Lincoln, NE 68583 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; United States Department of Agriculture (USDA); University of North Carolina; University of North Carolina Charlotte; University of California System; University of California Berkeley; University of Arizona; United States Department of Agriculture (USDA); University System of Maryland; University of Maryland College Park; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; University of Missouri System; University of Missouri Columbia; National Center for Genome Resources (NCGR); University of Arizona; RIKEN; Iowa State University; University of Wisconsin System; University of Wisconsin Stevens Point; University of Missouri System; University of Missouri Columbia; University of Nebraska System; University of Nebraska Lincoln	Jackson, SA (corresponding author), Purdue Univ, Dept Agron, 915 W State St, W Lafayette, IN 47906 USA.	sjackson@purdue.edu	Umezawa, Taishi/E-3028-2010; Barry, Kerrie Whitelaw/AAA-5500-2020; Wing, Rod A/Z-2885-2019; Schmutz, Jeremy/N-3173-2013; Shinozaki, Kazuo/AAB-4945-2019; Grimwood, Jane/ABD-5737-2021; Sakurai, Tetsuya/B-2690-2010; Shinozaki, Kazuo/G-4202-2013; Cheng, Jianlin/N-8209-2013	Umezawa, Taishi/0000-0003-3750-0503; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Wing, Rod A/0000-0001-6633-6226; Schmutz, Jeremy/0000-0001-8062-9172; Shinozaki, Kazuo/0000-0002-6317-9867; Sakurai, Tetsuya/0000-0003-2046-8973; Shinozaki, Kazuo/0000-0002-6317-9867; Cheng, Jianlin/0000-0003-0305-2853; Sandhu, Devinder/0000-0003-4193-3408; Shu, Shengqiang/0000-0002-4336-8994; Valliyodan, Babu/0000-0001-9457-9508; zhu, liucun/0000-0002-8334-0216; jackson, scott/0000-0002-3172-1607; Hyten, David/0000-0001-6324-9389; Yu, Yeisoo/0000-0002-8410-0310; Rokhsar, Daniel/0000-0002-8704-2224; Goodstein, David/0000-0001-6287-2697; Thelen, Jay/0000-0001-5995-1562	National Science Foundation [DBI-0421620, DBI-0501877, 082225]; United Soybean Board	National Science Foundation(National Science Foundation (NSF)); United Soybean Board	We thank N. Weeks for informatics support and C. Gunter for critical reading of the manuscript. We acknowledge funding from the National Science Foundation (DBI-0421620 to G. S.; DBI-0501877 and 082225 to S. A. J.) and the United Soybean Board.	Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Arumuganathan K., 1991, PLANT MOL BIOL REP, V9, P208, DOI [DOI 10.1007/BF02672069, 10.1007/BF02672069]; Barkoulas M, 2007, CURR OPIN PLANT BIOL, V10, P660, DOI 10.1016/j.pbi.2007.07.012; Beckstette M, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-389; Beisson F, 2003, PLANT PHYSIOL, V132, P681, DOI 10.1104/pp.103.022988; Bertioli DJ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-45; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; Bruggmann R, 2006, GENOME RES, V16, P1241, DOI 10.1101/gr.5338906; Choi IY, 2007, GENETICS, V176, P685, DOI 10.1534/genetics.107.070821; Fridborg I, 1999, PLANT CELL, V11, P1019, DOI 10.1105/tpc.11.6.1019; Gill N, 2009, PLANT PHYSIOL, V151, P1167, DOI 10.1104/pp.109.137935; Haas BJ, 2003, NUCLEIC ACIDS RES, V31, P5654, DOI 10.1093/nar/gkg770; Herve C, 2009, PLANT PHYSIOL, V149, P1462, DOI 10.1104/pp.108.126136; HYTEN DL, BMC GENOMIC IN PRESS; HYTEN DL, CROP SCI IN PRESS; Jaffe DB, 2003, GENOME RES, V13, P91, DOI 10.1101/gr.828403; Jaillon O, 2007, NATURE, V449, P463, DOI 10.1038/nature06148; Krzywinski M, 2009, GENOME RES, V19, P1639, DOI 10.1101/gr.092759.109; Lai CP, 2004, PLANT PHYSIOL, V134, P1586, DOI 10.1104/pp.103.037820; Lavin M, 2005, SYST BIOL, V54, P575, DOI 10.1080/10635150590947131; Lin JY, 2005, GENETICS, V170, P1221, DOI 10.1534/genetics.105.041616; Ma JX, 2004, GENOME RES, V14, P860, DOI 10.1101/gr.1466204; Maroof MAS, 2009, CROP SCI, V49, P69, DOI 10.2135/cropsci2008.06.0362; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Meyer JDF, 2009, PLANT PHYSIOL, V150, P295, DOI 10.1104/pp.108.134551; Michelmore RW, 1998, GENOME RES, V8, P1113, DOI 10.1101/gr.8.11.1113; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Pfeil BE, 2005, SYST BIOL, V54, P441, DOI 10.1080/10635150590945359; Roy SW, 2007, MOL BIOL EVOL, V24, P171, DOI 10.1093/molbev/msl159; Salamov AA, 2000, GENOME RES, V10, P516, DOI 10.1101/gr.10.4.516; Schlueter JA, 2004, GENOME, V47, P868, DOI 10.1139/G04-047; Schlueter JA, 2008, J HERED, V99, P390, DOI 10.1093/jhered/esn010; Simillion C, 2008, BIOINFORMATICS, V24, P127, DOI 10.1093/bioinformatics/btm449; Skoneczka JA, 2009, CROP SCI, V49, P247, DOI 10.2135/cropsci2008.07.0403; Song QJ, 2004, THEOR APPL GENET, V109, P122, DOI 10.1007/s00122-004-1602-3; Stone SL, 2001, P NATL ACAD SCI USA, V98, P11806, DOI 10.1073/pnas.201413498; Tang HB, 2008, GENOME RES, V18, P1944, DOI 10.1101/gr.080978.108; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tuskan GA, 2006, SCIENCE, V313, P1596, DOI 10.1126/science.1128691; Umezawa T, 2008, DNA RES, V15, P333, DOI 10.1093/dnares/dsn024; Vahedian M, 1995, PLANT MOL BIOL, V29, P857, DOI 10.1007/BF00041174; Wang BB, 2006, P NATL ACAD SCI USA, V103, P7175, DOI 10.1073/pnas.0602039103; Wang HC, 2009, P NATL ACAD SCI USA, V106, P3853, DOI 10.1073/pnas.0813376106; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701	44	2851	3152	44	580	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					178	183		10.1038/nature08670	http://dx.doi.org/10.1038/nature08670			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075913	Green Submitted, Green Published, hybrid			2022-12-01	WOS:000273582700025
J	Crossley, S; Faria, J; Shen, M; Resasco, DE				Crossley, Steven; Faria, Jimmy; Shen, Min; Resasco, Daniel E.			Solid Nanoparticles that Catalyze Biofuel Upgrade Reactions at the Water/Oil Interface	SCIENCE			English	Article							STABILIZED EMULSIONS; LIQUID ALKANES; BIO-OIL; BIOMASS; ADSORPTION; PARTICLES; PYROLYSIS	A recoverable catalyst that simultaneously stabilizes emulsions would be highly advantageous in streamlining processes such as biomass refining, in which the immiscibility and thermal instability of crude products greatly complicates purification procedures. Here, we report a family of solid catalysts that can stabilize water-oil emulsions and catalyze reactions at the liquid/liquid interface. By depositing palladium onto carbon nanotube-inorganic oxide hybrid nanoparticles, we demonstrate biphasic hydrodeoxygenation and condensation catalysis in three substrate classes of interest in biomass refining. Microscopic characterization of the emulsions supports localization of the hybrid particles at the interface.	[Crossley, Steven; Faria, Jimmy; Shen, Min; Resasco, Daniel E.] Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA	University of Oklahoma System; University of Oklahoma - Norman	Resasco, DE (corresponding author), Univ Oklahoma, Sch Chem Biol & Mat Engn, Norman, OK 73019 USA.	resasco@ou.edu	Resasco, Daniel E/AAS-6213-2021; Shen, Min/A-1394-2010; Faria, J./J-3428-2017	Faria, J./0000-0002-8920-3538; Crossley, Steven/0000-0002-1017-9839; Resasco, Daniel/0000-0001-5342-0621	EPSCoR [0814361] Funding Source: National Science Foundation	EPSCoR(National Science Foundation (NSF)NSF - Office of the Director (OD))		Binks BP, 2005, LANGMUIR, V21, P3296, DOI 10.1021/la046915z; Binks BP, 2004, LANGMUIR, V20, P1130, DOI 10.1021/la0303557; Binks BP, 2000, LANGMUIR, V16, P8622, DOI 10.1021/la000189s; Binks BP, 2002, CURR OPIN COLLOID IN, V7, P21, DOI 10.1016/S1359-0294(02)00008-0; BRUCKNER R, 2002, ADV ORGANIC CHEM REA, P283; BRUNELLE JP, 1978, PURE APPL CHEM, V50, P1211, DOI 10.1351/pac197850091211; CHEN NY, 1979, J AM CHEM SOC, V101, P6783, DOI 10.1021/ja00516a065; Dai LL, 2005, LANGMUIR, V21, P2641, DOI 10.1021/la047256t; Dinsmore AD, 2002, SCIENCE, V298, P1006, DOI 10.1126/science.1074868; Elliott DC, 2007, ENERG FUEL, V21, P1792, DOI 10.1021/ef070044u; Huber GW, 2006, CHEM REV, V106, P4044, DOI 10.1021/cr068360d; Huber GW, 2005, SCIENCE, V308, P1446, DOI 10.1126/science.1111166; Huber GW, 2006, CATAL TODAY, V111, P119, DOI 10.1016/j.cattod.2005.10.010; Iglesia E, 1997, APPL CATAL A-GEN, V161, P59, DOI 10.1016/S0926-860X(97)00186-5; Lambert S, 2009, J CATAL, V261, P23, DOI 10.1016/j.jcat.2008.10.014; Mohan D, 2006, ENERG FUEL, V20, P848, DOI 10.1021/ef0502397; Regalbuto JR, 1999, J CATAL, V184, P335, DOI 10.1006/jcat.1999.2471; Resasco DE, 2002, J NANOPART RES, V4, P131, DOI 10.1023/A:1020174126542; SAIZJIMENEZ C, 1986, ORG GEOCHEM, V10, P869, DOI 10.1016/S0146-6380(86)80024-9; Shen M, 2009, LANGMUIR, V25, P10843, DOI 10.1021/la901380b; Simonetti DA, 2008, CHEMSUSCHEM, V1, P725, DOI 10.1002/cssc.200800105; STARKS CM, 1971, J AM CHEM SOC, V93, P195, DOI 10.1021/ja00730a033; Wang RK, 2008, J AM CHEM SOC, V130, P14721, DOI 10.1021/ja804982b; West RM, 2008, CHEMSUSCHEM, V1, P417, DOI 10.1002/cssc.200800001; Whitesides GM, 2002, SCIENCE, V295, P2418, DOI 10.1126/science.1070821; Zhao C, 2009, ANGEW CHEM INT EDIT, V48, P3987, DOI 10.1002/anie.200900404	26	623	640	26	936	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					68	72		10.1126/science.1180769	http://dx.doi.org/10.1126/science.1180769			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044571				2022-12-01	WOS:000273395400031
J	Nakagawa, A; Shi, Y; Kage-Nakadai, E; Mitani, S; Xue, D				Nakagawa, Akihisa; Shi, Yong; Kage-Nakadai, Eriko; Mitani, Shohei; Xue, Ding			Caspase-Dependent Conversion of Dicer Ribonuclease into a Death-Promoting Deoxyribonuclease	SCIENCE			English	Article							APOPTOTIC DNA-DEGRADATION; C-ELEGANS; RNA-INTERFERENCE; CAENORHABDITIS-ELEGANS; ENDONUCLEASE-G; CHROMATIN CONDENSATION; ACTIVATED DNASE; CELL-DEATH; GENE; DROSOPHILA	Chromosome fragmentation is a hallmark of apoptosis, conserved in diverse organisms. In mammals, caspases activate apoptotic chromosome fragmentation by cleaving and inactivating an apoptotic nuclease inhibitor. We report that inactivation of the Caenorhabditis elegans dcr-1 gene, which encodes the Dicer ribonuclease important for processing of small RNAs, compromises apoptosis and blocks apoptotic chromosome fragmentation. DCR-1 was cleaved by the CED-3 caspase to generate a C-terminal fragment with deoxyribonuclease activity, which produced 3' hydroxyl DNA breaks on chromosomes and promoted apoptosis. Thus, caspase-mediated activation of apoptotic DNA degradation is conserved. DCR-1 functions in fragmenting chromosomal DNA during apoptosis, in addition to processing of small RNAs, and undergoes a protease-mediated conversion from a ribonuclease to a deoxyribonuclease.	[Nakagawa, Akihisa; Shi, Yong; Xue, Ding] Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA; [Kage-Nakadai, Eriko; Mitani, Shohei] Japan Sci & Technol Agcy, Tokyo 1628666, Japan; [Kage-Nakadai, Eriko; Mitani, Shohei] Tokyo Womens Med Univ, Dept Physiol, Tokyo 1628666, Japan	University of Colorado System; University of Colorado Boulder; Japan Science & Technology Agency (JST); Tokyo Women's Medical University	Xue, D (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	ding.xue@colorado.edu		XUE, DING/0000-0002-8429-8136	Burroughs Wellcome Fund Award; Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; NIH [R01 GM59083, R01 GM79097]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059083, R01GM079097] Funding Source: NIH RePORTER	Burroughs Wellcome Fund Award(Burroughs Wellcome Fund); Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. Blumenthal, N. Pace, M. Yarus, L. He, X. D. Liu, and S. Marquez for comments; Y. Kohara for dcr-1 cDNA; Q. H. Liu for purified fly Dicer-2 protein; K. Morita for the alg-1 RNAi construct; and members of the Xue lab for helpful discussions. This work was supported by a Burroughs Wellcome Fund Award (D. X.), a grant from Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan (S. M.), and NIH grants R01 GM59083 and R01 GM79097 (D. X.).	Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Bernstein E, 2001, NATURE, V409, P363, DOI 10.1038/35053110; Buttner S, 2007, MOL CELL, V25, P233, DOI 10.1016/j.molcel.2006.12.021; Carmell MA, 2004, NAT STRUCT MOL BIOL, V11, P214, DOI 10.1038/nsmb729; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Duchaine TF, 2006, CELL, V124, P343, DOI 10.1016/j.cel.2005.11.036; Durrieu F, 2000, CURR BIOL, V10, P923, DOI 10.1016/S0960-9822(00)00620-5; Elbashir SM, 2001, GENE DEV, V15, P188, DOI 10.1101/gad.862301; ELLIS RE, 1991, GENETICS, V129, P79; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jaskiewicz L, 2008, CURR TOP MICROBIOL, V320, P77; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Kennedy S, 2004, NATURE, V427, P645, DOI 10.1038/nature02302; Knight SW, 2001, SCIENCE, V293, P2269, DOI 10.1126/science.1062039; Kokel D, 2006, NAT CHEM BIOL, V2, P338, DOI 10.1038/nchembio791; Lamontagne B, 2004, J MOL BIOL, V338, P401, DOI 10.1016/j.jmb.2004.02.059; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu JD, 2004, SCIENCE, V305, P1437, DOI 10.1126/science.1102513; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Liu XS, 1998, P NATL ACAD SCI USA, V95, P8461, DOI 10.1073/pnas.95.15.8461; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; MacRae IJ, 2007, CURR OPIN STRUC BIOL, V17, P138, DOI 10.1016/j.sbi.2006.12.002; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Parrish JZ, 2003, EMBO J, V22, P3451, DOI 10.1093/emboj/cdg320; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Pavelec DM, 2009, GENETICS, V183, P1283, DOI 10.1534/genetics.109.108134; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sakahira H, 1998, NATURE, V391, P96, DOI 10.1038/34214; Samejima K, 2005, NAT REV MOL CELL BIO, V6, P677, DOI 10.1038/nrm1715; Simmer F, 2002, CURR BIOL, V12, P1317, DOI 10.1016/S0960-9822(02)01041-2; Stanfield GM, 2000, MOL CELL, V5, P423, DOI 10.1016/S1097-2765(00)80437-2; Tabara H, 1999, CELL, V99, P123, DOI 10.1016/S0092-8674(00)81644-X; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Widlak P, 2005, J CELL BIOCHEM, V94, P1078, DOI 10.1002/jcb.20409; Widlak P, 2000, J BIOL CHEM, V275, P8226, DOI 10.1074/jbc.275.11.8226; Wu YC, 2000, GENE DEV, V14, P536; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; Zhang HD, 2004, CELL, V118, P57, DOI 10.1016/j.cell.2004.06.017; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	52	93	106	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 16	2010	328	5976					327	334		10.1126/science.1182374	http://dx.doi.org/10.1126/science.1182374			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	583NR	20223951	Green Accepted			2022-12-01	WOS:000276685000029
J	Savage, DF; Afonso, B; Chen, AH; Silver, PA				Savage, David F.; Afonso, Bruno; Chen, Anna H.; Silver, Pamela A.			Spatially Ordered Dynamics of the Bacterial Carbon Fixation Machinery	SCIENCE			English	Article							CARBOXYSOMES; PROTEINS	Cyanobacterial carbon fixation is a major component of the global carbon cycle. This process requires the carboxysome, an organelle-like proteinaceous microcompartment that sequesters the enzymes of carbon fixation from the cytoplasm. Here, fluorescently tagged carboxysomes were found to be spatially ordered in a linear fashion. As a consequence, cells undergoing division evenly segregated carboxysomes in a nonrandom process. Mutation of the cytoskeletal protein ParA specifically disrupted carboxysome order, promoted random carboxysome segregation during cell division, and impaired carbon fixation after disparate partitioning. Thus, cyanobacteria use the cytoskeleton to control the spatial arrangement of carboxysomes and to optimize the metabolic process of carbon fixation.	[Savage, David F.; Afonso, Bruno; Chen, Anna H.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu			Fundacao para a Ciencia e a Tecnologia and Graduate Program in Areas of Basic and Applied Biology (GABBA); Army Research Office [W911NF-09-1-0226]	Fundacao para a Ciencia e a Tecnologia and Graduate Program in Areas of Basic and Applied Biology (GABBA); Army Research Office	We thank R. Milo, R. Ward, R. Losick, S. Stanley, and E. Garner for comments on the manuscript; M. Ericsson and L. Benecchi for electron microscopy; and S. Golden for reagents. D. F. S. is a U.S. Department of Energy Biosciences Fellow of the Life Sciences Research Foundation. B. A. is supported by the Fundacao para a Ciencia e a Tecnologia and Graduate Program in Areas of Basic and Applied Biology (GABBA). This work was supported by Army Research Office Award W911NF-09-1-0226.	Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Ebersbach G, 2005, ANNU REV GENET, V39, P453, DOI 10.1146/annurev.genet.38.072902.091252; Elowitz MB, 1999, J BACTERIOL, V181, P197, DOI 10.1128/JB.181.1.197-203.1999; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Iancu CV, 2010, J MOL BIOL, V396, P105, DOI 10.1016/j.jmb.2009.11.019; JENSEN TE, 1976, ARCH MICROBIOL, V111, P1, DOI 10.1007/BF00446542; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Komelli A, 2007, ANNU REV BIOCHEM, V76, P351, DOI 10.1146/annurev.biochem.74.082803.133444; Ohkawa H, 1998, CAN J BOT, V76, P1035, DOI 10.1139/b98-076; Overmann J, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 2, THIRD EDITION, P32, DOI 10.1007/0-387-30742-7_3; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; SHIVELY JM, 1973, J BACTERIOL, V116, P1405, DOI 10.1128/JB.116.3.1405-1411.1973; Soufo HJD, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-10; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Thanbichler M, 2008, NAT REV MICROBIOL, V6, P28, DOI 10.1038/nrmicro1795; Thompson SR, 2006, P NATL ACAD SCI USA, V103, P8209, DOI 10.1073/pnas.0600919103; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913	19	224	229	3	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1258	1261		10.1126/science.1186090	http://dx.doi.org/10.1126/science.1186090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203050				2022-12-01	WOS:000275162100040
J	Hwang, CS; Shemorry, A; Varshavsky, A				Hwang, Cheol-Sang; Shemorry, Anna; Varshavsky, Alexander			N-Terminal Acetylation of Cellular Proteins Creates Specific Degradation Signals	SCIENCE			English	Article							END RULE PATHWAY; UBIQUITIN LIGASE; MAT-ALPHA-2 REPRESSOR; YEAST; ACETYLTRANSFERASE; PROTEOMICS; RETICULUM; MEMBRANE; SENSOR; GENES	The retained N-terminal methionine (Met) residue of a nascent protein is often N-terminally acetylated (Nt-acetylated). Removal of N-terminal Met by Met-aminopeptidases frequently leads to Nt-acetylation of the resulting N-terminal alanine (Ala), valine (Val), serine (Ser), threonine (Thr), and cysteine (Cys) residues. Although a majority of eukaryotic proteins (for example, more than 80% of human proteins) are cotranslationally Nt-acetylated, the function of this extensively studied modification is largely unknown. Using the yeast Saccharomyces cerevisiae, we found that the Nt-acetylated Met residue could act as a degradation signal (degron), targeted by the Doa10 ubiquitin ligase. Moreover, Doa10 also recognized the Nt-acetylated Ala, Val, Ser, Thr, and Cys residues. Several examined proteins of diverse functions contained these N-terminal degrons, termed N-Ac-degrons, which are a prevalent class of degradation signals in cellular proteins.	[Hwang, Cheol-Sang; Shemorry, Anna; Varshavsky, Alexander] CALTECH, Div Biol, Pasadena, CA 91125 USA	California Institute of Technology	Varshavsky, A (corresponding author), CALTECH, Div Biol, Pasadena, CA 91125 USA.	avarsh@caltech.edu	Hwang, Cheol-Sang/Q-7391-2019	Hwang, Cheol-Sang/0000-0002-0105-5957	NIH; March of Dimes Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007616] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes Foundation(March of Dimes); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Zhou (Caltech) for MS analyses and C. Brower for comments on the paper. We are grateful to members of the Varshavsky laboratory for their advice in the course of this study and particularly thank O. Batygin for her technical assistance. This work was supported by grants from NIH and the March of Dimes Foundation to A. V.	Arnesen T, 2009, P NATL ACAD SCI USA, V106, P8157, DOI 10.1073/pnas.0901931106; BACHMAIR A, 1989, CELL, V56, P1019, DOI 10.1016/0092-8674(89)90635-1; BACHMAIR A, 1986, SCIENCE, V234, P179, DOI 10.1126/science.3018930; CHEN P, 1993, CELL, V74, P357, DOI 10.1016/0092-8674(93)90426-Q; Deng M, 2006, NATURE, V443, P827, DOI 10.1038/nature05170; Frottin F, 2006, MOL CELL PROTEOMICS, V5, P2336, DOI 10.1074/mcp.M600225-MCP200; Gautschi M, 2003, MOL CELL BIOL, V23, P7403, DOI 10.1128/MCB.23.20.7403-7414.2003; Goetze S, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000236; Hassink G, 2005, BIOCHEM J, V388, P647, DOI 10.1042/BJ20041241; HOCHSTRASSER M, 1990, CELL, V61, P697, DOI 10.1016/0092-8674(90)90481-S; Hu RG, 2005, NATURE, V437, P981, DOI 10.1038/nature04027; Hu RG, 2008, P NATL ACAD SCI USA, V105, P76, DOI 10.1073/pnas.0710568105; Hwang CS, 2009, P NATL ACAD SCI USA, V106, P2142, DOI 10.1073/pnas.0812316106; Hwang CS, 2008, P NATL ACAD SCI USA, V105, P19188, DOI 10.1073/pnas.0808891105; JOHNSON AD, 1995, CURR OPIN GENET DEV, V5, P552, DOI 10.1016/0959-437X(95)80022-0; JORNVALL H, 1975, J THEOR BIOL, V55, P1, DOI 10.1016/S0022-5193(75)80105-6; MAYER A, 1989, SCIENCE, V244, P1480, DOI 10.1126/science.2544030; Mogk A, 2007, TRENDS CELL BIOL, V17, P165, DOI 10.1016/j.tcb.2007.02.001; MULLEN JR, 1989, EMBO J, V8, P2067, DOI 10.1002/j.1460-2075.1989.tb03615.x; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Polevoda B, 2003, J MOL BIOL, V325, P595, DOI 10.1016/S0022-2836(02)01269-X; Ravid T, 2006, EMBO J, V25, P533, DOI 10.1038/sj.emboj.7600946; Swanson R, 2001, GENE DEV, V15, P2660, DOI 10.1101/gad.933301; Tasaki T, 2007, TRENDS BIOCHEM SCI, V32, P520, DOI 10.1016/j.tibs.2007.08.010; Varshavsky A, 1996, P NATL ACAD SCI USA, V93, P12142, DOI 10.1073/pnas.93.22.12142; Varshavsky A, 2005, METHOD ENZYMOL, V399, P777, DOI 10.1016/S0076-6879(05)99051-4; Varshavsky A, 2008, J BIOL CHEM, V283, P34469, DOI 10.1074/jbc.X800009200; Wang HQ, 2009, MOL CELL, V34, P686, DOI 10.1016/j.molcel.2009.04.032; Zill OA, 2008, GENE DEV, V22, P1704, DOI 10.1101/gad.1640008	29	438	468	5	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					973	977		10.1126/science.1183147	http://dx.doi.org/10.1126/science.1183147			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20110468	Green Accepted			2022-12-01	WOS:000274625800033
J	Xu, H; Zuend, SJ; Woll, MG; Tao, Y; Jacobsen, EN				Xu, Hao; Zuend, Stephan J.; Woll, Matthew G.; Tao, Ye; Jacobsen, Eric N.			Asymmetric Cooperative Catalysis of Strong Bronsted Acid-Promoted Reactions Using Chiral Ureas	SCIENCE			English	Article							DIELS-ALDER REACTIONS; LEWIS-ACID	Cationic organic intermediates participate in a wide variety of useful synthetic transformations, but their high reactivity can render selectivity in competing pathways difficult to control. Here, we describe a strategy for inducing enantioselectivity in reactions of protio-iminium ions, wherein a chiral catalyst interacts with the highly reactive intermediate through a network of noncovalent interactions. This interaction leads to an attenuation of the reactivity of the iminium ion and allows high enantioselectivity in cycloadditions with electron-rich alkenes (the Povarov reaction). A detailed experimental and computational analysis of this catalyst system has revealed the precise nature of the catalyst-substrate interactions and the likely basis for enantioinduction.	[Xu, Hao; Zuend, Stephan J.; Woll, Matthew G.; Tao, Ye; Jacobsen, Eric N.] Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA	Harvard University	Jacobsen, EN (corresponding author), Harvard Univ, Dept Chem & Chem Biol, Cambridge, MA 02138 USA.	jacobsen@chemistry.harvard.edu		Tao, Ye/0000-0002-6846-5109	NIH [GM-43214, P50 GM-69721]; Dreyfus Foundation; American Chemical Society; Roche; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043214, R01GM043214, P50GM069721] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dreyfus Foundation; American Chemical Society(American Chemical Society); Roche(Roche Holding); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by NIH (grants GM-43214 and P50 GM-69721) and by fellowship support from the Dreyfus Foundation (to H. X.), the American Chemical Society and Roche (to S.J.Z.), and the American Chemical Society through the Irving S. Sigal Postdoctoral Fellowship (to M. G. W.). We thank L. P. C. Nielsen for helpful discussions. Metrical parameters for a derivative of compound 4a<INF>exo</INF> are available free of charge from the Cambridge Crystallographic Data Centre.	Akiyama T, 2004, ANGEW CHEM INT EDIT, V43, P1566, DOI 10.1002/anie.200353240; Akiyama T, 2007, CHEM REV, V107, P5744, DOI 10.1021/cr068374j; Akiyama T, 2006, J AM CHEM SOC, V128, P13070, DOI 10.1021/ja064676r; Batey RA, 1999, CHEM COMMUN, P651, DOI 10.1039/a809614g; Doyle AG, 2007, CHEM REV, V107, P5713, DOI 10.1021/cr068373r; EIGEN M, 1964, ANGEW CHEM INT EDIT, V3, P1, DOI 10.1002/anie.196400011; Elia GR, 1996, CAN J CHEM, V74, P591, DOI 10.1139/v96-063; Frisch M., 2016, GAUSSIAN16; GONZALEZ J, 1992, J ORG CHEM, V57, P3031, DOI 10.1021/jo00037a016; Hatano M, 2008, J AM CHEM SOC, V130, P16858, DOI 10.1021/ja806875c; Isaacs N., 1995, PHYSICAL ORGANIC CHE, P296; ISHIHARA K, 1994, J AM CHEM SOC, V116, P11179, DOI 10.1021/ja00103a052; Ishitani H, 1996, TETRAHEDRON LETT, V37, P7357, DOI 10.1016/0040-4039(96)01655-3; KELLY TR, 1994, J AM CHEM SOC, V116, P7072, DOI 10.1021/ja00095a009; Klausen RS, 2009, ORG LETT, V11, P887, DOI 10.1021/ol802887h; Kouznetsov VV, 2009, TETRAHEDRON, V65, P2721, DOI 10.1016/j.tet.2008.12.059; LEESON PD, 1992, J MED CHEM, V35, P1954, DOI 10.1021/jm00089a004; Liu H, 2009, J AM CHEM SOC, V131, P4598, DOI 10.1021/ja900806q; Mayr H, 1997, J AM CHEM SOC, V119, P12727, DOI 10.1021/ja972860u; Nakashima D, 2006, J AM CHEM SOC, V128, P9626, DOI 10.1021/ja062508t; Raheem IT, 2007, J AM CHEM SOC, V129, P13404, DOI 10.1021/ja076179w; Schreiner PR, 2002, ORG LETT, V4, P217, DOI 10.1021/ol017117s; SEEBACH D, 1975, ANGEW CHEM INT EDIT, V14, P634, DOI 10.1002/anie.197506342; Sessler JL, 2006, MONOGR SUPRAMOL CHEM, P1, DOI 10.1039/9781847552471; Takamura M, 2001, J AM CHEM SOC, V123, P6801, DOI 10.1021/ja010654n; Tan KL, 2007, ANGEW CHEM INT EDIT, V46, P1315, DOI 10.1002/anie.200603354; Uraguchi D, 2004, J AM CHEM SOC, V126, P11804, DOI 10.1021/ja046185h; Vachal P, 2002, J AM CHEM SOC, V124, P10012, DOI 10.1021/ja027246j; Weil T, 2008, ORG LETT, V10, P1513, DOI 10.1021/ol800149y; WITHERUP KM, 1995, J AM CHEM SOC, V117, P6682, DOI 10.1021/ja00130a005; Xia CF, 2002, TETRAHEDRON LETT, V43, P9405, DOI 10.1016/S0040-4039(02)02331-6; Yamamoto H, 2005, ANGEW CHEM INT EDIT, V44, P1924, DOI 10.1002/anie.200460394	32	391	394	8	195	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					986	990		10.1126/science.1182826	http://dx.doi.org/10.1126/science.1182826			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	556XE	20167783	Green Accepted			2022-12-01	WOS:000274625800037
J	Huppa, JB; Axmann, M; Mortelmaier, MA; Lillemeier, BF; Newell, EW; Brameshuber, M; Klein, LO; Schutz, GJ; Davis, MM				Huppa, Johannes B.; Axmann, Markus; Moertelmaier, Manuel A.; Lillemeier, Bjoern F.; Newell, Evan W.; Brameshuber, Mario; Klein, Lawrence O.; Schuetz, Gerhard J.; Davis, Mark M.			TCR-peptide-MHC interactions in situ show accelerated kinetics and increased affinity	NATURE			English	Article							T-CELL-RECEPTOR; 2-DIMENSIONAL DISSOCIATION-CONSTANT; IMMUNOLOGICAL SYNAPSE; ADHESION MOLECULES; RECOGNITION; ACTIVATION; COMPLEX; BINDING; SENSITIVITY; ANTIGEN	The recognition of foreign antigens by T lymphocytes is essential to most adaptive immune responses. It is driven by specific T-cell antigen receptors (TCRs) binding to antigenic peptide-major histocompatibility complex (pMHC) molecules on other cells(1). If productive, these interactions promote the formation of an immunological synapse(2,3). Here we show that synaptic TCR-pMHC binding dynamics differ significantly from TCR-pMHC binding in solution. We used single-molecule microscopy and fluorescence resonance energy transfer (FRET) between fluorescently tagged TCRs and their cognate pMHC ligands to measure the kinetics of TCR-pMHC binding in situ. When compared with solution measurements, the dissociation of this complex was increased significantly (4-12-fold). Disruption of actin polymers reversed this effect, indicating that cytoskeletal dynamics destabilize this interaction directly or indirectly. Nevertheless, TCR affinity for pMHC was significantly elevated as the result of a large (about 100-fold) increase in the association rate, a likely consequence of complementary molecular orientation and clustering. In helper T cells, the CD4 molecule has been proposed to bind cooperatively with the TCR to the same pMHC complex. However, CD4 blockade had no effect on the synaptic TCR affinity, nor did it destabilize TCR-pMHC complexes, indicating that the TCR binds pMHC independently of CD4.	[Huppa, Johannes B.; Moertelmaier, Manuel A.; Lillemeier, Bjoern F.; Newell, Evan W.; Klein, Lawrence O.; Davis, Mark M.] Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA; [Davis, Mark M.] Beckman Ctr B221, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Axmann, Markus; Moertelmaier, Manuel A.; Brameshuber, Mario; Schuetz, Gerhard J.] Johannes Kepler Univ Linz, Inst Biophys, A-4040 Linz, Austria	Stanford University; Howard Hughes Medical Institute; Johannes Kepler University Linz	Davis, MM (corresponding author), Stanford Univ, Dept Microbiol & Immunol, Stanford Sch Med, Stanford, CA 94305 USA.	mmdavis@stanford.edu	Newell, Evan W/F-9711-2012; Schuetz, Gerhard/B-1243-2008; Huppa, Johannes Bernhard/AAY-9471-2021	Newell, Evan W/0000-0002-2889-243X; Schuetz, Gerhard/0000-0003-1542-1089; Huppa, Johannes Bernhard/0000-0003-2634-8198; Brameshuber, Mario/0000-0001-8672-2255; Lillemeier, Bjorn/0000-0002-9425-6327; Moertelmaier, Manuel/0000-0003-4239-9809; Axmann, Markus/0000-0001-9818-9734; Davis, Mark/0000-0001-6868-657X	National Institutes of Health [RO1 AI52211]; Howard Hughes Medical Institute; Frontier Research Center (iFREC); Wilhelm Macke Stiftung; American Cancer Society; National Science Foundation; Austrian Science Fund [Y250-B10]; Austrian Ministry for Science and Research; Austrian Science Fund (FWF) [Y 250] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [T32AI007290, R01AI052211, R01AI022511] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Frontier Research Center (iFREC); Wilhelm Macke Stiftung; American Cancer Society(American Cancer Society); National Science Foundation(National Science Foundation (NSF)); Austrian Science Fund(Austrian Science Fund (FWF)); Austrian Ministry for Science and Research; Austrian Science Fund (FWF)(Austrian Science Fund (FWF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. E. Tynan, A. K. Chakraborty and S. R. Quake for helpful discussions, and P. P. J. Ebert for help with the flow cytometry experiments. This work was supported by grants from the National Institutes of Health (RO1 AI52211) and the Howard Hughes Medical Institute to M. M. D. J. B. H. is partly supported by the Immunology Frontier Research Center (iFREC) consortium, M. A. M. received a postdoctoral fellowship from the Wilhelm Macke Stiftung, and E.W.N. from the American Cancer Society's Steven Stanley and Edward Albert Bielfelt Fund. L.O.K. is supported by a National Science Foundation predoctoral fellowship. M. A., M. B. and G. J. S. received grants from the Austrian Science Fund (project Y250-B10) and the GEN-AU project of the Austrian Ministry for Science and Research.	BELL GI, 1978, SCIENCE, V200, P618, DOI 10.1126/science.347575; Choudhuri K, 2005, NATURE, V436, P578, DOI 10.1038/nature03843; CORR M, 1994, SCIENCE, V265, P946, DOI 10.1126/science.8052850; Dai S, 2008, IMMUNITY, V28, P324, DOI 10.1016/j.immuni.2008.01.008; Davis MM, 2007, ANNU REV IMMUNOL, V25, P681, DOI 10.1146/annurev.immunol.24.021605.090600; Dustin ML, 1996, J CELL BIOL, V132, P465, DOI 10.1083/jcb.132.3.465; Fricke GM, 2006, BIOPHYS CHEM, V119, P205, DOI 10.1016/j.bpc.2005.09.019; Garcia KC, 1998, SCIENCE, V279, P1166, DOI 10.1126/science.279.5354.1166; Grakoui A, 1999, SCIENCE, V285, P221, DOI 10.1126/science.285.5425.221; Huppa JB, 2003, NAT IMMUNOL, V4, P749, DOI 10.1038/ni951; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Kaizuka Y, 2007, P NATL ACAD SCI USA, V104, P20296, DOI 10.1073/pnas.0710258105; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Krogsgaard M, 2003, MOL CELL, V12, P1367, DOI 10.1016/S1097-2765(03)00474-X; Li QJ, 2004, NAT IMMUNOL, V5, P791, DOI 10.1038/ni1095; Lillemeier BF, 2010, NAT IMMUNOL, V11, P90, DOI 10.1038/ni.1832; Lillemeier BF, 2006, P NATL ACAD SCI USA, V103, P18992, DOI 10.1073/pnas.0609009103; MATSUI K, 1994, P NATL ACAD SCI USA, V91, P12862, DOI 10.1073/pnas.91.26.12862; Moertelmaier M, 2005, APPL PHYS LETT, V87, DOI 10.1063/1.2158031; Monks CRF, 1998, NATURE, V395, P82, DOI 10.1038/25764; Schamel WWA, 2005, J EXP MED, V202, P493, DOI 10.1084/jem.20042155; Sykulev Y, 1996, IMMUNITY, V4, P565, DOI 10.1016/S1074-7613(00)80483-5; Tsumoto K, 1998, J IMMUNOL METHODS, V219, P119, DOI 10.1016/S0022-1759(98)00127-6; Tynan FE, 2007, NAT IMMUNOL, V8, P268, DOI 10.1038/ni1432; VANDERMERWE PA, 1995, CURR BIOL, V5, P74; Wang JH, 1998, EMBO J, V17, P10, DOI 10.1093/emboj/17.1.10; Weikl TR, 2004, BIOPHYS J, V87, P3665, DOI 10.1529/biophysj.104.045609; Wu LC, 2002, NATURE, V418, P552, DOI 10.1038/nature00920; Xiong Y, 2001, J BIOL CHEM, V276, P5659, DOI 10.1074/jbc.M009580200; Zhu DM, 2007, BIOPHYS J, V92, P1022, DOI 10.1529/biophysj.106.089649	30	341	352	5	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					963	U143		10.1038/nature08746	http://dx.doi.org/10.1038/nature08746			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164930	Green Accepted			2022-12-01	WOS:000274582700049
J	Pape, JW; Johnson, WD; Fitzgerald, DW				Pape, Jean William; Johnson, Warren D., Jr.; Fitzgerald, Daniel W.			The Earthquake in Haiti - Dispatch from Port-au-Prince	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Fitzgerald, Daniel W.] Weill Cornell Med Coll, GHESKIO Ctr, New York, NY USA; [Fitzgerald, Daniel W.] Weill Cornell Med Coll, Ctr Global Hlth, New York, NY USA	Cornell University; Cornell University					FIC NIH HHS [D43 TW000018] Funding Source: Medline; NIAID NIH HHS [UM1 AI069421, U01 AI069421] Funding Source: Medline; FOGARTY INTERNATIONAL CENTER [D43TW000018] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI069421, UM1AI069421] Funding Source: NIH RePORTER	FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))			0	25	25	0	6	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					575	577		10.1056/NEJMp1001015	http://dx.doi.org/10.1056/NEJMp1001015			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	556ED	20107209	Bronze			2022-12-01	WOS:000274571200003
J	Karlas, A; Machuy, N; Shin, Y; Pleissner, KP; Artarini, A; Heuer, D; Becker, D; Khalil, H; Ogilvie, LA; Hess, S; Maurer, AP; Muller, E; Wolff, T; Rudel, T; Meyer, TF				Karlas, Alexander; Machuy, Nikolaus; Shin, Yujin; Pleissner, Klaus-Peter; Artarini, Anita; Heuer, Dagmar; Becker, Daniel; Khalil, Hany; Ogilvie, Lesley A.; Hess, Simone; Maeurer, Andre P.; Mueller, Elke; Wolff, Thorsten; Rudel, Thomas; Meyer, Thomas F.			Genome-wide RNAi screen identifies human host factors crucial for influenza virus replication	NATURE			English	Article							ION-CHANNEL PROTEIN; A-VIRUS; GENES; EXPORT; INTERFERENCE; TRANSCRIPTION; INFECTION; COMPLEX; TARGETS; ATPASE	Influenza A virus, being responsible for seasonal epidemics and reoccurring pandemics, represents a worldwide threat to public health(1). High mutation rates facilitate the generation of viral escape mutants, rendering vaccines and drugs directed against virus-encoded targets potentially ineffective(2). In contrast, targeting host cell determinants temporarily dispensable for the host but crucial for virus replication could prevent viral escape. Here we report the discovery of 287 human host cell genes influencing influenza A virus replication in a genome-wide RNA interference (RNAi) screen. Using an independent assay we confirmed 168 hits (59%) inhibiting either the endemic H1N1 (119 hits) or the current pandemic swine-origin (121 hits) influenza A virus strains, with an overlap of 60%. Notably, a subset of these common hits was also essential for replication of a highly pathogenic avian H5N1 strain. In-depth analyses of several factors provided insights into their infection stage relevance. Notably, SON DNA binding protein (SON)(3) was found to be important for normal trafficking of influenza virions to late endosomes early in infection. We also show that a small molecule inhibitor of CDC-like kinase 1 (CLK1)(4) reduces influenza virus replication by more than two orders of magnitude, an effect connected with impaired splicing of the viral M2 messenger RNA. Furthermore, influenza-virus-infected p27(-/-) (cyclin-dependent kinase inhibitor 1B; Cdkn1b) mice accumulated significantly lower viral titres in the lung, providing in vivo evidence for the importance of this gene. Thus, our results highlight the potency of genome-wide RNAi screening for the dissection of virus-host interactions and the identification of drug targets for a broad range of influenza viruses.	[Karlas, Alexander; Machuy, Nikolaus; Shin, Yujin; Artarini, Anita; Heuer, Dagmar; Becker, Daniel; Khalil, Hany; Ogilvie, Lesley A.; Hess, Simone; Maeurer, Andre P.; Mueller, Elke; Rudel, Thomas; Meyer, Thomas F.] Max Planck Inst Infect Biol, Dept Mol Biol, D-10117 Berlin, Germany; [Pleissner, Klaus-Peter] Max Planck Inst Infect Biol, Core Facil Bioinformat, D-10117 Berlin, Germany; [Wolff, Thorsten] Robert Koch Inst, D-13353 Berlin, Germany	Max Planck Society; Max Planck Society; Robert Koch Institute	Meyer, TF (corresponding author), Max Planck Inst Infect Biol, Dept Mol Biol, Charitepl 1, D-10117 Berlin, Germany.	meyer@mpiib-berlin.mpg.de	Meyer, Thomas F. F/J-2485-2013; Khalil, Hany/J-7700-2017	Meyer, Thomas F. F/0000-0002-6120-8679; Khalil, Hany/0000-0001-9738-4087; Ogilvie, Lesley/0000-0001-9794-2915; Artarini, Anita/0000-0002-0235-7973; Karlas, Alexander/0000-0002-2187-2057	EU [LSHB-CT-2004-005276]; ERA-Net Pathogenomics [0313938A]; FCI; RiNA network Berlin; German Government support via BMG; German Government support via BMBF	EU(European Commission); ERA-Net Pathogenomics; FCI(Fonds der Chemischen Industrie); RiNA network Berlin; German Government support via BMG; German Government support via BMBF(Federal Ministry of Education & Research (BMBF))	The authors would like to thank M. Drabkina, G. Heins, D. Khalil and D. Manntz for technical support, and K. Hoffmann and the experimental animal facility, headed by U. Klemm, for supporting mouse experiments. We also thank A. Pekosz for providing the influenza luciferase reporter construct and S. Becker for the pandemic H1N1 influenza strain. This work was supported through the EU FP6 project RIGHT (LSHB-CT-2004-005276), ERA-Net Pathogenomics (grant no. 0313938A) and a grant from FCI to T. F. M., and the RiNA network Berlin to T. R. and T. F. M. T. W. acknowledges German Government support via BMG (FSI program) and BMBF (FluResearchNet). H. K. and A. A. are student fellows of the Egyptian Government and IMPRS-IDI, respectively.	Boutros M, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r66; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Brideau C, 2003, J BIOMOL SCREEN, V8, P634, DOI 10.1177/1087057103258285; Bullock AN, 2009, STRUCTURE, V17, P352, DOI 10.1016/j.str.2008.12.023; Cherry S, 2005, GENE DEV, V19, P445, DOI 10.1101/gad.1267905; Cheung TKW, 2005, J GEN VIROL, V86, P1447, DOI 10.1099/vir.0.80727-0; Cullen BR, 2003, TRENDS BIOCHEM SCI, V28, P419, DOI 10.1016/S0968-0004(03)00142-7; Elton D, 2001, J VIROL, V75, P408, DOI 10.1128/JVI.75.1.408-419.2001; Falcon S, 2007, BIOINFORMATICS, V23, P257, DOI 10.1093/bioinformatics/btl567; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; GUINEA R, 1995, J VIROL, V69, P2306, DOI 10.1128/JVI.69.4.2306-2312.1995; Hagiwara M, 2005, BBA-PROTEINS PROTEOM, V1754, P324, DOI 10.1016/j.bbapap.2005.09.010; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hopkins AL, 2002, NAT REV DRUG DISCOV, V1, P727, DOI 10.1038/nrd892; Horimoto T, 2005, NAT REV MICROBIOL, V3, P591, DOI 10.1038/nrmicro1208; Huang YQ, 2004, P NATL ACAD SCI USA, V101, P9666, DOI 10.1073/pnas.0403533101; Joshi-Tope G, 2005, NUCLEIC ACIDS RES, V33, pD428, DOI 10.1093/nar/gki072; Josset L, 2008, J CLIN VIROL, V43, P381, DOI 10.1016/j.jcv.2008.08.017; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Ludwig S, 2003, TRENDS MOL MED, V9, P46, DOI 10.1016/S1471-4914(02)00010-2; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Machuy N, 2005, MOL CELL PROTEOMICS, V4, P44, DOI 10.1074/mcp.M400089-MCP200; Muraki M, 2004, J BIOL CHEM, V279, P24246, DOI 10.1074/jbc.M314298200; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; PEREZ L, 1994, J GEN VIROL, V75, P2595, DOI 10.1099/0022-1317-75-10-2595; Salomon R, 2006, J EXP MED, V203, P689, DOI 10.1084/jem.20051938; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; SESSIONS OM, 2009, DISCOVERY INSECT HUM, V458, P1047; Shih SR, 1996, EMBO J, V15, P5415, DOI 10.1002/j.1460-2075.1996.tb00925.x; Sun CT, 2001, J BIOL CHEM, V276, P24059, DOI 10.1074/jbc.M101330200	33	521	555	5	100	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					818	U132		10.1038/nature08760	http://dx.doi.org/10.1038/nature08760			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20081832	Green Published			2022-12-01	WOS:000274394300042
J	Kumagai, A; Shevchenko, A; Shevchenko, A; Dunphy, WG				Kumagai, Akiko; Shevchenko, Anna; Shevchenko, Andrej; Dunphy, William G.			Treslin Collaborates with TopBP1 in Triggering the Initiation of DNA Replication	CELL			English	Article							XENOPUS EGG EXTRACTS; POLYMERASE-ALPHA; S-PHASE; BUDDING YEAST; ATR; CDK; CHROMATIN; COMPLEX; PROTEIN; CDC45	TopBP1 has important roles in both DNA replication and checkpoint regulation in vertebrates. We have identified a protein called Treslin that associates with TopBP1 in Xenopus egg extracts. Depletion of Treslin from egg extracts strongly inhibits chromosomal DNA replication. Binding of Treslin to chromatin in egg extracts occurs independently of TopBP1. However, loading of the initiator protein Cdc45 onto chromatin cannot take place in the absence of Treslin. Prior to the initiation of DNA replication, Treslin associates with TopBP1 in a Cdk2-dependent manner. Ablation of Treslin from human cells also strongly inhibits DNA replication. Taken together, these results indicate that Treslin and TopBP1 collaborate in the Cdk2-mediated loading of Cdc45 onto replication origins. Thus, Treslin regulates a pivotal step in the initiation of DNA replication in vertebrates.	[Kumagai, Akiko; Dunphy, William G.] CALTECH, Div Biol 147 75, Pasadena, CA 91125 USA; [Shevchenko, Anna; Shevchenko, Andrej] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany	California Institute of Technology; Max Planck Society	Dunphy, WG (corresponding author), CALTECH, Div Biol 147 75, Pasadena, CA 91125 USA.	dunphy@caltech.edu			National Institutes of Health [GM043974, GM070891]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM043974, R01GM043974, R01GM070891] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to laboratory members for comments on the manuscript. We would also like to thank Rochelle Diamond for assistance with the FACS analyses and T.C. Spelsberg (Mayo Clinic) for the U2OS T-REx cells. This work was supported by National Institutes of Health grants GM043974 and GM070891 to W.G.D.	Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Botchan M, 2007, NATURE, V445, P272, DOI 10.1038/445272a; Delacroix S, 2007, GENE DEV, V21, P1472, DOI 10.1101/gad.1547007; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Garcia V, 2005, DNA REPAIR, V4, P1227, DOI 10.1016/j.dnarep.2005.04.001; Hashimoto Y, 2003, EMBO J, V22, P2526, DOI 10.1093/emboj/cdg238; Hashimoto Y, 2006, GENES CELLS, V11, P993, DOI 10.1111/j.1365-2443.2006.00998.x; Jares P, 2000, GENE DEV, V14, P1528; Junqueira M, 2008, J PROTEOME RES, V7, P3382, DOI 10.1021/pr800140v; Kumagai A, 2000, MOL CELL, V6, P839, DOI 10.1016/S1097-2765(05)00092-4; Kumagai A, 2006, CELL, V124, P943, DOI 10.1016/j.cell.2005.12.041; Lee J, 2007, J BIOL CHEM, V282, P28036, DOI 10.1074/jbc.M704635200; Matsuno K, 2006, MOL CELL BIOL, V26, P4843, DOI 10.1128/MCB.02267-05; McGarry TJ, 1998, CELL, V93, P1043, DOI 10.1016/S0092-8674(00)81209-X; Mendez J, 2003, BIOESSAYS, V25, P1158, DOI 10.1002/bies.10370; Mimura S, 2000, GENES CELLS, V5, P439, DOI 10.1046/j.1365-2443.2000.00340.x; Mimura S, 1998, EMBO J, V17, P5699, DOI 10.1093/emboj/17.19.5699; Monroe DG, 2003, J CELL BIOCHEM, V90, P315, DOI 10.1002/jcb.10633; Mordes DA, 2008, GENE DEV, V22, P1478, DOI 10.1101/gad.1666208; Pacek M, 2004, EMBO J, V23, P3667, DOI 10.1038/sj.emboj.7600369; Sangrithi MN, 2005, CELL, V121, P887, DOI 10.1016/j.cell.2005.05.015; Sclafani RA, 2007, ANNU REV GENET, V41, P237, DOI 10.1146/annurev.genet.41.110306.130308; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; Tanaka S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-16; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Tercero JA, 2000, EMBO J, V19, P2082, DOI 10.1093/emboj/19.9.2082; Van Hatten RA, 2002, J CELL BIOL, V159, P541, DOI 10.1083/jcb.200207090; Walter J, 2000, MOL CELL, V5, P617, DOI 10.1016/S1097-2765(00)80241-5; Yan S, 2006, J CELL BIOL, V173, P181, DOI 10.1083/jcb.200601076; Yoo HY, 2009, MOL BIOL CELL, V20, P2351, DOI 10.1091/mbc.E08-12-1190; Yoo HY, 2004, J BIOL CHEM, V279, P53353, DOI 10.1074/jbc.M408026200; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	33	169	174	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					349	U59		10.1016/j.cell.2009.12.049	http://dx.doi.org/10.1016/j.cell.2009.12.049			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20116089	Bronze, Green Accepted			2022-12-01	WOS:000274297700013
J	Ecker, AS; Berens, P; Keliris, GA; Bethge, M; Logothetis, NK; Tolias, AS				Ecker, Alexander S.; Berens, Philipp; Keliris, Georgios A.; Bethge, Matthias; Logothetis, Nikos K.; Tolias, Andreas S.			Decorrelated Neuronal Firing in Cortical Microcircuits	SCIENCE			English	Article							PRIMARY VISUAL-CORTEX; AREA MT; NOISE CORRELATIONS; INFORMATION; VARIABILITY; DISCHARGE; ACCURACY; MACAQUE; CONNECTIVITY; SYNAPSES	Correlated trial-to-trial variability in the activity of cortical neurons is thought to reflect the functional connectivity of the circuit. Many cortical areas are organized into functional columns, in which neurons are believed to be densely connected and to share common input. Numerous studies report a high degree of correlated variability between nearby cells. We developed chronically implanted multitetrode arrays offering unprecedented recording quality to reexamine this question in the primary visual cortex of awake macaques. We found that even nearby neurons with similar orientation tuning show virtually no correlated variability. Our findings suggest a refinement of current models of cortical microcircuit architecture and function: Either adjacent neurons share only a few percent of their inputs or, alternatively, their activity is actively decorrelated.	[Ecker, Alexander S.; Berens, Philipp; Tolias, Andreas S.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Ecker, Alexander S.; Berens, Philipp; Keliris, Georgios A.; Bethge, Matthias; Logothetis, Nikos K.] Max Planck Inst Biol Cybernet, D-72076 Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp; Bethge, Matthias] Univ Tubingen, Inst Theoret Phys, D-72076 Tubingen, Germany; [Ecker, Alexander S.; Berens, Philipp; Bethge, Matthias] Univ Tubingen, Ctr Integrat Neurosci, D-72076 Tubingen, Germany; [Logothetis, Nikos K.] Univ Manchester, Div Imaging Sci & Biomed Engn, Manchester M1 7HL, Lancs, England; [Tolias, Andreas S.] Michael E DeBakey Vet Affairs Med Ctr, Houston, TX 77030 USA; [Tolias, Andreas S.] Rice Univ, Dept Computat & Appl Math, Houston, TX 77005 USA	Baylor College of Medicine; Max Planck Society; Eberhard Karls University of Tubingen; Eberhard Karls University of Tubingen; University of Manchester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Michael E DeBakey VA Medical Center; Rice University	Tolias, AS (corresponding author), Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA.	atolias@cns.bcm.edu	Bethge, Matthias/B-1554-2008; Logothetis, Nikos/U-9282-2019; Ecker, Alexander S/A-5184-2010; Keliris, Georgios A/B-6692-2008; Berens, Philipp/A-5653-2009	Ecker, Alexander S/0000-0003-2392-5105; Keliris, Georgios A/0000-0001-6732-1261; Berens, Philipp/0000-0002-0199-4727	National Eye Institute, NIH [R01 EY018847]; Max Planck Society; U.S. Department of Defense [W81XWH-08-2-0147]; Department of Veterans Affairs; Arnold and Mabel Beckman Foundation; German Federal Ministry of Education and Research (BMBF) [FKZ:01GQ0601]; NATIONAL EYE INSTITUTE [R01EY018847] Funding Source: NIH RePORTER	National Eye Institute, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Max Planck Society(Max Planck SocietyFoundation CELLEX); U.S. Department of Defense(United States Department of Defense); Department of Veterans Affairs(US Department of Veterans Affairs); Arnold and Mabel Beckman Foundation; German Federal Ministry of Education and Research (BMBF)(Federal Ministry of Education & Research (BMBF)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))	We thank M. Subramanian, A. Hoenselaar, T. J. Williford, and D. Murray for help with experiments; R. J. Cotton for his contribution in setting up recording equipment; and the Siapas laboratory at Caltech for providing the recording software. We thank R. J. Cotton, P. Dayan, S. Deneve, K. D. Harris, E. V. Lubenov, W. J. Ma, J. H. Macke, A. Renart, J. de la Rocha, A. G. Siapas, and S. M. Smirnakis for comments on the manuscript and discussions. This work was supported by the National Eye Institute, NIH (R01 EY018847), the Max Planck Society, the U.S. Department of Defense (W81XWH-08-2-0147), a VA Merit Award from the Department of Veterans Affairs, and an Arnold and Mabel Beckman Foundation Young Investigator Award to A. S. T., and by the German Federal Ministry of Education and Research (BMBF) through the Bernstein award to M. B. (FKZ:01GQ0601).	Abbott LF, 1999, NEURAL COMPUT, V11, P91, DOI 10.1162/089976699300016827; AERTSEN AMHJ, 1989, J NEUROPHYSIOL, V61, P900, DOI 10.1152/jn.1989.61.5.900; Averbeck BB, 2003, J NEUROSCI, V23, P7630; Averbeck BB, 2006, J NEUROPHYSIOL, V95, P3633, DOI 10.1152/jn.00919.2005; BACH M, 1986, EXP BRAIN RES, V61, P451; Bair W, 2001, J NEUROSCI, V21, P1676, DOI 10.1523/JNEUROSCI.21-05-01676.2001; Braitenberg V, 1991, ANATOMY CORTEX STAT; BRYANT HL, 1973, J NEUROPHYSIOL, V36, P205, DOI 10.1152/jn.1973.36.2.205; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; de la Rocha J, 2007, NATURE, V448, P802, DOI 10.1038/nature06028; Gawne TJ, 1996, CEREB CORTEX, V6, P482, DOI 10.1093/cercor/6.3.482; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; Gray CM, 1995, J NEUROSCI METH, V63, P43, DOI 10.1016/0165-0270(95)00085-2; Gutnisky DA, 2008, NATURE, V452, P220, DOI 10.1038/nature06563; Harris KD, 2000, J NEUROPHYSIOL, V84, P401, DOI 10.1152/jn.2000.84.1.401; HELLWIG B, 1994, BIOL CYBERN, V71, P1, DOI 10.1007/BF00198906; Hertz J, 2010, NEURAL COMPUT, V22, P427, DOI 10.1162/neco.2009.06-08-806; Huang X, 2009, J NEUROPHYSIOL, V101, P3012, DOI 10.1152/jn.00010.2009; Kohn A, 2005, J NEUROSCI, V25, P3661, DOI 10.1523/JNEUROSCI.5106-04.2005; Lee D, 1998, J NEUROSCI, V18, P1161; Poulet JFA, 2008, NATURE, V454, P881, DOI 10.1038/nature07150; Reich DS, 2001, SCIENCE, V294, P2566, DOI 10.1126/science.1065839; Renart A, 2010, SCIENCE, V327, P587, DOI 10.1126/science.1179850; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Smith MA, 2008, J NEUROSCI, V28, P12591, DOI 10.1523/JNEUROSCI.2929-08.2008; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; Tolias AS, 2007, J NEUROPHYSIOL, V98, P3780, DOI 10.1152/jn.00260.2007; Wilke SD, 2002, NEURAL COMPUT, V14, P155, DOI 10.1162/089976602753284482; Yu YC, 2009, NATURE, V458, P501, DOI 10.1038/nature07722; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	31	429	433	0	41	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					584	587		10.1126/science.1179867	http://dx.doi.org/10.1126/science.1179867			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110506				2022-12-01	WOS:000274020500039
J	Wilson, CG; Sherman, PW				Wilson, Christopher G.; Sherman, Paul W.			Anciently Asexual Bdelloid Rotifers Escape Lethal Fungal Parasites by Drying Up and Blowing Away	SCIENCE			English	Article							RED-QUEEN; SEX	Asexuality has major theoretical advantages over sexual reproduction. An important evolutionary puzzle, therefore, is why exclusively asexual metazoan lineages rarely endure. The Red Queen hypothesis posits that asexuality is rapidly extinguished by relentlessly coevolving parasites and pathogens. If so, any long-lasting asexual lineage must have unusual alternative mechanisms to deal with these biotic enemies. Bdelloid rotifers are freshwater invertebrates that abandoned sexual reproduction millions of years ago. Here, we show that cultured populations of bdelloids can rid themselves of a deadly fungal parasite through complete desiccation (anhydrobiosis) and disperse by wind to establish new populations in its absence. In Red Queen models, spatiotemporal escape can decouple and protect asexuals from coevolving enemies. Thus, our results may help to explain the persistence of the anciently asexual Bdelloidea.	[Wilson, Christopher G.; Sherman, Paul W.] Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14850 USA	Cornell University	Wilson, CG (corresponding author), Cornell Univ, Dept Neurobiol & Behav, Ithaca, NY 14850 USA.	cgw8@cornell.edu		Wilson, Christopher/0000-0001-7649-5255	Sigma Xi; U.S. Department of Agriculture; Cornell University	Sigma Xi; U.S. Department of Agriculture(United States Department of Agriculture (USDA)); Cornell University	We thank D. Slottje, G. Masters, and J. Hue for research assistance; K. Hodge, S. Glockling, D. Fontaneto, and G. Barron for helpful advice; U.S. Agricultural Research Service collection of Entomopathogenic Fungi (ARSEF) for fungal isolates; and T. Seeley, J. Scarl, K. Reeve, R. Raguso, C. Lively, N. Hairston, and R. Booker for useful commentaries. Financial support was provided by Sigma Xi, U.S. Department of Agriculture, and Cornell University (Department of Neurobiology and Behavior and an S. H. Weiss Presidential Fellowship to P. W. S.).	Agrawal AF, 2006, PLOS BIOL, V4, P1364, DOI 10.1371/journal.pbio.0040265; Barraclough TG, 2007, MOL BIOL EVOL, V24, P1952, DOI 10.1093/molbev/msm123; BARRON GL, 1991, CAN J BOT, V69, P494, DOI 10.1139/b91-067; Bell G., 1982, MASTERPIECE NATURE; Caceres CE, 2002, OECOLOGIA, V131, P402, DOI 10.1007/s00442-002-0897-5; Fontaneto D, 2008, MOL ECOL, V17, P3136, DOI 10.1111/j.1365-294X.2008.03806.x; HAMILTON WD, 1980, OIKOS, V35, P282, DOI 10.2307/3544435; HAMILTON WD, 1990, P NATL ACAD SCI USA, V87, P3566, DOI 10.1073/pnas.87.9.3566; Jenkins DG, 1998, HYDROBIOLOGIA, V387, P15, DOI 10.1023/A:1017080029317; Jokela J, 2009, AM NAT, V174, pS43, DOI 10.1086/599080; Judson Olivia P., 1996, Trends in Ecology and Evolution, V11, P41, DOI 10.1016/0169-5347(96)81040-8; Judson OP, 1997, J THEOR BIOL, V186, P33, DOI 10.1006/jtbi.1996.0339; LADLE RJ, 1993, P ROY SOC B-BIOL SCI, V253, P155, DOI 10.1098/rspb.1993.0096; Normark BB, 2003, BIOL J LINN SOC, V79, P69, DOI 10.1046/j.1095-8312.2003.00182.x; Ricci C, 2001, HYDROBIOLOGIA, V446, P1, DOI 10.1023/A:1017548418201; Salathe M, 2008, TRENDS ECOL EVOL, V23, P439, DOI 10.1016/j.tree.2008.04.010; Tunnacliffe A, 2003, PHILOS T ROY SOC B, V358, P1755, DOI 10.1098/rstb.2002.1214; Welch DBM, 2008, P NATL ACAD SCI USA, V105, P5145, DOI 10.1073/pnas.0800972105; West SA, 1999, J EVOLUTION BIOL, V12, P1003	19	51	53	0	65	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 29	2010	327	5965					574	576		10.1126/science.1179252	http://dx.doi.org/10.1126/science.1179252			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110504				2022-12-01	WOS:000274020500036
J	Frank, DC; Esper, J; Raible, CC; Buntgen, U; Trouet, V; Stocker, B; Joos, F				Frank, David C.; Esper, Jan; Raible, Christoph C.; Buentgen, Ulf; Trouet, Valerie; Stocker, Benjamin; Joos, Fortunat			Ensemble reconstruction constraints on the global carbon cycle sensitivity to climate	NATURE			English	Article							NORTHERN-HEMISPHERE TEMPERATURES; ATMOSPHERIC CO2; LAST MILLENNIUM; ANTARCTIC ICE; FEEDBACKS; COMMITMENTS; RESOLUTION; HOLOCENE; CORE	The processes controlling the carbon flux and carbon storage of the atmosphere, ocean and terrestrial biosphere are temperature sensitive(1-4) and are likely to provide a positive feedback leading to amplified anthropogenic warming(3). Owing to this feedback, at time-scales ranging from interannual to the 20-100-kyr cycles of Earth's orbital variations(1,5-7), warming of the climate system causes a net release of CO2 into the atmosphere; this in turn amplifies warming. But the magnitude of the climate sensitivity of the global carbon cycle (termed gamma), and thus of its positive feedback strength, is under debate, giving rise to large uncertainties in global warming projections(8,9). Here we quantify the median gamma as 7.7 p. p. m. v. CO2 per degrees C warming, with a likely range of 1.7-21.4 p. p. m. v. CO2 per degrees C. Sensitivity experiments exclude significant influence of pre-industrial land-use change on these estimates. Our results, based on the coupling of a probabilistic approach with an ensemble of proxy-based temperature reconstructions and pre-industrial CO2 data from three ice cores, provide robust constraints for gamma on the policy-relevant multi-decadal to centennial timescales. By using an ensemble of >200,000 members, quantification of gamma is not only improved, but also likelihoods can be assigned, thereby providing a benchmark for future model simulations. Although uncertainties do not at present allow exclusion of gamma calculated from any of ten coupled carbon-climate models, we find that gamma is about twice as likely to fall in the lowermost than in the uppermost quartile of their range. Our results are incompatibly lower (P < 0.05) than recent pre-industrial empirical estimates of similar to 40 p. p. m. v. CO2 per degrees C (refs 6, 7), and correspondingly suggest similar to 80% less potential amplification of ongoing global warming.	[Frank, David C.; Buentgen, Ulf; Trouet, Valerie] Swiss Fed Res Inst WSL, CH-8903 Birmensdorf, Switzerland; [Frank, David C.; Raible, Christoph C.; Stocker, Benjamin; Joos, Fortunat] Univ Bern, Oeschger Ctr Climate Change Res, CH-3012 Bern, Switzerland; [Esper, Jan] Johannes Gutenberg Univ Mainz, Dept Geog, D-55099 Mainz, Germany; [Raible, Christoph C.; Stocker, Benjamin; Joos, Fortunat] Univ Bern, Inst Phys, CH-3012 Bern, Switzerland	Swiss Federal Institutes of Technology Domain; Swiss Federal Institute for Forest, Snow & Landscape Research; University of Bern; Johannes Gutenberg University of Mainz; University of Bern	Frank, DC (corresponding author), Swiss Fed Res Inst WSL, Zurcherstr 111, CH-8903 Birmensdorf, Switzerland.	david.frank@wsl.ch	Trouet, Valerie/AAE-4888-2021; Joos, Fortunat/B-4118-2018; buentgen, ulf/J-6952-2013; Frank, David/C-7764-2013; Esper, Jan/O-3127-2018; Stocker, Benjamin David/K-3194-2015; Raible, Christoph/M-8309-2016	Joos, Fortunat/0000-0002-9483-6030; Esper, Jan/0000-0003-3919-014X; Stocker, Benjamin David/0000-0003-2697-9096; Raible, Christoph/0000-0003-0176-0602; Frank, David/0000-0001-5463-5640; Trouet, Valerie/0000-0002-2683-8704	Swiss National Science Foundation (NCCR-Climate); European Union [226701, 017008]	Swiss National Science Foundation (NCCR-Climate)(Swiss National Science Foundation (SNSF)); European Union(European Commission)	We thank P. Friedlingstein, R. Knutti and T. Stocker for comments, the C4MIP consortium for use of their model output, and the Swiss National Science Foundation (NCCR-Climate) and the European Union projects Carbo-Extreme (226701) and Millennium (017008) for funding.	Archer D, 2008, CLIMATIC CHANGE, V90, P283, DOI 10.1007/s10584-008-9413-1; Briffa KR, 2000, QUATERNARY SCI REV, V19, P87, DOI 10.1016/S0277-3791(99)00056-6; Brohan P, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006548; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Cook E. R., 1981, Tree-Ring Bulletin, V41, P45; Cox P, 2008, SCIENCE, V321, P1642, DOI 10.1126/science.1158907; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; D'Arrigo R, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006352; Elsig J, 2009, NATURE, V461, P507, DOI 10.1038/nature08393; Esper J, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2004GL021236; Esper J, 2002, SCIENCE, V295, P2250, DOI 10.1126/science.1066208; Esper J, 2009, CLIMATIC CHANGE, V94, P267, DOI [10.1007/s10584-008-9492-z, 10.1007/s10584-008-9492-Z]; Etheridge DM, 1996, J GEOPHYS RES-ATMOS, V101, P4115, DOI 10.1029/95JD03410; Frank D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030571; Frank D, 2007, QUATERNARY SCI REV, V26, P3298, DOI 10.1016/j.quascirev.2007.08.002; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gerber S, 2003, CLIM DYNAM, V20, P281, DOI 10.1007/s00382-002-0270-8; Hegerl GC, 2007, J CLIMATE, V20, P650, DOI 10.1175/JCLI4011.1; Hegerl GC, 2006, NATURE, V440, P1029, DOI 10.1038/nature04679; Heimann M, 2008, NATURE, V451, P289, DOI 10.1038/nature06591; Huntingford C, 2009, TELLUS B, V61, P355, DOI 10.1111/j.1600-0889.2009.00414.x; Jones C, 2009, NAT GEOSCI, V2, P484, DOI 10.1038/ngeo555; Jones PD, 1998, HOLOCENE, V8, P455, DOI 10.1191/095968398667194956; Joos F, 2004, SCOPE SER, V62, P165; Joos F, 1999, SCIENCE, V284, P464, DOI 10.1126/science.284.5413.464; Joos F, 2008, P NATL ACAD SCI USA, V105, P1425, DOI 10.1073/pnas.0707386105; Juckes MN, 2007, CLIM PAST, V3, P591, DOI 10.5194/cp-3-591-2007; Lee TCK, 2008, CLIM DYNAM, V31, P263, DOI 10.1007/s00382-007-0351-9; MacDonald GM, 2006, SCIENCE, V314, P285, DOI 10.1126/science.1131722; Macfarlane DG, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025005; Mann ME, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL017814; Mann ME, 1999, GEOPHYS RES LETT, V26, P759, DOI 10.1029/1999GL900070; Mann ME, 2008, P NATL ACAD SCI USA, V105, P13252, DOI 10.1073/pnas.0805721105; Moberg A, 2005, NATURE, V433, P613, DOI 10.1038/nature03265; Plattner GK, 2008, J CLIMATE, V21, P2721, DOI 10.1175/2007JCLI1905.1; Pongratz J, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2009GB003488; Scheffer M, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2005GL025044; Siegenthaler U, 2005, TELLUS B, V57, P51, DOI 10.1111/j.1600-0889.2005.00131.x; Soloman SQD, 2007, CLIMATE CHANGE 2007; Strassmann KM, 2008, TELLUS B, V60, P583, DOI 10.1111/j.1600-0889.2008.00340.x; Thompson DWJ, 2008, NATURE, V453, P646, DOI 10.1038/nature06982; Thornton PE, 2009, BIOGEOSCIENCES, V6, P2099, DOI 10.5194/bg-6-2099-2009; Trouet V, 2009, SCIENCE, V324, P78, DOI 10.1126/science.1166349; Tschumi J, 2000, J GLACIOL, V46, P45, DOI 10.3189/172756500781833359; von Storch H, 2004, SCIENCE, V306, P679, DOI 10.1126/science.1096109; Woodwell GM, 1998, CLIMATIC CHANGE, V40, P495, DOI 10.1023/A:1005345429236	46	202	209	6	138	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					527	U143		10.1038/nature08769	http://dx.doi.org/10.1038/nature08769			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110999				2022-12-01	WOS:000273981100048
J	Maynard, A; Bloor, K				Maynard, Alan; Bloor, Karen			Will financial incentives and penalties improve hospital care?	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							PERFORMANCE; QUALITY; PAY; MEDICARE		[Maynard, Alan] Univ York, York Hlth Policy Grp, York YO10 5DD, N Yorkshire, England	University of York - UK	Maynard, A (corresponding author), Univ York, York Hlth Policy Grp, York YO10 5DD, N Yorkshire, England.	akm3@york.ac.uk		Bloor, Karen/0000-0003-4852-9854				Baker G., 2005, PROVIDER PAY FOR PER; Campbell SM, 2009, NEW ENGL J MED, V361, P368, DOI 10.1056/NEJMsa0807651; *DEP HLTH, IMP ASS COMM QUAL IN; *DEP HLTH, 2009, FIG YOU CAN TRUST BR; Department of Health, 2008, US COMM QUAL INN CQU; Department of Health, 2008, GUID ROUT COLL PAT R; Doran T, 2008, LANCET, V372, P728, DOI 10.1016/S0140-6736(08)61123-X; Fleetcroft Robert, 2006, J Health Serv Res Policy, V11, P27, DOI 10.1258/135581906775094316; Grossbart SR, 2006, MED CARE RES REV, V63, p29S, DOI 10.1177/1077558705283643; *HOUS COMM HLTH CO, 2008, PUBL EXP HLTH PERS S; Hughes D, 1999, SOCIOL HEALTH ILL, V21, P71, DOI 10.1111/1467-9566.00143; KAHNEMAN D, 1979, ECONOMETRICA, V47, P263, DOI 10.2307/1914185; Lindenauer PK, 2007, NEW ENGL J MED, V356, P486, DOI 10.1056/NEJMsa064964; Mehrotra A, 2009, AM J MED QUAL, V24, P19, DOI 10.1177/1062860608326634; Milstein A, 2009, NEW ENGL J MED, V360, P2388, DOI 10.1056/NEJMp0809125; National Patient Safety Agency. National Patient Safety Agency, 2009, NEV EV FRAM 2009 10; *NHS NW, ADV QUAL; *PREM, P4P POND; *PREM, ADV QUAL N W ENGL; Rosenthal MB, 2007, NEW ENGL J MED, V357, P1573, DOI 10.1056/NEJMp078184; Ryan AM, 2009, HEALTH SERV RES, V44, P821, DOI 10.1111/j.1475-6773.2009.00956.x; [No title captured]	22	18	18	0	3	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 21	2010	340								c88	10.1136/bmj.c88	http://dx.doi.org/10.1136/bmj.c88			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548HP	20093280				2022-12-01	WOS:000273951400011
J	Yeh, HC; Duncan, BB; Schmidt, MI; Wang, NY; Brancati, FL				Yeh, Hsin-Chieh; Duncan, Bruce B.; Schmidt, Maria Ines; Wang, Nae-Yuh; Brancati, Frederick L.			Smoking, Smoking Cessation, and Risk for Type 2 Diabetes Mellitus A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							ATHEROSCLEROSIS RISK; WEIGHT-GAIN; INSULIN-RESISTANCE; COMMUNITIES; OBESITY; INFLAMMATION; EFFICIENCY	Background: Cigarette smoking is an established predictor of incident type 2 diabetes mellitus, but the effects of smoking cessation on diabetes risk are unknown. Objective: To test the hypothesis that smoking cessation increases diabetes risk in the short term, possibly owing to cessation-related weight gain. Design: Prospective cohort study. Setting: The ARIC (Atherosclerosis Risk in Communities) Study. Patients: 10 892 middle-aged adults who initially did not have diabetes in 1987 to 1989. Measurements: Smoking was assessed by interview at baseline and at subsequent follow-up. Incident diabetes was ascertained by fasting glucose assays through 1998 and self-report of physician diagnosis or use of diabetes medications through 2004. Results: During 9 years of follow-up, 1254 adults developed type 2 diabetes. Compared with adults who never smoked, the adjusted hazard ratio of incident diabetes in the highest tertile of pack-years was 1.42 (95% CI, 1.20 to 1.67). In the first 3 years of follow-up, 380 adults quit smoking. After adjustment for age, race, sex, education, adiposity, physical activity, lipid levels, blood pressure, and ARIC Study center, compared with adults who never smoked, the hazard ratios of diabetes among former smokers, new quitters, and continuing smokers were 1.22 (CI, 0.99 to 1.50), 1.73 (CI, 1.19 to 2.53), and 1.31 (CI, 1.04 to 1.65), respectively. Further adjustment for weight change and leukocyte count attenuated these risks substantially. In an analysis of long-term risk after quitting, the highest risk occurred in the first 3 years (hazard ratio, 1.91 [CI, 1.19 to 3.05]), then gradually decreased to 0 at 12 years. Limitation: Residual confounding is possible even with meticulous adjustment for established diabetes risk factors. Conclusion: Cigarette smoking predicts incident type 2 diabetes, but smoking cessation leads to higher short-term risk. For smokers at risk for diabetes, smoking cessation should be coupled with strategies for diabetes prevention and early detection.	[Yeh, Hsin-Chieh] Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, Baltimore, MD 21205 USA; Univ Fed Rio Grande do Sul, BR-90470280 Porto Alegre, RS, Brazil; Univ N Carolina, Chapel Hill, NC USA	Johns Hopkins University; Universidade Federal do Rio Grande do Sul; University of North Carolina; University of North Carolina Chapel Hill	Yeh, HC (corresponding author), Johns Hopkins Univ, Welch Ctr Prevent Epidemiol & Clin Res, 2024 E Monument St,Suite 2-600, Baltimore, MD 21205 USA.	hyeh1@jhmi.edu	Schmidt, Maria/V-3196-2019; Duncan, Bruce B/L-4140-2016; Schmidt, Maria Inês/AGP-6441-2022; Schmidt, Maria Inês/AGT-5691-2022	Duncan, Bruce B/0000-0002-7491-2630; Schmidt, Maria Inês/0000-0002-3837-0731; Wang, Nae-Yuh/0000-0001-6513-9730	NHLBI [N01-HC-55015, N01-HC-55016, N01-HC-55018, N01HC-55019, N01-HC-55020, N01-HC-55021, N01-HC-55022]; NIDDK [5R01-DK56918-03]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC055015, N01HC055021, N01HC055016, N01HC055020, N01HC055018, N01HC055019, N01HC055022] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R41HL055018, R42HL055018, R41HL055019] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK079637, R01DK056918, P60DK079637] Funding Source: NIH RePORTER	NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	The ARIC Study is supported by contracts from the NHLBI (N01-HC-55015, N01-HC-55016, N01-HC-55018, N01HC-55019, N01-HC-55020, N01-HC-55021, and N01-HC-55022) and a grant from the NIDDK (5R01-DK56918-03).	BAECKE JAH, 1982, AM J CLIN NUTR, V36, P936; Balkau B, 2006, EUR J CARDIOV PREV R, V13, P334, DOI 10.1097/00149831-200606000-00007; Blaschke F, 2006, ARTERIOSCL THROM VAS, V26, P28, DOI 10.1161/01.ATV.0000191663.12164.77; Chinn S, 2005, LANCET, V365, P1629, DOI 10.1016/S0140-6736(05)66511-7; Chiolero A, 2008, AM J CLIN NUTR, V87, P801, DOI 10.1093/ajcn/87.4.801; Duncan BB, 2003, OBES RES, V11, P1339, DOI 10.1038/oby.2003.181; Duncan BB, 2003, DIABETES, V52, P1799, DOI 10.2337/diabetes.52.7.1799; EFRON B, 1977, J AM STAT ASSOC, V72, P557, DOI 10.2307/2286217; Ferrara CM, 2001, INT J OBESITY, V25, P1322, DOI 10.1038/sj.ijo.0801716; Hur NW, 2007, EUR J CARDIOV PREV R, V14, P244, DOI 10.1097/01.hjr.0000239474.41379.79; Liu R, 2001, METABOLISM, V50, P79, DOI 10.1053/meta.2001.19436; Liu S, 2007, ARCH INTERN MED, V167, P1676, DOI 10.1001/archinte.167.15.1676; NAGELE U, 1984, J CLIN CHEM CLIN BIO, V22, P165; O'Hara P, 1998, AM J EPIDEMIOL, V148, P821, DOI 10.1093/oxfordjournals.aje.a009706; O'Malley SS, 2006, ARCH INTERN MED, V166, P667, DOI 10.1001/archinte.166.6.667; Paynter NP, 2006, AM J EPIDEMIOL, V164, P1075, DOI 10.1093/aje/kwj323; Rehani K, 2008, BBA-MOL CELL RES, V1783, P375, DOI 10.1016/j.bbamcr.2007.12.003; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Sopori M, 2002, NAT REV IMMUNOL, V2, P372, DOI 10.1038/nri803; Strissel KJ, 2007, DIABETES, V56, P2910, DOI 10.2337/db07-0767; Tuncman G, 2006, P NATL ACAD SCI USA, V103, P10741, DOI 10.1073/pnas.0603509103; *U N CAR ARIC COOR, 1987, 2 U N CAR ARIC COORD; *U N CAR ARIC COOR, 1987, 11 U N CAR ARIC COOR; Wannamethee SG, 2001, DIABETES CARE, V24, P1590, DOI 10.2337/diacare.24.9.1590; WARNICK GR, 1982, CLIN CHEM, V28, P1574; Willi C, 2007, JAMA-J AM MED ASSOC, V298, P2654, DOI 10.1001/jama.298.22.2654; WILLIAMS OD, 1989, AM J EPIDEMIOL, V129, P687, DOI 10.1093/oxfordjournals.aje.a115184; Wittebole X, 2007, CLIN EXP IMMUNOL, V147, P28, DOI 10.1111/j.1365-2249.2006.03248.x; Yeh HC, 2005, DIABETES CARE, V28, P1472, DOI 10.2337/diacare.28.6.1472	29	231	238	2	39	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					10	W3		10.7326/0003-4819-152-1-201001050-00005	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00005			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FJ	20048267	Green Accepted			2022-12-01	WOS:000273556600002
J	Raff, M				Raff, Martin			New Routes into the Human Brain	CELL			English	Editorial Material							RETT-SYNDROME; MOUSE MODEL; AUTISM; NEUROBIOLOGY; NEUROLIGINS; DISORDERS; MUTATIONS; REVERSAL; DISEASE; CELLS		UCL, MRC, Mol Cell Biol Lab, London WC1E 6BT, England	University of London; University College London	Raff, M (corresponding author), UCL, MRC, Mol Cell Biol Lab, Mortimer St, London WC1E 6BT, England.	m.raff@ucl.ac.uk						Abrahams BS, 2008, NAT REV GENET, V9, P341, DOI 10.1038/nrg2346; Chahrour M, 2007, NEURON, V56, P422, DOI 10.1016/j.neuron.2007.10.001; Ehninger D, 2008, NEURON, V60, P950, DOI 10.1016/j.neuron.2008.12.007; Fyffe SL, 2008, NEURON, V59, P947, DOI 10.1016/j.neuron.2008.07.030; Gaspard N, 2008, NATURE, V455, P351, DOI 10.1038/nature07287; Guy J, 2007, SCIENCE, V315, P1143, DOI 10.1126/science.1138389; Hyman SE, 2008, NATURE, V455, P890, DOI 10.1038/nature07454; Jamain S, 2003, NAT GENET, V34, P27, DOI 10.1038/ng1136; Jamain S, 2008, P NATL ACAD SCI USA, V105, P1710, DOI 10.1073/pnas.0711555105; Laumonnier F, 2004, AM J HUM GENET, V74, P552, DOI 10.1086/382137; RAFF M, 2006, HIST NEUROSCIENCE AU, V5, P505; ROSEN DR, 1993, NATURE, V362, P59, DOI 10.1038/362059a0; Sudhof TC, 2008, NATURE, V455, P903, DOI 10.1038/nature07456; Yamamoto A, 2000, CELL, V101, P57, DOI 10.1016/S0092-8674(00)80623-6; Yamanaka S, 2009, CELL, V137, P13, DOI 10.1016/j.cell.2009.03.034	15	6	6	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1209	1211		10.1016/j.cell.2009.12.010	http://dx.doi.org/10.1016/j.cell.2009.12.010			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064362	Bronze			2022-12-01	WOS:000273048700003
J	Shen, XH; Kim, WJ; Fujiwara, Y; Simon, MD; Liu, YC; Mysliwiec, MR; Yuan, GC; Lee, Y; Orkin, SH				Shen, Xiaohua; Kim, Woojin; Fujiwara, Yuko; Simon, Matthew D.; Liu, Yingchun; Mysliwiec, Matthew R.; Yuan, Guo-Cheng; Lee, Youngsook; Orkin, Stuart H.			Jumonji Modulates Polycomb Activity and Self-Renewal versus Differentiation of Stem Cells	CELL			English	Article							MODEL-BASED ANALYSIS; TRANSCRIPTIONAL REPRESSION; HISTONE METHYLATION; GENE; PROTEIN; DEMETHYLASE; NETWORK; PLURIPOTENCY; CHROMATIN; ROLES	Trimethylation on histone H3 lysine 27 (H3K27me3) by Polycomb repressive complex 2 (PRC2) regulates the balance between self-renewal and differentiation of embryonic stem cells (ESCs). The mechanisms controlling the activity and recruitment of PRC2 are largely unknown. Here we demonstrate that the founding member of the Jumonji family, JMJ (JUMONJI or JARID2), is associated with PRC2, colocalizes with PRC2 and H3K27me3 on chromatin, and modulates PRC2 function. In vitro JMJ inhibits PRC2 methyltransferase activity, consistent with increased H3K27me3 marks at PRC2 targets in Jmj(-/-) ESCs. Paradoxically, JMJ is required for efficient binding of PRC2, indicating that the interplay of PRC2 and JMJ fine-tunes deposition of the H3K27me3 mark. During differentiation, activation of genes marked by H3K27me3 and lineage commitments are delayed in Jmj(-/-) ESCs. Our results demonstrate that dynamic regulation of Polycomb complex activity orchestrated by JMJ balances self-renewal and differentiation, highlighting the involvement of chromatin dynamics in cell-fate transitions.	[Shen, Xiaohua; Kim, Woojin; Fujiwara, Yuko; Orkin, Stuart H.] Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Shen, Xiaohua; Kim, Woojin; Fujiwara, Yuko; Orkin, Stuart H.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Orkin, Stuart H.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Orkin, Stuart H.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Liu, Yingchun; Yuan, Guo-Cheng] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Liu, Yingchun; Yuan, Guo-Cheng] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Simon, Matthew D.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Mysliwiec, Matthew R.; Lee, Youngsook] Univ Wisconsin, Sch Med & Publ Hlth, Dept Anat, Madison, WI 53706 USA	Harvard University; Boston Children's Hospital; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Massachusetts General Hospital; University of Wisconsin System; University of Wisconsin Madison	Orkin, SH (corresponding author), Childrens Hosp, Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA.	stuart_orkin@dfci.harvard.edu	liu, ying/GXF-4294-2022; Simon, Matthew/ABF-9127-2020; LIU, YING/GZL-7252-2022; Hu, Ruogu/B-2203-2008	Simon, Matthew/0000-0001-7423-5265	Claudia Adams Barr Program in Cancer Research; National Institutes of Health [HL67050]; American Heart Association [0615633Z]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL067050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK049216] Funding Source: NIH RePORTER	Claudia Adams Barr Program in Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Heart Association(American Heart Association); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank T. Magnuson, K. Helin, Q. Yan, K. H. Hansen, and R. Fang for reagents; K.H. Hansen, A. Kuo, and O. Gozani for advice on peptide- binding assays; R. Tomaino and S. Gygi for performing mass spec sequencing; DFCI Microarray Core for processing microarray samples; T. Liu and X.S. Liu for assistance with MAT; Q. Yan, B. Wilson, J. Xu, and J. Perry for criticism. X.S. and G.Y. are supported by the Claudia Adams Barr Program in Cancer Research. M.D.S. is a HHWF fellow. Y.L. is supported by the National Institutes of Health grant HL67050 and M. R. M. by American Heart Association grant 0615633Z. S.H.O. is an investigator of the HHMI.	Ambrosi DJ, 2007, STEM CELLS, V25, P1104, DOI 10.1634/stemcells.2006-0532; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken CP, 2008, CANCER RES, V68, P7621, DOI 10.1158/0008-5472.CAN-08-1217; Cao R, 2008, MOL CELL BIOL, V28, P1862, DOI 10.1128/MCB.01589-07; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; De Santa F, 2007, CELL, V130, P1083, DOI 10.1016/j.cell.2007.08.019; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Efroni S, 2008, CELL STEM CELL, V2, P437, DOI 10.1016/j.stem.2008.03.021; Gagneten S, 1997, NUCLEIC ACIDS RES, V25, P3326, DOI 10.1093/nar/25.16.3326; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Johnson WE, 2006, P NATL ACAD SCI USA, V103, P12457, DOI 10.1073/pnas.0601180103; Jung J, 2005, DEV DYNAM, V232, P21, DOI 10.1002/dvdy.20204; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Klose RJ, 2007, NAT REV MOL CELL BIO, V8, P307, DOI 10.1038/nrm2143; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Kuzmichev A, 2005, P NATL ACAD SCI USA, V102, P1859, DOI 10.1073/pnas.0409875102; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Margueron R, 2008, MOL CELL, V32, P503, DOI 10.1016/j.molcel.2008.11.004; Mikkelsen TS, 2008, NATURE, V454, P49, DOI 10.1038/nature07056; Montgomery ND, 2005, CURR BIOL, V15, P942, DOI 10.1016/j.cub.2005.04.051; Mysliwiec MR, 2006, GENESIS, V44, P407, DOI 10.1002/dvg.20221; Nekrasov M, 2007, EMBO J, V26, P4078, DOI 10.1038/sj.emboj.7601837; Nottke A, 2009, DEVELOPMENT, V136, P879, DOI 10.1242/dev.020966; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Reich M, 2006, NAT GENET, V38, P500, DOI 10.1038/ng0506-500; Sarma K, 2008, MOL CELL BIOL, V28, P2718, DOI 10.1128/MCB.02017-07; Sasai N, 2007, FEBS J, V274, P6139, DOI 10.1111/j.1742-4658.2007.06135.x; Savla U, 2008, DEVELOPMENT, V135, P813, DOI 10.1242/dev.016006; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Simon MD, 2007, CELL, V128, P1003, DOI 10.1016/j.cell.2006.12.041; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tzatsos A, 2009, P NATL ACAD SCI USA, V106, P2641, DOI 10.1073/pnas.0813139106; Umlauf David, 2004, Methods Mol Biol, V287, P99; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Walker E, 2007, CELL STEM CELL, V1, P71, DOI 10.1016/j.stem.2007.04.002; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Yamane K, 2007, MOL CELL, V25, P801, DOI 10.1016/j.molcel.2007.03.001; Zarach JM, 2004, DEVELOPMENT, V131, P4189, DOI 10.1242/dev.01303; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	48	341	355	2	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1303	1314		10.1016/j.cell.2009.12.003	http://dx.doi.org/10.1016/j.cell.2009.12.003			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064376	Green Accepted, Bronze			2022-12-01	WOS:000273048700018
J	Goldenberg, RL; McClure, EM; Saleem, S; Reddy, UM				Goldenberg, Robert L.; McClure, Elizabeth M.; Saleem, Sarah; Reddy, Uma M.			Infection-related stillbirths	LANCET			English	Review							PARVOVIRUS B19 INFECTION; INTRAUTERINE FETAL-DEATH; BORNE RELAPSING FEVER; CONGENITAL-SYPHILIS; HISTOLOGIC CHORIOAMNIONITIS; ANTIRETROVIRAL THERAPY; DEVELOPING-COUNTRIES; AMNIOTIC-FLUID; PREGNANT-WOMEN; PRETERM LABOR	Infection is an important cause of stillbirths worldwide: in low-income and middle-income countries, 50% of stillbirths or more are probably caused by infection. By contrast, in high-income countries only 10-25% of stillbirths are caused by infection. Syphilis, where prevalent, causes most infectious stillbirths, and is the infection most amenable to screening and treatment. Ascending bacterial infection is a common cause of stillbirths, but prevention has proven elusive. Many viral infections cause stillbirths but aside from vaccination for common childhood diseases, we do not have a clear prevention strategy. Malaria, because of its high prevalence and extensive placental damage, accounts for large numbers of stillbirths. Intermittent malarial prophylaxis and insecticide-treated bednets should decrease stillbirths. Many infections borne by animals and vectors cause stillbirths, and these types of infections occur frequently in low-income countries. Research that better defines the relation between these infections and stillbirths, and develops strategies to reduce associated adverse outcomes, should play an important part in reduction of stillbirths in low-income countries.	[Goldenberg, Robert L.] Drexel Univ, Coll Med, Dept Obstet & Gynecol, Philadelphia, PA 19102 USA; [McClure, Elizabeth M.] Univ N Carolina, Chapel Hill, NC USA; [McClure, Elizabeth M.] Res Triangle Inst, Durham, NC USA; [Saleem, Sarah] Aga Khan Univ, Karachi, Pakistan; [Reddy, Uma M.] Eunice Kennedy Shriver Natl Inst Child Hlth & Hum, Bethesda, MD USA	Drexel University; University of North Carolina; University of North Carolina Chapel Hill; Research Triangle Institute; Aga Khan University; National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)	Goldenberg, RL (corresponding author), Drexel Univ, Coll Med, Dept Obstet & Gynecol, 245 N 15th St,17th Floor,Room 17113, Philadelphia, PA 19102 USA.	rgoldenb@drexelmed.edu			National Institute of Child Health and Human Development Global Network; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [U01HD040636, U01HD040607] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development Global Network(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	RLG, EMM, and SS are funded by grants from the National Institute of Child Health and Human Development Global Network.	AABY P, 1988, LANCET, V1, P516; ACOG Committee on Obstetric Practice, 2004, Obstet Gynecol, V104, P1125; Ahmed RE, 2008, J MED VIROL, V80, P1747, DOI 10.1002/jmv.21284; AXEMO P, 1993, GYNECOL OBSTET INVES, V35, P108, DOI 10.1159/000292676; Bhutta ZA, 2005, PEDIATRICS, V115, P519, DOI 10.1542/peds.2004-1441; Blackwell S, 2003, J Matern Fetal Neonatal Med, V14, P151, DOI 10.1080/713606613; BLANC WA, 1961, J PEDIATR-US, V59, P473, DOI 10.1016/S0022-3476(61)80232-1; Brocklehurst P, 1998, BRIT J OBSTET GYNAEC, V105, P836, DOI 10.1111/j.1471-0528.1998.tb10227.x; Buekens P, 2008, MATERN CHILD HLTH J, V12, P283, DOI 10.1007/s10995-007-0246-8; Chi BH, 2007, OBSTET GYNECOL, V110, P989, DOI 10.1097/01.AOG.0000281667.35113.a5; Cnattingius S, 2002, SEMIN PERINATOL, V26, P25, DOI 10.1053/sper.2002.29841; Colbourn T, 2007, HEALTH TECHNOL ASSES, V11, pIX; Coll O, 2008, J PERINAT MED, V36, P15, DOI 10.1515/JPM.2008.002; COOPER LZ, 2006, INFECT DIS FETUS NEW, P893; COPPER RL, 1994, OBSTET GYNECOL, V84, P490; Cotter AM, 2006, J INFECT DIS, V193, P1195, DOI 10.1086/503045; Cutts FT, 1997, B WORLD HEALTH ORGAN, V75, P55; Dayan GH, 2003, J INFECT DIS, V187, pS235, DOI 10.1086/368037; de Silva NR, 1999, LANCET, V353, P1145, DOI 10.1016/S0140-6736(98)06308-9; Desai M, 2007, LANCET INFECT DIS, V7, P93, DOI 10.1016/S1473-3099(07)70021-X; Di Mario S, 2007, SEX TRANSM DIS, V34, pS11, DOI 10.1097/01.olq.0000258130.07476.e3; DiGiulio DB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003056; Dorman EK, 2002, ULTRASOUND OBST GYN, V19, P165, DOI 10.1046/j.0960-7692.2001.00545.x; Dupont HT, 1997, CLIN INFECT DIS, V25, P139, DOI 10.1086/514496; Enders M, 2004, PRENATAL DIAG, V24, P513, DOI 10.1002/pd.940; Folgosa E, 1996, GENITOURIN MED, V72, P339; Folgosa E, 1997, APMIS, V105, P329, DOI 10.1111/j.1699-0463.1997.tb00578.x; Fretts RC, 2005, AM J OBSTET GYNECOL, V193, P1923, DOI 10.1016/j.ajog.2005.03.074; FRISK G, 1992, J INFECTION, V24, P141, DOI 10.1016/0163-4453(92)92798-N; Genc M, 2000, SEX TRANSM INFECT, V76, P73, DOI 10.1136/sti.76.2.73; GERSHON AA, 2006, INFECT DIS FETUS NEW, P693; Gibbs RS, 2007, NEW ENGL J MED, V357, P918, DOI 10.1056/NEJMcpc079021; Gibbs RS, 2002, SEMIN PERINATOL, V26, P75, DOI 10.1053/sper.2002.29839; Goldenberg RL, 2003, AM J OBSTET GYNECOL, V189, P861, DOI 10.1067/S0002-9378(03)00470-8; Goldenberg RL, 2000, NEW ENGL J MED, V342, P1500, DOI 10.1056/NEJM200005183422007; Goldenberg RL, 2006, AM J OBSTET GYNECOL, V195, P1065, DOI 10.1016/j.ajog.2006.05.046; Gregg NM, 1941, T OPHTHALMOL SOC AUS, V3, P35; HALL SM, 1990, BMJ-BRIT MED J, V300, P1166; HARDY JM, 1961, AM J PUBLIC HEALTH N, V51, P1182, DOI 10.2105/AJPH.51.8.1182; Hay SI, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000048; HORN P, 1955, OBSTET GYNECOL, V6, P121; Hossain M, 2007, SEX TRANSM DIS, V34, pS22, DOI 10.1097/01.olq.0000261049.84824.40; Howard J, 2009, J CLIN VIROL, V44, P215, DOI 10.1016/j.jcv.2008.12.013; Jamieson DJ, 2009, LANCET, V374, P451, DOI 10.1016/S0140-6736(09)61304-0; JANA N, 1994, INT J GYNECOL OBSTET, V44, P119, DOI 10.1016/0020-7292(94)90064-7; Jones JL, 2001, OBSTET GYNECOL SURV, V56, P296, DOI 10.1097/00006254-200105000-00025; Jongen VHWM, 1997, ACTA OBSTET GYN SCAN, V76, P834, DOI 10.3109/00016349709024361; Kenyon S, 2013, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD001058; KINNEY JS, 1988, J INFECT DIS, V157, P663, DOI 10.1093/infdis/157.4.663; Korteweg FJ, 2008, PLACENTA, V29, P71, DOI 10.1016/j.placenta.2007.07.003; Kumar A, 2007, AM J TROP MED HYG, V77, P69, DOI 10.4269/ajtmh.2007.77.69; Lahra MM, 2007, AM J OBSTET GYNECOL, V196, P229, DOI 10.1016/j.ajog.2006.10.900; Lamont RF, 2003, BJOG-INT J OBSTET GY, V110, P71, DOI 10.1016/S1470-0328(03)00034-X; Lawn J, 2005, B WORLD HEALTH ORGAN, V83, P409; LINGAM S, 1985, DEV MED CHILD NEUROL, V27, P670, DOI 10.1111/j.1469-8749.1985.tb14141.x; Lumbiganon P, 2002, INT J STD AIDS, V13, P486, DOI 10.1258/09564620260079653; MACDONALD AB, 1987, NEW YORK STATE J MED, V87, P615; MADAN E, 1988, ANN CLIN LAB SCI, V18, P39; Martin C, 2004, J CLIN MICROBIOL, V42, P4396, DOI 10.1128/JCM.42.9.4396-4398.2004; Maruyama Y, 2007, J OBSTET GYNAECOL RE, V33, P619, DOI 10.1111/j.1447-0756.2007.00621.x; McClure EM, 2006, INT J GYNECOL OBSTET, V94, P82, DOI 10.1016/j.ijgo.2006.03.023; McConnell J, 2003, LANCET INFECT DIS, V3, P604, DOI 10.1016/S1473-3099(03)00787-4; MCGREGOR IA, 1983, T ROY SOC TROP MED H, V77, P232, DOI 10.1016/0035-9203(83)90081-0; MELKERT PWJ, 1988, BRIT J OBSTET GYNAEC, V95, P1070, DOI 10.1111/j.1471-0528.1988.tb06516.x; Mhalu FS, 1996, E AFR MED J, V73, P583; Miller E, 1998, BRIT J OBSTET GYNAEC, V105, P174, DOI 10.1111/j.1471-0528.1998.tb10048.x; Moyo SR, 1996, INT J GYNECOL OBSTET, V54, P115, DOI 10.1016/0020-7292(96)02705-1; Moyo SR, 1995, INT J GYNECOL OBSTET, V51, P211, DOI 10.1016/0020-7292(95)80004-2; NAEYE RL, 1977, J PEDIATR-US, V90, P965, DOI 10.1016/S0022-3476(77)80573-8; Newman RD, 2003, J INFECT DIS, V187, P1765, DOI 10.1086/374878; Ng WF, 2006, PATHOLOGY, V38, P210, DOI 10.1080/00313020600696280; Niklasson B, 2007, BIRTH DEFECTS RES A, V79, P488, DOI 10.1002/bdra.20359; Nimri L, 2004, AM J TROP MED HYG, V71, P831, DOI 10.4269/ajtmh.2004.71.831; Nuovo GJ, 2005, DIAGN MOL PATHOL, V14, P152, DOI 10.1097/01.pas.0000176769.18423.37; Okie S, 2008, NEW ENGL J MED, V358, P2425, DOI 10.1056/NEJMp0803483; Okun N, 2005, OBSTET GYNECOL, V105, P857, DOI 10.1097/01.AOG.0000157108.32059.8f; Oladapo OT, 2007, AUST NZ J OBSTET GYN, V47, P383, DOI 10.1111/j.1479-828X.2007.00761.x; OLAGBUJI BN, 2009, ARCH GYNECOL OBSTET, DOI DOI 10.1007/S0040-009-1186-X; Onadeko M O, 1996, Afr J Med Med Sci, V25, P331; Ornoy A, 2006, REPROD TOXICOL, V21, P446, DOI 10.1016/j.reprotox.2005.12.007; Pillay T, 2004, INT J TUBERC LUNG D, V8, P59; Potter D, 2006, SEX TRANSM DIS, V33, P604, DOI 10.1097/01.olq.0000216029.00424.ae; Rawlinson WD, 2008, PATHOLOGY, V40, P149, DOI 10.1080/00313020701813792; Riipinen A, 2008, CLIN INFECT DIS, V47, P1519, DOI 10.1086/593190; Romero R, 1998, AM J OBSTET GYNECOL, V179, P186, DOI 10.1016/S0002-9378(98)70271-6; Rydzak CE, 2008, SEX TRANSM DIS, V35, P775, DOI 10.1097/OLQ.0b013e318176196d; Salakhov E, 2004, SEX TRANSM DIS, V31, P127, DOI 10.1097/01.OLQ.0000109516.47951.B8; Schmahmann B, 2007, TEXTILE, V5, P10, DOI 10.2752/147597507780338925; Schmid G, 2004, B WORLD HEALTH ORGAN, V82, P402; Schwarz NG, 2008, CLIN INFECT DIS, V47, P1017, DOI 10.1086/591968; Sethi S, 2007, SEX TRANSM INFECT, V83, P592, DOI 10.1136/sti.2007.025551; Sheffield JS, 2002, OBSTET GYNECOL, V100, P126, DOI 10.1016/S0029-7844(02)02010-0; SKEKETEE RW, 2001, AM J TROP MED, V64, P28; Smith B, 2009, SCAND J INFECT DIS, V41, P21, DOI 10.1080/00365540802468094; Stanton C, 2006, LANCET, V367, P1487, DOI 10.1016/S0140-6736(06)68586-3; Stanwell-Smith R, 1994, Commun Dis Rep CDR Rev, V4, pR28; STROBINO BA, 1993, AM J OBSTET GYNECOL, V169, P367, DOI 10.1016/0002-9378(93)90088-Z; Syridou G, 2008, J MED VIROL, V80, P1776, DOI 10.1002/jmv.21293; Tolfvenstam T, 2001, LANCET, V357, P1494, DOI 10.1016/S0140-6736(00)04647-X; Tolockiene E, 2001, ACTA OBSTET GYN SCAN, V80, P511, DOI 10.1034/j.1600-0412.2001.080006511.x; Tongsong T, 2008, FETAL DIAGN THER, V23, P169, DOI 10.1159/000116737; Tuomala RE, 2002, NEW ENGL J MED, V346, P1863, DOI 10.1056/NEJMoa991159; Van Geertruyden JP, 2004, AM J TROP MED HYG, V71, P35, DOI 10.4269/ajtmh.2004.71.35; Vasquez-Manzanilla O, 2007, J TROP PEDIATRICS, V53, P274, DOI 10.1093/tropej/fmm025; Watson-Jones D, 2002, J INFECT DIS, V186, P940, DOI 10.1086/342952; Watson-Jones D, 2007, B WORLD HEALTH ORGAN, V85, P9, DOI 10.2471/BLT.06.033258; Wright C, 1996, BRIT J OBSTET GYNAEC, V103, P133, DOI 10.1111/j.1471-0528.1996.tb09664.x; 2001, MMWR MORB MORTAL WKL, V50, P573	108	135	141	0	14	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 24	2010	375	9724					1482	1490		10.1016/S0140-6736(09)61712-8	http://dx.doi.org/10.1016/S0140-6736(09)61712-8			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	590FL	20223514	Bronze, Green Submitted, Green Published, Green Accepted			2022-12-01	WOS:000277210000034
J	Vijay-Kumar, M; Aitken, JD; Carvalho, FA; Cullender, TC; Mwangi, S; Srinivasan, S; Sitaraman, SV; Knight, R; Ley, RE; Gewirtz, AT				Vijay-Kumar, Matam; Aitken, Jesse D.; Carvalho, Frederic A.; Cullender, Tyler C.; Mwangi, Simon; Srinivasan, Shanthi; Sitaraman, Shanthi V.; Knight, Rob; Ley, Ruth E.; Gewirtz, Andrew T.			Metabolic Syndrome and Altered Gut Microbiota in Mice Lacking Toll-Like Receptor 5	SCIENCE			English	Article							OBESITY; INNATE; INFLAMMATION; IMMUNITY; COLITIS	Metabolic syndrome is a group of obesity-related metabolic abnormalities that increase an individual's risk of developing type 2 diabetes and cardiovascular disease. Here, we show that mice genetically deficient in Toll-like receptor 5 (TLR5), a component of the innate immune system that is expressed in the gut mucosa and that helps defend against infection, exhibit hyperphagia and develop hallmark features of metabolic syndrome, including hyperlipidemia, hypertension, insulin resistance, and increased adiposity. These metabolic changes correlated with changes in the composition of the gut microbiota, and transfer of the gut microbiota from TLR5-deficient mice to wild-type germ-free mice conferred many features of metabolic syndrome to the recipients. Food restriction prevented obesity, but not insulin resistance, in the TLR5-deficient mice. These results support the emerging view that the gut microbiota contributes to metabolic disease and suggest that malfunction of the innate immune system may promote the development of metabolic syndrome.	[Vijay-Kumar, Matam; Aitken, Jesse D.; Carvalho, Frederic A.; Gewirtz, Andrew T.] Emory Univ, Dept Pathol, Atlanta, GA 30322 USA; [Cullender, Tyler C.; Ley, Ruth E.] Cornell Univ, Dept Microbiol, Ithaca, NY 14853 USA; [Mwangi, Simon; Srinivasan, Shanthi; Sitaraman, Shanthi V.] Emory Univ, Dept Med, Atlanta, GA 30322 USA; [Knight, Rob] Univ Colorado, Howard Hughes Med Inst, Dept Chem & Biochem, Boulder, CO 80309 USA	Emory University; Cornell University; Emory University; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder	Gewirtz, AT (corresponding author), Emory Univ, Dept Pathol, Atlanta, GA 30322 USA.	agewirt@emory.edu	Carvalho, Frédéric/K-2204-2015; Vijay-Kumar, Matam/Q-8988-2019; Ley, Ruth E/M-8542-2014; Srinivasan, Shanthi/A-6133-2013; Eckhardt, Erik/G-1567-2010; Knight, Rob/D-1299-2010	Carvalho, Frédéric/0000-0003-1592-2369; Ley, Ruth E/0000-0002-9087-1672; Knight, Rob/0000-0002-0975-9019	NIH [DK061417, K01 (DK083275), DK06439]; Crohn's and Colitis Foundation of America (CCFA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK061417, K01DK083275] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Crohn's and Colitis Foundation of America (CCFA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank F. A. Anania, D. G. Harrison, and I. R. Williams for valuable discussions and comments, and N. Scalfone and M. Hamady for technical assistance. This work was supported by an NIH grant (DK061417 and an associated American Recovery and Reinvestment Act supplement) and a Senior Award from the Crohn's and Colitis Foundation of America (CCFA) to A. T. G. M.V.-K. is a recipient of Career Development Awards from CCFA and K01 (DK083275) from NIH. This research used a Digestive Disease Research and Development Center (DDRDC) core facility that is supported by NIH grant DK06439.	Backhed F, 2004, P NATL ACAD SCI USA, V101, P15718, DOI 10.1073/pnas.0407076101; Cani PD, 2008, DIABETES, V57, P1470, DOI 10.2337/db07-1403; Garrett WS, 2007, CELL, V131, P33, DOI 10.1016/j.cell.2007.08.017; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Ley RE, 2005, P NATL ACAD SCI USA, V102, P11070, DOI 10.1073/pnas.0504978102; Ley RE, 2006, NATURE, V444, P1022, DOI 10.1038/4441022a; Lozupone C, 2005, APPL ENVIRON MICROB, V71, P8228, DOI 10.1128/AEM.71.12.8228-8235.2005; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, SCI TRANSL MED, V1, DOI 10.1126/scitranslmed.3000322; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vijay-Kumar M, 2007, J CLIN INVEST, V117, P3909, DOI 10.1172/JCI33084; Wang YF, 2008, OBESITY, V16, P2323, DOI 10.1038/oby.2008.351; WOODS SC, 1979, NATURE, V282, P503, DOI 10.1038/282503a0; Yan QW, 2007, DIABETES, V56, P2533, DOI 10.2337/db07-0007	16	1418	1521	7	401	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					228	231		10.1126/science.1179721	http://dx.doi.org/10.1126/science.1179721			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20203013	Green Accepted			2022-12-01	WOS:000276459600042
J	Ginzburg, E; O'Neill, WW; Goldschmidt-Clermont, PJ; de Marchena, E; Pust, D; Green, BA				Ginzburg, Enrique; O'Neill, William W.; Goldschmidt-Clermont, Pascal J.; de Marchena, Eduardo; Pust, Daniel; Green, Barth A.			Rapid Medical Relief - Project Medishare and the Haitian Earthquake	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Ginzburg, Enrique; Pust, Daniel] Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL 33152 USA; [O'Neill, William W.; Goldschmidt-Clermont, Pascal J.; de Marchena, Eduardo] Univ Miami, Dept Med, Leonard M Miller Sch Med, Miami, FL USA; [Green, Barth A.] Univ Miami, Dept Neurosurg, Leonard M Miller Sch Med, Miami, FL USA	University of Miami; University of Miami; University of Miami	Ginzburg, E (corresponding author), Univ Miami, Leonard M Miller Sch Med, Dept Surg, Miami, FL 33152 USA.								0	32	34	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMp1002026	http://dx.doi.org/10.1056/NEJMp1002026			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20181963				2022-12-01	WOS:000275365900006
J	Zhao, D; McBride, D; Nandi, S; McQueen, HA; McGrew, MJ; Hocking, PM; Lewis, PD; Sang, HM; Clinton, M				Zhao, D.; McBride, D.; Nandi, S.; McQueen, H. A.; McGrew, M. J.; Hocking, P. M.; Lewis, P. D.; Sang, H. M.; Clinton, M.			Somatic sex identity is cell autonomous in the chicken	NATURE			English	Article							DOSAGE COMPENSATION; DETERMINING GENE; DIFFERENTIATION; EXPRESSION; EMBRYOS; BIRDS; RNAS; SRY	In the mammalian model of sex determination, embryos are considered to be sexually indifferent until the transient action of a sex-determining gene initiates gonadal differentiation. Although this model is thought to apply to all vertebrates, this has yet to be established. Here we have examined three lateral gynandromorph chickens (a rare, naturally occurring phenomenon in which one side of the animal appears male and the other female) to investigate the sex-determining mechanism in birds. These studies demonstrated that gynandromorph birds are genuine male: female chimaeras, and indicated that male and female avian somatic cells may have an inherent sex identity. To test this hypothesis, we transplanted presumptive mesoderm between embryos of reciprocal sexes to generate embryos containing male: female chimaeric gonads. In contrast to the outcome for mammalian mixed-sex chimaeras, in chicken mixed-sex chimaeras the donor cells were excluded from the functional structures of the host gonad. In an example where female tissue was transplanted into a male host, donor cells contributing to the developing testis retained a female identity and expressed a marker of female function. Our study demonstrates that avian somatic cells possess an inherent sex identity and that, in birds, sexual differentiation is substantively cell autonomous.	[Zhao, D.; McBride, D.; Nandi, S.; McGrew, M. J.; Sang, H. M.; Clinton, M.] Univ Edinburgh, Roslin Inst, Div Dev Biol, Roslin EH25 9PS, Midlothian, Scotland; [Hocking, P. M.] Univ Edinburgh, Roslin Inst, Div Genet & Genom, Roslin EH25 9PS, Midlothian, Scotland; [Hocking, P. M.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [McQueen, H. A.] Univ Edinburgh, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Lewis, P. D.] Univ KwaZulu Natal, Dept Anim & Poultry Sci, Pietermaritzburg, South Africa	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of Edinburgh; University of Kwazulu Natal	Clinton, M (corresponding author), Univ Edinburgh, Roslin Inst, Div Dev Biol, Roslin EH25 9PS, Midlothian, Scotland.	Michael.clinton@roslin.ed.ac.uk	McQueen, Heather/AAS-3294-2020	McQueen, Heather/0000-0002-4228-6081	DEFRA; BBSRC [BB/E015425/1]; Biotechnology and Biological Sciences Research Council [BB/E015425/2, BB/E015425/1, BB/E011276/2, BBS/E/R/00001603, BB/H012486/1] Funding Source: researchfish; BBSRC [BB/E011276/2, BBS/E/R/00001603, BB/E015425/2, BB/H012486/1] Funding Source: UKRI	DEFRA(Department for Environment, Food & Rural Affairs (DEFRA)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This work was supported by DEFRA and BBSRC (BB/E015425/1). We thank G. Miele, G. Robertson, S. Wilson, A. Sherman, M. Hutchison, F. Thomson and R. Mitchell for technical support and for provision of fertilized eggs and embryos. We also thank T. Cannon for donation of gynandromorph bird G1, and R. Field and N. Russell for photography.	Agate RJ, 2003, P NATL ACAD SCI USA, V100, P4873, DOI 10.1073/pnas.0636925100; Arnold AP, 1997, J NEUROBIOL, V33, P572, DOI 10.1002/(SICI)1097-4695(19971105)33:5<572::AID-NEU6>3.3.CO;2-6; Birkhead T., 2008, WISDOM BIRDS ILLUSTR; BURGOYNE PS, 1988, DEVELOPMENT, V104, P683; Clinton M, 1998, J EXP ZOOL, V281, P457, DOI 10.1002/(SICI)1097-010X(19980801)281:5&lt;457::AID-JEZ10&gt;3.0.CO;2-6; Clinton M, 2001, BRIT POULTRY SCI, V42, P134, DOI 10.1080/713655025; CLINTON M, 2006, DIFFERENTIAL DISPLAY, P157; COCK A. G., 1955, JOUR GENETICS, V53, P49, DOI 10.1007/BF02981508; Dewing P, 2003, MOL BRAIN RES, V118, P82, DOI 10.1016/S0169-328X(03)00339-5; Ellegren H, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-40; Glickman SE, 2005, HORM BEHAV, V48, P403, DOI 10.1016/j.yhbeh.2005.07.013; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; HARRY JL, 1995, NAT GENET, V11, P347, DOI 10.1038/ng1195-347; HENRIQUE D, 1995, NATURE, V375, P787, DOI 10.1038/375787a0; HOLLANDER WF, 1975, J HERED, V66, P197, DOI 10.1093/oxfordjournals.jhered.a108612; Hori T, 2000, MOL BIOL CELL, V11, P3645, DOI 10.1091/mbc.11.10.3645; Hutt F.B., 1949, GENETICS OF THE FOWL; JOST A, 1970, PHILOS T ROY SOC B, V259, P119, DOI 10.1098/rstb.1970.0052; Lau NC, 2001, SCIENCE, V294, P858, DOI 10.1126/science.1065062; Lee RC, 2001, SCIENCE, V294, P862, DOI 10.1126/science.1065329; Lillie FR, 1917, P NATL ACAD SCI USA, V3, P464, DOI 10.1073/pnas.3.7.464; Matsuda M, 2007, P NATL ACAD SCI USA, V104, P3865, DOI 10.1073/pnas.0611707104; McGrew MJ, 2008, DEVELOPMENT, V135, P2289, DOI 10.1242/dev.022020; McQueen HA, 1996, NAT GENET, V12, P321, DOI 10.1038/ng0396-321; McQueen HA, 2001, CURR BIOL, V11, P253, DOI 10.1016/S0960-9822(01)00070-7; McQueen HA, 2009, CHROMOSOME RES, V17, P687, DOI 10.1007/s10577-009-9056-8; Melamed E, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-9-r202; Nishikimi H, 2000, MOL REPROD DEV, V55, P20, DOI 10.1002/(SICI)1098-2795(200001)55:1&lt;20::AID-MRD4&gt;3.0.CO;2-E; Nomura O, 1999, J STEROID BIOCHEM, V71, P103, DOI 10.1016/S0960-0760(99)00127-2; OWENS IPF, 1995, TRENDS ECOL EVOL, V10, P44, DOI 10.1016/S0169-5347(00)88967-3; PATEK CE, 1991, DEVELOPMENT, V113, P311; RENFREE MB, 1988, PHILOS T ROY SOC B, V322, P41, DOI 10.1098/rstb.1988.0112; Sambrook JF., 2001, MOL CLONING LAB MANU; Scholz B, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-12; Sekido R, 2009, TRENDS GENET, V25, P19, DOI 10.1016/j.tig.2008.10.008; Smith CA, 2001, J EXP ZOOL, V290, P691, DOI 10.1002/jez.1119; Smith CA, 2009, NATURE, V461, P267, DOI 10.1038/nature08298; Smith CA, 2009, INT J DEV BIOL, V53, P59, DOI 10.1387/ijdb.082742cs; Stern C. D., 1993, ESSENTIAL DEV BIOL P, P193; Volff JN, 2003, TRENDS GENET, V19, P196, DOI 10.1016/S0168-9525(03)00051-9; Wade J, 1996, P NATL ACAD SCI USA, V93, P5264, DOI 10.1073/pnas.93.11.5264; Wade J, 2004, ANN NY ACAD SCI, V1016, P540, DOI 10.1196/annals.1298.015; WS O, 1988, NATURE, V331, P716, DOI DOI 10.1038/331716A0	43	140	150	4	74	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					237	U115		10.1038/nature08852	http://dx.doi.org/10.1038/nature08852			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220842	Green Accepted			2022-12-01	WOS:000275366100038
J	Kumar, D; Nath, L; Kamal, MA; Varshney, A; Jain, A; Singh, S; Rao, KVS				Kumar, Dhiraj; Nath, Lekha; Kamal, Md. Azhar; Varshney, Ankur; Jain, Avinash; Singh, Sarman; Rao, Kanury V. S.			Genome-wide Analysis of the Host Intracellular Network that Regulates Survival of Mycobacterium tuberculosis	CELL			English	Article							AUTOPHAGY; MACROPHAGES; PATHOGEN; BIOLOGY; ACTIVATION; PHAGOSOME; VIRULENCE; INTERPLAY; GROWTH; LIPIDS	We performed a genome-wide siRNA screen to identify host factors that regulated pathogen load in human macrophages infected with a virulent strain of Mycobacterium tuberculosis. Iterative rounds of confirmation, followed by validation, identified 275 such molecules that were all found to functionally associate with each other through a dense network of interactions. This network then yielded to a molecular description of the host cell functional modules that were both engaged and perturbed by the pathogen. Importantly, a subscreen against a panel of field isolates revealed that the molecular composition of the host interface varied with both genotype and the phenotypic properties of the pathogen. An analysis of these differences, however, permitted identification of those host factors that were invariantly involved, regardless of the diversification in adaptive mechanisms employed by the pathogen. Interestingly, these factors were found to predominantly function through the regulation of autophagy.	[Kumar, Dhiraj; Nath, Lekha; Kamal, Md. Azhar; Varshney, Ankur; Jain, Avinash; Rao, Kanury V. S.] Ctr Genet Engn & Biotechnol, Immunol Grp, New Delhi 110067, India; [Singh, Sarman] All India Inst Med Sci, Dept Lab Med, Div Clin Microbiol, New Delhi 110029, India	Department of Biotechnology (DBT) India; International Center for Genetic Engineering & Biotechnology (ICGEB); International Center for Genetic Engineering & Biotechnology (ICGEB), New Delhi; All India Institute of Medical Sciences (AIIMS) New Delhi	Rao, KVS (corresponding author), Ctr Genet Engn & Biotechnol, Immunol Grp, Aruna Asaf Ali Marg, New Delhi 110067, India.	kanury@icgeb.res.in	Kamal, Mohammad Azhar/H-9624-2012; Singh, Sarman/AAR-8914-2020	Singh, Sarman/0000-0002-0749-9647; Kamal, Mohammad Azhar/0000-0002-0180-3441	Department of Biotechnology, Government of India; Institute of Life Sciences, Hyderabad	Department of Biotechnology, Government of India(Department of Biotechnology (DBT) India); Institute of Life Sciences, Hyderabad	This study was funded in part by the Department of Biotechnology, Government of India, and in part by the Institute of Life Sciences, Hyderabad. We are grateful to V. Biswas, M. Jain, N. Karwal, R. Kashikar, S. Kumari, A. Kumar, K. Midha, M. K. Midha, S. Seth, S. Sharma, M. Sharma, Z. Sidiqui, A. Srivastava, and S. Tirpattiwar for technical assistance during the various stages of the RNA interference screen. We also thank S. Kulkarni (BARC) for spoligotyping analysis of the field isolates used in this study.	Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brudey K, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-23; Davila S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000218; DECHASTELIER C, 2009, IMMUNOBIOLO IN PRESS; Flynn JL, 1999, TRENDS MICROBIOL, V7, P477, DOI 10.1016/S0966-842X(99)01611-X; Flynn JL, 2001, ANNU REV IMMUNOL, V19, P93, DOI 10.1146/annurev.immunol.19.1.93; Fratti RA, 2003, P NATL ACAD SCI USA, V100, P5437, DOI 10.1073/pnas.0737613100; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gertow K, 2004, DIABETOLOGIA, V47, P1118, DOI 10.1007/s00125-004-1417-4; Ginsberg AM, 2007, NAT MED, V13, P290, DOI 10.1038/nm0307-290; Gutierrez MG, 2009, CELL MICROBIOL, V11, P406, DOI 10.1111/j.1462-5822.2008.01263.x; Gutierrez MG, 2004, CELL, V119, P753, DOI 10.1016/j.cell.2004.11.038; Jain M, 2007, P NATL ACAD SCI USA, V104, P5133, DOI 10.1073/pnas.0610634104; Kaufmann SHE, 2005, J EXP MED, V201, P1693, DOI 10.1084/jem.20050842; Koul A, 2004, NAT REV MICROBIOL, V2, P189, DOI 10.1038/nrmicro840; Kuijl C, 2007, NATURE, V450, P725, DOI 10.1038/nature06345; Levine B, 2007, NAT REV IMMUNOL, V7, P767, DOI 10.1038/nri2161; MacMicking JD, 2003, SCIENCE, V302, P654, DOI 10.1126/science.1088063; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Monack DM, 2004, NAT REV MICROBIOL, V2, P747, DOI 10.1038/nrmicro955; Nau GJ, 2002, P NATL ACAD SCI USA, V99, P1503, DOI 10.1073/pnas.022649799; Pandey AK, 2008, P NATL ACAD SCI USA, V105, P4376, DOI 10.1073/pnas.0711159105; Park JS, 2006, J LEUKOCYTE BIOL, V79, P80, DOI 10.1189/jlb.0505250; Schaible UE, 2005, TRENDS MICROBIOL, V13, P373, DOI 10.1016/j.tim.2005.06.009; SEGLEN PO, 1982, P NATL ACAD SCI-BIOL, V79, P1889, DOI 10.1073/pnas.79.6.1889; Singh SB, 2006, SCIENCE, V313, P1438, DOI 10.1126/science.1129577; Theus SA, 2006, INFECT IMMUN, V74, P6865, DOI 10.1128/IAI.00561-06; Ting LM, 1999, J IMMUNOL, V163, P3898; van der Wel N, 2007, CELL, V129, P1287, DOI 10.1016/j.cell.2007.05.059; Van Limbergen J, 2009, MUCOSAL IMMUNOL, V2, P315, DOI 10.1038/mi.2009.20; Vergne I, 2004, ANNU REV CELL DEV BI, V20, P367, DOI 10.1146/annurev.cellbio.20.010403.114015; Warner DF, 2007, NAT MED, V13, P282, DOI 10.1038/nm0307-282; Young D, 2008, NAT REV MICROBIOL, V6, P520, DOI 10.1038/nrmicro1919	33	277	286	1	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					731	743		10.1016/j.cell.2010.02.012	http://dx.doi.org/10.1016/j.cell.2010.02.012			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211141	Bronze			2022-12-01	WOS:000275197400021
J	Boisset, JC; van Cappellen, W; Andrieu-Soler, C; Galjart, N; Dzierzak, E; Robin, C				Boisset, Jean-Charles; van Cappellen, Wiggert; Andrieu-Soler, Charlotte; Galjart, Niels; Dzierzak, Elaine; Robin, Catherine			In vivo imaging of haematopoietic cells emerging from the mouse aortic endothelium	NATURE			English	Article							STEM-CELLS; AGM REGION; DEFINITIVE HEMATOPOIESIS; HAEMOGENIC ENDOTHELIUM; EMBRYO; EXPRESSION; GENERATION; MARKS; COLONIZATION; MIGRATION	Haematopoietic stem cells (HSCs), responsible for blood production in the adult mouse, are first detected in the dorsal aorta starting at embryonic day 10.5 (E10.5)(1-3). Immunohistological analysis of fixed embryo sections has revealed the presence of haematopoietic cell clusters attached to the aortic endothelium where HSCs might localize(4-6). The origin of HSCs has long been controversial and several candidates of the direct HSC precursors have been proposed (for review see ref. 7), including a specialized endothelial cell population with a haemogenic potential. Such cells have been described both in vitro in the embryonic stem cell (ESC) culture system(8,9) and retrospectively in vivo by endothelial lineage tracing(5,10) and conditional deletion experiments(11). Whether the transition from haemogenic endothelium to HSC actually occurs in the mouse embryonic aorta is still unclear and requires direct and real-time in vivo observation. To address this issue we used time-lapse confocal imaging and a new dissection procedure to visualize the deeply located aorta. Here we show the dynamic de novo emergence of phenotypically defined HSCs (Sca1(+), c-kit(+), CD41(+)) directly from ventral aortic haemogenic endothelial cells.	[Boisset, Jean-Charles; Andrieu-Soler, Charlotte; Galjart, Niels; Dzierzak, Elaine; Robin, Catherine] Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands; [Boisset, Jean-Charles; Dzierzak, Elaine; Robin, Catherine] Erasmus MC, Erasmus Stem Cell Inst, NL-3000 CA Rotterdam, Netherlands; [van Cappellen, Wiggert] Erasmus MC, Dept Reprod & Dev, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Robin, C (corresponding author), Erasmus MC, Dept Cell Biol, NL-3000 CA Rotterdam, Netherlands.	c.robin@erasmusmc.nl	Galjart, Niels/D-1146-2010	Galjart, Niels/0000-0003-1964-3607; Andrieu-Soler, Charlotte/0000-0002-3287-6117	NWO [917-76-345]; NIH [R37 DKO54077]; BSIK [SCDD 03038]	NWO(Netherlands Organization for Scientific Research (NWO)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); BSIK(Ministry of Economic Affairs, Netherlands)	We thank F. Grosveld for critical discussions, T. Graf and T. Schroeder for the CD41-YFP mice and the department of Neuroscience (Erasmus MC) for the tissue chopper. This work was supported by NWO (Vidi) grant 917-76-345 (C. R., J.-C.B.), NIH R37 DKO54077 (E. D.) and BSIK SCDD 03038 (E. D.).	Adamo L, 2009, NATURE, V459, P1131, DOI 10.1038/nature08073; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Cai ZL, 2000, IMMUNITY, V13, P423, DOI 10.1016/S1074-7613(00)00042-X; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Corbel C, 2002, DEV BIOL, V243, P301, DOI 10.1006/dbio.2001.0553; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; de Bruijn MFTR, 2002, IMMUNITY, V16, P673, DOI 10.1016/S1074-7613(02)00313-8; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; GARCIAPORRERO JA, 1995, ANAT EMBRYOL, V192, P427; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Kumaravelu P, 2002, DEVELOPMENT, V129, P4891; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Ma XQ, 2002, STEM CELLS, V20, P514, DOI 10.1634/stemcells.20-6-514; Matsubara A, 2005, J EXP MED, V202, P1483, DOI 10.1084/jem.20051325; Medvinsky A, 1996, CELL, V86, P897, DOI 10.1016/S0092-8674(00)80165-8; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Molyneaux KA, 2001, DEV BIOL, V240, P488, DOI 10.1006/dbio.2001.0436; MULLER AM, 1994, IMMUNITY, V1, P291, DOI 10.1016/1074-7613(94)90081-7; North T, 1999, DEVELOPMENT, V126, P2563; North TE, 2002, IMMUNITY, V16, P661, DOI 10.1016/S1074-7613(02)00296-0; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Robin C, 2006, DEV CELL, V11, P171, DOI 10.1016/j.devcel.2006.07.002; Sanchez MJ, 1996, IMMUNITY, V5, P513, DOI 10.1016/S1074-7613(00)80267-8; Taoudi S, 2008, CELL STEM CELL, V3, P99, DOI 10.1016/j.stem.2008.06.004; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Tavian M, 1996, BLOOD, V87, P67, DOI 10.1182/blood.V87.1.67.bloodjournal87167; Zhang JH, 2007, EXP HEMATOL, V35, P490, DOI 10.1016/j.exphem.2006.11.011; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	30	615	632	3	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					116	U131		10.1038/nature08764	http://dx.doi.org/10.1038/nature08764			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20154729				2022-12-01	WOS:000275117500045
J	Hirschey, MD; Shimazu, T; Goetzman, E; Jing, E; Schwer, B; Lombard, DB; Grueter, CA; Harris, C; Biddinger, S; Ilkayeva, OR; Stevens, RD; Li, Y; Saha, AK; Ruderman, NB; Bain, JR; Newgard, CB; Farese, RV; Alt, F; Kahn, CR; Verdin, E				Hirschey, Matthew D.; Shimazu, Tadahiro; Goetzman, Eric; Jing, Enxuan; Schwer, Bjoern; Lombard, David B.; Grueter, Carrie A.; Harris, Charles; Biddinger, Sudha; Ilkayeva, Olga R.; Stevens, Robert D.; Li, Yu; Saha, Asish K.; Ruderman, Neil B.; Bain, James R.; Newgard, Christopher B.; Farese, Robert V., Jr.; Alt, FrederickW.; Kahn, C. Ronald; Verdin, Eric			SIRT3 regulates mitochondrial fatty-acid oxidation by reversible enzyme deacetylation	NATURE			English	Article							COA DEHYDROGENASE-DEFICIENCY; GENE-EXPRESSION PROFILES; HEPATIC STEATOSIS; LIVER-DISEASE; ACETYLATION; RISK; SIRTUINS; ROLES; MICE	Sirtuins are NAD(+)-dependent protein deacetylases. They mediate adaptive responses to a variety of stresses, including calorie restriction and metabolic stress. Sirtuin 3 (SIRT3) is localized in the mitochondrial matrix, where it regulates the acetylation levels of metabolic enzymes, including acetyl coenzyme A synthetase 2 (refs 1, 2). Mice lacking both Sirt3 alleles appear phenotypically normal under basal conditions, but show marked hyperacetylation of several mitochondrial proteins(3). Here we report that SIRT3 expression is upregulated during fasting in liver and brown adipose tissues. During fasting, livers from mice lacking SIRT3 had higher levels of fatty-acid oxidation intermediate products and triglycerides, associated with decreased levels of fatty-acid oxidation, compared to livers from wild-type mice. Mass spectrometry of mitochondrial proteins shows that long-chain acyl coenzyme A dehydrogenase (LCAD) is hyperacetylated at lysine 42 in the absence of SIRT3. LCAD is deacetylated in wild-type mice under fasted conditions and by SIRT3 in vitro and in vivo; and hyperacetylation of LCAD reduces its enzymatic activity. Mice lacking SIRT3 exhibit hallmarks of fatty-acid oxidation disorders during fasting, including reduced ATP levels and intolerance to cold exposure. These findings identify acetylation as a novel regulatory mechanism for mitochondrial fatty-acid oxidation and demonstrate that SIRT3 modulates mitochondrial intermediary metabolism and fatty-acid use during fasting.	[Hirschey, Matthew D.; Shimazu, Tadahiro; Schwer, Bjoern; Verdin, Eric] Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA; [Hirschey, Matthew D.; Shimazu, Tadahiro; Schwer, Bjoern; Verdin, Eric] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Goetzman, Eric] Univ Pittsburgh, Sch Med, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA 15201 USA; [Jing, Enxuan; Biddinger, Sudha; Kahn, C. Ronald] Harvard Univ, Sch Med, Joslin Diabet Ctr, Boston, MA 02215 USA; [Schwer, Bjoern; Lombard, David B.; Alt, FrederickW.] Harvard Univ, Sch Med, Childrens Hosp,Immune Dis Inst,Dept Genet, Howard Hughes Med Inst,Program Cellular & Mol Med, Boston, MA 02115 USA; [Grueter, Carrie A.; Harris, Charles; Farese, Robert V., Jr.] Univ Calif San Francisco, Gladstone Inst Cardiovasc Dis, San Francisco, CA 94158 USA; [Ilkayeva, Olga R.; Stevens, Robert D.; Bain, James R.; Newgard, Christopher B.] Duke Univ, Med Ctr, Sarah W Stedman Nutr & Metab Ctr, Durham, NC 27704 USA; [Li, Yu] Cell Signaling Technol, Danvers, MA 01923 USA; [Saha, Asish K.; Ruderman, Neil B.] Boston Univ, Med Ctr, Diabet Unit, Boston, MA 02118 USA; [Saha, Asish K.; Ruderman, Neil B.] Boston Univ, Med Ctr, Dept Physiol & Med Biophys, Boston, MA 02118 USA	University of California System; University of California San Francisco; The J David Gladstone Institutes; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; Harvard University; Harvard Medical School; Joslin Diabetes Center, Inc.; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; Howard Hughes Medical Institute; University of California System; University of California San Francisco; The J David Gladstone Institutes; Duke University; Boston University; Boston University	Verdin, E (corresponding author), Gladstone Inst Virol & Immunol, San Francisco, CA 94158 USA.	everdin@gladstone.ucsf.edu	SHIMAZU, Tadahiro/ABC-3950-2020; Verdin, Eric/AAB-7999-2019; Kahn, Ronald/AAY-2435-2021	Kahn, Ronald/0000-0002-7583-9228; Verdin, Eric/0000-0003-3703-3183; Bain, James R./0000-0002-8917-9187; Saha, Asish/0000-0003-1001-5110; Lombard, David/0000-0002-4292-0185; Grueter, Carrie/0000-0002-1913-2527; Ruderman, Neil/0000-0002-6589-6587; Hirschey, Matthew/0000-0003-4541-5376	Elison Medical Foundation; National Institute on Aging; National Institutes of Health (NIH) [PO1 HL068758-06A1, DK019514-29, R01 DK067509-04]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL068758] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK067509, P30DK026743, R01DK019514, K01DK076573, U2CDK059637, U24DK059637] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG022325] Funding Source: NIH RePORTER	Elison Medical Foundation; National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank T. Canavan and J. J. Maher for primary hepatocyte preparation (P30 DK026743); C. Harris, L. Swift and the Mouse Metabolic Phenotyping Center (DK59637) for analysis of plasma and tissue lipid analysis; J. Wong for electron microscopy studies, S. Mihalik and D. Cuebas for synthesis of the 2,6-dimethylheptanoyl-CoA; A.-W. Mohsen for purification of recombinant pig ETF; Y.-C. Si for assistance with adenoviral studies; A. Wilson and J. Carroll for preparation of figures; and G. Howard and S. Ordway for editorial review. This work was supported in part by a Senior Scholarship in Aging from the Elison Medical Foundation to E. V. and by institutional support from the J. David Gladstone Institutes. F. W. A. is an Investigator of the Howard Hughes Medical Institute and recipient of an Ellison Medical Foundation Senior Scholar Award. D. B. L. is supported by a K08 award from the National Institute on Aging and the National Institutes of Health. B. S. is supported by an Ellison Medical Foundation/AFAR Senior Postdoctoral Research Grant. N.B.R. and A. K. S. are supported by National Institutes of Health (NIH) grants PO1 HL068758-06A1, DK019514-29 and R01 DK067509-04.	Ahn BH, 2008, P NATL ACAD SCI USA, V105, P14447, DOI 10.1073/pnas.0803790105; Bennett MJ, 2007, METHOD CELL BIOL, V80, P179, DOI 10.1016/S0091-679X(06)80009-9; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Cox KB, 2001, HUM MOL GENET, V10, P2069, DOI 10.1093/hmg/10.19.2069; Eaton S, 1996, BIOCHEM J, V320, P345, DOI 10.1042/bj3200345; FOLCH J, 1957, J BIOL CHEM, V226, P497; FRERMAN FE, 1985, BIOCHEM MED METAB B, V33, P38, DOI 10.1016/0006-2944(85)90124-3; GRAHAM JM, 1999, CURR PROTOCOLS CEL S, V4; Guarente L, 2006, NATURE, V444, P868, DOI 10.1038/nature05486; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Herrema H, 2008, HEPATOLOGY, V47, P1894, DOI 10.1002/hep.22284; Hirschey MD, 2009, METHOD ENZYMOL, V457, P137, DOI 10.1016/S0076-6879(09)05008-3; Hsiao PJ, 2007, J GASTROEN HEPATOL, V22, P2118, DOI 10.1111/j.1440-1746.2006.04698.x; Jensen MV, 2006, J BIOL CHEM, V281, P22342, DOI 10.1074/jbc.M604350200; Kim JY, 2000, AM J PHYSIOL-ENDOC M, V279, pE1039, DOI 10.1152/ajpendo.2000.279.5.E1039; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; Kurtz DM, 1998, P NATL ACAD SCI USA, V95, P15592, DOI 10.1073/pnas.95.26.15592; Lombard DB, 2007, MOL CELL BIOL, V27, P8807, DOI 10.1128/MCB.01636-07; MCGARRY JD, 1980, ANNU REV BIOCHEM, V49, P395, DOI 10.1146/annurev.bi.49.070180.002143; MORRISON WR, 1964, J LIPID RES, V5, P600; OLIVER H, 1972, FLEXIBLE SYSTEM ENZY; Rikova K, 2007, CELL, V131, P1190, DOI 10.1016/j.cell.2007.11.025; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Saha AK, 2004, BIOCHEM BIOPH RES CO, V314, P580, DOI 10.1016/j.bbrc.2003.12.120; Schuler A Michele, 2002, ILAR J, V43, P57; Schwer B, 2002, J CELL BIOL, V158, P647, DOI 10.1083/jcb.200205057; Schwer B, 2008, CELL METAB, V7, P104, DOI 10.1016/j.cmet.2007.11.006; Schwer B, 2006, P NATL ACAD SCI USA, V103, P10224, DOI 10.1073/pnas.0603968103; Schwer B, 2009, AGING CELL, V8, P604, DOI 10.1111/j.1474-9726.2009.00503.x; Shibata M, 2007, DIABETES CARE, V30, P2940, DOI 10.2337/dc07-0792; Son CG, 2005, GENOME RES, V15, P443, DOI 10.1101/gr.3124505; Spiekerkoetter U, 2006, HORM METAB RES, V38, P625, DOI 10.1055/s-2006-954581; Srere P.A., 1969, METHODS ENZYM, V1, P3, DOI [10.1016/0076-6879(69)13005-0, DOI 10.1016/0076-6879(69)13005-0]; STREMMEL W, 1986, P NATL ACAD SCI USA, V83, P3086, DOI 10.1073/pnas.83.10.3086; Taniguchi CM, 2005, J CLIN INVEST, V115, P718, DOI 10.1172/JCI200523187; Targher G, 2005, DIABETES, V54, P3541, DOI 10.2337/diabetes.54.12.3541; Tolwani RJ, 2005, PLOS GENET, V1, P205, DOI 10.1371/journal.pgen.0010023; Ueki K, 2004, P NATL ACAD SCI USA, V101, P10422, DOI 10.1073/pnas.0402511101; Wu JY, 2004, J CLIN INVEST, V113, P434, DOI 10.1172/JCI200419574; Yang HY, 2007, CELL, V130, P1095, DOI 10.1016/j.cell.2007.07.035; Yechoor VK, 2004, P NATL ACAD SCI USA, V101, P16525, DOI 10.1073/pnas.0407574101; Zhang DY, 2007, P NATL ACAD SCI USA, V104, P17075, DOI 10.1073/pnas.0707060104; Zhang W, 2008, LIFE SCI, V83, P35, DOI 10.1016/j.lfs.2008.04.021	43	1140	1181	8	262	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					121	U137		10.1038/nature08778	http://dx.doi.org/10.1038/nature08778			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203611	Green Submitted, Green Accepted			2022-12-01	WOS:000275117500046
J	Parks, M; Rosebraugh, C				Parks, Mary; Rosebraugh, Curtis			Weighing Risks and Benefits of Liraglutide -- The FDA's Review of a New Antidiabetic Therapy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							COHORT		[Parks, Mary] US FDA, Div Metab & Endocrinol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Rosebraugh, Curtis] US FDA, Off Drug Evaluat 2, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Parks, M (corresponding author), US FDA, Div Metab & Endocrinol Prod, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Costante G, 2007, J CLIN ENDOCR METAB, V92, P450, DOI 10.1210/jc.2006-1590; Food and Drug Administration, 2008, GUID IND DIAB MELL E; MCCONNELL EE, 1986, J NATL CANCER I, V76, P283; Noel RA, 2009, DIABETES CARE, V32, P834, DOI 10.2337/dc08-1755	4	198	209	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					774	777		10.1056/NEJMp1001578	http://dx.doi.org/10.1056/NEJMp1001578			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563DQ	20164475				2022-12-01	WOS:000275108300003
J	van Gool, WA; van de Beek, D; Eikelenboom, P				van Gool, Willem A.; van de Beek, Diederik; Eikelenboom, Piet			Systemic infection and delirium: when cytokines and acetylcholine collide	LANCET			English	Article							NEURODEGENERATIVE DISEASE; CHRONIC NEUROINFLAMMATION; BRAIN; INFLAMMATION; SEPSIS	Systemic infection and drugs with anticholinergic effects are well-recognised and prevalent risk factors for delirium in elderly people. Experimental findings and neuropathological observations suggest that activation of microglia is pivotal for mediation of the behavioural effects of systemic infections. The microglial response is usually regulated tightly, but defensive features could turn neurotoxic once microglial cells escape from cholinergic inhibition. A self-propelling neuroinflammatory reaction might follow, and this cascade could account for the strong association between delirium and long-term cognitive impairment and even dementia. Here, we propose a hypothetical model, suggesting that poor outcome after delirium can be averted in vulnerable elderly people by use of readily available drugs. Agents that either restore cholinergic control of microglia or directly inhibit neuroinflammation warrant testing in clinical trials.	[van Gool, Willem A.; van de Beek, Diederik; Eikelenboom, Piet] Acad Med Ctr, Dept Neurol, NL-1100 DD Amsterdam, Netherlands; [van de Beek, Diederik] Acad Med Ctr, CINIMA, NL-1100 DD Amsterdam, Netherlands; [Eikelenboom, Piet] GGZ InGeest, PCA Valeriuskliniek, Amsterdam, Netherlands	University of Amsterdam; Academic Medical Center Amsterdam; University of Amsterdam; Academic Medical Center Amsterdam	van Gool, WA (corresponding author), Acad Med Ctr, Dept Neurol, H2-217,POB 22660, NL-1100 DD Amsterdam, Netherlands.	w.a.vangool@amc.uva.nl	Van Gool, Willem A/G-5985-2012; Eikelenboom, Piet/AAF-6359-2020; van de Beek, Diederik/Y-2713-2019; van de beek, diederik/A-2935-2010	van de Beek, Diederik/0000-0002-4571-044X; Van Gool, Willem/0000-0003-3174-8233				De Simone R, 2005, J NEUROINFLAMM, V2, DOI 10.1186/1742-2094-2-4; Ebersoldt M, 2007, INTENS CARE MED, V33, P941, DOI 10.1007/s00134-007-0622-2; Franceschi C, 2007, MECH AGEING DEV, V128, P92, DOI 10.1016/j.mad.2006.11.016; Garden GA, 2006, J NEUROIMMUNE PHARM, V1, P127, DOI 10.1007/s11481-006-9015-5; Henry CJ, 2009, BRAIN BEHAV IMMUN, V23, P309, DOI 10.1016/j.bbi.2008.09.002; Henry CJ, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-15; Hoozemans JJM, 2006, INT J DEV NEUROSCI, V24, P157, DOI 10.1016/j.ijdevneu.2005.11.001; Kat MG, 2008, DEMENT GERIATR COGN, V26, P1, DOI 10.1159/000140611; Lemstra AW, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-4; MacLullich AMJ, 2009, INT REV PSYCHIATR, V21, P30, DOI 10.1080/09540260802675031; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Nizri E, 2008, J NEUROIMMUNOL, V203, P12, DOI 10.1016/j.jneuroim.2008.06.018; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Qin LY, 2007, GLIA, V55, P453, DOI 10.1002/glia.20467; Quan N, 2007, BRAIN BEHAV IMMUN, V21, P727, DOI 10.1016/j.bbi.2007.05.005; Siddiqi N, 2006, AGE AGEING, V35, P350, DOI 10.1093/ageing/afl005; Teeling JL, 2009, NEUROSCIENCE, V158, P1062, DOI 10.1016/j.neuroscience.2008.07.031; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; WAAGE A, 1989, J EXP MED, V170, P1859, DOI 10.1084/jem.170.6.1859; Willard LB, 1999, NEUROSCIENCE, V88, P193	20	342	352	9	36	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					773	775		10.1016/S0140-6736(09)61158-2	http://dx.doi.org/10.1016/S0140-6736(09)61158-2			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20189029				2022-12-01	WOS:000275211200034
J	Shembade, N; Ma, A; Harhaj, EW				Shembade, Noula; Ma, Averil; Harhaj, Edward W.			Inhibition of NF-kappa B Signaling by A20 Through Disruption of Ubiquitin Enzyme Complexes	SCIENCE			English	Article							CONJUGATING ENZYME; ACTIVATION; UBC13; RESPONSES; REQUIRES; SUSCEPTIBILITY; TERMINATION; TNFAIP3; REGION	A20 negatively regulates inflammation by inhibiting the nuclear factor kappa B (NF-kappa B) transcription factor in the tumor necrosis factor receptor (TNFR) and Toll-like receptor (TLR) pathways. A20 contains deubiquitinase and E3 ligase domains and thus has been proposed to function as a ubiquitin-editing enzyme downstream of TNFR1 by inactivating ubiquitinated RIP1. However, it remains unclear how A20 terminates NF-kappa B signaling downstream of TLRs. We have shown that A20 inhibited the E3 ligase activities of TRAF6, TRAF2, and cIAP1 by antagonizing interactions with the E2 ubiquitin conjugating enzymes Ubc13 and UbcH5c. A20, together with the regulatory molecule TAX1BP1, interacted with Ubc13 and UbcH5c and triggered their ubiquitination and proteasome-dependent degradation. These findings suggest a mechanism of A20 action in the inhibition of inflammatory signaling pathways.	[Shembade, Noula; Harhaj, Edward W.] Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA; [Ma, Averil] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	University of Miami; University of California System; University of California San Francisco	Shembade, N (corresponding author), Univ Miami, Miller Sch Med, Dept Microbiol & Immunol, Sylvester Comprehens Canc Ctr, Miami, FL 33136 USA.	nshembade@med.miami.edu; eharhaj@med.miami.edu			NIH [RO1GM083143, RO1CA135362]; NATIONAL CANCER INSTITUTE [R01CA135362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083143] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. C. Sun, L. Matesic, D. Abbott, C. Vincenz, P. Storz, R. Beyaert, and the Belgian Coordinated Collections of Microorganisms/Laboratory of Molecular Biology of Ghent University (BCCMTM/LMBP) for reagents and H. Ishikawa for assistance in the preparation of BMDMs and BMDCs. The project described was supported by NIH grants RO1GM083143 and RO1CA135362 awarded to E. W. H. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Cancer Institute/National Institute of General Medical Sciences or the National Institutes of Health.	Bertrand MJM, 2008, MOL CELL, V30, P689, DOI 10.1016/j.molcel.2008.05.014; Boone DL, 2004, NAT IMMUNOL, V5, P1052, DOI 10.1038/ni1110; Compagno M, 2009, NATURE, V459, P717, DOI 10.1038/nature07968; Conze DB, 2008, MOL CELL BIOL, V28, P3538, DOI 10.1128/MCB.02098-07; Coornaert B, 2009, J BIOL CHEM, V284, P8217, DOI 10.1074/jbc.R800032200; Deng L, 2000, CELL, V103, P351, DOI 10.1016/S0092-8674(00)00126-4; Dieguez-Gonzalez R, 2009, ARTHRITIS RES THER, V11, DOI 10.1186/ar2650; Fukushima T, 2007, P NATL ACAD SCI USA, V104, P6371, DOI 10.1073/pnas.0700548104; Fung EYMG, 2009, GENES IMMUN, V10, P188, DOI 10.1038/gene.2008.99; Kato M, 2009, NATURE, V459, P712, DOI 10.1038/nature07969; Klinkenberg M, 2001, FEBS LETT, V498, P93, DOI 10.1016/S0014-5793(01)02504-2; Lamothe B, 2007, J BIOL CHEM, V282, P4102, DOI 10.1074/jbc.M609503200; Lee EG, 2000, SCIENCE, V289, P2350, DOI 10.1126/science.289.5488.2350; Musone SL, 2008, NAT GENET, V40, P1062, DOI 10.1038/ng.202; Shembade N, 2008, NAT IMMUNOL, V9, P254, DOI 10.1038/ni1563; Shembade N, 2007, J VIROL, V81, P13735, DOI 10.1128/JVI.01790-07; Shembade N, 2007, EMBO J, V26, P3910, DOI 10.1038/sj.emboj.7601823; Shembade N, 2009, EMBO J, V28, P513, DOI 10.1038/emboj.2008.285; Shi CS, 2003, J BIOL CHEM, V278, P15429, DOI 10.1074/jbc.M211796200; SMITH MR, 1990, GENE DEV, V4, P1875, DOI 10.1101/gad.4.11.1875; Wertz IE, 2004, NATURE, V430, P694, DOI 10.1038/nature02794; Wooff J, 2004, FEBS LETT, V566, P229, DOI 10.1016/j.febslet.2004.04.038; Xia ZP, 2009, NATURE, V461, P114, DOI 10.1038/nature08247; Yamamoto M, 2006, NAT IMMUNOL, V7, P962, DOI 10.1038/ni1367	24	444	473	1	48	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1135	1139		10.1126/science.1182364	http://dx.doi.org/10.1126/science.1182364			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185725	Green Accepted			2022-12-01	WOS:000274901100038
J	Samet, JM; Wipfli, HL				Samet, Jonathan M.; Wipfli, Heather L.			Globe still in grip of addiction	NATURE			English	Editorial Material							CHINA; DISEASE		[Samet, Jonathan M.] Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA; USC Inst Global Hlth, Los Angeles, CA 90033 USA	University of Southern California	Samet, JM (corresponding author), Univ So Calif, Keck Sch Med, Dept Prevent Med, Los Angeles, CA 90033 USA.	jsamet@usc.edu						*CANC RES UK, 2009, CANC STATS KEY FACTS; *CDCP, 2009, LUNG CANC TRENDS; *CORP ACC INT, 2008, PROT TOB IND INT 200; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; Michaels David, 2008, ENVIRON HEALTH PERSP, DOI DOI 10.1289/EHP.117-A218A; Muggli ME, 2008, PLOS MED, V5, P1729, DOI 10.1371/journal.pmed.0050251; Organization WH Control RfIT, 2008, WHO REP GLOB TOB EP; Robinson S, 2008, GEN LIFESTYLE SURVEY; Shafey O, 2009, TOBACCO ATLAS; Wald N, 1991, UK SMOKING STAT; World Health Organization, 2009, WHO REP GLOB TOB EP; Wright AA, 2007, NEW ENGL J MED, V356, P1493, DOI 10.1056/NEJMp078018; Yang GH, 1999, JAMA-J AM MED ASSOC, V282, P1247, DOI 10.1001/jama.282.13.1247; 2010, PEOPLES DAILY O 0118	14	30	30	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 25	2010	463	7284					1020	1021		10.1038/4631020a	http://dx.doi.org/10.1038/4631020a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	563DR	20182492				2022-12-01	WOS:000275108400017
J	Grainge, MJ; West, J; Card, TR				Grainge, Matthew J.; West, Joe; Card, Timothy R.			Venous thromboembolism during active disease and remission in inflammatory bowel disease: a cohort study	LANCET			English	Article							DEEP-VEIN THROMBOSIS; POPULATION-BASED COHORT; PULMONARY-EMBOLISM; RISK; OSTEOPOROSIS; PREVENTION; MORTALITY; DATABASE; RATES	Background Patients with inflammatory bowel disease who develop deep vein thrombosis or pulmonary embolism often have active disease at the time of thromboembolism. We therefore aimed to quantify the risk of venous thromboembolism prospectively during different activity phases of inflammatory bowel disease. Methods From the General Practice Research Database, we matched patients with prospectively recorded inflammatory bowel disease from November, 1987, until July, 2001 with up to five controls by age, sex, and general practice. A flare was defined as the period 120 days after a new corticosteroid prescription. We used Cox regression analysis with time-varying covariates to accommodate changes in the state of inflammatory bowel disease, and whether patients were at high risk of venous thromboembolism after hospitalisation. Findings 13 756 patients with inflammatory bowel disease and 71672 matched controls were included in the analysis, and of these 139 patients and 165 controls developed venous thromboembolism. Overall, patients with inflammatory bowel disease had a higher risk of venous thromboembolism than did controls (hazard ratio 3.4, 95% CI 2.7-4.3; p<0.0001; absolute risk 2.6 per 1000 per person-years). At the time of a flare, however, this increase in risk was much more prominent (8.4, 5.5-12.8; p<0.0001; 9.0 per 1000 person-years). This relative risk at the time of a flare was higher during non-hospitailised periods (15.8, 9.8-25.5; p<0.0001; 6.4 per 1000 person-years) than during hospitalised periods (3.2, 1.7-6.3; p=0.0006; 37.5 per 1000 person-years). Interpretation Trials of primary prophylaxis of venous thromboembolism are warranted to find out whether this important complication can be prevented.	[Grainge, Matthew J.; West, Joe; Card, Timothy R.] Univ Nottingham, Div Epidemiol & Publ Hlth, Nottingham NG7 2RD, England; [West, Joe; Card, Timothy R.] Nottingham Univ Hosp NHS Trust, Queens Med Ctr, Natl Inst Hlth, Nottingham Digest Dis Ctr,Res Biomed Res Unit, Nottingham, England; [Card, Timothy R.] Kings Mill Hosp, Dept Gastroenterol, Nottingham, England	University of Nottingham; Nottingham University Hospital NHS Trust; University of Nottingham	Grainge, MJ (corresponding author), Univ Nottingham, City Hosp, Div Epidemiol & Publ Hlth, Sch Community Hlth Sci, Clin Sci Bldg Phase 2, Nottingham NG5 1PB, England.	matthew.grainge@nottingham.ac.uk	West, Joe/I-6637-2012; Card, Tim/J-8651-2013; West, Joe/M-3867-2019	West, Joe/0000-0002-1135-9356; Card, Tim/0000-0003-2555-2250; West, Joe/0000-0002-1135-9356; Grainge, Matthew/0000-0001-7181-4042	National Association for Colitis and Crohn's Disease; UK National Institute for Health Research	National Association for Colitis and Crohn's Disease; UK National Institute for Health Research(National Institute for Health Research (NIHR))	The National Association for Colitis and Crohn's Disease funded the purchase of data used in this study. JW is funded by a UK National Institute for Health Research clinician scientist fellowship.	ANDERSON FA, 1991, ARCH INTERN MED, V151, P933, DOI 10.1001/archinte.151.5.933; Bernstein CN, 2007, CAN J GASTROENTEROL, V21, P507, DOI 10.1155/2007/924257; Bernstein CN, 2001, THROMB HAEMOSTASIS, V85, P430; Card T, 2004, GUT, V53, P251, DOI 10.1136/gut.2003.026799; Cohen AT, 2006, BMJ-BRIT MED J, V332, P325, DOI 10.1136/bmj.38733.466748.7C; COLLINS R, 1988, NEW ENGL J MED, V318, P1162, DOI 10.1056/NEJM198805053181805; Gigerenzer G, 2003, BMJ-BRIT MED J, V327, P741, DOI 10.1136/bmj.327.7417.741; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Grip O, 2000, SCAND J GASTROENTERO, V35, P619, DOI 10.1080/003655200750023589; Heit JA, 2005, ANN INTERN MED, V143, P697, DOI 10.7326/0003-4819-143-10-200511150-00006; Heit JA, 1999, ARCH INTERN MED, V159, P445, DOI 10.1001/archinte.159.5.445; Huerta C, 2007, ARCH INTERN MED, V167, P935, DOI 10.1001/archinte.167.9.935; Irving PM, 2005, CLIN GASTROENTEROL H, V3, P617, DOI 10.1016/S1542-3565(05)00154-0; Jilma B, 2005, THROMB HAEMOSTASIS, V94, P797, DOI 10.1160/T04-10-0652; Kelman CW, 2003, BRIT MED J, V327, P1072, DOI 10.1136/bmj.327.7423.1072; Koutroubakis IE, 2008, AM J GASTROENTEROL, V103, P2281, DOI 10.1111/j.1572-0241.2008.02060.x; Lawrenson R, 2000, BRIT J CLIN PHARMACO, V49, P591, DOI 10.1046/j.1365-2125.2000.00199.x; Levitan N, 1999, MEDICINE, V78, P285, DOI 10.1097/00005792-199909000-00001; Lewis JD, 2002, PHARMACOEPIDEM DR S, V11, P211, DOI 10.1002/pds.698; Lewis JD, 2004, GASTROENTEROLOGY, V126, P665, DOI 10.1053/j.gastro.2003.12.003; Miehsler W, 2004, GUT, V53, P542, DOI 10.1136/gut.2003.025411; Nguyen GC, 2008, AM J GASTROENTEROL, V103, P2272, DOI 10.1111/j.1572-0241.2008.02052.x; Novacek G, 2008, GASTROENTEROLOGY, V134, pA641; Schwarz T, 2003, ARCH INTERN MED, V163, P2759, DOI 10.1001/archinte.163.22.2759; Scott EM, 2000, GUT, V46, P1, DOI 10.1136/gut.46.suppl_1.I1; Smeeth L, 2006, LANCET, V367, P1075, DOI 10.1016/S0140-6736(06)68474-2; Solem CA, 2004, AM J GASTROENTEROL, V99, P97, DOI 10.1046/j.1572-0241.2003.04026.x; *STAT CORP, 2007, SURV AN EP TABL STAT; TALBOT RW, 1986, MAYO CLIN PROC, V61, P140, DOI 10.1016/S0025-6196(12)65200-8; Valentine JF, 1999, AM J GASTROENTEROL, V94, P878; Wells PS, 1998, ANN INTERN MED, V129, P997, DOI 10.7326/0003-4819-129-12-199812150-00002; WELLS PS, 1995, LANCET, V345, P1326, DOI 10.1016/S0140-6736(95)92535-X; Whitaker HJ, 2006, STAT MED, V25, P1768, DOI 10.1002/sim.2302	33	457	473	0	24	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 20	2010	375	9715					657	663		10.1016/S0140-6736(09)61963-2	http://dx.doi.org/10.1016/S0140-6736(09)61963-2			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20149425				2022-12-01	WOS:000275210900034
J	Viswanathan, SR; Daley, GQ				Viswanathan, Srinivas R.; Daley, George Q.			Lin28: A MicroRNA Regulator with a Macro Role	CELL			English	Article							EMBRYONIC STEM-CELLS; SELF-RENEWAL; POSTTRANSCRIPTIONAL REGULATION; CAENORHABDITIS-ELEGANS; CANCER-CELLS; EXPRESSION; RNA; LIN-28; PROMOTES; TRANSFORMATION		[Viswanathan, Srinivas R.; Daley, George Q.] Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, Boston, MA 02115 USA; [Viswanathan, Srinivas R.; Daley, George Q.] Howard Hughes Med Inst, Boston, MA 02115 USA; [Viswanathan, Srinivas R.; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Dana Farber Canc Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	Daley, GQ (corresponding author), Childrens Hosp, Stem Cell Transplantat Program, Div Pediat Hematol Oncol, 300 Longwood Ave, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Viswanathan, Srinivas/ABA-6316-2021	Viswanathan, Srinivas/0000-0003-1856-3023				AMBROS V, 1984, SCIENCE, V226, P409, DOI 10.1126/science.6494891; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Chang TC, 2008, NAT GENET, V40, P43, DOI 10.1038/ng.2007.30; Chang TC, 2009, P NATL ACAD SCI USA, V106, P3384, DOI 10.1073/pnas.0808300106; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hagan JP, 2009, NAT STRUCT MOL BIOL, V16, P1021, DOI 10.1038/nsmb.1676; Hartge P, 2009, NAT GENET, V41, P637, DOI 10.1038/ng0609-637; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Jeong SH, 2009, EXP MOL MED, V41, P912, DOI 10.3858/emm.2009.41.12.097; Johnson SM, 2005, CELL, V120, P635, DOI 10.1016/j.cell.2005.01.014; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Lehrbach NJ, 2009, NAT STRUCT MOL BIOL, V16, P1016, DOI 10.1038/nsmb.1675; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; MAN M, 2009, EMBO J, V28, P347; Mani SA, 2008, CELL, V133, P704, DOI 10.1016/j.cell.2008.03.027; Martinez NJ, 2008, GENE DEV, V22, P2535, DOI 10.1101/gad.1678608; Melton C, 2010, NATURE, V463, P621, DOI 10.1038/nature08725; Michlewski G, 2008, MOL CELL, V32, P383, DOI 10.1016/j.molcel.2008.10.013; Moss EG, 1997, CELL, V88, P637, DOI 10.1016/S0092-8674(00)81906-6; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Nishino J, 2008, CELL, V135, P227, DOI 10.1016/j.cell.2008.09.017; Pasquinelli AE, 2000, NATURE, V408, P86, DOI 10.1038/35040556; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Qiu CH, 2010, NUCLEIC ACIDS RES, V38, P1240, DOI 10.1093/nar/gkp1071; Roush S, 2008, TRENDS CELL BIOL, V18, P505, DOI 10.1016/j.tcb.2008.07.007; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Shell S, 2007, P NATL ACAD SCI USA, V104, P11400, DOI 10.1073/pnas.0704372104; Takamizawa J, 2004, CANCER RES, V64, P3753, DOI 10.1158/0008-5472.CAN-04-0637; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trabucchi M, 2009, NATURE, V459, P1010, DOI 10.1038/nature08025; Valsesia-Wittmann S, 2004, CANCER CELL, V6, P625, DOI 10.1016/j.ccr.2004.09.033; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Viswanathan SR, 2009, NAT GENET, V41, P843, DOI 10.1038/ng.392; Weidhaas JB, 2007, CANCER RES, V67, P11111, DOI 10.1158/0008-5472.CAN-07-2858; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Yamanaka S, 2008, PHILOS T R SOC B, V363, P2079, DOI 10.1098/rstb.2008.2261; Yu F, 2007, CELL, V131, P1109, DOI 10.1016/j.cell.2007.10.054	41	319	342	0	19	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					445	449		10.1016/j.cell.2010.02.007	http://dx.doi.org/10.1016/j.cell.2010.02.007			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178735	Bronze			2022-12-01	WOS:000274668400005
J	Hung, RJ; Yazdani, U; Yoon, J; Wu, H; Yang, TH; Gupta, N; Huang, ZY; van Berkel, WJH; Terman, JR				Hung, Ruei-Jiun; Yazdani, Umar; Yoon, Jimok; Wu, Heng; Yang, Taehong; Gupta, Nidhi; Huang, Zhiyu; van Berkel, Willem J. H.; Terman, Jonathan R.			Mical links semaphorins to F-actin disassembly	NATURE			English	Article							GROWTH CONES; DROSOPHILA; COLLAPSE; MOLECULE; PROTEIN; 3A; MICROTUBULES; ORGANIZATION; CYTOSKELETON; MORPHOLOGY	How instructive cues present on the cell surface have their precise effects on the actin cytoskeleton is poorly understood. Semaphorins are one of the largest families of these instructive cues and are widely studied for their effects on cell movement, navigation, angiogenesis, immunology and cancer(1). Semaphorins/collapsins were characterized in part on the basis of their ability to drastically alter actin cytoskeletal dynamics in neuronal processes(2), but despite considerable progress in the identification of semaphorin receptors and their signalling pathways(3), the molecules linking them to the precise control of cytoskeletal elements remain unknown. Recently, highly unusual proteins of the Mical family of enzymes have been found to associate with the cytoplasmic portion of plexins, which are large cell-surface semaphorin receptors, and to mediate axon guidance, synaptogenesis, dendritic pruning and other cell morphological changes(4-7). Mical enzymes perform reduction-oxidation (redox) enzymatic reactions(4,5,8-10) and also contain domains found in proteins that regulate cell morphology(4,11). However, nothing is known of the role of Mical or its redox activity in mediating morphological changes. Here we report that Mical directly links semaphorins and their plexin receptors to the precise control of actin filament (F-actin) dynamics. We found that Mical is both necessary and sufficient for semaphorin-plexin-mediated F-actin reorganization in vivo. Likewise, we purified Mical protein and found that it directly binds F-actin and disassembles both individual and bundled actin filaments. We also found that Mical utilizes its redox activity to alter F-actin dynamics in vivo and in vitro, indicating a previously unknown role for specific redox signalling events in actin cytoskeletal regulation. Mical therefore is a novel F-actin-disassembly factor that provides a molecular conduit through which actin reorganization-a hallmark of cell morphological changes including axon navigation-can be precisely achieved spatiotemporally in response to semaphorins.	[Hung, Ruei-Jiun; Yazdani, Umar; Yoon, Jimok; Wu, Heng; Yang, Taehong; Gupta, Nidhi; Huang, Zhiyu; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Yazdani, Umar; Yoon, Jimok; Wu, Heng; Yang, Taehong; Gupta, Nidhi; Huang, Zhiyu; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Dept Pharmacol, Dallas, TX 75390 USA; [Hung, Ruei-Jiun; Yazdani, Umar; Yoon, Jimok; Wu, Heng; Yang, Taehong; Gupta, Nidhi; Huang, Zhiyu; Terman, Jonathan R.] Univ Texas SW Med Ctr Dallas, Grad Program Neurosci, Dallas, TX 75390 USA; [van Berkel, Willem J. H.] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands	University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Wageningen University & Research	Terman, JR (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA.	jonathan.terman@utsouthwestern.edu	van Berkel, Willem J.H./O-2431-2014; Gupta, Nidhi/ADR-1996-2022	van Berkel, Willem J.H./0000-0002-6551-2782; Gupta, Nidhi/0000-0002-1086-1336	US National Institute of Mental Health [MH085923]; Basil O'Connor Starter Scholar Research Award; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH085923] Funding Source: NIH RePORTER	US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Basil O'Connor Starter Scholar Research Award(March of Dimes); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank C. Cowan, M. Rosen and T. Sudhof for comments on drafts of our manuscript and M. Bailey, C. Gilpin, H. He, T. Januszewski, H. Kramer, W. Lin, T. Wedgeworth, X. Zhang and the University of Texas Southwestern Electron Microscopy Core Facility for discussions and assistance. We also thank the Bloomington, Harvard and Japanese stock centres for flies and H. Aberle, L. Cooley, C. Goodman, A. Kolodkin, B. Lee, L. Luo, J. Merriam and X. Zhang for flies and/or reagents. This work was supported by the US National Institute of Mental Health (MH085923) and a Basil O'Connor Starter Scholar Research Award to J. R. T. J. R. T. is a Klingenstein Fellow and the Rita C. and William P. Clements, Jr, Scholar in Medical Research.	Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; BROADIE K, 1993, DEVELOPMENT, P227; Campbell DS, 2001, J NEUROSCI, V21, P8538, DOI 10.1523/JNEUROSCI.21-21-08538.2001; Dent EW, 2004, J NEUROSCI, V24, P3002, DOI 10.1523/JNEUROSCI.4963-03.2004; FAN JH, 1993, J CELL BIOL, V121, P867, DOI 10.1083/jcb.121.4.867; FAN JH, 1995, NEURON, V14, P263, DOI 10.1016/0896-6273(95)90284-8; Fenstermaker V, 2004, J NEUROBIOL, V58, P403, DOI 10.1002/neu.10304; Geng W, 2000, GENETICS, V156, P1817; GODEMENT P, 1994, J NEUROSCI, V14, P7024; Guild GM, 2002, J CELL SCI, V115, P641; Gupta N., 2008, FLAVINS FLAVOPROTEIN, P345; KAPFHAMMER JP, 1987, J NEUROSCI, V7, P201; Kirilly D, 2009, NAT NEUROSCI, V12, P1497, DOI 10.1038/nn.2415; Liu Y, 2005, J NEUROSCI, V25, P10556, DOI 10.1523/JNEUROSCI.2710-05.2005; LUO YL, 1993, CELL, V75, P217, DOI 10.1016/0092-8674(93)80064-L; Murray MJ, 1998, J NEUROBIOL, V37, P607, DOI 10.1002/(SICI)1097-4695(199812)37:4<607::AID-NEU9>3.3.CO;2-H; Nadella M, 2005, P NATL ACAD SCI USA, V102, P16830, DOI 10.1073/pnas.0504838102; Sakai JA, 2006, DEVELOPMENT, V133, P1035, DOI 10.1242/dev.02272; Sanchez-Soriano N, 2005, J NEUROSCI, V25, P78, DOI 10.1523/JNEUROSCI.2377-04.2005; Schmidt EF, 2008, J NEUROSCI, V28, P2287, DOI 10.1523/JNEUROSCI.5646-07.2008; Siebold C, 2005, P NATL ACAD SCI USA, V102, P16836, DOI 10.1073/pnas.0504997102; Sutherland JD, 1999, CURR OPIN CELL BIOL, V11, P142, DOI 10.1016/S0955-0674(99)80018-0; Suzuki T, 2002, J BIOL CHEM, V277, P14933, DOI 10.1074/jbc.M111842200; Terman JR, 2002, CELL, V109, P887, DOI 10.1016/S0092-8674(02)00794-8; Tilney LG, 2005, P NATL ACAD SCI USA, V102, P18785, DOI 10.1073/pnas.0509437102; Tilney LG, 2000, J CELL SCI, V113, P1255; TOSNEY KW, 1985, J NEUROSCI, V5, P2345; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Turner CM, 1998, MECH DEVELOP, V70, P181, DOI 10.1016/S0925-4773(97)00194-9; Zhou YP, 2008, TRENDS BIOCHEM SCI, V33, P161, DOI 10.1016/j.tibs.2008.01.006	30	188	194	2	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					823	827		10.1038/nature08724	http://dx.doi.org/10.1038/nature08724			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148037	Green Accepted			2022-12-01	WOS:000274394300043
J	Chapman, JW; Nesbit, RL; Burgin, LE; Reynolds, DR; Smith, AD; Middleton, DR; Hill, JK				Chapman, Jason W.; Nesbit, Rebecca L.; Burgin, Laura E.; Reynolds, Don R.; Smith, Alan D.; Middleton, Douglas R.; Hill, Jane K.			Flight Orientation Behaviors Promote Optimal Migration Trajectories in High-Flying Insects	SCIENCE			English	Article							MONARCH BUTTERFLIES; COMPASS ORIENTATION; SOUTHERN BRITAIN; VANESSA-ATALANTA; BOUNDARY-LAYER; HIGH-ALTITUDE; WIND; MOTH; LEPIDOPTERA; MECHANISMS	Many insects undertake long-range seasonal migrations to exploit temporary breeding sites hundreds or thousands of kilometers apart, but the behavioral adaptations that facilitate these movements remain largely unknown. Using entomological radar, we showed that the ability to select seasonally favorable, high-altitude winds is widespread in large day-and night-flying migrants and that insects adopt optimal flight headings that partially correct for crosswind drift, thus maximizing distances traveled. Trajectory analyses show that these behaviors increase migration distances by 40% and decrease the degree of drift from seasonally optimal directions. These flight behaviors match the sophistication of those seen in migrant birds and help explain how high-flying insects migrate successfully between seasonal habitats.	[Chapman, Jason W.; Nesbit, Rebecca L.; Reynolds, Don R.; Smith, Alan D.] Rothamsted Res, Plant & Invertebrate Ecol Dept, Harpenden AL5 2JQ, Herts, England; [Nesbit, Rebecca L.; Hill, Jane K.] Univ York, Dept Biol, York YO10 5YW, N Yorkshire, England; [Burgin, Laura E.; Middleton, Douglas R.] Met Off, Exeter EX1 3PB, Devon, England; [Reynolds, Don R.] Univ Greenwich, Nat Resources Inst, Chatham ME4 4TB, Kent, England; [Burgin, Laura E.] Univ Exeter, Sch Geog, Exeter EX4 8RJ, Devon, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; University of York - UK; Met Office - UK; University of Greenwich; University of Exeter	Chapman, JW (corresponding author), Rothamsted Res, Plant & Invertebrate Ecol Dept, Harpenden AL5 2JQ, Herts, England.	jason.chapman@bbsrc.ac.uk	Chapman, Jason/H-8236-2012; Hill, Jane K./AAJ-3374-2021; Hill, Jane K/G-5151-2011; Reynolds, Donald R/C-7361-2013; Burgin, Laura/I-4724-2012	Hill, Jane K./0000-0003-1871-7715; Burgin, Laura/0000-0003-1247-9971; Chapman, Jason/0000-0002-7475-4441; Reynolds, Donald/0000-0001-8749-7491	U.K. Biotechnology and Biological Sciences Research Council	U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We thank S. Clark, L. Castle, D. Ladd, P. Clark, G. Hays, J. Phillips, T. Alerstam, D. Thomson, and M. Hort. Rothamsted Research receives grant-aided support from U.K. Biotechnology and Biological Sciences Research Council.	Aarestrup K, 2009, SCIENCE, V325, P1660, DOI 10.1126/science.1178120; Akesson S, 2007, BIOSCIENCE, V57, P123, DOI 10.1641/B570207; Alerstam T, 2006, SCIENCE, V313, P791, DOI 10.1126/science.1129048; Carde RT, 2008, CURR BIOL, V18, pR472, DOI 10.1016/j.cub.2008.04.018; Chapman JW, 2008, CURR BIOL, V18, pR908, DOI 10.1016/j.cub.2008.08.014; Chapman JW, 2008, CURR BIOL, V18, P514, DOI 10.1016/j.cub.2008.02.080; Chapman JW, 2004, INT J PEST MANAGE, V50, P225, DOI 10.1080/09670870410001731961; Chapman JW, 2004, B ENTOMOL RES, V94, P123, DOI 10.1079/BER2004287; Green M, 2002, J THEOR BIOL, V218, P485, DOI 10.1006/jtbi.2002.3094; Green M, 2004, ARDEA, V92, P145; Holland RA, 2006, SCIENCE, V313, P794, DOI 10.1126/science.1127272; Merlin C, 2009, SCIENCE, V325, P1700, DOI 10.1126/science.1176221; Mikkola K, 2003, ENTOMOL FENNICA, V14, P15; Mouritsen H, 2002, P NATL ACAD SCI USA, V99, P10162, DOI 10.1073/pnas.152137299; Nesbit RL, 2009, ANIM BEHAV, V78, P1119, DOI 10.1016/j.anbehav.2009.07.039; Pollard E, 1998, ECOL LETT, V1, P77; Schmaljohann H, 2009, BEHAV ECOL SOCIOBIOL, V63, P1609, DOI 10.1007/s00265-009-0758-x; Sparks TH, 2005, GLOBAL CHANGE BIOL, V11, P507, DOI 10.1111/j.1365-2486.2005.00910.x; Srygley RB, 2008, INTEGR COMP BIOL, V48, P119, DOI 10.1093/icb/icn011; Stefanescu C, 2007, J ANIM ECOL, V76, P888, DOI 10.1111/j.1365-2656.2007.01262.x; Wood CR, 2009, B ENTOMOL RES, V99, P525, DOI 10.1017/S0007485308006548; Wood CR, 2006, INT J BIOMETEOROL, V50, P193, DOI 10.1007/s00484-005-0014-7	22	206	229	10	158	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					682	685		10.1126/science.1182990	http://dx.doi.org/10.1126/science.1182990			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133570				2022-12-01	WOS:000274251800036
J	Yuan, J; Luo, KT; Zhang, LZ; Cheville, JC; Lou, ZK				Yuan, Jian; Luo, Kuntian; Zhang, Lizhi; Cheville, John C.; Lou, Zhenkun			USP10 Regulates p53 Localization and Stability by Deubiquitinating p53	CELL			English	Article							ATM-DEPENDENT PHOSPHORYLATION; UBIQUITIN-SPECIFIC PROTEASE; RING-FINGER DOMAIN; DNA-DAMAGE; NUCLEAR EXPORT; P53-MDM2 PATHWAY; MDM2; DEGRADATION; HAUSP; ACTIVATION	Stability and localization of p53 is essential for its tumor suppressor function. Ubiquitination by the E3 ubiquitin ligase Mdm2 is the major regulatory mechanism of p53, which induces p53 nuclear export and degradation. However, it is unclear whether ubiquitinated cytoplasmic p53 can be recycled. Here, we report that USP10, a cytoplasmic ubiquitin-specific protease, deubiquitinates p53, reversing Mdm2-induced p53 nuclear export and degradation. After DNA damage, USP10 is stabilized, and a fraction of USP10 translocates to the nucleus to activate p53. The translocation and stabilization of USP10 is regulated by ATM -mediated phosphorylation of USP10 at Thr42 and Ser337. Finally, USP10 suppresses tumor cell growth in cells with wild-type p53, with USP10 expression downregulated in a high percentage of clear cell carcinomas, known to have few p53 mutations. These findings reveal USP10 to be a novel regulator of p53, providing an alternative mechanism of p53 inhibition in cancers with wildtype p53.	[Yuan, Jian; Luo, Kuntian; Lou, Zhenkun] Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA; [Zhang, Lizhi; Cheville, John C.] Mayo Clin, Dept Pathol, Rochester, MN 55905 USA	Mayo Clinic; Mayo Clinic	Lou, ZK (corresponding author), Mayo Clin, Dept Oncol, Div Oncol Res, Rochester, MN 55905 USA.	lou.zhenkun@mayo.edu	Yuan, Jian/B-1310-2012	Yuan, Jian/0000-0002-2801-8849	Richard Schulze Family Foundation and Research; National Institutes of Health [CA130996]; NATIONAL CANCER INSTITUTE [R01CA130996, R01CA148940] Funding Source: NIH RePORTER	Richard Schulze Family Foundation and Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank Bert Vogelstein (Johns Hopkins University), Thomas Roberts (Dana-Farber Cancer Institute and Harvard Medical School), Peter Howley (National Cancer Institute), and Tyler Jacks (MIT Center for Cancer Research) for providing reagents used in this study. This work was supported in part by grants from the Richard Schulze Family Foundation and Research Grant and the National Institutes of Health (CA130996).	Abraham RT, 2001, GENE DEV, V15, P2177, DOI 10.1101/gad.914401; Appella E, 2001, EUR J BIOCHEM, V268, P2764, DOI 10.1046/j.1432-1327.2001.02225.x; Banin S, 1998, SCIENCE, V281, P1674, DOI 10.1126/science.281.5383.1674; Boyd SD, 2000, NAT CELL BIOL, V2, P563, DOI 10.1038/35023500; Brooks CL, 2007, ONCOGENE, V26, P7262, DOI 10.1038/sj.onc.1210531; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Chehab NH, 2000, GENE DEV, V14, P278; Cummins JM, 2004, NATURE, V428, DOI 10.1038/nature02501; Deng SS, 2007, BREAST CANCER RES TR, V104, P21, DOI 10.1007/s10549-006-9393-7; Everett RD, 1997, EMBO J, V16, P1519, DOI 10.1093/emboj/16.7.1519; Freedman DA, 1998, MOL CELL BIOL, V18, P7288, DOI 10.1128/MCB.18.12.7288; Geyer RK, 2000, NAT CELL BIOL, V2, P569, DOI 10.1038/35023507; Grunda JM, 2006, J NEURO-ONCOL, V80, P261, DOI 10.1007/s11060-006-9191-4; Haupt Y, 1997, NATURE, V387, P296, DOI 10.1038/387296a0; Hickson I, 2004, CANCER RES, V64, P9152, DOI 10.1158/0008-5472.CAN-04-2727; Hirao A, 2000, SCIENCE, V287, P1824, DOI 10.1126/science.287.5459.1824; Honda R, 1997, FEBS LETT, V420, P25, DOI 10.1016/S0014-5793(97)01480-4; Hu M, 2006, PLOS BIOL, V4, P228, DOI 10.1371/journal.pbio.0040027; Khosravi R, 1999, P NATL ACAD SCI USA, V96, P14973, DOI 10.1073/pnas.96.26.14973; Kubbutat MHG, 1997, MOL CELL BIOL, V17, P460, DOI 10.1128/MCB.17.1.460; LANE DP, 1992, NATURE, V358, P15, DOI 10.1038/358015a0; Li MY, 2002, NATURE, V416, P648, DOI 10.1038/nature737; Li MY, 2004, MOL CELL, V13, P879, DOI 10.1016/S1097-2765(04)00157-1; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lohrum MAE, 2001, MOL CELL BIOL, V21, P8521, DOI 10.1128/MCB.21.24.8521-8532.2001; Marchenko ND, 2007, CELL CYCLE, V6, P1718, DOI 10.4161/cc.6.14.4503; Maya R, 2001, GENE DEV, V15, P1067, DOI 10.1101/gad.886901; Meulmeester E, 2005, MOL CELL, V18, P565, DOI 10.1016/j.molcel.2005.04.024; Nikolaev AY, 2003, CELL, V112, P29, DOI 10.1016/S0092-8674(02)01255-2; Pereg Y, 2005, P NATL ACAD SCI USA, V102, P5056, DOI 10.1073/pnas.0408595102; Riley T, 2008, NAT REV MOL CELL BIO, V9, P402, DOI 10.1038/nrm2395; Sheng Y, 2006, NAT STRUCT MOL BIOL, V13, P285, DOI 10.1038/nsmb1067; Shieh SY, 1997, CELL, V91, P325, DOI 10.1016/S0092-8674(00)80416-X; Shieh SY, 2000, GENE DEV, V14, P289; Shim H, 1997, P NATL ACAD SCI USA, V94, P6658, DOI 10.1073/pnas.94.13.6658; Shirangi TR, 2002, FASEB J, V16, P420, DOI 10.1096/fj.01-0617fje; Soncini C, 2001, ONCOGENE, V20, P3869, DOI 10.1038/sj.onc.1204553; Song MS, 2008, NATURE, V455, P813, DOI 10.1038/nature07290; Soussi T, 2000, HUM MUTAT, V15, P105, DOI 10.1002/(SICI)1098-1004(200001)15:1<105::AID-HUMU19>3.0.CO;2-G; Stommel JM, 1999, EMBO J, V18, P1660, DOI 10.1093/emboj/18.6.1660; Stommel JM, 2004, EMBO J, V23, P1547, DOI 10.1038/sj.emboj.7600145; Terzian T, 2008, GENE DEV, V22, P1337, DOI 10.1101/gad.1662908; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Xirodimas DP, 2001, EXP CELL RES, V270, P66, DOI 10.1006/excr.2001.5314	44	364	389	3	57	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					384	U121		10.1016/j.cell.2009.12.032	http://dx.doi.org/10.1016/j.cell.2009.12.032			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20096447	Green Accepted, Bronze			2022-12-01	WOS:000274297700016
J	Daniel, R; Mallen, CD; Cooper, J				Daniel, Rebecca; Mallen, Christian David; Cooper, Jason			10-minute consultation Female stress urinary incontinence	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Mallen, Christian David] Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele ST5 5BG, Staffs, England; [Cooper, Jason] Univ Hosp N Staffordshire, Stoke On Trent ST4 6QG, Staffs, England	Keele University; Keele University		r.daniel@cphc.keele.ac.uk		Mallen, Christian/0000-0002-2677-1028					0	2	2	0	5	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2010	340								b5533	10.1136/bmj.b5533	http://dx.doi.org/10.1136/bmj.b5533			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CT	20123833				2022-12-01	WOS:000274343300008
J	Choiniere, JN; Xu, X; Clark, JM; Forster, CA; Guo, Y; Han, FL				Choiniere, Jonah N.; Xu, Xing; Clark, James M.; Forster, Catherine A.; Guo, Yu; Han, Fenglu			A Basal Alvarezsauroid Theropod from the Early Late Jurassic of Xinjiang, China	SCIENCE			English	Article							LONG FEATHERS; MANIRAPTORAN; DINOSAURIA; AGE	The fossil record of Jurassic theropod dinosaurs closely related to birds remains poor. A new theropod from the earliest Late Jurassic of western China represents the earliest diverging member of the enigmatic theropod group Alvarezsauroidea and confirms that this group is a basal member of Maniraptora, the clade containing birds and their closest theropod relatives. It extends the fossil record of Alvarezsauroidea by 63 million years and provides evidence for maniraptorans earlier in the fossil record than Archaeopteryx. The new taxon confirms extreme morphological convergence between birds and derived alvarezsauroids and illuminates incipient stages of the highly modified alvarezsaurid forelimb.	[Choiniere, Jonah N.; Clark, James M.; Forster, Catherine A.] George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA; [Xu, Xing; Guo, Yu; Han, Fenglu] Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China	George Washington University; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS	Choiniere, JN (corresponding author), George Washington Univ, Dept Biol Sci, Washington, DC 20052 USA.	jonah.choiniere@gmail.com		Choiniere, Jonah/0000-0002-1008-0687	National Science Foundation Division of Earth Sciences and Office of International Science and Engineering of the USA; National Natural Sciences Foundation of China; Chinese Academy of Sciences; GWU; Jurassic Foundation; Hilmar Sallee bequest; George Washington University; Directorate For Geosciences [0922187] Funding Source: National Science Foundation	National Science Foundation Division of Earth Sciences and Office of International Science and Engineering of the USA; National Natural Sciences Foundation of China(National Natural Science Foundation of China (NSFC)); Chinese Academy of Sciences(Chinese Academy of Sciences); GWU; Jurassic Foundation; Hilmar Sallee bequest; George Washington University; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	We thank W. Ding and T. Yu for finding the specimen, and the crew of the 2004 Sino-American field expedition for excavating the specimen; H.-j. Wang, X. Ding, and L. Xiang for preparing the fossil; A. Buscalioni, C. Mehling, and M. Norell for specimen access; and P. Barrett, H. Cameron, J. Conrad, M. Ellison, D. Hone, C. Sullivan, and A. Turner for discussions. Support for this research was provided by the National Science Foundation Division of Earth Sciences and Office of International Science and Engineering of the USA, the National Natural Sciences Foundation of China, and the Chinese Academy of Sciences; and the GWU Facilitating Fund, the Jurassic Foundation, the Hilmar Sallee bequest, and the George Washington University.	Bonaparte JF., 1991, REV MUSEO ARGENTINO, V4, P17; Chiappe LM, 1998, NATURE, V392, P275, DOI 10.1038/32642; Chiappe Luis M., 2002, P87; Clark James M., 2006, P26; Clark JM, 2004, DINOSAURIA, 2ND EDITION, P151; Clark James M., 2002, P31; Feduccia A, 2002, AUK, V119, P1187, DOI 10.1642/0004-8038(2002)119[1187:BADSAT]2.0.CO;2; GOLOBOFF PA, 2003, TNT VERSION 1 1; GRADSTEIN F.M., 2005, GEOLOGIC TIME SCALE; HOLTZ TR, 1994, J VERTEBR PALEONTOL, V14, P480, DOI 10.1080/02724634.1995.10011574; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Hutchinson JR, 1998, J VERTEBR PALEONTOL, V18, P447, DOI 10.1080/02724634.1998.10011073; Karhu AA., 1996, PALEONTOL J, V30, P583; Kessler E., 2005, ACTA PALAEONTOL ROMA, V5, P349; Li RH., 2003, JURASSIC SYSTEM N CH; Liu YQ, 2006, CHINESE SCI BULL, V51, P2634, DOI 10.1007/s11434-006-2165-2; Longrich NR, 2009, CRETACEOUS RES, V30, P239, DOI 10.1016/j.cretres.2008.07.005; MADSEN JH, 1976, B UTAH GEOLOGICAL MI, V109, P1; Makovicky PJ, 2004, DINOSAURIA, 2ND EDITION, P184; Martinelli AG, 2007, ZOOTAXA, P1; Naish D, 2004, NEUES JAHRB GEOL P-M, P385; NORELL MA, 1993, AM J SCI, V293A, P407, DOI 10.2475/ajs.293.A.407; Novas FE, 1997, J VERTEBR PALEONTOL, V17, P137, DOI 10.1080/02724634.1997.10010959; Novas Fernando E., 2002, P121; Novas Fernando E., 1996, Memoirs of the Queensland Museum, V39, P675; OSTROM JH, 1969, PEABODY MUS NAT HIST, V30; PEREZMORENO BP, 1994, NATURE, V370, P363, DOI 10.1038/370363a0; PERLE A, 1993, NATURE, V362, P623, DOI DOI 10.1038/362623A0; Perle A., 1994, AM MUS NOVIT, V3105, P1; Pol D, 2001, CLADISTICS, V17, P285, DOI 10.1111/j.1096-0031.2001.tb00125.x; Pol D, 2006, SYST BIOL, V55, P512, DOI 10.1080/10635150600755446; Sereno PC, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P69; Suzuki Shigeru, 2002, Contributions in Science (Los Angeles), V494, P1; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Turner AH, 2009, AM MUS NOVIT, P1; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Zhang FC, 2002, NATURWISSENSCHAFTEN, V89, P394, DOI 10.1007/s00114-002-0353-8; Zhang FC, 2008, NATURE, V455, P1105, DOI 10.1038/nature07447	38	101	108	3	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					571	574		10.1126/science.1182143	http://dx.doi.org/10.1126/science.1182143			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110503				2022-12-01	WOS:000274020500035
J	Dunn, KM; Saunders, KW; Rutter, CM; Banta-Green, CJ; Merrill, JO; Sullivan, MD; Weisner, CM; Silverberg, MJ; Campbell, CI; Psaty, BM; Von Korff, M				Dunn, Kate M.; Saunders, Kathleen W.; Rutter, Carolyn M.; Banta-Green, Caleb J.; Merrill, Joseph O.; Sullivan, Mark D.; Weisner, Constance M.; Silverberg, Michael J.; Campbell, Cynthia I.; Psaty, Bruce M.; Von Korff, Michael			Opioid Prescriptions for Chronic Pain and Overdose A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							CHRONIC NONCANCER PAIN; MUSCULOSKELETAL PAIN; ANALGESICS; THERAPY; DEATHS; TRENDS; PHYSICIANS; MORTALITY; EFFICACY; ABUSE	Background: Long-term opioid therapy for chronic noncancer pain is becoming increasingly common in community practice. Concomitant with this change in practice, rates of fatal opioid overdose have increased. The extent to which overdose risks are elevated among patients receiving medically prescribed long-term opioid therapy is unknown. Objective: To estimate rates of opioid overdose and their association with an average prescribed daily opioid dose among patients receiving medically prescribed, long-term opioid therapy. Design: Cox proportional hazards models were used to estimate overdose risk as a function of average daily opioid dose (morphine equivalents) received at the time of overdose. Setting: HMO. Patients: 9940 persons who received 3 or more opioid prescriptions within 90 days for chronic noncancer pain between 1997 and 2005. Measurements: Average daily opioid dose over the previous 90 days from automated pharmacy data. Primary outcomes-nonfatal and fatal overdoses-were identified through diagnostic codes from inpatient and outpatient care and death certificates and were confirmed by medical record review. Results: 51 opioid-related overdoses were identified, including 6 deaths. Compared with patients receiving 1 to 20 mg/d of opioids (0.2% annual overdose rate), patients receiving 50 to 99 mg/d had a 3.7-fold increase in overdose risk (95% CI, 1.5 to 9.5) and a 0.7% annual overdose rate. Patients receiving 100 mg/d or more had an 8.9-fold increase in overdose risk (CI, 4.0 to 19.7) and a 1.8% annual overdose rate. Limitations: Increased overdose risk among patients receiving higher dose regimens may be due to confounding by patient differences and by use of opioids in ways not intended by prescribing physicians. The small number of overdoses in the study cohort is also a limitation. Conclusion: Patients receiving higher doses of prescribed opioids are at increased risk for overdose, which underscores the need for close supervision of these patients.	[Von Korff, Michael] Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, Seattle, WA 98101 USA; Univ Washington, Seattle, WA 98195 USA; Keele Univ, Arthrit Res Campaign Natl Primary Care Ctr, Keele, Staffs, England; No Calif Kaiser Permanente, Oakland, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA	Group Health Cooperative; University of Washington; University of Washington Seattle; Keele University; Kaiser Permanente; University of California System; University of California San Francisco	Von Korff, M (corresponding author), Grp Hlth Cooperat Puget Sound, Grp Hlth Res Inst, 1730 Minor Ave,Suite 1600, Seattle, WA 98101 USA.	vonkorff.m@ghc.org	Rutter, Carolyn/AAZ-3677-2021	Banta-Green, Caleb/0000-0003-4084-6943; VonKorff, Michael/0000-0001-5386-8477	National Institute of Drug Abuse [DA022557]; Wellcome Trust [083572]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA022557] Funding Source: NIH RePORTER	National Institute of Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	Grant Support: This research was supported by a grant to Dr. Von Korff from the National Institute of Drug Abuse (DA022557). Dr. Dunn participated in this work with Dr. Von Korff at the Group Health Research Institute through a grant from the Wellcome Trust (083572).	Ballantyne JC, 2008, CLIN J PAIN, V24, P469, DOI 10.1097/AJP.0b013e31816b2f26; Ballantyne Jane C, 2007, Pain Physician, V10, P479; Ballantyne JC, 2003, NEW ENGL J MED, V349, P1943, DOI 10.1056/NEJMra025411; BOUDREAU D, 2009, PHARMACOEPIDEMIOL DR; Breivik H, 2005, EUR J PAIN, V9, P127, DOI 10.1016/j.ejpain.2004.05.013; Caudill-Slosberg MA, 2004, PAIN, V109, P514, DOI 10.1016/j.pain.2004.03.006; Chou R, 2009, J PAIN, V10, P113, DOI 10.1016/j.jpain.2008.10.008; Eriksen J, 2006, PAIN, V125, P172, DOI 10.1016/j.pain.2006.06.009; Fernandez W, 2006, J SUBST ABUSE TREAT, V31, P151, DOI 10.1016/j.jsat.2006.04.008; Fishman PA, 2003, MED CARE, V41, P84, DOI 10.1097/00005650-200301000-00011; Fishman SM, 2006, PHARMACOEPIDEM DR S, V15, P628, DOI 10.1002/pds.1292; Franklin GM, 2005, AM J IND MED, V48, P91, DOI 10.1002/ajim.20191; Furlan AD, 2006, CAN MED ASSOC J, V174, P1589, DOI 10.1503/cmaj.051528; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hall AJ, 2008, JAMA-J AM MED ASSOC, V300, P2613, DOI 10.1001/jama.2008.802; Hartung DM, 2007, ANN PHARMACOTHER, V41, P921, DOI 10.1345/aph.1K066; Kuehn BM, 2009, JAMA-J AM MED ASSOC, V301, P1213, DOI 10.1001/jama.2009.367; Martell BA, 2007, ANN INTERN MED, V146, P116, DOI 10.7326/0003-4819-146-2-200701160-00006; McLellan AT, 2008, JAMA-J AM MED ASSOC, V300, P2672, DOI 10.1001/jama.2008.793; Paulozzi LJ, 2006, PHARMACOEPIDEM DR S, V15, P618, DOI 10.1002/pds.1276; Paulozzi LJ, 2006, AM J PREV MED, V31, P506, DOI 10.1016/j.amepre.2006.08.017; Reidenberg MM, 2007, CLIN PHARMACOL THER, V81, P903, DOI 10.1038/sj.clpt.6100127; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1085, DOI 10.1016/0895-4356(93)90106-B; SAS/STAT, 2008, SAS STAT 9 2 US GUID; Saunders KW, 2005, PHARMACOEPIDEMIOLOGY, 4TH EDITION, P223; Shah NG, 2008, ADDICTION, V103, P126, DOI 10.1111/j.1360-0443.2007.02054.x; THERNEAU TM, 2000, STAT BIOL HEALTH, pR7; Trescot AM, 2008, PAIN PHYSICIAN, V11, pS5; Von Korff M, 2004, PAIN, V109, P207, DOI 10.1016/j.pain.2004.02.019; Von Korff M, 2008, CLIN J PAIN, V24, P521, DOI 10.1097/AJP.0b013e318169d03b; Washington State Department of Health, 2007, HLTH WASH STAT 2007; Won A, 2006, J GERONTOL A-BIOL, V61, P165, DOI 10.1093/gerona/61.2.165; Wysowski DK, 2007, DRUG SAFETY, V30, P533, DOI 10.2165/00002018-200730060-00007	33	929	938	1	74	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					85	+		10.7326/0003-4819-152-2-201001190-00006	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083827	Green Accepted			2022-12-01	WOS:000273953000003
J	Baker, MC; Mathieu, E; Fleming, FM; Deming, M; King, JD; Garba, A; Koroma, JB; Bockarie, M; Kabore, A; Sankara, DP; Molyneux, DH				Baker, M. C.; Mathieu, E.; Fleming, F. M.; Deming, M.; King, J. D.; Garba, A.; Koroma, J. B.; Bockarie, M.; Kabore, A.; Sankara, D. P.; Molyneux, D. H.			Neglected Tropical Diseases 3 Mapping, monitoring, and surveillance of neglected tropical diseases: towards a policy framework	LANCET			English	Article							CIRCULATING CATHODIC ANTIGEN; SUB-SAHARAN AFRICA; LOA-LOA INFECTION; LYMPHATIC FILARIASIS; BANCROFTIAN FILARIASIS; RAPID ASSESSMENT; URINARY SCHISTOSOMIASIS; ONCHOCERCIASIS CONTROL; COST-EFFECTIVENESS; SPATIAL-ANALYSIS	As national programmes respond to the new opportunities presented for scaling up preventive chemotherapy programmes for the coadministration of drugs to target lymphatic filariasis, onchocerciasis, schistosomiasis, soil-transmitted helminthiasis, and trachoma, possible synergies between existing disease-specific policies and protocols need to be examined. In this report we compare present policies for mapping, monitoring, and surveillance for these diseases, drawing attention to both the challenges and opportunities for integration. Although full integration of all elements of mapping, monitoring, and surveillance strategies might not be feasible for the diseases targeted through the preventive chemotherapy approach, there are opportunities for integration, and we present examples of integrated strategies. Finally, if advantage is to be taken of scaled up interventions to address neglected tropical diseases, efforts to develop rapid, inexpensive, and easy-to-use methods, whether disease-specific or integrated, should be increased. We present a framework for development of an integrated monitoring and evaluation system that combines both integrated and disease-specific strategies.	[Baker, M. C.] RTI Int, Ctr Int Hlth, Washington, DC 20005 USA; [Mathieu, E.; Deming, M.] Ctr Dis Control & Prevent, Div Parasit Dis, Parasit Dis Branch, Atlanta, GA USA; [Fleming, F. M.] Univ London Imperial Coll Sci Technol & Med, Schistosomiasis Control Initiat, London, England; [King, J. D.] Emory Univ, Carter Ctr, Atlanta, GA 30322 USA; [Garba, A.] RISEAL, NTD Control Program, Niamey, Niger; [Koroma, J. B.] Minist Hlth & Sanitat, Natl Onchocerciasis Neglected Trop Dis Control Pr, Freetown, Sierra Leone; [Bockarie, M.; Molyneux, D. H.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England; [Kabore, A.] Liverpool Associates Hlth, Liverpool, Merseyside, England	Research Triangle Institute; Centers for Disease Control & Prevention - USA; Imperial College London; Emory University; Ministry of Health & Sanitation Sierra Leone; Liverpool School of Tropical Medicine; University of Liverpool	Baker, MC (corresponding author), RTI Int, Ctr Int Hlth, 805 15th St NW,Suite 601, Washington, DC 20005 USA.	mcb93@georgetown.edu	Bockarie, Moses/AAV-4578-2020; Bockarie, Moses/AAW-3130-2021	Garba, Amadou/0000-0002-6298-8259	USAID	USAID(United States Agency for International Development (USAID))	We thank Annie Baridjord for her administrative supporting in preparing this report. The views of the authors are their own and do not necessarily represent those of the US Centers for Disease Control and Prevention. This study is made possible by the generous support of the American people through USAID. The contents are the responsibility of the authors and do not necessarily reflect the views of USAID or the US Government.	Amazigo U, 2007, SOC SCI MED, V64, P2070, DOI 10.1016/j.socscimed.2007.01.018; [Anonymous], 2006, PREV CHEM HUM HELM C; Ansell J, 2002, ANN TROP MED PARASIT, V96, P145, DOI 10.1179/000349802125000682; *APOC, 2002, COMM SELF MON IV TRE; *APOC WHO, 1998, COMM DIR TREATM INV; *APOC WHO, 2002, IND PART MON CDTI PR; Baker MC, 2007, INT J HEALTH PLAN M, V22, P337, DOI 10.1002/hpm.900; BAKER MC, 2008, ASTMH 57 ANN M NEW O; Boatin BA, 2006, ADV PARASIT, V61, P349, DOI 10.1016/S0065-308X(05)61009-3; Bockarie MJ, 2007, AM J TROP MED HYG, V77, P591, DOI 10.4269/ajtmh.2007.77.591; Bockarie MJ, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1686; Boussinesq M, 1997, ANN TROP MED PARASIT, V91, P573, DOI 10.1080/00034989760671; Bradley M, 2001, T ROY SOC TROP MED H, V95, P72, DOI 10.1016/S0035-9203(01)90338-4; Brooker S, 2000, PARASITOL TODAY, V16, P303, DOI 10.1016/S0169-4758(00)01687-2; Brooker S, 2005, TROP MED INT HEALTH, V10, P647, DOI 10.1111/j.1365-3156.2005.01446.x; Brooker S, 2007, T ROY SOC TROP MED H, V101, P1, DOI 10.1016/j.trstmh.2006.08.004; Brooks M, 2009, J VET EMERG CRIT CAR, V19, P1, DOI 10.1111/j.1476-4431.2009.00385.x; Butler D, 2009, NATURE, V457, P772, DOI 10.1038/457772a; Clements ACA, 2008, INT J PARASITOL, V38, P401, DOI 10.1016/j.ijpara.2007.08.001; De Rochars MVEB, 2004, AM J TROP MED HYG, V71, P598, DOI 10.4269/ajtmh.2004.71.598; Diawara L, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000497; DUKE BOL, 1993, PROCEDURAL MANUAL IV; Emerson PM, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000197; Gardon J, 1997, LANCET, V350, P18, DOI 10.1016/S0140-6736(96)11094-1; Gonzalez RJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000404; Gyapong JO, 2001, T ROY SOC TROP MED H, V95, P681, DOI 10.1016/S0035-9203(01)90115-4; Gyapong JO, 2002, ANN TROP MED PARASIT, V96, P695, DOI 10.1179/000349802125001735; Helmy H, 2006, T ROY SOC TROP MED H, V100, P656, DOI 10.1016/j.trstmh.2005.08.015; Homeida M, 2002, ANN TROP MED PARASIT, V96, P93, DOI 10.1179/000349802125000673; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; KING JD, 2009, AM J TROP M IN PRESS; Koukounari A, 2006, AM J TROP MED HYG, V75, P278, DOI 10.4269/ajtmh.2006.75.278; Legesse M, 2007, T ROY SOC TROP MED H, V101, P668, DOI 10.1016/j.trstmh.2006.11.009; Lengeler C, 2002, B WORLD HEALTH ORGAN, V80, P235; Mabey DCW, 2003, LANCET, V362, P223, DOI 10.1016/S0140-6736(03)13914-1; Mariotti SP, 2009, BRIT J OPHTHALMOL, V93, P563, DOI 10.1136/bjo.2008.148494; Measure DHS, DEM HLTH SURV; Michel CEC, 2006, LANCET, V367, P1585, DOI 10.1016/S0140-6736(06)68695-9; Miller K, 2004, OPHTHAL EPIDEMIOL, V11, P255, DOI 10.1080/09286580490514577; Mohammed KA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000171; Molyneux DH, 2009, T ROY SOC TROP MED H, V103, P338, DOI 10.1016/j.trstmh.2008.12.016; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Montresor A., 1998, GUIDELINES EVALUATIO; Montresor A, 2002, HELMINTH CONTROL SCH; Murdoch ME, 2002, ANN TROP MED PARASIT, V96, P283, DOI 10.1179/000349802125000826; Ngondi J, 2009, T ROY SOC TROP MED H, V103, P1001, DOI 10.1016/j.trstmh.2008.11.023; NGOUMOU P, 1994, ANN TROP MED PARASIT, V88, P463, DOI 10.1080/00034983.1994.11812893; Ngoumou P., 1993, MANUAL RAPID EPIDEMI; Njenga SM, 2007, ANN TROP MED PARASIT, V101, P161, DOI 10.1179/136485907X156933; Noma M, 2002, ANN TROP MED PARASIT, V96, P29, DOI 10.1179/000349802125000637; Onapa AW, 2005, ANN TROP MED PARASIT, V99, P141, DOI 10.1179/136485905X19829; Osei-Atweneboano MY, 2007, LANCET, V369, P2021, DOI 10.1016/S0140-6736(07)60942-8; Ottesen EA, 2006, ADV PARASIT, V61, P395, DOI 10.1016/S0065-308X(05)61010-X; Ramzy RMR, 2006, LANCET, V367, P992, DOI 10.1016/S0140-6736(06)68426-2; REMME JHF, 1995, PARASITOL TODAY, V11, P403, DOI 10.1016/0169-4758(95)80017-4; RESNIKOFF S, 2007, REV INT TRACHOME PAT, V84, P59; Richards FO, 2001, TRENDS PARASITOL, V17, P558, DOI 10.1016/S1471-4922(01)02112-2; Richards FO, 2006, B WORLD HEALTH ORGAN, V84, P673, DOI 10.2471/BLT.06.029652; Richter J., 2000, ULTRASOUND SCHISTOSO; Savioli L, 1999, MONITORING HELMINTH; STINGL P, 1984, T ROY SOC TROP MED H, V78, P254, DOI 10.1016/0035-9203(84)90291-8; Stothard JR, 2006, ACTA TROP, V97, P219, DOI 10.1016/j.actatropica.2005.11.004; Takougang I, 2002, B WORLD HEALTH ORGAN, V80, P852; Taylor MJ, 2009, PARASITE VECTOR, V2, DOI 10.1186/1756-3305-2-7; Thomson MC, 2000, LANCET, V356, P1077, DOI 10.1016/S0140-6736(00)02733-1; Thylefors B, 2006, ANN TROP MED PARASIT, V100, P733, DOI 10.1179/136485906X112202; THYLEFORS B, 1987, B WORLD HEALTH ORGAN, V65, P477; United Nations Children's Fund (UNICEF), MULT IND CLUST SURV; Utzinger J, 2006, PLOS MED, V3, P585, DOI 10.1371/journal.pmed.0030112; Wanji Samuel, 2005, Filaria J, V4, P2, DOI 10.1186/1475-2883-4-2; Weil GJ, 2007, TRENDS PARASITOL, V23, P78, DOI 10.1016/j.pt.2006.12.001; Weil GJ, 2000, J INFECT DIS, V182, P1796, DOI 10.1086/317629; WHITE GB, 2002, ANN TROP MED PARA S2, V96, pS3; WHO, 1995, ONCH ITS CONTR REP W; WHO, 2006, TRACH CONTR GUID PRO; World Health Organization, 2008, Weekly Epidemiological Record, V83, P333; World Health Organization, 2008, Weekly Epidemiological Record, V83, P237; World Health Organization, 2004, MIDL MAN COURS EPI M; World Health Organization, 1987, WHO TECHN REP SER, V752; World Health Organization, 2002, WHO TECHN REP SER; World Health Organization, 2005, WHOCDSCPECEE200550; 2007, WKLY EPIDEMIOL REC, V29, P256	82	53	54	1	15	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					231	238		10.1016/S0140-6736(09)61458-6	http://dx.doi.org/10.1016/S0140-6736(09)61458-6			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109924				2022-12-01	WOS:000273853800033
J	Muller, PAJ; Caswell, PT; Doyle, B; Iwanicki, MP; Tan, EH; Karim, S; Lukashchuk, N; Gillespie, DA; Ludwig, RL; Gosselin, P; Cromer, A; Brugge, JS; Sansom, OJ; Norman, JC; Vousden, KH				Muller, Patricia A. J.; Caswell, Patrick T.; Doyle, Brendan; Iwanicki, Marcin P.; Tan, Ee H.; Karim, Saadia; Lukashchuk, Natalia; Gillespie, David A.; Ludwig, Robert L.; Gosselin, Pauline; Cromer, Anne; Brugge, Joan S.; Sansom, Owen J.; Norman, Jim C.; Vousden, Karen H.			Mutant p53 Drives Invasion by Promoting Integrin Recycling	CELL			English	Article							LI-FRAUMENI-SYNDROME; TUMOR-SUPPRESSOR; CELL-MIGRATION; IN-VIVO; ALPHA-5-BETA-1 INTEGRIN; 3D MICROENVIRONMENTS; EPITHELIAL-CELLS; BREAST-CANCER; MOUSE MODELS; GAIN	p53 is a tumor suppressor protein whose function is frequently lost in cancers through missense mutations within the Tp53 gene. This results in the expression of point-mutated p53 proteins that have both lost wild-type tumor suppressor activity and show gain of functions that contribute to transformation and metastasis. Here, we show that mutant p53 expression can promote invasion, loss of directionality of migration, and metastatic behavior. These activities of p53 reflect enhanced integrin and epidermal growth factor receptor (EGFR) trafficking, which depends on Rab-coupling protein (RCP) and results in constitutive activation of EGFR/integrin signaling. We provide evidence that mutant p53 promotes cell invasion via the inhibition of TAp63, and simultaneous loss of p53 and TAp63 recapitulates the phenotype of mutant p53 in cells. These findings open the possibility that blocking alpha5/beta1-integrin and/or the EGF receptor will have therapeutic benefit in mutant p53-expressing cancers.	[Muller, Patricia A. J.; Caswell, Patrick T.; Doyle, Brendan; Tan, Ee H.; Karim, Saadia; Lukashchuk, Natalia; Gillespie, David A.; Ludwig, Robert L.; Sansom, Owen J.; Norman, Jim C.; Vousden, Karen H.] Beatson Inst Canc Res, Glasgow G61 1BD, Lanark, Scotland; [Iwanicki, Marcin P.; Gosselin, Pauline; Cromer, Anne; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Beatson Institute; Harvard University; Harvard Medical School	Norman, JC (corresponding author), Beatson Inst Canc Res, Switchback Rd, Glasgow G61 1BD, Lanark, Scotland.	j.norman@beatson.gla.ac.uk; k.vousden@beatson.gla.ac.uk	Gillespie, David/R-4771-2019; Caswell, Patrick/N-3063-2015; Muller, Patricia AJ/AAH-1888-2019	Gillespie, David/0000-0002-6338-0544; Caswell, Patrick/0000-0002-2633-2324; Muller, Patricia AJ/0000-0002-0926-1499; NORMAN, Jim/0000-0002-0098-3014; Sansom, Owen J./0000-0001-9540-3010; Tan, Ee Hong/0000-0002-5971-6455	Cancer Research UK; BCRF [GM064346]; NIGMS [GM064346]; Netherlands Organisation for Scientific Research	Cancer Research UK(Cancer Research UK); BCRF; NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Netherlands Organisation for Scientific Research(Netherlands Organization for Scientific Research (NWO))	This work in K.H.V.'s, J.C.N.'s, and O.J.S.'s laboratories is supported by Cancer Research UK, and the work in J.S.B.'s laboratory by BCRF and NIGMS (GM064346). P.A.J.M. is a recipient of a Rubicon Fellowship from the Netherlands Organisation for Scientific Research. The p53R172H mice were obtained from the MMHRC and the p53 flox mice kindly provided by Anton Berns. We would like to thank Derek Miller for assistance and advice with the in vivo studies and Sam Lawn and Lyne McGarry for help with the Matrigel invasion assay. We are also grateful to Gerry Melino for the p63-responsive reporter construct.	Adorno M, 2009, CELL, V137, P87, DOI 10.1016/j.cell.2009.01.039; Attardi LD, 1999, CELL MOL LIFE SCI, V55, P48, DOI 10.1007/s000180050269; Blagosklonny MV, 2000, FASEB J, V14, P1901, DOI 10.1096/fj.99-1078rev; Bourdon JC, 2007, BRIT J CANCER, V97, P277, DOI 10.1038/sj.bjc.6603886; Brockbank EC, 2005, BRIT J CANCER, V92, P102, DOI 10.1038/sj.bjc.6602255; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Cantor JP, 2007, INT J CANCER, V120, P24, DOI 10.1002/ijc.22073; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Caswell P, 2008, TRENDS CELL BIOL, V18, P257, DOI 10.1016/j.tcb.2008.03.004; Caswell PT, 2008, J CELL BIOL, V183, P143, DOI 10.1083/jcb.200804140; Caswell PT, 2007, DEV CELL, V13, P496, DOI 10.1016/j.devcel.2007.08.012; CHO YJ, 1994, SCIENCE, V265, P346, DOI 10.1126/science.8023157; Epstein CB, 1998, ONCOGENE, V16, P2115, DOI 10.1038/sj.onc.1201734; Flores ER, 2005, CANCER CELL, V7, P363, DOI 10.1016/j.ccr.2005.02.019; Gaiddon C, 2001, MOL CELL BIOL, V21, P1874, DOI 10.1128/MCB.21.5.1874-1887.2001; Jonkers J, 2001, NAT GENET, V29, P418, DOI 10.1038/ng747; KUPFER A, 1982, P NATL ACAD SCI-BIOL, V79, P2603, DOI 10.1073/pnas.79.8.2603; LANE DP, 1994, BRIT MED BULL, V50, P582, DOI 10.1093/oxfordjournals.bmb.a072911; Lang GA, 2004, CELL, V119, P861, DOI 10.1016/j.cell.2004.11.006; Li Y, 2007, ONCOGENE, V26, P2220, DOI 10.1038/sj.onc.1210311; LIN JY, 1995, ONCOGENE, V10, P2387; Marsh V, 2008, NAT GENET, V40, P1436, DOI 10.1038/ng.256; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Muthuswamy SK, 2001, NAT CELL BIOL, V3, P785, DOI 10.1038/ncb0901-785; Olive KP, 2004, CELL, V119, P847, DOI 10.1016/j.cell.2004.11.004; Petitjean A, 2007, ONCOGENE, V26, P2157, DOI 10.1038/sj.onc.1210302; Roberts M, 2001, CURR BIOL, V11, P1392, DOI 10.1016/S0960-9822(01)00442-0; Sansom OJ, 2004, GENE DEV, V18, P1385, DOI 10.1101/gad.287404; Sansom OJ, 2006, P NATL ACAD SCI USA, V103, P14122, DOI 10.1073/pnas.0604130103; Schwartz MA, 2002, NAT CELL BIOL, V4, pE65, DOI 10.1038/ncb0402-e65; Seton-Rogers SE, 2004, P NATL ACAD SCI USA, V101, P1257, DOI 10.1073/pnas.0308090100; Sigal A, 2000, CANCER RES, V60, P6788; Soussi T, 2000, ANN NY ACAD SCI, V910, P121; Strano S, 2002, J BIOL CHEM, V277, P18817, DOI 10.1074/jbc.M201405200; Vogelstein B, 2000, NATURE, V408, P307, DOI 10.1038/35042675; Vousden KH, 2009, CELL, V137, P413, DOI 10.1016/j.cell.2009.04.037; White DP, 2007, J CELL BIOL, V177, P515, DOI 10.1083/jcb.200609004; Zhang JQ, 2009, J CLIN INVEST, V119, P2171, DOI 10.1172/JCI37622	38	579	591	6	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1327	1341		10.1016/j.cell.2009.11.026	http://dx.doi.org/10.1016/j.cell.2009.11.026			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064378	Bronze			2022-12-01	WOS:000273048700020
J	Ito, T; Ando, H; Suzuki, T; Ogura, T; Hotta, K; Imamura, Y; Yamaguchi, Y; Handa, H				Ito, Takumi; Ando, Hideki; Suzuki, Takayuki; Ogura, Toshihiko; Hotta, Kentaro; Imamura, Yoshimasa; Yamaguchi, Yuki; Handa, Hiroshi			Identification of a Primary Target of Thalidomide Teratogenicity	SCIENCE			English	Article							UBIQUITIN LIGASE; MULTIPLE-MYELOMA; LIMB DEFECTS; DNA-DAMAGE; OUTGROWTH; EXPRESSION; ZEBRAFISH; PATHWAY; ORIGIN; CELLS	Half a century ago, thalidomide was widely prescribed to pregnant women as a sedative but was found to be teratogenic, causing multiple birth defects. Today, thalidomide is still used in the treatment of leprosy and multiple myeloma, although how it causes limb malformation and other developmental defects is unknown. Here, we identified cereblon (CRBN) as a thalidomide-binding protein. CRBN forms an E3 ubiquitin ligase complex with damaged DNA binding protein 1 (DDB1) and Cul4A that is important for limb outgrowth and expression of the fibroblast growth factor Fgf8 in zebrafish and chicks. Thalidomide initiates its teratogenic effects by binding to CRBN and inhibiting the associated ubiquitin ligase activity. This study reveals a basis for thalidomide teratogenicity and may contribute to the development of new thalidomide derivatives without teratogenic activity.	[Ito, Takumi; Handa, Hiroshi] Tokyo Inst Technol, Integrated Res Inst, Yokohama, Kanagawa 2268503, Japan; [Ando, Hideki; Hotta, Kentaro; Yamaguchi, Yuki; Handa, Hiroshi] Tokyo Inst Technol, Grad Sch Biosci & Biotechnol, Yokohama, Kanagawa 2268501, Japan; [Suzuki, Takayuki; Ogura, Toshihiko] Tohoku Univ, Inst Dev Aging & Canc, Sendai, Miyagi 9808575, Japan; [Suzuki, Takayuki] Japan Sci & Technol Agcy, Kawaguchi, Saitama 3320012, Japan; [Imamura, Yoshimasa] Astellas Pharma Inc, Drug Discovery Res, Tsukuba 3058585, Japan	Tokyo Institute of Technology; Tokyo Institute of Technology; Tohoku University; Japan Science & Technology Agency (JST); Astellas Pharmaceuticals	Handa, H (corresponding author), Tokyo Inst Technol, Integrated Res Inst, Yokohama, Kanagawa 2268503, Japan.	handa.h.aa@m.titech.ac.jp	Yamaguchi, Yuki/B-9390-2015	Yamaguchi, Yuki/0000-0002-0197-614X; Ito, Takumi/0000-0002-9997-2664	JST; Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT) [20370084, 21770226]; New Energy and Technology Development Organization	JST(Japan Science & Technology Agency (JST)); Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); New Energy and Technology Development Organization	We thank T. Wada, S. Sakamoto, and S. Ishihara for discussions; P. Raychaudhuri, T. Matsunaga, S. Krauss, B. Thisse, A. Kawakami, S. Noji, J. Izpisua-Belmonte, K. Kawakami, and J. Yamauchi for valuable reagents; Y. Tsuboi for technical support; and P. Sharp and A. Berk for comments on this manuscript. This work was supported by Special Coordination Funds for Promoting Science and Technology from JST, by the Global COE (Center of Excellence) Program from the Japan Ministry of Education, Culture, Sports, Science, and Technology (MEXT), and by a grant for Research and Development Projects in Cooperation with Academic Institutions from the New Energy and Technology Development Organization (H. H. and H. A.). This work was also supported by grants-in-aid for Scientific Research (20370084 to T. O.) and for Young Scientists (21770226 to T. S.) from MEXT and by the Precursory Research for Embryonic Science and Technology program from JST (T. S.). T. I. was a Japan Society for the Promotion of Science Research Fellow. An application for a patent has been filed in the Japan Patent Office.	Angers S, 2006, NATURE, V443, P590, DOI 10.1038/nature05175; Cang Y, 2007, P NATL ACAD SCI USA, V104, P2733, DOI 10.1073/pnas.0611311104; Cang Y, 2006, CELL, V127, P929, DOI 10.1016/j.cell.2006.09.045; Chung F, 2004, CLIN CANCER RES, V10, P5949, DOI 10.1158/1078-0432.CCR-04-0421; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P4082, DOI 10.1073/pnas.91.9.4082; Davis MC, 2007, NATURE, V447, P473, DOI 10.1038/nature05838; Franks ME, 2004, LANCET, V363, P1802, DOI 10.1016/S0140-6736(04)16308-3; Groisman R, 2003, CELL, V113, P357, DOI 10.1016/S0092-8674(03)00316-7; Gupta D, 2001, LEUKEMIA, V15, P1950, DOI 10.1038/sj.leu.2402295; Hansen JM, 2002, DEV DYNAM, V225, P186, DOI 10.1002/dvdy.10150; HIGGINS JJ, 1927, NEUROLOGY, V63, P2004; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Knobloch J, 2008, CELL CYCLE, V7, P1121, DOI 10.4161/cc.7.9.5793; Knobloch J, 2007, FASEB J, V21, P1410, DOI 10.1096/fj.06-7603com; Lewandoski M, 2000, NAT GENET, V26, P460, DOI 10.1038/82609; Melchert M, 2007, INT J BIOCHEM CELL B, V39, P1489, DOI 10.1016/j.biocel.2007.01.022; Miller MT, 1999, TERATOLOGY, V60, P306, DOI 10.1002/(SICI)1096-9926(199911)60:5<306::AID-TERA11>3.0.CO;2-Y; Moon AM, 2000, NAT GENET, V26, P455, DOI 10.1038/82601; MOREIRA AL, 1993, J EXP MED, V177, P1675, DOI 10.1084/jem.177.6.1675; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Ohtake F, 2007, NATURE, V446, P562, DOI 10.1038/nature05683; Pajni-Underwood S, 2007, DEVELOPMENT, V134, P2359, DOI 10.1242/dev.001677; Parman T, 1999, NAT MED, V5, P582, DOI 10.1038/8466; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Pickart CM, 2004, CELL, V116, P181, DOI 10.1016/S0092-8674(03)01074-2; RIDDLE RD, 1993, CELL, V75, P1401, DOI 10.1016/0092-8674(93)90626-2; Sakamoto S, 2009, CHEM REC, V9, P66, DOI 10.1002/tcr.20170; SHESKIN J, 1965, CLIN PHARMACOL THER, V6, P303; Singhal S, 1999, NEW ENGL J MED, V341, P1565, DOI 10.1056/NEJM199911183412102; Streit A, 2001, J ANAT, V199, P99, DOI 10.1017/S0021878201008263; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Tanaka M, 2002, NATURE, V416, P527, DOI 10.1038/416527a; Therapontos C, 2009, P NATL ACAD SCI USA, V106, P8573, DOI 10.1073/pnas.0901505106; Veldman MB, 2008, PEDIATR RES, V64, P470, DOI 10.1203/PDR.0b013e318186e609; Yabu T, 2005, BLOOD, V106, P125, DOI 10.1182/blood-2004-09-3679; Zeldis JB, 1999, CLIN THER, V21, P319, DOI 10.1016/S0149-2918(00)88289-2	36	1155	1241	17	371	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1345	1350		10.1126/science.1177319	http://dx.doi.org/10.1126/science.1177319			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223979				2022-12-01	WOS:000275418700032
J	Thomas, DJB; Skelton-Robinson, M				Thomas, D. J. B.; Skelton-Robinson, Martin			A Patient's Journey Recovering from severe brain injury	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Thomas, D. J. B.; Skelton-Robinson, Martin] Hillingdon Hosp NHS Trust, Uxbridge UB8 3NN, Middx, England		Thomas, DJB (corresponding author), Hillingdon Hosp NHS Trust, Uxbridge UB8 3NN, Middx, England.	drdthomas678@btinternet.com							0	1	1	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 11	2010	340								c839	10.1136/bmj.c839	http://dx.doi.org/10.1136/bmj.c839			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FE	20223871				2022-12-01	WOS:000275656900014
J	Noto, T; Kurth, HM; Kataoka, K; Aronica, L; DeSouza, LV; Siu, KWM; Pearlman, RE; Gorovsky, MA; Mochizuki, K				Noto, Tomoko; Kurth, Henriette M.; Kataoka, Kensuke; Aronica, Lucia; DeSouza, Leroi V.; Siu, K. W. Michael; Pearlman, Ronald E.; Gorovsky, Martin A.; Mochizuki, Kazufumi			The Tetrahymena Argonaute-Binding Protein Giw1p Directs a Mature Argonaute-siRNA Complex to the Nucleus	CELL			English	Article							PROGRAMMED DNA ELIMINATION; PASSENGER-STRAND CLEAVAGE; DICER-LIKE PROTEIN; SMALL RNAS; GENOME REARRANGEMENT; HISTONE H3; METHYLATION; FAMILY; SLICER; INVOLVEMENT	Emerging evidence suggests that RNA interference (RNAi)-related processes act both in the cytoplasm and in the nucleus. However, the process by which the RNAi machinery is transported into the nucleus remains poorly understood. The Tetrahymena Argonaute protein Twi1p localizes to the nucleus and is crucial for small RNA-directed programmed DNA elimination. In this study, we identify Giw1p, which binds to Twi1p and is required for its nuclear localization. Furthermore, the endoribonuclease ( Slicer) activity of Twi1p plays a vital role in the removal of one of the two strands of Twi1p-associated small interfering RNAs (siRNAs), leading to a functionally mature Twi1p-siRNA complex. Slicer activity is also shown to be required for nuclear localization of Twi1p and for its association with Giw1p. These results suggest that Giw1p senses the state of Twi1p-associated siRNAs and selectively transports the mature Twi1p-siRNA complex into the nucleus.	[Noto, Tomoko; Kurth, Henriette M.; Kataoka, Kensuke; Aronica, Lucia; Mochizuki, Kazufumi] Austrian Acad Sci, IMBA, Inst Mol Biotechnol, A-1030 Vienna, Austria; [DeSouza, Leroi V.; Siu, K. W. Michael] York Univ, Dept Chem, N York, ON M3J 1P3, Canada; [Pearlman, Ronald E.] York Univ, Dept Biol, N York, ON M3J 1P3, Canada; [DeSouza, Leroi V.; Siu, K. W. Michael; Pearlman, Ronald E.] York Univ, Ctr Res Mass Spectrometry, N York, ON M3J 1P3, Canada; [Gorovsky, Martin A.] Univ Rochester, Dept Biol, Rochester, NY 14627 USA	Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); York University - Canada; York University - Canada; York University - Canada; University of Rochester	Mochizuki, K (corresponding author), Austrian Acad Sci, IMBA, Inst Mol Biotechnol, Dr Bohr Gasse 3, A-1030 Vienna, Austria.	kazufumi.mochizuki@imba.oeaw.ac.at	Mochizuki, Kazufumi/AAW-4382-2020; Kataoka, Kensuke/D-1877-2016; Aronica, Lucia/P-7255-2019; DeSouza, Leroi V/H-3831-2013; Mochizuki, Kazufumi/A-5686-2016	Mochizuki, Kazufumi/0000-0001-7987-9852; Kataoka, Kensuke/0000-0001-6113-289X; Aronica, Lucia/0000-0002-8991-4858; Mochizuki, Kazufumi/0000-0001-7987-9852	European Research Council (ERC) [MEST-CE-2005-019676]; Canadian Institutes for Health Research [MOP13347]; National Institutes of Health [GM21793, GM72752]; ERC; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM021793, R01GM072752] Funding Source: NIH RePORTER	European Research Council (ERC)(European Research Council (ERC)European Commission); Canadian Institutes for Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); ERC(European Research Council (ERC)European Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Leemor Joshua-Tor for E. coli strain expressing GST-hAgo2, Kathy Karrer for Tlr1 clones, and Tim Clausen, Javier Martinez, Thomas Marlovits, Josef Loidl, Stefan Westermann, and their laboratories for materials and technical advice. The research leading to these results received funding from the European Research Council (ERC) Marie Curie Action "Early Stage Training'' (MEST-CE-2005-019676) under the European Community's Sixth Framework Programme to H. M. K. and L. A., from the Ontario Research and Development Challenge Fund and MDS SCIEX to K.W.M.S., from a Canadian Institutes for Health Research grant (MOP13347) to R.E.P., from National Institutes of Health grants GM21793 and GM72752 to M.A.G., from an ERC Starting Grant	Aravin AA, 2008, MOL CELL, V31, P785, DOI 10.1016/j.molcel.2008.09.003; Aronica L, 2008, GENE DEV, V22, P2228, DOI 10.1101/gad.481908; Bednenko J, 2009, MOL CELL BIOL, V29, P5020, DOI 10.1128/MCB.00076-09; Bowman GR, 2005, J EUKARYOT MICROBIOL, V52, P291, DOI 10.1111/j.1550-7408.2005.00045.x; Brennecke J, 2007, CELL, V128, P1089, DOI 10.1016/j.cell.2007.01.043; Chalker DL, 2001, GENE DEV, V15, P1287, DOI 10.1101/gad.884601; Couvillion MT, 2009, GENE DEV, V23, P2016, DOI 10.1101/gad.1821209; Cox DN, 2000, DEVELOPMENT, V127, P503; Coyne RS, 1999, MOL CELL, V4, P865, DOI 10.1016/S1097-2765(00)80396-2; Fillingham JS, 2004, EUKARYOT CELL, V3, P157, DOI 10.1128/EC.3.1.157-169.2004; Forstemann K, 2007, CELL, V130, P287, DOI 10.1016/j.cell.2007.05.056; Guang S, 2008, SCIENCE, V321, P537, DOI 10.1126/science.1157647; Janowski BA, 2006, NAT STRUCT MOL BIOL, V13, P787, DOI 10.1038/nsmb1140; Kim DH, 2006, NAT STRUCT MOL BIOL, V13, P793, DOI 10.1038/nsmb1142; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Kurth HM, 2009, RNA, V15, P675, DOI 10.1261/rna.1455509; Lee SR, 2006, GENE DEV, V20, P28, DOI 10.1101/gad.1377006; Leuschner PJF, 2006, EMBO REP, V7, P314, DOI 10.1038/sj.embor.7400637; Li CF, 2006, CELL, V126, P93, DOI 10.1016/j.cell.2006.05.032; Liu Y, 2007, GENE DEV, V21, P1530, DOI 10.1101/gad.1544207; Loidl J, 2004, J CELL SCI, V117, P5791, DOI 10.1242/jcs.01504; Maiti M, 2007, GENE DEV, V21, P590, DOI 10.1101/gad.1497607; Malone CD, 2005, MOL CELL BIOL, V25, P9151, DOI 10.1128/MCB.25.20.9151-9164.2005; Malone CD, 2009, CELL, V136, P656, DOI 10.1016/j.cell.2009.01.045; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Miyoshi K, 2005, GENE DEV, V19, P2837, DOI 10.1101/gad.1370605; Mochizuki K, 2005, GENE DEV, V19, P77, DOI 10.1101/gad.1265105; Mochizuki K, 2004, GENE DEV, V18, P2068, DOI 10.1101/gad.1219904; Mochizuki K, 2002, CELL, V110, P689, DOI 10.1016/S0092-8674(02)00909-1; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pal-Bhadra M, 2002, MOL CELL, V9, P315, DOI 10.1016/S1097-2765(02)00440-9; Pontes O, 2006, CELL, V126, P79, DOI 10.1016/j.cell.2006.05.031; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Rivas FV, 2005, NAT STRUCT MOL BIOL, V12, P340, DOI 10.1038/nsmb918; Sigova A, 2004, GENE DEV, V18, P2359, DOI 10.1101/gad.1218004; Steiner FA, 2009, NAT STRUCT MOL BIOL, V16, P207, DOI 10.1038/nsmb.1541; Taverna SD, 2002, CELL, V110, P701, DOI 10.1016/S0092-8674(02)00941-8; Tolia NH, 2007, NAT CHEM BIOL, V3, P36, DOI 10.1038/nchembio848; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang YL, 2008, NATURE, V456, P921, DOI 10.1038/nature07666; Weinmann L, 2009, CELL, V136, P496, DOI 10.1016/j.cell.2008.12.023; Wuitschick JD, 2002, NUCLEIC ACIDS RES, V30, P2524, DOI 10.1093/nar/30.11.2524; Yao MC, 2003, SCIENCE, V300, P1581, DOI 10.1126/science.1084737; Zheng XW, 2007, EMBO J, V26, P1691, DOI 10.1038/sj.emboj.7601603	44	65	66	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					692	703		10.1016/j.cell.2010.02.010	http://dx.doi.org/10.1016/j.cell.2010.02.010			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211138	Bronze, Green Accepted			2022-12-01	WOS:000275197400018
J	Lang, AE; Schmidt, G; Schlosser, A; Hey, TD; Larrinua, IM; Sheets, JJ; Mannherz, HG; Aktories, K				Lang, Alexander E.; Schmidt, Gudula; Schlosser, Andreas; Hey, Timothy D.; Larrinua, Ignacio M.; Sheets, Joel J.; Mannherz, Hans G.; Aktories, Klaus			Photorhabdus luminescens Toxins ADP-Ribosylate Actin and RhoA to Force Actin Clustering	SCIENCE			English	Article							YERSINIA-PESTIS; PROTEINS; BIOCHEMISTRY; COMPLEXES; PROFILIN; BIOLOGY	The bacterium Photorhabdus luminescens is mutualistically associated with entomopathogenetic nematodes. These nematodes invade insect larvae and release the bacteria from their intestine, which kills the insects through the action of toxin complexes. We elucidated the mode of action of two of these insecticidal toxins from P. luminescens. We identified the biologically active components TccC3 and TccC5 as adenosine diphosphate (ADP)-ribosyltransferases, which modify unusual amino acids. TccC3 ADP-ribosylated threonine-148 of actin, resulting in actin polymerization. TccC5 ADP-ribosylated Rho guanosine triphosphatase proteins at glutamine-61 and glutamine-63, inducing their activation. The concerted action of both toxins inhibited phagocytosis of target insect cells and induced extensive intracellular polymerization and clustering of actin. Several human pathogenic bacteria produce related toxins.	[Lang, Alexander E.; Schmidt, Gudula; Aktories, Klaus] Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany; [Lang, Alexander E.] Univ Freiburg, Fak Biol, D-79104 Freiburg, Germany; [Schlosser, Andreas] Univ Freiburg, Core Facil Prote, Zentrum Biosyst Anal, D-79104 Freiburg, Germany; [Hey, Timothy D.; Larrinua, Ignacio M.; Sheets, Joel J.] Dow AgroSci, Discovery Res, Indianapolis, IN 46268 USA; [Mannherz, Hans G.] Max Planck Inst Mol Physiol, D-44227 Dortmund, Germany; [Mannherz, Hans G.] Ruhr Univ Bochum, Abt Anat & Embryol, D-44801 Bochum, Germany	University of Freiburg; University of Freiburg; University of Freiburg; Dow Chemical Company; Max Planck Society; Ruhr University Bochum	Aktories, K (corresponding author), Univ Freiburg, Inst Expt & Klin Pharmakol & Toxikol, D-79104 Freiburg, Germany.	klaus.aktories@pharmakol.uni-freiburg.de	Aktories, Klaus/CAJ-5682-2022	Aktories, Klaus/0000-0002-5397-0436; Mannherz, Hans Georg/0000-0001-8158-5722	Deutsche Forschungsgemeinschaft DFG	Deutsche Forschungsgemeinschaft DFG(German Research Foundation (DFG))	We thank Agilent Technologies for supporting us with instrumentation, R. S. Goody (Dortmund, Germany) for help in stopped-flow measurements, and M. Geyer (Dortmund, Germany) for providing profilin. The study was financially supported by the Deutsche Forschungsgemeinschaft DFG to K. A. and H. G. M.	AKTORIES K, 1989, J CELL BIOL, V109, P1385, DOI 10.1083/jcb.109.4.1385; AKTORIES K, 1986, NATURE, V322, P390, DOI 10.1038/322390a0; Barth H, 2004, MICROBIOL MOL BIOL R, V68, P373, DOI 10.1128/MMBR.68.3.373-402.2004; Bowen D, 1998, SCIENCE, V280, P2129, DOI 10.1126/science.280.5372.2129; Burridge K, 2004, CELL, V116, P167, DOI 10.1016/S0092-8674(04)00003-0; De La Cruz EM, 2000, BIOPHYS J, V78, P2516, DOI 10.1016/S0006-3495(00)76797-X; Ffrench-Constant R, 2003, FEMS MICROBIOL REV, V26, P433, DOI 10.1111/j.1574-6976.2003.tb00625.x; Fieldhouse RJ, 2008, TRENDS BIOCHEM SCI, V33, P546, DOI 10.1016/j.tibs.2008.08.003; Hares MC, 2008, MICROBIOL-SGM, V154, P3503, DOI 10.1099/mic.0.2008/018440-0; Irobi E, 2004, EMBO J, V23, P3599, DOI 10.1038/sj.emboj.7600372; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Joyce SA, 2006, CURR OPIN MICROBIOL, V9, P127, DOI 10.1016/j.mib.2006.01.004; Lee SC, 2007, J MOL BIOL, V366, P1558, DOI 10.1016/j.jmb.2006.12.057; Mannherz HG, 2007, J MOL BIOL, V366, P745, DOI 10.1016/j.jmb.2006.11.100; Parkhill J, 2001, NATURE, V413, P523, DOI 10.1038/35097083; PRING M, 1992, BIOCHEMISTRY-US, V31, P1827, DOI 10.1021/bi00121a035; Romero S, 2004, CELL, V119, P419, DOI 10.1016/j.cell.2004.09.039; Schmidt G, 1997, NATURE, V387, P725, DOI 10.1038/42735; SUN HQ, 1995, CURR OPIN CELL BIOL, V7, P102, DOI 10.1016/0955-0674(95)80051-4; Vetter IR, 2001, SCIENCE, V294, P1299, DOI 10.1126/science.1062023; Vogelsgesang M, 2007, N-S ARCH PHARMACOL, V374, P347, DOI 10.1007/s00210-006-0113-y; Waterfield N, 2005, CELL MICROBIOL, V7, P373, DOI 10.1111/j.1462-5822.2004.00467.x; Waterfield NR, 2001, TRENDS MICROBIOL, V9, P185, DOI 10.1016/S0966-842X(01)01978-3	23	169	175	1	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1139	1142		10.1126/science.1184557	http://dx.doi.org/10.1126/science.1184557			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185726				2022-12-01	WOS:000274901100039
J	Popp, C; Dean, W; Feng, SH; Cokus, SJ; Andrews, S; Pellegrini, M; Jacobsen, SE; Reik, W				Popp, Christian; Dean, Wendy; Feng, Suhua; Cokus, Shawn J.; Andrews, Simon; Pellegrini, Matteo; Jacobsen, Steven E.; Reik, Wolf			Genome-wide erasure of DNA methylation in mouse primordial germ cells is affected by AID deficiency	NATURE			English	Article							EPIGENETIC INHERITANCE; DEMETHYLATION; DEAMINASE; 5-HYDROXYMETHYLCYTOSINE; 5-METHYLCYTOSINE; PLURIPOTENT; DYNAMICS; ELEMENTS	Epigenetic reprogramming including demethylation of DNA occurs in mammalian primordial germ cells (PGCs) and in early embryos, and is important for the erasure of imprints and epimutations, and the return to pluripotency(1-9). The extent of this reprogramming and its molecular mechanisms are poorly understood. We previously showed that the cytidine deaminases AID and APOBEC1 can deaminate 5-methylcytosine in vitro and in Escherichia coli, and in the mouse are expressed in tissues in which demethylation occurs(10). Here we profiled DNA methylation throughout the genome by unbiased bisulphite next generation sequencing(11-13) in wild-type and AID-deficient mouse PGCs at embryonic day (E) 13.5. Wild-type PGCs revealed marked genome-wide erasure of methylation to a level below that of methylation deficient (Np95(-/-), also called Uhrf1(-/-)) embryonic stem cells, with female PGCs being less methylated than male ones. By contrast, AID-deficient PGCs were up to three times more methylated than wild-type ones; this substantial difference occurred throughout the genome, with introns, intergenic regions and transposons being relatively more methylated than exons. Relative hypermethylation in AID-deficient PGCs was confirmed by analysis of individual loci in the genome. Our results reveal that erasure of DNA methylation in the germ line is a global process, hence limiting the potential for transgenerational epigenetic inheritance. AID deficiency interferes with genome-wide erasure of DNA methylation patterns, indicating that AID has a critical function in epigenetic reprogramming and potentially in restricting the inheritance of epimutations in mammals.	[Feng, Suhua; Cokus, Shawn J.; Pellegrini, Matteo; Jacobsen, Steven E.] Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA; [Popp, Christian; Dean, Wendy; Reik, Wolf] Babraham Inst, Lab Dev Genet & Imprinting, Cambridge CB22 3AT, England; [Popp, Christian; Dean, Wendy; Reik, Wolf] Univ Cambridge, Ctr Trophoblast Res, Cambridge CB2 3EG, England; [Andrews, Simon] Babraham Inst, Bioinformat Grp, Cambridge CB22 3AT, England; [Jacobsen, Steven E.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; University of Cambridge; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Babraham Institute; Howard Hughes Medical Institute; University of California System; University of California Los Angeles	Jacobsen, SE (corresponding author), Univ Calif Los Angeles, Dept Mol Cell & Dev Biol, Los Angeles, CA 90095 USA.	jacobsen@ucla.edu; wolf.reik@bbsrc.ac.uk	Reik, Wolf/I-6794-2012; Dean, Wendy/GSE-3948-2022	Dean, Wendy/0000-0001-9441-5044; Pellegrini, Matteo/0000-0001-9355-9564; Reik, Wolf/0000-0003-0216-9881	BBSRC; MRC; EU NoE The Epigenome; CellCentric; HHMI; NSF; NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM060398] Funding Source: NIH RePORTER; BBSRC [BBS/E/B/0000M220] Funding Source: UKRI; MRC [G0700098] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BBS/E/B/0000M220, BBS/E/B/0000M982] Funding Source: researchfish; Medical Research Council [G0700098, G0300723B] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); EU NoE The Epigenome; CellCentric; HHMI(Howard Hughes Medical Institute); NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank H. Morgan for his contributions to some of the early analysis of Aid<SUP>-/-</SUP> mice, A. Segonds-Pichon for help with statistical evaluation, and J. Hetzel for assisting in preparing the Illumina Solexa libraries and their sequencing. We also thank S. Petersen-Mahrt, C. Rada and F. Santos for advice and discussions. C. P. was a Boehringer-Ingelheim predoctoral Fellow. S. F. is a Howard Hughes Medical Institute Fellow of the Life Science Research Foundation. S. E. J. is an investigator of the Howard Hughes Medical Institute. This work was supported by BBSRC, MRC, EU NoE The Epigenome, and CellCentric (to W. R.), and by HHMI, NSF Plant Genome Research Programme, and NIH (to S. E. J.).	BHUTANI N, 2009, NATURE          1221, DOI DOI 10.1038/NATURE08752; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Dean W, 2001, P NATL ACAD SCI USA, V98, P13734, DOI 10.1073/pnas.241522698; Gehring M, 2009, TRENDS GENET, V25, P82, DOI 10.1016/j.tig.2008.12.001; Gehring M, 2009, SCIENCE, V324, P1447, DOI 10.1126/science.1171609; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hajkova P, 2008, NATURE, V452, P877, DOI 10.1038/nature06714; Hsieh TF, 2009, SCIENCE, V324, P1451, DOI [10.1126/science.1172417, 10.1126/science.112417]; Kriaucionis S, 2009, SCIENCE, V324, P929, DOI 10.1126/science.1169786; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Larijani M, 2005, MOL IMMUNOL, V42, P599, DOI 10.1016/j.molimm.2004.09.007; Lee J, 2002, DEVELOPMENT, V129, P1807; Lister R, 2009, NATURE, V462, P315, DOI 10.1038/nature08514; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Meissner A, 2008, NATURE, V454, P766, DOI 10.1038/nature07107; Morgan HD, 2004, J BIOL CHEM, V279, P52353, DOI 10.1074/jbc.M407695200; Muramatsu M, 2000, CELL, V102, P553, DOI 10.1016/S0092-8674(00)00078-7; Neuberger MS, 2003, TRENDS BIOCHEM SCI, V28, P305, DOI 10.1016/S0968-0004(03)00111-7; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2001, SCIENCE, V293, P1089, DOI 10.1126/science.1063443; Robbiani DF, 2009, MOL CELL, V36, P631, DOI 10.1016/j.molcel.2009.11.007; Sasaki H, 2008, NAT REV GENET, V9, P129, DOI 10.1038/nrg2295; Seki Y, 2007, DEVELOPMENT, V134, P2627, DOI 10.1242/dev.005611; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Teixeira FK, 2009, SCIENCE, V323, P1600, DOI 10.1126/science.1165313; Whitelaw NC, 2008, CURR OPIN GENET DEV, V18, P273, DOI 10.1016/j.gde.2008.07.001; Yamazaki Y, 2003, P NATL ACAD SCI USA, V100, P12207, DOI 10.1073/pnas.2035119100; Zvetkova I, 2005, NAT GENET, V37, P1274, DOI 10.1038/ng1663	30	647	676	1	96	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1101	U126		10.1038/nature08829	http://dx.doi.org/10.1038/nature08829			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20098412	Green Accepted			2022-12-01	WOS:000275108400041
J	Raj, A; Rifkin, SA; Andersen, E; van Oudenaarden, A				Raj, Arjun; Rifkin, Scott A.; Andersen, Erik; van Oudenaarden, Alexander			Variability in gene expression underlies incomplete penetrance	NATURE			English	Article							CAENORHABDITIS-ELEGANS; GATA-FACTOR; C-ELEGANS; SINGLE-CELL; TRANSCRIPTION; SKN-1; ENDODERM; POP-1; ELT-2; DIFFERENTIATION	The phenotypic differences between individual organisms can often be ascribed to underlying genetic and environmental variation. However, even genetically identical organisms in homogeneous environments vary, indicating that randomness in developmental processes such as gene expression may also generate diversity. To examine the consequences of gene expression variability in multicellular organisms, we studied intestinal specification in the nematode Caenorhabditis elegans in which wild-type cell fate is invariant and controlled by a small transcriptional network. Mutations in elements of this network can have indeterminate effects: some mutant embryos fail to develop intestinal cells, whereas others produce intestinal precursors. By counting transcripts of the genes in this network in individual embryos, we show that the expression of an otherwise redundant gene becomes highly variable in the mutants and that this variation is subjected to a threshold, producing an ON/OFF expression pattern of the master regulatory gene of intestinal differentiation. Our results demonstrate that mutations in developmental networks can expose otherwise buffered stochastic variability in gene expression, leading to pronounced phenotypic variation.	[Raj, Arjun; Rifkin, Scott A.; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [Raj, Arjun; Rifkin, Scott A.; Andersen, Erik; van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA; [Andersen, Erik] Princeton Univ, Lewis Sigler Inst Integrat Genom, Princeton, NJ 08544 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Princeton University	van Oudenaarden, A (corresponding author), MIT, Dept Phys, Cambridge, MA 02139 USA.	avano@mit.edu	van Oudenaarden, Alexander/AAA-1705-2019	Rifkin, Scott/0000-0001-8476-3256; Andersen, Erik/0000-0003-0229-9651; Raj, Arjun/0000-0002-2915-6960	National Institutes of Health (NIH); National Science Foundation [DMS-0603392]; Burroughs-Wellcome Fund; NIH NRSA [5F32GM080966]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080966] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD003936] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Science Foundation(National Science Foundation (NSF)); Burroughs-Wellcome Fund(Burroughs Wellcome Fund); NIH NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank H. R. Horvitz for early discussions and technical assistance. We also thank H. R. Horvitz and J. Gore for a critical reading of the manuscript. This work was funded by a National Institutes of Health (NIH) Director's Pioneer Award to A.v.O. A. R. was supported by a National Science Foundation MSPRF fellowship DMS-0603392 and a Burroughs-Wellcome Fund Career Award at the Scientific Interface. S. A. R. was supported by an NIH NRSA postdoctoral fellowship 5F32GM080966.	Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; BOWERMAN B, 1992, CELL, V68, P1061, DOI 10.1016/0092-8674(92)90078-Q; Broitman-Maduro G, 2005, DEV CELL, V8, P427, DOI 10.1016/j.devcel.2005.01.014; Calvo D, 2001, EMBO J, V20, P7197, DOI 10.1093/emboj/20.24.7197; Chang HH, 2008, NATURE, V453, P544, DOI 10.1038/nature06965; Chubb JR, 2006, CURR BIOL, V16, P1018, DOI 10.1016/j.cub.2006.03.092; Eldar A, 2009, NATURE, V460, P510, DOI 10.1038/nature08150; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Fukushige T, 1998, DEV BIOL, V198, P286, DOI 10.1016/S0012-1606(98)80006-7; Fukushige T, 1999, P NATL ACAD SCI USA, V96, P11883, DOI 10.1073/pnas.96.21.11883; Golding I, 2005, CELL, V123, P1025, DOI 10.1016/j.cell.2005.09.031; Goszczynski B, 2005, GENETICS, V171, P545, DOI 10.1534/genetics.105.044909; HORVITZ HR, 1980, GENETICS, V96, P435; Hume DA, 2000, BLOOD, V96, P2323, DOI 10.1182/blood.V96.7.2323.h8002323_2323_2328; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Laubichler MD, 2002, MUTATING CONCEPTS EV, P63; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; LIN RL, 1995, CELL, V83, P599, DOI 10.1016/0092-8674(95)90100-0; Maamar H, 2007, SCIENCE, V317, P526, DOI 10.1126/science.1140818; Maduro MF, 2005, DEV BIOL, V285, P510, DOI 10.1016/j.ydbio.2005.06.022; Maduro MF, 2005, DEV BIOL, V284, P509, DOI 10.1016/j.ydbio.2005.05.016; Maduro MF, 2002, DEV BIOL, V248, P128, DOI 10.1006/dbio.2002.0721; Maduro MF, 2001, MOL CELL, V7, P475, DOI 10.1016/S1097-2765(01)00195-2; Maduro MF, 2009, BBA-GENE REGUL MECH, V1789, P250, DOI 10.1016/j.bbagrm.2008.07.013; Maduro MF, 2007, DEV BIOL, V301, P590, DOI 10.1016/j.ydbio.2006.08.029; McGhee J.D., 2007, C ELEGANS INTESTINE, P1; McGhee JD, 2007, DEV BIOL, V302, P627, DOI 10.1016/j.ydbio.2006.10.024; McGhee JD, 2009, DEV BIOL, V327, P551, DOI 10.1016/j.ydbio.2008.11.034; Nowak MA, 1997, NATURE, V388, P167, DOI 10.1038/40618; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; PECCOUD J, 1995, THEOR POPUL BIOL, V48, P222, DOI 10.1006/tpbi.1995.1027; Queitsch C, 2002, NATURE, V417, P618, DOI 10.1038/nature749; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Raser JM, 2004, SCIENCE, V304, P1811, DOI 10.1126/science.1098641; Romaschoff DD, 1925, J PSYCHOL NEUROL, V31, P323; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shi Y, 1998, GENE DEV, V12, P943, DOI 10.1101/gad.12.7.943; SUEI GM, 2007, SCIENCE, V315, P1716; Timofeeff-Ressowsky NW, 1925, J PSYCHOL NEUROL, V31, P305; Vogt O, 1926, Z GESAMTE NEUROL PSY, V101, P805, DOI 10.1007/BF02878364; Voss TC, 2006, MOL ENDOCRINOL, V20, P2641, DOI 10.1210/me.2006-0091; Waddington C. H, 1940, ORG AND GENES; Wagner GP, 1997, EVOLUTION, V51, P329, DOI 10.1111/j.1558-5646.1997.tb02420.x; Walker AK, 2000, J BIOL CHEM, V275, P22166, DOI 10.1074/jbc.M001746200; Wernet MF, 2006, NATURE, V440, P174, DOI 10.1038/nature04615; Zhu JW, 1998, GENE DEV, V12, P3809, DOI 10.1101/gad.12.24.3809; Zhu JW, 1997, GENE DEV, V11, P2883, DOI 10.1101/gad.11.21.2883	50	452	463	3	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					913	U84		10.1038/nature08781	http://dx.doi.org/10.1038/nature08781			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164922	Green Submitted, Green Accepted			2022-12-01	WOS:000274582700038
J	Ejeta, G				Ejeta, Gebisa			African Green Revolution Needn't Be a Mirage	SCIENCE			English	Editorial Material								Africa missed out on the scientific breakthroughs that revolutionized agriculture in Asia. However, with locally developed and locally relevant technologies, a built-up human and institutional capacity, and supportive national policy and leadership, an African Green Revolution can be a reality.	Purdue Univ, Dept Agron, W Lafayette, IN 47907 USA	Purdue University System; Purdue University; Purdue University West Lafayette Campus	Ejeta, G (corresponding author), Purdue Univ, Dept Agron, Lilly Hall Life Sci,915 W State St, W Lafayette, IN 47907 USA.	gejeta@purdue.edu		Adedokun, Olajire/0000-0001-6002-7377				Collier P, 2008, OXFORD REV ECON POL, V24, P337, DOI 10.1093/oxrep/grn019; Collinson M., 2000, HIST FARMING SYSTEMS, DOI 10.1079/9780851994055.0000; *G8 SUMM 2009, RESP LEAD SUST FUT; Gabre-Madhin EZ, 2004, WORLD DEV, V32, P745, DOI 10.1016/j.worlddev.2003.11.004; GLICKMAN D, 2009, CHICAGO COUNCIL GLOB; Hall A. J., 2000, KNOWLEDGE POLICY TEC, V13, P70, DOI DOI 10.1007/S12130-000-1005-Y; HOLMES H, 2005, AFRICAN FOOD CRISIS; Kates RW, 2007, P NATL ACAD SCI USA, V104, P16747, DOI 10.1073/pnas.0708566104; Mutume G., 2007, AFRICA RENEWAL, V21, P10; RUTTAN VH, 1994, AGR ENV HLTH SUSTAIN; Witcombe JR, 2005, EXP AGR, V41, P299, DOI 10.1017/S0014479705002656	11	55	56	2	34	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					831	832		10.1126/science.1187152	http://dx.doi.org/10.1126/science.1187152			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554AQ	20150493				2022-12-01	WOS:000274408300050
J	Tan, KR; Brown, M; Labouebe, G; Yvon, C; Creton, C; Fritschy, JM; Rudolph, U; Luscher, C				Tan, Kelly R.; Brown, Matthew; Labouebe, Gwenael; Yvon, Cedric; Creton, Cyril; Fritschy, Jean-Marc; Rudolph, Uwe; Luescher, Christian			Neural bases for addictive properties of benzodiazepines	NATURE			English	Article							VENTRAL TEGMENTAL AREA; EVOKED SYNAPTIC PLASTICITY; DOPAMINE NEURONS; IN-VIVO; GABA(B) RECEPTORS; MODULATION; ABUSE; CELLS; ACID; ALPHA-1-BETA-2-GAMMA-2	Benzodiazepines are widely used in clinics and for recreational purposes, but will lead to addiction in vulnerable individuals. Addictive drugs increase the levels of dopamine and also trigger long-lasting synaptic adaptations in the mesolimbic reward system that ultimately may induce the pathological behaviour. The neural basis for the addictive nature of benzodiazepines, however, remains elusive. Here we show that benzodiazepines increase firing of dopamine neurons of the ventral tegmental area through the positive modulation of GABA(A) (gamma-aminobutyric acid type A) receptors in nearby interneurons. Such disinhibition, which relies on alpha 1-containing GABA(A) receptors expressed in these cells, triggers drug-evoked synaptic plasticity in excitatory afferents onto dopamine neurons and underlies drug reinforcement. Taken together, our data provide evidence that benzodiazepines share defining pharmacological features of addictive drugs through cell-type-specific expression of alpha 1-containing GABA(A) receptors in the ventral tegmental area. The data also indicate that subunit-selective benzodiazepines sparing alpha 1 may be devoid of addiction liability.	[Tan, Kelly R.; Brown, Matthew; Labouebe, Gwenael; Yvon, Cedric; Creton, Cyril; Luescher, Christian] Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland; [Fritschy, Jean-Marc] Univ Zurich, Inst Pharmacol & Toxicol, CH-8057 Zurich, Switzerland; [Rudolph, Uwe] Harvard Univ, Sch Med, Lab Genet Neuropharmacol, McLean Hosp, Belmont, MA 02478 USA; [Rudolph, Uwe] Harvard Univ, Sch Med, Dept Psychiat, Belmont, MA 02478 USA; [Luescher, Christian] Univ Hosp Geneva, Dept Clin Neurosci, Neurol Clin, CH-1211 Geneva, Switzerland; [Luescher, Christian] Geneva Neurosci Ctr, CH-1211 Geneva, Switzerland	University of Geneva; University of Zurich; Harvard University; McLean Hospital; Harvard University; University of Geneva	Luscher, C (corresponding author), Univ Geneva, Dept Basic Neurosci, Fac Med, CH-1211 Geneva, Switzerland.	christian.luscher@unige.ch	Lüscher, Christian/A-2496-2011	Lüscher, Christian/0000-0001-7917-4596; Fritschy, Jean-Marc/0000-0002-8552-3702; Brown, Matthew/0000-0001-6983-962X	National Institute on Drug Abuse (NIDA) [DA019022]; Swiss National Science Foundation; Swiss Initiative in Systems Biology; European Commission [LSHM-CT-2005-19063]; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA019022] Funding Source: NIH RePORTER	National Institute on Drug Abuse (NIDA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Initiative in Systems Biology; European Commission(European CommissionEuropean Commission Joint Research Centre); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	We thank members of the Luscher laboratory as well as M. Frerking, M. Serafin and H. Mohler for critical reading of the manuscript. Y. Yanagawa provided the GAD67-GFP Delta neo mouse line, and we thank K. A. Miczek and H. U. Zeilhofer for help with the GABA<INF>A</INF> mutant mouse lines. This work is supported by the National Institute on Drug Abuse (NIDA; DA019022; C. L., P. Slesinger), the Swiss National Science Foundation, the Swiss Initiative in Systems Biology (Neurochoice) and the European Commission Coordination Action ENINET (LSHM-CT-2005-19063). The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIDA or the National Institutes of Health.	ARENDT RM, 1987, PSYCHOPHARMACOLOGY, V93, P72, DOI 10.1007/BF02439589; Argilli E, 2008, J NEUROSCI, V28, P9092, DOI 10.1523/JNEUROSCI.1001-08.2008; Barberis A, 2007, EUR J NEUROSCI, V25, P2726, DOI 10.1111/j.1460-9568.2007.05530.x; Bellone C, 2006, NAT NEUROSCI, V9, P636, DOI 10.1038/nn1682; BERRIDGE KC, 1995, NEUROSCI BIOBEHAV R, V19, P121, DOI 10.1016/0149-7634(94)00026-W; Cameron DL, 1997, NEUROSCIENCE, V77, P155, DOI 10.1016/S0306-4522(96)00444-7; Doherty M, 2007, BRAIN RES, V1150, P62, DOI 10.1016/j.brainres.2007.02.081; FRITSCHY JM, 1995, J COMP NEUROL, V359, P154, DOI 10.1002/cne.903590111; FUCHS V, 1984, DRUG ALCOHOL DEPEN, V14, P179, DOI 10.1016/0376-8716(84)90043-7; GRACE AA, 1979, EUR J PHARMACOL, V59, P211, DOI 10.1016/0014-2999(79)90283-8; GRACE AA, 1983, NEUROSCIENCE, V10, P301, DOI 10.1016/0306-4522(83)90135-5; Heikkinen AE, 2009, NEUROPSYCHOPHARMACOL, V34, P290, DOI 10.1038/npp.2008.89; Hsia AY, 1998, J NEUROPHYSIOL, V79, P2013, DOI 10.1152/jn.1998.79.4.2013; Hyland BI, 2002, NEUROSCIENCE, V114, P475, DOI 10.1016/S0306-4522(02)00267-1; JOHNSON SW, 1992, J PHYSIOL-LONDON, V450, P455, DOI 10.1113/jphysiol.1992.sp019136; KALIVAS PW, 1990, J PHARMACOL EXP THER, V253, P858; KLITENICK MA, 1992, J NEUROSCI, V12, P2623; Koob GF, 2009, PHARMACOPSYCHIATRY, V42, pS32, DOI 10.1055/s-0029-1216356; Labouebe G, 2007, NAT NEUROSCI, V10, P1559, DOI 10.1038/nn2006; Long P, 2009, J BIOL CHEM, V284, P8717, DOI 10.1074/jbc.M805322200; Low K, 2000, SCIENCE, V290, P131, DOI 10.1126/science.290.5489.131; Luscher C, 2008, NAT NEUROSCI, V11, P737, DOI 10.1038/nn0708-737; Luscher C, 2006, PLOS MED, V3, P2005, DOI 10.1371/journal.pmed.0030437; Mameli M, 2007, SCIENCE, V317, P530, DOI 10.1126/science.1142365; Mameli M, 2009, NAT NEUROSCI, V12, P1036, DOI 10.1038/nn.2367; Margolis EB, 2006, J PHYSIOL-LONDON, V577, P907, DOI 10.1113/jphysiol.2006.117069; McKernan RM, 2000, NAT NEUROSCI, V3, P587, DOI 10.1038/75761; MOHLER H, 1992, ADV BIOCHEM PSYCHOPH, V47, P41; Morris HV, 2009, APPETITE, V52, P675, DOI 10.1016/j.appet.2009.03.006; O'Brien P, 2005, CHEM WORLD-UK, V2, P28; Okada H, 2004, J NEUROCHEM, V89, P7, DOI 10.1111/j.1471-4159.2004.02271.x; Paxinos G., 2004, MOUSE BRAIN STEREOTA, V2; PILOTTO R, 1984, PSYCHOPHARMACOLOGY, V84, P174, DOI 10.1007/BF00427442; Poncer JC, 1996, NEUROPHARMACOLOGY, V35, P1169, DOI 10.1016/S0028-3908(96)00055-X; Redish AD, 2008, BEHAV BRAIN SCI, V31, P415, DOI 10.1017/S0140525X0800472X; Robinson S, 2004, P NATL ACAD SCI USA, V101, P13329, DOI 10.1073/pnas.0405084101; Rowlett JK, 2005, P NATL ACAD SCI USA, V102, P915, DOI 10.1073/pnas.0405621102; Rudolph U, 2006, CURR OPIN PHARMACOL, V6, P18, DOI 10.1016/j.coph.2005.10.003; Rudolph U, 1999, NATURE, V401, P796, DOI 10.1038/44579; Saal D, 2003, NEURON, V37, P577, DOI 10.1016/S0896-6273(03)00021-7; Sigel E, 1998, MOL PHARMACOL, V54, P1097, DOI 10.1124/mol.54.6.1097; Soyka M, 2000, PHARMACOPSYCHIATRY, V33, P138, DOI 10.1055/s-2000-11224; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Ungless MA, 2004, SCIENCE, V303, P2040, DOI 10.1126/science.1093360; Xi ZX, 1998, BRAIN RES, V798, P156, DOI 10.1016/S0006-8993(98)00406-5; Yee BK, 2005, P NATL ACAD SCI USA, V102, P17154, DOI 10.1073/pnas.0508752102; YERBURY RE, 1989, PHARMACOL BIOCHEM BE, V33, P303, DOI 10.1016/0091-3057(89)90504-2; Zhao SL, 2004, EUR J NEUROSCI, V19, P1133, DOI 10.1111/j.1460-9568.2004.03206.x	48	241	246	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					769	U78		10.1038/nature08758	http://dx.doi.org/10.1038/nature08758			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148031	Green Accepted			2022-12-01	WOS:000274394300031
J	Duncan, JR; Paterson, DS; Hoffman, JM; Mokler, DJ; Borenstein, NS; Belliveau, RA; Krous, HF; Haas, EA; Stanley, C; Nattie, EE; Trachtenberg, FL; Kinney, HC				Duncan, Jhodie R.; Paterson, David S.; Hoffman, Jill M.; Mokler, David J.; Borenstein, Natalia S.; Belliveau, Richard A.; Krous, Henry F.; Haas, Elisabeth A.; Stanley, Christina; Nattie, Eugene E.; Trachtenberg, Felicia L.; Kinney, Hannah C.			Brainstem Serotonergic Deficiency in Sudden Infant Death Syndrome	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECEPTOR-BINDING; MEDULLA-OBLONGATA; NEURONS; ABNORMALITIES; VICTIMS; REGIONS; RISK	Context Sudden infant death syndrome ( SIDS) is postulated to result from abnormalities in brainstem control of autonomic function and breathing during a critical developmental period. Abnormalities of serotonin (5-hydroxytryptamine [5-HT]) receptor binding in regions of the medulla oblongata involved in this control have been reported in infants dying from SIDS. Objective To test the hypothesis that 5-HT receptor abnormalities in infants dying from SIDS are associated with decreased tissue levels of 5-HT, its key biosynthetic enzyme ( tryptophan hydroxylase [TPH2]), or both. Design, Setting, and Participants Autopsy study conducted to analyze levels of 5-HT and its metabolite, 5-hydroxyindoleacetic acid (5-HIAA); levels of TPH2; and 5-HT1A receptor binding. The data set was accrued between 2004 and 2008 and consisted of 41 infants dying from SIDS (cases), 7 infants with acute death from known causes (controls), and 5 hospitalized infants with chronic hypoxia-ischemia. Main Outcome Measures Serotonin and metabolite tissue levels in the raphe obscurus and paragigantocellularis lateralis (PGCL); TPH2 levels in the raphe obscurus; and 5-HT1A binding density in 5 medullary nuclei that contain 5-HT neurons and 5 medullary nuclei that receive 5-HT projections. Results Serotonin levels were 26% lower in SIDS cases (n=35) compared with age-adjusted controls (n=5) in the raphe obscurus(55.4 [95% confidence interval {CI}, 47.2-63.6] vs 75.5 [95% CI, 54.2-96.8] pmol/mg protein, P=.05) and the PGCL (31.4 [ 95% CI, 23.7-39.0] vs 40.0 [95% CI, 20.1-60.0] pmol/mg protein, P=.04). There was no evidence of excessive 5-HT degradation assessed by 5-HIAA levels, 5-HIAA: 5-HT ratio, or both. In the raphe obscurus, TPH2 levels were 22% lower in the SIDS cases (n=34) compared with controls (n=5) (151.2% of standard [ 95% CI, 137.5%-165.0%] vs 193.9% [ 95% CI, 158.6%-229.2%], P=.03). 5-HT1A receptor binding was 29% to 55% lower in 3 medullary nuclei that receive 5-HT projections. In 4 nuclei, 3 of which contain 5-HT neurons, there was a decrease with age in 5-HT1A receptor binding in the SIDS cases but no change in the controls ( age x diagnosis interaction). The profile of 5-HT and TPH2 abnormalities differed significantly between the SIDS and hospitalized groups ( 5-HT in the raphe obscurus: 55.4 [95% CI, 47.2-63.6] vs 85.6 [ 95% CI, 61.8-109.4] pmol/mg protein, P=.02; 5-HT in the PGCL: 31.4 [95% CI, 23.7-39.0] vs 71.1 [95% CI, 49.0-93.2] pmol/mg protein, P=.002; TPH2 in the raphe obscurus: 151.2% [ 95% CI, 137.5%-165.0%] vs 102.6% [ 95% CI, 58.7%-146.4%], P=.04). Conclusion Compared with controls, SIDS was associated with lower 5-HT and TPH2 levels, consistent with a disorder of medullary 5-HT deficiency. JAMA. 2010; 303(5):430-437 www.jama.com	[Duncan, Jhodie R.; Paterson, David S.; Hoffman, Jill M.; Borenstein, Natalia S.; Belliveau, Richard A.; Kinney, Hannah C.] Childrens Hosp, Dept Pathol, Boston, MA 02115 USA; [Duncan, Jhodie R.; Paterson, David S.; Hoffman, Jill M.; Borenstein, Natalia S.; Belliveau, Richard A.; Kinney, Hannah C.] Harvard Univ, Sch Med, Boston, MA USA; [Mokler, David J.] Univ New England, Coll Osteopath Med, Dept Biochem Sci, Biddeford, ME USA; [Krous, Henry F.; Haas, Elisabeth A.] Rady Childrens Hosp San Diego, San Diego, CA USA; [Krous, Henry F.; Haas, Elisabeth A.] Univ Calif San Diego, Sch Med, San Diego, CA 92103 USA; [Stanley, Christina] San Diego Cty Med Examiners Off, San Diego, CA USA; [Nattie, Eugene E.] Dartmouth Med Sch, Dept Physiol, Lebanon, NH USA; [Trachtenberg, Felicia L.] New England Res Inst, Watertown, MA 02172 USA	Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; University of New England - Maine; Rady Childrens Hospital San Diego; University of California System; University of California San Diego; Dartmouth College; HealthCore, Inc	Kinney, HC (corresponding author), Childrens Hosp, Dept Pathol, Enders 1112-1,300 Longwood Ave, Boston, MA 02115 USA.	hannah.kinney@childrens.harvard.edu	Mokler, David J./H-3114-2019	Mokler, David J./0000-0001-7340-3431	National Health and Medical Research Council of Australia; CJ Murphy Foundation; CJ Foundation; National Institute of Child Health and Development [R37-HD20991, PO1-HD036379]; Developmental Disabilities Research Center, Children's Hospital Boston [P30-HD18655]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P01HD036379, R01HD020991, P30HD018655] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R37HD020991] Funding Source: NIH RePORTER	National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); CJ Murphy Foundation; CJ Foundation; National Institute of Child Health and Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Developmental Disabilities Research Center, Children's Hospital Boston; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))	This study was supported by the First Candle/SIDS Alliance, CJ Martin Overseas Fellowship (National Health and Medical Research Council of Australia), CJ Murphy Foundation for Solving the Puzzle of SIDS, CJ Foundation for SIDS, National Institute of Child Health and Development (R37-HD20991 and PO1-HD036379), and Developmental Disabilities Research Center, Children's Hospital Boston (P30-HD18655)	Alenina N, 2009, P NATL ACAD SCI USA, V106, P10332, DOI 10.1073/pnas.0810793106; Cummings KJ, 2009, AM J PHYSIOL-REG I, V296, pR1783, DOI 10.1152/ajpregu.00122.2009; EATON MJ, 1995, DEV BIOL, V170, P169, DOI 10.1006/dbio.1995.1205; FILIANO JJ, 1994, BIOL NEONATE, V65, P194; Hauck FR, 2008, PEDIATRICS, V122, P660, DOI 10.1542/peds.2007-0135; Hodges MR, 2009, J NEUROSCI, V29, P10341, DOI 10.1523/JNEUROSCI.1963-09.2009; Hunt CE, 2005, ARCH DIS CHILD, V90, P48, DOI 10.1136/adc.2004.051458; Kinney HC, 2007, AUTON NEUROSCI-BASIC, V132, P81, DOI 10.1016/j.autneu.2006.11.001; Kinney HC, 2009, NEW ENGL J MED, V361, P795, DOI 10.1056/NEJMra0803836; Kinney HC, 2009, ANNU REV PATHOL-MECH, V4, P517, DOI 10.1146/annurev.pathol.4.110807.092322; Kinney HC, 2003, J NEUROPATH EXP NEUR, V62, P1178, DOI 10.1093/jnen/62.11.1178; Kinney HC, 2001, J NEUROPATH EXP NEUR, V60, P228, DOI 10.1093/jnen/60.3.228; KONTUR PJ, 1994, J NEUROCHEM, V62, P282; KOPP N, 1993, NEUROPEDIATRICS, V24, P25, DOI 10.1055/s-2008-1071508; Krous HF, 2004, PEDIATRICS, V114, P234, DOI 10.1542/peds.114.1.234; LOWRY OH, 1951, J BIOL CHEM, V193, P265; Machaalani R, 2009, ACTA NEUROPATHOL, V117, P257, DOI 10.1007/s00401-008-0468-x; Mansouri J, 2001, J NEUROPATH EXP NEUR, V60, P141, DOI 10.1093/jnen/60.2.141; Moon RY, 2007, LANCET, V370, P1578, DOI 10.1016/S0140-6736(07)61662-6; Nattie E, 2009, BIOESSAYS, V31, P130, DOI 10.1002/bies.200800200; Obonai T, 1998, PEDIATRICS, V101, P285, DOI 10.1542/peds.101.2.285; Olszewski J., 1967, CYTOARCHITECTURE HUM; Ozawa Y, 2002, NEUROPEDIATRICS, V33, P142, DOI 10.1055/s-2002-33678; Panigrahy A, 2000, J NEUROPATH EXP NEUR, V59, P377, DOI 10.1093/jnen/59.5.377; Paterson DS, 2006, JAMA-J AM MED ASSOC, V296, P2124, DOI 10.1001/jama.296.17.2124; Paxinos G, 1995, ATLAS HUMAN BRAINSTE; Poets Christian F, 2004, Paediatr Respir Rev, V5 Suppl A, pS383, DOI 10.1016/S1526-0542(04)90068-1; Sridhar R, 2003, PEDIATR PULM, V36, P113, DOI 10.1002/ppul.10287; TAKASHIMA S, 1991, NEUROPEDIATRICS, V22, P97, DOI 10.1055/s-2008-1071424; Thach B, 2008, EMBO REP, V9, P114, DOI 10.1038/sj.embor.7401163; Weese-Mayer DE, 2007, AM J MED GENET A, V143A, P771, DOI 10.1002/ajmg.a.31722; WILLINGER M, 1994, PEDIATRICS, V93, P814; WILLINGER M, 1991, Pediatric Pathology, V11, P677	33	213	217	0	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					430	437		10.1001/jama.2010.45	http://dx.doi.org/10.1001/jama.2010.45			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124538	Green Accepted, Bronze			2022-12-01	WOS:000274143600018
J	Chen, MS; White, MC				Chen, Mark S.; White, M. Christina			Combined Effects on Selectivity in Fe-Catalyzed Methylene Oxidation	SCIENCE			English	Article							C-H BONDS; SATURATED-HYDROCARBONS; HYDROGEN-PEROXIDE; HYDROXYLATION; OXYGENATION; OXYFUNCTIONALIZATION; FUNCTIONALIZATION; SCLAREOLIDE; COMPLEXES; MOLECULES	Methylene C-H bonds are among the most difficult chemical bonds to selectively functionalize because of their abundance in organic structures and inertness to most chemical reagents. Their selective oxidations in biosynthetic pathways underscore the power of such reactions for streamlining the synthesis of molecules with complex oxygenation patterns. We report that an iron catalyst can achieve methylene C-H bond oxidations in diverse natural-product settings with predictable and high chemo-, site-, and even diastereoselectivities. Electronic, steric, and stereoelectronic factors, which individually promote selectivity with this catalyst, are demonstrated to be powerful control elements when operating in combination in complex molecules. This small-molecule catalyst displays site selectivities complementary to those attained through enzymatic catalysis.	[Chen, Mark S.; White, M. Christina] Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA	University of Illinois System; University of Illinois Urbana-Champaign	White, MC (corresponding author), Univ Illinois, Dept Chem, Roger Adams Lab, Urbana, IL 61801 USA.	white@scs.uiuc.edu	Chen, Mark/AAX-6131-2020	Chen, Mark/0000-0001-5415-4660	A. P. Sloan Foundation; Camille and Henry Dreyfus Foundation; Bristol-Myers Squibb; Pfizer; Abbott; University of Illinois	A. P. Sloan Foundation(Alfred P. Sloan Foundation); Camille and Henry Dreyfus Foundation; Bristol-Myers Squibb(Bristol-Myers Squibb); Pfizer(Pfizer); Abbott(Abbott Laboratories); University of Illinois	Dedicated to Professor Eric N. Jacobsen on his 50th birthday for his inspirational work on selective oxidations. We gratefully acknowledge R. J. Pakula for performing gas chromatography experiments toward elucidating the steric effects on oxidation site selectivity; M. A. Bigi, D. J. Covell, and E. M. Stang for helpful discussions and checking our spectroscopic data; and S. A. Reed for helpful discussions and checking our experimental procedure. M. S. C. was a Harvard University graduate student who completed his doctoral work with M. C. W. at the University of Illinois at Urbana-Champaign. This work was submitted to M. S. C.'s committee as part of his thesis on 28 August 2009 and was presented by M. C. W. at the Welch Symposium on 27 October 2009. We are grateful to the A. P. Sloan Foundation, the Camille and Henry Dreyfus Foundation, Bristol-Myers Squibb, Pfizer, Abbott, and the University of Illinois for financial support. M. S. C. is a 2008 Bristol-Myers Squibb Graduate Fellow in Synthetic Organic Chemistry. A U. S. patent on "Selective Aliphatic C-H Oxidation" is pending (application 12/245,086).	Ata A, 2007, CHEM PHARM BULL, V55, P118, DOI 10.1248/cpb.55.118; BARTON DHR, 1990, TETRAHEDRON, V46, P3743; Brodsky BH, 2005, J AM CHEM SOC, V127, P15391, DOI 10.1021/ja055549i; Chen K, 2009, NATURE, V459, P824, DOI 10.1038/nature08043; Chen MS, 2007, SCIENCE, V318, P783, DOI 10.1126/science.1148597; Chen MS, 2004, J AM CHEM SOC, V126, P1346, DOI 10.1021/ja039107n; Clardy J, 2004, NATURE, V432, P829, DOI 10.1038/nature03194; COLLMAN JP, 1990, J AM CHEM SOC, V112, P3689, DOI 10.1021/ja00165a081; Das S, 2006, SCIENCE, V312, P1941, DOI 10.1126/science.1127899; Davis EM, 2000, TOP CURR CHEM, V209, P53; Desai LV, 2004, J AM CHEM SOC, V126, P9542, DOI 10.1021/ja046831c; ELIEL EL, 1966, J AM CHEM SOC, V88, P3327, DOI 10.1021/ja00966a027; Farooq A, 2000, Z NATURFORSCH C, V55, P341; Fraunhoffer KJ, 2005, ORG LETT, V7, P223, DOI 10.1021/ol047800p; GROVES JT, 1979, J AM CHEM SOC, V101, P5290; Hanson RL, 2002, ORG PROCESS RES DEV, V6, P482, DOI 10.1021/op020028q; Kim C, 1997, J AM CHEM SOC, V119, P5964, DOI 10.1021/ja9642572; Lee JS, 2003, ORG LETT, V5, P2247, DOI 10.1021/ol034551g; Lim MH, 1999, B CHEM SOC JPN, V72, P707, DOI 10.1246/bcsj.72.707; Mas-Balleste R, 2006, SCIENCE, V312, P1885, DOI 10.1126/science.1129814; MELLO R, 1989, J AM CHEM SOC, V111, P6749, DOI 10.1021/ja00199a039; Okuno T, 1997, J CHEM SOC DALTON, P3547, DOI 10.1039/a700030h; OLAH GA, 1992, CHEM REV, V92, P69, DOI 10.1021/cr00009a003; Ortiz de Montellano PR, 2005, CYTOCHROME P450 STRU, V3rd; Stang EM, 2009, NAT CHEM, V1, P547, DOI [10.1038/NCHEM.351, 10.1038/nchem.351]; UMBREIT MA, 1977, J AM CHEM SOC, V99, P5526, DOI 10.1021/ja00458a072; Vermeulen NA, 2009, TETRAHEDRON, V65, P3078, DOI 10.1016/j.tet.2008.11.082; Wender PA, 2005, ORG LETT, V7, P79, DOI 10.1021/ol047859w; White MC, 2001, J AM CHEM SOC, V123, P7194, DOI 10.1021/ja015884g; Yang J, 2002, J ORG CHEM, V67, P5057, DOI 10.1021/jo020174u	30	575	579	12	261	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					566	571		10.1126/science.1183602	http://dx.doi.org/10.1126/science.1183602			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC); Current Chemical Reactions (CCR-EXPANDED)	Science & Technology - Other Topics	549CT	20110502				2022-12-01	WOS:000274020500034
J	Becker, T; Loch, G; Beyer, M; Zinke, I; Aschenbrenner, AC; Carrera, P; Inhester, T; Schultze, JL; Hoch, M				Becker, Thomas; Loch, Gerrit; Beyer, Marc; Zinke, Ingo; Aschenbrenner, Anna C.; Carrera, Pilar; Inhester, Therese; Schultze, Joachim L.; Hoch, Michael			FOXO-dependent regulation of innate immune homeostasis	NATURE			English	Article							LIFE-SPAN; DROSOPHILA; HOMOLOG; METABOLISM; EXPRESSION; DROSOMYCIN; INFECTION; MUTANTS; CHICO; TOLL	The innate immune system represents an ancient host defence mechanism that protects against invading microorganisms. An important class of immune effector molecules to fight pathogen infections are antimicrobial peptides (AMPs) that are produced in plants and animals(1). In Drosophila, the induction of AMPs in response to infection is regulated through the activation of the evolutionarily conserved Toll and immune deficiency (IMD) pathways(2). Here we show that AMP activation can be achieved independently of these immunoregulatory pathways by the transcription factor FOXO, a key regulator of stress resistance, metabolism and ageing. In non-infected animals, AMP genes are activated in response to nuclear FOXO activity when induced by starvation, using insulin signalling mutants, or by applying small molecule inhibitors. AMP induction is lost in foxo null mutants but enhanced when FOXO is overexpressed. Expression of AMP genes in response to FOXO activity can also be triggered in animals unable to respond to immune challenges due to defects in both the Toll and IMD pathways. Molecular experiments at the Drosomycin promoter indicate that FOXO directly binds to its regulatory region, thereby inducing its transcription. In vivo studies in Drosophila, but also studies in human lung, gut, kidney and skin cells indicate that a FOXO-dependent regulation of AMPs is evolutionarily conserved. Our results indicate a new mechanism of cross-regulation of metabolism and innate immunity by which AMP genes can be activated under normal physiological conditions in response to the oscillating energy status of cells and tissues. This regulation seems to be independent of the pathogen-responsive innate immunity pathways whose activation is often associated with tissue damage and repair. The sparse production of AMPs in epithelial tissues in response to FOXO may help modulating the defence reaction without harming the host tissues, in particular when animals are suffering from energy shortage or stress.	[Becker, Thomas; Loch, Gerrit; Zinke, Ingo; Aschenbrenner, Anna C.; Carrera, Pilar; Hoch, Michael] Univ Bonn, Dev Genet & Mol Physiol Unit, LIMES Inst, D-53115 Bonn, Germany; [Beyer, Marc; Inhester, Therese; Schultze, Joachim L.] Univ Bonn, Mol Immune & Cell Biol Unit, LIMES Inst, D-53115 Bonn, Germany	University of Bonn; University of Bonn	Hoch, M (corresponding author), Univ Bonn, Dev Genet & Mol Physiol Unit, LIMES Inst, Carl Troll Str 31, D-53115 Bonn, Germany.	m.hoch@uni-bonn.de	Schultze, Joachim L./ABA-8176-2020; Schultze, Joachim L/D-7794-2011; Beyer, Marc/ABE-1408-2021	Schultze, Joachim L./0000-0003-2812-9853; Schultze, Joachim L/0000-0003-2812-9853; Beyer, Marc/0000-0001-9704-148X; Aschenbrenner, Anna/0000-0002-9429-5457	DFG [SFBs 645, 704]	DFG(German Research Foundation (DFG))	For sending flies and constructs, we thank M. Tatar (foxo<SUP>21</SUP>, foxo<SUP>W24</SUP> and UAS foxo TM), B. Lemaitre (Relish<SUP>E20</SUP>, spatzle<SUP>RM7</SUP>), S. Cohen (UAS foxo-GFP) and M. Boutros (luciferase vectors). Thanks to M. Famulok for providing the Steppke inhibitor SecinH3. N. Novak, J. Grell and A. Schmitz assisted with luciferase assays. We thank S. Mario-Wegner for help with transgenic luciferase flies. We thank members of the Famulok, Schultze and Hoch laboratory for discussions. This work was supported by grants from the DFG to M. H. (SFBs 645 and 704).	Bauer M, 2006, PHYSIOL GENOMICS, V25, P393, DOI 10.1152/physiolgenomics.00009.2006; Bischoff V, 2006, PLOS PATHOG, V2, P139, DOI 10.1371/journal.ppat.0020014; Bohni R, 1999, CELL, V97, P865, DOI 10.1016/S0092-8674(00)80799-0; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Evans EA, 2008, AGING CELL, V7, P879, DOI 10.1111/j.1474-9726.2008.00435.x; Ferrandon D, 1998, EMBO J, V17, P1217, DOI 10.1093/emboj/17.5.1217; Flatt T, 2008, J EXP BIOL, V211, P2712, DOI 10.1242/jeb.014878; Furuyama T, 2000, BIOCHEM J, V349, P629, DOI 10.1042/0264-6021:3490629; Fuss B, 2006, NATURE, V444, P945, DOI 10.1038/nature05412; Garsin DA, 2003, SCIENCE, V300, P1921, DOI 10.1126/science.1080147; Hafen E, 2004, SWISS MED WKLY, V134, P711; Hafner M, 2006, NATURE, V444, P941, DOI 10.1038/nature05415; Hoffmann JA, 2002, NAT IMMUNOL, V3, P121, DOI 10.1038/ni0202-121; Hwangbo DS, 2004, NATURE, V429, P562, DOI 10.1038/nature02549; LEMAITRE B, 2007, ANNU REV IMMUNOL, V697, P743; Libert S, 2008, MOL IMMUNOL, V45, P810, DOI 10.1016/j.molimm.2007.06.353; Min KJ, 2008, AGING CELL, V7, P199, DOI 10.1111/j.1474-9726.2008.00373.x; Puig O, 2003, GENE DEV, V17, P2006, DOI 10.1101/gad.1098703; Ryu JH, 2008, SCIENCE, V319, P777, DOI 10.1126/science.1149357; Selsted ME, 2005, NAT IMMUNOL, V6, P551, DOI 10.1038/ni1206; Simon A, 2008, ANTIMICROB AGENTS CH, V52, P1407, DOI 10.1128/AAC.00155-07; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Uvell H, 2007, TRENDS GENET, V23, P342, DOI 10.1016/j.tig.2007.05.003; Wu JL, 2007, CELL MICROBIOL, V9, P1073, DOI 10.1111/j.1462-5822.2006.00853.x; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012; Zasloff M, 2006, NAT MED, V12, P606, DOI 10.1038/nm0606-607; Zinke I, 2002, EMBO J, V21, P6162, DOI 10.1093/emboj/cdf600	30	243	250	2	58	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					369	373		10.1038/nature08698	http://dx.doi.org/10.1038/nature08698			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090753				2022-12-01	WOS:000273748100047
J	Gong, HX; Shen, B; Flevaris, P; Chow, C; Lam, SCT; Voyno-Yasenetskaya, TA; Kozasa, T; Du, XP				Gong, Haixia; Shen, Bo; Flevaris, Panagiotis; Chow, Christina; Lam, Stephen C. -T.; Voyno-Yasenetskaya, Tatyana A.; Kozasa, Tohru; Du, Xiaoping			G Protein Subunit G alpha(13) Binds to Integrin alpha(IIb)beta(3) and Mediates Integrin "Outside-In" Signaling	SCIENCE			English	Article							SHAPE CHANGE; P115 RHOGEF; ACTIVATION; SRC; PLATELETS; KINASES; SWITCH; ROLES; MODEL	Integrins mediate cell adhesion to the extracellular matrix and transmit signals within the cell that stimulate cell spreading, retraction, migration, and proliferation. The mechanism of integrin outside-in signaling has been unclear. We found that the heterotrimeric guanine nucleotide-binding protein (G protein) G alpha(13) directly bound to the integrin beta(3) cytoplasmic domain and that G alpha(13)-integrin interaction was promoted by ligand binding to the integrin alpha(IIb)beta(3) and by guanosine triphosphate (GTP) loading of G alpha(13). Interference of G alpha(13) expression or a myristoylated fragment of G alpha(13) that inhibited interaction of alpha(IIb)beta(3) with G alpha(13) diminished activation of protein kinase c-Src and stimulated the small guanosine triphosphatase RhoA, consequently inhibiting cell spreading and accelerating cell retraction. We conclude that integrins are noncanonical G alpha(13)-coupled receptors that provide a mechanism for dynamic regulation of RhoA.	[Gong, Haixia; Shen, Bo; Flevaris, Panagiotis; Chow, Christina; Lam, Stephen C. -T.; Voyno-Yasenetskaya, Tatyana A.; Kozasa, Tohru; Du, Xiaoping] Univ Illinois, Dept Pharmacol, Chicago, IL 60612 USA	University of Illinois System; University of Illinois Chicago; University of Illinois Chicago Hospital	Du, XP (corresponding author), Univ Illinois, Dept Pharmacol, 835 S Wolcott Ave,Room E403, Chicago, IL 60612 USA.	xdu@uic.edu	Shen, Bo/G-2012-2014	Shen, Bo/0000-0002-5237-6144; Chow, Christina/0000-0003-3944-4234	National Heart, Lung, and Blood Institute [HL080264, HL062350, HL068819]; National Institute of General Medical Sciences [GM061454, GM074001]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL062350, R01HL080264, R01HL068819] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM074001, R01GM061454] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants HL080264, HL062350, and HL068819 from the National Heart, Lung, and Blood Institute (X. D.) and GM061454 and GM074001 from the National Institute of General Medical Sciences (T. K.). We thank G. Nucifora for help with bone marrow transplantation and K. O'Brien and M. K. Delaney for proofreading.	Arias-Salgado EG, 2003, P NATL ACAD SCI USA, V100, P13298, DOI 10.1073/pnas.2336149100; Arthur WT, 2000, CURR BIOL, V10, P719, DOI 10.1016/S0960-9822(00)00537-6; Brass L F, 1991, Prog Hemost Thromb, V10, P127; COLLER BS, 1980, BLOOD, V55, P169; DU XP, 1991, CELL, V65, P409, DOI 10.1016/0092-8674(91)90458-B; Flevaris P, 2007, J CELL BIOL, V179, P553, DOI 10.1083/jcb.200703185; Flevaris P, 2009, BLOOD, V113, P893, DOI 10.1182/blood-2008-05-155978; Ginsberg MH, 2005, CURR OPIN CELL BIOL, V17, P509, DOI 10.1016/j.ceb.2005.08.010; Gu MY, 1999, J CELL BIOL, V147, P1085, DOI 10.1083/jcb.147.5.1085; Hart MJ, 1998, SCIENCE, V280, P2112, DOI 10.1126/science.280.5372.2112; Huang JS, 2007, J BIOL CHEM, V282, P10210, DOI 10.1074/jbc.M605678200; Hynes RO, 2002, CELL, V110, P673, DOI 10.1016/S0092-8674(02)00971-6; Klages B, 1999, J CELL BIOL, V144, P745, DOI 10.1083/jcb.144.4.745; Kozasa T, 1998, SCIENCE, V280, P2109, DOI 10.1126/science.280.5372.2109; Li ZY, 2006, BLOOD, V107, P965, DOI 10.1182/blood-2005-03-1308; Ma YQ, 2007, J THROMB HAEMOST, V5, P1345, DOI 10.1111/j.1538-7836.2007.02537.x; Moers A, 2003, NAT MED, V9, P1418, DOI 10.1038/nm943; Moissoglu K, 2006, BIOL CELL, V98, P547, DOI 10.1042/BC20060025; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Ren XD, 2000, METHOD ENZYMOL, V325, P264; Riobo NA, 2005, TRENDS PHARMACOL SCI, V26, P146, DOI 10.1016/j.tips.2005.01.007; Senyuk V, 2009, CANCER RES, V69, P262, DOI 10.1158/0008-5472.CAN-08-2534; Shattil SJ, 2005, TRENDS CELL BIOL, V15, P399, DOI 10.1016/j.tcb.2005.06.005; Tanabe S, 2004, METHOD ENZYMOL, V390, P285; Vidal C, 2002, BLOOD, V100, P4462, DOI 10.1182/blood.V100.13.4462	25	161	168	2	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					340	343		10.1126/science.1174779	http://dx.doi.org/10.1126/science.1174779			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075254	Green Accepted			2022-12-01	WOS:000273629700046
J	McKinnon, L; Smith, PA; Nol, E; Martin, JL; Doyle, FI; Abraham, KF; Gilchrist, HG; Morrison, RIG; Bety, J				McKinnon, L.; Smith, P. A.; Nol, E.; Martin, J. L.; Doyle, F. I.; Abraham, K. F.; Gilchrist, H. G.; Morrison, R. I. G.; Bety, J.			Lower Predation Risk for Migratory Birds at High Latitudes	SCIENCE			English	Article							LONG-DISTANCE MIGRATION; RED KNOTS; NEST PREDATION; SHOREBIRDS; NORTH; CIRCUMPOLAR; SONGBIRDS; EVOLUTION; PRESSURE; PATTERNS	Quantifying the costs and benefits of migration distance is critical to understanding the evolution of long-distance migration. In migratory birds, life history theory predicts that the potential survival costs of migrating longer distances should be balanced by benefits to lifetime reproductive success, yet quantification of these reproductive benefits in a controlled manner along a large geographical gradient is challenging. We measured a controlled effect of predation risk along a 3350-kilometer south-north gradient in the Arctic and found that nest predation risk declined more than twofold along the latitudinal gradient. These results provide evidence that birds migrating farther north may acquire reproductive benefits in the form of lower nest predation risk.	[McKinnon, L.; Bety, J.] Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada; [McKinnon, L.; Bety, J.] Univ Quebec, Ctr Etud Nord, Rimouski, PQ G5L 3A1, Canada; [Smith, P. A.; Morrison, R. I. G.] Environm Canada, Natl Wildlife Res Ctr, Ottawa, ON K1A 0H3, Canada; [Nol, E.] Trent Univ, Environm & Life Sci Grad Program, Ecol & Conservat Grp, Peterborough, ON K9J 7B8, Canada; [Nol, E.] Trent Univ, Dept Biol, Peterborough, ON K9J 7B8, Canada; [Martin, J. L.] CNRS, Ctr Ecol Fonct & Evolut, Dept Dynam Syst Ecol, F-34033 Montpellier, France; [Doyle, F. I.] Wildlife Dynam Consulting, Telkwa, BC V0J 2X0, Canada; [Abraham, K. F.] Ontario Minist Nat Resources, Wildlife Res & Dev Sect, Peterborough, ON K9J 7B8, Canada; [Gilchrist, H. G.] Carleton Univ, Dept Biol, Ottawa, ON K1S 5B6, Canada; [Gilchrist, H. G.] Carleton Univ, Natl Wildlife Res Ctr, Environm Canada, Ottawa, ON K1S 5B6, Canada	University of Quebec; University of Quebec; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada; Trent University; Trent University; UDICE-French Research Universities; PSL Research University Paris; Ecole Pratique des Hautes Etudes (EPHE); Institut Agro; Montpellier SupAgro; CIRAD; Centre National de la Recherche Scientifique (CNRS); Institut de Recherche pour le Developpement (IRD); Universite Paul-Valery; Universite de Montpellier; Ministry of Natural Resources & Forestry; Carleton University; Carleton University; Environment & Climate Change Canada; Canadian Wildlife Service; National Wildlife Research Centre - Canada	McKinnon, L (corresponding author), Univ Quebec, Dept Biol, Rimouski, PQ G5L 3A1, Canada.	laura.mckinnon3@gmail.com	Martin, Jean-Louis/E-5059-2010	Bety, Joel/0000-0002-8775-6411	ArcticNet; Environment Canada; Fonds Quebecois de Recherche sur la Nature et les Technologies; Garfield Weston Foundation; Institut Paul Emile Victor; International Polar Year (IPY) Project ArcticWOLVES; Natural Sciences and Engineering Research Council of Canada; Northern Ecosystem Initiatives; Northern Scientific Training Program; Ontario Ministry of Natural Resources	ArcticNet; Environment Canada(CGIAR); Fonds Quebecois de Recherche sur la Nature et les Technologies(FQRNT); Garfield Weston Foundation; Institut Paul Emile Victor; International Polar Year (IPY) Project ArcticWOLVES; Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Northern Ecosystem Initiatives; Northern Scientific Training Program; Ontario Ministry of Natural Resources	Funded by ArcticNet, Environment Canada, Fonds Quebecois de Recherche sur la Nature et les Technologies, a Garfield Weston Foundation Award for Northern Research, Institut Paul Emile Victor (formerly Institut Francais de Recherches et Technologies Polaires), International Polar Year (IPY) Project ArcticWOLVES, Natural Sciences and Engineering Research Council of Canada (Northern Internship Program and Discovery Grant), Northern Ecosystem Initiatives, Northern Scientific Training Program, and the Ontario Ministry of Natural Resources. Logistical support was provided by the Ontario Ministry of Natural Resources, the Polar Continental Shelf Project, Parks Canada, and D. Leclerc. We also thank the Department of National Defense and staff of the Environment Canada weather station for logistic support at Alert; Vicky Johnston and crew for support on Prince Charles Island; the many field assistants who monitored artificial nests: A. Blachford, A. Bechet, J. Carrier, M. Cloutier, A.-M. d'Aoust-Messier, E. d'Astous, T. Daufresne, S. Gan, D. Hogan, L. Jolicoeur, C. Juillet, J.-R. Julien, B. Laliberte, P. Y. l'Herault, R. Lopez, P. Meister, M. Nelligan, D. Ootoova, L. Qangug, D. C. Rabouam, G. Reid, N. Ward, and S. Williams; G. Gauthier and D. Berteaux, leaders of the IPY ArcticWOLVES project, for fostering collaboration between the authors; and O. Gilg, C. Juillet, L. P. Nguyen, T. Piersma, D. Reid, and two anonymous reviewers for helpful discussions or comments on early versions of the manuscript.	Alerstam T, 2003, OIKOS, V103, P247, DOI 10.1034/j.1600-0706.2003.12559.x; Baker AJ, 2004, P ROY SOC B-BIOL SCI, V271, P875, DOI 10.1098/rspb.2003.2663; BOLAND JM, 1990, CONDOR, V92, P284, DOI 10.2307/1368226; Butler RW, 2000, AUK, V117, P518, DOI 10.1642/0004-8038(2000)117[0518:SSFSNA]2.0.CO;2; COX DR, 1972, J R STAT SOC B, V34, P187; Ganter B, 2000, ARCTIC, V53, P289; Kis J, 2000, ARDEA, V88, P155; Kvist A, 2001, NATURE, V413, P730, DOI 10.1038/35099556; LAIRD M, 1961, CAN J ZOOLOG, V39, P209, DOI 10.1139/z61-025; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; Martin TE, 2000, P ROY SOC B-BIOL SCI, V267, P2287, DOI 10.1098/rspb.2000.1281; MARTIN TE, 1995, ECOL MONOGR, V65, P101, DOI 10.2307/2937160; Martin TE, 2000, SCIENCE, V287, P1482, DOI 10.1126/science.287.5457.1482; Morrison RIG, 2007, J AVIAN BIOL, V38, P479, DOI 10.1111/j.2007.0908-8857.03934.x; Morrison RIG, 2006, ARDEA, V94, P607; Piersma T, 2003, FUNCT ECOL, V17, P356, DOI 10.1046/j.1365-2435.2003.00741.x; Piersma T, 1997, OIKOS, V80, P623, DOI 10.2307/3546640; Schekkerman H, 2003, OECOLOGIA, V134, P332, DOI 10.1007/s00442-002-1124-0; STEARNS SC, 1976, Q REV BIOL, V51, P3, DOI 10.1086/409052; van de Kam J, 2004, SHOREBIRDS ILLUSTRAT; Wikelski M, 2003, NATURE, V423, P704, DOI 10.1038/423704a; Ydenberg RC, 2004, P ROY SOC B-BIOL SCI, V271, P1263, DOI 10.1098/rspb.2004.2713	22	185	193	4	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					326	327		10.1126/science.1183010	http://dx.doi.org/10.1126/science.1183010			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075251				2022-12-01	WOS:000273629700041
J	Holbrook, TL; Galarneau, MR; Dye, JL; Quinn, K; Dougherty, AL				Holbrook, Troy Lisa; Galarneau, Michael R.; Dye, Judy L.; Quinn, Kimberly; Dougherty, Amber L.			Morphine Use after Combat Injury in Iraq and Post-Traumatic Stress Disorder	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							MENTAL-HEALTH PROBLEMS; MAJOR TRAUMA; RISK-FACTORS; PTSD; AFGHANISTAN; CARE; PHARMACOTHERAPY; INTERVENTION; PREVENTION; SYMPTOMS	BACKGROUND Post-traumatic stress disorder (PTSD) is a common adverse mental health outcome among seriously injured civilians and military personnel who are survivors of trauma. Pharmacotherapy in the aftermath of serious physical injury or exposure to traumatic events may be effective for the secondary prevention of PTSD. METHODS We identified 696 injured U. S. military personnel without serious traumatic brain injury from the Navy-Marine Corps Combat Trauma Registry Expeditionary Medical Encounter Database. Complete data on medications administered were available for all personnel selected. The diagnosis of PTSD was obtained from the Career History Archival Medical and Personnel System and verified in a review of medical records. RESULTS Among the 696 patients studied, 243 received a diagnosis of PTSD and 453 did not. The use of morphine during early resuscitation and trauma care was significantly associated with a lower risk of PTSD after injury. Among the patients in whom PTSD developed, 61% received morphine; among those in whom PTSD did not develop, 76% received morphine (odds ratio, 0.47; P<0.001). This association remained significant after adjustment for injury severity, age, mechanism of injury, status with respect to amputation, and selected injury-related clinical factors. CONCLUSIONS Our findings suggest that the use of morphine during trauma care may reduce the risk of subsequent development of PTSD after serious injury.	[Holbrook, Troy Lisa; Galarneau, Michael R.; Dye, Judy L.; Quinn, Kimberly; Dougherty, Amber L.] Naval Hlth Res Ctr, San Diego, CA 92106 USA; [Holbrook, Troy Lisa] EPI SOAR Consulting, San Diego, CA USA	United States Department of Defense; United States Navy; Naval Medical Research Center (NMRC); Naval Health Research Center (NHRC)	Holbrook, TL (corresponding author), Naval Hlth Res Ctr, 140 Sylvester Rd, San Diego, CA 92106 USA.	troy@epi-soar.com			U.S. Navy Bureau of Medicine and Surgery [60808]	U.S. Navy Bureau of Medicine and Surgery	Supported by U.S. Navy Bureau of Medicine and Surgery under the Wounded, Ill, and Injured-Psychological Health-Traumatic Brain Injury Program (work unit 60808).	[Anonymous], 2000, DIAGNOSTIC STAT MANU; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BAKER WA, 1976, INORG CHIM ACTA, V16, P5, DOI 10.1016/S0020-1693(00)91684-0; BRAUN P, 1990, J CLIN PSYCHIAT, V51, P236; Bryant RA, 2009, BIOL PSYCHIAT, V65, P438, DOI 10.1016/j.biopsych.2008.10.032; Davidson JRT, 2006, J CLIN PSYCHIAT, V67, P34; Davidson JRT, 2004, J CLIN PSYCHIAT, V65, P44; Ducrocq F, 2005, ENCEPHALE, V31, P212; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Galarneau MR, 2006, MIL MED, V171, P691, DOI 10.7205/MILMED.171.8.691; Gelpin E, 1996, J CLIN PSYCHIAT, V57, P390; Gennarelli T., 2005, ABBREVIATED INJURY S; Grieger TA, 2006, AM J PSYCHIAT, V163, P1777, DOI 10.1176/appi.ajp.163.10.1777; Gunderson EKE, 2005, MIL MED, V170, P172; Hoge CW, 2007, AM J PSYCHIAT, V164, P150, DOI 10.1176/appi.ajp.164.1.150; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Holbrook TL, 2001, J TRAUMA, V51, P287, DOI 10.1097/00005373-200108000-00010; Holbrook TL, 2005, J TRAUMA, V58, P764, DOI 10.1097/01.TA.0000159247.48547.7D; Holbrook TL, 2001, J TRAUMA, V50, P270, DOI 10.1097/00005373-200102000-00012; Koren D, 2005, AM J PSYCHIAT, V162, P276, DOI 10.1176/appi.ajp.162.2.276; Marmar CR, 2002, PSYCHIAT QUART, V73, P259, DOI 10.1023/A:1020459916113; MCGAUGH JL, 1988, BRAIN RES, V446, P37, DOI 10.1016/0006-8993(88)91294-2; Michaels AJ, 1998, J TRAUMA, V44, P644, DOI 10.1097/00005373-199804000-00013; Michaels AJ, 1999, J TRAUMA, V47, P867, DOI 10.1097/00005373-199911000-00009; Michaels AJ, 1999, J TRAUMA, V47, P460, DOI 10.1097/00005373-199909000-00005; Morgan CA, 2003, BIOL PSYCHIAT, V53, P834, DOI 10.1016/S0006-3223(03)00116-1; *NAT CTR POSTTR ST, EP FACTS PTSD; Norman SB, 2008, PSYCHOL MED, V38, P533, DOI 10.1017/S0033291707001389; Pitman RK, 2005, CNS SPECTRUMS, V10, P99, DOI 10.1017/S109285290001943X; Saxe G, 2001, J AM ACAD CHILD PSY, V40, P915, DOI 10.1097/00004583-200108000-00013; Schlesselman J.J., 1982, CASE CONTROL STUDIES; Stein MB, 2007, J TRAUMA STRESS, V20, P923, DOI 10.1002/jts.20270; Vaiva G, 2003, BIOL PSYCHIAT, V54, P947, DOI 10.1016/S0006-3223(03)00412-8; Zatzick D, 2006, PSYCHIAT SERV, V57, P1726, DOI 10.1176/appi.ps.57.12.1726; Zatzick Douglas, 2003, Semin Clin Neuropsychiatry, V8, P158, DOI 10.1016/S1084-3612(03)00016-9; Zatzick Douglas, 2003, Semin Clin Neuropsychiatry, V8, P168, DOI 10.1016/S1084-3612(03)00015-7; Zatzick DF, 2007, J TRAUMA STRESS, V20, P401, DOI 10.1002/jts.20256; Zhang W, 2007, EXPERT OPIN PHARMACO, V8, P1861, DOI 10.1517/14656566.8.12.1861	39	286	295	2	35	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					110	117		10.1056/NEJMoa0903326	http://dx.doi.org/10.1056/NEJMoa0903326			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FU	20071700				2022-12-01	WOS:000273558500008
J	Woolf, SH				Woolf, Steven H.			The 2009 Breast Cancer Screening Recommendations of the US Preventive Services Task Force	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Woolf, Steven H.] Virginia Commonwealth Univ, Dept Family Med, Richmond, VA 23298 USA; [Woolf, Steven H.] Virginia Commonwealth Univ, Dept Epidemiol & Community Hlth, Richmond, VA 23298 USA	Virginia Commonwealth University; Virginia Commonwealth University	Woolf, SH (corresponding author), Virginia Commonwealth Univ, West Hosp, Dept Family Med, 1200 Broad St,POB 980251, Richmond, VA 23298 USA.	swoolf@vcu.edu						Agency for Healthcare Research and Quality, US PREV SERV TASK FO; Berg AO, 2002, ANN INTERN MED, V137, P344, DOI 10.7326/0003-4819-137-5_Part_1-200209030-00011; Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; CONDON S, 2009, CBS NEWS        1118; Duffy SW, 2002, CANCER-AM CANCER SOC, V95, P458, DOI 10.1002/cncr.10765; Eggen D, 2009, WASHINGTON POST 1118; Gaus CR, 2003, HLTH AFF MILLWOOD S; Shaneyfelt TM, 2009, JAMA-J AM MED ASSOC, V301, P868, DOI 10.1001/jama.2009.225; Thomas DB, 2002, JNCI-J NATL CANCER I, V94, P1445, DOI 10.1093/jnci/94.19.1445; Woolf SH, 1997, JAMA-J AM MED ASSOC, V278, P2105, DOI 10.1001/jama.278.23.2105	10	55	55	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					162	163		10.1001/jama.2009.1989	http://dx.doi.org/10.1001/jama.2009.1989			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068210				2022-12-01	WOS:000273522600027
J	Kumar, SV; Wigge, PA				Kumar, S. Vinod; Wigge, Philip A.			H2A.Z-Containing Nucleosomes Mediate the Thermosensory Response in Arabidopsis	CELL			English	Article							RNA-POLYMERASE-II; FLOWERING TIME; HIGH-TEMPERATURE; AMBIENT-TEMPERATURE; CIRCADIAN CLOCK; CLIMATE-CHANGE; CHROMATIN; H2A.Z; TRANSCRIPTION; EXPRESSION	Plants are highly sensitive to temperature and can perceive a difference of as little as 1 degrees C. How temperature is sensed and integrated in development is unknown. In a forward genetic screen in Arabidopsis, we have found that nucleosomes containing the alternative histone H2A.Z are essential to perceiving ambient temperature correctly. Genotypes deficient in incorporating H2A.Z into nucleosomes phenocopy warm grown plants, and show a striking constitutive warm temperature transcriptome. We show that nucleosomes containing H2A.Z display distinct responses to temperature in vivo, independently of transcription. Using purified nucleosomes, we are able to show that H2A.Z confers distinct DNA-unwrapping properties on nucleosomes, indicating a direct mechanism for the perception of temperature through DNA-nucleosome fluctuations. Our results show that H2A.Z-containing nucleosomes provide thermosensory information that is used to coordinate the ambient temperature transcriptome. We observe the same effect in budding yeast, indicating that this is an evolutionarily conserved mechanism.	[Kumar, S. Vinod; Wigge, Philip A.] John Innes Ctr, Norwich NR4 7UH, Norfolk, England	UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center	Wigge, PA (corresponding author), John Innes Ctr, Colney Lane, Norwich NR4 7UH, Norfolk, England.	philip.wigge@bbsrc.ac.uk	Wigge, Philip Anthony/ABD-5113-2021; Wigge, Philip/B-3333-2010	Wigge, Philip Anthony/0000-0003-4822-361X; Kumar, S Vinod/0000-0001-9265-4906	JIC; BBSRC; ERC; Biotechnology and Biological Sciences Research Council [BBS/E/J/00000610] Funding Source: researchfish	JIC; BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); ERC(European Research Council (ERC)European Commission); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	This study was made possible by the unflagging support and encouragement of Chris Lamb, and we dedicate it to his memory. We thank Andrew Maule for the gift of the HSP70::LUC reporter line. Rich Meagher kindly provided the antibody to H2A.Z. We thank all members of the lab for discussions and advice. We are indebted to Katja Jaeger for help in initiating the project. We thank Hugh Pelham, Caroline Dean, Liam Dolan, Judith Irwin, Michael Bevan, and Andrew Maule for discussions. This project was funded by start-up funds from the JIC, BBSRC, and ERC.	Ausin I, 2004, NAT GENET, V36, P162, DOI 10.1038/ng1295; Balasubramanian S, 2006, PLOS GENET, V2, P980, DOI 10.1371/journal.pgen.0020106; Blazquez MA, 2003, NAT GENET, V33, P168, DOI 10.1038/ng1085; Boeger H, 2003, MOL CELL, V11, P1587, DOI 10.1016/S1097-2765(03)00231-4; Boeger H, 2008, CELL, V133, P716, DOI 10.1016/j.cell.2008.02.051; Brand M, 2008, NAT PROTOC, V3, P398, DOI 10.1038/nprot.2008.8; Cerdan PD, 2003, NATURE, V423, P881, DOI 10.1038/nature01636; Choi K, 2005, PLANT CELL, V17, P2647, DOI 10.1105/tpc.105.035485; Creyghton MP, 2008, CELL, V135, P649, DOI 10.1016/j.cell.2008.09.056; Almeida Alex-Alan F. de, 2007, Braz. J. Plant Physiol., V19, P83, DOI 10.1590/S1677-04202007000200001; Deal RB, 2005, PLANT CELL, V17, P2633, DOI 10.1105/tpc.105.035196; Fan JY, 2002, NAT STRUCT BIOL, V9, P172, DOI 10.1038/nsb767; Fitter AH, 2002, SCIENCE, V296, P1689, DOI 10.1126/science.1071617; Gasch AP, 2000, MOL BIOL CELL, V11, P4241, DOI 10.1091/mbc.11.12.4241; Gendrel AV, 2002, SCIENCE, V297, P1871, DOI 10.1126/science.1074950; Gould PD, 2006, PLANT CELL, V18, P1177, DOI 10.1105/tpc.105.039990; Gray WM, 1998, P NATL ACAD SCI USA, V95, P7197, DOI 10.1073/pnas.95.12.7197; Halliday KJ, 2003, PLANT J, V33, P875, DOI 10.1046/j.1365-313X.2003.01674.x; Heggie L, 2005, INT J DEV BIOL, V49, P675, DOI 10.1387/ijdb.041926lh; Hodges C, 2009, SCIENCE, V325, P626, DOI 10.1126/science.1172926; Ishibashi T, 2009, BIOCHEMISTRY-US, V48, P5007, DOI 10.1021/bi900196c; Kaplan N, 2009, NATURE, V458, P362, DOI 10.1038/nature07667; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Kim HJ, 2004, NAT GENET, V36, P167, DOI 10.1038/ng1298; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Kobor MS, 2004, PLOS BIOL, V2, P587, DOI 10.1371/journal.pbio.0020131; Koini MA, 2009, CURR BIOL, V19, P408, DOI 10.1016/j.cub.2009.01.046; Krogan NJ, 2003, MOL CELL, V12, P1565, DOI 10.1016/S1097-2765(03)00497-0; Lam FH, 2008, NATURE, V453, P246, DOI 10.1038/nature06867; Larkindale J, 2008, PLANT PHYSIOL, V146, P748, DOI 10.1104/pp.107.112060; Lee JH, 2007, GENE DEV, V21, P397, DOI 10.1101/gad.1518407; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Li B, 2005, P NATL ACAD SCI USA, V102, P18385, DOI 10.1073/pnas.0507975102; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Martin-Trillo M, 2006, DEVELOPMENT, V133, P1241, DOI 10.1242/dev.02301; Mavrich TN, 2008, NATURE, V453, P358, DOI 10.1038/nature06929; Meneghini MD, 2003, CELL, V112, P725, DOI 10.1016/S0092-8674(03)00123-5; Michael TP, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040014; Mittler R, 2006, TRENDS PLANT SCI, V11, P15, DOI 10.1016/j.tplants.2005.11.002; Mizuguchi G, 2004, SCIENCE, V303, P343, DOI 10.1126/science.1090701; Petesch SJ, 2008, CELL, V134, P74, DOI 10.1016/j.cell.2008.05.029; Poethig RS, 2003, SCIENCE, V301, P334, DOI 10.1126/science.1085328; POLACH KJ, 1995, J MOL BIOL, V254, P130, DOI 10.1006/jmbi.1995.0606; Raisner RM, 2005, CELL, V123, P233, DOI 10.1016/j.cell.2005.10.002; Salome PA, 2005, PLANT CELL, V17, P791, DOI 10.1105/tpc.104.029504; Samach A, 2005, CURR OPIN PLANT BIOL, V8, P483, DOI 10.1016/j.pbi.2005.07.011; Segal E, 2009, NAT REV GENET, V10, P443, DOI 10.1038/nrg2591; Sung DY, 2001, PLANT PHYSIOL, V126, P789, DOI 10.1104/pp.126.2.789; Sung S, 2005, ANNU REV PLANT BIOL, V56, P491, DOI 10.1146/annurev.arplant.56.032604.144307; Thambirajah AA, 2006, J BIOL CHEM, V281, P20036, DOI 10.1074/jbc.M601975200; Tsankov AM, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100106; Whittle CM, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000187; Wilczek AM, 2009, SCIENCE, V323, P930, DOI 10.1126/science.1165826; Willis CG, 2008, P NATL ACAD SCI USA, V105, P17029, DOI 10.1073/pnas.0806446105; Zhang CJ, 2005, FLUID PHASE EQUILIBR, V231, P1, DOI 10.1016/j.fluid.2005.03.018; Zilberman D, 2008, NATURE, V456, P125, DOI 10.1038/nature07324	56	618	663	9	223	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					136	147		10.1016/j.cell.2009.11.006	http://dx.doi.org/10.1016/j.cell.2009.11.006			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20079334	Bronze			2022-12-01	WOS:000273391900021
J	Sheu, YJ; Stillman, B				Sheu, Yi-Jun; Stillman, Bruce			The Dbf4-Cdc7 kinase promotes S phase by alleviating an inhibitory activity in Mcm4	NATURE			English	Article							EUKARYOTIC DNA-REPLICATION; CDK-DEPENDENT PHOSPHORYLATION; BUDDING YEAST; CELL-CYCLE; SACCHAROMYCES-CEREVISIAE; COMPLEX; CDC7-DBF4; INITIATION; CHECKPOINT; CHROMATIN	Eukaryotic DNA replication uses kinase regulatory pathways to facilitate coordination with other processes during cell division cycles and response to environmental cues. At least two cell cycle-regulated protein kinase systems, the S-phase-specific cyclin-dependent protein kinases (S-CDKs) and the Dbf4-Cdc7 kinase (DDK, Dbf4-dependent protein kinase) are essential activators for initiation of DNA replication(1-5). Although the essential mechanism of CDK activation of DNA replication in Saccharomyces cerevisiae has been established(6,7), exactly how DDK acts has been unclear. Here we show that the amino terminal serine/threonine-rich domain (NSD) of Mcm4 has both inhibitory and facilitating roles in DNA replication control and that the sole essential function of DDK is to relieve an inhibitory activity residing within the NSD. By combining an mcm4 mutant lacking the inhibitory activity with mutations that bypass the requirement for CDKs for initiation of DNA replication, we show that DNA synthesis can occur in G1 phase when CDKs and DDK are limited. However, DDK is still required for efficient S phase progression. In the absence of DDK, CDK phosphorylation at the distal part of the Mcm4 NSD becomes crucial. Moreover, DDK-null cells fail to activate the intra-S-phase checkpoint in the presence of hydroxyurea-induced DNA damage and are unable to survive this challenge. Our studies establish that the eukaryote-specific NSD of Mcm4 has evolved to integrate several protein kinase regulatory signals for progression through S phase.	[Sheu, Yi-Jun; Stillman, Bruce] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Cold Spring Harbor Laboratory	Stillman, B (corresponding author), Cold Spring Harbor Lab, 1 Bungtown Rd, Cold Spring Harbor, NY 11724 USA.	stillman@cshl.edu		Stillman, Bruce/0000-0002-9453-4091; Sheu, Yi-Jun/0000-0003-1612-5708	US National Institute of General Medical Sciences; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM045436] Funding Source: NIH RePORTER	US National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Acknowledgements We thank A. Stenlund and H.-G. Wendel for critical reading of the manuscript, J. Li, H. Araki and J. Diffley for plasmids and yeast strains. This work was supported by a grant from the US National Institute of General Medical Sciences.	Aparicio OM, 1997, CELL, V91, P59, DOI 10.1016/S0092-8674(01)80009-X; Bell SP, 2002, ANNU REV BIOCHEM, V71, P333, DOI 10.1146/annurev.biochem.71.110601.135425; Cho WH, 2006, P NATL ACAD SCI USA, V103, P11521, DOI 10.1073/pnas.0604990103; Devault A, 2008, MOL BIOL CELL, V19, P2267, DOI 10.1091/mbc.E07-06-0614; Diffley JFX, 2004, CURR BIOL, V14, pR778, DOI 10.1016/j.cub.2004.09.019; Forsburg SL, 2004, MICROBIOL MOL BIOL R, V68, P109, DOI 10.1128/MMBR.68.1.109-131.2004; Francis LI, 2009, GENE DEV, V23, P643, DOI 10.1101/gad.1759609; Gambus A, 2006, NAT CELL BIOL, V8, P358, DOI 10.1038/ncb1382; Hardy CFJ, 1997, P NATL ACAD SCI USA, V94, P3151, DOI 10.1073/pnas.94.7.3151; Jiang W, 1999, EMBO J, V18, P5703, DOI 10.1093/emboj/18.20.5703; LASKEY RA, 1989, SCIENCE, V246, P609, DOI 10.1126/science.2683076; Lei M, 1997, GENE DEV, V11, P3365, DOI 10.1101/gad.11.24.3365; Masai H, 2002, J CELL PHYSIOL, V190, P287, DOI 10.1002/jcp.10070; Masai H, 2006, J BIOL CHEM, V281, P39249, DOI 10.1074/jbc.M608935200; Masumoto H, 2002, NATURE, V415, P651, DOI 10.1038/nature713; Montagnoli A, 2006, J BIOL CHEM, V281, P10281, DOI 10.1074/jbc.M512921200; Moyer SE, 2006, P NATL ACAD SCI USA, V103, P10236, DOI 10.1073/pnas.0602400103; Ogi H, 2008, GENE, V414, P32, DOI 10.1016/j.gene.2008.02.010; Pacek M, 2006, MOL CELL, V21, P581, DOI 10.1016/j.molcel.2006.01.030; RAO PN, 1970, NATURE, V225, P159, DOI 10.1038/225159a0; Sclafani RA, 2000, J CELL SCI, V113, P2111; Sheu YJ, 2006, MOL CELL, V24, P101, DOI 10.1016/j.molcel.2006.07.033; Shimada K, 2002, GENE DEV, V16, P3236, DOI 10.1101/gad.239802; Stillman B, 1996, SCIENCE, V274, P1659, DOI 10.1126/science.274.5293.1659; Tanaka S, 2007, NATURE, V445, P328, DOI 10.1038/nature05465; Weinreich M, 1999, EMBO J, V18, P5334, DOI 10.1093/emboj/18.19.5334; Zegerman P, 2007, NATURE, V445, P281, DOI 10.1038/nature05432; Zou L, 1998, SCIENCE, V280, P593, DOI 10.1126/science.280.5363.593	28	213	217	0	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					113	U127		10.1038/nature08647	http://dx.doi.org/10.1038/nature08647			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054399	Green Accepted			2022-12-01	WOS:000273344900041
J	Wasser, S; Poole, J; Lee, P; Lindsay, K; Dobson, A; Hart, J; Douglas-Hamilton, I; Wittemyer, G; Granli, P; Morgan, B; Gunn, J; Alberts, S; Beyers, R; Chiyo, P; Croze, H; Estes, R; Gobush, K; Joram, P; Kikoti, A; Kingdon, J; King, L; Macdonald, D; Moss, C; Mutayoba, B; Njumbi, S; Omondi, P; Nowak, K				Wasser, Samuel; Poole, Joyce; Lee, Phyllis; Lindsay, Keith; Dobson, Andrew; Hart, John; Douglas-Hamilton, Iain; Wittemyer, George; Granli, Petter; Morgan, Bethan; Gunn, Jody; Alberts, Susan; Beyers, Rene; Chiyo, Patrick; Croze, Harvey; Estes, Richard; Gobush, Kathleen; Joram, Ponjoli; Kikoti, Alfred; Kingdon, Jonathan; King, Lucy; Macdonald, David; Moss, Cynthia; Mutayoba, Benezeth; Njumbi, Steve; Omondi, Patrick; Nowak, Katarzyna			Elephants, Ivory, and Trade	SCIENCE			English	Editorial Material									[Wasser, Samuel; Gobush, Kathleen] Univ Washington, Seattle, WA 98195 USA; [Poole, Joyce; Granli, Petter] ElephantVoices, N-3236 Sandefjord, Norway; [Poole, Joyce; Lee, Phyllis; Lindsay, Keith; Croze, Harvey; Moss, Cynthia] Amboseli Trust Elephants, Nairobi 00509, Kenya; [Lee, Phyllis; Morgan, Bethan] Univ Stirling, Stirling FK9 4LA, Scotland; [Dobson, Andrew; Nowak, Katarzyna] Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08540 USA; [Hart, John] Tshuapa Lomami Lualaba Project, Kinshasa, DEM REP CONGO; [Douglas-Hamilton, Iain; Wittemyer, George; King, Lucy] Save Elephants, Nairobi 00200, Kenya; [Wittemyer, George] Colorado State Univ, Ft Collins, CO 80523 USA; [Morgan, Bethan] Zool Soc San Diego, Cent Africa Program, Yaounde, Cameroon; [Gunn, Jody] Anglia Ruskin Univ, Cambridge CB1 1PT, England; [Alberts, Susan; Chiyo, Patrick] Duke Univ, Durham, NC 27708 USA; [Beyers, Rene] Univ British Columbia, Vancouver, BC V6T 1Z4, Canada; [Joram, Ponjoli] Udzungwa Mt Natl Pk, Sanje, Tanzania; [Kikoti, Alfred] Univ Massachusetts, Amherst, MA 01003 USA; [Kingdon, Jonathan; Macdonald, David; Nowak, Katarzyna] Univ Oxford, WildCRU, Oxford OX13 5QL, England; [Mutayoba, Benezeth] Sokoine Univ Agr, Morogoro, Tanzania; [Njumbi, Steve] Int Fund Anim Welf, Nairobi 00603, Kenya; [Omondi, Patrick] Kenya Wildlife Serv, Nairobi 00100, Kenya	University of Washington; University of Washington Seattle; University of Stirling; Princeton University; Colorado State University; Zoological Society of San Diego; Anglia Ruskin University; Duke University; University of British Columbia; University of Massachusetts System; University of Massachusetts Amherst; University of Oxford; Sokoine University of Agriculture	Wasser, S (corresponding author), Univ Washington, Seattle, WA 98195 USA.	wassers@u.washington.edu; knowak@princeton.edu	Nowak, Katarzyna/AAT-5468-2021; Wasser, Samuel K/I-5542-2015	Nowak, Katarzyna/0000-0002-4992-7910; King, Dr Lucy/0000-0002-2877-5225; Lee, Phyllis/0000-0002-4296-3513				[Anonymous], 1991, AFRICAN WILDLIFE RES; BEYERS R, 2008, THESIS U BRIT COLUMB; Blake S, 2009, BIOTROPICA, V41, P459, DOI 10.1111/j.1744-7429.2009.00512.x; Blanc J.J., 2007, AFRICAN ELEPHANT STA, DOI 10.2305/iucn.ch.2007.ssc-op.33.en; Bulte E, 2004, SCIENCE, V306, P420, DOI 10.1126/science.1105392; *CITES, 2007, 533 COP14 CITES; *CITES, 2009, 442 COP15 CITES; *CITES, 2007, 2007022 COP14 CITES; *CITES, 2009, 363 SC58 CITES; *CITES, 2009, 4 COP15 CITES; *CITES, 2004, 293 COP13 CITES; *CITES, 2009, 5 COP15 CITES; Coppolillo P, 2004, BIOL CONSERV, V115, P419, DOI 10.1016/S0006-3207(03)00159-9; Frank B, 2006, ECOL ECON, V60, P320, DOI 10.1016/j.ecolecon.2005.12.007; KAHINDI O, AFR J ECOL; Lewis SL, 2009, NATURE, V457, P1003, DOI 10.1038/nature07771; MILLIKEN T, 2009, 441 COP15 TRAFFIC; NIELSEN J, 2007, NPR             0102; Smith KF, 2009, SCIENCE, V324, P594, DOI 10.1126/science.1174460; Stokstad E, 2010, SCIENCE, V327, P632, DOI 10.1126/science.327.5966.632; Van Aarde RJ, 2009, ENVIRON CONSERV, V36, P8, DOI 10.1017/S0376892909005438; Wasser SK, 2008, CONSERV BIOL, V22, P1065, DOI 10.1111/j.1523-1739.2008.01012.x; Wasser SK, 2009, SCI AM, V301, P68, DOI 10.1038/scientificamerican0709-68; 2009, GMA NEWS TV     0520; 2009, THISDAY         1029	25	38	39	2	93	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1331	1332		10.1126/science.1187811	http://dx.doi.org/10.1126/science.1187811			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	567CA	20223971				2022-12-01	WOS:000275418700024
J	Delonnay, PB				Delonnay, Paul B.			Returning Home to Haiti - Providing Medical Care after the Earthquake	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Boston Med Ctr, Boston, MA USA	Boston Medical Center									0	4	4	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMpv1001789	http://dx.doi.org/10.1056/NEJMpv1001789			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20173033				2022-12-01	WOS:000275365900036
J	Knowles, SM				Knowles, Sherry M.			Fixing the Legal Framework for Pharmaceutical Research	SCIENCE			English	Editorial Material							INNOVATION		GlaxoSmithKline, King Of Prussia, PA 19406 USA	GlaxoSmithKline	Knowles, SM (corresponding author), GlaxoSmithKline, King Of Prussia, PA 19406 USA.	sherry.m.knowles@gsk.com						Bunch JN, 2005, TEX LAW REV, V83, P1747; Cahoy DR, 2003, AM BUS LAW J, V41, P1, DOI 10.1111/j.1744-1714.2003.tb00001.x; DiMasi JA, 2003, J HEALTH ECON, V22, P151, DOI 10.1016/S0167-6296(02)00126-1; DiMasi JA, 2002, PHARMACOECONOMICS, V20, P1, DOI 10.2165/00019053-200220003-00001; DIMASI JA, 1991, J HEALTH ECON, V10, P107, DOI 10.1016/0167-6296(91)90001-4; DiMasi JA, 2007, MANAG DECIS ECON, V28, P469, DOI 10.1002/mde.1360; Higgins MJ, 2009, SCIENCE, V326, P370, DOI 10.1126/science.1176116; 1995, Patent No. 6410516	8	7	7	2	4	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1083	1084		10.1126/science.1184188	http://dx.doi.org/10.1126/science.1184188			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	560KJ	20150445				2022-12-01	WOS:000274901100018
J	Madan, V; Lear, JT; Szeimies, RM				Madan, Vishal; Lear, John T.; Szeimies, Rolf-Markus			Non-melanoma skin cancer	LANCET			English	Article							BASAL-CELL CARCINOMA; RENAL-TRANSPLANT RECIPIENTS; RANDOMIZED CONTROLLED-TRIAL; IMIQUIMOD 5-PERCENT CREAM; 5-YEAR FOLLOW-UP; AMINOLEVULINATE PHOTODYNAMIC THERAPY; HUMAN-PAPILLOMAVIRUS INFECTION; SQUAMOUS-CELL; SURGICAL EXCISION; SUN EXPOSURE	The rising incidence and morbidity of non-melanoma skin cancers has generated great interest in untravelling of their pathogenesis and in the search for new non-invasive treatments. Whereas the role of cumulative sun exposure in pathogenesis of squamous-cell carcinoma seems clear, the relation between sun-exposure patterns and subtypes of basal-cell carcinoma remains undetermined. Several complex genotypic, phenotypic, and environmental factors contribute to pathogenesis of non-melanoma skin cancers. Unlike basal-cell carcinoma, squamous-cell carcinomas can arise from precursor lesions. Diagnosis of non-melanoma skin cancer is made clinically and confirmed by histological testing. Prognosis depends on lesion and host characteristics, which also dictate choice of treatment. Prevention strategies aim at reduction of sun exposure, but are of unproven benefit, especially for basal-cell carcinoma. Surgical excision with predetermined margins is the mainstay of treatment for squamous-cell carcinoma and for most basal-cell carcinomas. Of the new non-invasive treatments, only photodynamic therapy and topical imiquimod have become established treatments for specific subtypes of basal-cell carcinoma, and the search for more effective and tissue-salvaging therapies continues.	[Madan, Vishal; Lear, John T.] Salford Royal Hosp NHS Fdn Trust, Dermatol Ctr, Salford M6 8HD, Lancs, England; [Szeimies, Rolf-Markus] Univ Klinikum Regensburg, Dermatol Klin & Poliklin, Regensburg, Germany	Salford Royal NHS Foundation Trust; Salford Royal Hospital; University of Regensburg	Lear, JT (corresponding author), Salford Royal Hosp NHS Fdn Trust, Dermatol Ctr, Salford M6 8HD, Lancs, England.	john.lear@srft.nhs.uk	lear, john/I-5465-2015	lear, john/0000-0002-2969-9922	3M Healthcare; Galderma; LEO; Novartis; Shire; Stiefel; Almirall; Almirall-Hermal; Biocam; Energist; Intendis; Meda; Photocure; Photonamic; Waldmann Medizintechnik	3M Healthcare(3M); Galderma; LEO(LEO Pharma); Novartis(Novartis); Shire; Stiefel; Almirall(Almirall); Almirall-Hermal(Almirall); Biocam; Energist; Intendis; Meda; Photocure; Photonamic; Waldmann Medizintechnik	VM. declares that he has no conflicts of interest. JTL has received honoraria for presentations and research funding from 3M Healthcare, Galderma, LEO, Novartis, Shire, Stiefel, and Almirall. R-MS has received honoraria for presentations and research funding from Almirall-Hermal, Biocam, Energist, Galderma, Intendis, Meda, Photocure, Photonamic, Waldmann Medizintechnik, and 3M Healthcare, and is a member of the advisory boards of Galderma, Peplin, and Intendis.	American Cancer Society, DET GUID SKIN CANC B; Asgari MM, 2008, J INVEST DERMATOL, V128, P1409, DOI 10.1038/sj.jid.5701227; Avril MF, 1997, BRIT J CANCER, V76, P100, DOI 10.1038/bjc.1997.343; Basset-Seguin N, 2008, EUR J DERMATOL, V18, P547, DOI 10.1684/ejd.2008.0472; Bastiaens MT, 2001, AM J HUM GENET, V68, P884, DOI 10.1086/319500; Bastiaens MT, 1998, J INVEST DERMATOL, V110, P880, DOI 10.1046/j.1523-1747.1998.00217.x; Bath-Hextall F, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005414.pub2; Bath-Hextall FJ, 2007, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003412.pub2; Bavinck JNB, 2008, J INVEST DERMATOL, V128, P1355, DOI 10.1038/jid.2008.123; Beham A, 1998, Adv Anat Pathol, V5, P269, DOI 10.1097/00125480-199809000-00001; Benjamin CL, 2007, TOXICOL APPL PHARM, V224, P241, DOI 10.1016/j.taap.2006.12.006; Boldrini L, 2003, INT J MOL MED, V11, P607; Brantsch KD, 2008, LANCET ONCOL, V9, P713, DOI 10.1016/S1470-2045(08)70178-5; Brash DE, 2006, BRIT J DERMATOL, V154, P8, DOI 10.1111/j.1365-2133.2006.07230.x; Brellier F, 2008, BRIT J DERMATOL, V159, P445, DOI 10.1111/j.1365-2133.2008.08650.x; Brewster DH, 2007, BRIT J DERMATOL, V156, P1295, DOI 10.1111/j.1365-2133.2007.07892.x; Caccialanza M, 2001, EUR J DERMATOL, V11, P25; Campbell SM, 2008, BRIT J DERMATOL, V159, P387, DOI 10.1111/j.1365-2133.2008.08668.x; Campolmi P, 2008, DERMATOL THER, V21, P402, DOI 10.1111/j.1529-8019.2008.00221.x; Campolmi P, 2002, DERMATOL SURG, V28, P909, DOI 10.1046/j.1524-4725.2002.02076.x; *CANC RES UK, SUNSMART; Cancer Research UK, CANCERSTATS KEY FACT; Chen J, 2008, JNCI-J NATL CANCER I, V100, P1215, DOI 10.1093/jnci/djn260; Cherpelis BS, 2002, DERMATOL SURG, V28, P268, DOI 10.1046/j.1524-4725.2002.01169.x; CHILDERS BJ, 1994, PLAST RECONSTR SURG, V93, P1169, DOI 10.1097/00006534-199405000-00009; Chren MM, 2007, J INVEST DERMATOL, V127, P1351, DOI 10.1038/sj.jid.5700740; Cox NH, 2007, BRIT J DERMATOL, V156, P11, DOI 10.1111/j.1365-2133.2006.07610.x; Danaee H, 2006, J INVEST DERMATOL, V126, P1152, DOI 10.1038/sj.jid.5700209; de Haas ERM, 2006, J INVEST DERMATOL, V126, P2679, DOI 10.1038/sj.jid.5700460; de Vries E, 2004, J INVEST DERMATOL, V123, P634, DOI 10.1111/j.0022-202X.2004.23306.x; Demirkan  N C, 2000, Pathol Oncol Res, V6, P272; Diepgen TL, 2002, BRIT J DERMATOL, V146, P1, DOI 10.1046/j.1365-2133.146.s61.2.x; Diffey BL, 2005, BRIT J DERMATOL, V153, P679, DOI 10.1111/j.1365-2133.2005.06799.x; Dinehart SM, 2005, DERMATOL SURG, V31, P1379; DRAKE LA, 1993, J AM ACAD DERMATOL, V28, P628, DOI 10.1016/S0190-9622(08)81782-3; Dummer R, 2003, BRIT J DERMATOL, V149, P57, DOI 10.1046/j.0366-077X.2003.05630.x; Eigentler TK, 2007, J AM ACAD DERMATOL, V57, P616, DOI 10.1016/j.jaad.2007.05.022; English DR, 1997, CANCER CAUSE CONTROL, V8, P271, DOI 10.1023/A:1018440801577; Galletly NP, 2008, BRIT J DERMATOL, V159, P152, DOI 10.1111/j.1365-2133.2008.08577.x; Gawkrodger DJ, 2004, OCCUP MED-OXFORD, V54, P458, DOI 10.1093/occmed/kqh098; Geisse J, 2004, J AM ACAD DERMATOL, V50, P722, DOI 10.1016/j.jaad.2003.11.066; GLASS AG, 1989, JAMA-J AM MED ASSOC, V262, P2097, DOI 10.1001/jama.262.15.2097; Glogau RG, 2000, J AM ACAD DERMATOL, V42, pS23, DOI 10.1067/mjd.2000.103339; Gollnick H, 2008, EUR J DERMATOL, V18, P677, DOI 10.1684/ejd.2008.0519; Goodwin RG, 2004, CLIN EXP DERMATOL, V29, P328, DOI 10.1111/j.1365-2230.2004.01523.x; Green A, 1999, LANCET, V354, P723, DOI 10.1016/S0140-6736(98)12168-2; Green A, 1992, Epithelial Cell Biol, V1, P47; Griffiths RW, 2005, BRIT J PLAST SURG, V58, P795, DOI 10.1016/j.bjps.2005.02.010; Gross K, 2007, DERMATOL SURG, V33, P433, DOI 10.1111/j.1524-4725.2007.33090.x; Gudbjartsson DF, 2008, NAT GENET, V40, P886, DOI 10.1038/ng.161; Hahn H, 1996, CELL, V85, P841, DOI 10.1016/S0092-8674(00)81268-4; HALL VL, 1986, CLIN RADIOL, V37, P33, DOI 10.1016/S0009-9260(86)80161-1; Han A, 2007, CANCER-AM CANCER SOC, V109, P1053, DOI 10.1002/cncr.22509; Harwood CA, 2000, J MED VIROL, V61, P289, DOI 10.1002/1096-9071(200007)61:3&lt;289::AID-JMV2&gt;3.0.CO;2-Z; Ho WL, 2008, BRIT J DERMATOL, V158, P217, DOI 10.1111/j.1365-2133.2007.08363.x; Hobbs J, 1999, J AM ACAD DERMATOL, V41, P496, DOI 10.1016/S0190-9622(99)70129-5; Hoey SEH, 2007, BRIT J DERMATOL, V156, P1301, DOI 10.1111/j.1365-2133.2007.07936.x; Holme SA, 2000, BRIT J DERMATOL, V143, P1224, DOI 10.1046/j.1365-2133.2000.03892.x; Huber A, 2004, DERMATOL SURG, V30, P429, DOI 10.1111/j.1524-4725.2004.30116.x; Humphreys TR, 1998, ARCH DERMATOL, V134, P1247, DOI 10.1001/archderm.134.10.1247; Karagas MR, 2007, J INVEST DERMATOL, V127, P2901, DOI 10.1038/sj.jid.5700934; Karagas MR, 2006, J NATL CANCER I, V98, P389, DOI 10.1093/jnci/djj092; Karagas MR, 1995, SKIN CANC MECH HUMAN, P79; Katalinic A, 2003, BRIT J DERMATOL, V149, P1200, DOI 10.1111/j.1365-2133.2003.05554.x; Kennedy C, 2005, BRIT J DERMATOL, V152, P194, DOI 10.1111/j.1365-2133.2005.06411.x; Kleinerman RA, 2009, PEDIATR RADIOL, V39, pS27, DOI 10.1007/s00247-008-1015-6; KRICKER A, 1995, INT J CANCER, V60, P482, DOI 10.1002/ijc.2910600410; KRICKER A, 1995, INT J CANCER, V60, P489, DOI 10.1002/ijc.2910600411; KUERBITZ SJ, 1992, P NATL ACAD SCI USA, V89, P7491, DOI 10.1073/pnas.89.16.7491; Kuijpers Danielle I, 2006, J Drugs Dermatol, V5, P642; LANDTHALER M, 1995, ARCH DERMATOL, V131, P182, DOI 10.1001/archderm.131.2.182; Lear JT, 2000, BRIT J DERMATOL, V142, P8, DOI 10.1046/j.1365-2133.2000.03339.x; Lear JT, 2005, CLIN EXP DERMATOL, V30, P49, DOI 10.1111/j.1365-2230.2004.01669.x; Lear JT, 1996, CARCINOGENESIS, V17, P1891, DOI 10.1093/carcin/17.9.1891; Leibovitch I, 2005, J AM ACAD DERMATOL, V53, P452, DOI 10.1016/j.jaad.2005.04.087; Lichter MD, 2000, ARCH DERMATOL, V136, P1007, DOI 10.1001/archderm.136.8.1007; LINDELOF B, 1991, LANCET, V338, P91, DOI 10.1016/0140-6736(91)90083-2; Lindelof B, 2000, BRIT J DERMATOL, V143, P513, DOI 10.1046/j.1365-2133.2000.03703.x; Liu CY, 2002, ANN PHARMACOTHER, V36, P1897; Madan V, 2005, PHOTODIAGN PHOTODYN, V2, P273, DOI 10.1016/S1572-1000(05)00101-8; Mallon E, 1996, DERMATOL SURG, V22, P854, DOI 10.1111/j.1524-4725.1996.tb00588.x; Man I, 2005, BRIT J DERMATOL, V152, P755, DOI 10.1111/j.1365-2133.2005.06537.x; Marehbian J, 2007, CANCER CAUSE CONTROL, V18, P895, DOI 10.1007/s10552-007-9034-4; Marigo V, 1996, NATURE, V384, P176, DOI 10.1038/384176a0; MARKS R, 1998, LANCET, V331, P795; McCord MW, 2000, INT J RADIAT ONCOL, V47, P89, DOI 10.1016/S0360-3016(99)00533-7; McCormack CJ, 1997, ARCH DERMATOL, V133, P593, DOI 10.1001/archderm.133.5.593; Moloney FJ, 2006, BRIT J DERMATOL, V154, P790, DOI 10.1111/j.1365-2133.2006.07156.x; Moloney FJ, 2006, BRIT J DERMATOL, V154, P498, DOI 10.1111/j.1365-2133.2005.07021.x; Morton CA, 2008, BRIT J DERMATOL, V159, P1245, DOI 10.1111/j.1365-2133.2008.08882.x; Mosterd K, 2008, BRIT J DERMATOL, V159, P864, DOI 10.1111/j.1365-2133.2008.08787.x; Mosterd K, 2008, LANCET ONCOL, V9, P1149, DOI 10.1016/S1470-2045(08)70260-2; Motley R, 2003, BRIT J PLAST SURG, V56, P85, DOI 10.1016/S0007-1226(03)00028-6; MOTLEY RJ, 1995, BRIT J DERMATOL, V132, P437, DOI 10.1111/j.1365-2133.1995.tb08679.x; National Collaborating Centre for Cancer, 2006, IMPR OUTC PEOPL SKIN; Neale RE, 2007, J AM ACAD DERMATOL, V56, P380, DOI 10.1016/j.jaad.2006.08.039; Newman JC, 2007, DERMATOL SURG, V33, P957, DOI 10.1111/j.1524-4725.2007.33198.x; Odenbro A, 2005, BRIT J CANCER, V92, P1326, DOI 10.1038/sj.bjc.6602475; Otley CC, 2006, AUSTRALAS J DERMATOL, V47, P231, DOI 10.1111/j.1440-0960.2006.00287.x; Otto AI, 1999, CANCER RES, V59, P1212; Pacifico A, 2008, BRIT J DERMATOL, V158, P291, DOI 10.1111/j.1365-2133.2007.08360.x; Petit JY, 2000, PLAST RECONSTR SURG, V105, P2544, DOI 10.1097/00006534-200006000-00039; Punjabi S, 2008, INT J DERMATOL, V47, P78, DOI 10.1111/j.1365-4632.2007.03363.x; Ramachandran S, 2001, PHARMACOGENETICS, V11, P247, DOI 10.1097/00008571-200104000-00008; Ramachandran S, 2001, CANCER, V92, P354, DOI 10.1002/1097-0142(20010715)92:2<354::AID-CNCR1330>3.0.CO;2-F; Reifenberger J, 2005, BRIT J DERMATOL, V152, P43, DOI 10.1111/J.1365-2133.2005.06353.X; REYMANN F, 1979, DERMATOLOGICA, V158, P368, DOI 10.1159/000250782; Rhodes LE, 2007, ARCH DERMATOL, V143, P1131, DOI 10.1001/archderm.143.9.1131; Ridley AJ, 2009, INT J RADIAT BIOL, V85, P177, DOI 10.1080/09553000902740150; Rippey JJ, 1998, HISTOPATHOLOGY, V32, P393; Rodriguez-Vigil T, 2007, J AM ACAD DERMATOL, V56, P91, DOI 10.1016/j.jaad.2006.07.007; Rowert-Huber J, 2007, BRIT J DERMATOL, V156, P8, DOI 10.1111/j.1365-2133.2007.07860.x; Rosso S, 1996, BRIT J CANCER, V73, P1447, DOI 10.1038/bjc.1996.275; ROWE DE, 1989, J DERMATOL SURG ONC, V15, P315, DOI 10.1111/j.1524-4725.1989.tb03166.x; ROWE DE, 1992, J AM ACAD DERMATOL, V26, P976, DOI 10.1016/0190-9622(92)70144-5; ROWE DE, 1989, J DERMATOL SURG ONC, V15, P424, DOI 10.1111/j.1524-4725.1989.tb03249.x; Runger TM, 2007, J INVEST DERMATOL, V127, P2103, DOI 10.1038/sj.jid.5700988; Salasche SJ, 2000, J AM ACAD DERMATOL, V42, pS4, DOI 10.1067/mjd.2000.103342; Saleh S, 2007, HUM PATHOL, V38, P1023, DOI 10.1016/j.humpath.2006.12.006; SANDS AT, 1995, NATURE, V377, P162, DOI 10.1038/377162a0; Scotto J., 1983, NIH PUB; Sedda AF, 2008, CLIN EXP DERMATOL, V33, P745, DOI 10.1111/j.1365-2230.2008.02852.x; SEXTON M, 1990, J AM ACAD DERMATOL, V23, P1118, DOI 10.1016/0190-9622(90)70344-H; Shamanin V, 1996, JNCI-J NATL CANCER I, V88, P802, DOI 10.1093/jnci/88.12.802; Shay JW, 1996, TRENDS GENET, V12, P129, DOI 10.1016/0168-9525(96)30018-8; Slater, 2002, MINIMUM DATASET HIST, P1; SLOAN KB, 1990, ARCH DERMATOL RES, V282, P484, DOI 10.1007/BF00402629; Soler AM, 2001, BRIT J DERMATOL, V145, P467, DOI 10.1046/j.1365-2133.2001.04407.x; Soufir N, 2006, BRIT J CANCER, V95, P548, DOI 10.1038/sj.bjc.6603303; Soufir N, 2002, J INVEST DERMATOL, V119, P1355, DOI 10.1046/j.1523-1747.2002.19603.x; Staples MP, 2006, MED J AUSTRALIA, V184, P6, DOI 10.5694/j.1326-5377.2006.tb00086.x; Stern RS, 1998, JNCI-J NATL CANCER I, V90, P1278, DOI 10.1093/jnci/90.17.1278; Sterry W, 2006, EUR J DERMATOL, V16, P467, DOI 10.1684/ejd.2006.0035; Szeimies RM, 2006, BRIT J DERMATOL, V154, P16, DOI 10.1111/j.1365-2133.2006.07232.x; Telfer NR, 2008, BRIT J DERMATOL, V159, P35, DOI 10.1111/j.1365-2133.2008.08666.x; Thissen MRTM, 2000, DERMATOL SURG, V26, P759, DOI 10.1046/j.1524-4725.2000.ds00064.x; Tucker SB, 2006, J AM ACAD DERMATOL, V54, P1033, DOI 10.1016/j.jaad.2006.02.035; Ulrich M, 2007, BRIT J DERMATOL, V157, P56, DOI 10.1111/j.1365-2133.2007.08275.x; Veness MJ, 2008, J MED IMAG RADIAT ON, V52, P278, DOI 10.1111/j.1440-1673.2008.01956.x; Veness MJ, 2008, LANCET ONCOL, V9, P702, DOI 10.1016/S1470-2045(08)70185-2; Veness MJ, 2006, AUSTRALAS J DERMATOL, V47, P28, DOI 10.1111/j.1440-0960.2006.00218.x; Veness MJ, 2005, LARYNGOSCOPE, V115, P870, DOI 10.1097/01.MLG.0000158349.64337.ED; Vidal D, 2007, ARCH DERMATOL, V143, P266, DOI 10.1001/archderm.143.2.266; Walker P, 2006, AUSTRALAS J DERMATOL, V47, P1, DOI 10.1111/j.1440-0960.2006.00216.x; WEINSTOCK MA, 1995, ARCH DERMATOL, V131, P701, DOI 10.1001/archderm.131.6.701; Wentzell JM, 2008, DERMATOL SURG, V34, P851, DOI 10.1111/j.1524-4725.2008.34161.x; Wilkins K, 2006, J AM ACAD DERMATOL, V54, P189, DOI 10.1016/j.jaad.2004.11.060; WILSON BD, 1992, ARCH DERMATOL, V128, P1597, DOI 10.1001/archderm.128.12.1597; WOLF DJ, 1987, ARCH DERMATOL, V123, P340, DOI 10.1001/archderm.123.3.340; Wong CSM, 2003, BMJ-BRIT MED J, V327, P794, DOI 10.1136/bmj.327.7418.794; World Health Organization, ULTR RAD INTERSUN PR; Yu M, 2008, J INVEST DERMATOL, V128, P1797, DOI 10.1038/sj.jid.5701243; Zeitouni NC, 2003, MOL IMMUNOL, V39, P1133, DOI 10.1016/S0161-5890(03)00083-X; 2007, J CUTAN MED SURG, V11, P45	154	550	566	2	85	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					673	685		10.1016/S0140-6736(09)61196-X	http://dx.doi.org/10.1016/S0140-6736(09)61196-X			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20171403				2022-12-01	WOS:000275210900036
J	Barrett, CB				Barrett, Christopher B.			Measuring Food Insecurity	SCIENCE			English	Editorial Material							NUTRITIONAL-STATUS; POVERTY	Food security is a growing concern worldwide. More than 1 billion people are estimated to lack sufficient dietary energy availability, and at least twice that number suffer micronutrient deficiencies. Because indicators inform action, much current research focuses on improving food insecurity measurement. Yet estimated prevalence rates and patterns remain tenuous because measuring food security, an elusive concept, remains difficult.	Cornell Univ, Dept Appl Econ & Management, Ithaca, NY 14853 USA	Cornell University	Barrett, CB (corresponding author), Cornell Univ, Dept Appl Econ & Management, Warren Hall, Ithaca, NY 14853 USA.	cbb2@cornell.edu	Barrett, Christopher B./A-9750-2009	Barrett, Christopher B./0000-0001-9139-2721				Arimond M, 2004, J NUTR, V134, P2579, DOI 10.1093/jn/134.10.2579; Barrett C.B, 2002, HDB AGR EC B, V2; Barrett CB, 2005, FOOD AID 50 YEARS; BARRETT CB, 2010, INT STUDIES COMPENDI; Carter MR, 2006, J DEV STUD, V42, P178, DOI 10.1080/00220380500405261; Chantarat S, 2007, AM J AGR ECON, V89, P1262, DOI 10.1111/j.1467-8276.2007.01094.x; Chen S, 2008, DEV WORLD IS POORER; Cook J., 2000, MEASURING FOOD SECUR; Darnton-Hill I, 2005, AM J CLIN NUTR, V81, p1198S; Dasgupta P, 1997, J ECONOMETRICS, V77, P5, DOI 10.1016/S0304-4076(96)01804-0; FAO, 2009, MOR PEOPL EV AR VICT; FAO, 2005, VOLUNTARY GUIDELINES; FAO, 2006, STAT FOOD AGR 2006 F; FAO, 2009, STAT FOOD INS WORLD; Fogel R. W., 2004, ESCAPE HUNGER PREMAT; Food and Agriculture Organization (FAO), FOOD SEC STAT; Frongillo Edward A, 2006, J Nutr, V136, p1409S; Horton S, COPENHAGEN CONSENSUS; *INT FED RED CROSS, WORLD DIS REP; Maxwell DG, 1996, FOOD POLICY, V21, P291, DOI 10.1016/0306-9192(96)00005-X; Mude AG, 2009, FOOD POLICY, V34, P329, DOI 10.1016/j.foodpol.2009.05.003; National Research Council Committee on National Statistics Division of Behavioral and Social Sciences and Education, 2005, MEAS FOOD INS HUNG P; *SCI COUNC CONS GR, 2009, STRIP REV SOC SCI CG; SEN AMARTYA, 1981, POVERTY FAMINES ESSA, P1; Shapouri S., 2009, FOOD SECURITY ASSESS; Smith L. C., 2006, FOOD INSECURITY SUBS, V146; *UNU FAO WHO, 2004, HUM EN REQ; Webb Patrick, 2006, J Nutr, V136, p1404S; WHO, VIT MIN NUTR INF SYS; World Bank, 2006, REP NUTR CENTR DEV; [No title captured]	31	557	576	15	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					825	828		10.1126/science.1182768	http://dx.doi.org/10.1126/science.1182768			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554AQ	20150491				2022-12-01	WOS:000274408300048
J	Fedoroff, NV; Battisti, DS; Beachy, RN; Cooper, PJM; Fischhoff, DA; Hodges, CN; Knauf, VC; Lobell, D; Mazur, BJ; Molden, D; Reynolds, MP; Ronald, PC; Rosegrant, MW; Sanchez, PA; Vonshak, A; Zhu, JK				Fedoroff, N. V.; Battisti, D. S.; Beachy, R. N.; Cooper, P. J. M.; Fischhoff, D. A.; Hodges, C. N.; Knauf, V. C.; Lobell, D.; Mazur, B. J.; Molden, D.; Reynolds, M. P.; Ronald, P. C.; Rosegrant, M. W.; Sanchez, P. A.; Vonshak, A.; Zhu, J. -K.			Radically Rethinking Agriculture for the 21st Century	SCIENCE			English	Editorial Material								Population growth, arable land and fresh water limits, and climate change have profound implications for the ability of agriculture to meet this century's demands for food, feed, fiber, and fuel while reducing the environmental impact of their production. Success depends on the acceptance and use of contemporary molecular techniques, as well as the increasing development of farming systems that use saline water and integrate nutrient flows.	[Fedoroff, N. V.] US Dept State, Off Sci & Technol, USAID, Washington, DC 20520 USA; [Battisti, D. S.] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Beachy, R. N.] Natl Inst Food & Agr, USDA, Washington, DC 20250 USA; [Cooper, P. J. M.] Int Crops Res Inst Semi Arid Trop, Nairobi, Kenya; [Fischhoff, D. A.] Monsanto Co, St Louis, MO 63167 USA; [Hodges, C. N.] Seawater Fdn, Tucson, AZ 85711 USA; [Knauf, V. C.] Arcadia Biosci, Davis, CA 95618 USA; [Lobell, D.] Stanford Univ, Dept Environm Earth Syst Sci, Stanford, CA 94305 USA; [Lobell, D.] Stanford Univ, Program Food Secur & Environm, Stanford, CA 94305 USA; [Mazur, B. J.] DuPont Expt Stn, Wilmington, DE 19805 USA; [Molden, D.] Int Water Management Inst, Battaramulla, Colombo, Sri Lanka; [Reynolds, M. P.] Int Maize & Wheat Improvement Ctr, Texcoco 56130, Edo De Mexico, Mexico; [Ronald, P. C.] Univ Calif Davis, Dept Plant Pathol, Davis, CA 95616 USA; [Rosegrant, M. W.] Int Food Policy Res Inst, Washington, DC 20006 USA; [Sanchez, P. A.] Columbia Univ, Earth Inst, Palisades, NY 10964 USA; [Vonshak, A.] Ben Gurion Univ Negev, Jacob Blaustein Inst Desert Res, IL-84990 Sede Boqer, Israel; [Zhu, J. -K.] Univ Calif Riverside, Dept Bot & Plant Sci, Riverside, CA 92521 USA; [Zhu, J. -K.] King Abdullah Univ Sci & Technol, Ctr Plant Stress Genom & Technol, Thuwal, Saudi Arabia	United States Agency for International Development (USAID); University of Washington; University of Washington Seattle; United States Department of Agriculture (USDA); CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); Monsanto; Stanford University; Stanford University; DuPont; CGIAR; International Water Management Institute (IWMI); CGIAR; International Maize & Wheat Improvement Center (CIMMYT); University of California System; University of California Davis; CGIAR; International Food Policy Research Institute (IFPRI); Columbia University; Ben Gurion University; University of California System; University of California Riverside; King Abdullah University of Science & Technology	Fedoroff, NV (corresponding author), US Dept State, Off Sci & Technol, USAID, Washington, DC 20520 USA.	fedoroff@state.gov	Zhu, Jian-Kang/F-7658-2011; Reynolds, Matthew M/S-3578-2016; Battisti, David S/A-3340-2013; Ronald, Pamela/AAK-7664-2020	Zhu, Jian-Kang/0000-0001-5134-731X; Reynolds, Matthew M/0000-0002-4291-4316; Battisti, David S/0000-0003-4871-1293; Lobell, David/0000-0002-5969-3476; Molden, David/0000-0003-3201-9518; Vonshak, Avigad/0000-0001-8737-0749	NIGMS NIH HHS [R01 GM059138, R01 GM070795-09, R01 GM070795, R01 GM059138-15] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070795, R01GM059138] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		[Anonymous], 2007, CONSERVATION GLOBAL; Battisti DS, 2009, SCIENCE, V323, P240, DOI 10.1126/science.1164363; Brookes G., 2008, AgBioForum, V11, P21; Chopin T., 2008, ENCY ECOLOGY ECOLOGI, V3rd ed., P2463, DOI [10.1016/b978-008045405-4.00065-3, DOI 10.1016/B978-008045405-4.00065-3]; Comprehensive Assessment of Water Management in Agriculture, 2007, WAT FOOD WAT LIF COM; Food and Agriculture Organization of the United Nations, 2009, STAT WORLD FISH AQ 2; Gregory PJ, 2009, J EXP BOT, V60, P2827, DOI 10.1093/jxb/erp080; Intergovernmental Panel on Climate Change, 2007, CLIM CHANG 2007 IMP; James C., 2008, GLOBAL STATUS COMMER; Land Commodities Asset Management AG, 2009, LAND COMM GLOB AGR F; Lantican MA, 2003, AGR ECON, V29, P353, DOI 10.1016/S0169-5150(03)00062-8; Morison JIL, 2008, PHILOS T R SOC B, V363, P639, DOI 10.1098/rstb.2007.2175; Qaderi MM, 2009, ENVIRON SCI ENG, P1, DOI 10.1007/978-3-540-88246-6_1; Rothbard S., 2002, TILAPIA FARMING 21 C, P60; Royal Society, 2009, REAP BEN SCI SUST IN; Schlenker W, 2009, P NATL ACAD SCI USA, V106, P15594, DOI 10.1073/pnas.0906865106; *UN FAO, 2001, INT AGR AQ; World Bank, 2008, AGRIC RURAL DEV, P1, DOI 10.1596/978-0-8213-7163- 3	18	440	470	9	264	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					833	834		10.1126/science.1186834	http://dx.doi.org/10.1126/science.1186834			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150494	Green Accepted, Green Published			2022-12-01	WOS:000274408300051
J	Gegear, RJ; Foley, LE; Casselman, A; Reppert, SM				Gegear, Robert J.; Foley, Lauren E.; Casselman, Amy; Reppert, Steven M.			Animal cryptochromes mediate magnetoreception by an unconventional photochemical mechanism	NATURE			English	Article							BLUE-LIGHT PHOTORECEPTOR; DROSOPHILA; CLOCK; MODEL; ORIENTATION; DEFINE; PERIOD; BIRDS	Understanding the biophysical basis of animal magnetoreception has been one of the greatest challenges in sensory biology. Recently it was discovered that the light-dependent magnetic sense of Drosophila melanogaster is mediated by the ultraviolet (UV)-A/blue light photoreceptor cryptochrome (Cry)(1). Here we show, using a transgenic approach, that the photoreceptive, Drosophila-like type 1 Cry and the transcriptionally repressive, vertebrate-like type 2 Cry of the monarch butterfly (Danaus plexippus) can both function in the magnetoreception system of Drosophila and require UV-A/blue light (wavelength below 420 nm) to do so. The lack of magnetic responses for both Cry types at wavelengths above 420 nm does not fit the widely held view that tryptophan triad-generated radical pairs mediate the ability of Cry to sense a magnetic field. We bolster this assessment by using a mutant form of Drosophila and monarch type 1 Cry and confirm that the tryptophan triad pathway is not crucial in magnetic transduction. Together, these results suggest that animal Crys mediate light-dependent magnetoreception through an unconventional photochemical mechanism. This work emphasizes the utility of Drosophila transgenesis for elucidating the precise mechanisms of Cry-mediated magnetosensitivity in insects and also in vertebrates such as migrating birds.	[Gegear, Robert J.; Foley, Lauren E.; Casselman, Amy; Reppert, Steven M.] Univ Massachusetts, Sch Med, Dept Neurobiol, Worcester, MA 01605 USA	University of Massachusetts System; University of Massachusetts Worcester	Reppert, SM (corresponding author), Univ Massachusetts, Sch Med, Dept Neurobiol, 364 Plantat St, Worcester, MA 01605 USA.	robert.gegear@umassmed.edu; steven.reppert@umassmed.edu		Gegear, Robert/0000-0001-9886-1324	National Institutes of Health; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086794] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Q. Yuan for performing the assays in Fig. 3d and the cryptochrome alignments in Supplementary Fig. 1, and P. Emery, C. Merlin and D. R. Weaver for discussions. This work was supported by a grant from the National Institutes of Health.	Berndt A, 2007, J BIOL CHEM, V282, P13011, DOI 10.1074/jbc.M608872200; Emery P, 1998, CELL, V95, P669, DOI 10.1016/S0092-8674(00)81637-2; Gegear RJ, 2008, NATURE, V454, P1014, DOI 10.1038/nature07183; Hoang N, 2008, PLOS BIOL, V6, P1559, DOI 10.1371/journal.pbio.0060160; Hogben HJ, 2009, CHEM PHYS LETT, V480, P118, DOI 10.1016/j.cplett.2009.08.051; Kaneko M, 2000, J COMP NEUROL, V422, P66, DOI 10.1002/(SICI)1096-9861(20000619)422:1<66::AID-CNE5>3.0.CO;2-2; Lohmann KJ, 2007, J EXP BIOL, V210, P3697, DOI 10.1242/jeb.001313; Maeda K, 2008, NATURE, V453, P387, DOI 10.1038/nature06834; Mouritsen H, 2005, CURR OPIN NEUROBIOL, V15, P406, DOI 10.1016/j.conb.2005.06.003; Ozturk N, 2007, COLD SPRING HARB SYM, V72, P119, DOI 10.1101/sqb.2007.72.015; Ozturk N, 2008, J BIOL CHEM, V283, P3256, DOI 10.1074/jbc.M708612200; PHILLIPS JB, 1992, ETHOL ECOL EVOL, V4, P33, DOI 10.1080/08927014.1992.9525348; Reppert SM, 2006, CELL, V124, P233, DOI 10.1016/j.cell.2006.01.009; Ritz T, 2000, BIOPHYS J, V78, P707, DOI 10.1016/S0006-3495(00)76629-X; Ritz T, 2002, NEURON, V34, P503, DOI 10.1016/S0896-6273(02)00707-9; Rodgers CT, 2009, P NATL ACAD SCI USA, V106, P353, DOI 10.1073/pnas.0711968106; Rutila JE, 1998, CELL, V93, P805, DOI 10.1016/S0092-8674(00)81441-5; Sheeba V, 2008, J NEUROPHYSIOL, V99, P976, DOI 10.1152/jn.00930.2007; Solov'yov IA, 2009, BIOPHYS J, V96, P4804, DOI 10.1016/j.bpj.2009.03.048; Song SH, 2007, J BIOL CHEM, V282, P17608, DOI 10.1074/jbc.M702874200; Stanewsky R, 2003, J NEUROBIOL, V54, P111, DOI 10.1002/neu.10164; Tu DC, 2004, SCIENCE, V306, P129, DOI 10.1126/science.1101484; vanVickle-Chavez SJ, 2007, J BIOL CHEM, V282, P10561, DOI 10.1074/jbc.M609314200; Wiltschko R, 2005, CURR BIOL, V15, P1518, DOI 10.1016/j.cub.2005.07.037; Wiltschko W, 2005, J COMP PHYSIOL A, V191, P675, DOI 10.1007/s00359-005-0627-7; Yoshii T, 2009, PLOS BIOL, V7, P813, DOI 10.1371/journal.pbio.1000086; Yuan Q, 2007, MOL BIOL EVOL, V24, P948, DOI 10.1093/molbev/msm011; Zhu HS, 2008, PLOS BIOL, V6, P138, DOI 10.1371/journal.pbio.0060004; Zhu HS, 2005, CURR BIOL, V15, pR953, DOI 10.1016/j.cub.2005.11.030	29	183	197	1	137	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					804	U114		10.1038/nature08719	http://dx.doi.org/10.1038/nature08719			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20098414	Green Submitted, Green Accepted			2022-12-01	WOS:000274394300039
J	Capelson, M; Liang, Y; Schulte, R; Mair, W; Wagner, U; Hetzer, MW				Capelson, Maya; Liang, Yun; Schulte, Roberta; Mair, William; Wagner, Ulrich; Hetzer, Martin W.			Chromatin-Bound Nuclear Pore Components Regulate Gene Expression in Higher Eukaryotes	CELL			English	Article							RNA-POLYMERASE-II; DROSOPHILA-MELANOGASTER; MESSENGER-RNA; P-TEFB; TRANSCRIPTIONAL CONTROL; SPATIAL-ORGANIZATION; MOBILE NUCLEOPORIN; TERMINAL DOMAIN; IN-VIVO; COMPLEX	Nuclear pore complexes have recently been shown to play roles in gene activation; however their potential involvement in metazoan transcription remains unclear. Here we show that the nucleoporins Sec13, Nup98, and Nup88, as well as a group of FG-repeat nucleoporins, bind to the Drosophila genome at functionally distinct loci that often do not represent nuclear envelope contact sites. Whereas Nup88 localizes to silent loci, Sec13, Nup98, and a subset of FG-repeat nucleoporins bind to developmentally regulated genes undergoing transcription induction. Strikingly, RNAi-mediated knockdown of intranuclear Sec13 and Nup98 specifically inhibits transcription of their target genes and prevents efficient reactivation of transcription after heat shock, suggesting an essential role of NPC components in regulating complex gene expression programs of multicellular organisms.	[Capelson, Maya; Liang, Yun; Schulte, Roberta; Mair, William; Hetzer, Martin W.] Salk Inst Biol Studies, Mol & Cellular Biol Lab, La Jolla, CA 92037 USA; [Wagner, Ulrich] Univ Calif Sch Med, Ludwig Inst Canc Res, La Jolla, CA 92037 USA	Salk Institute; Ludwig Institute for Cancer Research	Hetzer, MW (corresponding author), Salk Inst Biol Studies, Mol & Cellular Biol Lab, 10010 N Torrey Pines Rd, La Jolla, CA 92037 USA.	hetzer@salk.edu	Liang, Yun/K-5639-2013	Mair, William/0000-0002-0661-1342	NIHGMS [R01GM057438]; Damon Runyon Cancer Research Foundation [DRG 1952-07]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057438] Funding Source: NIH RePORTER	NIHGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Damon Runyon Cancer Research Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Tony Hunter and members of the Hetzer lab for critically reading the manuscript, Leanne Jones and members of her lab for sharing fly reagents and expertise, and Andy Dillin for sharing injection and microscopy equipment. We also thank Elissa P. Lei, P. A. Fisher, S. Gigliotti, and C. Samakovlis for generously providing antibodies and Daniel Anderson for help with image analysis. The project was supported by R01GM057438 from the NIHGMS. M. C. was supported by the Damon Runyon Cancer Research Foundation fellowship (DRG 1952-07).	Agudo D, 2004, INT J CANCER, V109, P717, DOI 10.1002/ijc.20034; Akhtar A, 2007, NAT REV GENET, V8, P507, DOI 10.1038/nrg2122; Alber F, 2007, NATURE, V450, P695, DOI 10.1038/nature06405; Alber F, 2007, NATURE, V450, P683, DOI 10.1038/nature06404; ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; ASHBURNER M, 1967, CHROMOSOMA, V21, P398, DOI 10.1007/BF00336950; ASHBURNER M, 1971, NATURE-NEW BIOL, V230, P222, DOI 10.1038/newbio230222a0; Beck M, 2004, SCIENCE, V306, P1387, DOI 10.1126/science.1104808; Belgareh N, 2001, J CELL BIOL, V154, P1147, DOI 10.1083/jcb.200101081; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brohawn SG, 2009, STRUCTURE, V17, P1156, DOI 10.1016/j.str.2009.07.014; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Capelson M, 2009, EMBO REP, V10, P697, DOI 10.1038/embor.2009.147; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Chao SH, 2001, J BIOL CHEM, V276, P31793, DOI 10.1074/jbc.M102306200; Cherbas L, 2003, DEVELOPMENT, V130, P271, DOI 10.1242/dev.00205; Cho EJ, 2001, GENE DEV, V15, P3319, DOI 10.1101/gad.935901; D'Angelo MA, 2009, CELL, V136, P284, DOI 10.1016/j.cell.2008.11.037; DAVIS LI, 1987, P NATL ACAD SCI USA, V84, P7552, DOI 10.1073/pnas.84.21.7552; Debler EW, 2008, MOL CELL, V32, P815, DOI 10.1016/j.molcel.2008.12.001; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Dilworth DJ, 2005, J CELL BIOL, V171, P955, DOI 10.1083/jcb.200509061; Enninga J, 2003, MOL CELL BIOL, V23, P7271, DOI 10.1128/MCB.23.20.7271-7284.2003; Gigliotti S, 1998, J CELL BIOL, V142, P1195, DOI 10.1083/jcb.142.5.1195; GREBER UF, 1990, EMBO J, V9, P1495, DOI 10.1002/j.1460-2075.1990.tb08267.x; Griffis ER, 2004, MOL BIOL CELL, V15, P1991, DOI 10.1091/mbc.E03-10-0743; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Gruenbaum Y, 2003, INT REV CYTOL, V226, P1, DOI 10.1016/S0074-7696(03)01001-5; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Hamann S, 1998, NUCLEIC ACIDS RES, V26, P4108, DOI 10.1093/nar/26.18.4108; Hawryluk-Gara LA, 2005, MOL BIOL CELL, V16, P2382, DOI 10.1091/mbc.E04-10-0857; Hetzer MW, 2005, ANNU REV CELL DEV BI, V21, P347, DOI 10.1146/annurev.cellbio.21.090704.151152; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; HUET F, 1993, DEVELOPMENT, V118, P613; Ishii K, 2002, CELL, V109, P551, DOI 10.1016/S0092-8674(02)00756-0; Kasper LH, 1999, MOL CELL BIOL, V19, P764; Loiodice I, 2004, MOL BIOL CELL, V15, P3333, DOI 10.1091/mbc.E03-12-0878; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Menon BB, 2005, P NATL ACAD SCI USA, V102, P5749, DOI 10.1073/pnas.0501768102; MIRAULT ME, 1977, COLD SPRING HARB SYM, V42, P819, DOI 10.1101/SQB.1978.042.01.082; Ni ZY, 2004, MOL CELL, V13, P55, DOI 10.1016/S1097-2765(03)00526-4; Palancade B, 2003, EUR J BIOCHEM, V270, P3859, DOI 10.1046/j.1432-1033.2003.03794.x; Patturajan M, 1998, J BIOL CHEM, V273, P4689, DOI 10.1074/jbc.273.8.4689; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Roth P, 2003, J CELL BIOL, V163, P701, DOI 10.1083/jcb.200304046; Schmid M, 2006, MOL CELL, V21, P379, DOI 10.1016/j.molcel.2005.12.012; Shim EY, 2002, GENE DEV, V16, P2135, DOI 10.1101/gad.999002; Siniossoglou S, 1996, CELL, V84, P265, DOI 10.1016/S0092-8674(00)80981-2; Slape C, 2004, LEUKEMIA LYMPHOMA, V45, P1341, DOI 10.1080/10428190310001659325; SPRADLING A, 1975, CELL, V4, P395, DOI 10.1016/0092-8674(75)90160-9; Strasser K, 2000, J CELL BIOL, V150, P695, DOI 10.1083/jcb.150.4.695; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; THUMMEL CS, 1990, BIOESSAYS, V12, P561, DOI 10.1002/bies.950121202; Uv AE, 2000, GENE DEV, V14, P1945; Vasu S, 2001, J CELL BIOL, V155, P339, DOI 10.1083/jcb.200108007; Weis K, 2002, CURR OPIN CELL BIOL, V14, P328, DOI 10.1016/S0955-0674(02)00337-X; Wente SR, 2000, SCIENCE, V288, P1374, DOI 10.1126/science.288.5470.1374	59	317	324	0	32	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					372	U100		10.1016/j.cell.2009.12.054	http://dx.doi.org/10.1016/j.cell.2009.12.054			19	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144761	Bronze, Green Accepted			2022-12-01	WOS:000274297700015
J	Raihani, NJ; Grutter, AS; Bshary, R				Raihani, Nichola J.; Grutter, Alexandra S.; Bshary, Redouan			Punishers Benefit From Third-Party Punishment in Fish	SCIENCE			English	Article							ALTRUISTIC PUNISHMENT; PARTNER CONTROL		[Raihani, Nichola J.] Zool Soc London, Inst Zool, London NW1 4RY, England; [Grutter, Alexandra S.] Univ Neuchatel, Inst Biol, CH-2009 Neuchatel, Switzerland; [Bshary, Redouan] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia	Zoological Society of London; University of Neuchatel; University of Queensland	Raihani, NJ (corresponding author), Zool Soc London, Inst Zool, Regents Pk, London NW1 4RY, England.	nichola.raihani@ioz.ac.uk	Raihani, Nichola J/C-2083-2015; Grutter, Alexandra S/J-2737-2013	Raihani, Nichola J/0000-0003-2339-9889; Grutter, Alexandra S/0000-0003-1688-2821; Bshary, Redouan/0000-0001-7198-8472				Boyd R, 2003, P NATL ACAD SCI USA, V100, P3531, DOI 10.1073/pnas.0630443100; Bshary R, 2002, ANIM BEHAV, V63, P547, DOI 10.1006/anbe.2001.1937; Bshary R, 2008, NATURE, V455, P964, DOI 10.1038/nature07184; Fehr E, 2002, NATURE, V415, P137, DOI 10.1038/415137a; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Grutter AS, 2003, P ROY SOC B-BIOL SCI, V270, pS242, DOI 10.1098/rsbl.2003.0077; Jaffe K, 2004, ACTA BIOTHEOR, V52, P155, DOI 10.1023/B:ACBI.0000043440.36462.1a	7	93	98	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					171	171		10.1126/science.1183068	http://dx.doi.org/10.1126/science.1183068			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056883	Green Submitted			2022-12-01	WOS:000273394000025
J	Davis, RE; Ngo, VN; Lenz, G; Tolar, P; Young, RM; Romesser, PB; Kohlhammer, H; Lamy, L; Zhao, H; Yang, YD; Xu, WH; Shaffer, AL; Wright, G; Xiao, WM; Powell, J; Jiang, JK; Thomas, CJ; Rosenwald, A; Ott, G; Muller-Hermelink, HK; Gascoyne, RD; Connors, JM; Johnson, NA; Rimsza, LM; Campo, E; Jaffe, ES; Wilson, WH; Delabie, J; Smeland, EB; Fisher, RI; Braziel, RM; Tubbs, RR; Cook, JR; Weisenburger, DD; Chan, WC; Pierce, SK; Staudt, LM				Davis, R. Eric; Ngo, Vu N.; Lenz, Georg; Tolar, Pavel; Young, Ryan M.; Romesser, Paul B.; Kohlhammer, Holger; Lamy, Laurence; Zhao, Hong; Yang, Yandan; Xu, Weihong; Shaffer, Arthur L.; Wright, George; Xiao, Wenming; Powell, John; Jiang, Jian-Kang; Thomas, Craig J.; Rosenwald, Andreas; Ott, German; Muller-Hermelink, Hans Konrad; Gascoyne, Randy D.; Connors, Joseph M.; Johnson, Nathalie A.; Rimsza, Lisa M.; Campo, Elias; Jaffe, Elaine S.; Wilson, Wyndham H.; Delabie, Jan; Smeland, Erlend B.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.; Weisenburger, Dennis D.; Chan, Wing C.; Pierce, Susan K.; Staudt, Louis M.			Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma	NATURE			English	Article							ANTIGEN RECEPTOR; IG-ALPHA; TYROSINE KINASE; INTERNALIZATION; IMMUNOGLOBULIN; INHIBITORS; INITIATION; MOLECULE; SURVIVAL; TARGET	A role for B-cell-receptor (BCR) signalling in lymphomagenesis has been inferred by studying immunoglobulin genes in human lymphomas(1,2) and by engineering mouse models(3), but genetic and functional evidence for its oncogenic role in human lymphomas is needed. Here we describe a form of 'chronic active' BCR signalling that is required for cell survival in the activated B-cell-like (ABC) subtype of diffuse large B-cell lymphoma (DLBCL). The signalling adaptor CARD11 is required for constitutive NF-kappa B pathway activity and survival in ABC DLBCL4. Roughly 10% of ABC DLBCLs have mutant CARD11 isoforms that activate NF-kappa B-5, but the mechanism that engages wild-type CARD11 in other ABC DLBCLs was unknown. An RNA interference genetic screen revealed that a BCR signalling component, Bruton's tyrosine kinase, is essential for the survival of ABC DLBCLs with wild-type CARD11. In addition, knockdown of proximal BCR subunits (IgM, Ig-kappa, CD79A and CD79B) killed ABC DLBCLs with wildtype CARD11 but not other lymphomas. The BCRs in these ABC DLBCLs formed prominent clusters in the plasma membrane with low diffusion, similarly to BCRs in antigen-stimulated normal B cells. Somatic mutations affecting the immunoreceptor tyrosine-based activation motif (ITAM) signalling modules(6) of CD79B and CD79A were detected frequently in ABC DLBCL biopsy samples but rarely in other DLBCLs and never in Burkitt's lymphoma or mucosa-associated lymphoid tissue lymphoma. In 18% of ABC DLBCLs, one functionally critical residue of CD79B, the first ITAM tyrosine, was mutated. These mutations increased surface BCR expression and attenuated Lyn kinase, a feedback inhibitor of BCR signalling. These findings establish chronic active BCR signalling as a new pathogenetic mechanism in ABC DLBCL, suggesting several therapeutic strategies.	[Davis, R. Eric; Ngo, Vu N.; Lenz, Georg; Young, Ryan M.; Romesser, Paul B.; Kohlhammer, Holger; Lamy, Laurence; Zhao, Hong; Yang, Yandan; Xu, Weihong; Shaffer, Arthur L.; Wilson, Wyndham H.; Staudt, Louis M.] NCI, Metab Branch, NIH, Bethesda, MD 20892 USA; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Tolar, Pavel; Pierce, Susan K.] NIAID, Immunogenet Lab, NIH, Rockville, MD 20852 USA; [Romesser, Paul B.] NIH, Howard Hughes Med Inst, Res Scholars Program, Bethesda, MD 20892 USA; [Wright, George] NCI, Biometr Res Branch, Div Canc Treatment & Diag, NIH, Bethesda, MD 20892 USA; [Xiao, Wenming; Powell, John] NIH, Bioinformat & Mol Anal Sect, Div Computat Biosci, Ctr Informat Technol, Bethesda, MD 20892 USA; [Jiang, Jian-Kang; Thomas, Craig J.] NHGRI, NIH, Chem Genom Ctr, Rockville, MD 20850 USA; [Rosenwald, Andreas; Muller-Hermelink, Hans Konrad] Univ Wurzburg, Dept Pathol, D-97080 Wurzburg, Germany; [Ott, German] Robert Bosch Krankenhaus, Dept Clin Pathol, D-70376 Stuttgart, Germany; [Ott, German] Dr Margarete Fischer Bosch Inst Clin Pharmacol, D-70376 Stuttgart, Germany; [Gascoyne, Randy D.; Connors, Joseph M.; Johnson, Nathalie A.] British Columbia Canc Agcy, Vancouver, BC V5Z 4E6, Canada; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ 85724 USA; [Rimsza, Lisa M.; Fisher, Richard I.; Braziel, Rita M.; Tubbs, Raymond R.; Cook, J. R.] SW Oncol Grp, Ann Arbor, MI 48106 USA; [Campo, Elias] Univ Barcelona, Hosp Clin, E-08036 Barcelona, Spain; [Delabie, Jan] Rikshosp Univ Hosp, Pathol Clin, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Rikshosp Univ Hosp, Inst Canc Res, N-0310 Oslo, Norway; [Smeland, Erlend B.] Univ Oslo, Ctr Canc Biomed, Fac Div, Norwegian Radium Hosp, N-0310 Oslo, Norway; [Fisher, Richard I.] Univ Rochester, Sch Med, James P Wilmot Canc Ctr, Rochester, NY 14642 USA; [Braziel, Rita M.] Oregon Hlth & Sci Univ, Portland, OR 97239 USA; [Tubbs, Raymond R.; Cook, J. R.] Cleveland Clin Pathol, Cleveland, OH 44195 USA; [Tubbs, Raymond R.; Cook, J. R.] Inst Lab Med, Cleveland, OH 44195 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE 68198 USA; [Weisenburger, Dennis D.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Microbiol, Omaha, NE 68198 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID); Howard Hughes Medical Institute; National Institutes of Health (NIH) - USA; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH Center for Information Technology (CIT); National Institutes of Health (NIH) - USA; NIH National Center for Advancing Translational Sciences (NCATS); NIH National Human Genome Research Institute (NHGRI); University of Wurzburg; Bosch; Robert Bosch Krankenhaus; Eberhard Karls University of Tubingen; Eberhard Karls University Hospital; British Columbia Cancer Agency; University of Arizona; Southwest Oncology Group; University of Barcelona; Hospital Clinic de Barcelona; University of Oslo; National Hospital Norway; University of Oslo; National Hospital Norway; University of Oslo; University of Rochester; Oregon Health & Science University; Cleveland Clinic Foundation; University of Nebraska System; University of Nebraska Medical Center; University of Nebraska System; University of Nebraska Medical Center	Staudt, LM (corresponding author), NCI, Metab Branch, NIH, Bethesda, MD 20892 USA.	lstaudt@mail.nih.gov	Connors, Joseph/AAF-5284-2019; Wright, George W/M-1660-2017; Staudt, Louis/AAC-5324-2019; Jaffe, Elaine/G-8981-2014; Campo, Elias/AAC-5593-2019; Smeland, Erlend/AAO-3214-2020; Lenz, Georg/I-6844-2012	Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Romesser, Paul/0000-0001-8268-2903; Thomas, Craig/0000-0001-9386-9001; Delabie, Jan/0000-0001-5023-0689; Tolar, Pavel/0000-0003-4693-7299; Ngo, Vu/0000-0002-9501-6990	National Institutes of Health; National Cancer Institute; Center for Cancer Research; National Institute of Allergy and Infectious Disease; National Human Genome Research Institute; CENTER FOR INFORMATION TECHNOLOGY [ZIACT000260] Funding Source: NIH RePORTER; NATIONAL CANCER INSTITUTE [ZIABC011008, ZIABC011007, ZIABC011070, ZIASC000550] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIBHG200319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI001126] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of Allergy and Infectious Disease(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); CENTER FOR INFORMATION TECHNOLOGY(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Center for Information Technology (CIT)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank L. Honigberg for PCI-32765, L. Dang for IKK-beta inhibitors, S. Ansher for dasatinib, and S. Tohda for the TMD8 cell line. This research was supported by the Intramural Research Program of the National Institutes of Health, the National Cancer Institute, the Center for Cancer Research, the National Institute of Allergy and Infectious Disease, and the National Human Genome Research Institute. P. B. R. was a Howard Hughes Medical Institute-National Institutes of Health Research Scholar.	Alizadeh AA, 2000, NATURE, V403, P503, DOI 10.1038/35000501; BAHLER DW, 1992, P NATL ACAD SCI USA, V89, P6770, DOI 10.1073/pnas.89.15.6770; Blethrow Justin, 2004, Curr Protoc Mol Biol, VChapter 18, DOI 10.1002/0471142727.mb1811s66; Chan VWF, 1997, IMMUNITY, V7, P69, DOI 10.1016/S1074-7613(00)80511-7; Chen LF, 2008, BLOOD, V111, P2230, DOI 10.1182/blood-2007-07-100115; Dal Porto JM, 2004, MOL IMMUNOL, V41, P599, DOI 10.1016/j.molimm.2004.04.008; Davis RE, 2001, J EXP MED, V194, P1861, DOI 10.1084/jem.194.12.1861; Gauld SB, 2004, ONCOGENE, V23, P8001, DOI 10.1038/sj.onc.1208075; Gazumyan A, 2006, J EXP MED, V203, P1785, DOI 10.1084/jem.20060221; Gordon MS, 2003, P NATL ACAD SCI USA, V100, P4126, DOI 10.1073/pnas.0735266100; Hantschel O, 2007, P NATL ACAD SCI USA, V104, P13283, DOI 10.1073/pnas.0702654104; Jiang S, 2007, ASSAY DRUG DEV TECHN, V5, P49, DOI 10.1089/adt.2006.032; Jin S, 2007, J CELL SCI, V120, P379, DOI 10.1242/jcs.03349; KLEIN G, 1986, CANCER RES, V46, P3211; Kraus M, 1999, IMMUNITY, V11, P537, DOI 10.1016/S1074-7613(00)80129-6; Kraus M, 2004, CELL, V117, P787, DOI 10.1016/j.cell.2004.05.014; Lam KP, 1997, CELL, V90, P1073, DOI 10.1016/S0092-8674(00)80373-6; Lam LT, 2005, CLIN CANCER RES, V11, P28; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Lenz G, 2008, SCIENCE, V319, P1676, DOI 10.1126/science.1153629; Ma H, 2001, J IMMUNOL, V166, P1507, DOI 10.4049/jimmunol.166.3.1507; Ngo VN, 2006, NATURE, V441, P106, DOI 10.1038/nature04687; Niiro H, 2004, J IMMUNOL, V173, P5601, DOI 10.4049/jimmunol.173.9.5601; Pan ZY, 2007, CHEMMEDCHEM, V2, P58, DOI 10.1002/cmdc.200600221; Refaeli Y, 2008, PLOS BIOL, V6, P1208, DOI 10.1371/journal.pbio.0060152; RETH M, 1989, NATURE, V338, P383, DOI 10.1038/338383b0; Staudt LM, 2005, ADV IMMUNOL, V87, P163, DOI 10.1016/S0065-2776(05)87005-1; STEWART DM, 1995, HYBRIDOMA, V14, P243, DOI 10.1089/hyb.1995.14.243; Thome M, 2004, NAT REV IMMUNOL, V4, P348, DOI 10.1038/nri1352; Tolar P, 2005, NAT IMMUNOL, V6, P1168, DOI 10.1038/ni1262; Tolar P, 2009, IMMUNITY, V30, P44, DOI 10.1016/j.immuni.2008.11.007; Torres RM, 1999, IMMUNITY, V11, P527, DOI 10.1016/S1074-7613(00)80128-4	32	1109	1228	5	152	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					88	U97		10.1038/nature08638	http://dx.doi.org/10.1038/nature08638			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054396	Green Accepted			2022-12-01	WOS:000273344900036
J	Bandell, M; Patapoutian, A				Bandell, Michael; Patapoutian, Ardem			Itching for Insight	CELL			English	Editorial Material							SENSORY NEURONS; PRURITUS; SUBSETS		[Bandell, Michael; Patapoutian, Ardem] Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA; [Patapoutian, Ardem] Scripps Res Inst, Dept Cell Biol, La Jolla, CA 92037 USA	Novartis; Scripps Research Institute	Patapoutian, A (corresponding author), Novartis Res Fdn, Genom Inst, San Diego, CA 92121 USA.	apatapoutian@gnf.org						Abila B, 1994, Afr J Med Med Sci, V23, P139; Cavanaugh DJ, 2009, P NATL ACAD SCI USA, V106, P9075, DOI 10.1073/pnas.0901507106; Dong XZ, 2001, CELL, V106, P619, DOI 10.1016/S0092-8674(01)00483-4; Ikoma A, 2006, NAT REV NEUROSCI, V7, P535, DOI 10.1038/nrn1950; Liu Q, 2007, NAT NEUROSCI, V10, P946, DOI 10.1038/nn1937; MNYIKA KS, 1991, J TROP MED HYG, V94, P27; Paus R, 2006, J CLIN INVEST, V116, P1174, DOI 10.1172/JCI28553; Rau KK, 2009, J NEUROSCI, V29, P8612, DOI 10.1523/JNEUROSCI.1057-09.2009; Sun YG, 2009, SCIENCE, V325, P1531, DOI 10.1126/science.1174868	9	4	4	0	3	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1224	1226		10.1016/j.cell.2009.12.012	http://dx.doi.org/10.1016/j.cell.2009.12.012			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064368	Bronze			2022-12-01	WOS:000273048700010
J	Honigman, B				Honigman, Benjamin			The Heart of the Matter	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												benjamin.honigman@ucdenver.edu						Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	515 N STATE ST, CHICAGO, IL 60610-0946 USA	0098-7484			JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	DEC 23	2009	302	24					2638	2639		10.1001/jama.2009.1808	http://dx.doi.org/10.1001/jama.2009.1808			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	535JU	20040544				2022-12-01	WOS:000272965300001
J	Poulikakos, PI; Zhang, C; Bollag, G; Shokat, KM; Rosen, N				Poulikakos, Poulikos I.; Zhang, Chao; Bollag, Gideon; Shokat, Kevan M.; Rosen, Neal			RAF inhibitors transactivate RAF dimers and ERK signalling in cells with wild-type BRAF	NATURE			English	Article							KINASE INHIBITOR; SELECTIVE INHIBITOR; ONCOGENIC BRAF; B-RAF; ACTIVATION; MECHANISM; CRAF; HETERODIMERIZATION; SENSITIVITY; MELANOMA	Tumours with mutant BRAF are dependent on the RAF-MEK-ERK signalling pathway for their growth(1-3). We found that ATP-competitive RAF inhibitors inhibit ERK signalling in cells with mutant BRAF, but unexpectedly enhance signalling in cells with wild-type BRAF. Here we demonstrate the mechanistic basis for these findings. We used chemical genetic methods to show that drug-mediated transactivation of RAF dimers is responsible for paradoxical activation of the enzyme by inhibitors. Induction of ERK signalling requires direct binding of the drug to the ATP-binding site of one kinase of the dimer and is dependent on RAS activity. Drug binding to one member of RAF homodimers (CRAF-CRAF) or heterodimers (CRAF-BRAF) inhibits one protomer, but results in transactivation of the drug-free protomer. In BRAF(V600E) tumours, RAS is not activated, thus transactivation is minimal and ERK signalling is inhibited in cells exposed to RAF inhibitors. These results indicate that RAF inhibitors will be effective in tumours in which BRAF is mutated. Furthermore, because RAF inhibitors do not inhibit ERK signalling in other cells, the model predicts that they would have a higher therapeutic index and greater antitumour activity than mitogen-activated protein kinase (MEK) inhibitors, but could also cause toxicity due to MEK/ERK activation. These predictions have been borne out in a recent clinical trial of the RAF inhibitor PLX4032 (refs 4, 5). The model indicates that promotion of RAF dimerization by elevation of wild-type RAF expression or RAS activity could lead to drug resistance in mutant BRAF tumours. In agreement with this prediction, RAF inhibitors do not inhibit ERK signalling in cells that coexpress BRAF(V600E) and mutant RAS.	[Poulikakos, Poulikos I.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USA; [Poulikakos, Poulikos I.; Rosen, Neal] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Zhang, Chao; Shokat, Kevan M.] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Bollag, Gideon] Plexxikon Inc, Berkeley, CA 94710 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Plexxikon	Rosen, N (corresponding author), Mem Sloan Kettering Canc Ctr, Program Mol Pharmacol & Chem, New York, NY 10065 USA.	rosenn@mskcc.org	Rosen, Neal/ABF-2677-2020		Melanoma Research Alliance; Starr Cancer Consortium; NIH/NCI [1P01CA129243-02]; Joan's Legacy: United Against Lung Cancer Foundation; NIH [2R01EB001987]; The Children's Tumor Foundation; Waxman Foundation; NATIONAL CANCER INSTITUTE [U01CA091178, P01CA129243] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R01EB001987] Funding Source: NIH RePORTER	Melanoma Research Alliance; Starr Cancer Consortium; NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Joan's Legacy: United Against Lung Cancer Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); The Children's Tumor Foundation; Waxman Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))	We are grateful to W. Kolch for the BRAF plasmids and M. Baccarini for the RAF knockout MEFs. We thank J. Blair for synthesis of JAB compounds and A. Dar, S. Chandarlapaty and D. Solit for discussions. This work has been funded by the Melanoma Research Alliance, the Starr Cancer Consortium, an NIH/NCI P01 grant (1P01CA129243-02) and by Joan's Legacy: United Against Lung Cancer Foundation ( P. I. P., N. R.). K. M. S. would like to thank NIH-2R01EB001987, The Children's Tumor Foundation and the Waxman Foundation for funding.	Bankston D, 2002, ORG PROCESS RES DEV, V6, P777, DOI 10.1021/op020205n; Blair JA, 2007, NAT CHEM BIOL, V3, P229, DOI 10.1038/nchembio866; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chapman P, 2009, EJC SUPPL, V7, P5, DOI 10.1016/S1359-6349(09)72036-1; Cutler RE, 1998, P NATL ACAD SCI USA, V95, P9214, DOI 10.1073/pnas.95.16.9214; Dummer R, 2008, J CLIN ONCOL S, V26; FLAHERTY K, 2009, J CLIN ONCOL S, V27, pNIL18; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Heidorn SJ, 2010, CELL, V140, P209, DOI 10.1016/j.cell.2009.12.040; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Karreth FA, 2009, MOL CELL, V36, P477, DOI 10.1016/j.molcel.2009.10.017; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Konecny GE, 2006, CANCER RES, V66, P1630, DOI 10.1158/0008-5472.CAN-05-1182; McDermott U, 2007, P NATL ACAD SCI USA, V104, P19936, DOI 10.1073/pnas.0707498104; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Solit DB, 2006, NATURE, V439, P358, DOI 10.1038/nature04304; Sun Y, 1999, ANTICANCER RES, V19, P919; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, CANCER RES, V64, P2338, DOI 10.1158/0008-5472.CAN-03-3433; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Young A, 2009, ADV CANCER RES, V102, P1, DOI 10.1016/S0065-230X(09)02001-6	26	1303	1348	1	124	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					427	U126		10.1038/nature08902	http://dx.doi.org/10.1038/nature08902			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20179705	Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000275657100050
J	Bayne, EH; White, SA; Kagansky, A; Bijos, DA; Sanchez-Pulido, L; Hoe, KL; Kim, DU; Park, HO; Ponting, CP; Rappsilber, J; Allshire, RC				Bayne, Elizabeth H.; White, Sharon A.; Kagansky, Alexander; Bijos, Dominika A.; Sanchez-Pulido, Luis; Hoe, Kwang-Lae; Kim, Dong-Uk; Park, Han-Oh; Ponting, Chris P.; Rappsilber, Juri; Allshire, Robin C.			Stc1: A Critical Link between RNAi and Chromatin Modification Required for Heterochromatin Integrity	CELL			English	Article							H3 LYSINE-9 METHYLATION; BINDING-PROTEIN TAZ1; HIDDEN MARKOV-MODELS; FISSION YEAST; HISTONE H3; SCHIZOSACCHAROMYCES-POMBE; CHROMOSOME SEGREGATION; COMPREHENSIVE ANALYSIS; CHROMODOMAIN PROTEIN; CENTROMERE FUNCTION	In fission yeast, RNAi directs heterochromatin formation at centromeres, telomeres, and the mating type locus. Noncoding RNAs transcribed from repeat elements generate siRNAs that are incorporated into the Argonaute-containing RITS complex and direct it to nascent homologous transcripts. This leads to recruitment of the CLRC complex, including the histone methyltransferase Clr4, promoting H3K9 methylation and heterochromatin formation. A key question is what mediates the recruitment of Clr4/CLRC to transcript-bound RITS. We have identified a LIM domain protein, Stc1, that is required for centromeric heterochromatin integrity. Our analyses show that Stc1 is specifically required to establish H3K9 methylation via RNAi, and interacts both with the RNAi effector Ago1, and with the chromatin-modifying CLRC complex. Moreover, tethering Stc1 to a euchromatic locus is sufficient to induce silencing and heterochromatin formation independently of RNAi. We conclude that Stc1 associates with RITS on centromeric transcripts and recruits CLRC, thereby coupling RNAi to chromatin modification.	[Bayne, Elizabeth H.; White, Sharon A.; Kagansky, Alexander; Bijos, Dominika A.; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Bayne, Elizabeth H.; White, Sharon A.; Kagansky, Alexander; Bijos, Dominika A.; Rappsilber, Juri; Allshire, Robin C.] Univ Edinburgh, Sch Biol Sci, Inst Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland; [Sanchez-Pulido, Luis; Ponting, Chris P.] Univ Oxford, MRC Funct Genom Unit, Oxford OX1 3QX, England; [Hoe, Kwang-Lae; Kim, Dong-Uk] Korea Res Inst Biosci & Biotechnol, Integrat Om Res Ctr, Taejon 305806, South Korea; [Park, Han-Oh] Bioneer Corp, Taejon 306220, South Korea	University of Edinburgh; University of Edinburgh; University of Oxford; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Allshire, RC (corresponding author), Univ Edinburgh, Sch Biol Sci, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland.	robin.allshire@ed.ac.uk	Bayne, Elizabeth H/G-5411-2010; Kagansky, Alexander/B-3137-2011; Rappsilber, Juri/B-7265-2015; Ponting, Chris/AAV-2621-2021; Rappsilber, Juri/ABF-3328-2020	Bayne, Elizabeth H/0000-0001-8775-999X; Kagansky, Alexander/0000-0002-6219-6892; Rappsilber, Juri/0000-0001-5999-1310; Allshire, Robin/0000-0002-8005-3625; Hoe, Kwang Lae/0000-0002-3943-4549; Sanchez Pulido, Luis/0000-0002-2300-8502; Ponting, Chris/0000-0003-0202-7816	Epigenome Network of Excellence [(EC-FP6/Contract/LSHG-CT-2004-503433]; EC Marie-Curie Excellence [MEXT-CT-014171]; EMBO-LTF [ALT325-2008]; MRC [G0301153]; MRC-FGU; Wellcome Trust [084229/Z/07/Z]; MRC [MC_U137761446] Funding Source: UKRI; Medical Research Council [G0301153, MC_U137761446] Funding Source: researchfish	Epigenome Network of Excellence; EC Marie-Curie Excellence(European Commission); EMBO-LTF(European Molecular Biology Organization (EMBO)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC-FGU(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Allshire Lab members for advice, F. Alves for mass spectrometry support, and J. Hayles for deriving the haploid deletion collection. We are grateful to T. Urano for provision of anti-H3K9me2 and Z. Cande, D. Moazed, and J. Partridge for strains. This research was supported by the Epigenome Network of Excellence (EC-FP6/Contract/LSHG-CT-2004-503433 to R.C.A.), an EC Marie-Curie Excellence grant (MEXT-CT-014171 to J.R.); EMBO-LTF (ALT325-2008 to L.S.P.), an MRC Strategic grant (G0301153 to R.C.A.), MRC-FGU Core Support (to C.P.P.), Wellcome Trust Senior Research fellowship (084229/Z/07/Z to J. R.); Wellcome Trust Programme grant (065061/Z to R.C.A.). R.C.A. is a Wellcome Trust Principal Research Fellow.	ALLSHIRE RC, 1995, GENE DEV, V9, P218, DOI 10.1101/gad.9.2.218; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bahler J, 1998, YEAST, V14, P943, DOI 10.1002/(SICI)1097-0061(199807)14:10<943::AID-YEA292>3.0.CO;2-Y; Bannister AJ, 2001, NATURE, V410, P120, DOI 10.1038/35065138; Bayne EH, 2008, SCIENCE, V322, P602, DOI 10.1126/science.1164029; Bernstein E, 2005, GENE DEV, V19, P1635, DOI 10.1101/gad.1324305; Briggs SD, 2002, NATURE, V418, P498, DOI 10.1038/nature00970; Buhler M, 2007, NAT STRUCT MOL BIOL, V14, P1041, DOI 10.1038/nsmb1315; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Eddy SR, 1996, CURR OPIN STRUC BIOL, V6, P361, DOI 10.1016/S0959-440X(96)80056-X; EKWALL K, 1995, SCIENCE, V269, P1429, DOI 10.1126/science.7660126; Ekwall K, 1996, J CELL SCI, V109, P2637; FUNABIKI H, 1993, J CELL BIOL, V121, P961, DOI 10.1083/jcb.121.5.961; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Grewal SIS, 2007, NAT REV GENET, V8, P35, DOI 10.1038/nrg2008; Grewal SIS, 1998, GENETICS, V150, P563; Hall IM, 2003, P NATL ACAD SCI USA, V100, P193, DOI 10.1073/pnas.232688099; Hall IM, 2002, SCIENCE, V297, P2232, DOI 10.1126/science.1076466; Hansen KR, 2006, NUCLEIC ACIDS RES, V34, P78, DOI 10.1093/nar/gkj415; Hong Eun-Jin Erica, 2005, RNA Biol, V2, P106, DOI 10.4161/rna.2.3.2131; Horn PJ, 2005, GENE DEV, V19, P1705, DOI 10.1101/gad.1328005; Iida T, 2008, MOL CELL, V31, P178, DOI 10.1016/j.molcel.2008.07.003; Jia ST, 2005, NAT CELL BIOL, V7, P1007, DOI 10.1038/ncb1300; Jia ST, 2004, SCIENCE, V304, P1971, DOI 10.1126/science.1099035; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Kagansky A, 2009, SCIENCE, V324, P1716, DOI 10.1126/science.1172026; Kanoh J, 2005, CURR BIOL, V15, P1808, DOI 10.1016/j.cub.2005.09.041; Kim HS, 2004, J BIOL CHEM, V279, P42850, DOI 10.1074/jbc.M407259200; Klenov MS, 2007, NUCLEIC ACIDS RES, V35, P5430, DOI 10.1093/nar/gkm576; Kloc A, 2008, TRENDS GENET, V24, P511, DOI 10.1016/j.tig.2008.08.002; Kniola B, 2001, MOL BIOL CELL, V12, P2767, DOI 10.1091/mbc.12.9.2767; Li F, 2005, CURR BIOL, V15, P1448, DOI 10.1016/j.cub.2005.07.021; Matsuyama A, 2004, YEAST, V21, P1289, DOI 10.1002/yea.1181; Matzke M, 2009, CURR OPIN CELL BIOL, V21, P367, DOI 10.1016/j.ceb.2009.01.025; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Nakagawachi T, 2003, ONCOGENE, V22, P8835, DOI 10.1038/sj.onc.1207183; Nakayam J, 2001, SCIENCE, V292, P110, DOI 10.1126/science.1060118; Neuwald AF, 2000, NUCLEIC ACIDS RES, V28, P3570, DOI 10.1093/nar/28.18.3570; Ng HH, 2002, J BIOL CHEM, V277, P34655, DOI 10.1074/jbc.C200433200; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Oeffinger M, 2007, NAT METHODS, V4, P951, DOI 10.1038/NMETH1101; Pidoux A, 2004, METHODS, V33, P252, DOI 10.1016/j.ymeth.2003.11.021; Pidoux AL, 2009, MOL CELL, V33, P299, DOI 10.1016/j.molcel.2009.01.019; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Shankaranarayana GD, 2003, CURR BIOL, V13, P1240, DOI 10.1016/S0960-9822(03)00489-5; Soding J, 2005, NUCLEIC ACIDS RES, V33, pW244, DOI 10.1093/nar/gki408; Sugiyama T, 2007, CELL, V128, P491, DOI 10.1016/j.cell.2006.12.035; Thon G, 2005, GENETICS, V171, P1583, DOI 10.1534/genetics.105.048298; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe T, 2003, CHROMOSOME RES, V11, P137, DOI 10.1023/A:1022815931524; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wiren M, 2005, EMBO J, V24, P2906, DOI 10.1038/sj.emboj.7600758; Yamada T, 2005, MOL CELL, V20, P173, DOI 10.1016/j.molcel.2005.10.002; Zhang K, 2008, NAT STRUCT MOL BIOL, V15, P381, DOI 10.1038/nsmb.1406	55	153	154	0	14	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					666	677		10.1016/j.cell.2010.01.038	http://dx.doi.org/10.1016/j.cell.2010.01.038			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211136	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000275197400016
J	Nesbitt, SJ; Sidor, CA; Irmis, RB; Angielczyk, KD; Smith, RMH; Tsuji, LA				Nesbitt, Sterling J.; Sidor, Christian A.; Irmis, Randall B.; Angielczyk, Kenneth D.; Smith, Roger M. H.; Tsuji, Linda A.			Ecologically distinct dinosaurian sister group shows early diversification of Ornithodira	NATURE			English	Article							NEW-MEXICO; ARCHOSAUR; KAROO; EVOLUTION	The early evolutionary history of Ornithodira (avian-line archosaurs) has hitherto been documented by incomplete (Lagerpeton(1)) or unusually specialized forms (pterosaurs and Silesaurus(2)). Recently, a variety of Silesaurus-like taxa have been reported from the Triassic period of both Gondwana and Laurasia, but their relationships to each other and to dinosaurs remain a subject of debate(3-5). Here we report on a new avian-line archosaur from the early Middle Triassic (Anisian) of Tanzania. Phylogenetic analysis places Asilisaurus kongwe gen. et sp. nov. as an avian-line archosaur and a member of the Silesauridae, which is here considered the sister taxon to Dinosauria. Silesaurids were diverse and had a wide distribution by the Late Triassic, with a novel ornithodiran bauplan including leaf-shaped teeth, a beak-like lower jaw, long, gracile limbs, and a quadrupedal stance. Our analysis suggests that the dentition and diet of silesaurids, ornithischians and sauropodomorphs evolved independently from a plesiomorphic carnivorous form. As the oldest avian-line archosaur, Asilisaurus demonstrates the antiquity of both Ornithodira and the dinosaurian lineage. The initial diversification of Archosauria, previously documented by crocodilian-line archosaurs in the Anisian(6), can now be shown to include a contemporaneous avian-line radiation. The unparalleled taxonomic diversity of the Manda archosaur assemblage indicates that archosaur diversification was well underway by the Middle Triassic or earlier.	[Nesbitt, Sterling J.] Columbia Univ, Lamont Doherty Earth Observ, Palisades, NY 10964 USA; [Nesbitt, Sterling J.] Amer Museum Nat Hist, Div Paleontol, New York, NY 10024 USA; [Sidor, Christian A.] Univ Washington, Burke Museum, Seattle, WA 98195 USA; [Sidor, Christian A.] Univ Washington, Dept Biol, Seattle, WA 98195 USA; [Irmis, Randall B.] Utah Museum Nat Hist, Salt Lake City, UT 84112 USA; [Irmis, Randall B.] Univ Utah, Dept Geol & Geophys, Salt Lake City, UT 84112 USA; [Angielczyk, Kenneth D.] Field Museum, Dept Geol, Chicago, IL 60605 USA; [Smith, Roger M. H.] Iziko S African Museum, ZA-8000 Cape Town, South Africa; [Tsuji, Linda A.] Humboldt Univ, Museum Nat Kunde, D-10115 Berlin, Germany	Columbia University; American Museum of Natural History (AMNH); University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Utah System of Higher Education; University of Utah; Field Museum of Natural History (Chicago); Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung	Nesbitt, SJ (corresponding author), Univ Texas Austin, Jackson Sch Geosci, Austin, TX 78712 USA.	nesbitt@jsg.utexas.edu	Smith, Roger/AAF-7947-2019	Nesbitt, Sterling/0000-0002-7017-1652	National Geographic Society Research and Exploration [7587-05]; Evolving Earth Foundation; Grainger Foundation; NSF [DBI-0306158]	National Geographic Society Research and Exploration(National Geographic Society); Evolving Earth Foundation; Grainger Foundation; NSF(National Science Foundation (NSF))	We thank L. Herzog for preparation of the material and P. Barrett, P. Makovicky, A. Turner and N. Smith for discussions. We acknowledge A. Tibaijuka and C. Saanane for their help with permits and fieldwork logistics. Funding was provided by a National Geographic Society Research and Exploration grant (7587-05 to C. A. S.), the Evolving Earth Foundation (to S.J.N.), The Grainger Foundation (to K. D. A.), an NSF Postdoctoral Research Fellowship (DBI-0306158 to K. D. A.), and NSF Graduate Research Fellowships (to S.J.N. and R. B. I.).	ARCUCCI A, 1987, Ameghiniana, V24, P89; Barrett Paul M., 2000, P42, DOI 10.1017/CBO9780511549717.004; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Butler RJ, 2009, J VERTEBR PALEONTOL, V29, P1022, DOI 10.1671/039.029.0404; Catuneanu O, 2005, J AFR EARTH SCI, V43, P211, DOI 10.1016/j.jafrearsci.2005.07.007; CHARIG AJ, 1957, DISS U CAMBR 1955 56, P28; CROMPTON A. W., 1955, PROC ZOOL SOC LONDON, V125, P617; Dzik J, 2003, J VERTEBR PALEONTOL, V23, P556, DOI 10.1671/A1097; DZIK J, 2007, PALEONT POL, V64, P1; Ezcurra MD, 2006, GEODIVERSITAS, V28, P649; Ferigolo J., 2007, HIST BIOL, V19, P23, DOI [DOI 10.1080/08912960600845767, 10.1080/08912960600845767]; Gay SA, 1999, J AFR EARTH SCI, V29, P195, DOI 10.1016/S0899-5362(99)00089-5; Haughton S. H., 1932, Quarterly Journal of the Geological Society of London, V88, P634; HUENE FRIEDRICH V., 1939, NEUES JAHRB MINERAL GEOL U PALAONT ABT B BEILAGE BD, V81, P61; Irmis RB, 2007, SCIENCE, V317, P358, DOI 10.1126/science.1143325; Langer MC, 2006, J SYST PALAEONTOL, V4, P309, DOI 10.1017/S1477201906001970; Martinez RN, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004397; Nesbitt SJ, 2003, P ROY SOC B-BIOL SCI, V270, pS234, DOI 10.1098/rsbl.2003.0066; Nesbitt SJ, 2007, J SYST PALAEONTOL, V5, P209, DOI 10.1017/S1477201907002040; Nesbitt SJ, 2009, J VERTEBR PALEONTOL, V29, P498, DOI 10.1671/039.029.0218; NOVAS FE, 1989, J PALEONTOL, V63, P677, DOI 10.1017/S0022336000041317; Novas FE, 1996, J VERTEBR PALEONTOL, V16, P723, DOI 10.1080/02724634.1996.10011361; Romer A. S., 1971, Breviora, VNo. 378, P1; Romer A.S., 1972, Breviora, VNo. 394, P1; Rubidge BS, 2005, S AFR J GEOL, V108, P135, DOI 10.2113/108.1.135; Sidor C, 2008, J VERTEBR PALEONTOL, V28, p142A; VONHUENE F, 1938, NOVA ACTA LEOPOLDINA, V6, P7; WALKER AD, 1970, PHILOS T ROY SOC B, V257, P323, DOI 10.1098/rstb.1970.0028; Wopfner H, 2002, J AFR EARTH SCI, V34, P167, DOI 10.1016/S0899-5362(02)00016-7; Zanno LE, 2009, P ROY SOC B-BIOL SCI, V276, P3505, DOI 10.1098/rspb.2009.1029	30	201	211	1	54	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					95	98		10.1038/nature08718	http://dx.doi.org/10.1038/nature08718			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203608				2022-12-01	WOS:000275117500040
J	Sarewitz, D				Sarewitz, Daniel			Curing climate backlash	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com							0	23	23	0	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 4	2010	464	7285					28	28		10.1038/464028a	http://dx.doi.org/10.1038/464028a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	563GZ	20203581	Bronze			2022-12-01	WOS:000275117500012
J	Southwell, DG; Froemke, RC; Alvarez-Buylla, A; Stryker, MP; Gandhi, SP				Southwell, Derek G.; Froemke, Robert C.; Alvarez-Buylla, Arturo; Stryker, Michael P.; Gandhi, Sunil P.			Cortical Plasticity Induced by Inhibitory Neuron Transplantation	SCIENCE			English	Article							FLUORESCENT PROTEIN EXPRESSION; OCULAR DOMINANCE PLASTICITY; DEVELOPING VISUAL-CORTEX; CRITICAL-PERIOD; GANGLIONIC EMINENCE; BASAL FOREBRAIN; ES CELLS; MOUSE; ADULT; BRAIN	Critical periods are times of pronounced brain plasticity. During a critical period in the postnatal development of the visual cortex, the occlusion of one eye triggers a rapid reorganization of neuronal responses, a process known as ocular dominance plasticity. We have shown that the transplantation of inhibitory neurons induces ocular dominance plasticity after the critical period. Transplanted inhibitory neurons receive excitatory synapses, make inhibitory synapses onto host cortical neurons, and promote plasticity when they reach a cellular age equivalent to that of endogenous inhibitory neurons during the normal critical period. These findings suggest that ocular dominance plasticity is regulated by the execution of a maturational program intrinsic to inhibitory neurons. By inducing plasticity, inhibitory neuron transplantation may facilitate brain repair.	[Southwell, Derek G.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Southwell, Derek G.; Alvarez-Buylla, Arturo] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Froemke, Robert C.] Univ Calif San Francisco, Dept Otolaryngol, San Francisco, CA 94143 USA; [Stryker, Michael P.; Gandhi, Sunil P.] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Alvarez-Buylla, A (corresponding author), Univ Calif San Francisco, Dept Neurol Surg, 513 Parnassus Ave, San Francisco, CA 94143 USA.	abuylla@stemcell.ucsf.edu; stryker@phy.ucsf.edu; sunil@phy.ucsf.edu		Alvarez-Buylla, Arturo/0000-0003-4426-8925; Southwell, Derek/0000-0001-6465-3869; Froemke, Robert/0000-0002-1230-6811; Stryker, Michael/0000-0003-1546-5831	National Institutes of Health [R01 NS048528, P50 MH077972, EY016317]; Dana Foundation [P0001351]; Adelson Medical Research Foundation; California Institute for Regenerative Medicine; NIDCD [K99/R00]; NATIONAL EYE INSTITUTE [F32EY016317] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [P50MH077972] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS048528] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Dana Foundation; Adelson Medical Research Foundation; California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank A. Kriegstein, P. Parker, and members of the Kriegstein laboratory for help with the electrophysiological recordings, R. Romero for assistance with histology, and P. McQuillen for sharing histology equipment. This work was funded by grants R01 NS048528 (A.A.-B.) and P50 MH077972 (M. P. S.) from the National Institutes of Health, grant P0001351 from the Dana Foundation (M. P. S.), and a grant from the Adelson Medical Research Foundation (M. P. S.). D. G. S. was supported by a predoctoral training grant from the California Institute for Regenerative Medicine. S. P. G. was supported by postdoctoral fellowship EY016317 from the National Institutes of Health. R. C. F. is a recipient of a NIDCD K99/R00 Career Award.	Alvarez-Dolado M, 2006, J NEUROSCI, V26, P7380, DOI 10.1523/JNEUROSCI.1540-06.2006; Anderson SA, 1997, SCIENCE, V278, P474, DOI 10.1126/science.278.5337.474; Cang JH, 2005, VISUAL NEUROSCI, V22, P685, DOI 10.1017/S0952523805225178; Fagiolini M, 2004, SCIENCE, V303, P1681, DOI 10.1126/science.1091032; Fagiolini M, 2000, NATURE, V404, P183, DOI 10.1038/35004582; Froemke RC, 2007, NATURE, V450, P425, DOI 10.1038/nature06289; Gandhi SP, 2008, P NATL ACAD SCI USA, V105, P16797, DOI 10.1073/pnas.0806159105; Gonchar Yuri, 2007, Front Neuroanat, V1, P3, DOI 10.3389/neuro.05.003.2007; Hadjantonakis AK, 1998, MECH DEVELOP, V76, P79, DOI 10.1016/S0925-4773(98)00093-8; Hanover JL, 1999, J NEUROSCI, V19, part. no.; Hensch TK, 2004, ANNU REV NEUROSCI, V27, P549, DOI 10.1146/annurev.neuro.27.070203.144327; Hensch TK, 1998, SCIENCE, V282, P1504, DOI 10.1126/science.282.5393.1504; Huang ZJ, 1999, CELL, V98, P739, DOI 10.1016/S0092-8674(00)81509-3; Kaneko M, 2008, NAT NEUROSCI, V11, P497, DOI 10.1038/nn2068; Kawaguchi Y, 1997, CEREB CORTEX, V7, P476, DOI 10.1093/cercor/7.6.476; Maffei A, 2006, NATURE, V443, P81, DOI 10.1038/nature05079; Maya-Vetencourt JF, 2008, SCIENCE, V320, P385, DOI 10.1126/science.1150516; Nery S, 2002, NAT NEUROSCI, V5, P1279, DOI 10.1038/nn971; Pizzorusso T, 2002, SCIENCE, V298, P1248, DOI 10.1126/science.1072699; Sugiyama S, 2008, CELL, V134, P508, DOI 10.1016/j.cell.2008.05.054; Taha S, 2002, NEURON, V36, P483, DOI 10.1016/S0896-6273(02)00966-2; Tamamaki N, 2003, J COMP NEUROL, V467, P60, DOI 10.1002/cne.10905; Vintersten K, 2004, GENESIS, V40, P241, DOI 10.1002/gene.20095; Wichterle H, 2001, DEVELOPMENT, V128, P3759; Wichterle H, 1999, NAT NEUROSCI, V2, P461, DOI 10.1038/8131; Wonders CP, 2006, NAT REV NEUROSCI, V7, P687, DOI 10.1038/nrn1954	26	200	202	0	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 26	2010	327	5969					1145	1148		10.1126/science.1183962	http://dx.doi.org/10.1126/science.1183962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185728	Green Accepted			2022-12-01	WOS:000274901100041
J	Han, JY; Yuan, P; Yang, H; Zhang, JQ; Soh, BS; Li, P; Lim, SL; Cao, SY; Tay, JL; Orlov, YL; Lufkin, T; Ng, HH; Tam, WL; Lim, B				Han, Jianyong; Yuan, Ping; Yang, Henry; Zhang, Jinqiu; Soh, Boon Seng; Li, Pin; Lim, Siew Lan; Cao, Suying; Tay, Junliang; Orlov, Yuriy L.; Lufkin, Thomas; Ng, Huck-Hui; Tam, Wai-Leong; Lim, Bing			Tbx3 improves the germ-line competency of induced pluripotent stem cells	NATURE			English	Article							SELF-RENEWAL; FIBROBLASTS; INDUCTION; NANOG; NETWORK; OCT4	Induced pluripotent stem (iPS) cells can be obtained by the introduction of defined factors into somatic cells(1). The combination of Oct4 (also known as Pou5f1), Sox2 and Klf4 (which we term OSK) constitutes the minimal requirement for generating iPS cells from mouse embryonic fibroblasts. These cells are thought to resemble embryonic stem cells (ESCs) on the basis of global gene expression analyses; however, few studies have tested the ability and efficiency of iPS cells to contribute to chimaerism, colonization of germ tissues, and most importantly, germ-line transmission and live birth from iPS cells produced by tetraploid complementation. Using genomic analyses of ESC genes that have roles in pluripotency and fusion-mediated somatic cell reprogramming, here we show that the transcription factor Tbx3 significantly improves the quality of iPS cells. iPS cells generated with OSK and Tbx3 (OSKT) are superior in both germ-cell contribution to the gonads and germline transmission frequency. However, global gene expression profiling could not distinguish between OSK and OSKT iPS cells. Genome-wide chromatin immunoprecipitation sequencing analysis of Tbx3-binding sites in ESCs suggests that Tbx3 regulates pluripotency-associated and reprogramming factors, in addition to sharing many common downstream regulatory targets with Oct4, Sox2, Nanog and Smad1. This study underscores the intrinsic qualitative differences between iPS cells generated by different methods, and highlights the need to rigorously characterize iPS cells beyond in vitro studies.	[Han, Jianyong; Yuan, Ping; Zhang, Jinqiu; Soh, Boon Seng; Li, Pin; Lim, Siew Lan; Cao, Suying; Tay, Junliang; Lufkin, Thomas; Ng, Huck-Hui; Tam, Wai-Leong; Lim, Bing] Stem Cell Dev Biol, Singapore 138648, Singapore; [Orlov, Yuriy L.] Genome Inst Singapore, Syst Biol, Singapore 138648, Singapore; [Han, Jianyong] China Agr Univ, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing 100193, Peoples R China; [Yang, Henry] Singapore Immunol Network, Singapore 138648, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 117543, Singapore; [Lim, Bing] Harvard Med Sch, Beth Israel Deaconess Med Ctr, Ctr Life Sci, Boston, MA 02115 USA	Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); China Agricultural University; Agency for Science Technology & Research (A*STAR); A*STAR - Singapore Immunology Network (SIgN); National University of Singapore; Harvard University; Beth Israel Deaconess Medical Center; Harvard Medical School	Tam, WL (corresponding author), Whitehead Inst Biomed Res, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	tamwl@wi.mit.edu; limb1@gis.a-star.edu.sg	Lufkin, Thomas/AAG-7476-2019; Ng, Huck Hui/A-1135-2009; Lufkin, Thomas/B-5352-2011; Orlov, Yuriy L/F-1520-2013; Tam, Wai Leong/P-1497-2019	Lufkin, Thomas/0000-0002-7902-4771; Lufkin, Thomas/0000-0002-7902-4771; Orlov, Yuriy L/0000-0003-0587-1609; Tam, Wai Leong/0000-0003-2365-5264; Yuan, Ping/0000-0001-7243-3487; NG, HUCK HUI/0000-0001-6352-8417	Agency for Science, Technology and Research (Singapore); Singapore Stem Cell Consortium [SSCC-06-003]; National Institutes of Health (NIH) [DK047636, AI54973]; A*STAR Post-doctoral Fellowship; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047636] Funding Source: NIH RePORTER	Agency for Science, Technology and Research (Singapore)(Agency for Science Technology & Research (A*STAR)); Singapore Stem Cell Consortium; National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); A*STAR Post-doctoral Fellowship(Agency for Science Technology & Research (A*STAR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	This work is supported by the Agency for Science, Technology and Research (Singapore) and the Singapore Stem Cell Consortium grant (SSCC-06-003). The work is also partially supported by National Institutes of Health (NIH) grants to B. L. (DK047636 and AI54973). W.-L. T. is supported by the A*STAR Post-doctoral Fellowship. We acknowledge the Genome Technology and Biology group for technical support. We are grateful to T. Huber, P. Robson and L. Stanton for critical comments, V. Cacheux-Rataboul for karyotype analyses, Y. Loon Lee, P. Gaughwin and colleagues from the Stem Cell and Developmental Biology group for technical assistance. We also thank T. Wakayama and N. Li for imparting mouse embryo manipulation techniques.	Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Chin MH, 2009, CELL STEM CELL, V5, P111, DOI 10.1016/j.stem.2009.06.008; Chua SW, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl024; Daley GQ, 2009, CELL STEM CELL, V4, P200, DOI 10.1016/j.stem.2009.02.009; Eakin GS, 2006, NAT PROTOC, V1, P1145, DOI 10.1038/nprot.2006.173; Feng B, 2009, NAT CELL BIOL, V11, P197, DOI 10.1038/ncb1827; Hotta A, 2008, J CELL BIOCHEM, V105, P940, DOI 10.1002/jcb.21912; Huangfu DW, 2008, NAT BIOTECHNOL, V26, P795, DOI 10.1038/nbt1418; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Jiang JM, 2008, NAT CELL BIOL, V10, P353, DOI 10.1038/ncb1698; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marson A, 2008, CELL STEM CELL, V3, P132, DOI 10.1016/j.stem.2008.06.019; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Ohta H, 2008, BIOL REPROD, V79, P486, DOI 10.1095/biolreprod.107.067116; Okita K, 2008, SCIENCE, V322, P949, DOI 10.1126/science.1164270; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Shi Y, 2008, CELL STEM CELL, V3, P568, DOI 10.1016/j.stem.2008.10.004; Silva J, 2006, NATURE, V441, P997, DOI 10.1038/nature04914; Silva J, 2008, PLOS BIOL, V6, P2237, DOI 10.1371/journal.pbio.0060253; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tam WL, 2008, STEM CELLS, V26, P2019, DOI 10.1634/stemcells.2007-1115; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wernig M, 2007, NATURE, V448, P318, DOI 10.1038/nature05944; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	25	213	254	1	77	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1096	+		10.1038/nature08735	http://dx.doi.org/10.1038/nature08735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20139965	Green Accepted			2022-12-01	WOS:000275108400040
J	Kang, C; Riazuddin, S; Mundorff, J; Krasnewich, D; Friedman, P; Mullikin, JC; Drayna, D				Kang, Changsoo; Riazuddin, Sheikh; Mundorff, Jennifer; Krasnewich, Donna; Friedman, Penelope; Mullikin, James C.; Drayna, Dennis			Mutations in the Lysosomal Enzyme-Targeting Pathway and Persistent Stuttering	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PSEUDO-HURLER POLYDYSTROPHY; I-CELL DISEASE; MUCOLIPIDOSIS-III; GENE; LINKAGE; N-ACETYLGLUCOSAMINE-1-PHOSPHOTRANSFERASE; PHENOTYPE; ETIOLOGY; SAMPLE	BACKGROUND Stuttering is a disorder of unknown cause characterized by repetitions, prolongations, and interruptions in the flow of speech. Genetic factors have been implicated in this disorder, and previous studies of stuttering have identified linkage to markers on chromosome 12. METHODS We analyzed the chromosome 12q23.3 genomic region in consanguineous Pakistani families, some members of which had nonsyndromic stuttering and in unrelated case and control subjects from Pakistan and North America. RESULTS We identified a missense mutation in the N-acetylglucosamine-1-phosphate transferase gene (GNPTAB), which encodes the alpha and beta catalytic subunits of GlcNAc-phosphotransferase (GNPT [EC 2.7.8.15]), that was associated with stuttering in a large, consanguineous Pakistani family. This mutation occurred in the affected members of approximately 10% of Pakistani families studied, but it occurred only once in 192 chromosomes from unaffected, unrelated Pakistani control subjects and was not observed in 552 chromosomes from unaffected, unrelated North American control subjects. This and three other mutations in GNPTAB occurred in unrelated subjects with stuttering but not in control subjects. We also identified three mutations in the GNPTG gene, which encodes the gamma subunit of GNPT, in affected subjects of Asian and European descent but not in control subjects. Furthermore, we identified three mutations in the NAGPA gene, which encodes the so-called uncovering enzyme, in other affected subjects but not in control subjects. These genes encode enzymes that generate the mannose-6-phosphate signal, which directs a diverse group of hydrolases to the lysosome. Deficits in this system are associated with the mucolipidoses, rare lysosomal storage disorders that are most commonly associated with bone, connective tissue, and neurologic symptoms. CONCLUSIONS Susceptibility to nonsyndromic stuttering is associated with variations in genes governing lysosomal metabolism.	[Kang, Changsoo; Drayna, Dennis] Natl Inst Deafness & Other Commun Disorders, NIH, Bethesda, MD USA; [Mullikin, James C.] NHGRI, Genome Technol Branch, NIH, Bethesda, MD 20892 USA; [Friedman, Penelope] NIH, Ctr Clin, Bethesda, MD 20892 USA; [Riazuddin, Sheikh] Univ Punjab, Ctr Excellence Mol Biol, Lahore, Pakistan; [Mundorff, Jennifer] Hollins Commun Res Inst, Roanoke, VA USA	National Institutes of Health (NIH) - USA; NIH National Institute on Deafness & Other Communication Disorders (NIDCD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); University of Punjab	Drayna, D (corresponding author), 5 Res Ct,Rm 2B-46, Rockville, MD 20850 USA.	drayna@nidcd.nih.gov	Resource Center, NINDS Human Genetics/AGF-2474-2022; Sander-Effron, Samuel/AAX-2231-2020		National Institute on Deafness and Other Communication Disorders [Z01-000046-09]; National Human Genome Research Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200330, ZIBHG000196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [ZIADC000046] Funding Source: NIH RePORTER	National Institute on Deafness and Other Communication Disorders(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	Supported by grants from the Intramural Research Program of the National Institute on Deafness and Other Communication Disorders (Z01-000046-09, to Dr. Drayna) and the National Human Genome Research Institute (to Dr. Mullikin).	ANDREWS G, 1991, ARCH GEN PSYCHIAT, V48, P1034; Bao M, 1996, J BIOL CHEM, V271, P31437, DOI 10.1074/jbc.271.49.31437; Bargal R, 2007, MOL GENET METAB, V91, P299, DOI 10.1016/j.ymgme.2007.04.007; Bargal R, 2006, MOL GENET METAB, V88, P359, DOI 10.1016/j.ymgme.2006.03.003; BLOODSTEIN O, 1961, J SPEECH HEAR DISORD, V26, P395, DOI 10.1044/jshd.2604.395; Bloodstein O., 2021, HDB STUTTERING, Vseventh; CORPET F, 1988, NUCLEIC ACIDS RES, V16, P10881, DOI 10.1093/nar/16.22.10881; Dworzynski K, 2007, AM J SPEECH-LANG PAT, V16, P169, DOI 10.1044/1058-0360(2007/021); Felsenfeld S, 2000, BEHAV GENET, V30, P359, DOI 10.1023/A:1002765620208; Felsenfeld S, 1997, J SPEECH LANG HEAR R, V40, P778, DOI 10.1044/jslhr.4004.778; HOWIE PM, 1981, J SPEECH HEAR RES, V24, P317, DOI 10.1044/jshr.2403.317; KORNFELD S, 2001, METABOLIC MOL BASES, V3, P3469; Kudo M, 2006, AM J HUM GENET, V78, P451, DOI 10.1086/500849; LEROY JG, GENEREVIEWS; MCFARLANE WB, 1991, J FLUENCY DISORD, V16, P117; Ooki S, 2005, TWIN RES HUM GENET, V8, P69, DOI 10.1375/twin.8.1.69; Otomo T, 2009, J HUM GENET, V54, P145, DOI 10.1038/jhg.2009.3; Pinkel D, 1998, NAT GENET, V20, P207, DOI 10.1038/2524; Raas-Rothschild A, 2004, J MED GENET, V41, DOI 10.1136/jmg.2003.015222; Raas-Rothschild A, 2000, J CLIN INVEST, V105, P673, DOI 10.1172/JCI5826; REITMAN ML, 1981, J CLIN INVEST, V67, P1574, DOI 10.1172/JCI110189; Riaz N, 2005, AM J HUM GENET, V76, P647, DOI 10.1086/429226; Riley G., 1994, STUTTERING SEVERITY; Shugart YY, 2004, AM J MED GENET A, V124A, P133, DOI 10.1002/ajmg.a.20347; Smuts I, 2009, ANN NY ACAD SCI, V1151, P77, DOI 10.1111/j.1749-6632.2008.03451.x; Suresh R, 2006, AM J HUM GENET, V78, P554, DOI 10.1086/501370; Tiede S, 2005, AM J MED GENET A, V137A, P235, DOI 10.1002/ajmg.a.30868; Viswanath N, 2004, HUM BIOL, V76, P401, DOI 10.1353/hub.2004.0050; Webster R. L., 1979, CONTROVERSIES STUTTE, P209; Wittke-Thompson JK, 2007, J FLUENCY DISORD, V32, P33, DOI 10.1016/j.jfludis.2006.12.002; Yairi E, 1999, J SPEECH LANG HEAR R, V42, P1097, DOI 10.1044/jslhr.4205.1097	31	120	135	0	22	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					677	685		10.1056/NEJMoa0902630	http://dx.doi.org/10.1056/NEJMoa0902630			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20147709	Green Accepted			2022-12-01	WOS:000274845600006
J	Kat, L; Schipper, K; Knibbe, J; Abma, TA				Kat, Linda; Schipper, Karen; Knibbe, Jeroen; Abma, Tineke A.			A Patient's Journey Acquired brain injury	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Kat, Linda; Schipper, Karen; Knibbe, Jeroen] Reinaerde, Amsterdam, Netherlands; [Schipper, Karen; Abma, Tineke A.] Vrije Univ Amsterdam Med Ctr, Dept Med Humanities, EMGO Inst, NL-1081 BT Amsterdam, Netherlands	Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER	Schipper, K (corresponding author), Reinaerde, Amsterdam, Netherlands.	k.schipper@vumc.nl	Abma, Tineke/AER-4580-2022	Abma, Tineke/0000-0002-8902-322X					0	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 19	2010	340								c808	10.1136/bmj.c808	http://dx.doi.org/10.1136/bmj.c808			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JX	20172926				2022-12-01	WOS:000274739200010
J	Bibbins-Domingo, K; Chertow, GM; Coxson, PG; Moran, A; Lightwood, JM; Pletcher, MJ; Goldman, L				Bibbins-Domingo, Kirsten; Chertow, Glenn M.; Coxson, Pamela G.; Moran, Andrew; Lightwood, James M.; Pletcher, Mark J.; Goldman, Lee			Projected Effect of Dietary Salt Reductions on Future Cardiovascular Disease	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BLOOD-PRESSURE; SODIUM RESTRICTION; COST-EFFECTIVENESS; SUBGROUP ANALYSIS; HYPERTENSION; METAANALYSIS; PREVENTION; STRATEGIES; PREDICTION; STROKE	BACKGROUND The U. S. diet is high in salt, with the majority coming from processed foods. Reducing dietary salt is a potentially important target for the improvement of public health. METHODS We used the Coronary Heart Disease (CHD) Policy Model to quantify the benefits of potentially achievable, population-wide reductions in dietary salt of up to 3 g per day (1200 mg of sodium per day). We estimated the rates and costs of cardiovascular disease in subgroups defined by age, sex, and race; compared the effects of salt reduction with those of other interventions intended to reduce the risk of cardiovascular disease; and determined the cost-effectiveness of salt reduction as compared with the treatment of hypertension with medications. RESULTS Reducing dietary salt by 3 g per day is projected to reduce the annual number of new cases of CHD by 60,000 to 120,000, stroke by 32,000 to 66,000, and myocardial infarction by 54,000 to 99,000 and to reduce the annual number of deaths from any cause by 44,000 to 92,000. All segments of the population would benefit, with blacks benefiting proportionately more, women benefiting particularly from stroke reduction, older adults from reductions in CHD events, and younger adults from lower mortality rates. The cardiovascular benefits of reduced salt intake are on par with the benefits of population-wide reductions in tobacco use, obesity, and cholesterol levels. A regulatory intervention designed to achieve a reduction in salt intake of 3 g per day would save 194,000 to 392,000 quality-adjusted life-years and $10 billion to $24 billion in health care costs annually. Such an intervention would be cost-saving even if only a modest reduction of 1 g per day were achieved gradually between 2010 and 2019 and would be more cost-effective than using medications to lower blood pressure in all persons with hypertension. CONCLUSIONS Modest reductions in dietary salt could substantially reduce cardiovascular events and medical costs and should be a public health target.	[Bibbins-Domingo, Kirsten; Coxson, Pamela G.; Pletcher, Mark J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten; Pletcher, Mark J.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Lightwood, James M.] Univ Calif San Francisco, Sch Pharm, Dept Clin Pharm, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten; Coxson, Pamela G.] Univ Calif San Francisco, San Francisco Gen Hosp, Div Gen Internal Med, San Francisco, CA 94143 USA; [Bibbins-Domingo, Kirsten; Coxson, Pamela G.] Univ Calif San Francisco, San Francisco Gen Hosp, Ctr Vulnerable Populat, San Francisco, CA 94143 USA; [Chertow, Glenn M.] Stanford Univ, Dept Med, Palo Alto, CA 94304 USA; [Moran, Andrew; Goldman, Lee] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; Stanford University; Columbia University	Bibbins-Domingo, K (corresponding author), Univ Calif San Francisco, Dept Med, Box 1364 UCSF SFGH, San Francisco, CA 94143 USA.			Chertow, Glenn/0000-0002-7599-0534	American Heart Association Western States Affiliate [09GRNT2060096]; University of California, San Francisco Clinical and Translational Sciences Institute [UL1 RR024131]; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024131] Funding Source: NIH RePORTER	American Heart Association Western States Affiliate(American Heart Association); University of California, San Francisco Clinical and Translational Sciences Institute(University of California System); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	Supported in part by a grant-in-aid from the American Heart Association Western States Affiliate (09GRNT2060096) and an intramural pilot grant from the University of California, San Francisco Clinical and Translational Sciences Institute (NIH-NCRR UCSF-CTSI UL1 RR024131).	*ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; Asaria P, 2007, LANCET, V370, P2044, DOI 10.1016/S0140-6736(07)61698-5; Ayala C., 2009, Morbidity and Mortality Weekly Report, V58, P281; Bibbins-Domingo K, 2007, NEW ENGL J MED, V357, P2371, DOI 10.1056/NEJMsa073166; Bibbins-Domingo K, 2009, NEW ENGL J MED, V360, P1179, DOI 10.1056/NEJMoa0807265; BLAIS CA, 1986, AM J CLIN NUTR, V44, P232, DOI 10.1093/ajcn/44.2.232; Bray GA, 2004, AM J CARDIOL, V94, P222, DOI 10.1016/j.amjcard.2004.03.070; Cappuccio FP, 1997, LANCET, V350, P850, DOI 10.1016/S0140-6736(97)02264-2; Chambless LE, 2004, AM J EPIDEMIOL, V160, P259, DOI 10.1093/aje/kwh189; Chobanian AV, 2009, NEW ENGL J MED, V361, P1516; Chobanian AV, 2009, NEW ARMEN MED J, V3, P60, DOI 10.1056/NEJMsa0903829; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; D'Agostino RB, 2001, JAMA-J AM MED ASSOC, V286, P180, DOI 10.1001/jama.286.2.180; Danaei G, 2009, PLOS MED, V6, DOI 10.1371/journal.pmed.1000058; Food Standards Agency, 2008, DIET SOD LEV SURV; Furberg CD, 2002, JAMA-J AM MED ASSOC, V288, P2981; Griffith JL, 2003, JAMA-J AM MED ASSOC, V289, P178; Hajjar I, 2003, JAMA-J AM MED ASSOC, V290, P199, DOI 10.1001/jama.290.2.199; Havas S, 2007, JAMA-J AM MED ASSOC, V298, P1439, DOI 10.1001/jama.298.12.1439; He F, 2002, J HUM HYPERTENS, V16, P761, DOI 10.1038/sj.jhh.1001459; He FJ, 2009, J HUM HYPERTENS, V23, P363, DOI 10.1038/jhh.2008.144; He FJ, 2006, HYPERTENSION, V48, P861, DOI 10.1161/01.HYP.0000245672.27270.4a; He FJ, 2003, HYPERTENSION, V42, P1093, DOI 10.1161/01.HYP.0000102864.05174.E8; He FJ, 2004, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD004937, DOI 10.1002/14651858.CD004937]; Heidenreich PA, 2008, J GEN INTERN MED, V23, P509, DOI 10.1007/s11606-008-0515-2; Hooper L., 2004, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003656.PUB2; Institute of Medicine Panel on Dietary Reference Intakes for Electrolytes and Water, 2005, DIET REF INT WAT POT; Kissela B, 2004, STROKE, V35, P426, DOI 10.1161/01.STR.0000110982.74967.39; LAW MR, 1991, BRIT MED J, V302, P939; LAW MR, 1991, BMJ-BRIT MED J, V302, P819, DOI 10.1136/bmj.302.6780.819; Lightwood JM, 2009, AM J PREV MED, V36, P13, DOI 10.1016/j.amepre.2008.09.030; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; MACGREGOR GA, 1989, LANCET, V2, P1244, DOI 10.1016/S0140-6736(89)91852-7; Maruthur NM, 2009, CIRCULATION, V119, P2026, DOI 10.1161/CIRCULATIONAHA.108.809491; MATTES RD, 1991, J AM COLL NUTR, V10, P383; Otten JJ., 2006, DIETARY REFERENCE IN; Palar K, 2009, AM J HEALTH PROMOT, V24, P49, DOI 10.4278/ajhp.080826-QUAN-164; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Sacks FM, 2001, NEW ENGL J MED, V344, P3, DOI 10.1056/NEJM200101043440101; STAMLER J, 1989, HYPERTENSION, V14, P570, DOI 10.1161/01.HYP.14.5.570; Swift PA, 2005, HYPERTENSION, V46, P308, DOI 10.1161/01.HYP.0000172662.12480.7f; U.S. Department of Agriculture: Agricultural Research Service, 2008, NUTR INT FOOD MEAN A; Vollmer WM, 2001, ANN INTERN MED, V135, P1019, DOI 10.7326/0003-4819-135-12-200112180-00005; WHO, 2021, NEW WHO BENCHM HELP; Williams GR, 1999, STROKE, V30, P2523, DOI 10.1161/01.STR.30.12.2523; Wong MD, 2002, NEW ENGL J MED, V347, P1585, DOI 10.1056/NEJMsa012979	46	827	860	2	176	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 18	2010	362	7					590	599		10.1056/NEJMoa0907355	http://dx.doi.org/10.1056/NEJMoa0907355			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	556ED	20089957	Green Accepted			2022-12-01	WOS:000274571200007
J	Shi, DL; Xu, Y; Hopkinson, BM; Morel, FMM				Shi, Dalin; Xu, Yan; Hopkinson, Brian M.; Morel, Francois M. M.			Effect of Ocean Acidification on Iron Availability to Marine Phytoplankton	SCIENCE			English	Article							ACQUISITION; SEAWATER; LIGANDS; GROWTH; CARBON; CALCIFICATION; COMPLEXATION; TEMPERATURE; REDUCTION; IRON(III)	The acidification caused by the dissolution of anthropogenic carbon dioxide (CO(2)) in the ocean changes the chemistry and hence the bioavailability of iron (Fe), a limiting nutrient in large oceanic regions. Here, we show that the bioavailability of dissolved Fe may decline because of ocean acidification. Acidification of media containing various Fe compounds decreases the Fe uptake rate of diatoms and coccolithophores to an extent predicted by the changes in Fe chemistry. A slower Fe uptake by a model diatom with decreasing pH is also seen in experiments with Atlantic surface water. The Fe requirement of model phytoplankton remains unchanged with increasing CO(2). The ongoing acidification of seawater is likely to increase the Fe stress of phytoplankton populations in some areas of the ocean.	[Shi, Dalin; Xu, Yan; Hopkinson, Brian M.; Morel, Francois M. M.] Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA	Princeton University	Shi, DL (corresponding author), Princeton Univ, Dept Geosci, Princeton, NJ 08544 USA.	dshi@princeton.edu	Shi, Dalin/E-6361-2011	Shi, Dalin/0000-0003-4432-1992	NSF; BP and Ford Motor Company; Directorate For Geosciences [0825192] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); BP and Ford Motor Company; Directorate For Geosciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	The authors wish to thank J.-P. Bellenger and T. Wichard for helpful discussions and supplying azotochelin. The authors gratefully acknowledge C. Haldeman and S. Glenn (Rutgers University) for assistance with water collection off the New Jersey coast and M. Lomas, K. Buck, M. Tiahlo (Bermuda Institute of Ocean Sciences), and the captain and crew of the R/V Atlantic Explorer for their help on the experiments conducted in the BATS region. Funding was provided by NSF and by a grant from BP and Ford Motor Company to the Princeton Environmental Institute.	Ramos JBE, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2006GB002898; Boyd PW, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2005GB002494; Breitbarth E., 2009, BIOGEOSCI DISCUSS, V6, P6781, DOI DOI 10.5194/BGD-6-6781-2009; Castruita M, 2006, APPL ENVIRON MICROB, V72, P2918, DOI 10.1128/AEM.72.4.2918-2924.2006; Castruita M, 2008, LIMNOL OCEANOGR, V53, P890, DOI 10.4319/lo.2008.53.3.0890; Coale KH, 1996, NATURE, V379, P621, DOI 10.1038/379621a0; Feng Y, 2008, EUR J PHYCOL, V43, P87, DOI 10.1080/09670260701664674; Gattuso JP, 1998, GLOBAL PLANET CHANGE, V18, P37, DOI 10.1016/S0921-8181(98)00035-6; Gledhill M, 1998, MAR CHEM, V59, P283, DOI 10.1016/S0304-4203(97)00097-2; GLEDHILL M, 1994, MAR CHEM, V47, P41, DOI 10.1016/0304-4203(94)90012-4; Kustka AB, 2007, J PHYCOL, V43, P715, DOI 10.1111/j.1529-8817.2007.00359.x; Macrellis HM, 2001, MAR CHEM, V76, P175, DOI 10.1016/S0304-4203(01)00061-5; Maldonado MT, 2001, J PHYCOL, V37, P298, DOI 10.1046/j.1529-8817.2001.037002298.x; Moffett J. W., 2001, BIOGEOCHEMISTRY IRON, P343; Reinfelder JR, 2000, NATURE, V407, P996, DOI 10.1038/35039612; RICH HW, 1990, LIMNOL OCEANOGR, V35, P652, DOI 10.4319/lo.1990.35.3.0652; Riebesell U, 2000, NATURE, V407, P364, DOI 10.1038/35030078; Riebesell U, 2007, NATURE, V450, P545, DOI 10.1038/nature06267; Rost B, 2003, LIMNOL OCEANOGR, V48, P55, DOI 10.4319/lo.2003.48.1.0055; RUE EL, 1995, MAR CHEM, V50, P117, DOI 10.1016/0304-4203(95)00031-L; Shaked Y, 2005, LIMNOL OCEANOGR, V50, P872, DOI 10.4319/lo.2005.50.3.0872; Strzepek RF, 2004, NATURE, V431, P689, DOI 10.1038/nature02954; SULTEMEYER DF, 1987, PHOTOSYNTH RES, V12, P25, DOI 10.1007/BF00019148; Sunda W, 2003, MAR CHEM, V84, P35, DOI 10.1016/S0304-4203(03)00101-4; Sunda W.G.P..N.M., 2005, ALGAL CULTURING TECH, V4, P35, DOI [10.1016/b978-012088426-1/50005-6, DOI 10.1016/B978-012088426-1/50005-6]; SUNDA WG, 1995, MAR CHEM, V50, P189, DOI 10.1016/0304-4203(95)00035-P; Sunda WG, 1997, NATURE, V390, P389, DOI 10.1038/37093; Tortell PD, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032583; Xue XP, 1998, J PHYCOL, V34, P939, DOI 10.1046/j.1529-8817.1998.340939.x	29	241	259	13	369	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					676	679		10.1126/science.1183517	http://dx.doi.org/10.1126/science.1183517			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20075213				2022-12-01	WOS:000274251800034
J	Doeller, CF; Barry, C; Burgess, N				Doeller, Christian F.; Barry, Caswell; Burgess, Neil			Evidence for grid cells in a human memory network	NATURE			English	Article							MEDIAL TEMPORAL-LOBE; ENTORHINAL CORTEX; SPATIAL NAVIGATION; PATH-INTEGRATION; HEAD-DIRECTION; HIPPOCAMPUS; MODEL; BRAIN; FMRI; REPRESENTATIONS	Grid cells in the entorhinal cortex of freely moving rats provide a strikingly periodic representation of self-location(1) which is indicative of very specific computational mechanisms(2-4). However, the existence of grid cells in humans and their distribution throughout the brain are unknown. Here we show that the preferred firing directions of directionally modulated grid cells in rat entorhinal cortex are aligned with the grids, and that the spatial organization of grid-cell firing is more strongly apparent at faster than slower running speeds. Because the grids are also aligned with each other(1,5), we predicted a macroscopic signal visible to functional magnetic resonance imaging (fMRI) in humans. We then looked for this signal as participants explored a virtual reality environment, mimicking the rats' foraging task: fMRI activation and adaptation showing a speed-modulated six-fold rotational symmetry in running direction. The signal was found in a network of entorhinal/subicular, posterior and medial parietal, lateral temporal and medial prefrontal areas. The effect was strongest in right entorhinal cortex, and the coherence of the directional signal across entorhinal cortex correlated with spatial memory performance. Our study illustrates the potential power of combining single-unit electrophysiology with fMRI in systems neuroscience. Our results provide evidence for grid-cell-like representations in humans, and implicate a specific type of neural representation in a network of regions which supports spatial cognition and also autobiographical memory.	[Doeller, Christian F.; Barry, Caswell; Burgess, Neil] UCL Inst Cognit Neurosci, London WC1N 3AR, England; [Doeller, Christian F.; Burgess, Neil] UCL Inst Neurol, London WC1N 3BG, England; [Barry, Caswell] UCL, Dept Cell & Dev Biol, London WC1E 6BT, England; [Barry, Caswell] UCL, Inst Behav Neurosci, London WC1H 0AP, England	University of London; University College London; University of London; University College London; University of London; University College London; University of London; University College London	Doeller, CF (corresponding author), UCL Inst Cognit Neurosci, London WC1N 3AR, England.	c.doeller@ucl.ac.uk; n.burgess@ucl.ac.uk	Doeller, Christian/E-6376-2012; Burgess, Neil/B-2420-2009	Burgess, Neil/0000-0003-0646-6584	UK Medical Research Council; European Union; Medical Research Council [G0501672] Funding Source: researchfish; MRC [G0501672] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union(European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We acknowledge K. Jeffery and J. O'Keefe for providing help and facilities for single-unit recording; the Wellcome Trust Centre for Neuroimaging at UCL for providing help and scanning facilities; J. Krupic and R. Hayman for help with single-unit data collection; A. Jeewajee for help with analyses; J. King for help with virtual reality programming; and useful discussions with P. Dayan, K. Friston, U. Frith, C. Hall, A. Jeewajee, J. O'Keefe and M. Witter. This work was funded by the UK Medical Research Council and the European Union (SpaceBrain grant).	Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 2005, NEUROIMAGE, V26, P839, DOI 10.1016/j.neuroimage.2005.02.018; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Barry C, 2007, NAT NEUROSCI, V10, P682, DOI 10.1038/nn1905; BOCCARA CN, 2008, FENS ABSTR, V4; Buchel C, 1998, NEUROIMAGE, V8, P140, DOI 10.1006/nimg.1998.0351; Burgess N, 2007, HIPPOCAMPUS, V17, P801, DOI 10.1002/hipo.20327; Byrne P, 2007, PSYCHOL REV, V114, P340, DOI 10.1037/0033-295X.114.2.340; CHEN LL, 1994, EXP BRAIN RES, V101, P8, DOI 10.1007/BF00243212; Doeller CF, 2008, P NATL ACAD SCI USA, V105, P5915, DOI 10.1073/pnas.0801489105; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Ekstrom AD, 2003, NATURE, V425, P184, DOI 10.1038/nature01964; Epstein R, 2003, NEURON, V37, P865, DOI 10.1016/S0896-6273(03)00117-X; Fernandez G, 1999, HIPPOCAMPUS, V9, P35, DOI 10.1002/(SICI)1098-1063(1999)9:1<35::AID-HIPO4>3.0.CO;2-Z; Fischl B, 2009, NEUROIMAGE, V47, P8, DOI 10.1016/j.neuroimage.2009.04.033; GAFFAN D, 1994, J COGNITIVE NEUROSCI, V6, P305, DOI 10.1162/jocn.1994.6.4.305; Grill-Spector K, 2006, TRENDS COGN SCI, V10, P14, DOI 10.1016/j.tics.2005.11.006; Hafting T, 2005, NATURE, V436, P801, DOI 10.1038/nature03721; Hasselmo ME, 2009, NEUROBIOL LEARN MEM, V92, P559, DOI 10.1016/j.nlm.2009.07.005; Howard MW, 2005, PSYCHOL REV, V112, P75, DOI 10.1037/0033-295X.112.1.75; Hutton C, 2002, NEUROIMAGE, V16, P217, DOI 10.1006/nimg.2001.1054; INSAUSTI R, 1995, J COMP NEUROL, V355, P171, DOI 10.1002/cne.903550203; Jeewajee A, 2008, HIPPOCAMPUS, V18, P1175, DOI 10.1002/hipo.20510; Knierim JJ, 2006, LEARN MEMORY, V13, P405, DOI 10.1101/lm.224606; Logothetis NK, 2008, NATURE, V453, P869, DOI 10.1038/nature06976; Maguire EA, 2001, PHILOS T R SOC B, V356, P1441, DOI 10.1098/rstb.2001.0944; McNaughton BL, 2006, NAT REV NEUROSCI, V7, P663, DOI 10.1038/nrn1932; O'Keefe J, 1978, HIPPOCAMPUS COGNITIV; Olsen RK, 2009, J NEUROSCI, V29, P11880, DOI 10.1523/JNEUROSCI.2245-09.2009; Park S, 2007, NEURON, V54, P335, DOI 10.1016/j.neuron.2007.04.006; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; RECCE M K, 1989, Society for Neuroscience Abstracts, V15, P1250; Sargolini F, 2006, SCIENCE, V312, P758, DOI 10.1126/science.1125572; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Taube JS, 1998, PROG NEUROBIOL, V55, P225, DOI 10.1016/S0301-0082(98)00004-5; Weiskopf N, 2006, NEUROIMAGE, V33, P493, DOI 10.1016/j.neuroimage.2006.07.029; Whitlock JR, 2008, P NATL ACAD SCI USA, V105, P14755, DOI 10.1073/pnas.0804216105; Wolbers T, 2007, J NEUROSCI, V27, P9408, DOI 10.1523/JNEUROSCI.2146-07.2007	38	407	420	4	125	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	2010	463	7281					657	U87		10.1038/nature08704	http://dx.doi.org/10.1038/nature08704			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20090680	Green Accepted, Green Published			2022-12-01	WOS:000274193900035
J	Gribble, FM				Gribble, Fiona M.			alpha(2A)-Adrenergic Receptors and Type 2 Diabetes	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England	Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge	Gribble, FM (corresponding author), Addenbrookes Hosp, Cambridge Inst Med Res, Cambridge, England.			Gribble, Fiona/0000-0002-4232-2898	Wellcome Trust [088357] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		DEVRIES A, 1949, AM J MED, V6, P51, DOI 10.1016/0002-9343(49)90006-6; McCarthy MI, 2009, CURR DIABETES REP, V9, P164, DOI 10.1007/s11892-009-0027-4; ROSENGREN AH, 2009, SCIENCE         1119; Small KM, 2006, P NATL ACAD SCI USA, V103, P5472, DOI 10.1073/pnas.0601345103	4	20	21	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					361	362		10.1056/NEJMcibr0911499	http://dx.doi.org/10.1056/NEJMcibr0911499			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548OT	20107223				2022-12-01	WOS:000273975000014
J	Harkins, C				Harkins, Claire			Lobby Watch The Portman Group	BRITISH MEDICAL JOURNAL			English	Editorial Material							INDUSTRY		Univ Strathclyde, Dept Geog & Sociol, Glasgow G1 1XN, Lanark, Scotland	University of Strathclyde	Harkins, C (corresponding author), Univ Strathclyde, Dept Geog & Sociol, Glasgow G1 1XN, Lanark, Scotland.	c.harkins@strath.ac.uk						*ALC, LEAD HLTH CHAR CALL; Babor TF, 1996, ADDICTION, V91, P5, DOI 10.1111/j.1360-0443.1996.tb03150.x; *BMA, UND INFL DAM EFF ALC; *BMA SCOTL, WRITT RESP SCOTT GOV; CAREY J, RECREATIONAL DRUG WA; Coussins J, 2004, BRIT MED J, V329, P404, DOI 10.1136/bmj.329.7462.404-b; Donaldson LJ, 2008, 150 YEARS ANN REPORT; EDWARDS G, 1992, ALCOHOL POLICY PUBLI; *FAME DAT, CO REP PORTM GROUP; *HOUS COMM HLTH CO, ALC REP 1 SESS 2009; *PORTM GROUP, BMA IGN WORLD CLASS; *PORTM GROUP, CHANG SCOTL REL ALC; *PORTM GROUP, HLTH COMM RESP; *PRIM MIN STRAT UN, ALC HARM RED STRAT E; *PROTM GROUP, US; *SCOTT GOV, CHANG SCOTL REL ALC; SMITH R, 1994, BRIT MED J, V309, P1597, DOI 10.1136/bmj.309.6969.1597; Stevens A, 2007, SOC POLICY SOC, V6, P25, DOI 10.1017/S1474746406003319; *U SHEFF SCH HLTH, MOD BAS APPR ALC MIN	19	6	6	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 20	2010	340								b5659	10.1136/bmj.b5659	http://dx.doi.org/10.1136/bmj.b5659			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548HO	20089577				2022-12-01	WOS:000273951300005
J	Rowe, HM; Jakobsson, J; Mesnard, D; Rougemont, J; Reynard, S; Aktas, T; Maillard, PV; Layard-Liesching, H; Verp, S; Marquis, J; Spitz, F; Constam, DB; Trono, D				Rowe, Helen M.; Jakobsson, Johan; Mesnard, Daniel; Rougemont, Jacques; Reynard, Severine; Aktas, Tugce; Maillard, Pierre V.; Layard-Liesching, Hillary; Verp, Sonia; Marquis, Julien; Spitz, Francois; Constam, Daniel B.; Trono, Didier			KAP1 controls endogenous retroviruses in embryonic stem cells	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; RNAI SCREEN; BINDING; COREPRESSOR; GENOME; RETROTRANSPOSONS; METHYLATION; EXPRESSION; REPRESSION; HP1	More than forty per cent of the mammalian genome is derived from retroelements, of which about one-quarter are endogenous retroviruses (ERVs)(1). Some are still active, notably in mice the highly polymorphic early transposon (ETn)/MusD and intracisternal A-type particles (IAP)(2,3). ERVs are transcriptionally silenced during early embryogenesis by histone and DNA methylation(4-6) (and reviewed in ref. 7), although the initiators of this process, which is essential to protect genome integrity(8), remain largely unknown. KAP1 (KRAB-associated protein 1, also known as tripartite motif-containing protein 28, TRIM28) represses genes by recruiting the histone methyltransferase SETDB1, heterochromatin protein 1 (HP1) and the NuRD histone deacetylase complex(9), but few of its physiological targets are known. Two lines of evidence suggest that KAP1-mediated repression could contribute to the control of ERVs: first, KAP1 can trigger permanent gene silencing during early embryogenesis(10), and second, a KAP1 complex silences the retrovirus murine leukaemia virus in embryonic cells(11-13). Consistent with this hypothesis, here we show that KAP1 deletion leads to a marked upregulation of a range of ERVs, in particular IAP elements, in mouse embryonic stem (ES) cells and in early embryos. We further demonstrate that KAP1 acts synergistically with DNA methylation to silence IAP elements, and that it is enriched at the 5' untranslated region (5'UTR) of IAP genomes, where KAP1 deletion leads to the loss of histone 3 lysine 9 trimethylation (H3K9me3), a hallmark of KAP1-mediated repression. Correspondingly, IAP 5'UTR sequences can impose in cis KAP1-dependent repression on a heterologous promoter in ES cells. Our results establish that KAP1 controls endogenous retroelements during early embryonic development.	[Rowe, Helen M.; Jakobsson, Johan; Mesnard, Daniel; Rougemont, Jacques; Reynard, Severine; Maillard, Pierre V.; Layard-Liesching, Hillary; Verp, Sonia; Marquis, Julien; Constam, Daniel B.; Trono, Didier] Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland; [Aktas, Tugce; Spitz, Francois] EMBL Heidelberg, D-69117 Heidelberg, Germany	Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; European Molecular Biology Laboratory (EMBL)	Trono, D (corresponding author), Ecole Polytech Fed Lausanne, Sch Life Sci, CH-1015 Lausanne, Switzerland.	didier.trono@epfl.ch	Maillard, Pierre V/V-4305-2019; Rowe, Helen/AAQ-7138-2021; Jakobsson, Johan/E-7745-2014	Maillard, Pierre V/0000-0003-4611-388X; Rowe, Helen/0000-0001-5881-0290; Jakobsson, Johan/0000-0003-0669-7673; Aktas, Tugce/0000-0003-1599-9454; Constam, Daniel B./0000-0002-6256-3891; Spitz, Francois/0000-0002-1960-829X	Swiss National Science Foundation; Infectigen Association and the Strauss Foundation; Swedish Research Council	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Infectigen Association and the Strauss Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission)	We thank P. Turelli and I. Barde for advice, F. Cammas and R. Losson for the Kap1<SUP>loxp/loxP</SUP> and Kap1<SUP>+/-</SUP> mice, D. Schultz for the KAP1-specific antibody, and K. Harshman at the genomics platform for the Illumina high throughput sequencing. This work was supported by grants from the Swiss National Science Foundation, the Infectigen Association and the Strauss Foundation to D. T., and by a post-doctoral fellowship from the Swedish Research Council to J.J.	Bryja V, 2006, NAT PROTOC, V1, P2082, DOI 10.1038/nprot.2006.355; Cammas F, 2004, GENE DEV, V18, P2147, DOI 10.1101/gad.302904; Dewannieux M, 2004, NAT GENET, V36, P534, DOI 10.1038/ng1353; Emerson RO, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000325; Faulkner GJ, 2009, NAT GENET, V41, P563, DOI 10.1038/ng.368; Fazzio TG, 2008, CELL, V134, P162, DOI 10.1016/j.cell.2008.05.031; Friedman JR, 1996, GENE DEV, V10, P2067, DOI 10.1101/gad.10.16.2067; Haas DL, 2003, J VIROL, V77, P9439, DOI 10.1128/JVI.77.17.9439-9450.2003; Hu G, 2009, GENE DEV, V23, P837, DOI 10.1101/gad.1769609; Krebs CJ, 2005, GENOMICS, V85, P752, DOI 10.1016/j.ygeno.2005.03.004; Maillard PV, 2007, PLOS PATHOG, V3, P2052, DOI 10.1371/journal.ppat.0030200; Maksakova IA, 2008, CELL MOL LIFE SCI, V65, P3329, DOI 10.1007/s00018-008-8494-3; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; MIETZ JA, 1987, J VIROL, V61, P3020, DOI 10.1128/JVI.61.10.3020-3029.1987; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Modin C, 2000, VIROLOGY, V278, P368, DOI 10.1006/viro.2000.0683; Morgan HD, 1999, NAT GENET, V23, P314, DOI 10.1038/15490; Riclet R, 2009, MOL BIOL CELL, V20, P296, DOI 10.1091/mbc.E08-05-0510; Sripathy SP, 2006, MOL CELL BIOL, V26, P8623, DOI 10.1128/MCB.00487-06; Tam OH, 2008, NATURE, V453, P534, DOI 10.1038/nature06904; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Watanabe T, 2008, NATURE, V453, P539, DOI 10.1038/nature06908; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Whitelaw E, 2001, NAT GENET, V27, P361, DOI 10.1038/86850; Wiznerowicz M, 2007, J BIOL CHEM, V282, P34535, DOI 10.1074/jbc.M705898200; Wolf D, 2008, J VIROL, V82, P4675, DOI 10.1128/JVI.02445-07; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Zhang Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000007	29	496	505	3	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					237	240		10.1038/nature08674	http://dx.doi.org/10.1038/nature08674			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075919				2022-12-01	WOS:000273582700037
J	Abramson, J; Giraud, M; Benoist, C; Mathis, D				Abramson, Jakub; Giraud, Matthieu; Benoist, Christophe; Mathis, Diane			Aire's Partners in the Molecular Control of Immunological Tolerance	CELL			English	Article							THYMIC EPITHELIAL-CELLS; TRANSCRIPTIONAL ELONGATION; GENE-EXPRESSION; II TRANSCRIPTION; T-CELLS; BINDING; PROTEIN; PHOSPHORYLATION; AUTOIMMUNITY; BREAKS	Aire induces the expression of a battery of peripheral-tissue self-antigens (PTAs) in thymic stromal cells, promoting the clonal deletion of differentiating T cells that recognize them. Just how Aire targets and induces PTA transcripts remains largely undefined. Screening via Aire-targeted coimmunoprecipitation followed by mass spectrometry, and validating by multiple RNAi-mediated knockdown approaches, we identified a large set of proteins that associate with Aire. They fall into four major functional classes: nuclear transport, chromatin binding/structure, transcription and pre-mRNA processing. One set of Aire interactions centered on DNA protein kinase and a group of proteins it partners with to resolve DNA double-stranded breaks or promote transcriptional elongation. Another set of interactions was focused on the pre-mRNA splicing and maturation machinery, potentially explaining the markedly more effective processing of PTA transcripts in the presence of Aire. These findings suggest a model to explain Aire's widespread targeting and induction of weakly transcribed chromatin regions.	[Abramson, Jakub; Giraud, Matthieu; Benoist, Christophe; Mathis, Diane] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Benoist, Christophe; Mathis, Diane] Broad Inst, Boston, MA 02115 USA; [Mathis, Diane] Harvard Stem Cell Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University	Benoist, C (corresponding author), Harvard Univ, Sch Med, Dept Pathol, 77 Ave Louis Pasteur, Boston, MA 02115 USA.	cbdm@hms.harvard.edu; cbdm@hms.harvard.edu	Giraud, Matthieu/E-4972-2017; ABRAMSON, JAKUB/K-1348-2012	Giraud, Matthieu/0000-0002-1208-9677; 	Joslin Diabetes Center's NIDDK; Juvenile Diabetes Research Foundation [10-2007-601, 03-2005-1138]; Campbell and Hall Charity Fund; Harold Whitworth Pierce Charitable Trust; Philippe Foundation	Joslin Diabetes Center's NIDDK(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); Campbell and Hall Charity Fund; Harold Whitworth Pierce Charitable Trust; Philippe Foundation	We thank Drs. N. Hacohen, D. Gray, D. Mayerova, S. Haxhinasto, and E. Husebye for materials, techniques, and/or discussions; and N. Asinovski, K. Leatherbee, Dr. A. Ortiz-Lopez, C. Campbell, G. Buruzula, J. LaVecchio, and J. Chen for technical assistance. This work was supported by the Joslin Diabetes Center's NIDDK-funded DERC core facilities. J. A. was supported by fellowships from the Juvenile Diabetes Research Foundation (JDRF#: 10-2007-601 and 03-2005-1138) and M. G. by fellowships from the Campbell and Hall Charity Fund, The Harold Whitworth Pierce Charitable Trust, and the Philippe Foundation.	Anderson MS, 2002, SCIENCE, V298, P1395, DOI 10.1126/science.1075958; Belotserkovskaya R, 2003, SCIENCE, V301, P1090, DOI 10.1126/science.1085703; Bottomley MJ, 2001, NAT STRUCT BIOL, V8, P626, DOI 10.1038/89675; Das R, 2007, MOL CELL, V26, P867, DOI 10.1016/j.molcel.2007.05.036; Derbinski J, 2008, P NATL ACAD SCI USA, V105, P657, DOI 10.1073/pnas.0707486105; Gray D, 2007, J EXP MED, V204, P2521, DOI 10.1084/jem.20070795; Guerau-De-Arellano M, 2008, P NATL ACAD SCI USA, V105, P14011, DOI 10.1073/pnas.0806616105; Halonen M, 2004, HUM MUTAT, V23, P245, DOI 10.1002/humu.20003; Hargreaves DC, 2009, CELL, V138, P129, DOI 10.1016/j.cell.2009.05.047; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; Heo K, 2008, MOL CELL, V30, P86, DOI 10.1016/j.molcel.2008.02.029; Johnnidis JB, 2005, P NATL ACAD SCI USA, V102, P7233, DOI 10.1073/pnas.0502670102; Ju BG, 2006, SCIENCE, V312, P1798, DOI 10.1126/science.1127196; Koh AS, 2008, P NATL ACAD SCI USA, V105, P15878, DOI 10.1073/pnas.0808470105; Krishnakumar R, 2008, SCIENCE, V319, P819, DOI 10.1126/science.1149250; Kyewski B, 2006, ANNU REV IMMUNOL, V24, P571, DOI 10.1146/annurev.immunol.23.021704.115601; Lamond AI, 2003, NAT REV MOL CELL BIO, V4, P605, DOI 10.1038/nrm1172; Liiv I, 2008, BBA-MOL CELL RES, V1783, P74, DOI 10.1016/j.bbamcr.2007.09.003; Lin SR, 2008, NAT STRUCT MOL BIOL, V15, P819, DOI 10.1038/nsmb.1461; Mahaney BL, 2009, BIOCHEM J, V417, P639, DOI 10.1042/BJ20080413; Mathis D, 2009, ANNU REV IMMUNOL, V27, P287, DOI 10.1146/annurev.immunol.25.022106.141532; Misteli T, 1999, MOL CELL, V3, P697, DOI 10.1016/S1097-2765(01)80002-2; Mondal N, 2001, NATURE, V413, P435, DOI 10.1038/35096590; Moore MJ, 2009, CELL, V136, P688, DOI 10.1016/j.cell.2009.02.001; Muslimovic A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005859; Org T, 2008, EMBO REP, V9, P370, DOI 10.1038/sj.embor.2008.11; Oven I, 2007, MOL CELL BIOL, V27, P8815, DOI 10.1128/MCB.01085-07; Pitkanen J, 2000, J BIOL CHEM, V275, P16802, DOI 10.1074/jbc.M908944199; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Starr TK, 2003, ANNU REV IMMUNOL, V21, P139, DOI 10.1146/annurev.immunol.21.120601.141107; Su MA, 2008, J CLIN INVEST, V118, P1712, DOI 10.1172/JCI34523; SURH CD, 1992, J EXP MED, V176, P611, DOI 10.1084/jem.176.2.611; van Attikum H, 2009, TRENDS CELL BIOL, V19, P207, DOI 10.1016/j.tcb.2009.03.001; Villasenor J, 2008, P NATL ACAD SCI USA, V105, P15854, DOI 10.1073/pnas.0808069105	34	216	224	0	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					123	135		10.1016/j.cell.2009.12.030	http://dx.doi.org/10.1016/j.cell.2009.12.030			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085707	Bronze			2022-12-01	WOS:000273391900020
J	Pece, S; Tosoni, D; Confalonieri, S; Mazzarol, G; Vecchi, M; Ronzoni, S; Bernard, L; Viale, G; Pelicci, PG; Di Fiore, PP				Pece, Salvatore; Tosoni, Daniela; Confalonieri, Stefano; Mazzarol, Giovanni; Vecchi, Manuela; Ronzoni, Simona; Bernard, Loris; Viale, Giuseppe; Pelicci, Pier Giuseppe; Di Fiore, Pier Paolo			Biological and Molecular Heterogeneity of Breast Cancers Correlates with Their Cancer Stem Cell Content	CELL			English	Article							MAMMARY-GLAND; IN-VIVO; DIFFERENTIATION; POPULATION; TUMORS; RECONSTRUCTION; MORPHOGENESIS; PROGENITORS; CARCINOMAS; DIVISIONS	Pathways that govern stem cell (SC) function are often subverted in cancer. Here, we report the isolation to near purity of human normal mammary SCs (hNMSCs), from cultured mammospheres, on the basis of their ability to retain the lipophilic dye PKH26 as a consequence of their quiescent nature. PKH26-positive cells possess all the characteristics of hNMSCs. The transcriptional profile of PKH26-positive cells (hNMSC signature) was able to predict biological and molecular features of breast cancers. By using markers of the hNMSC signature, we prospectively isolated SCs from the normal gland and from breast tumors. Poorly differentiated (G3) cancers displayed higher content of prospectively isolated cancer SCs (CSCs) than did well-differentiated (G1) cancers. By comparing G3 and G1 tumors in xenotransplantation experiments, we directly demonstrated that G3s are enriched in CSCs. Our data support the notion that the heterogeneous phenotypical and molecular traits of human breast cancers are a function of their CSC content.	[Pece, Salvatore; Tosoni, Daniela; Confalonieri, Stefano; Vecchi, Manuela; Di Fiore, Pier Paolo] Fdn Ist FIRC Oncol Mol, IFOM, I-20139 Milan, Italy; [Pece, Salvatore; Viale, Giuseppe; Pelicci, Pier Giuseppe; Di Fiore, Pier Paolo] Univ Milan, Dipartimento Med Chirurg & Odontoiatria, I-20122 Milan, Italy; [Pece, Salvatore; Tosoni, Daniela; Mazzarol, Giovanni; Ronzoni, Simona; Bernard, Loris; Viale, Giuseppe; Pelicci, Pier Giuseppe; Di Fiore, Pier Paolo] Ist Europeo Oncol, I-20141 Milan, Italy	IFOM - FIRC Institute of Molecular Oncology; University of Milan; IRCCS European Institute of Oncology (IEO)	Pece, S (corresponding author), Fdn Ist FIRC Oncol Mol, IFOM, Via Adamello 16, I-20139 Milan, Italy.	salvatore.pece@ifom-ieo-campus.it; piergiuseppe.pelicci@ifom-ieo-campus.it; pierpaolo.difiore@ifom-ieo-campus.it	Pelicci, Pier Giuseppe/AAL-6572-2020; Tosoni, Daniela/K-4524-2014; Pece, Salvatore/B-9609-2013; Ronzoni, Simona/AAQ-1669-2020; Confalonieri, Stefano/AAQ-6786-2020; Vecchi, Manuela/L-3502-2017; Di Fiore, Pier Paolo/K-2130-2012; Viale, Giuseppe/AAE-8921-2019; Bernard, Loris/K-5953-2014	Pece, Salvatore/0000-0003-1764-3929; Confalonieri, Stefano/0000-0001-6886-9851; Vecchi, Manuela/0000-0002-2750-9160; Di Fiore, Pier Paolo/0000-0002-2252-0950; 	Associazione Italiana per la Ricerca sul Cancro; MIUR; European Community [FP6, FP7]; CARIPLO foundation; Ferrari Foundation; Monzino Foundation; Vollaro Foundation; European Research Commission	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); MIUR(Ministry of Education, Universities and Research (MIUR)); European Community(European Commission); CARIPLO foundation(Fondazione Cariplo); Ferrari Foundation; Monzino Foundation; Vollaro Foundation; European Research Commission(European CommissionEuropean Commission Joint Research Centre)	We thank the Division of Senology at IEO, in particular V. Galimberti, A. Luini, P. Naninato, and P. Arnone, for the collection of human samples; G. Dontu, R.B. Clarke, C. Streuli, and J. M. Verdi for generously providing reagents; A. Cocito for statistical consultation and assistance; G. Matera, D. Galvagno, A. Fiocchi, G. Taliento, O. Oldazzi, A. Cavallon, V. Stufano, D. Nicosia, and M. Garre; the IEO Biobank and the centralized facilities of the IFOM-IEO Campus for technical assistance; P. Nuciforo for histopathological analysis; and G. Bonizzi, A. Cicalese, E. Belloni, and P. R. Romano for insightful discussions. This work was supported by grants from the Associazione Italiana per la Ricerca sul Cancro and MIUR to S. P., P. G. P., and P. P. D. F.; the European Community (FP6 and FP7) and the CARIPLO foundation to P. P. D. F. and P. G. P.; the Ferrari Foundation and the Monzino Foundation to P. P. D. F.; the G. Vollaro Foundation to S. P.; and the European Research Commission to P. P. D.	Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; CARTER WG, 1990, J CELL BIOL, V111, P3141, DOI 10.1083/jcb.111.6.3141; Chepko G, 1997, TISSUE CELL, V29, P239, DOI 10.1016/S0040-8166(97)80024-9; Cicalese A, 2009, CELL, V138, P1083, DOI 10.1016/j.cell.2009.06.048; Dontu G, 2003, GENE DEV, V17, P1253, DOI 10.1101/gad.1061803; Eirew P, 2008, NAT MED, V14, P1384, DOI 10.1038/nm.1791; Gonczy P, 2008, NAT REV MOL CELL BIO, V9, P355, DOI 10.1038/nrm2388; Huang S, 1999, BLOOD, V94, P2595, DOI 10.1182/blood.V94.8.2595.420k37_2595_2604; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jones C, 2004, CANCER RES, V64, P3037, DOI 10.1158/0008-5472.CAN-03-2028; Kuperwasser C, 2004, P NATL ACAD SCI USA, V101, P4966, DOI 10.1073/pnas.0401064101; Lanzkron SM, 1999, BLOOD, V93, P1916, DOI 10.1182/blood.V93.6.1916.406k15_1916_1921; Liao MJ, 2007, CANCER RES, V67, P8131, DOI 10.1158/0008-5472.CAN-06-4493; Lim E, 2009, NAT MED, V15, P907, DOI 10.1038/nm.2000; McCaffrey LM, 2009, GENE DEV, V23, P1450, DOI 10.1101/gad.1795909; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pece S, 2004, J CELL BIOL, V167, P215, DOI 10.1083/jcb.200406140; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Proia DA, 2006, NAT PROTOC, V1, P206, DOI 10.1038/nprot.2006.31; Raouf A, 2008, CELL STEM CELL, V3, P109, DOI 10.1016/j.stem.2008.05.018; Shackleton M, 2006, NATURE, V439, P84, DOI 10.1038/nature04372; Shipitsin M, 2007, CANCER CELL, V11, P259, DOI 10.1016/j.ccr.2007.01.013; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Stingl J, 1998, DIFFERENTIATION, V63, P201, DOI 10.1046/j.1432-0436.1998.6340201.x; Stingl J, 2006, NATURE, V439, P993, DOI 10.1038/nature04496; Stingl J, 2007, NAT REV CANCER, V7, P791, DOI 10.1038/nrc2212; Vecchi M, 2007, ONCOGENE, V26, P4284, DOI 10.1038/sj.onc.1210208; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Wei CL, 2006, CELL, V124, P207, DOI 10.1016/j.cell.2005.10.043; WILLIAMS JM, 1983, DEV BIOL, V97, P274, DOI 10.1016/0012-1606(83)90086-6	30	654	694	0	84	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 8	2010	140	1					62	73		10.1016/j.cell.2009.12.007	http://dx.doi.org/10.1016/j.cell.2009.12.007			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20074520	Bronze			2022-12-01	WOS:000273391900015
J	Tischfield, MA; Baris, HN; Wu, C; Rudolph, G; Van Maldergem, L; He, W; Chan, WM; Andrews, C; Demer, JL; Robertson, RL; Mackey, DA; Ruddle, JB; Bird, TD; Gottlob, I; Pieh, C; Traboulsi, EI; Pomeroy, SL; Hunter, DG; Soul, JS; Newlin, A; Sabol, LJ; Doherty, EJ; de Uzcategui, CE; de Uzcategui, N; Collins, MLZ; Sener, EC; Wabbels, B; Hellebrand, H; Meitinger, T; de Berardinis, T; Magli, A; Schiavi, C; Pastore-Trossello, M; Koc, F; Wong, AM; Levin, AV; Geraghty, MT; Descartes, M; Flaherty, M; Jamieson, RV; Moller, HU; Meuthen, I; Callen, DF; Kerwin, J; Lindsay, S; Meindl, A; Gupta, ML; Pellman, D; Engle, EC				Tischfield, Max A.; Baris, Hagit N.; Wu, Chen; Rudolph, Guenther; Van Maldergem, Lionel; He, Wei; Chan, Wai-Man; Andrews, Caroline; Demer, Joseph L.; Robertson, Richard L.; Mackey, David A.; Ruddle, Jonathan B.; Bird, Thomas D.; Gottlob, Irene; Pieh, Christina; Traboulsi, Elias I.; Pomeroy, Scott L.; Hunter, David G.; Soul, Janet S.; Newlin, Anna; Sabol, Louise J.; Doherty, Edward J.; de Uzcategui, Clara E.; de Uzcategui, Nicolas; Collins, Mary Louise Z.; Sener, Emin C.; Wabbels, Bettina; Hellebrand, Heide; Meitinger, Thomas; de Berardinis, Teresa; Magli, Adriano; Schiavi, Costantino; Pastore-Trossello, Marco; Koc, Feray; Wong, Agnes M.; Levin, Alex V.; Geraghty, Michael T.; Descartes, Maria; Flaherty, Maree; Jamieson, Robyn V.; Moller, H. U.; Meuthen, Ingo; Callen, David F.; Kerwin, Janet; Lindsay, Susan; Meindl, Alfons; Gupta, Mohan L., Jr.; Pellman, David; Engle, Elizabeth C.			Human TUBB3 Mutations Perturb Microtubule Dynamics, Kinesin Interactions, and Axon Guidance	CELL			English	Article							CONGENITAL FIBROSIS; BETA-TUBULIN; EXTRAOCULAR-MUSCLES; ALPHA-TUBULIN; IN-VITRO; ISOTYPE; YEAST; IDENTIFICATION; TRANSPORT; PROTEIN	We report that eight heterozygous missense mutations in TUBB3, encoding the neuron-specific beta-tubulin isotype III, result in a spectrum of human nervous system disorders that we now call the TUBB3 syndromes. Each mutation causes the ocular motility disorder CFEOM3, whereas some also result in intellectual and behavioral impairments, facial paralysis, and/or later-onset axonal sensorimotor polyneuropathy. Neuroimaging reveals a spectrum of abnormalities including hypoplasia of oculomotor nerves and dysgenesis of the corpus callosum, anterior commissure, and corticospinal tracts. A knock-in disease mouse model reveals axon guidance defects without evidence of cortical cell migration abnormalities. We show that the disease-associated mutations can impair tubulin heterodimer formation in vitro, although folded mutant heterodimers can still polymerize into microtubules. Modeling each mutation in yeast tubulin demonstrates that all alter dynamic instability whereas a subset disrupts the interaction of microtubules with kinesin motors. These findings demonstrate that normal TUBB3 is required for axon guidance and maintenance in mammals.	[Tischfield, Max A.; Wu, Chen; He, Wei; Chan, Wai-Man; Andrews, Caroline; Pomeroy, Scott L.; Soul, Janet S.; Engle, Elizabeth C.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Tischfield, Max A.; Wu, Chen; He, Wei; Chan, Wai-Man; Andrews, Caroline; Pomeroy, Scott L.; Engle, Elizabeth C.] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Tischfield, Max A.; Baris, Hagit N.; He, Wei; Chan, Wai-Man; Andrews, Caroline; Engle, Elizabeth C.] Childrens Hosp, Program Genom, Boston, MA 02115 USA; [Tischfield, Max A.; Engle, Elizabeth C.] Childrens Hosp, Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Baris, Hagit N.; Engle, Elizabeth C.] Childrens Hosp, Dept Med Genet, Boston, MA 02115 USA; [Pellman, David] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Hunter, David G.; Engle, Elizabeth C.] Childrens Hosp, Dept Ophthalmol, Boston, MA 02115 USA; [Robertson, Richard L.] Childrens Hosp, Dept Radiol, Boston, MA 02115 USA; [Tischfield, Max A.; Wu, Chen; Pomeroy, Scott L.; Engle, Elizabeth C.] Harvard Univ, Sch Med, Program Neurosci, Boston, MA 02115 USA; [Gupta, Mohan L., Jr.; Pellman, David] Harvard Univ, Sch Med, Div Hematol Oncol, Boston, MA 02115 USA; [Pomeroy, Scott L.; Soul, Janet S.; Engle, Elizabeth C.] Harvard Univ, Sch Med, Dept Neurol, Boston, MA 02115 USA; [Gupta, Mohan L., Jr.; Pellman, David] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Rudolph, Guenther] Univ Munich, Univ Eye Hosp, D-80539 Munich, Germany; [Van Maldergem, Lionel] Univ Liege, Ctr Genet Humaine, B-4000 Liege, Belgium; [Wu, Chen; Chan, Wai-Man; Andrews, Caroline; Pellman, David; Engle, Elizabeth C.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Ophthalmol, Los Angeles, CA 90095 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Jules Stein Eye Inst, Los Angeles, CA 90095 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Neurol, Los Angeles, CA 90095 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Neurosci Interdepartmental Program, Los Angeles, CA 90095 USA; [Demer, Joseph L.] Univ Calif Los Angeles, David Geffen Sch Med, Bioengn Interdepartmental Program, Los Angeles, CA 90095 USA; [Mackey, David A.; Ruddle, Jonathan B.] Univ Melbourne, Royal Victorian Eye & Ear Hosp, Dept Ophthalmol, Ctr Eye Res Australia, Melbourne, Vic 3002, Australia; [Mackey, David A.] Univ Tasmania, Royal Hobart Hosp, Dept Ophthalmol, Hobart, Tas 7000, Australia; [Bird, Thomas D.] Univ Washington, Sch Med, Dept Neurol, Seattle, WA 98195 USA; [Bird, Thomas D.] Univ Washington, Sch Med, Dept Med, Seattle, WA 98195 USA; [Bird, Thomas D.] VA Puget Sound Hlth Care Syst, GRECC, Seattle, WA 98195 USA; [Gottlob, Irene] Univ Leicester, Ophthalmol Grp, Leicester LE2 7LX, Leics, England; [Pieh, Christina] Univ Freiburg, Univ Eye Hosp, D-79106 Freiburg, Germany; [Traboulsi, Elias I.] Cleveland Clin i32, Cole Eye Inst, Cleveland, OH 44195 USA; [Newlin, Anna] NorthShore Univ HealthSyst, Ctr Genet Med, Evanston, IL 60201 USA; [Sabol, Louise J.] Geisinger Med Inst, Dept Ophthalmol, Danville, PA 17822 USA; [Doherty, Edward J.] St Johns Hosp, Atlantic Hlth Sci Ctr, St John, NB E2L 4L2, Canada; [de Uzcategui, Clara E.] Inst Oftalmol, Caracas 1010, Venezuela; [de Uzcategui, Nicolas] Upstate Med Univ SUNY, Dept Ophthalmol, Syracuse, NY 13210 USA; [Collins, Mary Louise Z.] Greater Baltimore Med Ctr, Dept Ophthalmol, Baltimore, MD 21204 USA; [Sener, Emin C.] Hacettepe Univ Hosp, Dept Ophthalmol, TR-06100 Ankara, Turkey; [Wabbels, Bettina] Univ Bonn, Dept Ophthalmol, D-53127 Bonn, Germany; [Hellebrand, Heide; Meindl, Alfons] Tech Univ Munich, Klinikum Rechts Isar, Dept Obstet & Gynaecol, D-81675 Munich, Germany; [Meitinger, Thomas] Tech Univ Munich, Klinikum Rechts Isar, Inst Human Genet, D-81675 Munich, Germany; [Meitinger, Thomas] Helmholtz Zentrum Munchen, Inst Human Genet, D-85764 Neuherberg, Germany; [de Berardinis, Teresa; Magli, Adriano] Univ Naples Federico II, Dept Ophthalmol Sci, Fac Med & Surg, I-80138 Naples, Italy; [Schiavi, Costantino] Univ Bologna, Dept Ophthalmol, I-40126 Bologna, Italy; [Pastore-Trossello, Marco] St Orsola Marcello Malpighi Hosp, Dept Neuroradiol, I-40138 Bologna, Italy; [Koc, Feray] Acibadem Univ, Kocaeli Hosp, Dept Ophthalmol & Strabismus & Neuroophthalmol, TR-41100 Kocaeli, Turkey; [Wong, Agnes M.] Hosp Sick Children, Dept Ophthalmol & Vis Sci, Toronto, ON M5G 1X8, Canada; [Levin, Alex V.] Wills Eye Inst, Philadelphia, PA 19107 USA; [Geraghty, Michael T.] Childrens Hosp Eastern Ontario, Dept Genet, Ottawa, ON K1H 8L1, Canada; [Descartes, Maria] Univ Alabama Birmingham, Dept Genet, Birmingham, AL 35294 USA; [Flaherty, Maree] Childrens Hosp Westmead, Dept Ophthalmol, Sydney, NSW 2145, Australia; [Jamieson, Robyn V.] Childrens Hosp Westmead, Dept Clin Genet, Sydney, NSW 2145, Australia; [Jamieson, Robyn V.] Univ Sydney, Sydney, NSW 2008, Australia; [Moller, H. U.] Viborg Hosp, Dept Ophthalmol, DK-8000 Viborg, Denmark; [Meuthen, Ingo] Kliniken Stadt Koln, Dept Hematol Oncol, D-51067 Cologne, Germany; [Callen, David F.] Univ Adelaide, Sch Med, Breast Canc Genet Grp, Adelaide, SA 5005, Australia; [Kerwin, Janet; Lindsay, Susan] Newcastle Univ, Inst Human Genet, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England; [Lindsay, Susan] Newcastle Univ, MRC Wellcome Trust Human Dev Biol Resource Newcas, Newcastle Upon Tyne NE1 3BZ, Tyne & Wear, England	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; University of Munich; University of Liege; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; Centre for Eye Research Australia; Royal Victorian Eye & Ear Hospital; University of Melbourne; Royal Hobart Hospital; University of Tasmania; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Geriatric Research Education & Clinical Center; US Department of Veterans Affairs; Veterans Health Administration (VHA); Vet Affairs Puget Sound Health Care System; University of Leicester; University of Freiburg; Cleveland Clinic Foundation; NorthShore University Health System; Geisinger Medical Center; State University of New York (SUNY) System; State University of New York (SUNY) Upstate Medical Center; Greater Baltimore Medical Center; Hacettepe University; University of Bonn; Technical University of Munich; Technical University of Munich; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; University of Naples Federico II; University of Bologna; IRCCS Azienda Ospedaliero-Universitaria di Bologna; Acibadem University; Kocaeli State Hospital; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); Jefferson University; University of Ottawa; Children's Hospital of Eastern Ontario; University of Alabama System; University of Alabama Birmingham; University of Sydney; University of Sydney; University of Sydney; Aarhus University; University of Adelaide; Newcastle University - UK; Newcastle University - UK	Gupta, ML (corresponding author), Univ Chicago, Dept Mol Genet & Cell Biol, Chicago, IL 60637 USA.	mlgupta@uchicago.edu; elizabeth.engle@childrens.harvard.edu	Jamieson, Robyn/M-5161-2019; Wu, Chen/B-3932-2010; Lindsay, Susan/B-3828-2013; Van Maldergem, Lionel/O-3242-2019; Wabbels, Bettina/AAT-4804-2021; Magli, Adriano/AAU-7380-2020; Van Maldergem, Lionel/G-9849-2017; Meitinger, Thomas/O-1318-2015; Mackey, David A/H-5340-2014; Schiavi, Costantino/Q-8909-2019; Callen, David F/G-1975-2012; Traboulsi, Elias/AAY-7443-2020	Jamieson, Robyn/0000-0002-7285-0253; Lindsay, Susan/0000-0003-2980-4582; Van Maldergem, Lionel/0000-0001-8880-5214; Wabbels, Bettina/0000-0002-7767-114X; Magli, Adriano/0000-0002-6490-2068; Van Maldergem, Lionel/0000-0001-8880-5214; Mackey, David A/0000-0001-7914-4709; DE BERARDINIS, Teresa/0000-0001-6872-0432; Soul, Janet/0000-0001-6998-7753; schiavi, costantino/0000-0002-5753-6987; Hunter, David/0000-0002-4587-4794; Callen, David/0000-0002-6189-9991; Meitinger, Thomas/0000-0002-8838-8403; Robertson, Richard/0000-0001-8811-4405	NIH [R01 EY012498, R01 EY013583, HD18655, F32 EY016306, R01 GM061345-08]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [P30HD018655] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY012498, R01EY013583, F32EY016306, T32EY007143, R01EY008313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM061345] Funding Source: NIH RePORTER; MRC [G0700089, G9900837] Funding Source: UKRI; Medical Research Council [G9900837, G0700089] Funding Source: researchfish	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank the families for their participation; Michelle DeLisle and Carrie Wu for technical assistance and members of the Engle lab for their thoughtful comments; A. Nurten Akarsu, Peter Kang, Lisa S Kearns, James Hoekel, Marijean Miller, Marilyn Miller, Peter Roggenkamper, and Sandra Staffieri for pedigree referrals and/or clinical exam data. This work was supported by NIH R01 EY012498, R01 EY013583, HD18655 (E. C. E.), F32 EY016306 (H. B.), R01 GM061345-08 (D. P.), and VA Research Funds (T. D. B.). E. C. E. and D. P. are investigators of the Howard Hughes Medical Institute.	Al-Bassam J, 2002, J CELL BIOL, V157, P1187, DOI 10.1083/jcb.200201048; BANERJEE A, 1990, J BIOL CHEM, V265, P1794; Carminati JL, 1997, J CELL BIOL, V138, P629, DOI 10.1083/jcb.138.3.629; Carvalho P, 2004, DEV CELL, V6, P815, DOI 10.1016/j.devcel.2004.05.001; Chevalier-Larsen E, 2006, BBA-MOL BASIS DIS, V1762, P1094, DOI 10.1016/j.bbadis.2006.04.002; CLEVELAND DW, 1978, CELL, V15, P1021, DOI 10.1016/0092-8674(78)90286-6; Coksaygan T, 2006, EXP NEUROL, V197, P475, DOI 10.1016/j.expneurol.2005.10.030; Demer JL, 2005, INVEST OPHTH VIS SCI, V46, P530, DOI 10.1167/iovs.04-1125; DeZwaan TM, 1997, J CELL BIOL, V138, P1023, DOI 10.1083/jcb.138.5.1023; Doherty EJ, 1999, INVEST OPHTH VIS SCI, V40, P1687; Gordon-Weeks PR, 2004, J NEUROBIOL, V58, P70, DOI 10.1002/neu.10266; Gupta ML, 2006, NAT CELL BIOL, V8, P913, DOI 10.1038/ncb1457; Jaglin XH, 2009, NAT GENET, V41, P746, DOI 10.1038/ng.380; JIANG YQ, 1992, J CELL SCI, V103, P643; JOSHI HC, 1990, CELL MOTIL CYTOSKEL, V16, P159, DOI 10.1002/cm.970160302; Kalil K, 2005, CURR OPIN NEUROBIOL, V15, P521, DOI 10.1016/j.conb.2005.08.005; Katsetos CD, 2003, J CHILD NEUROL, V18, P851, DOI 10.1177/088307380301801205; Keays DA, 2007, CELL, V128, P45, DOI 10.1016/j.cell.2006.12.017; Khan IA, 1996, BIOCHEMISTRY-US, V35, P3704, DOI 10.1021/bi951247p; Lewis SA, 1996, J CELL BIOL, V132, P1, DOI 10.1083/jcb.132.1.1; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; Li L, 2007, GENESIS, V45, P560, DOI 10.1002/dvg.20325; LOPATA MA, 1987, J CELL BIOL, V105, P1707, DOI 10.1083/jcb.105.4.1707; Lowe J, 2001, J MOL BIOL, V313, P1045, DOI 10.1006/jmbi.2001.5077; LUDUENA RF, 1993, MOL BIOL CELL, V4, P445, DOI 10.1091/mbc.4.5.445; Mackey DA, 2002, HUM GENET, V110, P510, DOI 10.1007/s00439-002-0707-5; Miyake N, 2008, SCIENCE, V321, P839, DOI 10.1126/science.1156121; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; PANDA D, 1994, P NATL ACAD SCI USA, V91, P11358, DOI 10.1073/pnas.91.24.11358; Poirier K, 2007, HUM MUTAT, V28, P1055, DOI 10.1002/humu.20572; REIJO RA, 1994, MOL BIOL CELL, V5, P29, DOI 10.1091/mbc.5.1.29; Uchimura S, 2006, EMBO J, V25, P5932, DOI 10.1038/sj.emboj.7601442; WEBSTER DR, 1987, P NATL ACAD SCI USA, V84, P9040, DOI 10.1073/pnas.84.24.9040; Yamada K, 2003, NAT GENET, V35, P318, DOI 10.1038/ng1261; Yamada K, 2004, INVEST OPHTH VIS SCI, V45, P2218, DOI 10.1167/iovs.03-1413	35	383	393	2	52	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					74	87		10.1016/j.cell.2009.12.011	http://dx.doi.org/10.1016/j.cell.2009.12.011			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20074521	Bronze, Green Accepted			2022-12-01	WOS:000273391900016
J	Wang, F; Yang, W				Wang, Feng; Yang, Wei			Structural Insight into Translesion Synthesis by DNA Pol II	CELL			English	Article							POLYMERASE-II; ESCHERICHIA-COLI; SPONTANEOUS MUTAGENESIS; ABASIC LESION; Y-FAMILY; ZETA; REPLICATION; MECHANISM; FIDELITY; SNAPSHOTS	E. coli DNA Pol II and eukaryotic Rev3 are B-family polymerases that can extend primers past a damaged or mismatched site when the high-fidelity replicative polymerases in the same family are ineffective. We report here the biochemical and structural properties of DNA Pol II that facilitate this translesion synthesis. DNA Pol II can extend primers past lesions either directly or by template skipping, in which small protein cavities outside of the active site accommodate looped-out template nucleotides 1 or 2 bp upstream. Because of multiple looping-out alternatives, mutation spectra of bypass synthesis are complicated. Moreover, translesion synthesis is enhanced by altered partitioning of DNA substrate between the polymerase active site and the proofreading exonuclease site. Compared to the replicative B family polymerases, DNA Pol II has subtle amino acid changes remote from the active site that allow it to replicate normal DNA with high efficiency yet conduct translesion synthesis when needed.	[Wang, Feng; Yang, Wei] NIDDK, Mol Biol Lab, NIH, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)	Yang, W (corresponding author), NIDDK, Mol Biol Lab, NIH, 9000 Rockville Pike,Bldg 5,Room B1-03, Bethesda, MD 20892 USA.	wei.yang@nih.gov	Yang, Wei/D-4926-2011; Yang, Wei/ABB-4785-2020	Yang, Wei/0000-0002-3591-2195; Yang, Wei/0000-0002-3591-2195	National Institute of Diabetes and Digestive and Kidney Diseases intramural research program at National Institutes of Health	National Institute of Diabetes and Digestive and Kidney Diseases intramural research program at National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Doublie for purified gp43 protein and the gp43-beta- clone, W. Konigsberg for the gp43 exo- clone, our labmates for technical support, D. Leahy and R. Craigie for critical reading of the manuscript, and F. Dyda for maintaining the X-ray equipment. The research is funded by the National Institute of Diabetes and Digestive and Kidney Diseases intramural research program at National Institutes of Health.	Abdulovic AL, 2008, NUCLEIC ACIDS RES, V36, P2082, DOI 10.1093/nar/gkn054; Al Mamun AAM, 2006, MUTAT RES-FUND MOL M, V593, P164, DOI 10.1016/j.mrfmmm.2005.07.016; Al Mamun AAM, 2007, MUTAT RES-FUND MOL M, V625, P29, DOI 10.1016/j.mrfmmm.2007.05.002; Andersen PL, 2008, CELL RES, V18, P162, DOI 10.1038/cr.2007.114; ANDERSON WF, 1994, J MOL BIOL, V238, P120, DOI 10.1006/jmbi.1994.1765; Arana ME, 2007, DNA REPAIR, V6, P213, DOI 10.1016/j.dnarep.2006.09.012; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Beard WA, 2002, J BIOL CHEM, V277, P47393, DOI 10.1074/jbc.M210036200; Bebenek A, 2001, J BIOL CHEM, V276, P10387, DOI 10.1074/jbc.M007707200; Bebenek K, 2004, ADV PROTEIN CHEM, V69, P137; Becherel OJ, 2001, P NATL ACAD SCI USA, V98, P8566, DOI 10.1073/pnas.141113398; Berman AJ, 2007, EMBO J, V26, P3494, DOI 10.1038/sj.emboj.7601780; BONNER CA, 1990, P NATL ACAD SCI USA, V87, P7663, DOI 10.1073/pnas.87.19.7663; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; CAI H, 1995, J BIOL CHEM, V270, P15327, DOI 10.1074/jbc.270.25.15327; Chang DJ, 2009, NAT CHEM BIOL, V5, P82, DOI 10.1038/nchembio.139; Curti E, 2009, MOL MICROBIOL, V71, P315, DOI 10.1111/j.1365-2958.2008.06526.x; Doublie S, 1999, STRUCTURE, V7, pR31, DOI 10.1016/S0969-2126(99)80017-3; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Foster PL, 2005, MUTAT RES-FUND MOL M, V569, P3, DOI 10.1016/j.mrfmmm.2004.07.017; Franklin MC, 2001, CELL, V105, P657, DOI 10.1016/S0092-8674(01)00367-1; Freisinger E, 2004, EMBO J, V23, P1494, DOI 10.1038/sj.emboj.7600158; Fuchs RP, 2007, DNA REPAIR, V6, P1032, DOI 10.1016/j.dnarep.2007.02.021; Gan GN, 2008, CELL RES, V18, P174, DOI 10.1038/cr.2007.117; Garcia-Diaz M, 2006, CELL, V124, P331, DOI 10.1016/j.cel.2005.10.039; Hogg M, 2004, EMBO J, V23, P1483, DOI 10.1038/sj.emboj.7600150; Hogg M, 2007, J BIOL CHEM, V282, P1432, DOI 10.1074/jbc.M605675200; IWASAKI H, 1991, MOL GEN GENET, V226, P24, DOI 10.1007/BF00273583; Jarosz DF, 2006, NATURE, V439, P225, DOI 10.1038/nature04318; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Joyce CM, 2004, BIOCHEMISTRY-US, V43, P14317, DOI 10.1021/bi048422z; Kroeger KM, 2004, BIOCHEMISTRY-US, V43, P6723, DOI 10.1021/bi049813g; Lawrence CW, 2001, PHILOS T R SOC B, V356, P41, DOI 10.1098/rstb.2000.0001; Lee HR, 2009, BIOCHEMISTRY-US, V48, P2087, DOI 10.1021/bi8016284; Ling H, 2004, MOL CELL, V13, P751, DOI 10.1016/S1097-2765(04)00101-7; McKenzie GJ, 2001, CURR OPIN MICROBIOL, V4, P586, DOI 10.1016/S1369-5274(00)00255-1; Moon AF, 2007, DNA REPAIR, V6, P1709, DOI 10.1016/j.dnarep.2007.05.009; Napolitano R, 2000, EMBO J, V19, P6259, DOI 10.1093/emboj/19.22.6259; Neeley WL, 2007, J BIOL CHEM, V282, P12741, DOI 10.1074/jbc.M700575200; Ohmori H, 2001, MOL CELL, V8, P7, DOI 10.1016/S1097-2765(01)00278-7; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; PazElizur T, 1996, J BIOL CHEM, V271, P24662, DOI 10.1074/jbc.271.40.24662; REHAKRANTZ LJ, 2009, BIOCH IN PRESS 0621; SCHAAPER RM, 1993, J BIOL CHEM, V268, P23762; Schenten D, 2009, J EXP MED, V206, P477, DOI 10.1084/jem.20080669; Sharief FS, 1999, GENOMICS, V59, P90, DOI 10.1006/geno.1999.5843; Sonoda E, 2003, EMBO J, V22, P3188, DOI 10.1093/emboj/cdg308; Steitz TA, 1999, J BIOL CHEM, V274, P17395, DOI 10.1074/jbc.274.25.17395; STRAUSS BS, 1985, CANCER SURV, V4, P493; STREISINGER G, 1966, COLD SPRING HARB SYM, V31, P77, DOI 10.1101/SQB.1966.031.01.014; Wagner J, 2002, DNA REPAIR, V1, P159, DOI 10.1016/S1568-7864(01)00012-X; Wilson RC, 2008, MOL CELL, V29, P767, DOI 10.1016/j.molcel.2008.01.014; Yang W, 2007, P NATL ACAD SCI USA, V104, P15591, DOI 10.1073/pnas.0704219104; Yeiser B, 2002, P NATL ACAD SCI USA, V99, P8737, DOI 10.1073/pnas.092269199; Zeng G, 1998, BIOTECHNIQUES, V25, P206, DOI 10.2144/98252bm05; Zhong XJ, 2006, NUCLEIC ACIDS RES, V34, P4731, DOI 10.1093/nar/gkl465	56	82	83	1	10	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1279	1289		10.1016/j.cell.2009.11.043	http://dx.doi.org/10.1016/j.cell.2009.11.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064374	Bronze, Green Accepted			2022-12-01	WOS:000273048700016
J	Amundson, D; Dadekian, G; Etienne, M; Gleeson, T; Hicks, T; Killian, D; Kratovil, K; Lewis, C; Monsour, M; Pasiuk, B; Rhodes, D; Miller, EJ				Amundson, Dennis; Dadekian, Greg; Etienne, Mill; Gleeson, Todd; Hicks, Thomas; Killian, Dermot; Kratovil, Kristina; Lewis, Chris; Monsour, Michael; Pasiuk, Bret; Rhodes, Dolores; Miller, Edward J.			Practicing Internal Medicine Onboard the USNS COMFORT in the Aftermath of the Haitian Earthquake	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								On 12 January 2010, a 7.0-magnitude earthquake devastated the island nation of Haiti, leading to the world's largest humanitarian effort in over 6 decades. The catastrophe caused massive destruction of homes and buildings and overwhelmed the Haitian health care system. The United States responded immediately with a massive relief effort, sending U. S. military forces and civilian volunteers to Haiti's aid and providing a tertiary care medical center aboard the USNS COMFORT hospital ship. The COMFORT offered sophisticated medical care to a geographically isolated population and helped to transfer resource-intensive patients from other treatment facilities. Working collaboratively with the surgical staff, ancillary services, and nursing staff, internists aboard the COMFORT were integral to supporting the mission of the hospital ship and provided high-level care to the casualties. This article provides the perspective of the U. S. Navy internists who participated in the initial response to the Haitian earthquake disaster onboard the COMFORT.	[Miller, Edward J.] Natl Naval Med Ctr, Cardiol Sect, Dept Internal Med, Bethesda, MD 20889 USA; USN Hosp, Pensacola, FL 32512 USA; USN, Med Ctr Portsmouth, Portsmouth, VA 23708 USA; USN, San Diego Med Ctr, San Diego, CA 92152 USA	Walter Reed National Military Medical Center; United States Department of Defense; United States Navy; United States Department of Defense; United States Navy; United States Department of Defense; United States Navy	Miller, EJ (corresponding author), Natl Naval Med Ctr, Cardiol Sect, Dept Internal Med, 8901 Wisconsin Ave, Bethesda, MD 20889 USA.	edward.miller@med.navy.mil		Miller, Edward/0000-0002-2156-5962					0	34	34	0	6	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 1	2010	152	11					733	737		10.7326/0003-4819-152-11-201006010-00215	http://dx.doi.org/10.7326/0003-4819-152-11-201006010-00215			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	608CT	20197507				2022-12-01	WOS:000278560000007
J	Talcott, JA; Rossi, C; Shipley, WU; Clark, JA; Slater, JD; Niemierko, A; Zietman, AL				Talcott, James A.; Rossi, Carl; Shipley, William U.; Clark, Jack A.; Slater, Jerry D.; Niemierko, Andrzej; Zietman, Anthony L.			Patient-Reported Long-term Outcomes After Conventional and High-Dose Combined Proton and Photon Radiation for Early Prostate Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; OF-LIFE OUTCOMES; CONFORMAL RADIOTHERAPY; PATIENTS PERCEPTIONS; THERAPY; ADENOCARCINOMA; IRRADIATION; CARCINOMA; SEQUELAE; ESCALATION	Context Increased radiation doses improve prostate cancer control but also increase toxicity to adjacent normal tissue. Proton radiation may attenuate adverse effects. Objective To determine long-term, patient-reported, dose-related toxicity. Design, Setting, and Patients We performed a post hoc cross-sectional survey of surviving participants in the Proton Radiation Oncology Group (PROG) 9509-a randomized trial comparing 70.2 Gy vs 79.2 Gy of combined photon and proton radiation for 393 men with clinically localized prostate cancer (stage T1b-T2b, prostate-specific antigen <15 ng/mL, and no radiographic evidence of metastasis). The estimated 10-year biochemical progression rate for patients receiving standard dose was 32% (95% confidence interval, 26%-39%) compared with 17% (95% confidence interval, 11%-23%) for patients receiving high dose (P<.001). We surveyed 280 of the surviving 337 patients (83%) from April 2007 to September 2008. Main Outcome Measures Prostate Cancer Symptom Indices, a validated measure of urinary incontinence, urinary obstruction and irritation, bowel problems, and sexual dysfunction, and related quality-of-life instruments. Results At a median of 9.4 years after treatment (range, 7.4-12.1 years), participants' demographic and clinical characteristics were similar. Patient-reported outcomes were reported as mean (SD) scale score for standard dose vs high dose: urinary obstruction/irritation (23.3 [13.7] vs 24.6 [14.0]; P=.36), urinary incontinence (10.6 [17.7] vs 9.7 [15.8]; P=.99), bowel problems (7.7 [7.8] vs 7.9 [9.1]; P=.70), sexual dysfunction (68.2 [34.6] vs 65.9 [34.7]; P=.65), and most other outcomes were also similar, although patients receiving standard dose whose cancers had more often progressed expressed less confidence that their cancers were under control (mean [SD] scale score for standard dose, 76.0 [25.4] vs high dose, 86.2 [17.9]; P<.001). Many patients characterized their urinary and bowel function as normal despite reporting symptoms that, for other prostate cancer patients before and early after cancer treatment, caused substantial distress. Conclusion Among men with clinically localized prostate cancer, treatment with higher-dose radiation compared with standard dose was not associated with an increase in patient-reported prostate cancer symptoms after a median of 9.4 years. JAMA. 2010; 303(11): 1046-1053	[Talcott, James A.] Massachusetts Gen Hosp, MGH Canc Ctr, Ctr Outcomes Res, Boston, MA 02114 USA; [Rossi, Carl; Slater, Jerry D.] Loma Linda Univ, Med Ctr, Loma Linda, CA USA; [Shipley, William U.; Niemierko, Andrzej; Zietman, Anthony L.] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA; [Clark, Jack A.] Edith Nourse Rogers Mem Vet Adm Hosp, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA 01730 USA; [Clark, Jack A.] Boston Univ, Sch Publ Hlth, Boston, MA USA; [Talcott, James A.; Shipley, William U.; Niemierko, Andrzej; Zietman, Anthony L.] Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Loma Linda University; Harvard University; Massachusetts General Hospital; Boston University; Harvard University; Harvard Medical School	Talcott, JA (corresponding author), Ctr Outcomes Res, Charlestown Navy Yard,Bldg 120,6th St,2nd Floor, Charlestown, MA 02129 USA.	jtalcott@partners.org	Niemierko, Andrzej/GSV-8546-2022; Talcott, James/CAG-8759-2022; Niemierko, Andrzej/AAJ-2313-2020	Niemierko, Andrzej/0000-0002-8895-5500; Clark, Jack/0000-0002-7424-1670	Massachusetts General Hospital, Boston, MA	Massachusetts General Hospital, Boston, MA	Funding/Support: This research was supported by the Bertucci Genitourinary Cancer Research Fund, Massachusetts General Hospital, Boston, MA.	[Anonymous], 1991, COMMUNICATIONS SIGNA; BENK VA, 1993, INT J RADIAT ONCOL, V26, P551, DOI 10.1016/0360-3016(93)90978-5; Chen RC, 2009, J CLIN ONCOL, V27, P3916, DOI 10.1200/JCO.2008.18.6486; Clark JA, 2003, MED CARE, V41, P923, DOI 10.1097/00005650-200308000-00006; Clark JA, 2001, MED CARE, V39, P1118, DOI 10.1097/00005650-200110000-00009; Clark JA, 2006, J CLIN ONCOL, V24, P4457, DOI 10.1200/JCO.2006.06.2893; Dearnaley DP, 1999, LANCET, V353, P267, DOI 10.1016/S0140-6736(98)05180-0; Do YK, 2010, CANCER CAUSE CONTROL, V21, P31, DOI 10.1007/s10552-009-9431-y; Gardner BG, 2002, J UROLOGY, V167, P123, DOI 10.1016/S0022-5347(05)65395-5; Garg AK, 2006, INT J RADIAT ONCOL, V66, P1294, DOI 10.1016/j.ijrobp.2006.07.1386; Hanks GE, 1998, INT J RADIAT ONCOL, V41, P501, DOI 10.1016/S0360-3016(98)00089-3; Jacob R, 2004, CANCER-AM CANCER SOC, V100, P538, DOI 10.1002/cncr.11927; Jayadevappa R, 2007, CANCER-AM CANCER SOC, V109, P2229, DOI 10.1002/cncr.22675; Korfage IJ, 2006, SOC SCI MED, V63, P911, DOI 10.1016/j.socscimed.2006.01.027; LAWTON CA, 1991, INT J RADIAT ONCOL, V21, P935, DOI 10.1016/0360-3016(91)90732-J; Little DJ, 2003, UROLOGY, V62, P707, DOI 10.1016/S0090-4295(03)00504-1; LITWIN MS, 1995, JAMA-J AM MED ASSOC, V273, P129, DOI 10.1001/jama.273.2.129; Loeffler JS, 1997, SEMIN ONCOL, V24, P686; Mangar SA, 2006, RADIOTHER ONCOL, V80, P355, DOI 10.1016/j.radonc.2006.07.037; Schulz-Ertner D, 2007, J CLIN ONCOL, V25, P953, DOI 10.1200/JCO.2006.09.7816; SHIPLEY WU, 1995, INT J RADIAT ONCOL, V32, P3, DOI 10.1016/0360-3016(95)00063-5; STEWART A, 1992, MEASURING FUNCTION S; Talcott JA, 2003, J CLIN ONCOL, V21, P3979, DOI 10.1200/JCO.2003.01.199; Talcott JA, 2006, J UROLOGY, V176, P1558, DOI 10.1016/j.juro.2006.06.067; Wachter S, 2001, RADIOTHER ONCOL, V59, P65, DOI 10.1016/S0167-8140(01)00281-X; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Yeoh EE, 2006, INT J RADIAT ONCOL, V66, P1072, DOI 10.1016/j.ijrobp.2006.06.005; Yonemoto LT, 1997, INT J RADIAT ONCOL, V37, P21, DOI 10.1016/S0360-3016(96)00311-2; YU CL, 2003, QUAL LIFE RES, V12, P41; Zietman AL, 2005, JAMA-J AM MED ASSOC, V294, P1233, DOI 10.1001/jama.294.10.1233; Zietman AL, 2010, J CLIN ONCOL, V28, P1106, DOI 10.1200/JCO.2009.25.8475	31	75	76	0	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1046	1053		10.1001/jama.2010.287	http://dx.doi.org/10.1001/jama.2010.287			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233822	Bronze			2022-12-01	WOS:000275594100017
J	Fritz-Laylin, LK; Prochnik, SE; Ginger, ML; Dacks, JB; Carpenter, ML; Field, MC; Kuo, A; Paredez, A; Chapman, J; Pham, J; Shu, SQ; Neupane, R; Cipriano, M; Mancuso, J; Tu, H; Salamov, A; Lindquist, E; Shapiro, H; Lucas, S; Grigoriev, IV; Cande, WZ; Fulton, C; Rokhsar, DS; Dawson, SC				Fritz-Laylin, Lillian K.; Prochnik, Simon E.; Ginger, Michael L.; Dacks, Joel B.; Carpenter, Meredith L.; Field, Mark C.; Kuo, Alan; Paredez, Alex; Chapman, Jarrod; Pham, Jonathan; Shu, Shengqiang; Neupane, Rochak; Cipriano, Michael; Mancuso, Joel; Tu, Hank; Salamov, Asaf; Lindquist, Erika; Shapiro, Harris; Lucas, Susan; Grigoriev, Igor V.; Cande, W. Zacheus; Fulton, Chandler; Rokhsar, Daniel S.; Dawson, Scott C.			The Genome of Naegleria gruberi Illuminates Early Eukaryotic Versatility	CELL			English	Article							FATTY-ACID SYNTHESIS; GENE-EXPRESSION; CELL; HYDROGENASE; TRICHOMONAS; EVOLUTION; GIARDIA; ORIGIN; PROTEINS; REVEALS	Genome sequences of diverse free-living protists are essential for understanding eukaryotic evolution and molecular and cell biology. The free-living amoebo-flagellate Naegleria gruberi belongs to a varied and ubiquitous protist clade (Heterolobosea) that diverged from other eukaryotic lineages over a billion years ago. Analysis of the 15,727 protein-coding genes encoded by Naegleria's 41 Mb nuclear genome indicates a capacity for both aerobic respiration and anaerobic metabolism with concomitant hydrogen production, with fundamental implications for the evolution of organelle metabolism. The Naegleria genome facilitates substantially broader phylogenomic comparisons of free-living eukaryotes than previously possible, allowing us to identify thousands of genes likely present in the pan-eukaryotic ancestor, with 40% likely eukaryotic inventions. Moreover, we construct a comprehensive catalog of amoeboid-motility genes. The Naegleria genome, analyzed in the context of other protists, reveals a remarkably complex ancestral eukaryote with a rich repertoire of cytoskeletal, sexual, signaling, and metabolic modules.	[Fritz-Laylin, Lillian K.; Carpenter, Meredith L.; Paredez, Alex; Cande, W. Zacheus; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [Neupane, Rochak] Univ Calif Berkeley, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Prochnik, Simon E.; Kuo, Alan; Chapman, Jarrod; Shu, Shengqiang; Tu, Hank; Salamov, Asaf; Lindquist, Erika; Shapiro, Harris; Lucas, Susan; Grigoriev, Igor V.; Rokhsar, Daniel S.] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Ginger, Michael L.] Univ Lancaster, Div Biomed & Life Sci, Sch Hlth & Med, Lancaster LA1 4YQ, England; [Dacks, Joel B.] Univ Alberta, Dept Cell Biol, Edmonton, AB, Canada; [Dacks, Joel B.; Field, Mark C.] Univ Cambridge, Dept Pathol, Cambridge CB2 1QT, England; [Pham, Jonathan; Cipriano, Michael; Dawson, Scott C.] Univ Calif Davis, Dept Microbiol, Davis, CA 95616 USA; [Mancuso, Joel] Gatan Inc, Pleasanton, CA 94588 USA; [Fulton, Chandler] Brandeis Univ, Dept Biol, Waltham, MA 02454 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; Lancaster University; University of Alberta; University of Cambridge; University of California System; University of California Davis; Brandeis University	Rokhsar, DS (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 545 Life Sci Addit, Berkeley, CA 94720 USA.	dsrokhsar@gmail.com; scdawson@ucdavis.edu	Field, Mark/AAD-6455-2021; Paredez, Alexander/E-7171-2014; Dacks, Joel/AAE-3308-2021; Carpenter, Meredith/B-4290-2011; Paredez, Alexander R/B-9799-2009	Paredez, Alexander/0000-0002-9298-3264; Dacks, Joel/0000-0003-4520-5694; Paredez, Alexander R/0000-0002-9298-3264; Carpenter, Meredith/0000-0002-9798-9374; Dawson, Scott/0000-0002-0843-1759; Rokhsar, Daniel/0000-0002-8704-2224; Fritz-Laylin, Lillian/0000-0002-9237-9403; Shu, Shengqiang/0000-0002-4336-8994; Grigoriev, Igor/0000-0002-3136-8903; Field, Mark/0000-0002-4866-2885; Cipriano, Michael/0000-0001-8163-8812; Ginger, Michael/0000-0002-9643-8482	University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Royal Society University; Wellcome Trust; U. of Alberta	University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Royal Society University(Royal Society of London); Wellcome Trust(Wellcome Trust); U. of Alberta	We thank Woodrow Fischer, Matt Welch, Dyche Mullins, David Drubin, and Anosha Siripala for discussions; Jeremy Thorner, Nicole King, Jason Stajich, Elaine Lai, and Stephen Remillard for comments on the manuscript; Zoe Assaf for manuscript editing. This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program and by the University of California, Lawrence Berkeley National Laboratory under contract No. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under Contract No. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract No. DE-AC02-06NA25396. Additional support was provided by a Royal Society University Research Fellowship to M.L.G., a Tien Scholars Fellowship in Environmental Sciences and Biodiversity to L.K.F.-L., a Wellcome Trust and Parke-Davis Fellowship, as well as start-up funding from the U. of Alberta, to J.B.D., and funding by Wellcome Trust for M.C.F.	ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Archibald JM, 2002, MOL BIOL EVOL, V19, P422, DOI 10.1093/oxfordjournals.molbev.a004097; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Atteia A, 2006, J BIOL CHEM, V281, P9909, DOI 10.1074/jbc.M507862200; Aury JM, 2006, NATURE, V444, P171, DOI 10.1038/nature05230; Avidor-Reiss T, 2004, CELL, V117, P527, DOI 10.1016/S0092-8674(04)00412-X; Balk J, 2004, EMBO J, V23, P2105, DOI 10.1038/sj.emboj.7600216; Benson DA, 2007, NUCLEIC ACIDS RES, V35, pD21, DOI [10.1093/nar/gkw1070, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkp1024, 10.1093/nar/gks1195, 10.1093/nar/gkn723, 10.1093/nar/gkr1202, 10.1093/nar/gkx1094]; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Boxma B, 2005, NATURE, V434, P74, DOI 10.1038/nature03343; Boxma B, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-230; Brinkmann H, 2007, ADV EXP MED BIOL, V607, P20; Burki F, 2008, BIOL LETTERS, V4, P366, DOI 10.1098/rsbl.2008.0224; Carlton JM, 2007, SCIENCE, V315, P207, DOI 10.1126/science.1132894; Cavalier-Smith T, 2002, INT J SYST EVOL MICR, V52, P297, DOI 10.1099/00207713-52-2-297; Ciccarelli FD, 2006, SCIENCE, V311, P1283, DOI 10.1126/science.1123061; CLARK CG, 1987, MOL CELL BIOL, V7, P3027, DOI 10.1128/MCB.7.9.3027; Dacks JB, 2003, P ROY SOC B-BIOL SCI, V270, pS168, DOI 10.1098/rsbl.2003.0058; Dacks JB, 2007, J CELL SCI, V120, P2977, DOI 10.1242/jcs.013250; De Jonckheere JF, 2002, ACTA PROTOZOOL, V41, P309; DINGLE AD, 1966, J CELL BIOL, V31, P43, DOI 10.1083/jcb.31.1.43; Eichinger L, 2005, NATURE, V435, P43, DOI 10.1038/nature03481; Eisen JA, 2006, PLOS BIOL, V4, P1620, DOI 10.1371/journal.pbio.0040286; Embley TM, 2006, PHILOS T R SOC B, V361, P1055, DOI 10.1098/rstb.2006.1844; Finn RD, 2014, NUCLEIC ACIDS RES, V42, pD222, DOI [10.1093/nar/gkt1223, 10.1093/nar/gkp985, 10.1093/nar/gkr1065]; Flanagan LA, 2001, J CELL BIOL, V155, P511, DOI 10.1083/jcb.200105148; FRANKE J, 1977, P NATL ACAD SCI USA, V74, P2157, DOI 10.1073/pnas.74.5.2157; FULTON C, 1993, J EUKARYOT MICROBIOL, V40, P520, DOI 10.1111/j.1550-7408.1993.tb04945.x; Fulton C., 1970, Methods Cell Physiol., V4, P341; FULTON C, 1974, EXP CELL RES, V88, P365, DOI 10.1016/0014-4827(74)90253-5; FULTON C, 1984, P NATL ACAD SCI-BIOL, V81, P2406, DOI 10.1073/pnas.81.8.2406; Hampl V, 2009, P NATL ACAD SCI USA, V106, P3859, DOI 10.1073/pnas.0807880106; Hartman H, 2002, P NATL ACAD SCI USA, V99, P1420, DOI 10.1073/pnas.032658599; Hug LA, 2010, MOL BIOL EVOL, V27, P311, DOI 10.1093/molbev/msp237; Iwasa JH, 2007, CURR BIOL, V17, P395, DOI 10.1016/j.cub.2007.02.012; Iyer LM, 2008, INT J PARASITOL, V38, P1, DOI 10.1016/j.ijpara.2007.07.018; JANDAK J, 1990, BIOCHIM BIOPHYS ACTA, V1029, P117, DOI 10.1016/0005-2736(90)90444-S; Keeling PJ, 2008, NAT REV GENET, V9, P605, DOI 10.1038/nrg2386; Kurland CG, 2006, SCIENCE, V312, P1011, DOI 10.1126/science.1121674; Lee SH, 2007, NAT REV MICROBIOL, V5, P287, DOI 10.1038/nrmicro1617; Lee SH, 2006, CELL, V126, P691, DOI 10.1016/j.cell.2006.06.045; Li JB, 2004, CELL, V117, P541, DOI 10.1016/S0092-8674(04)00450-7; Linardopoulou EV, 2007, PLOS GENET, V3, P2477, DOI 10.1371/journal.pgen.0030237; Loftus B, 2005, NATURE, V433, P865, DOI 10.1038/nature03291; Mangus DA, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-7-223; MARALIKOVA B, 2009, CELL MICROBIOL; Maruyama S, 2007, J EUKARYOT MICROBIOL, V54, P333, DOI 10.1111/j.1550-7408.2007.00273.x; Merchant SS, 2007, SCIENCE, V318, P245, DOI 10.1126/science.1143609; Morrison HG, 2007, SCIENCE, V317, P1921, DOI 10.1126/science.1143837; Mus F, 2007, J BIOL CHEM, V282, P25475, DOI 10.1074/jbc.M701415200; NORDBORG M, 2003, HDB STAT GENETICS; Ntefidou M, 2003, PLANT PHYSIOL, V133, P1517, DOI 10.1104/pp.103.034223; Peitsch WK, 2006, EXP CELL RES, V312, P2605, DOI 10.1016/j.yexcr.2006.04.017; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Putz S, 2006, EUKARYOT CELL, V5, P579, DOI 10.1128/EC.5.3.579-586.2006; Ramesh MA, 2005, CURR BIOL, V15, P185, DOI 10.1016/j.cub.2005.01.003; ROBINSON BS, 1992, J PROTOZOOL, V39, P702, DOI 10.1111/j.1550-7408.1992.tb04452.x; Rodriguez-Ezpeleta N, 2007, CURR BIOL, V17, P1420, DOI 10.1016/j.cub.2007.07.036; Sanchez LB, 2000, J BIOL CHEM, V275, P5794, DOI 10.1074/jbc.275.8.5794; Shu CJ, 2003, TRENDS BIOCHEM SCI, V28, P121, DOI 10.1016/S0968-0004(03)00032-X; SIMPSON GG, 1949, MEANING EVOLUTION ST; Slamovits CH, 2006, EUKARYOT CELL, V5, P148, DOI 10.1128/EC.5.1.148-154.2006; Slamovits CH, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-34; Song M, 2008, NEUROSCIENCE, V152, P670, DOI 10.1016/j.neuroscience.2007.10.068; Stechmann A, 2002, SCIENCE, V297, P89, DOI 10.1126/science.1071196; Stechmann A, 2008, CURR BIOL, V18, P580, DOI 10.1016/j.cub.2008.03.037; Tatusov RL, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-41; TIBAYRENC M, 1990, P NATL ACAD SCI USA, V87, P2414, DOI 10.1073/pnas.87.7.2414; Toret CP, 2006, J CELL SCI, V119, P4585, DOI 10.1242/jcs.03251; van Grinsven KWA, 2008, J BIOL CHEM, V283, P1411, DOI 10.1074/jbc.M702528200; Visvesvara GS, 2007, FEMS IMMUNOL MED MIC, V50, P1, DOI 10.1111/j.1574-695X.2007.00232.x; Yoon HS, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-14	74	322	330	1	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					631	642		10.1016/j.cell.2010.01.032	http://dx.doi.org/10.1016/j.cell.2010.01.032			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211133	Green Submitted, Bronze			2022-12-01	WOS:000275197400013
J	Tobin, DM; Vary, JC; Ray, JP; Walsh, GS; Dunstan, SJ; Bang, ND; Hagge, DA; Khadge, S; King, MC; Hawn, TR; Moens, CB; Ramakrishnan, L				Tobin, David M.; Vary, Jay C., Jr.; Ray, John P.; Walsh, Gregory S.; Dunstan, Sarah J.; Bang, Nguyen D.; Hagge, Deanna A.; Khadge, Saraswoti; King, Mary-Claire; Hawn, Thomas R.; Moens, Cecilia B.; Ramakrishnan, Lalita			The lta4h Locus Modulates Susceptibility to Mycobacterial Infection in Zebrafish and Humans	CELL			English	Article							NECROSIS-FACTOR-ALPHA; TUBERCULOUS MENINGITIS; MARINUM INFECTION; MACROPHAGE DEATH; LIPID MEDIATORS; INNATE IMMUNITY; IN-VIVO; LEUKOTRIENE; INDUCTION; GRANULOMA	Exposure to Mycobacterium tuberculosis produces varied early outcomes, ranging from resistance to infection to progressive disease. Here we report results from a forward genetic screen in zebrafish larvae that identify multiple mutant classes with distinct patterns of innate susceptibility to Mycobacterium marinum. A hypersusceptible mutant maps to the lta4h locus encoding leukotriene A(4) hydrolase, which catalyzes the final step in the synthesis of leukotriene B-4 (LTB4), a potent chemoattractant and proinflammatory eicosanoid. lta4h mutations confer hypersusceptibility independent of LTB4 reduction, by redirecting eicosanoid substrates to anti-inflammatory lipoxins. The resultant anti-inflammatory state permits increased mycobacterial proliferation by limiting production of tumor necrosis factor. In humans, we find that protection from both tuberculosis and multibacillary leprosy is associated with heterozygosity for LTA4H polymorphisms that have previously been correlated with differential LTB4 production. Our results suggest conserved roles for balanced eicosanoid production in vertebrate resistance to mycobacterial infection.	[Tobin, David M.; Ray, John P.; Ramakrishnan, Lalita] Univ Washington, Dept Microbiol, Seattle, WA 98195 USA; [Vary, Jay C., Jr.; King, Mary-Claire; Hawn, Thomas R.; Ramakrishnan, Lalita] Univ Washington, Dept Med, Seattle, WA 98195 USA; [King, Mary-Claire] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA; [Ramakrishnan, Lalita] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Walsh, Gregory S.; Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Howard Hughes Med Inst, Seattle, WA 98109 USA; [Walsh, Gregory S.; Moens, Cecilia B.] Fred Hutchinson Canc Res Ctr, Div Basic Sci, Seattle, WA 98109 USA; [Dunstan, Sarah J.] Univ Oxford, Hosp Trop Dis, Clin Res Unit, Ho Chi Minh City, Vietnam; [Dunstan, Sarah J.] Univ Oxford, Nuffield Dept Clin Med, Ctr Trop Med, Oxford OX3 7LJ, England; [Bang, Nguyen D.] Pham Ngoc Thach Hosp TB & Lung Dis, Ho Chi Minh City, Vietnam; [Hagge, Deanna A.; Khadge, Saraswoti] Anandaban Hosp, Mycobacterial Res Lab, Kathmandu, Nepal	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Fred Hutchinson Cancer Center; Howard Hughes Medical Institute; Fred Hutchinson Cancer Center; University of Oxford; University of Oxford	Ramakrishnan, L (corresponding author), Univ Washington, Dept Microbiol, Box 357242, Seattle, WA 98195 USA.	lalitar@uw.edu	Dunstan, Sarah/AAO-9597-2020; Moens, Cecilia/AAN-1536-2020; Ray, John/F-3187-2015	Ray, John/0000-0001-7294-4260; Tobin, David/0000-0003-3465-5518; Hagge, Deanna A./0000-0002-3792-2266; Dunstan, Sarah/0000-0001-7873-933X; Vary, James/0000-0001-5390-5426; King, Mary-Claire/0000-0001-9426-1743; Ramakrishnan, Lalita/0000-0003-0692-5533; Moens, Cecilia/0000-0002-1099-0728	Burroughs Wellcome Fund; Akibene Foundation; Keck Foundation; National Institutes of Health; American Cancer Society Postdoctoral Fellowship; National Institutes of Health Bacterial Pathogenesis Training; Odland Endowment of the University of Washington; American Skin Association; Human Frontiers Science Program; Dana Foundation; Heiser Program for Research in Tuberculosis and Leprosy; Wellcome Trust of Great Britain; Leprosy Mission International; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI054503] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); Akibene Foundation; Keck Foundation(W.M. Keck Foundation); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Cancer Society Postdoctoral Fellowship(American Cancer Society); National Institutes of Health Bacterial Pathogenesis Training; Odland Endowment of the University of Washington; American Skin Association; Human Frontiers Science Program(Human Frontier Science Program); Dana Foundation; Heiser Program for Research in Tuberculosis and Leprosy; Wellcome Trust of Great Britain(Wellcome Trust); Leprosy Mission International; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank D. Payan for suggesting the zebrafish; J. Bennett and C.B. Wilson for encouragement and help in obtaining zebrafish facilities; C.N. Serhan for advice on eicosanoids; K. Winglee for developing FPC analysis; A. Carmany- Rampey, P. Grant, and C. Miller for setting up early pressure screens; R. Kim and D. Beery for assistance with microinjections; J. Cameron and L. Swaim for fish husbandry; H. Clay for the tnf/fms image; and A. Huttenlocher for the mpo antibody. For the human studies, we gratefully acknowledge all participants and the clinical staff of the Hospital of Tropical Diseases (particularly T.T.H. Chau and G. Thwaites), Pham Ngoc Thach Hospital for Tuberculosis and Lung Disease (particularly N.H. Dung, N.T.B. Yen and N.T.N. Lan), and Hung Vuong Obstetric Hospital (N.T. Hieu) for facilitating the patient sample collection, M. Janer and S. Li for DNA genotyping, and M. K. Lee for statistical advice. This work was supported by the Burroughs Wellcome Fund (L.R. and T.R.H.), the Akibene Foundation and the Keck Foundation (L.R.), the National Institutes of Health (L.R. and M.C.K.), an American Cancer Society Postdoctoral Fellowship and National Institutes of Health Bacterial Pathogenesis Training Grant (D.M.T.), the Odland Endowment of the University of Washington, Dermatology Foundation Dermatologist Investigator Research Fellowship, National Institutes of Health National Research Service Award, and the American Skin Association (J.C.V.), the Human Frontiers Science Program (G.S.W.), the Dana Foundation (T.R.H. and S.J.D.), the Heiser Program for Research in Tuberculosis and Leprosy (T.R.H.), the Wellcome Trust of Great Britain (S.J.D.) and the Leprosy Mission International (D.A.H.). C.B.M. is an investigator with the Howard Hughes Medical Institute. M.C.K. is an American Cancer Society Professor.	Agarwal N, 2009, NATURE, V460, P98, DOI 10.1038/nature08123; Alter A, 2008, HUM GENET, V123, P227, DOI 10.1007/s00439-008-0474-z; Bafica A, 2005, J CLIN INVEST, V115, P1601, DOI 10.1172/JCI23949; Bahary N, 2004, METHOD CELL BIOL, V77, P305; Beattie CE, 1999, METHODS CELL BIOL, V60, P71; Bekker LG, 2000, INFECT IMMUN, V68, P6954, DOI 10.1128/IAI.68.12.6954-6961.2000; Blackmore TK, 2008, CLIN INFECT DIS, V47, pE83, DOI 10.1086/592695; Chen MJ, 2008, J EXP MED, V205, P2791, DOI 10.1084/jem.20080767; Clay H, 2008, IMMUNITY, V29, P283, DOI 10.1016/j.immuni.2008.06.011; Clay H, 2007, CELL HOST MICROBE, V2, P29, DOI 10.1016/j.chom.2007.06.004; Cobat A, 2009, J EXP MED, V206, P2583, DOI 10.1084/jem.20090892; Cosma C. L., 2006, CURRENT PROTOCOLS MI, DOI 10.1002/; Davis JM, 2009, CELL, V136, P37, DOI 10.1016/j.cell.2008.11.014; Davis JM, 2002, IMMUNITY, V17, P693, DOI 10.1016/S1074-7613(02)00475-2; Divangahi M, 2009, NAT IMMUNOL, V10, P899, DOI 10.1038/ni.1758; ElAhmady O, 1997, ANN CLIN BIOCHEM, V34, P160, DOI 10.1177/000456329703400205; FLYNN JL, 1995, IMMUNITY, V2, P561, DOI 10.1016/1074-7613(95)90001-2; Fortin A, 2007, ANNU REV GENOM HUM G, V8, P163, DOI 10.1146/annurev.genom.8.080706.092315; GOLDMAN G, 1993, SURGERY, V113, P297; Haeggstrom JZ, 2004, J BIOL CHEM, V279, P50639, DOI 10.1074/jbc.R400027200; Hardwick C, 2006, SEX TRANSM INFECT, V82, P513, DOI 10.1136/sti.2005.017863; Hawn TR, 2006, J INFECT DIS, V194, P1127, DOI 10.1086/507907; Helgadottir A, 2006, NAT GENET, V38, P68, DOI 10.1038/ng1692; Herbomel P, 2001, DEV BIOL, V238, P274, DOI 10.1006/dbio.2001.0393; JOHNSON SL, 1995, GENETICS, V139, P1727; Kaushal D, 2002, P NATL ACAD SCI USA, V99, P8330, DOI 10.1073/pnas.102055799; Keane J, 2001, NEW ENGL J MED, V345, P1098, DOI 10.1056/NEJMoa011110; KOCH R, 1882, AETIOLOGY TUBERCULOS; Le Guyader D, 2008, BLOOD, V111, P132, DOI 10.1182/blood-2007-06-095398; Liew FY, 2005, NAT REV IMMUNOL, V5, P446, DOI 10.1038/nri1630; MIDDLEBROOK G, 1947, J EXP MED, V86, P175, DOI 10.1084/jem.86.2.175; Misch EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000231; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; ORNING L, 1991, J BIOL CHEM, V266, P1375; Pan H, 2005, NATURE, V434, P767, DOI 10.1038/nature03419; Paul-Clark MJ, 2004, J EXP MED, V200, P69, DOI 10.1084/jem.20040566; Peters-Golden M, 2007, NEW ENGL J MED, V357, P1841, DOI 10.1056/NEJMra071371; PETTITT TR, 1991, J BIOL CHEM, V266, P8720; Rao NL, 2007, J PHARMACOL EXP THER, V321, P1154, DOI 10.1124/jpet.106.115436; Russell DG, 2007, NAT REV MICROBIOL, V5, P39, DOI 10.1038/nrmicro1538; Scollard DM, 2006, CLIN MICROBIOL REV, V19, P338, DOI 10.1128/CMR.19.2.338-381.2006; Serhan CN, 2007, ANNU REV IMMUNOL, V25, P101, DOI 10.1146/annurev.immunol.25.022106.141647; Steyn AJC, 2002, P NATL ACAD SCI USA, V99, P3147, DOI 10.1073/pnas.052705399; Swaim LE, 2006, INFECT IMMUN, V74, P6108, DOI 10.1128/IAI.00887-06; Thwaites G, 2000, J NEUROL NEUROSUR PS, V68, P289, DOI 10.1136/jnnp.68.3.289; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Tobin DM, 2008, CELL MICROBIOL, V10, P1027, DOI 10.1111/j.1462-5822.2008.01133.x; Volkman HE, 2010, SCIENCE, V327, P466, DOI 10.1126/science.1179663; Wolf AJ, 2007, J IMMUNOL, V179, P2509, DOI 10.4049/jimmunol.179.4.2509	50	374	382	3	43	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					717	730		10.1016/j.cell.2010.02.013	http://dx.doi.org/10.1016/j.cell.2010.02.013			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211140	Green Accepted, Bronze			2022-12-01	WOS:000275197400020
J	Barnes, AM; Carter, EM; Cabral, WA; Weis, M; Chang, WZ; Makareeva, E; Leikin, S; Rotimi, CN; Eyre, DR; Raggio, CL; Marini, JC				Barnes, Aileen M.; Carter, Erin M.; Cabral, Wayne A.; Weis, MaryAnn; Chang, Weizhong; Makareeva, Elena; Leikin, Sergey; Rotimi, Charles N.; Eyre, David R.; Raggio, Cathleen L.; Marini, Joan C.			Lack of Cyclophilin B in Osteogenesis Imperfecta with Normal Collagen Folding	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							TRIPLE-HELIX FORMATION; CIS-TRANS-ISOMERASE; PROLYL 3-HYDROXYLATION; FK506-BINDING PROTEIN; ENDOPLASMIC-RETICULUM; I COLLAGEN; MUTATIONS; LETHAL; CRTAP; DEFICIENCY	Osteogenesis imperfecta is a heritable disorder that causes bone fragility. Mutations in type I collagen result in autosomal dominant osteogenesis imperfecta, whereas mutations in either of two components of the collagen prolyl 3-hydroxylation complex (cartilage-associated protein [CRTAP] and prolyl 3-hydroxylase 1 [P3H1]) cause autosomal recessive osteogenesis imperfecta with rhizomelia (shortening of proximal segments of upper and lower limbs) and delayed collagen folding. We identified two siblings who had recessive osteogenesis imperfecta without rhizomelia. They had a homozygous start-codon mutation in the peptidyl-prolyl isomerase B gene (PPIB), which results in a lack of cyclophilin B (CyPB), the third component of the complex. The proband's collagen had normal collagen folding and normal prolyl 3-hydroxylation, suggesting that CyPB is not the exclusive peptidyl-prolyl cis-trans isomerase that catalyzes the rate-limiting step in collagen folding, as is currently thought.	[Barnes, Aileen M.; Cabral, Wayne A.; Chang, Weizhong; Makareeva, Elena; Leikin, Sergey; Marini, Joan C.] NICHHD, NIH, Bethesda, MD 20892 USA; [Rotimi, Charles N.] NHGRI, NIH, Bethesda, MD 20892 USA; [Carter, Erin M.; Raggio, Cathleen L.] Hosp Special Surg, New York, NY 10021 USA; [Weis, MaryAnn; Eyre, David R.] Univ Washington, Orthopaed Res Labs, Seattle, WA 98195 USA	National Institutes of Health (NIH) - USA; NIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD); National Institutes of Health (NIH) - USA; NIH National Human Genome Research Institute (NHGRI); University of Washington; University of Washington Seattle	Marini, JC (corresponding author), NICHD, Bone & Extracellular Matrix Branch, NIH, Bldg 10,Rm 10N260,9000 Rockville Pike, Bethesda, MD 20892 USA.	oidoc@helix.nih.gov	Leikin, Sergey/A-5518-2008; Makareeva, Elena/F-5183-2011	Leikin, Sergey/0000-0001-7095-0739; Makareeva, Elena/0000-0002-5815-0760; Barnes, Aileen/0000-0001-8021-4997	National Institute of Child Health and Human Development; National Human Genome Research Institute Center for Research on Genomics and Global Health; National Institutes of Health [AR37318, AR36794, HD22657, DK-54001]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [ZIAHD008830, ZIAHD000408, ZIAHD000256] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [P01HD022657] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [ZIAHG200362] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR037318, R37AR036794, R01AR036794, R37AR037318] Funding Source: NIH RePORTER	National Institute of Child Health and Human Development(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); National Human Genome Research Institute Center for Research on Genomics and Global Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Supported by intramural funding from the National Institute of Child Health and Human Development (to Drs. Marini and Leikin) and the National Human Genome Research Institute Center for Research on Genomics and Global Health (to Dr. Rotimi) and by grants (AR37318, AR36794, and HD22657, to Dr. Eyre; and DK-54001, to Dr. Rotimi) from the National Institutes of Health.	BACHINGER HP, 1993, AM J MED GENET, V45, P152, DOI 10.1002/ajmg.1320450204; BACHINGER HP, 1987, J BIOL CHEM, V262, P17144; BACHINGER HP, 1980, EUR J BIOCHEM, V106, P619, DOI 10.1111/j.1432-1033.1980.tb04610.x; Baldridge D, 2008, HUM MUTAT, V29, P1435, DOI 10.1002/humu.20799; Barnes AM, 2006, NEW ENGL J MED, V355, P2757, DOI 10.1056/NEJMoa063804; Cabral WA, 2008, NAT GENET, V40, P927, DOI 10.1038/ng0708-927a; Cabral WA, 2007, NAT GENET, V39, P359, DOI 10.1038/ng1968; Ishikawa Y, 2008, J BIOL CHEM, V283, P31584, DOI 10.1074/jbc.M802535200; Ishikawa Y, 2009, J BIOL CHEM, V284, P17641, DOI 10.1074/jbc.M109.007070; Marini JC, 2004, NELSON TXB PEDIAT, P2336; Marini JC, 2007, CELL CYCLE, V6, P1675, DOI 10.4161/cc.6.14.4474; Marini JC, 2007, HUM MUTAT, V28, P209, DOI 10.1002/humu.20429; Morello R, 2006, CELL, V127, P291, DOI 10.1016/j.cell.2006.08.039; Myllyharju J, 2004, TRENDS GENET, V20, P33, DOI 10.1016/j.tig.2003.11.004; Obafemi AA, 2008, AM J MED GENET A, V146A, P2725, DOI 10.1002/ajmg.a.32508; PRICE ER, 1991, P NATL ACAD SCI USA, V88, P1903, DOI 10.1073/pnas.88.5.1903; RAGHUNATH M, 1994, J MOL BIOL, V236, P940, DOI 10.1006/jmbi.1994.1199; SILLENCE DO, 1979, J MED GENET, V16, P101, DOI 10.1136/jmg.16.2.101; SMITH T, 1995, J BIOL CHEM, V270, P18323, DOI 10.1074/jbc.270.31.18323; STEINMANN B, 1991, J BIOL CHEM, V266, P1299; Tryon RC, 2007, GENOMICS, V90, P93, DOI 10.1016/j.ygeno.2007.03.009; Van Dijk FS, 2009, EUR J HUM GENET, V17, P1560, DOI 10.1038/ejhg.2009.75; Vranka JA, 2004, J BIOL CHEM, V279, P23615, DOI 10.1074/jbc.M312807200; Wang P, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-7-226; Willaert A, 2009, J MED GENET, V46, P233, DOI 10.1136/jmg.2008.062729; Zeng BF, 1998, BIOCHEM J, V330, P109, DOI 10.1042/bj3300109	26	135	138	1	12	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					521	528		10.1056/NEJMoa0907705	http://dx.doi.org/10.1056/NEJMoa0907705			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20089953	Green Accepted			2022-12-01	WOS:000274397200009
J	Lamont, T; Luettel, D; Scarpello, J; O'Driscoll, BR; Connew, S				Lamont, Tara; Luettel, Dagmar; Scarpello, John; O'Driscoll, B. Ronan; Connew, Steven			Safety Alerts Improving the safety of oxygen therapy in hospitals: summary of a safety report from the National Patient Safety Agency	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Lamont, Tara; Luettel, Dagmar; Scarpello, John] Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England; [O'Driscoll, B. Ronan] Salford Royal NHS Fdn Trust, Salford M6 8HD, Lancs, England; [Connew, Steven] Colchester Hosp Univ NHS Fdn Trust, Colchester CO4 5JL, Essex, England	Salford Royal NHS Foundation Trust	Lamont, T (corresponding author), Natl Patient Safety Agcy, Natl Reporting & Learning Serv, London W1T 5HD, England.	tara.lamont@npsa.nhs.uk						*BRIT THOR SOC, NAT AUD RES EM OX US; DAVIS R M, 1989, California Agriculture, V43, P4; Leach RM, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.a2790; *NAT I HLTH CLIN E, 2007, CLIN GUID NAT I HLTH, V50; National Patient Safety Agency, 2007, REC RESP APPR EARL S; O'Driscoll BR, 2008, THORAX, V63, DOI 10.1136/thx.2008.102947; SLUTSKY AS, 1994, INTENS CARE MED, V20, P64, DOI 10.1007/BF02425061	7	9	9	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 26	2010	340								c187	10.1136/bmj.c187	http://dx.doi.org/10.1136/bmj.c187			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YA	20103511				2022-12-01	WOS:000274089200001
J	Burrill, DR; Silver, PA				Burrill, Devin R.; Silver, Pamela A.			Making Cellular Memories	CELL			English	Article							TOGGLE SWITCH; CIRCUITRY; NETWORKS; MODEL		[Burrill, Devin R.; Silver, Pamela A.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Silver, PA (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	pamela_silver@hms.harvard.edu			NIH; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM036373] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Special thanks to the Silver lab, J. Way, F. Winston, and A. Salic for helpful discussion. D. R. B. is supported by the NSF Synthetic Biology Engineering Research Center, and P. A. S. by grants from the NIH.	Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Alon U, 2006, INTRO SYSTEMS BIOL D; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Barrett RM, 2008, LEARN MEMORY, V15, P460, DOI 10.1101/lm.917508; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Chickarmane V, 2006, PLOS COMPUT BIOL, V2, P1080, DOI 10.1371/journal.pcbi.0020123; Demongeot L, 2000, CR ACAD SCI III-VIE, V323, P69, DOI 10.1016/S0764-4469(00)00112-8; Dodd IB, 2007, CELL, V129, P813, DOI 10.1016/j.cell.2007.02.053; EISEN H, 1970, P NATL ACAD SCI USA, V66, P855, DOI 10.1073/pnas.66.3.855; Ferrell JE, 2002, CURR OPIN CELL BIOL, V14, P140, DOI 10.1016/S0955-0674(02)00314-9; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Kramer BP, 2004, NAT BIOTECHNOL, V22, P867, DOI 10.1038/nbt980; Kramer BP, 2003, BIOTECHNOL BIOENG, V83, P810, DOI 10.1002/bit.10731; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; MONOD J, 1961, COLD SPRING HARB SYM, V26, P389, DOI 10.1101/SQB.1961.026.01.048; MORTENSEN R, 2006, CURR PROTOC MOL BIOL, V23; Muller-Hill B, 1996, LAC OPERON SHORT HIS, V1st; Muotri AR, 2006, NATURE, V441, P1087, DOI 10.1038/nature04959; NINFA AJ, 2004, SCI STKE, V232, pPE20; NOVAK B, 1993, J CELL SCI, V106, P1153; Ogasawara H, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.256pe7; Ptashne M., 2004, GENETIC SWITCH PHAGE; Schulze A, 2001, GENE DEV, V15, P981, DOI 10.1101/gad.191101; Shetty Reshma P, 2008, J Biol Eng, V2, P5, DOI 10.1186/1754-1611-2-5; Stefanko DP, 2009, P NATL ACAD SCI USA, V106, P9447, DOI 10.1073/pnas.0903964106; Tanaka K, 2008, NEURON, V59, P608, DOI 10.1016/j.neuron.2008.06.026; Thron CD, 1996, BIOPHYS CHEM, V57, P239, DOI 10.1016/0301-4622(95)00075-5; Vermaak D, 2003, CURR OPIN CELL BIOL, V15, P266, DOI 10.1016/S0955-0674(03)00043-7; Weber W, 2007, BIOTECHNOL BIOENG, V98, P894, DOI 10.1002/bit.21463; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	35	93	94	0	21	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					13	18		10.1016/j.cell.2009.12.034	http://dx.doi.org/10.1016/j.cell.2009.12.034			6	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085698	Bronze, Green Accepted			2022-12-01	WOS:000273391900007
J	Tanaka, S; Sawaya, MR; Yeates, TO				Tanaka, Shiho; Sawaya, Michael R.; Yeates, Todd O.			Structure and Mechanisms of a Protein-Based Organelle in Escherichia coli	SCIENCE			English	Article							SALMONELLA-TYPHIMURIUM LT2; CARBOXYSOME SHELL; THIOBACILLUS-NEAPOLITANUS; CRYSTAL-STRUCTURE; ETHANOLAMINE; MICROCOMPARTMENTS; 1,2-PROPANEDIOL; PROKARYOTES; PROPIONATE; INSIGHTS	Many bacterial cells contain proteinaceous microcompartments that act as simple organelles by sequestering specific metabolic processes involving volatile or toxic metabolites. Here we report the three-dimensional (3D) crystal structures, with resolutions between 1.65 and 2.5 angstroms, of the four homologous proteins (EutS, EutL, EutK, and EutM) that are thought to be the major shell constituents of a functionally complex ethanolamine utilization (Eut) microcompartment. The Eut microcompartment is used to sequester the metabolism of ethanolamine in bacteria such as Escherichia coli and Salmonella enterica. The four Eut shell proteins share an overall similar 3D fold, but they have distinguishing structural features that help explain the specific roles they play in the microcompartment. For example, EutL undergoes a conformational change that is probably involved in gating molecular transport through shell protein pores, whereas structural evidence suggests that EutK might bind a nucleic acid component. Together these structures give mechanistic insight into bacterial microcompartments.	[Tanaka, Shiho; Yeates, Todd O.] Univ Calif Los Angeles, Dept Chem & Biochem, Los Angeles, CA 90095 USA; [Sawaya, Michael R.] Univ Calif Los Angeles, Howard Hughes Med Inst, Los Angeles, CA 90095 USA; [Sawaya, Michael R.; Yeates, Todd O.] Univ Calif Los Angeles, Dept Energy, Inst Genom & Prote, Los Angeles, CA 90095 USA; [Yeates, Todd O.] Univ Calif Los Angeles, Inst Mol Biol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; Howard Hughes Medical Institute; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles	Yeates, TO (corresponding author), Univ Calif Los Angeles, Dept Chem & Biochem, 611 Charles Young Dr E, Los Angeles, CA 90095 USA.	yeates@mbi.ucla.edu		Yeates, Todd/0000-0001-5709-9839	Howard Hughes Medical Institute Funding Source: Medline; Direct For Biological Sciences [0843065] Funding Source: National Science Foundation	Howard Hughes Medical Institute(Howard Hughes Medical Institute); Direct For Biological Sciences(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Badger MR, 2003, J EXP BOT, V54, P609, DOI 10.1093/jxb/erg076; Cannon GC, 2001, APPL ENVIRON MICROB, V67, P5351, DOI 10.1128/AEM.67.12.5351-5361.2001; Carrillo-Tripp M, 2009, NUCLEIC ACIDS RES, V37, pD436, DOI 10.1093/nar/gkn840; CASPAR DLD, 1962, COLD SPRING HARB SYM, V27, P1, DOI 10.1101/sqb.1962.027.001.005; CHEN P, 1994, J BACTERIOL, V176, P5474, DOI 10.1128/JB.176.17.5474-5482.1994; Cheng SQ, 2008, BIOESSAYS, V30, P1084, DOI 10.1002/bies.20830; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; ENGLISH RS, 1994, MOL MICROBIOL, V12, P647, DOI 10.1111/j.1365-2958.1994.tb01052.x; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Iancu CV, 2007, J MOL BIOL, V372, P764, DOI 10.1016/j.jmb.2007.06.059; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; Klein MG, 2009, J MOL BIOL, V392, P319, DOI 10.1016/j.jmb.2009.03.056; Kofoid E, 1999, J BACTERIOL, V181, P5317, DOI 10.1128/JB.181.17.5317-5329.1999; Molina-Henares AJ, 2006, FEMS MICROBIOL REV, V30, P157, DOI 10.1111/j.1574-6976.2005.00008.x; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; RONDON MR, 1995, J BACTERIOL, V177, P7119, DOI 10.1128/JB.177.24.7119-7124.1995; RONDON MR, 1995, J BACTERIOL, V177, P5434, DOI 10.1128/jb.177.19.5434-5439.1995; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Schmid MF, 2006, J MOL BIOL, V364, P526, DOI 10.1016/j.jmb.2006.09.024; SHIVELY JM, 1973, SCIENCE, V182, P584, DOI 10.1126/science.182.4112.584; SHIVELY JM, 1988, INT REV CYTOL, V113, P35; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Zhang RG, 2002, J BIOL CHEM, V277, P19183, DOI 10.1074/jbc.M112171200	26	168	174	2	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					81	84		10.1126/science.1179513	http://dx.doi.org/10.1126/science.1179513			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044574				2022-12-01	WOS:000273395400035
J	Yoshida-Moriguchi, T; Yu, LP; Stalnaker, SH; Davis, S; Kunz, S; Madson, M; Oldstone, MBA; Schachter, H; Wells, L; Campbell, KP				Yoshida-Moriguchi, Takako; Yu, Liping; Stalnaker, Stephanie H.; Davis, Sarah; Kunz, Stefan; Madson, Michael; Oldstone, Michael B. A.; Schachter, Harry; Wells, Lance; Campbell, Kevin P.			O-Mannosyl Phosphorylation of Alpha-Dystroglycan Is Required for Laminin Binding	SCIENCE			English	Article							CONGENITAL MUSCULAR-DYSTROPHY; LASSA FEVER VIRUS; ABNORMAL GLYCOSYLATION; RECEPTOR; MUTATIONS; GLYCOSYLTRANSFERASE; GLYCOPROTEINS; GLYCANS; FORM	Alpha-dystroglycan (alpha-DG) is a cell-surface glycoprotein that acts as a receptor for both extracellular matrix proteins containing laminin-G domains and certain arenaviruses. Receptor binding is thought to be mediated by a posttranslational modification, and defective binding with laminin underlies a subclass of congenital muscular dystrophy. Using mass spectrometry- and nuclear magnetic resonance (NMR)-based structural analyses, we identified a phosphorylated O-mannosyl glycan on the mucin-like domain of recombinant alpha-DG, which was required for laminin binding. We demonstrated that patients with muscle-eye-brain disease and Fukuyama congenital muscular dystrophy, as well as mice with myodystrophy, commonly have defects in a postphosphoryl modification of this phosphorylated O-linked mannose, and that this modification is mediated by the like-acetylglucosaminyltransferase (LARGE) protein. These findings expand our understanding of the mechanisms that underlie congenital muscular dystrophy.	[Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Dept Mol Physiol & Biophys, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Dept Neurol, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yoshida-Moriguchi, Takako; Davis, Sarah; Campbell, Kevin P.] Univ Iowa, Dept Internal Med, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Yu, Liping] Univ Iowa, Med Nucl Magnet Resonance Facil, Roy J & Lucille A Carver Coll Med, Iowa City, IA 52242 USA; [Stalnaker, Stephanie H.; Wells, Lance] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Kunz, Stefan] Univ Lausanne, Lausanne, Switzerland; [Kunz, Stefan] Univ Hosp Ctr, Inst Microbiol, Lausanne, Switzerland; [Madson, Michael] Bio Logist, Clear Lake, IA 50428 USA; [Oldstone, Michael B. A.] Scripps Res Inst, Dept Immunol & Microbial Sci, La Jolla, CA 92037 USA; [Schachter, Harry] Hosp Sick Children, Toronto, ON M5G 1X8, Canada	Howard Hughes Medical Institute; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University of Iowa; University System of Georgia; University of Georgia; University of Lausanne; Scripps Research Institute; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids)	Campbell, KP (corresponding author), Univ Iowa, Howard Hughes Med Inst, Roy J & Lucille A Carver Coll Med, 4283 Carver Biomed Res Bldg,285 Newton Rd, Iowa City, IA 52242 USA.	kevin-campbell@uiowa.edu	Wells, Lance/H-3118-2013; Kishore, Gade/C-6943-2011; Kunz, Stefan/K-5840-2017	Kishore, Gade/0000-0003-0911-4381; Campbell, Kevin/0000-0003-2066-5889; Yu, Liping/0000-0003-3536-6427; Wells, Lance/0000-0003-4956-5363; Kunz, Stefan/0000-0001-6030-9550	NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045927, R21AI055540, R01AI055540, R01AI009484] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK054759] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [U54NS053672] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCRR NIH HHS [P41 RR018502] Funding Source: Medline; NIAID NIH HHS [R01 AI009484-40, R01 AI045927-10, R21 AI055540, R01 AI055540, R01 AI009484, R01 AI045927-09, R01 AI045927-08, R01 AI009484-41, R01 AI045927, AI55540] Funding Source: Medline; NIDDK NIH HHS [P30 DK 54759, P30 DK054759] Funding Source: Medline; NINDS NIH HHS [1U54NS053672, U54 NS053672] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Barresi R, 2004, NAT MED, V10, P696, DOI 10.1038/nm1059; Beltran-Valero de Bernabe D, 2002, AM J HUM GENET, V71, P1033, DOI 10.1086/342975; Brockington M, 2001, AM J HUM GENET, V69, P1198, DOI 10.1086/324412; Cao W, 1998, SCIENCE, V282, P2079, DOI 10.1126/science.282.5396.2079; Chiba A, 1997, J BIOL CHEM, V272, P2156; Combs AC, 2005, BIOCHEM J, V390, P303, DOI 10.1042/BJ20050375; DAHMS NM, 1989, J BIOL CHEM, V264, P12115; GANDER JE, 1974, ANNU REV MICROBIOL, V28, P103, DOI 10.1146/annurev.mi.28.100174.000535; GEE SH, 1994, CELL, V77, P675, DOI 10.1016/0092-8674(94)90052-3; Grewal PK, 2001, NAT GENET, V28, P151, DOI 10.1038/88865; IBRAGHIMOVBESKROVNAYA O, 1992, NATURE, V355, P696, DOI 10.1038/355696a0; ILG T, 1994, J BIOL CHEM, V269, P24073; Ilg T, 1996, J BIOL CHEM, V271, P21583, DOI 10.1074/jbc.271.35.21583; Kanagawa M, 2004, CELL, V117, P953, DOI 10.1016/j.cell.2004.06.003; Kobayashi K, 1998, NATURE, V394, P388, DOI 10.1038/28653; Kunz S, 2005, J VIROL, V79, P5979, DOI 10.1128/JVI.79.10.5979-5987.2005; Kunz S, 2001, J CELL BIOL, V155, P301, DOI 10.1083/jcb.200104103; Longman C, 2003, HUM MOL GENET, V12, P2853, DOI 10.1093/hmg/ddg307; Manya H, 2004, P NATL ACAD SCI USA, V101, P500, DOI 10.1073/pnas.0307228101; Manzini MC, 2008, HUM MUTAT, V29, pE231, DOI 10.1002/humu.20844; Michele DE, 2002, NATURE, V418, P417, DOI 10.1038/nature00837; Sasaki T, 1998, BBA-GEN SUBJECTS, V1425, P599, DOI 10.1016/S0304-4165(98)00114-7; Spiropoulou CF, 2002, J VIROL, V76, P5140, DOI 10.1128/JVI.76.10.5140-5146.2002; van Reeuwijk J, 2005, J MED GENET, V42, P907, DOI 10.1136/jmg.2005.031963; Yoshida A, 2001, DEV CELL, V1, P717, DOI 10.1016/S1534-5807(01)00070-3	25	244	250	0	54	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					88	92		10.1126/science.1180512	http://dx.doi.org/10.1126/science.1180512			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044576	Green Accepted, Green Submitted			2022-12-01	WOS:000273395400037
J	Cauchemez, S; Donnelly, CA; Reed, C; Ghani, AC; Fraser, C; Kent, CK; Finelli, L; Ferguson, NM				Cauchemez, Simon; Donnelly, Christl A.; Reed, Carrie; Ghani, Azra C.; Fraser, Christophe; Kent, Charlotte K.; Finelli, Lyn; Ferguson, Neil M.			Household Transmission of 2009 Pandemic Influenza A (H1N1) Virus in the United States	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							ASIAN INFLUENZA; OSELTAMIVIR; CONTACTS; PATTERNS; STRAIN; MODEL	BACKGROUND As of June 11, 2009, a total of 17,855 probable or confirmed cases of 2009 pandemic influenza A (H1N1) had been reported in the United States. Risk factors for transmission remain largely uncharacterized. We characterize the risk factors and describe the transmission of the virus within households. METHODS Probable and confirmed cases of infection with the 2009 H1N1 virus in the United States were reported to the Centers for Disease Control and Prevention with the use of a standardized case form. We investigated transmission of infection in 216 households - including 216 index patients and their 600 household contacts - in which the index patient was the first case patient and complete information on symptoms and age was available for all household members. RESULTS An acute respiratory illness developed in 78 of 600 household contacts (13%). In 156 households (72% of the 216 households), an acute respiratory illness developed in none of the household contacts; in 46 households (21%), illness developed in one contact; and in 14 households (6%), illness developed in more than one contact. The proportion of household contacts in whom acute respiratory illness developed decreased with the size of the household, from 28% in two-member households to 9% in six-member households. Household contacts 18 years of age or younger were twice as susceptible as those 19 to 50 years of age ( relative susceptibility, 1.96; Bayesian 95% credible interval, 1.05 to 3.78; P = 0.005), and household contacts older than 50 years of age were less susceptible than those who were 19 to 50 years of age ( relative susceptibility, 0.17; 95% credible interval, 0.02 to 0.92; P = 0.03). Infectivity did not vary with age. The mean time between the onset of symptoms in a case patient and the onset of symptoms in the household contacts infected by that patient was 2.6 days ( 95% credible interval, 2.2 to 3.5). CONCLUSIONS The transmissibility of the 2009 H1N1 influenza virus in households is lower than that seen in past pandemics. Most transmissions occur soon before or after the onset of symptoms in a case patient.	[Cauchemez, Simon; Donnelly, Christl A.; Ghani, Azra C.; Fraser, Christophe; Ferguson, Neil M.] Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, London W2 1PG, England; [Reed, Carrie; Kent, Charlotte K.; Finelli, Lyn] Ctr Dis Control & Prevent, Atlanta, GA USA	Imperial College London; Centers for Disease Control & Prevention - USA	Cauchemez, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis Epidemiol, MRC, Ctr Outbreak Anal & Modelling, Norfolk Pl, London W2 1PG, England.	s.cauchemez@imperial.ac.uk	Finelli, Lyn/AAK-2360-2020; Ferguson, Neil/B-8578-2008; Ghani, Azra/B-8560-2009; Fraser, Christophe/A-8109-2008	Ferguson, Neil/0000-0002-1154-8093; Fraser, Christophe/0000-0003-2399-9657; Donnelly, Christl/0000-0002-0195-2463; Ghani, Azra/0000-0002-0007-4910	Medical Research Council; Bill and Melinda Gates Foundation; European Union; Models of Infectious Disease Agent Study initiative of the National Institute of General Medical Sciences; Royal Society; Research Councils U. K.; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM088491] Funding Source: NIH RePORTER; Medical Research Council [G0600719B] Funding Source: researchfish	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); European Union(European Commission); Models of Infectious Disease Agent Study initiative of the National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Royal Society(Royal Society of London); Research Councils U. K.(UK Research & Innovation (UKRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Supported by grants from the Medical Research Council, the Bill and Melinda Gates Foundation, the European Union Framework 7 program (FluModCont), and the Models of Infectious Disease Agent Study initiative of the National Institute of General Medical Sciences ( all for the work at Imperial College), the Royal Society ( to Dr. Fraser), and Research Councils U. K. ( to Dr. Cauchemez).	Carrat F, 2002, ARCH INTERN MED, V162, P1842, DOI 10.1001/archinte.162.16.1842; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; *CDCP, 2009 H1N1 FLU SIT UP; *CDCP, H1N1 FLU CLIN PUBL H; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P536; Centers for Disease Control and Prevention (CDC), 2009, MMWR Morb Mortal Wkly Rep, V58, P521; Centers for Disease Control and Prevention (CDC), 2009, CDC REC AM TIM PERS; CHIN TDY, 1960, PUBLIC HEALTH REP, V75, P149, DOI 10.2307/4590751; DAVIS LE, 1970, AM J EPIDEMIOL, V92, P240, DOI 10.1093/oxfordjournals.aje.a121203; Dawood FS, 2009, NEW ENGL J MED, V360, P2605, DOI 10.1056/NEJMoa0903810; Ferguson NM, 2006, NATURE, V442, P448, DOI 10.1038/nature04795; FRANK AL, 1981, J INFECT DIS, V144, P433, DOI 10.1093/infdis/144.5.433; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Germann TC, 2006, P NATL ACAD SCI USA, V103, P5935, DOI 10.1073/pnas.0601266103; HALL CB, 1979, J INFECT DIS, V140, P610, DOI 10.1093/infdis/140.4.610; Hayden FG, 2004, J INFECT DIS, V189, P440, DOI 10.1086/381128; LONGINI IM, 1982, AM J EPIDEMIOL, V115, P736, DOI 10.1093/oxfordjournals.aje.a113356; Maclntyre CR, 2009, EMERG INFECT DIS, V15, P233, DOI 10.3201/eid1502.081167; *NOV SWIN OR INFL, 2009, NEW ENGL J MED, V361, P102; RAMPEY AH, 1992, BIOMETRICS, V48, P117, DOI 10.2307/2532743; Spiegelhalter DJ, 2002, J R STAT SOC B, V64, P583, DOI 10.1111/1467-9868.00353; Welliver R, 2001, JAMA-J AM MED ASSOC, V285, P748, DOI 10.1001/jama.285.6.748; WOODALL J, 1958, BRIT MED J, V2, P1316, DOI 10.1136/bmj.2.5108.1316	23	355	364	0	28	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2619	2627		10.1056/NEJMoa0905498	http://dx.doi.org/10.1056/NEJMoa0905498			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042753	Green Accepted			2022-12-01	WOS:000273181300009
J	Curran, M				Curran, Marjorie			Haiti - A View from the Ship	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									MassGen Hosp Children, Boston, MA USA	Harvard University; Massachusetts General Hospital									0	1	1	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11								10.1056/NEJMpv1002319	http://dx.doi.org/10.1056/NEJMpv1002319			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570CY	20200363				2022-12-01	WOS:000275650400041
J	Neumann, H; Wang, KH; Davis, L; Garcia-Alai, M; Chin, JW				Neumann, Heinz; Wang, Kaihang; Davis, Lloyd; Garcia-Alai, Maria; Chin, Jason W.			Encoding multiple unnatural amino acids via evolution of a quadruplet-decoding ribosome	NATURE			English	Article							TRANSFER-RNA SYNTHETASE; EXPANDED GENETIC-CODE; ESCHERICHIA-COLI; IN-VIVO; RECOMBINANT PROTEINS; MAMMALIAN-CELLS; MESSENGER-RNA; PYRROLYSINE; SUPPRESSORS; CYCLIZATION	The in vivo, genetically programmed incorporation of designer amino acids allows the properties of proteins to be tailored with molecular precision(1). The Methanococcus jannaschii tyrosyl-transfer-RNA synthetase-tRNA(CUA) (MjTyrRS-tRNA(CUA))(2,3) and the Methanosarcina barkeri pyrrolysyl-tRNA synthetase-tRNACUA (MbPylRS-tRNA(CUA))(4-6) orthogonal pairs have been evolved to incorporate a range of unnatural amino acids in response to the amber codon in Escherichia coli(1,6,7). However, the potential of synthetic genetic code expansion is generally limited to the low efficiency incorporation of a single type of unnatural amino acid at a time, because every triplet codon in the universal genetic code is used in encoding the synthesis of the proteome. To encode efficiently many distinct unnatural amino acids into proteins we require blank codons and mutually orthogonal aminoacyl-tRNA synthetase-tRNA pairs that recognize unnatural amino acids and decode the new codons. Here we synthetically evolve an orthogonal ribosome(8,9) (ribo-Q1) that efficiently decodes a series of quadruplet codons and the amber codon, providing several blank codons on an orthogonal messenger RNA, which it specifically translates(8). By creating mutually orthogonal aminoacyl-tRNA synthetase-tRNA pairs and combining them with ribo-Q1 we direct the incorporation of distinct unnatural amino acids in response to two of the new blank codons on the orthogonal mRNA. Using this code, we genetically direct the formation of a specific, redox-insensitive, nanoscale protein cross-link by the bio-orthogonal cycloaddition of encoded azide-and alkyne-containing amino acids(10). Because the synthetase-tRNA pairs used have been evolved to incorporate numerous unnatural amino acids(1,6,7), it will be possible to encode more than 200 unnatural amino acid combinations using this approach. As ribo-Q1 independently decodes a series of quadruplet codons, this work provides foundational technologies for the encoded synthesis and synthetic evolution of unnatural polymers in cells.	[Neumann, Heinz; Wang, Kaihang; Davis, Lloyd; Garcia-Alai, Maria; Chin, Jason W.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Chin, JW (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	chin@mrc-lmb.cam.ac.uk	Neumann, Heinz/F-7875-2014; Neumann, Heinz/ABC-7323-2021	Neumann, Heinz/0000-0001-9657-1913; Wang, Kaihang/0000-0001-7657-8755	ERC; MRC; Trinity College, Cambridge; Medical Research Council [MC_UP_A024_1008, MC_U105181009] Funding Source: researchfish; MRC [MC_U105181009, MC_UP_A024_1008] Funding Source: UKRI	ERC(European Research Council (ERC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Trinity College, Cambridge; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We are grateful to P. B. Kapadnis for synthesizing CAK and to W. An for assistance with some experiments. J. W. C. is grateful to the ERC and the MRC for funding. K. W. is grateful to Trinity College, Cambridge for a fellowship.	Anderson JC, 2004, P NATL ACAD SCI USA, V101, P7566, DOI 10.1073/pnas.0401517101; Atkins JF, 2009, MICROBIOL MOL BIOL R, V73, P178, DOI 10.1128/MMBR.00010-08; Camarero JA, 1998, ANGEW CHEM INT EDIT, V37, P347, DOI 10.1002/(SICI)1521-3773(19980216)37:3<347::AID-ANIE347>3.0.CO;2-5; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, J AM CHEM SOC, V124, P9026, DOI 10.1021/ja027007w; Hohsaka T, 2002, CURR OPIN CHEM BIOL, V6, P809, DOI 10.1016/S1367-5931(02)00376-9; KHAZAIE K, 1984, EUR J BIOCHEM, V144, P485, DOI 10.1111/j.1432-1033.1984.tb08491.x; Kramer EB, 2007, RNA, V13, P87, DOI 10.1261/rna.294907; LAUGHREA M, 1987, EUR J BIOCHEM, V169, P59, DOI 10.1111/j.1432-1033.1987.tb13580.x; Li Peng, 2002, Current Topics in Medicinal Chemistry, V2, P325, DOI 10.2174/1568026023394209; Magliery TJ, 2001, J MOL BIOL, V307, P755, DOI 10.1006/jmbi.2001.4518; Monahan SL, 2003, CHEM BIOL, V10, P573, DOI 10.1016/S1074-5521(03)00124-8; Mukai T, 2008, BIOCHEM BIOPH RES CO, V371, P818, DOI 10.1016/j.bbrc.2008.04.164; Murakami H, 1998, J AM CHEM SOC, V120, P7520, DOI 10.1021/ja971890u; Neumann H, 2008, NAT CHEM BIOL, V4, P232, DOI 10.1038/nchembio.73; Nguyen DP, 2009, J AM CHEM SOC, V131, P8720, DOI 10.1021/ja900553w; Ohtsuki T, 2005, FEBS LETT, V579, P6769, DOI 10.1016/j.febslet.2005.11.010; Polycarpo C, 2004, P NATL ACAD SCI USA, V101, P12450, DOI 10.1073/pnas.0405362101; Rackham O, 2005, NAT CHEM BIOL, V1, P159, DOI 10.1038/nchembio719; Rodriguez EA, 2006, P NATL ACAD SCI USA, V103, P8650, DOI 10.1073/pnas.0510817103; Rostovtsev VV, 2002, ANGEW CHEM INT EDIT, V41, P2596, DOI 10.1002/1521-3773(20020715)41:14<2596::AID-ANIE2596>3.0.CO;2-4; Scott CP, 1999, P NATL ACAD SCI USA, V96, P13638, DOI 10.1073/pnas.96.24.13638; Selmer M, 2006, SCIENCE, V313, P1935, DOI 10.1126/science.1131127; Srinivasan G, 2002, SCIENCE, V296, P1459, DOI 10.1126/science.1069588; Stahl G, 2002, TRENDS BIOCHEM SCI, V27, P178, DOI 10.1016/S0968-0004(02)02064-9; Steer BA, 1999, J BIOL CHEM, V274, P35601, DOI 10.1074/jbc.274.50.35601; Trauger JW, 2000, NATURE, V407, P215, DOI 10.1038/35025116; Walensky LD, 2004, SCIENCE, V305, P1466, DOI 10.1126/science.1099191; Wang KH, 2007, NAT BIOTECHNOL, V25, P770, DOI 10.1038/nbt1314; Xie JM, 2006, NAT REV MOL CELL BIO, V7, P775, DOI 10.1038/nrm2005	30	448	462	3	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					441	444		10.1038/nature08817	http://dx.doi.org/10.1038/nature08817			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20154731				2022-12-01	WOS:000275657100053
J	Srivastava, S; Santos, A; Critchley, K; Kim, KS; Podsiadlo, P; Sun, K; Lee, J; Xu, CL; Lilly, GD; Glotzer, SC; Kotov, NA				Srivastava, Sudhanshu; Santos, Aaron; Critchley, Kevin; Kim, Ki-Sub; Podsiadlo, Paul; Sun, Kai; Lee, Jaebeom; Xu, Chuanlai; Lilly, G. Daniel; Glotzer, Sharon C.; Kotov, Nicholas A.			Light-Controlled Self-Assembly of Semiconductor Nanoparticles into Twisted Ribbons	SCIENCE			English	Article							CDTE NANOCRYSTALS; NANOWIRES; PHOTOLUMINESCENCE; MECHANISM; SHEETS; GROWTH; FILMS	The collective properties of nanoparticles manifest in their ability to self-organize into complex microscale structures. Slow oxidation of tellurium ions in cadmium telluride (CdTe) nanoparticles results in the assembly of 1- to 4-micrometer-long flat ribbons made of several layers of individual cadmium sulfide (CdS)/CdTe nanocrystals. Twisting of the ribbons with an equal distribution of left and right helices was induced by illumination with visible light. The pitch lengths (250 to 1500 nanometers) varied with illumination dose, and the twisting was associated with the relief of mechanical shear stress in assembled ribbons caused by photooxidation of CdS. Unusual shapes of multiparticle assemblies, such as ellipsoidal clouds, dog-bone agglomerates, and ribbon bunches, were observed as intermediate stages. Computer simulations revealed that the balance between attraction and electrostatic repulsion determines the resulting geometry and dimensionality of the nanoparticle assemblies.	[Srivastava, Sudhanshu; Santos, Aaron; Critchley, Kevin; Kim, Ki-Sub; Podsiadlo, Paul; Lee, Jaebeom; Xu, Chuanlai; Lilly, G. Daniel; Glotzer, Sharon C.; Kotov, Nicholas A.] Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA; [Critchley, Kevin] Univ Leeds, Sch Phys & Astron, Leeds LS2 9JT, W Yorkshire, England; [Kim, Ki-Sub] Chungju Natl Univ, Dept Chem & Biol Engn, Chungju 380702, Chungbuk, South Korea; [Podsiadlo, Paul] Argonne Natl Lab, Ctr Nanoscale Mat, Argonne, IL 60439 USA; [Sun, Kai; Kotov, Nicholas A.] Univ Michigan, Dept Mat Sci & Engn, Ann Arbor, MI 48109 USA; [Glotzer, Sharon C.; Kotov, Nicholas A.] Univ Michigan, Dept Biomed Engn, Ann Arbor, MI 48109 USA; [Lee, Jaebeom; Kotov, Nicholas A.] Pusan Natl Univ, Coll Nanosci & Nanoengn, Dept Nanomed Engn, Miryang 627706, South Korea; [Xu, Chuanlai] Jiangnan Univ, Sch Food Sci & Technol, Wuxi 214122, Jiangsu, Peoples R China	University of Michigan System; University of Michigan; University of Leeds; United States Department of Energy (DOE); Argonne National Laboratory; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan; Pusan National University; Jiangnan University	Glotzer, SC (corresponding author), Univ Michigan, Dept Chem Engn, Ann Arbor, MI 48109 USA.	sglotzer@umich.edu; kotov@umich.edu	Kotov, Nicholas/AAZ-4204-2021; Critchley, Kevin/D-3123-2018	Kotov, Nicholas/0000-0002-6864-5804; Critchley, Kevin/0000-0002-0112-8626; Lee, Jaebeom/0000-0002-8414-7290	Air Force Office of Scientific Research [FA9550-06-1-0337]; Fannie and John Hertz Foundation; Ministry of Education, Science and Technology [R33-2008-000-10021-0]; Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy [DE-AC02-06CH11357]; Argonne National Laboratory; NSF [DMR-9871177, DMR-0320740]; J. S. McDonnell Foundation for the development of BUBBA; Marie Curie Actions [MOIF-CT-2006-039636]	Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); Fannie and John Hertz Foundation; Ministry of Education, Science and Technology(Ministry of Education, Science & Technology (MEST), Republic of Korea); Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy(United States Department of Energy (DOE)); Argonne National Laboratory(United States Department of Energy (DOE)); NSF(National Science Foundation (NSF)); J. S. McDonnell Foundation for the development of BUBBA; Marie Curie Actions(European Commission)	We acknowledge joint financial support by the Air Force Office of Scientific Research under Multiuniversity Research Initiative grant FA9550-06-1-0337. P. P. thanks the Fannie and John Hertz Foundation for support of his work through a graduate fellowship. This research was supported by the World Class University program through the Korea Science and Engineering Foundation funded by the Ministry of Education, Science and Technology (grant R33-2008-000-10021-0). We thank J. Kim (Univ. of Michigan) for helpful suggestions and discussions and W. Chen (JiangNan University) for assistance with some TEM data. P. P.'s work at the Center for Nanoscale Materials was supported by the Office of Science, Office of Basic Energy Sciences, of the U.S. Department of Energy under contract no. DE-AC02-06CH11357. P. P. acknowledges the support of the Willard Frank Libby postdoctoral fellowship from Argonne National Laboratory. The transmission electron microscope used in the study was supported by NSF grant DMR-9871177, and the scanning electron microscope used was supported by NSF grant DMR-0320740. S. C. G. and A. S. acknowledge the support of the J. S. McDonnell Foundation for the development of BUBBA. K. C. thanks Marie Curie Actions MOIF-CT-2006-039636 for financial support.	Bierman MJ, 2008, SCIENCE, V320, P1060, DOI 10.1126/science.1157131; Busch S, 1999, EUR J INORG CHEM, P1643; Cho KS, 2005, J AM CHEM SOC, V127, P7140, DOI 10.1021/ja050107s; Glotzer SC, 2004, AICHE J, V50, P2978, DOI 10.1002/aic.10413; Glotzer SC, 2007, NAT MATER, V6, P557, DOI 10.1038/nmat1949; Goriely A, 2000, PHYS REV E, V61, P4508, DOI 10.1103/PhysRevE.61.4508; Guo J, 2005, J PHYS CHEM B, V109, P17467, DOI 10.1021/jp044770z; Han XD, 2007, NANO LETT, V7, P452, DOI 10.1021/nl0627689; Jankowski E, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3223834; Li CL, 2005, CHEM LETT, V34, P92, DOI 10.1246/cl.2005.92; Li LS, 2007, ANGEW CHEM INT EDIT, V46, P5873, DOI 10.1002/anie.200701328; McMillen T, 2002, J NONLINEAR SCI, V12, P241, DOI 10.1007/s00332-002-0493-1; NAIR MTS, 1994, J APPL PHYS, V75, P1557, DOI 10.1063/1.356391; RAO KVK, 1968, J AM CERAM SOC, V51, P467, DOI 10.1111/j.1151-2916.1968.tb11923.x; Talapin DV, 2007, J PHYS CHEM C, V111, P14049, DOI 10.1021/jp074319i; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Tang ZY, 2002, SCIENCE, V297, P237, DOI 10.1126/science.1072086; VOSSMEYER T, 1995, SCIENCE, V267, P1476, DOI 10.1126/science.267.5203.1476; Wang Y, 2003, J AM CHEM SOC, V125, P2830, DOI 10.1021/ja029231r; Yang RS, 2006, J AM CHEM SOC, V128, P1466, DOI 10.1021/ja0578000; Yang S, 2006, J AM CHEM SOC, V128, P10460, DOI 10.1021/ja0619049; Yu MF, 2001, PHYS REV B, V64, DOI 10.1103/PhysRevB.64.241403; Yu WW, 2003, CHEM MATER, V15, P2854, DOI 10.1021/cm034081k; Zhang ZL, 2007, NANO LETT, V7, P1670, DOI 10.1021/nl0706300; Zhou Y, 2006, CHEM MATER, V18, P403, DOI 10.1021/cm051928z	25	290	298	9	499	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1355	1359		10.1126/science.1177218	http://dx.doi.org/10.1126/science.1177218			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20150443				2022-12-01	WOS:000275418700035
J	Steidl, C; Lee, T; Shah, SP; Farinha, P; Han, G; Nayar, T; Delaney, A; Jones, SJ; Iqbal, J; Weisenburger, DD; Bast, MA; Rosenwald, A; Muller-Hermelink, HK; Rimsza, LM; Campo, E; Delabie, J; Braziel, RM; Cook, JR; Tubbs, RR; Jaffe, ES; Lenz, G; Connors, JM; Staudt, LM; Chan, WC; Gascoyne, RD				Steidl, Christian; Lee, Tang; Shah, Sohrab P.; Farinha, Pedro; Han, Guangming; Nayar, Tarun; Delaney, Allen; Jones, Steven J.; Iqbal, Javeed; Weisenburger, Dennis D.; Bast, Martin A.; Rosenwald, Andreas; Muller-Hermelink, Hans-Konrad; Rimsza, Lisa M.; Campo, Elias; Delabie, Jan; Braziel, Rita M.; Cook, James R.; Tubbs, Ray R.; Jaffe, Elaine S.; Lenz, Georg; Connors, Joseph M.; Staudt, Louis M.; Chan, Wing C.; Gascoyne, Randy D.			Tumor-Associated Macrophages and Survival in Classic Hodgkin's Lymphoma	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							INDEPENDENT PROGNOSTIC-FACTOR; REGULATORY T-CELLS; GENE-EXPRESSION; FOLLICULAR LYMPHOMA; DISEASE; MICROENVIRONMENT; CHEMOTHERAPY; MICROARRAY; SIGNATURES; PREDICTOR	BACKGROUND Despite advances in treatments for Hodgkin's lymphoma, about 20% of patients still die from progressive disease. Current prognostic models predict the outcome of treatment with imperfect accuracy, and clinically relevant biomarkers have not been established to improve on the International Prognostic Score. METHODS Using gene-expression profiling, we analyzed 130 frozen samples obtained from patients with classic Hodgkin's lymphoma during diagnostic lymph-node biopsy to determine which cellular signatures were correlated with treatment outcome. We confirmed our findings in an independent cohort of 166 patients, using immunohistochemical analysis. RESULTS Gene-expression profiling identified a gene signature of tumor-associated macrophages that was significantly associated with primary treatment failure (P = 0.02). In an independent cohort of patients, we found that an increased number of CD68+ macrophages was correlated with a shortened progression-free survival (P = 0.03) and with an increased likelihood of relapse after autologous hematopoietic stem-cell transplantation (P = 0.008), resulting in shortened disease-specific survival (P = 0.003). In multivariate analysis, this adverse prognostic factor outperformed the International Prognostic Score for disease-specific survival (P = 0.003 vs. P = 0.03). The absence of an elevated number of CD68+ cells in patients with limited-stage disease defined a subgroup of patients with a long-term disease-specific survival of 100% with the use of current treatment strategies. CONCLUSIONS An increased number of tumor-associated macrophages was strongly associated with shortened survival in patients with classic Hodgkin's lymphoma and provides a new biomarker for risk stratification.	[Steidl, Christian; Lee, Tang; Shah, Sohrab P.; Farinha, Pedro; Han, Guangming; Gascoyne, Randy D.] Univ British Columbia, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada; [Nayar, Tarun; Delaney, Allen; Jones, Steven J.] Univ British Columbia, Genome Sci Ctr, Vancouver, BC V5Z 1M9, Canada; [Connors, Joseph M.] Univ British Columbia, Div Med Oncol, British Columbia Canc Agcy, Vancouver, BC V5Z 1M9, Canada; [Shah, Sohrab P.] Univ British Columbia, Dept Comp Sci, Vancouver, BC V6T 1W5, Canada; [Iqbal, Javeed; Weisenburger, Dennis D.; Bast, Martin A.; Chan, Wing C.] Univ Nebraska Med Ctr, Dept Pathol, Omaha, NE USA; [Rosenwald, Andreas; Muller-Hermelink, Hans-Konrad] Univ Wurzburg, Dept Pathol, D-8700 Wurzburg, Germany; [Rimsza, Lisa M.] Univ Arizona, Dept Pathol, Tucson, AZ USA; [Campo, Elias] Univ Barcelona, Hosp Clin, Barcelona, Spain; [Delabie, Jan] Radium Hosp, Dept Pathol, Oslo, Norway; [Cook, James R.; Tubbs, Ray R.] Cleveland Clin, Dept Pathol & Lab Med, Cleveland, OH 44106 USA; [Cook, James R.; Tubbs, Ray R.] Cleveland Clin, Lerner Coll Med, Dept Mol Pathol, Cleveland, OH 44106 USA; [Jaffe, Elaine S.] NCI, Pathol Lab, Ctr Canc Res, NIH, Bethesda, MD 20892 USA; [Lenz, Georg; Staudt, Louis M.] NCI, Metab Branch, Ctr Canc Res, NIH, Bethesda, MD 20892 USA	University of British Columbia; University of British Columbia; British Columbia Cancer Agency; University of British Columbia; University of British Columbia; University of Nebraska System; University of Nebraska Medical Center; University of Wurzburg; University of Arizona; University of Barcelona; Hospital Clinic de Barcelona; University of Oslo; Cleveland Clinic Foundation; Case Western Reserve University; Cleveland Clinic Foundation; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Gascoyne, RD (corresponding author), British Columbia Canc Agcy, Dept Pathol & Adv Therapeut, 675 W 10th Ave,Rm 5-113, Vancouver, BC V5Z 1L3, Canada.	rgascoyn@bccancer.bc.ca	Staudt, Louis/AAC-5324-2019; Connors, Joseph/AAF-5284-2019; Lenz, Georg/I-6844-2012; Campo, Elias/AAC-5593-2019; Jaffe, Elaine S/G-8984-2014; Jones, Steven J/C-3621-2009	Connors, Joseph/0000-0002-1361-7531; Campo, Elias/0000-0001-9850-9793; Jaffe, Elaine S/0000-0003-4632-0301; Jones, Steven J/0000-0003-3394-2208; Iqbal, Javeed/0000-0003-3668-0629; Farinha, Pedro/0000-0001-9364-9391; Delabie, Jan/0000-0001-5023-0689	Deutsche Forschungsgemeinschaft; Cancer Research Society; Lymphoma Research Foundation; Michael Smith Foundation for Health Research; Roche Molecular Systems; Canadian Institutes of Health Research [178536]; National Cancer Institute [UO1-CA114778-01]; National Cancer Institute (NCI) [UO1-CA 114778]; Roche Canada; NATIONAL CANCER INSTITUTE [ZIABC011006, ZIABC011070, U01CA114778, ZIASC000550] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Cancer Research Society; Lymphoma Research Foundation; Michael Smith Foundation for Health Research(Michael Smith Foundation for Health Research); Roche Molecular Systems; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Roche Canada(Roche Holding); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Supported by grants from Deutsche Forschungsgemeinschaft, the Cancer Research Society, and the Lymphoma Research Foundation (to Dr. Steidl), the Michael Smith Foundation for Health Research (to Drs. Steidl and Shah), Roche Molecular Systems, the Canadian Institutes of Health Research (178536, to Dr. Gascoyne), the National Cancer Institute (UO1-CA114778-01, to Dr. Chan), and the Intramural Research Program of the National Cancer Institute (NCI) and by an NCI Strategic Partnering to Evaluate Cancer Signatures (SPECS) grant (UO1-CA 114778) to the Lymphoma/Leukemia Molecular Profiling Project consortium.; Dr. Gascoyne reports receiving consulting fees from Genentech, Roche Canada, and Eli Lilly and research support from Roche Canada. No other potential conflict of interest relevant to this article was reported.	Alvaro T, 2005, CLIN CANCER RES, V11, P1467, DOI 10.1158/1078-0432.CCR-04-1869; Alvaro-Naranjo T, 2005, LEUKEMIA LYMPHOMA, V46, P1581, DOI 10.1080/10428190500220654; [Anonymous], 1990, IARC Monogr Eval Carcinog Risks Hum, V50, P265; Bjorkholm M, 1995, ANN ONCOL, V6, P895; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; CANELLOS GP, 1992, NEW ENGL J MED, V327, P1478, DOI 10.1056/NEJM199211193272102; Chetaille B, 2009, BLOOD, V113, P2765, DOI 10.1182/blood-2008-07-168096; Dave SS, 2006, NEW ENGL J MED, V354, P2431, DOI 10.1056/NEJMoa055759; Dave SS, 2004, NEW ENGL J MED, V351, P2159, DOI 10.1056/NEJMoa041869; Devilard E, 2002, ONCOGENE, V21, P3095, DOI 10.1038/sj.onc.1205418; Diehl Volker, 2003, Hematology Am Soc Hematol Educ Program, P225, DOI 10.1182/asheducation-2003.1.225; Diepstra A, 2007, J CLIN ONCOL, V25, P3101, DOI 10.1200/JCO.2006.10.0917; Doussis-Anagnostopoulou IA, 2008, CLIN CANCER RES, V14, P1759, DOI 10.1158/1078-0432.CCR-07-1395; Duff MD, 2007, J SURG RES, V142, P119, DOI 10.1016/j.jss.2006.12.542; Falchi L, 2007, EUR J HAEMATOL, V79, P455, DOI 10.1111/j.1600-0609.2007.00952.x; Farinha P, 2005, BLOOD, V106, P2169, DOI 10.1182/blood-2005-04-1565; Hasenclever D, 1998, NEW ENGL J MED, V339, P1506, DOI 10.1056/NEJM199811193392104; Jones RJ, 2009, BLOOD, V113, P5920, DOI 10.1182/blood-2008-11-189688; Karube K, 2006, ANN ONCOL, V17, P110, DOI 10.1093/annonc/mdj064; Kelley TW, 2007, AM J CLIN PATHOL, V128, P958, DOI 10.1309/NB3947K383DJ0LQ2; Krishnapuram B, 2005, IEEE T PATTERN ANAL, V27, P957, DOI 10.1109/TPAMI.2005.127; Kuppers R, 2009, NAT REV CANCER, V9, P15, DOI 10.1038/nrc2542; Lenz G, 2008, NEW ENGL J MED, V359, P2313, DOI 10.1056/NEJMoa0802885; Mantovani A, 2002, TRENDS IMMUNOL, V23, P549, DOI 10.1016/S1471-4906(02)02302-5; Natkunam Y, 2005, BLOOD, V105, P3979, DOI 10.1182/blood-2004-08-3112; Odaka C, 2005, CELL IMMUNOL, V235, P21, DOI 10.1016/j.cellimm.2005.06.011; Perz JB, 2007, BONE MARROW TRANSPL, V39, P41, DOI 10.1038/sj.bmt.1705544; Sanchez-Aguilera A, 2006, BLOOD, V108, P662, DOI 10.1182/blood-2005-12-5125; Shaffer AL, 2006, IMMUNOL REV, V210, P67, DOI 10.1111/j.0105-2896.2006.00373.x; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Sup SJ, 2005, J CLIN ONCOL, V23, P3773, DOI 10.1200/JCO.2005.04.358; Tzankov A, 2008, HAEMATOLOGICA, V93, P193, DOI 10.3324/haematol.11702; Urs S, 2004, J NUTR, V134, P762, DOI 10.1093/jn/134.4.762; Younes A, 2003, CANCER, V98, P310, DOI 10.1002/cncr.11511	34	903	949	2	81	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					875	885		10.1056/NEJMoa0905680	http://dx.doi.org/10.1056/NEJMoa0905680			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20220182	Green Accepted			2022-12-01	WOS:000275365900008
J	Wang, F; Han, Y; Lim, CS; Lu, YH; Wang, J; Xu, J; Chen, HY; Zhang, C; Hong, MH; Liu, XG				Wang, Feng; Han, Yu; Lim, Chin Seong; Lu, Yunhao; Wang, Juan; Xu, Jun; Chen, Hongyu; Zhang, Chun; Hong, Minghui; Liu, Xiaogang			Simultaneous phase and size control of upconversion nanocrystals through lanthanide doping	NATURE			English	Article							DOPED NAYF4 NANOCRYSTALS; NANOPARTICLES; QUALITY; REDUCTION; EMISSION; IONS	Doping is a widely applied technological process in materials science that involves incorporating atoms or ions of appropriate elements into host lattices to yield hybrid materials with desirable properties and functions. For nanocrystalline materials, doping is of fundamental importance in stabilizing a specific crystallographic phase(1), modifying electronic properties(2-4), modulating magnetism(5) as well as tuning emission properties(6-9). Here we describe a material system in which doping influences the growth process to give simultaneous control over the crystallographic phase, size and optical emission properties of the resulting nanocrystals. We show that NaYF(4) nanocrystals can be rationally tuned in size (down to ten nanometres), phase (cubic or hexagonal) and upconversion(10-12) emission colour (green to blue) through use of trivalent lanthanide dopant ions introduced at precisely defined concentrations. We use first-principles calculations to confirm that the influence of lanthanide doping on crystal phase and size arises from a strong dependence on the size and dipole polarizability of the substitutional dopant ion. Our results suggest that the doping-induced structural and size transition, demonstrated here in NaYF(4) upconversion nanocrystals, could be extended to other lanthanide-doped nanocrystal systems for applications ranging from luminescent biological labels(12) to volumetric three-dimensional displays(13).	[Wang, Feng; Wang, Juan; Zhang, Chun; Liu, Xiaogang] Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore; [Han, Yu] King Abdullah Univ Sci & Technol, Div Chem & Life Sci & Engn, Membrane Res Ctr, Thuwal 239556900, Saudi Arabia; [Lim, Chin Seong; Hong, Minghui] ASTAR, Data Storage Inst, Opt Mat & Syst Div, Singapore 117608, Singapore; [Lu, Yunhao; Zhang, Chun] Natl Univ Singapore, Dept Phys, Singapore 117543, Singapore; [Xu, Jun; Chen, Hongyu] Nanyang Technol Univ, Div Chem & Biol Chem, Singapore 637371, Singapore; [Hong, Minghui] Natl Univ Singapore, Dept Elect & Comp Engn, Singapore 117543, Singapore	National University of Singapore; King Abdullah University of Science & Technology; Agency for Science Technology & Research (A*STAR); A*STAR - Data Storage Institute; National University of Singapore; Nanyang Technological University & National Institute of Education (NIE) Singapore; Nanyang Technological University; National University of Singapore	Liu, XG (corresponding author), Natl Univ Singapore, Dept Chem, Singapore 117543, Singapore.	chmlx@nus.edu.sg	Zhang, Chun/F-7638-2012; Lim, Chin Seong/K-4056-2015; Lu, Yunhao/N-4555-2016; Han, Yu/GZA-9220-2022; Wang, Feng/E-2436-2013; Wang, Juan/L-7686-2017; Han, Yu/N-2036-2015; Chen, Hongyu/C-4594-2008; xu, jun/B-3105-2011; Hongyu, Chen/ABZ-9662-2022; LIU, XIAOGANG/A-8038-2011	Zhang, Chun/0000-0002-1581-5806; Lim, Chin Seong/0000-0001-9163-8197; Wang, Feng/0000-0001-9471-4386; Wang, Juan/0000-0002-1340-9011; Han, Yu/0000-0003-1462-1118; LIU, XIAOGANG/0000-0003-2517-5790; xu, jun/0000-0002-3096-3217	National University of Singapore (NUS); Ministry of Education of Singapore; Singapore-MIT Alliance; Agency for Science, Technology and Research (A*STAR); NUS	National University of Singapore (NUS)(National University of Singapore); Ministry of Education of Singapore(Ministry of Education, Singapore); Singapore-MIT Alliance(Singapore-MIT Alliance for Research & Technology Centre (SMART)); Agency for Science, Technology and Research (A*STAR)(Agency for Science Technology & Research (A*STAR)); NUS(National University of Singapore)	We thank G. A. Ozin, X. Chen, F. Stellacci, C. Yan, Y. Xia, L. Cademartiri, T. Nann, Y. Li and Y. C. Cao for discussions. This study was supported in part by the National University of Singapore (NUS), the Ministry of Education of Singapore, the Singapore-MIT Alliance, and the Agency for Science, Technology and Research (A*STAR). X. L. is grateful to the NUS for a Young Investigator Award.	Alivisatos AP, 1996, SCIENCE, V271, P933, DOI 10.1126/science.271.5251.933; Auzel F, 2004, CHEM REV, V104, P139, DOI 10.1021/cr020357g; AYYUB P, 1995, PHYS REV B, V51, P6135, DOI 10.1103/PhysRevB.51.6135; BLOCHL PE, 1994, PHYS REV B, V50, P17979; Boyer JC, 2006, J AM CHEM SOC, V128, P7444, DOI 10.1021/ja061848b; Cademartiri L, 2006, J PHYS CHEM B, V110, P671, DOI 10.1021/jp0563585; Chen YF, 2005, J AM CHEM SOC, V127, P13331, DOI 10.1021/ja053151g; Downing E, 1996, SCIENCE, V273, P1185, DOI 10.1126/science.273.5279.1185; Ehlert O, 2008, ACS NANO, V2, P120, DOI 10.1021/nn7002458; Feng XD, 2006, SCIENCE, V312, P1504, DOI 10.1126/science.1125767; Heer S, 2004, ADV MATER, V16, P2102, DOI 10.1002/adma.200400772; Li ZQ, 2008, ADV MATER, V20, P4765, DOI 10.1002/adma.200801056; Lim B, 2009, SCIENCE, V324, P1302, DOI 10.1126/science.1170377; Liu CH, 2009, J MATER CHEM, V19, P489, DOI 10.1039/b815682d; Mai HX, 2006, J AM CHEM SOC, V128, P6426, DOI 10.1021/ja060212h; Norris DJ, 2001, NANO LETT, V1, P3, DOI 10.1021/nl005503h; Park YI, 2009, ADV MATER, V21, P4467, DOI 10.1002/adma.200901356; Perdew JP, 1996, PHYS REV LETT, V77, P3865, DOI 10.1103/PhysRevLett.77.3865; SHANNON RD, 1976, ACTA CRYSTALLOGR A, V32, P751, DOI 10.1107/S0567739476001551; Sivakumar R, 2005, J AM CHEM SOC, V127, P12464, DOI 10.1021/ja052583o; Sun SH, 2000, SCIENCE, V287, P1989, DOI 10.1126/science.287.5460.1989; Suyver JF, 2005, OPT MATER, V27, P1111, DOI 10.1016/j.optmat.2004.10.021; Tang ZY, 2006, SCIENCE, V314, P274, DOI 10.1126/science.1128045; Wang F, 2008, J AM CHEM SOC, V130, P5642, DOI 10.1021/ja800868a; Wang F, 2009, CHEM SOC REV, V38, P976, DOI 10.1039/b809132n; Wang LY, 2007, CHEM MATER, V19, P727, DOI 10.1021/cm061887m; Wang X, 2005, NATURE, V437, P121, DOI 10.1038/nature03968; Wernsdorfer W, 1997, PHYS REV LETT, V79, P4014, DOI 10.1103/PhysRevLett.79.4014; Yang YA, 2006, J AM CHEM SOC, V128, P12428, DOI 10.1021/ja064818h; Yi GS, 2006, ADV FUNCT MATER, V16, P2324, DOI 10.1002/adfm.200600053	30	2639	2741	106	3456	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 25	2010	463	7284					1061	1065		10.1038/nature08777	http://dx.doi.org/10.1038/nature08777			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182508				2022-12-01	WOS:000275108400032
J	Friedman, M; Shimada, K; Martin, LD; Everhart, MJ; Liston, J; Maltese, A; Triebold, M				Friedman, Matt; Shimada, Kenshu; Martin, Larry D.; Everhart, Michael J.; Liston, Jeff; Maltese, Anthony; Triebold, Michael			100-Million-Year Dynasty of Giant Planktivorous Bony Fishes in the Mesozoic Seas	SCIENCE			English	Article							SHARK LAMNIFORMES; EVOLUTION	Large-bodied suspension feeders (planktivores), which include the most massive animals to have ever lived, are conspicuously absent from Mesozoic marine environments. The only clear representatives of this trophic guild in the Mesozoic have been an enigmatic and apparently short-lived Jurassic group of extinct pachycormid fishes. Here, we report several new examples of these giant bony fishes from Asia, Europe, and North America. These fossils provide the first detailed anatomical information on this poorly understood clade and extend its range from the lower Middle Jurassic to the end of the Cretaceous, showing that this group persisted for more than 100 million years. Modern large-bodied, planktivorous vertebrates diversified after the extinction of pachycormids at the Cretaceous-Paleogene boundary, which is consistent with an opportunistic refilling of vacated ecospace.	[Friedman, Matt] Univ Oxford, Dept Earth Sci, Oxford OX1 3PR, England; [Shimada, Kenshu] Depaul Univ, Environm Sci Program, Chicago, IL 60614 USA; [Shimada, Kenshu] Depaul Univ, Dept Biol Sci, Chicago, IL 60614 USA; [Shimada, Kenshu; Everhart, Michael J.] Ft Hays State Univ, Sternberg Museum Nat Hist, Hays, KS 67601 USA; [Martin, Larry D.] Univ Kansas, Nat Hist Museum, Lawrence, KS 66045 USA; [Martin, Larry D.] Univ Kansas, Biodivers Res Ctr, Lawrence, KS 66045 USA; [Liston, Jeff] Univ Glasgow, Fac Biomed & Life Sci, Div Ecol & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; [Maltese, Anthony; Triebold, Michael] Triebold Paleontol & Rocky Mt Dinosaur Resource C, Woodland Pk, CO 80863 USA	University of Oxford; DePaul University; DePaul University; University of Kansas; University of Kansas; University of Glasgow	Friedman, M (corresponding author), Univ Oxford, Dept Earth Sci, Parks Rd, Oxford OX1 3PR, England.	mattf@earth.ox.ac.uk	Friedman, Matt/F-6991-2012; Liston, Jeff J./I-4600-2015	Liston, Jeff J./0000-0002-6763-5452	Environmental Protection Agency [FP916730]	Environmental Protection Agency(United States Environmental Protection Agency)	M. F. was funded by an Environmental Protection Agency Science to Achieve Results Fellowship (award FP916730). We thank T. Uyeno and M. Manabe for provenance data for the Japanese pachycormid, S. Moore-Fay for exacting specimen preparation, R. Nicholls for his reconstruction of + Bonnerichthys, and M. Brazeau, L. Sallan, and three anonymous reviewers for their constructive comments.	Bartholomai Alan, 2004, Memoirs of the Queensland Museum, V49, P521; Cappetta H., 1993, P593; Cavin L, 2002, GEOLOGICAL AND BIOLOGICAL EFFECTS OF IMPACT EVENTS, P141; CAVIN L, 2008, MESOZOIC FISHES, V4, P199; Cione AL, 1998, ANTARCT SCI, V10, P83, DOI 10.1017/S095410209800011X; Collin Rachel, 1997, P451, DOI 10.1016/B978-012155210-7/50024-7; Falkowski PG, 2004, SCIENCE, V305, P354, DOI 10.1126/science.1095964; Fitzgerald EMG, 2006, P ROY SOC B-BIOL SCI, V273, P2955, DOI 10.1098/rspb.2006.3664; Freedman JA, 2002, REV FISH BIOL FISHER, V12, P403, DOI 10.1023/A:1025365210414; Friedman M, 2009, P NATL ACAD SCI USA, V106, P5218, DOI 10.1073/pnas.0808468106; Jarman SN, 2001, BIOL J LINN SOC, V73, P199, DOI 10.1006/bjls.2001.0538; Jessen H., 1972, Fossils Strata, VNo. 1, P1; Lambers P.H., 1992, THESIS RIJKSUUNIVERS; LISTON J, 2004, MESOZOIC FISHES, V3, P379; Liston J.J., 2004, Archives of Natural History, V31, P236, DOI 10.3366/anh.2004.31.2.236; Liston J.J., 2008, MESOZOIC FISHES 4 HO, P181; Mainwaring A.J., 1978, THESIS U LONDON LOND; MARTILL DM, 1988, GEOL PALAEONTOL, P670; Nelson J.S., 2006, FISHES WORLD; Nicholls EL, 2004, J VERTEBR PALEONTOL, V24, P838, DOI 10.1671/0272-4634(2004)024[0838:GIOTTN]2.0.CO;2; Page L.M., 1991, FIELD GUIDE FRESHWAT; Parris DC, 2007, GEOL SOC AM SPEC PAP, V427, P99, DOI 10.1130/2007.2427(07); Sanderson S. Laurie, 1993, P37; Shimada K, 2007, J VERTEBR PALEONTOL, V27, P512, DOI 10.1671/0272-4634(2007)27[512:MOFMSL]2.0.CO;2; STEWART JD, 1988, GEOLOGY PALEONTOLOGY, P80; Woodward A.S, 1902, FOSSIL FISHES ENGLIS	26	88	90	1	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					990	993		10.1126/science.1184743	http://dx.doi.org/10.1126/science.1184743			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167784	Green Published, Green Accepted			2022-12-01	WOS:000274625800038
J	Kim, J; Guermah, M; Roeder, RG				Kim, Jaehoon; Guermah, Mohamed; Roeder, Robert G.			The Human PAF1 Complex Acts in Chromatin Transcription Elongation Both Independently and Cooperatively with SII/TFIIS	CELL			English	Article							RNA-POLYMERASE-II; SACCHAROMYCES-CEREVISIAE; HISTONE METHYLATION; H2B UBIQUITYLATION; GENE-EXPRESSION; IN-VIVO; RTF1; INITIATION; NUCLEOSOMES; COMPONENT	Genetic and cell-based studies have implicated the PAF1 complex (PAF1C) in transcription-associated events, but there has been no evidence showing a direct role in facilitating transcription of a natural chromatin template. Here, we demonstrate an intrinsic ability of human PAF1C (hPAF1C) to facilitate activator (p53)- and histone acetyltransferase (p300)-dependent transcription elongation from a recombinant chromatin template in a biochemically defined RNA polymerase II transcription system. This represents a PAF1C function distinct from its established role in histone ubiquitylation and methylation. Importantly, we further demonstrate a strong synergy between hPAF1C and elongation factor SII/TFIIS and an underlying mechanism involving direct hPAF1C-SII interactions and cooperative binding to RNA polymerase II. Apart from a distinct PAF1C function, the present observations provide a molecular mechanism for the cooperative function of distinct transcription elongation factors in chromatin transcription.	[Kim, Jaehoon; Guermah, Mohamed; Roeder, Robert G.] Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA	Rockefeller University	Roeder, RG (corresponding author), Rockefeller Univ, Biochem & Mol Biol Lab, New York, NY 10065 USA.	roeder@mail.rockefeller.edu	Kim, Jaehoon/G-2711-2011	Kim, Jaehoon/0000-0003-4035-0438	NIH [DK071900, CA129325]; Leukemia and Lymphoma Society SCOR; Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE [R01CA129325] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK071900] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Leukemia and Lymphoma Society SCOR(Leukemia and Lymphoma Society); Starr Foundation Cancer Consortium; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank Drs. O. Rozenblatt-Rosen and M. Meyerson for anti-hCTR9 antibody and Dr. D. Reinberg for anti-hSKI8 antibody. This work was supported by NIH grants (DK071900 and CA129325), a Leukemia and Lymphoma Society SCOR grant, and a Starr Foundation Cancer Consortium grant. J.K. is a senior fellow of the Charles H. Revson Foundation.	Adelman K, 2006, MOL CELL BIOL, V26, P250, DOI 10.1128/MCB.26.1.250-260.2006; Arndt KM, 2003, TRENDS GENET, V19, P543, DOI 10.1016/j.tig.2003.08.008; Betz JL, 2002, MOL GENET GENOMICS, V268, P272, DOI 10.1007/s00438-002-0752-8; Bondarenko VA, 2006, MOL CELL, V24, P469, DOI 10.1016/j.molcel.2006.09.009; Chaudhary K, 2007, ONCOGENE, V26, P7499, DOI 10.1038/sj.onc.1210582; Costa PJ, 2000, GENETICS, V156, P535; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Ding L, 2009, CELL STEM CELL, V4, P403, DOI 10.1016/j.stem.2009.03.009; Gomes NP, 2006, GENE DEV, V20, P601, DOI 10.1101/gad.1398206; Guermah M, 2006, CELL, V125, P275, DOI 10.1016/j.cell.2006.01.055; HAN M, 1988, CELL, V55, P1137, DOI 10.1016/0092-8674(88)90258-9; IZBAN MG, 1992, GENE DEV, V6, P1342, DOI 10.1101/gad.6.7.1342; Kim J, 2005, MOL CELL, V20, P759, DOI 10.1016/j.molcel.2005.11.012; Kim J, 2009, CELL, V137, P459, DOI 10.1016/j.cell.2009.02.027; Kireeva ML, 2005, MOL CELL, V18, P97, DOI 10.1016/j.molcel.2005.02.027; KNEZETIC JA, 1986, CELL, V45, P95, DOI 10.1016/0092-8674(86)90541-6; Krogan NJ, 2003, MOL CELL, V11, P721, DOI 10.1016/S1097-2765(03)00091-1; Li B, 2007, CELL, V128, P707, DOI 10.1016/j.cell.2007.01.015; LORCH Y, 1987, CELL, V49, P203, DOI 10.1016/0092-8674(87)90561-7; Mosimann C, 2006, CELL, V125, P327, DOI 10.1016/j.cell.2006.01.053; Mueller CL, 2004, MOL CELL, V14, P447, DOI 10.1016/S1097-2765(04)00257-6; Mueller CL, 2002, MOL CELL BIOL, V22, P1971, DOI 10.1128/MCB.22.7.1971-1980.2002; Ng HH, 2003, J BIOL CHEM, V278, P33625, DOI 10.1074/jbc.C300270200; Orphanides G, 1998, CELL, V92, P105, DOI 10.1016/S0092-8674(00)80903-4; Osley MA, 2004, BBA-GENE STRUCT EXPR, V1677, P74, DOI 10.1016/j.bbaexp.2003.10.013; Pokholok DK, 2002, MOL CELL, V9, P799, DOI 10.1016/S1097-2765(02)00502-6; Porter SE, 2005, EUKARYOT CELL, V4, P209, DOI 10.1128/EC.4.1.209-220.2005; Qiu HF, 2006, MOL CELL BIOL, V26, P3135, DOI 10.1128/MCB.26.8.3135-3148.2006; Renner DB, 2001, J BIOL CHEM, V276, P42601, DOI 10.1074/jbc.M104967200; Rondon AG, 2004, EMBO REP, V5, P47, DOI 10.1038/sj.embor.7400045; Rozenblatt-Rosen O, 2005, MOL CELL BIOL, V25, P612, DOI 10.1128/MCB.25.2.612-620.2005; Rozenblatt-Rosen O, 2009, P NATL ACAD SCI USA, V106, P755, DOI 10.1073/pnas.0812023106; Sheldon KE, 2005, MOL CELL, V20, P225, DOI 10.1016/j.molcel.2005.08.026; Shi XM, 1996, MOL CELL BIOL, V16, P669; Shi XM, 1997, MOL CELL BIOL, V17, P1160, DOI 10.1128/MCB.17.3.1160; Sim RJ, 2004, GENE DEV, V18, P2437, DOI 10.1101/gad.1235904; Squazzo SL, 2002, EMBO J, V21, P1764, DOI 10.1093/emboj/21.7.1764; Stolinski LA, 1997, MOL CELL BIOL, V17, P4490, DOI 10.1128/MCB.17.8.4490; Tenney K, 2006, P NATL ACAD SCI USA, V103, P11970, DOI 10.1073/pnas.0603620103; Ujvari A, 2006, NAT STRUCT MOL BIOL, V13, P49, DOI 10.1038/nsmb1026; Wang PF, 2008, MOL CELL BIOL, V28, P2930, DOI 10.1128/MCB.00654-07; Warner MH, 2007, MOL CELL BIOL, V27, P6103, DOI 10.1128/MCB.00772-07; Wood A, 2003, J BIOL CHEM, V278, P34739, DOI 10.1074/jbc.C300269200; WORKMAN JL, 1987, CELL, V51, P613, DOI 10.1016/0092-8674(87)90130-9; Xiao TJ, 2005, MOL CELL BIOL, V25, P637, DOI 10.1128/MCB.25.2.637-651.2005; Yart A, 2005, MOL CELL BIOL, V25, P5052, DOI 10.1128/MCB.25.12.5052-5060.2005; Youn MY, 2007, J BIOL CHEM, V282, P34727, DOI 10.1074/jbc.M705411200; Zhu B, 2005, GENE DEV, V19, P1668, DOI 10.1101/gad.1292105	48	181	188	2	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					491	503		10.1016/j.cell.2009.12.050	http://dx.doi.org/10.1016/j.cell.2009.12.050			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178742	Bronze, Green Accepted			2022-12-01	WOS:000274668400013
J	Romer, W; Pontani, LL; Sorre, B; Rentero, C; Berland, L; Chambon, V; Lamaze, C; Bassereau, P; Sykes, C; Gaus, K; Johannes, L				Roemer, Winfried; Pontani, Lea-Laetitia; Sorre, Benoit; Rentero, Carles; Berland, Ludwig; Chambon, Valerie; Lamaze, Christophe; Bassereau, Patricia; Sykes, Cecile; Gaus, Katharina; Johannes, Ludger			Actin Dynamics Drive Membrane Reorganization and Scission in Clathrin-Independent Endocytosis	CELL			English	Article							GPI-ANCHORED PROTEINS; TOXIN B-SUBUNIT; SHIGA TOXIN; RETROGRADE TRANSPORT; LIPID DOMAINS; PHASE; MODEL; CURVATURE; SEPARATION; ENDOSOMES	Nascent transport intermediates detach from donor membranes by scission. This process can take place in the absence of dynamin, notably in clathrin-independent endocytosis, by mechanisms that are yet poorly defined. We show here that in cells scission of Shiga toxin-induced tubular endocytic membrane invaginations is preceded by cholesterol-dependent membrane reorganization and correlates with the formation of membrane domains on model membranes, suggesting that domain boundary forces are driving tubule membrane constriction. Actin triggers scission by inducing such membrane reorganization process. Tubule occurrence is indeed increased upon cellular depletion of the actin nucleator component Arp2, and the formation of a cortical actin shell in liposomes is sufficient to trigger the scission of Shiga toxin-induced tubules in a cholesterol-dependent but dynamin-independent manner. Our study suggests that membranes in tubular Shiga toxin-induced invaginations are poised to undergo actin-triggered reorganization leading to scission by a physical mechanism that may function independently from or in synergy with pinchase activity.	[Roemer, Winfried; Chambon, Valerie; Lamaze, Christophe; Johannes, Ludger] Inst Curie, CNRS, Ctr Rech, Traff Signaling & Delivery Grp,UMR 144, F-75248 Paris 05, France; [Pontani, Lea-Laetitia; Sykes, Cecile] Univ Paris 06, Inst Curie, Ctr Rech, Biomimetism Cell Movement Grp,CNRS,UMR 168, F-75252 Paris 05, France; [Sorre, Benoit; Berland, Ludwig; Bassereau, Patricia] Univ Paris 06, Inst Curie, Ctr Rech, Membrane & Cell Funct Grp,CNRS,UMR 168, F-75252 Paris 05, France; [Sorre, Benoit] Inst Curie, CNRS, Ctr Rech, Mol Mech Intracellular Transport Grp,UMR 144, F-75248 Paris 05, France; [Rentero, Carles; Gaus, Katharina] Univ New S Wales, Ctr Vasc Res, Sydney, NSW, Australia; [Rentero, Carles; Gaus, Katharina] Prince Wales Hosp, Dept Haematol, Sydney, NSW 2052, Australia	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Centre National de la Recherche Scientifique (CNRS); Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Chemistry (INC); UDICE-French Research Universities; PSL Research University Paris; Sorbonne Universite; UNICANCER; Institut Curie; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); UDICE-French Research Universities; PSL Research University Paris; UNICANCER; Institut Curie; Sorbonne Universite; Universite Paris Cite; University of New South Wales Sydney	Romer, W (corresponding author), Inst Curie, CNRS, Ctr Rech, Traff Signaling & Delivery Grp,UMR 144, F-75248 Paris 05, France.	winfried.roemer@curie.fr; johannes@curie.fr	Johannes, Ludger/W-8593-2019; Sykes, Cécile/B-1271-2016; Johannes, Ludger/M-9778-2017; Rentero Alfonso, Carles/L-4430-2017; Lamaze, Christophe/M-4912-2017; Bassereau, Patricia/P-8657-2018	Johannes, Ludger/0000-0002-2168-0004; Sykes, Cécile/0000-0003-3057-2600; Johannes, Ludger/0000-0002-2168-0004; Rentero Alfonso, Carles/0000-0003-4684-0278; Sorre, Benoit/0000-0001-8810-3298; LAMAZE, Christophe/0000-0001-5430-2707; Gaus, Katharina/0000-0002-8009-9658; Bassereau, Patricia/0000-0002-8544-6778	Association de Recherche Contre le Cancer [3143]; Curie Institute (PIC Vectorisation); Agence Nationale pour la Recherche (Physicochimie du Vivant); European Commission [NoE/NMP3-CT-2004-502235]; Human Frontier Science Program Organization [RGP26/2007, RPG58/2005]; ANR; CNRS; Direction Generale pour l'Armement and Fondation pour la Recherche Medicale; French Ministry of Science and Technology	Association de Recherche Contre le Cancer(Fondation ARC pour la Recherche sur le Cancer); Curie Institute (PIC Vectorisation); Agence Nationale pour la Recherche (Physicochimie du Vivant)(French National Research Agency (ANR)); European Commission(European CommissionEuropean Commission Joint Research Centre); Human Frontier Science Program Organization(Human Frontier Science Program); ANR(French National Research Agency (ANR)); CNRS(Centre National de la Recherche Scientifique (CNRS)); Direction Generale pour l'Armement and Fondation pour la Recherche Medicale; French Ministry of Science and Technology	We thank Satyajit Mayor, Madan Rao, Pierre Sens, Luis Bagatolli, and Emmanuel Derivery for helpful discussions and Dylan Owen for help in Laurdan experiments. The authors acknowledge the help of the PICT-IBiSA imaging staff and the use of the advanced microscopy equipment of the Nikon Imaging Centre at Institut Curie-CNRS. Our laboratories were supported by Association de Recherche Contre le Cancer (n<SUP>o</SUP>3143), Curie Institute (PIC Vectorisation), Agence Nationale pour la Recherche (Physicochimie du Vivant), European Commission (SoftComp, NoE/NMP3-CT-2004-502235), Human Frontier Science Program Organization (RGP26/2007 and RPG58/2005), and ANR program blanc (ProLipScis). W. R. (CNRS), L. B., B. S. (Direction Generale pour l'Armement and Fondation pour la Recherche Medicale), and L. L. P. (French Ministry of Science and Technology) were supported by fellowships from the indicated organizations.	Allain JM, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.158104; Amessou M., 2006, CURR PROTOC CELL BIO, V15, p15.10, DOI [10.1002/0471143030.cb1510s32, DOI 10.1002/0471143030.CB1510S32]; Bacia K, 2005, P NATL ACAD SCI USA, V102, P3272, DOI 10.1073/pnas.0408215102; Bagatolli LA, 2000, BIOPHYS J, V78, P290, DOI 10.1016/S0006-3495(00)76592-1; Baumgart T, 2007, P NATL ACAD SCI USA, V104, P3165, DOI 10.1073/pnas.0611357104; Bonifacino JS, 2004, CELL, V116, P153, DOI 10.1016/S0092-8674(03)01079-1; Bonifacino JS, 2006, NAT REV MOL CELL BIO, V7, P568, DOI 10.1038/nrm1985; Damm EM, 2005, J CELL BIOL, V168, P477, DOI 10.1083/jcb.200407113; Dietrich C, 2001, BIOPHYS J, V80, P1417, DOI 10.1016/S0006-3495(01)76114-0; Ewers H, 2010, NAT CELL BIOL, V12, P11, DOI 10.1038/ncb1999; Falguieres T, 2001, MOL BIOL CELL, V12, P2453, DOI 10.1091/mbc.12.8.2453; Gaus K, 2003, P NATL ACAD SCI USA, V100, P15554, DOI 10.1073/pnas.2534386100; Goswami D, 2008, CELL, V135, P1085, DOI 10.1016/j.cell.2008.11.032; Guha A, 2003, J CELL SCI, V116, P3373, DOI 10.1242/jcs.00637; Heimburg T, 2005, P NATL ACAD SCI USA, V102, P9790, DOI 10.1073/pnas.0503823102; Heuvingh J, 2007, P NATL ACAD SCI USA, V104, P16928, DOI 10.1073/pnas.0704749104; Honerkamp-Smith AR, 2008, BIOPHYS J, V95, P236, DOI 10.1529/biophysj.107.128421; Johannes L, 2008, CELL, V135, P1175, DOI 10.1016/j.cell.2008.12.009; Kaiser HJ, 2009, P NATL ACAD SCI USA, V106, P16645, DOI 10.1073/pnas.0908987106; Kaksonen M, 2005, CELL, V123, P305, DOI 10.1016/j.cell.2005.09.024; Kirkham M, 2005, BBA-MOL CELL RES, V1745, P273, DOI 10.1016/j.bbamcr.2005.06.002; Lauvrak SU, 2004, J CELL SCI, V117, P2321, DOI 10.1242/jcs.01081; Lingwood D, 2008, P NATL ACAD SCI USA, V105, P10005, DOI 10.1073/pnas.0804374105; Liu AP, 2006, BIOPHYS J, V91, P4064, DOI 10.1529/biophysj.106.090852; Liu J, 2006, P NATL ACAD SCI USA, V103, P10277, DOI 10.1073/pnas.0601045103; Liu J, 2009, PLOS BIOL, V7, DOI 10.1371/journal.pbio.1000204; Macia E, 2006, DEV CELL, V10, P839, DOI 10.1016/j.devcel.2006.04.002; Mallard F, 1998, J CELL BIOL, V143, P973, DOI 10.1083/jcb.143.4.973; Mallard Frederic, 2003, Methods Mol Med, V73, P209; Mathivet L, 1996, BIOPHYS J, V70, P1112, DOI 10.1016/S0006-3495(96)79693-5; Mayor S, 2007, NAT REV MOL CELL BIO, V8, P603, DOI 10.1038/nrm2216; McConnell HM, 2003, ANNU REV BIOPH BIOM, V32, P469, DOI 10.1146/annurev.biophys.32.110601.141704; Mettlen M, 2009, BIOCHEM SOC T, V37, P1022, DOI 10.1042/BST0371022; Pautot S, 2003, P NATL ACAD SCI USA, V100, P10718, DOI 10.1073/pnas.1931005100; Polozov IV, 2008, NAT CHEM BIOL, V4, P248, DOI 10.1038/nchembio.77; Pontani LL, 2009, BIOPHYS J, V96, P192, DOI 10.1016/j.bpj.2008.09.029; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Riedl J, 2008, NAT METHODS, V5, P605, DOI 10.1038/nmeth.1220; Romer W, 2007, NATURE, V450, P670, DOI 10.1038/nature05996; Roux A, 2005, EMBO J, V24, P1537, DOI 10.1038/sj.emboj.7600631; Saint-Pol A, 2004, DEV CELL, V6, P525, DOI 10.1016/S1534-5807(04)00100-5; SANDVIG K, 1992, NATURE, V358, P510, DOI 10.1038/358510a0; Scheiffele P, 1999, J BIOL CHEM, V274, P2038, DOI 10.1074/jbc.274.4.2038; Sens P, 2008, CURR OPIN CELL BIOL, V20, P476, DOI 10.1016/j.ceb.2008.04.004; Sharma P, 2004, CELL, V116, P577, DOI 10.1016/S0092-8674(04)00167-9; Simons K, 2004, ANNU REV BIOPH BIOM, V33, P269, DOI 10.1146/annurev.biophys.32.110601.141803; Sorre B, 2009, P NATL ACAD SCI USA, V106, P5622, DOI 10.1073/pnas.0811243106; Souza CM, 2007, BBA-MOL CELL BIOL L, V1771, P442, DOI 10.1016/j.bbalip.2006.08.006; Tsai B, 2003, EMBO J, V22, P4346, DOI 10.1093/emboj/cdg439; Windschiegl B, 2006, LANGMUIR, V22, P7454, DOI 10.1021/la060146x; Windschiegl B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006238; Zalevsky J, 2001, CURR BIOL, V11, P1903, DOI 10.1016/S0960-9822(01)00603-0	52	195	196	0	48	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					540	553		10.1016/j.cell.2010.01.010	http://dx.doi.org/10.1016/j.cell.2010.01.010			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178746	Bronze			2022-12-01	WOS:000274668400017
J	Hertzman, C; Siddiqi, A; Hertzman, E; Irwin, LG; Vaghri, Z; Houweling, TAJ; Bell, R; Tinajero, A; Marmot, M				Hertzman, Clyde; Siddiqi, Arjumand; Hertzman, Emily; Irwin, Lori G.; Vaghri, Ziba; Houweling, Tanja A. J.; Bell, Ruth; Tinajero, Alfredo; Marmot, Michael			Bucking the inequality gradient through early child development	BRITISH MEDICAL JOURNAL			English	Editorial Material							DEVELOPING-COUNTRIES; SOCIOECONOMIC INEQUALITIES; HEALTH; PROGRAMS; MORTALITY; INTERVENTION; EDUCATION; NATIONS; WORLD		[Hertzman, Clyde; Hertzman, Emily; Irwin, Lori G.; Vaghri, Ziba] Univ British Columbia, Vancouver, BC V6T 1Z3, Canada; [Siddiqi, Arjumand] Univ N Carolina, Sch Publ Hlth, Chapel Hill, NC USA; [Houweling, Tanja A. J.] Inst Child Hlth, UCL Ctr Int Hlth & Dev, London, England; [Tinajero, Alfredo] Hincks Dellcrest Ctr, Toronto, ON, Canada; [Marmot, Michael] UCL, WHO Commiss Social Determinants Hlth, London WC1E 6BT, England	University of British Columbia; University of North Carolina; University of North Carolina Chapel Hill; University of London; University College London; University of London; University College London	Hertzman, C (corresponding author), Univ British Columbia, 440-2206 East Mall, Vancouver, BC V6T 1Z3, Canada.	clyde.hertzman@ubc.ca	Vaghri, Ziba/AAX-9150-2021; Houweling, Tanja/GRF-6127-2022; Marmot, M G/Y-3920-2019	Marmot, M G/0000-0002-2431-6419; Houweling, Tanja AJ/0000-0001-6090-4376; Vaghri, Dr. Ziba/0000-0001-9708-8704	British Heart Foundation [RG/07/008/23674] Funding Source: Medline; Medical Research Council [G8802774, G0902037, G0100222, G19/35] Funding Source: Medline; MRC [G0902037] Funding Source: UKRI	British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		ADLER NE, 1994, AM PSYCHOL, V49, P15, DOI 10.1037/0003-066X.49.1.15; Anderson LM, 2003, AM J PREV MED, V24, P32, DOI 10.1016/S0749-3797(02)00655-4; [Anonymous], 2009, DOING BETT CHILDR; Bradley RH, 2002, ANNU REV PSYCHOL, V53, P371, DOI 10.1146/annurev.psych.53.100901.135233; Braveman P, 2002, SOC SCI MED, V54, P1621, DOI 10.1016/S0277-9536(01)00331-8; Burchinal MR, 2003, EARLY CHILD RES Q, V18, P401, DOI 10.1016/j.ecresq.2003.09.003; *CIV SOC, 2007, REP COMM SOC DET HLT, P109; Clifford D., 1998, QUALITY CHILD CARE Q; *DEP CHILDR SCH FA, SUR START CHILDR CTR; Engle PL, 2007, LANCET, V369, P229, DOI 10.1016/S0140-6736(07)60112-3; EVANS JL, 1993, COORD NOTEB, P13; Fernald LCH, 2008, LANCET, V371, P828, DOI 10.1016/S0140-6736(08)60382-7; Grantham-McGregor S, 2007, LANCET, V369, P60, DOI 10.1016/S0140-6736(07)60032-4; Houweling TAJ, 2005, INT J EPIDEMIOL, V34, P1257, DOI 10.1093/ije/dyi190; Houweling TAJ, 2001, LANCET, V357, P1671, DOI 10.1016/S0140-6736(00)04829-7; Hutchings J, 2007, BMJ-BRIT MED J, V334, P678, DOI 10.1136/bmj.39126.620799.55; Irwin LG, 2007, EARLY CHILD DEV POWE; Kershaw P., 2005, BRIT COLUMBIA ATLAS; Kershaw P., 2009, 15 15 COMPREHENSIVE; Kuh D, 2004, LIFE COURSE APPROACH; KUNST AE, 1994, AM J PUBLIC HEALTH, V84, P932, DOI 10.2105/AJPH.84.6.932; KUNST AE, 1995, J EPIDEMIOL COMMUN H, V49, P117, DOI 10.1136/jech.49.2.117; Ludwig J., 2007, SOCIAL POLICY REPORT, V21, P3, DOI DOI 10.1002/j.2379-3988.2007.tb00052.x; Melhuish E, 2008, LANCET, V372, P1641, DOI 10.1016/S0140-6736(08)61687-6; Palfrey JS, 2005, PEDIATRICS, V116, P144, DOI 10.1542/peds.2004-2515; Siddiqi A, 2007, INT J HEALTH SERV, V37, P63, DOI 10.2190/JU86-457P-7656-W4W7; Smith Judith R., 1997, CONSEQUENCES GROWING, P132; Temple JA, 2007, ECON EDUC REV, V26, P126, DOI 10.1016/j.econedurev.2005.11.004; *UN, 2008, CHILD CAR TRANS INN; *UN, 2007, EFA GLOB MON REP STR; *UN, 1 REP 1 INT COMP STU; Unicef, 2007, STAT WORLDS CHILDR 2; Vandell DL, 1996, EARLY CHILD RES Q, V11, P269, DOI 10.1016/S0885-2006(96)90009-5; vanDoorslaer E, 1997, J HEALTH ECON, V16, P93, DOI 10.1016/S0167-6296(96)00532-2; Willms J. D., 2006, 5 UIS UNESCO I STAT; World Health Organization, 2008, COM SOC DET HLTH, V89	36	32	33	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 10	2010	340								c468	10.1136/bmj.c468	http://dx.doi.org/10.1136/bmj.c468			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	554ZT	20147358	Green Published			2022-12-01	WOS:000274476900003
J	Mizushima, N; Yoshimori, T; Levine, B				Mizushima, Noboru; Yoshimori, Tamotsu; Levine, Beth			Methods in Mammalian Autophagy Research	CELL			English	Article							DROSOPHILA FAT-BODY; CELL-DEATH; HUNTINGTONS-DISEASE; MONITORING AUTOPHAGY; 3-KINASE INHIBITORS; SIGNALING PATHWAYS; LC3; PROTEIN; LYSOSOMES; MICE		[Mizushima, Noboru] Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan; [Yoshimori, Tamotsu] Osaka Univ, Dept Cellular Regulat, Microbial Dis Res Inst, Suita, Osaka 5650871, Japan; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Levine, Beth] Univ Texas SW Med Ctr Dallas, Dept Microbiol, Dallas, TX 75390 USA	Tokyo Medical & Dental University (TMDU); Osaka University; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Mizushima, N (corresponding author), Tokyo Med & Dent Univ, Dept Physiol & Cell Biol, Tokyo 1138519, Japan.	nmizu.phy2@tmd.ac.jp; beth.levine@utsouthwestern.edu	Mizushima, Noboru/C-3635-2009; Yoshimori, Tamotsu/K-9626-2014	Mizushima, Noboru/0000-0002-6258-6444; Yoshimori, Tamotsu/0000-0001-9787-3788	NATIONAL CANCER INSTITUTE [R01CA084254, R01CA109618] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057156] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA85254, R01 CA109618-05, R01 CA084254-10S1, R01 CA084254, R01 CA084254-10, R01 CA109618] Funding Source: Medline; NIAID NIH HHS [U54 AI057156-06S18820, U54 AI057156] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bampton ETW, 2005, AUTOPHAGY, V1, P23, DOI 10.4161/auto.1.1.1495; Bjorkoy G, 2005, J CELL BIOL, V171, P603, DOI 10.1083/jcb.200507002; Blommaart EFC, 1997, EUR J BIOCHEM, V243, P240, DOI 10.1111/j.1432-1033.1997.0240a.x; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Cadwell K, 2008, NATURE, V456, P259, DOI 10.1038/nature07416; Cann GM, 2008, DEV DYNAM, V237, P187, DOI 10.1002/dvdy.21392; CARO LHP, 1988, EUR J BIOCHEM, V175, P325, DOI 10.1111/j.1432-1033.1988.tb14200.x; Cecconi F, 2008, DEV CELL, V15, P344, DOI 10.1016/j.devcel.2008.08.012; Chan EYW, 2007, J BIOL CHEM, V282, P25464, DOI 10.1074/jbc.M703663200; Chan EYW, 2009, MOL CELL BIOL, V29, P157, DOI 10.1128/MCB.01082-08; Deretic V, 2009, CELL HOST MICROBE, V5, P527, DOI 10.1016/j.chom.2009.05.016; Eskelinen EL, 2008, AUTOPHAGY, V4, P257, DOI 10.4161/auto.5179; Feldman ME, 2009, PLOS BIOL, V7, P371, DOI 10.1371/journal.pbio.1000038; Fimia GM, 2007, NATURE, V447, P1121, DOI 10.1038/nature05925; Fujita N, 2008, MOL BIOL CELL, V19, P4651, DOI 10.1091/mbc.E08-03-0312; Fujita N, 2008, MOL BIOL CELL, V19, P2092, DOI 10.1091/mbc.E07-12-1257; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Gao WT, 2008, AUTOPHAGY, V4, P754, DOI 10.4161/auto.6360; Hara T, 2008, J CELL BIOL, V181, P497, DOI 10.1083/jcb.200712064; He CC, 2009, ANNU REV GENET, V43, P67, DOI 10.1146/annurev-genet-102808-114910; He CC, 2009, AUTOPHAGY, V5, P520, DOI 10.4161/auto.5.4.7768; Hosokawa N, 2006, FEBS LETT, V580, P2623, DOI 10.1016/j.febslet.2006.04.008; Hosokawa N, 2009, MOL BIOL CELL, V20, P1981, DOI 10.1091/mbc.E08-12-1248; Itakura E, 2008, MOL BIOL CELL, V19, P5360, DOI 10.1091/mbc.E08-01-0080; Iwai-Kanai E, 2008, AUTOPHAGY, V4, P322, DOI 10.4161/auto.5603; Jahreiss L, 2008, TRAFFIC, V9, P574, DOI 10.1111/j.1600-0854.2008.00701.x; Kabeya Y, 2000, EMBO J, V19, P5720, DOI 10.1093/emboj/19.21.5720; Kamimoto T, 2006, J BIOL CHEM, V281, P4467, DOI 10.1074/jbc.M509409200; Katayama H, 2008, CELL STRUCT FUNCT, V33, P1, DOI 10.1247/csf.07011; Kimura S, 2008, CELL STRUCT FUNCT, V33, P109, DOI 10.1247/csf.08005; Kimura S, 2007, AUTOPHAGY, V3, P452, DOI 10.4161/auto.4451; Klionsky DJ, 2008, AUTOPHAGY, V4, P849, DOI 10.4161/auto.6845; Klionsky DJ, 2008, AUTOPHAGY, V4, P151, DOI 10.4161/auto.5338; Knight ZA, 2006, CELL, V125, P733, DOI 10.1016/j.cell.2006.03.035; Komatsu M, 2005, J CELL BIOL, V169, P425, DOI 10.1083/jcb.200412022; Komatsu M, 2007, CELL, V131, P1149, DOI 10.1016/j.cell.2007.10.035; Kroemer G, 2008, NAT REV MOL CELL BIO, V9, P1004, DOI 10.1038/nrm2529; Kuma A, 2004, NATURE, V432, P1032, DOI 10.1038/nature03029; Kuma A, 2007, AUTOPHAGY, V3, P323, DOI 10.4161/auto.4012; Kundu M, 2008, BLOOD, V112, P1493, DOI 10.1182/blood-2008-02-137398; Levine B, 2008, CELL, V132, P27, DOI 10.1016/j.cell.2007.12.018; Longatti A, 2009, CELL DEATH DIFFER, V16, P956, DOI 10.1038/cdd.2009.39; Maiuri MC, 2007, EMBO J, V26, P2527, DOI 10.1038/sj.emboj.7601689; Marino G, 2007, J BIOL CHEM, V282, P18573, DOI 10.1074/jbc.M701194200; Matsui Y, 2007, CIRC RES, V100, P914, DOI 10.1161/01.RES.0000261924.76669.36; Matsunaga K, 2009, NAT CELL BIOL, V11, P385, DOI 10.1038/ncb1846; Melendez A, 2003, SCIENCE, V301, P1387, DOI 10.1126/science.1087782; Mizushima N, 2001, J CELL BIOL, V152, P657, DOI 10.1083/jcb.152.4.657; Mizushima N, 2004, INT J BIOCHEM CELL B, V36, P2491, DOI 10.1016/j.biocel.2004.02.005; Mizushima N, 2004, MOL BIOL CELL, V15, P1101, DOI 10.1091/mbc.E03-09-0704; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; Mizushima N, 2007, AUTOPHAGY, V3, P542, DOI 10.4161/auto.4600; Nakaso K, 2004, BRAIN RES, V1012, P42, DOI 10.1016/j.brainres.2004.03.029; Nishiyama J, 2007, AUTOPHAGY, V3, P591, DOI 10.4161/auto.4964; PUNNONEN EL, 1994, EUR J CELL BIOL, V65, P14; Pyo JO, 2005, J BIOL CHEM, V280, P20722, DOI 10.1074/jbc.M413934200; Qu XP, 2003, J CLIN INVEST, V112, P1809, DOI 10.1172/JCI200320039; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Rubinsztein DC, 2007, NAT REV DRUG DISCOV, V6, P304, DOI 10.1038/nrd2272; Rubinsztein DC, 2006, NATURE, V443, P780, DOI 10.1038/nature05291; Rubinsztein DC, 2009, AUTOPHAGY, V5, P585, DOI 10.4161/auto.5.5.8823; Rusten TE, 2004, DEV CELL, V7, P179, DOI 10.1016/j.devcel.2004.07.005; SAITOH T, 2009, P NATL ACAD SCI US; Saitoh T, 2008, NATURE, V456, P264, DOI 10.1038/nature07383; Sarkar S, 2008, HUM MOL GENET, V17, P170, DOI 10.1093/hmg/ddm294; Sarkar S, 2007, NAT CHEM BIOL, V3, P331, DOI 10.1038/nchembio883; Sarkar S, 2007, J BIOL CHEM, V282, P5641, DOI 10.1074/jbc.M609532200; Scott RC, 2004, DEV CELL, V7, P167, DOI 10.1016/j.devcel.2004.07.009; Shvets E, 2008, AUTOPHAGY, V4, P621, DOI 10.4161/auto.5939; Sou Y, 2008, MOL BIOL CELL, V19, P4762, DOI 10.1091/mbc.E08-03-0309; Suzuki K, 2001, EMBO J, V20, P5971, DOI 10.1093/emboj/20.21.5971; Tanida I, 2008, AUTOPHAGY, V4, P131, DOI 10.4161/auto.5233; Tanida I, 2005, AUTOPHAGY, V1, P84, DOI 10.4161/auto.1.2.1697; Tannous P, 2008, P NATL ACAD SCI USA, V105, P9745, DOI 10.1073/pnas.0706802105; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; van der Vaart A, 2008, TRAFFIC, V9, P281, DOI 10.1111/j.1600-0854.2007.00674.x; Virgin HW, 2009, NAT IMMUNOL, V10, P461, DOI 10.1038/ni.1726; Wang QJ, 2006, J NEUROSCI, V26, P8057, DOI 10.1523/JNEUROSCI.2261-06.2006; Williams A, 2008, NAT CHEM BIOL, V4, P295, DOI 10.1038/nchembio.79; Xue LZ, 2002, BIOCHEM PHARMACOL, V64, P441, DOI 10.1016/S0006-2952(02)01181-4; Yamamoto A, 1998, CELL STRUCT FUNCT, V23, P33, DOI 10.1247/csf.23.33; Yoshimoto K, 2004, PLANT CELL, V16, P2967, DOI 10.1105/tpc.104.025395; Yue ZY, 2003, P NATL ACAD SCI USA, V100, P15077, DOI 10.1073/pnas.2436255100; Zeng XH, 2006, J CELL SCI, V119, P259, DOI 10.1242/jcs.02735; Zhang LH, 2007, P NATL ACAD SCI USA, V104, P19023, DOI 10.1073/pnas.0709695104; Zhu HX, 2007, J CLIN INVEST, V117, P1782, DOI 10.1172/JCI27523	86	3430	3594	17	701	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 5	2010	140	3					313	326		10.1016/j.cell.2010.01.028	http://dx.doi.org/10.1016/j.cell.2010.01.028			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144757	Green Accepted, Bronze			2022-12-01	WOS:000274297700010
J	Si, K; Choi, YB; White-Grindley, E; Majumdar, A; Kandel, ER				Si, Kausik; Choi, Yun-Beom; White-Grindley, Erica; Majumdar, Amitabha; Kandel, Eric R.			Aplysia CPEB Can Form Prion-like Multimers in Sensory Neurons that Contribute to Long-Term Facilitation	CELL			English	Article							LOCAL PROTEIN-SYNTHESIS; B1 MESSENGER-RNA; CYTOPLASMIC POLYADENYLATION; TRANSLATIONAL CONTROL; SYNAPTIC PLASTICITY; FLUORESCENT PROTEIN; YEAST PRIONS; IN-VITRO; HUNTINGTIN; MECHANISM	Prions are proteins that can assume at least two distinct conformational states, one of which is dominant and self-perpetuating. Previously we found that a translation regulator CPEB from Aplysia, ApCPEB, that stabilizes activity-dependent changes in synaptic efficacy can display prion-like properties in yeast. Here we find that, when exogenously expressed in sensory neurons, ApCPEB can form an amyloidogenic self-sustaining multimer, consistent with it being a prion-like protein. In addition, we find that conversion of both the exogenous and the endogenous ApCPEB to the multimeric state is enhanced by the neurotransmitter serotonin and that an antibody that recognizes preferentially the multimeric ApCPEB blocks persistence of synaptic facilitation. These results are consistent with the idea that ApCPEB can act as a self-sustaining prion-like protein in the nervous system and thereby might allow the activity-dependent change in synaptic efficacy to persist for long periods of time.	[Si, Kausik; White-Grindley, Erica; Majumdar, Amitabha] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Si, Kausik] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Howard Hughes Med Inst, New York, NY 10032 USA; [Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Kavli Inst Brain Sci, New York, NY 10032 USA; [Choi, Yun-Beom; Kandel, Eric R.] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Neurosci, New York, NY 10032 USA; [Choi, Yun-Beom] Columbia Univ, Coll Phys & Surg, New York State Psychiat Inst, Dept Neurol, New York, NY 10032 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; Columbia University; Howard Hughes Medical Institute; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute; Columbia University; New York State Psychiatry Institute	Si, K (corresponding author), Stowers Inst Med Res, 1000 E 50th St, Kansas City, MO 64110 USA.	ksi@Stowers-Institute.org		majumdar, amitabha/0000-0002-6594-0672	HHMI; Searle Scholars Program; March of Dimes Basil O'Connor Starter Scholar Award; The Esther A. & Joseph Klingenstein Fund; The McKnight Endowment Fund for Neuroscience	HHMI(Howard Hughes Medical Institute); Searle Scholars Program; March of Dimes Basil O'Connor Starter Scholar Award(March of Dimes); The Esther A. & Joseph Klingenstein Fund; The McKnight Endowment Fund for Neuroscience	We thank Dr. Thomas Jessel and Dr. Richard Axel of Columbia University for their critical comments. Special thanks to Kevin Karl, Agnieszka Janisiewicz, Jonah Lehrer, and Ruby Hsu of Columbia University and Fengzhen Ren of the Stowers Institute for their technical support. We thank Katherine Perko, Joel Schwartz, and Winfried Wiegraebe of the Stowers Institute for their assistance in image processing, Diana Baumann of the Stowers Institute for maintaining Aplysia, and Nancy Lane of the Stowers Institute for her help in preparation of the manuscript. The work was supported by HHMI to E. R. K. K. S. is supported by Searle Scholars Program, March of Dimes Basil O'Connor Starter Scholar Award, The Esther A. & Joseph Klingenstein Fund, and The McKnight Endowment Fund for Neuroscience.	Barkoff AF, 2000, DEV BIOL, V220, P97, DOI 10.1006/dbio.2000.9613; Casadio A, 1999, CELL, V99, P221, DOI 10.1016/S0092-8674(00)81653-0; Coustou V, 1997, P NATL ACAD SCI USA, V94, P9773, DOI 10.1073/pnas.94.18.9773; de Moor CH, 1999, EMBO J, V18, P2294, DOI 10.1093/emboj/18.8.2294; Derkatch IL, 2001, CELL, V106, P171, DOI 10.1016/S0092-8674(01)00427-5; Frey U, 1997, NATURE, V385, P533, DOI 10.1038/385533a0; Glover JR, 1997, CELL, V89, P811, DOI 10.1016/S0092-8674(00)80264-0; HAKE LE, 1994, CELL, V79, P617, DOI 10.1016/0092-8674(94)90547-9; HEGDE AN, 1993, P NATL ACAD SCI USA, V90, P7436, DOI 10.1073/pnas.90.16.7436; Higgs HN, 2001, ANNU REV BIOCHEM, V70, P649, DOI 10.1146/annurev.biochem.70.1.649; Hu CD, 2002, MOL CELL, V9, P789, DOI 10.1016/S1097-2765(02)00496-3; Huang YS, 2006, EMBO J, V25, P4865, DOI 10.1038/sj.emboj.7601322; Huang YS, 2003, GENE DEV, V17, P638, DOI 10.1101/gad.1053003; Kaang BK, 1996, NEUROSCI LETT, V221, P29, DOI 10.1016/S0304-3940(96)13279-1; KAANG BK, 1992, P NATL ACAD SCI USA, V89, P1133, DOI 10.1073/pnas.89.3.1133; Kang HJ, 1996, SCIENCE, V273, P1402, DOI 10.1126/science.273.5280.1402; Kayed R, 2003, SCIENCE, V300, P486, DOI 10.1126/science.1079469; Kimura Y, 2003, CELL STRUCT FUNCT, V28, P187; Kohrmann M, 1999, MOL BIOL CELL, V10, P2945, DOI 10.1091/mbc.10.9.2945; Krobitsch S, 2000, P NATL ACAD SCI USA, V97, P1589, DOI 10.1073/pnas.97.4.1589; LeVine H, 1999, METHOD ENZYMOL, V309, P274; Lindquist S, 1998, BIOCHEM SOC T, V26, P486, DOI 10.1042/bst0260486; Maddelein ML, 2002, P NATL ACAD SCI USA, V99, P7402, DOI 10.1073/pnas.072199199; Martin KC, 1997, CELL, V91, P927, DOI 10.1016/S0092-8674(00)80484-5; Meyer-Luehmann M, 2006, SCIENCE, V313, P1781, DOI 10.1126/science.1131864; Miniaci MC, 2008, NEURON, V59, P1024, DOI 10.1016/j.neuron.2008.07.036; Minshall N, 1999, RNA, V5, P27, DOI 10.1017/S1355838299981220; MONTAROLO PG, 1986, SCIENCE, V234, P1249, DOI 10.1126/science.3775383; Muchowski PJ, 2002, P NATL ACAD SCI USA, V99, P727, DOI 10.1073/pnas.022628699; Osherovich LZ, 2004, PLOS BIOL, V2, P442, DOI 10.1371/journal.pbio.0020086; Osherovich LZ, 2001, CELL, V106, P183, DOI 10.1016/S0092-8674(01)00440-8; Osherovich LZ, 2002, DEV CELL, V2, P143, DOI 10.1016/S1534-5807(02)00118-1; Parham SN, 2001, EMBO J, V20, P2111, DOI 10.1093/emboj/20.9.2111; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; PRUSINER SB, 1983, CELL, V35, P349, DOI 10.1016/0092-8674(83)90168-X; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Scherzinger E, 1997, CELL, V90, P549, DOI 10.1016/S0092-8674(00)80514-0; Shorter J, 2005, NAT REV GENET, V6, P435, DOI 10.1038/nrg1616; Si K, 2003, CELL, V115, P879, DOI 10.1016/S0092-8674(03)01020-1; Si K, 2003, CELL, V115, P893, DOI 10.1016/S0092-8674(03)01021-3; Sondheimer N, 2000, MOL CELL, V5, P163, DOI 10.1016/S1097-2765(00)80412-8; Steward O, 2001, ANNU REV NEUROSCI, V24, P299, DOI 10.1146/annurev.neuro.24.1.299; Taylor KL, 1999, SCIENCE, V283, P1339, DOI 10.1126/science.283.5406.1339; Tsutsui H, 2005, EMBO REP, V6, P233, DOI 10.1038/sj.embor.7400361; Wacker JL, 2004, NAT STRUCT MOL BIOL, V11, P1215, DOI 10.1038/nsmb860; Weissmann C, 2004, NAT REV MICROBIOL, V2, P861, DOI 10.1038/nrmicro1025; Wickner RB, 1995, YEAST, V11, P1671, DOI 10.1002/yea.320111609; Wilczynska A, 2005, J CELL SCI, V118, P981, DOI 10.1242/jcs.01692; Zhang SF, 2004, CELL, V119, P137, DOI 10.1016/j.cell.2004.09.012	49	268	273	0	35	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					421	U179		10.1016/j.cell.2010.01.008	http://dx.doi.org/10.1016/j.cell.2010.01.008			21	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144764	Bronze			2022-12-01	WOS:000274297700019
J	Naka, K; Hoshii, T; Muraguchi, T; Tadokoro, Y; Ooshio, T; Kondo, Y; Nakao, S; Motoyama, N; Hirao, A				Naka, Kazuhito; Hoshii, Takayuki; Muraguchi, Teruyuki; Tadokoro, Yuko; Ooshio, Takako; Kondo, Yukio; Nakao, Shinji; Motoyama, Noboru; Hirao, Atsushi			TGF-beta-FOXO signalling maintains leukaemia-initiating cells in chronic myeloid leukaemia	NATURE			English	Article							HEMATOPOIETIC STEM-CELLS; CHRONIC MYELOGENOUS LEUKEMIA; ABL-EXPRESSING CELLS; BCR-ABL; TRANSCRIPTION FACTOR; OXIDATIVE STRESS; MURINE MODEL; BONE-MARROW; APOPTOSIS; MICE	Chronic myeloid leukaemia (CML) is caused by a defined genetic abnormality that generates BCR-ABL, a constitutively active tyrosine kinase(1). It is widely believed that BCR-ABL activates Akt signalling that suppresses the forkhead O transcription factors (FOXO), supporting the proliferation or inhibiting the apoptosis of CML cells(2-4). Although the use of the tyrosine kinase inhibitor imatinib is a breakthrough for CML therapy, imatinib does not deplete the leukaemia-initiating cells (LICs) that drive the recurrence of CML(5-8). Here, using a syngeneic transplantation system and a CML-like myeloproliferative disease mouse model, we show that Foxo3a has an essential role in the maintenance of CML LICs. We find that cells with nuclear localization of Foxo3a and decreased Akt phosphorylation are enriched in the LIC population. Serial transplantation of LICs generated from Foxo3a(+/+) and Foxo3a(-/-) mice shows that the ability of LICs to cause disease is significantly decreased by Foxo3a deficiency. Furthermore, we find that TGF-beta is a critical regulator of Akt activation in LICs and controls Foxo3a localization. A combination of TGF-beta inhibition, Foxo3a deficiency and imatinib treatment led to efficient depletion of CML in vivo. Furthermore, the treatment of human CML LICs with a TGF-beta inhibitor impaired their colony-forming ability in vitro. Our results demonstrate a critical role for the TGF-beta-FOXO pathway in the maintenance of LICs, and strengthen our understanding of the mechanisms that specifically maintain CML LICs in vivo.	[Naka, Kazuhito; Hoshii, Takayuki; Muraguchi, Teruyuki; Tadokoro, Yuko; Ooshio, Takako; Hirao, Atsushi] Kanazawa Univ, Div Mol Genet, Ctr Canc & Stem Cell Res, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan; [Ooshio, Takako; Hirao, Atsushi] Japan Sci & Technol Agcy, CREST, Chiyoda Ku, Tokyo 1020075, Japan; [Kondo, Yukio; Nakao, Shinji] Kanazawa Univ, Grad Sch Med Sci, Div Canc Med, Kanazawa, Ishikawa 9208641, Japan; [Motoyama, Noboru] Natl Ctr Gerontol & Geriatr, Natl Inst Longev Sci, Dept Geriatr Med, Aichi 4748522, Japan	Kanazawa University; Japan Science & Technology Agency (JST); Kanazawa University	Naka, K (corresponding author), Kanazawa Univ, Div Mol Genet, Ctr Canc & Stem Cell Res, Canc Res Inst, Kanazawa, Ishikawa 9200934, Japan.	kazunaka@kenroku.kanazawa-u.ac.jp; ahirao@kenroku.kanazawa-u.ac.jp	Naka, Kazuhito/X-3756-2019	Naka, Kazuhito/0000-0001-6646-6004; Ooshio, Takako/0000-0001-6508-8152	Ministry of Education, Culture, Sports, Science and Technology, Japan [17GS0419]; Grants-in-Aid for Scientific Research [21390290] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology, Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank H. Honda for BCR-ABL cDNA, C. A. Schmitt for MSCV-dnFoxo-ires-GFP, T. Nakamura for MSCV-NUP98-HOXA9, T. Kitamura for Plat-E retroviral packaging cells, T. Suda, N. Komatsu and K. Miyazono for discussions, and M. Sakae and T. Hatakeyama for expert technical support. We also thank Novartis International AG for imatinib (STI571). K. N. was supported by a grant-in-aid for Scientific Research (C), and A. H. was supported by grants-in-aid for Scientific Research (B) and Creative Scientific Research (17GS0419) from the Ministry of Education, Culture, Sports, Science and Technology, Japan.	Bhaskar PT, 2007, DEV CELL, V12, P487, DOI 10.1016/j.devcel.2007.03.020; Bouchard C, 2007, GENE DEV, V21, P2775, DOI 10.1101/gad.453107; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dash AB, 2002, P NATL ACAD SCI USA, V99, P7622, DOI 10.1073/pnas.102583199; Ema H, 2006, NAT PROTOC, V1, P2979, DOI 10.1038/nprot.2006.447; Essafi A, 2005, ONCOGENE, V24, P2317, DOI 10.1038/sj.onc.1208421; Ghaffari S, 2003, P NATL ACAD SCI USA, V100, P6523, DOI 10.1073/pnas.0731871100; Graham SM, 2002, BLOOD, V99, P319, DOI 10.1182/blood.V99.1.319; Hu YG, 2006, P NATL ACAD SCI USA, V103, P16870, DOI 10.1073/pnas.0606509103; Ito K, 2008, NATURE, V453, P1072, DOI 10.1038/nature07016; Jorgensen HG, 2007, BLOOD, V109, P4016, DOI 10.1182/blood-2006-11-057521; KODAMA H, 1994, EXP HEMATOL, V22, P979; Komatsu N, 2003, J BIOL CHEM, V278, P6411, DOI 10.1074/jbc.M211562200; Massague J, 2008, CELL, V134, P215, DOI 10.1016/j.cell.2008.07.001; Michor F, 2005, NATURE, V435, P1267, DOI 10.1038/nature03669; Miyamoto K, 2007, CELL STEM CELL, V1, P101, DOI 10.1016/j.stem.2007.02.001; Moller GMO, 2007, FEBS LETT, V581, P1329, DOI 10.1016/j.febslet.2007.02.048; Neering SJ, 2007, BLOOD, V110, P2578, DOI 10.1182/blood-2007-02-073031; Pear WS, 1998, BLOOD, V92, P3780, DOI 10.1182/blood.V92.10.3780.422k15_3780_3792; PELLICANO F, 2009, BLOOD           1201, DOI DOI 10.1182/BLOOD-2009-06-226621; Ren R, 2005, NAT REV CANCER, V5, P172, DOI 10.1038/nrc1567; Roeder I, 2006, NAT MED, V12, P1181, DOI 10.1038/nm1487; Sawyer JS, 2003, J MED CHEM, V46, P3953, DOI 10.1021/jm0205705; Tothova Z, 2007, CELL, V128, P325, DOI 10.1016/j.cell.2007.01.003; Yalcin S, 2008, J BIOL CHEM, V283, P25692, DOI 10.1074/jbc.M800517200; Yamazaki S, 2006, EMBO J, V25, P3515, DOI 10.1038/sj.emboj.7601236; Yamazaki S, 2009, BLOOD, V113, P1250, DOI 10.1182/blood-2008-04-146480; Zhao C, 2009, NATURE, V458, P776, DOI 10.1038/nature07737	28	437	461	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 4	2010	463	7281					676	U111		10.1038/nature08734	http://dx.doi.org/10.1038/nature08734			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130650	Green Submitted			2022-12-01	WOS:000274193900039
J	Sanders, AE; Wang, CL; Katz, M; Derby, CA; Barzilai, N; Ozelius, L; Lipton, RB				Sanders, Amy E.; Wang, Cuiling; Katz, Mindy; Derby, Carol A.; Barzilai, Nir; Ozelius, Laurie; Lipton, Richard B.			Association of a Functional Polymorphism in the Cholesteryl Ester Transfer Protein (CETP) Gene With Memory Decline and Incidence of Dementia	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; ALZHEIMERS-DISEASE; IDENTIFIES VARIANTS; TASK-FORCE; GENOTYPE; RISK; APOE; SENSITIVITY; LONGEVITY; TESTS	Context Polymorphisms in the cholesteryl ester transfer protein ( CETP) gene have been associated with exceptional longevity and lower cardiovascular risk, but associations with memory decline and dementia risk are unclear. Objective To test the hypothesis that a single-nucleotide polymorphism ( SNP) at CETP codon 405 ( isoleucine to valine V405; SNP rs5882) is associated with a lower rate of memory decline and lower risk of incident dementia, including Alzheimer disease ( AD). Design, Setting, and Participants Prospective cohort study comprising 608 community-dwelling adults without dementia aged 70 years or older from the Einstein Aging Study with CETP genotype available. Fifteen participants with prevalent dementia were excluded, and 70 without follow-up-63 lost to follow-up and 7 new to the study-were excluded from the Cox proportional hazards model, which included 523 participants in the analysis. Standardized neuropsychological and neurological measures were administered annually from 1994-2009. Linear mixed-effects models adjusted for sex, education, race, medical comorbidities, and apolipoprotein (APOE) epsilon 4 examined associations of V405 genotype with longitudinal performance on cognitive tests of episodic memory ( Free and Cued Selective Reminding Test [FCSRT], possible scores of 0-48), attention ( Digit Span), and psychomotor speed ( Digit Symbol Substitution). The V405 genotype was the main predictor of incident dementia or AD in similarly adjusted Cox proportional hazards models with age as the time scale. Main Outcome Measures Memory decline and incident dementia. Results Valine allele frequency was 43.5%. A total of 40 cases of incident dementia occurred during follow-up (mean[(SD], 4.3 [3.1] years). Compared with isoleucine homozygotes, valine homozygotes had significantly slower memory decline on the FCSRT (0.43 points per year of age for isoleucine; 95% confidence interval [CI], -0.58 to -0.29 vs 0.21 points per year of age for valine; 95% CI, -0.39 to -0.04; difference in linear age slope, 0.22; 95% CI, 0.02 to 0.41; P=.03) and no significant differences on the Digit Span or Digit Symbol Substitution tests. Valine homozygotes also had lower risk of dementia ( hazard ratio, 0.28; 95% CI, 0.10-0.85; P=.02) and AD ( hazard ratio, 0.31; 95% CI, 0.10-0.95; P=.04). Conclusion This preliminary report suggests that CETP V405 valine homozygosity is associated with slower memory decline and lower incident dementia and AD risk. JAMA. 2010;303(2):150-158 www.jama.com	[Sanders, Amy E.; Katz, Mindy; Derby, Carol A.; Lipton, Richard B.] Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, Bronx, NY 10461 USA; [Wang, Cuiling; Derby, Carol A.; Lipton, Richard B.] Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA; [Barzilai, Nir; Lipton, Richard B.] Yeshiva Univ Albert Einstein Coll Med, Inst Aging Res, Bronx, NY 10461 USA; [Ozelius, Laurie] Mt Sinai Sch Med, Dept Genet, New York, NY USA; [Ozelius, Laurie] Mt Sinai Sch Med, Dept Genom Sci & Neurol, New York, NY USA	Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Yeshiva University; Albert Einstein College of Medicine; Icahn School of Medicine at Mount Sinai; Icahn School of Medicine at Mount Sinai	Lipton, RB (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Neurol, 1165 Morris Pk Ave,Rousso Bldg,Room 346, Bronx, NY 10461 USA.	richard.lipton@einstein.yu.edu	Lipton, Richard B/B-5060-2011; Sanders, Amy/AAF-6601-2020; Sanders, Amy/AAI-2633-2019; Lipton, Richard Bruce/AAY-2818-2021		National Institute on Aging [AG03949, AG03949-24S1, AG-027734, AG-18728]; National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH) [UL1 RR025750, KL2 RR025749, TL1 RR025748]; NATIONAL CENTER FOR RESEARCH RESOURCES [TL1RR025748, KL2RR025749, UL1RR025750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG018728, P01AG027734, P01AG003949] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	The Einstein Aging Study is supported by the National Institute on Aging program project grant AG03949 and Supplement (Biorepository) AG03949-24S1. Dr Barzilai is supported by grants AG-027734 and AG-18728 from the National Institute on Aging. Dr Sanders is supported by the Einstein Clinical and Translation Science Award grant UL1 RR025750 and KL2 RR025749 and TL1 RR025748 from the National Center for Research Resources (NCRR), a component of the National Institutes of Health (NIH), and NIH Roadmap for Medical Research.	ALBERS JJ, 1992, INT J CLIN LAB RES, V21, P264, DOI 10.1007/BF02591657; *AM PSYCH ASS, 1994, DIAGN STAT MAN MENT, P133; Arias-Vasquez A, 2007, NEUROGENETICS, V8, P189, DOI 10.1007/s10048-007-0089-x; Barzilai N, 2006, NEUROLOGY, V67, P2170, DOI 10.1212/01.wnl.0000249116.50854.65; Barzilai N, 2003, JAMA-J AM MED ASSOC, V290, P2030, DOI 10.1001/jama.290.15.2030; Bennett DA, 2009, NEUROLOGY, V72, P1495, DOI 10.1212/WNL.0b013e3181a2e87d; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; BUSCHKE H, 1984, J CLIN NEUROPSYCHOL, V6, P433, DOI 10.1080/01688638408401233; Carter CJ, 2007, NEUROCHEM INT, V50, P12, DOI 10.1016/j.neuint.2006.07.007; Coon KD, 2007, J CLIN PSYCHIAT, V68, P613, DOI 10.4088/JCP.v68n0419; Dullaart RPF, 2008, PHARMACOGENOMICS, V9, P747, DOI 10.2217/14622416.9.6.747; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grober E, 1999, NEUROBIOL AGING, V20, P573, DOI 10.1016/S0197-4580(99)00063-9; GROBER E, 1988, NEUROLOGY, V38, P900, DOI 10.1212/WNL.38.6.900; GROBER E, ALZHEIMER D IN PRESS; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Johnson W, 2007, NEUROSCI LETT, V420, P189, DOI 10.1016/j.neulet.2007.05.013; Lambert JC, 2009, NAT GENET, V41, P1094, DOI 10.1038/ng.439; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Lipton RB, 2003, J AM GERIATR SOC, V51, P1382, DOI 10.1046/j.1532-5415.2003.51455.x; Martin GM, 2007, PLOS GENET, V3, P1121, DOI 10.1371/journal.pgen.0030125; MASUR DM, 1994, NEUROLOGY, V44, P1427, DOI 10.1212/WNL.44.8.1427; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Proust-Lima C, 2007, AM J EPIDEMIOL, V165, P344, DOI 10.1093/aje/kwk017; Qureischie H, 2009, J NEURAL TRANSM, V116, P467, DOI 10.1007/s00702-008-0180-y; Rodriguez E, 2006, J NEUROL, V253, P181, DOI 10.1007/s00415-005-0945-2; Sanders AE, 2008, J GERONTOL A-BIOL, V63, P1356, DOI 10.1093/gerona/63.12.1356; Scarmeas N, 2009, JAMA-J AM MED ASSOC, V302, P627, DOI 10.1001/jama.2009.1144; SCHACHTER F, 1994, NAT GENET, V6, P29, DOI 10.1038/ng0194-29; SHEIKH J I, 1986, Clinical Gerontologist, V5, P165; Suribhatla S, 2004, INT J GERIATR PSYCH, V19, P1140, DOI 10.1002/gps.1196; Tan QH, 2004, BIOGERONTOLOGY, V5, P89, DOI 10.1023/B:BGEN.0000025072.30441.1c; Thiebaut ACM, 2004, STAT MED, V23, P3803, DOI 10.1002/sim.2098; Thompson A, 2008, JAMA-J AM MED ASSOC, V299, P2777, DOI 10.1001/jama.299.23.2777; Thompson JF, 2005, ATHEROSCLEROSIS, V181, P45, DOI 10.1016/j.atherosclerosis.2005.01.015; Tounsi H, 1999, ALZ DIS ASSOC DIS, V13, P38, DOI 10.1097/00002093-199903000-00006; Vellas B, 2008, LANCET NEUROL, V7, P436, DOI 10.1016/S1474-4422(08)70087-5; Verghese J, 2006, J AM GERIATR SOC, V54, P255, DOI 10.1111/j.1532-5415.2005.00580.x; Verghese J, 2010, J NEUROL, V257, P392, DOI 10.1007/s00415-009-5332-y; Wechsler D, 1981, ADULT INTELLIGENCE S; YAMADA T, 1995, ACTA NEUROPATHOL, V90, P633	41	75	82	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					150	158		10.1001/jama.2009.1988	http://dx.doi.org/10.1001/jama.2009.1988			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068209	Green Accepted, Bronze			2022-12-01	WOS:000273522600025
J	Horie, M; Honda, T; Suzuki, Y; Kobayashi, Y; Daito, T; Oshida, T; Ikuta, K; Jern, P; Gojobori, T; Coffin, JM; Tomonaga, K				Horie, Masayuki; Honda, Tomoyuki; Suzuki, Yoshiyuki; Kobayashi, Yuki; Daito, Takuji; Oshida, Tatsuo; Ikuta, Kazuyoshi; Jern, Patric; Gojobori, Takashi; Coffin, John M.; Tomonaga, Keizo			Endogenous non-retroviral RNA virus elements in mammalian genomes	NATURE			English	Article							BORNA-DISEASE VIRUS; DNA; PROTEIN; SEQUENCES; BIOLOGY; CDNA	Retroviruses are the only group of viruses known to have left a fossil record, in the form of endogenous proviruses, and approximately 8% of the human genome is made up of these elements(1,2). Although many other viruses, including non-retroviral RNA viruses, are known to generate DNA forms of their own genomes during replication(3-5), none has been found as DNA in the germline of animals. Bornaviruses, a genus of non-segmented, negative-sense RNA virus, are unique among RNA viruses in that they establish persistent infection in the cell nucleus(6-8). Here we show that elements homologous to the nucleoprotein (N) gene of bornavirus exist in the genomes of several mammalian species, including humans, non-human primates, rodents and elephants. These sequences have been designated endogenous Borna-like N (EBLN) elements. Some of the primate EBLNs contain an intact open reading frame (ORF) and are expressed as mRNA. Phylogenetic analyses showed that EBLNs seem to have been generated by different insertional events in each specific animal family. Furthermore, the EBLN of a ground squirrel was formed by a recent integration event, whereas those in primates must have been formed more than 40 million years ago. We also show that the N mRNA of a current mammalian bornavirus, Borna disease virus (BDV), can form EBLN-like elements in the genomes of persistently infected cultured cells. Our results provide the first evidence for endogenization of non-retroviral virus-derived elements in mammalian genomes and give novel insights not only into generation of endogenous elements, but also into a role of bornavirus as a source of genetic novelty in its host.	[Horie, Masayuki; Honda, Tomoyuki; Daito, Takuji; Ikuta, Kazuyoshi; Tomonaga, Keizo] Osaka Univ, Dept Virol, Res Inst Microbial Dis BIKEN, Suita, Osaka 5650871, Japan; [Honda, Tomoyuki] Japan Soc Promot Sci, Chiyoda Ku, Tokyo 1028472, Japan; [Suzuki, Yoshiyuki; Kobayashi, Yuki; Gojobori, Takashi] Natl Inst Genet, Ctr Informat Biol, Mishima, Shizuoka 4118540, Japan; [Suzuki, Yoshiyuki; Kobayashi, Yuki; Gojobori, Takashi] Natl Inst Genet, DNA Data Bank Japan, Mishima, Shizuoka 4118540, Japan; [Oshida, Tatsuo] Obihiro Univ Agr & Vet Med, Dept Life Sci & Agr, Obihiro, Hokkaido 0808555, Japan; [Jern, Patric; Coffin, John M.] Tufts Univ, Sch Med, Dept Mol Biol & Microbiol, Boston, MA 02111 USA; [Tomonaga, Keizo] Japan Sci & Technol Agcy, PRESTO, Chiyoda Ku, Tokyo 1020075, Japan	Osaka University; Japan Society for the Promotion of Science; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Obihiro University of Agriculture & Veterinary Medicine; Tufts University; Japan Science & Technology Agency (JST)	Tomonaga, K (corresponding author), Osaka Univ, Dept Virol, Res Inst Microbial Dis BIKEN, Suita, Osaka 5650871, Japan.	tomonaga@biken.osaka-u.ac.jp	Jern, Patric/AAR-2133-2021	Jern, Patric/0000-0003-3393-5825; Horie, Masayuki/0000-0003-4682-7698	Ministry of Education, Culture, Sports, Science and Technology (MEXT); Japan Science and Technology Agency; Ministry of Health, Labor and Welfare of Japan; National Cancer Institute [R37 CA 089441]; Wenner-Gren Foundation; George Kirby Foundation; NATIONAL CANCER INSTITUTE [R37CA089441] Funding Source: NIH RePORTER	Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Japan Science and Technology Agency(Japan Science & Technology Agency (JST)); Ministry of Health, Labor and Welfare of Japan(Ministry of Health, Labour and Welfare, Japan); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Wenner-Gren Foundation; George Kirby Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank A. Kawahara for helping the capture of the wild shrews (Sorex unguiculatus and Sorex gracillimus) at Kiritappu wetland, Hokkaido, Japan. We thank I. Francischetti for provision of Gaboon viper (Bitis gabonica) venom gland tissue and a cDNA library, D. Vaughan for thirteen-lined ground squirrel (Spermophilus tridecemlineatus) brain and liver tissues, and K. Maeda, T. Miyazawa and N. Ohtaki for providing culture cell lines from several mammalian species. This work was supported by the Ministry of Education, Culture, Sports, Science and Technology (MEXT) Grants-in-aid for Scientific Research on Priority Areas (Infection and Host Responses; Matrix of Infection Phenomena) (K. T.), PRESTO (RNA and Biofunctions) from Japan Science and Technology Agency (JST) (K. T.), a Health Labour Sciences Research Grants for Research on Measures for Intractable Diseases (H20 nanchiippan 035) from the Ministry of Health, Labor and Welfare of Japan (K. T.), research grant R37 CA 089441 from the National Cancer Institute (J. M. C.) and a fellowship from the Wenner-Gren Foundation (P. J.). J. M. C. was a Research Professor of the American Cancer Society with support from the George Kirby Foundation.	Chase G, 2007, J VIROL, V81, P743, DOI 10.1128/JVI.01351-06; de la Torre JC, 2002, FRONT BIOSCI-LANDMRK, V7, pD569, DOI 10.2741/torre; Duffy S, 2008, NAT REV GENET, V9, P267, DOI 10.1038/nrg2323; Esnault C, 2000, NAT GENET, V24, P363, DOI 10.1038/74184; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Francischetti IMB, 2004, GENE, V337, P55, DOI 10.1016/j.gene.2004.03.024; Geuking MB, 2009, SCIENCE, V323, P393, DOI 10.1126/science.1167375; Holmes EC, 2003, J VIROL, V77, P3893, DOI 10.1128/JVI.77.7.3893-3897.2003; Hui EKW, 1998, CELL MOL LIFE SCI, V54, P1403, DOI 10.1007/s000180050262; Jern P, 2008, ANNU REV GENET, V42, P709, DOI 10.1146/annurev.genet.42.110807.091501; Kazazian HH, 2004, SCIENCE, V303, P1626, DOI 10.1126/science.1089670; Kistler AL, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-88; Klenerman P, 1997, NATURE, V390, P298, DOI 10.1038/36876; Korber B, 1998, SCIENCE, V280, P1868, DOI 10.1126/science.280.5371.1868; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; LIPKIN WI, 2007, FIELDS VIROLOGY, P1829; Lovatt A, 1999, J VIROL METHODS, V82, P185, DOI 10.1016/S0166-0934(99)00111-1; Maestre J, 1995, EMBO J, V14, P6333, DOI 10.1002/j.1460-2075.1995.tb00324.x; Mercer JM, 2003, SCIENCE, V299, P1568, DOI 10.1126/science.1079705; MINAMI M, 1995, GENOMICS, V29, P403, DOI 10.1006/geno.1995.9004; Morrish TA, 2002, NAT GENET, V31, P159, DOI 10.1038/ng898; Ohtaki N, 2007, J VIROL, V81, P5940, DOI 10.1128/JVI.02137-06; Pavlicek A, 2006, GENOMIC DISORDERS: THE GENOMIC BASIS OF DISEASE, P57, DOI 10.1007/978-1-59745-039-3_4; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Tomonaga K, 2002, MICROBES INFECT, V4, P491, DOI 10.1016/S1286-4579(02)01564-2; Wo YYP, 2006, ANAL BIOCHEM, V358, P149, DOI 10.1016/j.ab.2006.04.030; Zhang ZL, 2004, TRENDS GENET, V20, P62, DOI 10.1016/j.tig.2003.12.005; ZHDANOV VM, 1975, NATURE, V256, P471, DOI 10.1038/256471a0	29	306	325	1	78	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					84	U90		10.1038/nature08695	http://dx.doi.org/10.1038/nature08695			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054395	Green Accepted			2022-12-01	WOS:000273344900035
J	Gupta, RK; Arany, Z; Seale, P; Mepani, RJ; Ye, L; Conroe, HM; Roby, YA; Kulaga, H; Reed, RR; Spiegelman, BM				Gupta, Rana K.; Arany, Zoltan; Seale, Patrick; Mepani, Rina J.; Ye, Li; Conroe, Heather M.; Roby, Yang A.; Kulaga, Heather; Reed, Randall R.; Spiegelman, Bruce M.			Transcriptional control of preadipocyte determination by Zfp423	NATURE			English	Article							PPAR-GAMMA; OLIGONUCLEOTIDE ARRAYS; CEREBELLAR DEVELOPMENT; ADIPOSE CONVERSION; ADIPOCYTE LINEAGE; GENE-EXPRESSION; IN-VIVO; CELLS; DIFFERENTIATION; ADIPOGENESIS	The worldwide epidemic of obesity has increased the urgency to develop a deeper understanding of physiological systems related to energy balance and energy storage, including the mechanisms controlling the development of fat cells (adipocytes). The differentiation of committed preadipocytes to adipocytes is controlled by PPAR gamma and several other transcription factors(1), but the molecular basis for preadipocyte determination is not understood. Using a new method for the quantitative analysis of transcriptional components, we identified the zinc-finger protein Zfp423 as a factor enriched in preadipose versus non-preadipose fibroblasts. Ectopic expression of Zfp423 in non-adipogenic NIH 3T3 fibroblasts robustly activates expression of Pparg in undifferentiated cells and permits cells to undergo adipocyte differentiation under permissive conditions. Short hairpin RNA (shRNA)-mediated reduction of Zfp423 expression in 3T3-L1 cells blunts preadipocyte Pparg expression and diminishes the ability of these cells to differentiate. Furthermore, both brown and white adipocyte differentiation is markedly impaired in Zfp423-deficient mouse embryos. Zfp423 regulates Pparg expression, in part, through amplification of the BMP signalling pathway, an effect dependent on the SMAD-binding capacity of Zfp423. This study identifies Zfp423 as a transcriptional regulator of preadipocyte determination.	[Gupta, Rana K.; Arany, Zoltan; Seale, Patrick; Mepani, Rina J.; Ye, Li; Conroe, Heather M.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Gupta, Rana K.; Arany, Zoltan; Seale, Patrick; Mepani, Rina J.; Ye, Li; Conroe, Heather M.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Div Metab & Chron Dis, Boston, MA 02115 USA; [Gupta, Rana K.; Arany, Zoltan; Seale, Patrick; Mepani, Rina J.; Ye, Li; Conroe, Heather M.; Spiegelman, Bruce M.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Roby, Yang A.; Kulaga, Heather; Reed, Randall R.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Ctr Sensory Biol,Dept Mol Biol & Genet, Baltimore, MD 21205 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University	Spiegelman, BM (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	bruce_spiegelman@dfci.harvard.edu	Gupta, Rana/R-3051-2019	Gupta, Rana/0000-0002-9001-4531	Ruth Kirstein NRSA [F32 DK079507-01]; NHLBI [K08 HL79172-01]; Smith Family Foundation; NIH [DK081605, DK31405]; NIDCD [R01DC008295]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL079172] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK081605, R01DK031405, R37DK031405, F32DK079507, P30DK040561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC008295] Funding Source: NIH RePORTER	Ruth Kirstein NRSA; NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Smith Family Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIDCD(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We are grateful to S. Kleiner and S. Kajimura for critical reading of the manuscript and to all members of the Spiegelman laboratory for useful discussions. We thank B. Wagner for technical assistance in using robotic liquid handlers, B. Seed's laboratory for help with high-through query of Primer bank, and J. Brestelli for performing high-throughput queries of the Primer 3 program. We are also grateful to D. Bernlohr for the FABP4 antiserum. R. K. G. is supported by the Ruth Kirstein NRSA (F32 DK079507-01), Z. A. is supported by K08 HL79172-01 (NHLBI) and the Smith Family Foundation Grant, P. S. is supported by NIH DK081605, and the research described in this study was supported by NIH DK31405 to B. M. S. and by NIDCD R01DC008295 to R. R. R.	Alcaraz WA, 2006, P NATL ACAD SCI USA, V103, P19424, DOI 10.1073/pnas.0609184103; Barak Y, 1999, MOL CELL, V4, P585, DOI 10.1016/S1097-2765(00)80209-9; Bowers RR, 2006, P NATL ACAD SCI USA, V103, P13022, DOI 10.1073/pnas.0605789103; Cheng LE, 2007, DEV BIOL, V307, P43, DOI 10.1016/j.ydbio.2007.04.005; Cheng LE, 2007, NEURON, V54, P547, DOI 10.1016/j.neuron.2007.04.029; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Gray PA, 2004, SCIENCE, V306, P2255, DOI 10.1126/science.1104935; GREEN H, 1976, CELL, V7, P105, DOI 10.1016/0092-8674(76)90260-9; GREEN H, 1975, CELL, V5, P19, DOI 10.1016/0092-8674(75)90087-2; Hata A, 2000, CELL, V100, P229, DOI 10.1016/S0092-8674(00)81561-5; Hata K, 2003, MOL BIOL CELL, V14, P545, DOI 10.1091/mbc.e02-06-0356; Jimenez MA, 2007, MOL CELL BIOL, V27, P743, DOI 10.1128/MCB.01557-06; Jin WZ, 2006, DEV CELL, V10, P461, DOI 10.1016/j.devcel.2006.02.016; Kajimura S, 2009, NATURE, V460, P1154, DOI 10.1038/nature08262; Kubota N, 1999, MOL CELL, V4, P597, DOI 10.1016/S1097-2765(00)80210-5; Li C, 2001, P NATL ACAD SCI USA, V98, P31, DOI 10.1073/pnas.011404098; Lockhart DJ, 1996, NAT BIOTECHNOL, V14, P1675, DOI 10.1038/nbt1296-1675; Rodeheffer MS, 2008, CELL, V135, P240, DOI 10.1016/j.cell.2008.09.036; Rosen ED, 1999, MOL CELL, V4, P611, DOI 10.1016/S1097-2765(00)80211-7; Seale P, 2008, NATURE, V454, P961, DOI 10.1038/nature07182; Tang QQ, 2004, P NATL ACAD SCI USA, V101, P9607, DOI 10.1073/pnas.0403100101; Tang W, 2008, SCIENCE, V322, P583, DOI 10.1126/science.1156232; TODARO GJ, 1963, J CELL BIOL, V17, P299, DOI 10.1083/jcb.17.2.299; Tsai RYL, 1997, J NEUROSCI, V17, P4159; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Warming S, 2006, MOL CELL BIOL, V26, P6913, DOI 10.1128/MCB.02255-05	27	353	365	3	64	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					619	U187		10.1038/nature08816	http://dx.doi.org/10.1038/nature08816			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20200519	Green Accepted			2022-12-01	WOS:000275974200054
J	Basch, E				Basch, Ethan			The Missing Voice of Patients in Drug-Safety Reporting	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SYMPTOMS		Mem Sloan Kettering Canc Ctr, Hlth Outcomes Grp, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center	Basch, E (corresponding author), Mem Sloan Kettering Canc Ctr, Hlth Outcomes Grp, 1275 York Ave, New York, NY 10021 USA.				NATIONAL CANCER INSTITUTE [K07CA124851] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA124851, K07 CA124851-03] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Basch E, 2009, JNCI-J NATL CANCER I, V101, P1624, DOI 10.1093/jnci/djp386; Ioannidis JPA, 2004, ANN INTERN MED, V141, P781, DOI 10.7326/0003-4819-141-10-200411160-00009; *NAT AC SCI I MED, 2006, FUT DRUG SAF PROM PR; Pakhomov SV, 2008, AM J MANAG CARE, V14, P530; Weingart SN, 2005, ARCH INTERN MED, V165, P234, DOI 10.1001/archinte.165.2.234	5	409	415	0	16	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10					865	869		10.1056/NEJMp0911494	http://dx.doi.org/10.1056/NEJMp0911494			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20220181	Green Accepted, Green Published			2022-12-01	WOS:000275365900001
J	Horton, R				Horton, Richard			Offline: History lessons	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					710	710		10.1016/S0140-6736(10)60245-0	http://dx.doi.org/10.1016/S0140-6736(10)60245-0			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Arts &amp; Humanities Citation Index (A&amp;HCI)	General & Internal Medicine	564JW	20189013				2022-12-01	WOS:000275211200011
J	Van de Velde, W; Zehirov, G; Szatmari, A; Debreczeny, M; Ishihara, H; Kevei, Z; Farkas, A; Mikulass, K; Nagy, A; Tiricz, H; Satiat-Jeunemaitre, B; Alunni, B; Bourge, M; Kucho, K; Abe, M; Kereszt, A; Maroti, G; Uchiumi, T; Kondorosi, E; Mergaert, P				Van de Velde, Willem; Zehirov, Grigor; Szatmari, Agnes; Debreczeny, Monika; Ishihara, Hironobu; Kevei, Zoltan; Farkas, Attila; Mikulass, Kata; Nagy, Andrea; Tiricz, Hilda; Satiat-Jeunemaitre, Beatrice; Alunni, Benoit; Bourge, Mickael; Kucho, Ken-ichi; Abe, Mikiko; Kereszt, Attila; Maroti, Gergely; Uchiumi, Toshiki; Kondorosi, Eva; Mergaert, Peter			Plant Peptides Govern Terminal Differentiation of Bacteria in Symbiosis	SCIENCE			English	Article							MEDICAGO-TRUNCATULA; LEGUME SYMBIOSIS; ANTIMICROBIAL PEPTIDES; RHIZOBIUM-MELILOTI; CELL-CYCLE; GENES; NODULES; ORGANIZATION; MODEL	Legume plants host nitrogen-fixing endosymbiotic Rhizobium bacteria in root nodules. In Medicago truncatula, the bacteria undergo an irreversible (terminal) differentiation mediated by hitherto unidentified plant factors. We demonstrated that these factors are nodule-specific cysteine-rich (NCR) peptides that are targeted to the bacteria and enter the bacterial membrane and cytosol. Obstruction of NCR transport in the dnf1-1 signal peptidase mutant correlated with the absence of terminal bacterial differentiation. On the contrary, ectopic expression of NCRs in legumes devoid of NCRs or challenge of cultured rhizobia with peptides provoked symptoms of terminal differentiation. Because NCRs resemble antimicrobial peptides, our findings reveal a previously unknown innovation of the host plant, which adopts effectors of the innate immune system for symbiosis to manipulate the cell fate of endosymbiotic bacteria.	[Van de Velde, Willem; Szatmari, Agnes; Satiat-Jeunemaitre, Beatrice; Alunni, Benoit; Bourge, Mickael; Kondorosi, Eva; Mergaert, Peter] CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France; [Zehirov, Grigor; Ishihara, Hironobu; Kucho, Ken-ichi; Abe, Mikiko; Uchiumi, Toshiki] Kagoshima Univ, Grad Sch Sci & Engn, Kagoshima 8900065, Japan; [Szatmari, Agnes] Hungarian Acad Sci, Inst Plant Protect, H-1022 Budapest, Hungary; [Debreczeny, Monika; Kevei, Zoltan; Farkas, Attila; Mikulass, Kata; Nagy, Andrea; Tiricz, Hilda; Kereszt, Attila; Maroti, Gergely; Kondorosi, Eva] Bay Zoltan Fdn Appl Res, Inst Plant Genom Human Biotechnol & Bioenergy, H-6726 Szeged, Hungary	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; Kagoshima University; Hungarian Academy of Sciences; Hungarian Centre for Agricultural Research	Kondorosi, E (corresponding author), CNRS, Inst Sci Vegetal, F-91198 Gif Sur Yvette, France.	eva.kondorosi@isv.cnrs-gif.fr	Mergaert, Peter/M-1265-2019; Kevei, Zoltan/AAF-5054-2021; Satiat-Jeunemaitre, Beatrice/M-6055-2013	Mergaert, Peter/0000-0002-5919-7317; Kevei, Zoltan/0000-0002-3065-3198; Maroti, Gergely/0000-0002-3705-0461; Kondorosi, Eva/0000-0002-4065-8515; Satiat-Jeunemaitre, Beatrice/0000-0001-7125-0814; Szatmari, Agnes/0000-0001-8768-8212; Kereszt, Attila/0000-0002-4421-6554; Bourge, Mickael/0000-0002-4111-6208	Agence National de la Recherche [ANR-05-BLAN-0129]; Japanese Society for the Promotion of Science; Hungarian National Office for Research and Technology [OMFB-00441/2007]; French Ministry of Research	Agence National de la Recherche(French National Research Agency (ANR)); Japanese Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); Hungarian National Office for Research and Technology(National Office for Research and Technology); French Ministry of Research(Ministry of Research, FranceEuropean Commission)	We thank S. Long, T. Bisseling, G. Ferguson, and R. Whitford for helpful comments on the manuscript; S. Brown, M. Yamaura, P. Laporte, P. Durand, E. Klement, E. Magyarodi, and the IMAGIF platform for technical support; and S. Long, D. Wang, D. Barker, P. Ludden, and N. Suganuma for providing materials. This work was supported by the Agence National de la Recherche project ANR-05-BLAN-0129 (W.V.d. V., A. S., E. K. and P. M.), the Japanese Society for the Promotion of Science (G.Z. and T. U.), the Hungarian National Office for Research and Technology Teller program OMFB-00441/2007 (M. D., A. F., K. M., A.N., H. T., A. K., G. M. and E. K.), and a Ph.D. fellowship from the French Ministry of Research (B. A.). E. Kondorosi et al. European patent no. 09305547.3-2107 related to the antimicrobial activity of NCR peptides is pending.	Alunni B, 2007, MOL PLANT MICROBE IN, V20, P1138, DOI 10.1094/MPMI-20-9-1138; Beijerinck MW., 1888, BOT ZTG, V46, P725; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Cheng JJ, 2007, MICROBIOL-SGM, V153, P375, DOI 10.1099/mic.0.2006/001362-0; Graham MA, 2004, PLANT PHYSIOL, V135, P1179, DOI 10.1104/pp.104.037531; Jones KM, 2007, NAT REV MICROBIOL, V5, P619, DOI 10.1038/nrmicro1705; Kondorosi E, 2000, CURR OPIN PLANT BIOL, V3, P488, DOI 10.1016/S1369-5266(00)00118-7; Latch JN, 1997, J BACTERIOL, V179, P2373, DOI 10.1128/jb.179.7.2373-2381.1997; Mergaert P, 2006, P NATL ACAD SCI USA, V103, P5230, DOI 10.1073/pnas.0600912103; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Oono R, 2009, NEW PHYTOL, V183, P967, DOI 10.1111/j.1469-8137.2009.02941.x; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; Prell J, 2006, TRENDS MICROBIOL, V14, P161, DOI 10.1016/j.tim.2006.02.005; Schopfer CR, 1999, SCIENCE, V286, P1697, DOI 10.1126/science.286.5445.1697; Sibley CD, 2006, MICROBIOL-SGM, V152, P443, DOI 10.1099/mic.0.28455-0; Silverstein KAT, 2005, PLANT PHYSIOL, V138, P600, DOI 10.1104/pp.105.060079; Silverstein KAT, 2007, PLANT J, V51, P262, DOI 10.1111/j.1365-313X.2007.03136.x; Szczyglowski K, 1998, MOL PLANT MICROBE IN, V11, P684, DOI 10.1094/MPMI.1998.11.7.684; Van de Velde W, 2006, PLANT PHYSIOL, V141, P711, DOI 10.1104/pp.106.078691; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990; Verma DPS, 1996, TRENDS MICROBIOL, V4, P364, DOI 10.1016/0966-842X(96)10053-6; Wang D, 2010, SCIENCE, V327, P1126, DOI 10.1126/science.1184096; Wright R, 1997, J BACTERIOL, V179, P5869, DOI 10.1128/jb.179.18.5869-5877.1997	23	355	371	7	123	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1122	1126		10.1126/science.1184057	http://dx.doi.org/10.1126/science.1184057			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185722				2022-12-01	WOS:000274901100034
J	Cain, KP; McCarthy, KD; Heilig, CM; Monkongdee, P; Tasaneeyapan, T; Kanara, N; Kimerling, ME; Chheng, P; Thai, S; Sar, B; Phanuphak, P; Teeratakulpisarn, N; Phanuphak, N; Nguyen, HD; Hoang, TQ; Le, HT; Varma, JK				Cain, Kevin P.; McCarthy, Kimberly D.; Heilig, Charles M.; Monkongdee, Patama; Tasaneeyapan, Theerawit; Kanara, Nong; Kimerling, Michael E.; Chheng, Phalkun; Thai, Sopheak; Sar, Borann; Phanuphak, Praphan; Teeratakulpisarn, Nipat; Phanuphak, Nittaya; Nguyen Huy Dung; Hoang Thi Quy; Le Hung Thai; Varma, Jay K.			An Algorithm for Tuberculosis Screening and Diagnosis in People with HIV	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							RECONSTITUTION INFLAMMATORY SYNDROME; ISONIAZID PREVENTIVE THERAPY; IMMUNE RECONSTITUTION; INFECTED PERSONS; RISK-FACTORS; PULMONARY TUBERCULOSIS; SPUTUM SMEARS; PREVALENCE; RATES; DEATH	BACKGROUND Tuberculosis screening is recommended for people with human immunodeficiency virus (HIV) infection to facilitate early diagnosis and safe initiation of antiretroviral therapy and isoniazid preventive therapy. No internationally accepted, evidence-based guideline addresses the optimal means of conducting such screening, although screening for chronic cough is common. METHODS We consecutively enrolled people with HIV infection from eight outpatient clinics in Cambodia, Thailand, and Vietnam. For each patient, three samples of sputum and one each of urine, stool, blood, and lymph-node aspirate (for patients with lymphadenopathy) were obtained for mycobacterial culture. We compared the characteristics of patients who received a diagnosis of tuberculosis (on the basis of having one or more specimens that were culture-positive) with those of patients who did not have tuberculosis to derive an algorithm for screening and diagnosis. RESULTS Tuberculosis was diagnosed in 267 (15%) of 1748 patients (median CD4+ T-lymphocyte count, 242 per cubic millimeter; interquartile range, 82 to 396). The presence of a cough for 2 or 3 weeks or more during the preceding 4 weeks had a sensitivity of 22 to 33% for detecting tuberculosis. The presence of cough of any duration, fever of any duration, or night sweats lasting 3 or more weeks in the preceding 4 weeks was 93% sensitive and 36% specific for tuberculosis. In the 1199 patients with any of these symptoms, a combination of two negative sputum smears, a normal chest radiograph, and a CD4+ cell count of 350 or more per cubic millimeter helped to rule out a diagnosis of tuberculosis, whereas a positive diagnosis could be made only for the 113 patients (9%) with one or more positive sputum smears; mycobacterial culture was required for most other patients. CONCLUSIONS In persons with HIV infection, screening for tuberculosis should include asking questions about a combination of symptoms rather than only about chronic cough. It is likely that antiretroviral therapy and isoniazid preventive therapy can be started safely in people whose screening for all three symptoms is negative, whereas diagnosis in most others will require mycobacterial culture.	[Cain, Kevin P.; McCarthy, Kimberly D.; Heilig, Charles M.; Varma, Jay K.] Ctr Dis Control & Prevent, Div TB Eliminat, Atlanta, GA USA; [Monkongdee, Patama; Tasaneeyapan, Theerawit; Varma, Jay K.] Thailand Minist Publ Hlth CDC Collaborat, Nonthaburi, Thailand; [Phanuphak, Praphan; Teeratakulpisarn, Nipat; Phanuphak, Nittaya] Thai Red Cross AIDS Res Ctr, Bangkok, Thailand; [Kanara, Nong] US CDC, Global AIDS Program, Phnom Penh, Cambodia; [Thai, Sopheak] Sihanouk Hosp Ctr Hope, Phnom Penh, Cambodia; [Sar, Borann] Inst Pasteur Cambodia, Phnom Penh, Cambodia; [Kimerling, Michael E.; Chheng, Phalkun] Univ Alabama Birmingham, Birmingham, AL USA; [Nguyen Huy Dung; Hoang Thi Quy] Pham Ngoc Thach Hosp TB & Lung Dis, Ho Chi Minh City, Vietnam; [Le Hung Thai] US CDC, Global AIDS Program, Ho Chi Minh City, Vietnam; [Kimerling, Michael E.] Bill & Melinda Gates Fdn, Seattle, WA USA	Centers for Disease Control & Prevention - USA; Ministry of Public Health - Thailand; Thai Red Cross Society; Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Cambodia; University of Alabama System; University of Alabama Birmingham; Bill & Melinda Gates Foundation	Cain, KP (corresponding author), CDC, 1600 Clifton Rd,MS-E-10, Atlanta, GA 30333 USA.	kcain@cdc.gov	Phanuphak, Nittaya/AAA-8579-2019; Hug, Balthasar L./G-1568-2010; Heilig, Charles M/C-2753-2008	Heilig, Charles M/0000-0003-1075-1310	U.S. Agency for International Development	U.S. Agency for International Development(United States Agency for International Development (USAID))	Supported by a grant from the U.S. Agency for International Development.	Akksilp S, 2007, EMERG INFECT DIS, V13, P1001, DOI 10.3201/eid1307.061506; Balcells ME, 2006, EMERG INFECT DIS, V12, P744; Baron EJ, 2007, MANUAL OF CLINICAL MICROBIOLOGY, 9TH ED, P1; Cain KR, 2007, INT J TUBERC LUNG D, V11, P1008; Cain KP, 2009, EMERG INFECT DIS, V15, P258, DOI 10.3201/eid1502.080942; CHHENG P, 2008, INT J TUBERC LUNG S1, V12, P54; Day JH, 2006, INT J TUBERC LUNG D, V10, P523; French MA, 2009, CLIN INFECT DIS, V48, P101, DOI 10.1086/595006; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Harries AD, 1998, INT J TUBERC LUNG D, V2, P999; Kimerling ME, 2002, INT J TUBERC LUNG D, V6, P988; Lawn SD, 2008, AM J RESP CRIT CARE, V177, P680, DOI 10.1164/rccm.200709-1311PP; Manabe YC, 2007, JAIDS-J ACQ IMM DEF, V46, P456, DOI 10.1097/QAI.0b013e3181594c8c; Manabe YC, 2009, J INFECT DIS, V199, P437, DOI 10.1086/595985; Manosuthi W, 2006, JAIDS-J ACQ IMM DEF, V43, P42, DOI 10.1097/01.qai.0000230521.86964.86; Meintjes G, 2008, LANCET INFECT DIS, V8, P516, DOI 10.1016/S1473-3099(08)70184-1; Mohammed A, 2004, INT J TUBERC LUNG D, V8, P792; Monkongdee P, 2009, AM J RESP CRIT CARE, V180, P903, DOI 10.1164/rccm.200905-0692OC; Mtei L, 2005, CLIN INFECT DIS, V40, P1500, DOI 10.1086/429825; Mukadi YD, 2001, AIDS, V15, P143, DOI 10.1097/00002030-200101260-00002; Quy HT, 2006, INT J TUBERC LUNG D, V10, P45; Shah S, 2009, JAIDS-J ACQ IMM DEF, V50, P537, DOI 10.1097/QAI.0b013e318196761c; Shelburne SA, 2005, AIDS, V19, P399, DOI 10.1097/01.aids.0000161769.06158.8a; SMITH RL, 1994, CHEST, V106, P684, DOI 10.1378/chest.106.3.684; Swaminathan S, 2004, INT J TUBERC LUNG D, V8, P896; *WHO, 2007, WHOHTMTB2007379; *WHO, 2004, INT POL COLL TB HIV; World Health Organization, 2008, WHOHTMTB2008393; Zhang HP, 1999, RECURSIVE PARTITIONI	29	196	203	0	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					707	716		10.1056/NEJMoa0907488	http://dx.doi.org/10.1056/NEJMoa0907488			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181972	Bronze			2022-12-01	WOS:000274845600009
J	Tennant, PWG; Pearce, MS; Bythell, M; Rankin, J				Tennant, Peter W. G.; Pearce, Mark S.; Bythell, Mary; Rankin, Judith			20-year survival of children born with congenital anomalies: a population-based study	LANCET			English	Article							NEW-YORK-STATE; PRENATAL-DIAGNOSIS; DOWNS-SYNDROME; HEART-DISEASE; SPINA-BIFIDA; 1ST-YEAR SURVIVAL; INFANTS BORN; ORAL CLEFTS; MORTALITY; MALFORMATIONS	Background Congenital anomalies are a leading cause of perinatal and infant mortality. Advances in care have improved the prognosis for some congenital anomaly groups and subtypes, but there remains a paucity of knowledge about survival for many others, especially beyond the first year of life. We estimated survival up to 20 years of age for a range of congenital anomaly groups and subtypes. Methods Information about children with at least one congenital anomaly, delivered between 1985 and 2003, was obtained from the UK Northern Congenital Abnormality Survey (NorCAS). Anomalies were categorised by group (the system affected), subtype (the individual disorder), and syndrome according to European Surveillance of Congenital Anomalies (EUROCAT) guidelines. Local hospital and national mortality records were used to identify the survival status of liveborn children. Survival up to 20 years of age was estimated by use of Kaplan-Meier methods. Cox proportional hazards regression was used to examine factors that affected survival. Findings 13758 cases of congenital anomaly were notified to NorCAS between 1985 and 2003. Survival status was available for 10 850 (99.0%) of 10 964 livebirths. 20-year survival was 85.5% (95% CI 84.8-86.3) in individuals born with at least one congenital anomaly, 89.5% (88.4-90.6) for cardiovascular system anomalies, 79.1% (76.7-81.3) for chromosomal anomalies, 93.2% (91.6-94.5) for urinary system anomalies, 83.2% (79.8-86.0) for digestive system anomalies, 97.6% (95.9-98.6) for orofacial clefts, and 66.2% (61.5-70.5) for nervous system anomalies. Survival varied between subtypes within the same congenital anomaly group. The proportion of terminations for fetal anomaly increased throughout the study period (from 12.4%, 9.8-15.5, in 1985 to 18.3%, 15.6-21.2, in 2003; p<0.0001) and, together with year of birth, was an independent predictor of survival (adjusted hazard ratio [HR] for proportion of terminations 0.95, 95% CI 0.91-0.99, p=0.023; adjusted HR for year of birth 0.94, 0.92-0.96, p<0.0001). Interpretation Estimates of survival for congenital anomaly groups and subtypes will be valuable for families and health professionals when a congenital anomaly is detected, and will assist in planning for the future care needs of affected individuals.	[Tennant, Peter W. G.; Pearce, Mark S.; Rankin, Judith] Newcastle Univ, Inst Hlth & Soc, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England; [Bythell, Mary; Rankin, Judith] Reg Matern Survey Off, Newcastle Upon Tyne, Tyne & Wear, England	Newcastle University - UK; Newcastle University - UK	Rankin, J (corresponding author), Newcastle Univ, Inst Hlth & Soc, Framlington Pl, Newcastle Upon Tyne NE2 4HH, Tyne & Wear, England.	j.m.rankin@ncl.ac.uk		Tennant, Peter/0000-0003-1555-069X; Pearce, Mark/0000-0002-0583-3779	BDF Newlife; Healthcare Quality Improvement Partnership; National Institute of Health Research (Department of Health)	BDF Newlife; Healthcare Quality Improvement Partnership; National Institute of Health Research (Department of Health)(National Institute for Health Research (NIHR))	We are grateful to all the Link Clinicians in the northern region for their continued collaboration and support of NorCAS. We thank Danielle Crowder at the Regional Maternity Survey Office, Jane Salotti at Newcastle University, and staff at the Office for National Statistics. We thank Patricia Boyd (medical geneticist) and Chris Wright (paediatric pathologist) for their help with coding the congenital anomaly cases and commenting on the report. This study was funded by BDF Newlife. NorCAS is funded by the Healthcare Quality Improvement Partnership. JR is funded by a Personal Award Scheme Career Scientist Award from the National Institute of Health Research (Department of Health).	Agha MM, 2006, BIRTH DEFECTS RES A, V76, P46, DOI 10.1002/bdra.20218; ALTHOUSE R, 1980, ARCH DIS CHILD, V55, P845, DOI 10.1136/adc.55.11.845; Altman DG, 1991, PRACTICAL STAT MED R; BAIRD PA, 1989, HUM GENET, V82, P291, DOI 10.1007/BF00291175; BAMFORTH SJ, 1989, AM J HUM GENET, V44, P225; BMJ, 1995, BMJ, V310, P7; Boneva RS, 2001, CIRCULATION, V103, P2376; Bourke J, 2005, PAEDIATR PERINAT EP, V19, P284, DOI 10.1111/j.1365-3016.2005.00666.x; Boyd PA, 2005, BMJ-BRIT MED J, V330, P27, DOI 10.1136/bmj.38300.665301.3A; Cleves MA, 2003, BIRTH DEFECTS RES A, V67, P662, DOI 10.1002/bdra.10119; Dastgiri S, 2003, ARCH DIS CHILD, V88, P391, DOI 10.1136/adc.88.5.391; Druschel C, 1996, PUBLIC HEALTH REP, V111, P359; Druschel CM, 1996, CLEFT PALATE-CRAN J, V33, P400, DOI 10.1597/1545-1569(1996)033<0400:FYOLMA>2.3.CO;2; EUROCAT, EUROCAT SYNDR GUID D; EUROCAT, COD EUROCAT SUBGR CO; *EUROCAT, ASS AN SURV DAT HYP; Forrester MB, 2003, AM J MED GENET A, V119A, P311, DOI 10.1002/ajmg.a.20151; Frid C, 1999, J INTELL DISABIL RES, V43, P234, DOI 10.1046/j.1365-2788.1999.00198.x; Fuchs IB, 2007, ULTRASOUND OBST GYN, V29, P38, DOI 10.1002/uog.3900; GILSTRAP LC, 1988, AM J OBSTET GYNECOL, V159, P579, DOI 10.1016/S0002-9378(88)80012-7; Glasson EJ, 2002, CLIN GENET, V62, P390, DOI 10.1034/j.1399-0004.2002.620506.x; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Hayes C, 1997, INT J EPIDEMIOL, V26, P822, DOI 10.1093/ije/26.4.822; KALTER H, 1991, INT J EPIDEMIOL, V20, P173, DOI 10.1093/ije/20.1.173; Leonard H, 2001, ARCH DIS CHILD-FETAL, V85, pF204, DOI 10.1136/fn.85.3.F204; Leonard S, 2000, PAEDIATR PERINAT EP, V14, P163; Nembhard WN, 2001, TERATOLOGY, V64, P267, DOI 10.1002/tera.1073; PALTA M, 1994, ARCH PEDIAT ADOL MED, V148, P1295, DOI 10.1001/archpedi.1994.02170120057009; Peller AJ, 2004, OBSTET GYNECOL, V104, P957, DOI 10.1097/01.AOG.0000142718.53380.8f; Perloff JK, 2001, CIRCULATION, V103, P2637; Rankin J, 2005, ARCH DIS CHILD-FETAL, V90, pF374, DOI 10.1136/adc.2003.047902; Rasmussen SA, 2006, J PEDIATR-US, V148, P806, DOI 10.1016/j.jpeds.2006.01.010; Richmond S, 2005, BJOG-INT J OBSTET GY, V112, P1349, DOI 10.1111/j.1471-0528.2005.00660.x; Rosano A, 2000, J EPIDEMIOL COMMUN H, V54, P660, DOI 10.1136/jech.54.9.660; SAMANEK M, 1992, PEDIATR CARDIOL, V13, P152; Smith NP, 2005, ARCH DIS CHILD, V90, P426, DOI 10.1136/adc.2003.045765; Stoll C, 2000, CLEFT PALATE-CRAN J, V37, P41, DOI 10.1597/1545-1569(2000)037<0041:AMICWO>2.3.CO;2; Wong LYC, 2001, PAEDIATR PERINAT EP, V15, P374, DOI 10.1046/j.1365-3016.2001.00371.x; World Health Organization (WHO), 2009, LIF TABL WHO MEMB ST; World Health Organization (WHO), INT STAT CLASS DIS R; Wren C, 2000, HEART, V83, P414, DOI 10.1136/heart.83.4.414	41	265	277	0	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 20	2010	375	9715					649	656		10.1016/S0140-6736(09)61922-X	http://dx.doi.org/10.1016/S0140-6736(09)61922-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JT	20092884				2022-12-01	WOS:000275210900033
J	Smith, SB; Qu, HQ; Taleb, N; Kishimoto, NY; Scheel, DW; Lu, Y; Patch, AM; Grabs, R; Wang, JH; Lynn, FC; Miyatsuka, T; Mitchell, J; Seerke, R; Desir, J; Eijnden, SV; Abramowicz, M; Kacet, N; Weill, J; Renard, ME; Gentile, M; Hansen, I; Dewar, K; Hattersley, AT; Wang, R; Wilson, ME; Johnson, JD; Polychronakos, C; German, MS				Smith, Stuart B.; Qu, Hui-Qi; Taleb, Nadine; Kishimoto, Nina Y.; Scheel, David W.; Lu, Yang; Patch, Ann-Marie; Grabs, Rosemary; Wang, Juehu; Lynn, Francis C.; Miyatsuka, Takeshi; Mitchell, John; Seerke, Rina; Desir, Julie; Eijnden, Serge Vanden; Abramowicz, Marc; Kacet, Nadine; Weill, Jacques; Renard, Marie-Eve; Gentile, Mattia; Hansen, Inger; Dewar, Ken; Hattersley, Andrew T.; Wang, Rennian; Wilson, Maria E.; Johnson, Jeffrey D.; Polychronakos, Constantin; German, Michael S.			Rfx6 directs islet formation and insulin production in mice and humans	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CONGENITAL MALABSORPTIVE DIARRHEA; AUTOSOMAL RECESSIVE SYNDROME; CELL-DIFFERENTIATION; DNA-BINDING; MUTANT NEUROGENIN-3; ENDOCRINE PANCREAS; PRIMARY CILIA; EXPRESSION; REVEALS	Insulin from the beta-cells of the pancreatic islets of Langerhans controls energy homeostasis in vertebrates, and its deficiency causes diabetes mellitus. During embryonic development, the transcription factor neurogenin 3 (Neurog3) initiates the differentiation of the beta-cells and other islet cell types from pancreatic endoderm, but the genetic program that subsequently completes this differentiation remains incompletely understood. Here we show that the transcription factor Rfx6 directs islet cell differentiation downstream of Neurog3. Mice lacking Rfx6 failed to generate any of the normal islet cell types except for pancreatic-polypeptide-producing cells. In human infants with a similar autosomal recessive syndrome of neonatal diabetes, genetic mapping and subsequent sequencing identified mutations in the human RFX6 gene. These studies demonstrate a unique position for Rfx6 in the hierarchy of factors that coordinate pancreatic islet development in both mice and humans. Rfx6 could prove useful in efforts to generate beta-cells for patients with diabetes.	[Qu, Hui-Qi; Taleb, Nadine; Lu, Yang; Grabs, Rosemary; Mitchell, John; Polychronakos, Constantin] McGill Univ, Dept Paediat, Montreal, PQ H3H 1P3, Canada; [Qu, Hui-Qi; Taleb, Nadine; Lu, Yang; Grabs, Rosemary; Mitchell, John; Polychronakos, Constantin] McGill Univ, Dept Human Genet, Montreal, PQ H3H 1P3, Canada; [Smith, Stuart B.; Kishimoto, Nina Y.; Scheel, David W.; Wang, Juehu; Lynn, Francis C.; Miyatsuka, Takeshi; Seerke, Rina; German, Michael S.] Univ Calif San Francisco, Ctr Diabet, San Francisco, CA 94143 USA; [Patch, Ann-Marie; Hattersley, Andrew T.] Peninsula Med Sch, Inst Biomed & Clin Sci, Exeter EX2 5DW, Devon, England; [Desir, Julie; Eijnden, Serge Vanden; Abramowicz, Marc] ULB, Hop Erasme, Dept Neonatol, B-1070 Brussels, Belgium; [Hansen, Inger] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Kacet, Nadine; Weill, Jacques; Renard, Marie-Eve] Hop Calmette, Dept Neonatol, F-59037 Lille, France; [Gentile, Mattia] Di Venere Gen Hosp, Med Genet Unit, I-70012 Bari, Italy; [Dewar, Ken] McGill Univ, Dept Human Genet, Montreal, PQ H3A 1B1, Canada; [Dewar, Ken] McGill Univ, Ctr Hlth, Res Inst, Montreal, PQ H3A 1B1, Canada; [Wang, Rennian] Univ Western Ontario, Child Hlth Res Inst, Dept Physiol, London, ON N6C 2V5, Canada; [Wang, Rennian] Univ Western Ontario, Child Hlth Res Inst, Dept Med & Pharmacol, London, ON N6C 2V5, Canada; [Wilson, Maria E.; Johnson, Jeffrey D.] Metabolex Inc, Hayward, CA 94545 USA; [German, Michael S.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA	McGill University; McGill University; University of California System; University of California San Francisco; University of Exeter; Universite Libre de Bruxelles; Emory University; Universite de Lille - ISITE; CHU Lille; McGill University; McGill University; Western University (University of Western Ontario); Western University (University of Western Ontario); University of California System; University of California San Francisco	Polychronakos, C (corresponding author), McGill Univ, Dept Paediat, Montreal, PQ H3H 1P3, Canada.	constantin.polychronakos@mcgill.ca; mgerman@diabetes.ucsf.edu	Gentile, Mattia/AEQ-3183-2022; Qu, Hui-Qi/B-4719-2009; Patch, Ann-Marie/C-4201-2018; Patch, Ann-Marie/F-8060-2011; Abramowicz, Marc/AAX-6419-2020; Wang, Rennian/N-3879-2015; Mitchell, John/E-5727-2016	Gentile, Mattia/0000-0002-5299-6036; Qu, Hui-Qi/0000-0001-9317-4488; Patch, Ann-Marie/0000-0001-6121-4019; Hattersley, Andrew/0000-0001-5620-473X; Polychronakos, Constantin/0000-0002-7624-6635; Lynn, Francis/0000-0001-9318-1063; Mitchell, John/0000-0002-6055-6858; Abramowicz, Marc/0000-0003-0623-8768	Larry L. Hillblom Foundation; Juvenile Diabetes Research Foundation; American Diabetes Association; Nora Eccles Treadwell Foundation; Canadian Institutes of Health Research; National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U19DK061245, R01DK021344, P30DK063720] Funding Source: NIH RePORTER	Larry L. Hillblom Foundation; Juvenile Diabetes Research Foundation(Juvenile Diabetes Research Foundation); American Diabetes Association(American Diabetes Association); Nora Eccles Treadwell Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all the patients and their families for the participation in this study and P. Riley for allowing us access to her clinical data. We thank G. Grodsky, G. Bell, W. Rutter, R. Gasa and members of the German laboratory for discussions, F. Schaufle and the DERC Microscopy Core Laboratory, C. Mrejen and the UCSF DERC Genomics Core, N. Killeen and the UCSF DERC Transgenic Core Laboratory for help with the generation of the Rfx6-targeted mice, R. Koshy for technical assistance, Y. Zhang and S. Zhao for assistance with mouse husbandry and genotyping, the Massively Parallel Sequencing team at the McGill University and Genome Quebec Innovation Center for DNA sequencing and J. Wasserscheid for bioinformatics analyses. This work was supported by grants from the Larry L. Hillblom Foundation (S. B. S. and M. S. G.), the Juvenile Diabetes Research Foundation (S. B. S., F. C. L., T. M., R. W., C. P. and M. S. G.), the American Diabetes Association (M. S. G.), the Nora Eccles Treadwell Foundation (M. S. G.), the Canadian Institutes of Health Research (H.-Q.Q.), and the National Institutes of Health/National Institute of Diabetes and Digestive and Kidney Diseases (M. S. G.).	Aftab S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-226; Ait-Lounis A, 2007, DIABETES, V56, P950, DOI 10.2337/db06-1187; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Apelqvist A, 1999, NATURE, V400, P877, DOI 10.1038/23716; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; Cano DA, 2004, DEVELOPMENT, V131, P3457, DOI 10.1242/dev.01189; Cano DA, 2006, GASTROENTEROLOGY, V131, P1856, DOI 10.1053/j.gastro.2006.10.050; Chang YF, 2007, ANNU REV BIOCHEM, V76, P51, DOI 10.1146/annurev.biochem.76.050106.093909; Chappell L, 2008, AM J MED GENET A, V146A, P1713, DOI 10.1002/ajmg.a.32304; Copeland NG, 2001, NAT REV GENET, V2, P769, DOI 10.1038/35093556; Cortina G, 2007, HUM PATHOL, V38, P570, DOI 10.1016/j.humpath.2006.10.014; DAVID E, 1995, J BIOL CHEM, V270, P8353, DOI 10.1074/jbc.270.14.8353; Emery P, 1996, MOL CELL BIOL, V16, P4486; Emery P, 1996, NUCLEIC ACIDS RES, V24, P803, DOI 10.1093/nar/24.5.803; Gajiwala KS, 2000, NATURE, V403, P916, DOI 10.1038/35002634; Gasa R, 2008, DIFFERENTIATION, V76, P381, DOI 10.1111/j.1432-0436.2007.00228.x; Gentile M, 1999, AM J MED GENET, V87, P82, DOI 10.1002/(SICI)1096-8628(19991105)87:1<82::AID-AJMG17>3.3.CO;2-S; Gradwohl G, 2000, P NATL ACAD SCI USA, V97, P1607, DOI 10.1073/pnas.97.4.1607; Gu GQ, 2002, DEVELOPMENT, V129, P2447; Hakonarson H, 2008, DIABETES, V57, P1143, DOI 10.2337/db07-1305; Hodges E, 2007, NAT GENET, V39, P1522, DOI 10.1038/ng.2007.42; Jensen J, 2000, DIABETES, V49, P163, DOI 10.2337/diabetes.49.2.163; Jensen JN, 2007, NEW ENGL J MED, V356, P1781; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Lee CS, 2002, GENE DEV, V16, P1488, DOI 10.1101/gad.985002; Liu X, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-271; Lynn FC, 2007, P NATL ACAD SCI USA, V104, P10500, DOI 10.1073/pnas.0704054104; Lynn FC, 2007, DIABETES, V56, P2938, DOI 10.2337/db07-0175; Lyttle BM, 2008, DIABETOLOGIA, V51, P1169, DOI 10.1007/s00125-008-1006-z; McCarthy MI, 2008, DIABETES, V57, P2889, DOI 10.2337/db08-0343; Mitchell J, 2004, DIABETOLOGIA, V47, P2160, DOI 10.1007/s00125-004-1576-3; Miyatsuka T, 2009, DIABETES, V58, P1863, DOI 10.2337/db09-0390; Murtaugh LC, 2007, DEVELOPMENT, V134, P427, DOI 10.1242/dev.02770; Nekrep N, 2008, DEVELOPMENT, V135, P2151, DOI 10.1242/dev.015859; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Schwitzgebel VM, 2000, DEVELOPMENT, V127, P3533; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Soriano P, 1999, NAT GENET, V21, P70, DOI 10.1038/5007; Steemers Frank J., 2007, Biotechnology Journal, V2, P41, DOI 10.1002/biot.200600213; STEFAN Y, 1983, DIABETES, V32, P293, DOI 10.2337/diabetes.32.4.293; Wang JF, 2006, NEW ENGL J MED, V355, P270, DOI 10.1056/NEJMoa054288; Wang S, 2008, DEV BIOL, V317, P531, DOI 10.1016/j.ydbio.2008.02.052	42	224	232	0	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 11	2010	463	7282					775	780		10.1038/nature08748	http://dx.doi.org/10.1038/nature08748			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148032	Green Submitted, Green Accepted			2022-12-01	WOS:000274394300032
J	Okada, Y; Yamagata, K; Hong, K; Wakayama, T; Zhang, Y				Okada, Yuki; Yamagata, Kazuo; Hong, Kwonho; Wakayama, Teruhiko; Zhang, Yi			A role for the elongator complex in zygotic paternal genome demethylation	NATURE			English	Article							DNA DEMETHYLATION; PREIMPLANTATION EMBRYOS; S-ADENOSYLMETHIONINE; MOUSE; GENE; METHYLATION; PROTEIN; GLYCOSYLASE; ARABIDOPSIS; SUBUNIT	The life cycle of mammals begins when a sperm enters an egg. Immediately after fertilization, both the maternal and paternal genomes undergo dramatic reprogramming to prepare for the transition from germ cell to somatic cell transcription programs(1). One of the molecular events that takes place during this transition is the demethylation of the paternal genome(2,3). Despite extensive efforts, the factors responsible for paternal DNA demethylation have not been identified(4). To search for such factors, we developed a live cell imaging system that allows us to monitor the paternal DNA methylation state in zygotes. Through short-interfering-RNA-mediated knockdown in mouse zygotes, we identified Elp3 (also called KAT9), a component of the elongator complex(5), to be important for paternal DNA demethylation. We demonstrate that knockdown of Elp3 impairs paternal DNA demethylation as indicated by reporter binding, immunostaining and bisulphite sequencing. Similar results were also obtained when other elongator components, Elp1 and Elp4, were knocked down. Importantly, injection of messenger RNA encoding the Elp3 radical SAM domain mutant, but not the HAT domain mutant, into MII oocytes before fertilization also impaired paternal DNA demethylation, indicating that the SAM radical domain is involved in the demethylation process. Our study not only establishes a critical role for the elongator complex in zygotic paternal genome demethylation, but also indicates that the demethylation process may be mediated through a reaction that requires an intact radical SAM domain.	[Okada, Yuki; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA; [Okada, Yuki; Hong, Kwonho; Zhang, Yi] Univ N Carolina, Lineberger Comprehens Canc Ctr, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Yamagata, Kazuo; Wakayama, Teruhiko] RIKEN, Ctr Dev Biol, Lab Genom Reprogramming, Chuo Ku, Kobe, Hyogo 6500047, Japan	Howard Hughes Medical Institute; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; RIKEN	Zhang, Y (corresponding author), Univ N Carolina, Lineberger Comprehens Canc Ctr, Howard Hughes Med Inst, Chapel Hill, NC 27599 USA.	yi_zhang@med.unc.edu		Zhang, Yi/0000-0002-2789-0811; Hong, Kwonho/0000-0001-7479-4091	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068804] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NIGMS NIH HHS [R01 GM068804, R01 GM068804-07] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Allen MD, 2006, EMBO J, V25, P4503, DOI 10.1038/sj.emboj.7601340; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; Bhattacharya SK, 1999, NATURE, V397, P579, DOI 10.1038/17533; Choi YH, 2002, CELL, V110, P33, DOI 10.1016/S0092-8674(02)00807-3; Gong ZH, 2002, CELL, V111, P803, DOI 10.1016/S0092-8674(02)01133-9; Hajkova P, 2002, MECH DEVELOP, V117, P15, DOI 10.1016/S0925-4773(02)00181-8; Hawkes NA, 2002, J BIOL CHEM, V277, P3047, DOI 10.1074/jbc.M110445200; Howell CY, 2001, CELL, V104, P829, DOI 10.1016/S0092-8674(01)00280-X; Jackson-Grusby L, 2001, NAT GENET, V27, P31, DOI 10.1038/83730; Jin SG, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000013; Jorgensen HF, 2006, NUCLEIC ACIDS RES, V34, DOI 10.1093/nar/gkl527; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Mayer W, 2000, NATURE, V403, P501, DOI 10.1038/35000656; Ooi SKT, 2008, CELL, V133, P1145, DOI 10.1016/j.cell.2008.06.009; Opavsky R, 2007, PLOS GENET, V3, P1757, DOI 10.1371/journal.pgen.0030167; Oswald J, 2000, CURR BIOL, V10, P475, DOI 10.1016/S0960-9822(00)00448-6; Paraskevopoulou C, 2006, MOL MICROBIOL, V59, P795, DOI 10.1111/j.1365-2958.2005.04989.x; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; Svejstrup JQ, 2007, CURR OPIN CELL BIOL, V19, P331, DOI 10.1016/j.ceb.2007.04.005; Tagami H, 2004, CELL, V116, P51, DOI 10.1016/S0092-8674(03)01064-X; Tahiliani M, 2009, SCIENCE, V324, P930, DOI 10.1126/science.1170116; Torres-Padilla ME, 2006, INT J DEV BIOL, V50, P455, DOI 10.1387/ijdb.052073mt; Tremblay KD, 1997, MOL CELL BIOL, V17, P4322, DOI 10.1128/MCB.17.8.4322; Wang SC, 2007, TRENDS BIOCHEM SCI, V32, P101, DOI 10.1016/j.tibs.2007.01.002; Wittschieben BO, 1999, MOL CELL, V4, P123, DOI 10.1016/S1097-2765(00)80194-X; Yamagata K, 2009, J REPROD DEVELOP, V55, P343, DOI 10.1262/jrd.20166	30	223	229	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					554	U177		10.1038/nature08732	http://dx.doi.org/10.1038/nature08732			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20054296	Green Accepted, Green Submitted			2022-12-01	WOS:000273981100054
J	Flegal, KM; Carroll, MD; Ogden, CL; Curtin, LR				Flegal, Katherine M.; Carroll, Margaret D.; Ogden, Cynthia L.; Curtin, Lester R.			Prevalence and Trends in Obesity Among US Adults, 1999-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							BODY-MASS INDEX; UNITED-STATES; OVERWEIGHT; MORTALITY; WHITE; COMMUNITIES; POPULATION; WEIGHT; HEALTH; FAT	Context The prevalence of obesity increased in the United States between 19761980 and 1988-1994 and again between 1988-1994 and 1999-2000. Objective To examine trends in obesity from 1999 through 2008 and the current prevalence of obesity and overweight for 2007-2008. Design, Setting, and Participants Analysis of height and weight measurements from 5555 adult men and women aged 20 years or older obtained in 2007-2008 as part of the National Health and Nutrition Examination Survey (NHANES), a nationally representative sample of the US population. Data from the NHANES obtained in 20072008 were compared with results obtained from 1999 through 2006. Main Outcome Measure Estimates of the prevalence of overweight and obesity in adults. Overweight was defined as a body mass index (BMI) of 25.0 to 29.9. Obesity was defined as a BMI of 30.0 or higher. Results In 2007-2008, the age-adjusted prevalence of obesity was 33.8% (95% confidence interval [CI], 31.6%-36.0%) overall, 32.2% (95% CI, 29.5%-35.0%) among men, and 35.5% (95% CI, 33.2%-37.7%) among women. The corresponding prevalence estimates for overweight and obesity combined (BMI >= 25) were 68.0% (95% CI, 66.3%-69.8%), 72.3% (95% CI, 70.4%-74.1%), and 64.1% (95% CI, 61.3%-66.9%). Obesity prevalence varied by age group and by racial and ethnic group for both men and women. Over the 10-year period, obesity showed no significant trend among women (adjusted odds ratio [AOR] for 2007-2008 vs 1999-2000, 1.12 [95% CI, 0.89-1.32]). For men, there was a significant linear trend (AOR for 2007-2008 vs 1999-2000, 1.32 [95% CI, 1.12-1.58]); however, the 3 most recent data points did not differ significantly from each other. Conclusions In 2007-2008, the prevalence of obesity was 32.2% among adult men and 35.5% among adult women. The increases in the prevalence of obesity previously observed do not appear to be continuing at the same rate over the past 10 years, particularly for women and possibly for men. JAMA. 2010;303(3):235-241	[Flegal, Katherine M.; Carroll, Margaret D.; Ogden, Cynthia L.; Curtin, Lester R.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Flegal, KM (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4315, Hyattsville, MD 20782 USA.	kmf2@cdc.gov	Flegal, Katherine M/A-4608-2013; FENTON, MIRIAM C/B-6430-2011	Flegal, Katherine/0000-0002-0838-469X				Abell JE, 2008, AM J PUBLIC HEALTH, V98, P63, DOI 10.2105/AJPH.2006.093781; Aloia JF, 1999, OSTEOPOROSIS INT, V10, P114, DOI 10.1007/s001980050204; Berghofer A, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-200; Bouchard C, 2008, INT J OBESITY, V32, pS2, DOI 10.1038/ijo.2008.231; Costa DL, 1997, NAT BUR EC, P47; Cowie CC, 2009, DIABETES CARE, V32, P287, DOI 10.2337/dc08-1296; Cutler JA, 2008, HYPERTENSION, V52, P818, DOI 10.1161/HYPERTENSIONAHA.108.113357; Ferndandez JR, 2003, AM J CLIN NUTR, V77, P71, DOI 10.1093/ajcn/77.1.71; Flegal C.L, OBESITY ADULTS US NO; Flegal KM, 2007, JAMA-J AM MED ASSOC, V298, P2028, DOI 10.1001/jama.298.17.2028; Flegal KM, 2009, AM J CLIN NUTR, V89, P500, DOI 10.3945/ajcn.2008.26847; Flegal KM, 1998, INT J OBESITY, V22, P39, DOI 10.1038/sj.ijo.0800541; Flegal KM, 2002, JAMA-J AM MED ASSOC, V288, P1723, DOI 10.1001/jama.288.14.1723; Gallagher D, 1996, AM J EPIDEMIOL, V143, P228, DOI 10.1093/oxfordjournals.aje.a008733; Giang T, 2008, J PUBLIC HEALTH MAN, V14, P272, DOI 10.1097/01.PHH.0000316486.57512.bf; Glanz K, 2004, PREV MED, V39, pS75, DOI 10.1016/j.ypmed.2004.01.004; Gregg EW, 2005, JAMA-J AM MED ASSOC, V293, P1868, DOI 10.1001/jama.293.15.1868; Gu DF, 2006, JAMA-J AM MED ASSOC, V295, P776, DOI 10.1001/jama.295.7.776; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; KUCZMARSKI RJ, 1994, JAMA-J AM MED ASSOC, V272, P205, DOI 10.1001/jama.272.3.205; Kumanyika SK, 2008, CIRCULATION, V118, P428, DOI 10.1161/CIRCULATIONAHA.108.189702; Malnick SDH, 2006, QJM-INT J MED, V99, P565, DOI 10.1093/qjmed/hcl085; McKinlay J, 2000, LANCET, V356, P757, DOI 10.1016/S0140-6736(00)02641-6; Misra A, 2003, INT J OBESITY, V27, P1294, DOI 10.1038/sj.ijo.0802412; National Center for Health Statistics, 2008, HLTH US 2008 CHARTB; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Orpana HM, 2010, OBESITY, V18, P214, DOI 10.1038/oby.2009.191; Pi-Sunyer FX, 1998, AM J CLIN NUTR, V68, P899; Rahman M, 2009, METABOLISM, V58, P1329, DOI 10.1016/j.metabol.2009.04.017; Ross R, 2009, NAT REV ENDOCRINOL, V5, P319, DOI 10.1038/nrendo.2009.78; Sanchez Ana M., 2000, Ethnicity and Disease, V10, P24; Stevens J, 1998, OBES RES, V6, P268, DOI 10.1002/j.1550-8528.1998.tb00349.x; Stevens J, 2003, INT J OBESITY, V27, P287, DOI 10.1038/sj.ijo.0802255; Tjepkema Michael, 2006, Health Rep, V17, P9; Velleman P.F., 1981, APPL BASICS COMPUTIN; WHO, 2004, LANCET, V363, P902; WHO Expert Committee on Physical Status: the Use and Interpretation of Anthropometry (1993: Geneva S Organization WH, 1995, PHYS STAT US INT ANT	37	4656	4750	4	252	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					235	241		10.1001/jama.2009.2014	http://dx.doi.org/10.1001/jama.2009.2014			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20071471	Bronze			2022-12-01	WOS:000273690600019
J	Eckel, RH; Alberti, KGMM; Grundy, SM; Zimmet, PZ				Eckel, Robert H.; Alberti, K. G. M. M.; Grundy, Scott M.; Zimmet, Paul Z.			The metabolic syndrome	LANCET			English	Editorial Material							CARDIORESPIRATORY FITNESS; CARDIOVASCULAR EVENTS; RISK-FACTORS; MEN; MORTALITY		[Eckel, Robert H.] Univ Colorado, Denver Sch Med, Denver, CO 80045 USA; [Alberti, K. G. M. M.] Univ London Imperial Coll Sci Technol & Med, London, England; [Grundy, Scott M.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA; [Zimmet, Paul Z.] Baker IDI Heart & Diabet Inst, Melbourne, Vic, Australia	University of Colorado System; University of Colorado Anschutz Medical Campus; University of Colorado Denver; Imperial College London; University of Texas System; University of Texas Southwestern Medical Center Dallas; Baker Heart and Diabetes Institute	Eckel, RH (corresponding author), Univ Colorado, Denver Sch Med, Anschutz Med Campus, Denver, CO 80045 USA.	robert.eckel@ucdenver.edu						Alberti KGMM, 2009, CIRCULATION, V120, P1640, DOI 10.1161/CIRCULATIONAHA.109.192644; Alberti KGMM, 2005, LANCET, V366, P1059, DOI 10.1016/S0140-6736(05)67402-8; Cameron AJ, 2008, OBESITY, V16, P2707, DOI 10.1038/oby.2008.412; Cornier MA, 2008, ENDOCR REV, V29, P777, DOI 10.1210/er.2008-0024; Cubbon RM, 2009, CLIN SCI, V117, P173, DOI 10.1042/CS20080263; Ford ES, 2008, DIABETES CARE, V31, P1898, DOI 10.2337/dc08-0423; Gami AS, 2007, J AM COLL CARDIOL, V49, P403, DOI 10.1016/j.jacc.2006.09.032; Garaulet M, 2009, CURR OPIN LIPIDOL, V20, P127, DOI 10.1097/MOL.0b013e3283292399; Grundy SM, 2006, NAT REV DRUG DISCOV, V5, P294, DOI 10.1038/nrd2005; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Junyent M, 2009, J NUTR, V139, P842, DOI 10.3945/jn.108.101196; Kahn R, 2005, DIABETES CARE, V28, P2289, DOI 10.2337/diacare.28.9.2289; Kodama S, 2009, JAMA-J AM MED ASSOC, V301, P2024, DOI 10.1001/jama.2009.681; Koskinen J, 2009, CIRCULATION, V120, P229, DOI 10.1161/CIRCULATIONAHA.108.845065; LaMonte MJ, 2005, CIRCULATION, V112, P505, DOI 10.1161/CIRCULATIONAHA.104.503805; Reis JP, 2009, PEDIATRICS, V124, pE371, DOI 10.1542/peds.2009-0213; Sjostrom L, 2007, NEW ENGL J MED, V357, P741, DOI 10.1056/NEJMoa066254; Tabak AG, 2009, LANCET, V373, P2215, DOI 10.1016/S0140-6736(09)60619-X; Wannamethee SG, 2005, ARCH INTERN MED, V165, P2644, DOI 10.1001/archinte.165.22.2644	19	562	587	0	103	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					181	183		10.1016/S0140-6736(09)61794-3	http://dx.doi.org/10.1016/S0140-6736(09)61794-3			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109902				2022-12-01	WOS:000273853800009
J	Bloom, AA; Palmer, PI; Fraser, A; Reay, DS; Frankenberg, C				Bloom, A. Anthony; Palmer, Paul I.; Fraser, Annemarie; Reay, David S.; Frankenberg, Christian			Large-Scale Controls of Methanogenesis Inferred from Methane and Gravity Spaceborne Data	SCIENCE			English	Article							EMISSIONS; VARIABILITY; CONSUMPTION; BASIN	Wetlands are the largest individual source of methane (CH4), but the magnitude and distribution of this source are poorly understood on continental scales. We isolated the wetland and rice paddy contributions to spaceborne CH4 measurements over 2003-2005 using satellite observations of gravity anomalies, a proxy for water-table depth Gamma, and surface temperature analyses T-S. We find that tropical and higher-latitude CH4 variations are largely described by Gamma and T-S variations, respectively. Our work suggests that tropical wetlands contribute 52 to 58% of global emissions, with the remainder coming from the extra-tropics, 2% of which is from Arctic latitudes. We estimate a 7% rise in wetland CH4 emissions over 2003-2007, due to warming of mid-latitude and Arctic wetland regions, which we find is consistent with recent changes in atmospheric CH4.	[Bloom, A. Anthony; Palmer, Paul I.; Fraser, Annemarie; Reay, David S.] Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland; [Frankenberg, Christian] SRON Netherlands Inst Space Res, Utrecht, Netherlands	University of Edinburgh	Palmer, PI (corresponding author), Univ Edinburgh, Sch Geosci, Edinburgh, Midlothian, Scotland.	pip@ed.ac.uk	Frankenberg, Christian/A-2944-2013; Bloom, A Anthony/G-8072-2017; Fraser, Annemarie/D-3874-2012; Reay, David/F-4054-2010; Palmer, Paul I/F-7008-2010	Frankenberg, Christian/0000-0002-0546-5857; Palmer, Paul I/0000-0002-1487-0969; Reay, Dave/0000-0001-5829-9007	United Kingdom Natural Environmental Research Council [NE/F007973/1]; National Centre for Earth Observation	United Kingdom Natural Environmental Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); National Centre for Earth Observation	We thank J. Melack for providing feedback on the manuscript and R. Hipkin and F. Simons for assistance with GRACE gravity data. This work is funded by United Kingdom Natural Environmental Research Council studentship NE/F007973/1 and the National Centre for Earth Observation.	Bousquet P, 2006, NATURE, V443, P439, DOI 10.1038/nature05132; Bovensmann H, 1999, J ATMOS SCI, V56, P127, DOI 10.1175/1520-0469(1999)056<0127:SMOAMM>2.0.CO;2; Cao MK, 1996, J GEOPHYS RES-ATMOS, V101, P14399, DOI 10.1029/96JD00219; Chen JL, 2007, J GEODESY, V81, P237, DOI 10.1007/s00190-006-0104-2; Dlugokencky EJ, 2003, GEOPHYS RES LETT, V30, DOI 10.1029/2003GL018126; Evans JR, 2007, NEW PHYTOL, V175, P1, DOI 10.1111/j.1469-8137.2007.02114.x; Fiore A, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2003JD003855; Frankenberg C, 2008, ATMOS CHEM PHYS, V8, P5061, DOI 10.5194/acp-8-5061-2008; Frankenberg C, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL034300; FUNG I, 1991, J GEOPHYS RES-ATMOS, V96, P13033, DOI 10.1029/91JD01247; Gedney N, 2004, GEOPHYS RES LETT, V31, DOI 10.1029/2004GL020919; Joabsson A, 1999, TRENDS ECOL EVOL, V14, P385, DOI 10.1016/S0169-5347(99)01649-3; Kalnay E, 1996, B AM METEOROL SOC, V77, P437, DOI 10.1175/1520-0477(1996)077<0437:TNYRP>2.0.CO;2; Le Mer J, 2001, EUR J SOIL BIOL, V37, P25, DOI 10.1016/S1164-5563(01)01067-6; Lemoine JM, 2007, ADV SPACE RES, V39, P1620, DOI 10.1016/j.asr.2007.03.062; Matthews E, 1991, GLOBAL BIOGEOCHEM CY, V5, P3, DOI 10.1029/90GB02311; Matthews E, 1987, GLOBAL BIOGEOCHEM CY, V1, P61, DOI 10.1029/GB001i001p00061; McLeod AR, 2008, NEW PHYTOL, V180, P124, DOI 10.1111/j.1469-8137.2008.02571.x; Melack JM, 2004, GLOBAL CHANGE BIOL, V10, P530, DOI 10.1111/j.1365-2486.2004.00763.x; Oki T, 1998, EARTH INTERACT, V2, P1; Rigby M, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2008GL036037; Segers R, 1998, BIOGEOCHEMISTRY, V41, P23, DOI 10.1023/A:1005929032764; Smith P, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P497; Tapley BD, 2004, SCIENCE, V305, P503, DOI 10.1126/science.1099192; van der Werf GR, 2006, ATMOS CHEM PHYS, V6, P3423, DOI 10.5194/acp-6-3423-2006; Walter BP, 2001, J GEOPHYS RES-ATMOS, V106, P34189, DOI 10.1029/2001JD900165; Ward D. M., 1985, Advances in Aquatic Microbiology, V3, P141	27	225	242	7	181	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					322	325		10.1126/science.1175176	http://dx.doi.org/10.1126/science.1175176			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075250				2022-12-01	WOS:000273629700040
J	Mathur, D; Bost, A; Driver, I; Ohlstein, B				Mathur, Divya; Bost, Alyssa; Driver, Ian; Ohlstein, Benjamin			A Transient Niche Regulates the Specification of Drosophila Intestinal Stem Cells	SCIENCE			English	Article							SELF-RENEWAL; PROLIFERATION; ACTIVATION; MIDGUT; SPERMATOGENESIS; MELANOGASTER; MAINTENANCE; DIVISION; NOTCH; OVARY	Stem cell niches are locations where stem cells reside and self-renew. Although studies have shown how niches maintain stem cell fate during tissue homeostasis, less is known about their roles in establishing stem cells. The adult Drosophila midgut is maintained by intestinal stem cells (ISCs); however, how they are established is unknown. Here, we show that an ISC progenitor generates a niche cell via Notch signaling. This niche uses the bone morphogenetic protein 2/4 homolog, decapentaplegic, to allow progenitors to divide in an undifferentiated state and subsequently breaks down and dies, resulting in the specification of ISCs in the adult midgut. Our results demonstrate a paradigm for stem cell-niche biology, where progenitors generate transient niches that determine stem cell fate and may give insights into stem cell specification in other tissues.	[Mathur, Divya; Bost, Alyssa; Ohlstein, Benjamin] Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA; [Driver, Ian] Columbia Univ, Integrated Program Cellular Mol Struct & Genet St, Med Ctr, New York, NY 10032 USA	Columbia University; Columbia University	Ohlstein, B (corresponding author), Columbia Univ, Dept Genet & Dev, Med Ctr, New York, NY 10032 USA.	bo2160@columbia.edu		Driver, Ian/0000-0002-2674-5532	Searle Scholars Award; Charles Bohmfalk Research Award; NIH [R01 DK082456-01]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082456] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007088] Funding Source: NIH RePORTER	Searle Scholars Award; Charles Bohmfalk Research Award; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Wolken and S. Selway for technical assistance with the Pswitch screen; members of the Drosophila community for sending fly stocks; Developmental Studies Hybridoma Bank for antibodies; E. Matunis, M. Buszczak, and J. Wilhelm for helpful discussions; and anonymous reviewers for comments. B. O. is the recipient of the 2009 Searle Scholars Award, the Charles Bohmfalk Research Award, and an NIH grant (R01 DK082456-01).	Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; BRUMMEL TJ, 1994, CELL, V78, P251, DOI 10.1016/0092-8674(94)90295-X; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Chitnis A, 2006, DEV DYNAM, V235, P886, DOI 10.1002/dvdy.20683; Doetsch F, 2003, CURR OPIN GENET DEV, V13, P543, DOI 10.1016/j.gde.2003.08.012; ELSHATOURY HH, 1957, J EMBRYOL EXP MORPH, V5, P9; HARTENSTEIN V, 1992, ROUX ARCH DEV BIOL, V201, P194, DOI 10.1007/BF00188752; Jiang HQ, 2009, DEVELOPMENT, V136, P483, DOI 10.1242/dev.026955; Kawase E, 2004, DEVELOPMENT, V131, P1365, DOI 10.1242/dev.01025; Kiger AA, 2001, SCIENCE, V294, P2542, DOI 10.1126/science.1066707; Lee WC, 2009, DEVELOPMENT, V136, P2255, DOI 10.1242/dev.035196; Micchelli CA, 2006, NATURE, V439, P475, DOI 10.1038/nature04371; Nicholson L, 2008, GENETICS, V178, P215, DOI 10.1534/genetics.107.081968; Ohlstein B, 2004, CURR OPIN CELL BIOL, V16, P693, DOI 10.1016/j.ceb.2004.09.003; Ohlstein B, 2006, NATURE, V439, P470, DOI 10.1038/nature04333; Ohlstein B, 2007, SCIENCE, V315, P988, DOI 10.1126/science.1136606; Robertson CW, 1936, J MORPHOL, V59, P351, DOI 10.1002/jmor.1050590207; SCHOFIELD R, 1978, BLOOD CELLS, V4, P7; SEKELSKY JJ, 1995, GENETICS, V139, P1347; Shivdasani AA, 2003, CURR BIOL, V13, P2065, DOI 10.1016/j.cub.2003.10.063; Tulina N, 2001, SCIENCE, V294, P2546, DOI 10.1126/science.1066700; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; Xie T, 2000, SCIENCE, V290, P328, DOI 10.1126/science.290.5490.328; Xie T, 1998, CELL, V94, P251, DOI 10.1016/S0092-8674(00)81424-5; Yamashita YM, 2003, SCIENCE, V301, P1547, DOI 10.1126/science.1087795; Yilmaz OH, 2006, BLOOD, V107, P924, DOI 10.1182/blood-2005-05-2140; Zhang JW, 2003, NATURE, V425, P836, DOI 10.1038/nature02041	27	130	134	0	14	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					210	213		10.1126/science.1181958	http://dx.doi.org/10.1126/science.1181958			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056890	Green Accepted			2022-12-01	WOS:000273394000037
J	Hood, E; Fellman, J; Spencer, RGM; Hernes, PJ; Edwards, R; D'Amore, D; Scott, D				Hood, Eran; Fellman, Jason; Spencer, Robert G. M.; Hernes, Peter J.; Edwards, Rick; D'Amore, David; Scott, Durelle			Glaciers as a source of ancient and labile organic matter to the marine environment	NATURE			English	Article							CARBON; ALASKA; EXPORT; FATE	Riverine organic matter supports of the order of one-fifth of estuarine metabolism(1). Coastal ecosystems are therefore sensitive to alteration of both the quantity and lability of terrigenous dissolved organic matter (DOM) delivered by rivers. The lability of DOM is thought to vary with age, with younger, relatively unaltered organic matter being more easily metabolized by aquatic heterotrophs than older, heavily modified material(2-4). This view is developed exclusively from work in watersheds where terrestrial plant and soil sources dominate streamwater DOM. Here we characterize streamwater DOM from 11 coastal watersheds on the Gulf of Alaska that vary widely in glacier coverage (0-64 per cent). In contrast to non-glacial rivers, we find that the bioavailability of DOM to marine microorganisms is significantly correlated with increasing C-14 age. Moreover, the most heavily glaciated watersheds are the source of the oldest (similar to 4 kyr C-14 age) and most labile (66 per cent bioavailable) DOM. These glacial watersheds have extreme runoff rates, in part because they are subject to some of the highest rates of glacier volume loss on Earth(5). We estimate the cumulative flux of dissolved organic carbon derived from glaciers contributing runoff to the Gulf of Alaska at 0.13 +/- 0.01 Tg yr(-1) (1 Tg = 10(12) g), of which similar to 0.10 Tg is highly labile. This indicates that glacial runoff is a quantitatively important source of labile reduced carbon to marine ecosystems. Moreover, because glaciers and ice sheets represent the second largest reservoir of water in the global hydrologic system, our findings indicate that climatically driven changes in glacier volume could alter the age, quantity and reactivity of DOM entering coastal oceans.	[Hood, Eran] Univ Alaska SE, Environm Sci & Geog Program, Juneau, AK 99801 USA; [Fellman, Jason] Univ Alaska Fairbanks, Inst Arctic Biol, Fairbanks, AK 99775 USA; [Spencer, Robert G. M.; Hernes, Peter J.] Univ Calif Davis, Dept Land Air & Water Resources, Davis, CA 95616 USA; [Edwards, Rick; D'Amore, David] US Forest Serv, Pacific NW Res Stn, USDA, Juneau, AK 99801 USA; [Scott, Durelle] Virginia Tech, Blacksburg, VA 24061 USA	University of Alaska System; University of Alaska Southeastern; University of Alaska System; University of Alaska Fairbanks; University of California System; University of California Davis; United States Department of Agriculture (USDA); United States Forest Service; Virginia Polytechnic Institute & State University	Hood, E (corresponding author), Univ Alaska SE, Environm Sci & Geog Program, Juneau, AK 99801 USA.	eran.hood@uas.alaska.edu			US National Science Foundation [EAR-0838587]; University of Alaska Seed Grant; USDA Forest Service, Pacific Northwest Research Station; Division Of Earth Sciences [0838497, 0838587] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); University of Alaska Seed Grant; USDA Forest Service, Pacific Northwest Research Station(United States Department of Agriculture (USDA)United States Forest Service); Division Of Earth Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	E. Neal and K. Smikrud contributed to the GOA glacier water flux estimates and K. Smikrud also provided Fig. 1. A. Arendt provided data on glacial wastage. We thank X. Xu at the KCCAMS facility for <SUP>14</SUP>C analyses, and R. Dyda and B. Holmes at UC Davis for assistance with lignin and <SUP>13</SUP>C-DOC analyses, respectively. Funding came from the US National Science Foundation (EAR-0838587), a University of Alaska Seed Grant ( to E. H.) and the USDA Forest Service, Pacific Northwest Research Station. The use of trade or firm names in this publication does not imply endorsement by the US Department of Agriculture.	Anesio AM, 2009, GLOBAL CHANGE BIOL, V15, P955, DOI 10.1111/j.1365-2486.2008.01758.x; Arendt AA, 2002, SCIENCE, V297, P382, DOI 10.1126/science.1072497; Bardgett RD, 2007, BIOLOGY LETT, V3, P487, DOI 10.1098/rsbl.2007.0242; Barker JD, 2006, ARCT ANTARCT ALP RES, V38, P163, DOI 10.1657/1523-0430(2006)38[163:AADODO]2.0.CO;2; CHINLEO G, 1992, MAR ECOL PROG SER, V87, P87, DOI 10.3354/meps087087; DEEVEY ES, 1957, SCIENCE, V125, P182, DOI 10.1126/science.125.3240.182; Druffel ERM, 2000, GEOPHYS RES LETT, V27, P1495, DOI 10.1029/1999GL002398; Fellman JB, 2008, BIOGEOCHEMISTRY, V88, P169, DOI 10.1007/s10533-008-9203-x; Hanna E, 2005, J GEOPHYS RES-ATMOS, V110, DOI 10.1029/2004JD005641; Hernes PJ, 2003, J GEOPHYS RES-OCEANS, V108, DOI 10.1029/2002JC001421; Hodson A, 2008, ECOL MONOGR, V78, P41, DOI 10.1890/07-0187.1; Holmes RM, 2008, GEOPHYS RES LETT, V35, DOI 10.1029/2007GL032837; Hood E, 2008, NAT GEOSCI, V1, P583, DOI 10.1038/ngeo280; Hood E, 2009, J GEOPHYS RES-BIOGEO, V114, DOI 10.1029/2009JG000971; Larsen CF, 2007, J GEOPHYS RES-EARTH, V112, DOI 10.1029/2006JF000586; Ludwig W, 1996, GLOBAL BIOGEOCHEM CY, V10, P23, DOI 10.1029/95GB02925; Mayorga E, 2005, NATURE, V436, P538, DOI 10.1038/nature03880; MCKNIGHT DM, 1994, LIMNOL OCEANOGR, V39, P1972, DOI 10.4319/lo.1994.39.8.1972; McKnight DM., 2003, AQUATIC ECOSYSTEMS, P71, DOI 10.1016/B978-012256371-3/50004-4; Meier MF, 2007, SCIENCE, V317, P1064, DOI 10.1126/science.1143906; Neal EG, 2002, J HYDROL, V263, P188, DOI 10.1016/S0022-1694(02)00058-6; Opsahl S, 1999, LIMNOL OCEANOGR, V44, P2017, DOI 10.4319/lo.1999.44.8.2017; Opsahl S, 1997, NATURE, V386, P480, DOI 10.1038/386480a0; Rabalais NN, 2002, ANNU REV ECOL SYST, V33, P235, DOI 10.1146/annurev.ecolsys.33.010802.150513; Raymond PA, 2001, NATURE, V409, P497, DOI 10.1038/35054034; Raymond PA, 2007, GLOBAL BIOGEOCHEM CY, V21, DOI 10.1029/2007GB002934; Royer TC, 2006, GEOPHYS RES LETT, V33, DOI 10.1029/2006GL026767; Schiff SL, 1997, BIOGEOCHEMISTRY, V36, P43, DOI 10.1023/A:1005744131385; Simpson JJ, 2005, ARCTIC, V58, P137; SKIDMORE ML, 2000, APPL ENVIRON MICROB, V66, P3124; SMITH SV, 1993, REV GEOPHYS, V31, P75, DOI 10.1029/92RG02584; Sondergaard M, 2003, OPHELIA, V57, P161, DOI 10.1080/00785236.2003.10409512; Spencer RGM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2008GL036831; Weishaar JL, 2003, ENVIRON SCI TECHNOL, V37, P4702, DOI 10.1021/es030360x	34	365	378	12	235	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1044	U100		10.1038/nature08580	http://dx.doi.org/10.1038/nature08580			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033045				2022-12-01	WOS:000272996000044
J	Lutes, AA; Neaves, WB; Baumann, DP; Wiegraebe, W; Baumann, P				Lutes, Aracely A.; Neaves, William B.; Baumann, Diana P.; Wiegraebe, Winfried; Baumann, Peter			Sister chromosome pairing maintains heterozygosity in parthenogenetic lizards	NATURE			English	Article							CNEMIDOPHORUS-TESSELATUS; SKIN HISTOCOMPATIBILITY; TEIID LIZARDS	Although bisexual reproduction has proven to be highly successful, parthenogenetic all-female populations occur frequently in certain taxa, including the whiptail lizards of the genus Aspidoscelis. Allozyme analysis revealed a high degree of fixed heterozygosity in these parthenogenetic species(1,2), supporting the view that they originated from hybridization events between related sexual species. It has remained unclear how the meiotic program is altered to produce diploid eggs while maintaining heterozygosity. Here we show that meiosis commences with twice the number of chromosomes in parthenogenetic versus sexual species, a mechanism that provides the basis for generating gametes with unreduced chromosome content without fundamental deviation from the classic meiotic program. Our observation of synaptonemal complexes and chiasmata demonstrate that a typical meiotic program occurs and that heterozygosity is not maintained by bypassing recombination. Instead, fluorescent in situ hybridization probes that distinguish between homologues reveal that bivalents form between sister chromosomes, the genetically identical products of the first of two premeiotic replication cycles. Sister chromosome pairing provides a mechanism for the maintenance of heterozygosity, which is critical for offsetting the reduced fitness associated with the lack of genetic diversity in parthenogenetic species.	[Lutes, Aracely A.; Neaves, William B.; Baumann, Diana P.; Wiegraebe, Winfried; Baumann, Peter] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Lutes, Aracely A.; Baumann, Peter] Univ Kansas, Med Ctr, Dept Mol & Integrat Physiol, Kansas City, KS 66160 USA; [Neaves, William B.] Univ Missouri, Sch Med, Kansas City, MO 64110 USA; [Baumann, Peter] Howard Hughes Med Inst, Kansas City, MO 64110 USA	Stowers Institute for Medical Research; University of Kansas; University of Kansas Medical Center; University of Missouri System; University of Missouri Kansas City; Howard Hughes Medical Institute	Baumann, P (corresponding author), Stowers Inst Med Res, Kansas City, MO 64110 USA.	peb@stowers.org		Baumann, Peter/0000-0003-4892-1485	Stowers Institute for Medical Research; Pew Charitable Trusts	Stowers Institute for Medical Research; Pew Charitable Trusts	We thank the staff of the Reptile Facility for their dedication to animal husbandry; C. Painter and his colleagues at the New Mexico Department of Game and Fish for scientific collection permits; F. Li for electron microscopy; the Stowers Institute Microscopy, Cytometry and Molecular Biology Facilities for support; and S. Hawley, J. Cole, C. Townsend and members of the Baumann and Blanchette laboratories for discussions and comments. We also thank S. Hawley for critical reading of the manuscript. This work was funded by the Stowers Institute for Medical Research, and the Pew Scholars Program in the Biological Sciences sponsored by the Pew Charitable Trusts. P. B. is an Early Career Scientist with the Howard Hughes Medical Institute.	Cordes JE, 2006, COPEIA, P14, DOI 10.1643/0045-8511(2006)006[0014:EASIOS]2.0.CO;2; Cordes JE, 2003, J HERPETOL, V37, P185, DOI 10.1670/0022-1511(2003)037[0185:SHBSPC]2.0.CO;2; CUELLAR O, 1977, TRANSPLANTATION, V24, P127, DOI 10.1097/00007890-197708000-00006; CUELLAR O, 1971, J MORPHOL, V133, P139, DOI 10.1002/jmor.1051330203; DENK W, 1990, SCIENCE, V248, P73, DOI 10.1126/science.2321027; DESSAUER HC, 1986, J HERED, V77, P8, DOI 10.1093/oxfordjournals.jhered.a110176; DESSAUER HC, 1989, EVOLUTION ECOLOGY UN, V466, P49; Edgar BA, 2001, CELL, V105, P297, DOI 10.1016/S0092-8674(01)00334-8; Gonzalez R. C., 2008, DIGITAL IMAGE PROCES; LOWE C H, 1966, Journal of the Arizona Academy of Science, V4, P81; MACGREGOR HC, 1964, SCIENCE, V143, P1043, DOI 10.1126/science.143.3610.1043; MASLIN TP, 1967, J EXP ZOOL, V166, P137, DOI 10.1002/jez.1401660114; Moore Melody K., 1997, Methods in Cell Science, V19, P161, DOI 10.1023/A:1009716712646; Neaves W. B., 1971, Breviora, VNo. 381, P1; NEAVES WB, 1969, J EXP ZOOL, V171, P175, DOI 10.1002/jez.1401710205; NEAVES WB, 1968, SCIENCE, V160, P1004, DOI 10.1126/science.160.3831.1004; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; PARKER ED, 1976, GENETICS, V84, P791; Reeder TW, 2002, AM MUS NOVIT, P1, DOI 10.1206/0003-0082(2002)365<0001:PROWLO>2.0.CO;2; Sarthy J, 2009, EMBO J, V28, P3390, DOI 10.1038/emboj.2009.275; Townsend C.R., 1979, International Zoo Yearbook, V19, P80, DOI 10.1111/j.1748-1090.1979.tb00533.x; VRIJENHOEK RC, 1989, EVOLUTION ECOLOGY UN, V466, P19; WHITE M. J. D., 1963, AUSTRALIAN JOUR ZOOL, V11, P1, DOI 10.1071/ZO9630001; Wright J. W., 1967, Mammalian Chromosomes Newsletter, V8, P95	24	73	79	0	69	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					283	U164		10.1038/nature08818	http://dx.doi.org/10.1038/nature08818			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20173738	Green Accepted			2022-12-01	WOS:000275366100048
J	Youds, JL; Mets, DG; McIlwraith, MJ; Martin, JS; Ward, JD; ONeil, NJ; Rose, AM; West, SC; Meyer, BJ; Boulton, SJ				Youds, Jillian L.; Mets, David G.; McIlwraith, Michael J.; Martin, Julie S.; Ward, Jordan D.; ONeil, Nigel J.; Rose, Ann M.; West, Stephen C.; Meyer, Barbara J.; Boulton, Simon J.			RTEL-1 Enforces Meiotic Crossover Interference and Homeostasis	SCIENCE			English	Article							CAENORHABDITIS-ELEGANS; STRAND-EXCHANGE; C-ELEGANS; RECOMBINATION; CHROMOSOME; PROTEINS; YEAST	Meiotic crossovers (COs) are tightly regulated to ensure that COs on the same chromosome are distributed far apart ( crossover interference, COI) and that at least one CO is formed per homolog pair (CO homeostasis). CO formation is controlled in part during meiotic double-strand break (DSB) creation in Caenorhabditis elegans, but a second level of control must also exist because meiotic DSBs outnumber COs. We show that the anti-recombinase RTEL-1 is required to prevent excess meiotic COs, probably by promoting meiotic synthesis-dependent strand annealing. Two distinct classes of meiotic COs are increased in rtel-1 mutants, and COI and homeostasis are compromised. We propose that RTEL-1 implements the second level of CO control by promoting noncrossovers.	[Youds, Jillian L.; Martin, Julie S.; Ward, Jordan D.; Boulton, Simon J.] Canc Res UK, London Res Inst, DNA Damage Response Lab, S Mimms EN6 3LD, Herts, England; [Mets, David G.; Meyer, Barbara J.] Univ Calif Berkeley, Howard Hughes Med Inst, Dept Mol & Cell Biol, Berkeley, CA 94720 USA; [McIlwraith, Michael J.; West, Stephen C.] Canc Res UK, London Res Inst, Genet Recombinat Lab, S Mimms EN6 3LD, Herts, England; [ONeil, Nigel J.; Rose, Ann M.] Univ British Columbia, Fac Med, Dept Med Genet, Vancouver, BC V6T 1Z4, Canada	Cancer Research UK; Howard Hughes Medical Institute; University of California System; University of California Berkeley; Cancer Research UK; University of British Columbia	Boulton, SJ (corresponding author), Canc Res UK, London Res Inst, DNA Damage Response Lab, Clare Hall, S Mimms EN6 3LD, Herts, England.	simon.boulton@cancer.org.uk	Ward, Jordan/C-1505-2008; O'Neil, Nigel/J-4012-2014; Ward, Jordan/H-3444-2019	Ward, Jordan/0000-0001-9870-8936; O'Neil, Nigel/0000-0002-1992-6976; Ward, Jordan/0000-0001-9870-8936; Meyer, Barbara/0000-0002-6530-4588; West, Stephen/0000-0001-8848-9418; Mcilwraith, Michael/0000-0003-1559-4369	Cancer Research UK; Canadian Institute of Health Research; Cancer Research UK [11582] Funding Source: researchfish	Cancer Research UK(Cancer Research UK); Canadian Institute of Health Research(Canadian Institutes of Health Research (CIHR)); Cancer Research UK(Cancer Research UK)	This work was supported by Cancer Research UK (S.J.B. and S. C. W.) and the Canadian Institute of Health Research ( A. M. R.). B.J.M. is an investigator of the Howard Hughes Medical Institute.	Barber LJ, 2008, CELL, V135, P261, DOI 10.1016/j.cell.2008.08.016; Bhalla N, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000235; Bishop DK, 2004, CELL, V117, P9, DOI 10.1016/S0092-8674(04)00297-1; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Colaiacovo MP, 2003, DEV CELL, V5, P463, DOI 10.1016/S1534-5807(03)00232-6; Garcia-Muse T, 2007, CHROMOSOME RES, V15, P607, DOI 10.1007/s10577-007-1146-x; Hillers KJ, 2003, CURR BIOL, V13, P1641, DOI 10.1016/j.cub.2003.08.026; Hollingsworth NM, 2004, GENE DEV, V18, P117, DOI 10.1101/gad.1165904; Krogh BO, 2004, ANNU REV GENET, V38, P233, DOI 10.1146/annurev.genet.38.072902.091500; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; McMahill MS, 2007, PLOS BIOL, V5, P2589, DOI 10.1371/journal.pbio.0050299; Meneely PM, 2002, GENETICS, V162, P1169; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Tsai CJ, 2008, GENE DEV, V22, P194, DOI 10.1101/gad.1618508; Wood WB, 1988, NEMATODE CAENORHABDI; Zetka M., 2009, V5, P43, DOI 10.1159/000166618	16	126	134	0	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1254	1258		10.1126/science.1183112	http://dx.doi.org/10.1126/science.1183112			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203049	Green Accepted			2022-12-01	WOS:000275162100039
J	Richardson, CE; Kooistra, T; Kim, DH				Richardson, Claire E.; Kooistra, Tristan; Kim, Dennis H.			An essential role for XBP-1 in host protection against immune activation in C. elegans	NATURE			English	Article							UNFOLDED PROTEIN-RESPONSE; PLASMA-CELL DIFFERENTIATION; CAENORHABDITIS-ELEGANS; TRANSCRIPTION FACTOR; ENDOPLASMIC-RETICULUM; ER STRESS; BACTERIA; PATHWAY; INDUCE; KINASE	The detection and compensatory response to the accumulation of unfolded proteins in the endoplasmic reticulum (ER), termed the unfolded protein response (UPR), represents a conserved cellular homeostatic mechanism with important roles in normal development and in the pathogenesis of disease(1). The IRE1-XBP1/Hac1 pathway is a major branch of the UPR that has been conserved from yeast to human(2-6). X-box binding protein 1 (XBP1) is required for the differentiation of the highly secretory plasma cells of the mammalian adaptive immune system(7,8), but recent work also points to reciprocal interactions between the UPR and other aspects of immunity and inflammation(9-11). We have been studying innate immunity in the nematode Caenorhabditis elegans, having established a principal role for a conserved PMK-1 p38 mitogen-activated protein kinase (MAPK) pathway in mediating resistance to microbial pathogens(12). Here we show that during C. elegans development, XBP-1 has an essential role in protecting the host during activation of innate immunity. Activation of the PMK-1-mediated response to infection with Pseudomonas aeruginosa induces the XBP-1-dependent UPR. Whereas a loss-of-function xbp-1 mutant develops normally in the presence of relatively non-pathogenic bacteria, infection of the xbp-1 mutant with P. aeruginosa leads to disruption of ER morphology and larval lethality. Unexpectedly, the larval lethality phenotype on pathogenic P. aeruginosa is suppressed by loss of PMK-1-mediated immunity. Furthermore, hyperactivation of PMK-1 causes larval lethality in the xbp-1 mutant even in the absence of pathogenic bacteria. Our data establish innate immunity as a physiologically relevant inducer of ER stress during C. elegans development and indicate that an ancient, conserved role for XBP-1 may be to protect the host organism from the detrimental effects of mounting an innate immune response to microbes.	[Richardson, Claire E.; Kooistra, Tristan; Kim, Dennis H.] MIT, Dept Biol, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Kim, DH (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	dhkim@mit.edu		Richardson, Claire/0000-0002-7532-1808	NIH [DK43351, DK57521, R01-GM084477]; Howard Hughes Medical Institute; Burroughs Wellcome Fund; Ellison Medical Foundation	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); Ellison Medical Foundation(Lawrence Ellison Foundation)	Electron microscopy was performed by M. McKee in the Microscopy Core of the Center for Systems Biology/Program in Membrane Biology at Massachusetts General Hospital (supported by NIH grants DK43351 and DK57521). We thank E. Hartwieg and G. Voeltz for discussions regarding the interpretation of electron microscopy images. We thank T. Stiernagle and the Caenorhabditis Genetics Center (supported by the NIH), and S. Mitani and the National Bioresource Project of Japan for strains. T. K. was supported by summer research fellowships from the Howard Hughes Medical Institute. This work was supported by NIH grant R01-GM084477, a Career Award in the Biomedical Sciences from the Burroughs Wellcome Fund, and an Ellison Medical Foundation New Scholar Award (to D. H. K.).	Bischof LJ, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000176; BRENNER S, 1974, GENETICS, V77, P71; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cox JS, 1996, CELL, V87, P391, DOI 10.1016/S0092-8674(00)81360-4; Dong C, 2002, ANNU REV IMMUNOL, V20, P55, DOI 10.1146/annurev.immunol.20.091301.131133; Hoogewijs D, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-9; Iwakoshi NN, 2003, NAT IMMUNOL, V4, P321, DOI 10.1038/ni907; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kaser A, 2008, CELL, V134, P743, DOI 10.1016/j.cell.2008.07.021; Kaufman RJ, 2002, NAT REV MOL CELL BIO, V3, P411, DOI 10.1038/nrm829; Kim DH, 2004, P NATL ACAD SCI USA, V101, P10990, DOI 10.1073/pnas.0403546101; Kim DH, 2002, SCIENCE, V297, P623, DOI 10.1126/science.1073759; Mori K, 1996, GENES CELLS, V1, P803, DOI 10.1046/j.1365-2443.1996.d01-274.x; Pocock R, 2008, NAT NEUROSCI, V11, P894, DOI 10.1038/nn.2152; Pujol N, 2001, CURR BIOL, V11, P809, DOI 10.1016/S0960-9822(01)00241-X; RAHME LG, 1995, SCIENCE, V268, P1899, DOI 10.1126/science.7604262; Reddy KC, 2009, SCIENCE, V323, P382, DOI 10.1126/science.1166527; Reimold AM, 2001, NATURE, V412, P300, DOI 10.1038/35085509; Rual JF, 2004, GENOME RES, V14, P2162, DOI 10.1101/gr.2505604; Rutkowski DT, 2006, PLOS BIOL, V4, P2024, DOI 10.1371/journal.pbio.0040374; Schroder M, 2005, ANNU REV BIOCHEM, V74, P739, DOI 10.1146/annurev.biochem.73.011303.074134; Shapira M, 2006, P NATL ACAD SCI USA, V103, P14086, DOI 10.1073/pnas.0603424103; Shen XH, 2005, PLOS GENET, V1, P355, DOI 10.1371/journal.pgen.0010037; Shen XH, 2001, CELL, V107, P893, DOI 10.1016/S0092-8674(01)00612-2; Shivers RP, 2009, CELL HOST MICROBE, V6, P321, DOI 10.1016/j.chom.2009.09.001; Styer KL, 2008, SCIENCE, V322, P460, DOI 10.1126/science.1163673; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Todd DJ, 2008, NAT REV IMMUNOL, V8, P663, DOI 10.1038/nri2359; Troemel ER, 2006, PLOS GENET, V2, P1725, DOI 10.1371/journal.pgen.0020183; Troemel ER, 2008, PLOS BIOL, V6, P2736, DOI 10.1371/journal.pbio.0060309; Willems E, 2008, ANAL BIOCHEM, V379, P127, DOI 10.1016/j.ab.2008.04.036; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Zhang KZ, 2006, CELL, V124, P587, DOI 10.1016/j.cell.2005.11.040; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	35	209	221	3	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1092	U114		10.1038/nature08762	http://dx.doi.org/10.1038/nature08762			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182512	Green Submitted, Green Accepted			2022-12-01	WOS:000275108400039
J	Messina, G; Biressi, S; Monteverde, S; Magli, A; Cassano, M; Perani, L; Roncaglia, E; Tagliafico, E; Starnes, L; Campbell, CE; Grossi, M; Goldhamer, DJ; Gronostajski, RM; Cossu, G				Messina, Graziella; Biressi, Stefano; Monteverde, Stefania; Magli, Alessandro; Cassano, Marco; Perani, Laura; Roncaglia, Elena; Tagliafico, Enrico; Starnes, Linda; Campbell, Christine E.; Grossi, Milena; Goldhamer, David J.; Gronostajski, Richard M.; Cossu, Giulio			Nfix Regulates Fetal-Specific Transcription in Developing Skeletal Muscle	CELL			English	Article							NUCLEAR-FACTOR-I; GENE-EXPRESSION; BETA-GLOBIN; ENHANCER; BINDING; PROTEIN; PROGENITORS; DOWNSTREAM; INTERACTS; MYOBLASTS	Skeletal myogenesis, like hematopoiesis, occurs in successive developmental stages that involve different cell populations and expression of different genes. We show here that the transcription factor nuclear factor one X (Nfix), whose expression is activated by Pax7 in fetal muscle, in turn activates the transcription of fetal specific genes such as MCK and beta-enolase while repressing embryonic genes such as slow myosin. In the case of the MCK promoter, Nfix forms a complex with PKC theta that binds, phosphorylates, and activates MEF2A. Premature expression of Nfix activates fetal and suppresses embryonic genes in embryonic muscle, whereas muscle-specific ablation of Nfix prevents fetal and maintains embryonic gene expression in the fetus. Therefore, Nfix acts as a transcriptional switch from embryonic to fetal myogenesis.	[Messina, Graziella; Monteverde, Stefania; Perani, Laura; Cossu, Giulio] Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy; [Messina, Graziella; Cossu, Giulio] Univ Milan, Dept Biol, I-20133 Milan, Italy; [Biressi, Stefano] Stanford Univ, Dept Neurol & Neurol Sci, Sch Med, Stanford, CA 94305 USA; [Magli, Alessandro; Roncaglia, Elena; Tagliafico, Enrico] Univ Modena & Reggio Emilia, Dept Biomed Sci, I-41125 Modena, Italy; [Cassano, Marco] KULeuven, Stem Cell Inst Leuven, B-3000 Louvain, Belgium; [Starnes, Linda] Univ Roma La Sapienza, Dept Histol & Med Embryol, I-00161 Rome, Italy; [Campbell, Christine E.; Gronostajski, Richard M.] SUNY Buffalo, Dept Biochem, New York State Ctr Excellence Bioinformat & Life, Dev Genom Grp,Program Neurosci, Buffalo, NY 14214 USA; [Grossi, Milena] Univ Roma La Sapienza, Dept Cell & Dev Biol, I-00185 Rome, Italy; [Goldhamer, David J.] Univ Connecticut, Dept Mol & Cell Biol, Ctr Regenerat Biol, Storrs, CT 06269 USA	Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; University of Milan; Stanford University; Universita di Modena e Reggio Emilia; KU Leuven; Sapienza University Rome; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Sapienza University Rome; University of Connecticut	Cossu, G (corresponding author), Ist Sci San Raffaele, Div Regenerat Med, I-20132 Milan, Italy.	cossu.giulio@hsr.it	Perani, Laura/AAN-2838-2020; Magli, Alessandro/K-5961-2019; Messina, Graziella/A-1469-2014; Tagliafico, Enrico/C-9079-2009; Cassano, Marco/T-3473-2019; Biressi, Stefano/AAD-8956-2020	Perani, Laura/0000-0001-8616-3377; Magli, Alessandro/0000-0003-3874-2838; Messina, Graziella/0000-0001-8189-0727; Tagliafico, Enrico/0000-0003-0981-2542; Cassano, Marco/0000-0002-8526-1319; Cossu, Giulio/0000-0001-5863-9593; Starnes, Linda/0000-0002-7322-9928; Gronostajski, Richard/0000-0003-4264-208X; Biressi, Stefano Augusto Maria/0000-0001-8631-3419	EC; ERC; Ministry of Research (FIRB) and of Health; Telethon; AFM; Fondazione Roma; Duchenne Parent Project (Italy); NASA [NNJ06HA59]; NIHLBI [H080624]; NIH [AR052777]; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR052777] Funding Source: NIH RePORTER	EC(European CommissionEuropean Commission Joint Research Centre); ERC(European Research Council (ERC)European Commission); Ministry of Research (FIRB) and of Health; Telethon(Fondazione Telethon); AFM(Association Francaise contre les Myopathies); Fondazione Roma(Fondazione RomaEuropean Commission); Duchenne Parent Project (Italy); NASA(National Aeronautics & Space Administration (NASA)); NIHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by grants from EC (Optistem, Angioscaff), ERC, Ministry of Research (FIRB) and of Health, Telethon, AFM, Fondazione Roma, and the Duchenne Parent Project (Italy). R. M. G. and C. E. C. were supported by grants from NASA (NNJ06HA59) and NIHLBI (H080624). D.J.G. was supported by grant from the NIH (AR052777). We thank C. Bonfanti, S. Benedetti, A. Innocenzi, A. Dellavalle, G. Cusella-De Angelis, M. Bouche', S. Molinari, F. Cotelli, L. Del Giacco, A. Pistocchi, L. Jovine, M. Sampaolesi, and C. Nervi for help and discussion; C. Bachurski for the NFI-Engrailed construct; S. Schiaffino for the NFATc4 plasmid; and M. Buckingham and S. Tajbakhsh for critical reading of this manuscript. We also thank A. Palini for the cell sorting, the Centre for Conditional Mutagenesis (CFCM), and C. Panzeri (ALEMBIC) for the electron microscopy.	Bachurski CJ, 2003, MOL CELL BIOL, V23, P9014, DOI 10.1128/MCB.23.24.9014-9024.2003; Biressi S, 2007, DEV BIOL, V308, P281, DOI 10.1016/j.ydbio.2007.06.006; Biressi S, 2007, DEV BIOL, V304, P633, DOI 10.1016/j.ydbio.2007.01.016; Calabria E, 2009, P NATL ACAD SCI USA, V106, P13335, DOI 10.1073/pnas.0812911106; Campbell CE, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-52; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chaudhry AZ, 1998, J BIOL CHEM, V273, P18538, DOI 10.1074/jbc.273.29.18538; Chaudhry AZ, 1997, DEV DYNAM, V208, P313; Chen JCJ, 2005, GENESIS, V41, P116, DOI 10.1002/gene.20104; das Neves L, 1999, P NATL ACAD SCI USA, V96, P11946, DOI 10.1073/pnas.96.21.11946; Driller K, 2007, MOL CELL BIOL, V27, P3855, DOI 10.1128/MCB.02293-06; FEO S, 1995, MOL CELL BIOL, V15, P5991; Ferrari S, 1997, CELL GROWTH DIFFER, V8, P23; FUNK WD, 1992, P NATL ACAD SCI USA, V89, P9484, DOI 10.1073/pnas.89.20.9484; GEORGEWEINSTEIN M, 1993, DEV BIOL, V156, P209, DOI 10.1006/dbio.1993.1071; Gillis TE, 2007, PHYSIOL GENOMICS, V32, P16, DOI 10.1152/physiolgenomics.00197.2007; Gronostajski RM, 2000, GENE, V249, P31, DOI 10.1016/S0378-1119(00)00140-2; GUNNING P, 1991, FASEB J, V5, P3064, DOI 10.1096/fasebj.5.15.1835946; Hutcheson DA, 2009, GENE DEV, V23, P997, DOI 10.1101/gad.1769009; Jiang P, 2002, DEV BIOL, V243, P281, DOI 10.1006/dbio.2002.0574; Johanson M, 1999, BIOCHEM BIOPH RES CO, V265, P222, DOI 10.1006/bbrc.1999.1390; JOSTES B, 1990, MECH DEVELOP, V33, P27, DOI 10.1016/0925-4773(90)90132-6; Kassar-Duchossoy L, 2004, NATURE, V431, P466, DOI 10.1038/nature02876; Kaufmann U, 1999, J CELL SCI, V112, P55; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; KRUSE U, 1991, NUCLEIC ACIDS RES, V19, P6641, DOI 10.1093/nar/19.23.6641; LIU JP, 1993, CELL, V75, P59, DOI 10.1016/0092-8674(93)90679-K; Messina G, 2005, MOL BIOL CELL, V16, P1469, DOI 10.1091/mbc.E04-07-0612; Molinari S, 2004, MOL CELL BIOL, V24, P2944, DOI 10.1128/MCB.24.7.2944-2957.2004; Palstra RJ, 2008, ADV GENET, V61, P107, DOI 10.1016/S0065-2660(07)00004-1; Peterson KR, 2003, CURR OPIN HEMATOL, V10, P123, DOI 10.1097/00062752-200303000-00004; Saka Y, 2008, METHODS, V45, P192, DOI 10.1016/j.ymeth.2008.06.005; Seale P, 2000, CELL, V102, P777, DOI 10.1016/S0092-8674(00)00066-0; Siedner S, 2003, J PHYSIOL-LONDON, V548, P493, DOI 10.1113/JPHYSIOL.2002.036509; Starnes LM, 2009, BLOOD, V114, P1753, DOI 10.1182/blood-2008-12-196196; Steele-Perkins G, 2005, MOL CELL BIOL, V25, P685, DOI 10.1128/MCB.25.2.685-698.2005; Steele-Perkins G, 2003, MOL CELL BIOL, V23, P1075, DOI 10.1128/MCB.23.3.1075-1084.2003; STOCKDALE FE, 1992, DEV BIOL, V154, P284, DOI 10.1016/0012-1606(92)90068-R; Zappelli F, 1996, DEV BIOL, V180, P156, DOI 10.1006/dbio.1996.0292	39	127	128	1	25	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					554	566		10.1016/j.cell.2010.01.027	http://dx.doi.org/10.1016/j.cell.2010.01.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178747	Bronze			2022-12-01	WOS:000274668400018
J	Gebbers, R; Adamchuk, VI				Gebbers, Robin; Adamchuk, Viacheslav I.			Precision Agriculture and Food Security	SCIENCE			English	Editorial Material								Precision agriculture comprises a set of technologies that combines sensors, information systems, enhanced machinery, and informed management to optimize production by accounting for variability and uncertainties within agricultural systems. Adapting production inputs site-specifically within a field and individually for each animal allows better use of resources to maintain the quality of the environment while improving the sustainability of the food supply. Precision agriculture provides a means to monitor the food production chain and manage both the quantity and quality of agricultural produce.	[Gebbers, Robin] Leibniz Inst Agr Engn ATB, Dept Agr Engn, D-14469 Potsdam, Germany; [Adamchuk, Viacheslav I.] Univ Nebraska, Dept Biol Syst Engn, Lincoln, NE 68583 USA	Leibniz Institut fur Agrartechnik und Biookonomie (ATB); University of Nebraska System; University of Nebraska Lincoln	Gebbers, R (corresponding author), Leibniz Inst Agr Engn ATB, Dept Agr Engn, Max Eyth Allee 100, D-14469 Potsdam, Germany.	rgebbers@atb-potsdam.de						Adamchuk VI, 2004, COMPUT ELECTRON AGR, V44, P71, DOI 10.1016/j.compag.2004.03.002; [Anonymous], 2006, HDB PRECISION AGR; BAURIEGEL E, 2009, PRECISION AGR 09, P203; Frazier B. E., 1997, The state of site specific management for agriculture., P149; Griffin T. W., 2005, Revista de Politica Agricola, V14, P20; Heege HJ, 2008, PRECIS AGRIC, V9, P115, DOI 10.1007/s11119-008-9055-3; Heraud J. A., 2009, ASABE DISTINGUISHED, V33, P1; IPEMA, 2009, PRECISION LIVESTOCK, P135; Maltz E, 2009, PRECISION LIVESTOCK, P17; McBratney Alex, 2005, Precision Agriculture, V6, P7, DOI 10.1007/s11119-005-0681-8; MOORE M, 1998, THESIS SILSOE COLL C; Pierce FJ, 1999, ADV AGRON, V67, P1, DOI 10.1016/S0065-2113(08)60513-1; Robert PC, 2002, PLANT SOIL, V247, P143, DOI 10.1023/A:1021171514148; Stafford J. V., 2006, HDB PRECISION AGR, P19; van Henten E.J., 2009, PRECISION AGR 09	15	548	573	21	298	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					828	831		10.1126/science.1183899	http://dx.doi.org/10.1126/science.1183899			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150492				2022-12-01	WOS:000274408300049
J	Grossman, SR; Shylakhter, I; Karlsson, EK; Byrne, EH; Morales, S; Frieden, G; Hostetter, E; Angelino, E; Garber, M; Zuk, O; Lander, ES; Schaffner, SF; Sabeti, PC				Grossman, Sharon R.; Shylakhter, Ilya; Karlsson, Elinor K.; Byrne, Elizabeth H.; Morales, Shannon; Frieden, Gabriel; Hostetter, Elizabeth; Angelino, Elaine; Garber, Manuel; Zuk, Or; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.			A Composite of Multiple Signals Distinguishes Causal Variants in Regions of Positive Selection	SCIENCE			English	Article								The human genome contains hundreds of regions whose patterns of genetic variation indicate recent positive natural selection, yet for most the underlying gene and the advantageous mutation remain unknown. We developed a method, composite of multiple signals (CMS), that combines tests for multiple signals of selection and increases resolution by up to 100-fold. By applying CMS to candidate regions from the International Haplotype Map, we localized population-specific selective signals to 55 kilobases (median), identifying known and novel causal variants. CMS can not just identify individual loci but implicates precise variants selected by evolution.	[Grossman, Sharon R.; Shylakhter, Ilya; Karlsson, Elinor K.; Byrne, Elizabeth H.; Morales, Shannon; Frieden, Gabriel; Hostetter, Elizabeth; Angelino, Elaine; Sabeti, Pardis C.] Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA; [Grossman, Sharon R.; Shylakhter, Ilya; Karlsson, Elinor K.; Byrne, Elizabeth H.; Morales, Shannon; Hostetter, Elizabeth; Garber, Manuel; Zuk, Or; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Grossman, Sharon R.; Shylakhter, Ilya; Karlsson, Elinor K.; Byrne, Elizabeth H.; Morales, Shannon; Hostetter, Elizabeth; Garber, Manuel; Zuk, Or; Lander, Eric S.; Schaffner, Stephen F.; Sabeti, Pardis C.] Harvard Univ, Cambridge, MA 02142 USA; [Morales, Shannon] Mt Sinai Sch Med, New York, NY 10029 USA; [Angelino, Elaine; Lander, Eric S.; Sabeti, Pardis C.] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Lander, Eric S.] MIT, Dept Biol, Cambridge, MA 02139 USA	Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Icahn School of Medicine at Mount Sinai; Harvard University; Harvard Medical School; Massachusetts Institute of Technology (MIT)	Grossman, SR (corresponding author), Harvard Univ, Dept Organism & Evolutionary Biol, Ctr Syst Biol, Cambridge, MA 02138 USA.	shari.grossman@post.harvard.edu; ilya_shl@alum.mit.edu; psabeti@oeb.harvard.edu	Schaffner, Stephen F/D-1189-2011; Sabeti, Pardis/GQH-8610-2022	Grossman, Sharon/0000-0001-6422-1134; Schaffner, Stephen/0000-0001-6699-3568; Karlsson, Elinor/0000-0002-4343-3776	Burroughs Wellcome Foundation; Packard Foundation; American Cancer Society	Burroughs Wellcome Foundation(Burroughs Wellcome Fund); Packard Foundation(The David & Lucile Packard Foundation); American Cancer Society(American Cancer Society)	We thank K. Andersen, J. Lohmueller, B. Stranger, S. McCarroll, K. Lohmueller, K. Lindblad-Toh, M. Guttman, and J. Rinn for functional guidance, and E. Phelan, D. Altshuler, and the Sabeti Lab for helpful discussions throughout. P. C. S. is supported by the Burroughs Wellcome and Packard foundations. E. K. K. is supported by the American Cancer Society.	Ahmed ZM, 2003, HUM MOL GENET, V12, P3215, DOI 10.1093/hmg/ddg358; Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Kazmierczak P, 2007, NATURE, V449, P87, DOI 10.1038/nature06091; Lin CY, 2007, PLOS GENET, V3, P867, DOI 10.1371/journal.pgen.0030087; Park KS, 2006, J HUM GENET, V51, P85, DOI 10.1007/s10038-005-0327-8; Reiners J, 2005, HUM MOL GENET, V14, P3933, DOI 10.1093/hmg/ddi417; Sabeti PC, 2006, SCIENCE, V312, P1614, DOI 10.1126/science.1124309; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Schaffner SF, 2005, GENOME RES, V15, P1576, DOI 10.1101/gr.3709305; SHAPIRO L, 1995, NATURE, V374, P327, DOI 10.1038/374327a0; Sturm RA, 2009, HUM MOL GENET, V18, pR9, DOI 10.1093/hmg/ddp003; Teshima KM, 2006, GENOME RES, V16, P702, DOI 10.1101/gr.5105206; Thomas PD, 2003, NUCLEIC ACIDS RES, V31, P334, DOI 10.1093/nar/gkg115; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI [10.2307/2408641, 10.1111/j.1558-5646.1984.tb05657.x]; Williamson SH, 2007, PLOS GENET, V3, P901, DOI 10.1371/journal.pgen.0030090	17	346	359	1	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					883	886		10.1126/science.1183863	http://dx.doi.org/10.1126/science.1183863			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20056855	Green Submitted			2022-12-01	WOS:000274408300067
J	Blumenthal, K; Volpp, KG				Blumenthal, Karen; Volpp, Kevin G.			Enhancing the Effectiveness of Food Labeling in Restaurants	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INFORMATION; CHOICES		[Blumenthal, Karen; Volpp, Kevin G.] Univ Penn, Ctr Hlth Incent, Leonard Davis Inst Hlth Econ, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Univ Penn, Dept Hlth Care Management, Wharton Sch, Philadelphia, PA 19104 USA; [Blumenthal, Karen; Volpp, Kevin G.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Volpp, Kevin G.] Philadelphia Vet Affairs Med Ctr, Ctr Hlth Equ Res & Promot, Philadelphia, PA USA	University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; US Department of Veterans Affairs; Veterans Health Administration (VHA); University of Pennsylvania; Pennsylvania Medicine; Philadelphia Veterans Affairs Medical Center	Volpp, KG (corresponding author), Univ Penn, Ctr Hlth Incent, Leonard Davis Inst Hlth Econ, 1232 Blockley Hall,423 Guardian Dr, Philadelphia, PA 19104 USA.	volpp70@wharton.upenn.edu		Volpp, Kevin/0000-0003-1423-4599				Downs J. S., 2009, NY TIMES, pA31; Downs JS, 2009, AM ECON REV, V99, P159, DOI 10.1257/aer.99.2.159; Elbel B, 2009, HEALTH AFFAIR, V28, pW1110, DOI 10.1377/hlthaff.28.6.w1110; Fagotto E., 2007, ISSUES SCI TECHNOL, V23, P73; Fitch RC, 2009, AM J HEALTH PROMOT, V24, P129, DOI 10.4278/ajhp.08031426; Harnack LJ, 2008, INT J BEHAV NUTR PHY, V5, DOI 10.1186/1479-5868-5-63; Lando AM, 2007, J NUTR EDUC BEHAV, V39, P157, DOI 10.1016/j.jneb.2006.12.010; Loewenstein G, 2007, JAMA-J AM MED ASSOC, V298, P2415, DOI 10.1001/jama.298.20.2415; Rothman RL, 2006, AM J PREV MED, V31, P391, DOI 10.1016/j.amepre.2006.07.025; THALER RH, 1981, J POLIT ECON, V89, P392, DOI 10.1086/260971	10	39	40	0	14	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					553	554		10.1001/jama.2010.85	http://dx.doi.org/10.1001/jama.2010.85			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145233				2022-12-01	WOS:000274378700028
J	Smith, RJ; Okano, JT; Kahn, JS; Bodine, EN; Blower, S				Smith, Robert J.; Okano, Justin T.; Kahn, James S.; Bodine, Erin N.; Blower, Sally			Evolutionary Dynamics of Complex Networks of HIV Drug-Resistant Strains: The Case of San Francisco	SCIENCE			English	Article							ACQUIRED-IMMUNODEFICIENCY-SYNDROME; ACTIVE ANTIRETROVIRAL THERAPY; FAILING THERAPY; MENS HEALTH; ZIDOVUDINE; TRANSMISSION; MUTATIONS; INFECTION; SENSITIVITY; LAMIVUDINE	Over the past two decades, HIV resistance to antiretroviral drugs (ARVs) has risen to high levels in the wealthier countries of the world, which are able to afford widespread treatment. We have gained insights into the evolution and transmission dynamics of ARV resistance by designing a biologically complex multistrain network model. With this model, we traced the evolutionary history of ARV resistance in San Francisco and predict its future dynamics. By using classification and regression trees, we identified the key immunologic, virologic, and treatment factors that increase ARV resistance. Our modeling shows that 60% of the currently circulating ARV-resistant strains in San Francisco are capable of causing self-sustaining epidemics, because each individual infected with one of these strains can cause, on average, more than one new resistant infection. It is possible that a new wave of ARV-resistant strains that pose a substantial threat to global public health is emerging.	[Smith, Robert J.; Okano, Justin T.; Bodine, Erin N.; Blower, Sally] Univ Calif Los Angeles, David Geffen Sch Med, Ctr Biomed Modeling, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA; [Kahn, James S.] Univ Calif San Francisco, Dept Med, Div Aids, San Francisco, CA 94110 USA	University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California San Francisco	Blower, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Ctr Biomed Modeling, Semel Inst Neurosci & Human Behav, Los Angeles, CA 90024 USA.	sblower@mednet.ucla.edu		Smith?, Stacey/0000-0002-6529-3321; Bodine, Erin/0000-0001-7885-1233; Okano, Justin/0000-0002-2476-9370	National Institute of Allergy and Infectious Diseases (NIAID) [RO1 AI041935, P30-AI27763]; Natural Sciences and Engineering Research Council of Canada; Mathematics of Information Technology and Complex Systems; John Simon Guggenheim Foundation; National Academies Keck Foundation; Semel Institute for Neuroscience Human Behavior; NCRR [K24RR024369]; AHRQ [R18-HS017784]; AGENCY FOR HEALTHCARE RESEARCH AND QUALITY [R18HS017784] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [K24RR024369] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P30AI027763, R01AI041935] Funding Source: NIH RePORTER; AHRQ [5R18HS017784-02] Funding Source: Federal RePORTER	National Institute of Allergy and Infectious Diseases (NIAID)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Mathematics of Information Technology and Complex Systems; John Simon Guggenheim Foundation; National Academies Keck Foundation; Semel Institute for Neuroscience Human Behavior; NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); AGENCY FOR HEALTHCARE RESEARCH AND QUALITY(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); AHRQ(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality)	R.J.S., J.T.O., E.N.B., and S. B. acknowledge the financial support of the National Institute of Allergy and Infectious Diseases (NIAID) (RO1 AI041935). R.J.S. is supported by a Natural Sciences and Engineering Research Council of Canada discovery grant, an Early Researcher award, and funding from Mathematics of Information Technology and Complex Systems. In addition, S. B. acknowledges the John Simon Guggenheim Foundation, the National Academies Keck Foundation, and the Semel Institute for Neuroscience & Human Behavior. J.S.K. acknowledges NIAID grants P30-AI27763, NCRR K24RR024369, and AHRQ R18-HS017784. We thank R. Breban, D. Freimer, J. Freimer, N. Freimer, N. Jewell, E. Kajita, T. Pylko, V. Supervie, and R. Vardavas for useful discussions throughout the course of this research.	BLOWER SM, 1994, INT STAT REV, V62, P229, DOI 10.2307/1403510; Blower SM, 2000, SCIENCE, V287, P650, DOI 10.1126/science.287.5453.650; Booth CL, 2007, J ANTIMICROB CHEMOTH, V59, P1047, DOI 10.1093/jac/dkm082; Breimann L, 1984, CLASSIFICATION REGRE; Darwin C, 2003, ORIGIN SPECIES; ERON JJ, 1995, NEW ENGL J MED, V333, P1662, DOI 10.1056/NEJM199512213332502; Goudsmit J, 2001, AIDS, V15, P2293, DOI 10.1097/00002030-200111230-00011; Granich RM, 2009, LANCET, V373, P48, DOI 10.1016/S0140-6736(08)61697-9; Hammer SM, 2008, JAMA-J AM MED ASSOC, V300, P555, DOI 10.1001/jama.300.5.555; Kandathil AJ, 2009, INDIAN J MED MICROBI, V27, P231, DOI 10.4103/0255-0857.53205; Katlama C, 1996, JAMA-J AM MED ASSOC, V276, P118, DOI 10.1001/jama.276.2.118; Kuritzkes DR, 2004, AIDS PATIENT CARE ST, V18, P259, DOI 10.1089/108729104323076007; LANG W, 1987, JAMA-J AM MED ASSOC, V257, P326, DOI 10.1001/jama.257.3.326; LANG W, 1991, J ACQ IMMUN DEF SYND, V4, P713; LANG W, 1993, J ACQ IMMUN DEF SYND, V6, P191; LARDER BA, 1989, SCIENCE, V243, P1731, DOI 10.1126/science.2467383; Louie JK, 2002, J INFECT DIS, V186, P1023, DOI 10.1086/343862; Martinez-Picado J, 2008, VIRUS RES, V134, P104, DOI 10.1016/j.virusres.2007.12.021; Phillips A, 2001, NAT MED, V7, P993, DOI 10.1038/nm0901-993; Powers KA, 2008, LANCET INFECT DIS, V8, P553, DOI 10.1016/S1473-3099(08)70156-7; Ross L, 2008, AIDS RES HUM RETROV, V24, P617, DOI 10.1089/aid.2007.0188; Schmit JC, 1998, AIDS, V12, P2007, DOI 10.1097/00002030-199815000-00012; Taylor BS, 2008, NEW ENGL J MED, V358, P1590, DOI 10.1056/NEJMra0706737; Tchetgen E, 2001, J ACQ IMMUN DEF SYND, V26, P118, DOI 10.1097/00126334-200102010-00003; Truong HHA, 2006, AIDS, V20, P2193, DOI 10.1097/01.aids.0000252059.85236.af; Vardavas R, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000152; WINKELSTEIN W, 1987, JAMA-J AM MED ASSOC, V257, P321, DOI 10.1001/jama.257.3.321; Zaric GS, 1998, SIMULATION, V71, P262, DOI 10.1177/003754979807100406	28	94	106	4	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					697	701		10.1126/science.1180556	http://dx.doi.org/10.1126/science.1180556			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20075214				2022-12-01	WOS:000274251800040
J	Stiess, M; Maghelli, N; Kapitein, LC; Gomis-Ruth, S; Wilsch-Brauninger, M; Hoogenraad, CC; Tolic-Norrelykke, IM; Bradke, F				Stiess, Michael; Maghelli, Nicola; Kapitein, Lukas C.; Gomis-Rueth, Susana; Wilsch-Braeuninger, Michaela; Hoogenraad, Casper C.; Tolic-Norrelykke, Iva M.; Bradke, Frank			Axon Extension Occurs Independently of Centrosomal Microtubule Nucleation	SCIENCE			English	Article							GAMMA-TUBULIN; NEURONAL CENTROSOME; POLARIZATION; POLARITY; COMPLEX; CELL; CYTOSKELETON; PLASTICITY; DENDRITES; TRANSPORT	Microtubules are polymeric protein structures and components of the cytoskeleton. Their dynamic polymerization is important for diverse cellular functions. The centrosome is the classical site of microtubule nucleation and is thought to be essential for axon growth and neuronal differentiation-processes that require microtubule assembly. We found that the centrosome loses its function as a microtubule organizing center during development of rodent hippocampal neurons. Axons still extended and regenerated through acentrosomal microtubule nucleation, and axons continued to grow after laser ablation of the centrosome in early neuronal development. Thus, decentralized microtubule assembly enables axon extension and regeneration, and, after axon initiation, acentrosomal microtubule nucleation arranges the cytoskeleton, which is the source of the sophisticated morphology of neurons.	[Stiess, Michael; Gomis-Rueth, Susana; Bradke, Frank] Max Planck Inst Neurobiol, Independent Jr Res Grp Axonal Growth & Regenerat, D-82152 Martinsried, Germany; [Maghelli, Nicola; Wilsch-Braeuninger, Michaela; Tolic-Norrelykke, Iva M.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Kapitein, Lukas C.; Hoogenraad, Casper C.] Erasmus MC, Dept Neurosci, NL-3015 GE Rotterdam, Netherlands	Max Planck Society; Max Planck Society; Erasmus University Rotterdam; Erasmus MC	Bradke, F (corresponding author), Max Planck Inst Neurobiol, Independent Jr Res Grp Axonal Growth & Regenerat, Klopferspitz 18, D-82152 Martinsried, Germany.	fbradke@neuro.mpg.de	Stiess, Michael/ABF-9835-2020; Kapitein, Lukas C/J-4776-2016; Hoogenraad, Casper/B-8866-2011; Tolić, Iva/F-1704-2014	Stiess, Michael/0000-0001-5363-0389; Kapitein, Lukas C/0000-0001-9418-6739; Hoogenraad, Casper/0000-0002-2666-0758; Tolić, Iva/0000-0003-1305-7922; Bradke, Frank/0000-0002-0345-3772; Maghelli, Nicola/0000-0001-8450-8271	Erasmus Medical Center; Netherlands Organization for Scientific Research; Netherlands Organization for Health Research and Development; European Science Foundation (ESF-EURYI); Human Frontier Science Program; Max Planck Society; International Foundation for Research in Paraplegia; Deutsche Forschungsgemeinschaft	Erasmus Medical Center; Netherlands Organization for Scientific Research(Netherlands Organization for Scientific Research (NWO)); Netherlands Organization for Health Research and Development(Netherlands Organization for Health Research and Development); European Science Foundation (ESF-EURYI)(European Science Foundation (ESF)); Human Frontier Science Program(Human Frontier Science Program); Max Planck Society(Max Planck Society); International Foundation for Research in Paraplegia; Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank L. Meyn, N. Keijzer, and M. Kuijpers for preparing hippocampal neurons; M. Braun for electron microscopy; T. Gollisch and D. Neukirchen for critically reading the manuscript; W. B. Huttner for his support; P. Gordon-Weeks, R. Klein, J. Kleylein-Sohn, E. Nigg, O. Stemmann, and G. Tavosanis for discussions; and A. Khodjakov, M. Distel, R. Koster, E. Nigg, and J. Salisbury for sharing antibodies and plasmids. Supported by the Erasmus Medical Center and the Netherlands Organization for Scientific Research (L. C. K.), the Netherlands Organization for Health Research and Development, the European Science Foundation (ESF-EURYI) (C. C. H.), a Career Development Award from the Human Frontier Science Program (F. B. and C. C. H.), the Max Planck Society, the International Foundation for Research in Paraplegia, and the Deutsche Forschungsgemeinschaft (F. B.).	AHMAD FJ, 1994, NEURON, V12, P271, DOI 10.1016/0896-6273(94)90270-4; Ahmad FJ, 1998, J CELL BIOL, V140, P391, DOI 10.1083/jcb.140.2.391; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Baas PW, 2005, TRENDS CELL BIOL, V15, P518, DOI 10.1016/j.tcb.2005.08.004; Bartolini F, 2006, J CELL SCI, V119, P4155, DOI 10.1242/jcs.03227; Basto R, 2006, CELL, V125, P1375, DOI 10.1016/j.cell.2006.05.025; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; Doxsey S, 2005, ANNU REV CELL DEV BI, V21, P411, DOI 10.1146/annurev.cellbio.21.122303.120418; Gomis-Ruth S, 2008, CURR BIOL, V18, P992, DOI 10.1016/j.cub.2008.06.026; Haren L, 2006, J CELL BIOL, V172, P505, DOI 10.1083/jcb.200510028; Higginbotham HR, 2007, TRENDS NEUROSCI, V30, P276, DOI 10.1016/j.tins.2007.04.001; Jaworski J, 2009, NEURON, V61, P85, DOI 10.1016/j.neuron.2008.11.013; Khodjakov A, 2000, CURR BIOL, V10, P59, DOI 10.1016/S0960-9822(99)00276-6; Kimura T, 2005, J NEUROCHEM, V93, P1371, DOI 10.1111/j.1471-4159.2005.03063.x; Li R, 2008, NAT REV MOL CELL BIO, V9, P860, DOI 10.1038/nrm2522; Luders J, 2006, NAT CELL BIOL, V8, P137, DOI 10.1038/ncb1349; Luders J, 2007, NAT REV MOL CELL BIO, V8, P161, DOI 10.1038/nrm2100; Ma YT, 2004, CURR BIOL, V14, P725, DOI 10.1016/j.cub.2004.03.061; Maghelli N, 2008, J BIOPHOTONICS, V1, P299, DOI 10.1002/jbio.200810026; TANAKA E, 1995, J CELL BIOL, V128, P139, DOI 10.1083/jcb.128.1.139; Tang CJC, 2009, NAT CELL BIOL, V11, P825, DOI 10.1038/ncb1889; Terada S, 2000, CELL, V103, P141, DOI 10.1016/S0092-8674(00)00094-5; Wang L, 2002, CURR BIOL, V12, P1496, DOI 10.1016/S0960-9822(02)01078-3; Wang XQ, 2009, NATURE, V461, P947, DOI 10.1038/nature08435; Wiese C, 2006, J CELL SCI, V119, P4143, DOI 10.1242/jcs.03226; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; YU WQ, 1993, J CELL BIOL, V122, P349, DOI 10.1083/jcb.122.2.349; Zmuda JF, 1998, CELL MOTIL CYTOSKEL, V41, P18, DOI 10.1002/(SICI)1097-0169(1998)41:1<18::AID-CM2>3.0.CO;2-B; Zolessi FR, 2006, NEURAL DEV, V1, DOI 10.1186/1749-8104-1-2	30	190	192	0	21	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					704	707		10.1126/science.1182179	http://dx.doi.org/10.1126/science.1182179			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20056854				2022-12-01	WOS:000274251800042
J	Shelly, M; Lim, BK; Cancedda, L; Heilshorn, SC; Gao, HF; Poo, MM				Shelly, Maya; Lim, Byung Kook; Cancedda, Laura; Heilshorn, Sarah C.; Gao, Hongfeng; Poo, Mu-ming			Local and Long-Range Reciprocal Regulation of cAMP and cGMP in Axon/Dendrite Formation	SCIENCE			English	Article							DETERMINES NEURONAL POLARITY; AXON FORMATION; HIPPOCAMPAL-NEURONS; SAD KINASES; CYCLIC-AMP; IN-VIVO; POLARIZATION; GROWTH; MODULATION; MECHANISMS	Cytosolic cyclic adenosine monophosphate (cAMP) and cyclic guanosine monophosphate (cGMP) often mediate antagonistic cellular actions of extracellular factors, from the regulation of ion channels to cell volume control and axon guidance. We found that localized cAMP and cGMP activities in undifferentiated neurites of cultured hippocampal neurons promote and suppress axon formation, respectively, and exert opposite effects on dendrite formation. Fluorescence resonance energy transfer imaging showed that alterations of the amount of cAMP resulted in opposite changes in the amount of cGMP, and vice versa, through the activation of specific phosphodiesterases and protein kinases. Local elevation of cAMP in one neurite resulted in cAMP reduction in all other neurites of the same neuron. Thus, local and long-range reciprocal regulation of cAMP and cGMP together ensures coordinated development of one axon and multiple dendrites.	[Shelly, Maya; Lim, Byung Kook; Cancedda, Laura; Heilshorn, Sarah C.; Gao, Hongfeng; Poo, Mu-ming] Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA; [Cancedda, Laura] Italian Inst Technol, Dept Neurosci & Brain Technol, I-16163 Genoa, Italy	University of California System; University of California Berkeley; Istituto Italiano di Tecnologia - IIT	Poo, MM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, Div Neurobiol, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA.	mpoo@uclink.berkeley.edu		Lim, Byungkook/0000-0002-3766-5415; Cancedda, Laura/0000-0003-0566-057X; Heilshorn, Sarah/0000-0002-9801-6304; shelly, maya/0000-0002-2211-1751	National Institutes of Health [NS-22764]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS022764] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank R. Thakar, S. Li, M. Nasir, and D. Liepmann (University of California at Berkeley) for help with poly(dimethylsiloxane) microfluidic molds; J. Zhang (Johns Hopkins University) for the ICUE and AKAR FRET probes; M. J. Lohse (University of Wurzburg) for the cGES-DE5 FRET probe; M. Feller and S. Pautot (University of California at Berkeley) for advice on FRET imaging and bead coating; and M. Hung for help with culture preparations. This work was supported in part by a grant from the National Institutes of Health (NS-22764).	Adler CE, 2006, NAT NEUROSCI, V9, P511, DOI 10.1038/nn1666; Arimura N, 2007, NAT REV NEUROSCI, V8, P194, DOI 10.1038/nrn2056; Barnes AP, 2008, CURR OPIN NEUROBIOL, V18, P44, DOI 10.1016/j.conb.2008.05.003; Barnes AP, 2007, CELL, V129, P549, DOI 10.1016/j.cell.2007.03.025; Bradke F, 1999, SCIENCE, V283, P1931, DOI 10.1126/science.283.5409.1931; Buttner N, 2003, J NEUROPHYSIOL, V90, P586, DOI 10.1152/jn.00007.2003; Choi YJ, 2008, GENE DEV, V22, P2485, DOI 10.1101/gad.1685008; CRAIG AM, 1994, ANNU REV NEUROSCI, V17, P267, DOI 10.1146/annurev.neuro.17.1.267; Da Silva JS, 2005, NAT NEUROSCI, V8, P606, DOI 10.1038/nn1442; de Anda FC, 2005, NATURE, V436, P704, DOI 10.1038/nature03811; DiPilato LM, 2004, P NATL ACAD SCI USA, V101, P16513, DOI 10.1073/pnas.0405973101; DOTTI CG, 1988, J NEUROSCI, V8, P1454; Esch T, 1999, J NEUROSCI, V19, P6417; Fivaz M, 2008, CURR BIOL, V18, P44, DOI 10.1016/j.cub.2007.11.051; Gao Y, 2003, J NEUROSCI, V23, P11770; GOLDBERG DJ, 1987, DEV BIOL, V124, P35, DOI 10.1016/0012-1606(87)90456-8; Goldberg N D, 1975, Adv Cyclic Nucleotide Res, V5, P307; GOSLIN K, 1989, J CELL BIOL, V108, P1507, DOI 10.1083/jcb.108.4.1507; HARTZELL HC, 1986, NATURE, V323, P273, DOI 10.1038/323273a0; Hempel A, 1996, AM J PHYSIOL-HEART C, V270, pH1264, DOI 10.1152/ajpheart.1996.270.4.H1264; Hilliard MA, 2006, DEV CELL, V10, P379, DOI 10.1016/j.devcel.2006.01.013; Hopker VH, 1999, NATURE, V401, P69, DOI 10.1038/43441; Jacobson C, 2006, NEURON, V49, P797, DOI 10.1016/j.neuron.2006.02.005; Jiang H, 2005, CELL, V120, P123, DOI 10.1016/j.cell.2004.12.033; Kishi M, 2005, SCIENCE, V307, P929, DOI 10.1126/science.1107403; LOHOF AM, 1992, J NEUROSCI, V12, P1253; Menager C, 2004, J NEUROCHEM, V89, P109, DOI 10.1046/j.1471-4159.2004.02302.x; Menniti FS, 2006, NAT REV DRUG DISCOV, V5, P660, DOI 10.1038/nrd2058; Ming GL, 1997, NEURON, V19, P1225, DOI 10.1016/S0896-6273(00)80414-6; Nikolaev VO, 2006, NAT METHODS, V3, P23, DOI 10.1038/nmeth816; Nishiyama M, 2003, NATURE, V423, P990, DOI 10.1038/nature01751; Ossipova O, 2003, NAT CELL BIOL, V5, P889, DOI 10.1038/ncb1048; PENARASGADO C, 1994, AM J PHYSIOL-CELL PH, V267, pC1319, DOI 10.1152/ajpcell.1994.267.5.C1319; Polleux F, 2000, NATURE, V404, P567, DOI 10.1038/35007001; Saito T, 2001, DEV BIOL, V240, P237, DOI 10.1006/dbio.2001.0439; Schwamborn JC, 2004, NAT NEUROSCI, V7, P923, DOI 10.1038/nn1295; Shelly M, 2007, CELL, V129, P565, DOI 10.1016/j.cell.2007.04.012; Shi SH, 2003, CELL, V112, P63, DOI 10.1016/S0092-8674(02)01249-7; Song HJ, 1997, NATURE, V388, P275, DOI 10.1038/40864; Togashi K, 2008, NEURON, V58, P694, DOI 10.1016/j.neuron.2008.03.017; Toriyama M, 2006, J CELL BIOL, V175, P147, DOI 10.1083/jcb.200604160; Wildonger J, 2008, GENE DEV, V22, P2447, DOI 10.1101/gad.1724108; Witte H, 2008, J CELL BIOL, V180, P619, DOI 10.1083/jcb.200707042; Witte H, 2008, CURR OPIN NEUROBIOL, V18, P479, DOI 10.1016/j.conb.2008.09.019; Yoshimura T, 2005, CELL, V120, P137, DOI 10.1016/j.cell.2004.11.012; Zaccolo M, 2007, CIRC RES, V100, P1569, DOI 10.1161/CIRCRESAHA.106.144501; Zhang J, 2001, P NATL ACAD SCI USA, V98, P14997, DOI 10.1073/pnas.211566798; ZHENG JQ, 1994, J CELL BIOL, V127, P1693, DOI 10.1083/jcb.127.6.1693	48	184	191	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					547	552		10.1126/science.1179735	http://dx.doi.org/10.1126/science.1179735			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110498				2022-12-01	WOS:000274020500029
J	Heidorn, SJ; Milagre, C; Whittaker, S; Nourry, A; Niculescu-Duvas, I; Dhomen, N; Hussain, J; Reis-Filho, JS; Springer, CJ; Pritchard, C; Marais, R				Heidorn, Sonja J.; Milagre, Carla; Whittaker, Steven; Nourry, Arnaud; Niculescu-Duvas, Ion; Dhomen, Nathalie; Hussain, Jahan; Reis-Filho, Jorge S.; Springer, Caroline J.; Pritchard, Catrin; Marais, Richard			Kinase-Dead BRAF and Oncogenic RAS Cooperate to Drive Tumor Progression through CRAF	CELL			English	Article							B-RAF; K-RAS; ACTIVATION; MELANOMA; INHIBITOR; PATHWAY; HETERODIMERIZATION; MUTATIONS; MECHANISM	We describe a mechanism of tumorigenesis mediated by kinase-dead BRAF in the presence of oncogenic RAS. We show that drugs that selectively inhibit BRAF drive RAS-dependent BRAF binding to CRAF, CRAF activation, and MEK-ERK signaling. This does not occur when oncogenic BRAF is inhibited, demonstrating that BRAF inhibition per se does not drive pathway activation; it only occurs when BRAF is inhibited in the presence of oncogenic RAS. Kinase-dead BRAF mimics the effects of the BRAF-selective drugs and kinase-dead Braf and oncogenic Ras cooperate to induce melanoma in mice. Our data reveal another paradigm of BRAF-mediated signaling that promotes tumor progression. They highlight the importance of understanding pathway signaling in clinical practice and of genotyping tumors prior to administering BRAF-selective drugs, to identify patients who are likely to respond and also to identify patients who may experience adverse effects.	[Heidorn, Sonja J.; Milagre, Carla; Whittaker, Steven; Dhomen, Nathalie; Marais, Richard] Inst Canc Res, Signal Transduct Team, Sect Cell & Mol Biol, London SW3 6JB, England; [Hussain, Jahan; Pritchard, Catrin] Univ Leicester, Dept Biochem, Leicester LE1 7RH, Leics, England; [Reis-Filho, Jorge S.] Inst Canc Res, Breakthrough Breast Canc Res Ctr, London SW3 6JB, England; [Nourry, Arnaud; Niculescu-Duvas, Ion; Springer, Caroline J.] Inst Canc Res, Gene & Oncogene Targeting Team, Canc Res UK Ctr Canc Therapeut, Sutton SM2 5NG, Surrey, England	Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; University of Leicester; Royal Marsden NHS Foundation Trust; University of London; Institute of Cancer Research - UK; Cancer Research UK; University of London; Institute of Cancer Research - UK	Marais, R (corresponding author), Inst Canc Res, Signal Transduct Team, Sect Cell & Mol Biol, 237 Fulham Rd, London SW3 6JB, England.	richard.marais@icr.ac.uk	Whittaker, Steven/AAS-9874-2020	Pritchard, Catrin/0000-0003-1859-4487; Springer, Caroline/0000-0002-0650-4002; Gill, Sonja/0000-0002-7273-9053; Dhomen, Nathalie/0000-0003-1961-2173; Whittaker, Steven/0000-0001-9062-7947; Marais, Richard/0000-0001-7484-4183	Institute of Cancer Research, Cancer Research UK [C107/A10433]; Wellcome Trust [080333/Z/06/Z]; Breakthrough Breast Cancer; NHS	Institute of Cancer Research, Cancer Research UK(Cancer Research UK); Wellcome Trust(Wellcome TrustEuropean Commission); Breakthrough Breast Cancer; NHS	The Institute of Cancer Research, Cancer Research UK (C107/A10433), and the Wellcome Trust (080333/Z/06/Z) funded this work. J.S.R.-F. is funded in part by Breakthrough Breast Cancer. We acknowledge NHS funding to the NIHR Biomedical Research Centre. We thank Professor Nick Hayward (QIMR, Queensland) for D04, MM415, and MM485 cell lines; Professor Tyler Jacks (MIT, Boston) for the Kras LSL-G12D mice; Dr. Kay Savage (ICR) and Annette Lane (ICR) for technical assistance with histological and immunohistochemical preparations; and Alice Smith (ICR) for technical assistance with DNA sequencing. All ICR authors are part of a "Rewards to Inventors Scheme," which could provide financial benefit to any authors that contribute to any program that is subsequently commercialized.	[Anonymous], 1988, LAB ANIM-UK, V22, P195; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Dankort D, 2009, NAT GENET, V41, P544, DOI 10.1038/ng.356; Dhomen N, 2009, CANCER CELL, V15, P294, DOI 10.1016/j.ccr.2009.02.022; Dumaz N, 2006, CANCER RES, V66, P9483, DOI 10.1158/0008-5472.CAN-05-4227; FABIAN JR, 1994, P NATL ACAD SCI USA, V91, P5982, DOI 10.1073/pnas.91.13.5982; FLAHERTY K, 2009, J CLIN ONCOL, V27, pS15; Frye SV, 2009, NAT CHEM BIOL, V5, P448, DOI 10.1038/nchembio.f.11; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Garnett MJ, 2004, CANCER CELL, V6, P313, DOI 10.1016/j.ccr.2004.09.022; Gray-Schopfer V, 2007, NATURE, V445, P851, DOI 10.1038/nature05661; Halilovic E, 2008, CURR OPIN PHARMACOL, V8, P419, DOI 10.1016/j.coph.2008.06.014; Hall-Jackson CA, 1999, CHEM BIOL, V6, P559, DOI 10.1016/S1074-5521(99)80088-X; Ikenoue T, 2003, CANCER RES, V63, P8132; Jackson EL, 2001, GENE DEV, V15, P3243, DOI 10.1101/gad.943001; Johnson LN, 1998, FEBS LETT, V430, P1, DOI 10.1016/S0014-5793(98)00606-1; King AJ, 2006, CANCER RES, V66, P11100, DOI 10.1158/0008-5472.CAN-06-2554; Kolch W, 2000, BIOCHEM J, V351, P289, DOI 10.1042/0264-6021:3510289; MARSHALL CJ, 1995, CELL, V80, P179, DOI 10.1016/0092-8674(95)90401-8; Mason CS, 1999, EMBO J, V18, P2137, DOI 10.1093/emboj/18.8.2137; Meuwissen R, 2001, ONCOGENE, V20, P6551, DOI 10.1038/sj.onc.1204837; Montagut C, 2008, CANCER RES, V68, P4853, DOI 10.1158/0008-5472.CAN-07-6787; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schwartz GK, 2009, J CLIN ONCOL S, V27, p15s; Sebolt-Leopold JS, 1999, NAT MED, V5, P810, DOI 10.1038/10533; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Yajima I, 2006, GENESIS, V44, P34, DOI 10.1002/gene.20182	32	1104	1137	0	67	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					209	221		10.1016/j.cell.2009.12.040	http://dx.doi.org/10.1016/j.cell.2009.12.040			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141835	Green Published, hybrid			2022-12-01	WOS:000273826500012
J	Haig, AJ; Tomkins, CC				Haig, Andrew J.; Tomkins, Christy C.			Diagnosis and Management of Lumbar Spinal Stenosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							LOW-BACK-PAIN; CLINICAL-PRACTICE GUIDELINE; SYMPTOMS; SURGERY		[Haig, Andrew J.; Tomkins, Christy C.] Univ Michigan, Ann Arbor, MI 48108 USA	University of Michigan System; University of Michigan	Haig, AJ (corresponding author), Univ Michigan, 325 E Eisenhower, Ann Arbor, MI 48108 USA.	andyhaig@umich.edu	Tomkins-Lane, Christy/H-5367-2016; Haig, Andrew/B-5206-2013	Tomkins-Lane, Christy/0000-0002-0416-8965; 				Botwin Kenneth, 2007, Pain Physician, V10, P547; Chou R, 2007, ANN INTERN MED, V147, P505, DOI 10.7326/0003-4819-147-7-200710020-00008; Chou R, 2009, SPINE, V34, P1066, DOI 10.1097/BRS.0b013e3181a1390d; Deyo RA, 2005, SPINE, V30, P1441, DOI 10.1097/01.brs.0000166503.37969.8a; Drew B, 2000, J SPINAL DISORD, V13, P253, DOI 10.1097/00002517-200006000-00010; Haig AJ, 2006, ARCH PHYS MED REHAB, V87, P897, DOI 10.1016/j.apmr.2006.03.016; Haig AJ, 2007, J BONE JOINT SURG AM, V89A, P358, DOI 10.2106/JBJS.E.00704; Kalichman L, 2009, SPINE J, V9, P545, DOI 10.1016/j.spinee.2009.03.005; North American Spine Society, 2007, EV BAS CLIN GUID MUL; Yagci I, 2009, AM J PHYS MED REHAB, V88, P843, DOI 10.1097/PHM.0b013e3181b333a9	10	57	61	0	9	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					71	72		10.1001/jama.2009.1946	http://dx.doi.org/10.1001/jama.2009.1946			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051574				2022-12-01	WOS:000273296900024
J	Peng, JC; Valouev, A; Swigut, T; Zhang, JM; Zhao, YM; Sidow, A; Wysocka, J				Peng, Jamy C.; Valouev, Anton; Swigut, Tomek; Zhang, Junmei; Zhao, Yingming; Sidow, Arend; Wysocka, Joanna			Jarid2/Jumonji Coordinates Control of PRC2 Enzymatic Activity and Target Gene Occupancy in Pluripotent Cells	CELL			English	Article							EMBRYONIC STEM-CELLS; HISTONE METHYLTRANSFERASE ACTIVITY; POLYCOMB-REPRESSIVE COMPLEX-2; GENOME-WIDE ANALYSIS; DEVELOPMENTAL REGULATORS; MOUSE DEVELOPMENT; POLE BLASTOMERES; H3K4 DEMETHYLASE; XENOPUS-LAEVIS; EZH2	Polycomb Repressive Complex 2 (PRC2) regulates key developmental genes in embryonic stem (ES) cells and during development. Here we show that Jarid2/Jumonji, a protein enriched in pluripotent cells and a founding member of the Jumonji C (JmjC) domain protein family, is a PRC2 subunit in ES cells. Genome-wide ChIP-seq analyses of Jarid2, Ezh2, and Suz12 binding reveal that Jarid2 and PRC2 occupy the same genomic regions. We further show that Jarid2 promotes PRC2 recruitment to the target genes while inhibiting PRC2 histone methyltransferase activity, suggesting that it acts as a "molecular rheostat" that finely calibrates PRC2 functions at developmental genes. Using Xenopus laevis as a model we demonstrate that Jarid2 knockdown impairs the induction of gastrulation genes in blastula embryos and results in failure of differentiation. Our findings illuminate a mechanism of histone methylation regulation in pluripotent cells and during early cell-fate transitions.	[Peng, Jamy C.; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Valouev, Anton; Sidow, Arend] Stanford Univ, Sch Med, Dept Pathol, Stanford, CA 94305 USA; [Sidow, Arend] Stanford Univ, Sch Med, Dept Genet, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Zhang, Junmei] Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; [Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Chicago	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu	Peng, Jamy/N-1134-2018	Peng, Jamy/0000-0002-4043-8475; Swigut, Tomek/0000-0002-7649-6781	CIRM New Faculty [RN1005791]; W. M. Keck Distinguished Young Scholar, and Searle Scholar Awards; American Cancer Society Postdoctoral Fellowship [PF0816001DDC]; NIH [R01DK082664]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082664] Funding Source: NIH RePORTER	CIRM New Faculty; W. M. Keck Distinguished Young Scholar, and Searle Scholar Awards; American Cancer Society Postdoctoral Fellowship(American Cancer Society); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Authors thank E. Benevolenskaya for Jarid1a antibodies; G. Narlikar for nucleosomes; Y. Zhang and Y. Shi, for the PRC2 and Jarid1a expression constructs; A. Vonica for the Xbra cDNA; and E. Heard (LF2), T. Magnuson (Eed-/-), and B. Panning (E14) for ES cell lines. We thank Z. Weng, P. Lacroute, and Stanford Pathology/Genetics UHT Sequencing Initiative for sequencing ChIP libraries; A. Sun for help with Eed-FLAG line derivation; R. Bajpai and Z. Ma for advice on ES culture and HMT assay, respectively. We thank members of the Wysocka lab for discussions; and E. Duncan, E. Grow, Z. Ma, A. Ring, A. Rada, and A. Roos for comments on the manuscript. This work was supported by the CIRM New Faculty (RN1005791), W. M. Keck Distinguished Young Scholar, and Searle Scholar Awards for J.W., American Cancer Society Postdoctoral Fellowship (PF0816001DDC) for J.C.P., and NIH R01DK082664 for Y.Z.	Akkers RC, 2009, DEV CELL, V17, P425, DOI 10.1016/j.devcel.2009.08.005; Assou S, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-10; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Beissbarth T, 2004, BIOINFORMATICS, V20, P1464, DOI 10.1093/bioinformatics/bth088; Blythe SA, 2009, DEV DYNAM, V238, P1422, DOI 10.1002/dvdy.21931; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Cao R, 2004, MOL CELL, V15, P57, DOI 10.1016/j.molcel.2004.06.020; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Davisson M, 2006, MAMM GENOME, V17, P363, DOI 10.1007/s00335-006-0001-2; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Faust C, 1998, DEVELOPMENT, V125, P4495; HEASMAN J, 1984, CELL, V37, P185, DOI 10.1016/0092-8674(84)90314-3; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kim H, 2009, NUCLEIC ACIDS RES, V37, P2940, DOI 10.1093/nar/gkp149; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kimelman D, 2006, NAT REV GENET, V7, P360, DOI 10.1038/nrg1837; Klose RJ, 2007, CELL, V128, P889, DOI 10.1016/j.cell.2007.02.013; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kortschak RD, 2000, TRENDS BIOCHEM SCI, V25, P294, DOI 10.1016/S0968-0004(00)01597-8; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lan F, 2008, CURR OPIN CELL BIOL, V20, P316, DOI 10.1016/j.ceb.2008.03.004; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Lopez-Bigas N, 2008, MOL CELL, V31, P520, DOI 10.1016/j.molcel.2008.08.004; Martin C, 2006, J BIOL CHEM, V281, P8365, DOI 10.1074/jbc.M513425200; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Morin-Kensicki Elizabeth M., 2001, Genesis The Journal of Genetics and Development, V31, P142, DOI 10.1002/gene.10017; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Shirato H, 2009, J BIOL CHEM, V284, P733, DOI 10.1074/jbc.M804994200; Simon JA, 2009, NAT REV MOL CELL BIO; SNAPE A, 1987, DEV BIOL, V119, P503, DOI 10.1016/0012-1606(87)90053-4; Sun Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003406; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Takeuchi T, 2006, DEV DYNAM, V235, P2449, DOI 10.1002/dvdy.20851; Tu SJ, 2008, NAT STRUCT MOL BIOL, V15, P419, DOI 10.1038/nsmb.1400; Valouev A, 2008, NAT METHODS, V5, P829, DOI 10.1038/NMETH.1246; Zhou Q, 2007, P NATL ACAD SCI USA, V104, P16438, DOI 10.1073/pnas.0701014104	47	415	430	0	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1290	1302		10.1016/j.cell.2009.12.002	http://dx.doi.org/10.1016/j.cell.2009.12.002			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064375	Green Accepted, Bronze			2022-12-01	WOS:000273048700017
J	El-Sadr, WM; Mayer, KH; Hodder, SL				El-Sadr, Wafaa M.; Mayer, Kenneth H.; Hodder, Sally L.			AIDS in America -- Forgotten but Not Gone.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							HIV; BEHAVIORS		[El-Sadr, Wafaa M.] Columbia Univ, Int Ctr AIDS Care & Treatment Programs, Mailman Sch Publ Hlth, New York, NY 10027 USA; [El-Sadr, Wafaa M.] Columbia Univ, Dept Med, Harlem Hosp, New York, NY USA; [El-Sadr, Wafaa M.] Columbia Univ, Coll Phys & Surg, New York, NY USA; [Mayer, Kenneth H.] Fenway Inst Fenway Hlth, Boston, MA USA; [Mayer, Kenneth H.] Brown Univ, Dept Med, Providence, RI 02912 USA; [Mayer, Kenneth H.] Brown Univ, Dept Community Hlth, Providence, RI 02912 USA; [Hodder, Sally L.] Univ Med & Dent New Jersey, Dept Med, Newark, NJ 07103 USA	Columbia University; Columbia University; Columbia University; Fenway Health; Brown University; Brown University; Rutgers State University New Brunswick; Rutgers State University Medical Center	El-Sadr, WM (corresponding author), Columbia Univ, Int Ctr AIDS Care & Treatment Programs, Mailman Sch Publ Hlth, New York, NY 10027 USA.				NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI068619, UM1AI068619] Funding Source: NIH RePORTER; NIAID NIH HHS [UM1 AI068619] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		*CDCP, 2007, HIV PREV SEL POP HIG; *GOV DISTR COL DEP, 2008, DISTR COL HIV AIDS E; Hall HI, 2008, JAMA-J AM MED ASSOC, V300, P520, DOI 10.1001/jama.300.5.520; Millett GA, 2007, AIDS, V21, P2083, DOI 10.1097/QAD.0b013e3282e9a64b; Nguyen TQ, 2008, AIDS, V22, P281, DOI 10.1097/QAD.0b013e3282f2ef58	5	108	108	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11					967	970		10.1056/NEJMp1000069	http://dx.doi.org/10.1056/NEJMp1000069			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20147707	Green Published, Green Accepted			2022-12-01	WOS:000275650400002
J	Pasini, D; Cloos, PAC; Walfridsson, J; Olsson, L; Bukowski, JP; Johansen, JV; Bak, M; Tommerup, N; Rappsilber, J; Helin, K				Pasini, Diego; Cloos, Paul A. C.; Walfridsson, Julian; Olsson, Linda; Bukowski, John-Paul; Johansen, Jens V.; Bak, Mads; Tommerup, Niels; Rappsilber, Juri; Helin, Kristian			JARID2 regulates binding of the Polycomb repressive complex 2 to target genes in ES cells	NATURE			English	Article							HISTONE METHYLTRANSFERASE ACTIVITY; DEVELOPMENTAL REGULATORS; CARDIAC DEVELOPMENT; JUMONJI; EZH2; DIFFERENTIATION; GASTRULATION; METHYLATION; PROTEINS; ENHANCER	The Polycomb group (PcG) proteins have an important role in controlling the expression of genes essential for development, differentiation and maintenance of cell fates(1,2). The Polycomb repressive complex 2 (PRC2) is believed to regulate transcriptional repression by catalysing the di- and tri-methylation of lysine 27 on histone H3 (H3K27me2/3)(2). At present, it is unknown how the PcG proteins are recruited to their target promoters in mammalian cells(3). Here we show that PRC2 forms a stable complex with the Jumonji- and ARID-domain-containing protein, JARID2 (ref. 4). Using genome-wide location analysis, we show that JARID2 binds to more than 90% of previously mapped PcG target genes. Notably, we show that JARID2 is sufficient to recruit PcG proteins to a heterologous promoter, and that inhibition of JARID2 expression leads to a major loss of PcG binding and to a reduction of H3K27me3 levels on target genes. Consistent with an essential role for PcG proteins in early development(5-8), we demonstrate that JARID2 is required for the differentiation of mouse embryonic stem cells. Thus, these results demonstrate that JARID2 is essential for the binding of PcG proteins to target genes and, consistent with this, for the proper differentiation of embryonic stem cells and normal development.	[Pasini, Diego; Cloos, Paul A. C.; Walfridsson, Julian; Olsson, Linda; Bukowski, John-Paul; Johansen, Jens V.; Helin, Kristian] Univ Copenhagen, BRIC, DK-2200 Copenhagen N, Denmark; [Pasini, Diego; Cloos, Paul A. C.; Walfridsson, Julian; Olsson, Linda; Bukowski, John-Paul; Helin, Kristian] Univ Copenhagen, Ctr Epigenet, DK-2200 Copenhagen N, Denmark; [Bak, Mads; Tommerup, Niels] Univ Copenhagen, Dept Cellular & Mol Med, Wilhelm Johannsen Ctr Funct Genome Res, DK-2200 Copenhagen N, Denmark; [Rappsilber, Juri] Univ Edinburgh, Wellcome Trust Ctr Cell Biol, Edinburgh EH9 3JR, Midlothian, Scotland	University of Copenhagen; University of Copenhagen; University of Copenhagen; University of Edinburgh	Helin, K (corresponding author), Univ Copenhagen, BRIC, Ole Maaloes Vej 5, DK-2200 Copenhagen N, Denmark.	kristian.helin@bric.ku.dk	Tommerup, Niels/T-8776-2017; Rappsilber, Juri/ABF-3328-2020; Pasini, Diego/J-9674-2012; Helin, Kristian/K-2526-2019; Rappsilber, Juri/B-7265-2015; Helin, Kristian/HDM-8306-2022	Tommerup, Niels/0000-0003-2304-0112; Pasini, Diego/0000-0002-9879-6486; Rappsilber, Juri/0000-0001-5999-1310; Vilstrup Johansen, Jens/0000-0001-7094-6801; Helin, Kristian/0000-0003-1975-6097; Cloos, Paul/0000-0001-5863-0054; Bak, Mads/0000-0003-2762-1002	Danish Medical Research Council; Benzon Foundation; NordForsk (Nordic Union); Danish National Research Foundation; Lundbeck Foundation; Danish Cancer Society; Novo Nordisk Foundation; Danish Natural Science Research Council; Lundbeck Foundation [R13-2007-1172, R67-2010-6206] Funding Source: researchfish	Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Benzon Foundation; NordForsk (Nordic Union); Danish National Research Foundation(Danmarks Grundforskningsfond); Lundbeck Foundation(Lundbeckfonden); Danish Cancer Society(Danish Cancer Society); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Danish Natural Science Research Council(Danish Natural Science Research Council); Lundbeck Foundation(Lundbeckfonden)	We thank K. Hansen for the RING1B antibody, J. Vikesaa for bioinformatics support, and F. de Lima Alves for assistance during mass spectrometry analyses. We thank L. Morey for critical reading of the manuscript, and members of the Helin laboratory for discussions, technical advice and support. D. P. was supported by a post-doctoral fellowship from the Danish Medical Research Council, P. A. C. C. by a grant from the Benzon Foundation and J. W. by a post-doctoral fellowship from NordForsk (Nordic Union). J. R. is a Senior Research Fellow of the Wellcome Trust. The Wilhelm Johannsen Center is supported by the Danish National Research Foundation and the Lundbeck Foundation. The work in the Helin laboratory was supported by grants from the Danish National Research Foundation, the Danish Cancer Society, the Novo Nordisk Foundation, the Danish Medical Research Council, and the Danish Natural Science Research Council.	Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2009, NAT REV CANCER, V9, P773, DOI 10.1038/nrc2736; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Cao R, 2002, SCIENCE, V298, P1039, DOI 10.1126/science.1076997; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Chamberlain SJ, 2008, STEM CELLS, V26, P1496, DOI 10.1634/stemcells.2008-0102; Christensen J, 2007, CELL, V128, P1063, DOI 10.1016/j.cell.2007.02.003; Cloos PAC, 2008, GENE DEV, V22, P1115, DOI 10.1101/gad.1652908; Czermin B, 2002, CELL, V111, P185, DOI 10.1016/S0092-8674(02)00975-3; Faust C, 1998, DEVELOPMENT, V125, P4495; Hansen KH, 2008, NAT CELL BIOL, V10, P1291, DOI 10.1038/ncb1787; Ji HK, 2008, NAT BIOTECHNOL, V26, P1293, DOI 10.1038/nbt.1505; Kim T, 2004, MOL CELL BIOL, V24, P10151, DOI 10.1128/MCB.24.23.10151-10160.2004; Kim TG, 2003, J BIOL CHEM, V278, P42247, DOI 10.1074/jbc.M307386200; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Kuzmichev A, 2002, GENE DEV, V16, P2893, DOI 10.1101/gad.1035902; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Margueron R, 2009, NATURE, V461, P762, DOI 10.1038/nature08398; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; Muller J, 2002, CELL, V111, P197, DOI 10.1016/S0092-8674(02)00976-5; O'Carroll D, 2001, MOL CELL BIOL, V21, P4330, DOI 10.1128/MCB.21.13.4330-4336.2001; Pasini D, 2004, EMBO J, V23, P4061, DOI 10.1038/sj.emboj.7600402; Pasini D, 2008, COLD SH Q B, V73, P253, DOI 10.1101/sqb.2008.73.009; Pasini D, 2008, GENE DEV, V22, P1345, DOI 10.1101/gad.470008; Pasini D, 2007, MOL CELL BIOL, V27, P3769, DOI 10.1128/MCB.01432-06; Schuettengruber B, 2007, CELL, V128, P735, DOI 10.1016/j.cell.2007.02.009; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Shen XH, 2008, MOL CELL, V32, P491, DOI 10.1016/j.molcel.2008.10.016; Takeuchi T, 1999, MECH DEVELOP, V86, P29, DOI 10.1016/S0925-4773(99)00100-8; TAKEUCHI T, 1995, GENE DEV, V9, P1211, DOI 10.1101/gad.9.10.1211; Villa R, 2007, CANCER CELL, V11, P513, DOI 10.1016/j.ccr.2007.04.009; Voncken JW, 2003, P NATL ACAD SCI USA, V100, P2468, DOI 10.1073/pnas.0434312100; Wilm M, 1996, NATURE, V379, P466, DOI 10.1038/379466a0	33	415	424	0	33	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					306	U193		10.1038/nature08788	http://dx.doi.org/10.1038/nature08788			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20075857				2022-12-01	WOS:000275366100053
J	Wheeler, MT; Heidenreich, PA; Froelicher, VF; Hlatky, MA; Ashley, EA				Wheeler, Matthew T.; Heidenreich, Paul A.; Froelicher, Victor F.; Hlatky, Mark A.; Ashley, Euan A.			Cost-Effectiveness of Preparticipation Screening for Prevention of Sudden Cardiac Death in Young Athletes	ANNALS OF INTERNAL MEDICINE			English	Article							HEART-ASSOCIATION COUNCIL; CORONARY-ARTERY ANOMALIES; BRUGADA-TYPE ECG; HYPERTROPHIC CARDIOMYOPATHY; CARDIOVASCULAR-DISEASE; SCIENTIFIC STATEMENT; DEFECTS COMMITTEE; PHYSICAL-ACTIVITY; HIGH-SCHOOL; ELECTROCARDIOGRAPHIC PATTERNS	Background: Inclusion of 12-lead electrocardiography (ECG) in preparticipation screening of young athletes is controversial because of concerns about cost-effectiveness. Objective: To evaluate the cost-effectiveness of ECG plus cardiovascular-focused history and physical examination compared with cardiovascular-focused history and physical examination alone for preparticipation screening. Design: Decision-analysis, cost-effectiveness model. Data Sources: Published epidemiologic and preparticipation screening data, vital statistics, and other publicly available data. Target Population: Competitive athletes in high school and college aged 14 to 22 years. Time Horizon: Lifetime. Perspective: Societal. Intervention: Nonparticipation in competitive athletic activity and disease-specific treatment for identified athletes with heart disease. Outcome Measure: Incremental health care cost per life-year gained. Results of Base-Case Analysis: Addition of ECG to preparticipation screening saves 2.06 life-years per 1000 athletes at an incremental total cost of $89 per athlete and yields a cost-effectiveness ratio of $42 900 per life-year saved (95% CI, $21 200 to $71 300 per life-year saved) compared with cardiovascular-focused history and physical examination alone. Compared with no screening, ECG plus cardiovascular-focused history and physical examination saves 2.6 life-years per 1000 athletes screened and costs $199 per athlete, yielding a cost-effectiveness ratio of $76 100 per life-year saved ($62 400 to $130 000). Results of Sensitivity Analysis: Results are sensitive to the relative risk reduction associated with nonparticipation and the cost of initial screening. Limitations: Effectiveness data are derived from 1 major European study. Patterns of causes of sudden death may vary among countries. Conclusion: Screening young athletes with 12-lead ECG plus cardiovascular-focused history and physical examination may be cost-effective.	[Ashley, Euan A.] Stanford Univ, Div Cardiovasc Med, Stanford, CA 94305 USA; Vet Affairs Palo Alto Hlth Care Syst, Palo Alto, CA USA	Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Ashley, EA (corresponding author), Stanford Univ, Div Cardiovasc Med, 300 Pasteur Dr,Falk Cardiovasc Res Bldg, Stanford, CA 94305 USA.	euan@stanford.edu	Heidenreich, Paul/AAU-6864-2021	Heidenreich, Paul/0000-0001-7730-8490; Wheeler, Matthew/0000-0001-8721-3022; Hlatky, Mark/0000-0003-4686-9441; Froelicher, Victor/0000-0001-8831-4853	Breetwor Foundation; Stanford Cardiovascular Institute; National Heart, Lung, and Blood Institute, National Institutes of Health [5HL 07034]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [F32HL097462, T32HL007034] Funding Source: NIH RePORTER	Breetwor Foundation; Stanford Cardiovascular Institute; National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	From the Breetwor Foundation and the Stanford Cardiovascular Institute. Dr. Wheeler was supported by a U.S. Public Health Service training grant (5HL 07034) from the National Heart, Lung, and Blood Institute, National Institutes of Health.	AGNARSSON UT, 1992, J INTERN MED, V232, P499, DOI 10.1111/j.1365-2796.1992.tb00623.x; *AM MED ASS, 2008, MED RBRVS 2008 PHYS; Arola A, 1997, AM J EPIDEMIOL, V146, P385, DOI 10.1093/oxfordjournals.aje.a009291; Bar-Dayan Y, 2005, CARDIOLOGY, V104, P6, DOI 10.1159/000086046; Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P2256, DOI 10.1016/j.jacc.2007.12.061; Basavarajaiah S, 2008, J AM COLL CARDIOL, V51, P1033, DOI 10.1016/j.jacc.2007.10.055; Blangy H, 2005, ARCH MAL COEUR VAISS, V98, P175; Cantor SB, 1999, J CLIN EPIDEMIOL, V52, P517, DOI 10.1016/S0895-4356(99)00021-9; Chaitman BR, 2007, CIRCULATION, V116, P2610, DOI 10.1161/CIRCULATIONAHA.107.711465; Chan PS, 2006, J AM COLL CARDIOL, V47, P2513, DOI 10.1016/j.jacc.2006.01.070; Corrado D, 2005, EUR HEART J, V26, P516, DOI 10.1093/eurheartj/ehi108; Corrado D, 2003, J AM COLL CARDIOL, V42, P1959, DOI 10.1016/j.jacc.2003.03.002; Corrado D, 1998, NEW ENGL J MED, V339, P364, DOI 10.1056/NEJM199808063390602; Corrado D, 2006, JAMA-J AM MED ASSOC, V296, P1593, DOI 10.1001/jama.296.13.1593; Davis JA, 2001, J AM COLL CARDIOL, V37, P593, DOI 10.1016/S0735-1097(00)01136-0; Drezner JA, 2008, HEART RHYTHM, V5, P794, DOI 10.1016/j.hrthm.2008.03.001; FIXLER DE, 1990, CIRCULATION, V81, P137, DOI 10.1161/01.CIR.81.1.137; Fuller CM, 2000, MED SCI SPORT EXER, V32, P887; Fuller CM, 1997, MED SCI SPORT EXER, V29, P1131, DOI 10.1097/00005768-199709000-00003; FYLER DC, 1980, PEDIATRICS S, V65, P377; Gallagher MM, 2008, INT J CARDIOL, V130, P44, DOI 10.1016/j.ijcard.2007.07.159; Gemayel C, 2001, J AM COLL CARDIOL, V38, P1773, DOI 10.1016/S0735-1097(01)01654-0; Gold MR., 1996, COST EFFECTIVENESS H; Griebsch I, 2005, PEDIATRICS, V115, pE600, DOI 10.1542/peds.2004-2127; Hyduk Alexandra, 2005, Morbidity and Mortality Weekly Report, V54, P1; *INT OL COMM MED C, 2004, SUDD CARD VASC DEATH, V2008; *IT MIN HLTH, 1982, GAZZETTA UFFICI 0305, P63; Joseph A, 1993, J AM COLL CARDIOL, V22, P459, DOI 10.1016/0735-1097(93)90050-B; Junttila MJ, 2004, EUR HEART J, V25, P874, DOI 10.1016/j.ehj.2004.01.011; Kaplan RM., 1982, HEALTH PSYCHOL, V1, P61, DOI [10.1037/0278-6133.1.1.61, DOI 10.1037/0278-6133.1.1.61]; KRAHN AD, 1992, ANN INTERN MED, V116, P456, DOI 10.7326/0003-4819-116-6-456; Kyto V, 2007, AM J EPIDEMIOL, V165, P570, DOI 10.1093/aje/kwk076; Lawless CE, 2008, MED SCI SPORT EXER, V40, P787, DOI 10.1249/MSS.0b013e318164dd18; Leslie LK, 2008, CIRC-CARDIOVASC QUAL, V1, P134, DOI 10.1161/CIRCOUTCOMES.108.825232; Lipshultz SE, 2003, NEW ENGL J MED, V348, P1647, DOI 10.1056/NEJMoa021715; MacAuley D, 2008, BRIT MED J, V337, pa739; Magalski A, 2008, J AM COLL CARDIOL, V51, P2250, DOI 10.1016/j.jacc.2008.01.065; Maron BJ, 2007, CARDIOL CLIN, V25, P399, DOI 10.1016/j.ccl.2007.07.006; Maron BJ, 2007, CIRCULATION, V115, P1643, DOI 10.1161/CIRCULATIONAHA.107.181423; Maron BJ, 1998, CIRCULATION, V97, P2294, DOI 10.1161/01.CIR.97.22.2294; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1322, DOI 10.1016/j.jacc.2005.02.007; Maron BJ, 2005, J AM COLL CARDIOL, V45, P1318, DOI 10.1016/j.jacc.2005.02.006; MARON BJ, 1987, J AM COLL CARDIOL, V10, P1214, DOI 10.1016/S0735-1097(87)80121-3; Maron BJ, 1996, CIRCULATION, V94, P850, DOI 10.1161/01.CIR.94.4.850; MARON BJ, 1995, CIRCULATION, V92, P785, DOI 10.1161/01.CIR.92.4.785; Maron BJ, 1996, JAMA-J AM MED ASSOC, V276, P199, DOI 10.1001/jama.276.3.199; Milewicz DM, 2005, CIRCULATION, V111, pE150, DOI 10.1161/01.CIR.0000155243.70456.F4; Minino AM, 2007, NATL VITAL STAT REP, V55, P1; Minino Arialdi M, 2007, Natl Vital Stat Rep, V55, P1; Mittmann N, 1999, PHARMACOECONOMICS, V15, P369, DOI 10.2165/00019053-199915040-00004; Miura K, 2002, HEART, V87, P126, DOI 10.1136/heart.87.2.126; Myerburg RJ, 2007, CIRCULATION, V116, P2616, DOI 10.1161/CIRCULATIONAHA.107.733519; *NAT COLL ATHL ASS, 2007, 1981 82 2004 05 NCAA, V2008; *NAT CTR HLTH STAT, 2007, DHHS PUBL; *NAT FED STAT HIGH, 2008, 2006 07 HIGH SCH ATH; Nichol G, 2003, CIRCULATION, V108, P697, DOI 10.1161/01.CIR.0000084545.65645.28; Nistri S, 2003, AM J CARDIOL, V91, P1021, DOI 10.1016/S0002-9149(03)00132-2; Nora M, 2007, CIRCULATION, V116, P845; Oe H, 2005, PACE, V28, P549, DOI 10.1111/j.1540-8159.2005.40020.x; *OFF STAT HLTH PLA, 2007, ANN FIN DAT HOSP CHA; PAFFENBARGER RS, 1986, NEW ENGL J MED, V314, P605, DOI 10.1056/NEJM198603063141003; Pelliccia A, 2000, CIRCULATION, V102, P278; PELLICCIA A, 1991, NEW ENGL J MED, V324, P295, DOI 10.1056/NEJM199101313240504; PELLICCIA A, 1995, AM J CARDIOL, V75, P827, DOI 10.1016/S0002-9149(99)80421-4; PELLICCIA A, 1993, AM J CARDIOL, V72, P978, DOI 10.1016/0002-9149(93)91120-7; Pelliccia A, 2007, EUR HEART J, V28, P2006, DOI 10.1093/eurheartj/ehm219; Pelliccia A, 2006, EUR HEART J, V27, P2196, DOI 10.1093/eurheartj/ehl137; Pelliccia Antonio, 2002, Cardiol Rev, V10, P85, DOI 10.1097/00045415-200203000-00006; PYERITZ RE, 1979, NEW ENGL J MED, V300, P772, DOI 10.1056/NEJM197904053001406; Quaglini S, 2006, EUR HEART J, V27, P1824, DOI 10.1093/eurheartj/ehl115; RICH S, 1987, ANN INTERN MED, V107, P216, DOI 10.7326/0003-4819-107-2-216; RISSER WL, 1985, J SCHOOL HEALTH, V55, P270, DOI 10.1111/j.1746-1561.1985.tb04140.x; Sanders GD, 2005, NEW ENGL J MED, V353, P1471, DOI 10.1056/NEJMsa051989; Sharma S, 1999, BRIT J SPORT MED, V33, P319, DOI 10.1136/bjsm.33.5.319; Smith J, 1998, MAYO CLIN PROC, V73, P419; Sofi F, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a346; Sung L, 2004, J CLIN EPIDEMIOL, V57, P1161, DOI 10.1016/j.jclinepi.2004.05.003; Tanaka Y, 2006, MED SCI SPORT EXER, V38, P2, DOI 10.1249/01.mss.0000183187.88000.53; TENGS TO, 1995, RISK ANAL, V15, P369, DOI 10.1111/j.1539-6924.1995.tb00330.x; Thompson PD, 2007, CIRCULATION, V115, P2358, DOI 10.1161/CIRCULATIONAHA.107.181485; THOMPSON TR, 1982, CLEVELAND CLIN Q, V49, P225, DOI 10.3949/ccjm.49.4.225; *US BUR CENS, 2009, CENS POP; VANCAMP SP, 1995, MED SCI SPORT EXER, V27, P641; Vetter VL, 2008, CIRCULATION, V117, P2407, DOI 10.1161/CIRCULATIONAHA.107.189473; VIDAILLET HJ, 1987, NEW ENGL J MED, V317, P65, DOI 10.1056/NEJM198707093170201; WEIDENBENER EJ, 1995, CLIN J SPORT MED, V5, P86, DOI 10.1097/00042752-199504000-00003; Weinstein MC, 1996, JAMA-J AM MED ASSOC, V276, P1253, DOI 10.1001/jama.276.15.1253; Wilson MG, 2008, BRIT J SPORT MED, V42, P207, DOI 10.1136/bjsm.2007.039420; YAMANAKA O, 1990, CATHETER CARDIO DIAG, V21, P28, DOI 10.1002/ccd.1810210110; Yock CA, 2003, AM J MED, V115, P382, DOI 10.1016/S0002-9343(03)00296-1	90	173	177	0	19	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 2	2010	152	5					276	W91		10.7326/0003-4819-152-5-201003020-00005	http://dx.doi.org/10.7326/0003-4819-152-5-201003020-00005			23	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565XJ	20194233	Green Accepted			2022-12-01	WOS:000275329600002
J	van Kuppeveld, FJM; de Jong, AS; Lanke, KH; Verhaegh, GW; Melchers, WJG; Swanink, CMA; Bleijenberg, G; Netea, MG; Galama, JMD; van der Meer, JWM				van Kuppeveld, Frank J. M.; de Jong, Arjan S.; Lanke, Kjerstin H.; Verhaegh, Gerald W.; Melchers, Willem J. G.; Swanink, Caroline M. A.; Bleijenberg, Gijs; Netea, Mihai G.; Galama, Jochem M. D.; van der Meer, Jos W. M.			Prevalence of xenotropic murine leukaemia virus-related virus in patients with chronic fatigue syndrome in the Netherlands: retrospective analysis of samples from an established cohort	BMJ-BRITISH MEDICAL JOURNAL			English	Article							INFECTIOUS RETROVIRUS; PROSTATE-CANCER; BLOOD-CELLS; XMRV; TUMORS	Objective The presence of the retrovirus xenotropic murine leukaemia virus-related virus (XMRV) has been reported in peripheral blood mononuclear cells of patients with chronic fatigue syndrome. Considering the potentially great medical and social relevance of such a discovery, we investigated whether this finding could be confirmed in an independent European cohort of patients with chronic fatigue syndrome. Design Analysis of a well defined cohort of patients and matched neighbourhood controls by polymerase chain reaction. Setting Certified (ISO 15189) laboratory of clinical virology in a university hospital in the Netherlands. Population Between December 1991 and April 1992, peripheral blood mononuclear cells were isolated from 76 patients and 69 matched neighbourhood controls. In this study we tested cells from 32 patients and 43 controls from whom original cryopreserved phials were still available. Main outcome measures Detection of XMRV in peripheral blood mononuclear cells by real time polymerase chain reaction assay targeting the XMRV integrase gene and/or a nested polymerase chain reaction assay targeting the XMRV gag gene. Results We detected no XMRV sequences in any of the patients or controls in either of the assays, in which relevant positive and negative isolation controls and polymerase chain reaction controls were included. Spiking experiments showed that we were able to detect at least 10 copies of XMRV sequences per 105 peripheral blood mononuclear cells by real time as well as by nested polymerase chain reaction, demonstrating high sensitivity of both assays. Conclusions This study failed to show the presence of XMRV in peripheral blood mononuclear cells of patients with chronic fatigue syndrome from a Dutch cohort. These data cast doubt on the claim that XMRV is associated with chronic fatigue syndrome in the majority of patients.	[van Kuppeveld, Frank J. M.; de Jong, Arjan S.; Lanke, Kjerstin H.; Melchers, Willem J. G.; Swanink, Caroline M. A.; Galama, Jochem M. D.] Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands; [Netea, Mihai G.; van der Meer, Jos W. M.] Radboud Univ Nijmegen, Med Ctr, Dept Internal Med, NL-6500 HB Nijmegen, Netherlands; [Bleijenberg, Gijs] Radboud Univ Nijmegen, Med Ctr, Expert Ctr Chron Fatigue, NL-6500 HB Nijmegen, Netherlands; [van Kuppeveld, Frank J. M.; de Jong, Arjan S.; Lanke, Kjerstin H.; Melchers, Willem J. G.; Bleijenberg, Gijs; Netea, Mihai G.; Galama, Jochem M. D.; van der Meer, Jos W. M.] Nijmegen Inst Infect Inflammat & Immun, Nijmegen, Netherlands; [van Kuppeveld, Frank J. M.; Lanke, Kjerstin H.; Melchers, Willem J. G.] Nijmegen Ctr Mol Life Sci, Nijmegen, Netherlands; [Bleijenberg, Gijs] Nijmegen Ctr Evidence Based Practice, Nijmegen, Netherlands	Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen; Radboud University Nijmegen	van Kuppeveld, FJM (corresponding author), Radboud Univ Nijmegen, Med Ctr, Dept Med Microbiol, NL-6500 HB Nijmegen, Netherlands.	f.vankuppeveld@ncmls.ru.nl	Verhaegh, Gerald/L-4708-2015; Melchers, Willem/C-8819-2015; Netea, Mihai/N-5155-2014; Jong, A.S./L-4416-2015; van der Meer, Jos W.M./C-8521-2013; Bleijenberg, Gijs/E-6984-2010	Verhaegh, Gerald/0000-0003-0227-2280; Melchers, Willem/0000-0002-5446-2230; van der Meer, Jos W.M./0000-0001-5120-3690; van Kuppeveld, Frank/0000-0001-5800-749X				Cho HJ, 2006, CURR OPIN PSYCHIATR, V19, P67, DOI 10.1097/01.yco.0000194370.40062.b0; Clancy A, 2008, EUR J CLIN MICROBIOL, V27, P1177, DOI 10.1007/s10096-008-0556-9; D'Arcy F, 2008, EUR UROL SUPPL, V7, P271, DOI 10.1016/S1569-9056(08)60798-8; DAUGHERTY SA, 1991, REV INFECT DIS, V13, pS39; Dong B, 2007, P NATL ACAD SCI USA, V104, P1655, DOI 10.1073/pnas.0610291104; Erlwein O, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0008519; EYPASCH E, 1995, BRIT MED J, V311, P619, DOI 10.1136/bmj.311.7005.619; Fischera N, 2008, J CLIN VIROL, V43, P277, DOI 10.1016/j.jcv.2008.04.016; FUKUDA K, 1994, ANN INTERN MED, V121, P953, DOI 10.7326/0003-4819-121-12-199412150-00009; Hesselink AT, 2005, J CLIN MICROBIOL, V43, P4868, DOI 10.1128/JCM.43.9.4868-4871.2005; Hohn O, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-92; HOLMES GP, 1987, JAMA-J AM MED ASSOC, V257, P2297, DOI 10.1001/jama.257.17.2297; Jansen CA, 2006, BLOOD, V107, P1427, DOI 10.1182/blood-2005-07-2907; Knouf EC, 2009, J VIROL, V83, P7353, DOI 10.1128/JVI.00546-09; Lombardi VC, 2009, SCIENCE, V326, P585, DOI 10.1126/science.1179052; Lyall M, 2003, J PSYCHOSOM RES, V55, P79, DOI 10.1016/S0022-3999(02)00515-9; Mikovits J, 2009, CYTOKINE, V48, P10, DOI 10.1016/j.cyto.2009.07.043; Prins JB, 2006, LANCET, V367, P346, DOI 10.1016/S0140-6736(06)68073-2; Schlaberg R, 2009, P NATL ACAD SCI USA, V106, P16351, DOI 10.1073/pnas.0906922106; SHARPE MC, 1991, J ROY SOC MED, V84, P118, DOI 10.1177/014107689108400224; Swanink CMA, 1996, J INFECT DIS, V173, P460, DOI 10.1093/infdis/173.2.460; SWARTZ MN, 1988, NEW ENGL J MED, V319, P1726, DOI 10.1056/NEJM198812293192608; Urisman A, 2006, PLOS PATHOG, V2, P211, DOI 10.1371/journal.ppat.0020025; VERCOULEN JHMM, 1994, J PSYCHOSOM RES, V38, P383, DOI 10.1016/0022-3999(94)90099-X; White PD, 2001, LANCET, V358, P1946, DOI 10.1016/S0140-6736(01)06961-6	25	111	111	0	14	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2010	340								c1018	10.1136/bmj.c1018	http://dx.doi.org/10.1136/bmj.c1018			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TH	20185493	Green Published, hybrid			2022-12-01	WOS:000275001300001
J	Zheng, Y; Josefowicz, S; Chaudhry, A; Peng, XP; Forbush, K; Rudensky, AY				Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Peng, Xiao P.; Forbush, Katherine; Rudensky, Alexander Y.			Role of conserved non-coding DNA elements in the Foxp3 gene in regulatory T-cell fate	NATURE			English	Article							TRANSCRIPTION FACTOR FOXP3; HUMAN GENOME; EXPRESSION; METHYLATION; LINEAGE	Immune homeostasis is dependent on tight control over the size of a population of regulatory T (T-reg) cells capable of suppressing over-exuberant immune responses. The T-reg cell subset is comprised of cells that commit to the T-reg lineage by upregulating the transcription factor Foxp3 either in the thymus (tT(reg)) or in the periphery (iT(reg))(1,2). Considering a central role for Foxp3 in T-reg cell differentiation and function(3,4), we proposed that conserved non-coding DNA sequence (CNS) elements at the Foxp3 locus encode information defining the size, composition and stability of the T-reg cell population. Here we describe the function of three Foxp3 CNS elements (CNS1-3) in T-reg cell fate determination in mice. The pioneer element CNS3, which acts to potently increase the frequency of T-reg cells generated in the thymus and the periphery, binds c-Rel in in vitro assays. In contrast, CNS1, which contains a TGF-beta-NFAT response element, is superfluous for tT(reg) cell differentiation, but has a prominent role in iT(reg) cell generation in gut-associated lymphoid tissues. CNS2, although dispensable for Foxp3 induction, is required for Foxp3 expression in the progeny of dividing T-reg cells. Foxp3 binds to CNS2 in a Cbf-beta-Runx1 and CpG DNA demethylation-dependent manner, suggesting that Foxp3 recruitment to this 'cellular memory module' facilitates the heritable maintenance of the active state of the Foxp3 locus and, therefore, T-reg lineage stability. Together, our studies demonstrate that the composition, size and maintenance of the T-reg cell population are controlled by Foxp3 CNS elements engaged in response to distinct cell-extrinsic or -intrinsic cues.	[Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Forbush, Katherine; Rudensky, Alexander Y.] Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA; [Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Forbush, Katherine; Rudensky, Alexander Y.] Univ Washington, Dept Immunol, Seattle, WA 98195 USA; [Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Peng, Xiao P.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10065 USA; [Zheng, Ye; Josefowicz, Steven; Chaudhry, Ashutosh; Peng, Xiao P.; Rudensky, Alexander Y.] Mem Sloan Kettering Canc Ctr, Program Immunol, New York, NY 10065 USA	Howard Hughes Medical Institute; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Rudensky, AY (corresponding author), Univ Washington, Howard Hughes Med Inst, Seattle, WA 98195 USA.	rudenska@mskcc.org	Zheng, Ye/G-4866-2015; Josefowicz, Steven Z/B-8716-2011	Zheng, Ye/0000-0001-5012-4309; Chaudhry, Ashutosh/0000-0003-3379-5236; josefowicz, steven/0000-0001-7453-779X	National Institutes of Health; CRI-Irvington Institute; CRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI034206] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CRI-Irvington Institute; CRI; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank T.-T. Chu and L. Karpik for expert technical assistance and mouse colony management, S. Roh for embryonic stem cell culture and screening, J. Rasmussen and A. Kas for bioinformatics support, A. Beg for providing c-Rel knockout mice, P. Treuting for histopathology analysis, J. Gerard for assistance in luciferase reporter assays, and C. Wilson, S. Tarakhovsky and L.-F. Lu for critical comments on the manuscript. This work was supported by grants from the National Institutes of Health (to A.Y.R.). Y.Z. and A. C. were supported by the CRI-Irvington Institute postdoctoral fellowship. S.Z.J. was supported by the CRI pre-doctoral training grant. A.Y.R. is an investigator with the Howard Hughes Medical Institute.	Birney E, 2007, NATURE, V447, P799, DOI 10.1038/nature05874; Bruno L, 2009, J EXP MED, V206, P2329, DOI 10.1084/jem.20090226; Burchill MA, 2007, J IMMUNOL, V178, P280, DOI 10.4049/jimmunol.178.1.280; Dubchak Inna, 2006, V338, P69; Fontenot JD, 2005, IMMUNITY, V22, P329, DOI 10.1016/j.immuni.2005.01.016; Gavin MA, 2007, NATURE, V445, P771, DOI 10.1038/nature05543; Heintzman ND, 2007, NAT GENET, V39, P311, DOI 10.1038/ng1966; Kim HP, 2007, J EXP MED, V204, P1543, DOI 10.1084/jem.20070109; Kitoh A, 2009, IMMUNITY, V31, P609, DOI 10.1016/j.immuni.2009.09.003; Lee EC, 2001, GENOMICS, V73, P56, DOI 10.1006/geno.2000.6451; Liu YZ, 2008, NAT IMMUNOL, V9, P632, DOI 10.1038/ni.1607; Maurange C, 2002, GENE DEV, V16, P2672, DOI 10.1101/gad.242702; Ono M, 2007, NATURE, V446, P685, DOI 10.1038/nature05673; Polansky JK, 2008, EUR J IMMUNOL, V38, P1654, DOI 10.1002/eji.200838105; Rao S, 2003, J IMMUNOL, V170, P3724, DOI 10.4049/jimmunol.170.7.3724; Rudra D, 2009, NAT IMMUNOL, V10, P1170, DOI 10.1038/ni.1795; Ruthenburg AJ, 2007, MOL CELL, V25, P15, DOI 10.1016/j.molcel.2006.12.014; Sakaguchi S, 2008, CELL, V133, P775, DOI 10.1016/j.cell.2008.05.009; Sather BD, 2007, J EXP MED, V204, P1335, DOI 10.1084/jem.20070081; Tone Y, 2008, NAT IMMUNOL, V9, P194, DOI 10.1038/ni1549; Williams DB, 2007, SURG OBES RELAT DIS, V3, P8, DOI 10.1016/j.soard.2006.10.003; Yao Z, 2007, BLOOD, V109, P4368, DOI 10.1182/blood-2006-11-055756; Zheng Y, 2007, NATURE, V445, P936, DOI 10.1038/nature05563; Zheng Y, 2007, NAT IMMUNOL, V8, P457, DOI 10.1038/ni1455	24	837	871	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					808	U120		10.1038/nature08750	http://dx.doi.org/10.1038/nature08750			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20072126	Green Accepted			2022-12-01	WOS:000274394300040
J	Teno, JM; Mitchell, SL; Gozalo, PL; Dosa, D; Hsu, A; Intrator, O; Mor, V				Teno, Joan M.; Mitchell, Susan L.; Gozalo, Pedro L.; Dosa, David; Hsu, Amy; Intrator, Orna; Mor, Vincent			Hospital Characteristics Associated With Feeding Tube Placement in Nursing Home Residents With Advanced Cognitive Impairment	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RANDOMIZED CONTROLLED-TRIAL; ADVANCED DEMENTIA; CARE; LIFE; END	Context Tube-feeding is of questionable benefit for nursing home residents with advanced dementia. Approximately two-thirds of US nursing home residents who are tube fed had their feeding tube inserted during an acute care hospitalization. Objective To identify US hospital characteristics associated with higher rates of feeding tube insertion in nursing home residents with advanced cognitive impairment. Design, Setting, and Patients The sample included nursing home residents aged 66 years or older with advanced cognitive impairment admitted to acute care hospitals between 2000 and 2007. Rate of feeding tube placement was based on a 20% sample of all Medicare Claims files and was assessed in hospitals with at least 30 such admissions during the 8-year period. A multivariable model with the unit of the analysis being the hospital admission identified hospital-level factors independently associated with feeding tube insertion rates, including bed size, ownership, urban location, and medical school affiliation. Measures of each hospital's care practices for all patients with serious chronic illnesses were evaluated, including intensive care unit (ICU) use in the last 6 months of life, the use of hospice services, and the ratio of specialist to primary care physicians. Patient-level characteristics were also considered. Main Outcome Measure Endoscopic or surgical insertion of a gastrostomy tube during a hospitalization. Results In 2797 acute care hospitals with 280 869 admissions among 163 022 nursing home residents with advanced cognitive impairment, the rate of feeding tube insertion varied from 0 to 38.9 per 100 hospitalizations (mean [SD], 6.5 [5.3]; median [interquartile range], 5.3 [2.6-9.3]). The mean rate of feeding tube insertions per 100 admissions was 7.9 in 2000, decreasing to 6.2 in 2007. Higher insertion rates were associated with the following hospital features: for-profit ownership vs government owned (8.5 vs 5.5 insertions per 100 hospitalizations; adjusted odds ratio [AOR], 1.33; 95% confidence interval [CI], 1.21-1.46), larger size (>310 beds vs <101 beds: 8.0 vs 4.3 insertions per 100 hospitalizations; AOR, 1.48; 95% CI, 1.35-1.63), and greater ICU use in the last 6 months of life (highest vs lowest decile: 10.1 vs 2.9 insertions per 100 hospitalizations; AOR, 2.60; 95% CI, 2.20-3.06). These differences persisted after controlling for patient characteristics. Specialist to primary care ratio and hospice use were weakly or not associated with feeding tube placement. Conclusion Among nursing home residents with advanced cognitive impairment admitted to acute care hospitals, for-profit ownership, larger hospital size, and greater ICU use was associated with increased rates of feeding tube insertion, even after adjusting for patient-level characteristics. JAMA. 2010; 303(6): 544-550	[Teno, Joan M.; Gozalo, Pedro L.; Dosa, David; Hsu, Amy; Intrator, Orna; Mor, Vincent] Brown Univ, Warren Alpert Sch Med, Ctr Gerontol & Hlth Care Res, Providence, RI 02912 USA; [Mitchell, Susan L.] Harvard Univ, Sch Med, Inst Aging Res, Boston, MA USA; [Dosa, David; Intrator, Orna] Providence Vet Affairs Med Ctr, Providence, RI USA	Brown University; Harvard University; Harvard Medical School; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Teno, JM (corresponding author), Brown Univ, Warren Alpert Sch Med, Ctr Gerontol & Hlth Care Res, 121 S Main St, Providence, RI 02912 USA.	joan_teno@brown.edu			National Institute on Aging [RC1AG036418, P01AG027296, K24AG033640]; NATIONAL INSTITUTE ON AGING [RC1AG036418, P01AG027296, K24AG033640] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This research was funded by grants RC1AG036418 and P01AG027296 from the National Institute on Aging. Dr Mitchell is supported by grant K24AG033640 from the National Institute on Aging.	Ahronheim JC, 2001, J AM GERIATR SOC, V49, P148, DOI 10.1046/j.1532-5415.2001.49035.x; [Anonymous], ICD 9 PROV DIAGN COD; Braun UK, 2005, J AM GERIATR SOC, V53, P242, DOI 10.1111/j.1532-5415.2005.53109.x; Duszak R, 2003, J VASC INTERV RADIOL, V14, P1031; Finucane TE, 1999, JAMA-J AM MED ASSOC, V282, P1365, DOI 10.1001/jama.282.14.1365; Gessert CE, 2000, J AM GERIATR SOC, V48, P1593, DOI 10.1111/j.1532-5415.2000.tb03869.x; Gessert CE, 2006, J AM GERIATR SOC, V54, P1199, DOI 10.1111/j.1532-5415.2006.00824.x; Gillick MR, 2000, NEW ENGL J MED, V342, P206, DOI 10.1056/NEJM200001203420312; HARTMAIER SL, 1995, J GERONTOL A-BIOL, V50, pM128, DOI 10.1093/gerona/50A.2.M128; Kuo S, 2009, J AM MED DIR ASSOC, V10, P264, DOI 10.1016/j.jamda.2008.10.010; Lin CY, 2009, MED CARE, V47, P524, DOI 10.1097/MLR.0b013e31819261bd; Mebane-Sims I, 2009, ALZHEIMERS DEMENT, V5, P234, DOI 10.1016/j.jalz.2009.03.001; Meier DE, 2001, ARCH INTERN MED, V161, P594, DOI 10.1001/archinte.161.4.594; Mitchell SL, 1997, ARCH INTERN MED, V157, P327, DOI 10.1001/archinte.157.3.327; Mitchell SL, 2003, JAMA-J AM MED ASSOC, V290, P73, DOI 10.1001/jama.290.1.73; Mitchell SL, 2007, JAMA-J AM MED ASSOC, V298, P2527, DOI 10.1001/jama.298.17.jrr70001; Mitchell SL, 2007, J AM GERIATR SOC, V55, P432, DOI 10.1111/j.1532-5415.2007.01086.x; Molloy DW, 2000, JAMA-J AM MED ASSOC, V283, P1437, DOI 10.1001/jama.283.11.1437; MORRIS JN, 1994, J GERONTOL, V49, pM174, DOI 10.1093/geronj/49.4.M174; OBrien LA, 1997, J GEN INTERN MED, V12, P364, DOI 10.1046/j.1525-1497.1997.00061.x; Rhodes R, 2009, J CLIN ONCOL, V27, P5496, DOI 10.1200/JCO.2009.24.2206; Rich SE, 2009, J AM GERIATR SOC, V57, P146, DOI 10.1111/j.1532-5415.2008.02090.x; Teno JM, 2009, J PALLIAT MED, V12, P359, DOI 10.1089/jpm.2008.0168; Volandes AE, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b2159; Wennberg J. E., 2008, TRACKING CARE PATIEN	25	99	101	0	15	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					544	550		10.1001/jama.2010.79	http://dx.doi.org/10.1001/jama.2010.79			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553PG	20145231	Bronze, Green Accepted			2022-12-01	WOS:000274378700026
J	Kelly, CM; Juurlink, DN; Gomes, T; Duong-Hua, M; Pritchard, KI; Austin, PC; Paszat, LF				Kelly, Catherine M.; Juurlink, David N.; Gomes, Tara; Duong-Hua, Minh; Pritchard, Kathleen I.; Austin, Peter C.; Paszat, Lawrence F.			Selective serotonin reuptake inhibitors and breast cancer mortality in women receiving tamoxifen: a population based cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							DRUG-DRUG INTERACTIONS; QUALITY-OF-LIFE; ADJUVANT TAMOXIFEN; HOT FLASHES; IN-VITRO; ANTIDEPRESSANT USE; CYP2D6 GENOTYPE; LOW-INCOME; METABOLISM; RECURRENCE	Objective To characterise whether some selective serotonin reuptake inhibitor (SSRI) antidepressants reduce tamoxifen's effectiveness by inhibiting its bioactivation by cytochrome P450 2D6 (CYP2D6). Design Population based cohort study. Participants Women living in Ontario aged 66 years or older treated with tamoxifen for breast cancer between 1993 and 2005 who had overlapping treatment with a single SSRI. Main outcome measures Risk of death from breast cancer after completion of tamoxifen treatment, as a function of the proportion of time on tamoxifen during which each SSRI had been co-prescribed. Results Of 2430 women treated with tamoxifen and a single SSRI, 374 (15.4%) died of breast cancer during follow-up ( mean follow-up 2.38 years, SD 2.59). After adjustment for age, duration of tamoxifen treatment, and other potential confounders, absolute increases of 25%, 50%, and 75% in the proportion of time on tamoxifen with overlapping use of paroxetine ( an irreversible inhibitor of CYP2D6) were associated with 24%, 54%, and 91% increases in the risk of death from breast cancer, respectively (P<0.05 for each comparison). By contrast, no such risk was seen with other antidepressants. We estimate that use of paroxetine for 41% of tamoxifen treatment ( the median overlap in our sample) would result in one additional breast cancer death within five years of cessation of tamoxifen for every 19.7 (95% confidence interval 12.5 to 46.3) patients so treated; the risk with more extensive overlap would be greater. Conclusion Paroxetine use during tamoxifen treatment is associated with an increased risk of death from breast cancer, supporting the hypothesis that paroxetine can reduce or abolish the benefit of tamoxifen in women with breast cancer.	[Juurlink, David N.; Pritchard, Kathleen I.; Paszat, Lawrence F.] Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada; [Juurlink, David N.; Pritchard, Kathleen I.; Paszat, Lawrence F.] Sunnybrook Res Inst, Toronto, ON, Canada; [Juurlink, David N.; Pritchard, Kathleen I.; Paszat, Lawrence F.] Univ Toronto, Dept Med, Toronto, ON, Canada; [Juurlink, David N.] Univ Toronto, Dept Pediat, Toronto, ON, Canada; [Juurlink, David N.; Pritchard, Kathleen I.; Austin, Peter C.; Paszat, Lawrence F.] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada; [Duong-Hua, Minh] Canadian Inst Hlth Informat, Toronto, ON, Canada	University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; Sunnybrook Research Institute; University Toronto Affiliates; Sunnybrook Health Science Center; University of Toronto; University of Toronto; University of Toronto; Canadian Institute Health Information	Juurlink, DN (corresponding author), Sunnybrook Hlth Sci Ctr, Dept Med, Toronto, ON M4N 3M5, Canada.	dnj@ices.on.ca	Hug, Balthasar L./G-1568-2010	Gomes, Tara/0000-0002-1468-1965; Kelly, Professor Catherine M./0000-0001-8355-6714; Austin, Peter/0000-0003-3337-233X	Sunnybrook Hospital Foundation; Canadian Institutes of Health Research; Heart and Stroke Foundation of Ontario; Ontario Ministry of Health and Long-Term Care; Ontario Drug Innovation Fund; National Cancer Institute of Canada Clinical Trials Group; AstraZeneca; YM Biosciences; Bristol Myers; Squibb; Sanofi-Aventis; Amgen; Ortho-Biotech; Pfizer; Novartis; GlaxoSmithKline; Ortho Biotech; Roche	Sunnybrook Hospital Foundation; Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Heart and Stroke Foundation of Ontario(Heart & Stroke Foundation of Ontario); Ontario Ministry of Health and Long-Term Care(Ministry of Health and Long-Term Care, Ontario); Ontario Drug Innovation Fund; National Cancer Institute of Canada Clinical Trials Group; AstraZeneca(AstraZeneca); YM Biosciences; Bristol Myers(Bristol-Myers Squibb); Squibb; Sanofi-Aventis(Sanofi-Aventis); Amgen(Amgen); Ortho-Biotech; Pfizer(Pfizer); Novartis(Novartis); GlaxoSmithKline(GlaxoSmithKline); Ortho Biotech; Roche(Roche Holding)	CMK was supported by a fellowship award from the Sunnybrook Hospital Foundation. DNJ was supported by a New Investigator award from the Canadian Institutes of Health Research. PCA is supported by a Career Investigator award from the Heart and Stroke Foundation of Ontario. LFP is supported by a Clinician Scientist award from the Ontario Ministry of Health and Long-Term Care. This research was supported by the Institute for Clinical Evaluative Sciences ( ICES), which is funded by an annual grant from the Ontario Ministry of Health and Long-Term Care. The study was supported in part by the Ontario Drug Policy Research Network, funded by the Ontario Drug Innovation Fund. The funder had no role in the design, analysis, conduct or reporting of the study. The opinions, results and conclusions reported in this paper are those of the authors and are independent from the funding sources. No endorsement by ICES or the Ontario MOHLTC is intended or should be inferred.; Competing interests: All authors have completed the Unified Competing Interest form at www. icmje.org_disclosure. pdf (available on request from the corresponding author. During the past three years KIP has been a consultant for Sanofi-Aventis, AstraZeneca, Roche, Pfizer, Ortho-Biotech, YM Biosciences, Novartis, Abraxis, Amgen, and GlaxoSmithKline (GSK). KIP has received research funding either directly through per case funding for studies, or indirectly through the National Cancer Institute of Canada Clinical Trials Group, contracted with pharmaceutical companies including AstraZeneca, YM Biosciences, Bristol Myers, Squibb, Sanofi-Aventis, Amgen, Ortho-Biotech, Pfizer, Novartis, GlaxoSmithKline, and Ortho Biotech. KIP has received honorariums or been part of speaker's bureaux from Sanofi-Aventis, AstraZeneca, Pfizer, Roche, YM Biosciences, and Novartis. KIP has given paid expert testimony for Sanofi-Aventis, AstraZeneca, and GlaxoSmithKline. KIP has been a member of Advisory Committees for Sanofi-Aventis, AstraZeneca, Ortho- Biotech, Roche, Pfizer, Novartis, YM Biosciences, and GlaxoSmithKline. All other authors declare ( 1) no support from any company for the submitted work; ( 2) no relationships with any companies that might have an interest in the submitted work in the previous 3 years; ( 3) their spouses, partners, or children have no financial relationships that may be relevant to the submitted work; and ( 4) no non-financial interests that may be relevant to the submitted work.	AHEM TP, 2009, CANCER EPIDEM BIOMAR, V18, P2562; Alfaro CL, 2000, J CLIN PHARMACOL, V40, P58, DOI 10.1177/00912700022008702; Amchin J, 2001, J CLIN PHARMACOL, V41, P443, DOI 10.1177/00912700122010159; Anderson BO, 2008, CANCER-AM CANCER SOC, V113, P2221, DOI 10.1002/cncr.23844; AUSTIN PC, J CLIN EPIDEMIOL, V63, P46; Ball SE, 1997, BRIT J CLIN PHARMACO, V43, P619, DOI 10.1046/j.1365-2125.1997.00591.x; Bertelsen KM, 2003, DRUG METAB DISPOS, V31, P289, DOI 10.1124/dmd.31.3.289; Borges S, 2006, CLIN PHARMACOL THER, V80, P61, DOI 10.1016/j.clpt.2006.03.013; Burgess C, 2005, BRIT MED J, V330, P702, DOI 10.1136/bmj.38343.670868.D3; Chubak J, 2008, BREAST CANCER RES TR, V112, P123, DOI 10.1007/s10549-007-9828-9; COLE MP, 1971, BRIT J CANCER, V25, P270, DOI 10.1038/bjc.1971.33; Coyne JC, 2004, GEN HOSP PSYCHIAT, V26, P121, DOI 10.1016/j.genhosppsych.2003.08.012; CREWE HK, 1992, BRIT J CLIN PHARMACO, V34, P262, DOI 10.1111/j.1365-2125.1992.tb04134.x; Day R, 1999, J CLIN ONCOL, V17, P2659, DOI 10.1200/JCO.1999.17.9.2659; Desta Z, 2004, J PHARMACOL EXP THER, V310, P1062, DOI 10.1124/jpet.104.065607; Early Breast Cancer Trialists' Collaborative Group (EBCTCG), 2005, LANCET, V365, P1687, DOI 10.1016/s0140-6736(05)66544-0; Ell K, 2005, J CLIN ONCOL, V23, P3052, DOI 10.1200/JCO.2005.08.041; Fann JR, 2008, GEN HOSP PSYCHIAT, V30, P112, DOI 10.1016/j.genhosppsych.2007.10.008; Goetz MP, 2007, BREAST CANCER RES TR, V101, P113, DOI 10.1007/s10549-006-9428-0; Goetz MP, 2005, J CLIN ONCOL, V23, P9312, DOI 10.1200/JCO.2005.03.3266; Hemeryck A, 2002, CURR DRUG METAB, V3, P13, DOI 10.2174/1389200023338017; Ingelman-Sundberg M, 2005, PHARMACOGENOMICS J, V5, P6, DOI 10.1038/sj.tpj.6500285; Jin Y, 2005, JNCI-J NATL CANCER I, V97, P30, DOI 10.1093/jnci/dji005; Johnson MD, 2004, BREAST CANCER RES TR, V85, P151, DOI 10.1023/B:BREA.0000025406.31193.e8; Juurlink DN, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2942; Juurlink DN, 2009, CAN MED ASSOC J, V180, P713, DOI 10.1503/cmaj.082001; Juurlink DN, 2005, BRIT J CLIN PHARMACO, V59, P102, DOI 10.1111/j.1365-2125.2005.02230.x; Juurlink DN, 2004, J AM GERIATR SOC, V52, P794, DOI 10.1111/j.1532-5415.2004.52221.x; Juurlink DN, 2003, JAMA-J AM MED ASSOC, V289, P1652, DOI 10.1001/jama.289.13.1652; Kiyotani K, 2008, CANCER SCI, V99, P995, DOI 10.1111/j.1349-7006.2008.00780.x; Kurdyak PA, 2005, J CLIN PSYCHOPHARM, V25, P561, DOI 10.1097/01.jcp.0000186869.67418.bc; Lash TL, 2008, BRIT J CANCER, V99, P616, DOI 10.1038/sj.bjc.6604533; Lehmann D, 2004, J CLIN PHARMACOL, V44, P861, DOI 10.1177/0091270004266618; Lim YC, 2006, J PHARMACOL EXP THER, V318, P503, DOI 10.1124/jpet.105.100511; Loprinzi CL, 2008, MENOPAUSE, V15, P655, DOI 10.1097/gme.0b013e3181679150; Loprinzi CL, 2000, LANCET, V356, P2059, DOI 10.1016/S0140-6736(00)03403-6; Mamdani M, 2003, ARCH INTERN MED, V163, P481, DOI 10.1001/archinte.163.4.481; Mortimer JE, 2008, BREAST CANCER RES TR, V108, P421, DOI 10.1007/s10549-007-9612-x; Park-Wyllie LY, 2006, NEW ENGL J MED, V354, P1352, DOI 10.1056/NEJMoa055191; Rae JM, 2009, PHARMACOGENOMICS J, V9, P258, DOI 10.1038/tpj.2009.14; Reich M, 2008, BREAST CANCER RES TR, V110, P9, DOI 10.1007/s10549-007-9706-5; Salkeld E, 2008, J CLIN PSYCHOPHARM, V28, P230, DOI 10.1097/JCP.0b013e318166c52e; Schneeweiss S, 2001, AM J EPIDEMIOL, V154, P854, DOI 10.1093/aje/154.9.854; SCHOENFELD D, 1982, BIOMETRIKA, V69, P239, DOI 10.1093/biomet/69.1.239; Schroth W, 2007, J CLIN ONCOL, V25, P5187, DOI 10.1200/JCO.2007.12.2705; Schroth W, 2009, JAMA-J AM MED ASSOC, V302, P1429, DOI 10.1001/jama.2009.1420; Stearns V, 2003, JNCI-J NATL CANCER I, V95, P1758, DOI 10.1093/jnci/djg108; Tatsumi M, 1997, EUR J PHARMACOL, V340, P249, DOI 10.1016/S0014-2999(97)01393-9; Venkatakrishnan K, 2007, XENOBIOTICA, V37, P1225, DOI 10.1080/00498250701670945; Venkatakrishnan K, 2005, DRUG METAB DISPOS, V33, P845, DOI 10.1124/dmd.105.004077; Xu Y, 2008, ANN ONCOL, V19, P1423, DOI 10.1093/annonc/mdn155	51	264	272	0	23	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 8	2010	340								c693	10.1136/bmj.c693	http://dx.doi.org/10.1136/bmj.c693			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZQ	20142325	hybrid, Green Published			2022-12-01	WOS:000274476600004
J	Khandelwal, A; Cho, SH; Marella, H; Sakata, Y; Perroud, PF; Pan, A; Quatrano, RS				Khandelwal, A.; Cho, S. H.; Marella, H.; Sakata, Y.; Perroud, P. -F.; Pan, A.; Quatrano, R. S.			Role of ABA and ABI3 in Desiccation Tolerance	SCIENCE			English	Article							PHYSCOMITRELLA-PATENS; STRESS; MOSS		[Perroud, P. -F.; Quatrano, R. S.] Washington Univ, Dept Biol, St Louis, MO 63130 USA; [Khandelwal, A.; Pan, A.] Monsanto Co, St Louis, MO 63017 USA; [Cho, S. H.] Penn State Univ, Dept Biol, State Coll, PA 16802 USA; [Marella, H.] Donald Danforth Plant Sci Ctr, St Louis, MO 63132 USA; [Sakata, Y.] Tokyo Univ Agr, Dept Biosci, Tokyo 1568502, Japan	Washington University (WUSTL); Monsanto; Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Donald Danforth Plant Science Center; Tokyo University of Agriculture	Quatrano, RS (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	rsq@wustl.edu	Yoichi, Sakata/M-7482-2013	Yoichi, Sakata/0000-0002-9625-4966; Perroud, Pierre-Francois/0000-0001-7607-3618	NSF [EF-0425749]; Washington University	NSF(National Science Foundation (NSF)); Washington University	We thank L. Gunther and L. Maines for technical support and D. Cove and S. McDaniel for many helpful discussions. Supported by funds from NSF (EF-0425749) and Washington University.	[Anonymous], 1997, MECH ENV STRESS RESI; Finkelstein R, 2008, ANNU REV PLANT BIOL, V59, P387, DOI 10.1146/annurev.arplant.59.032607.092740; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; Johri M. M., 2008, Physiology and Molecular Biology of Plants, V14, P23, DOI 10.1007/s12298-008-0003-5; KNIGHT CD, 1995, PLANT CELL, V7, P499, DOI 10.1105/tpc.7.5.499; Marella HH, 2006, PLANT J, V46, P1032, DOI 10.1111/j.1365-313X.2006.02764.x; Oliver MJ, 2005, INTEGR COMP BIOL, V45, P788, DOI 10.1093/icb/45.5.788; Perroud PF, 2008, PLANT CELL, V20, P411, DOI 10.1105/tpc.107.053256; Rensing SA, 2008, SCIENCE, V319, P64, DOI 10.1126/science.1150646	9	150	161	1	66	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					546	546		10.1126/science.1183672	http://dx.doi.org/10.1126/science.1183672			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110497				2022-12-01	WOS:000274020500028
J	Keith, DW; Parson, E; Morgan, MG				Keith, David W.; Parson, Edward; Morgan, M. Granger			Research on global sun block needed now	NATURE			English	Editorial Material									[Keith, David W.] Univ Calgary, Energy & Environm Syst Grp, Calgary, AB T2N 1N4, Canada; [Parson, Edward] Univ Michigan, Ann Arbor, MI 48109 USA; [Morgan, M. Granger] Carnegie Mellon Univ, Dept Engn & Publ Policy, Pittsburgh, PA 15213 USA	University of Calgary; University of Michigan System; University of Michigan; Carnegie Mellon University	Keith, DW (corresponding author), Univ Calgary, Energy & Environm Syst Grp, Calgary, AB T2N 1N4, Canada.	keith@ucalgary.ca	Keith, David W/E-9777-2010	Keith, David W/0000-0002-8224-3780	Direct For Social, Behav & Economic Scie [0949710] Funding Source: National Science Foundation	Direct For Social, Behav & Economic Scie(National Science Foundation (NSF)NSF - Directorate for Social, Behavioral & Economic Sciences (SBE))		Heckendorn P, 2009, ENVIRON RES LETT, V4, DOI 10.1088/1748-9326/4/4/045108; Robock A, 2008, J GEOPHYS RES-ATMOS, V113, DOI [10.1029/2008JD010050, 10.1175/2779.1]; Tilmes S, 2009, J GEOPHYS RES-ATMOS, V114, DOI 10.1029/2008JD011420	3	141	143	0	19	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					426	427		10.1038/463426a	http://dx.doi.org/10.1038/463426a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	548QK	20110972				2022-12-01	WOS:000273981100022
J	Zhong, L; D'Urso, A; Toiber, D; Sebastian, C; Henry, RE; Vadysirisack, DD; Guimaraes, A; Marinelli, B; Wikstrom, JD; Nir, T; Clish, CB; Vaitheesvaran, B; Iliopoulos, O; Kurland, I; Dor, Y; Weissleder, R; Shirihai, OS; Ellisen, LW; Espinosa, JM; Mostoslavsky, R				Zhong, Lei; D'Urso, Agustina; Toiber, Debra; Sebastian, Carlos; Henry, Ryan E.; Vadysirisack, Douangsone D.; Guimaraes, Alexander; Marinelli, Brett; Wikstrom, Jakob D.; Nir, Tomer; Clish, Clary B.; Vaitheesvaran, Bhavapriya; Iliopoulos, Othon; Kurland, Irwin; Dor, Yuval; Weissleder, Ralph; Shirihai, Orian S.; Ellisen, Leif W.; Espinosa, Joaquin M.; Mostoslavsky, Raul			The Histone Deacetylase Sirt6 Regulates Glucose Homeostasis via Hif1 alpha	CELL			English	Article							HYPOXIA-INDUCIBLE FACTOR-1; CALORIE RESTRICTION; MITOCHONDRIAL-FUNCTION; GENOMIC INSTABILITY; GENE-EXPRESSION; LIFE-SPAN; HIF-1-ALPHA; CELLS; HIF-1; ACETYLATION	SIRT6 is a member of a highly conserved family of NAD(+)-dependent deacetylases with various roles in metabolism, stress resistance, and life span. SIRT6-deficient mice develop normally but succumb to a lethal hypoglycemia early in life; however, the mechanism underlying this hypoglycemia remained unclear. Here, we demonstrate that SIRT6 functions as a histone H3K9 deacetylase to control the expression of multiple glycolytic genes. Specifically, SIRT6 appears to function as a corepressor of the transcription factor Hif1 alpha, a critical regulator of nutrient stress responses. Consistent with this notion, SIRT6-deficient cells exhibit increased Hif1 alpha activity and show increased glucose uptake with upregulation of glycolysis and diminished mitochondrial respiration. Our studies uncover a role for the chromatin factor SIRT6 as a master regulator of glucose homeostasis and may provide the basis for novel therapeutic approaches against metabolic diseases, such as diabetes and obesity.	[Zhong, Lei; D'Urso, Agustina; Toiber, Debra; Sebastian, Carlos; Vadysirisack, Douangsone D.; Iliopoulos, Othon; Ellisen, Leif W.; Mostoslavsky, Raul] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA; [Henry, Ryan E.; Espinosa, Joaquin M.] Univ Colorado, Dept Mol Cellular & Dev Biol, Howard Hughes Med Inst, Boulder, CO 80309 USA; [Guimaraes, Alexander; Marinelli, Brett; Weissleder, Ralph] Massachusetts Gen Hosp, Ctr Syst Biol, Boston, MA 02114 USA; [Iliopoulos, Othon] Massachusetts Gen Hosp, Dept Med, Hematol Oncol Unit, Boston, MA 02114 USA; [Wikstrom, Jakob D.; Shirihai, Orian S.] Boston Univ, Sch Med, Dept Mol Med, Boston, MA 02118 USA; [Nir, Tomer; Dor, Yuval] Hebrew Univ Jerusalem, Hadassah Med Sch, Inst Med Res Israel Canada, Dept Dev Biol & Canc Res, IL-91120 Jerusalem, Israel; [Clish, Clary B.] Broad Inst MIT & Harvard, Ctr Prote, Cambridge, MA 02142 USA; [Vaitheesvaran, Bhavapriya; Kurland, Irwin] Albert Einstein Coll Med, Michael F Price Ctr, Bronx, NY 10461 USA; [Wikstrom, Jakob D.] Stockholm Univ, Arrhenius Labs F3, Wenner Gren Inst, SE-10691 Stockholm, Sweden	Harvard University; Harvard Medical School; Massachusetts General Hospital; Howard Hughes Medical Institute; University of Colorado System; University of Colorado Boulder; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Boston University; Hebrew University of Jerusalem; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Yeshiva University; Albert Einstein College of Medicine; Stockholm University	Mostoslavsky, R (corresponding author), Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Canc, Boston, MA 02114 USA.	rmostoslavsky@mgh.harvard.edu	Clish, Clary/AAB-7124-2019; Sebastian, Carlos/H-8014-2018; Dor, Yuval/C-2405-2011; Ellisen, Leif W/AAA-6572-2022; Clish, Clary B/ABB-9374-2021; Sebastian, Carlos/CAG-6271-2022	Sebastian, Carlos/0000-0001-6623-8028; Ellisen, Leif W/0000-0003-0444-7910; Clish, Clary B/0000-0001-8259-9245; DUrso, Agustina/0000-0003-1406-4390; Shirihai, Orian/0000-0002-9502-2661; Wikstrom, Jakob/0000-0002-4287-1774	V Foundation; Sidney Kimmel Cancer Research Foundation; AFAR; The Massachusetts Life Sciences Center; Joslin Diabetes Center; Metabolic Physiology Core [P30 DK57521]; Brain Power for Israel Fund; NIH [RO1 CA117907]; Howard Hughes Medical Institute; NATIONAL CANCER INSTITUTE [R01CA122589, R01CA117907] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK058132, R01DK088190, R01DK035914, P30DK057521, R01DK056690] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093072] Funding Source: NIH RePORTER	V Foundation; Sidney Kimmel Cancer Research Foundation; AFAR; The Massachusetts Life Sciences Center; Joslin Diabetes Center; Metabolic Physiology Core; Brain Power for Israel Fund; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by the V Foundation (R.M.), the Sidney Kimmel Cancer Research Foundation (R.M.), a New Investigator Grant from AFAR (R.M.), A New Investigator Award from The Massachusetts Life Sciences Center (R.M.), a P&F Award from the Joslin Diabetes Center (R.M.), and Grant P30 DK57521 from the Metabolic Physiology Core (BADERC). D. T. is supported by a fellowship from the Brain Power for Israel Fund. Y.D. is supported by JDRF. J.M.E. is supported by NIH-RO1 CA117907 and the Howard Hughes Medical Institute. We thank Magali Silberman, Daniel Holoch, Pere Puigserver, John Dominy, Matthew Vander Heiden, Mike Zimmer, David Lombard, Bjoern Schwer, Fred Alt, Katrin Chua, and members of the Bardeesy, Hochedlinger, Hock, and Ramaswamy labs for reagents and helpful discussions. We thank Kelly Shay, Laura Prickett-Rice, and Kate Folz-Donahue for technical assistance. We are also thankful to Nabeel Bardeesy and Hanno Hock for critically reading the manuscript and Jose Polo for assistance with the ChIP assays.	Aragones J, 2009, CELL METAB, V9, P11, DOI 10.1016/j.cmet.2008.10.001; Arany Z, 1996, P NATL ACAD SCI USA, V93, P12969, DOI 10.1073/pnas.93.23.12969; Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Barzilai N, 2009, J GERONTOL A-BIOL, V64, P187, DOI 10.1093/gerona/gln061; Bassing CH, 2002, P NATL ACAD SCI USA, V99, P8173, DOI 10.1073/pnas.122228699; Baur JA, 2006, NATURE, V444, P337, DOI 10.1038/nature05354; Bensaad K, 2006, CELL, V126, P107, DOI 10.1016/j.cell.2006.05.036; Bert AG, 2006, RNA, V12, P1074, DOI 10.1261/rna.2320506; Boiselle PM, 1998, RADIOGRAPHICS, V18, P1061, DOI 10.1148/radiographics.18.5.9747607; Canto C, 2009, NATURE, V458, P1056, DOI 10.1038/nature07813; Carmeliet P, 1998, NATURE, V394, P485, DOI 10.1038/28867; Chen D, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000486; Cheng HL, 2003, P NATL ACAD SCI USA, V100, P10794, DOI 10.1073/pnas.1934713100; Cohen HY, 2004, SCIENCE, V305, P390, DOI 10.1126/science.1099196; Core LJ, 2008, SCIENCE, V319, P1791, DOI 10.1126/science.1150843; Donner AJ, 2007, MOL CELL, V27, P121, DOI 10.1016/j.molcel.2007.05.026; Finkel T, 2009, NATURE, V460, P587, DOI 10.1038/nature08197; Frye RA, 2000, BIOCHEM BIOPH RES CO, V273, P793, DOI 10.1006/bbrc.2000.3000; Fukuda R, 2007, CELL, V129, P111, DOI 10.1016/j.cell.2007.01.047; Haigis MC, 2006, GENE DEV, V20, P2913, DOI 10.1101/gad.1467506; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hirota K, 2005, BIOCHEM BIOPH RES CO, V338, P610, DOI 10.1016/j.bbrc.2005.08.193; Hu CJ, 2006, MOL CELL BIOL, V26, P3514, DOI 10.1128/MCB.26.9.3514-3526.2006; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; Kallio PJ, 1998, EMBO J, V17, P6573, DOI 10.1093/emboj/17.22.6573; Kawahara TLA, 2009, CELL, V136, P62, DOI 10.1016/j.cell.2008.10.052; Kilic M, 2007, ONCOGENE, V26, P2027, DOI 10.1038/sj.onc.1210008; Kim JW, 2006, CELL METAB, V3, P177, DOI 10.1016/j.cmet.2006.02.002; Lagouge M, 2006, CELL, V127, P1109, DOI 10.1016/j.cell.2006.11.013; Lewis GD, 2008, J CLIN INVEST, V118, P3503, DOI 10.1172/JCI35111; Liu J, 2009, NATURE, V459, P387, DOI 10.1038/nature08040; Longo VD, 2006, CELL, V126, P257, DOI 10.1016/j.cell.2006.07.002; Lu HS, 2002, J BIOL CHEM, V277, P23111, DOI 10.1074/jbc.M202487200; Lum JJ, 2007, GENE DEV, V21, P1037, DOI 10.1101/gad.1529107; Mehta R, 2009, SCIENCE, V324, P1196, DOI 10.1126/science.1173507; Michishita E, 2008, NATURE, V452, P492, DOI 10.1038/nature06736; Milne JC, 2007, NATURE, V450, P712, DOI 10.1038/nature06261; Mostoslavsky R, 2006, CELL, V124, P315, DOI [10.1016/j.cell.2005.11.044, 10.1016/J.CEL.2005.11.044]; Murray-Rust TA, 2006, FEBS LETT, V580, P1911, DOI 10.1016/j.febslet.2006.02.012; Nemoto S, 2004, SCIENCE, V306, P2105, DOI 10.1126/science.1101731; Papandreou I, 2006, CELL METAB, V3, P187, DOI 10.1016/j.cmet.2006.01.012; PESSIN JE, 1992, ANNU REV PHYSIOL, V54, P911, DOI 10.1146/annurev.ph.54.030192.004403; Seagroves TN, 2001, MOL CELL BIOL, V21, P3436, DOI 10.1128/MCB.21.10.3436-3444.2001; Serikawa KA, 2003, MOL CELL PROTEOMICS, V2, P191, DOI 10.1074/mcp.D200002-MCP200; WARBURG O, 1956, SCIENCE, V123, P309, DOI 10.1126/science.123.3191.309; Xia XB, 2009, P NATL ACAD SCI USA, V106, P4260, DOI 10.1073/pnas.0810067106; Xu J, 2004, ENDOCRINOLOGY, V145, P1087, DOI 10.1210/en.2003-1173; Yu JJ, 2009, ANN NY ACAD SCI, V1173, pE10, DOI 10.1111/j.1749-6632.2009.04952.x; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001; Zimmer M, 2008, MOL CELL, V32, P838, DOI 10.1016/j.molcel.2008.12.004	50	736	769	1	100	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					280	293		10.1016/j.cell.2009.12.041	http://dx.doi.org/10.1016/j.cell.2009.12.041			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141841	Green Accepted, Bronze			2022-12-01	WOS:000273826500018
J	Aspinall, W				Aspinall, Willy			A route to more tractable expert advice	NATURE			English	Editorial Material									[Aspinall, Willy] Univ Bristol, Bristol BS8 1RJ, Avon, England; [Aspinall, Willy] Aspinall & Associates, Tisbury SP3 6HF, England	University of Bristol	Aspinall, W (corresponding author), Univ Bristol, Bristol BS8 1RJ, Avon, England.	Willy.Aspinall@Bristol.ac.uk	Aspinall, Willy/AAW-1022-2020	Aspinall, Willy/0000-0001-6014-6042				Aspinall W, 1998, PROBABILISTIC SAFETY ASSESSMENT AND MANAGEMENT (PSAM 4), VOLS 1-4, P2113; Cooke, 1991, EXPERTS UNCERTAINTY, P10016; Cooke RM, 2008, RELIAB ENG SYST SAFE, V93, P745, DOI 10.1016/j.ress.2007.03.017; Krupnick A., 2006, NOT SURE THING MAKIN; Oppenheimer M, 2007, SCIENCE, V317, P1505, DOI 10.1126/science.1144831; TYSHENKO MG, 2009, EXP EL WORKSH RES LA	6	199	203	0	38	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					294	295		10.1038/463294a	http://dx.doi.org/10.1038/463294a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	545PM	20090733				2022-12-01	WOS:000273748100021
J	Farzaneh-Far, R; Lin, J; Epel, ES; Harris, WS; Blackburn, EH; Whooley, MA				Farzaneh-Far, Ramin; Lin, Jue; Epel, Elissa S.; Harris, William S.; Blackburn, Elizabeth H.; Whooley, Mary A.			Association of Marine Omega-3 Fatty Acid Levels With Telomeric Aging in Patients With Coronary Heart Disease	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							POLYUNSATURATED FATTY-ACIDS; DEPRESSIVE SYMPTOMS; OXIDATIVE-STRESS; QUANTITATIVE PCR; OMEGA-3 INDEX; RISK-FACTOR; LENGTH; BLOOD; DEATH; LIFE	Context Increased dietary intake of marine omega-3 fatty acids is associated with prolonged survival in patients with coronary heart disease. However, the mechanisms underlying this protective effect are poorly understood. Objective To investigate the association of omega-3 fatty acid blood levels with temporal changes in telomere length, an emerging marker of biological age. Design, Setting, and Participants Prospective cohort study of 608 ambulatory outpatients in California with stable coronary artery disease recruited from the Heart and Soul Study between September 2000 and December 2002 and followed up to January 2009 (median, 6.0 years; range, 5.0-8.1 years). Main Outcome Measures We measured leukocyte telomere length at baseline and again after 5 years of follow-up. Multivariable linear and logistic regression models were used to investigate the association of baseline levels of omega-3 fatty acids (docosahexaenoic acid [DHA] and eicosapentaenoic acid [EPA]) with subsequent change in telomere length. Results Individuals in the lowest quartile of DHA + EPA experienced the fastest rate of telomere shortening (0.13 telomere-to-single-copy gene ratio [T/S] units over 5 years; 95% confidence interval [CI], 0.09-0.17), whereas those in the highest quartile experienced the slowest rate of telomere shortening (0.05 T/S units over 5 years; 95% CI, 0.02-0.08; P < .001 for linear trend across quartiles). Levels of DHA + EPA were associated with less telomere shortening before (unadjusted beta coefficient x 10(-3) = 0.06; 95% CI, 0.02-0.10) and after (adjusted beta coefficient x 10(-3) = 0.05; 95% CI, 0.01-0.08) sequential adjustment for established risk factors and potential confounders. Each 1-SD increase in DHA + EPA levels was associated with a 32% reduction in the odds of telomere shortening (adjusted odds ratio, 0.68; 95% CI, 0.47-0.98). Conclusion Among this cohort of patients with coronary artery disease, there was an inverse relationship between baseline blood levels of marine omega-3 fatty acids and the rate of telomere shortening over 5 years. JAMA. 2010;303(3):250-257	[Farzaneh-Far, Ramin] Univ Calif San Francisco, Div Cardiol, San Francisco Gen Hosp, San Francisco, CA 94110 USA; [Farzaneh-Far, Ramin; Whooley, Mary A.] Univ Calif San Francisco, Dept Med, San Francisco, CA USA; [Lin, Jue; Blackburn, Elizabeth H.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94143 USA; [Whooley, Mary A.] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA 94143 USA; [Whooley, Mary A.] Vet Affairs Med Ctr, San Francisco, CA 94121 USA; [Harris, William S.] Univ S Dakota, Sanford Res USD, Sioux Falls, SD USA; [Harris, William S.] Univ S Dakota, Sanford Sch Med, Sioux Falls, SD USA	San Francisco General Hospital Medical Center; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; US Department of Veterans Affairs; Veterans Health Administration (VHA); Sanford Health; University of South Dakota; University of South Dakota	Farzaneh-Far, R (corresponding author), Univ Calif San Francisco, Div Cardiol, San Francisco Gen Hosp, Room 5G1,1001 Potrero Ave, San Francisco, CA 94110 USA.	rfarzanehfar@medicine.ucsf.edu	Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353	GlaxoSmithKline; Monsanto; American Heart Association [0875014N]; Department of Veterans Affairs; National Heart, Lung, and Blood Institute [R01 HL079235]; Robert Wood Johnson Foundation; American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; Bernard and Barbro Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL079235] Funding Source: NIH RePORTER	GlaxoSmithKline(GlaxoSmithKline); Monsanto; American Heart Association(American Heart Association); Department of Veterans Affairs(US Department of Veterans Affairs); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); American Federation for Aging Research; Ischemia Research and Education Foundation; Nancy Kirwan Heart Research Fund; Bernard and Barbro Foundation; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Dr Harris reports that he is an advisor to, a speaker for, and has received research grants from companies with interests in omega-3 fatty acids, including GlaxoSmithKline and Monsanto. In addition, he has recently founded a company (OmegaQuant Analytics) to offer blood omega-3 fatty acid testing. No other disclosures were reported.; Dr Farzaneh-Far is supported by an American Heart Association Fellow-to-Faculty Transition Award (grant 0875014N). The Heart and Soul Study was supported by the Department of Veterans Affairs (Epidemiology Merit Review Program), the National Heart, Lung, and Blood Institute (grant R01 HL079235), the Robert Wood Johnson Foundation (Generalist Physician Faculty Scholars Program), the American Federation for Aging Research (Paul Beeson Faculty Scholars in Aging Research Program), the Ischemia Research and Education Foundation, and the Nancy Kirwan Heart Research Fund. Dr Lin is supported by the Bernard and Barbro Foundation.	Albanese E, 2009, AM J CLIN NUTR, V90, P392, DOI 10.3945/ajcn.2009.27580; Albert CM, 2002, NEW ENGL J MED, V346, P1113, DOI 10.1056/NEJMoa012918; Aviv A, 2008, J GERONTOL A-BIOL, V63, P979, DOI 10.1093/gerona/63.9.979; Aviv A, 2009, AM J CLIN NUTR, V89, P1721, DOI 10.3945/ajcn.2009.27807; Aviv A, 2009, AM J EPIDEMIOL, V169, P323, DOI 10.1093/aje/kwn338; Bekaert S, 2007, AGING CELL, V6, P639, DOI 10.1111/j.1474-9726.2007.00321.x; Blackburn EH, 2001, CELL, V106, P661, DOI 10.1016/S0092-8674(01)00492-5; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Brouilette S, 2003, ARTERIOSCL THROM VAS, V23, P842, DOI 10.1161/01.ATV.0000067426.96344.32; Brouilette SW, 2007, LANCET, V369, P107, DOI 10.1016/S0140-6736(07)60071-3; BURR ML, 1989, LANCET, V2, P757; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chan SRWL, 2004, PHILOS T R SOC B, V359, P109, DOI 10.1098/rstb.2003.1370; Eitsuka T, 2005, BBA-MOL CELL BIOL L, V1737, P1, DOI 10.1016/j.bbalip.2005.08.017; Epel ES, 2009, HORM-INT J ENDOCRINO, V8, P7, DOI 10.14310/horm.2002.1217; Epel ES, 2009, AGING-US, V1, P81; Farzaneh-Far R, 2008, ARTERIOSCL THROM VAS, V28, P1379, DOI 10.1161/ATVBAHA.108.167049; Furumoto K, 1998, LIFE SCI, V63, P935, DOI 10.1016/S0024-3205(98)00351-8; Fuster JJ, 2006, CIRC RES, V99, P1167, DOI 10.1161/01.RES.0000251281.00845.18; Gao L, 2007, J BIOL CHEM, V282, P2529, DOI 10.1074/jbc.M607622200; Gil ME, 2004, MOL BIOTECHNOL, V27, P169, DOI 10.1385/MB:27:2:169; Hamazaki K, 2009, CLIN NEPHROL, V71, P508; Harris WS, 2008, AM J CLIN NUTR, V87, p1997S, DOI 10.1093/ajcn/87.6.1997S; Harris WS, 2008, ATHEROSCLEROSIS, V197, P12, DOI 10.1016/j.atherosclerosis.2007.11.008; Harris WS, 2004, PREV MED, V39, P212, DOI 10.1016/j.ypmed.2004.02.030; Hunt SC, 2008, AGING CELL, V7, P451, DOI 10.1111/j.1474-9726.2008.00397.x; Jolly CA, 2001, J NUTR, V131, P2753, DOI 10.1093/jn/131.10.2753; Kris-Etherton PM, 2002, CIRCULATION, V106, P2747, DOI 10.1161/01.CIR.0000038493.65177.94; Lee JH, 2008, MAYO CLIN PROC, V83, P324, DOI 10.4065/83.3.324; Lin J, 2010, J IMMUNOL METHODS, V352, P71, DOI 10.1016/j.jim.2009.09.012; Marchioli R, 2002, CIRCULATION, V105, P1897, DOI 10.1161/01.CIR.0000014682.14181.F2; Milne GL, 2008, J BIOL CHEM, V283, P15533, DOI 10.1074/jbc.R700047200; Nettleton JA, 2008, AM J CLIN NUTR, V88, P1405, DOI 10.3945/ajcn.2008.26429; Njajou OT, 2009, J GERONTOL A-BIOL, V64, P860, DOI 10.1093/gerona/glp061; Nordfjall K, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000375; Olovnikov AM, 1996, EXP GERONTOL, V31, P443, DOI 10.1016/0531-5565(96)00005-8; Ornish D, 2008, LANCET ONCOL, V9, P1048, DOI 10.1016/S1470-2045(08)70234-1; Paul L, 2009, J NUTR, V139, P1273, DOI 10.3945/jn.109.104984; Pepe S, 2007, ANN NY ACAD SCI, V1114, P381, DOI 10.1196/annals.1396.046; Richards JB, 2007, AM J CLIN NUTR, V86, P1420, DOI 10.1093/ajcn/86.5.1420; Romieu I, 2008, ENVIRON HEALTH PERSP, V116, P1237, DOI 10.1289/ehp.10578; Ruo B, 2003, JAMA-J AM MED ASSOC, V290, P215, DOI 10.1001/jama.290.2.215; Satoh M, 2009, CLIN SCI, V116, P827, DOI 10.1042/CS20080404; Shrier I, 2008, BMC MED RES METHODOL, V8, DOI 10.1186/1471-2288-8-70; Spyridopoulos I, 2004, CIRCULATION, V110, P3136, DOI 10.1161/01.CIR.0000142866.50300.EB; Tan JSL, 2009, ARCH OPHTHALMOL-CHIC, V127, P656, DOI 10.1001/archophthalmol.2009.76; Tanaka Y, 2007, J CELL BIOCHEM, V102, P689, DOI 10.1002/jcb.21322; Tomiyama H, 2005, HYPERTENS RES, V28, P651, DOI 10.1291/hypres.28.651; Valdes AM, 2005, LANCET, V366, P662, DOI 10.1016/S0140-6736(05)66630-5; Visioli F, 2007, PHARMACOL RES, V55, P199, DOI 10.1016/j.phrs.2007.01.008; Weng NP, 1996, J EXP MED, V183, P2471, DOI 10.1084/jem.183.6.2471; Whooley MA, 2008, JAMA-J AM MED ASSOC, V300, P2379, DOI 10.1001/jama.2008.711; Wong JMY, 2003, LANCET, V362, P983, DOI 10.1016/S0140-6736(03)14369-3; Xu Q, 2009, AM J CLIN NUTR, V89, P1857, DOI 10.3945/ajcn.2008.26986	55	223	235	0	33	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					250	257		10.1001/jama.2009.2008	http://dx.doi.org/10.1001/jama.2009.2008			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20085953	Green Accepted, Bronze			2022-12-01	WOS:000273690600021
J	Fogarty, J; McCally, M				Fogarty, John; McCally, Michael			Health and Safety Risks of Carbon Capture and Storage	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Fogarty, John] Univ New Mexico, Dept Family Med, Albuquerque, NM 87131 USA; [McCally, Michael] Mt Sinai Sch Med, Dept Prevent Med, New York, NY USA	University of New Mexico; Icahn School of Medicine at Mount Sinai	McCally, M (corresponding author), 64 Lodge Trl, Santa Fe, NM 87506 USA.	michaelmccally@comcast.net						BAXTER PJ, 1989, BRIT MED J, V298, P1437, DOI 10.1136/bmj.298.6685.1437; *CTR HLTH GLOB ENV, HLTH SOL LOW CARB EC; Ford M, 2000, CLIN TOXICOLOGY; HAMILTON A, 1998, IND TOXICOLOGY; Haszeldine RS, 2009, SCIENCE, V325, P1647, DOI 10.1126/science.1172246; *INT EN AG, PROSP CO2 CAPT STOR; Schrag DP, 2007, SCIENCE, V315, P812, DOI 10.1126/science.1137632; Spreng D, 2007, ENERG POLICY, V35, P850, DOI 10.1016/j.enpol.2006.10.009; 2009, ECONOMIST       0305, P74; 2009, ECONOMIST       0305, P20	10	19	20	1	8	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					67	68		10.1001/jama.2009.1951	http://dx.doi.org/10.1001/jama.2009.1951			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051572				2022-12-01	WOS:000273296900022
J	Ossowski, S; Schneeberger, K; Lucas-Lledo, JI; Warthmann, N; Clark, RM; Shaw, RG; Weigel, D; Lynch, M				Ossowski, Stephan; Schneeberger, Korbinian; Lucas-Lledo, Jose Ignacio; Warthmann, Norman; Clark, Richard M.; Shaw, Ruth G.; Weigel, Detlef; Lynch, Michael			The Rate and Molecular Spectrum of Spontaneous Mutations in Arabidopsis thaliana	SCIENCE			English	Article							GENOME-WIDE VIEW; SHORT READS; DIVERSITY; SEQUENCE	To take complete advantage of information on within-species polymorphism and divergence from close relatives, one needs to know the rate and the molecular spectrum of spontaneous mutations. To this end, we have searched for de novo spontaneous mutations in the complete nuclear genomes of five Arabidopsis thaliana mutation accumulation lines that had been maintained by single-seed descent for 30 generations. We identified and validated 99 base substitutions and 17 small and large insertions and deletions. Our results imply a spontaneous mutation rate of 7 x 10(-9) base substitutions per site per generation, the majority of which are G:C -> A:T transitions. We explain this very biased spectrum of base substitution mutations as a result of two main processes: deamination of methylated cytosines and ultraviolet light-induced mutagenesis.	[Lucas-Lledo, Jose Ignacio; Lynch, Michael] Indiana Univ, Dept Biol, Bloomington, IN 47405 USA; [Ossowski, Stephan; Schneeberger, Korbinian; Warthmann, Norman; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Clark, Richard M.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Shaw, Ruth G.] Univ Minnesota, Dept Ecol Evolut & Behav, St Paul, MN 55108 USA	Indiana University System; Indiana University Bloomington; Max Planck Society; Utah System of Higher Education; University of Utah; University of Minnesota System; University of Minnesota Twin Cities	Lucas-Lledo, JI (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	joslucas@indiana.edu; weigel@weigelworld.org	Weigel, Detlef/AAR-3312-2021; Lucas Lledó, José Ignacio/L-3112-2014; Weigel, Detlef/C-1418-2008; Ossowski, Stephan/E-2139-2011; Schneeberger, Korbinian/U-6329-2019; Warthmann, Norman/E-1069-2011; Weigel, Detlef/GSJ-0799-2022; Lledó, José Ignacio Lucas/AAA-5392-2019	Lucas Lledó, José Ignacio/0000-0001-6254-8942; Weigel, Detlef/0000-0002-2114-7963; Ossowski, Stephan/0000-0002-7416-9568; Schneeberger, Korbinian/0000-0002-5512-0443; Warthmann, Norman/0000-0002-1178-8409; Weigel, Detlef/0000-0002-2114-7963; Lledó, José Ignacio Lucas/0000-0001-6254-8942	NIGMS NIH HHS [R01 GM036827, GM36827] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM036827] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; COULONDRE C, 1978, NATURE, V274, P775, DOI 10.1038/274775a0; Denver DR, 2009, P NATL ACAD SCI USA, V106, P16310, DOI 10.1073/pnas.0904895106; Friedberg E.C., 2006, DNA REPAIR MUTAGENES; Kaul S, 2000, NATURE, V408, P796, DOI 10.1038/35048692; Kawabe A, 2008, GENETICS, V179, P985, DOI 10.1534/genetics.107.085282; Keightley PD, 2009, GENOME RES, V19, P1195, DOI 10.1101/gr.091231.109; LINDAHL T, 1974, BIOCHEMISTRY-US, V13, P3405, DOI 10.1021/bi00713a035; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Lynch M, 2008, MOL BIOL EVOL, V25, P2409, DOI 10.1093/molbev/msn185; Lynch M, 2008, P NATL ACAD SCI USA, V105, P9272, DOI 10.1073/pnas.0803466105; Marriage TN, 2009, HEREDITY, V103, P310, DOI 10.1038/hdy.2009.67; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Quail MA, 2008, NAT METHODS, V5, P1005, DOI 10.1038/nmeth.1270; Schneeberger K, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-9-r98; Schultz ST, 1999, P NATL ACAD SCI USA, V96, P11393, DOI 10.1073/pnas.96.20.11393; Shaw FH, 2002, EVOLUTION, V56, P453, DOI 10.1111/j.0014-3820.2002.tb01358.x; Shaw RG, 2000, GENETICS, V155, P369; WOLFE KH, 1987, P NATL ACAD SCI USA, V84, P9054, DOI 10.1073/pnas.84.24.9054; Wright SI, 2002, MOL BIOL EVOL, V19, P1407, DOI 10.1093/oxfordjournals.molbev.a004204	21	714	723	9	203	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					92	94		10.1126/science.1180677	http://dx.doi.org/10.1126/science.1180677			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044577	Green Published, Green Accepted			2022-12-01	WOS:000273395400038
J	Vargas-Parada, L				Vargas-Parada, Laura			H1N1: A Mexican Perspective	CELL			English	Editorial Material																			0	9	10	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1203	1205		10.1016/j.cell.2009.12.019	http://dx.doi.org/10.1016/j.cell.2009.12.019			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064360	Bronze			2022-12-01	WOS:000273048700001
J	Harrington, MJ; Masic, A; Holten-Andersen, N; Waite, JH; Fratzl, P				Harrington, Matthew J.; Masic, Admir; Holten-Andersen, Niels; Waite, J. Herbert; Fratzl, Peter			Iron-Clad Fibers: A Metal-Based Biological Strategy for Hard Flexible Coatings	SCIENCE			English	Article							MUSSEL ADHESIVE; MYTILUS-EDULIS; BYSSAL THREADS; CROSS-LINKING; PROTEINS; COMPLEXES; COORDINATION; CATECHOLATE; PEPTIDES; CUTICLE	The extensible byssal threads of marine mussels are shielded from abrasion in wave-swept habitats by an outer cuticle that is largely proteinaceous and approximately fivefold harder than the thread core. Threads from several species exhibit granular cuticles containing a protein that is rich in the catecholic amino acid 3,4-dihydroxyphenylalanine (dopa) as well as inorganic ions, notably Fe3+. Granular cuticles exhibit a remarkable combination of high hardness and high extensibility. We explored byssus cuticle chemistry by means of in situ resonance Raman spectroscopy and demonstrated that the cuticle is a polymeric scaffold stabilized by catecholato-iron chelate complexes having an unusual clustered distribution. Consistent with byssal cuticle chemistry and mechanics, we present a model in which dense cross-linking in the granules provides hardness, whereas the less cross-linked matrix provides extensibility.	[Harrington, Matthew J.; Masic, Admir; Fratzl, Peter] Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany; [Waite, J. Herbert] Univ Calif Santa Barbara, Dept Mol Cellular & Dev Biol, Santa Barbara, CA 93106 USA; [Holten-Andersen, Niels] Univ Chicago, Dept Chem, Chicago, IL 60637 USA	Max Planck Society; University of California System; University of California Santa Barbara; University of Chicago	Harrington, MJ (corresponding author), Max Planck Inst Colloids & Interfaces, Dept Biomat, D-14424 Potsdam, Germany.	Matt.Harrington@mpikg.mpg.de	Fratzl, Peter/H-9095-2012	Fratzl, Peter/0000-0003-4437-7830; Masic, Admir/0000-0002-1207-4926; Holten-Andersen, Niels/0000-0002-5318-9674	Alexander von Humboldt Foundation; Federal Ministry of Education and Research; NIH [R01DE018468]; Danish Natural Science Research Council [272-08-0087]; Materials Research and Engineering Center Program of NSF [DMR05-20415]; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [R01DE018468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH [R01DE015415] Funding Source: NIH RePORTER	Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Danish Natural Science Research Council(Danish Natural Science Research Council); Materials Research and Engineering Center Program of NSF; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL &CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR))	L. Bertinetti (University of Torino) provided technical expertise in operating diffuse-reflectance ultraviolet-vis spectrometry. S. Wasko assisted with scanning electron microscopy (SEM). P. F., M.J.H., and A. M. are grateful for support by the Alexander von Humboldt Foundation and the Max Planck Society in the framework of the Max Planck Research Award funded by the Federal Ministry of Education and Research. M.J.H. was partially funded by an Alexander von Humboldt Research Fellowship for Postdoctoral Researchers. J.H.W. was funded by a grant from NIH (R01DE018468). N.H.A. thanks the Danish Natural Science Research Council for a post-doctoral fellowship (272-08-0087). This work made use of the Materials Research Laboratory central facilities at UCSB supported by the Materials Research and Engineering Center Program of NSF under award DMR05-20415.	AVDEEF A, 1978, J AM CHEM SOC, V100, P5362, DOI 10.1021/ja00485a018; BENEDICT CV, 1986, J MORPHOL, V189, P171, DOI 10.1002/jmor.1051890207; Broomell CC, 2006, J EXP BIOL, V209, P3219, DOI 10.1242/jeb.02373; Carrington E, 2004, AM MALACOL BULL, V18, P135; Chan CM, 2002, POLYMER, V43, P2981, DOI 10.1016/S0032-3861(02)00120-9; Haemers S, 2005, BIOMATERIALS, V26, P1231, DOI 10.1016/j.biomaterials.2004.04.032; Haemers S, 2002, LANGMUIR, V18, P4903, DOI 10.1021/la025626c; Harrington MJ, 2008, BIOMACROMOLECULES, V9, P1480, DOI 10.1021/bm8000827; Harrington MJ, 2009, J STRUCT BIOL, V167, P47, DOI 10.1016/j.jsb.2009.03.001; Holten-Andersen N, 2007, NAT MATER, V6, P669, DOI 10.1038/nmat1956; Holten-Andersen N, 2009, LANGMUIR, V25, P3323, DOI 10.1021/la8027012; Holten-Andersen N, 2009, BIOCHEMISTRY-US, V48, P2752, DOI 10.1021/bi900018m; Lee H, 2006, P NATL ACAD SCI USA, V103, P12999, DOI 10.1073/pnas.0605552103; Lee SM, 2009, SCIENCE, V324, P488, DOI 10.1126/science.1168162; Li HB, 2001, P NATL ACAD SCI USA, V98, P10682, DOI 10.1073/pnas.191189098; Lichtenegger HC, 2003, P NATL ACAD SCI USA, V100, P9144, DOI 10.1073/pnas.1632658100; MICHAUDSORET I, 1995, BIOCHEMISTRY-US, V34, P5504, DOI 10.1021/bi00016a022; Ohrstrom L, 1996, J AM CHEM SOC, V118, P3283, DOI 10.1021/ja953409a; Pires MM, 2009, J AM CHEM SOC, V131, P2706, DOI 10.1021/ja8088845; Schmitt L, 2000, BIOPHYS J, V78, P3275, DOI 10.1016/S0006-3495(00)76863-9; Sever MJ, 2004, ANGEW CHEM INT EDIT, V43, P448, DOI 10.1002/anie.200352759; Sun CJ, 2005, J BIOL CHEM, V280, P39332, DOI 10.1074/jbc.M508674200; TAYLOR SW, 1994, INORG CHEM, V33, P5819, DOI 10.1021/ic00103a032; Taylor SW, 1996, INORG CHEM, V35, P7572, DOI 10.1021/ic960514s; Vaccaro E, 2001, BIOMACROMOLECULES, V2, P906, DOI 10.1021/bm0100514; WAITE JH, 1985, BIOCHEMISTRY-US, V24, P5010, DOI 10.1021/bi00340a008; Wemeke SW, 2007, J EXP BIOL, V210, P2137, DOI 10.1242/jeb.006098; Zhang ZS, 1996, INORG CHEM, V35, P1571, DOI 10.1021/ic941303v; ZUCCARELLO LV, 1981, TISSUE CELL, V13, P701, DOI 10.1016/S0040-8166(81)80007-9	29	673	699	31	585	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	APR 9	2010	328	5975					216	220		10.1126/science.1181044	http://dx.doi.org/10.1126/science.1181044			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	580OU	20203014	Green Accepted			2022-12-01	WOS:000276459600039
J	von Engelhardt, J; Mack, V; Sprengel, R; Kavenstock, N; Li, KW; Stern-Bach, Y; Smit, AB; Seeburg, PH; Monyer, H				von Engelhardt, Jakob; Mack, Volker; Sprengel, Rolf; Kavenstock, Netta; Li, Ka Wan; Stern-Bach, Yael; Smit, August B.; Seeburg, Peter H.; Monyer, Hannah			CKAMP44: A Brain-Specific Protein Attenuating Short-Term Synaptic Plasticity in the Dentate Gyrus	SCIENCE			English	Article							AMPA RECEPTORS; KAINATE RECEPTORS; GLUTAMATE; DESENSITIZATION; DEACTIVATION; TRAFFICKING; AFFINITY	CKAMP44, identified here by a proteomic approach, is a brain-specific type I transmembrane protein that associates with AMPA receptors in synaptic spines. CKAMP44 expressed in Xenopus oocytes reduced GluA1- and A2-mediated steady-state currents, but did not affect kainate-or N-methyl-D-aspartate (NMDA) receptor-mediated currents. Mouse hippocampal CA1 pyramidal neurons expressed CKAMP44 at low abundance, and overexpression of CKAMP44 led to stronger and faster AMPA receptor desensitization, slower recovery from desensitization, and a reduction in the paired-pulse ratio of AMPA currents. By contrast, dentate gyrus granule cells exhibited strong CKAMP44 expression, and CKAMP44 knockout increased the paired-pulse ratio of AMPA currents in lateral and medial perforant path-granule cell synapses. CKAMP44 thus modulates short-term plasticity at specific excitatory synapses.	[von Engelhardt, Jakob; Mack, Volker; Monyer, Hannah] Univ Heidelberg, Dept Clin Neurobiol, D-6910 Heidelberg, Germany; [Mack, Volker; Li, Ka Wan; Smit, August B.] Vrije Univ Amsterdam, Ctr Neurogenom & Cognit Res, Dept Mol & Cellular Neurobiol, NL-1081 HV Amsterdam, Netherlands; [Sprengel, Rolf; Seeburg, Peter H.] Max Planck Inst Med Res, Dept Mol Neurobiol, D-69120 Heidelberg, Germany; [Kavenstock, Netta; Stern-Bach, Yael] Hebrew Univ Jerusalem, Hadassah Med Sch, Dept Biochem & Mol Biol, Inst Med Res Israel Canada, IL-91120 Jerusalem, Israel	Ruprecht Karls University Heidelberg; Vrije Universiteit Amsterdam; Max Planck Society; Hebrew University of Jerusalem	Monyer, H (corresponding author), Univ Heidelberg, Dept Clin Neurobiol, D-6910 Heidelberg, Germany.	monyer@urz.uni-hd.de	von Engelhardt, Jakob/G-7397-2015; von Engelhardt, Jakob/AAD-4920-2021; Smit, August B/E-8410-2011	von Engelhardt, Jakob/0000-0003-3861-3294; von Engelhardt, Jakob/0000-0003-3861-3294; li, ka wan/0000-0001-6983-5055; Monyer, Hannah/0000-0002-9332-5749	Schilling Foundation; EU-Synapse [LSHM-CT-2005-019055]; Nationales Genomforschungsnetz (NGFN); Center for Medical Systems Biology; Max Planck Society;  [SFB636]	Schilling Foundation; EU-Synapse; Nationales Genomforschungsnetz (NGFN); Center for Medical Systems Biology; Max Planck Society(Max Planck Society); 	We thank M. K. Schwarz for recombinant adeno-associated virus delivery into the brains of mouse pups, A. Zivkovich for electrophysiological experiments during the initial stages of this project, L. Layer and S. Giese for help with molecular cloning, R. van der Schors for his contribution to the mass spectrometry, and R. Hinz-Herkommer, I. Preugschat-Gumprecht, and R. Zilberstein for technical assistance. Supported by the Schilling Foundation (H. M.); EU-Synapse LSHM-CT-2005-019055 (H. M., P. H. S., Y.S.B.); SFB636 (R. S. P.) and Nationales Genomforschungsnetz (NGFN) (R. S. P.); the Center for Medical Systems Biology (K. W. L. and A. B. S.); and the Max Planck Society (R. S. P. and P. H. S.). The experimentally verified cDNA CKAMP44 sequences are annotated at the National Center for Biotechnology Information under the accession numbers GU479981 (CKAMP44a) and GU479982 (CKAMP44b).	Chen L, 2003, MOL PHARMACOL, V64, P703, DOI 10.1124/mol.64.3.703; COLQUHOUN D, 1992, J PHYSIOL-LONDON, V458, P261, DOI 10.1113/jphysiol.1992.sp019417; Heinemann SH, 2007, CELL MOL LIFE SCI, V64, P1329, DOI 10.1007/s00018-007-6565-5; Horning MS, 2004, NEURON, V41, P379, DOI 10.1016/S0896-6273(04)00018-2; MCNAUGHTON BL, 1980, BRAIN RES, V199, P1, DOI 10.1016/0006-8993(80)90226-7; Morimoto-Tomita M, 2009, NEURON, V61, P101, DOI 10.1016/j.neuron.2008.11.009; Palmer CL, 2005, PHARMACOL REV, V57, P253, DOI 10.1124/pr.57.2.7; Partin KM, 1996, J NEUROSCI, V16, P6634, DOI 10.1523/jneurosci.16-21-06634.1996; Priel A, 2005, J NEUROSCI, V25, P2682, DOI 10.1523/JNEUROSCI.4834-04.2005; Robert A, 2005, J NEUROSCI, V25, P3752, DOI 10.1523/JNEUROSCI.0188-05.2005; Schwenk J, 2009, SCIENCE, V323, P1313, DOI 10.1126/science.1167852; Stern-Bach Y, 1998, NEURON, V21, P907, DOI 10.1016/S0896-6273(00)80605-4; Tomita S, 2005, NATURE, V435, P1052, DOI 10.1038/nature03624; Tomita S, 2003, J CELL BIOL, V161, P805, DOI 10.1083/jcb.200212116; TRUSSELL LO, 1993, NEURON, V10, P1185, DOI 10.1016/0896-6273(93)90066-Z; Walker CS, 2009, CURR BIOL, V19, P900, DOI 10.1016/j.cub.2009.05.017; Wall MJ, 2005, EUR J NEUROSCI, V21, P2149, DOI 10.1111/j.1460-9568.2005.04048.x; Weston MC, 2006, J NEUROSCI, V26, P7650, DOI 10.1523/JNEUROSCI.1519-06.2006; Zheng Y, 2004, NATURE, V427, P451, DOI 10.1038/nature02244	19	194	197	1	24	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1518	1522		10.1126/science.1184178	http://dx.doi.org/10.1126/science.1184178			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20185686				2022-12-01	WOS:000275715200051
J	Kissa, K; Herbomel, P				Kissa, Karima; Herbomel, Philippe			Blood stem cells emerge from aortic endothelium by a novel type of cell transition	NATURE			English	Article							HAEMOGENIC ENDOTHELIUM; ZEBRAFISH DEVELOPMENT; TRANSGENIC ZEBRAFISH; HEMATOPOIETIC-CELLS; EMBRYOS	The ontogeny of haematopoietic stem cells (HSCs) during embryonic development is still highly debated, especially their possible lineage relationship to vascular endothelial cells(1,2). The first anatomical site from which cells with long-term HSC potential have been isolated is the aorta-gonad-mesonephros (AGM), more specifically the vicinity of the dorsal aortic floor(3). But although some authors have presented evidence that HSCs may arise directly from the aortic floor into the dorsal aortic lumen(4), others support the notion that HSCs first emerge within the underlying mesenchyme(5). Here we show by non-invasive, high-resolution imaging of live zebrafish embryos, that HSCs emerge directly from the aortic floor, through a stereotyped process that does not involve cell division but a strong bending then egress of single endothelial cells from the aortic ventral wall into the sub-aortic space, and their concomitant transformation into haematopoietic cells. The process is polarized not only in the dorso-ventral but also in the rostro-caudal versus medio-lateral direction, and depends on Runx1 expression: in Runx1-deficient embryos, the exit events are initially similar, but much rarer, and abort into violent death of the exiting cell. These results demonstrate that the aortic floor is haemogenic and that HSCs emerge from it into the sub-aortic space, not by asymmetric cell division but through a new type of cell behaviour, which we call an endothelial haematopoietic transition.	[Kissa, Karima; Herbomel, Philippe] Inst Pasteur, Unite Macrophages & Dev Immun, F-75724 Paris 15, France; [Kissa, Karima; Herbomel, Philippe] CNRS, URA2578, F-75724 Paris 15, France	Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; Centre National de la Recherche Scientifique (CNRS)	Herbomel, P (corresponding author), Inst Pasteur, Unite Macrophages & Dev Immun, 25 Rue Dr Roux, F-75724 Paris 15, France.	philippe.herbomel@pasteur.fr	Kissa, Karima/N-6801-2018	Kissa, Karima/0000-0002-7683-3661				Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Blum Y, 2008, DEV BIOL, V316, P312, DOI 10.1016/j.ydbio.2008.01.038; Bussmann J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000064; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Cooper MS, 2005, DEV DYNAM, V232, P359, DOI 10.1002/dvdy.20252; Dieterlen-Lievre F, 2006, TRENDS CARDIOVAS MED, V16, P128, DOI 10.1016/j.tcm.2006.02.005; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Gering M, 2005, DEV CELL, V8, P389, DOI 10.1016/j.devcel.2005.01.010; Godin I, 2002, NAT REV IMMUNOL, V2, P593, DOI 10.1038/nri857; Jin H, 2007, BLOOD, V109, P5208, DOI 10.1182/blood-2007-01-069005; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Lin HF, 2005, BLOOD, V106, P3803, DOI 10.1182/blood-2005-01-0179; Murayama E, 2006, IMMUNITY, V25, P963, DOI 10.1016/j.immuni.2006.10.015; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; Soroldoni Daniele, 2009, V546, P117, DOI 10.1007/978-1-60327-977-2_8; Taoudi S, 2007, P NATL ACAD SCI USA, V104, P9399, DOI 10.1073/pnas.0700984104; Westerfield M., 1993, GUIDE LAB USE ZEBRAF; Yoshimoto M, 2009, NATURE, V457, P801, DOI 10.1038/457801a; Zhu H, 2005, DEV BIOL, V281, P256, DOI 10.1016/j.ydbio.2005.01.034	21	636	654	3	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					112	U125		10.1038/nature08761	http://dx.doi.org/10.1038/nature08761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20154732				2022-12-01	WOS:000275117500044
J	Meyerhoff, A; Lietman, P				Meyerhoff, Andrea; Lietman, Paul			Losing the Opportunity to Study Influenza Drugs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Meyerhoff, Andrea] Johns Hopkins Sch Med, Div Clin Pharmacol, Dept Med, Baltimore, MD 21287 USA; [Lietman, Paul] Johns Hopkins Sch Med, Dept Pharmacol & Mol Sci, Baltimore, MD 21287 USA; [Lietman, Paul] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD 21287 USA; [Meyerhoff, Andrea] GexGroup Inc, Washington, DC USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine	Meyerhoff, A (corresponding author), Johns Hopkins Sch Med, Div Clin Pharmacol, Dept Med, Osler 501,600 N Wolfe St, Baltimore, MD 21287 USA.	ameyerh1@jhmi.edu						*DEP HLTH HUM SERV, 2009, SUMM REP NAT BIOD SC; *FDA, FDA APPR LAB MED OFF; FDA, EM US AUTH PER 4 FAC; Jefferson T, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b5106; MEYERHOFF A, 2009, NY TIMES        0520, pA23; Tran TH, 2009, LANCET, V373, P2085, DOI 10.1016/S0140-6736(09)61131-4; DATABASE PERAMIVIR S	7	4	4	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					878	879		10.1001/jama.2010.234	http://dx.doi.org/10.1001/jama.2010.234			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197536				2022-12-01	WOS:000275059500023
J	Krasteva, PV; Fong, JCN; Shikuma, NJ; Beyhan, S; Navarro, MVAS; Yildiz, FH; Sondermann, H				Krasteva, Petya V.; Fong, Jiunn C. N.; Shikuma, Nicholas J.; Beyhan, Sinem; Navarro, Marcos V. A. S.; Yildiz, Fitnat H.; Sondermann, Holger			Vibrio cholerae VpsT Regulates Matrix Production and Motility by Directly Sensing Cyclic di-GMP	SCIENCE			English	Article							RUGOSE COLONY MORPHOLOGY; O1 EL-TOR; BIOFILM FORMATION; ESCHERICHIA-COLI; IDENTIFICATION; TYPHIMURIUM; PROTEINS; SYSTEMS; CURLI	Microorganisms can switch from a planktonic, free-swimming life-style to a sessile, colonial state, called a biofilm, which confers resistance to environmental stress. Conversion between the motile and biofilm life-styles has been attributed to increased levels of the prokaryotic second messenger cyclic di-guanosine monophosphate (c-di-GMP), yet the signaling mechanisms mediating such a global switch are poorly understood. Here we show that the transcriptional regulator VpsT from Vibrio cholerae directly senses c-di-GMP to inversely control extracellular matrix production and motility, which identifies VpsT as a master regulator for biofilm formation. Rather than being regulated by phosphorylation, VpsT undergoes a change in oligomerization on c-di-GMP binding.	[Fong, Jiunn C. N.; Shikuma, Nicholas J.; Beyhan, Sinem; Yildiz, Fitnat H.] Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA; [Krasteva, Petya V.; Navarro, Marcos V. A. S.; Sondermann, Holger] Cornell Univ, Coll Vet Med, Dept Mol Med, Ithaca, NY 14853 USA	University of California System; University of California Santa Cruz; Cornell University	Yildiz, FH (corresponding author), Univ Calif Santa Cruz, Dept Microbiol & Environm Toxicol, Santa Cruz, CA 95064 USA.	yildiz@metx.ucsc.edu; hs293@cornell.edu	Krasteva, Petya/E-4132-2014; Navarro, Marcos VAS/C-9141-2013; Krasteva, Petya Violinova/ABF-2168-2020	Krasteva, Petya/0000-0002-1858-8127; Krasteva, Petya Violinova/0000-0002-1858-8127; Navarro, Marcos/0000-0002-2461-0431; Shikuma, Nicholas/0000-0001-5518-5020	Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy; National Center for Research Resources of the NIH; NIH [1R01GM081373, R01AI055987]; PEW Scholar award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055987] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [P30EB009998] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM081373] Funding Source: NIH RePORTER	Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy; National Center for Research Resources of the NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); PEW Scholar award; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Hubbard and W. Horne for providing access to light scattering and calorimetry, respectively, and to the staff at the National Synchrotron Light Source (NSLS; Brookhaven National Laboratories) for assistance with synchrotron data collection. The NSLS is supported by the Offices of Biological and Environmental Research and of Basic Energy Sciences of the U.S. Department of Energy, and by the National Center for Research Resources of the NIH. This work was supported by the NIH (1R01GM081373 to H. S. and R01AI055987 to F.H.Y.), and by a PEW Scholar award (H. S.). Atomic coordinates and structure factors have been deposited in the RCSB Protein Data Bank under ID code 3KLN and 3KLO. The microarray data have been deposited in NCBI's Gene Expression Omnibus and are accessible through GEO series accession number GSE19479.	Beyhan S, 2008, J BACTERIOL, V190, P7392, DOI 10.1128/JB.00564-08; Beyhan S, 2007, MOL MICROBIOL, V63, P995, DOI 10.1111/j.1365-2958.2006.05568.x; Beyhan S, 2007, J BACTERIOL, V189, P388, DOI 10.1128/JB.00981-06; Casper-Lindley C, 2004, J BACTERIOL, V186, P1574, DOI 10.1128/JB.186.5.1574-1578.2004; Chirwa NT, 2003, MICROBIOL-SGM, V149, P525, DOI 10.1099/mic.0.25841-0; Fong JCN, 2006, J BACTERIOL, V188, P1049, DOI 10.1128/JB.188.3.1049-1059.2006; Fong JCN, 2007, J BACTERIOL, V189, P2319, DOI 10.1128/JB.01569-06; Gao R, 2009, ANNU REV MICROBIOL, V63, P133, DOI 10.1146/annurev.micro.091208.073214; Hickman JW, 2008, MOL MICROBIOL, V69, P376, DOI 10.1111/j.1365-2958.2008.06281.x; Kader A, 2006, MOL MICROBIOL, V60, P602, DOI 10.1111/j.1365-2958.2006.05123.x; Lim B, 2006, MOL MICROBIOL, V60, P331, DOI 10.1111/j.1365-2958.2006.05106.x; Mizunoe Y, 1999, INFECT IMMUN, V67, P958, DOI 10.1128/IAI.67.2.958-963.1999; Romling U, 1998, J BACTERIOL, V180, P722; Sudarsan N, 2008, SCIENCE, V321, P411, DOI 10.1126/science.1159519; Weber H, 2006, MOL MICROBIOL, V62, P1014, DOI 10.1111/j.1365-2958.2006.05440.x; Yildiz FH, 1999, P NATL ACAD SCI USA, V96, P4028, DOI 10.1073/pnas.96.7.4028	16	287	305	5	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					866	868		10.1126/science.1181185	http://dx.doi.org/10.1126/science.1181185			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150502	Green Accepted			2022-12-01	WOS:000274408300062
J	Franks, PW; Hanson, RL; Knowler, WC; Sievers, ML; Bennett, PH; Looker, HC				Franks, Paul W.; Hanson, Robert L.; Knowler, William C.; Sievers, Maurice L.; Bennett, Peter H.; Looker, Helen C.			Childhood Obesity, Other Cardiovascular Risk Factors, and Premature Death	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							BODY-MASS INDEX; UNITED-STATES; METABOLIC SYNDROME; DIABETES-MELLITUS; PIMA-INDIANS; US CHILDREN; FOLLOW-UP; MORTALITY; ADOLESCENTS; OVERWEIGHT	BACKGROUND The effect of childhood risk factors for cardiovascular disease on adult mortality is poorly understood. METHODS In a cohort of 4857 American Indian children without diabetes (mean age, 11.3 years; 12,659 examinations) who were born between 1945 and 1984, we assessed whether body-mass index (BMI), glucose tolerance, and blood pressure and cholesterol levels predicted premature death. Risk factors were standardized according to sex and age. Proportional-hazards models were used to assess whether each risk factor was associated with time to death occurring before 55 years of age. Models were adjusted for baseline age, sex, birth cohort, and Pima or Tohono O'odham Indian heritage. RESULTS There were 166 deaths from endogenous causes (3.4% of the cohort) during a median follow-up period of 23.9 years. Rates of death from endogenous causes among children in the highest quartile of BMI were more than double those among children in the lowest BMI quartile (incidence-rate ratio, 2.30; 95% confidence interval [CI], 1.46 to 3.62). Rates of death from endogenous causes among children in the highest quartile of glucose intolerance were 73% higher than those among children in the lowest quartile (incidence-rate ratio, 1.73; 95% CI, 1.09 to 2.74). No significant associations were seen between rates of death from endogenous or external causes and childhood cholesterol levels or systolic or diastolic blood-pressure levels on a continuous scale, although childhood hypertension was significantly associated with premature death from endogenous causes (incidence-rate ratio, 1.57; 95% CI, 1.10 to 2.24). CONCLUSIONS Obesity, glucose intolerance, and hypertension in childhood were strongly associated with increased rates of premature death from endogenous causes in this population. In contrast, childhood hypercholesterolemia was not a major predictor of premature death from endogenous causes.	[Franks, Paul W.] Umea Univ Hosp, Genet Epidemiol & Clin Res Grp, Dept Publ Hlth & Clin Med, Med Sect, S-90187 Umea, Sweden; [Franks, Paul W.; Hanson, Robert L.; Knowler, William C.; Sievers, Maurice L.; Bennett, Peter H.; Looker, Helen C.] NIDDK, Diabet Epidemiol & Clin Res Sect, NIH, Phoenix, AZ USA; [Franks, Paul W.] Univ Cambridge, Inst Metab Sci, MRC, Epidemiol Unit, Cambridge, England; [Looker, Helen C.] Mt Sinai Sch Med, New York, NY USA	Umea University; National Institutes of Health (NIH) - USA; NIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK); University of Cambridge; Icahn School of Medicine at Mount Sinai	Franks, PW (corresponding author), Umea Univ Hosp, Genet Epidemiol & Clin Res Grp, Dept Publ Hlth & Clin Med, Med Sect, S-90187 Umea, Sweden.	paul.franks@medicin.umu.se	Hrafnkelsson, Hannes/C-8490-2011; Franks, Paul/AAA-3300-2020; Bennett, Peter/AAH-9605-2021; Hanson, Robert/O-3238-2015	Hanson, Robert/0000-0002-4252-7068; Franks, Paul/0000-0002-0520-7604	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK); Swedish Diabetes Association; Swedish Heart Lung Foundation; Swedish Research Council, Umea University; Vasterbotten regional health authority; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [ZIADK069097, ZIADK069000] Funding Source: NIH RePORTER	National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); Swedish Diabetes Association; Swedish Heart Lung Foundation(Swedish Heart-Lung Foundation); Swedish Research Council, Umea University(Swedish Research Council); Vasterbotten regional health authority; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Supported by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) intramural research program. Dr. Franks was supported in part by grants from the Swedish Diabetes Association, the Swedish Heart Lung Foundation, the Swedish Research Council, Umea University (Career Development Award), and the Vasterbotten regional health authority (Strategic Appointment 2006-09).	American Diabetes Association, 1999, DIABETES CARE, V22, pS1; Andersen LB, 2006, LANCET, V368, P299, DOI 10.1016/S0140-6736(06)69075-2; BENNETT PH, 1971, LANCET, V2, P125; *CDCP, 2000, PUBL CDCP, V314; Dahl-Regis M, 2002, ANN REPORT CHIEF MED; *DEP HLTH HUM SERV, 2004, CHILD HLTH US 2004; DIPIETRO L, 1994, INT J OBESITY, V18, P585; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; Fagot-Campagna A, 2001, DIABETES CARE, V24, P834, DOI 10.2337/diacare.24.5.834; Franks PW, 2007, DIABETES, V56, P2964, DOI 10.2337/db06-1639; Franks PW, 2006, DIABETES, V55, P460, DOI 10.2337/diabetes.55.02.06.db05-0823; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Gunnell DJ, 1998, AM J CLIN NUTR, V67, P1111, DOI 10.1093/ajcn/67.6.1111; HANSON RL, 1995, J CLIN EPIDEMIOL, V48, P903, DOI 10.1016/0895-4356(94)00217-E; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HOWARD BV, 1983, CIRCULATION, V68, P714, DOI 10.1161/01.CIR.68.4.714; KNOWLER WC, 1978, AM J EPIDEMIOL, V108, P497, DOI 10.1093/oxfordjournals.aje.a112648; Lakka HM, 2002, JAMA-J AM MED ASSOC, V288, P2709, DOI 10.1001/jama.288.21.2709; Lindsay RS, 2001, J CLIN ENDOCR METAB, V86, P4061, DOI 10.1210/jc.86.9.4061; Malik S, 2004, CIRCULATION, V110, P1245, DOI 10.1161/01.CIR.0000140677.20606.0E; McTigue K, 2006, JAMA-J AM MED ASSOC, V296, P79, DOI 10.1001/jama.296.1.79; MUST A, 1992, NEW ENGL J MED, V327, P1350, DOI 10.1056/NEJM199211053271904; Natl High Blood Pressure Educ Prog, 2004, PEDIATRICS, V114, P555; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Olshansky SJ, 2005, NEW ENGL J MED, V352, P1138, DOI 10.1056/NEJMsr043743; Pavkov ME, 2006, JAMA-J AM MED ASSOC, V296, P421, DOI 10.1001/jama.296.4.421; PETTITT DJ, 1983, NEW ENGL J MED, V308, P242, DOI 10.1056/NEJM198302033080502; PRENTICE RL, 1979, BIOMETRICS, V35, P25, DOI 10.2307/2529934; SIEVERS ML, 1990, J CLIN EPIDEMIOL, V43, P1231, DOI 10.1016/0895-4356(90)90024-J; *WHO DEP NONC DIS, 1999, REP WHO CONS DEF D 1	31	853	881	3	89	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					485	493		10.1056/NEJMoa0904130	http://dx.doi.org/10.1056/NEJMoa0904130			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147714	Green Accepted, Green Published			2022-12-01	WOS:000274397200005
J	Wensley, BG; Batey, S; Bone, FAC; Chan, ZM; Tumelty, NR; Steward, A; Kwa, LG; Borgia, A; Clarke, J				Wensley, Beth G.; Batey, Sarah; Bone, Fleur A. C.; Chan, Zheng Ming; Tumelty, Nuala R.; Steward, Annette; Kwa, Lee Gyan; Borgia, Alessandro; Clarke, Jane			Experimental evidence for a frustrated energy landscape in a three-helix-bundle protein family	NATURE			English	Article							INTERNAL-FRICTION; TRANSITION-STATE; CONTACT ORDER; DIFFUSION; BARRIER; STABILITY; KINETICS; MODEL; VISCOSITY; DYNAMICS	Energy landscape theory is a powerful tool for understanding the structure and dynamics of complex molecular systems, in particular biological macromolecules(1). The primary sequence of a protein defines its free-energy landscape and thus determines the folding pathway and the rate constants of folding and unfolding, as well as the protein's native structure. Theory has shown that roughness in the energy landscape will lead to slower folding(1), but derivation of detailed experimental descriptions of this landscape is challenging. Simple folding models(2,3) show that folding is significantly influenced by chain entropy; proteins in which the contacts are local fold quickly, owing to the low entropy cost of forming stabilizing, native contacts during folding(4,5). For some protein families, stability is also a determinant of folding rate constants(6). Where these simple metrics fail to predict folding behaviour, it is probable that there are features in the energy landscape that are unusual. Such general observations cannot explain the folding behaviour of the R15, R16 and R17 domains of alpha-spectrin. R15 folds similar to 3,000 times faster than its homologues, although they have similar structures, stabilities and, as far as can be determined, transition-state stabilities(7-10). Here we show that landscape roughness (internal friction) is responsible for the slower folding and unfolding of R16 and R17. We use chimaeric domains to demonstrate that this internal friction is a property of the core, and suggest that frustration in the landscape of the slow-folding spectrin domains may be due to misdocking of the long helices during folding. Theoretical studies have suggested that rugged landscapes will result in slower folding; here we show experimentally that such a phenomenon directly influences the folding kinetics of a 'normal' protein, that is, one with a significant energy barrier that folds on a relatively slow, millisecond-second, timescale.	[Wensley, Beth G.; Batey, Sarah; Bone, Fleur A. C.; Chan, Zheng Ming; Tumelty, Nuala R.; Steward, Annette; Kwa, Lee Gyan; Borgia, Alessandro; Clarke, Jane] Univ Cambridge, Dept Chem, MRC, Ctr Prot Engn, Cambridge CB2 1EW, England	University of Cambridge	Clarke, J (corresponding author), Univ Cambridge, Dept Chem, MRC, Ctr Prot Engn, Lensfield Rd, Cambridge CB2 1EW, England.	jc162@cam.ac.uk	Borgia, Alessandro/AAF-9203-2019	Borgia, Alessandro/0000-0002-4701-8967	Wellcome Trust [064417/Z/01/A]; UK Medical Research Council; MRC [MC_U105485808] Funding Source: UKRI; Medical Research Council [MC_U105485808] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	This work was supported by the Wellcome Trust (grant number 064417/Z/01/A). B. G. W. was supported by a UK Medical Research Council studentship. J.C. is a Wellcome Trust Senior Research Fellow. We thank W. Eaton, P. Wolynes, R. Best and B. Schuler for discussions.	ANSARI A, 1992, SCIENCE, V256, P1796, DOI 10.1126/science.1615323; Bachmann A, 2001, J MOL BIOL, V306, P375, DOI 10.1006/jmbi.2000.4399; BRYNGELSON JD, 1989, J PHYS CHEM-US, V93, P6902, DOI 10.1021/j100356a007; Cellmer T, 2008, P NATL ACAD SCI USA, V105, P18320, DOI 10.1073/pnas.0806154105; CHRUNYK BA, 1990, BIOCHEMISTRY-US, V29, P2149, DOI 10.1021/bi00460a027; Clarke J, 1999, STRUCT FOLD DES, V7, P1145, DOI 10.1016/S0969-2126(99)80181-6; FERSHT AR, 1992, J MOL BIOL, V224, P771, DOI 10.1016/0022-2836(92)90561-W; Frauenfelder H, 2006, P NATL ACAD SCI USA, V103, P15469, DOI 10.1073/pnas.0607168103; Gianni S, 2003, P NATL ACAD SCI USA, V100, P13286, DOI 10.1073/pnas.1835776100; Godoy-Ruiz R, 2008, J PHYS CHEM B, V112, P5938, DOI 10.1021/jp0757715; Gromiha MM, 2001, J MOL BIOL, V310, P27, DOI 10.1006/jmbi.2001.4775; Gruebele M, 2008, RSC BIOMOL SCI, P106, DOI 10.1039/9781847558282-00106; Henry ER, 2004, CHEM PHYS, V307, P163, DOI 10.1016/j.chemphys.2004.06.064; Jacob M, 1997, P NATL ACAD SCI USA, V94, P5622, DOI 10.1073/pnas.94.11.5622; Jas GS, 2001, J PHYS CHEM B, V105, P261, DOI 10.1021/jp0022048; Johnson CP, 2007, BLOOD, V109, P3538, DOI 10.1182/blood-2006-07-038588; KIEFHABER T, 1992, J MOL BIOL, V224, P217, DOI 10.1016/0022-2836(92)90585-8; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Kusunoki H, 2004, J MOL BIOL, V344, P495, DOI 10.1016/j.jmb.2004.09.019; Ladurner AG, 1999, NAT STRUCT BIOL, V6, P28; Munoz V, 1999, P NATL ACAD SCI USA, V96, P11311, DOI 10.1073/pnas.96.20.11311; Nettels D, 2007, P NATL ACAD SCI USA, V104, P2655, DOI 10.1073/pnas.0611093104; Oliveberg M, 1998, J MOL BIOL, V277, P933, DOI 10.1006/jmbi.1997.1612; Oliveberg M, 2001, CURR OPIN STRUC BIOL, V11, P94, DOI 10.1016/S0959-440X(00)00171-8; Otzen DE, 1999, BIOCHEMISTRY-US, V38, P6499, DOI 10.1021/bi982819j; Pabit SA, 2004, BIOCHEMISTRY-US, V43, P12532, DOI 10.1021/bi048822m; Pace C N, 1986, Methods Enzymol, V131, P266; Plaxco KW, 1998, P NATL ACAD SCI USA, V95, P13591, DOI 10.1073/pnas.95.23.13591; Plaxco KW, 1998, J MOL BIOL, V277, P985, DOI 10.1006/jmbi.1998.1645; Pogorelov TV, 2004, BIOPHYS J, V87, P207, DOI 10.1529/biophysj.104.042861; Pradeep L, 2007, J MOL BIOL, V366, P1016, DOI 10.1016/j.jmb.2006.11.064; Qiu LL, 2005, CHEM PHYS, V312, P325, DOI 10.1016/j.chemphys.2004.12.001; Sanchez IE, 2003, J MOL BIOL, V325, P367, DOI 10.1016/S0022-2836(02)01230-5; Scott KA, 2005, PROTEIN SCI, V14, P1617, DOI 10.1110/ps.051377105; Scott KA, 2004, J MOL BIOL, V344, P207, DOI 10.1016/j.jmb.2004.09.023; Scott KA, 2004, J MOL BIOL, V344, P195, DOI 10.1016/j.jmb.2004.09.037; Scott KA, 2006, J MOL BIOL, V359, P159, DOI 10.1016/j.jmb.2006.03.011; Silow M, 1997, BIOCHEMISTRY-US, V36, P7633, DOI 10.1021/bi970210x; Sutto L, 2007, P NATL ACAD SCI USA, V104, P19825, DOI 10.1073/pnas.0709922104; Szabo Z. G., 1969, COMPREHENSIVE CHEM K, V2, P1; Ternstrom T, 1999, P NATL ACAD SCI USA, V96, P14854, DOI 10.1073/pnas.96.26.14854; Wensley BG, 2009, J MOL BIOL, V390, P1074, DOI 10.1016/j.jmb.2009.05.010; Yang WY, 2003, NATURE, V423, P193, DOI 10.1038/nature01609; ZWANZIG R, 1988, P NATL ACAD SCI USA, V85, P2029, DOI 10.1073/pnas.85.7.2029	44	128	128	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					685	U122		10.1038/nature08743	http://dx.doi.org/10.1038/nature08743			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130652	Green Accepted			2022-12-01	WOS:000274193900041
J	Sen, GL; Reuter, JA; Webster, DE; Zhu, L; Khavari, PA				Sen, George L.; Reuter, Jason A.; Webster, Daniel E.; Zhu, Lilly; Khavari, Paul A.			DNMT1 maintains progenitor function in self-renewing somatic tissue	NATURE			English	Article							DNA METHYLATION; STEM-CELLS; GENE-EXPRESSION; DIFFERENTIATION; METHYLTRANSFERASE; GENOME; DEMETHYLATION; PROLIFERATION; KERATINOCYTES; PATTERNS	Progenitor cells maintain self-renewing tissues throughout life by sustaining their capacity for proliferation while suppressing cell cycle exit and terminal differentiation(1,2). DNA methylation(3-5) provides a potential epigenetic mechanism for the cellular memory needed to preserve the somatic progenitor state through repeated cell divisions. DNA methyltransferase 1 (DNMT1)(6,7) maintains DNA methylation patterns after cellular replication. Although dispensable for embryonic stem cell maintenance(8), the role for DNMT1 in maintaining the progenitor state in constantly replenished somatic tissues, such as mammalian epidermis, is unclear. Here we show that DNMT1 is essential for epidermal progenitor cell function. DNMT1 protein was found enriched in undifferentiated cells, where it was required to retain proliferative stamina and suppress differentiation. In tissue, DNMT1 depletion led to exit from the progenitor cell compartment, premature differentiation and eventual tissue loss. Genome-wide analysis showed that a significant portion of epidermal differentiation gene promoters were methylated in self-renewing conditions but were subsequently demethylated during differentiation. Furthermore, UHRF1 (refs 9, 10), a component of the DNA methylation machinery that targets DNMT1 to hemi-methylated DNA, is also necessary to suppress premature differentiation and sustain proliferation. In contrast, Gadd45A(11,12) and B-13, which promote active DNA demethylation, are required for full epidermal differentiation gene induction. These data demonstrate that proteins involved in the dynamic regulation of DNA methylation patterns are required for progenitor maintenance and self-renewal in mammalian somatic tissue.	[Sen, George L.; Reuter, Jason A.; Webster, Daniel E.; Zhu, Lilly; Khavari, Paul A.] Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA; [Sen, George L.; Reuter, Jason A.; Webster, Daniel E.; Zhu, Lilly; Khavari, Paul A.] Stanford Univ, Program Canc Biol, Stanford, CA 94305 USA; [Sen, George L.; Reuter, Jason A.; Webster, Daniel E.; Zhu, Lilly; Khavari, Paul A.] Stanford Univ, Stanford Inst Stem Cell Biol & Regenerat Med, Stanford, CA 94305 USA; [Khavari, Paul A.] Vet Affairs Palo Alto Healthcare Syst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Palo Alto Health Care System	Khavari, PA (corresponding author), Stanford Univ, Program Epithelial Biol, Stanford, CA 94305 USA.	khavari@stanford.edu		Webster, Dan/0000-0001-6874-8451	USVA Office of Research and Development; NIH/NIAMS [AR45192]; LVMH Recherche; NIH [AR055849]; NATIONAL CANCER INSTITUTE [T32CA009302, R01CA142635] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [F32AR055849, R01AR049737, K01AR057828, R01AR045192] Funding Source: NIH RePORTER	USVA Office of Research and Development; NIH/NIAMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); LVMH Recherche; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	This work was supported by the USVA Office of Research and Development, NIH/NIAMS AR45192, an unrestricted research gift from LVMH Recherche to P. A. K. and an NIH National Research Service Award AR055849 to G. L. S. We thank M. P. Scott, G. R. Crabtree, M. T. Fuller, J. Wysocka, H. Y. Chang, A. E. Oro, T. W. Ridky, B. J. Zarnegar, M. Kretz, D. Webster, R. Flockhart for critical comments and pre-submission review, X. Bao for help with figures, and G. Lai for informatics.	Andersen B, 1997, GENE DEV, V11, P1873, DOI 10.1101/gad.11.14.1873; Barreto G, 2007, NATURE, V445, P671, DOI 10.1038/nature05515; BESTOR T, 1988, J MOL BIOL, V203, P971, DOI 10.1016/0022-2836(88)90122-2; Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bostick M, 2007, SCIENCE, V317, P1760, DOI 10.1126/science.1147939; Carlson ME, 2008, NATURE, V454, P528, DOI 10.1038/nature07034; Damelin M, 2007, MOL CELL BIOL, V27, P3891, DOI 10.1128/MCB.00036-07; Eckert RL, 1997, J INVEST DERMATOL, V109, P501, DOI 10.1111/1523-1747.ep12336477; Fouse SD, 2008, CELL STEM CELL, V2, P160, DOI 10.1016/j.stem.2007.12.011; Fuks F, 2005, CURR OPIN GENET DEV, V15, P490, DOI 10.1016/j.gde.2005.08.002; GARDINERGARDEN M, 1987, J MOL BIOL, V196, P261, DOI 10.1016/0022-2836(87)90689-9; Giardine B, 2005, GENOME RES, V15, P1451, DOI 10.1101/gr.4086505; He J, 2008, NAT STRUCT MOL BIOL, V15, P1169, DOI 10.1038/nsmb.1499; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Irizarry RA, 2009, NAT GENET, V41, P178, DOI 10.1038/ng.298; Jaenisch R, 2003, NAT GENET, V33, P245, DOI 10.1038/ng1089; Khavari PA, 2006, NAT REV CANCER, V6, P270, DOI 10.1038/nrc1838; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Lazarov M, 2002, NAT MED, V8, P1105, DOI 10.1038/nm779; Lei H, 1996, DEVELOPMENT, V122, P3195; LI E, 1992, CELL, V69, P915, DOI 10.1016/0092-8674(92)90611-F; Ma DK, 2009, SCIENCE, V323, P1074, DOI 10.1126/science.1166859; Maurelli R, 2006, FASEB J, V20, P1516, DOI 10.1096/fj.05-4480fje; Morrison SJ, 2008, CELL, V132, P598, DOI 10.1016/j.cell.2008.01.038; Motohashi H, 2004, P NATL ACAD SCI USA, V101, P6379, DOI 10.1073/pnas.0305902101; Nakamura Y, 2007, EXP DERMATOL, V16, P143, DOI 10.1111/j.1600-0625.2006.00528.x; *NAT CANC I DCCPS, 2002, SEER INC SURV UNPUB; Orford KW, 2008, NAT REV GENET, V9, P115, DOI 10.1038/nrg2269; Rai K, 2008, CELL, V135, P1201, DOI 10.1016/j.cell.2008.11.042; Reik W, 2007, NATURE, V447, P425, DOI 10.1038/nature05918; Robbins PB, 2001, P NATL ACAD SCI USA, V98, P5193, DOI 10.1073/pnas.091484998; Sen GL, 2008, GENE DEV, V22, P1865, DOI 10.1101/gad.1673508; Sharif J, 2007, NATURE, V450, P908, DOI 10.1038/nature06397; Truong AB, 2006, GENE DEV, V20, P3185, DOI 10.1101/gad.1463206; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Weber M, 2005, NAT GENET, V37, P853, DOI 10.1038/ng1598; Weber M, 2007, CURR OPIN CELL BIOL, V19, P273, DOI 10.1016/j.ceb.2007.04.011; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990	38	321	337	1	42	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					563	U189		10.1038/nature08683	http://dx.doi.org/10.1038/nature08683			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20081831	Green Accepted			2022-12-01	WOS:000273981100056
J	Larson, HJ; Heymann, DL				Larson, Heidi J.; Heymann, David L.			Public Health Response to Influenza A(H1N1) as an Opportunity to Build Public Trust	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Larson, Heidi J.] Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, Fac Med, London SW7 1NA, England; [Heymann, David L.] London Sch Hyg & Trop Med, London WC1, England; [Heymann, David L.] Ctr Global Hlth Secur Chatham House, London, England	Imperial College London; University of London; London School of Hygiene & Tropical Medicine	Larson, HJ (corresponding author), Univ London Imperial Coll Sci Technol & Med, Inst Global Hlth, Fac Med, 15 Princes Gardens, London SW7 1NA, England.	h.larson@imperial.ac.uk	Larson, Heidi J./N-1018-2017	Larson, Heidi J./0000-0002-8477-7583				[Anonymous], 1996, LANCET, V348, P1529; Cooper LZ, 2008, PEDIATRICS, V122, P149, DOI 10.1542/peds.2008-0987; Dorozynski A, 1998, BRIT MED J, V317, P1034; Heymann DL, 2004, NEW ENGL J MED, V351, P1275, DOI 10.1056/NEJMp048204; Jegede AS, 2007, PLOS MED, V4, P417, DOI 10.1371/journal.pmed.0040073; [Anonymous], 2008, Bull World Health Organ, V86, P425; PETERS RG, 1997, DETERMINANTS TRUST C; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0; WHO, 2009, PAND INFL PREP RESP	9	81	82	0	12	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					271	272		10.1001/jama.2009.2023	http://dx.doi.org/10.1001/jama.2009.2023			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20085957				2022-12-01	WOS:000273690600025
J	Pospisilik, JA; Schramek, D; Schnidar, H; Cronin, SJF; Nehme, NT; Zhang, XY; Knauf, C; Cani, PD; Aumayr, K; Todoric, J; Bayer, M; Haschemi, A; Puviindran, V; Tar, K; Orthofer, M; Neely, GG; Dietzl, G; Manoukian, A; Funovics, M; Prager, G; Wagner, O; Ferrandon, D; Aberger, F; Hui, CC; Esterbauer, H; Penninger, JM				Pospisilik, J. Andrew; Schramek, Daniel; Schnidar, Harald; Cronin, Shane J. F.; Nehme, Nadine T.; Zhang, Xiaoyun; Knauf, Claude; Cani, Patrice D.; Aumayr, Karin; Todoric, Jelena; Bayer, Martina; Haschemi, Arvand; Puviindran, Vijitha; Tar, Krisztina; Orthofer, Michael; Neely, G. Gregory; Dietzl, Georg; Manoukian, Armen; Funovics, Martin; Prager, Gerhard; Wagner, Oswald; Ferrandon, Dominique; Aberger, Fritz; Hui, Chi-chung; Esterbauer, Harald; Penninger, Josef M.			Drosophila Genome-wide Obesity Screen Reveals Hedgehog as a Determinant of Brown versus White Adipose Cell Fate	CELL			English	Article							TRANSCRIPTIONAL CONTROL; SIGNALING PATHWAY; SONIC HEDGEHOG; ADULT MICE; DIFFERENTIATION; ADIPOGENESIS; METABOLISM; TISSUE; GENE; REGULATOR	Over 1 billion people are estimated to be overweight, placing them at risk for diabetes, cardiovascular disease, and cancer. We performed a systems-level genetic dissection of adiposity regulation using genome-wide RNAi screening in adult Drosophila. As a follow-up, the resulting similar to 500 candidate obesity genes were functionally classified using muscle-, oenocyte-, fat-body-, and neuronal-specific knockdown in vivo and revealed hedgehog signaling as the top-scoring fat-body-specific pathway. To extrapolate these findings into mammals, we generated fat-specific hedgehog-activation mutant mice. Intriguingly, these mice displayed near total loss of white, but not brown, fat compartments. Mechanistically, activation of hedgehog signaling irreversibly blocked differentiation of white adipocytes through direct, coordinate modulation of early adipogenic factors. These findings identify a role for hedgehog signaling in white/brown adipocyte determination and link in vivo RNAi-based scanning of the Drosophila genome to regulation of adipocyte cell fate in mammals.	[Todoric, Jelena; Bayer, Martina; Haschemi, Arvand; Tar, Krisztina; Wagner, Oswald; Esterbauer, Harald] Med Univ Vienna, Dept Med, A-1090 Vienna, Austria; [Todoric, Jelena; Bayer, Martina; Haschemi, Arvand; Tar, Krisztina; Wagner, Oswald; Esterbauer, Harald] Med Univ Vienna, Chem Lab Diagnost, A-1090 Vienna, Austria; [Funovics, Martin] Med Univ Vienna, Dept Radiol, A-1090 Vienna, Austria; [Prager, Gerhard] Med Univ Vienna, Dept Surg, A-1090 Vienna, Austria; [Pospisilik, J. Andrew; Schramek, Daniel; Cronin, Shane J. F.; Aumayr, Karin; Orthofer, Michael; Neely, G. Gregory; Penninger, Josef M.] Austrian Acad Sci, Inst Mol Biotechnol, A-1030 Vienna, Austria; [Schnidar, Harald; Aberger, Fritz] Salzburg Univ, Dept Mol Biol, A-5020 Salzburg, Austria; [Nehme, Nadine T.; Ferrandon, Dominique] Univ Strasbourg, Equipe Fdn Rech Med, UPR CNRS 9022, Inst Biol Mol & Cellulaire, F-67084 Strasbourg, France; [Zhang, Xiaoyun; Puviindran, Vijitha; Hui, Chi-chung] Univ Toronto, Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto, ON M5S 1A8, Canada; [Zhang, Xiaoyun; Puviindran, Vijitha; Hui, Chi-chung] Univ Toronto, Dept Mol Genet, Toronto, ON M5S 1A8, Canada; [Knauf, Claude] Univ Toulouse 3, INSERM U858, Team 3, Inst Med Mol Rangueil,IFR150,CHU Rangueil, F-31432 Toulouse 4, France; [Cani, Patrice D.] Catholic Univ Louvain, LDRI, Unit PMNT 73 69, B-1200 Brussels, Belgium; [Dietzl, Georg] Stanford Univ, Howard Hughes Med Inst, Stanford, CA 94305 USA; [Manoukian, Armen] Princess Margaret Hosp, Ontario Canc Inst, Toronto, ON M5G 2M9, Canada	Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Medical University of Vienna; Austrian Academy of Sciences; Vienna Biocenter (VBC); Institute of Molecular Biotechnology (IMBA); Salzburg University; UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; University of Toronto; University Toronto Affiliates; Hospital for Sick Children (SickKids); University of Toronto; CHU de Toulouse; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Toulouse; Universite Toulouse III - Paul Sabatier; Universite Catholique Louvain; Howard Hughes Medical Institute; Stanford University; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre	Esterbauer, H (corresponding author), Med Univ Vienna, Dept Med, Waehringer Guertel 18-20, A-1090 Vienna, Austria.	harald.esterbauer@meduniwien.ac.at; josef.penninger@imba.oeaw.ac.at	Neely, Greg/AAB-4642-2020; D., Cani Patrice/M-8055-2016; Aberger, Fritz/B-6357-2012; Schramek, Daniel/J-5792-2014; Schnidar, Harald/C-7049-2009; Penninger, Josef M/I-6860-2013; neely, graham/A-6511-2011; Schramek, Daniel/AAL-1470-2020	Neely, Greg/0000-0002-1957-9732; D., Cani Patrice/0000-0003-2040-2448; Aberger, Fritz/0000-0003-2009-6305; Penninger, Josef M/0000-0002-8194-3777; Schramek, Daniel/0000-0001-9977-2104; Knauf, Claude/0000-0001-5213-5378; Esterbauer, Harald/0000-0001-7343-7455; FERRANDON, Dominique/0000-0001-7680-7773; Haschemi, Arvand/0000-0001-9532-3205	JDRF; Marie-Curie Foundation; WWTF; CIHR; CCSRI; Austrian Academy of Sciences; GEN-AU (Genome Austria); Austrian Ministry of Science and Education; European Union; FRS-FNRS Belgium; CNRS; Programme MIME	JDRF(Juvenile Diabetes Research Foundation); Marie-Curie Foundation(European Commission); WWTF; CIHR(Canadian Institutes of Health Research (CIHR)); CCSRI; Austrian Academy of Sciences; GEN-AU (Genome Austria); Austrian Ministry of Science and Education; European Union(European Commission); FRS-FNRS Belgium(Fonds de la Recherche Scientifique - FNRS); CNRS(Centre National de la Recherche Scientifique (CNRS)); Programme MIME	The authors are indebted to the IMBA and MUW service departments, all members of the VDRC Drosophila library, and Barry Dickson, Pawel Pasierbek, Maria Novatchkova, Patricia Schittenhelm, Helen Damhofer, and Maria Ozsvar-Kozma for excellent technical help. J.A.P. was supported by fellowships from the JDRF and the Marie-Curie Foundation. This project, J. A. P., and H. E. are supported by the WWTF. C.-C. H. was supported by CIHR and CCSRI. J. M. P. is supported by the Austrian Academy of Sciences, GEN-AU (Genome Austria), the Austrian Ministry of Science and Education, and a European Union Advanced ERC grant. P. D. C. is a research associate from the FRS-FNRS Belgium. D. F. is supported by the CNRS and a Droselegans grant from the Programme MIME, and the D. F. laboratory is an "Equipe FRM'' (Fondation pour la Recherche Medicale).	Altarejos JY, 2008, NAT MED, V14, P1112, DOI 10.1038/nm.1866; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Baker KD, 2007, CELL METAB, V6, P257, DOI 10.1016/j.cmet.2007.09.002; Brown LJ, 2002, J BIOL CHEM, V277, P32899, DOI 10.1074/jbc.M202409200; Buhman KK, 2004, J NUTR, V134, P2979, DOI 10.1093/jn/134.11.2979; Cypess AM, 2009, NEW ENGL J MED, V360, P1509, DOI 10.1056/NEJMoa0810780; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Farmer SR, 2006, CELL METAB, V4, P263, DOI 10.1016/j.cmet.2006.07.001; Farmer SR, 2009, NATURE, V458, P839, DOI 10.1038/458839a; Farooqi IS, 2007, OBES REV, V8, P37, DOI 10.1111/j.1467-789X.2007.00315.x; Feldmann HM, 2009, CELL METAB, V9, P203, DOI 10.1016/j.cmet.2008.12.014; Gesta S, 2007, CELL, V131, P242, DOI 10.1016/j.cell.2007.10.004; Gronke S, 2007, PLOS BIOL, V5, P1248, DOI 10.1371/journal.pbio.0050137; Gronke S, 2005, CELL METAB, V1, P323, DOI 10.1016/j.cmet.2005.04.003; Gutierrez E, 2007, NATURE, V445, P275, DOI 10.1038/nature05382; Hader T, 2003, EMBO REP, V4, P511, DOI 10.1038/sj.embor.embor837; Hebrok M, 2000, DEVELOPMENT, V127, P4905; Heine VM, 2009, J CLIN INVEST, V119, P267, DOI 10.1172/JCI36376; JIANG J, 1995, CELL, V80, P563, DOI 10.1016/0092-8674(95)90510-3; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Koo SH, 2005, NATURE, V437, P1109, DOI 10.1038/nature03967; Lefterova MI, 2009, TRENDS ENDOCRIN MET, V20, P107, DOI 10.1016/j.tem.2008.11.005; Leopold P, 2007, NATURE, V450, P186, DOI 10.1038/nature06286; Li Z, 2008, INT J BIOL SCI, V4, P29; Lichtenbelt WDV, 2009, NEW ENGL J MED, V360, P1500, DOI 10.1056/NEJMoa0808718; Makino S, 2001, DEV BIOL, V239, P95, DOI 10.1006/dbio.2001.0419; Martin PM, 2006, J NEUROCHEM, V98, P279, DOI 10.1111/j.1471-4159.2006.03878.x; Matsuzaka T, 2007, NAT MED, V13, P1193, DOI 10.1038/nm1662; Melcher C, 2007, J ENDOCRINOL, V192, P467, DOI 10.1677/JOE-06-0066; Min KT, 1999, SCIENCE, V284, P1985, DOI 10.1126/science.284.5422.1985; Nybakken K, 2005, NAT GENET, V37, P1323, DOI 10.1038/ng1682; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Panakova D, 2005, NATURE, V435, P58, DOI 10.1038/nature03504; Rosen ED, 2006, NAT REV MOL CELL BIO, V7, P885, DOI 10.1038/nrm2066; Ross DA, 2004, MOL CELL BIOL, V24, P3505, DOI 10.1128/MCB.24.8.3505-3513.2004; Schlegel A, 2007, PLOS GENET, V3, P2037, DOI 10.1371/journal.pgen.0030199; Seale P, 2009, GENE DEV, V23, P788, DOI 10.1101/gad.1779209; Speakman J, 2008, LAB ANIM-UK, V42, P413, DOI 10.1258/la.2007.006067; Suh JM, 2006, CELL METAB, V3, P25, DOI 10.1016/j.cmet.2005.11.012; Suzawa M, 2003, NAT CELL BIOL, V5, P224, DOI 10.1038/ncb942; Thomas MK, 2000, DIABETES, V49, P2039, DOI 10.2337/diabetes.49.12.2039; Tseng YH, 2008, NATURE, V454, P1000, DOI 10.1038/nature07221; Virtanen KA, 2009, NEW ENGL J MED, V360, P1518, DOI 10.1056/NEJMoa0808949; *WHO, 2009, GLOB STRAT DIET PHYS; Wu X, 2002, J AM CHEM SOC, V124, P14520, DOI 10.1021/ja0283908; Yan ZJ, 2005, GENE DEV, V19, P1662, DOI 10.1101/gad.1323805; Yu C, 2005, J BIOL CHEM, V280, P13600, DOI 10.1074/jbc.M409468200; Zehentner BK, 2000, DNA CELL BIOL, V19, P275, DOI 10.1089/10445490050021186; ZHANG J, 1995, BIOCHEM J, V306, P205, DOI 10.1042/bj3060205; ZHANG YY, 1994, NATURE, V372, P425, DOI 10.1038/372425a0; Zingaretti MC, 2009, FASEB J, V23, P3113, DOI 10.1096/fj.09-133546	52	280	298	2	41	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					148	160		10.1016/j.cell.2009.12.027	http://dx.doi.org/10.1016/j.cell.2009.12.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20074523	Bronze			2022-12-01	WOS:000273391900022
J	Chen, DL; Shan, J; Zhu, WG; Qin, J; Gu, W				Chen, Delin; Shan, Jing; Zhu, Wei-Guo; Qin, Jun; Gu, Wei			Transcription-independent ARF regulation in oncogenic stress-mediated p53 responses	NATURE			English	Article							TUMOR-SUPPRESSOR PATHWAY; NUCLEOPHOSMIN; PROTEIN; EXPRESSION; CANCER; POLYUBIQUITINATION; PROLIFERATION; INDUCTION; TARGETS; MUTANT	The tumour suppressor ARF is specifically required for p53 activation under oncogenic stress(1-6). Recent studies showed that p53 activation mediated by ARF, but not that induced by DNA damage, acts as a major protection against tumorigenesis in vivo under certain biological settings(7,8), suggesting that the ARF-p53 axis has more fundamental functions in tumour suppression than originally thought. Because ARF is a very stable protein in most human cell lines, it has been widely assumed that ARF induction is mediated mainly at the transcriptional level and that activation of the ARF-p53 pathway by oncogenes is a much slower and largely irreversible process by comparison with p53 activation after DNA damage. Here we report that ARF is very unstable in normal human cells but that its degradation is inhibited in cancerous cells. Through biochemical purification, we identified a specific ubiquitin ligase for ARF and named it ULF. ULF interacts with ARF both in vitro and in vivo and promotes the lysine-independent ubiquitylation and degradation of ARF. ULF knockdown stabilizes ARF in normal human cells, triggering ARF-dependent, p53-mediated growth arrest. Moreover, nucleophosmin (NPM) and c-Myc, both of which are commonly overexpressed in cancer cells, are capable of abrogating ULF-mediated ARF ubiquitylation through distinct mechanisms, and thereby promote ARF stabilization in cancer cells. These findings reveal the dynamic feature of the ARF-p53 pathway and suggest that transcription-independent mechanisms are critically involved in ARF regulation during responses to oncogenic stress.	[Chen, Delin; Shan, Jing; Gu, Wei] Columbia Univ, Coll Phys & Surg, Inst Canc Genet, New York, NY 10032 USA; [Chen, Delin; Shan, Jing; Gu, Wei] Columbia Univ, Coll Phys & Surg, Dept Pathol & Cell Biol, New York, NY 10032 USA; [Zhu, Wei-Guo] Peking Univ, Hlth Sci Ctr, Dept Biochem & Mol Biol, Beijing 100191, Peoples R China; [Qin, Jun] Baylor Coll Med, Dept Biochem & Cell Biol, Houston, TX 77030 USA	Columbia University; Columbia University; Peking University; Baylor College of Medicine	Gu, W (corresponding author), Columbia Univ, Coll Phys & Surg, Inst Canc Genet, 1130 St Nicholas Ave, New York, NY 10032 USA.	wg8@columbia.edu	zhu, wei-guo/E-1334-2012	Zhu, Wei-Guo/0000-0001-8385-6581	National Institutes of Health/National Cancer Institute; Leukemia and Lymphoma Society; NSFC [30628028]; NATIONAL CANCER INSTITUTE [P01CA080058, R01CA118561, R01CA085533, P01CA097403, R01CA131439, R01CA129627] Funding Source: NIH RePORTER	National Institutes of Health/National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); NSFC(National Natural Science Foundation of China (NSFC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank R. Baer and R. Dalla-Favera for critical comments on this study; B. Falini and J. B. Yoon for providing reagents; W. Z. Zhang for helping in mass spectrometry analysis; E. McIntush for developing the anti-ULF antibody. This study was supported by grants from National Institutes of Health/National Cancer Institute, the Leukemia and Lymphoma Society and NSFC-30628028. W. G. is an Ellison Medical Foundation Senior Scholar in aging.	ABIDE WM, 2006, CANCER RES, V68, P352; Bertwistle D, 2004, MOL CELL BIOL, V24, P985, DOI 10.1128/MCB.24.3.985-996.2004; Brady SN, 2004, MOL CELL BIOL, V24, P9327, DOI 10.1128/MCB.24.21.9327-9338.2004; Brooks CL, 2006, MOL CELL, V21, P307, DOI 10.1016/j.molcel.2006.01.020; Buchholz M, 2005, ONCOGENE, V24, P6626, DOI 10.1038/sj.onc.1208804; Chen DL, 2005, CELL, V121, P1071, DOI 10.1016/j.cell.2005.03.037; Cheng K, 2007, ONCOGENE, V26, P7391, DOI 10.1038/sj.onc.1210549; Christophorou MA, 2006, NATURE, V443, P214, DOI 10.1038/nature05077; Colombo E, 2006, CANCER RES, V66, P3044, DOI 10.1158/0008-5472.CAN-05-2378; Colombo E, 2005, MOL CELL BIOL, V25, P8874, DOI 10.1128/MCB.25.20.8874-8886.2005; den Besten W, 2005, CELL CYCLE, V4, P1593; FEUERSTEIN N, 1987, J BIOL CHEM, V262, P11389; Finak G, 2008, NAT MED, V14, P518, DOI 10.1038/nm1764; Gil J, 2006, NAT REV MOL CELL BIO, V7, P667, DOI 10.1038/nrm1987; Grisendi S, 2005, NATURE, V437, P147, DOI 10.1038/nature03915; Grisendi S, 2006, NAT REV CANCER, V6, P493, DOI 10.1038/nrc1885; Itahana K, 2003, MOL CELL, V12, P1151, DOI 10.1016/S1097-2765(03)00431-3; Korgaonkar C, 2005, MOL CELL BIOL, V25, P1258, DOI 10.1128/MCB.25.4.1258-1271.2005; Kruse JP, 2009, CELL, V137, P609, DOI 10.1016/j.cell.2009.04.050; Kuo ML, 2004, GENE DEV, V18, P1862, DOI 10.1101/gad.1213904; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Li MY, 2003, SCIENCE, V302, P1972, DOI 10.1126/science.1091362; Lowe SW, 2003, CURR OPIN GENET DEV, V13, P77, DOI 10.1016/S0959-437X(02)00013-8; Martins CP, 2006, CELL, V127, P1323, DOI 10.1016/j.cell.2006.12.007; Matheu A, 2008, CANCER RES, V68, P6031, DOI 10.1158/0008-5472.CAN-07-6851; Moulin S, 2008, ONCOGENE, V27, P2382, DOI 10.1038/sj.onc.1210887; Nozawa Y, 1996, J PATHOL, V178, P48; PALINI B, 2005, NEW ENGL J MED, V352, P254; Quentmeier H, 2005, LEUKEMIA, V19, P1760, DOI 10.1038/sj.leu.2403899; Saporita AJ, 2007, CURR MED CHEM, V14, P1815; Sherr CJ, 2006, NAT REV CANCER, V6, P663, DOI 10.1038/nrc1954; Zindy F, 1998, GENE DEV, V12, P2424, DOI 10.1101/gad.12.15.2424	32	115	118	1	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					624	U193		10.1038/nature08820	http://dx.doi.org/10.1038/nature08820			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20208519	Green Accepted			2022-12-01	WOS:000275974200055
J	Hui, D; Elsayem, A; De La Cruz, M; Berger, A; Zhukovsky, DS; Palla, S; Evans, A; Fadul, N; Palmer, JL; Bruera, E				Hui, David; Elsayem, Ahmed; De La Cruz, Maxine; Berger, Ann; Zhukovsky, Donna S.; Palla, Shana; Evans, Avery; Fadul, Nada; Palmer, J. Lynn; Bruera, Eduardo			Availability and Integration of Palliative Care at US Cancer Centers	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							UNITED-STATES; SUPPORTIVE CARE; MEDICAL-CARE; DATA-BASE; LIFE; ONCOLOGY; QUALITY; END; HOSPITALS; SOCIETY	Context The current state of palliative care in cancer centers is not known. Objectives To determine the availability and degree of integration of palliative care services and to compare between National Cancer Institute (NCI) and non-NCI cancer centers in the United States. Design, Setting, and Participants A survey of 71 NCI-designated cancer centers and a random sample of 71 non-NCI cancer centers of both executives and palliative care clinical program leaders, where applicable, regarding their palliative care services between June and October 2009. Survey questions were generated after a comprehensive literature search, review of guidelines from the National Quality Forum, and discussions among 7 physicians with research interest in palliative oncology. Executives were also asked about their attitudes toward palliative care. Main Outcome Measure Availability of palliative care services in the cancer center, defined as the presence of at least 1 palliative care physician. Results A total of 142 and 120 surveys were sent to executives and program leaders, with response rates of 71% and 82%, respectively. National Cancer Institute cancer centers were significantly more likely to have a palliative care program (50/51 [98%] vs 39/50 [78%]; P=.002), at least 1 palliative care physician (46/50 [92%] vs 28/38 [74%]; P=.04), an inpatient palliative care consultation team (47/51 [92%] vs 28/50 [56%]; P<.001), and an outpatient palliative care clinic (30/51 [59%] vs 11/50 [22%]; P<.001). Few centers had dedicated palliative care beds (23/101 [23%]) or an institution-operated hospice (37/101 [37%]). The median (interquartile range) reported durations from referral to death were 7 (4-16), 7 (5-10), and 90 (30-120) days for inpatient consultation teams, inpatient units, and outpatient clinics, respectively. Research programs, palliative care fellowships, and mandatory rotations for oncology fellows were uncommon. Executives were supportive of stronger integration and increasing palliative care resources. Conclusion Most cancer centers reported a palliative care program, although the scope of services and the degree of integration varied widely. JAMA. 2010; 303(11): 1054-1061	[Hui, David; Elsayem, Ahmed; De La Cruz, Maxine; Zhukovsky, Donna S.; Evans, Avery; Fadul, Nada; Bruera, Eduardo] Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Houston, TX 77030 USA; [Palla, Shana; Palmer, J. Lynn] Univ Texas MD Anderson Canc Ctr, Dept Biostat, Houston, TX 77030 USA; [Berger, Ann] NCI, Dept Palliat Care, Ctr Clin Canc, Bethesda, MD 20892 USA	University of Texas System; UTMD Anderson Cancer Center; University of Texas System; UTMD Anderson Cancer Center; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Elsayem, A (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Palliat Care & Rehabil Med, Unit 1414,1515 Holcombe Blvd, Houston, TX 77030 USA.	aelsayem@mdanderson.org	Bruera, Eduardo/AAA-1550-2022		National Institutes of Health [RO1NR010162-01A1, RO1CA122292-01, RO1CA124481-01]; National Cancer Institute [CA16672]; Royal College of Physicians and Surgeons of Canada; NATIONAL CANCER INSTITUTE [R01CA122292, R01CA124481, P30CA016672] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [R01NR010162] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL000785] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Royal College of Physicians and Surgeons of Canada; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); CLINICAL CENTER	Funding/Support: This work was supported in part by grants RO1NR010162-01A1, RO1CA122292-01, and RO1CA124481-01 from the National Institutes of Health (Dr Bruera); grant CA16672 from the National Cancer Institute (Patient- Reported Outcomes, Survey and Population Research Shared Resources); and the Clinician Investigator Program, Royal College of Physicians and Surgeons of Canada (Dr Hui).	Baker JN, 2008, PEDIATR CLIN N AM, V55, P223, DOI 10.1016/j.pcl.2007.10.011; Bilimoria KY, 2008, ANN SURG ONCOL, V15, P683, DOI 10.1245/s10434-007-9747-3; Bilimoria KY, 2009, J CLIN ONCOL, V27, P4177, DOI 10.1200/JCO.2008.21.7018; Billings J A, 2001, J Palliat Med, V4, P309, DOI 10.1089/109662101753123913; Byock I, 2000, CA-CANCER J CLIN, V50, P123, DOI 10.3322/canjclin.50.2.123; Cheng Wen-Wu, 2005, J Palliat Med, V8, P1025, DOI 10.1089/jpm.2005.8.1025; Cherny NI, 2003, CANCER-AM CANCER SOC, V98, P2502, DOI 10.1002/cncr.11815; COLUZZI PH, 1995, J CLIN ONCOL, V13, P756, DOI 10.1200/JCO.1995.13.3.756; DONABEDIAN A, 1966, MILBANK FUND Q, V44, P166, DOI 10.2307/3348969; Earle CC, 2008, J CLIN ONCOL, V26, P3860, DOI 10.1200/JCO.2007.15.8253; El Osta B, 2008, J PALLIAT MED, V11, P51, DOI 10.1089/jpm.2007.0103; Elsayem A, 2004, J CLIN ONCOL, V22, P2008, DOI 10.1200/JCO.2004.11.003; Ferrell B, 2008, J CLIN ONCOL, V26, P3824, DOI 10.1200/JCO.2007.15.7552; Ferris FD, 2009, J CLIN ONCOL, V27, P3052, DOI 10.1200/JCO.2008.20.1558; Goldsmith B, 2008, J PALLIAT MED, V11, P1094, DOI 10.1089/jpm.2008.0053; Higginson IJ, 2003, J PAIN SYMPTOM MANAG, V25, P150, DOI 10.1016/S0885-3924(02)00599-7; Hui D, 2010, J PALLIAT MED, V13, P49, DOI 10.1089/jpm.2009.0166; INGHAM J, 1998, PRINCIPLES PRACTICE, P749; *IOM NAT CANC POL, 2001, IMPR PALL CAR CANC; Johnson CE, 2008, PALLIATIVE MED, V22, P51, DOI 10.1177/0269216307085181; Lagman R, 2005, SEMIN ONCOL, V32, P134, DOI 10.1053/j.seminoncol.2004.11.015; LENEXA KS, 2009, STANDARD DEFINITIONS; Levy MH, 2009, J NATL COMPR CANC NE, V7, P436, DOI 10.6004/jnccn.2009.0031; Meyers FJ, 2004, J PAIN SYMPTOM MANAG, V28, P548, DOI 10.1016/j.jpainsymman.2004.03.002; Meyers FJ, 2003, J CLIN ONCOL, V21, P1412, DOI 10.1200/JCO.2003.01.104; Morita T, 2005, J CLIN ONCOL, V23, P2637, DOI 10.1200/JCO.2005.12.107; Morrison RS, 2005, J PALLIAT MED, V8, P1127, DOI 10.1089/jpm.2005.8.1127; National Quality Forum, 2006, NAT FRAM PREF PRACT; Pan C X, 2001, J Palliat Med, V4, P315, DOI 10.1089/109662101753123922; Schnipper L, 1998, J CLIN ONCOL, V16, P1986; Temel JS, 2007, J CLIN ONCOL, V25, P2377, DOI 10.1200/JCO.2006.09.2627; World Health Organization, 2002, NAT CANC CONTR PROGR, V2nd, P83; Wright AA, 2008, JAMA-J AM MED ASSOC, V300, P1665, DOI 10.1001/jama.300.14.1665	33	349	353	1	20	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1054	1061		10.1001/jama.2010.258	http://dx.doi.org/10.1001/jama.2010.258			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233823	Green Accepted			2022-12-01	WOS:000275594100018
J	Snippert, HJ; Haegebarth, A; Kasper, M; Jaks, V; van Es, JH; Barker, N; van de Wetering, M; van den Born, M; Begthel, H; Vries, RG; Stange, DE; Toftgard, R; Clevers, H				Snippert, Hugo J.; Haegebarth, Andrea; Kasper, Maria; Jaks, Viljar; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; van den Born, Maaike; Begthel, Harry; Vries, Robert G.; Stange, Daniel E.; Toftgard, Rune; Clevers, Hans			Lgr6 Marks Stem Cells in the Hair Follicle That Generate All Cell Lineages of the Skin	SCIENCE			English	Article							LABEL-RETAINING CELLS; ADULT-MOUSE SKIN; POPULATION; EPIDERMIS; KERATINOCYTES; DISTINCT; BULGE; EXPRESSION; RENEWAL; DEFINES	Mammalian epidermis consists of three self-renewing compartments: the hair follicle, the sebaceous gland, and the interfollicular epidermis. We generated knock-in alleles of murine Lgr6, a close relative of the Lgr5 stem cell gene. Lgr6 was expressed in the earliest embryonic hair placodes. In adult hair follicles, Lgr6+ cells resided in a previously uncharacterized region directly above the follicle bulge. They expressed none of the known bulge stem cell markers. Prenatal Lgr6+ cells established the hair follicle, sebaceous gland, and interfollicular epidermis. Postnatally, Lgr6+ cells generated sebaceous gland and interfollicular epidermis, whereas contribution to hair lineages gradually diminished with age. Adult Lgr6+ cells executed long-term wound repair, including the formation of new hair follicles. We conclude that Lgr6 marks the most primitive epidermal stem cell.	[Snippert, Hugo J.; Haegebarth, Andrea; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; van den Born, Maaike; Begthel, Harry; Vries, Robert G.; Stange, Daniel E.; Clevers, Hans] Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, NL-3584 CT Utrecht, Netherlands; [Snippert, Hugo J.; Haegebarth, Andrea; van Es, Johan H.; Barker, Nick; van de Wetering, Marc; van den Born, Maaike; Begthel, Harry; Vries, Robert G.; Stange, Daniel E.; Clevers, Hans] Univ Med Ctr Utrecht, NL-3584 CT Utrecht, Netherlands; [Kasper, Maria; Jaks, Viljar; Toftgard, Rune] Karolinska Inst, Ctr Biosci, SE-14157 Huddinge, Sweden; [Kasper, Maria; Jaks, Viljar; Toftgard, Rune] Novum, Dept Biosci & Nutr, SE-14157 Huddinge, Sweden	Royal Netherlands Academy of Arts & Sciences; Hubrecht Institute (KNAW); Utrecht University; Utrecht University Medical Center; Karolinska Institutet; Karolinska Institutet	Clevers, H (corresponding author), Royal Netherlands Acad Arts & Sci, Hubrecht Inst KNAW, Uppsalalaan 8, NL-3584 CT Utrecht, Netherlands.	h.clevers@hubrecht.eu	Barker, Nick/A-5535-2011; van+Es, Johan/ABD-5411-2021; Barker, Nick/AAE-9833-2021; Jaks, Viljar/H-2467-2012; Kasper, Maria/Q-6318-2016; Stange, Daniel E/O-1837-2015; Barker, Nick/AAS-2774-2020	Barker, Nick/0000-0003-3566-4475; Jaks, Viljar/0000-0002-2221-6262; Stange, Daniel E/0000-0003-4246-2230; Kasper, Maria/0000-0002-6117-2717	Koningin Wilhelmina Fonds; European Research Council; European Molecular Biology Organization; Swedish Cancer Society; Swedish Research Council	Koningin Wilhelmina Fonds; European Research Council(European Research Council (ERC)European Commission); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Swedish Cancer Society(Swedish Cancer Society); Swedish Research Council(Swedish Research CouncilEuropean Commission)	We acknowledge M. Cozijnsen, J. Korving, A. Bergstrom, A. Dackland, and Hubrecht Imaging Centre for technical help and support. This work was supported by the Koningin Wilhelmina Fonds and a European Research Council grant to H. C., a European Molecular Biology Organization Long-Term Fellowship to A. H., and by grants from the Swedish Cancer Society and the Swedish Research Council to R. T. A patent is pending on work with Lgr5 and Lgr6 (A. H., N. B., and H. C.). GEO microarray accession number is GSE20269.	Alonso L, 2006, J CELL SCI, V119, P391, DOI 10.1242/jcs02793; Barker N, 2007, NATURE, V449, P1003, DOI 10.1038/nature06196; Blanpain C, 2004, CELL, V118, P635, DOI 10.1016/j.cell.2004.08.012; Braun KM, 2003, DEVELOPMENT, V130, P5241, DOI 10.1242/dev.00703; Claudinot S, 2005, P NATL ACAD SCI USA, V102, P14677, DOI 10.1073/pnas.0507250102; Clayton E, 2007, NATURE, V446, P185, DOI 10.1038/nature05574; COTSARELIS G, 1990, CELL, V61, P1329, DOI 10.1016/0092-8674(90)90696-C; Fuchs E, 2008, GENE DEV, V22, P976, DOI 10.1101/gad.1645908; Ghazizadeh S, 2001, EMBO J, V20, P1215, DOI 10.1093/emboj/20.6.1215; Horsley V, 2006, CELL, V126, P597, DOI 10.1016/j.cell.2006.06.048; Iseki S, 1996, BIOCHEM BIOPH RES CO, V218, P688, DOI 10.1006/bbrc.1996.0123; Ito M, 2005, NAT MED, V11, P1351, DOI 10.1038/nm1328; Ito M, 2004, DIFFERENTIATION, V72, P548, DOI 10.1111/j.1432-0436.2004.07209008.x; Ito M, 2007, NATURE, V447, P316, DOI 10.1038/nature05766; Jaks V, 2008, NAT GENET, V40, P1291, DOI 10.1038/ng.239; Jensen KB, 2009, CELL STEM CELL, V4, P427, DOI 10.1016/j.stem.2009.04.014; Jensen UB, 2008, J CELL SCI, V121, P609, DOI 10.1242/jcs.025502; Kasper M, 2006, MOL CELL BIOL, V26, P6283, DOI 10.1128/MCB.02317-05; Levy V, 2005, DEV CELL, V9, P855, DOI 10.1016/j.devcel.2005.11.003; Levy V, 2007, FASEB J, V21, P1358, DOI 10.1096/fj.06-6926com; Morris RJ, 2004, NAT BIOTECHNOL, V22, P411, DOI 10.1038/nbt950; Nijhof JGW, 2006, DEVELOPMENT, V133, P3027, DOI 10.1242/dev.02443; Pispa J, 2008, HUM MOL GENET, V17, P3380, DOI 10.1093/hmg/ddn232; Rhee H, 2006, SCIENCE, V312, P1946, DOI 10.1126/science.1128004; Trempus CS, 2003, J INVEST DERMATOL, V120, P501, DOI 10.1046/j.1523-1747.2003.12088.x; Tumbar T, 2004, SCIENCE, V303, P359, DOI 10.1126/science.1092436; van der Flier LG, 2009, CELL, V136, P903, DOI 10.1016/j.cell.2009.01.031; Van Loy T, 2008, GEN COMP ENDOCR, V155, P14, DOI 10.1016/j.ygcen.2007.06.022; Van Schoore G, 2005, HISTOCHEM CELL BIOL, V124, P35, DOI 10.1007/s00418-005-0002-3; Vidal VPI, 2005, CURR BIOL, V15, P1340, DOI 10.1016/j.cub.2005.06.064	30	538	570	7	86	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1385	1389		10.1126/science.1184733	http://dx.doi.org/10.1126/science.1184733			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223988				2022-12-01	WOS:000275418700043
J	Ammirante, M; Luo, JL; Grivennikov, S; Nedospasov, S; Karin, M				Ammirante, Massimo; Luo, Jun-Li; Grivennikov, Sergei; Nedospasov, Sergei; Karin, Michael			B-cell-derived lymphotoxin promotes castration-resistant prostate cancer	NATURE			English	Article							FACTOR-KAPPA-B; IKK-ALPHA; CHRONIC INFLAMMATION; T-CELLS; ACTIVATION; INTERLEUKIN-6; PROGRESSION; METASTASIS; EXPRESSION; RELEASE	Prostate cancer (CaP) progresses from prostatic intraepithelial neoplasia through locally invasive adenocarcinoma to castration-resistant metastatic carcinoma(1). Although radical prostatectomy, radiation and androgen ablation are effective therapies for androgen-dependent CaP, metastatic castration-resistant CaP is a major complication with high mortality(2). Androgens stimulate growth and survival of prostate epithelium and early CaP. Although most patients initially respond to androgen ablation, many develop castration-resistant CaP within 12-18 months(2). Despite extensive studies, the mechanisms underlying the emergence of castration-resistant CaP remain poorly understood and their elucidation is critical for developing improved therapies. Curiously, castration-resistant CaP remains androgen-receptor dependent, and potent androgen-receptor antagonists induce tumour regression in castrated mice(3). The role of inflammation in castration-resistant CaP has not been addressed, although it was reported that intrinsic NF-kappa B activation supports its growth(4). Inflammation is a localized protective reaction to injury or infection, but it also has a pathogenic role in many diseases, including cancer(5). Whereas acute inflammation is critical for host defence, chronic inflammation contributes to tumorigenesis and metastatic progression. The inflammation-responsive I kappa B kinase (IKK)-beta and its target NF-kB have important tumour-promoting functions within malignant cells and inflammatory cells(6). The latter, including macrophages and lymphocytes, are important elements of the tumour microenvironment(7-9), but the mechanisms underlying their recruitment remain obscure, although they are thought to depend on chemokine and cytokine production(10). We found that CaP progression is associated with inflammatory infiltration and activation of IKK-alpha, which stimulates metastasis by an NF-kappa B-independent, cell autonomous mechanism(11). Here we show that androgen ablation causes infiltration of regressing androgen-dependent tumours with leukocytes, including B cells, in which IKK-beta activation results in production of cytokines that activate IKK-alpha and STAT3 in CaP cells to enhance hormone-free survival.	[Ammirante, Massimo; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Ammirante, Massimo; Grivennikov, Sergei; Karin, Michael] Univ Calif San Diego, Sch Med, Ctr Canc, La Jolla, CA 92093 USA; [Luo, Jun-Li] Scripps Res Inst Florida, Dept Canc Biol, Jupiter, FL 33458 USA; [Nedospasov, Sergei] VA Engelhardt Mol Biol Inst, Lab Mol Immunol, Moscow 119991, Russia	University of California System; University of California San Diego; University of California System; University of California San Diego; Scripps Research Institute; Russian Academy of Sciences; Engelhardt Institute of Molecular Biology, RAS	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, 9500 Gilman Dr, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	Nedospasov, Sergei/Q-7319-2016; Grivennikov, Sergei/AAE-7365-2019; Nedospasov, Sergei/C-3043-2018; Nedospasov, Sergei/J-5936-2013; Nedospasov, Sergei/L-1990-2015	Grivennikov, Sergei/0000-0003-2987-0555; Luo, Jun-Li/0000-0002-7625-4766	Fondazione Italiana per la Ricerca sul Cancro; American-Italian Cancer Foundation; Life Science Research Fellowship; National Institutes of Health; US Army Medical Research and Material Command and Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE [R01CA127923] Funding Source: NIH RePORTER; Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Fondazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro); American-Italian Cancer Foundation; Life Science Research Fellowship; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army Medical Research and Material Command and Prostate Cancer Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)	We thank C. Sawyers for myc-CaP cells, L. Coussens for J<INF>H</INF><SUP>-/-</SUP> (FVB) mice, Y. X. Fu for LT beta R-Ig fusion protein, R. Rickert for help with B-cell phenotyping, H. Cheroutre for flow cytometer use and C. Ware for bone marrow. M. A. was supported by Fondazione Italiana per la Ricerca sul Cancro and American-Italian Cancer Foundation fellowships. J.-L.L. was supported by a Life Science Research Fellowship. Work in M.K.'s laboratory was supported by grants from the National Institutes of Health, the US Army Medical Research and Material Command and Prostate Cancer Foundation. M. K. is an American Cancer Society Research Professor.	Bai AL, 2008, P NATL ACAD SCI USA, V105, P13003, DOI 10.1073/pnas.0805599105; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bonizzi G, 2004, EMBO J, V23, P4202, DOI 10.1038/sj.emboj.7600391; Chen TS, 2000, CANCER RES, V60, P2132; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; de Visser KE, 2005, CANCER CELL, V7, P411, DOI 10.1016/j.ccr.2005.04.014; Ellwood-Yen K, 2003, CANCER CELL, V4, P223, DOI 10.1016/S1535-6108(03)00197-1; Eriksen KW, 2001, LEUKEMIA, V15, P787, DOI 10.1038/sj.leu.2402093; Ghiringhelli F, 2009, NAT MED, V15, P1170, DOI 10.1038/nm.2028; GREENBERG NM, 1995, P NATL ACAD SCI USA, V92, P3439, DOI 10.1073/pnas.92.8.3439; Gulley James, 2003, Clin Adv Hematol Oncol, V1, P49; Hamel K, 2008, J IMMUNOL, V180, P4994, DOI 10.4049/jimmunol.180.7.4994; Isaacs JT, 1999, UROL CLIN N AM, V26, P263, DOI 10.1016/S0094-0143(05)70066-5; Izmailova ES, 2007, ARTHRITIS RHEUM-US, V56, P117, DOI 10.1002/art.22303; Jin RJ, 2008, CANCER RES, V68, P6762, DOI 10.1158/0008-5472.CAN-08-0107; Karin M, 2006, CELL, V124, P823, DOI 10.1016/j.cell.2006.02.016; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Kim S, 2009, NATURE, V457, P102, DOI 10.1038/nature07623; Kortylewski M, 2007, J IMMUNOTHER, V30, P131, DOI 10.1097/01.cji.0000211327.76266.65; KUHN R, 1995, SCIENCE, V269, P1427, DOI 10.1126/science.7660125; Lee Y, 2006, IMMUNITY, V25, P499, DOI 10.1016/j.immuni.2006.06.016; Legler DF, 1998, J EXP MED, V187, P655, DOI 10.1084/jem.187.4.655; Liu X, 2006, AM J EPIDEMIOL, V164, P984, DOI 10.1093/aje/kwj294; Luo JL, 2004, CANCER CELL, V6, P297, DOI 10.1016/j.ccr.2004.08.012; Luo JL, 2007, NATURE, V446, P690, DOI 10.1038/nature05656; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Nimmerjahn F, 2007, ADV IMMUNOL, V96, P179, DOI 10.1016/S0065-2776(07)96005-8; Park BK, 2007, NAT MED, V13, P62, DOI 10.1038/nm1519; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Scaffidi P, 2002, NATURE, V418, P191, DOI 10.1038/nature00858; Senftleben U, 2001, SCIENCE, V293, P1495, DOI 10.1126/science.1062677; Smith PC, 2001, CYTOKINE GROWTH F R, V12, P33, DOI 10.1016/S1359-6101(00)00021-6; Tran C, 2009, SCIENCE, V324, P787, DOI 10.1126/science.1168175; Tumanov AV, 2003, IMMUNOL REV, V195, P106, DOI 10.1034/j.1600-065X.2003.00071.x; Watson PA, 2005, CANCER RES, V65, P11565, DOI 10.1158/0008-5472.CAN-05-3441; Wen DY, 2006, J PHARMACOL EXP THER, V317, P989, DOI 10.1124/jpet.105.097584; Worm MM, 1998, EUR J IMMUNOL, V28, P901, DOI 10.1002/(SICI)1521-4141(199803)28:03<901::AID-IMMU901>3.0.CO;2-S; Wu XT, 2001, MECH DEVELOP, V101, P61, DOI 10.1016/S0925-4773(00)00551-7; Zheng B, 2005, ARTHRITIS RHEUM-US, V52, P620, DOI 10.1002/art.20768	39	428	448	4	47	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					302	U187		10.1038/nature08782	http://dx.doi.org/10.1038/nature08782			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220849	Green Accepted			2022-12-01	WOS:000275366100052
J	Paterson, S; Vogwill, T; Buckling, A; Benmayor, R; Spiers, AJ; Thomson, NR; Quail, M; Smith, F; Walker, D; Libberton, B; Fenton, A; Hall, N; Brockhurst, MA				Paterson, Steve; Vogwill, Tom; Buckling, Angus; Benmayor, Rebecca; Spiers, Andrew J.; Thomson, Nicholas R.; Quail, Mike; Smith, Frances; Walker, Danielle; Libberton, Ben; Fenton, Andrew; Hall, Neil; Brockhurst, Michael A.			Antagonistic coevolution accelerates molecular evolution	NATURE			English	Article							LOCAL ADAPTATION; BACTERIA; PHAGE	The Red Queen hypothesis proposes that coevolution of interacting species (such as hosts and parasites) should drive molecular evolution through continual natural selection for adaptation and counter-adaptation(1-3). Although the divergence observed at some host-resistance(4-6) and parasite-infectivity(7-9) genes is consistent with this, the long time periods typically required to study coevolution have so far prevented any direct empirical test. Here we show, using experimental populations of the bacterium Pseudomonas fluorescens SBW25 and its viral parasite, phage Phi 2 (refs 10, 11), that the rate of molecular evolution in the phage was far higher when both bacterium and phage coevolved with each other than when phage evolved against a constant host genotype. Coevolution also resulted in far greater genetic divergence between replicate populations, which was correlated with the range of hosts that coevolved phage were able to infect. Consistent with this, the most rapidly evolving phage genes under coevolution were those involved in host infection. These results demonstrate, at both the genomic and phenotypic level, that antagonistic coevolution is a cause of rapid and divergent evolution, and is likely to be a major driver of evolutionary change within species.	[Paterson, Steve; Vogwill, Tom; Libberton, Ben; Fenton, Andrew; Hall, Neil; Brockhurst, Michael A.] Univ Liverpool, Sch Biol Sci, Liverpool L69 7ZB, Merseyside, England; [Buckling, Angus; Benmayor, Rebecca] Univ Oxford, Dept Zool, Oxford OX1 3PS, England; [Spiers, Andrew J.] Univ Abertay Dundee, SIMBIOS Ctr, Dundee DD1 1HG, Scotland; [Thomson, Nicholas R.; Quail, Mike; Smith, Frances; Walker, Danielle] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England	University of Liverpool; University of Oxford; University of Abertay Dundee; Wellcome Trust Sanger Institute	Brockhurst, MA (corresponding author), Univ Liverpool, Sch Biol Sci, Biosci Bldg,Crown St, Liverpool L69 7ZB, Merseyside, England.	michael.brockhurst@liverpool.ac.uk	Fenton, Andy/B-5972-2009; Paterson, Steve/D-2154-2009; Hall, Neil/A-8717-2013; Spiers, Andrew/I-3535-2012; Brockhurst, Michael A/A-6247-2009; Thomson, Nicholas/P-5988-2014	Fenton, Andy/0000-0002-7676-917X; Paterson, Steve/0000-0002-1307-2981; Hall, Neil/0000-0002-7995-3810; Spiers, Andrew/0000-0003-0463-8629; Libberton, Ben/0000-0001-9104-679X; Hall, Neil/0000-0003-2808-0009; Brockhurst, Michael/0000-0003-0362-820X; Vogwill, Tom/0000-0003-1044-6623; Thomson, Nicholas/0000-0002-4432-8505; Buckling, Angus/0000-0003-1170-4604	Natural Environment Research Council; Wellcome Trust; Leverhulme Trust; European Research Council; Natural Environment Research Council [NE/F001193/1, NBAF010002] Funding Source: researchfish; NERC [NBAF010002, NE/F001193/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Wellcome Trust(Wellcome TrustEuropean Commission); Leverhulme Trust(Leverhulme Trust); European Research Council(European Research Council (ERC)European Commission); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We are grateful to M. Begon and G. Hurst for comments on previous drafts of this manuscript. We acknowledge funding from the Natural Environment Research Council, the Wellcome Trust, the Leverhulme Trust and the European Research Council. We are grateful for technical assistance from staff at the Centre for Genomic Research, University of Liverpool.	Abedon S.T, 2005, BACTERIOPHAGES; Barrett LG, 2009, MOL BIOL EVOL, V26, P2499, DOI 10.1093/molbev/msp166; Barrick JE, 2009, COLD SH Q B, V74, P119, DOI 10.1101/sqb.2009.74.018; Barrick JE, 2009, NATURE, V461, P1243, DOI 10.1038/nature08480; Benmayor R, 2009, CURR BIOL, V19, P764, DOI 10.1016/j.cub.2009.03.023; Blanc G, 2005, MOL BIOL EVOL, V22, P2073, DOI 10.1093/molbev/msi199; Brockhurst MA, 2003, ECOL LETT, V6, P975, DOI 10.1046/j.1461-0248.2003.00531.x; Brockhurst MA, 2007, INFECT GENET EVOL, V7, P547, DOI 10.1016/j.meegid.2007.01.005; Buckling A, 2002, P ROY SOC B-BIOL SCI, V269, P931, DOI 10.1098/rspb.2001.1945; Bull JJ, 1997, GENETICS, V147, P1497; Ceyssens PJ, 2006, J BACTERIOL, V188, P6924, DOI 10.1128/JB.00831-06; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; EXCOFFIER L, 1992, GENETICS, V131, P479; HEDRICK PW, 1994, AM NAT, V143, P945, DOI 10.1086/285643; Morgan AD, 2006, J EVOLUTION BIOL, V19, P1956, DOI 10.1111/j.1420-9101.2006.01148.x; Morgan AD, 2005, NATURE, V437, P253, DOI 10.1038/nature03913; Mu JB, 2007, NAT GENET, V39, P126, DOI 10.1038/ng1924; Obbard DJ, 2006, CURR BIOL, V16, P580, DOI 10.1016/j.cub.2006.01.065; Poullain V, 2008, EVOLUTION, V62, P1, DOI 10.1111/j.1558-5646.2007.00260.x; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; SANTOS MA, 1991, NUCLEIC ACIDS RES, V19, P5442, DOI 10.1093/nar/19.19.5442; STENSETH NC, 1984, EVOLUTION, V38, P870, DOI 10.1111/j.1558-5646.1984.tb00358.x; Thompson J.N., 2005, INTERSPEC INTERACT; Van Valen L., 1973, EVOL THEORY, V1, P1, DOI DOI 10.1038/344864A0; VANVALEN L, 1974, J MOL EVOL, V3, P89, DOI 10.1007/BF01796554; Wichman HA, 1999, SCIENCE, V285, P422, DOI 10.1126/science.285.5426.422; Woolhouse MEJ, 2002, NAT GENET, V32, P569, DOI 10.1038/ng1202-569	27	345	356	4	277	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					275	U154		10.1038/nature08798	http://dx.doi.org/10.1038/nature08798			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20182425	Green Accepted			2022-12-01	WOS:000275366100046
J	Sharma, CM; Hoffmann, S; Darfeuille, F; Reignier, J; Findeiss, S; Sittka, A; Chabas, S; Reiche, K; Hackermuller, J; Reinhardt, R; Stadler, PF; Vogel, J				Sharma, Cynthia M.; Hoffmann, Steve; Darfeuille, Fabien; Reignier, Jeremy; Findeiss, Sven; Sittka, Alexandra; Chabas, Sandrine; Reiche, Kristin; Hackermueller, Joerg; Reinhardt, Richard; Stadler, Peter F.; Vogel, Joerg			The primary transcriptome of the major human pathogen Helicobacter pylori	NATURE			English	Article							ESCHERICHIA-COLI; RNA-POLYMERASE; GENE-EXPRESSION; COMPARATIVE GENOMICS; MESSENGER-RNA; 6S RNA; IDENTIFICATION; PROMOTER; SEQUENCE; BACTERIA	Genome sequencing of Helicobacter pylori has revealed the potential proteins and genetic diversity of this prevalent human pathogen, yet little is known about its transcriptional organization and noncoding RNA output. Massively parallel cDNA sequencing (RNA-seq) has been revolutionizing global transcriptomic analysis. Here, using a novel differential approach (dRNA-seq) selective for the 5' end of primary transcripts, we present a genome-wide map of H. pylori transcriptional start sites and operons. We discovered hundreds of transcriptional start sites within operons, and opposite to annotated genes, indicating that complexity of gene expression from the small H. pylori genome is increased by uncoupling of polycistrons and by genome-wide antisense transcription. We also discovered an unexpected number of similar to 60 small RNAs including the e-subdivision counterpart of the regulatory 6S RNA and associated RNA products, and potential regulators of cis- and trans-encoded target messenger RNAs. Our approach establishes a paradigm for mapping and annotating the primary transcriptomes of many living species.	[Sharma, Cynthia M.; Sittka, Alexandra; Vogel, Joerg] Max Planck Inst Infect Biol, RNA Biol Grp, D-10117 Berlin, Germany; [Hoffmann, Steve; Findeiss, Sven; Stadler, Peter F.] Univ Leipzig, Dept Comp Sci, D-04107 Leipzig, Germany; [Hoffmann, Steve; Findeiss, Sven; Stadler, Peter F.] Univ Leipzig, Interdisciplinary Ctr Bioinformat, D-04107 Leipzig, Germany; [Darfeuille, Fabien; Reignier, Jeremy; Chabas, Sandrine] INSERM, U869, F-33076 Bordeaux, France; [Darfeuille, Fabien; Reignier, Jeremy; Chabas, Sandrine] Univ Bordeaux, F-33076 Bordeaux, France; [Reiche, Kristin; Hackermueller, Joerg; Stadler, Peter F.] Fraunhofer Inst Cell Therapy & Immunol, RNom Grp, D-04103 Leipzig, Germany; [Reinhardt, Richard] Max Planck Inst Mol Genet, D-14195 Berlin, Germany; [Stadler, Peter F.] Max Planck Inst Math Sci, D-04103 Leipzig, Germany; [Stadler, Peter F.] Univ Vienna, Inst Theoret Chem, A-1090 Vienna, Austria; [Stadler, Peter F.] Santa Fe Inst, Santa Fe, NM 87501 USA; [Vogel, Joerg] Univ Wurzburg, Inst Mol Infect Biol, D-97080 Wurzburg, Germany	Max Planck Society; Leipzig University; Leipzig University; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; Fraunhofer Gesellschaft; Max Planck Society; Max Planck Society; University of Vienna; The Santa Fe Institute; University of Wurzburg	Vogel, J (corresponding author), Max Planck Inst Infect Biol, RNA Biol Grp, D-10117 Berlin, Germany.	joerg.vogel@uni-wuerzburg.de	Sharma, Cynthia/D-2869-2013; Stadler, Peter F. F/L-7857-2015; Hoffmann, Steve/E-1438-2013; Darfeuille, Fabien/M-3883-2014; Hackermüller, Jörg/F-2494-2016; Vogel, Jörg/D-5574-2011	Stadler, Peter F. F/0000-0002-5016-5191; Darfeuille, Fabien/0000-0003-1167-6113; Hackermüller, Jörg/0000-0003-4920-7072; Vogel, Jörg/0000-0003-2220-1404; Findeiss, Sven/0000-0002-3311-7745; Reiche, Kristin/0000-0002-4452-4872; Reinhardt, Richard/0000-0001-9376-2132; Sharma, Cynthia Mira/0000-0002-2321-9705	NGFN, BMBF, Germany; DFG [SPP1258]; Regulatory RNAs in Prokaryotes [VO8751/2, VO8751/4, STA850/7-1]; University of Leipzig; Freistaat Sachsen; German Research Foundation IZBI [BIZ6/1-4]; Volkswagen Stiftung [I/82 720]; French Agence Nationale de la Recherche [ANR-07-JCJC-0104-01]; French Association de la Recherche contre le Cancer (ARC); La Ligue Nationale contre le Cancer (LNCC)	NGFN, BMBF, Germany(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Regulatory RNAs in Prokaryotes; University of Leipzig; Freistaat Sachsen; German Research Foundation IZBI; Volkswagen Stiftung(Volkswagen); French Agence Nationale de la Recherche(French National Research Agency (ANR)); French Association de la Recherche contre le Cancer (ARC); La Ligue Nationale contre le Cancer (LNCC)	We thank F. Seifert; H. Hamoutene and B. Timmermann for technical support; M. Schmid for mass spectrometry analysis; H. De Reuse, A. van Vliet and M. K. Waldor for discussions; F. Thummler for library preparation; M. Droege for pyrosequencing support. J. V. and R. R. are supported by NGFN+ grants (BMBF, Germany), and J. V. and P. F. S. by DFG Priority Program SPP1258 Sensory and Regulatory RNAs in Prokaryotes (Grants VO8751/2, VO8751/4; STA850/7-1). S. H. was supported by a formel. 1 grant of the University of Leipzig, the Freistaat Sachsen (LIFE project), the German Research Foundation IZBI (BIZ6/1-4) and Volkswagen Stiftung (I/82 720). F. D. is supported by the French Agence Nationale de la Recherche (ANR-07-JCJC-0104-01), the French Association de la Recherche contre le Cancer (ARC) and La Ligue Nationale contre le Cancer (LNCC). We thank D. Rose for his supporting work and S. Washietl for a pre-release of the RNAcode software.	Akada JK, 2000, MOL MICROBIOL, V36, P1071, DOI 10.1046/j.1365-2958.2000.01918.x; Alm RA, 1999, NATURE, V397, P176, DOI 10.1038/16495; Appelmelk BJ, 1998, INFECT IMMUN, V66, P70, DOI 10.1128/IAI.66.1.70-76.1998; Barrick JE, 2005, RNA, V11, P774, DOI 10.1261/rna.7286705; Beier D, 1997, J BACTERIOL, V179, P4676, DOI 10.1128/jb.179.15.4676-4683.1997; Boneca IG, 2003, NUCLEIC ACIDS RES, V31, P1704, DOI 10.1093/nar/gkg250; Brock JE, 2008, RNA, V14, P2159, DOI 10.1261/rna.1089208; Burgess RR, 2001, CURR OPIN MICROBIOL, V4, P126, DOI 10.1016/S1369-5274(00)00177-6; Bury-Mone S, 2004, MOL MICROBIOL, V53, P623, DOI 10.1111/j.1365-2958.2004.04137.x; Cover TL, 2009, GASTROENTEROLOGY, V136, P1863, DOI 10.1053/j.gastro.2009.01.073; Croxen MA, 2007, J BACTERIOL, V189, P3359, DOI 10.1128/JB.00012-07; Forsyth MH, 1999, J BACTERIOL, V181, P2261, DOI 10.1128/JB.181.7.2261-2266.1999; Fozo EM, 2008, MICROBIOL MOL BIOL R, V72, P579, DOI 10.1128/MMBR.00025-08; Fujita Y, 2005, HELICOBACTER, V10, P567, DOI 10.1111/j.1523-5378.2005.00364.x; Gressmann H, 2005, PLOS GENET, V1, P419, DOI 10.1371/journal.pgen.0010043; Jenks PJ, 2001, RES MICROBIOL, V152, P725, DOI 10.1016/S0923-2508(01)01253-0; Kodzius R, 2006, NAT METHODS, V3, P211, DOI 10.1038/nmeth0306-211; Lenz DH, 2004, CELL, V118, P69, DOI 10.1016/j.cell.2004.06.009; Majdalani N, 2005, CRIT REV BIOCHEM MOL, V40, P93, DOI 10.1080/10409230590918702; Mao FL, 2009, NUCLEIC ACIDS RES, V37, pD459, DOI 10.1093/nar/gkn757; Merrell DS, 2003, INFECT IMMUN, V71, P3529, DOI 10.1128/IAI.71.6.3529-3539.2003; Petersen L, 2003, J MOL BIOL, V326, P1361, DOI 10.1016/S0022-2836(03)00034-2; Pflock M, 2005, INFECT IMMUN, V73, P6437, DOI 10.1128/IAI.73.10.6437-6445.2005; Phadnis SH, 1996, INFECT IMMUN, V64, P905, DOI 10.1128/IAI.64.3.905-912.1996; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Ramakrishnan V, 2002, CELL, V108, P557, DOI 10.1016/S0092-8674(02)00619-0; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Salama NR, 2004, J BACTERIOL, V186, P7926, DOI 10.1128/JB.186.23.7926-7935.2004; Saunders NJ, 1998, MOL MICROBIOL, V27, P1091, DOI 10.1046/j.1365-2958.1998.00768.x; Selinger DW, 2000, NAT BIOTECHNOL, V18, P1262, DOI 10.1038/82367; Sharma CM, 2009, CURR OPIN MICROBIOL, V12, P536, DOI 10.1016/j.mib.2009.07.006; Shi YM, 2009, NATURE, V459, P266, DOI 10.1038/nature08055; Shirai M, 1999, GENE, V239, P351, DOI 10.1016/S0378-1119(99)00389-3; Sorek R, 2010, NAT REV GENET, V11, P9, DOI 10.1038/nrg2695; Spohn G, 1999, J BACTERIOL, V181, P593, DOI 10.1128/JB.181.2.593-599.1999; Spohn G, 1997, MOL MICROBIOL, V26, P361, DOI 10.1046/j.1365-2958.1997.5831949.x; Suerbaum S, 2002, NEW ENGL J MED, V347, P1175, DOI 10.1056/NEJMra020542; Thompson LJ, 2003, INFECT IMMUN, V71, P2643, DOI 10.1128/IAI.71.5.2643-2655.2003; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Valentin-Hansen P, 2004, MOL MICROBIOL, V51, P1525, DOI 10.1111/j.1365-2958.2003.03935.x; Vanet A, 2000, J MOL BIOL, V297, P335, DOI 10.1006/jmbi.2000.3576; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang Z, 2004, NUCLEIC ACIDS RES, V32, pD590, DOI 10.1093/nar/gkh025; Wassarman KM, 2006, SCIENCE, V314, P1601, DOI 10.1126/science.1134830; Wassarman KM, 2000, CELL, V101, P613, DOI 10.1016/S0092-8674(00)80873-9; Waters LS, 2009, CELL, V136, P615, DOI 10.1016/j.cell.2009.01.043; Weinberg Z, 2007, NUCLEIC ACIDS RES, V35, P4809, DOI 10.1093/nar/gkm487; Wen Y, 2003, INFECT IMMUN, V71, P5921, DOI 10.1128/IAI.71.10.5921-5939.2003; Yada T, 2001, DNA RES, V8, P97, DOI 10.1093/dnares/8.3.97	50	850	872	0	168	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					250	255		10.1038/nature08756	http://dx.doi.org/10.1038/nature08756			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20164839				2022-12-01	WOS:000275366100040
J	Hittinger, CT; Goncalves, P; Sampaio, JP; Dover, J; Johnston, M; Rokas, A				Hittinger, Chris Todd; Goncalves, Paula; Sampaio, Jose Paulo; Dover, Jim; Johnston, Mark; Rokas, Antonis			Remarkably ancient balanced polymorphisms in a multi-locus gene network	NATURE			English	Article							BAYESIAN PHYLOGENETIC INFERENCE; SACCHAROMYCES-CEREVISIAE; ARABIDOPSIS-THALIANA; POPULATION GENOMICS; YEAST; SELECTION; SUBSTITUTION; EVOLUTION; DNA; KUDRIAVZEVII	Local adaptations within species are often governed by several interacting genes scattered throughout the genome. Single-locus models of selection cannot explain the maintenance of such complex variation because recombination separates co-adapted alleles. Here we report a previously unrecognized type of intraspecific multi-locus genetic variation that has been maintained over a vast period. The galactose (GAL) utilization gene network of Saccharomyces kudriavzevii, a relative of brewer's yeast, exists in two distinct states: a functional gene network in Portuguese strains and, in Japanese strains, a non-functional gene network of allelic pseudogenes. Genome sequencing of all available S. kudriavzevii strains revealed that none of the functional GAL genes were acquired from other species. Rather, these polymorphisms have been maintained for nearly the entire history of the species, despite more recent gene flow genome-wide. Experimental evidence suggests that inactivation of the GAL3 and GAL80 regulatory genes facilitated the origin and long-term maintenance of the two gene network states. This striking example of a balanced unlinked gene network polymorphism introduces a remarkable type of intraspecific variation that may be widespread.	[Hittinger, Chris Todd; Dover, Jim; Johnston, Mark] Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA; [Hittinger, Chris Todd; Dover, Jim; Johnston, Mark] Washington Univ, Sch Med, Dept Genet, Ctr Genome Sci, St Louis, MO 63108 USA; [Goncalves, Paula; Sampaio, Jose Paulo] Univ Nova Lisboa, Ctr Recursos Microbiol, Dept Ciencias Vida, Fac Ciencias & Tecnol, P-2829516 Caparica, Portugal; [Rokas, Antonis] Vanderbilt Univ, Dept Biol Sci, Nashville, TN 37235 USA	University of Colorado System; University of Colorado Anschutz Medical Campus; Washington University (WUSTL); Universidade Nova de Lisboa; Vanderbilt University	Johnston, M (corresponding author), Univ Colorado, Sch Med, Dept Biochem & Mol Genet, Aurora, CO 80045 USA.	mark.johnston@ucdenver.edu	Gonçalves, Paula/B-4016-2010; Rokas, Antonis/A-9775-2008; Johnston, Mark/R-6156-2019; Sampaio, Jose Paulo/C-5532-2011; Johnston, Mark/K-3543-2019; Gonçalves, Paula/CAH-0730-2022	Gonçalves, Paula/0000-0003-2103-1060; Rokas, Antonis/0000-0002-7248-6551; Sampaio, Jose Paulo/0000-0001-8145-5274; Johnston, Mark/0000-0002-4932-7229; Gonçalves, Paula/0000-0003-2103-1060	James S. McDonnell Foundation; National Institutes of Health [2T32HG00045, 5R01GM032540]; Fundacao para a Ciencia e a Tecnologia, Portugal [PTDC/BIA-BDE/71734/2006]; Searle Scholars Program; National Science Foundation [DEB-0844968]; Vanderbilt University; Division Of Environmental Biology [0844968] Funding Source: National Science Foundation; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [T32HG000045] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM032540] Funding Source: NIH RePORTER	James S. McDonnell Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Fundacao para a Ciencia e a Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Searle Scholars Program; National Science Foundation(National Science Foundation (NSF)); Vanderbilt University; Division Of Environmental Biology(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank E. Barrio; B. L. Williams; the Centraalbureau voor Schimmelcultures, Netherlands and the National Institute of Technology and Evaluation Biological Resource Center, Japan for providing strains; J. Fay for critical reading of the manuscript; and the Howard Hughes Medical Institute (HHMI) and S. B. Carroll for supporting preliminary experiments when C. T. H. was a HHMI Predoctoral Fellow. This work was also supported by the James S. McDonnell Foundation (C. T. H., M. J.); the National Institutes of Health (C. T. H., 2T32HG00045; M. J., 5R01GM032540); the Fundacao para a Ciencia e a Tecnologia, Portugal (P. G. and J. P. S., PTDC/BIA-BDE/71734/2006); the Searle Scholars Program (A. R.); the National Science Foundation (A. R., DEB-0844968) and Vanderbilt University (A. R.). C. T. H. is the Maclyn McCarty Fellow of the Helen Hay Whitney Foundation.	Altekar G, 2004, BIOINFORMATICS, V20, P407, DOI 10.1093/bioinformatics/btg427; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bensasson D, 2008, GENETICS, V178, P2161, DOI 10.1534/genetics.107.083980; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bhat PJ, 2001, MOL MICROBIOL, V40, P1059, DOI 10.1046/j.1365-2958.2001.02421.x; Brem RB, 2005, NATURE, V436, P701, DOI 10.1038/nature03865; Bubb KL, 2006, GENETICS, V173, P2165, DOI 10.1534/genetics.106.055715; Charlesworth D, 2006, PLOS GENET, V2, P379, DOI 10.1371/journal.pgen.0020064; Clark RM, 2007, SCIENCE, V317, P338, DOI 10.1126/science.1138632; Cliften P, 2003, SCIENCE, V301, P71, DOI 10.1126/science.1084337; Colosimo PF, 2005, SCIENCE, V307, P1928, DOI 10.1126/science.1107239; Coyne J.A., 2004, SPECIATION; DOBZHANSKY T, 1958, P NATL ACAD SCI USA, V44, P622, DOI 10.1073/pnas.44.6.622; Doniger SW, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000183; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Gerke J, 2009, SCIENCE, V323, P498, DOI 10.1126/science.1166426; Gibbons JG, 2009, MOL BIOL EVOL, V26, P2731, DOI 10.1093/molbev/msp188; Gietz RD, 1995, METHOD MOL CELL BIOL, V5, P255; GOFFEAU A, 1996, SCIENCE, V274, P563, DOI DOI 10.1126/SCIENCE.274.5287.546; Goldstein AL, 1999, YEAST, V15, P1541, DOI 10.1002/(SICI)1097-0061(199910)15:14<1541::AID-YEA476>3.0.CO;2-K; Gonzalez SS, 2006, FEMS YEAST RES, V6, P1221, DOI 10.1111/j.1567-1364.2006.00126.x; Guldener U, 1996, NUCLEIC ACIDS RES, V24, P2519, DOI 10.1093/nar/24.13.2519; Hawthorne DJ, 2001, NATURE, V412, P904, DOI 10.1038/35091062; Hittinger CT, 2007, NATURE, V449, P677, DOI 10.1038/nature06151; Hittinger CT, 2004, P NATL ACAD SCI USA, V101, P14144, DOI 10.1073/pnas.0404319101; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; HUGHES AL, 1988, NATURE, V335, P167, DOI 10.1038/335167a0; JOHNSTON M, 1987, MICROBIOL REV, V51, P458, DOI 10.1128/MMBR.51.4.458-476.1987; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Klein J, 1998, ANNU REV ECOL SYST, V29, P1, DOI 10.1146/annurev.ecolsys.29.1.1; Kroymann J, 2005, NATURE, V435, P95, DOI 10.1038/nature03480; LANAVE C, 1984, J MOL EVOL, V20, P86, DOI 10.1007/BF02101990; LEVENE H, 1953, AM NAT, V87, P331, DOI 10.1086/281792; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; MacLean RC, 2007, J EVOLUTION BIOL, V20, P1333, DOI 10.1111/j.1420-9101.2007.01351.x; Martchenko M, 2007, CURR BIOL, V17, P1007, DOI 10.1016/j.cub.2007.05.017; Mitchell-Olds T, 2007, NAT REV GENET, V8, P845, DOI 10.1038/nrg2207; Morgenstern B, 1999, BIOINFORMATICS, V15, P211, DOI 10.1093/bioinformatics/15.3.211; Navarro A, 2002, GENETICS, V161, P849; Neher RA, 2009, P NATL ACAD SCI USA, V106, P6866, DOI 10.1073/pnas.0812560106; NEI M, 1986, MOL BIOL EVOL, V3, P418; Ossowski S, 2008, GENOME RES, V18, P2024, DOI 10.1101/gr.080200.108; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ptashne M, 2001, GENES SIGNALS; Raj A, 2008, CELL, V135, P216, DOI 10.1016/j.cell.2008.09.050; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sampaio JP, 2008, APPL ENVIRON MICROB, V74, P2144, DOI 10.1128/AEM.02396-07; Schacherer J, 2009, NATURE, V458, P342, DOI 10.1038/nature07670; Shimodaira H, 1999, MOL BIOL EVOL, V16, P1114, DOI 10.1093/oxfordjournals.molbev.a026201; Smith AD, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-128; Stahl EA, 1999, NATURE, V400, P667, DOI 10.1038/23260; Steiner CC, 2007, PLOS BIOL, V5, P1880, DOI 10.1371/journal.pbio.0050219; Storz JF, 2007, PLOS GENET, V3, P448, DOI 10.1371/journal.pgen.0030045; Swofford DL, 2002, PAUP PHYLOGENETIC AN, DOI DOI 10.1111/J.0014-3820.2002.TB00191.X; Tsai IJ, 2008, P NATL ACAD SCI USA, V105, P4957, DOI 10.1073/pnas.0707314105; Turner TL, 2005, PLOS BIOL, V3, P1572, DOI 10.1371/journal.pbio.0030285; WRIGHT S, 1980, EVOLUTION, V34, P825, DOI 10.1111/j.1558-5646.1980.tb04022.x; Wu CI, 2004, NAT REV GENET, V5, P114, DOI 10.1038/nrg1269; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Zerbino DR, 2008, GENOME RES, V18, P821, DOI 10.1101/gr.074492.107	61	109	112	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					54	U61		10.1038/nature08791	http://dx.doi.org/10.1038/nature08791			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20164837	Green Accepted			2022-12-01	WOS:000275117500032
J	Jefferies, JL; Towbin, JA				Jefferies, John Lynn; Towbin, Jeffrey A.			Dilated cardiomyopathy	LANCET			English	Article							AMERICAN-HEART-ASSOCIATION; ACUTE MYOCARDIAL-INFARCTION; VENTRICULAR ASSIST DEVICE; ANKYRIN REPEAT PROTEIN; CARDIAC RESYNCHRONIZATION; NATRIURETIC PEPTIDE; HYPERTROPHIC CARDIOMYOPATHY; IMMUNOSUPPRESSIVE THERAPY; CARDIOVASCULAR-DISEASE; CYTOSKELETAL PROTEINS	Dilated cardiomyopathy is characterised by left ventricular dilation that is associated with systolic dysfunction. Diastolic dysfunction and impaired right ventricular function can develop. Affected individuals are at risk of left or right ventricular failure, or both. Heart failure symptoms can be exercise-induced or persistent at rest. Many patients are asymptomatic. Chronically treated patients sometimes present acutely with decompensated heart failure. Other life-threatening risks are ventricular arrhythmias and atrioventricular block, syncope, and sudden death. Genetic inheritance arises in 30-48% of patients, and inflammatory disorders such as myocarditis or toxic effects from medications, alcohol, or illicit drugs also result in dilated cardiomyopathy. Genes that cause dilated cardiomyopathy generally encode cytoskeletal and sarcomeric (contractile apparatus) proteins, although disturbance of calcium homeostasis also seems to be important. In children, disrupted mitochondrial function and metabolic abnormalities have a causal role. Treatments focus on improvement of cardiac efficiency and reduction of mechanical stress. Arrhythmia therapy and prevention of sudden death continue to be mainstays of treatment. Despite progress over the past 10 years, outcomes need to be improved.	[Towbin, Jeffrey A.] Cincinnati Childrens Hosp, Inst Heart, Cincinnati, OH 45229 USA; [Jefferies, John Lynn] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA	Cincinnati Children's Hospital Medical Center; Baylor College of Medicine	Towbin, JA (corresponding author), Cincinnati Childrens Hosp, Inst Heart, Cincinnati, OH 45229 USA.	jeffrey.towbin@cchmc.org	Siu, Sam C/G-3346-2011; Towbin, Jeffrey A./J-5595-2019	Siu, Sam C/0000-0002-1104-3669; Towbin, Jeffrey A./0000-0002-6585-714X				Abe T, 2001, Heart Fail Rev, V6, P195; Afonso L, 2007, AM J CARDIOL, V100, P1040, DOI 10.1016/j.amjcard.2007.04.049; Ahmad F, 2005, ANNU REV GENOM HUM G, V6, P185, DOI 10.1146/annurev.genom.6.080604.162132; Arimura T, 2007, Acta Myol, V26, P153; Arimura T, 2009, J AM COLL CARDIOL, V54, P334, DOI 10.1016/j.jacc.2008.12.082; Bardy GH, 2005, NEW ENGL J MED, V352, P225, DOI 10.1056/NEJMoa043399; Barresi R, 2000, J MED GENET, V37, P102, DOI 10.1136/jmg.37.2.102; Barth PG, 2004, AM J MED GENET A, V126A, P349, DOI 10.1002/ajmg.a.20660; Baryshnikova OK, 2008, BIOCHEMISTRY-US, V47, P10950, DOI 10.1021/bi801165c; Bello D, 2003, CIRCULATION, V108, P1945, DOI 10.1161/01.CIR.0000095029.57483.60; BERKO BA, 1987, NEW ENGL J MED, V316, P1186, DOI 10.1056/NEJM198705073161904; Bestetti RB, 1997, INT J CARDIOL, V60, P187, DOI 10.1016/S0167-5273(97)00083-1; Bione S, 1996, NAT GENET, V12, P385, DOI 10.1038/ng0496-385; Bowles NE, 2003, J AM COLL CARDIOL, V42, P466, DOI 10.1016/S0735-1097(03)00648-X; Bowles NE, 2000, HERZ, V25, P168, DOI 10.1007/s000590050003; Bowles Neil E, 2005, Heart Fail Clin, V1, P407, DOI 10.1016/j.hfc.2005.06.011; Braunwald E, 2008, NEW ENGL J MED, V358, P2148, DOI 10.1056/NEJMra0800239; Caforio ALP, 2008, AUTOIMMUNITY, V41, P35, DOI 10.1080/08916930701619235; Caforio ALP, 2007, CIRCULATION, V115, P76, DOI 10.1161/CIRCULATIONAHA.106.641472; Chang AN, 2005, HEART FAIL REV, V10, P225, DOI 10.1007/s10741-005-5252-6; Cleland JGF, 2005, NEW ENGL J MED, V352, P1539, DOI 10.1056/NEJMoa050496; Cooper LT, 2007, J AM COLL CARDIOL, V50, P1914, DOI 10.1016/j.jacc.2007.09.008; Cooper LT, 2008, AM J CARDIOL, V102, P1535, DOI 10.1016/j.amjcard.2008.07.041; Cox GF, 1997, CURR OPIN CARDIOL, V12, P329; Dennert R, 2008, EUR HEART J, V29, P2073, DOI 10.1093/eurheartj/ehn296; DRORY Y, 1991, AM J CARDIOL, V68, P1388, DOI 10.1016/0002-9149(91)90251-F; Duboscq-Bidot L, 2008, CARDIOVASC RES, V77, P118, DOI 10.1093/cvr/cvm015; Elliott P, 2008, EUR HEART J, V29, P270, DOI 10.1093/eurheartj/ehm342; Ellis Christopher R, 2007, Cardiol Rev, V15, P170, DOI 10.1097/CRD.0b013e31806450c4; Feng JN, 2002, MOL GENET METAB, V77, P119, DOI 10.1016/S1096-7192(02)00153-1; Frazier OH, 2001, J THORAC CARDIOV SUR, V122, P1186, DOI 10.1067/mtc.2001.118274; Friedrich MG, 2008, JACC-CARDIOVASC IMAG, V1, P652, DOI 10.1016/j.jcmg.2008.07.011; Frustaci A, 2003, CIRCULATION, V107, P857, DOI 10.1161/01.CIR.0000048147.15962.31; Gerull B, 2002, NAT GENET, V30, P201, DOI 10.1038/ng815; Gianni L, 2008, J CLIN ONCOL, V26, P3777, DOI 10.1200/JCO.2007.14.9401; Granzier HL, 2004, CIRC RES, V94, P284, DOI 10.1161/01.RES.0000117769.88862.F8; Haghighi K, 2003, J CLIN INVEST, V111, P869, DOI 10.1172/JCI200317892; Hayashi T, 2004, J AM COLL CARDIOL, V44, P2192, DOI 10.1016/j.jacc.2004.08.058; Hernandez AF, 2009, J AM COLL CARDIOL, V53, P184, DOI 10.1016/j.jacc.2008.09.031; Hershberger RE, 2009, J CARD FAIL, V15, P83, DOI 10.1016/j.cardfail.2009.01.006; Hilfiker-Kleiner D, 2008, TRENDS CARDIOVAS MED, V18, P173, DOI 10.1016/j.tcm.2008.05.002; Houtkooper RH, 2008, CELL MOL LIFE SCI, V65, P2493, DOI 10.1007/s00018-008-8030-5; Huang CH, 2009, BASIC RES CARDIOL, V104, P228, DOI 10.1007/s00395-008-0765-5; Hunt SA, 2005, J AM COLL CARDIOL, V46, P1; Hunt SA, 2009, J AM COLL CARDIOL, V53, pE1, DOI 10.1016/j.jacc.2008.11.013; Jaakkola K, 2000, J AM COLL CARDIOL, V36, P122, DOI 10.1016/S0735-1097(00)00706-3; Kamisago M, 2000, NEW ENGL J MED, V343, P1688, DOI 10.1056/NEJM200012073432304; Karkkainen S, 2007, ANN MED, V39, P91, DOI 10.1080/07853890601145821; Klatsky Arthur L, 2009, Expert Rev Cardiovasc Ther, V7, P499, DOI 10.1586/erc.09.22; Knoll R, 2002, CELL, V111, P943, DOI 10.1016/s0092-8674(02)01226-6; KOYAMA T, 2005, J CARDIOVASC SURG, V20, P39; Kuhl U, 2003, CIRCULATION, V107, P2793, DOI 10.1161/01.CIR.0000072766.67150.51; Laonigro I, 2009, EUR J HEART FAIL, V11, P453, DOI 10.1093/eurjhf/hfp037; Lebrecht D, 2007, CARDIOVASC TOXICOL, V7, P108, DOI 10.1007/s12012-007-0009-1; Leclercq C, 2002, EUR HEART J, V23, P1780, DOI 10.1053/euhj.2002.3232; Lehnart SE, 2007, CIRCULATION, V116, P2325, DOI 10.1161/CIRCULATIONAHA.107.711689; LeWinter MM, 2005, HEART FAIL REV, V10, P249, DOI 10.1007/s10741-005-5254-4; Li HS, 2008, AUTOIMMUN REV, V7, P168, DOI 10.1016/j.autrev.2007.11.010; Li Y, 2006, J IMMUNOL, V177, P8234, DOI 10.4049/jimmunol.177.11.8234; Linde C, 2002, J AM COLL CARDIOL, V40, P111, DOI 10.1016/S0735-1097(02)01932-0; Liu J, 2009, CURR MOL MED, V9, P287, DOI 10.2174/156652409787847218; Liu W, 2006, AUTOIMMUNITY, V39, P461, DOI 10.1080/08916930600893709; Lozano M D, 1997, J Card Fail, V3, P97, DOI 10.1016/S1071-9164(97)90041-5; MacLellan WR, 2003, NAT MED, V9, P1455, DOI 10.1038/nm1203-1455; Maisch B, 2004, HERZ, V29, P624, DOI 10.1007/s00059-004-2628-7; Maisel A, 2008, EUR J HEART FAIL, V10, P824, DOI 10.1016/j.ejheart.2008.07.014; Maisel AS, 2002, NEW ENGL J MED, V347, P161, DOI 10.1056/NEJMoa020233; Mann DL, 2007, ANN THORAC SURG, V84, P1226, DOI 10.1016/j.athoracsur.2007.03.095; Maron BJ, 2006, CIRCULATION, V113, P1807, DOI 10.1161/CIRCULATIONAHA.106.174287; MASON JW, 1995, NEW ENGL J MED, V333, P269, DOI 10.1056/NEJM199508033330501; McNally EM, 2007, ANNU REV PATHOL-MECH, V2, P87, DOI 10.1146/annurev.pathol.2.010506.091936; McNamara DM, 2001, CIRCULATION, V103, P2254; MICHELS VV, 1992, NEW ENGL J MED, V326, P77, DOI 10.1056/NEJM199201093260201; Mobini R, 2003, J AUTOIMMUN, V20, P345, DOI 10.1016/S0896-8411(03)00042-8; Mohapatra B, 2003, MOL GENET METAB, V80, P207, DOI 10.1016/S1096-7192(03)00142-2; Moss AJ, 2002, NEW ENGL J MED, V346, P877, DOI 10.1056/NEJMoa013474; Moulik M, 2009, J AM COLL CARDIOL, V54, P325, DOI 10.1016/j.jacc.2009.02.076; Mullens W, 2009, J AM COLL CARDIOL, V53, P765, DOI 10.1016/j.jacc.2008.11.024; MUNTONI F, 1993, NEW ENGL J MED, V329, P921, DOI 10.1056/NEJM199309233291304; Murphy RT, 2004, LANCET, V363, P371, DOI 10.1016/S0140-6736(04)15468-8; Olson TM, 2005, JAMA-J AM MED ASSOC, V293, P447, DOI 10.1001/jama.293.4.447; Olson TM, 2002, CIRCULATION, V105, P431, DOI 10.1161/hc0402.102930; Omland T, 2007, J AM COLL CARDIOL, V50, P205, DOI 10.1016/j.jacc.2007.03.038; Packer M, 1996, NEW ENGL J MED, V334, P1349, DOI 10.1056/NEJM199605233342101; Pantazis AA, 2009, CURR OPIN CARDIOL, V24, P209, DOI 10.1097/HCO.0b013e32832a11e7; Parks SB, 2008, AM HEART J, V156, P161, DOI 10.1016/j.ahj.2008.01.026; Parnaik VK, 2008, INT REV CEL MOL BIO, V266, P157, DOI 10.1016/S1937-6448(07)66004-3; Pignatelli RH, 2003, CIRCULATION, V108, P2672, DOI 10.1161/01.CIR.0000100664.10777.B8; Price JF, 2006, CIRCULATION, V114, P1063, DOI 10.1161/CIRCULATIONAHA.105.608869; Pyle WG, 2004, CIRC RES, V94, P296, DOI 10.1161/01.RES.0000116143.74830.A9; Redmann K, 1998, J CARDIAC SURG, V13, P453, DOI 10.1111/j.1540-8191.1998.tb01082.x; Richardson P, 1996, CIRCULATION, V93, P841, DOI 10.1161/01.CIR.93.5.841; Robinson P, 2007, CIRC RES, V101, P1266, DOI 10.1161/CIRCRESAHA.107.156380; Rodriguez-Perez JM, 2007, EXP MOL PATHOL, V82, P49, DOI 10.1016/j.yexmp.2006.10.002; ROGERS WJ, 1994, J AM COLL CARDIOL, V23, P393, DOI 10.1016/0735-1097(94)90426-X; Rosamond W, 2008, CIRCULATION, V117, pE25, DOI 10.1161/CIRCULATIONAHA.107.187998; Rose EA, 2001, NEW ENGL J MED, V345, P1435, DOI 10.1056/NEJMoa012175; Schachinger V, 2006, EUR HEART J, V27, P2775, DOI 10.1093/eurheartj/ehl388; Schmitt JP, 2003, SCIENCE, V299, P1410, DOI 10.1126/science.1081578; Schofer J, 2009, CIRCULATION, V120, P326, DOI 10.1161/CIRCULATIONAHA.109.849885; Sharma MS, 2006, ANN THORAC SURG, V82, P926, DOI 10.1016/j.athoracsur.2006.02.087; Siminiak T, 2009, AM J CARDIOL, V104, P565, DOI 10.1016/j.amjcard.2009.04.021; Spencer CT, 2005, PEDIATR CARDIOL, V26, P632, DOI 10.1007/s00246-005-0873-z; Stamm Christof, 2009, Ther Adv Cardiovasc Dis, V3, P215, DOI 10.1177/1753944709336190; Sugiura T, 2005, J CARD FAIL, V11, P504, DOI 10.1016/j.cardfail.2005.04.025; Sutton MGS, 2003, CIRCULATION, V107, P1985, DOI 10.1161/01.CIR.0000065226.24159.E9; Taneja V, 2007, J MOL CELL CARDIOL, V42, P1054, DOI 10.1016/j.yjmcc.2007.03.898; Taylor MRG, 2006, ORPHANET J RARE DIS, V1, DOI 10.1186/1750-1172-1-27; Taylor MRG, 2007, CIRCULATION, V115, P1244, DOI 10.1161/CIRCULATIONAHA.106.646778; Towbin JA, 1999, PEDIATR CLIN N AM, V46, P289, DOI 10.1016/S0031-3955(05)70119-X; Towbin JA, 2002, NATURE, V415, P227, DOI 10.1038/415227a; TOWBIN JA, 1993, CIRCULATION, V87, P1854, DOI 10.1161/01.CIR.87.6.1854; Towbin JA, 1998, CURR OPIN CELL BIOL, V10, P131, DOI 10.1016/S0955-0674(98)80096-3; Towbin JA, 2006, JAMA-J AM MED ASSOC, V296, P1867, DOI 10.1001/jama.296.15.1867; Towbin JA, 2006, J CARDIOVASC ELECTR, V17, P919, DOI 10.1111/j.1540-8167.2006.00530.x; Tsubata S, 2000, J CLIN INVEST, V106, P655, DOI 10.1172/JCI9224; Tulner SA, 2007, J CARD FAIL, V13, P178, DOI 10.1016/j.cardfail.2006.11.010; van Kimmenade RRJ, 2009, J AM COLL CARDIOL, V53, P884, DOI 10.1016/j.jacc.2008.11.032; van Tintelen JP, 2007, AM HEART J, V154, P1130, DOI 10.1016/j.ahj.2007.07.038; Vatta M, 2003, J AM COLL CARDIOL, V42, P2014, DOI 10.1016/j.jacc.2003.10.021; Vatta M, 2002, LANCET, V359, P936, DOI 10.1016/S0140-6736(02)08026-1; Vinge LE, 2008, CIRC RES, V102, P1458, DOI 10.1161/CIRCRESAHA.108.173195; Wallace KB, 2007, CARDIOVASC TOXICOL, V7, P101, DOI 10.1007/s12012-007-0008-2; WILDE AA, 2008, PACING CLIN ELECT S1, V31, P41; Wilhelmi MH, 2005, EUR J CARDIO-THORAC, V27, P122, DOI 10.1016/j.ejcts.2004.09.027; Wojnicz R, 2001, CIRCULATION, V104, P39, DOI 10.1161/01.CIR.104.1.39; Yamada S, 2008, STEM CELLS, V26, P2644, DOI 10.1634/stemcells.2008-0187; YUSUF S, 1991, NEW ENGL J MED, V325, P293, DOI 10.1056/NEJM199108013250501; Zhou Q, 2001, J CELL BIOL, V155, P605, DOI 10.1083/jcb.200107092; Zolk O, 2000, CIRCULATION, V101, P2674, DOI 10.1161/01.CIR.101.23.2674	130	362	398	5	38	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2010	375	9716					752	762		10.1016/S0140-6736(09)62023-7	http://dx.doi.org/10.1016/S0140-6736(09)62023-7			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	564JW	20189027				2022-12-01	WOS:000275211200032
J	Sansom, RS; Gabbott, SE; Purnell, MA				Sansom, Robert S.; Gabbott, Sarah E.; Purnell, Mark A.			Non-random decay of chordate characters causes bias in fossil interpretation	NATURE			English	Article							BURGESS SHALE; PRESERVATION; VERTEBRATES; PHYLOGENY; BRANCHIOSTOMA; ORGANISMS; EVOLUTION; TAPHONOMY; BIOLOGY; ORIGIN	Exceptional preservation of soft-bodied Cambrian chordates provides our only direct information on the origin of vertebrates(1,2). Fossil chordates from this interval offer crucial insights into how the distinctive body plan of vertebrates evolved, but reading this pre-biomineralization fossil record is fraught with difficulties, leading to controversial and contradictory interpretations(3,4). The cause of these difficulties is taphonomic: we lack data on when and how important characters change as they decompose, resulting in a lack of constraint on anatomical interpretation and a failure to distinguish phylogenetic absence of characters from loss through decay(3). Here we show, from experimental decay of amphioxus and ammocoetes, that loss of chordate characters during decay is non-random: the more phylogenetically informative are the most labile, whereas plesiomorphic characters are decay resistant. The taphonomic loss of synapomorphies and relatively higher preservation potential of chordate plesiomorphies will thus result in bias towards wrongly placing fossils on the chordate stem. Application of these data to Cathaymyrus (Cambrian period of China) and Metaspriggina (Cambrian period of Canada) highlights the difficulties: these fossils cannot be placed reliably in the chordate or vertebrate stem because they could represent the decayed remains of any non-biomineralized, total-group chordate. Preliminary data suggest that this decay filter also affects other groups of organisms and that 'stem-ward slippage' may be a widespread but currently unrecognized bias in our understanding of the early evolution of a number of phyla.	[Sansom, Robert S.; Gabbott, Sarah E.; Purnell, Mark A.] Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England	University of Leicester	Purnell, MA (corresponding author), Univ Leicester, Dept Geol, Leicester LE1 7RH, Leics, England.	mark.purnell@le.ac.uk	Sansom, Robert/H-1902-2012; Purnell, Mark/A-2336-2010	Purnell, Mark/0000-0002-1777-9220; Sansom, Robert/0000-0003-1926-2556	UK Natural Environment Research Council [NE/E015336/1]; NERC [NE/E015336/1] Funding Source: UKRI; Natural Environment Research Council [NE/E015336/1] Funding Source: researchfish	UK Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	This work was funded by UK Natural Environment Research Council grant NE/E015336/1. Specimens were provided by H. Escriva (Banyuls-sur-Mer, France) and B. Morland and S. Morland (Bellflask Ecological Survey), with practical assistance from C. Koch, C. Pratt and P. Griffiths. We thank D. Briggs for his feedback on the submitted manuscript.	Bartolomaeus T, 2005, HYDROBIOLOGIA, V535, P341, DOI 10.1007/s10750-004-1847-5; Briggs DEG, 2003, ANNU REV EARTH PL SC, V31, P275, DOI 10.1146/annurev.earth.31.100901.144746; BRIGGS DEG, 1993, LETHAIA, V26, P275, DOI 10.1111/j.1502-3931.1993.tb01532.x; Briggs DEG, 1995, PALAIOS, V10, P539, DOI 10.2307/3515093; BRIGGS DEG, 1993, PALEOBIOLOGY, V19, P107, DOI 10.1017/S0094837300012343; BUTTERFIELD NJ, 1990, PALEOBIOLOGY, V16, P272, DOI 10.1017/S0094837300009994; Butterfield NJ, 2003, INTEGR COMP BIOL, V43, P166, DOI 10.1093/icb/43.1.166; Delarbre C, 2002, MOL PHYLOGENET EVOL, V22, P184, DOI 10.1006/mpev.2001.1045; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Donoghue PCJ, 2005, TRENDS ECOL EVOL, V20, P312, DOI 10.1016/j.tree.2005.04.008; Donoghue PCJ, 2009, BIOESSAYS, V31, P178, DOI 10.1002/bies.200800128; Eriksson M, 1999, J PALEONTOL, V73, P403, DOI 10.1017/S002233600002792X; Fedewa Luke A., 2005, Journal of Herpetological Medicine and Surgery, V15, P13; Fuentes M, 2004, J EXP ZOOL PART B, V302B, P384, DOI 10.1002/jez.b.20025; Gaines RR, 2008, GEOLOGY, V36, P755, DOI 10.1130/G24961A.1; Gee H, 2008, NATURE, V453, P999, DOI 10.1038/453999a; Holland ND, 2001, BIOESSAYS, V23, P142, DOI 10.1002/1521-1878(200102)23:2<142::AID-BIES1021>3.0.CO;2-5; Janvier P, 1996, PALAEONTOLOGY, V39, P259; Janvier P, 1997, GEOBIOS-LYON, V30, P931, DOI 10.1016/S0016-6995(97)80217-3; Janvier P, 2003, CR PALEVOL, V2, P523, DOI 10.1016/j.crpv.2003.09.002; Mallatt J, 2003, J MORPHOL, V258, P1, DOI 10.1002/jmor.10081; Merz RA, 2006, INTEGR COMP BIOL, V46, P481, DOI 10.1093/icb/icj057; Morris SC, 2008, J PALEONTOL, V82, P424, DOI 10.1666/06-130.1; Richardson MK, 2003, J MORPHOL, V257, P348, DOI 10.1002/jmor.10119; Rouse GW, 1997, ZOOL SCR, V26, P139, DOI 10.1111/j.1463-6409.1997.tb00412.x; Sagemann J, 1999, GEOCHIM COSMOCHIM AC, V63, P1083, DOI 10.1016/S0016-7037(99)00087-3; Shu DG, 1996, NATURE, V384, P157, DOI 10.1038/384157a0; Smith MP, 2001, SYST ASSOC SPEC VOL, V61, P67; Swalla BJ, 2008, PHILOS T R SOC B, V363, P1557, DOI 10.1098/rstb.2007.2246; Yasui K, 2008, ZOOL SCI, V25, P1012, DOI 10.2108/zsj.25.1012	30	137	142	2	88	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					797	800		10.1038/nature08745	http://dx.doi.org/10.1038/nature08745			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20118914				2022-12-01	WOS:000274394300037
J	Trivedi, AN; Moloo, H; Mor, V				Trivedi, Amal N.; Moloo, Husein; Mor, Vincent			Increased Ambulatory Care Copayments and Hospitalizations among the Elderly	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEALTH MAINTENANCE ORGANIZATION; EMERGENCY-DEPARTMENT; SERVICES; BENEFITS; INSURANCE; PLAN; EVENTS	BACKGROUND When copayments for ambulatory care are increased, elderly patients may forgo important outpatient care, leading to increased use of hospital care. METHODS We compared longitudinal changes in the use of outpatient and inpatient care between enrollees in Medicare plans that increased copayments for ambulatory care and enrollees in matched control plans-similar plans that made no changes in these copayments. The study population included 899,060 beneficiaries enrolled in 36 Medicare plans during the period from 2001 through 2006. RESULTS In plans that increased copayments for ambulatory care, mean copayments nearly doubled for both primary care ($7.38 to $14.38) and specialty care ($12.66 to $22.05). In control plans, mean copayments for primary care and specialty care remained unchanged at $8.33 and $11.38, respectively. In the year after the rise in copayments, plans that increased cost sharing had 19.8 fewer annual outpatient visits per 100 enrollees (95% confidence interval [CI], 16.6 to 23.1), 2.2 additional annual hospital admissions per 100 enrollees (95% CI, 1.8 to 2.6), 13.4 more annual inpatient days per 100 enrollees (95% CI, 10.2 to 16.6), and an increase of 0.7 percentage points in the proportion of enrollees who were hospitalized (95% CI, 0.51 to 0.95), as compared with concurrent trends in control plans. These estimates were consistent among a cohort of continuously enrolled beneficiaries. The effects of increases in copayments for ambulatory care were magnified among enrollees living in areas of lower income and education and among enrollees who had hypertension, diabetes, or a history of myocardial infarction. CONCLUSIONS Raising cost sharing for ambulatory care among elderly patients may have adverse health consequences and may increase total spending on health care.	[Trivedi, Amal N.; Moloo, Husein; Mor, Vincent] Brown Univ, Alpert Med Sch, Dept Community Hlth, Providence, RI 02912 USA; [Trivedi, Amal N.] Providence VA Med Ctr, Res Enhancement Award Program, Providence, RI USA	Brown University; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center	Trivedi, AN (corresponding author), Brown Univ, Alpert Med Sch, Dept Community Hlth, Box G-S121, Providence, RI 02912 USA.	amal_trivedi@brown.edu			Veterans Affairs Health Services Research and Development Service	Veterans Affairs Health Services Research and Development Service(US Department of Veterans Affairs)	Dr. Trivedi is the recipient of a Pfizer Health Policy Scholars Award and a career development award from the Veterans Affairs Health Services Research and Development Service.	Agency for Healthcare Research and Quality Healthcare Cost and Utilization Project, HCUPNET; [Anonymous], 2001, INTERSTUDY COMPETITI; BECK RG, 1980, MED CARE, V18, P787, DOI 10.1097/00005650-198008000-00001; Buntin MB, 2004, J HEALTH ECON, V23, P525, DOI 10.1016/j.jhealeco.2003.10.005; CHANDRA A, 2007, 12972 NBER; CHERKIN DC, 1989, MED CARE, V27, P1036, DOI 10.1097/00005650-198911000-00005; Claxton G, 2006, HEALTH AFFAIR, V25, pW476, DOI 10.1377/hlthaff.25.w476; *COMM FUND, 2003, MED CHOIC PLANS CONT; CULYER AJ, 2000, HDB HLTH EC, P409; CUTLER DM, 1997, 6107 NBER; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Eichner MJ, 1998, AM ECON REV, V88, P117; Freiberg L Jr, 1976, Inquiry, V13, P54; Ginsburg PB, 2007, NEW ENGL J MED, V356, P1201, DOI 10.1056/NEJMp068272; Goldman DP, 2004, JAMA-J AM MED ASSOC, V291, P2344, DOI 10.1001/jama.291.19.2344; GRUBER J, ROLE CONSUMER COPAY; Helms LJ, 1978, COPAYMENTS DEMAND ME; Hsu J, 2006, HEALTH SERV RES, V41, P1801, DOI 10.1111/j.1475-6773.2006.00562.x; Hsu J, 2006, NEW ENGL J MED, V354, P2349, DOI 10.1056/NEJMsa054436; Magid DJ, 1997, NEW ENGL J MED, V336, P1722, DOI 10.1056/NEJM199706123362406; NEWHOUSE JP, 1981, NEW ENGL J MED, V305, P1501, DOI 10.1056/NEJM198112173052504; Rice T, 2004, MED CARE RES REV, V61, P415, DOI 10.1177/1077558704269498; RODDY PC, 1986, MED CARE, V24, P873, DOI 10.1097/00005650-198609000-00009; SCHEFFLER RM, 1984, MED CARE, V22, P247, DOI 10.1097/00005650-198403000-00008; SCITOVSKY AA, 1972, SOC SECUR BULL, V35, P3; Selby JV, 1996, NEW ENGL J MED, V334, P635, DOI 10.1056/NEJM199603073341006; SOUMERAI SB, 1994, NEW ENGL J MED, V331, P650, DOI 10.1056/NEJM199409083311006; Tamblyn R, 2001, JAMA-J AM MED ASSOC, V285, P421, DOI 10.1001/jama.285.4.421; Trivedi AN, 2008, NEW ENGL J MED, V358, P375, DOI 10.1056/NEJMsa070929; Trivedi AN, 2008, JAMA-J AM MED ASSOC, V300, P2879, DOI 10.1001/jama.2008.888; Trivedi AN, 2005, NEW ENGL J MED, V353, P692, DOI 10.1056/NEJMsa051207; Wharam JF, 2007, JAMA-J AM MED ASSOC, V297, P1093, DOI 10.1001/jama.297.10.1093; MEDICARE HEDIS3 0 19; MEDICAID SCHIP STATE	34	117	117	1	11	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 28	2010	362	4					320	328		10.1056/NEJMsa0904533	http://dx.doi.org/10.1056/NEJMsa0904533			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548OT	20107218				2022-12-01	WOS:000273975000008
J	Hodge, JG; Courtney, B				Hodge, James G., Jr.; Courtney, Brooke			Assessing the Legal Standard of Care in Public Health Emergencies	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PHYSICIANS		[Hodge, James G., Jr.] Arizona State Univ, Sandra Day O'Connor Coll Law, Publ Hlth Law & Policy Program, Tempe, AZ 85287 USA; [Courtney, Brooke] Univ Pittsburgh, Med Ctr, Ctr Biosecur, Baltimore, MD USA	Arizona State University; Arizona State University-Tempe; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh; University System of Maryland; University of Maryland Baltimore	Hodge, JG (corresponding author), Arizona State Univ, Sandra Day O'Connor Coll Law, Publ Hlth Law & Policy Program, POB 877906,Armstrong Hall,Room 120E, Tempe, AZ 85287 USA.	james.hodge.1@asu.edu						Fink S., 2009, NEW YORK TIMES MAGAZ, pMM28; Gostin LO, 2009, JAMA-J AM MED ASSOC, V302, P2365, DOI 10.1001/jama.2009.1780; Hall Mark A., 2003, HLTH CARE LAW ETHICS; Lewis MH, 2007, JAMA-J AM MED ASSOC, V297, P2633, DOI 10.1001/jama.297.23.2633; Institute of Medicine, 2010, CRISIS STANDARDS CAR, P69; KINNEY ED, 2009, IND HLTH L REV, V6; Powell T, 2008, DISASTER MED PUBLIC, V2, P20, DOI 10.1097/DMP.0b013e3181620794; Studdert DM, 2005, JAMA-J AM MED ASSOC, V293, P2609, DOI 10.1001/jama.293.21.2609; *US DEP HHS, 2009, DET PUBL HLTH EM EX; *WHIT HOUS OFF PRE, 2009, DECL NAT EM RESP 200	10	18	18	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					361	362		10.1001/jama.2010.31	http://dx.doi.org/10.1001/jama.2010.31			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20103761				2022-12-01	WOS:000273952800026
J	Robles, MS; Boyault, C; Knutti, D; Padmanabhan, K; Weitz, CJ				Robles, Maria S.; Boyault, Cyril; Knutti, Darko; Padmanabhan, Kiran; Weitz, Charles J.			Identification of RACK1 and Protein Kinase C alpha as Integral Components of the Mammalian Circadian Clock	SCIENCE			English	Article							GENE-EXPRESSION; PHOSPHORYLATION; ACTIVATION; MECHANISM; CRYPTOCHROME; DEGRADATION; OSCILLATION; REVEALS; PERIOD; BMAL1	At the core of the mammalian circadian clock is a negative feedback loop in which the dimeric transcription factor CLOCK-BMAL1 drives processes that in turn suppress its transcriptional activity. To gain insight into the mechanisms of circadian feedback, we analyzed mouse protein complexes containing BMAL1. Receptor for activated C kinase-1 (RACK1) and protein kinase C-alpha (PKC alpha) were recruited in a circadian manner into a nuclear BMAL1 complex during the negative feedback phase of the cycle. Overexpression of RACK1 and PKC alpha suppressed CLOCK-BMAL1 transcriptional activity, and RACK1 stimulated phosphorylation of BMAL1 by PKC alpha in vitro. Depletion of endogenous RACK1 or PKC alpha from fibroblasts shortened the circadian period, demonstrating that both molecules function in the clock oscillatory mechanism. Thus, the classical PKC signaling pathway is not limited to relaying external stimuli but is rhythmically activated by internal processes, forming an integral part of the circadian feedback loop.	[Robles, Maria S.; Boyault, Cyril; Knutti, Darko; Padmanabhan, Kiran; Weitz, Charles J.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Weitz, CJ (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA.	cweitz@hms.harvard.edu	Robles, Maria/ABH-1497-2020; Robles, Maria S/D-6307-2015; Boyault, Cyril/K-3593-2014; Padmanabhan, Kiran/N-2953-2013	Robles, Maria/0000-0001-9149-8761; Robles, Maria S/0000-0001-9149-8761; Boyault, Cyril/0000-0001-9614-4292; Padmanabhan, Kiran/0000-0001-7020-1682	Edward R. and Anne G. Lefler Center; G. Harold and Leila Y. Mathers Charitable Foundation; Swiss National Science Foundation; EMBO	Edward R. and Anne G. Lefler Center; G. Harold and Leila Y. Mathers Charitable Foundation; Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); EMBO(European Molecular Biology Organization (EMBO))	We thank P. Nakatani (Dana-Farber Cancer Institute) for the FH cassette; P. Sassone-Corsi (University of California, Irvine) for BMAL1 antiserum; M. J. Weber (University of Virginia), D. Mochly-Rosen (Stanford University), P. Blumberg (National Cancer Institute), and M. Grossi (University of Rome), respectively, for RACK1, C2, PKCa, and MYOD cDNAs; M. Liu for expert technical assistance; N. Vujovic for help with transactivation assays; and L. Lande-Diner for comments on the manuscript. Supported by grants from the Edward R. and Anne G. Lefler Center and the G. Harold and Leila Y. Mathers Charitable Foundation (C. J. W.), an Edward R. and Anne G. Lefler Center postdoctoral fellowship (M. S. R.), a Swiss National Science Foundation grant (D. K.), and an EMBO postdoctoral fellowship (C. B.).	Asher G, 2008, CELL, V134, P317, DOI 10.1016/j.cell.2008.06.050; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Busino L, 2007, SCIENCE, V316, P900, DOI 10.1126/science.1141194; Dardente H, 2007, BIOCHEM J, V402, P525, DOI 10.1042/BJ20060827; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Godinho SIH, 2007, SCIENCE, V316, P897, DOI 10.1126/science.1141138; Harrisingh MC, 2007, J NEUROSCI, V27, P12489, DOI 10.1523/JNEUROSCI.3680-07.2007; Hu LJ, 2006, J MOL NEUROSCI, V29, P55, DOI 10.1385/JMN:29:1:55; Imaizumi T., 2007, SCI STKE, ppe32; Jakubcakova V, 2007, NEURON, V54, P831, DOI 10.1016/j.neuron.2007.04.031; Lee B, 2007, EUR J NEUROSCI, V26, P451, DOI 10.1111/j.1460-9568.2007.05664.x; Lee HS, 2002, OSTEOARTHR CARTILAGE, V10, P890, DOI 10.1053/joca.2002.0842; Liu AC, 2007, CELL, V129, P605, DOI 10.1016/j.cell.2007.02.047; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Nakatani Y, 2003, METHOD ENZYMOL, V370, P430; Schak KM, 1999, BRAIN RES, V840, P158, DOI 10.1016/S0006-8993(99)01787-4; Schechtman D, 2001, ONCOGENE, V20, P6339, DOI 10.1038/sj.onc.1204778; Shim HS, 2007, EMBO REP, V8, P366, DOI 10.1038/sj.embor.7400920; Siepka SM, 2007, CELL, V129, P1011, DOI 10.1016/j.cell.2007.04.030; Sklan EH, 2006, PROG NEUROBIOL, V78, P117, DOI 10.1016/j.pneurobio.2005.12.002; Stebbins EG, 2001, J BIOL CHEM, V276, P29644, DOI 10.1074/jbc.M101044200; Takahashi JS, 2008, NAT REV GENET, V9, P764, DOI 10.1038/nrg2430; Tamaru T, 2003, GENES CELLS, V8, P973, DOI 10.1046/j.1365-2443.2003.00686.x; Tamaru T, 2009, NAT STRUCT MOL BIOL, V16, P446, DOI 10.1038/nsmb.1578; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoshitane H, 2009, MOL CELL BIOL, V29, P3675, DOI 10.1128/MCB.01864-08	26	101	109	1	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					463	466		10.1126/science.1180067	http://dx.doi.org/10.1126/science.1180067			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093473				2022-12-01	WOS:000273783100037
J	Barr, CD; Dominici, F				Barr, Christopher D.; Dominici, Francesca			Cap and Trade Legislation for Greenhouse Gas Emissions Public Health Benefits From Air Pollution Mitigation	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CLIMATE-CHANGE		[Barr, Christopher D.; Dominici, Francesca] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA	Harvard University; Harvard T.H. Chan School of Public Health	Barr, CD (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Biostat, 655 Huntington Ave,Bldg 2,Room 435A, Boston, MA 02115 USA.	cdbarr@gmail.com			NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES012054] Funding Source: NIH RePORTER; NIEHS NIH HHS [R01 ES012054-08, R01 ES012054-07, R01 ES012054] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Arneth A, 2009, SCIENCE, V326, P672, DOI 10.1126/science.1181568; Bell ML, 2008, ENVIRON HEALTH-GLOB, V7, DOI 10.1186/1476-069X-7-41; Bell ML, 2004, JAMA-J AM MED ASSOC, V292, P2372, DOI 10.1001/jama.292.19.2372; BRODER JM, 2009, NY TIMES        0630; Cifuentes L, 2001, SCIENCE, V293, P1257, DOI 10.1126/science.1063357; Dominici F, 2006, JAMA-J AM MED ASSOC, V295, P1127, DOI 10.1001/jama.295.10.1127; Paltsev S, 2008, CLIM POLICY, V8, P395, DOI 10.3763/cpol.2007.0437; Streets DG, 2006, ENVIRON SCI TECHNOL, V40, P2099, DOI 10.1021/es051275n; 2009 US GREENHOUSE G	9	2	2	1	7	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					69	70		10.1001/jama.2009.1955	http://dx.doi.org/10.1001/jama.2009.1955			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051573	Green Accepted			2022-12-01	WOS:000273296900023
J	Neill, DR; Wong, SH; Bellosi, A; Flynn, RJ; Daly, M; Langford, TKA; Bucks, C; Kane, CM; Fallon, PG; Pannell, R; Jolin, HE; McKenzie, ANJ				Neill, Daniel R.; Wong, See Heng; Bellosi, Agustin; Flynn, Robin J.; Daly, Maria; Langford, Theresa K. A.; Bucks, Christine; Kane, Colleen M.; Fallon, Padraic G.; Pannell, Richard; Jolin, Helen E.; McKenzie, Andrew N. J.			Nuocytes represent a new innate effector leukocyte that mediates type-2 immunity	NATURE			English	Article							IL-13; CELLS; REQUIREMENT; LYMPHOCYTES; EXPRESSION; MICE	Innate immunity provides the first line of defence against invading pathogens and provides important cues for the development of adaptive immunity. Type-2 immunity-responsible for protective immune responses to helminth parasites(1,2) and the underlying cause of the pathogenesis of allergic asthma(3,4)-consists of responses dominated by the cardinal type-2 cytokines interleukin (IL) 4, IL5 and IL13 (ref. 5). T cells are an important source of these cytokines in adaptive immune responses, but the innate cell sources remain to be comprehensively determined. Here, through the use of novel Il13-eGFP reporter mice, we present the identification and functional characterization of a new innate type-2 immune effector leukocyte that we have named the nuocyte. Nuocytes expand in vivo in response to the type-2-inducing cytokines IL25 and IL33, and represent the predominant early source of IL13 during helminth infection with Nippostrongylus brasiliensis. In the combined absence of IL25 and IL33 signalling, nuocytes fail to expand, resulting in a severe defect in worm expulsion that is rescued by the adoptive transfer of in vitro cultured wild-type, but not IL13-deficient, nuocytes. Thus, nuocytes represent a critically important innate effector cell in type-2 immunity.	[Neill, Daniel R.; Wong, See Heng; Bellosi, Agustin; Flynn, Robin J.; Daly, Maria; Langford, Theresa K. A.; Pannell, Richard; Jolin, Helen E.; McKenzie, Andrew N. J.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Bucks, Christine; Kane, Colleen M.] Centocor R&D Inc, Immunol Discovery Res, Radnor, PA 19087 USA; [Fallon, Padraic G.] Univ Dublin Trinity Coll, Inst Mol Med, Dublin 8, Ireland	MRC Laboratory Molecular Biology; Johnson & Johnson; Johnson & Johnson USA; Trinity College Dublin	McKenzie, ANJ (corresponding author), MRC, Mol Biol Lab, Hills Rd, Cambridge CB2 0QH, England.	anm@mrc-lmb.cam.ac.uk	Flynn, Robin/H-7387-2019; Neill, Daniel/E-1403-2012; Fallon, Padraic/Y-2711-2019; Flynn, Robin/A-7678-2010; Neill, Daniel/Q-6290-2019	Flynn, Robin/0000-0001-5304-3088; Neill, Daniel/0000-0002-7911-8153; Fallon, Padraic/0000-0002-8401-7293; Neill, Daniel/0000-0002-7911-8153	Asthma UK; Science Foundation Ireland; Medical Research Council [MC_U105178805] Funding Source: researchfish; Asthma UK [07/001] Funding Source: researchfish; MRC [MC_U105178805] Funding Source: UKRI	Asthma UK; Science Foundation Ireland(Science Foundation IrelandEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Asthma UK; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank members of the McKenzie laboratory for their comments on the manuscript. We thank D. Cousins for assistance with preliminary microarray analysis. R.J.F. was supported by Asthma UK. P.G.F. is supported by Science Foundation Ireland.	Arinobu Y, 2005, P NATL ACAD SCI USA, V102, P18105, DOI 10.1073/pnas.0509148102; Cui JQ, 1997, SCIENCE, V278, P1623, DOI 10.1126/science.278.5343.1623; Fallon PG, 2006, J EXP MED, V203, P1105, DOI 10.1084/jem.20051615; Fallon PG, 2002, IMMUNITY, V17, P7, DOI 10.1016/S1074-7613(02)00332-1; Grunig G, 1998, SCIENCE, V282, P2261, DOI 10.1126/science.282.5397.2261; HAIG DM, 1994, BLOOD, V83, P72; Holgate ST, 2008, NAT REV IMMUNOL, V8, P218, DOI 10.1038/nri2262; Larche M, 2003, J ALLERGY CLIN IMMUN, V111, P450, DOI 10.1067/mai.2003.169; Liu PT, 2003, GENOME RES, V13, P476, DOI 10.1101/gr.749203; Maizels RM, 2009, J EXP MED, V206, P2059, DOI 10.1084/jem.20091903; McKenzie GJ, 1998, CURR BIOL, V8, P339, DOI 10.1016/S0960-9822(98)70134-4; McKenzie GJ, 1999, J EXP MED, V189, P1565, DOI 10.1084/jem.189.10.1565; Min B, 2004, J EXP MED, V200, P507, DOI 10.1084/jem.20040590; Ohnmacht C, 2009, BLOOD, V113, P2816, DOI 10.1182/blood-2008-05-154773; Perrigoue JG, 2008, CELL MICROBIOL, V10, P1757, DOI 10.1111/j.1462-5822.2008.01174.x; Perrigoue JG, 2009, NAT IMMUNOL, V10, P697, DOI 10.1038/ni.1740; SHINKAI Y, 1992, CELL, V68, P855, DOI 10.1016/0092-8674(92)90029-C; TONO T, 1992, BLOOD, V80, P1448; Urban JF, 1998, IMMUNITY, V8, P255, DOI 10.1016/S1074-7613(00)80477-X; Voehringer D, 2006, J EXP MED, V203, P1435, DOI 10.1084/jem.20052448; Voehringer D, 2009, TRENDS PARASITOL, V25, P551, DOI 10.1016/j.pt.2009.09.004; Walter DM, 2001, J IMMUNOL, V167, P4668, DOI 10.4049/jimmunol.167.8.4668; Warming S, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni035; Yoshimoto T, 2009, NAT IMMUNOL, V10, P706, DOI 10.1038/ni.1737	24	1505	1572	1	152	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 29	2010	464	7293					1367	U9		10.1038/nature08900	http://dx.doi.org/10.1038/nature08900			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589LI	20200518	Green Accepted			2022-12-01	WOS:000277149000050
J	Gracheva, EO; Ingolia, NT; Kelly, YM; Cordero-Morales, JF; Hollopeter, G; Chesler, AT; Sanchez, EE; Perez, JC; Weissman, JS; Julius, D				Gracheva, Elena O.; Ingolia, Nicholas T.; Kelly, Yvonne M.; Cordero-Morales, Julio F.; Hollopeter, Gunther; Chesler, Alexander T.; Sanchez, Elda E.; Perez, John C.; Weissman, Jonathan S.; Julius, David			Molecular basis of infrared detection by snakes	NATURE			English	Article							TRIGEMINAL SYSTEM; ION CHANNELS; TRPA1; NEURONS; PIT; CROTALINE; PROJECTIONS; RECEPTORS; NUCLEUS; THERMOSENSATION	Snakes possess a unique sensory system for detecting infrared radiation, enabling them to generate a 'thermal image' of predators or prey. Infrared signals are initially received by the pit organ, a highly specialized facial structure that is innervated by nerve fibres of the somatosensory system. How this organ detects and transduces infrared signals into nerve impulses is not known. Here we use an unbiased transcriptional profiling approach to identify TRPA1 channels as infrared receptors on sensory nerve fibres that innervate the pit organ. TRPA1 orthologues from pit-bearing snakes (vipers, pythons and boas) are the most heat-sensitive vertebrate ion channels thus far identified, consistent with their role as primary transducers of infrared stimuli. Thus, snakes detect infrared signals through a mechanism involving radiant heating of the pit organ, rather than photochemical transduction. These findings illustrate the broad evolutionary tuning of transient receptor potential (TRP) channels as thermosensors in the vertebrate nervous system.	[Gracheva, Elena O.; Kelly, Yvonne M.; Cordero-Morales, Julio F.; Hollopeter, Gunther; Chesler, Alexander T.; Julius, David] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.; Julius, David] Univ Calif San Francisco, Dept Cellular & Mol Pharmacol, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Ingolia, Nicholas T.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biosci, San Francisco, CA 94158 USA; [Sanchez, Elda E.; Perez, John C.] Texas A&M Univ, Nat Toxins Res Ctr, Kingsville, TX 78363 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Texas A&M University System; Texas A&M University Kingsville	Julius, D (corresponding author), Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA.	julius@cmp.ucsf.edu	Kelly, Yvonne/AAR-3856-2020; Chesler, Alexander/V-2748-2019	Kelly, Yvonne/0000-0002-1494-0429; Chesler, Alexander/0000-0002-3131-0728; Cordero Morales, Julio/0000-0002-6505-5403; Gracheva, Elena O/0000-0002-0846-3427; Sanchez, Elda E./0000-0001-5222-8873; Weissman, Jonathan/0000-0003-2445-670X	Ruth L. Kirschstein National Research Service Award [GM080853]; NIH; Howard Hughes Medical Institute; National Institutes of Health, including NCRR [P40 RR018300-06, P01 AG010770, NS047723, NS055299]; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018300] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM080853] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS047723, R01NS055299, R37NS047723] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [P01AG010770] Funding Source: NIH RePORTER	Ruth L. Kirschstein National Research Service Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health, including NCRR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank A. Priel for advice and assistance with calcium imaging and electrophysiology, C. Chu for help with sequencing, J. Poblete for technical assistance, and the staff of the Natural Toxins Research Center serpentarium for animal husbandry. We thank P. Garrity for providing the dTrpA1 cDNA. This work was supported by a Ruth L. Kirschstein National Research Service Award (GM080853) (N.T.I.), a NIH Institutional Research Service Award in Molecular and Cellular Basis of Cardiovascular Disease (A. T. C.), the Howard Hughes Medical Institute (J. S. W.), and grants from the National Institutes of Health, including NCRR Viper grant P40 RR018300-06 (E. E. S. and J. C. P.), P01 AG010770 (J. S. W.) and NS047723 and NS055299 (D. J.).	Amemiya F, 1996, ANAT RECORD, V246, P135; Bandell M, 2004, NEURON, V41, P849, DOI 10.1016/S0896-6273(04)00150-3; Barrett R., 1970, BIOL REPTILIA, P227; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; BLEICHMAR H, 1962, Z ZELLFORSCH MIK ANA, V56, P748, DOI 10.1007/BF00336332; BULLOCK TH, 1952, SCIENCE, V115, P541, DOI 10.1126/science.115.2994.541-a; BUNING TD, 1981, CELL MOL NEUROBIOL, V1, P271, DOI 10.1007/BF00710682; Campbell AL, 2002, MICRON, V33, P211, DOI 10.1016/S0968-4328(01)00010-5; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Chuang HH, 2004, NEURON, V43, P859, DOI 10.1016/j.neuron.2004.08.038; DeCoursey TE, 1998, J GEN PHYSIOL, V112, P503, DOI 10.1085/jgp.112.4.503; Dong S, 2005, J MOL EVOL, V61, P12, DOI 10.1007/s00239-004-0190-9; Ebert J, 2007, THESIS RHEINISCHE F; Ebert Jill, 2006, P215; Eng SR, 2007, NEURAL DEV, V2, DOI 10.1186/1749-8104-2-3; Hamada FN, 2008, NATURE, V454, P217, DOI 10.1038/nature07001; HARTLINE PH, 1978, SCIENCE, V199, P1225, DOI 10.1126/science.628839; Hinman A, 2006, P NATL ACAD SCI USA, V103, P19564, DOI 10.1073/pnas.0609598103; Jordt SE, 2003, CURR OPIN NEUROBIOL, V13, P487, DOI 10.1016/S0959-4388(03)00101-6; Jordt SE, 2004, NATURE, V427, P260, DOI 10.1038/nature02282; Julius D, 2001, NATURE, V413, P203, DOI 10.1038/35093019; KISHIDA R, 1983, BRAIN RES, V263, P132, DOI 10.1016/0006-8993(83)91209-X; KISHIDA R, 1980, BRAIN RES, V195, P271, DOI 10.1016/0006-8993(80)90064-5; KISHIDA R, 1984, BRAIN RES, V322, P351, DOI 10.1016/0006-8993(84)90132-X; Kobayashi K, 2005, J COMP NEUROL, V493, P596, DOI 10.1002/cne.20794; Komatsu H, 1996, NEURON, V17, P707, DOI 10.1016/S0896-6273(00)80202-0; Krochmal AR, 2004, J EXP BIOL, V207, P4231, DOI 10.1242/jeb.01278; Liman ER, 2006, PFLUG ARCH EUR J PHY, V453, P125, DOI 10.1007/s00424-006-0120-3; Macpherson LJ, 2007, NATURE, V445, P541, DOI 10.1038/nature05544; Matsuura H, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-228; MOLENAAR GJ, 1978, J COMP NEUROL, V179, P137, DOI 10.1002/cne.901790109; MOLENAAR GJ, 1974, BRAIN RES, V78, P340, DOI 10.1016/0006-8993(74)90560-5; Myers BR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005741; NEWMAN EA, 1981, SCIENCE, V213, P789, DOI 10.1126/science.7256281; NOBLE G. K., 1937, PROC AMER PHIL SOC, V77, P263; Pappas TC, 2004, AM J PHYSIOL-CELL PH, V287, pC1219, DOI 10.1152/ajpcell.00040.2004; Prober DA, 2008, J NEUROSCI, V28, P10102, DOI 10.1523/JNEUROSCI.2740-08.2008; Ramot D, 2008, NAT NEUROSCI, V11, P908, DOI 10.1038/nn.2157; Safer AB, 2004, BEHAV BRAIN RES, V154, P55, DOI 10.1016/j.bbr.2004.01.020; SCHROEDER DM, 1976, J COMP NEUROL, V169, P1, DOI 10.1002/cne.901690102; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; TERASHIMA S, 1991, J NEUROPHYSIOL, V66, P623, DOI 10.1152/jn.1991.66.2.623; Tominaga M, 1998, NEURON, V21, P531, DOI 10.1016/S0896-6273(00)80564-4; Viswanath V, 2003, NATURE, V423, P822, DOI 10.1038/423822a; Wang GR, 2009, EUR J NEUROSCI, V30, P967, DOI 10.1111/j.1460-9568.2009.06901.x; WARREN JW, 1968, SCIENCE, V159, P439, DOI 10.1126/science.159.3813.439; Woolf CJ, 2007, NEURON, V55, P353, DOI 10.1016/j.neuron.2007.07.016	48	261	267	6	245	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 15	2010	464	7291					1006	U66		10.1038/nature08943	http://dx.doi.org/10.1038/nature08943			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	582XW	20228791	Green Accepted, Green Submitted			2022-12-01	WOS:000276635000031
J	He, YP; Wu, J; Dressman, DC; Iacobuzio-Donahue, C; Markowitz, SD; Velculescu, VE; Diaz, LA; Kinzler, KW; Vogelstein, B; Papadopoulos, N				He, Yiping; Wu, Jian; Dressman, Devin C.; Iacobuzio-Donahue, Christine; Markowitz, Sanford D.; Velculescu, Victor E.; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas			Heteroplasmic mitochondrial DNA mutations in normal and tumour cells	NATURE			English	Article							POINT MUTATIONS; CONTROL REGION; STEM-CELLS; MTDNA; INDIVIDUALS; CANCER; REPLICATION; FREQUENCY; DYNAMICS; GENETICS	The presence of hundreds of copies of mitochondrial DNA (mtDNA) in each human cell poses a challenge for the complete characterization of mtDNA genomes by conventional sequencing technologies(1). Here we describe digital sequencing of mtDNA genomes with the use of massively parallel sequencing-by-synthesis approaches. Although the mtDNA of human cells is considered to be homogeneous, we found widespread heterogeneity (heteroplasmy) in the mtDNA of normal human cells. Moreover, the frequency of heteroplasmic variants varied considerably between different tissues in the same individual. In addition to the variants identified in normal tissues, cancer cells harboured further homoplasmic and heteroplasmic mutations that could also be detected in patient plasma. These studies provide insights into the nature and variability of mtDNA sequences and have implications for mitochondrial processes during embryogenesis, cancer biomarker development and forensic analysis. In particular, they demonstrate that individual humans are characterized by a complex mixture of related mitochondrial genotypes rather than a single genotype.	[He, Yiping; Wu, Jian; Dressman, Devin C.; Velculescu, Victor E.; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA; [He, Yiping; Wu, Jian; Dressman, Devin C.; Velculescu, Victor E.; Diaz, Luis A., Jr.; Kinzler, Kenneth W.; Vogelstein, Bert; Papadopoulos, Nickolas] Johns Hopkins Kimmel Canc Ctr, Howard Hughes Med Inst, Baltimore, MD 21231 USA; [Iacobuzio-Donahue, Christine] Johns Hopkins Med Inst, Dept Pathol, Baltimore, MD 21231 USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Dept Med, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Case Western Reserve Univ, Ireland Canc Ctr, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Univ Hosp Cleveland, Case Med Ctr, Cleveland, OH 44106 USA; [Markowitz, Sanford D.] Howard Hughes Med Inst, Cleveland, OH 44106 USA	Johns Hopkins University; Johns Hopkins Medicine; Howard Hughes Medical Institute; Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; Case Western Reserve University; Case Western Reserve University; Case Western Reserve University; University Hospitals of Cleveland; Howard Hughes Medical Institute	Vogelstein, B (corresponding author), Johns Hopkins Kimmel Canc Ctr, Ludwig Ctr Canc Genet & Therapeut, Baltimore, MD 21231 USA.	vogelbe@jhmi.edu; npapado1@jhmi.edu	Iacobuzio-Donahue, Christine/ABF-1295-2020; Papadopoulos, Nickolas/K-7272-2012; Velculescu, Victor/ABF-4846-2020	Iacobuzio-Donahue, Christine/0000-0002-4672-3023; Velculescu, Victor/0000-0003-1195-438X; Diaz, Luis/0000-0002-7079-8914	The Virginia and D. K. Ludwig Fund for Cancer Research; National Institutes of Health [CA57345, CA 43460, CA 62924, CA121113]; NATIONAL CANCER INSTITUTE [R01CA043460, P50CA062924, R37CA043460, R01CA057345, R01CA121113, R37CA057345] Funding Source: NIH RePORTER	The Virginia and D. K. Ludwig Fund for Cancer Research; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank M. Whalen, J. Ptak, L. Dobbyn and N. Silliman for expert technical assistance. This work was supported by The Virginia and D. K. Ludwig Fund for Cancer Research and by National Institutes of Health grants CA57345, CA 43460, CA 62924 and CA121113.	Chatterjee A, 2006, ONCOGENE, V25, P4663, DOI 10.1038/sj.onc.1209604; Coller HA, 2005, MUTAT RES-FUND MOL M, V578, P256, DOI 10.1016/j.mrfmmm.2005.05.014; Coller HA, 2001, NAT GENET, V28, P147, DOI 10.1038/88859; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Dobrowolski SF, 2009, HUM MUTAT, V30, P891, DOI 10.1002/humu.21003; Fliss MS, 2000, SCIENCE, V287, P2017, DOI 10.1126/science.287.5460.2017; Greaves LC, 2009, AGING CELL, V8, P566, DOI 10.1111/j.1474-9726.2009.00505.x; Jones JB, 2001, CANCER RES, V61, P1299; Jones S, 2008, P NATL ACAD SCI USA, V105, P4283, DOI 10.1073/pnas.0712345105; Kajander OA, 2000, HUM MOL GENET, V9, P2821, DOI 10.1093/hmg/9.19.2821; Kraytsberg Y, 2008, METHODS, V46, P269, DOI 10.1016/j.ymeth.2008.10.005; KRAYTSBERG Y, 2009, METHOD MOL BIOL, V329, P369; Legros F, 2004, J CELL SCI, V117, P2653, DOI 10.1242/jcs.01134; Maitra A, 2004, GENOME RES, V14, P812, DOI 10.1101/gr.2228504; Marzuki S, 1997, J NEUROL SCI, V145, P155, DOI 10.1016/S0022-510X(96)00241-9; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Osborne A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005636; Polyak K, 1998, NAT GENET, V20, P291, DOI 10.1038/3108; Ramos A, 2009, ELECTROPHORESIS, V30, P1587, DOI 10.1002/elps.200800601; Santos C, 2008, J MOL EVOL, V67, P191, DOI 10.1007/s00239-008-9138-9; Schneider PM, 2007, FORENSIC SCI INT, V165, P238, DOI 10.1016/j.forsciint.2006.06.067; Sekiguchi K, 2003, MITOCHONDRION, V2, P401, DOI 10.1016/S1567-7249(03)00028-X; Sekiguchi K, 2004, J FORENSIC SCI, V49, P986; Sidransky D, 2002, NAT REV CANCER, V2, P210, DOI 10.1038/nrc755; Taylor RW, 2003, J CLIN INVEST, V112, P1351, DOI 10.1172/JCI200319435; Wang Y, 2001, P NATL ACAD SCI USA, V98, P4022, DOI 10.1073/pnas.061013598; White HE, 2005, GENET TEST, V9, P190, DOI 10.1089/gte.2005.9.190; Wong LJC, 2005, CLIN CHIM ACTA, V354, P1, DOI 10.1016/j.cccn.2004.11.003; Wong LJC, 2003, CANCER RES, V63, P3866; Zsurka G, 2005, NAT GENET, V37, P873, DOI 10.1038/ng1606	30	388	404	0	68	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					610	U175		10.1038/nature08802	http://dx.doi.org/10.1038/nature08802			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20200521	Green Accepted			2022-12-01	WOS:000275974200052
J	Manning, KD				Manning, Kimberly D.			Do Something	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												kdmanni@emory.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1018	1018		10.1001/jama.2010.82	http://dx.doi.org/10.1001/jama.2010.82			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233812				2022-12-01	WOS:000275594100001
J	Walker, EP				Walker, Eric P.			HIV Clinic	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												epwalker@uabmc.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					819	819		10.1001/jama.2010.209	http://dx.doi.org/10.1001/jama.2010.209			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197520				2022-12-01	WOS:000275059500001
J	Wang, JB; Guo, JJ; Yang, L; Zhang, YD; Sun, ZQ; Zhang, YJ				Wang, Jing-Bo; Guo, Jeff J.; Yang, Li; Zhang, Yan-De; Sun, Zhao-Qi; Zhang, Yan-Jun			Rare diseases and legislation in China	LANCET			English	Editorial Material									[Guo, Jeff J.; Zhang, Yan-Jun] Univ Cincinnati, Med Ctr, Coll Pharm, Cincinnati, OH 45267 USA; [Wang, Jing-Bo] Peoples Liberat Army 309 Hosp, Dept Ophthalmol, Beijing, Peoples R China; [Yang, Li] Jinan Normal Sch, Dept Med Serv, Jinan, Shandong, Peoples R China; [Zhang, Yan-De] Beijing Disabled Persons Federat, Beijing, Peoples R China; [Sun, Zhao-Qi] Anhui Univ, Sch Phys & Mat Sci, Hefei 230039, Anhui, Peoples R China	University System of Ohio; University of Cincinnati; Anhui University	Zhang, YJ (corresponding author), Univ Cincinnati, Med Ctr, Coll Pharm, Cincinnati, OH 45267 USA.	zhang2yj@mail.uc.edu	Zhang, Yanjun/G-1194-2012					Ayme S, 2008, LANCET, V371, P2048, DOI 10.1016/S0140-6736(08)60875-2; Chen Z, 2009, LANCET, V373, P1322, DOI 10.1016/S0140-6736(09)60753-4; *CHIN CHAR FED, CALL CAMP 2010 RAR D; *CHIN DOLLS CAR SU, 2009, SEM RAR DIS LEG; *CHIN DOLLS CAR SU, CHIN DOLLS CAR SUP A; *CHIN STAT FOOD DR, 2007, PROV DRUG REG; LING H, 2009, CHINA MED HERALD, V6, P4; Remuzzi G, 2008, LANCET, V371, P1978, DOI 10.1016/S0140-6736(08)60847-8; SUN ZQ, 2008, PROPOSAL EXPEDITING; ZHANG YJ, CHIN J PHAR IN PRESS; 2008, LANCET, V371, P1972	11	33	40	1	16	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 27	2010	375	9716					708	709		10.1016/S0140-6736(10)60240-1	http://dx.doi.org/10.1016/S0140-6736(10)60240-1			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JW	20189012				2022-12-01	WOS:000275211200010
J	Ehlenbach, WJ; Hough, CL; Crane, PK; Haneuse, SJPA; Carson, SS; Curtis, JR; Larson, EB				Ehlenbach, William J.; Hough, Catherine L.; Crane, Paul K.; Haneuse, Sebastien J. P. A.; Carson, Shannon S.; Curtis, J. Randall; Larson, Eric B.			Association Between Acute Care and Critical Illness Hospitalization and Cognitive Function in Older Adults	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							QUALITY-OF-LIFE; PEOPLE AGED 65; SURVIVORS; DEMENTIA; OUTCOMES; EPIDEMIOLOGY; DYSFUNCTION; DISEASE; DELIRIUM; MEMORY	Context Studies suggest that many survivors of critical illness experience long-term cognitive impairment but have not included premorbid measures of cognitive functioning and have not evaluated risk for dementia associated with critical illness. Objectives To determine whether decline in cognitive function was greater among older individuals who experienced acute care or critical illness hospitalizations relative to those not hospitalized and to determine whether the risk for incident dementia differed by these exposures. Design, Setting, and Participants Analysis of data from a prospective cohort study from 1994 through 2007 comprising 2929 individuals 65 years old and older without dementia at baseline residing in the community in the Seattle area and belonging to the Group Health Cooperative. Participants with 2 or more study visits were included, and those who had a hospitalization for a diagnosis of primary brain injury were censored at the time of hospitalization. Individuals were screened with the Cognitive Abilities Screening Instrument (CASI) (score range, 0-100) every 2 years at follow-up visits, and those with a score less than 86 underwent a clinical examination for dementia. Main Outcome Measures Score on the CASI at follow-up study visits and incident dementia diagnosed in study participants, adjusted for baseline cognitive scores, age, and other risk factors. Results During a mean (SD) follow-up of 6.1 (3.2) years, 1601 participants had no hospitalization, 1287 had 1 or more noncritical illness hospitalizations, and 41 had 1 or more critical illness hospitalizations. The CASI score was assessed more than 45 days after discharge for 94.3% of participants. Adjusted CASI scores averaged 1.01 points lower for visits following acute care illness hospitalization compared with follow-up visits not following any hospitalization (95% confidence interval [CI], -1.33 to -0.70; P<.001) and 2.14 points lower on average for visits following critical illness hospitalization (95% CI, -4.24 to -0.03; P=.047). There were 146 cases of dementia among those not hospitalized, 228 cases of dementia among those with 1 or more noncritical illness hospitalizations, and 5 cases of dementia among those with 1 or more critical illness hospitalizations. The adjusted hazard ratio for incident dementia was 1.4 following a noncritical illness hospitalization (95% CI, 1.1 to 1.7; P=.001) and 2.3 following a critical illness hospitalization (95% CI, 0.9 to 5.7; P=.09). Conclusions Among a cohort of older adults without dementia at baseline, those who experienced acute care hospitalization and critical illness hospitalization had a greater likelihood of cognitive decline compared with those who had no hospitalization. Noncritical illness hospitalization was significantly associated with the development of dementia. JAMA. 2010; 303(8): 763-770	[Ehlenbach, William J.] Dept Vet Affairs, Hlth Serv Res & Dev, Seattle, WA 98101 USA; [Ehlenbach, William J.; Hough, Catherine L.; Crane, Paul K.; Curtis, J. Randall; Larson, Eric B.] Univ Washington, Dept Med, Seattle, WA USA; [Haneuse, Sebastien J. P. A.; Larson, Eric B.] Grp Hlth Res Inst, Seattle, WA USA; [Carson, Shannon S.] Univ N Carolina, Div Pulm & Crit Care Med, Chapel Hill, NC USA	University of Washington; University of Washington Seattle; University of North Carolina; University of North Carolina Chapel Hill	Ehlenbach, WJ (corresponding author), Dept Vet Affairs, Hlth Serv Res & Dev, 1100 Olive Way,Ste 1400, Seattle, WA 98101 USA.	wje1@u.washington.edu	Ehlenbach, William J./R-5784-2019	Ehlenbach, William J./0000-0002-2864-5543; Crane, Paul/0000-0003-4278-7465	National Institutes of Health (NIH) National Institute on Aging [UO1 AG06781]; John A. Hartford Foundation; National Heart, Lung, and Blood Institute [1 K24 HL068593]; National Institute on Aging [R01 AG029672]; NIH [5T32HL007287-30]; Department of Veterans Affairs; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [T32HL007287, K24HL068593, R01HL096504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [U01AG006781, R01AG029672] Funding Source: NIH RePORTER	National Institutes of Health (NIH) National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); John A. Hartford Foundation; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	Funding/Support: The Adult Changes in Thought study is funded by a National Institutes of Health (NIH) National Institute on Aging Cooperative Grant (UO1 AG06781; principal investigator [PI]: Dr Larson). Additional funding for this study was provided by the John A. Hartford Foundation (PI: Dr Hough), a K24 Award from the National Heart, Lung, and Blood Institute (1 K24 HL068593; PI: Dr Curtis), and an R01 from the National Institute on Aging (R01 AG029672; PI: Dr Crane). Dr Ehlenbach was supported by an NIH Respiratory Research Training Grant (5T32HL007287-30; PI: Leonard Hudson, MD, University of Washington) and a Department of Veterans Affairs Health Services Research and Development Postdoctoral Fellowship.	Al-Saidi F, 2003, AM J RESP CRIT CARE, V167, pA737; American Psychiatric Association (Washington), 2000, DSM 4 T DIAGN STAT M; Angus D C, 2001, Crit Care Med, V29, P1303, DOI 10.1097/00003246-200107000-00002; Angus DC, 2000, JAMA-J AM MED ASSOC, V284, P2762, DOI 10.1001/jama.284.21.2762; Carson Shannon S, 2006, J Intensive Care Med, V21, P173, DOI 10.1177/0885066605282784; Carson SS, 2003, CRIT CARE CLIN, V19, P605, DOI 10.1016/S0749-0704(03)00051-4; Clark TG, 2002, LANCET, V359, P1309, DOI 10.1016/S0140-6736(02)08272-7; Crane PK, 2008, J CLIN EPIDEMIOL, V61, P1018, DOI 10.1016/j.jclinepi.2007.11.011; Diggle P., 2002, ANAL LONGITUDINAL DA; Diggle P. J., 2002, J R STAT SOC, V2nd, DOI DOI 10.2307/2983303; Elenkov IJ, 2005, NEUROIMMUNOMODULAT, V12, P255, DOI 10.1159/000087104; Girard TD, 2009, AM J RESP CRIT CARE, V179, pA5477; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hopkins R O, 1995, J Int Neuropsychol Soc, V1, P501; Hopkins RO, 2006, CLIN CHEST MED, V27, P679, DOI 10.1016/j.ccm.2006.06.003; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; HOPKINS RO, 1995, BRAIN COGNITION, V27, P180, DOI 10.1006/brcg.1995.1016; Hopkins RO, 2005, AM J RESP CRIT CARE, V171, P340, DOI 10.1164/rccm.200406-763OC; Hopkins RO, 2004, J INT NEUROPSYCH SOC, V10, P1005, DOI 10.1017/S135561770410711X; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; HOPKINS RO, 2005, INT NEUR SOC 33 ANN; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Jackson JC, 2004, NEUROPSYCHOL REV, V14, P87, DOI 10.1023/B:NERV.0000028080.39602.17; Jackson JC, 2003, ARCH CLIN NEUROPSYCH, V18, P688; Jackson JC, 2003, CRIT CARE MED, V31, P1226, DOI 10.1097/01.CCM.0000059996.30263.94; Kukull WA, 2002, ARCH NEUROL-CHICAGO, V59, P1737, DOI 10.1001/archneur.59.11.1737; Larson EB, 2006, ANN INTERN MED, V144, P73, DOI 10.7326/0003-4819-144-2-200601170-00004; MARQUIS K, 2000, AM J RESP CRIT CARE, V161, pA383; MCKHANN G, 1984, NEUROLOGY, V34, P939, DOI 10.1212/WNL.34.7.939; Pandharipande PP, 2007, JAMA-J AM MED ASSOC, V298, P2644, DOI 10.1001/jama.298.22.2644; Rothenhausler HB, 2001, GEN HOSP PSYCHIAT, V23, P88, DOI 10.1016/S0163-8343(01)00123-2; Rubenfeld GD, 2005, NEW ENGL J MED, V353, P1685, DOI 10.1056/NEJMoa050333; Rubenfeld GD, 2007, CHEST, V131, P554, DOI 10.1378/chest.06-1976; Rudolph JL, 2008, ANAESTHESIA, V63, P941, DOI 10.1111/j.1365-2044.2008.05523.x; SAMEJIMA F, 1969, PSYCHOMETRIKA, V34, P1; SAMEJIMA F, 1997, GRADED RESPONSE MODE; *SCI SOFTW INT, 2003, PARSC WIND COMP PROG; STARR JM, 1994, DRUG SAFETY, V11, P310, DOI 10.2165/00002018-199411050-00003; SUCHYTA MR, 2004, AM J RESP CRIT CARE, V169, pA18; Sukantarat KT, 2005, ANAESTHESIA, V60, P847, DOI 10.1111/j.1365-2044.2005.04148.x; Teng E L, 1994, Int Psychogeriatr, V6, P45, DOI 10.1017/S1041610294001602; Wang L, 2002, J AM GERIATR SOC, V50, P1525, DOI 10.1046/j.1532-5415.2002.50408.x; Wang L, 2004, J AM GERIATR SOC, V52, P2045, DOI 10.1111/j.1532-5415.2004.52568.x; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; ZEGER SL, 1986, BIOMETRICS, V42, P121, DOI 10.2307/2531248; Zsembik BA, 2001, J GERONTOL B-PSYCHOL, V56, pS266, DOI 10.1093/geronb/56.5.S266	46	354	364	1	27	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					763	770		10.1001/jama.2010.167	http://dx.doi.org/10.1001/jama.2010.167			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	559DD	20179286	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000274800000028
J	Dong, GG; Yang, Q; Wang, Q; Kim, YI; Wood, TL; Osteryoung, KW; van Oudenaarden, A; Golden, SS				Dong, Guogang; Yang, Qiong; Wang, Qiang; Kim, Yong-Ick; Wood, Thammajun L.; Osteryoung, Katherine W.; van Oudenaarden, Alexander; Golden, Susan S.			Elevated ATPase Activity of KaiC Applies a Circadian Checkpoint on Cell Division in Synechococcus elongatus	CELL			English	Article							GENE-EXPRESSION; BACILLUS-SUBTILIS; CLOCK SYSTEM; CYANOBACTERIA; PHOSPHORYLATION; PROTEIN; IDENTIFICATION; OSCILLATION; DOMAIN; FTSZ	A circadian clock coordinates physiology and behavior in diverse groups of living organisms. Another major cyclic cellular event, the cell cycle, is regulated by the circadian clock in the few cases where linkage of these cycles has been studied. In the cyanobacterium Synechococcus elongatus, the circadian clock gates cell division by an unknown mechanism. Using timelapse microscopy, we confirm the gating of cell division in the wild-type and demonstrate the regulation of cytokinesis by key clock components. Specifically, a state of the oscillator protein KaiC that is associated with elevated ATPase activity closes the gate by acting through a known clock output pathway to inhibit FtsZ ring formation at the division site. An activity that stimulates KaiC phosphorylation independently of the KaiA protein was also uncovered. We propose a model that separates the functions of KaiC ATPase and phosphorylation in cell division gating and other circadian behaviors.	[Dong, Guogang; Wood, Thammajun L.; Golden, Susan S.] Texas A&M Univ, Dept Biol, Ctr Biol Clocks Res, College Stn, TX 77843 USA; [Dong, Guogang; Kim, Yong-Ick; Golden, Susan S.] Univ Calif San Diego, Div Biol Sci, Ctr Chronobiol, La Jolla, CA 92093 USA; [Wang, Qiang; Osteryoung, Katherine W.] Michigan State Univ, Dept Plant Biol, E Lansing, MI 48824 USA; [Yang, Qiong; van Oudenaarden, Alexander] MIT, Dept Phys, Cambridge, MA 02139 USA; [van Oudenaarden, Alexander] MIT, Dept Biol, Cambridge, MA 02139 USA	Texas A&M University System; Texas A&M University College Station; University of California System; University of California San Diego; Michigan State University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Golden, SS (corresponding author), Texas A&M Univ, Dept Biol, Ctr Biol Clocks Res, College Stn, TX 77843 USA.	sgolden@ucsd.edu	van Oudenaarden, Alexander/AAA-1705-2019; Wang, Qiang/P-7806-2016; Kim, Yong-Ick/K-3535-2019; Yang, Qiong/G-9630-2016	Wang, Qiang/0000-0002-7388-4703; Kim, Yong-Ick/0000-0001-5491-616X; Yang, Qiong/0000-0002-2442-2094	NIH [R01 GM62419, P01 NS39546, R01 GM068957]; American Recovery and Reinvestment Act; NSF [PHY-0548484]; DOE [DE-FG-02-06ER15808]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM068957, R01GM062419] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [P01NS039546] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; NSF(National Science Foundation (NSF)); DOE(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank P. Luitel for helpful discussions, A. LiWang for sharing instrumentation and unpublished data, C.-C. Zhang for providing the FtsZ antiserum, and A. Suescun for technical assistance. We are grateful to J. Xiao, T. Liu, and I. M. Axmann for constructive suggestions on the ATPase assays. This work was supported by grants from the NIH (R01 GM62419 and P01 NS39546 to S. S. G., R01 GM068957 to A.v.O.), the American Recovery and Reinvestment Act (S. S. G.), NSF (PHY-0548484 to A.v.O.), and DOE (DE-FG-02-06ER15808 to K.W.O.). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institute of General Medical Sciences or the National Institutes of Health.	Bell-Pedersen D, 2005, NAT REV GENET, V6, P544, DOI 10.1038/nrg1633; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Clerico Eugenia M, 2007, Methods Mol Biol, V362, P155; Dong GG, 2008, CURR OPIN MICROBIOL, V11, P541, DOI 10.1016/j.mib.2008.10.003; Gregory JA, 2008, GENE DEV, V22, P3475, DOI 10.1101/gad.1732408; Hayashi F, 2004, J BIOL CHEM, V279, P52331, DOI 10.1074/jbc.M406604200; Hayashi F, 2003, GENES CELLS, V8, P287, DOI 10.1046/j.1365-2443.2003.00633.x; Hayashi F, 2006, BIOCHEM BIOPH RES CO, V348, P864, DOI 10.1016/j.bbrc.2006.07.143; Ishiura M, 1998, SCIENCE, V281, P1519, DOI 10.1126/science.281.5382.1519; Ivleva NB, 2006, P NATL ACAD SCI USA, V103, P17468, DOI 10.1073/pnas.0606639103; Ivleva NB, 2005, EMBO J, V24, P1202, DOI 10.1038/sj.emboj.7600606; Iwasaki H, 2000, CELL, V101, P223, DOI 10.1016/S0092-8674(00)80832-6; Iwasaki H, 2002, P NATL ACAD SCI USA, V99, P15788, DOI 10.1073/pnas.222467299; Kawai Y, 2003, MOL MICROBIOL, V47, P1113, DOI 10.1046/j.1365-2958.2003.03360.x; Kim YI, 2008, P NATL ACAD SCI USA, V105, P12825, DOI 10.1073/pnas.0800526105; Kitayama Y, 2003, EMBO J, V22, P2127, DOI 10.1093/emboj/cdg212; Kitayama Y, 2008, GENE DEV, V22, P1513, DOI 10.1101/gad.1661808; Kutsuna S, 2007, J BACTERIOL, V189, P7690, DOI 10.1128/JB.00835-07; LIU Y, 1995, GENE DEV, V9, P1469, DOI 10.1101/gad.9.12.1469; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Mackey Shannon R, 2007, Methods Mol Biol, V362, P115; Mackey SR, 2007, TRENDS MICROBIOL, V15, P381, DOI 10.1016/j.tim.2007.08.005; Margolin W, 2005, NAT REV MOL CELL BIO, V6, P862, DOI 10.1038/nrm1745; Matsuo T, 2003, SCIENCE, V302, P255, DOI 10.1126/science.1086271; Mazouni K, 2004, MOL MICROBIOL, V52, P1145, DOI 10.1111/j.1365-2958.2004.04042.x; Mihalcescu I, 2004, NATURE, V430, P81, DOI 10.1038/nature02533; Miyagishima SY, 2005, MOL MICROBIOL, V56, P126, DOI 10.1111/j.1365-2958.2005.04548.x; Mori T, 1996, P NATL ACAD SCI USA, V93, P10183, DOI 10.1073/pnas.93.19.10183; Mori T, 2001, J BACTERIOL, V183, P2439, DOI 10.1128/JB.183.8.2439-2444.2001; Mori Tetsuya, 2009, P183, DOI 10.1007/978-3-540-88431-6_11; Nagoshi E, 2004, CELL, V119, P693, DOI 10.1016/j.cell.2004.11.015; Nakajima M, 2005, SCIENCE, V308, P414, DOI 10.1126/science.1108451; Nishiwaki T, 2004, P NATL ACAD SCI USA, V101, P13927, DOI 10.1073/pnas.0403906101; Nishiwaki T, 2000, P NATL ACAD SCI USA, V97, P495, DOI 10.1073/pnas.97.1.495; Nishiwaki T, 2007, EMBO J, V26, P4029, DOI 10.1038/sj.emboj.7601832; Rust MJ, 2007, SCIENCE, V318, P809, DOI 10.1126/science.1148596; Schmitz O, 2000, SCIENCE, V289, P765, DOI 10.1126/science.289.5480.765; Smith RM, 2006, P NATL ACAD SCI USA, V103, P8564, DOI 10.1073/pnas.0508696103; Takai N, 2006, P NATL ACAD SCI USA, V103, P12109, DOI 10.1073/pnas.0602955103; Takai N, 2006, J BIOL RHYTHM, V21, P235, DOI 10.1177/0748730406289400; Terauchi K, 2007, P NATL ACAD SCI USA, V104, P16377, DOI 10.1073/pnas.0706292104; Tomita J, 2005, SCIENCE, V307, P251, DOI 10.1126/science.1102540; Wang JM, 2004, J STRUCT BIOL, V148, P259, DOI 10.1016/j.jsb.2004.07.003; Weart RB, 2007, CELL, V130, P335, DOI 10.1016/j.cell.2007.05.043; Williams SB, 2002, P NATL ACAD SCI USA, V99, P15357, DOI 10.1073/pnas.232517099; Xu Y, 2004, P NATL ACAD SCI USA, V101, P13933, DOI 10.1073/pnas.0404768101; Ye JQ, 2004, BBA-BIOENERGETICS, V1659, P1, DOI 10.1016/j.bbabio.2004.06.003; Zhang XF, 2006, MOL MICROBIOL, V60, P658, DOI 10.1111/j.1365-2958.2006.05138.x	49	100	100	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					529	539		10.1016/j.cell.2009.12.042	http://dx.doi.org/10.1016/j.cell.2009.12.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178745	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000274668400016
J	McCormack, MP; Young, LF; Vasudevan, S; de Graaf, CA; Codrington, R; Rabbitts, TH; Jane, SM; Curtis, DJ				McCormack, Matthew P.; Young, Lauren F.; Vasudevan, Sumitha; de Graaf, Carolyn A.; Codrington, Rosalind; Rabbitts, Terence H.; Jane, Stephen M.; Curtis, David J.			The Lmo2 Oncogene Initiates Leukemia in Mice by Inducing Thymocyte Self-Renewal	SCIENCE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; T-CELL LEUKEMIA; GENE-THERAPY; CHROMOSOMAL TRANSLOCATIONS; RETROVIRAL INSERTION; PROTEIN RBTN2; SCID-X1; HEMATOPOIESIS; TRANSCRIPTION; ACTIVATION	The LMO2 oncogene causes a subset of human T cell acute lymphoblastic leukemias (T-ALL), including four cases that arose as adverse events in gene therapy trials. To investigate the cellular origin of LMO2-induced leukemia, we used cell fate mapping to study mice in which the Lmo2 gene was constitutively expressed in the thymus. Lmo2 induced self-renewal of committed T cells in the mice more than 8 months before the development of overt T-ALL. These self-renewing cells retained the capacity for T cell differentiation but expressed several genes typical of hematopoietic stem cells (HSCs), suggesting that Lmo2 might reactivate an HSC-specific transcriptional program. Forced expression of one such gene, Hhex, was sufficient to initiate self-renewal of thymocytes in vivo. Thus, Lmo2 promotes the self-renewal of preleukemic thymocytes, providing a mechanism by which committed T cells can then accumulate additional genetic mutations required for leukemic transformation.	[McCormack, Matthew P.; Young, Lauren F.; Vasudevan, Sumitha; Jane, Stephen M.; Curtis, David J.] Royal Melbourne Hosp, Rotary Bone Marrow Res Labs, Parkville, Vic 3050, Australia; [McCormack, Matthew P.; Jane, Stephen M.; Curtis, David J.] Univ Melbourne, Dept Med, Parkville, Vic 3010, Australia; [de Graaf, Carolyn A.] Walter & Eliza Hall Inst Med Res, Parkville, Vic 3050, Australia; [de Graaf, Carolyn A.] Univ Melbourne, Dept Med Biol, Parkville, Vic 3010, Australia; [Codrington, Rosalind; Rabbitts, Terence H.] St James Univ Hosp, Leeds Inst Mol Med, Leeds LS9 7TF, W Yorkshire, England	Royal Melbourne Hospital; University of Melbourne; Walter & Eliza Hall Institute; University of Melbourne; Saint James's University Hospital; University of Leeds	McCormack, MP (corresponding author), Royal Melbourne Hosp, Rotary Bone Marrow Res Labs, Grattan St, Parkville, Vic 3050, Australia.	mccormack@wehi.edu.au	Curtis, David/H-4996-2014; Jane, Stephen/D-6659-2011; Rabbitts, Terence/D-6262-2016	Curtis, David/0000-0001-9497-0996; Rabbitts, Terence/0000-0002-4982-2609; McCormack, Matthew/0000-0003-1536-5611; Jane, Stephen Marsden/0000-0002-1045-0481	Cancer Council of Victoria; National Health and Medical Research Council of Australia (NHMRC) [382901]; Leukaemia Foundation; Medical Research Council UK [G0600914]; Leukaemia Research UK [07036]; Medical Research Council [G0600914] Funding Source: researchfish; MRC [G0600914] Funding Source: UKRI	Cancer Council of Victoria(Canadian Institutes of Health Research (CIHR)Cancer Council Victoria); National Health and Medical Research Council of Australia (NHMRC)(National Health and Medical Research Council (NHMRC) of Australia); Leukaemia Foundation; Medical Research Council UK(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leukaemia Research UK; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank C. Talora and I. Screpanti for Lck-Notch3-IC transgenic mice; D. Izon for the MIG-Hhex retroviral vector; A. Strasser for comments on the manuscript; G. Smyth for advice on bioinformatics; and L. Ta, R. Bowyer, L. Mizhiritzky, and J. Davis for animal husbandry. This work was supported by grants (to M. P. M., S. M. J., and D. J. C.) from the Cancer Council of Victoria and National Health and Medical Research Council of Australia (NHMRC) (project grant 382901); a grant-in-aid (to M. P. M. and D.J.C.) from the Leukaemia Foundation; and grants (to T. H. R.) from the Medical Research Council UK (programme grant G0600914) and Leukaemia Research UK (programme grant 07036). D.J.C. is an R. D. Wright Biomedical Research Fellow, and S.M.J. is a Principal Research Fellow of the NHMRC.	Aifantis I, 2008, NAT REV IMMUNOL, V8, P380, DOI 10.1038/nri2304; Ferrando AA, 2002, CANCER CELL, V1, P75, DOI 10.1016/S1535-6108(02)00018-1; Hacein-Bey-Abina S, 2003, SCIENCE, V302, P415, DOI 10.1126/science.1088547; Hacein-Bey-Abina S, 2008, J CLIN INVEST, V118, P3132, DOI 10.1172/JCI35700; Hall MA, 2003, P NATL ACAD SCI USA, V100, P992, DOI 10.1073/pnas.0237324100; Howe SJ, 2008, J CLIN INVEST, V118, P3143, DOI 10.1172/JCI35798; LARSON RC, 1995, ONCOGENE, V11, P853; LARSON RC, 1994, ONCOGENE, V9, P3675; McCormack MP, 2004, NEW ENGL J MED, V350, P913, DOI 10.1056/NEJMra032207; McCormack MP, 2003, MOL CELL BIOL, V23, P9003, DOI 10.1128/MCB.23.24.9003-9013.2003; Nam CH, 2006, MOL THER, V13, P15, DOI 10.1016/j.ymthe.2005.09.010; Patterson LJ, 2007, BLOOD, V109, P2389, DOI 10.1182/blood-2006-02-003087; Pui CH, 2006, NEW ENGL J MED, V354, P166, DOI 10.1056/NEJMra052603; Rabbitts TH, 1998, GENE DEV, V12, P2651, DOI 10.1101/gad.12.17.2651; Schwarz BA, 2006, IMMUNOL REV, V209, P47, DOI 10.1111/j.0105-2896.2006.00350.x; Van Vlierberghe P, 2006, BLOOD, V108, P3520, DOI 10.1182/blood-2006-04-019927; WARREN AJ, 1994, CELL, V78, P45, DOI 10.1016/0092-8674(94)90571-1; Yamada Y, 1998, P NATL ACAD SCI USA, V95, P3890, DOI 10.1073/pnas.95.7.3890	18	167	174	1	13	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					879	883		10.1126/science.1182378	http://dx.doi.org/10.1126/science.1182378			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20093438				2022-12-01	WOS:000274408300066
J	Parvanov, ED; Petkov, PM; Paigen, K				Parvanov, Emil D.; Petkov, Petko M.; Paigen, Kenneth			Prdm9 Controls Activation of Mammalian Recombination Hotspots	SCIENCE			English	Article							HISTONE H3 METHYLTRANSFERASE; MEIOTIC RECOMBINATION; MOUSE		[Parvanov, Emil D.; Petkov, Petko M.; Paigen, Kenneth] Jackson Lab, Bar Harbor, ME 04609 USA	Jackson Laboratory	Petkov, PM (corresponding author), Jackson Lab, 600 Main St, Bar Harbor, ME 04609 USA.	Petko.Petkov@jax.org; Ken.Paigen@jax.org		Petkov, Petko/0000-0002-6694-9150; Parvanov, Emil/0000-0001-6744-0949	NIH [GM 078643, GM 083408, GM 078452, GM 076468, CA 34196]; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM078643, R01GM083408, P50GM076468, R01GM078452] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	The authors are indebted to E. Sargent, T. Billings, and G. Gilbert for technical assistance. The work was supported in part by NIH grants GM 078643, 083408, 078452, and 076468 and CA 34196.	Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Kon N, 1997, P NATL ACAD SCI USA, V94, P13765, DOI 10.1073/pnas.94.25.13765; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Neumann R, 2006, HUM MOL GENET, V15, P1401, DOI 10.1093/hmg/ddl063; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; SHIROISHI T, 1991, EMBO J, V10, P681, DOI 10.1002/j.1460-2075.1991.tb07997.x	9	388	394	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					835	835		10.1126/science.1181495	http://dx.doi.org/10.1126/science.1181495			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044538	Green Accepted			2022-12-01	WOS:000274408300052
J	Moss, RH; Edmonds, JA; Hibbard, KA; Manning, MR; Rose, SK; van Vuuren, DP; Carter, TR; Emori, S; Kainuma, M; Kram, T; Meehl, GA; Mitchell, JFB; Nakicenovic, N; Riahi, K; Smith, SJ; Stouffer, RJ; Thomson, AM; Weyant, JP; Wilbanks, TJ				Moss, Richard H.; Edmonds, Jae A.; Hibbard, Kathy A.; Manning, Martin R.; Rose, Steven K.; van Vuuren, Detlef P.; Carter, Timothy R.; Emori, Seita; Kainuma, Mikiko; Kram, Tom; Meehl, Gerald A.; Mitchell, John F. B.; Nakicenovic, Nebojsa; Riahi, Keywan; Smith, Steven J.; Stouffer, Ronald J.; Thomson, Allison M.; Weyant, John P.; Wilbanks, Thomas J.			The next generation of scenarios for climate change research and assessment	NATURE			English	Article							MODEL; ATMOSPHERE	Advances in the science and observation of climate change are providing a clearer understanding of the inherent variability of Earth's climate system and its likely response to human and natural influences. The implications of climate change for the environment and society will depend not only on the response of the Earth system to changes in radiative forcings, but also on how humankind responds through changes in technology, economies, lifestyle and policy. Extensive uncertainties exist in future forcings of and responses to climate change, necessitating the use of scenarios of the future to explore the potential consequences of different response options. To date, such scenarios have not adequately examined crucial possibilities, such as climate change mitigation and adaptation, and have relied on research processes that slowed the exchange of information among physical, biological and social scientists. Here we describe a new process for creating plausible scenarios to investigate some of the most challenging and important questions about climate change confronting the global community.	[Moss, Richard H.; Edmonds, Jae A.; Smith, Steven J.; Thomson, Allison M.] Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, College Pk, MD 20740 USA; [Hibbard, Kathy A.; Meehl, Gerald A.] Natl Ctr Atmospher Res, Climate & Global Dynam Div, Boulder, CO 80305 USA; [Manning, Martin R.] Victoria Univ Wellington, New Zealand Climate Change Res Inst, Wellington, New Zealand; [Rose, Steven K.] Elect Power Res Inst, Washington, DC 20036 USA; [van Vuuren, Detlef P.; Kram, Tom] Netherlands Environm Assessment Agcy, NL-3720 AH Bilthoven, Netherlands; [Carter, Timothy R.] Finnish Environm Inst, Helsinki 00251, Finland; [Emori, Seita; Kainuma, Mikiko] Natl Inst Environm Studies, Tsukuba, Ibaraki 3058506, Japan; [Mitchell, John F. B.] Met Off, Exeter EX1 3PB, Devon, England; [Nakicenovic, Nebojsa; Riahi, Keywan] Int Inst Appl Syst Anal, A-2361 Laxenburg, Austria; [Nakicenovic, Nebojsa] Vienna Univ Technol, A-1040 Vienna, Austria; [Stouffer, Ronald J.] NOAA, Geophys Fluid Dynam Lab, Princeton, NJ 08542 USA; [Weyant, John P.] Stanford Univ, Stanford, CA 94305 USA; [Wilbanks, Thomas J.] Oak Ridge Natl Lab, Div Environm Sci, Oak Ridge, TN 37831 USA	United States Department of Energy (DOE); Pacific Northwest National Laboratory; University System of Maryland; University of Maryland College Park; National Center Atmospheric Research (NCAR) - USA; Victoria University Wellington; Electric Power Research Institute (EPRI); Netherlands National Institute for Public Health & the Environment; Finnish Environment Institute; National Institute for Environmental Studies - Japan; Met Office - UK; International Institute for Applied Systems Analysis (IIASA); Technische Universitat Wien; National Oceanic Atmospheric Admin (NOAA) - USA; Stanford University; United States Department of Energy (DOE); Oak Ridge National Laboratory	Moss, RH (corresponding author), Univ Maryland, Pacific NW Natl Lab, Joint Global Change Res Inst, 5825 Univ Res Court,Suite 3500, College Pk, MD 20740 USA.	rhm@pnl.gov	Smith, Steven/F-4502-2010; Riahi, Keywan/B-6426-2011; Carter, Timothy R/N-4411-2017; Smith, Steven/HDM-9496-2022; Thomson, Allison M/B-1254-2010; Thomson, Allison/GRO-3207-2022; Emori, Seita/D-1950-2012; van Vuuren, Detlef P./A-4764-2009	Smith, Steven/0000-0003-3248-5607; Riahi, Keywan/0000-0001-7193-3498; Carter, Timothy R/0000-0002-4026-8859; Thomson, Allison M/0000-0001-5326-1755; van Vuuren, Detlef P./0000-0003-0398-2831; Moss, Richard/0000-0001-5005-0063				Alcamo J., 1995, CLIMATE CHANGE 1994, P247; [Anonymous], 2000, SPECIAL REPORT EMISS; [Anonymous], 2009, EMSEMBLES CLIMATE CH; Arrhenius S., 1896, PHILOS MAGAZINE J SC, V41, P237, DOI DOI 10.1080/14786449608620846; Bradfield R, 2005, FUTURES, V37, P795, DOI 10.1016/j.futures.2005.01.003; CAIVIN K, 2009, ENERG ECON, V31, pS107; CARPENTER SR, 2005, ECOSYSTEMS HUMAN WEL, V2, P551; Carter T., 2007, GEN GUIDELINES USE S; Carter T.R., 2000, CLIMATE CHANGE 21 CE; Carter T. R., 1994, IPCC TECHNICAL GUIDE; Carter TR, 2007, AR4 CLIMATE CHANGE 2007: IMPACTS, ADAPTATION, AND VULNERABILITY, P133; CARTER TR, 1991, INT J CLIMATOL, V11, P251; Christensen JH, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P847; Clarke L., 2007, SCENARIOS GREENHOUSE; Clarke L, 2009, ENERG ECON, V31, pS63, DOI 10.1016/j.eneco.2009.10.014; Cox PM, 2000, NATURE, V408, P184, DOI 10.1038/35041539; Downing TE, 2001, CLIMATE CHANGE 2001: IMPACTS, ADAPTATION, AND VULNERABILITY, P105; Fisher B, 2007, AR4 CLIMATE CHANGE 2007: MITIGATION OF CLIMATE CHANGE, P169; Friedlingstein P, 2006, J CLIMATE, V19, P3337, DOI 10.1175/JCLI3800.1; Gaffin SR, 2004, GLOBAL ENVIRON CHANG, V14, P105, DOI 10.1016/j.gloenvcha.2004.02.004; Grubler A, 2001, NATURE, V412, P15, DOI 10.1038/35083752; Grubler A, 2007, TECHNOL FORECAST SOC, V74, P980, DOI 10.1016/j.techfore.2006.05.023; Hafele Wolfgang, 1981, ENERGY FINITE WORLD; HANSEN J, 1988, J GEOPHYS RES-ATMOS, V93, P9341, DOI 10.1029/JD093iD08p09341; Herrera Amilcar O., 1976, CATASTROPHE NEW SOC; Hibbard K. A., 2007, EOS T, V88, P217, DOI DOI 10.1029/2007EO200002; Hijioka Y., 2008, J GLOB ENV ENG, V13, P97; HULME M, 1995, ENERG POLICY, V23, P347, DOI 10.1016/0301-4215(95)90159-5; Huntingford C, 2000, CLIM DYNAM, V16, P575, DOI 10.1007/s003820000067; Huntingford C, 2007, SCIENCE, V316, P829; Hurtt G. C., 2009, ILEAPS NEWSL, V7, P6; Intergovt Panel Climate Change, 1990, CLIMATE CHANGE: THE IPCC SCIENTIFIC ASSESSMENT, P1; International Energy Agency, 2009, WORLD EN OUTL; JEFFERSON M, 1983, POSITIVE EC, P122; Kahn Herman, 1967, YEAR 2000 FRAMEWORK; KEELING CD, 1960, TELLUS, V12, P200, DOI 10.1111/j.2153-3490.1960.tb01300.x; Lamarque J.-F., 2009, IGAC NEWSL, V41, P12; Le Treut H, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P93; Leggett J., 1992, CLIMATE CHANGE 1992, P69; LEONTIEF W, 1976, FUTURE WORLD EC STUD; Malone E, 2009, NEW HORIZ ENVIRON EC, P8; MANABE S, 1967, J ATMOS SCI, V24, P241, DOI 10.1175/1520-0469(1967)024<0241:TEOTAW>2.0.CO;2; MANABE S, 1975, J PHYS OCEANOGR, V5, P3, DOI 10.1175/1520-0485(1975)005<0003:AGOACM>2.0.CO;2; Matsuoka Y, 2006, ENERGY J, V3, P343; MEADOWS D H, 1972, P205; Mearns LO, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P739; Meehl GA, 2007, ICPO PUBLICATION, V112; Meehl GA, 2009, B AM METEOROL SOC, V90, P1467, DOI 10.1175/2009BAMS2778.1; MELILLO JM, 1995, GLOBAL BIOGEOCHEM CY, V9, P407; Mesarovic M. D., 1974, MANKIND TURNING POIN; Mitchell TD, 2003, CLIMATIC CHANGE, V60, P217, DOI 10.1023/A:1026035305597; MORITA T, 2007, CLIMATE CHANGE 2001, P115; Moss R., 2008, NEW SCENARIOS ANAL E; Murphy J, 2009, UK CLIMATE PROJECTIO; Nakicenovic N., 1998, MITIGATION ADAPTATIO, V3, P95, DOI DOI 10.1023/A:1009699523349; Parson E, 2007, GLOBAL CHANGE SCENAR; Pittock AB, 2001, NATURE, V413, P249, DOI 10.1038/35095194; Randall DA, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P589; Rao S, 2008, IR08020 IIASA; Riahi K., 2006, ENERGY J, V3, P177; Riahi K, 2007, TECHNOL FORECAST SOC, V74, P887, DOI 10.1016/j.techfore.2006.05.026; Robertson J., 1983, SANE ALTERNATIVE CHO; Ruosteenoja K., 2003, FUTURE CLIMATE WORLD; Schneider SH, 2001, NATURE, V411, P17, DOI 10.1038/35075167; Schwartz P., 1996, ART LONG VIEW PLANNI; Smith J.B., 1996, VULNERABILITY ADAPTA, V1996th; Smith SJ, 2006, ENERG J, P373; Svedin U., 1987, SURPRISING FUTURES N; Taylor KE, 2009, SUMMARY CMIP5 EXPT D; U.S. Climate Change Science Program, 2003, STRAT PLAN CLIM CHAN; *UK CLIM IMP PROGR, 2001, SOC SCEN CLIM CHANG; *US DOE, 2009, SCI CHALL FUT DIR CL; Van Vuuren DP, 2008, P NATL ACAD SCI USA, V105, P15258, DOI 10.1073/pnas.0711129105; van Vuuren D.P., 2008, WORK PLAN DATA EXCHA; van Vuuren DP, 2007, CLIMATIC CHANGE, V81, P119, DOI 10.1007/s10584-006-9172-9; van Vuuren DP, 2007, GLOBAL ENVIRON CHANG, V17, P114, DOI 10.1016/j.gloenvcha.2006.04.004; VANVUUREN DP, 2006, ENERGY J, V3, P201; Vuuren D, 2008, CLIMATIC CHANGE, V91, P237, DOI 10.1007/s10584-008-9485-y; Watson R.T., 1998, REGIONAL IMPACTS CLI; Weyant J., 2009, REPORT 2 6 VERSUS 2; Weyant J, 1996, CLIMATE CHANGE 1995, P367; Weyant JR, 2006, ENERG J, P1; Wigley TML, 2007, HUMAN-INDUCED CLIMATE CHANGE: AN INTERDISCIPLINARY ASSESSMENT, P84, DOI 10.1017/CBO9780511619472.009; *WMO UNEP ICSU, 1984, WCP83 WMOUNEPICSU UN; *WMO UNEP ICSU, 1986, 661 WMOUNEPICSU UNES; *WORLD EN COUNC, 1993, EN TOM WORLD	86	4114	4267	92	2119	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					747	756		10.1038/nature08823	http://dx.doi.org/10.1038/nature08823			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	553VG	20148028				2022-12-01	WOS:000274394300028
J	Brown, RE				Brown, Raeford E., Jr.			Coda: Don't Touch Me	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												rbrow1@email.eky.edu	Brown, Raeford/I-1211-2019	Brown, Raeford/0000-0002-2295-2657				Brown RE, 2009, JAMA-J AM MED ASSOC, V302, P2409, DOI 10.1001/jama.2009.1675	1	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					494	494		10.1001/jama.303.6.494	http://dx.doi.org/10.1001/jama.303.6.494			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145217				2022-12-01	WOS:000274378700002
J	Liu, CM; Young, AL; Starling-Windhof, A; Bracher, A; Saschenbrecker, S; Rao, BV; Rao, KV; Berninghausen, O; Mielke, T; Hartl, FU; Beckmann, R; Hayer-Hartl, M				Liu, Cuimin; Young, Anna L.; Starling-Windhof, Amanda; Bracher, Andreas; Saschenbrecker, Sandra; Rao, Bharathi Vasudeva; Rao, Karnam Vasudeva; Berninghausen, Otto; Mielke, Thorsten; Hartl, F. Ulrich; Beckmann, Roland; Hayer-Hartl, Manajit			Coupled chaperone action in folding and assembly of hexadecameric Rubisco	NATURE			English	Article							RIBULOSE-BISPHOSPHATE CARBOXYLASE; PHOTO-CROSS-LINKING; ESCHERICHIA-COLI; RIBULOSE-1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; 1,5-BISPHOSPHATE CARBOXYLASE/OXYGENASE; SMALL SUBUNITS; AMINO-ACID; RBCX GENE; IN-VIVO; PROTEIN	Form I Rubisco (ribulose 1,5-bisphosphate carboxylase/oxygenase), a complex of eight large (RbcL) and eight small (RbcS) subunits, catalyses the fixation of atmospheric CO2 in photosynthesis. The limited catalytic efficiency of Rubisco has sparked extensive efforts to re-engineer the enzyme with the goal of enhancing agricultural productivity. To facilitate such efforts we analysed the formation of cyanobacterial form I Rubisco by in vitro reconstitution and cryo-electron microscopy. We show that RbcL subunit folding by the GroEL/GroES chaperonin is tightly coupled with assembly mediated by the chaperone RbcX(2). RbcL monomers remain partially unstable and retain high affinity for GroEL until captured by RbcX(2). As revealed by the structure of a RbcL(8)-(RbcX2)(8) assembly intermediate, RbcX(2) acts as a molecular staple in stabilizing the RbcL subunits as dimers and facilitates RbcL(8) core assembly. Finally, addition of RbcS results in RbcX(2) release and holoenzyme formation. Specific assembly chaperones may be required more generally in the formation of complex oligomeric structures when folding is closely coupled to assembly.	[Liu, Cuimin; Starling-Windhof, Amanda; Bracher, Andreas; Saschenbrecker, Sandra; Rao, Bharathi Vasudeva; Rao, Karnam Vasudeva; Hartl, F. Ulrich; Hayer-Hartl, Manajit] Max Planck Inst Biochem, Dept Cellular Biochem, D-82152 Martinsried, Germany; [Young, Anna L.; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Dept Chem & Biochem, Ctr Integrated Prot Sci CIPSM, D-81377 Munich, Germany; [Young, Anna L.; Berninghausen, Otto; Beckmann, Roland] Univ Munich, Gene Ctr, D-81377 Munich, Germany; [Mielke, Thorsten] Max Planck Inst Mol Genet, USN, D-14195 Berlin, Germany; [Mielke, Thorsten] Charite, Inst Med Phys & Biophys, D-10098 Berlin, Germany	Max Planck Society; University of Munich; University of Munich; Max Planck Society; Free University of Berlin; Humboldt University of Berlin; Charite Universitatsmedizin Berlin	Hayer-Hartl, M (corresponding author), Max Planck Inst Biochem, Dept Cellular Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	uhartl@biochem.mpg.de; beckmann@lmb.uni-muenchen.de; mhartl@biochem.mpg.de	Hartl, F. Ulrich/Y-8206-2019; Hayer-Hartl, Manajit/V-8078-2017	Hayer-Hartl, Manajit/0000-0001-8213-6742; Saschenbrecker, Sandra/0000-0002-4769-915X; , Amanda/0000-0003-2483-3886	Deutsche Forschungsgemeinschaft [SFB 594]; Ernst-Jung Foundation; Korber Foundation; European Union and the Center for Integrated Protein Science Munich (CIPSM)	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); Ernst-Jung Foundation; Korber Foundation; European Union and the Center for Integrated Protein Science Munich (CIPSM)	Assistance by K. Valer and J. Basquin in the MPIB crystallization facility, by C. Ungewickell in the Gene Center cryo-EM facility as well as by the staff at SLS-beamline X10SA-PX-II is acknowledged. We thank the Deutsche Forschungsgemeinschaft (SFB 594), the Ernst-Jung Foundation, the Korber Foundation, the European Union and the Center for Integrated Protein Science Munich (CIPSM) for financial support.	Andersson I, 2003, ARCH BIOCHEM BIOPHYS, V414, P130, DOI 10.1016/S0003-9861(03)00164-4; Andersson I, 2008, J EXP BOT, V59, P1555, DOI 10.1093/jxb/ern091; Andrews T.J., 1987, BIOCH PLANTS, P131, DOI 10.1016/B978-0-12-675410-0.50009-9; Andrews TJ, 2003, ARCH BIOCHEM BIOPHYS, V414, P159, DOI 10.1016/S0003-9861(03)00100-0; ANDREWS TJ, 1988, J BIOL CHEM, V263, P12213; BARRACLOUGH R, 1980, BIOCHIM BIOPHYS ACTA, V608, P19, DOI 10.1016/0005-2787(80)90129-X; Brinker A, 2001, CELL, V107, P223, DOI 10.1016/S0092-8674(01)00517-7; Chin JW, 2002, P NATL ACAD SCI USA, V99, P11020, DOI 10.1073/pnas.172226299; Chin JW, 2002, CHEMBIOCHEM, V3, P1135, DOI 10.1002/1439-7633(20021104)3:11<1135::AID-CBIC1135>3.0.CO;2-M; Emlyn-Jones D, 2006, PLANT CELL PHYSIOL, V47, P1630, DOI 10.1093/pcp/pcl028; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Evans W, 1997, CHEM BRIT, V33, P22; GOLOUBINOFF P, 1989, NATURE, V342, P884, DOI 10.1038/342884a0; GOLOUBINOFF P, 1989, NATURE, V337, P44, DOI 10.1038/337044a0; GUTTERIDGE S, 1995, PLANT CELL, V7, P809, DOI 10.1105/tpc.7.7.809; Hartl FU, 2009, NAT STRUCT MOL BIOL, V16, P574, DOI 10.1038/nsmb.1591; HayerHartl MK, 1996, EMBO J, V15, P6111, DOI 10.1002/j.1460-2075.1996.tb00999.x; Lakshmipathy SK, 2007, J BIOL CHEM, V282, P12186, DOI 10.1074/jbc.M609871200; LANGER T, 1992, EMBO J, V11, P4757, DOI 10.1002/j.1460-2075.1992.tb05581.x; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Leslie A. G. W., 1992, JOINT CCP4 ESF EACBM, V26; Li LA, 1997, J BACTERIOL, V179, P3793, DOI 10.1128/jb.179.11.3793-3796.1997; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; MARTIN J, 1991, NATURE, V352, P36, DOI 10.1038/352036a0; MARTIN J, 1993, NATURE, V366, P228, DOI 10.1038/366228a0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NEWMAN J, 1993, J BIOL CHEM, V268, P25876; NEWMAN J, 1993, ACTA CRYSTALLOGR D, V49, P548, DOI 10.1107/S090744499300530X; Onizuka T, 2004, PLANT CELL PHYSIOL, V45, P1390, DOI 10.1093/pcp/pch160; Perrakis A, 1999, NAT STRUCT BIOL, V6, P458, DOI 10.1038/8263; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; ROESSNER D, 1994, J CHROMATOGR A, V687, P249, DOI 10.1016/0021-9673(94)00818-3; Ryu YH, 2006, NAT METHODS, V3, P263, DOI 10.1038/NMETH864; Saschenbrecker S, 2007, CELL, V129, P1189, DOI 10.1016/j.cell.2007.04.025; SCHNEIDER G, 1990, J MOL BIOL, V211, P989, DOI 10.1016/0022-2836(90)90088-4; Spreitzer RJ, 2005, P NATL ACAD SCI USA, V102, P17225, DOI 10.1073/pnas.0508042102; Spreitzer RJ, 2002, ANNU REV PLANT BIOL, V53, P449, DOI 10.1146/annurev.arplant.53.100301.135233; Tabita FR, 2007, MICROBIOL MOL BIOL R, V71, P576, DOI 10.1128/MMBR.00015-07; Tabita FR, 1999, PHOTOSYNTH RES, V60, P1, DOI 10.1023/A:1006211417981; Tanaka S, 2007, ACTA CRYSTALLOGR D, V63, P1109, DOI 10.1107/S090744490704228X; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Tarnawski M, 2008, ACTA BIOCHIM POL, V55, P777; THOW G, 1994, BIOCHEMISTRY-US, V33, P5109, DOI 10.1021/bi00183a014; Vagin AA, 2001, ACTA CRYSTALLOGR D, V57, P1451, DOI 10.1107/S0907444901012409; VANDERVIES SM, 1986, EMBO J, V5, P2439, DOI 10.1002/j.1460-2075.1986.tb04519.x; VANDERVIES SM, 1992, BIOCHEMISTRY-US, V31, P3635, DOI 10.1021/bi00129a012; WEINER MP, 1994, GENE, V151, P119, DOI 10.1016/0378-1119(94)90641-6; Weissman JS, 1996, CELL, V84, P481, DOI 10.1016/S0092-8674(00)81293-3; Whitney SM, 2008, J EXP BOT, V59, P1909, DOI 10.1093/jxb/erm311; WISEMAN T, 1989, ANAL BIOCHEM, V179, P131, DOI 10.1016/0003-2697(89)90213-3	50	127	140	5	61	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					197	U81		10.1038/nature08651	http://dx.doi.org/10.1038/nature08651			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075914				2022-12-01	WOS:000273582700028
J	Khraiwesh, B; Arif, MA; Seumel, GI; Ossowski, S; Weigel, D; Reski, R; Frank, W				Khraiwesh, Basel; Arif, M. Asif; Seumel, Gotelinde I.; Ossowski, Stephan; Weigel, Detlef; Reski, Ralf; Frank, Wolfgang			Transcriptional Control of Gene Expression by MicroRNAs	CELL			English	Article							DIRECTED DNA METHYLATION; DEPENDENT RNA-POLYMERASE; TRANS-ACTING SIRNAS; PHYSCOMITRELLA-PATENS; ARABIDOPSIS-THALIANA; C-ELEGANS; MAMMALIAN-CELLS; MESSENGER-RNAS; DICER HOMOLOG; PLANTS	MicroRNAs (miRNAs) control gene expression in animals and plants. Like another class of small RNAs, siRNAs, they affect gene expression posttranscriptionally. While siRNAs in addition act in transcriptional gene silencing, a role of miRNAs in transcriptional regulation has been less clear. We show here that in moss Physcomitrella patens mutants without a DICER-LIKE1b gene, maturation of miRNAs is normal but cleavage of target RNAs is abolished and levels of these transcripts are drastically reduced. These mutants accumulate miRNA: target-RNA duplexes and show hypermethylation of the genes encoding target RNAs, leading to gene silencing. This pathway occurs also in the wild-type upon hormone treatment. We propose that initiation of epigenetic silencing by DNA methylation depends on the ratio of the miRNA and its target RNA.	[Khraiwesh, Basel; Arif, M. Asif; Seumel, Gotelinde I.; Reski, Ralf; Frank, Wolfgang] Univ Freiburg, Fac Biol, D-79104 Freiburg, Germany; [Ossowski, Stephan; Weigel, Detlef] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany; [Seumel, Gotelinde I.; Reski, Ralf; Frank, Wolfgang] Freiburg Initiat Syst Biol, D-79104 Freiburg, Germany; [Khraiwesh, Basel; Reski, Ralf] Ctr Biol Signalling Studies, D-79104 Freiburg, Germany	University of Freiburg; Max Planck Society	Reski, R (corresponding author), Univ Freiburg, Fac Biol, Schaenzlestr 1, D-79104 Freiburg, Germany.	ralf.reski@biologie.uni-freiburg.de; wolfgang.frank@biologie.uni-freiburg.de	Weigel, Detlef/GSJ-0799-2022; Weigel, Detlef/C-1418-2008; Khraiwesh, Basel/G-7509-2015; Weigel, Detlef/AAR-3312-2021; Ossowski, Stephan/E-2139-2011	Weigel, Detlef/0000-0002-2114-7963; Weigel, Detlef/0000-0002-2114-7963; Khraiwesh, Basel/0000-0001-7026-1263; Ossowski, Stephan/0000-0002-7416-9568; Reski, Ralf/0000-0002-5496-6711; Arif, M Asif/0000-0003-3237-7796	Landesstiftung Baden-Wurttemberg [P-LS-RNS/40]; German Federal Ministry of Education and Research [FRISYS 0313921]; Excellence Initiative of the German Federal and State Governments [EXC 294]; European Community [LSHG-CT-2006-037900]; German Academic Exchange Service	Landesstiftung Baden-Wurttemberg; German Federal Ministry of Education and Research(Federal Ministry of Education & Research (BMBF)); Excellence Initiative of the German Federal and State Governments; European Community(European Commission); German Academic Exchange Service(Deutscher Akademischer Austausch Dienst (DAAD))	This work was supported by Landesstiftung Baden-Wurttemberg (P-LS-RNS/40 to D. W., W. F., and R. R.), the German Federal Ministry of Education and Research (FRISYS 0313921 to W. F. and R. R.), the Excellence Initiative of the German Federal and State Governments (EXC 294 to R. R.), the European Community FP6 IP SIROCCO (LSHG-CT-2006-037900 to D. W.), and the German Academic Exchange Service (DAAD to M. A. A.). We thank G. Gierga and R. Haas for technical assistance, K. M. Folta for advice on nuclear runons, and T. Laux, W. R. Hess, R. Baumeister, and P. Beyer for comments on the manuscript.	Arazi T, 2005, PLANT J, V43, P837, DOI 10.1111/j.1365-313X.2005.02499.x; Axtell MJ, 2007, PLANT CELL, V19, P1750, DOI 10.1105/tpc.107.051706; Axtell MJ, 2006, CELL, V127, P565, DOI 10.1016/j.cell.2006.09.032; Bao N, 2004, DEV CELL, V7, P653, DOI 10.1016/j.devcel.2004.10.003; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Bender J, 2004, CURR OPIN PLANT BIOL, V7, P521, DOI 10.1016/j.pbi.2004.07.003; Boyko A, 2008, ENVIRON MOL MUTAGEN, V49, P61, DOI 10.1002/em.20347; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Cao XF, 2002, P NATL ACAD SCI USA, V99, P16491, DOI 10.1073/pnas.162371599; Carthew RW, 2009, CELL, V136, P642, DOI 10.1016/j.cell.2009.01.035; Cokus SJ, 2008, NATURE, V452, P215, DOI 10.1038/nature06745; Doi N, 2003, CURR BIOL, V13, P41, DOI 10.1016/S0960-9822(02)01394-5; Duchaine TF, 2006, CELL, V124, P343, DOI 10.1016/j.cel.2005.11.036; Dunoyer P, 2005, NAT GENET, V37, P1356, DOI 10.1038/ng1675; Dyachenko OV, 2006, BIOCHEMISTRY-MOSCOW+, V71, P461, DOI 10.1134/S000629790604016X; Egener Tanja, 2002, BMC Plant Biology, V2, DOI 10.1186/1471-2229-2-6; Fattash I, 2007, BMC PLANT BIOL, V7, DOI 10.1186/1471-2229-7-13; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Folta KM, 2006, NAT PROTOC, V1, P3094, DOI 10.1038/nprot.2006.471; Frank W, 2005, PLANT BIOLOGY, V7, P220, DOI 10.1055/s-2005-865645; Frank W, 2005, PLANTA, V220, P384, DOI 10.1007/s00425-004-1351-1; Gasciolli V, 2005, CURR BIOL, V15, P1494, DOI 10.1016/j.cub.2005.07.024; Golden TA, 2002, PLANT PHYSIOL, V130, P808, DOI 10.1104/pp.003491; Gonzalez S, 2008, CELL CYCLE, V7, P2601, DOI 10.4161/cc.7.16.6541; Henderson IR, 2008, GENE DEV, V22, P1597, DOI 10.1101/gad.1667808; Henderson IR, 2006, NAT GENET, V38, P721, DOI 10.1038/ng1804; Henderson IR, 2004, DEVELOPMENT, V131, P3829, DOI 10.1242/dev.01294; Herr AJ, 2005, SCIENCE, V308, P118, DOI 10.1126/science.1106910; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; Kanno T, 2005, NAT GENET, V37, P761, DOI 10.1038/ng1580; Khraiwesh B, 2008, PLANT PHYSIOL, V148, P684, DOI 10.1104/pp.108.128025; Kim DH, 2008, P NATL ACAD SCI USA, V105, P16230, DOI 10.1073/pnas.0808830105; Koprivova A, 2003, PLANT BIOLOGY, V5, P582, DOI 10.1055/s-2003-44721; Li LC, 2002, BIOINFORMATICS, V18, P1427, DOI 10.1093/bioinformatics/18.11.1427; Lister R, 2008, CELL, V133, P523, DOI 10.1016/j.cell.2008.03.029; Liu QH, 2003, SCIENCE, V301, P1921, DOI 10.1126/science.1088710; Luo QJ, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000457; MacRae IJ, 2008, P NATL ACAD SCI USA, V105, P512, DOI 10.1073/pnas.0710869105; Matzke M, 2007, CURR OPIN PLANT BIOL, V10, P512, DOI 10.1016/j.pbi.2007.06.007; Mlotshwa S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001755; Moissiard G, 2007, RNA, V13, P1268, DOI 10.1261/rna.541307; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Onodera Y, 2005, CELL, V120, P613, DOI 10.1016/j.cell.2005.02.007; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Park W, 2002, CURR BIOL, V12, P1484, DOI 10.1016/S0960-9822(02)01017-5; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Pontier D, 2005, GENE DEV, V19, P2030, DOI 10.1101/gad.348405; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Richardt S, 2010, PLANT MOL BIOL, V72, P27, DOI 10.1007/s11103-009-9550-6; Ronemus M, 2006, PLANT CELL, V18, P1559, DOI 10.1105/tpc.106.042127; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Strepp R, 1998, P NATL ACAD SCI USA, V95, P4368, DOI 10.1073/pnas.95.8.4368; Tabara H, 2002, CELL, V109, P861, DOI 10.1016/S0092-8674(02)00793-6; Talmor-Neiman M, 2006, PLANT J, V48, P511, DOI 10.1111/j.1365-313X.2006.02895.x; Tomari Y, 2005, GENE DEV, V19, P517, DOI 10.1101/gad.1284105; Tomari Y, 2004, SCIENCE, V306, P1377, DOI 10.1126/science.1102755; Vaistij FE, 2002, PLANT CELL, V14, P857, DOI 10.1105/tpc.010480; Varkonyi-Gasic E, 2007, PLANT METHODS, V3, DOI 10.1186/1746-4811-3-12; Voinnet O, 2009, CELL, V136, P669, DOI 10.1016/j.cell.2009.01.046; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Zilberman D, 2004, CURR BIOL, V14, P1214, DOI 10.1016/j.cub.2004.06.055	62	333	374	1	102	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					111	122		10.1016/j.cell.2009.12.023	http://dx.doi.org/10.1016/j.cell.2009.12.023			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085706	Bronze			2022-12-01	WOS:000273391900019
J	Nomura, DK; Long, JZ; Niessen, S; Hoover, HS; Ng, SW; Cravatt, BF				Nomura, Daniel K.; Long, Jonathan Z.; Niessen, Sherry; Hoover, Heather S.; Ng, Shu-Wing; Cravatt, Benjamin F.			Monoacylglycerol Lipase Regulates a Fatty Acid Network that Promotes Cancer Pathogenesis	CELL			English	Article							ENZYME-ACTIVITY PROFILES; LYSOPHOSPHATIDIC ACID; BREAST-CANCER; MONOGLYCERIDE LIPASE; CELL-PROLIFERATION; TRANSFORMED-CELLS; METABOLISM; PROTEIN; KINASE; GROWTH	Tumor cells display progressive changes in metabolism that correlate with malignancy, including development of a lipogenic phenotype. How stored fats are liberated and remodeled to support cancer pathogenesis, however, remains unknown. Here, we show that the enzyme monoacylglycerol lipase (MAGL) is highly expressed in aggressive human cancer cells and primary tumors, where it regulates a fatty acid network enriched in oncogenic signaling lipids that promotes migration, invasion, survival, and in vivo tumor growth. Overexpression of MAGL in nonaggressive cancer cells recapitulates this fatty acid network and increases their pathogenicity-phenotypes that are reversed by an MAGL inhibitor. Impairments in MAGL-dependent tumor growth are rescued by a high-fat diet, indicating that exogenous sources of fatty acids can contribute to malignancy in cancers lacking MAGL activity. Together, these findings reveal how cancer cells can co-opt a lipolytic enzyme to translate their lipogenic state into an array of protumorigenic signals.	[Nomura, Daniel K.; Long, Jonathan Z.; Cravatt, Benjamin F.] Scripps Res Inst, Skaggs Inst Chem Biol, La Jolla, CA 92037 USA; [Nomura, Daniel K.; Long, Jonathan Z.; Cravatt, Benjamin F.] Scripps Res Inst, Dept Physiol Chem, La Jolla, CA 92037 USA; [Niessen, Sherry; Hoover, Heather S.] Scripps Res Inst, Ctr Physiol Prote, La Jolla, CA 92037 USA; [Ng, Shu-Wing] Harvard Univ, Sch Med, Brigham & Womens Hosp, Lab Gynecol Oncol, Boston, MA 02115 USA	Scripps Research Institute; Scripps Research Institute; Scripps Research Institute; Harvard University; Brigham & Women's Hospital; Harvard Medical School	Cravatt, BF (corresponding author), Scripps Res Inst, Skaggs Inst Chem Biol, 10550 N Torrey Pines Rd, La Jolla, CA 92037 USA.	cravatt@scripps.edu		Long, Jonathan/0000-0003-2631-7463	National Institutes of Health [CA132630, CA087660]; Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE [R37CA087660, R01CA132630, R01CA087660] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Skaggs Institute for Chemical Biology; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank the members of the Cravatt laboratory for helpful discussion and critical reading of the manuscript. In particular, we acknowledge Gabriel M. Simon for assistance with data analysis, Michele K. McKinney, and Jacqueline L. Blankman for technical assistance. This work was supported by the National Institutes of Health (CA132630, CA087660) and the Skaggs Institute for Chemical Biology.	Ahn K, 2008, CHEM REV, V108, P1687, DOI 10.1021/cr0782067; Bektas M, 2005, J CELL BIOL, V169, P801, DOI 10.1083/jcb.200407123; Blankman JL, 2007, CHEM BIOL, V14, P1347, DOI 10.1016/j.chembiol.2007.11.006; Buzzai M, 2005, ONCOGENE, V24, P4165, DOI 10.1038/sj.onc.1208622; Buzzai M, 2007, CANCER RES, V67, P6745, DOI 10.1158/0008-5472.CAN-06-4447; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Chiang KP, 2006, CHEM BIOL, V13, P1041, DOI 10.1016/j.chembiol.2006.08.008; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; De Schrijver E, 2003, CANCER RES, V63, P3799; DeBerardinis RJ, 2008, CURR OPIN GENET DEV, V18, P54, DOI 10.1016/j.gde.2008.02.003; DeBerardinis RJ, 2008, CELL METAB, V7, P11, DOI 10.1016/j.cmet.2007.10.002; DeBerardinis RJ, 2007, P NATL ACAD SCI USA, V104, P19345, DOI 10.1073/pnas.0709747104; DeBerardinis RJ, 2006, J BIOL CHEM, V281, P37372, DOI 10.1074/jbc.M608372200; Dinh TP, 2002, CHEM PHYS LIPIDS, V121, P149, DOI 10.1016/S0009-3084(02)00150-0; Endsley MP, 2007, INT J CANCER, V121, P984, DOI 10.1002/ijc.22761; Fackler OT, 2008, J CELL BIOL, V181, P879, DOI 10.1083/jcb.200802081; Gao XX, 2008, MOL BIOL CELL, V19, P4366, DOI 10.1091/mbc.E08-05-0449; Gatenby RA, 2004, NAT REV CANCER, V4, P891, DOI 10.1038/nrc1478; Gjerstorff MF, 2006, INT J ONCOL, V28, P1327; Gschwind A, 2002, CANCER RES, V62, P6329; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Jessani N, 2005, NAT METHODS, V2, P691, DOI 10.1038/NMETH778; Jessani N, 2004, P NATL ACAD SCI USA, V101, P13756, DOI 10.1073/pnas.0404727101; Jessani N, 2002, P NATL ACAD SCI USA, V99, P10335, DOI 10.1073/pnas.162187599; Jones RG, 2009, GENE DEV, V23, P537, DOI 10.1101/gad.1756509; Kalaany NY, 2009, NATURE, V458, P725, DOI 10.1038/nature07782; Karlsson M, 2001, GENE, V272, P11, DOI 10.1016/S0378-1119(01)00559-5; Kroemer G, 2008, CANCER CELL, V13, P472, DOI 10.1016/j.ccr.2008.05.005; Kuhajda FP, 2000, P NATL ACAD SCI USA, V97, P3450, DOI 10.1073/pnas.050582897; Liu HB, 2004, ANAL CHEM, V76, P4193, DOI 10.1021/ac0498563; Liu Y, 2006, PROSTATE CANCER P D, V9, P230, DOI 10.1038/sj.pcan.4500879; Liu YS, 1999, P NATL ACAD SCI USA, V96, P14694, DOI 10.1073/pnas.96.26.14694; Long JZ, 2009, CHEM BIOL, V16, P744, DOI 10.1016/j.chembiol.2009.05.009; Long JZ, 2009, NAT CHEM BIOL, V5, P37, DOI 10.1038/nchembio.129; Mackie K, 2006, AAPS J, V8, pE298, DOI 10.1007/BF02854900; MARNETT LJ, 1992, CANCER RES, V52, P5575; McGarry JD, 1997, EUR J BIOCHEM, V244, P1, DOI 10.1111/j.1432-1033.1997.00001.x; McMahon B, 2007, PATHOPHYSIOL HAEMO T, V36, P184, DOI 10.1159/000175156; Menendez JA, 2007, NAT REV CANCER, V7, P763, DOI 10.1038/nrc2222; Mills GB, 2003, NAT REV CANCER, V3, P582, DOI 10.1038/nrc1143; Nomura DK, 2008, NAT CHEM BIOL, V4, P373, DOI 10.1038/nchembio.86; Patricelli MP, 2001, PROTEOMICS, V1, P1067, DOI 10.1002/1615-9861(200109)1:9<1067::AID-PROT1067>3.0.CO;2-4; Prentki M, 2008, ENDOCR REV, V29, P647, DOI 10.1210/er.2008-0007; Przybytkowski E, 2007, BIOCHEM CELL BIOL, V85, P301, DOI 10.1139/O07-001; Puustinen P, 2009, CANCER RES, V69, P2870, DOI 10.1158/0008-5472.CAN-08-2760; Ren J, 2006, CANCER RES, V66, P3006, DOI 10.1158/0008-5472.CAN-05-1292; Saghatelian A, 2004, BIOCHEMISTRY-US, V43, P14332, DOI 10.1021/bi0480335; Sarnataro D, 2006, MOL PHARMACOL, V70, P1298, DOI 10.1124/mol.106.025601; Seftor EA, 2002, CLIN EXP METASTAS, V19, P233, DOI 10.1023/A:1015591624171; Smith CA, 2006, ANAL CHEM, V78, P779, DOI 10.1021/ac051437y; Stylli SS, 2008, J CLIN NEUROSCI, V15, P725, DOI 10.1016/j.jocn.2008.03.003; Vazquez-Martin A, 2008, CELL PROLIFERAT, V41, P59, DOI 10.1111/j.1365-2184.2007.00498.x; Wang DZ, 2008, CANCER RES, V68, P6468, DOI 10.1158/0008-5472.CAN-08-0896; WELCH DR, 1991, INT J CANCER, V47, P227, DOI 10.1002/ijc.2910470211; Wise DR, 2008, P NATL ACAD SCI USA, V105, P18782, DOI 10.1073/pnas.0810199105; Yuan TL, 2008, ONCOGENE, V27, P5497, DOI 10.1038/onc.2008.245; Zechner R, 2005, CURR OPIN LIPIDOL, V16, P333, DOI 10.1097/01.mol.0000169354.20395.1c; Zhao Q, 2005, J BIOL CHEM, V280, P26735, DOI 10.1074/jbc.M412828200; Zhou WB, 2007, CANCER RES, V67, P2964, DOI 10.1158/0008-5472.CAN-06-3439; Zunder ER, 2008, CANCER CELL, V14, P180, DOI 10.1016/j.ccr.2008.06.014	61	683	719	4	133	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					49	61		10.1016/j.cell.2009.11.027	http://dx.doi.org/10.1016/j.cell.2009.11.027			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20079333	Green Accepted, Bronze, Green Submitted			2022-12-01	WOS:000273391900014
J	Chow, BY; Han, X; Dobry, AS; Qian, XF; Chuong, AS; Li, MJ; Henninger, MA; Belfort, GM; Lin, YX; Monahan, PE; Boyden, ES				Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Belfort, Gabriel M.; Lin, Yingxi; Monahan, Patrick E.; Boyden, Edward S.			High-performance genetically targetable optical neural silencing by light-driven proton pumps	NATURE			English	Article							IN-VIVO; MILLISECOND-TIMESCALE; CLAMP ANALYSIS; PH-DEPENDENCE; BACTERIORHODOPSIN; NEURONS; HALORHODOPSIN; RHODOPSINS; BRAIN; ARCHAERHODOPSIN	The ability to silence the activity of genetically specified neurons in a temporally precise fashion would provide the opportunity to investigate the causal role of specific cell classes in neural computations, behaviours and pathologies. Here we show that members of the class of light-driven outward proton pumps can mediate powerful, safe, multiple-colour silencing of neural activity. The gene archaerhodopsin-3 (Arch)(1) from Halorubrum sodomense enables near-100% silencing of neurons in the awake brain when virally expressed in the mouse cortex and illuminated with yellow light. Arch mediates currents of several hundred picoamps at low light powers, and supports neural silencing currents approaching 900 pA at light powers easily achievable in vivo. Furthermore, Arch spontaneously recovers from light-dependent inactivation, unlike light-driven chloride pumps that enter long-lasting inactive states in response to light. These properties of Arch are appropriate to mediate the optical silencing of significant brain volumes over behaviourally relevant timescales. Arch function in neurons is well tolerated because pH excursions created by Arch illumination are minimized by self-limiting mechanisms to levels comparable to those mediated by channelrhodopsins(2,3) or natural spike firing. To highlight how proton pump ecological and genomic diversity may support new innovation, we show that the blue-green light-drivable proton pump from the fungus Leptosphaeria maculans(4) (Mac) can, when expressed in neurons, enable neural silencing by blue light, thus enabling alongside other developed reagents the potential for independent silencing of two neural populations by blue versus red light. Light-driven proton pumps thus represent a high-performance and extremely versatile class of 'optogenetic' voltage and ion modulator, which will broadly enable new neuro-scientific, biological, neurological and psychiatric investigations.	[Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Monahan, Patrick E.; Boyden, Edward S.] MIT, Media Lab, Synthet Neurobiol Grp, Cambridge, MA 02139 USA; [Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Monahan, Patrick E.; Boyden, Edward S.] MIT, Dept Biol Engn, Cambridge, MA 02139 USA; [Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Belfort, Gabriel M.; Lin, Yingxi; Monahan, Patrick E.; Boyden, Edward S.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Chow, Brian Y.; Han, Xue; Dobry, Allison S.; Qian, Xiaofeng; Chuong, Amy S.; Li, Mingjie; Henninger, Michael A.; Belfort, Gabriel M.; Lin, Yingxi; Monahan, Patrick E.; Boyden, Edward S.] MIT, McGovern Inst Brain Res, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Boyden, ES (corresponding author), MIT, Media Lab, Synthet Neurobiol Grp, Cambridge, MA 02139 USA.	esb@media.mit.edu		/0000-0002-7002-1275; Li, Mingjie/0000-0001-5337-4901	NIH [DP2 OD002002-01, 1K99MH085944]; NSF [0835878, 0848804]; McGovern Institute Neurotechnology; Department of Defense, NARSAD; Alfred P. Sloan Foundation, Jerry and Marge Burnett; SFN Research Award for Innovation in Neuroscience; MIT Media Lab; Benesse Foundation; Wallace H. Coulter Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH [K99MH085944] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002002] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); McGovern Institute Neurotechnology; Department of Defense, NARSAD(NARSADUnited States Department of Defense); Alfred P. Sloan Foundation, Jerry and Marge Burnett(Alfred P. Sloan Foundation); SFN Research Award for Innovation in Neuroscience; MIT Media Lab; Benesse Foundation; Wallace H. Coulter Foundation; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	E. S. B. acknowledges funding by the NIH Director's New Innovator Award (DP2 OD002002-01), as well as the NSF (0835878 and 0848804), the McGovern Institute Neurotechnology Award Program, the Department of Defense, NARSAD, the Alfred P. Sloan Foundation, Jerry and Marge Burnett, the SFN Research Award for Innovation in Neuroscience, the MIT Media Lab, the Benesse Foundation, and the Wallace H. Coulter Foundation. X. H. acknowledges the Helen Hay Whitney Foundation and NIH 1K99MH085944. The authors thank E. Klinman for help with transfections, R. Desimone for advice, J. Lin for technical aid on intracellular pH measurements, K. Ihara for discussions about archaerhodopsins, and M. Hemann and N. Gershenfeld and the Center for Bits and Atoms for use of their respective laboratory facilities.	Aravanis AM, 2007, J NEURAL ENG, V4, pS143, DOI 10.1088/1741-2560/4/3/S02; BAMBERG E, 1993, P NATL ACAD SCI USA, V90, P639, DOI 10.1073/pnas.90.2.639; BERNSTEIN JG, 2008, P SOC PHOTOOPT INSTR, V6854; Berthold P, 2008, PLANT CELL, V20, P1665, DOI 10.1105/tpc.108.057919; Bevensee MO, 1996, J PHYSIOL-LONDON, V494, P315, DOI 10.1113/jphysiol.1996.sp021494; Boyden ES, 2005, NAT NEUROSCI, V8, P1263, DOI 10.1038/nn1525; Chesler M, 2003, PHYSIOL REV, V83, P1183, DOI 10.1152/physrev.00010.2003; Enamil N, 2006, J MOL BIOL, V358, P675, DOI 10.1016/j.jmb.2006.02.032; Gradinaru V, 2008, BRAIN CELL BIOL, V36, P129, DOI 10.1007/s11068-008-9027-6; Han X, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000299; Han X, 2009, NEURON, V62, P191, DOI 10.1016/j.neuron.2009.03.011; Ihara K, 1999, J MOL BIOL, V285, P163, DOI 10.1006/jmbi.1998.2286; Klare Johann P., 2008, V45, P73, DOI 10.1007/400_2007_041; Lanyi JK, 2006, BBA-BIOENERGETICS, V1757, P1012, DOI 10.1016/j.bbabio.2005.11.003; Leinekugel X, 2002, SCIENCE, V296, P2049, DOI 10.1126/science.1071111; Lin JY, 2009, BIOPHYS J, V96, P1803, DOI 10.1016/j.bpj.2008.11.034; Luecke H, 1999, J MOL BIOL, V291, P899, DOI 10.1006/jmbi.1999.3027; LUKASHEV EP, 1994, PHOTOCHEM PHOTOBIOL, V60, P69, DOI 10.1111/j.1751-1097.1994.tb03945.x; Meyer TM, 2000, NEUROREPORT, V11, P33, DOI 10.1097/00001756-200001170-00007; Ming M, 2006, BIOPHYS J, V90, P3322, DOI 10.1529/biophysj.105.076547; MOGI T, 1989, J BIOL CHEM, V264, P14197; Nagel G, 2003, P NATL ACAD SCI USA, V100, P13940, DOI 10.1073/pnas.1936192100; Narikawa K, 2000, J NEUROPHYSIOL, V84, P2171, DOI 10.1152/jn.2000.84.4.2171; Richter DW, 1996, J NEUROSCI METH, V67, P121, DOI 10.1016/0165-0270(96)00042-8; TATENO M, 1994, ARCH BIOCHEM BIOPHYS, V315, P127, DOI 10.1006/abbi.1994.1480; Trapp S, 1996, J PHYSIOL-LONDON, V496, P695, DOI 10.1113/jphysiol.1996.sp021720; Waschuk SA, 2005, P NATL ACAD SCI USA, V102, P6879, DOI 10.1073/pnas.0409659102; Wehr M, 2003, NATURE, V426, P442, DOI 10.1038/nature02116; Zhang F, 2007, NATURE, V446, P633, DOI 10.1038/nature05744; Zhao SL, 2008, BRAIN CELL BIOL, V36, P141, DOI 10.1007/s11068-008-9034-7	30	805	875	5	207	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					98	102		10.1038/nature08652	http://dx.doi.org/10.1038/nature08652			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054397	Green Accepted, Green Submitted			2022-12-01	WOS:000273344900038
J	Katan, MB; Ludwig, DS				Katan, Martijn B.; Ludwig, David S.			Extra Calories Cause Weight Gain-But How Much?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material									[Katan, Martijn B.] Vrije Univ Amsterdam, Inst Hlth Sci, NL-1081 HV Amsterdam, Netherlands; [Ludwig, David S.] Childrens Hosp, Dept Med, Optimal Weight Life Program, Boston, MA 02115 USA	Vrije Universiteit Amsterdam; Harvard University; Boston Children's Hospital	Katan, MB (corresponding author), Vrije Univ Amsterdam, Inst Hlth Sci, De Boelelaan 1085, NL-1081 HV Amsterdam, Netherlands.	katan99@falw.vu.nl	Katan, Martijn/ABB-6613-2021	Ludwig, David/0000-0003-3307-8544	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K24DK082730] Funding Source: NIH RePORTER; NIDDK NIH HHS [K24DK082730] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Goldsmith R, 2010, AM J PHYSIOL-REG I, V298, pR79, DOI 10.1152/ajpregu.00053.2009; Hall KD, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007940; Hall KD, 2008, AM J CLIN NUTR, V88, P1495, DOI 10.3945/ajcn.2008.26333; Hill JO, 2003, SCIENCE, V299, P853, DOI 10.1126/science.1079857; MCDOWELL MA, 2005, ADV DATA, V361, P1; OGDEN CL, 2004, ADV DATA, V347, P1, DOI DOI 10.1377/HLTHAFF.28.5.W822; Shils ME, 2006, MODERN NUTR HLTH DIS, P982; Swinburn B, 2009, AM J CLIN NUTR, V90, P1453, DOI 10.3945/ajcn.2009.28595; Wang YC, 2006, PEDIATRICS, V118, pE1721, DOI 10.1542/peds.2006-0682; WEINSIER RL, 1993, INT J OBESITY, V17, P693	10	67	68	1	16	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 6	2010	303	1					65	66		10.1001/jama.2009.1912	http://dx.doi.org/10.1001/jama.2009.1912			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539YS	20051571	Green Published			2022-12-01	WOS:000273296900021
J	Nachega, JB; Leisegang, R; Bishai, D; Nguyen, H; Hislop, M; Cleary, S; Regensberg, L; Maartens, G				Nachega, Jean B.; Leisegang, Rory; Bishai, David; Nguyen, Hoang; Hislop, Michael; Cleary, Susan; Regensberg, Leon; Maartens, Gary			Association of Antiretroviral Therapy Adherence and Health Care Costs	ANNALS OF INTERNAL MEDICINE			English	Article							RESOURCE-LIMITED SETTINGS; HIV-INFECTED PATIENTS; PHARMACY RECORDS; VIRAL LOAD; BASE-LINE; 1ST YEAR; RESISTANCE; MORTALITY; SURVIVAL; OUTCOMES	Background: Antiretroviral therapy (ART) adherence predicts HIV disease progression and survival, but its effect on direct health care costs is unclear. Objective: To determine the effect of ART adherence on direct health care costs among adults in a resource-limited setting. Design: Cohort study. Setting: Aid for AIDS, a private-sector disease management program in South Africa. Patients: 6833 HIV-infected adults who started ART between 6 August 2000 and 30 April 2006. Measurements: Monthly direct health care costs authorized by Aid for AIDS were averaged over all months. Pharmacy claim adherence, expressed as a percentage, was categorized into quartiles, from 1 (lowest) to 4 (highest). Effects of covariates on monthly total costs were assessed with a 2-step model with logit for probability of nonzero costs and a generalized linear model (GLM). Results: Total mean monthly costs were $370 (SD, $644). Mean monthly costs of ART were $32 (SD, $18); hospitalizations, $151 (SD, $436); consultations, $76 (SD, $66); investigations, $37 (SD, $50); and non-ART medications, $53 (SD, $180). Total mean monthly costs ranged from $313 (SD, $598) for quartile 4 to $376 (SD, $657) for quartile 1. Hospitalization costs increased from 29% to 51% of total costs as adherence decreased. In the GLM 2-step model, moving from adherence quartile 1 to quartile 2, 3, or 4 increased the probability of having nonzero total monthly costs by 0.078, 0.15, and 0.21 percentage point, respectively (P < 0.001). For patients with nonzero costs, increasing adherence from quartile 1 to quartile 2, 3, or 4 decreased total monthly costs by $70, $133, and $192, respectively (P < 0.001). Moving from adherence quartiles 1 to 4 had the highest decrease in net overall median monthly health care costs (-$85 [interquartile range,-$116 to-$41]). Limitations: Indirect health care costs were not included. Experience may not reflect that of public HIV/AIDS programs. Conclusion: High ART adherence was associated with lower mean monthly direct health care costs, particularly reduced hospitalization costs, in this South African HIV cohort.	Johns Hopkins Bloomberg Sch Publ Hlth, Baltimore, MD USA; Groote Schuur Hosp, Cape Town, South Africa; Univ Cape Town, ZA-7925 Cape Town, South Africa	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; University of Cape Town; University of Cape Town	Nachega, JB (corresponding author), Harvard Univ, Sch Publ Hlth, Ctr Biostat AIDS Res, 651 Huntington Ave,SPH 2 Bldg,Room 437C, Boston, MA 02115 USA.	jnachega@hsph.harvard.edu	Maartens, Gary/S-2788-2019; , David Bishai/GRO-4211-2022; Maartens, Gary/F-3836-2014; Cleary, Susan/AHE-7259-2022	Maartens, Gary/0000-0003-3080-6606; Maartens, Gary/0000-0003-3080-6606; Cleary, Susan/0000-0002-9071-7958; Bishai, David/0000-0003-0714-9062; Nachega, Jean/0000-0002-2862-4443	Division of AIDS, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health [R01 AI 5535901, R01 AI 016137]; Mentored Patient-Oriented Research Career Award [K23 AI068582-01]; European Developing Countries Clinical Trial Partnership Senior Fellowship Award [TA-08-40200-021]; Center for Biostatistics in AIDS Research, Harvard School of Public of Health; Doris Duke Charitable Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI055359, R01AI016137, K23AI068582] Funding Source: NIH RePORTER	Division of AIDS, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); Mentored Patient-Oriented Research Career Award; European Developing Countries Clinical Trial Partnership Senior Fellowship Award; Center for Biostatistics in AIDS Research, Harvard School of Public of Health; Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	By the Division of AIDS, National Institute of Allergy and Infectious Diseases, U. S. National Institutes of Health, grants R01 AI 5535901 and R01 AI 016137 (Drs. Nachega and Maartens) and Mentored Patient-Oriented Research Career Award K23 AI068582-01 (Dr. Nachega); the European Developing Countries Clinical Trial Partnership Senior Fellowship Award, TA-08-40200-021 (Dr. Nachega); the 2009 John McGoldrick Senior Fellowship Award, Center for Biostatistics in AIDS Research, Harvard School of Public of Health (Dr. Nachega); and the Doris Duke Charitable Foundation Operations Research on AIDS Care and Treatment in Africa Award (Dr. Maartens).	Bangsberg DR, 2008, J INFECT DIS, V197, pS272, DOI 10.1086/533415; Bangsberg DR, 2001, AIDS, V15, P1181, DOI 10.1097/00002030-200106150-00015; Bishai D, 2007, AIDS, V21, P1333, DOI 10.1097/QAD.0b013e328137709e; Bisson GP, 2008, PLOS MED, V5, P777, DOI 10.1371/journal.pmed.0050109; Blough DK, 1999, J HEALTH ECON, V18, P153, DOI 10.1016/S0167-6296(98)00032-0; Bodri M, 2006, ANTIVIR THER, V11, P63; Braitstein P, 2006, LANCET, V367, P817, DOI 10.1016/S0140-6736(06)68337-2; Byakika-Tusiime J, 2005, INT J STD AIDS, V16, P38, DOI 10.1258/0956462052932548; Chesney MA, 2006, JAIDS-J ACQ IMM DEF, V43, pS149, DOI 10.1097/01.qai.0000243112.91293.26; Choo PW, 1999, MED CARE, V37, P846, DOI 10.1097/00005650-199909000-00002; Cleary Susan M, 2006, Cost Eff Resour Alloc, V4, P20, DOI 10.1186/1478-7547-4-20; Acurcio FDA, 2006, REV ESP SALUD PUBLIC, V80, P41, DOI [10.1590/S1135-57272006000100005, 10.1590/s1135-57272006000100005]; Egger M., 2007, C RETR OPP INF CROI; Fewell Z, 2004, STATA J, V4, P402, DOI 10.1177/1536867X0400400403; Freedberg KA, 2001, NEW ENGL J MED, V344, P824, DOI 10.1056/NEJM200103153441108; Freedberg KA, 2006, JAIDS-J ACQ IMM DEF, V43, pS113, DOI 10.1097/01.qai.0000248334.52072.25; Gardner EM, 2008, APPL HEALTH ECON HEA, V6, P145, DOI 10.2165/00148365-200806020-00006; Gross R, 2008, HIV CLIN TRIALS, V9, P202, DOI 10.1310/hct0903-202; Gross R, 2006, J INFECT DIS, V194, P1108, DOI 10.1086/507680; Grossberg R, 2004, J CLIN EPIDEMIOL, V57, P1107, DOI 10.1016/j.jclinepi.2004.04.002; Harrigan PR, 2005, J INFECT DIS, V191, P339, DOI 10.1086/427192; Hirsch JD, 2009, J MANAGE CARE PHARM, V15, P32, DOI 10.18553/jmcp.2009.15.1.32; Hogg RS, 2002, AIDS, V16, P1051, DOI 10.1097/00002030-200205030-00012; Huber P. J., 1967, P 5 BERK S MATH STAT, V1, P221; Jones A.M., 2000, HDB HLTH EC, P265; Kilian Reinhold, 2002, J Ment Health Policy Econ, V5, P21; Low-Beer S, 2000, J ACQ IMMUN DEF SYND, V23, P360; Manning WG, 1998, J HEALTH ECON, V17, P283, DOI 10.1016/S0167-6296(98)00025-3; Manning WG, 2005, J HEALTH ECON, V24, P465, DOI 10.1016/j.jhealeco.2004.09.011; Mills E, 2007, LANCET, V370, P1885, DOI 10.1016/S0140-6736(07)61790-5; Mullahy J, 1998, J HEALTH ECON, V17, P247, DOI 10.1016/S0167-6296(98)00030-7; Nachega JB, 2007, ANN INTERN MED, V146, P564, DOI 10.7326/0003-4819-146-8-200704170-00007; Nachega JB, 2006, JAIDS-J ACQ IMM DEF, V43, P78, DOI 10.1097/01.qai.0000225015.43266.46; *OAND CORP, 2009, FXCONVERTER CURR CON; Oyugi JH, 2007, AIDS, V21, P965, DOI 10.1097/QAD.0b013e32802e6bfa; Palella FJ, 1998, NEW ENGL J MED, V338, P853, DOI 10.1056/NEJM199803263381301; Paterson DL, 2000, ANN INTERN MED, V133, P21, DOI 10.7326/0003-4819-133-1-200007040-00004; Purdum AG, 2004, AIDS CARE, V16, P767, DOI 10.1080/09540120412331269602; REGENSBERG L, 2009, AFA CLIN GUIDELINES; *STAT S AFR, 2009, CONS PRIC IND IND; STEINER JF, 1988, MED CARE, V26, P814, DOI 10.1097/00005650-198808000-00007; Steiner JF, 1997, J CLIN EPIDEMIOL, V50, P105, DOI 10.1016/S0895-4356(96)00268-5; Thompson SG, 2000, BRIT MED J, V320, P1197, DOI 10.1136/bmj.320.7243.1197; Walensky RP, 2006, J INFECT DIS, V194, P11, DOI 10.1086/505147; Walensky RP, 2009, ANN INTERN MED, V151, P157, DOI 10.7326/0003-4819-151-3-200908040-00138; Weiser S, 2003, JAIDS-J ACQ IMM DEF, V34, P281, DOI 10.1097/00126334-200311010-00004; WHITE H, 1980, ECONOMETRICA, V48, P817, DOI 10.2307/1912934; Wood E, 2006, AIDS, V20, P1117, DOI 10.1097/01.aids.0000226951.49353.ed	48	49	50	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 5	2010	152	1					18	W5		10.7326/0003-4819-152-1-201001050-00006	http://dx.doi.org/10.7326/0003-4819-152-1-201001050-00006			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	543FJ	20048268				2022-12-01	WOS:000273556600003
J	West, KP; Black, RE				West, Keith P., Jr.; Black, Robert E.			Rajiv Shah at USAID: reviving nutrition for the world's poor	LANCET			English	Editorial Material							INTERVENTIONS		[West, Keith P., Jr.; Black, Robert E.] Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	West, KP (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Ctr Human Nutr, Dept Int Hlth, Baltimore, MD 21205 USA.	kwest@jhsph.edu		Black, Robert/0000-0001-9926-7984				[Anonymous], 2004, CLIN MAN AC DIARRH; [Anonymous], 2008, LANCET, DOI [DOI 10.1016/S0140-6736(07)61693-6, 10.1016/S0140-6736(07)61693-6]; Christian P, 2009, AM J EPIDEMIOL, V170, P1127, DOI 10.1093/aje/kwp253; Dewey KG, 2008, MATERN CHILD NUTR, V4, P24, DOI 10.1111/j.1740-8709.2007.00124.x; FAO, 2014, STAT FOOD AGR; G8 Summi, 2009, CHAIRS SUMM; Horton S., 2008, BEST PRACTICE PAPER; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	14	1	1	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN-FEB	2010	375	9712					355	357		10.1016/S0140-6736(10)60100-6	http://dx.doi.org/10.1016/S0140-6736(10)60100-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	552PK	20113812				2022-12-01	WOS:000274305500008
J	Kapahi, P; Vijg, J				Kapahi, Pankaj; Vijg, Jan			Aging - Lost in Translation?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							EXTENDS LIFE-SPAN; MICE		[Kapahi, Pankaj] Buck Inst Age Res, Novato, CA USA; [Vijg, Jan] Albert Einstein Coll Med, Dept Genet, Bronx, NY 10467 USA	Buck Institute for Research on Aging; Yeshiva University; Albert Einstein College of Medicine	Kapahi, P (corresponding author), Buck Inst Age Res, Novato, CA USA.				NATIONAL INSTITUTE ON AGING [R01AG031337] Funding Source: NIH RePORTER; NIA NIH HHS [R01 AG031337] Funding Source: Medline	NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Anisimov VN, 2008, CELL CYCLE, V7, P2769, DOI 10.4161/cc.7.17.6625; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Selman C, 2009, SCIENCE, V326, P140, DOI 10.1126/science.1177221; Vijg J, 2008, NATURE, V454, P1065, DOI 10.1038/nature07216	4	4	4	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2669	2670		10.1056/NEJMcibr0909815	http://dx.doi.org/10.1056/NEJMcibr0909815			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042759				2022-12-01	WOS:000273181300018
J	Faasse, K; Cundy, T; Petrie, KJ				Faasse, Kate; Cundy, Tim; Petrie, Keith J.			Medicine and the Media Thyroxine: anatomy of a health scare	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									[Faasse, Kate; Petrie, Keith J.] Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand; [Cundy, Tim] Univ Auckland, Dept Med, Auckland, New Zealand	University of Auckland; University of Auckland	Petrie, KJ (corresponding author), Univ Auckland, Dept Psychol Med, Auckland 1, New Zealand.	kj.petrie@auckland.ac.nz		Cundy, Timothy/0000-0003-4890-9400; Faasse, Kate/0000-0003-3073-3718				Page LA, 2006, J PSYCHOSOM RES, V60, P413, DOI 10.1016/j.jpsychores.2005.11.008; Petrie KJ, 2004, BRIT J HEALTH PSYCH, V9, P101, DOI 10.1348/135910704322778759; Saravanan P, 2002, CLIN ENDOCRINOL, V57, P577, DOI 10.1046/j.1365-2265.2002.01654.x	3	43	43	0	7	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	DEC 29	2009	339								b5613	10.1136/bmj.b5613	http://dx.doi.org/10.1136/bmj.b5613			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	539JA	20040484				2022-12-01	WOS:000273249000013
J	Brass, AL; Huang, IC; Benita, Y; John, SP; Krishnan, MN; Feeley, EM; Ryan, BJ; Weyer, JL; van der Weyden, L; Fikrig, E; Adams, DJ; Xavier, RJ; Farzan, M; Elledge, SJ				Brass, Abraham L.; Huang, I-Chueh; Benita, Yair; John, Sinu P.; Krishnan, Manoj N.; Feeley, Eric M.; Ryan, Bethany J.; Weyer, Jessica L.; van der Weyden, Louise; Fikrig, Erol; Adams, David J.; Xavier, Ramnik J.; Farzan, Michael; Elledge, Stephen J.			The IFITM Proteins Mediate Cellular Resistance to Influenza A H1N1 Virus, West Nile Virus, and Dengue Virus	CELL			English	Article							SACCHAROMYCES-CEREVISIAE; RNA INTERFERENCE; GENE FAMILY; CELLS; ENDOCYTOSIS; EXPRESSION; SCREEN; TRANSCRIPTION; COMPLEXES; INFECTION	Influenza viruses exploit host cell machinery to replicate, resulting in epidemics of respiratory illness. In turn, the host expresses antiviral restriction factors to defend against infection. To find host cell modifiers of influenza A H1N1 viral infection, we used a functional genomic screen and identified over 120 influenza A virus-dependency factors with roles in endosomal acidification, vesicular trafficking, mitochondrial metabolism, and RNA splicing. We discovered that the interferon-inducible transmembrane proteins IFITM1, 2, and 3 restrict an early step in influenza A viral replication. The IFITM proteins confer basal resistance to influenza A virus but are also inducible by interferons type I and II and are critical for interferon's virustatic actions. Further characterization revealed that the IFITM proteins inhibit the early replication of flaviviruses, including dengue virus and West Nile virus. Collectively this work identifies a family of antiviral restriction factors that mediate cellular innate immunity to at least three major human pathogens.	[Brass, Abraham L.; John, Sinu P.; Feeley, Eric M.; Ryan, Bethany J.] Massachusetts Gen Hosp, MIT, Ragon Inst, Charlestown, MA 02129 USA; [Brass, Abraham L.; John, Sinu P.; Feeley, Eric M.; Ryan, Bethany J.] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Brass, Abraham L.; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Gastrointestinal Unit, Boston, MA 02114 USA; [Benita, Yair; Xavier, Ramnik J.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Brass, Abraham L.; Elledge, Stephen J.] Harvard Univ, Sch Med, Brigham & Womens Hosp, Howard Hughes Med Inst,Dept Genet,Div Genet, Boston, MA 02115 USA; [Huang, I-Chueh; Weyer, Jessica L.; Farzan, Michael] Harvard Univ, Sch Med, New England Primate Res Ctr, Dept Microbiol & Mol Genet, Southborough, MA 01772 USA; [Krishnan, Manoj N.; Fikrig, Erol] Yale Univ, Sch Med, Dept Internal Med, Infect Dis Sect, New Haven, CT 06520 USA; [Fikrig, Erol] Yale Univ, Sch Med, Howard Hughes Med Inst, New Haven, CT 06520 USA; [van der Weyden, Louise; Adams, David J.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, England	Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Yale University; Howard Hughes Medical Institute; Yale University; Wellcome Trust Sanger Institute	Brass, AL (corresponding author), Massachusetts Gen Hosp, MIT, Ragon Inst, Charlestown, MA 02129 USA.	abrass@partners.org; farzan@hms.harvard.edu; selledge@genetics.med.harvard.edu	van der Weyden, Louise/AAV-5711-2021; Benita, Yair/E-3094-2012; John, Sinu/AAS-2054-2020	van der Weyden, Louise/0000-0002-0645-1879; Farzan, Michael/0000-0002-2990-5319; Feeley, Eric/0000-0003-0910-8758; Adams, David/0000-0001-9490-0306	NIH [AI 50031, AI070343, AI062773, DK060049, DK043351, U54 AI057159]; Cancer Research UK and the Wellcome Trust; Kay Kendall Leukaemia Foundation; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI062773, N01AI050031, U01AI070343, U54AI057159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK043351, P30DK040561, R01DK060049] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Cancer Research UK and the Wellcome Trust; Kay Kendall Leukaemia Foundation; New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank the ICCB-Longwood; C. Shamu, S. Chang, S. Rudnicki, S. Johnston, K. Rudnicki, D. Wrobel, M. Ocana, and Z. Cooper; Ragon Institute; L. Whiteman, K. Hartman, A. Piechocka-Trocha, J. Proudfoot, and T. Diefenbach. We thank J. Philips, A. Mehle, M. Franti, F. Diaz-Griffero, J. Mabry (CDC), and J. Chou for helpful discussions. Funding support: A. L. B. wishes to express his gratitude to the Phillip T. and Susan M. Ragon Foundation for their generous support. A.L.B. (MGH GI Unit, Harvard Center for AIDS Research); M.N.K. and E.F. (NIH grants AI 50031 and AI070343); Y. B. and R.J.X. (CSIBD, CCIB, Genetics and Genomics Core, and NIH grants AI062773, DK060049, and DK043351); I.C.H. and M.F. (NERCE U54 AI057159). D.J.A. is supported by Cancer Research UK and the Wellcome Trust. L.v.d.W. is supported by a fellowship from the Kay Kendall Leukaemia Foundation. This study was supported by the New England Regional Center of Excellence for Biodefense and Emerging Infectious Diseases (NIH grant U54 AI057159 to D. Kasper). S. J. E. and E. F. are Investigators with the Howard Hughes Medical Institute.	Alber D, 1996, J INTERF CYTOK RES, V16, P375, DOI 10.1089/jir.1996.16.375; [Anonymous], ORTHOMYXOVIRIDAE VIR; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2005, NUCLEIC ACIDS RES, V33, pD154, DOI 10.1093/nar/gki070; Behringer R., 2003, MANIPULATING MOUSE E; Boulo S, 2007, VIRUS RES, V124, P12, DOI 10.1016/j.virusres.2006.09.013; BOULOY M, 1978, P NATL ACAD SCI USA, V75, P4886, DOI 10.1073/pnas.75.10.4886; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Cai HQ, 2007, DEV CELL, V12, P671, DOI 10.1016/j.devcel.2007.04.005; Chen C, 2008, P NATL ACAD SCI USA, V105, P11790, DOI 10.1073/pnas.0803711105; EVANS SS, 1993, J IMMUNOL, V150, P736; FRIEDMAN RL, 1984, CELL, V38, P745, DOI 10.1016/0092-8674(84)90270-8; Ge Q, 2003, P NATL ACAD SCI USA, V100, P2718, DOI 10.1073/pnas.0437841100; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Glodowski DR, 2007, MOL BIOL CELL, V18, P4387, DOI 10.1091/mbc.E07-05-0486; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hanna SL, 2005, J VIROL, V79, P13262, DOI 10.1128/JVI.79.21.13262-13274.2005; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hoffhines AJ, 2006, J BIOL CHEM, V281, P37877, DOI 10.1074/jbc.M609398200; Holler O, 2009, REV SCI TECH OIE, V28, P219, DOI 10.20506/rst.28.1.1867; Huang IC, 2008, J VIROL, V82, P4834, DOI 10.1128/JVI.00079-08; Huang IC, 2006, J BIOL CHEM, V281, P3198, DOI 10.1074/jbc.M508381200; IMAI T, 1993, J IMMUNOL, V151, P6470; Kanehisa M, 2004, NUCLEIC ACIDS RES, V32, pD277, DOI 10.1093/nar/gkh063; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krishnan MN, 2007, J VIROL, V81, P4881, DOI 10.1128/JVI.02210-06; Lange U C, 2003, BMC Dev Biol, V3, P1, DOI 10.1186/1471-213X-3-1; Lange UC, 2008, MOL CELL BIOL, V28, P4688, DOI 10.1128/MCB.00272-08; LEWIN AR, 1991, EUR J BIOCHEM, V199, P417, DOI 10.1111/j.1432-1033.1991.tb16139.x; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Martin CSS, 2009, TRENDS MICROBIOL, V17, P514, DOI 10.1016/j.tim.2009.08.002; Massenet S, 1999, MOL CELL BIOL, V19, P2142; Mitchell Joyce A, 2003, AMIA Annu Symp Proc, P460; Moffatt P, 2008, J BONE MINER RES, V23, P1497, DOI 10.1359/JBMR.080412; Monto AS, 2009, CLIN INFECT DIS, V48, pS20, DOI 10.1086/591853; Morriswood B, 2007, J CELL SCI, V120, P2574, DOI 10.1242/jcs.007005; Nakhaei P, 2009, SEMIN IMMUNOL, V21, P215, DOI 10.1016/j.smim.2009.05.001; Sieczkarski SB, 2003, TRAFFIC, V4, P333, DOI 10.1034/j.1600-0854.2003.00090.x; Sieczkarski SB, 2002, J VIROL, V76, P10455, DOI 10.1128/JVI.76.20.10455-10464.2002; SKEHEL JJ, 1995, AM J RESP CRIT CARE, V152, pS13, DOI 10.1164/ajrccm/152.4_Pt_2.S13; Smith RA, 2006, GENES IMMUN, V7, P113, DOI 10.1038/sj.gene.6364278; Stevens SW, 2001, RNA, V7, P1543; Takaoka A, 2006, CELL MICROBIOL, V8, P907, DOI 10.1111/j.1462-5822.2006.00716.x; Vastrik I, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-3-r39; Wheeler DL, 2005, NUCLEIC ACIDS RES, V33, pD39, DOI 10.1093/nar/gki062; Yoshii K, 2009, ARCH VIROL, V154, P573, DOI 10.1007/s00705-009-0345-5	46	912	950	1	90	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1243	1254		10.1016/j.cell.2009.12.017	http://dx.doi.org/10.1016/j.cell.2009.12.017			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064371	Green Accepted, Bronze			2022-12-01	WOS:000273048700013
J	Moreira, LA; Iturbe-Ormaetxe, I; Jeffery, JA; Lu, GJ; Pyke, AT; Hedges, LM; Rocha, BC; Hall-Mendelin, S; Day, A; Riegler, M; Hugo, LE; Johnson, KN; Kay, BH; McGraw, EA; van den Hurk, AF; Ryan, PA; O'Neill, SL				Moreira, Luciano A.; Iturbe-Ormaetxe, Inaki; Jeffery, Jason A.; Lu, Guangjin; Pyke, Alyssa T.; Hedges, Lauren M.; Rocha, Bruno C.; Hall-Mendelin, Sonja; Day, Andrew; Riegler, Markus; Hugo, Leon E.; Johnson, Karyn N.; Kay, Brian H.; McGraw, Elizabeth A.; van den Hurk, Andrew F.; Ryan, Peter A.; O'Neill, Scott L.			A Wolbachia Symbiont in Aedes aegypti Limits Infection with Dengue, Chikungunya, and Plasmodium	CELL			English	Article							MONOCLONAL-ANTIBODIES; STATISTICAL-ANALYSIS; VIRULENT WOLBACHIA; MOSQUITO; CHOLESTEROL; EXPRESSION; DROSOPHILA; PROTEIN; FEVER; PCR	Wolbachia are maternally inherited intracellular bacterial symbionts that are estimated to infect more than 60% of all insect species. While Wolbachia is commonly found in many mosquitoes it is absent from the species that are considered to be of major importance for the transmission of human pathogens. The successful introduction of a life-shortening strain of Wolbachia into the dengue vector Aedes aegypti that halves adult lifespan has recently been reported. Here we show that this same Wolbachia infection also directly inhibits the ability of a range of pathogens to infect this mosquito species. The effect is Wolbachia strain specific and relates to Wolbachia priming of the mosquito innate immune system and potentially competition for limiting cellular resources required for pathogen replication. We suggest that this Wolbachia-mediated pathogen interference may work synergistically with the life-shortening strategy proposed previously to provide a powerful approach for the control of insect transmitted diseases.	[Moreira, Luciano A.; Iturbe-Ormaetxe, Inaki; Hedges, Lauren M.; Riegler, Markus; Johnson, Karyn N.; McGraw, Elizabeth A.; O'Neill, Scott L.] Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia; [Moreira, Luciano A.; Rocha, Bruno C.] Fiocruz MS, Rene Rachou Res Inst, Belo Horizonte, MG, Brazil; [Jeffery, Jason A.; Lu, Guangjin; Hugo, Leon E.; Kay, Brian H.; Ryan, Peter A.] Queensland Inst Med Res, Brisbane, Qld 4029, Australia; [Pyke, Alyssa T.; van den Hurk, Andrew F.] Queensland Hlth Forens Serv, Coopers Plains, Qld 4108, Australia; [Pyke, Alyssa T.; van den Hurk, Andrew F.] Queensland Hlth Sci Serv, Coopers Plains, Qld 4108, Australia; [Hall-Mendelin, Sonja; Day, Andrew; van den Hurk, Andrew F.] Univ Queensland, Sch Chem & Mol Biosci, Brisbane, Qld 4072, Australia	University of Queensland; Fundacao Oswaldo Cruz; QIMR Berghofer Medical Research Institute; Queensland Health; Queensland Health; University of Queensland	O'Neill, SL (corresponding author), Univ Queensland, Sch Biol Sci, Brisbane, Qld 4072, Australia.	scott.oneill@uq.edu.au	O'Neill, Scott/R-9560-2019; van den Hurk, Andrew/X-9831-2019; van den Hurk, Andrew F/G-7992-2012; O'Neill, Scott L/B-3568-2009; Rocha, Bruno C/M-6397-2015; McGraw, Elizabeth/GRF-0434-2022; Johnson, Karyn N/B-7980-2008; Hugo, R. Leon E/O-3013-2018; McGraw, Elizabeth A/A-6658-2012	O'Neill, Scott/0000-0002-4131-3615; van den Hurk, Andrew/0000-0001-6262-831X; O'Neill, Scott L/0000-0002-4131-3615; Rocha, Bruno C/0000-0003-0118-3913; Johnson, Karyn N/0000-0001-8647-8985; Hugo, R. Leon E/0000-0002-6767-9850; McGraw, Elizabeth A/0000-0001-7973-088X; Ryan, Peter/0000-0003-0674-4441; Riegler, Markus/0000-0001-7363-431X; Pyke, Alyssa/0000-0003-3512-4321	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia	Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation; National Health and Medical Research Council, Australia(National Health and Medical Research Council (NHMRC) of Australia)	We are grateful to Nichola Kenny and Wai Yuen Cheah for technical support and Paul Addison and Amy Fong for help with mosquito histology. We are also thankful to Roy Hall and Natalie Prow for providing the anti-dengue and B10 antibodies, Antoniana Krettli for the anti- CSP antibody, and Jose Ribeiro for useful discussions on saliva collection. We are particularly thankful for wild caught mosquito material supplied by Petrina Johnson and Scott Ritchie. We would like to thank FIOCRUZ - Brazil for the support on the malaria experiments. We thank members of the O'Neill and McGraw laboratories for critical reading of the manuscript. This research was supported by a grant from the Foundation for the National Institutes of Health through the Grand Challenges in Global Health Initiative of the Bill and Melinda Gates Foundation and the National Health and Medical Research Council, Australia.	Adams B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006763; Atella GC, 2009, ACTA TROP, V109, P159, DOI 10.1016/j.actatropica.2008.10.004; Barclay E, 2008, LANCET, V371, P973, DOI 10.1016/S0140-6736(08)60435-3; Blitzer EJ, 2005, INSECT MOL BIOL, V14, P301, DOI 10.1111/j.1365-2583.2005.00560.x; Braig HR, 1998, J BACTERIOL, V180, P2373, DOI 10.1128/JB.180.9.2373-2378.1998; Broom AK, 1998, PATHOLOGY, V30, P286, DOI 10.1080/00313029800169456; Brownlie JC, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000368; Brownstin JS, 2003, J INVERTEBR PATHOL, V84, P24, DOI 10.1016/S0022-2011(03)00082-X; Clark DC, 2007, J GEN VIROL, V88, P1175, DOI 10.1099/vir.0.82609-0; COOK PE, 2008, TRANSGENESIS MANAGEM; Cook PE, 2006, P NATL ACAD SCI USA, V103, P18060, DOI 10.1073/pnas.0604875103; DECAMARGO MT, 1978, J PARASITOL, V64, P924, DOI 10.2307/3279533; Dobson SL, 2004, HEREDITY, V93, P135, DOI 10.1038/sj.hdy.6800458; Dobson SL, 1999, INSECT BIOCHEM MOLEC, V29, P153, DOI 10.1016/S0965-1748(98)00119-2; Dutton TJ, 2004, INSECT MOL BIOL, V13, P317, DOI 10.1111/j.0962-1075.2004.00490.x; GENTRY MK, 1982, AM J TROP MED HYG, V31, P548, DOI 10.4269/ajtmh.1982.31.548; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hilgenboecker K, 2008, FEMS MICROBIOL LETT, V281, P215, DOI 10.1111/j.1574-6968.2008.01110.x; Jeyaprakash A, 2000, INSECT MOL BIOL, V9, P393, DOI 10.1046/j.1365-2583.2000.00203.x; Jin CY, 2009, APPL ENVIRON MICROB, V75, P3373, DOI 10.1128/AEM.00207-09; Joehanes R, 2008, BIOINFORMATICS, V24, P2788, DOI 10.1093/bioinformatics/btn523; Kay B, 2005, LANCET, V365, P613, DOI 10.1016/S0140-6736(05)17913-6; Knox TB, 2003, J MED ENTOMOL, V40, P950, DOI 10.1603/0022-2585-40.6.950; Kremer N, 2009, HEREDITY, V103, P248, DOI 10.1038/hdy.2009.63; KRETTLI AU, 1988, PARASITE IMMUNOL, V10, P523, DOI 10.1111/j.1365-3024.1988.tb00240.x; Kyle JL, 2008, ANNU REV MICROBIOL, V62, P71, DOI 10.1146/annurev.micro.62.081307.163005; Lin MQ, 2003, INFECT IMMUN, V71, P5324, DOI 10.1128/IAI.71.9.5324-5331.2003; Lu YPE, 1999, J VIROL, V73, P4272, DOI 10.1128/JVI.73.5.4272-4278.1999; Mackenzie JM, 2007, CELL HOST MICROBE, V2, P229, DOI 10.1016/j.chom.2007.09.003; McMeniman CJ, 2009, SCIENCE, V323, P141, DOI 10.1126/science.1165326; Miller WJ, 2006, APPL ENVIRON MICROB, V72, P826, DOI 10.1128/AEM.72.1.826-835.2006; Min KT, 1997, P NATL ACAD SCI USA, V94, P10792, DOI 10.1073/pnas.94.20.10792; Ng LFP, 2009, MICROBES INFECT, V11, P1163, DOI 10.1016/j.micinf.2009.09.001; ONeill SL, 1997, INFLUENTIAL PASSENGE; Osborne SE, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000656; Pachauri R. K., 2007, CLIMATE CHANGE 2007; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Rasgon JL, 2003, J MED ENTOMOL, V40, P125, DOI 10.1603/0022-2585-40.2.125; Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132; Rodrigues FG, 2008, INSECT MOL BIOL, V17, P175, DOI 10.1111/j.1365-2583.2008.00791.x; RUTLEDGE L. C., 1964, MOSQUITO NEWS, V24, P407; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; Sinkins SP, 2000, INSECT TRANSGENESIS, P271; Staples JE, 2009, CLIN INFECT DIS, V49, P942, DOI 10.1086/605496; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Tsetsarkin KA, 2007, PLOS PATHOG, V3, P1895, DOI 10.1371/journal.ppat.0030201; TURELL MJ, 1988, AM J TROP MED HYG, V39, P597, DOI 10.4269/ajtmh.1988.39.597; VANDENHURK AF, 2009, VECTOR BORNE ZOONOTI; Weeks AR, 2007, PLOS BIOL, V5, P997, DOI 10.1371/journal.pbio.0050114; Woodring Jennifer L., 1996, P51; World Health Organization, 2009, FACT SHEET; Wu M, 2004, PLOS BIOL, V2, P327, DOI 10.1371/journal.pbio.0020069; Xi ZY, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000098; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	56	1055	1098	5	309	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1268	1278		10.1016/j.cell.2009.11.042	http://dx.doi.org/10.1016/j.cell.2009.11.042			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064373	Bronze, Green Published			2022-12-01	WOS:000273048700015
J	Iezzoni, LI; Ronan, LJ				Iezzoni, Lisa I.; Ronan, Laurence J.			Disability Legacy of the Haitian Earthquake	ANNALS OF INTERNAL MEDICINE			English	Editorial Material							AMPUTATION		[Iezzoni, Lisa I.] Massachusetts Gen Hosp, Mongan Inst Hlth Policy, Boston, MA 02114 USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School	Iezzoni, LI (corresponding author), Massachusetts Gen Hosp, Mongan Inst Hlth Policy, 50 Staniford St,Room 901B, Boston, MA 02114 USA.	liezzoni@partners.org						Bigelow J, 2004, DISABIL REHABIL, V26, P246, DOI 10.1080/09638280310001644915; Collins Diane M., 2006, Critical Reviews in Biomedical Engineering, V34, P379, DOI 10.1615/CritRevBiomedEng.v34.i5.20; Cummings D, 1996, PROSTHET ORTHOT INT, V20, P51; Cummings Donald R, 2006, Phys Med Rehabil Clin N Am, V17, P15, DOI 10.1016/j.pmr.2005.10.002; Esquenazi A, 2004, DISABIL REHABIL, V26, P831, DOI 10.1080/09638280410001708850; Iezzoni LI, 2008, JAMA-J AM MED ASSOC, V299, P332, DOI 10.1001/jama.299.3.332; Kirschner KL, 2007, JAMA-J AM MED ASSOC, V297, P1121, DOI 10.1001/jama.297.10.1121; Sontag Deborah, 2010, NY TIMES, pA1; Sullivan SR, 2010, NEW ENGL J MED, V362, DOI 10.1056/NEJMp1000976; *UN OFF COORD HUM, 2010, 25 UN OFF COORD HUM; United Nations Office for the Coordination of Humanitarian Affairs, 2010, 24 UN OFF COORD HUM; Ustun TB, 2003, HEALTH CARE FINANC R, V24, P77; *WHO, 2010, REV UN HUM AFF GLOB; World Health O, 2001, INT CLASS FUNCT DIS	14	27	27	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JUN 15	2010	152	12					812	814		10.7326/0003-4819-152-12-201006150-00234	http://dx.doi.org/10.7326/0003-4819-152-12-201006150-00234			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	611OP	20231547				2022-12-01	WOS:000278827700008
J	Chapman, JA; Kirkness, EF; Simakov, O; Hampson, SE; Mitros, T; Weinmaier, T; Rattei, T; Balasubramanian, PG; Borman, J; Busam, D; Disbennett, K; Pfannkoch, C; Sumin, N; Sutton, GG; Viswanathan, LD; Walenz, B; Goodstein, DM; Hellsten, U; Kawashima, T; Prochnik, SE; Putnam, NH; Shu, SQ; Blumberg, B; Dana, CE; Gee, L; Kibler, DF; Law, L; Lindgens, D; Martinez, DE; Peng, JS; Wigge, PA; Bertulat, B; Guder, C; Nakamura, Y; Ozbek, S; Watanabe, H; Khalturin, K; Hemmrich, G; Franke, A; Augustin, R; Fraune, S; Hayakawa, E; Hayakawa, S; Hirose, M; Hwang, JS; Ikeo, K; Nishimiya-Fujisawa, C; Ogura, A; Takahashi, T; Steinmetz, PRH; Zhang, XM; Aufschnaiter, R; Eder, MK; Gorny, AK; Salvenmoser, W; Heimberg, AM; Wheeler, BM; Peterson, KJ; Boettger, A; Tischler, P; Wolf, A; Gojobori, T; Remington, KA; Strausberg, RL; Venter, JC; Technau, U; Hobmayer, B; Bosch, TCG; Holstein, TW; Fujisawa, T; Bode, HR; David, CN; Rokhsar, DS; Steele, RE				Chapman, Jarrod A.; Kirkness, Ewen F.; Simakov, Oleg; Hampson, Steven E.; Mitros, Therese; Weinmaier, Thomas; Rattei, Thomas; Balasubramanian, Prakash G.; Borman, Jon; Busam, Dana; Disbennett, Kathryn; Pfannkoch, Cynthia; Sumin, Nadezhda; Sutton, Granger G.; Viswanathan, Lakshmi Devi; Walenz, Brian; Goodstein, David M.; Hellsten, Uffe; Kawashima, Takeshi; Prochnik, Simon E.; Putnam, Nicholas H.; Shu, Shengquiang; Blumberg, Bruce; Dana, Catherine E.; Gee, Lydia; Kibler, Dennis F.; Law, Lee; Lindgens, Dirk; Martinez, Daniel E.; Peng, Jisong; Wigge, Philip A.; Bertulat, Bianca; Guder, Corina; Nakamura, Yukio; Ozbek, Suat; Watanabe, Hiroshi; Khalturin, Konstantin; Hemmrich, Georg; Franke, Andre; Augustin, Rene; Fraune, Sebastian; Hayakawa, Eisuke; Hayakawa, Shiho; Hirose, Mamiko; Hwang, Jung Shan; Ikeo, Kazuho; Nishimiya-Fujisawa, Chiemi; Ogura, Atshushi; Takahashi, Toshio; Steinmetz, Patrick R. H.; Zhang, Xiaoming; Aufschnaiter, Roland; Eder, Marie-Kristin; Gorny, Anne-Kathrin; Salvenmoser, Willi; Heimberg, Alysha M.; Wheeler, Benjamin M.; Peterson, Kevin J.; Boettger, Angelika; Tischler, Patrick; Wolf, Alexander; Gojobori, Takashi; Remington, Karin A.; Strausberg, Robert L.; Venter, J. Craig; Technau, Ulrich; Hobmayer, Bert; Bosch, Thomas C. G.; Holstein, Thomas W.; Fujisawa, Toshitaka; Bode, Hans R.; David, Charles N.; Rokhsar, Daniel S.; Steele, Robert E.			The dynamic genome of Hydra	NATURE			English	Article							TYROSINE KINASE; SEA-ANEMONE; STEM-CELLS; GENE; MOLECULES; MAINTENANCE; EXPRESSION; EVOLUTION; ORIGINS; CLUSTER	The freshwater cnidarian Hydra was first described in 1702(1) and has been the object of study for 300 years. Experimental studies of Hydra between 1736 and 1744 culminated in the discovery of asexual reproduction of an animal by budding, the first description of regeneration in an animal, and successful transplantation of tissue between animals(2). Today, Hydra is an important model for studies of axial patterning(3), stem cell biology(4) and regeneration(5). Here we report the genome of Hydra magnipapillata and compare it to the genomes of the anthozoan Nematostella vectensis(6) and other animals. The Hydra genome has been shaped by bursts of transposable element expansion, horizontal gene transfer, trans-splicing, and simplification of gene structure and gene content that parallel simplification of the Hydra life cycle. We also report the sequence of the genome of a novel bacterium stably associated with H. magnipapillata. Comparisons of the Hydra genome to the genomes of other animals shed light on the evolution of epithelia, contractile tissues, developmentally regulated transcription factors, the Spemann-Mangold organizer, pluripotency genes and the neuromuscular junction.	[Blumberg, Bruce; Dana, Catherine E.; Gee, Lydia; Law, Lee; Lindgens, Dirk; Peng, Jisong; Bode, Hans R.; Steele, Robert E.] Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA; [Chapman, Jarrod A.; Goodstein, David M.; Hellsten, Uffe; Prochnik, Simon E.; Putnam, Nicholas H.; Shu, Shengquiang] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Kirkness, Ewen F.; Borman, Jon; Busam, Dana; Disbennett, Kathryn; Pfannkoch, Cynthia; Sumin, Nadezhda; Sutton, Granger G.; Viswanathan, Lakshmi Devi; Walenz, Brian; Remington, Karin A.; Strausberg, Robert L.; Venter, J. Craig] J Craig Venter Inst, Rockville, MD 20850 USA; [Simakov, Oleg; Balasubramanian, Prakash G.; Bertulat, Bianca; Guder, Corina; Nakamura, Yukio; Ozbek, Suat; Watanabe, Hiroshi; Holstein, Thomas W.] Heidelberg Univ, Dept Mol Evolut & Genom, Inst Zool, D-69120 Heidelberg, Germany; [Simakov, Oleg; Mitros, Therese; Kawashima, Takeshi; Putnam, Nicholas H.; Rokhsar, Daniel S.] Univ Calif Berkeley, Dept Mol & Cell Biol, Ctr Integrat Genom, Berkeley, CA 94720 USA; [Hampson, Steven E.; Kibler, Dennis F.] Univ Calif Irvine, Dept Comp Sci, Irvine, CA 92697 USA; [Weinmaier, Thomas; Rattei, Thomas; Tischler, Patrick] Tech Univ Munich, Dept Genome Oriented Bioinformat, D-85354 Freising Weihenstephan, Germany; [Blumberg, Bruce; Gee, Lydia; Law, Lee; Lindgens, Dirk; Peng, Jisong; Bode, Hans R.] Univ Calif Irvine, Dept Dev & Cell Biol, Irvine, CA 92717 USA; [Dana, Catherine E.; Steele, Robert E.] Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92697 USA; [Martinez, Daniel E.] Pomona Coll, Dept Biol, Claremont, CA 91711 USA; [Wigge, Philip A.] Salk Inst Biol Studies, La Jolla, CA 92037 USA; [Khalturin, Konstantin; Hemmrich, Georg; Franke, Andre; Augustin, Rene; Fraune, Sebastian; Bosch, Thomas C. G.] Univ Kiel, Inst Zool, D-24098 Kiel, Germany; [Hayakawa, Eisuke; Hayakawa, Shiho; Hirose, Mamiko; Hwang, Jung Shan; Ikeo, Kazuho; Nishimiya-Fujisawa, Chiemi; Ogura, Atshushi; Gojobori, Takashi; Fujisawa, Toshitaka] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Takahashi, Toshio] Suntory Inst Bioorgan Res, Osaka 6188503, Japan; [Steinmetz, Patrick R. H.; Technau, Ulrich] Univ Vienna, Dept Mol Evolut & Dev, A-1090 Vienna, Austria; [Zhang, Xiaoming] Univ Kansas, Med Ctr, Dept Anat & Cell Biol, Kansas City, KS 66160 USA; [Aufschnaiter, Roland; Eder, Marie-Kristin; Gorny, Anne-Kathrin; Salvenmoser, Willi; Hobmayer, Bert] Univ Innsbruck, Inst Zool, A-6020 Innsbruck, Austria; [Aufschnaiter, Roland; Eder, Marie-Kristin; Gorny, Anne-Kathrin; Salvenmoser, Willi; Hobmayer, Bert] Univ Innsbruck, Ctr Mol Biosci, A-6020 Innsbruck, Austria; [Heimberg, Alysha M.; Peterson, Kevin J.] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA; [Wheeler, Benjamin M.] N Carolina State Univ, Dept Comp Sci, Raleigh, NC 27695 USA; [Boettger, Angelika; Wolf, Alexander; David, Charles N.] Univ Munich, Dept Biol 2, D-82152 Planegg Martinsried, Germany	University of California System; University of California Irvine; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; J. Craig Venter Institute; Ruprecht Karls University Heidelberg; University of California System; University of California Berkeley; University of California System; University of California Irvine; Technical University of Munich; University of California System; University of California Irvine; University of California System; University of California Irvine; Claremont Colleges; Pomona College; Salk Institute; University of Kiel; Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Suntory Holdings Ltd; University of Vienna; University of Kansas; University of Kansas Medical Center; University of Innsbruck; University of Innsbruck; Dartmouth College; University of North Carolina; North Carolina State University; University of Munich	Steele, RE (corresponding author), Univ Calif Irvine, Ctr Dev Biol, Irvine, CA 92717 USA.	dsrokhsar@gmail.com; resteele@uci.edu	Simakov, Oleg/G-4572-2015; Wolf, Alexander/K-2178-2013; Guder, Corina/L-8413-2014; Fraune, Sebastian/B-7970-2010; Watanabe, Hiroshi/GOP-0177-2022; Bertulat, Bianca/F-5330-2012; Simakov, Oleg/AAV-2494-2020; Weinmaier, Thomas/K-5780-2013; Putnam, Nicholas/B-9968-2008; Wigge, Philip/B-3333-2010; Kawashima, Takeshi/M-4510-2015; Bosch, Thomas C. G./D-5218-2011; Hwang, Jung Shan/AAJ-3014-2020; Hemmrich-Stanisak, Georg/D-4319-2012; Franke, Andre/B-2151-2010; Rattei, Thomas/F-1366-2011; Özbek, Suat/D-3701-2014; Wigge, Philip Anthony/ABD-5113-2021	Simakov, Oleg/0000-0002-3585-4511; Guder, Corina/0000-0002-8438-5168; Fraune, Sebastian/0000-0002-6940-9571; Watanabe, Hiroshi/0000-0001-8887-5407; Simakov, Oleg/0000-0002-3585-4511; Weinmaier, Thomas/0000-0002-9552-3220; Putnam, Nicholas/0000-0002-1315-782X; Hwang, Jung Shan/0000-0002-0908-2036; Hemmrich-Stanisak, Georg/0000-0002-2896-4691; Franke, Andre/0000-0003-1530-5811; Rattei, Thomas/0000-0002-0592-7791; Wigge, Philip Anthony/0000-0003-4822-361X; Dana, Catherine/0000-0003-3788-7955; Rokhsar, Daniel/0000-0002-8704-2224; Wolf, Alexander/0000-0003-0649-3363; Goodstein, David/0000-0001-6287-2697; Technau, Ulrich/0000-0003-4472-8258; Holstein, Thomas/0000-0003-0480-4674; Steinmetz, Patrick/0000-0002-3705-2774; Bottger, Angelika/0000-0003-3273-9558; Hayakawa, Eisuke/0000-0003-1054-4266; Shu, Shengqiang/0000-0002-4336-8994; Ozbek, Suat/0000-0003-2569-3942	National Science Foundation [IBN-0120591]; NSF [DEB-0716960]; Austrian Science Fund; Norwegian Research Council; Austrian Science Fund [FWF P16685, FWF P20734]; R. Melmon and the Gordon and Betty Moore Foundation; Office of Science of the US Department of Energy [DE-AC02-05CH11231]; Ministry of Education, Culture, Sports, Science, and Technology of Japan; Deutsche Forschungsgemeinschaft [SFB617-A1, SFB488-A12]; TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [R24RR015088] Funding Source: NIH RePORTER; Austrian Science Fund (FWF) [P 20734, P 21108] Funding Source: researchfish	National Science Foundation(National Science Foundation (NSF)); NSF(National Science Foundation (NSF)); Austrian Science Fund(Austrian Science Fund (FWF)); Norwegian Research Council(Research Council of NorwayEuropean Commission); Austrian Science Fund(Austrian Science Fund (FWF)); R. Melmon and the Gordon and Betty Moore Foundation; Office of Science of the US Department of Energy(United States Department of Energy (DOE)); Ministry of Education, Culture, Sports, Science, and Technology of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); TOYOBO Biotechnology Foundation; Alexander von Humboldt Foundation(Alexander von Humboldt Foundation); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); Austrian Science Fund (FWF)(Austrian Science Fund (FWF))	We are grateful to S. Clifton, R. Wilson and the EST sequencing group at the Genome Sequencing Center at the Washington University School of Medicine for their efforts in generating the Hydra ESTs and to the National Science Foundation for its support of the Hydra EST project (grant number IBN-0120591). Funding for the sequencing of the Hydra genome was provided by the National Human Genome Research Institute. We thank J. Gerhart who, as co-chair of the National Human Genome Research Institute Working Group on Comparative Genome Evolution, advocated sequencing of the Hydra genome. The septate junction electron micrograph in Fig. 3 was provided by G. Rieger. K. J. P. thanks N. Margulis for technical assistance and the NSF for support ( grant number DEB-0716960). U. T. was supported by the Austrian Science Fund and the Norwegian Research Council. B. H. was supported by Austrian Science Fund grants FWF P16685 and FWF P20734. D. S. R. was supported by R. Melmon and the Gordon and Betty Moore Foundation. Work at the US Department of Energy Joint Genome Institute was supported by the Office of Science of the US Department of Energy under Contract No. DE-AC02-05CH11231. T. F. and T. G. were supported by Grants-In-Aid for Scientific Research from the Ministry of Education, Culture, Sports, Science, and Technology of Japan. T. C. G. B. was supported by grants from the Deutsche Forschungsgemeinschaft ( DFG SFB617-A1) and from the DFG Cluster of Excellence programs 'The Future Ocean' and 'Inflammation at Interfaces'. T. W. H. was supported by grants from the Deutsche Forschungsgemeinschaft including SFB488-A12 and the DFG Cluster of Excellence program 'CellNetworks'. Support for H. W. was provided by the TOYOBO Biotechnology Foundation and the Alexander von Humboldt Foundation. Support for A. B., B. B., C. G., C. N. D., H. W., P. G. B., S. O., T. F. (Mercator Professor) and Y. N. was provided by the Deutsche Forschungsgemeinschaft.	Alexopoulos H, 2004, CURR BIOL, V14, pR879, DOI 10.1016/j.cub.2004.09.067; Bode HR, 1984, PATTERN FORMATION PR, V1, P213; Bridge DM, 2000, DEV BIOL, V220, P253, DOI 10.1006/dbio.2000.9653; Broun M, 2005, DEVELOPMENT, V132, P2907, DOI 10.1242/dev.01848; Browne EN, 1909, J EXP ZOOL, V7, P1, DOI 10.1002/jez.1400070102; Butts T, 2008, TRENDS GENET, V24, P259, DOI 10.1016/j.tig.2007.09.006; Chourrout D, 2006, NATURE, V442, P684, DOI 10.1038/nature04863; DAVID CN, 1977, DEV BIOL, V58, P372, DOI 10.1016/0012-1606(77)90098-7; Ding LX, 2004, INT J SYST EVOL MICR, V54, P2223, DOI 10.1099/ijs.0.02975-0; Douris V, 2010, MOL BIOL EVOL, V27, P684, DOI 10.1093/molbev/msp286; Feng B, 2009, CELL STEM CELL, V4, P301, DOI 10.1016/j.stem.2009.03.005; Fraune S, 2007, P NATL ACAD SCI USA, V104, P13146, DOI 10.1073/pnas.0703375104; Grimson A, 2008, NATURE, V455, P1193, DOI 10.1038/nature07415; Hobmayer B, 2000, NATURE, V407, P186, DOI 10.1038/35025063; Holstein TW, 2003, DEV DYNAM, V226, P257, DOI 10.1002/dvdy.10227; Jager M, 2006, MOL PHYLOGENET EVOL, V39, P468, DOI 10.1016/j.ympev.2005.12.005; Lynch M, 2007, NAT REV GENET, V8, P803, DOI 10.1038/nrg2192; Mokady O, 1998, P NATL ACAD SCI USA, V95, P3673, DOI 10.1073/pnas.95.7.3673; Pace JK, 2008, P NATL ACAD SCI USA, V105, P17023, DOI 10.1073/pnas.0806548105; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reidling JC, 2000, J BIOL CHEM, V275, P10323, DOI 10.1074/jbc.275.14.10323; Ryan JF, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000153; Takahashi T, 1997, P NATL ACAD SCI USA, V94, P1241, DOI 10.1073/pnas.94.4.1241; Technau U, 2005, TRENDS GENET, V21, P633, DOI 10.1016/j.tig.2005.09.007; Trembley A., 1744, MEMOIRES SERVIR HIST; van Leeuwenhoek A., 1702, COLLECTED LETT A VAN, VXIV, P169; WESTFALL JA, 1971, J CELL BIOL, V51, P318, DOI 10.1083/jcb.51.1.318; Wittlieb J, 2006, P NATL ACAD SCI USA, V103, P6208, DOI 10.1073/pnas.0510163103; Yen MR, 2007, PROG BIOPHYS MOL BIO, V94, P5, DOI 10.1016/j.pbiomolbio.2007.03.006; Zacharias H, 2004, ZOOLOGY, V107, P219, DOI 10.1016/j.zool.2004.04.005	30	561	585	5	130	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					592	596		10.1038/nature08830	http://dx.doi.org/10.1038/nature08830			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20228792	hybrid, Green Accepted			2022-12-01	WOS:000275974200048
J	Visel, A; Zhu, YW; May, D; Afzal, V; Gong, E; Attanasio, C; Blow, MJ; Cohen, JC; Rubin, EM; Pennacchio, LA				Visel, Axel; Zhu, Yiwen; May, Dalit; Afzal, Veena; Gong, Elaine; Attanasio, Catia; Blow, Matthew J.; Cohen, Jonathan C.; Rubin, Edward M.; Pennacchio, Len A.			Targeted deletion of the 9p21 non-coding coronary artery disease risk interval in mice	NATURE			English	Article							CHROMOSOME 9P21; MYOCARDIAL-INFARCTION; TUMOR SUPPRESSION; HEART-DISEASE; INK4A LOCUS; ASSOCIATION; ATHEROSCLEROSIS; EXPRESSION; HYPERCHOLESTEROLEMIA; SUSCEPTIBILITY	Sequence polymorphisms in a 58-kilobase (kb) interval on chromosome 9p21 confer a markedly increased risk of coronary artery disease (CAD), the leading cause of death worldwide(1,2). The variants have a substantial effect on the epidemiology of CAD and other life-threatening vascular conditions because nearly one-quarter of Caucasians are homozygous for risk alleles. However, the risk interval is devoid of protein-coding genes and the mechanism linking the region to CAD risk has remained enigmatic. Here we show that deletion of the orthologous 70-kb non-coding interval on mouse chromosome 4 affects cardiac expression of neighbouring genes, as well as proliferation properties of vascular cells. Chr4(Delta 70kb/Delta 70kb) mice are viable, but show increased mortality both during development and as adults. Cardiac expression of two genes near the non-coding interval, Cdkn2a and Cdkn2b, is severely reduced in chr4(Delta 70kb/Delta 70kb) mice, indicating that distant-acting gene regulatory functions are located in the non-coding CAD risk interval. Allele-specific expression of Cdkn2b transcripts in heterozygous mice showed that the deletion affects expression through a cis-acting mechanism. Primary cultures of chr4(Delta 70kb/Delta 70kb) aortic smooth muscle cells exhibited excessive proliferation and diminished senescence, a cellular phenotype consistent with accelerated CAD pathogenesis. Taken together, our results provide direct evidence that the CAD risk interval has a pivotal role in regulation of cardiac Cdkn2a/b expression, and suggest that this region affects CAD progression by altering the dynamics of vascular cell proliferation.	[Visel, Axel; Zhu, Yiwen; May, Dalit; Afzal, Veena; Gong, Elaine; Attanasio, Catia; Blow, Matthew J.; Rubin, Edward M.; Pennacchio, Len A.] Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, Berkeley, CA 94720 USA; [Visel, Axel; Blow, Matthew J.; Rubin, Edward M.; Pennacchio, Len A.] Joint Genome Inst, US DOE, Walnut Creek, CA 94598 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dept Mol Genet, Dallas, TX 75390 USA; [Cohen, Jonathan C.] Univ Texas SW Med Ctr Dallas, Ctr Human Nutr, Dallas, TX 75390 USA	United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas	Pennacchio, LA (corresponding author), Univ Calif Berkeley, Lawrence Berkeley Lab, Genom Div, MS 84-171, Berkeley, CA 94720 USA.	LAPennacchio@lbl.gov	attanasio, catia/D-5042-2017; Visel, Axel/A-9398-2009; Blow, Matthew/G-6369-2012	attanasio, catia/0000-0001-8077-5719; Visel, Axel/0000-0002-4130-7784; Blow, Matthew/0000-0002-8844-9149; Pennacchio, Len/0000-0002-8748-3732	National Heart, Lung, and Blood Institute; EMBO; Department of Energy, University of California [DE-AC02-05CH11231]; MMPC [DK59630]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL066681, R21HL098940, R01HL082896] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003988] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U2CDK059630, U24DK059630] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); EMBO(European Molecular Biology Organization (EMBO)); Department of Energy, University of California(United States Department of Energy (DOE)University of California System); MMPC; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank G. Owens for critical suggestions and discussion, T. Ley for providing vector pTURBO-Cre, and D. Lee for help with plasma lipid analysis. L. A. P., E. M. R. and J.C.C. were supported by the National Heart, Lung, and Blood Institute, D. M. and C. A. by EMBO long-term fellowships and L. A. P. by the National Human Genome Research Institute. Research was conducted at the E.O. Lawrence Berkeley National Laboratory and performed under Department of Energy Contract DE-AC02-05CH11231, University of California. Plasma lipid analysis at the University of Cincinnati Mouse Metabolic Phenotyping Center was supported by MMPC DK59630. All animal work was reviewed and approved by the LBNL Animal Welfare and Research Committee.	Besson A, 2004, NAT REV CANCER, V4, P948, DOI 10.1038/nrc1501; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Diez-Juan A, 2001, FASEB J, V15, P1989, DOI 10.1096/fj.01-0130com; DIMRI GP, 1995, P NATL ACAD SCI USA, V92, P9363, DOI 10.1073/pnas.92.20.9363; Gizard F, 2005, J CLIN INVEST, V115, P3228, DOI 10.1172/JCI22756; Gonzalez P, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-5; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Hinohara K, 2008, J HUM GENET, V53, P357, DOI 10.1007/s10038-008-0248-4; Jarinova O, 2009, ARTERIOSCL THROM VAS, V29, P1671, DOI 10.1161/ATVBAHA.109.189522; Kamijo T, 1997, CELL, V91, P649, DOI 10.1016/S0092-8674(00)80452-3; Karolchik D, 2008, NUCLEIC ACIDS RES, V36, pD773, DOI 10.1093/nar/gkm966; Latres E, 2000, EMBO J, V19, P3496, DOI 10.1093/emboj/19.13.3496; Lemmens R, 2009, EUR J HUM GENET, V17, P1287, DOI 10.1038/ejhg.2009.42; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; Lloyd-Jones D, 2009, CIRCULATION, V119, pE21, DOI 10.1161/CIRCULATIONAHA.108.191261; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; PAIGEN B, 1985, ATHEROSCLEROSIS, V57, P65, DOI 10.1016/0021-9150(85)90138-8; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; PLUMP AS, 1992, CELL, V71, P343, DOI 10.1016/0092-8674(92)90362-G; Rodriguez I, 2007, CELL CYCLE, V6, P620, DOI 10.4161/cc.6.5.3927; Schunkert H, 2008, CIRCULATION, V117, P1675, DOI 10.1161/CIRCULATIONAHA.107.730614; Serrano M, 1996, CELL, V85, P27, DOI 10.1016/S0092-8674(00)81079-X; Sharpless NE, 2004, ONCOGENE, V23, P379, DOI 10.1038/sj.onc.1207074; Shen GQ, 2008, J HUM GENET, V53, P144, DOI 10.1007/s10038-007-0230-6; Topol EJ, 2006, HUM MOL GENET, V15, pR117, DOI 10.1093/hmg/ddl183; Ueda Y, 2000, J BIOL CHEM, V275, P20368, DOI 10.1074/jbc.M000730200; Yoshida T, 2008, CIRC RES, V102, P1548, DOI 10.1161/CIRCRESAHA.108.176974; ZHANG SH, 1992, SCIENCE, V258, P468, DOI 10.1126/science.1411543; Zhou L, 2008, ARTERIOSCL THROM VAS, V28, P2085, DOI 10.1161/ATVBAHA.108.176065	31	348	360	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					409	U103		10.1038/nature08801	http://dx.doi.org/10.1038/nature08801			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20173736	Green Submitted, Green Accepted			2022-12-01	WOS:000275657100046
J	Clutton-Brock, T; Sheldon, BC				Clutton-Brock, Tim; Sheldon, Ben C.			The Seven Ages of Pan	SCIENCE			English	Editorial Material							POPULATIONS; CHIMPANZEES; FITNESS		[Clutton-Brock, Tim] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England; [Sheldon, Ben C.] Univ Oxford, Dept Zool, Edward Grey Inst, Oxford OX1 3PS, England	University of Cambridge; University of Oxford	Clutton-Brock, T (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.	thcb@cam.ac.uk; ben.sheldon@zoo.ox.ac.uk	Hood, Sean David/H-5058-2014; Shrivastava, Prani/AAU-8347-2020; Sheldon, Ben C/A-8056-2010	Hood, Sean David/0000-0003-2852-7923; Sheldon, Ben C/0000-0002-5240-7828				Charmantier A, 2008, SCIENCE, V320, P800, DOI 10.1126/science.1157174; Charpentier MJE, 2008, P NATL ACAD SCI USA, V105, P1988, DOI 10.1073/pnas.0711219105; Ellegren H, 2008, NATURE, V452, P169, DOI 10.1038/nature06737; Goodall J., 1986, CHIMPANZEES GOMBE PA; Goodall J., 1968, ANIM BEHAV MONOGR, V1, P165; Harcourt AH, 2007, GORILLA SOC; Jones OR, 2008, J ANIM ECOL, V77, P612, DOI 10.1111/j.1365-2656.2008.01382.x; Kluijver H. N., 1951, Ardea, V39, P1; KOYAMA N, 1992, PRIMATES, V33, P33, DOI 10.1007/BF02382761; Kruuk LEB, 2008, ANNU REV ECOL EVOL S, V39, P525, DOI 10.1146/annurev.ecolsys.39.110707.173542; Lopez-Vaamonde C, 2009, J EVOLUTION BIOL, V22, P983, DOI 10.1111/j.1420-9101.2009.01706.x; Nishida T, 2003, AM J PRIMATOL, V59, P99, DOI 10.1002/ajp.10068; Pusey AE, 2007, CONSERV BIOL, V21, P623, DOI 10.1111/j.1523-1739.2007.00704.x; Thompson ME, 2007, CURR BIOL, V17, P2150, DOI 10.1016/j.cub.2007.11.033; Wroblewski EE, 2009, ANIM BEHAV, V77, P873, DOI 10.1016/j.anbehav.2008.12.014; [No title captured]	16	31	32	1	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 5	2010	327	5970					1207	1208		10.1126/science.1187796	http://dx.doi.org/10.1126/science.1187796			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203037				2022-12-01	WOS:000275162100023
J	Greer, PL; Hanayama, R; Bloodgood, BL; Mardinly, AR; Lipton, DM; Flavell, SW; Kim, TK; Griffith, EC; Waldon, Z; Maehr, R; Ploegh, HL; Chowdhury, S; Worley, PF; Steen, J; Greenberg, ME				Greer, Paul L.; Hanayama, Rikinari; Bloodgood, Brenda L.; Mardinly, Alan R.; Lipton, David M.; Flavell, Steven W.; Kim, Tae-Kyung; Griffith, Eric C.; Waldon, Zachary; Maehr, Rene; Ploegh, Hidde L.; Chowdhury, Shoaib; Worley, Paul F.; Steen, Judith; Greenberg, Michael E.			The Angelman Syndrome Protein Ube3A Regulates Synapse Development by Ubiquitinating Arc	CELL			English	Article							FRAGILE-X-SYNDROME; ACTIVITY-DEPENDENT REGULATION; MENTAL-RETARDATION; E6-ASSOCIATED PROTEIN; RECEPTOR TRAFFICKING; BDNF TRANSCRIPTION; AMPA RECEPTORS; MOUSE MODEL; GENE; PHOSPHORYLATION	Angelman Syndrome is a debilitating neurological disorder caused by mutation of the E3 ubiquitin ligase Ube3A, a gene whose mutation has also recently been associated with autism spectrum disorders (ASDs). The function of Ube3A during nervous system development and how Ube3A mutations give rise to cognitive impairment in individuals with Angleman Syndrome and ASDs are not clear. We report here that experience-driven neuronal activity induces Ube3A transcription and that Ube3A then regulates excitatory synapse development by controlling the degradation of Arc, a synaptic protein that promotes the internalization of the AMPA subtype of glutamate receptors. We find that disruption of Ube3A function in neurons leads to an increase in Arc expression and a concomitant decrease in the number of AMPA receptors at excitatory synapses. We propose that this deregulation of AMPA receptor expression at synapses may contribute to the cognitive dysfunction that occurs in Angelman Syndrome and possibly other ASDs.	[Greer, Paul L.; Hanayama, Rikinari; Bloodgood, Brenda L.; Mardinly, Alan R.; Lipton, David M.; Flavell, Steven W.; Kim, Tae-Kyung; Griffith, Eric C.; Greenberg, Michael E.] Harvard Univ, Sch Med, Dept Neurobiol, Boston, MA 02115 USA; [Greer, Paul L.] Harvard Univ, Sch Med, Program Biol & Biomed Sci, Boston, MA 02115 USA; [Chowdhury, Shoaib; Worley, Paul F.] Johns Hopkins Univ, Sch Med, Dept Neurosci, Baltimore, MD 21205 USA; [Maehr, Rene; Ploegh, Hidde L.] Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Waldon, Zachary; Steen, Judith] Childrens Hosp, FM Kirby Neurobiol Ctr, Boston, MA 02115 USA; [Waldon, Zachary; Steen, Judith] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Johns Hopkins University; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital	Greenberg, ME (corresponding author), Harvard Univ, Sch Med, Dept Neurobiol, 220 Longwood Ave, Boston, MA 02115 USA.	meg@hms.harvard.edu	Hanayama, Rikinari/AAO-4959-2021; Kim, Tae-Kyung/AAX-4230-2020; Hanayama, Rikinari/D-2940-2011	Hanayama, Rikinari/0000-0003-2102-3386; Kim, Tae-Kyung/0000-0001-5161-9864; Mardinly, Alan/0000-0001-9891-6719; Flavell, Steven/0000-0001-9464-1877; Bloodgood, Brenda/0000-0002-4797-9119; Griffith, Eric/0000-0003-0428-3215	National Science Foundation; Human Frontier Science Program Fellowship; National Institute of Mental Health [MH53608]; AS Foundation; National Institutes of Health [NS28829]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH053608] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS028829, R37NS028829] Funding Source: NIH RePORTER	National Science Foundation(National Science Foundation (NSF)); Human Frontier Science Program Fellowship(Human Frontier Science Program); National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); AS Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank S. Margolis for sharing unpublished results and C. Chen, J. Zieg, and S. Cohen for helpful discussions; J. Zieg for assistance with figure making; K. Condon and M. Ehlers for their generous advice on culturing Ube3A knockout neurons; R. Greenberg for assistance with enriched environment experiments; and E. Bennechi for sectioning array tomography ribbons. This research was supported by a National Science Foundation predoctoral fellowship (P.L.G), a Human Frontier Science Program Fellowship (R.H.), a grant from the National Institute of Mental Health (MH53608 to P.F.W), an AS Foundation grant during the initial stages of this work, and a National Institutes of Health grant (NS28829) (M.E.G).	Albrecht U, 1997, NAT GENET, V17, P75, DOI 10.1038/ng0997-75; Chen WG, 2003, SCIENCE, V302, P885, DOI 10.1126/science.1086446; Chowdhury S, 2006, NEURON, V52, P445, DOI 10.1016/j.neuron.2006.08.033; Clayton-Smith J, 2003, J MED GENET, V40, P87, DOI 10.1136/jmg.40.2.87; Cook EH, 1997, AM J HUM GENET, V60, P928; Cooper EM, 2004, J BIOL CHEM, V279, P41208, DOI 10.1074/jbc.M401302200; Dolen G, 2008, J PHYSIOL-LONDON, V586, P1503, DOI 10.1113/jphysiol.2008.150722; Dolen G, 2007, NEURON, V56, P955, DOI 10.1016/j.neuron.2007.12.001; Engert JC, 2000, NAT GENET, V24, P120, DOI 10.1038/72769; Flavell SW, 2008, NEURON, V60, P1022, DOI 10.1016/j.neuron.2008.11.029; Flavell SW, 2006, SCIENCE, V311, P1008, DOI 10.1126/science.1122511; Gilfillan GD, 2008, AM J HUM GENET, V82, P1003, DOI 10.1016/j.ajhg.2008.01.013; Glessner JT, 2009, NATURE, V459, P569, DOI 10.1038/nature07953; Greer PL, 2008, NEURON, V59, P846, DOI 10.1016/j.neuron.2008.09.002; Jiang YH, 1998, NEURON, V21, P799, DOI 10.1016/S0896-6273(00)80596-6; Kamionka M, 2004, PROTEIN SCI, V13, P2370, DOI 10.1110/ps.04824304; Kessels HW, 2009, NEURON, V61, P340, DOI 10.1016/j.neuron.2009.01.015; Kishino T, 1997, NAT GENET, V15, P70, DOI 10.1038/ng0197-70; Kumar S, 1999, J BIOL CHEM, V274, P18785, DOI 10.1074/jbc.274.26.18785; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Man HY, 2007, P NATL ACAD SCI USA, V104, P3579, DOI 10.1073/pnas.0611698104; Matsuura T, 1997, NAT GENET, V15, P74, DOI 10.1038/ng0197-74; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Miura K, 2002, NEUROBIOL DIS, V9, P149, DOI 10.1006/nbdi.2001.0463; Morrow EM, 2008, SCIENCE, V321, P218, DOI 10.1126/science.1157657; Nakamoto M, 2007, P NATL ACAD SCI USA, V104, P15537, DOI 10.1073/pnas.0707484104; Newpher TM, 2008, NEURON, V58, P472, DOI 10.1016/j.neuron.2008.04.030; Paradis S, 2007, NEURON, V53, P217, DOI 10.1016/j.neuron.2006.12.012; Park S, 2008, NEURON, V59, P70, DOI 10.1016/j.neuron.2008.05.023; Rose J, 2009, NEURON, V61, P351, DOI 10.1016/j.neuron.2008.12.030; Ryu KY, 2007, EMBO J, V26, P2693, DOI 10.1038/sj.emboj.7601722; SCHEFFNER M, 1993, CELL, V75, P495, DOI 10.1016/0092-8674(93)90384-3; Sharfe N, 2003, J IMMUNOL, V170, P6024, DOI 10.4049/jimmunol.170.12.6024; Shepherd JD, 2006, NEURON, V52, P475, DOI 10.1016/j.neuron.2006.08.034; Sutcliffe JS, 2003, J AM ACAD CHILD PSY, V42, P253, DOI 10.1097/00004583-200302000-00021; van Woerden GM, 2007, NAT NEUROSCI, V10, P280, DOI 10.1038/nn1845; Verde EMR, 2006, NEURON, V52, P461, DOI 10.1016/j.neuron.2006.09.031; Williams CA, 2006, AM J MED GENET A, V140A, P413, DOI 10.1002/ajmg.a.31074; Yan QJ, 2005, NEUROPHARMACOLOGY, V49, P1053, DOI 10.1016/j.neuropharm.2005.06.004; Yashiro K, 2009, NAT NEUROSCI, V12, P777, DOI 10.1038/nn.2327; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037	41	428	447	2	56	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					704	716		10.1016/j.cell.2010.01.026	http://dx.doi.org/10.1016/j.cell.2010.01.026			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211139	Green Submitted, Green Accepted, Bronze			2022-12-01	WOS:000275197400019
J	Jha, P; Kumar, R; Khera, A; Bhattacharya, M; Arora, P; Gajalakshmi, V; Bhatia, P; Kam, D; Bassani, DG; Sullivan, A; Suraweera, W; McLaughlin, C; Dhingra, N; Nagelkerke, N				Jha, Prabhat; Kumar, Rajesh; Khera, Ajay; Bhattacharya, Madhulekha; Arora, Paul; Gajalakshmi, Vendhan; Bhatia, Prakash; Kam, Derek; Bassani, Diego G.; Sullivan, Ashleigh; Suraweera, Wilson; McLaughlin, Catherine; Dhingra, Neeraj; Nagelkerke, Nico		Million Death Study Collaborators	HIV mortality and infection in India: estimates from nationally representative mortality survey of 1.1 million homes	BMJ-BRITISH MEDICAL JOURNAL			English	Article							TUBERCULOSIS PATIENTS; DEATHS; DISEASES; SMOKING; ADULTS	Objective To determine the rates of death and infection from HIV in India. Design Nationally representative survey of deaths. Setting 1.1 million homes in India. Population 123 000 deaths at all ages from 2001 to 2003. Main outcome measures HIV mortality and infection. Results HIV accounted for 8.1% (99% confidence interval 5.0% to 11.2%) of all deaths among adults aged 25-34 years. In this age group, about 40% of deaths from HIV were due to AIDS, 26% were due to tuberculosis, and the rest were attributable to other causes. Nationally, HIV infection accounted for about 100 000 ( 59 000 to 140 000) deaths or 3.2% (1.9% to 4.6%) of all deaths among people aged 15-59 years. Deaths from HIV were concentrated in the states and districts with higher HIV prevalence and in men. The mortality results imply an HIV prevalence at age 15-49 years of 0.26% (0.13% to 0.39%) in 2004, comparable to results from a 2005/6 household survey that tested for HIV (0.28%). Collectively, these data suggest that India had about 1.4-1.6 million HIV infected adults aged 15-49 years in 2004-6, about 40% lower than the official estimate of 2.3 million for 2006. All cause mortality increased in men aged 25-34 years between 1997 and 2002 in the states with higher HIV prevalence but declined after that. HIV prevalence in young pregnant women, a proxy measure of incidence in the general population, fell between 2000 and 2007. Thus, HIV mortality and prevalence may have fallen further since our study. Conclusion HIV attributable death and infection in India is substantial, although it is lower than previously estimated.	[Jha, Prabhat; Arora, Paul; Kam, Derek; Bassani, Diego G.; Sullivan, Ashleigh; Nagelkerke, Nico] Univ Toronto, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst, St Michaels Hosp,Dalla Lana Sch Publ Hlth, Toronto, ON M5C 1N8, Canada; [Kumar, Rajesh] Postgrad Inst Med Educ & Res, Sch Publ Hlth, Chandigarh 160012, India; [Khera, Ajay; Dhingra, Neeraj] Govt India, Natl AIDS Control Org, Minist Hlth & Family Welf, New Delhi 110001, India; [Bhattacharya, Madhulekha] Natl Inst Hlth & Family Welfare, New Delhi 110067, India; [Gajalakshmi, Vendhan] Epidemiol Res Ctr, Chennai 600010, Tamil Nadu, India; [Bhatia, Prakash] Osmania Med Coll & Hosp, Hyderabad, Andhra Pradesh, India; [Nagelkerke, Nico] United Arab Emirates Univ, Dept Community Med, Al Ain, U Arab Emirates	University of Toronto; Li Ka Shing Knowledge Institute; University Toronto Affiliates; Saint Michaels Hospital Toronto; Post Graduate Institute of Medical Education & Research (PGIMER), Chandigarh; Indian Council of Medical Research (ICMR); ICMR - National Institute of Epidemiology (NIE); United Arab Emirates University	Jha, P (corresponding author), Univ Toronto, Ctr Global Hlth Res, Li Ka Shing Knowledge Inst, St Michaels Hosp,Dalla Lana Sch Publ Hlth, Toronto, ON M5C 1N8, Canada.	prabhat.jha@utoronto.ca	Bassani, Diego/G-2827-2015; Bhattacharya, Madhulekha/ABU-4692-2022; Suraweera, Wilson MG/O-8962-2014	Bassani, Diego/0000-0001-6704-3820; Suraweera, Wilson/0000-0001-9673-5746; K T, Shenoy/0000-0002-2826-6869; Pednekar, Mangesh/0000-0001-6266-5356; Shenoy, KT/0000-0001-8751-7456	US National Institutes of Health [R01 TW05991-01]; Canadian Institute of Health Research (CIHR) [IEG-53506]; International Research Development Centre [102172]; Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto; Canada research chair program; CIHR Banting and Best Canada; FOGARTY INTERNATIONAL CENTER [R01TW005991] Funding Source: NIH RePORTER	US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Canadian Institute of Health Research (CIHR)(Canadian Institutes of Health Research (CIHR)); International Research Development Centre; Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto; Canada research chair program(Canada Research Chairs); CIHR Banting and Best Canada(Canadian Institutes of Health Research (CIHR)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC))	External funding is from the Fogarty International Centre of the US National Institutes of Health ( grant R01 TW05991-01), Canadian Institute of Health Research (CIHR; IEG-53506), International Research Development Centre ( grant 102172), and Li Ka Shing Knowledge Institute and Keenan Research Centre at St Michael's Hospital, University of Toronto (unrestricted CGHR support). PJ is supported by the Canada research chair program. PA is supported by supported by a CIHR Banting and Best Canada graduate scholarship. The funding sources had no role in the design or conduct of the study, or in the collection, analysis, or interpretation of the data. PJ had full access to all the data and had final responsibility for the decision to submit for publication.	Arora P, 2008, LANCET, V372, P289, DOI 10.1016/S0140-6736(08)61105-8; Berke Olaf, 2004, Int J Health Geogr, V3, P18, DOI 10.1186/1476-072X-3-18; Bernabe-Ortiz A, 2008, REV CHIL INFECTOL, V25, P104, DOI /S0716-10182008000300002; Bhat PNM, 2002, POP STUD-J DEMOG, V56, P119, DOI 10.1080/00324720215930; Bhattacharya M, 2008, Indian J Public Health, V52, P21; Bhore AV, 2003, INT J STD AIDS, V14, P37, DOI 10.1258/095646203321043246; Boerma JT, 2003, LANCET, V362, P1929, DOI 10.1016/S0140-6736(03)14967-7; Boerma JT, 1998, AIDS, V12, pS3; Chacko S, 1995, J Assoc Physicians India, V43, P535; Dandona L, 2008, INT J EPIDEMIOL, V37, P1274, DOI 10.1093/ije/dyn161; *DEP EC SOC AFF UN, 2008, DEM YB 2006; Duarte EC, 2009, J EPIDEMIOL COMMUN H, V63, P233, DOI 10.1136/jech.2008.078972; Gajalakshmi V, 2003, LANCET, V362, P507, DOI 10.1016/S0140-6736(03)14109-8; Gajalakshmi V, 2002, BMC PUBLIC HEALTH, V2, DOI 10.1186/1471-2458-2-7; Hira SK, 2003, NATL MED J INDIA, V16, P126; Hira SK, 1999, LANCET, V354, P1175, DOI 10.1016/S0140-6736(99)03718-6; *IIPS ORC MACR, 2006, NAT FAM HLTH SURV 3; Jha P, 2006, PLOS MED, V3, P191, DOI 10.1371/journal.pmed.0030018; Jha P, 2002, NATL MED J INDIA, V15, P32; JHA P, 2001, SCIENCE, V13, P292; JHA P, 2008, COMMONWEALTH HLTH MI; Jha P, 2008, NEW ENGL J MED, V358, P1137, DOI 10.1056/NEJMsa0707719; Joshi R, 2006, INT J EPIDEMIOL, V35, P1522, DOI 10.1093/ije/dyl168; Kingkaew N, 2009, INT J INFECT DIS, V13, P722, DOI 10.1016/j.ijid.2008.11.013; Konde-Lule J K, 1995, Health Transit Rev, V5 Suppl, P27; Kumar R, 2006, Indian J Public Health, V50, P90; Kumar R, 2006, LANCET, V367, P1164, DOI 10.1016/S0140-6736(06)68435-3; KUMAR R, 2005, NATL COMMISSION MACR, P58; KUMARASAMY N, 2009, INT J INFECT DI 0724; Lopman BA, 2006, PLOS MED, V3, P1273, DOI 10.1371/journal.pmed.0030312; Mathers C, 2008, GLOBAL BURDEN OF DISEASE: 2004 UPDATE, P1; *NACO, 2006, NAT BEH SURV SURV 20; *NACO, 2006, ANN REP 2006; *NACO, 2001, NAT BAS HIGH RISK BR; *NACO, 2007, ART TREATM REP; *NACO MIN HLTH FAM, 2007, LAB MAN TECHN ICTCS; *NACO NAT I HLTH F, 2007, ANN HIV SENT SURV 20; *NACO NIMS, 2006, TECHN REP IND HIV ES; *NACO NIMS, 2007, TECHN REP IND HIV ES; Pandey A, 2009, INDIAN J MED RES, V129, P50; Raizada N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002970; *REG GEN IND, 2005, MED CERT CAUS DEATH; *REG GEN IND, 2005, SAMPL REG SYST STAT; Registrar General of India and Center for Global Health Research, 2009, CAUS DEATH IND 2001; Rothman K. J., 2008, MODERN EPIDEMIOLOGY; Sharma SK, 2005, INDIAN J MED RES, V121, P550; Sinha DN, 2006, TECHNICAL DOCUMENT V; SIVANANDAN V, 2004, ASSESSMENT COMPLETEN; Sobhani R, 2007, INDIAN J MED RES, V126, P116; Swaminathan S, 2008, J BIOSCIENCES, V33, P527, DOI 10.1007/s12038-008-0071-2; Todd J, 1997, AIDS, V11, P801, DOI 10.1097/00002030-199706000-00013; Todd J, 2007, AIDS, V21, pS55, DOI 10.1097/01.aids.0000299411.75269.e8; *UNAIDS, 2008, 2008 REP GLOB AIDS E; *UNAIDS WHO WORK G, 2003, UNAIDS0349E WHO WORK; Venkataramana CBS, 2001, TROP MED INT HEALTH, V6, P1040, DOI 10.1046/j.1365-3156.2001.00814.x; Williams BG, 2005, P NATL ACAD SCI USA, V102, P9619, DOI 10.1073/pnas.0501615102	56	34	34	0	2	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 23	2010	340								c621	10.1136/bmj.c621	http://dx.doi.org/10.1136/bmj.c621			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TF	20179131	Green Published, hybrid			2022-12-01	WOS:000275001100018
J	Halic, M; Moazed, D				Halic, Mario; Moazed, Danesh			Dicer-Independent Primal RNAs Trigger RNAi and Heterochromatin Formation	CELL			English	Article							FISSION YEAST CENTROMERES; C-ELEGANS; HISTONE H3; SIRNA GENERATION; IN-VITRO; INTERFERENCE; RITS; COMPLEX; POLYMERASE; CHROMODOMAIN	Assembly of fission yeast pericentromeric heterochromatin and generation of small interfering RNAs (siRNAs) from noncoding centromeric transcripts are mutually dependent processes. How this interdependent positive feedback loop is first triggered is a fundamental unanswered question. Here, we show that two distinct Argonaute (Ago1)-dependent pathways mediate small RNA generation. RNA-dependent RNA polymerase complex (RDRC) and Dicer act on specific noncoding RNAs to generate siRNAs by a mechanism that requires the slicer activity of Ago1 but is independent of pre-existing heterochromatin. In the absence of RDRC or Dicer, a distinct class of small RNAs, called primal small RNAs (priRNAs), associates with Ago1. priRNAs are degradation products of abundant transcripts, which bind to Ago1 and target antisense transcripts that result from bidirectional transcription of DNA repeats. Our results suggest that a transcriptome surveillance mechanism based on random association of RNA degradation products with Argonaute triggers siRNA amplification and heterochromatin assembly within DNA repeats.	[Halic, Mario; Moazed, Danesh] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Moazed, Danesh] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Howard Hughes Medical Institute	Moazed, D (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	danesh@hms.harvard.edu	Halic, Mario/X-2163-2018		EMBO; National Institutes of Health [GM72805]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072805, R01GM061641] Funding Source: NIH RePORTER	EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of the Moazed lab for helpful discussions, Aaron Johnson, Daniel Holoch, Geng Li, and Silvija Bilokapic for comments on the manuscript, and Serafin Colmenares for the observation that Rdp1 overexpression suppresses the requirement for Cid12. This work was supported by an EMBO long-term fellowship to M. H. and a grant from the National Institutes of Health to D. M. (GM72805). D. M. is a Howard Hughes Medical Institute investigator.	Aoki K, 2007, EMBO J, V26, P5007, DOI 10.1038/sj.emboj.7601910; Aravin AA, 2007, SCIENCE, V318, P761, DOI 10.1126/science.1146484; Baulcombe D, 2004, NATURE, V431, P356, DOI 10.1038/nature02874; Buhler M, 2008, NAT STRUCT MOL BIOL, V15, P1015, DOI 10.1038/nsmb.1481; Buhler M, 2007, CELL, V129, P707, DOI 10.1016/j.cell.2007.03.038; Buhler M, 2006, CELL, V125, P873, DOI 10.1016/j.cell.2006.04.025; Buker SM, 2007, NAT STRUCT MOL BIOL, V14, P200, DOI 10.1038/nsmb1211; Cam HP, 2005, NAT GENET, V37, P809, DOI 10.1038/ng1602; Chen CCG, 2005, CURR BIOL, V15, P378, DOI 10.1016/j.cub.2005.01.009; Colmenares SU, 2007, MOL CELL, V27, P449, DOI 10.1016/j.molcel.2007.07.007; DeBeauchamp JL, 2008, MOL CELL BIOL, V28, P2154, DOI 10.1128/MCB.01637-07; Farazi TA, 2008, DEVELOPMENT, V135, P1201, DOI 10.1242/dev.005629; Ghildiyal M, 2009, NAT REV GENET, V10, P94, DOI 10.1038/nrg2504; Gullerova M, 2008, CELL, V132, P983, DOI 10.1016/j.cell.2008.02.040; Hammond SM, 2000, NATURE, V404, P293, DOI 10.1038/35005107; Hannon GJ, 2002, NATURE, V418, P244, DOI 10.1038/418244a; Henderson IR, 2007, NATURE, V447, P418, DOI 10.1038/nature05917; Huang J, 2003, GENE DEV, V17, P2162, DOI 10.1101/gad.1108403; Hutvagner G, 2008, NAT REV MOL CELL BIO, V9, P22, DOI 10.1038/nrm2321; Iida T, 2006, CURR BIOL, V16, P1459, DOI 10.1016/j.cub.2006.05.061; Lee SR, 2009, RNA, V15, P1363, DOI 10.1261/rna.1630309; Maroney PA, 2008, NAT PROTOC, V3, P279, DOI 10.1038/nprot.2007.530; Mello CC, 2004, NATURE, V431, P338, DOI 10.1038/nature02872; Moazed D, 2009, NATURE, V457, P413, DOI 10.1038/nature07756; Motamedi MR, 2008, MOL CELL, V32, P778, DOI 10.1016/j.molcel.2008.10.026; Motamedi MR, 2004, CELL, V119, P789, DOI 10.1016/j.cell.2004.11.034; Noma K, 2004, NAT GENET, V36, P1174, DOI 10.1038/ng1452; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Partridge JF, 2002, CURR BIOL, V12, P1652, DOI 10.1016/S0960-9822(02)01177-6; Sadaie M, 2004, EMBO J, V23, P3825, DOI 10.1038/sj.emboj.7600401; Schalch T, 2009, MOL CELL, V34, P36, DOI 10.1016/j.molcel.2009.02.024; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; Smardon A, 2000, CURR BIOL, V10, P169, DOI 10.1016/S0960-9822(00)00323-7; Tomari Y, 2004, CELL, V116, P831, DOI 10.1016/S0092-8674(04)00218-1; Trombetta ES, 2005, ANNU REV IMMUNOL, V23, P975, DOI 10.1146/annurev.immunol.22.012703.104538; Verdel A, 2004, SCIENCE, V303, P672, DOI 10.1126/science.1093686; Volpe TA, 2002, SCIENCE, V297, P1833, DOI 10.1126/science.1074973; Wang SW, 2008, MOL CELL BIOL, V28, P656, DOI 10.1128/MCB.01531-07; Wang YL, 2008, NATURE, V456, P209, DOI 10.1038/nature07315	40	133	142	0	26	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					504	516		10.1016/j.cell.2010.01.019	http://dx.doi.org/10.1016/j.cell.2010.01.019			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178743	Green Accepted, Bronze			2022-12-01	WOS:000274668400014
J	Hemmelgarn, BR; Manns, BJ; Lloyd, A; James, MT; Klarenbach, S; Quinn, RR; Wiebe, N; Tonelli, M				Hemmelgarn, Brenda R.; Manns, Braden J.; Lloyd, Anita; James, Matthew T.; Klarenbach, Scott; Quinn, Robert R.; Wiebe, Natasha; Tonelli, Marcello		Alberta Kidney Disease Network	Relation Between Kidney Function, Proteinuria, and Adverse Outcomes	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GLOMERULAR-FILTRATION-RATE; ADMINISTRATIVE DATA; CARDIOVASCULAR EVENTS; RENAL-INSUFFICIENCY; DISEASE; PREVALENCE; DEATH; MICROALBUMINURIA; POPULATION; EQUATION	Context The current staging system for chronic kidney disease is based primarily on estimated glomerular filtration rate (eGFR) with lower eGFR associated with higher risk of adverse outcomes. Although proteinuria is also associated with adverse outcomes, it is not used to refine risk estimates of adverse events in this current system. Objective To determine the association between reduced GFR, proteinuria, and adverse clinical outcomes. Design, Setting, and Participants Community-based cohort study with participants identified from a province-wide laboratory registry that includes eGFR and proteinuria measurements from Alberta, Canada, between 2002 and 2007. There were 920 985 adults who had at least 1 outpatient serum creatinine measurement and who did not require renal replacement treatment at baseline. Proteinuria was assessed by urine dipstick or albumin-creatinine ratio (ACR). Main Outcome Measures All-cause mortality, myocardial infarction, and progression to kidney failure. Results The majority of individuals (89.1%) had an eGFR of 60 mL/min/1.73 m(2) or greater. Over median follow-up of 35 months ( range, 0-59 months), 27 959 participants (3.0%) died. The fully adjusted rate of all-cause mortality was higher in study participants with lower eGFRs or heavier proteinuria. Adjusted mortality rates were more than 2-fold higher among individuals with heavy proteinuria measured by urine dipstick and eGFR of 60 mL/min/1.73 m(2) or greater, as compared with those with eGFR of 45 to 59.9 mL/min/1.73 m(2) and normal protein excretion (rate, 7.2 [95% CI, 6.6-7.8] vs 2.9 [95% CI, 2.7-3.0] per 1000 person-years, respectively; rate ratio, 2.5 [95% CI, 2.3-2.7]). Similar results were observed when proteinuria was measured by ACR (15.9 [ 95% CI, 14.0-18.1] and 7.0 [95% CI, 6.4-7.6] per 1000 person-years for heavy and absent proteinuria, respectively; rate ratio, 2.3 [95% CI, 2.0-2.6]) and for the outcomes of hospitalization with acute myocardial infarction, end-stage renal disease, and doubling of serum creatinine level. Conclusion The risks of mortality, myocardial infarction, and progression to kidney failure associated with a given level of eGFR are independently increased in patients with higher levels of proteinuria. JAMA. 2010;303(5):423-429 www.jama.com	[Hemmelgarn, Brenda R.; Manns, Braden J.; James, Matthew T.; Quinn, Robert R.] Foothills Med Ctr, Div Nephrol, Calgary, AB T2N 2T9, Canada; [Hemmelgarn, Brenda R.; Manns, Braden J.; James, Matthew T.; Quinn, Robert R.] Univ Calgary, Dept Med, Calgary, AB, Canada; [Hemmelgarn, Brenda R.; Manns, Braden J.; James, Matthew T.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB, Canada; [Lloyd, Anita; Klarenbach, Scott; Wiebe, Natasha; Tonelli, Marcello] Univ Alberta, Dept Med, Edmonton, AB, Canada; [Klarenbach, Scott; Tonelli, Marcello] Univ Alberta, Dept Publ Hlth Sci, Edmonton, AB, Canada	University of Calgary; University of Calgary; University of Calgary; University of Alberta; University of Alberta	Hemmelgarn, BR (corresponding author), Foothills Med Ctr, Div Nephrol, 1403 29th St NW, Calgary, AB T2N 2T9, Canada.	brenda.hemmelgarn@albertahealthservices.ca	Wiebe, Natasha/V-7803-2019; Manns, Braden J/I-8942-2012; Quinn, Robert R/E-7017-2011; Tonelli, Marcello/B-3028-2009; Hug, Balthasar L./G-1568-2010; Hemmelgarn, Brenda R./I-6894-2012	Wiebe, Natasha/0000-0002-5613-1582; Tonelli, Marcello/0000-0002-0846-3187; 	Alberta Heritage Foundation for Medical Research (AHFMR); Canadian Institutes of Health Research; Alberta Health and Wellness and the Universities of Alberta and Calgary; KRESCENT	Alberta Heritage Foundation for Medical Research (AHFMR)(Alberta Heritage Foundation for Medical Research); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Alberta Health and Wellness and the Universities of Alberta and Calgary; KRESCENT	Drs Hemmelgarn, Tonelli, and Klarenbach were supported by awards from the Alberta Heritage Foundation for Medical Research (AHFMR). Drs Hemmelgarn, Manns, and Tonelli were also supported by awards from the Canadian Institutes of Health Research. Drs Hemmelgarn, Manns, Klarenbach, and Tonelli were supported by a joint initiative between Alberta Health and Wellness and the Universities of Alberta and Calgary. Dr James was supported by a KRESCENT and AHFMR Fellowship. This work was supported by a grant from the AHFMR Interdisciplinary Team Grants Program to Drs Hemmelgarn, Manns, and Tonelli.	Akbari A, 2004, ARCH INTERN MED, V164, P1788, DOI 10.1001/archinte.164.16.1788; *ALB HLTH WELLN, PREM ASS PROGR PREM; Altman DG., 1990, PRACTICAL STAT MED R, DOI DOI 10.1201/9780429258589; [Anonymous], 2002, AM J KIDNEY DIS S1, V39, pS1; Austin PC, 2002, AM HEART J, V144, P290, DOI 10.1067/mhj.2002.123839; Chen MLW, 2003, AM J KIDNEY DIS, V42, P623, DOI 10.1016/S0272-6386(03)00870-9; CIAVARELLA A, 1989, DIABETES RES CLIN PR, V7, P307, DOI 10.1016/0168-8227(89)90020-X; Coca SG, 2009, AM J KIDNEY DIS, V53, P961, DOI 10.1053/j.ajkd.2008.11.034; Coresh J, 2007, JAMA-J AM MED ASSOC, V298, P2038, DOI 10.1001/jama.298.17.2038; FEEST TG, 1993, BMJ-BRIT MED J, V306, P481, DOI 10.1136/bmj.306.6876.481; Garg AX, 2002, KIDNEY INT, V61, P2165, DOI 10.1046/j.1523-1755.2002.00356.x; Go AS, 2004, NEW ENGL J MED, V351, P1296, DOI 10.1056/NEJMoa041031; Hemmelgarn BR, 2009, BMC NEPHROL, V10, DOI 10.1186/1471-2369-10-30; Hillege HL, 2002, CIRCULATION, V106, P1777, DOI 10.1161/01.CIR.0000031732.78052.81; Hossain MP, 2009, AM J KIDNEY DIS, V53, P166, DOI 10.1053/j.ajkd.2007.10.047; Hsu C, 2000, AM J KIDNEY DIS, V36, P415, DOI 10.1053/ajkd.2000.8996; Hux JE, 2002, DIABETES CARE, V25, P512, DOI 10.2337/diacare.25.3.512; Klausen K, 2004, CIRCULATION, V110, P32, DOI 10.1161/01.CIR.0000133312.96477.48; Lamb EJ, 2009, ANN CLIN BIOCHEM, V46, P205, DOI 10.1258/acb.2009.009007; Levey AS, 2009, ANN INTERN MED, V150, P604, DOI 10.7326/0003-4819-150-9-200905050-00006; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Mann JFE, 2001, ANN INTERN MED, V134, P629, DOI 10.7326/0003-4819-134-8-200104170-00007; Manns BJ, 2001, CLIN INVEST MED, V24, P164; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Quan HD, 2009, HYPERTENSION, V54, P1423, DOI 10.1161/HYPERTENSIONAHA.109.139279; Shlipak MG, 2005, NEW ENGL J MED, V352, P2049, DOI 10.1056/NEJMoa043161; Sin DD, 2003, CHEST, V124, P51, DOI 10.1378/chest.124.1.51; Statistics Canada, ETHN PORTR CAN HIGHL	28	729	760	1	49	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					423	429		10.1001/jama.2010.39	http://dx.doi.org/10.1001/jama.2010.39			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124537	Bronze			2022-12-01	WOS:000274143600017
J	Greenhalgh, T				Greenhalgh, Trisha			GMC Wakefield Verdict Why did the Lancet take so long?	BRITISH MEDICAL JOURNAL			English	Editorial Material									UCL, London WC1E 6BT, England	University of London; University College London	Greenhalgh, T (corresponding author), UCL, London WC1E 6BT, England.	p.greenhalgh@pcps.ucl.ac.uk	Greenhalgh, Trisha/B-1825-2015	Greenhalgh, Trisha/0000-0003-2369-8088				Chen RT, 1998, LANCET, V351, P611, DOI 10.1016/S0140-6736(05)78423-3; Horton R, 2004, LANCET, V363, P747, DOI 10.1016/S0140-6736(04)15714-0; Murch SH, 2004, LANCET, V363, P750, DOI 10.1016/S0140-6736(04)15715-2; Wakefield AJ, 1998, LANCET, V351, P637, DOI 10.1016/S0140-6736(97)11096-0	4	3	3	0	7	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 2	2010	340								c644	10.1136/bmj.c644	http://dx.doi.org/10.1136/bmj.c644			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553CU	20124363				2022-12-01	WOS:000274343400041
J	Steen, EJ; Kang, YS; Bokinsky, G; Hu, ZH; Schirmer, A; McClure, A; del Cardayre, SB; Keasling, JD				Steen, Eric J.; Kang, Yisheng; Bokinsky, Gregory; Hu, Zhihao; Schirmer, Andreas; McClure, Amy; del Cardayre, Stephen B.; Keasling, Jay D.			Microbial production of fatty-acid-derived fuels and chemicals from plant biomass	NATURE			English	Article							ESCHERICHIA-COLI; ACYL-COENZYME; BIODIESEL; ETHANOL; IDENTIFICATION; BIOSYNTHESIS; REDUCTASE; BIOFUELS; GENES; CDNA	Increasing energy costs and environmental concerns have emphasized the need to produce sustainable renewable fuels and chemicals(1). Major efforts to this end are focused on the microbial production of high-energy fuels by cost-effective 'consolidated bioprocesses'(2). Fatty acids are composed of long alkyl chains and represent nature's 'petroleum', being a primary metabolite used by cells for both chemical and energy storage functions. These energy-rich molecules are today isolated from plant and animal oils for a diverse set of products ranging from fuels to oleochemicals. A more scalable, controllable and economic route to this important class of chemicals would be through the microbial conversion of renewable feedstocks, such as biomass-derived carbohydrates. Here we demonstrate the engineering of Escherichia coli to produce structurally tailored fatty esters (biodiesel), fatty alcohols, and waxes directly from simple sugars. Furthermore, we show engineering of the biodiesel-producing cells to express hemi-cellulases, a step towards producing these compounds directly from hemicellulose, a major component of plant-derived biomass.	[Steen, Eric J.; Kang, Yisheng; Bokinsky, Gregory; Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA; [Steen, Eric J.; Keasling, Jay D.] Synthet Biol Engn Res Ctr, Emeryville, CA 94608 USA; [Steen, Eric J.; Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Kang, Yisheng; Bokinsky, Gregory; Keasling, Jay D.] Univ Calif Berkeley, Inst QB3, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Hu, Zhihao; Schirmer, Andreas; McClure, Amy; del Cardayre, Stephen B.] LS9 Inc, San Francisco, CA 94080 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA	United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley	Keasling, JD (corresponding author), Joint BioEnergy Inst, 5885 Hollis Ave, Emeryville, CA 94608 USA.	delc@ls9.com; keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088	Tien Scholar Environmental Fellowship; Synthetic Biology Engineering Research Center (SynBERC); LS9, Inc. (South San Francisco, California) through the University of California	Tien Scholar Environmental Fellowship; Synthetic Biology Engineering Research Center (SynBERC); LS9, Inc. (South San Francisco, California) through the University of California	E.J.S. was supported by the Tien Scholar Environmental Fellowship and the Synthetic Biology Engineering Research Center (SynBERC). Y.K. and G. B. were supported by a grant from LS9, Inc. (South San Francisco, California) through the University of California Discovery Grant program. This research was performed at the Joint BioEnergy Institute. We thank M. Rude with help on the manuscript and J. Cronan and the LS9 Scientific Advisory Board for technical insight and discussion.	Adelsberger H, 2004, MICROBIOL-SGM, V150, P2257, DOI 10.1099/mic.0.27066-0; Aldai N, 2006, J CHROMATOGR A, V1110, P133, DOI 10.1016/j.chroma.2006.01.049; Atsumi S, 2008, NATURE, V451, P86, DOI 10.1038/nature06450; Cheng JB, 2004, J BIOL CHEM, V279, P37789, DOI 10.1074/jbc.M406225200; CHO HS, 1995, J BIOL CHEM, V270, P4216, DOI 10.1074/jbc.270.9.4216; Datsenko KA, 2000, P NATL ACAD SCI USA, V97, P6640, DOI 10.1073/pnas.120163297; Dehesh K, 1996, PLANT J, V9, P167, DOI 10.1046/j.1365-313X.1996.09020167.x; Fortman JL, 2008, TRENDS BIOTECHNOL, V26, P375, DOI 10.1016/j.tibtech.2008.03.008; Hill J, 2006, P NATL ACAD SCI USA, V103, P11206, DOI 10.1073/pnas.0604600103; Hoover DM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e43; INGRAM LO, 1987, APPL ENVIRON MICROB, V53, P2420, DOI 10.1128/AEM.53.10.2420-2425.1987; International Energy Agency, 2008, OIL MARK REP; JIANG P, 1994, J BACTERIOL, V176, P2814, DOI 10.1128/JB.176.10.2814-2821.1994; Kalscheuer R, 2006, MICROBIOL-SGM, V152, P2529, DOI 10.1099/mic.0.29028-0; Knothe G, 2008, ENERG FUEL, V22, P1358, DOI 10.1021/ef700639e; Li MZ, 2007, NAT METHODS, V4, P251, DOI 10.1038/NMETH1010; Link AJ, 1997, J BACTERIOL, V179, P6228, DOI 10.1128/jb.179.20.6228-6237.1997; Lu XF, 2008, METAB ENG, V10, P333, DOI 10.1016/j.ymben.2008.08.006; Lynd LR, 2005, CURR OPIN BIOTECH, V16, P577, DOI 10.1016/j.copbio.2005.08.009; MAGNUSON K, 1993, MICROBIOL REV, V57, P522, DOI 10.1128/MMBR.57.3.522-542.1993; Metz JG, 2000, PLANT PHYSIOL, V122, P635, DOI 10.1104/pp.122.3.635; Qian ZG, 2008, BIOTECHNOL BIOENG, V101, P587, DOI 10.1002/bit.21898; Reiser S, 1997, J BACTERIOL, V179, P2969, DOI 10.1128/jb.179.9.2969-2975.1997; Rude MA, 2009, CURR OPIN MICROBIOL, V12, P274, DOI 10.1016/j.mib.2009.04.004; Rupilius W., 2006, PALM OIL DEV, V44, P15; Sambrook J., 1989, MOL CLONING LAB MANU; Steen EJ, 2008, MICROB CELL FACT, V7, DOI 10.1186/1475-2859-7-36; Tsuruta H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004489; WHITEHEAD TR, 1990, J BACTERIOL, V172, P2408, DOI 10.1128/jb.172.5.2408-2412.1990	29	986	1106	9	796	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					559	U182		10.1038/nature08721	http://dx.doi.org/10.1038/nature08721			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20111002				2022-12-01	WOS:000273981100055
J	Lichtenberger, BM; Tan, PK; Niederleithner, H; Ferrara, N; Petzelbauer, P; Sibilia, M				Lichtenberger, Beate M.; Tan, Poi Kiang; Niederleithner, Heide; Ferrara, Napoleone; Petzelbauer, Peter; Sibilia, Maria			Autocrine VEGF Signaling Synergizes with EGFR in Tumor Cells to Promote Epithelial Cancer Development	CELL			English	Article							ENDOTHELIAL-GROWTH-FACTOR; FACTOR RECEPTOR; TYROSINE KINASE; EPIDERMAL-KERATINOCYTES; SKIN CARCINOGENESIS; THERAPEUTIC TARGET; ANTITUMOR EFFICACY; COLON-CANCER; LUNG-CANCER; INHIBITOR	It is established that tumor cell-derived VEGF acts on endothelial cells to promote angiogenesis and tumor growth. Here, we demonstrate that in K5-SOS-dependent mouse skin tumors, autocrine VEGF is required for tumor cell proliferation in a cell-autonomous and angiogenesis-independent manner. VEGF is upregulated in SOS-expressing tumors, and its deletion in epidermal cells delays tumorigenesis by suppressing angiogenesis and tumor cell proliferation. Epidermis-specific Flt1 deletion also impairs tumorigenesis and proliferation. Surprisingly, complete tumor inhibition occurs in the absence of VEGF in EGFR mutant mice, demonstrating that VEGFR and EGFR synergize in neoplastic cells to promote tumor growth. Mechanistically, K5-SOS upregulates VEGF, Flt1, and Neuropilin-1 in an Erk-dependent manner, thereby activating an autocrine proliferation loop, whereas EGFR prevents tumor cells from apoptosis. Moreover, Flt1 is upregulated in human SCC, and its inhibition in SCC cells impairs proliferation. Thus, in addition to regulating angiogenesis, VEGF has to be considered as a potent growth factor for epidermal tumors.	[Lichtenberger, Beate M.; Tan, Poi Kiang; Sibilia, Maria] Med Univ Vienna, Dept Med 1, Inst Canc Res, A-1090 Vienna, Austria; [Niederleithner, Heide; Petzelbauer, Peter] Med Univ Vienna, Div Gen Dermatol, Dept Dermatol, A-1090 Vienna, Austria; [Ferrara, Napoleone] Genentech Inc, San Francisco, CA 94080 USA	Medical University of Vienna; Medical University of Vienna; Roche Holding; Genentech	Sibilia, M (corresponding author), Med Univ Vienna, Dept Med 1, Inst Canc Res, Borschkegasse 8A, A-1090 Vienna, Austria.	maria.sibilia@meduniwien.ac.at	Lichtenberger, Beate M./AAD-1717-2019; petzelbauer, peter/GLU-3941-2022	Lichtenberger, Beate M./0000-0001-6882-0257; Sibilia, Maria/0000-0001-6129-5613; Petzelbauer, Peter/0000-0001-7080-5259	Boehringer Ingelheim Fonds; EC [QLG1-CT-2001-00869, LSHC-CT-2006-037731]; Austrian Federal Government's GEN-AU [GZ 200.147/1-VI/1a/2006]; Austrian Science Fund [FWF-P18421, FWF-P18782, SFB-23-B13, DK W1212]; Boehringer Ingelheim Austria	Boehringer Ingelheim Fonds(Boehringer Ingelheim); EC(European CommissionEuropean Commission Joint Research Centre); Austrian Federal Government's GEN-AU; Austrian Science Fund(Austrian Science Fund (FWF)); Boehringer Ingelheim Austria(Boehringer Ingelheim)	We are grateful to Martina Hammer for mouse care, to Ernst Kriehuber, Martin Holcmann, and Barbara Drobits for assistance with FACS analysis and sorting, Gerald Prager and Christoph Zielinski for advice on extracellular VEGFR inhibitors, Jacques van Meel, Flavio Solca, and Frank Hilberg (Boehringer Ingelheim Austria) for providing the compounds BI-1120 and BI-2992, and Pfizer for providing Sunitinib and CI-1040. We thank Erwin F. Wagner, Dieter Maurer, Juan Guinea-Viniegra, and Helia Schonthaler for critical reading of the manuscript. B. M. L was recipient of a Boehringer Ingelheim Fonds fellowship. This project was supported by the EC programs QLG1-CT-2001-00869 and LSHC-CT-2006-037731 (Growthstop), the Austrian Federal Government's GEN-AU program "Austromouse" (GZ 200.147/1-VI/1a/2006), and the Austrian Science Fund grants FWF-P18421, FWF-P18782, SFB-23-B13, and DK W1212. N.F. is an employee of Genentech, Inc. This work was supported in part by a grant from Boehringer Ingelheim Austria.	Ambati BK, 2006, NATURE, V443, P993, DOI 10.1038/nature05249; Bachelder RE, 2001, CANCER RES, V61, P5736; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Bergers G, 2003, NAT REV CANCER, V3, P401, DOI 10.1038/nrc1093; Bergers G, 2008, NAT REV CANCER, V8, P592, DOI 10.1038/nrc2442; Bielenberg DR, 2006, EXP CELL RES, V312, P584, DOI 10.1016/j.yexcr.2005.11.024; Casanova ML, 2002, CANCER RES, V62, P3402; Chung GG, 2006, CANCER, V106, P1677, DOI 10.1002/cncr.21783; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Eskens F, 2008, BRIT J CANCER, V98, P80, DOI 10.1038/sj.bjc.6604108; Fakhari M, 2002, J PEDIATR SURG, V37, P582, DOI 10.1053/jpsu.2002.31614; Fan F, 2005, ONCOGENE, V24, P2647, DOI 10.1038/sj.onc.1208246; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 2005, NATURE, V438, P967, DOI 10.1038/nature04483; Ferrara N, 2005, ONCOLOGY-BASEL, V69, P11, DOI 10.1159/000088479; Gerber HP, 1999, DEVELOPMENT, V126, P1149; Gerber HP, 2002, NATURE, V417, P954, DOI 10.1038/nature00821; Gray MJ, 2005, CANCER RES, V65, P3664, DOI 10.1158/0008-5472.CAN-04-2229; Hilberg F, 2008, CANCER RES, V68, P4774, DOI 10.1158/0008-5472.CAN-07-6307; Indra AK, 1999, NUCLEIC ACIDS RES, V27, P4324, DOI 10.1093/nar/27.22.4324; Kamiya T, 2006, ONCOL REP, V15, P369; Kim EJ, 2005, EXP DERMATOL, V14, P625, DOI 10.1111/j.0906-6705.2005.00345.x; Kurschat P, 2006, J BIOL CHEM, V281, P2721, DOI 10.1074/jbc.M507860200; Lee S, 2007, CELL, V130, P691, DOI 10.1016/j.cell.2007.06.054; Lee TH, 2007, PLOS MED, V4, P1101, DOI 10.1371/journal.pmed.0040186; Lefort K, 2007, GENE DEV, V21, P562, DOI 10.1101/gad.1484707; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Liu DX, 2007, J CLIN ENDOCR METAB, V92, P4686, DOI 10.1210/jc.2007-0097; Lunghi P, 2008, BLOOD, V112, P2450, DOI 10.1182/blood-2007-10-114348; Mercurio AM, 2004, SEMIN CANCER BIOL, V14, P115, DOI 10.1016/j.semcancer.2003.09.016; Mirones I, 2009, J INVEST DERMATOL, V129, P730, DOI 10.1038/jid.2008.292; Natarajan A, 2007, P NATL ACAD SCI USA, V104, P17081, DOI 10.1073/pnas.0704126104; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Parikh AA, 2004, AM J PATHOL, V164, P2139, DOI 10.1016/S0002-9440(10)63772-8; Potapova O, 2006, MOL CANCER THER, V5, P1280, DOI 10.1158/1535-7163.MCT-03-0156; Riely GJ, 2008, J THORAC ONCOL, V3, pS146, DOI 10.1097/JTO.0b013e318174e96e; Rossiter H, 2004, CANCER RES, V64, P3508, DOI 10.1158/0008-5472.CAN-03-2581; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; Sibilia M, 2000, CELL, V102, P211, DOI 10.1016/S0092-8674(00)00026-X; Sibilia M, 2007, DIFFERENTIATION, V75, P770, DOI 10.1111/j.1432-0436.2007.00238.x; Takahashi H, 2005, CLIN SCI, V109, P227, DOI 10.1042/CS20040370; Tan DCW, 2001, FEBS LETT, V494, P150, DOI 10.1016/S0014-5793(01)02314-6; Tarutani M, 1997, P NATL ACAD SCI USA, V94, P7400, DOI 10.1073/pnas.94.14.7400; Wagner B, 2006, EMBO J, V25, P752, DOI 10.1038/sj.emboj.7600988; Wilgus TA, 2005, AM J PATHOL, V167, P1257, DOI 10.1016/S0002-9440(10)61213-8; Zhou QY, 2008, CLIN CANCER RES, V14, P1540, DOI 10.1158/1078-0432.CCR-07-4544	46	265	276	1	23	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 22	2010	140	2					268	279		10.1016/j.cell.2009.12.046	http://dx.doi.org/10.1016/j.cell.2009.12.046			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141840	Bronze			2022-12-01	WOS:000273826500017
J	Li, NC; Lee, A; Whitmer, RA; Kivipelto, M; Lawler, E; Kazis, LE; Wolozin, B				Li, Nien-Chen; Lee, Austin; Whitmer, Rachel A.; Kivipelto, Miia; Lawler, Elizabeth; Kazis, Lewis E.; Wolozin, Benjamin			Use of angiotensin receptor blockers and risk of dementia in a predominantly male population: prospective cohort analysis	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ALZHEIMER-DISEASE PROGRESSION; MILD COGNITIVE IMPAIRMENT; ENZYME ACE INHIBITORS; QUALITY-OF-LIFE; CARDIOVASCULAR-DISEASE; BLOOD-PRESSURE; HYPERTENSIVE PATIENTS; HEART-FAILURE; SYSTEM; LOSARTAN	Objective To investigate whether angiotensin receptor blockers protect against Alzheimer's disease and dementia or reduce the progression of both diseases. Design Prospective cohort analysis. Setting Administrative database of the US Veteran Affairs, 2002-6. Population 819 491 predominantly male participants (98%) aged 65 or more with cardiovascular disease. Main outcome measures Time to incident Alzheimer's disease or dementia in three cohorts (angiotensin receptor blockers, lisinopril, and other cardiovascular drugs, the "cardiovascular comparator") over a four year period (fiscal years 2003-6) using Cox proportional hazard models with adjustments for age, diabetes, stroke, and cardiovascular disease. Disease progression was the time to admission to a nursing home or death among participants with pre-existing Alzheimer's disease or dementia. Results Hazard rates for incident dementia in the angiotensin receptor blocker group were 0.76 (95% confidence interval 0.69 to 0.84) compared with the cardiovascular comparator and 0.81 (0.73 to 0.90) compared with the lisinopril group. Compared with the cardiovascular comparator, angiotensin receptor blockers in patients with pre-existing Alzheimer's disease were associated with a significantly lower risk of admission to a nursing home (0.51, 0.36 to 0.72) and death (0.83, 0.71 to 0.97). Angiotensin receptor blockers exhibited a dose-response as well as additive effects in combination with angiotensin converting enzyme inhibitors. This combination compared with angiotensin converting enzyme inhibitors alone was associated with a reduced risk of incident dementia (0.54, 0.51 to 0.57) and admission to a nursing home (0.33, 0.22 to 0.49). Minor differences were shown in mean systolic and diastolic blood pressures between the groups. Similar results were observed for Alzheimer's disease. Conclusions Angiotensin receptor blockers are associated with a significant reduction in the incidence and progression of Alzheimer's disease and dementia compared with angiotensin converting enzyme inhibitors or other cardiovascular drugs in a predominantly male population.	[Li, Nien-Chen; Lee, Austin; Kazis, Lewis E.; Wolozin, Benjamin] Vet Affairs Med Ctr, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA; [Li, Nien-Chen; Kazis, Lewis E.] Boston Univ, Sch Publ Hlth,Management & Policy Program, Ctr Assessment Pharmaceut Practices & Pharmaceut, Dept Hlth Policy & Management, Boston, MA USA; [Lee, Austin] Massachusetts Gen Hosp, Dept Surg, Boston, MA 02114 USA; [Whitmer, Rachel A.] Kaiser Permanente, Div Res Epidemiol Etiol & Prevent, Oakland, CA USA; [Kivipelto, Miia] Karolinska Inst, Aging Res Ctr, Stockholm, Sweden; [Lawler, Elizabeth] VA Cooperat Studies Program, MAVERIC, Boston, MA USA; [Wolozin, Benjamin] Boston Univ, Sch Med, Dept Pharmacol, Boston, MA 02118 USA; [Wolozin, Benjamin] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA	US Department of Veterans Affairs; Veterans Health Administration (VHA); Boston University; Harvard University; Massachusetts General Hospital; Kaiser Permanente; Karolinska Institutet; US Department of Veterans Affairs; Veterans Health Administration (VHA); Harvard University; VA Boston Healthcare System; Boston University; Boston University	Wolozin, B (corresponding author), Vet Affairs Med Ctr, Ctr Hlth Qual Outcomes & Econ Res, Bedford, MA USA.	bwolozin@bu.edu	Kivipelto, Miia/AAS-3557-2021	Kivipelto, Miia/0000-0003-0992-3875; Kazis, Lewis/0000-0003-1800-5849	Retirement Research Foundation; Casten Foundation	Retirement Research Foundation; Casten Foundation	This work was supported by a grant award to BW from the Retirement Research Foundation and a donation from the Casten Foundation. The researchers operate independently of the funders of the study.; BW and RAW received a grant award from the Retirement Research Foundation to fund this research. BW received a donation from the Casten Foundation to fund this research.	Aisen PS, 2003, JAMA-J AM MED ASSOC, V289, P2819, DOI 10.1001/jama.289.21.2819; Andraws R, 2007, AM J CARDIOL, V99, P1006, DOI 10.1016/j.amjcard.2006.10.068; Biessels GJ, 2005, BIOCHEM SOC T, V33, P1041, DOI 10.1042/BST0331041; Braunwald E, 2004, NEW ENGL J MED, V351, P2058; BRETELER MMB, 1994, BRIT MED J, V308, P1604, DOI 10.1136/bmj.308.6944.1604; de la Torre JC, 2004, LANCET NEUROL, V3, P184, DOI 10.1016/S1474-4422(04)00683-0; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Encinas M, 2003, EUR J NUCL MED MOL I, V30, P1473, DOI 10.1007/s00259-003-1277-z; Fogari R, 2003, J HUM HYPERTENS, V17, P781, DOI 10.1038/sj.jhh.1001613; Forette F, 2002, ARCH INTERN MED, V162, P2046, DOI 10.1001/archinte.162.18.2046; Gallinat S, 1998, MOL BRAIN RES, V57, P111, DOI 10.1016/S0169-328X(98)00079-5; Geldmacher DS, 2003, J AM GERIATR SOC, V51, P937, DOI 10.1046/j.1365-2389.2003.51306.x; Hamed A, 2004, MED CARE, V42, P551, DOI 10.1097/01.mlr.0000128002.73998.87; Hanon O, 2008, J HYPERTENS, V26, P1642, DOI 10.1097/HJH.0b013e328301a280; Inagami T, 1999, CLIN EXP PHARMACOL P, V26, P544, DOI 10.1046/j.1440-1681.1999.03086.x; Jick H, 2000, LANCET, V356, P1627, DOI 10.1016/S0140-6736(00)03155-X; Kehoe PG, 2007, LANCET NEUROL, V6, P373, DOI 10.1016/S1474-4422(07)70077-7; Kehoe PG, 2009, TRENDS NEUROSCI, V32, P619, DOI 10.1016/j.tins.2009.07.006; Khachaturian AS, 2006, ARCH NEUROL-CHICAGO, V63, P686, DOI 10.1001/archneur.63.5.noc60013; Kinosian B, 2007, GERONTOLOGIST, V47, P356, DOI 10.1093/geront/47.3.356; Kivipelto M, 2001, BMJ-BRIT MED J, V322, P1447, DOI 10.1136/bmj.322.7300.1447; Kivipelto M, 2006, LANCET NEUROL, V5, P735, DOI 10.1016/S1474-4422(06)70537-3; Krikov M, 2008, J HYPERTENS, V26, P544, DOI 10.1097/HJH.0b013e3282f2dac9; Launer LJ, 2000, NEUROBIOL AGING, V21, P49, DOI 10.1016/S0197-4580(00)00096-8; Levey AS, 1999, ANN INTERN MED, V130, P461, DOI 10.7326/0003-4819-130-6-199903160-00002; Luchsinger JA, 2005, NEUROLOGY, V65, P545, DOI 10.1212/01.wnl.0000172914.08967.dc; Lucius R, 1998, J EXP MED, V188, P661, DOI 10.1084/jem.188.4.661; Majani G, 2005, J CARD FAIL, V11, P253, DOI 10.1016/j.cardfail.2004.11.004; Matchar DB, 2008, ANN INTERN MED, V148, P16, DOI 10.7326/0003-4819-148-1-200801010-00189; Nash DT, 2006, AM J CARDIOL, V97, P1262, DOI 10.1016/j.amjcard.2005.12.031; Newman AB, 2005, J AM GERIATR SOC, V53, P1101, DOI 10.1111/j.1532-5415.2005.53360.x; Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417; Ohrui T, 2004, NEUROLOGY, V63, P1324, DOI 10.1212/01.WNL.0000140705.23869.E9; Parhofer KG, 2007, CARDIOVASC DIABETOL, V6, DOI 10.1186/1475-2840-6-36; Poon IO, 2008, PHARMACOTHERAPY, V28, P366, DOI 10.1592/phco.28.3.366; PROHOVNIK I, 1988, NEUROLOGY, V38, P931, DOI 10.1212/WNL.38.6.931; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Raghavendra V, 1998, NEUROPEPTIDES, V32, P417, DOI 10.1016/S0143-4179(98)90065-8; Raghavendra V, 2001, NEUROPEPTIDES, V35, P65, DOI 10.1054/npep.2000.0845; RANADIVE SA, 1992, PHARM RES-DORDR, V9, P1480, DOI 10.1023/A:1015823315983; Rozzini L, 2006, INT J GERIATR PSYCH, V21, P550, DOI 10.1002/gps.1523; Ruitenberg A, 2005, ANN NEUROL, V57, P789, DOI 10.1002/ana.20493; Sjogren M, 2006, MECH AGEING DEV, V127, P138, DOI 10.1016/j.mad.2005.09.020; Skoog I, 2005, AM J HYPERTENS, V18, P1052, DOI 10.1016/j.amjhyper.2005.02.013; Smith F, 1996, J Biopharm Stat, V6, P395, DOI 10.1080/10543409608835152; Smith MW, 2003, MED CARE RES REV, V60, p92S, DOI 10.1177/1077558703256726; Stern Y, 1997, JAMA-J AM MED ASSOC, V277, P806, DOI 10.1001/jama.277.10.806; STERN Y, 1994, NEUROLOGY, V44, P2300, DOI 10.1212/WNL.44.12.2300; STOLL M, 1995, J CLIN INVEST, V95, P651, DOI 10.1172/JCI117710; Takeda S, 2009, HYPERTENSION, V54, P1345, DOI 10.1161/HYPERTENSIONAHA.109.138586; Tedesco MA, 1999, AM J HYPERTENS, V12, P1130, DOI 10.1016/S0895-7061(99)00156-9; Thone-Reineke C, 2006, J HYPERTENS, V24, pS115; Tsukuda K, 2009, HYPERTENSION, V54, P782, DOI 10.1161/HYPERTENSIONAHA.109.136879; Veld BAI, 2001, NEUROBIOL AGING, V22, P407, DOI 10.1016/S0197-4580(00)00241-4; Wang J, 2007, J CLIN INVEST, V117, P3393, DOI 10.1172/JCI31547; Weir RAP, 2008, EUR J HEART FAIL, V10, P157, DOI 10.1016/j.ejheart.2007.12.006; Whitmer RA, 2005, NEUROLOGY, V64, P277, DOI 10.1212/01.WNL.0000149519.47454.F2; Wilms Henrik, 2005, Am J Cardiovasc Drugs, V5, P245, DOI 10.2165/00129784-200505040-00004; Wolozin B, 2000, ARCH NEUROL-CHICAGO, V57, P1439, DOI 10.1001/archneur.57.10.1439; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317; Zaman MA, 2002, NAT REV DRUG DISCOV, V1, P621, DOI 10.1038/nrd873	61	328	341	1	24	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 12	2010	340								b5465	10.1136/bmj.b5465	http://dx.doi.org/10.1136/bmj.b5465			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	545CZ	20068258	Green Published, hybrid			2022-12-01	WOS:000273711400005
J	Bailor, MH; Sun, XY; Al-Hashimi, HM				Bailor, Maximillian H.; Sun, Xiaoyan; Al-Hashimi, Hashim M.			Topology Links RNA Secondary Structure with Global Conformation, Dynamics, and Adaptation	SCIENCE			English	Article							DIMERIZATION INITIATION SITE; CRYSTAL-STRUCTURE; DECODING SITE; NUCLEIC-ACIDS; BINDING; RECOGNITION; PREDICTION; NMR; AMINOGLYCOSIDES; JUNCTIONS	Thermodynamic rules that link RNA sequences to secondary structure are well established, but the link between secondary structure and three-dimensional global conformation remains poorly understood. We constructed comprehensive three-dimensional maps depicting the orientation of A-form helices across RNA junctions in the Protein Data Bank and rationalized our findings with modeling and nuclear magnetic resonance spectroscopy. We show that the secondary structures of junctions encode readily computable topological constraints that accurately predict the three-dimensional orientation of helices across all two-way junctions. Our results suggest that RNA global conformation is largely defined by topological constraints encoded at the secondary structural level and that tertiary contacts and intermolecular interactions serve to stabilize specific conformers within the topologically allowed ensemble.	[Bailor, Maximillian H.; Sun, Xiaoyan; Al-Hashimi, Hashim M.] Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA	University of Michigan System; University of Michigan	Al-Hashimi, HM (corresponding author), Univ Michigan, Dept Chem & Biophys, Ann Arbor, MI 48109 USA.	hashimi@umich.edu			NIH [R01 AI066975-01]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI066975] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank C. Brooks for stimulating discussions and A. Kurochkin for NMR expertise. We acknowledge the Michigan Economic Development Cooperation and the Michigan Technology Tri-Corridor for the support of the purchase of a 600-MHz spectrometer and the W. F. Keck Foundation, NSF, and NIH for funds for the purchase of a 800-MHz spectrometer. Supported by NIH grant R01 AI066975-01.	Al-Hashimi HM, 2008, CURR OPIN STRUC BIOL, V18, P321, DOI 10.1016/j.sbi.2008.04.004; Berman HM, 2002, ACTA CRYSTALLOGR D, V58, P899, DOI 10.1107/S0907444902003451; Bindewald E, 2008, NUCLEIC ACIDS RES, V36, pD392, DOI 10.1093/nar/gkm842; Blount KF, 2003, NUCLEIC ACIDS RES, V31, P5490, DOI 10.1093/nar/gkg755; Cruz JA, 2009, CELL, V136, P604, DOI 10.1016/j.cell.2009.02.003; Das R, 2007, P NATL ACAD SCI USA, V104, P14664, DOI 10.1073/pnas.0703836104; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Ennifar E, 2006, NUCLEIC ACIDS RES, V34, P2328, DOI 10.1093/nar/gkl317; Francois B, 2004, ANGEW CHEM INT EDIT, V43, P6735, DOI 10.1002/anie.200462092; Francois B, 2005, NUCLEIC ACIDS RES, V33, P5677, DOI 10.1093/nar/gki862; Frank AT, 2009, NUCLEIC ACIDS RES, V37, P3670, DOI 10.1093/nar/gkp156; Freisz S, 2008, ANGEW CHEM INT EDIT, V47, P4110, DOI 10.1002/anie.200800726; Hermann T, 2000, SCIENCE, V287, P820, DOI 10.1126/science.287.5454.820; Kondo J, 2007, CHEMMEDCHEM, V2, P1631, DOI 10.1002/cmdc.200700113; Kondo J, 2006, BIOCHIMIE, V88, P1027, DOI 10.1016/j.biochi.2006.05.017; Lilley DMJ, 2000, Q REV BIOPHYS, V33, P109, DOI 10.1017/S0033583500003590; LILLEY DMJ, 1995, NUCLEIC ACIDS RES, V23, P3363, DOI 10.1093/nar/23.17.3363; Mathews DH, 2006, CURR OPIN STRUC BIOL, V16, P270, DOI 10.1016/j.sbi.2006.05.010; Musselman C, 2006, J BIOMOL NMR, V36, P235, DOI 10.1007/s10858-006-9087-9; Parisien M, 2008, NATURE, V452, P51, DOI 10.1038/nature06684; PUGLISI JD, 1992, SCIENCE, V257, P76, DOI 10.1126/science.1621097; Schwalbe H, 2007, ANGEW CHEM INT EDIT, V46, P1212, DOI 10.1002/anie.200604163; Serganov A, 2007, NAT REV GENET, V8, P776, DOI 10.1038/nrg2172; Shapiro BA, 2007, CURR OPIN STRUC BIOL, V17, P157, DOI 10.1016/j.sbi.2007.03.001; Thomas JR, 2008, CHEM REV, V108, P1171, DOI 10.1021/cr0681546; Thore S, 2006, SCIENCE, V312, P1208, DOI 10.1126/science.1128451; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Vicens Q, 2001, STRUCTURE, V9, P647, DOI 10.1016/S0969-2126(01)00629-3; Zhang Q, 2007, NATURE, V450, P1263, DOI 10.1038/nature06389; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	30	150	152	1	37	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					202	206		10.1126/science.1181085	http://dx.doi.org/10.1126/science.1181085			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056889				2022-12-01	WOS:000273394000035
J	Rego, AT; Fronzes, R; Waksman, G				Rego, Ana Toste; Fronzes, Remi; Waksman, Gabriel			SnapShot: Bacterial Appendages I	CELL			English	Editorial Material							PILUS BIOGENESIS; OUTER-MEMBRANE; MICROSCOPY; PATHWAY; DOMAIN		[Rego, Ana Toste; Fronzes, Remi; Waksman, Gabriel] Birkbeck & Univ Coll London, Inst Struct Mol Biol, London WC1E 7HX, England	University of London; Birkbeck University London	Rego, AT (corresponding author), Birkbeck & Univ Coll London, Inst Struct Mol Biol, London WC1E 7HX, England.		Fronzes, Remi/T-2578-2019; Fronzes, Rémi/GLS-0406-2022	Toste Rego, Ana/0000-0002-8584-3386; Fronzes, Remi/0000-0003-3031-9824	MRC [G0800002] Funding Source: UKRI; Medical Research Council [G0800002] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Collins RF, 2004, J BIOL CHEM, V279, P39750, DOI 10.1074/jbc.M405971200; Collins RF, 2007, J BACTERIOL, V189, P6389, DOI 10.1128/JB.00648-07; Craig L, 2008, CURR OPIN STRUC BIOL, V18, P267, DOI 10.1016/j.sbi.2007.12.009; Craig L, 2006, MOL CELL, V23, P651, DOI 10.1016/j.molcel.2006.07.004; Golovanov AP, 2006, J MOL BIOL, V364, P186, DOI 10.1016/j.jmb.2006.08.078; Remaut H, 2008, CELL, V133, P640, DOI 10.1016/j.cell.2008.03.033; Satyshur KA, 2007, STRUCTURE, V15, P363, DOI 10.1016/j.str.2007.01.018; Waksman G, 2009, NAT REV MICROBIOL, V7, P765, DOI 10.1038/nrmicro2220	8	2	2	0	6	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 8	2010	140	1					162	U163	162.e1	10.1016/j.cell.2009.12.047	http://dx.doi.org/10.1016/j.cell.2009.12.047			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085708	Bronze			2022-12-01	WOS:000273391900023
J	Sonksen, P; Hillier, S				Sonksen, Peter; Hillier, Stephen			A Patient's Journey Spinal cord injury	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hillier, Stephen] The Surgery, Bishops Waltham SO32 1GR, Hants, England			phsonksen@aol.com; stephenhillier@doctors.org.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 7	2010	340								b5204	10.1136/bmj.b5204	http://dx.doi.org/10.1136/bmj.b5204			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542IG	20056693				2022-12-01	WOS:000273485700007
J	Kim, MY; Oskarsson, T; Acharyya, S; Nguyen, DX; Zhang, XHF; Norton, L; Massague, J				Kim, Mi-Young; Oskarsson, Thordur; Acharyya, Swarnali; Nguyen, Don X.; Zhang, Xiang H. -F.; Norton, Larry; Massague, Joan			Tumor Self-Seeding by Circulating Cancer Cells	CELL			English	Article							BREAST-CANCER; LUNG METASTASIS; INTERLEUKIN-6; MELANOMA; IL-6; INFLAMMATION; FASCIN; GENES; DISSEMINATION; ANGIOGENESIS	Cancer cells that leave the primary tumor can seed metastases in distant organs, and it is thought that this is a unidirectional process. Here we show that circulating tumor cells (CTCs) can also colonize their tumors of origin, in a process that we call "tumor self-seeding." Self-seeding of breast cancer, colon cancer, and melanoma tumors in mice is preferentially mediated by aggressive CTCs, including those with bone, lung, or brain-metastatic tropism. We find that the tumor-derived cytokines IL-6 and IL-8 act as CTC attractants whereas MMP1/collagenase-1 and the actin cytoskeleton component fascin-1 are mediators of CTC infiltration into mammary tumors. We show that self-seeding can accelerate tumor growth, angiogenesis, and stromal recruitment through seed-derived factors including the chemokine CXCL1. Tumor self-seeding could explain the relationships between anaplasia, tumor size, vascularity and prognosis, and local recurrence seeded by disseminated cells following ostensibly complete tumor excision.	[Kim, Mi-Young; Oskarsson, Thordur; Acharyya, Swarnali; Nguyen, Don X.; Zhang, Xiang H. -F.; Massague, Joan] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA; [Norton, Larry] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10021 USA; [Massague, Joan] Mem Sloan Kettering Canc Ctr, Howard Hughes Med Inst, New York, NY 10021 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Howard Hughes Medical Institute; Memorial Sloan Kettering Cancer Center	Massague, J (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10021 USA.	massaguj@mskcc.org	Kim, Mi Young/C-1829-2011; Oskarsson, Thordur/HBP-9601-2022	Massague, Joan/0000-0001-9324-8408; Zhang, Xiang/0000-0002-5674-8670; Oskarsson, Thordur/0000-0002-0983-6969; Norton, Larry/0000-0003-3701-9250	National Institutes of Health [CA94060]; Hearst Foundation; Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense Era of Hope postdoctoral fellowship; NATIONAL CANCER INSTITUTE [P01CA094060, P30CA008748] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Hearst Foundation; Alan and Sandra Gerry Metastasis Research Initiative; Department of Defense Era of Hope postdoctoral fellowship(United States Department of Defense); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to thank F. Miller for cell lines, T. Shree for MMTV-PyMT mice, P. Bos and S. Tavazoie for critical discussions, W. Shu for technical support, and D. Padua, G. Gupta, and A. Insinga for contributions during the initiation of this work. This work was funded by grants from the National Institutes of Health (CA94060), the Hearst Foundation, and the Alan and Sandra Gerry Metastasis Research Initiative. M.Y.K. is supported by a Department of Defense Era of Hope postdoctoral fellowship. J.M. is an Investigator of the Howard Hughes Medical Institute.	Adams JC, 2004, CURR OPIN CELL BIOL, V16, P590, DOI 10.1016/j.ceb.2004.07.009; Arihiro K, 2000, Breast Cancer, V7, P221, DOI 10.1007/BF02967464; ASLAKSON CJ, 1992, CANCER RES, V52, P1399; Balkwill F, 2005, CANCER CELL, V7, P211, DOI 10.1016/j.ccr.2005.02.013; Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Carmeliet P, 2005, ONCOLOGY-BASEL, V69, P4, DOI 10.1159/000088478; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; CHARBONNEAU H, 1988, P NATL ACAD SCI USA, V85, P7182, DOI 10.1073/pnas.85.19.7182; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dhawan P, 2002, J LEUKOCYTE BIOL, V72, P9; Dupre SA, 2007, INT J EXP PATHOL, V88, P351, DOI 10.1111/j.1365-2613.2007.00539.x; Egeblad M, 2002, NAT REV CANCER, V2, P161, DOI 10.1038/nrc745; Esfandi F, 2006, CANCER LETT, V244, P76, DOI 10.1016/j.canlet.2005.12.003; Galkina E, 2007, CURR DRUG TARGETS, V8, P1239, DOI 10.2174/138945007783220650; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Gupta GP, 2007, NATURE, V446, P765, DOI 10.1038/nature05760; Hashimoto Y, 2005, INT J BIOCHEM CELL B, V37, P1787, DOI 10.1016/j.biocel.2005.05.004; Helbig G, 2003, J BIOL CHEM, V278, P21631, DOI 10.1074/jbc.M300609200; Hodge DR, 2005, EUR J CANCER, V41, P2502, DOI 10.1016/j.ejca.2005.08.016; Hristov M, 2007, CIRC RES, V100, P590, DOI 10.1161/01.RES.0000259043.42571.68; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Joyce JA, 2009, NAT REV CANCER, V9, P239, DOI 10.1038/nrc2618; Kang YB, 2003, CANCER CELL, V3, P537, DOI 10.1016/S1535-6108(03)00132-6; Kishimoto T, 2005, ANNU REV IMMUNOL, V23, P1, DOI 10.1146/annurev.immunol.23.021704.115806; Knupfer H, 2007, BREAST CANCER RES TR, V102, P129, DOI 10.1007/s10549-006-9328-3; Kobayashi Y, 2008, FRONT BIOSCI-LANDMRK, V13, P2400, DOI 10.2741/2853; Langley RR, 2007, ENDOCR REV, V28, P297, DOI 10.1210/er.2006-0027; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Minn AJ, 2005, NATURE, V436, P518, DOI 10.1038/nature03799; Minn AJ, 2005, J CLIN INVEST, V115, P44, DOI 10.1172/JCI200522320; Minn AJ, 2007, P NATL ACAD SCI USA, V104, P6740, DOI 10.1073/pnas.0701138104; Nguyen DX, 2009, NAT REV CANCER, V9, P274, DOI 10.1038/nrc2622; Norton L, 2006, NAT MED, V12, P875, DOI 10.1038/nm0806-875; Pantel K, 2004, NAT REV CANCER, V4, P448, DOI 10.1038/nrc1370; Rafii S, 2003, CANCER CELL, V4, P331, DOI 10.1016/S1535-6108(03)00278-2; Rutka JT, 2008, NEOPLASIA, V10, P149, DOI 10.1593/neo.07909; Sasser AK, 2007, FASEB J, V21, P3763, DOI 10.1096/fj.07-8832com; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237; Scheel C, 2007, CANCER RES, V67, P11476, DOI 10.1158/0008-5472.CAN-07-1653; SCHEIBENBOGEN C, 1995, MELANOMA RES, V5, P179, DOI 10.1097/00008390-199506000-00006; Stoecklein NH, 2008, CANCER CELL, V13, P441, DOI 10.1016/j.ccr.2008.04.005; Tlsty TD, 2006, ANNU REV PATHOL-MECH, V1, P119, DOI 10.1146/annurev.pathol.1.110304.100224; Ugurel S, 2001, J CLIN ONCOL, V19, P577, DOI 10.1200/JCO.2001.19.2.577; Vignjevic D, 2007, CANCER RES, V67, P6844, DOI 10.1158/0008-5472.CAN-07-0929; WANG JM, 1990, BIOCHEM BIOPH RES CO, V169, P165, DOI 10.1016/0006-291X(90)91449-3; Waugh DJJ, 2008, CLIN CANCER RES, V14, P6735, DOI 10.1158/1078-0432.CCR-07-4843	47	942	982	6	240	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1315	1326		10.1016/j.cell.2009.11.025	http://dx.doi.org/10.1016/j.cell.2009.11.025			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064377	Green Accepted, Bronze			2022-12-01	WOS:000273048700019
J	Matsui, T; Leung, D; Miyashita, H; Maksakova, IA; Miyachi, H; Kimura, H; Tachibana, M; Lorincz, MC; Shinkai, Y				Matsui, Toshiyuki; Leung, Danny; Miyashita, Hiroki; Maksakova, Irina A.; Miyachi, Hitoshi; Kimura, Hiroshi; Tachibana, Makoto; Lorincz, Matthew C.; Shinkai, Yoichi			Proviral silencing in embryonic stem cells requires the histone methyltransferase ESET	NATURE			English	Article							MURINE LEUKEMIA-VIRUS; ZINC FINGER PROTEINS; DNA METHYLATION; BINDING-SITE; COMPLEXES; ELEMENTS; H3; HETEROCHROMATIN; RETROVIRUSES; MECHANISM	Endogenous retroviruses (ERVs), retrovirus-like elements with long terminal repeats, are widely dispersed in the euchromatic compartment in mammalian cells, comprising similar to 10% of the mouse genome(1). These parasitic elements are responsible for >10% of spontaneous mutations(2). Whereas DNA methylation has an important role in proviral silencing in somatic and germ-lineage cells(3-5), an additional DNA-methylation-independent pathway also functions in embryonal carcinoma and embryonic stem (ES) cells to inhibit transcription of the exogenous gammaretrovirus murine leukaemia virus (MLV)(6-8). Notably, a recent genome-wide study revealed that ERVs are also marked by histone H3 lysine 9 trimethylation (H3K9me3) and H4K20me3 in ES cells but not in mouse embryonic fibroblasts(9). However, the role that these marks have in proviral silencing remains unexplored. Here we show that the H3K9 methyltransferase ESET (also called SETDB1 or KMT1E) and the Kruppel-associated box (KRAB)associated protein 1 (KAP1, also called TRIM28)(10,11) are required for H3K9me3 and silencing of endogenous and introduced retroviruses specifically in mouse ES cells. Furthermore, whereas ESET enzymatic activity is crucial for HP1 binding and efficient proviral silencing, the H4K20 methyltransferases Suv420h1 and Suv420h2 are dispensable for silencing. Notably, in DNA methyltransferase triple knockout (Dnmt1(-/-) Dnmt3a(-/-) Dnmt3b(-/-)) mouse ES cells, ESET and KAP1 binding and ESET-mediated H3K9me3 are maintained and ERVs are minimally derepressed. We propose that a DNA-methylation-independent pathway involving KAP1 and ESET/ESET-mediated H3K9me3 is required for proviral silencing during the period early in embryogenesis when DNA methylation is dynamically reprogrammed.	[Matsui, Toshiyuki; Miyashita, Hiroki; Miyachi, Hitoshi; Tachibana, Makoto; Shinkai, Yoichi] Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, Kyoto 6068507, Japan; [Matsui, Toshiyuki; Miyashita, Hiroki; Tachibana, Makoto; Shinkai, Yoichi] Kyoto Univ, Grad Sch Biostudies, Sakyo Ku, Kyoto 6068507, Japan; [Leung, Danny; Maksakova, Irina A.; Lorincz, Matthew C.] Univ British Columbia, Dept Med Genet, Inst Life Sci, Vancouver, BC V6T 1Z3, Canada; [Kimura, Hiroshi] Osaka Univ, Grad Sch Frontier Biosci, Suita, Osaka 5650871, Japan	Kyoto University; Kyoto University; University of British Columbia; Osaka University	Shinkai, Y (corresponding author), Kyoto Univ, Inst Virus Res, Expt Res Ctr Infect Dis, Sakyo Ku, 53 Shogoin,Kawara Cho, Kyoto 6068507, Japan.	mlorincz@interchange.ubc.ca; yshinkai@virus.kyoto-u.ac.jp	Shinkai, Yoichi/N-3909-2014; Kimura, Hiroshi/B-9524-2015	Shinkai, Yoichi/0000-0002-6051-2484; Kimura, Hiroshi/0000-0003-0854-083X; Leung, Danny Chi Yeu/0000-0002-2472-894X; Lorincz, Matthew/0000-0003-0885-0467	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan; CIHR [77805, 92090]; Grants-in-Aid for Scientific Research [19061001] Funding Source: KAKEN	Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); CIHR(Canadian Institutes of Health Research (CIHR)); Grants-in-Aid for Scientific Research(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI))	We thank M. Okano for Dnmt1<SUP>-/-</SUP> Dnmt3a<SUP>-/-</SUP> Dnmt3b<SUP>-/-</SUP> ES cells; T. Jenuwein and P. Singh for Suv39h1<SUP>-/-</SUP> Suv39h2<SUP>-/-</SUP> ES cells; T. Jenuwein and G. Schotta for Suv420h1<SUP>-/-</SUP> Suv420h2<SUP>-/-</SUP> ES cells; K. Hata for Dnmt3l knockout mice testes; M. Hijikata for the large-T antigen expression vector; S. Kuramochi-Miyagawa for IAP and LINE-1 probes; S. Smale for HP1 alpha antiserum; and L. Gaudreau for H2AZ antiserum. We are also grateful to P. Goyal and members of the Shinkai laboratory for technical support and D. Mager for critically reading the manuscript. This work was supported in part by the Genome Network Project from the Ministry of Education, Culture, Sports, Science and Technology (MEXT) of Japan, Grants-in-aid from MEXT to Y.S. and CIHR grants 77805 and 92090 to M. C. L. M. C. L. is a Scholar of the Michael Smith Foundation for Health Research.	Bourc'his D, 2004, NATURE, V431, P96, DOI 10.1038/nature02886; Dodge JE, 2004, MOL CELL BIOL, V24, P2478, DOI 10.1128/MCB.24.6.2478-2486.2004; Dong KB, 2008, EMBO J, V27, P2691, DOI 10.1038/emboj.2008.193; HAWLEY RG, 1994, GENE THER, V1, P136; Kim SH, 2004, BIOCHEM BIOPH RES CO, V324, P58, DOI 10.1016/j.bbrc.2004.09.023; Kourmouli N, 2004, J CELL SCI, V117, P2491, DOI 10.1242/jcs.01238; Kuramochi-Miyagawa S, 2008, GENE DEV, V22, P908, DOI 10.1101/gad.1640708; Lachner M, 2001, NATURE, V410, P116, DOI 10.1038/35065132; Lane N, 2003, GENESIS, V35, P88, DOI 10.1002/gene.10168; Lorincz MC, 2000, MOL CELL BIOL, V20, P842, DOI 10.1128/MCB.20.3.842-850.2000; Maksakova IA, 2005, J VIROL, V79, P13865, DOI 10.1128/JVI.79.22.13865-13874.2005; Maksakova IA, 2006, PLOS GENET, V2, P1, DOI 10.1371/journal.pgen.0020002; Martens JHA, 2005, EMBO J, V24, P800, DOI 10.1038/sj.emboj.7600545; Meunier J, 2005, P NATL ACAD SCI USA, V102, P5471, DOI 10.1073/pnas.0408986102; Mikkelsen TS, 2007, NATURE, V448, P553, DOI 10.1038/nature06008; NIWA O, 1983, CELL, V32, P1105, DOI 10.1016/0092-8674(83)90294-5; Pannell D, 2000, EMBO J, V19, P5884, DOI 10.1093/emboj/19.21.5884; Peters AHFM, 2003, MOL CELL, V12, P1577, DOI 10.1016/S1097-2765(03)00477-5; Ryan RF, 1999, MOL CELL BIOL, V19, P4366; Sarraf SA, 2004, MOL CELL, V15, P595, DOI 10.1016/j.molcel.2004.06.043; Schotta G, 2004, GENE DEV, V18, P1251, DOI 10.1101/gad.300704; Schultz DC, 2002, GENE DEV, V16, P919, DOI 10.1101/gad.973302; Schultz DC, 2001, GENE DEV, V15, P428, DOI 10.1101/gad.869501; Tachibana M, 2005, GENE DEV, V19, P815, DOI 10.1101/gad.1284005; Tachibana M, 2008, EMBO J, V27, P2681, DOI 10.1038/emboj.2008.192; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TEICH NM, 1977, CELL, V12, P973, DOI 10.1016/0092-8674(77)90162-3; Tsumura A, 2006, GENES CELLS, V11, P805, DOI 10.1111/j.1365-2443.2006.00984.x; Vernet M, 1996, J VIROL, V70, P5630, DOI 10.1128/JVI.70.8.5630-5633.1996; Walsh CP, 1998, NAT GENET, V20, P116, DOI 10.1038/2413; Waterston RH, 2002, NATURE, V420, P520, DOI 10.1038/nature01262; Wolf D, 2008, P NATL ACAD SCI USA, V105, P12521, DOI 10.1073/pnas.0805540105; Wolf D, 2007, CELL, V131, P46, DOI 10.1016/j.cell.2007.07.026; Wolf D, 2009, NATURE, V458, P1201, DOI 10.1038/nature07844; Yoder JA, 1997, TRENDS GENET, V13, P335, DOI 10.1016/S0168-9525(97)01181-5	35	487	499	4	45	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					927	U149		10.1038/nature08858	http://dx.doi.org/10.1038/nature08858			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20164836	Green Published			2022-12-01	WOS:000276397300045
J	Fellay, J; Thompson, AJ; Ge, DL; Gumbs, CE; Urban, TJ; Shianna, KV; Little, LD; Qiu, P; Bertelsen, AH; Watson, M; Warner, A; Muir, AJ; Brass, C; Albrecht, J; Sulkowski, M; McHutchison, JG; Goldstein, DB				Fellay, Jacques; Thompson, Alexander J.; Ge, Dongliang; Gumbs, Curtis E.; Urban, Thomas J.; Shianna, Kevin V.; Little, Latasha D.; Qiu, Ping; Bertelsen, Arthur H.; Watson, Mark; Warner, Amelia; Muir, Andrew J.; Brass, Clifford; Albrecht, Janice; Sulkowski, Mark; McHutchison, John G.; Goldstein, David B.			ITPA gene variants protect against anaemia in patients treated for chronic hepatitis C	NATURE			English	Article							TRIPHOSPHATE PYROPHOSPHOHYDROLASE DEFICIENCY; NONSPHEROCYTIC HEMOLYTIC-ANEMIA; WHOLE-GENOME ASSOCIATION; INOSINE TRIPHOSPHATASE; HEXOKINASE DEFICIENCY; MISSENSE MUTATION; POPULATION; PHENOTYPE; RIBAVIRIN	Chronic infection with the hepatitis C virus (HCV) affects 170 million people worldwide and is an important cause of liver-related morbidity and mortality(1). The standard of care therapy combines pegylated interferon (pegIFN) alpha and ribavirin (RBV), and is associated with a range of treatment-limiting adverse effects(2). One of the most important of these is RBV-induced haemolytic anaemia, which affects most patients and is severe enough to require dose modification in up to 15% of patients. Here we show that genetic variants leading to inosine triphosphatase deficiency, a condition not thought to be clinically important, protect against haemolytic anaemia in hepatitis-C-infected patients receiving RBV.	[Fellay, Jacques; Ge, Dongliang; Gumbs, Curtis E.; Urban, Thomas J.; Shianna, Kevin V.; Little, Latasha D.; Goldstein, David B.] Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Thompson, Alexander J.; Muir, Andrew J.; McHutchison, John G.] Duke Univ, Div Gastroenterol, Sch Med, Div Gastroenterol, Durham, NC 27705 USA; [Thompson, Alexander J.; Muir, Andrew J.; McHutchison, John G.] Duke Univ, Duke Clin Res Inst, Durham, NC 27705 USA; [Qiu, Ping; Bertelsen, Arthur H.; Watson, Mark; Warner, Amelia; Brass, Clifford; Albrecht, Janice] Schering Plough Res Inst, Kenilworth, NJ 07033 USA; [Sulkowski, Mark] Johns Hopkins Univ, Sch Med, Baltimore, MD 21205 USA	Duke University; Duke University; Duke University; Merck & Company; Schering-Plough Research Institute; Johns Hopkins University	Goldstein, DB (corresponding author), Duke Univ, Ctr Human Genome Variat, Inst Genome Sci & Policy, Durham, NC 27708 USA.	mchut001@mc.duke.edu; d.goldstein@duke.edu	Goldstein, David/AAY-8125-2020; Fellay, Jacques/A-6681-2009	Fellay, Jacques/0000-0002-8240-939X; Ge, David/0000-0002-9732-8170	Schering-Plough Research Institute, Kenilworth, New Jersey; National Health and Medical Research Council of Australia; Gastroenterological Society of Australia	Schering-Plough Research Institute, Kenilworth, New Jersey(Merck & Company); National Health and Medical Research Council of Australia(National Health and Medical Research Council (NHMRC) of Australia); Gastroenterological Society of Australia	We are indebted to the IDEAL principal investigators, the study coordinators, nurses and patients involved in the study. We also thank E. Gustafson, P. Savino, D. Devlin, S. Noviello, M. Geffner, E. L. Heinzen, A. C. Need and E. T. Cirulli for their contributions to the study. This study was funded by the Schering-Plough Research Institute, Kenilworth, New Jersey. A.J.T. receives funding support from the National Health and Medical Research Council of Australia and the Gastroenterological Society of Australia.	Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arenas M, 2007, BBA-MOL BASIS DIS, V1772, P96, DOI 10.1016/j.bbadis.2006.10.006; Atanasova S, 2007, THER DRUG MONIT, V29, P6, DOI 10.1097/FTD.0b013e3180308554; Bierau J, 2007, PHARMACOGENOMICS, V8, P1221, DOI 10.2217/14622416.8.9.1221; Bonnefond A, 2009, DIABETES, V58, P2687, DOI 10.2337/db09-0652; Cao HN, 2002, J HUM GENET, V47, P620, DOI 10.1007/s100380200095; de Vooght KMK, 2009, HAEMATOL-HEMATOL J, V94, P1203, DOI 10.3324/haematol.2008.002881; Dickson SP, 2010, PLOS BIOL, V8, DOI 10.1371/journal.pbio.1000294; FRASER JH, 1975, CLIN BIOCHEM, V8, P353, DOI 10.1016/S0009-9120(75)93685-1; Ganesh SK, 2009, NAT GENET, V41, P1191, DOI 10.1038/ng.466; Ge DL, 2008, GENOME RES, V18, P640, DOI 10.1101/gr.071571.107; Ge DL, 2009, NATURE, V461, P399, DOI 10.1038/nature08309; Goldstein DB, 2009, NEW ENGL J MED, V360, P1696, DOI 10.1056/NEJMp0806284; Lavanchy D, 2009, LIVER INT, V29, P74, DOI 10.1111/j.1478-3231.2008.01934.x; Maeda T, 2005, MOL GENET METAB, V85, P271, DOI 10.1016/j.ymgme.2005.03.011; McHutchison JG, 2009, NEW ENGL J MED, V361, P580, DOI 10.1056/NEJMoa0808010; MOTULSKY AG, 1957, JAMA-J AM MED ASSOC, V165, P835, DOI 10.1001/jama.1957.72980250010016; Peters LL, 2001, BLOOD CELL MOL DIS, V27, P850, DOI 10.1006/bcmd.2001.0454; Price AL, 2006, NAT GENET, V38, P904, DOI 10.1038/ng1847; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Russmann S, 2006, CURR MED CHEM, V13, P3351, DOI 10.2174/092986706778773059; Shipkova M, 2006, CLIN CHEM, V52, P240, DOI 10.1373/clinchem.2005.059501; Stepchenkova EI, 2009, J MOL BIOL, V392, P602, DOI 10.1016/j.jmb.2009.07.051; Stocco G, 2009, CLIN PHARMACOL THER, V85, P164, DOI 10.1038/clpt.2008.154; Sumi S, 2002, HUM GENET, V111, P360, DOI 10.1007/s00439-002-0798-z; van Wijk R, 2003, BLOOD, V101, P345, DOI 10.1182/blood-2002-06-1851; Whitlock MC, 2005, J EVOLUTION BIOL, V18, P1368, DOI 10.1111/j.1420-9101.2005.00917.x	27	372	385	0	24	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					405	408		10.1038/nature08825	http://dx.doi.org/10.1038/nature08825			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20173735				2022-12-01	WOS:000275657100045
J	Hatzivassiliou, G; Song, K; Yen, I; Brandhuber, BJ; Anderson, DJ; Alvarado, R; Ludlam, MJC; Stokoe, D; Gloor, SL; Vigers, G; Morales, T; Aliagas, I; Liu, B; Sideris, S; Hoeflich, KP; Jaiswal, BS; Seshagiri, S; Koeppen, H; Belvin, M; Friedman, LS; Malek, S				Hatzivassiliou, Georgia; Song, Kyung; Yen, Ivana; Brandhuber, Barbara J.; Anderson, Daniel J.; Alvarado, Ryan; Ludlam, Mary J. C.; Stokoe, David; Gloor, Susan L.; Vigers, Guy; Morales, Tony; Aliagas, Ignacio; Liu, Bonnie; Sideris, Steve; Hoeflich, Klaus P.; Jaiswal, Bijay S.; Seshagiri, Somasekar; Koeppen, Hartmut; Belvin, Marcia; Friedman, Lori S.; Malek, Shiva			RAF inhibitors prime wild-type RAF to activate the MAPK pathway and enhance growth	NATURE			English	Article							B-RAF; SELECTIVE INHIBITOR; C-RAF; KINASE; PHOSPHORYLATION; EFFICACY; POTENT; MUTATIONS; MECHANISM; PROTEINS	Activating mutations in KRAS and BRAF are found in more than 30% of all human tumours and 40% of melanoma, respectively, thus targeting this pathway could have broad therapeutic effects(1). Small molecule ATP-competitive RAF kinase inhibitors have potent antitumour effects on mutant BRAF(V600E) tumours but, in contrast to mitogen-activated protein kinase kinase (MEK) inhibitors, are not potent against RAS mutant tumour models, despite RAF functioning as a key effector downstream of RAS and upstream of MEK2,3. Here we show that ATP-competitive RAF inhibitors have two opposing mechanisms of action depending on the cellular context. In BRAF(V600E) tumours, RAF inhibitors effectively block the mitogen-activated protein kinase (MAPK) signalling pathway and decrease tumour growth. Notably, in KRAS mutant and RAS/RAF wild-type tumours, RAF inhibitors activate the RAF-MEK-ERK pathway in a RAS-dependent manner, thus enhancing tumour growth in some xenograft models. Inhibitor binding activates wild-type RAF isoforms by inducing dimerization, membrane localization and interaction with RAS-GTP. These events occur independently of kinase inhibition and are, instead, linked to direct conformational effects of inhibitors on the RAF kinase domain. On the basis of these findings, we demonstrate that ATP-competitive kinase inhibitors can have opposing functions as inhibitors or activators of signalling pathways, depending on the cellular context. Furthermore, this work provides new insights into the therapeutic use of ATP-competitive RAF inhibitors.	[Hatzivassiliou, Georgia; Song, Kyung; Yen, Ivana; Anderson, Daniel J.; Alvarado, Ryan; Ludlam, Mary J. C.; Stokoe, David; Aliagas, Ignacio; Liu, Bonnie; Sideris, Steve; Hoeflich, Klaus P.; Jaiswal, Bijay S.; Seshagiri, Somasekar; Koeppen, Hartmut; Belvin, Marcia; Friedman, Lori S.; Malek, Shiva] Genentech Inc, San Francisco, CA 94080 USA; [Brandhuber, Barbara J.; Gloor, Susan L.; Vigers, Guy; Morales, Tony] Array BioPharma, Boulder, CO 80301 USA	Roche Holding; Genentech; Pfizer; Array BioPharma	Hatzivassiliou, G (corresponding author), Genentech Inc, San Francisco, CA 94080 USA.	hatzivassiliou.georgia@gene.com; malek.shiva@gene.com		Vigers, Guy/0000-0003-4451-8453; Malek, Shiva/0000-0002-9526-7968; Seshagiri, Somasekar/0000-0003-4272-6443; Anderson, Daniel/0000-0002-3249-2439				BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Cameron AJM, 2009, NAT STRUCT MOL BIOL, V16, P624, DOI 10.1038/nsmb.1606; Chapman P, 2009, EJC SUPPL, V7, P5, DOI 10.1016/S1359-6349(09)72036-1; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; Cho DC, 2009, J CLIN ONCOL, V27; Garnett MJ, 2005, MOL CELL, V20, P963, DOI 10.1016/j.molcel.2005.10.022; Goetz CA, 2003, J BIOL CHEM, V278, P51184, DOI 10.1074/jbc.M309183200; Hansen JD, 2008, BIOORG MED CHEM LETT, V18, P4692, DOI 10.1016/j.bmcl.2008.07.002; Hindie V, 2009, NAT CHEM BIOL, V5, P758, DOI 10.1038/nchembio.208; Hoeflich KP, 2009, CANCER RES, V69, P3042, DOI 10.1158/0008-5472.CAN-08-3563; Jaiswal BS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005717; JELINEK T, 1994, MOL CELL BIOL, V14, P8212, DOI 10.1128/MCB.14.12.8212; Khazak V, 2007, EXPERT OPIN THER TAR, V11, P1587, DOI 10.1517/14728222.11.12.1587; Kim JS, 2004, CANCER RES, V64, P1932, DOI 10.1158/0008-5472.CAN-03-3862; Lukyanov KA, 2000, J BIOL CHEM, V275, P25879, DOI 10.1074/jbc.C000338200; Malek S, 2006, EJC SUPPL, V4, P184, DOI 10.1016/S1359-6349(06)70614-0; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Okuzumi T, 2009, NAT CHEM BIOL, V5, P484, DOI 10.1038/nchembio.183; Rajakulendran T, 2009, NATURE, V461, P542, DOI 10.1038/nature08314; Rushworth LK, 2006, MOL CELL BIOL, V26, P2262, DOI 10.1128/MCB.26.6.2262-2272.2006; Schubbert S, 2007, NAT REV CANCER, V7, P295, DOI 10.1038/nrc2109; Schwartz GK, 2009, J CLIN ONCOL, V27; Stokoe D, 1997, EMBO J, V16, P2384, DOI 10.1093/emboj/16.9.2384; Terai K, 2005, EMBO REP, V6, P251, DOI 10.1038/sj.embor.7400349; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Wallace EM, 2006, J MED CHEM, V49, P441, DOI 10.1021/jm050834y; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Weber CK, 2001, CANCER RES, V61, P3595; Wellbrock C, 2004, NAT REV MOL CELL BIO, V5, P875, DOI 10.1038/nrm1498; Xiang XQ, 2002, J BIOL CHEM, V277, P44996, DOI 10.1074/jbc.M203953200; Yeh JJ, 2009, MOL CANCER THER, V8, P834, DOI 10.1158/1535-7163.MCT-08-0972; Yun JY, 2009, SCIENCE, V325, P1555, DOI 10.1126/science.1174229; Zang MW, 2008, J BIOL CHEM, V283, P31429, DOI 10.1074/jbc.M802855200	33	1185	1232	1	111	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					431	U132		10.1038/nature08833	http://dx.doi.org/10.1038/nature08833			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20130576	Bronze			2022-12-01	WOS:000275657100051
J	Agarwal, S; Loh, YH; McLoughlin, EM; Huang, JJ; Park, IH; Miller, JD; Huo, HG; Okuka, M; dos Reis, RM; Loewer, S; Ng, HH; Keefe, DL; Goldman, FD; Klingelhutz, AJ; Liu, L; Daley, GQ				Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Huang, Junjiu; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Okuka, Maja; dos Reis, Rosana Maria; Loewer, Sabine; Ng, Huck-Hui; Keefe, David L.; Goldman, Frederick D.; Klingelhutz, Aloysius J.; Liu, Lin; Daley, George Q.			Telomere elongation in induced pluripotent stem cells from dyskeratosis congenita patients	NATURE			English	Article							LIFE-SPAN; GENE-EXPRESSION; RNA COMPONENT; MAINTENANCE; MUTATIONS; DISEASE; LYMPHOCYTES; EXTENSION; DELIVERY; HTERT	Patients with dyskeratosis congenita (DC), a disorder of telomere maintenance, suffer degeneration of multiple tissues(1-3). Patient-specific induced pluripotent stem (iPS) cells(4) represent invaluable in vitro models for human degenerative disorders like DC. A cardinal feature of iPS cells is acquisition of indefinite self-renewal capacity, which is accompanied by induction of the telomerase reverse transcriptase gene (TERT)(5-7). We investigated whether defects in telomerase function would limit derivation and maintenance of iPS cells from patients with DC. Here we show that reprogrammed DC cells overcome a critical limitation in telomerase RNA component (TERC) levels to restore telomere maintenance and self-renewal. We discovered that TERC upregulation is a feature of the pluripotent state, that several telomerase components are targeted by pluripotency-associated transcription factors, and that in autosomal dominant DC, transcriptional silencing accompanies a 3' deletion at the TERC locus. Our results demonstrate that reprogramming restores telomere elongation in DC cells despite genetic lesions affecting telomerase, and show that strategies to increase TERC expression may be therapeutically beneficial in DC patients.	[Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Dana Farber Canc Inst, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Brigham & Womens Hosp, Div Hematol, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Harvard Stem Cell Inst, Boston, MA 02115 USA; [Agarwal, Suneet; Loh, Yuin-Han; McLoughlin, Erin M.; Park, In-Hyun; Miller, Justine D.; Huo, Hongguang; Loewer, Sabine; Daley, George Q.] Manton Ctr Orphan Dis Res, Boston, MA 02115 USA; [Huang, Junjiu; Okuka, Maja; dos Reis, Rosana Maria; Keefe, David L.; Liu, Lin] Univ S Florida, Coll Med, Dept Obstet & Gynecol, MDC 3125, Tampa, FL 33612 USA; [Huang, Junjiu] Sun Yat Sen Univ, Sch Life Sci, State Key Lab Biocontrol, Guangzhou 510275, Guangdong, Peoples R China; [Ng, Huck-Hui] Genome Inst Singapore, Gene Regulatory Lab, Singapore 138672, Singapore; [Ng, Huck-Hui] Natl Univ Singapore, Dept Biol Sci, Singapore 138672, Singapore; [Goldman, Frederick D.] Childrens Hosp Alabama, Dept Pediat, Birmingham, AL 35233 USA; [Klingelhutz, Aloysius J.] Univ Iowa, Dept Microbiol, Iowa City, IA 52242 USA; [Liu, Lin] Nankai Univ, Coll Life Sci, Tianjin 300071, Peoples R China; [Daley, George Q.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA	Harvard University; Boston Children's Hospital; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard Medical School; Harvard University; Brigham & Women's Hospital; Harvard University; State University System of Florida; University of South Florida; Sun Yat Sen University; Agency for Science Technology & Research (A*STAR); A*STAR - Genome Institute of Singapore (GIS); National University of Singapore; University of Iowa; Nankai University; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute	Daley, GQ (corresponding author), Childrens Hosp, Div Hematol Oncol, Boston, MA 02115 USA.	george.daley@childrens.harvard.edu	Ng, Huck Hui/A-1135-2009; Saude da mulher, Inct/J-9403-2013; Loh, Yuin-Han/E-1096-2014; dos Reis, Rosana Maria/E-3346-2012; Klingelhutz, Aloysius/L-9081-2018	Loh, Yuin-Han/0000-0002-4715-6454; dos Reis, Rosana Maria/0000-0001-9631-4167; Klingelhutz, Aloysius/0000-0003-4258-5046; NG, HUCK HUI/0000-0001-6352-8417	National Institutes of Health (NIH) [K08HL089150, R01AG0227388]; Manton Center for Orphan Disease Research; Amy Clare Potter Fellowship; Agency of Science, Technology and Research; Institute of Medical Biology, Singapore; James and Esther King Biomedical Research Program; MOST 973 project [2009CB941000]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL089150, U01HL100001] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG027388] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP1OD000256] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Manton Center for Orphan Disease Research; Amy Clare Potter Fellowship; Agency of Science, Technology and Research(Agency for Science Technology & Research (A*STAR)); Institute of Medical Biology, Singapore; James and Esther King Biomedical Research Program; MOST 973 project(National Basic Research Program of China); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	This work was funded by grants from the National Institutes of Health (NIH) and the Manton Center for Orphan Disease Research (G. Q. D.); NIH K08HL089150, Amy Clare Potter Fellowship and Manton Center for Orphan Disease Research (S. A.); the Agency of Science, Technology and Research and the Institute of Medical Biology, Singapore (Y.-H. L.); NIH R01AG0227388 (F. D. G. and A. J. K.); and the James and Esther King Biomedical Research Program and MOST 973 project (2009CB941000) (D. L. K and L. L).	Agarwal S, 1998, IMMUNITY, V9, P765, DOI 10.1016/S1074-7613(00)80642-1; Allsopp RC, 2003, BLOOD, V102, P517, DOI 10.1182/blood-2002-07-2334; Atkinson SP, 2005, CANCER RES, V65, P7585, DOI 10.1158/0008-5472.CAN-05-1715; Bodnar AG, 1998, SCIENCE, V279, P349, DOI 10.1126/science.279.5349.349; BROCCOLI D, 1995, P NATL ACAD SCI USA, V92, P9082, DOI 10.1073/pnas.92.20.9082; BRYAN TM, 1995, EMBO J, V14, P4240, DOI 10.1002/j.1460-2075.1995.tb00098.x; Cairney CJ, 2008, BIOCHIMIE, V90, P13, DOI 10.1016/j.biochi.2007.07.025; Calado RT, 2008, BLOOD, V111, P4446, DOI 10.1182/blood-2007-08-019729; Cawthon RM, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.10.e47; Chiu CP, 1996, STEM CELLS, V14, P239, DOI 10.1002/stem.140239; Fu D, 2003, MOL CELL, V11, P1361, DOI 10.1016/S1097-2765(03)00196-5; Greenberg Michael E, 2007, Curr Protoc Mol Biol, VChapter 4, DOI 10.1002/0471142727.mb0410s78; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; Heiss NS, 1998, NAT GENET, V19, P32, DOI 10.1038/ng0598-32; HIYAMA K, 1995, J IMMUNOL, V155, P3711; Kirwan M, 2008, CLIN GENET, V73, P103, DOI 10.1111/j.1399-0004.2007.00923.x; Kirwan M, 2009, BRIT J HAEMATOL, V144, P771, DOI 10.1111/j.1365-2141.2008.07516.x; Li S, 2004, CANCER RES, V64, P4833, DOI 10.1158/0008-5472.CAN-04-0953; Liu L, 2007, NAT CELL BIOL, V9, P1436, DOI 10.1038/ncb1664; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Marion RM, 2009, CELL STEM CELL, V4, P141, DOI 10.1016/j.stem.2008.12.010; Marrone A, 2004, BLOOD, V104, P3936, DOI 10.1182/blood-2004-05-1829; Mason PJ, 2005, CURR MOL MED, V5, P159, DOI 10.2174/1566524053586581; Mitchell JR, 1999, NATURE, V402, P551, DOI 10.1038/990141; Montanaro L, 2006, J PATHOL, V210, P10, DOI 10.1002/path.2023; Park IH, 2008, CELL, V134, P877, DOI 10.1016/j.cell.2008.07.041; Park IH, 2008, NAT PROTOC, V3, P1180, DOI 10.1038/nprot.2008.92; Park IH, 2008, NATURE, V451, P141, DOI 10.1038/natureO6534; Takahashi K, 2007, CELL, V131, P861, DOI 10.1016/j.cell.2007.11.019; Trahan C, 2009, RNA, V15, P235, DOI 10.1261/rna.1354009; Vaziri H, 1998, CURR BIOL, V8, P279, DOI 10.1016/S0960-9822(98)70109-5; Vulliamy T, 2001, NATURE, V413, P432, DOI 10.1038/35096585; Watanabe K, 2007, NAT BIOTECHNOL, V25, P681, DOI 10.1038/nbt1310; Westin ER, 2007, AGING CELL, V6, P383, DOI 10.1111/j.1474-9726.2007.00288.x; Wong JMY, 2006, GENE DEV, V20, P2848, DOI 10.1101/gad.1476206; Yam PY, 2002, MOL THER, V5, P479, DOI 10.1006/mthe.2002.0558; Yi XM, 1999, MOL CELL BIOL, V19, P3989; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526	38	227	236	1	50	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					292	U176		10.1038/nature08792	http://dx.doi.org/10.1038/nature08792			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20164838	Green Accepted			2022-12-01	WOS:000275366100050
J	Eiring, AM; Harb, JG; Neviani, P; Garton, C; Oaks, JJ; Spizzo, R; Liu, SJ; Schwind, S; Santhanam, R; Hickey, CJ; Becker, H; Chandler, JC; Andino, R; Cortes, J; Hokland, P; Huettner, CS; Bhatia, R; Roy, DC; Liebhaber, SA; Caligiuri, MA; Marcucci, G; Garzon, R; Croce, CM; Calin, GA; Perrotti, D				Eiring, Anna M.; Harb, Jason G.; Neviani, Paolo; Garton, Christopher; Oaks, Joshua J.; Spizzo, Riccardo; Liu, Shujun; Schwind, Sebastian; Santhanam, Ramasamy; Hickey, Christopher J.; Becker, Heiko; Chandler, Jason C.; Andino, Raul; Cortes, Jorge; Hokland, Peter; Huettner, Claudia S.; Bhatia, Ravi; Roy, Denis C.; Liebhaber, Stephen A.; Caligiuri, Michael A.; Marcucci, Guido; Garzon, Ramiro; Croce, Carlo M.; Calin, George A.; Perrotti, Danilo			miR-328 Functions as an RNA Decoy to Modulate hnRNP E2 Regulation of mRNA Translation in Leukemic Blasts	CELL			English	Article							CHRONIC MYELOID-LEUKEMIA; C/EBP-ALPHA; CD34(+) CELLS; BCR/ABL; BINDING; IDENTIFICATION; EXPRESSION; MICRORNAS; TARGETS; MYELOPEROXIDASE	MicroRNAs and heterogeneous ribonucleoproteins (hnRNPs) are posttranscriptional gene regulators that bind mRNA in a sequence-specific manner. Here, we report that loss of miR-328 occurs in blast crisis chronic myelogenous leukemia (CML-BC) in a BCR/ABL dose- and kinase-dependent manner through the MAPK-hnRNP E2 pathway. Restoration of miR-328 expression rescues differentiation and impairs survival of leukemic blasts by simultaneously interacting with the translational regulator poly(rC)-binding protein hnRNP E2 and with the mRNA encoding the survival factor PIM1, respectively. The interaction with hnRNP E2 is independent of the microRNA's seed sequence and it leads to release of CEBPA mRNA from hnRNP E2-mediated translational inhibition. Altogether, these data reveal the dual ability of a microRNA to control cell fate both through base pairing with mRNA targets and through a decoy activity that interferes with the function of regulatory proteins.	[Eiring, Anna M.; Harb, Jason G.; Neviani, Paolo; Garton, Christopher; Oaks, Joshua J.; Santhanam, Ramasamy; Caligiuri, Michael A.; Marcucci, Guido; Garzon, Ramiro; Croce, Carlo M.; Perrotti, Danilo] Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA; [Liu, Shujun; Schwind, Sebastian; Hickey, Christopher J.; Becker, Heiko; Chandler, Jason C.; Caligiuri, Michael A.; Marcucci, Guido; Garzon, Ramiro] Ohio State Univ, Dept Internal Med, Columbus, OH 43210 USA; [Schwind, Sebastian; Hickey, Christopher J.; Becker, Heiko; Caligiuri, Michael A.; Marcucci, Guido; Garzon, Ramiro; Croce, Carlo M.; Perrotti, Danilo] Ohio State Univ, Ctr Comprehens Canc, Columbus, OH 43210 USA; [Perrotti, Danilo] Ohio State Univ, Ctr RNA Biol, Columbus, OH 43210 USA; [Andino, Raul] Univ Calif San Francisco, Dept Microbiol & Immunol, San Francisco, CA 94143 USA; [Spizzo, Riccardo; Cortes, Jorge; Calin, George A.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Dept Leukemia, Houston, TX 77030 USA; [Spizzo, Riccardo; Cortes, Jorge; Calin, George A.] Univ Texas Houston, MD Anderson Canc Ctr, Ctr RNA Interference & Noncoding RNAs, Dept Expt Therapeut, Houston, TX 77030 USA; [Hokland, Peter] Aarhus Univ, Dept Hematol, DK-8000 Aarhus C, Denmark; [Huettner, Claudia S.] Harvard Univ, Sch Med, Dana Farber Canc Inst, Boston, MA 02115 USA; [Bhatia, Ravi] City Hope Natl Med Ctr, Dept Hematopoiet Stem Cell & Leukemia Res, Duarte, CA 91010 USA; [Roy, Denis C.] Hop Maison Neuve Rosemont, Dept Hematol Oncol, Montreal, PQ H3T 1J4, Canada; [Roy, Denis C.] Univ Montreal, Montreal, PQ H3T 1J4, Canada; [Liebhaber, Stephen A.] Univ Penn, Sch Med, Dept Genet & Med, Philadelphia, PA 19104 USA	University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; James Cancer Hospital & Solove Research Institute; University System of Ohio; Ohio State University; University System of Ohio; Ohio State University; University of California System; University of California San Francisco; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; University of Texas System; University of Texas Health Science Center Houston; UTMD Anderson Cancer Center; Aarhus University; Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; City of Hope; Universite de Montreal; Universite de Montreal; University of Pennsylvania	Perrotti, D (corresponding author), Ohio State Univ, Dept Mol Virol Immunol & Med Genet, Human Canc Genet Program, Columbus, OH 43210 USA.	danilo.perrotti@osumc.edu	Spizzo, Riccardo/V-1057-2019; Perrotti, Danilo/E-3852-2011; Garzon, Ramiro/E-3104-2011; Califano, Andrea/F-7239-2012; Eiring, Anna M./ABA-8673-2020; Calin, George/E-9390-2011; Young, Richard A/F-6495-2012	Spizzo, Riccardo/0000-0001-7772-0960; Eiring, Anna M./0000-0001-6533-9150; Young, Richard A/0000-0001-8855-8647; Cortes, Jorge/0000-0002-8636-1071; Calin, George/0000-0001-6704-5615; Hokland, Peter/0000-0002-1177-9756; Roy, Denis-Claude/0000-0002-5921-1692	National Cancer Institute [CA095512, CA16058]; NIH, Bethesda, MD, USA; US Army [W81XWH-07-1-0270]; American-Italian Cancer Foundation; Fonds de la Recherche en Sante du Quebec; OSU Graduate School; Leukemia and Lymphoma Society; M.D. Anderson Research Trust; University of Texas System Regents; NATIONAL CANCER INSTITUTE [P30CA016058, R01CA095512] Funding Source: NIH RePORTER	National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIH, Bethesda, MD, USA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US Army(United States Department of DefenseUnited States Army); American-Italian Cancer Foundation; Fonds de la Recherche en Sante du Quebec(Fonds de la Recherche en Sante du Quebec); OSU Graduate School; Leukemia and Lymphoma Society(Leukemia and Lymphoma Society); M.D. Anderson Research Trust; University of Texas System Regents; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This work was supported in part by grants from the National Cancer Institute CA095512 (D.P.), CA16058 (OSU-CCC), NIH, Bethesda, MD, USA; the US Army, CML Research Program, W81XWH-07-1-0270 (D. P.); the American-Italian Cancer Foundation (P.N.); Fonds de la Recherche en Sante du Quebec (D.C.R.); and AGGRS from The OSU Graduate School (A.M.E.). D.P. is a Scholar of The Leukemia and Lymphoma Society. G.A.C. is a Fellow of the M.D. Anderson Research Trust and Scholar of the University of Texas System Regents. We thank J.-S. Chang, M. Odeh, and A. Martin for technical assistance and S. Lee for editorial assistance; T. Skorski (Temple University, Philadelphia, PA, USA) for providing PIM1 cDNAs; F. Racke ( OSU, Columbus OH, USA) for histopathology analysis; B. Calabretta (TJU, Philadelphia, PA, USA), R. Arlinghaus ( MDACC, Houston, TX, USA), and K. Huebner (OSU) for critical reading of the manuscript.	Agirre X, 2008, MOL CANCER RES, V6, P1830, DOI 10.1158/1541-7786.MCR-08-0167; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Brown V, 2001, CELL, V107, P477, DOI 10.1016/S0092-8674(01)00568-2; Bueno MJ, 2008, CANCER CELL, V13, P496, DOI 10.1016/j.ccr.2008.04.018; Carpenter B, 2006, BBA-REV CANCER, V1765, P85, DOI 10.1016/j.bbcan.2005.10.002; Chang IS, 2007, BLOOD, V110, P994, DOI 10.1182/blood-2007-03-078303; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Darnell JC, 2001, CELL, V107, P489, DOI 10.1016/S0092-8674(01)00566-9; Eiring AM, 2008, BLOOD, V111, P816, DOI 10.1182/blood-2007-05-090472; Evans JR, 2003, ONCOGENE, V22, P8012, DOI 10.1038/sj.onc.1206645; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; Ferrari-Amorotti G, 2006, BLOOD, V108, P1353, DOI 10.1182/blood-2006-01-011833; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Fujimura K, 2008, RNA, V14, P425, DOI 10.1261/rna.780708; Garzon R, 2006, TRENDS MOL MED, V12, P580, DOI 10.1016/j.molmed.2006.10.006; George Ajish D, 2006, RNA Biol, V3, P57; Glisovic T, 2008, FEBS LETT, V582, P1977, DOI 10.1016/j.febslet.2008.03.004; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Hinman MN, 2008, CELL MOL LIFE SCI, V65, P3168, DOI 10.1007/s00018-008-8252-6; Hoover RR, 2001, ONCOGENE, V20, P5826, DOI 10.1038/sj.onc.1204549; Jamieson CHM, 2004, NEW ENGL J MED, V351, P657, DOI 10.1056/NEJMoa040258; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Keene JD, 2007, NAT REV GENET, V8, P533, DOI 10.1038/nrg2111; Keene JD, 2006, NAT PROTOC, V1, P302, DOI 10.1038/nprot.2006.47; Keeshan K, 2003, BLOOD, V102, P1267, DOI 10.1182/blood-2003-02-0477; Khabar KSA, 2005, J INTERF CYTOK RES, V25, P1, DOI 10.1089/jir.2005.25.1; Lal A, 2004, EMBO J, V23, P3092, DOI 10.1038/sj.emboj.7600305; Makeyev AV, 2002, RNA, V8, P265, DOI 10.1017/S1355838202024627; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; Nieborowska-Skorska M, 2002, BLOOD, V99, P4531, DOI 10.1182/blood.V99.12.4531; Notari M, 2006, BLOOD, V107, P2507, DOI 10.1182/blood-2005-09-3732; Ostareck-Lederer A, 2004, BIOL CELL, V96, P407, DOI 10.1016/j.biolcel.2004.03.010; Parker R, 2007, MOL CELL, V25, P635, DOI 10.1016/j.molcel.2007.02.011; Perrotti D, 2002, NAT GENET, V30, P48, DOI 10.1038/ng791; Perrotti D, 2007, CLIN CANCER RES, V13, P1638, DOI 10.1158/1078-0432.CCR-06-2320; ROSMARIN AG, 1989, BLOOD, V73, P131; Schultheis B, 2005, BLOOD, V105, P4893, DOI 10.1182/blood-2005-01-0210; Tenen DG, 2003, NAT REV CANCER, V3, P89, DOI 10.1038/nrc989; Vasudevan S, 2007, SCIENCE, V318, P1931, DOI 10.1126/science.1149460; Venturini L, 2007, BLOOD, V109, P4399, DOI 10.1182/blood-2006-09-045104; Wagner K, 2006, P NATL ACAD SCI USA, V103, P6338, DOI 10.1073/pnas.0508143103; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang W, 2001, LEUKEMIA, V15, P779, DOI 10.1038/sj.leu.2402094; Zalfa F, 2003, CELL, V112, P317, DOI 10.1016/S0092-8674(03)00079-5	45	376	407	2	49	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					652	665		10.1016/j.cell.2010.01.007	http://dx.doi.org/10.1016/j.cell.2010.01.007			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211135	Green Accepted, Bronze			2022-12-01	WOS:000275197400015
J	Wang, F; Wang, XH; Yuan, CG; Ma, JY				Wang, Fei; Wang, Xinhe; Yuan, Chong-Gang; Ma, Jiyan			Generating a Prion with Bacterially Expressed Recombinant Prion Protein	SCIENCE			English	Article							IN-VITRO; SCRAPIE; RESISTANT; PRP; CONFORMATION; PROPAGATION; MOLECULES; STRAINS; MICE	The prion hypothesis posits that a misfolded form of prion protein (PrP) is responsible for the infectivity of prion disease. Using recombinant murine PrP purified from Escherichia coli, we created a recombinant prion with the attributes of the pathogenic PrP isoform: aggregated, protease-resistant, and self-perpetuating. After intracerebral injection of the recombinant prion, wild-type mice developed neurological signs in similar to 130 days and reached the terminal stage of disease in similar to 150 days. Characterization of diseased mice revealed classic neuropathology of prion disease, the presence of protease-resistant PrP, and the capability of serially transmitting the disease; these findings confirmed that the mice succumbed to prion disease. Thus, as postulated by the prion hypothesis, the infectivity in mammalian prion disease results from an altered conformation of PrP.	[Wang, Fei; Wang, Xinhe; Ma, Jiyan] Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA; [Yuan, Chong-Gang; Ma, Jiyan] E China Normal Univ, Sch Life Sci, Shanghai 200062, Peoples R China	University System of Ohio; Ohio State University; East China Normal University	Ma, JY (corresponding author), Ohio State Univ, Dept Mol & Cellular Biochem, Columbus, OH 43210 USA.	ma.131@osu.edu	Wang, Fei/D-9550-2013	Ma, Jiyan/0000-0001-7150-1898	Ellison Medical Foundation; NIH [R01NS060729]; Ministry of Education of China [985]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS060729] Funding Source: NIH RePORTER	Ellison Medical Foundation(Lawrence Ellison Foundation); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ministry of Education of China(Ministry of Education, China); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank. A. Aguzzi, M.-S. Sy, and B. Wainer for reagents and A. Steele for comments on the manuscript. Supported by the Ellison Medical Foundation, NIH grant R01NS060729, and Ministry of Education of China project 985.	Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; Baron GS, 2006, J VIROL, V80, P2106, DOI 10.1128/JVI.80.5.2106-2117.2006; BESSEN RA, 1995, NATURE, V375, P698, DOI 10.1038/375698a0; BUELER H, 1993, CELL, V73, P1339, DOI 10.1016/0092-8674(93)90360-3; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; Castilla J, 2008, EMBO J, V27, P2557, DOI 10.1038/emboj.2008.181; Caughey B, 2006, NATURE, V443, P803, DOI 10.1038/nature05294; Caughey B, 2009, ANNU REV BIOCHEM, V78, P177, DOI 10.1146/annurev.biochem.78.082907.145410; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Deleault NR, 2007, P NATL ACAD SCI USA, V104, P9741, DOI 10.1073/pnas.0702662104; Deleault NR, 2005, J BIOL CHEM, V280, P26873, DOI 10.1074/jbc.M503973200; Deleault NR, 2003, NATURE, V425, P717, DOI 10.1038/nature01979; GABIZON R, 1987, P NATL ACAD SCI USA, V84, P4017, DOI 10.1073/pnas.84.12.4017; Geoghegan JC, 2007, J BIOL CHEM, V282, P36341, DOI 10.1074/jbc.M704447200; KOCISKO DA, 1994, NATURE, V370, P471, DOI 10.1038/370471a0; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Manuelidis L, 2007, J CELL BIOCHEM, V100, P897, DOI 10.1002/jcb.21090; Pan T, 2005, J VIROL, V79, P12355, DOI 10.1128/JVI.79.19.12355-12364.2005; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Raeber AJ, 1999, P NATL ACAD SCI USA, V96, P3987, DOI 10.1073/pnas.96.7.3987; Tamguney G, 2008, J GEN VIROL, V89, P1777, DOI 10.1099/vir.0.2008/001255-0; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; Wang F, 2007, BIOCHEMISTRY-US, V46, P7045, DOI 10.1021/bi700299h; Weissmann C, 2005, CELL, V122, P165, DOI 10.1016/j.cell.2005.07.001; White SH, 2001, J BIOL CHEM, V276, P32395, DOI 10.1074/jbc.R100008200	25	515	529	2	102	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1132	1135		10.1126/science.1183748	http://dx.doi.org/10.1126/science.1183748			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20110469	Green Accepted			2022-12-01	WOS:000274901100037
J	Srinivas, N; Jetter, P; Ueberbacher, BJ; Werneburg, M; Zerbe, K; Steinmann, J; Van der Meijden, B; Bernardini, F; Lederer, A; Dias, RLA; Misson, PE; Henze, H; Zumbrunn, J; Gombert, FO; Obrecht, D; Hunziker, P; Schauer, S; Ziegler, U; Kach, A; Eberl, L; Riedel, K; DeMarco, SJ; Robinson, JA				Srinivas, Nityakalyani; Jetter, Peter; Ueberbacher, Bernhard J.; Werneburg, Martina; Zerbe, Katja; Steinmann, Jessica; Van der Meijden, Benjamin; Bernardini, Francesca; Lederer, Alexander; Dias, Ricardo L. A.; Misson, Pauline E.; Henze, Heiko; Zumbrunn, Juerg; Gombert, Frank O.; Obrecht, Daniel; Hunziker, Peter; Schauer, Stefan; Ziegler, Urs; Kaech, Andres; Eberl, Leo; Riedel, Kathrin; DeMarco, Steven J.; Robinson, John A.			Peptidomimetic Antibiotics Target Outer-Membrane Biogenesis in Pseudomonas aeruginosa	SCIENCE			English	Article							ANTIMICROBIAL PEPTIDE PROTEGRIN; SOLID-STATE NMR; CYSTIC-FIBROSIS AIRWAY; ESCHERICHIA-COLI; HAIRPIN MIMETICS; LIPID-BILAYERS; BROAD-SPECTRUM; LIPOPOLYSACCHARIDE; IDENTIFICATION; PERMEABILITY	Antibiotics with new mechanisms of action are urgently required to combat the growing health threat posed by resistant pathogenic microorganisms. We synthesized a family of peptidomimetic antibiotics based on the antimicrobial peptide protegrin I. Several rounds of optimization gave a lead compound that was active in the nanomolar range against Gram-negative Pseudomonas spp., but was largely inactive against other Gram-negative and Gram-positive bacteria. Biochemical and genetic studies showed that the peptidomimetics had a non-membrane-lytic mechanism of action and identified a homolog of the beta-barrel protein LptD (Imp/OstA), which functions in outer-membrane biogenesis, as a cellular target. The peptidomimetic showed potent antimicrobial activity in a mouse septicemia infection model. Drug-resistant strains of Pseudomonas are a serious health problem, so this family of antibiotics may have important therapeutic applications.	[Bernardini, Francesca; Lederer, Alexander; Dias, Ricardo L. A.; Misson, Pauline E.; Henze, Heiko; Zumbrunn, Juerg; Gombert, Frank O.; Obrecht, Daniel; DeMarco, Steven J.] Polyphor AG, CH-4123 Allschwil, Switzerland; [Srinivas, Nityakalyani; Jetter, Peter; Ueberbacher, Bernhard J.; Werneburg, Martina; Zerbe, Katja; Steinmann, Jessica; Van der Meijden, Benjamin; Robinson, John A.] Univ Zurich, Dept Chem, CH-8057 Zurich, Switzerland; [Hunziker, Peter; Schauer, Stefan] Funct Genom Ctr Zurich, CH-8057 Zurich, Switzerland; [Ziegler, Urs; Kaech, Andres] Univ Zurich, Ctr Microscopy & Image Anal, CH-8057 Zurich, Switzerland; [Eberl, Leo; Riedel, Kathrin] Univ Zurich, Dept Microbiol, CH-8057 Zurich, Switzerland	Polyphor Ltd; University of Zurich; University of Zurich; University of Zurich	DeMarco, SJ (corresponding author), Polyphor AG, Hegenheimermattweg 125, CH-4123 Allschwil, Switzerland.	steve.demarco@polyphor.com; robinson@oci.uzh.ch	Eberl, Leo/AAE-8165-2019; Eberl, Leo/A-8380-2012; Riedel, Katharina/B-6091-2015	Eberl, Leo/0000-0002-7241-0864; GOMBERT, Frank Otto/0000-0002-7507-697X; Riedel, Katharina/0000-0002-4629-3019	Swiss National Science Foundation; Swiss Commission for Technology and Innovation; European Union	Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Swiss Commission for Technology and Innovation; European Union(European Commission)	We thank A. Meier for technical support. This study was supported by grants from the Swiss National Science Foundation, the Swiss Commission for Technology and Innovation, and the European Union 7th Framework Programme (project NABATIVI). Relevant patents are WO/2007/079605, WO/2007/079597, and WO/2004/018503. J.R. is a consultant for Polyphor AG. Patents that cover the structure, synthesis, and activity of the antibiotics (AGWO/2007/079605, WO/2007/079597, WO/2004/018503) are owned jointly by University of Zurich and Polyphor AG.	Bos MP, 2007, ANNU REV MICROBIOL, V61, P191, DOI 10.1146/annurev.micro.61.080706.093245; Braun M, 2002, MOL MICROBIOL, V45, P1289, DOI 10.1046/j.1365-2958.2002.03091.x; Buffy JJ, 2003, BIOPHYS J, V85, P2363, DOI 10.1016/S0006-3495(03)74660-8; Cho Y, 1998, INFECT IMMUN, V66, P2486, DOI 10.1128/IAI.66.6.2486-2493.1998; DELORENZO V, 1993, GENE, V123, P17, DOI 10.1016/0378-1119(93)90533-9; Dorman G, 2000, TRENDS BIOTECHNOL, V18, P64, DOI 10.1016/S0167-7799(99)01402-X; Ernst RK, 2006, J BACTERIOL, V188, P191, DOI 10.1128/JB.188.1.191-201.2006; Ernst RK, 1999, SCIENCE, V286, P1561, DOI 10.1126/science.286.5444.1561; Friedrich CL, 2000, ANTIMICROB AGENTS CH, V44, P2086, DOI 10.1128/AAC.44.8.2086-2092.2000; Gidalevitz D, 2003, P NATL ACAD SCI USA, V100, P6302, DOI 10.1073/pnas.0934731100; Guo L, 1998, CELL, V95, P189, DOI 10.1016/S0092-8674(00)81750-X; Jia WY, 2004, J BIOL CHEM, V279, P44966, DOI 10.1074/jbc.M404963200; Jiang LJ, 2000, HELV CHIM ACTA, V83, P3097, DOI 10.1002/1522-2675(20001220)83:12<3097::AID-HLCA3097>3.0.CO;2-1; KOKRYAKOV VN, 1993, FEBS LETT, V327, P231, DOI 10.1016/0014-5793(93)80175-T; Mani R, 2006, BIOCHEMISTRY-US, V45, P8341, DOI 10.1021/bi060305b; Mani R, 2006, P NATL ACAD SCI USA, V103, P16242, DOI 10.1073/pnas.0605079103; MOORE RA, 1986, ANTIMICROB AGENTS CH, V30, P923, DOI 10.1128/AAC.30.6.923; Robinson JA, 2005, BIOORGAN MED CHEM, V13, P2055, DOI 10.1016/j.bmc.2005.01.009; Robinson JA, 2008, DRUG DISCOV TODAY, V13, P944, DOI 10.1016/j.drudis.2008.07.008; Roth BL, 1997, APPL ENVIRON MICROB, V63, P2421, DOI 10.1128/AEM.63.6.2421-2431.1997; SAMPSON BA, 1989, GENETICS, V122, P491; Shankaramma SC, 2002, CHEMBIOCHEM, V3, P1126, DOI 10.1002/1439-7633(20021104)3:11<1126::AID-CBIC1126>3.0.CO;2-I; Sperandeo P, 2008, J BACTERIOL, V190, P4460, DOI 10.1128/JB.00270-08; Steinberg DA, 1997, ANTIMICROB AGENTS CH, V41, P1738, DOI 10.1128/AAC.41.8.1738; Stover CK, 2000, NATURE, V406, P959, DOI 10.1038/35023079; VAARA M, 1992, MICROBIOL REV, V56, P395, DOI 10.1128/MMBR.56.3.395-411.1992; Wu T, 2005, CELL, V121, P235, DOI 10.1016/j.cell.2005.02.015; Wu T, 2006, P NATL ACAD SCI USA, V103, P11754, DOI 10.1073/pnas.0604744103	28	394	412	4	188	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1010	1013		10.1126/science.1182749	http://dx.doi.org/10.1126/science.1182749			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	556XE	20167788	Green Accepted			2022-12-01	WOS:000274625800044
J	Bajpai, R; Chen, DA; Rada-Iglesias, A; Zhang, JM; Xiong, YQ; Helms, J; Chang, CP; Zhao, YM; Swigut, T; Wysocka, J				Bajpai, Ruchi; Chen, Denise A.; Rada-Iglesias, Alvaro; Zhang, Junmei; Xiong, Yiqin; Helms, Jill; Chang, Ching-Pin; Zhao, Yingming; Swigut, Tomek; Wysocka, Joanna			CHD7 cooperates with PBAF to control multipotent neural crest formation	NATURE			English	Article							EMBRYONIC STEM-CELLS; CHARGE-SYNDROME; POLYMERASE-II; CHROMATIN; EXPRESSION; MUTATIONS; TRANSCRIPTION; NETWORK; COMPLEX; PROTEIN	Heterozygous mutations in the gene encoding the CHD (chromo-domain helicase DNA-binding domain) member CHD7, an ATP-dependent chromatin remodeller homologous to the Drosophila trithorax-group protein Kismet(1,2), result in a complex constellation of congenital anomalies called CHARGE syndrome, which is a sporadic, autosomal dominant disorder characterized by malformations of the craniofacial structures, peripheral nervous system, ears, eyes and heart(3,4). Although it was postulated 25 years ago that CHARGE syndrome results from the abnormal development of the neural crest, this hypothesis remained untested(5). Here we show that, in both humans and Xenopus, CHD7 is essential for the formation of multipotent migratory neural crest (NC), a transient cell population that is ectodermal in origin but undergoes a major transcriptional reprogramming event to acquire a remarkably broad differentiation potential and ability to migrate throughout the body, giving rise to craniofacial bones and cartilages, the peripheral nervous system, pigmentation and cardiac structures(6,7). We demonstrate that CHD7 is essential for activation of the NC transcriptional circuitry, including Sox9, Twist and Slug. In Xenopus embryos, knockdown of Chd7 or overexpression of its catalytically inactive form recapitulates all major features of CHARGE syndrome. In human NC cells CHD7 associates with PBAF (polybromo-and BRG1-associated factor-containing complex) 8 and both remodellers occupy a NC-specific distal SOX9 enhancer(9) and a conserved genomic element located upstream of the TWIST1 gene. Consistently, during embryogenesis CHD7 and PBAF cooperate to promote NC gene expression and cell migration. Our work identifies an evolutionarily conserved role for CHD7 in orchestrating NC gene expression programs, provides insights into the synergistic control of distal elements by chromatin remodellers, illuminates the pathoembryology of CHARGE syndrome, and suggests a broader function for CHD7 in the regulation of cell motility.	[Bajpai, Ruchi; Chen, Denise A.; Rada-Iglesias, Alvaro; Swigut, Tomek; Wysocka, Joanna] Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA; [Xiong, Yiqin] Stanford Univ, Sch Med, Dept Med, Div Cardiovasc Med, Stanford, CA 94305 USA; [Helms, Jill; Chang, Ching-Pin] Stanford Univ, Sch Med, Dept Surg, Stanford, CA 94305 USA; [Wysocka, Joanna] Stanford Univ, Sch Med, Dept Dev Biol, Stanford, CA 94305 USA; [Zhang, Junmei] Univ Texas SW Med Ctr Dallas, Prot Chem Technol Ctr, Dallas, TX 75390 USA; [Zhao, Yingming] Univ Chicago, Ben May Dept Canc Res, Chicago, IL 60637 USA	Stanford University; Stanford University; Stanford University; Stanford University; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Chicago	Wysocka, J (corresponding author), Stanford Univ, Sch Med, Dept Chem & Syst Biol, Stanford, CA 94305 USA.	wysocka@stanford.edu	Xiong, Yiqin/H-1710-2012	Rada-Iglesias, Alvaro/0000-0001-7137-1341; Bajpai, Ruchi/0000-0001-7737-3567; Swigut, Tomek/0000-0002-7649-6781	CIRM SEED [RS1-00323]; Keck Foundation; Searle Scholar Award; EMBO; National Institutes of Health (NIH) [R01DK082664, R01HL085345]; March of Dimes [6-FY06-335]; Oak Foundation; NATIONAL CANCER INSTITUTE [R01CA126832] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085345] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK082664] Funding Source: NIH RePORTER	CIRM SEED; Keck Foundation(W.M. Keck Foundation); Searle Scholar Award; EMBO(European Molecular Biology Organization (EMBO)); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); March of Dimes(March of Dimes); Oak Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank laboratory members for input during the course of this work; S. Brugmann and A. C. Foley for sharing expertise in Xenopus and chick embryology, B. Bedogni, L. Ho and I. Shestopalov for reagents; A. Sanchez-Alvarado for the cartilage staining protocol; G. Crump and S. Cox for sharing unpublished information; and S. Brugmann, E. Duncan, Z. Ma, J. Peng, A. M. Ring and R. A. Roth for comments on the manuscript. This work was supported by CIRM SEED grant RS1-00323, a W. M. Keck Foundation Distinguished Young Scholar Award, a Searle Scholar Award to J. W., an EMBO long-term fellowship to A. R-I., National Institutes of Health (NIH) grant R01DK082664 to Y.Z., March of Dimes grant 6-FY06-335 to J. H., NIH grant R01HL085345 to C-P. C., and an Oak Foundation Fellowship to Y.X.	Bagheri-Fam S, 2006, DEV BIOL, V291, P382, DOI 10.1016/j.ydbio.2005.11.013; Bajpai R, 2009, CELL DEATH DIFFER, V16, P807, DOI 10.1038/cdd.2009.18; Bajpai R, 2008, MOL REPROD DEV, V75, P818, DOI 10.1002/mrd.20809; Barski A, 2007, CELL, V129, P823, DOI 10.1016/j.cell.2007.05.009; Boyer LA, 2005, CELL, V122, P947, DOI 10.1016/j.cell.2005.08.020; Del Barrio MG, 2004, DEV DYNAM, V229, P136, DOI 10.1002/dvdy.10456; DIGNAM JD, 1983, NUCLEIC ACIDS RES, V11, P1475, DOI 10.1093/nar/11.5.1475; Dupin E, 2006, ADV EXP MED BIOL, V589, P96; Eccles MR, 1999, CLIN GENET, V56, P1, DOI 10.1034/j.1399-0004.1999.560101.x; Fu YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000138; Heintzman ND, 2009, NATURE, V459, P108, DOI 10.1038/nature07829; HIGUCHI R, 1988, NUCLEIC ACIDS RES, V16, P7351, DOI 10.1093/nar/16.15.7351; Ho LN, 2009, P NATL ACAD SCI USA, V106, P5187, DOI 10.1073/pnas.0812888106; Kaeser MD, 2008, J BIOL CHEM, V283, P32254, DOI 10.1074/jbc.M806061200; KENNISON JA, 1988, P NATL ACAD SCI USA, V85, P8136, DOI 10.1073/pnas.85.21.8136; Kwon CS, 2007, TRENDS GENET, V23, P403, DOI 10.1016/j.tig.2007.05.010; Lee G, 2007, NAT BIOTECHNOL, V25, P1468, DOI 10.1038/nbt1365; Lemon B, 2001, NATURE, V414, P924, DOI 10.1038/414924a; Loring JF, 2007, HUMAN STEM CELL MANUAL: A LABORATORY GUIDE, P1; Minarcik J C, 2003, Orthod Craniofac Res, V6, P210, DOI 10.1046/j.1601-6335.2003.00268.x; Mohrmann L, 2005, BBA-GENE STRUCT EXPR, V1681, P59, DOI 10.1016/j.bbaexp.2004.10.005; Nieuwkoop P.D., 1994, SYSTEMATICAL CHRONOL, DOI 10.1201/9781003064565-29; Sanlaville D, 2007, EUR J HUM GENET, V15, P389, DOI 10.1038/sj.ejhg.5201778; Sauka-Spengler T, 2008, NAT REV MOL CELL BIO, V9, P557, DOI 10.1038/nrm2428; Schnetz MP, 2009, GENOME RES, V19, P590, DOI 10.1101/gr.086983.108; Seo S, 2005, DEVELOPMENT, V132, P105, DOI 10.1242/dev.01548; SHIMADA T, 1991, J CLIN INVEST, V88, P1043, DOI 10.1172/JCI115365; Shimizu K, 1999, P NATL ACAD SCI USA, V96, P6791, DOI 10.1073/pnas.96.12.6791; SIEBERT JR, 1985, TERATOLOGY, V31, P331, DOI 10.1002/tera.1420310303; Sive H. L., 2000, EARLY DEV XENOPUS LA; Srinivasan S, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000217; Stegmeier F, 2005, P NATL ACAD SCI USA, V102, P13212, DOI 10.1073/pnas.0506306102; Vissers LELM, 2004, NAT GENET, V36, P955, DOI 10.1038/ng1407; Wu JI, 2009, CELL, V136, P200, DOI 10.1016/j.cell.2009.01.009; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	35	389	407	0	40	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 18	2010	463	7283					958	U135		10.1038/nature08733	http://dx.doi.org/10.1038/nature08733			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20130577	Green Accepted			2022-12-01	WOS:000274582700048
J	Bignell, GR; Greenman, CD; Davies, H; Butler, AP; Edkins, S; Andrews, JM; Buck, G; Chen, LN; Beare, D; Latimer, C; Widaa, S; Hinton, J; Fahey, C; Fu, BY; Swamy, S; Dalgliesh, GL; Teh, BT; Deloukas, P; Yang, FT; Campbell, PJ; Futreal, PA; Stratton, MR				Bignell, Graham R.; Greenman, Chris D.; Davies, Helen; Butler, Adam P.; Edkins, Sarah; Andrews, Jenny M.; Buck, Gemma; Chen, Lina; Beare, David; Latimer, Calli; Widaa, Sara; Hinton, Jonathon; Fahey, Ciara; Fu, Beiyuan; Swamy, Sajani; Dalgliesh, Gillian L.; Teh, Bin T.; Deloukas, Panos; Yang, Fengtang; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.			Signatures of mutation and selection in the cancer genome	NATURE			English	Article							SOMATIC FRAMESHIFT MUTATIONS; CANDIDATE TUMOR-SUPPRESSOR; FRAGILE SITE STABILITY; COPY NUMBER VARIATION; GLIOBLASTOMA-MULTIFORME; CHROMOSOME FRAGILITY; LUNG ADENOCARCINOMA; COLORECTAL CANCERS; COLON CANCERS; GENE	The cancer genome is moulded by the dual processes of somatic mutation and selection. Homozygous deletions in cancer genomes occur over recessive cancer genes, where they can confer selective growth advantage, and over fragile sites, where they are thought to reflect an increased local rate of DNA breakage. However, most homozygous deletions in cancer genomes are unexplained. Here we identified 2,428 somatic homozygous deletions in 746 cancer cell lines. These overlie 11% of protein-coding genes that, therefore, are not mandatory for survival of human cells. We derived structural signatures that distinguish between homozygous deletions over recessive cancer genes and fragile sites. Application to clusters of unexplained homozygous deletions suggests that many are in regions of inherent fragility, whereas a small subset overlies recessive cancer genes. The results illustrate how structural signatures can be used to distinguish between the influences of mutation and selection in cancer genomes. The extensive copy number, genotyping, sequence and expression data available for this large series of publicly available cancer cell lines renders them informative reagents for future studies of cancer biology and drug discovery.	[Bignell, Graham R.; Greenman, Chris D.; Davies, Helen; Butler, Adam P.; Edkins, Sarah; Andrews, Jenny M.; Buck, Gemma; Chen, Lina; Beare, David; Latimer, Calli; Widaa, Sara; Hinton, Jonathon; Fahey, Ciara; Fu, Beiyuan; Swamy, Sajani; Dalgliesh, Gillian L.; Deloukas, Panos; Yang, Fengtang; Campbell, Peter J.; Futreal, P. Andrew; Stratton, Michael R.] Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England; [Teh, Bin T.] Van Andel Inst, Grand Rapids, MI 49503 USA; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England	Wellcome Trust Sanger Institute; Van Andel Institute; University of London; Institute of Cancer Research - UK	Stratton, MR (corresponding author), Wellcome Trust Sanger Inst, Cambridge CB10 1SA, England.	paf@sanger.ac.uk; mrs@sanger.ac.uk	Yang, Fan/GYU-4249-2022; Deloukas, Panos/B-2922-2013; Teh, Muy-Teck/B-9284-2016; Dalgliesh, Gillian/B-7799-2008	Deloukas, Panos/0000-0001-9251-070X; Teh, Muy-Teck/0000-0002-7725-8355; Buck, Gemma/0000-0001-5289-1050; Teh, Bin Tean/0000-0003-1514-1124; Yang, Fengtang/0000-0002-3573-2354; Edkins, Sarah/0000-0003-0717-1972; Dalgliesh, Gillian/0000-0001-8526-5064	Wellcome Trust [077012/Z/05/Z]; NATIONAL CANCER INSTITUTE [P01CA155258] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We would like to acknowledge the support of the Wellcome Trust under grant reference 077012/Z/05/Z.	Arlt MF, 2009, AM J HUM GENET, V84, P339, DOI 10.1016/j.ajhg.2009.01.024; Bader S, 1999, ONCOGENE, V18, P8044, DOI 10.1038/sj.onc.1203229; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bullions LC, 1997, MOL CELL BIOL, V17, P4501, DOI 10.1128/MCB.17.8.4501; Casper AM, 2002, CELL, V111, P779, DOI 10.1016/S0092-8674(02)01113-3; Dicks E, 2007, BIOINFORMATICS, V23, P1689, DOI 10.1093/bioinformatics/btm152; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Freeman JL, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-195; Freudenreich CH, 2007, FRONT BIOSCI-LANDMRK, V12, P4911, DOI 10.2741/2437; FUNG YKT, 1987, SCIENCE, V236, P1657, DOI 10.1126/science.2885916; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Greenman CD, 2010, BIOSTATISTICS, V11, P164, DOI 10.1093/biostatistics/kxp045; Iliopoulos D, 2006, CANCER LETT, V232, P27, DOI 10.1016/j.canlet.2005.06.048; KAMB A, 1994, NAT GENET, V8, P22, DOI 10.1038/ng0994-22; Krimpenfort P, 2007, NATURE, V448, P943, DOI 10.1038/nature06084; Li J, 1997, SCIENCE, V275, P1943, DOI 10.1126/science.275.5308.1943; Liu M, 2008, NATURE, V451, P841, DOI 10.1038/nature06547; Liu TX, 2007, NAT MED, V13, P78, DOI 10.1038/nm1512; Lukusa T, 2008, BBA-GENE REGUL MECH, V1779, P3, DOI 10.1016/j.bbagrm.2007.10.005; MARKOWITZ S, 1995, SCIENCE, V268, P1336, DOI 10.1126/science.7761852; McCarroll SA, 2008, NAT GENET, V40, P1166, DOI 10.1038/ng.238; Melo SA, 2009, NAT GENET, V41, P365, DOI 10.1038/ng.317; OZAWA M, 1989, EMBO J, V8, P1711, DOI 10.1002/j.1460-2075.1989.tb03563.x; Pasqualucci L, 2001, NATURE, V412, P341, DOI 10.1038/35085588; Perry GH, 2008, GENOME RES, V18, P1698, DOI 10.1101/gr.082016.108; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Ried K, 2000, HUM MOL GENET, V9, P1651, DOI 10.1093/hmg/9.11.1651; Sawinska M, 2007, GENE CHROMOSOME CANC, V46, P991, DOI 10.1002/gcc.20484; Schwartz M, 2005, GENE DEV, V19, P2715, DOI 10.1101/gad.340905; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Solomon DA, 2008, CANCER RES, V68, P8657, DOI 10.1158/0008-5472.CAN-08-2084; Solomon DA, 2009, CANCER RES, V69, P5630, DOI 10.1158/0008-5472.CAN-09-1055; Solomon DA, 2008, CANCER RES, V68, P10300, DOI 10.1158/0008-5472.CAN-08-3272; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Teng DHF, 1997, CANCER RES, V57, P4177; Thiagalingam S, 1996, NAT GENET, V13, P343, DOI 10.1038/ng0796-343; Vermeulen SJ, 1999, ONCOGENE, V18, P905, DOI 10.1038/sj.onc.1202348; Versteege I, 1998, NATURE, V394, P203, DOI 10.1038/28212; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010	40	511	522	0	63	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					893	U61		10.1038/nature08768	http://dx.doi.org/10.1038/nature08768			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164919	Green Accepted, hybrid			2022-12-01	WOS:000274582700035
J	Singh, JA				Singh, Jerome Amir			Organ transplantation between HIV-infected patients	LANCET			English	Editorial Material									[Singh, Jerome Amir] Univ KwaZulu Natal, CAPRISA, ZA-4001 Durban, Kwazulu Natal, South Africa; [Singh, Jerome Amir] Univ KwaZulu Natal, Howard Coll Sch Law, ZA-4001 Durban, Kwazulu Natal, South Africa; [Singh, Jerome Amir] Univ Toronto, Dalla Lana Sch Publ Hlth, Toronto, ON, Canada; [Singh, Jerome Amir] Univ Toronto, Joint Ctr Bioeth, Toronto, ON, Canada	University of Kwazulu Natal; University of Kwazulu Natal; University of Toronto; University of Toronto	Singh, JA (corresponding author), Univ KwaZulu Natal, CAPRISA, ZA-4001 Durban, Kwazulu Natal, South Africa.	singhj9@ukzn.ac.za	Singh, Jerome Amir/ABG-1573-2021					BERESFORD B, 2008, GUARDIAN LOND   1025; BONHAM AC, 2000, 18 INT C TRANSPL SOC; Calabrese LH, 2003, NEW ENGL J MED, V348, P2323, DOI 10.1056/NEJMoa022935; Frassetto LA, 2009, NAT REV NEPHROL, V5, P583, DOI 10.1038/nrneph.2009.140; Gow PJ, 2001, AIDS, V15, P291, DOI 10.1097/00002030-200101260-00029; Halpern SD, 2002, NEW ENGL J MED, V347, P284, DOI 10.1056/NEJMsb020632; Kuo PC, 2001, TRANSPLANTATION, V71, P1689, DOI 10.1097/00007890-200106150-00033; Rizvi SAH, 2003, KIDNEY INT, V63, P96, DOI 10.1046/j.1523-1755.63.s83.20.x; Roland ME, 2003, TRANSPLANTATION, V75, P425, DOI 10.1097/01.TP.0000046943.35335.18; RUTECKI GW, 2004, TRANSPLANTING HIV PO; TZAKIS AG, 1990, TRANSPLANTATION, V49, P354, DOI 10.1097/00007890-199002000-00025; *UN NETW ORG SHAR, 2008, US TRANSPL WAIT LIST; Wright CE, 2002, NEW ENGL J MED, V347, P1801	13	3	3	0	0	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					442	443		10.1016/S0140-6736(09)60338-X	http://dx.doi.org/10.1016/S0140-6736(09)60338-X			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20152530				2022-12-01	WOS:000274757900008
J	Angier, E; Sheikh, A				Angier, Elizabeth; Sheikh, Aziz			10-Minute Consultation Pollen food syndrome in a teenage student	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Sheikh, Aziz] Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland; [Angier, Elizabeth] No Gen Hosp, Allergy & Clin Immunol Unit, Sheffield S5 7AU, S Yorkshire, England	University of Edinburgh; Northern General Hospital	Sheikh, A (corresponding author), Univ Edinburgh, Ctr Populat Hlth Sci, Allergy & Resp Res Grp, Edinburgh EH8 9DX, Midlothian, Scotland.	Aziz.sheikh@ed.ac.uk	Sheikh, Aziz/D-2818-2009	Sheikh, Aziz/0000-0001-7022-3056				Vieths S, 2002, ANN NY ACAD SCI, V964, P47	1	0	0	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 1	2010	340								b3405	10.1136/bmj.b3405	http://dx.doi.org/10.1136/bmj.b3405			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553CT	20123832				2022-12-01	WOS:000274343300012
J	Farmer, CG; Sanders, K				Farmer, C. G.; Sanders, Kent			Unidirectional Airflow in the Lungs of Alligators	SCIENCE			English	Article							AMERICAN ALLIGATOR; THEROPOD DINOSAURS; PELVIC ASPIRATION; NILE CROCODILE; GAS-EXCHANGE; VENTILATION; EVOLUTION; MISSISSIPPIENSIS	The lungs of birds move air in only one direction during both inspiration and expiration through most of the tubular gas-exchanging bronchi (parabronchi), whereas in the lungs of mammals and presumably other vertebrates, air moves tidally into and out of terminal gas-exchange structures, which are cul-de-sacs. Unidirectional flow purportedly depends on bellowslike ventilation by air sacs and may have evolved to meet the high aerobic demands of sustained flight. Here, we show that air flows unidirectionally through parabronchi in the lungs of the American alligator, an amphibious ectotherm without air sacs, which suggests that this pattern dates back to the basal archosaurs of the Triassic and may have been present in their nondinosaur descendants (phytosaurs, aetosaurs, rauisuchians, crocodylomorphs, and pterosaurs) as well as in dinosaurs.	[Farmer, C. G.] Univ Utah, Dept Biol, Salt Lake City, UT 84112 USA; [Sanders, Kent] Univ Utah, Hlth Sci Ctr, Dept Radiol, Musculoskeletal Div, Salt Lake City, UT 84132 USA	Utah System of Higher Education; University of Utah; Utah System of Higher Education; University of Utah	Farmer, CG (corresponding author), Univ Utah, Dept Biol, 257 South 1400 East, Salt Lake City, UT 84112 USA.	cg.frmr@gmail.com			NSF [IOS-0818973]	NSF(National Science Foundation (NSF))	This work was supported by NSF (grant IOS-0818973 to C. G. F.).	Berner RA, 2007, SCIENCE, V316, P557, DOI 10.1126/science.1140273; BICKLER PE, 1985, AM J PHYSIOL, V249, pR477, DOI 10.1152/ajpregu.1985.249.4.R477; Brusatte SL, 2008, SCIENCE, V321, P1485, DOI 10.1126/science.1161833; Carrier DR, 2000, PALEOBIOLOGY, V26, P271, DOI 10.1666/0094-8373(2000)026<0271:TEOPAI>2.0.CO;2; Claessens LPAM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004497; Crompton A.W., 1979, P59; Dotterweich H., 1936, Zeitschrift fuer Vergleichende Physiologie, V23, P744, DOI 10.1007/BF00341105; Farmer CG, 2000, J EXP BIOL, V203, P1679; HAZELHOFF EH, 1951, POULTRY SCI, V30, P3, DOI 10.3382/ps.0300003; HICKS JW, 1992, RESP PHYSIOL, V88, P23, DOI 10.1016/0034-5687(92)90026-S; MOSER F, 1902, ARCH MIKROSK ANAT EN, V60, P587, DOI DOI 10.1007/BF02978399; O'Connor PM, 2005, NATURE, V436, P253, DOI 10.1038/nature03716; Perreau J, 1998, CRYPTOGAMIE MYCOL, V19, P1; PERRY SF, 1990, J COMP PHYSIOL B, V159, P761, DOI 10.1007/BF00691722; PERRY SF, 1988, J EXP BIOL, V134, P99; Perry SF, 1989, COMP PULMONARY PHYSL, P193; POWELL FL, 1989, RESP PHYSIOL, V78, P83, DOI 10.1016/0034-5687(89)90144-8; Ruben JA, 1999, SCIENCE, V283, P514, DOI 10.1126/science.283.5401.514; SCHEID P, 1987, BIRD RESPIRATION, V1, P97; WOLF SIEGFRIED, 1933, ZOOL JAHRB ABT ANAT U ONT, V57, P139; [No title captured]	21	98	99	1	58	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					338	340		10.1126/science.1180219	http://dx.doi.org/10.1126/science.1180219			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075253				2022-12-01	WOS:000273629700045
J	Ulijasz, AT; Cornilescu, G; Cornilescu, CC; Zhang, JR; Rivera, M; Markley, JL; Vierstra, RD				Ulijasz, Andrew T.; Cornilescu, Gabriel; Cornilescu, Claudia C.; Zhang, Junrui; Rivera, Mario; Markley, John L.; Vierstra, Richard D.			Structural basis for the photoconversion of a phytochrome to the activated Pfr form	NATURE			English	Article							CHROMOPHORE-BINDING DOMAIN; PSEUDOMONAS-AERUGINOSA BACTERIOPHYTOCHROME; INDUCED PROTON RELEASE; TETRAPYRROLE CHROMOPHORE; SIGNAL-TRANSDUCTION; DIPOLAR COUPLINGS; CRYSTAL-STRUCTURE; GROUND-STATE; GAF DOMAIN; CYANOBACTERIAL	Phytochromes are a collection of bilin-containing photoreceptors that regulate numerous photoresponses in plants and microorganisms through their ability to photointerconvert between a red-light-absorbing, ground state (Pr) and a far-red-light-absorbing, photoactivated state (Pfr)(1,2). Although the structures of several phytochromes as Pr have been determined(3-7), little is known about the structure of Pfr and how it initiates signalling. Here we describe the three-dimensional solution structure of the bilin-binding domain as Pfr, using the cyanobacterial phytochrome from Synechococcus OSB'. Contrary to predictions, light-induced rotation of the A pyrrole ring but not the D ring is the primary motion of the chromophore during photoconversion. Subsequent rearrangements within the protein then affect intradomain and interdomain contact sites within the phytochrome dimer. On the basis of our models, we propose that phytochromes act by propagating reversible light-driven conformational changes in the bilin to altered contacts between the adjacent output domains, which in most phytochromes direct differential phosphotransfer.	[Ulijasz, Andrew T.; Zhang, Junrui; Vierstra, Richard D.] Univ Wisconsin, Dept Genet, Madison, WI 53706 USA; [Cornilescu, Gabriel; Cornilescu, Claudia C.; Markley, John L.] Univ Wisconsin, Natl Magnet Resonance Facil Madison, Madison, WI 53706 USA; [Rivera, Mario] Univ Kansas, Lawrence, KS 66057 USA	University of Wisconsin System; University of Wisconsin Madison; University of Wisconsin System; University of Wisconsin Madison; University of Kansas	Vierstra, RD (corresponding author), Univ Wisconsin, Dept Genet, Madison, WI 53706 USA.	vierstra@wisc.edu	Cornilescu, Gabriel/H-3113-2011; Cornilescu, Claudia/H-1959-2012; Cornilescu, Claudia/K-1981-2015; Zhang, Junrui/J-2684-2012	Cornilescu, Gabriel/0000-0002-1204-8904; Cornilescu, Claudia/0000-0002-2401-7806; Ulijasz, Andrew/0000-0003-0739-1297	US National Science Foundation; American Heart Association; U. S. National Institutes of Health; US National Institute of Health; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002301] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U54GM074901] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [1022010] Funding Source: National Science Foundation	US National Science Foundation(National Science Foundation (NSF)); American Heart Association(American Heart Association); U. S. National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); US National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))	Acknowledgements We thank K. T. Forest and W. M. Westler for technical advice. This work was supported by a grant from the US National Science Foundation (R. D. V.) and a postdoctoral fellowship from the American Heart Association (A. T. U.). C. C. C. was supported by the U. S. National Institutes of Health. This study was a collaboration with the National Magnetic Resonance Facility at Madison, which is supported by the US National Institute of Health.	BISHOP JE, 1986, J BIOL CHEM, V261, P6790; Borucki B, 2005, J BIOL CHEM, V280, P34358, DOI 10.1074/jbc.M505493200; Cornilescu G, 2000, J AM CHEM SOC, V122, P10143, DOI 10.1021/ja0016194; Cornilescu G, 1999, J BIOMOL NMR, V13, P289, DOI 10.1023/A:1008392405740; Cornilescu G, 2008, J MOL BIOL, V383, P403, DOI 10.1016/j.jmb.2008.08.034; Essen LO, 2008, P NATL ACAD SCI USA, V105, P14709, DOI 10.1073/pnas.0806477105; Fischer AJ, 2005, BIOCHEMISTRY-US, V44, P15203, DOI 10.1021/bi051633z; FODOR SPA, 1990, BIOCHEMISTRY-US, V29, P11141, DOI 10.1021/bi00502a018; GARRETT DS, 1991, J MAGN RESON, V95, P214, DOI 10.1016/0022-2364(91)90341-P; Harper SM, 2003, SCIENCE, V301, P1541, DOI 10.1126/science.1086810; Inomata K, 2005, J BIOL CHEM, V280, P24491, DOI 10.1074/jbc.M504710200; Inomata K, 2006, J BIOL CHEM, V281, P28162, DOI 10.1074/jbc.M603983200; Inomata K, 2009, BIOCHEMISTRY-US, V48, P2817, DOI 10.1021/bi802334u; Karniol B, 2005, BIOCHEM J, V392, P103, DOI 10.1042/BJ20050826; Kneip C, 1999, BIOCHEMISTRY-US, V38, P15185, DOI 10.1021/bi990688w; LAGARIAS JC, 1979, J AM CHEM SOC, V101, P5030, DOI 10.1021/ja00511a038; LASKOWSKI RA, 1993, J APPL CRYSTALLOGR, V26, P283, DOI 10.1107/S0021889892009944; Oka Y, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000158; Ottiger M, 1998, J MAGN RESON, V134, P365, DOI 10.1006/jmre.1998.1546; Ottiger M, 1999, J BIOMOL NMR, V13, P187, DOI 10.1023/A:1008395916985; Quail PH, 2002, NAT REV MOL CELL BIO, V3, P85, DOI 10.1038/nrm728; Rockwell NC, 2006, ANNU REV PLANT BIOL, V57, P837, DOI 10.1146/annurev.arplant.56.032604.144208; Rohmer T, 2008, P NATL ACAD SCI USA, V105, P15229, DOI 10.1073/pnas.0805696105; RUDIGER W, 1983, P NATL ACAD SCI-BIOL, V80, P6244, DOI 10.1073/pnas.80.20.6244; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Schwieters CD, 2003, J MAGN RESON, V160, P65, DOI 10.1016/S1090-7807(02)00014-9; Seibeck S, 2007, FEBS LETT, V581, P5425, DOI 10.1016/j.febslet.2007.10.043; Strauss HM, 2005, BIOCHEMISTRY-US, V44, P8244, DOI 10.1021/bi050457r; Tjandra N, 1997, SCIENCE, V278, P1111, DOI 10.1126/science.278.5340.1111; Ulijasz AT, 2008, J BIOL CHEM, V283, P21251, DOI 10.1074/jbc.M801592200; Ulmer TS, 2003, J AM CHEM SOC, V125, P9179, DOI 10.1021/ja0350684; van Thor JJ, 2006, BIOPHYS J, V91, P1811, DOI 10.1529/biophysj.106.084335; van Thor JJ, 2001, BIOCHEMISTRY-US, V40, P11460, DOI 10.1021/bi002651d; Vierstra RD, 2005, HANDBOOK OF PHOTOSENSORY RECEPTORS, P171, DOI 10.1002/352760510X.ch8; von Stetten D, 2007, J BIOL CHEM, V282, P2116, DOI 10.1074/jbc.M608878200; Vreede J, 2005, BIOPHYS J, V88, P3525, DOI 10.1529/biophysj.104.055103; Wagner JR, 2008, J BIOL CHEM, V283, P12212, DOI 10.1074/jbc.M709355200; Wagner JR, 2007, J BIOL CHEM, V282, P12298, DOI 10.1074/jbc.M611824200; Wagner JR, 2005, NATURE, V438, P325, DOI 10.1038/nature04118; Wuthrich K., 1986, NMR PROTEINS NUCL AC; Yang X, 2008, P NATL ACAD SCI USA, V105, P14715, DOI 10.1073/pnas.0806718105; Yang X, 2007, P NATL ACAD SCI USA, V104, P12571, DOI 10.1073/pnas.0701737104; Yang XJ, 2009, P NATL ACAD SCI USA, V106, P15639, DOI 10.1073/pnas.0902178106	43	106	114	1	45	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 14	2010	463	7278					250	U143		10.1038/nature08671	http://dx.doi.org/10.1038/nature08671			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075921	Green Accepted, Green Submitted			2022-12-01	WOS:000273582700040
J	Ratnieks, FLW; Carreck, NL				Ratnieks, Francis L. W.; Carreck, Norman L.			Clarity on Honey Bee Collapse?	SCIENCE			English	Editorial Material							APIS-MELLIFERA; DISORDER		[Ratnieks, Francis L. W.; Carreck, Norman L.] Univ Sussex, Lab Apiculture & Social Insects, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England	University of Sussex	Ratnieks, FLW (corresponding author), Univ Sussex, Lab Apiculture & Social Insects, Dept Biol & Environm Sci, Brighton BN1 9QG, E Sussex, England.	f.ratnieks@sussex.ac.uk; norman.carreck@sussex.ac.uk	Carreck, Norman/AAN-6995-2021	Carreck, Norman/0000-0001-7779-9736				Ball B., 1997, Varroa! fight the mite., P11; Carreck N., 2005, P 39 INT AP C AUG 21, P32; Carreck N. L., 2002, APIACTA, V37, P44; CARRECK NL, 2009, P 41 INT AP C MONTP, P146; CCD Steering Committee, 2009, COL COLL DIS PROGR R; Cox-Foster DL, 2007, SCIENCE, V318, P283, DOI 10.1126/science.1146498; Johnson RM, 2009, P NATL ACAD SCI USA, V106, P14790, DOI 10.1073/pnas.0906970106; Malone LA, 2001, APIDOLOGIE, V32, P287, DOI 10.1051/apido:2001130; Martin SJ, 2001, J APPL ECOL, V38, P1082, DOI 10.1046/j.1365-2664.2001.00662.x; Maus Christian, 2003, Bulletin of Insectology, V56, P51; Mixon T, 2009, SCI BEE CULTURE, V1, P22; Naug D, 2009, BIOL CONSERV, V142, P2369, DOI 10.1016/j.biocon.2009.04.007; Neumann P, 2010, J APICULT RES, V49, P1, DOI 10.3896/IBRA.1.49.1.01; Oldroyd BP, 2007, PLOS BIOL, V5, P1195, DOI 10.1371/journal.pbio.0050168; Paxton RJ, 2010, J APICULT RES, V49, P80, DOI 10.3896/IBRA.1.49.1.11; vanEngelsdorp D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006481	16	200	213	3	144	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					152	153		10.1126/science.1185563	http://dx.doi.org/10.1126/science.1185563			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056879				2022-12-01	WOS:000273394000021
J	Low, HH; Sachse, C; Amos, LA; Lowe, J				Low, Harry H.; Sachse, Carsten; Amos, Linda A.; Lowe, Jan			Structure of a Bacterial Dynamin-like Protein Lipid Tube Provides a Mechanism For Assembly and Membrane Curving	CELL			English	Article							CRYSTAL-STRUCTURE; MITOCHONDRIAL FUSION; BINDING PROTEINS; GTPASE DOMAIN; CONSTRICTION; RESOLUTION; MODEL; CONFORMATION; CYTOSKELETON; INSTABILITY	Proteins of the dynamin superfamily mediate membrane fission, fusion, and restructuring events by polymerizing upon lipid bilayers and forcing regions of high curvature. In this work, we show the electron cryomicroscopy reconstruction of a bacterial dynamin-like protein (BDLP) helical filament decorating a lipid tube at similar to 11 angstrom resolution. We fitted the BDLP crystal structure and produced a molecular model for the entire filament. The BDLP GTPase domain dimerizes and forms the tube surface, the GTPase effector domain (GED) mediates self-assembly, and the paddle region contacts the lipids and promotes curvature. Association of BDLP with GMPPNP and lipid induces radical, large-scale conformational changes affecting polymerization. Nucleotide hydrolysis seems therefore to be coupled to polymer disassembly and dissociation from lipid, rather than membrane restructuring. Observed structural similarities with rat dynamin 1 suggest that our results have broad implication for other dynamin family members.	[Low, Harry H.; Sachse, Carsten; Amos, Linda A.; Lowe, Jan] MRC, Mol Biol Lab, Cambridge CB2 0QH, England	MRC Laboratory Molecular Biology	Low, HH (corresponding author), Univ London Birkbeck Coll, Sch Crystallog, Malet St, London WC1E 7HX, England.	h.low@mail.cryst.bbk.ac.uk; jyl@mrc-lmb.cam.ac.uk	Löwe, Jan/X-6998-2019; Low, Harry/T-4482-2019; Sachse, Carsten/AAY-9384-2020; Sachse, Carsten/H-2727-2012; Löwe, Jan/B-3882-2011	Sachse, Carsten/0000-0002-1168-5143; Sachse, Carsten/0000-0002-1168-5143; Amos, Linda/0000-0001-8305-5346; Lowe, Jan/0000-0002-5218-6615	Biotechnology and Biological Sciences Research Council [BBF0062841]; European Molecular Biology Organization long-term fellowship; Biotechnology and Biological Sciences Research Council [BB/F006284/1] Funding Source: researchfish; Medical Research Council [MC_U105184326, MC_U105184313] Funding Source: researchfish; BBSRC [BB/F006284/1] Funding Source: UKRI; MRC [MC_U105184313, MC_U105184326] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); European Molecular Biology Organization long-term fellowship(European Molecular Biology Organization (EMBO)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	H.L. was supported by Biotechnology and Biological Sciences Research Council grant BBF0062841. C.S. is supported by a European Molecular Biology Organization long-term fellowship. We would like to thank Christopher P. Mercogliano (MRC-LMB) for help with electron cryomicroscopy and Shaoxia Chen (MRC-LMB) for help and support with the electron microscopes.	Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; Chen YJ, 2004, NAT STRUCT MOL BIOL, V11, P574, DOI 10.1038/nsmb762; Crowther RA, 1996, J STRUCT BIOL, V116, P9, DOI 10.1006/jsbi.1996.0003; Danino D, 2004, J STRUCT BIOL, V147, P259, DOI 10.1016/j.jsb.2004.04.005; Daumke O, 2007, NATURE, V449, P923, DOI 10.1038/nature06173; FERGUSON KM, 1994, CELL, V79, P199, DOI 10.1016/0092-8674(94)90190-2; Fritz S, 2001, J CELL BIOL, V152, P683, DOI 10.1083/jcb.152.4.683; Garner EC, 2004, SCIENCE, V306, P1021, DOI 10.1126/science.1101313; Ghosh A, 2006, NATURE, V440, P101, DOI 10.1038/nature04510; Griffin EE, 2006, J BIOL CHEM, V281, P16599, DOI 10.1074/jbc.M601847200; Hoppins S, 2009, BBA-MOL CELL RES, V1793, P20, DOI 10.1016/j.bbamcr.2008.07.005; Koshiba T, 2004, SCIENCE, V305, P858, DOI 10.1126/science.1099793; Low HH, 2006, NATURE, V444, P766, DOI 10.1038/nature05312; Lowe J, 2004, ANNU REV BIOPH BIOM, V33, P177, DOI 10.1146/annurev.biophys.33.110502.132647; Lowe J, 2009, INT J BIOCHEM CELL B, V41, P323, DOI 10.1016/j.biocel.2008.08.010; Marks B, 2001, NATURE, V410, P231, DOI 10.1038/35065645; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; McNiven MA, 2000, J CELL BIOL, V151, P187, DOI 10.1083/jcb.151.1.187; Mears JA, 2007, STRUCTURE, V15, P1190, DOI 10.1016/j.str.2007.08.012; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Mozdy AD, 2003, NAT REV MOL CELL BIO, V4, P468, DOI 10.1038/nrm1125; Muhlberg AB, 1997, EMBO J, V16, P6676, DOI 10.1093/emboj/16.22.6676; Narayanan R, 2005, J CELL BIOL, V169, P117, DOI 10.1083/jcb.200502042; Niemann HH, 2001, EMBO J, V20, P5813, DOI 10.1093/emboj/20.21.5813; Okamoto PM, 1999, J BIOL CHEM, V274, P10277, DOI 10.1074/jbc.274.15.10277; PAI EF, 1990, EMBO J, V9, P2351, DOI 10.1002/j.1460-2075.1990.tb07409.x; Praefcke GJK, 2004, NAT REV MOL CELL BIO, V5, P133, DOI 10.1038/nrm1313; Prakash B, 2000, NATURE, V403, P567, DOI 10.1038/35000617; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; Ramachandran R, 2007, EMBO J, V26, P559, DOI 10.1038/sj.emboj.7601491; Reubold TF, 2005, P NATL ACAD SCI USA, V102, P13093, DOI 10.1073/pnas.0506491102; Roux A, 2006, NATURE, V441, P528, DOI 10.1038/nature04718; Sachse C, 2007, J MOL BIOL, V371, P812, DOI 10.1016/j.jmb.2007.05.088; Sever S, 1999, NATURE, V398, P481, DOI 10.1038/19024; Smirnova E, 1999, J BIOL CHEM, V274, P14942, DOI 10.1074/jbc.274.21.14942; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Stowell MHB, 1999, NAT CELL BIOL, V1, P27, DOI 10.1038/8997; Sweitzer SM, 1998, CELL, V93, P1021, DOI 10.1016/S0092-8674(00)81207-6; Thompson HM, 2004, NAT CELL BIOL, V6, P335, DOI 10.1038/ncb1112; van den Ent F, 2006, J BIOCHEM BIOPH METH, V67, P67, DOI 10.1016/j.jbbm.2005.12.008; Wang WK, 2001, ACTA CRYSTALLOGR D, V57, P545, DOI 10.1107/S0907444901002529; Zhang PJ, 2001, NAT CELL BIOL, V3, P922, DOI 10.1038/ncb1001-922	42	125	127	0	28	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1342	1352		10.1016/j.cell.2009.11.003	http://dx.doi.org/10.1016/j.cell.2009.11.003			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064379	Green Published, hybrid			2022-12-01	WOS:000273048700021
J	Wu, DY; Hugenholtz, P; Mavromatis, K; Pukall, R; Dalin, E; Ivanova, NN; Kunin, V; Goodwin, L; Wu, M; Tindall, BJ; Hooper, SD; Pati, A; Lykidis, A; Spring, S; Anderson, IJ; D'haeseleer, P; Zemla, A; Singer, M; Lapidus, A; Nolan, M; Copeland, A; Han, C; Chen, F; Cheng, JF; Lucas, S; Kerfeld, C; Lang, E; Gronow, S; Chain, P; Bruce, D; Rubin, EM; Kyrpides, NC; Klenk, HP; Eisen, JA				Wu, Dongying; Hugenholtz, Philip; Mavromatis, Konstantinos; Pukall, Ruediger; Dalin, Eileen; Ivanova, Natalia N.; Kunin, Victor; Goodwin, Lynne; Wu, Martin; Tindall, Brian J.; Hooper, Sean D.; Pati, Amrita; Lykidis, Athanasios; Spring, Stefan; Anderson, Iain J.; D'haeseleer, Patrik; Zemla, Adam; Singer, Mitchell; Lapidus, Alla; Nolan, Matt; Copeland, Alex; Han, Cliff; Chen, Feng; Cheng, Jan-Fang; Lucas, Susan; Kerfeld, Cheryl; Lang, Elke; Gronow, Sabine; Chain, Patrick; Bruce, David; Rubin, Edward M.; Kyrpides, Nikos C.; Klenk, Hans-Peter; Eisen, Jonathan A.			A phylogeny-driven genomic encyclopaedia of Bacteria and Archaea	NATURE			English	Article							MICROBIAL DIVERSITY; PROTEIN FAMILIES; DATABASE GOLD; PROJECTS; SEQUENCE	Sequencing of bacterial and archaeal genomes has revolutionized our understanding of the many roles played by microorganisms(1). There are now nearly 1,000 completed bacterial and archaeal genomes available(2), most of which were chosen for sequencing on the basis of their physiology. As a result, the perspective provided by the currently available genomes is limited by a highly biased phylogenetic distribution(3-5). To explore the value added by choosing microbial genomes for sequencing on the basis of their evolutionary relationships, we have sequenced and analysed the genomes of 56 culturable species of Bacteria and Archaea selected to maximize phylogenetic coverage. Analysis of these genomes demonstrated pronounced benefits ( compared to an equivalent set of genomes randomly selected from the existing database) in diverse areas including the reconstruction of phylogenetic history, the discovery of new protein families and biological properties, and the prediction of functions for known genes from other organisms. Our results strongly support the need for systematic 'phylogenomic' efforts to compile a phylogeny-driven 'Genomic Encyclopedia of Bacteria and Archaea' in order to derive maximum knowledge from existing microbial genome data as well as from genome sequences to come.	[Wu, Dongying; Hugenholtz, Philip; Mavromatis, Konstantinos; Dalin, Eileen; Ivanova, Natalia N.; Kunin, Victor; Hooper, Sean D.; Pati, Amrita; Lykidis, Athanasios; Anderson, Iain J.; D'haeseleer, Patrik; Lapidus, Alla; Nolan, Matt; Copeland, Alex; Chen, Feng; Cheng, Jan-Fang; Lucas, Susan; Kerfeld, Cheryl; Chain, Patrick; Rubin, Edward M.; Kyrpides, Nikos C.; Eisen, Jonathan A.] DOE Joint Genome Inst, Walnut Creek, CA 94598 USA; [Wu, Dongying; Singer, Mitchell; Eisen, Jonathan A.] Univ Calif Davis, Davis, CA 95616 USA; [Pukall, Ruediger; Tindall, Brian J.; Spring, Stefan; Lang, Elke; Gronow, Sabine; Klenk, Hans-Peter] Deutsch Sammlung Mikroorganism Zellkultur GmbH, German Collect Microorganisms & Cell Cultures, D-38124 Braunschweig, Germany; [Goodwin, Lynne; Han, Cliff; Chain, Patrick; Bruce, David] Los Alamos Natl Lab, DOE Joint Genome Inst, Los Alamos, NM 87545 USA; [D'haeseleer, Patrik; Zemla, Adam] Univ Virginia, Charlottesville, VA 22904 USA; [Wu, Martin] Lawrence Livermore Natl Lab, Livermore, CA 94550 USA	United States Department of Energy (DOE); University of California System; University of California Davis; Leibniz Institut fur Deutsche Sammlung von Mikroorganismen und Zellkulturen (DSMZ); United States Department of Energy (DOE); Los Alamos National Laboratory; University of Virginia; United States Department of Energy (DOE); Lawrence Livermore National Laboratory	Eisen, JA (corresponding author), DOE Joint Genome Inst, Walnut Creek, CA 94598 USA.	jaeisen@ucdavis.edu	Hugenholtz, Philip/AAD-9138-2019; Hugenholtz, Philip/G-9608-2011; Lapidus, Alla L/I-4348-2013; Spring, Stefan/N-6933-2013; Chain, Patrick/O-4140-2019; Eisen, Jonathan A./H-2706-2019; Kyrpides, Nikos C./A-6305-2014; chain, patrick/B-9777-2013	Hugenholtz, Philip/0000-0001-5386-7925; Hugenholtz, Philip/0000-0001-5386-7925; Lapidus, Alla L/0000-0003-0427-8731; Spring, Stefan/0000-0001-6247-0938; Chain, Patrick/0000-0003-3949-3634; Eisen, Jonathan A./0000-0002-0159-2197; Kyrpides, Nikos C./0000-0002-6131-0462; Han, Cliff/0000-0003-1972-0692; Cheng, Jan-Fang/0000-0001-7315-7613; Wu, Martin/0000-0003-3093-4077; Ivanova, Natalia/0000-0002-5802-9485; Mavrommatis, Konstantinos/0000-0003-4549-385X; Kunin, Victor/0000-0002-8741-7866	US Department of Energy's Office of Science, Biological and Environmental Research Program; University of California, Lawrence Berkeley National Laboratory [DE-AC02-05CH11231]; Lawrence Livermore National Laboratory [DE-AC52-07NA27344]; Los Alamos National Laboratory [DE-AC02-06NA25396]; Gordon and Betty Moore Foundation [1660]; DFG INST [599/1-1]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067012, R01GM054592] Funding Source: NIH RePORTER	US Department of Energy's Office of Science, Biological and Environmental Research Program(United States Department of Energy (DOE)); University of California, Lawrence Berkeley National Laboratory(University of California System); Lawrence Livermore National Laboratory(United States Department of Energy (DOE)); Los Alamos National Laboratory(United States Department of Energy (DOE)Los Alamos National Laboratory); Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); DFG INST(German Research Foundation (DFG)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the following people for assistance in aspects of the project including planning and discussions ( R. Stevens, G. Olsen, R. Edwards, J. Bristow, N. Ward, S. Baker, T. Lowe, J. Tiedje, G. Garrity, A. Darling, S. Giovannoni), analysis of genomes whose work could not be included in this report ( B. Henrissat, G. Xie, J. Kinney, I. Paulsen, N. Rawlings, M. Huntemann), project management ( M. Miller, M. Fenner, M. McGowen, A. Greiner), sequencing and finishing ( K. Ikeda, M. Chovatia, P. Richardson, T. Glavinadelrio, C. Detter), culture growth, DNA extraction, and metadata ( D. Gleim, E. Brambilla, S. Schneider, M. Schroder, M. Jando, G. Gehrich-Schroter, C. Wahrenburg, K. Steenblock, S. Welnitz, M. Kopitz, R. Fahnrich,H. Pomrenke, A. Schutze, M. Rohde, M. Goker), and manuscript editing ( M. Youle). This work was performed under the auspices of the US Department of Energy's Office of Science, Biological and Environmental Research Program, and by the University of California, Lawrence Berkeley National Laboratory under contract no. DE-AC02-05CH11231, Lawrence Livermore National Laboratory under contract no. DE-AC52-07NA27344, and Los Alamos National Laboratory under contract no. DE-AC02-06NA25396. Support for J. A. E., D. W. and M. W. was provided by the Gordon and Betty Moore Foundation Grant no. 1660 to J. A. E. Support for work at DSMZ was provided under DFG INST 599/1-1.	Achtman M, 2008, NAT REV MICROBIOL, V6, P431, DOI 10.1038/nrmicro1872; Barrangou R, 2007, SCIENCE, V315, P1709, DOI 10.1126/science.1138140; Beiko RG, 2008, SYST BIOL, V57, P844, DOI 10.1080/10635150802559265; Bernal A, 2001, NUCLEIC ACIDS RES, V29, P126, DOI 10.1093/nar/29.1.126; DeSantis TZ, 2006, APPL ENVIRON MICROB, V72, P5069, DOI 10.1128/AEM.03006-05; Doolittle RF, 2002, BIOESSAYS, V24, P293, DOI 10.1002/bies.10079; Eisen JA, 2000, CURR OPIN MICROBIOL, V3, P475, DOI 10.1016/S1369-5274(00)00125-9; Enright AJ, 2002, NUCLEIC ACIDS RES, V30, P1575, DOI 10.1093/nar/30.7.1575; Enright AJ, 1999, NATURE, V402, P86, DOI 10.1038/47056; Field D, 2008, NAT BIOTECHNOL, V26, P541, DOI 10.1038/nbt1360; Fraser CM, 2000, NATURE, V406, P799, DOI 10.1038/35021244; Hugenholtz P, 2002, GENOME BIOL, V3; Hugenholtz P, 2009, ENVIRON MICROBIOL, V11, P551, DOI 10.1111/j.1462-2920.2009.01888.x; Ishoey T, 2008, CURR OPIN MICROBIOL, V11, P198, DOI 10.1016/j.mib.2008.05.006; Kunin V, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-401; Kunin V, 2008, MICROBIOL MOL BIOL R, V72, P557, DOI 10.1128/MMBR.00009-08; Lapage S. P., 1992, INT CODE NOMENCLATUR; Liolios K, 2008, NUCLEIC ACIDS RES, V36, pD475, DOI 10.1093/nar/gkm884; Marcotte EM, 1999, SCIENCE, V285, P751, DOI 10.1126/science.285.5428.751; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Matsuura Y, 2000, J MOL BIOL, V296, P579, DOI 10.1006/jmbi.1999.3467; Moulton V, 2007, J THEOR BIOL, V246, P186, DOI 10.1016/j.jtbi.2006.12.021; Pace NR, 1997, SCIENCE, V276, P734, DOI 10.1126/science.276.5313.734; Pardi F, 2007, SYSTEMATIC BIOL, V56, P431, DOI 10.1080/10635150701411279; Sasse F, 1998, J NATL CANCER I, V90, P1559, DOI 10.1093/jnci/90.20.1559; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Waino M, 2003, EXTREMOPHILES, V7, P87, DOI 10.1007/s00792-002-0299-y; Ward N, 2001, NATURE, V414, P148, DOI 10.1038/35102737; Wu DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004207; Wu M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-10-r151	30	698	709	1	131	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1056	1060		10.1038/nature08656	http://dx.doi.org/10.1038/nature08656			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033048	Green Accepted, Green Published, hybrid			2022-12-01	WOS:000272996000047
J	Lane, R				Lane, Richard			A protocol for labrador retrievers?	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Lane, R (corresponding author), The Lancet, London NW1 7BY, England.							Church J, 2001, LANCET, V358, P930, DOI 10.1016/S0140-6736(01)06065-2; 2009, GUARDIAN        0427; 2002, US TODAY        0724	3	2	2	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	DEC-JAN	2009	374	9707					2038	2039		10.1016/S0140-6736(09)62134-6	http://dx.doi.org/10.1016/S0140-6736(09)62134-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	537OO	20109816				2022-12-01	WOS:000273122900009
J	Hagberg, CE; Falkevall, A; Wang, X; Larsson, E; Huusko, J; Nilsson, I; van Meeteren, LA; Samen, E; Lu, L; Vanwildemeersch, M; Klar, J; Genove, G; Pietras, K; Stone-Elander, S; Claesson-Welsh, L; Yla-Herttuala, S; Lindahl, P; Eriksson, U				Hagberg, Carolina E.; Falkevall, Annelie; Wang, Xun; Larsson, Erik; Huusko, Jenni; Nilsson, Ingrid; van Meeteren, Laurens A.; Samen, Erik; Lu, Li; Vanwildemeersch, Maarten; Klar, Joakim; Genove, Guillem; Pietras, Kristian; Stone-Elander, Sharon; Claesson-Welsh, Lena; Yla-Herttuala, Seppo; Lindahl, Per; Eriksson, Ulf			Vascular endothelial growth factor B controls endothelial fatty acid uptake	NATURE			English	Article							VEGF-B; LIPID-METABOLISM; TRANSPORT; ANGIOGENESIS; MOUSE; LACKING; FLT-1; PERMEABILITY; RECEPTOR-1; LETHALITY	The vascular endothelial growth factors (VEGFs) are major angiogenic regulators and are involved in several aspects of endothelial cell physiology(1). However, the detailed role of VEGF-B in blood vessel function has remained unclear(2,3). Here we show that VEGF-B has an unexpected role in endothelial targeting of lipids to peripheral tissues. Dietary lipids present in circulation have to be transported through the vascular endothelium to be metabolized by tissue cells, a mechanism that is poorly understood(4). Bioinformatic analysis showed that Vegfb was tightly co-expressed with nuclear-encoded mitochondrial genes across a large variety of physiological conditions in mice, pointing to a role for VEGF-B in metabolism. VEGF-B specifically controlled endothelial uptake of fatty acids via transcriptional regulation of vascular fatty acid transport proteins. As a consequence, Vegfb(-/-) mice showed less uptake and accumulation of lipids in muscle, heart and brown adipose tissue, and instead shunted lipids to white adipose tissue. This regulation was mediated by VEGF receptor 1 and neuropilin 1 expressed by the endothelium. The co-expression of VEGF-B and mitochondrial proteins introduces a novel regulatory mechanism, whereby endothelial lipid uptake and mitochondrial lipid use are tightly coordinated. The involvement of VEGF-B in lipid uptake may open up the possibility for novel strategies to modulate pathological lipid accumulation in diabetes, obesity and cardiovascular diseases.	[Hagberg, Carolina E.; Falkevall, Annelie; Wang, Xun; Nilsson, Ingrid; Vanwildemeersch, Maarten; Pietras, Kristian; Eriksson, Ulf] Karolinska Inst, Tissue Biol Grp, Div Matrix Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Hagberg, Carolina E.; Falkevall, Annelie; Wang, Xun; Vanwildemeersch, Maarten; Klar, Joakim; Pietras, Kristian; Eriksson, Ulf] Ludwig Inst Canc Res Ltd, Stockholm Branch, Karolinska Inst, SE-17177 Stockholm, Sweden; [Larsson, Erik; Lindahl, Per] Univ Gothenburg, Inst Biomed, SE-40530 Gothenburg, Sweden; [Huusko, Jenni; Yla-Herttuala, Seppo] Univ Kuopio, AI Virtanen Inst, Dept Biotechnol & Mol Med, FIN-70211 Kuopio, Finland; [van Meeteren, Laurens A.; Klar, Joakim; Claesson-Welsh, Lena] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Samen, Erik; Stone-Elander, Sharon] Karolinska Pharm, Karolinska Univ Hosp, SE-17176 Stockholm, Sweden; [Samen, Erik; Lu, Li; Stone-Elander, Sharon] Karolinska Inst, SE-17176 Stockholm, Sweden; [Genove, Guillem] Karolinska Inst, Lab Vasc Biol, Div Matrix Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden; [Lindahl, Per] Sahlgrens Univ Hosp, Wallenberg Lab Cardiovasc Res, SE-41345 Gothenburg, Sweden	Karolinska Institutet; Karolinska Institutet; Ludwig Institute for Cancer Research; University of Gothenburg; University of Eastern Finland; Uppsala University; Karolinska Institutet; Karolinska University Hospital; Karolinska Institutet; Karolinska Institutet; Sahlgrenska University Hospital	Eriksson, U (corresponding author), Karolinska Inst, Tissue Biol Grp, Div Matrix Biol, Dept Med Biochem & Biophys, SE-17177 Stockholm, Sweden.	ulf.pe.eriksson@ki.se	Larsson Lekholm, Erik/HDM-8032-2022; Pietras, Kristian/ABE-8727-2020; Genove, Guillem/F-1158-2011; van Meeteren, Laurens/A-9890-2008; Klar, Joakim/H-2900-2019; Van Meeteren, Laurens A./AGQ-6139-2022; Pietras, Kristian/ABG-2097-2021; Larsson Lekholm, Erik/AHE-0932-2022	Larsson Lekholm, Erik/0000-0003-1400-0119; van Meeteren, Laurens/0000-0001-9885-0668; Klar, Joakim/0000-0003-4185-7409; Pietras, Kristian/0000-0001-6738-4705; Larsson Lekholm, Erik/0000-0003-1400-0119; Yla-Herttuala, Seppo/0000-0001-7593-2708; Genove, Guillem/0000-0002-8558-3107; Hagberg, Carolina/0000-0002-5497-2855	Wilhelm och Else Stockmanns Stiftelse; Frans Wilhelm och Waldemar von Frenckells fond; European Commission [LSHG-CT-2004-503573]; Dutch Cancer Society; Novo Nordisk Foundation; Swedish Cancer Foundation; Swedish Research Council; Dr. Peter Wallenbergs Foundation for Economics and Technology; LeDucq Foundation; Swedish Brain Foundation and Hallstens Forskningsstiftelse; Karolinska Institutet	Wilhelm och Else Stockmanns Stiftelse; Frans Wilhelm och Waldemar von Frenckells fond; European Commission(European CommissionEuropean Commission Joint Research Centre); Dutch Cancer Society(KWF Kankerbestrijding); Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Swedish Cancer Foundation; Swedish Research Council(Swedish Research CouncilEuropean Commission); Dr. Peter Wallenbergs Foundation for Economics and Technology; LeDucq Foundation(Leducq Foundation); Swedish Brain Foundation and Hallstens Forskningsstiftelse; Karolinska Institutet(Karolinska Institutet)	We thank S. Rezian for technical assistance; W. C. Claycomb for the gift of the HL-1 cardiomyocytes; M. McMahon for the TIME cells; A. Nash for the 2H10 anti-VEGF-B monoclonal antibody; K. Plate and M. Shibuya for Flt1-TK<SUP>-/-</SUP> mouse organs; and D. Cheresh for the EC-SCL-Cre-ER<SUP>T</SUP> Nrp1<SUP>fl/fl</SUP> mice. C. E. H. was supported by Wilhelm och Else Stockmanns Stiftelse, and by Frans Wilhelm och Waldemar von Frenckells fond. E. L. was supported by Lymphangiogenomics, an Integrated Project funded by the European Commission within its FP6 Programme, under the thematic area 'Life sciences, genomics and biotechnology for health', contract number LSHG-CT-2004-503573. L. A. v. M. was supported by The Dutch Cancer Society. This study was supported by The Novo Nordisk Foundation, The Swedish Cancer Foundation, The Swedish Research Council, Dr. Peter Wallenbergs Foundation for Economics and Technology, The LeDucq Foundation, The Swedish Brain Foundation and Hallstens Forskningsstiftelse, and the Karolinska Institutet.	Aase K, 2001, CIRCULATION, V104, P358, DOI 10.1161/01.CIR.104.3.358; Acevedo LM, 2008, BLOOD, V111, P2674, DOI 10.1182/blood-2007-08-110205; Arany Z, 2008, NATURE, V451, P1008, DOI 10.1038/nature06613; Barrett T, 2007, NUCLEIC ACIDS RES, V35, pD760, DOI 10.1093/nar/gkl887; Bellomo D, 2000, CIRC RES, V86, pE29, DOI 10.1161/01.RES.86.2.e29; BREIER G, 1995, DEV DYNAM, V204, P228, DOI 10.1002/aja.1002040303; Carmeliet P, 1996, NATURE, V380, P435, DOI 10.1038/380435a0; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Faldt J, 2004, ENDOCRINOLOGY, V145, P2680, DOI 10.1210/en.2003-1319; Ferrara N, 1996, NATURE, V380, P439, DOI 10.1038/380439a0; Fischer C, 2008, NAT REV CANCER, V8, P942, DOI 10.1038/nrc2524; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; Hiratsuka S, 1998, P NATL ACAD SCI USA, V95, P9349, DOI 10.1073/pnas.95.16.9349; Jia ZZ, 2007, J MOL NEUROSCI, V33, P25, DOI 10.1007/s12031-007-0038-z; Karpanen T, 2008, CIRC RES, V103, P1018, DOI 10.1161/CIRCRESAHA.108.178459; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Leppanen P, 2005, CIRCULATION, V112, P1347, DOI 10.1161/CIRCULATIONAHA.105.534107; Li X, 2008, ARTERIOSCL THROM VAS, V28, P1614, DOI 10.1161/ATVBAHA.107.158725; Makinen T, 1999, J BIOL CHEM, V274, P21217, DOI 10.1074/jbc.274.30.21217; Migdal M, 1998, J BIOL CHEM, V273, P22272, DOI 10.1074/jbc.273.35.22272; Muoio D. M., 2007, NOVART FDN SYMP, V286, P196; Muoio Deborah M, 2007, Novartis Found Symp, V286, P24; Nagy JA, 2008, ANGIOGENESIS, V11, P109, DOI 10.1007/s10456-008-9099-z; Nauli AM, 2006, GASTROENTEROLOGY, V131, P1197, DOI 10.1053/j.gastro.2006.08.012; Olofsson B, 1996, J BIOL CHEM, V271, P19310, DOI 10.1074/jbc.271.32.19310; Olofsson B, 1998, P NATL ACAD SCI USA, V95, P11709, DOI 10.1073/pnas.95.20.11709; Petersen KF, 2002, J ROY SOC MED, V95, P8; Rissanen TT, 2003, CIRC RES, V92, P1098, DOI 10.1161/01.RES.0000073584.46059.E3; Rohrer L, 2006, BBA-MOL CELL BIOL L, V1761, P186, DOI 10.1016/j.bbalip.2006.01.009; Savage DB, 2007, PHYSIOL REV, V87, P507, DOI 10.1152/physrev.00024.2006; Scotney PD, 2002, CLIN EXP PHARMACOL P, V29, P1024, DOI 10.1046/j.1440-1681.2002.03769.x; Springer ML, 2005, AM J PHYSIOL-HEART C, V289, pH1307, DOI 10.1152/ajpheart.00164.2005; Stahl A, 2004, PFLUG ARCH EUR J PHY, V447, P722, DOI 10.1007/s00424-003-1106-z; Stahl A, 1999, MOL CELL, V4, P299, DOI 10.1016/S1097-2765(00)80332-9; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Tammela T, 2005, CARDIOVASC RES, V65, P550, DOI 10.1016/j.cardiores.2004.12.002; van der Vusse GJ, 2000, CARDIOVASC RES, V45, P279, DOI 10.1016/S0008-6363(99)00263-1; Villena JA, 2008, TRENDS ENDOCRIN MET, V19, P269, DOI 10.1016/j.tem.2008.07.005	38	333	355	4	90	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					917	U136		10.1038/nature08945	http://dx.doi.org/10.1038/nature08945			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20228789				2022-12-01	WOS:000276397300043
J	Chung, I; Akita, R; Vandlen, R; Toomre, D; Schlessinger, J; Mellman, I				Chung, Inhee; Akita, Robert; Vandlen, Richard; Toomre, Derek; Schlessinger, Joseph; Mellman, Ira			Spatial control of EGF receptor activation by reversible dimerization on living cells	NATURE			English	Article							LIVE CELLS; DOMAIN; SURFACE; MECHANISM; FAMILY	Epidermal growth factor receptor (EGFR) is a type I receptor tyrosine kinase, the deregulation of which has been implicated in a variety of human carcinomas(1-4). EGFR signalling is preceded by receptor dimerization, typically thought to result from a ligand-induced conformational change in the ectodomain that exposes a loop (dimerization arm) required for receptor association. Ligand binding may also trigger allosteric changes in the cytoplasmic domain of the receptor that is crucial for signalling(5-7). Despite these insights, ensemble-averaging approaches have not determined the precise mechanism of receptor activation in situ. Using quantum-dot-based optical tracking of single molecules(8-11) combined with a novel time-dependent diffusivity analysis, here we present the dimerization dynamics of individual EGFRs on living cells. Before ligand addition, EGFRs spontaneously formed finite-lifetime dimers kinetically stabilized by their dimerization arms(12-14). The dimers were primed both for ligand binding and for signalling, such that after EGF addition they rapidly showed a very slow diffusivity state that correlated with activation. Although the kinetic stability of unliganded dimers was in principle sufficient for EGF-independent activation, ligand binding was still required for signalling. Interestingly, dimers were enriched in the cell periphery in an actin-and receptor-expression-dependent fashion, resulting in a peripheral enhancement of EGF-induced signalling that may enable polarized responses to growth factors.	[Chung, Inhee; Akita, Robert; Vandlen, Richard; Mellman, Ira] Genentech Inc, San Francisco, CA 94080 USA; [Toomre, Derek] Yale Univ, Sch Med, Dept Cell Biol, New Haven, CT 06510 USA; [Schlessinger, Joseph] Yale Univ, Sch Med, Deparment Pharmacol, New Haven, CT 06510 USA	Roche Holding; Genentech; Yale University; Yale University	Mellman, I (corresponding author), Genentech Inc, 1 DNA Way, San Francisco, CA 94080 USA.	mellman.ira@gene.com	Mellman, Ira/ABG-5896-2020	Chung, Inhee/0000-0002-2312-6357	Research Foundation-Flanders; Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten'); Ghent University; National Institutes of Health; Spanish Ministerio de Ciencia y Tecnologia; Comunidad de Madrid; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR051448, R01AR051886, P50AR054086] Funding Source: NIH RePORTER	Research Foundation-Flanders(FWO); Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten'); Ghent University(Ghent University); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Spanish Ministerio de Ciencia y Tecnologia(Ministry of Science and Innovation, Spain (MICINN)Spanish Government); Comunidad de Madrid(Comunidad de Madrid); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	We thank F. Lammertyn and all colleagues of the Functional Proteomics group at VIB and Ecophysiology-Biochemistry-Toxicology, Centre for Proteome Analysis and Mass Spectrometry (EBT-CEPROMA) at Antwerp University for technical assistance; M. I. Puga and J. Paz-Ares for providing the prey cDNA library for Y2H screens; V. Storme for help with statistical analysis; J. Van Leene and M. Karimi for discussions; and M. De Cock for help in preparing the manuscript. This work was supported by the Research Foundation-Flanders (predoctoral fellowship to L. P.), the Agency for Innovation by Science and Technology in Flanders ('Generisch Basisonderzoek aan de Universiteiten', and predoctoral fellowships to S. T. and J. G.), the Special Research Fund of Ghent University (postdoctoral fellowship to W. G.), the National Institutes of Health (to J. L.) and the Spanish Ministerio de Ciencia y Tecnologia and the Comunidad de Madrid (to R. S.).	ALMEIDA PFF, 1995, LATERAL DIFFUSION ME; Bridges AJ, 1996, CURR MED CHEM, V3, P167; Chung IH, 2004, PHYS REV B, V70, DOI 10.1103/PhysRevB.70.165304; Clayton AHA, 2005, J BIOL CHEM, V280, P30392, DOI 10.1074/jbc.M504770200; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; Fallon L, 2006, NAT CELL BIOL, V8, P834, DOI 10.1038/ncb1441; Gambin Y, 2006, P NATL ACAD SCI USA, V103, P2098, DOI 10.1073/pnas.0511026103; Hynes NE, 2001, ENDOCR-RELAT CANCER, V8, P151, DOI 10.1677/erc.0.0080151; JACOBSON K, 1994, FASEB J, V8, P152; Jaiswal JK, 2003, NAT BIOTECHNOL, V21, P47, DOI 10.1038/nbt767; Johannessen LE, 2006, MOL CELL BIOL, V26, P389, DOI 10.1128/MCB.26.2.389-401.2006; Jura N, 2009, CELL, V137, P1293, DOI 10.1016/j.cell.2009.04.025; Klein P, 2004, P NATL ACAD SCI USA, V101, P929, DOI 10.1073/pnas.0307285101; Kusumi A, 2005, ANNU REV BIOPH BIOM, V34, P351, DOI 10.1146/annurev.biophys.34.040204.144637; Lidke DS, 2005, J CELL BIOL, V170, P619, DOI 10.1083/jcb.200503140; Macdonald-Obermann JL, 2009, J BIOL CHEM, V284, P13570, DOI 10.1074/jbc.M109.001487; Mattoon D, 2004, P NATL ACAD SCI USA, V101, P923, DOI 10.1073/pnas.0307286101; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Moriki T, 2001, J MOL BIOL, V311, P1011, DOI 10.1006/jmbi.2001.4923; Morone N, 2006, J CELL BIOL, V174, P851, DOI 10.1083/jcb.200606007; Naji A, 2007, BIOPHYS J, V93, pL49, DOI 10.1529/biophysj.l07.119222; Ozcan F, 2006, P NATL ACAD SCI USA, V103, P5735, DOI 10.1073/pnas.0601469103; RABINER LR, 1989, P IEEE, V77, P257, DOI 10.1109/5.18626; Red Brewer M, 2009, MOL CELL, V34, P641, DOI 10.1016/j.molcel.2009.04.034; SAFFMAN PG, 1975, P NATL ACAD SCI USA, V72, P3111, DOI 10.1073/pnas.72.8.3111; Sako Y, 2000, NAT CELL BIOL, V2, P168, DOI 10.1038/35004044; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; SORKIN A, 1993, SCIENCE, V261, P612, DOI 10.1126/science.8342026; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013	30	376	384	4	113	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					783	U163		10.1038/nature08827	http://dx.doi.org/10.1038/nature08827			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20208517				2022-12-01	WOS:000276205000050
J	Salaita, K; Nair, PM; Petit, RS; Neve, RM; Das, D; Gray, JW; Groves, JT				Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Neve, Richard M.; Das, Debopriya; Gray, Joe W.; Groves, Jay T.			Restriction of Receptor Movement Alters Cellular Response: Physical Force Sensing by EphA2	SCIENCE			English	Article							IMMUNOLOGICAL SYNAPSE; BREAST-CANCER; LIGANDS; REORGANIZATION; RECOGNITION; MECHANISMS; MICROSCOPY; SUBSTRATE; EPHRIN-A5; MIGRATION	Activation of the EphA2 receptor tyrosine kinase by ephrin-A1 ligands presented on apposed cell surfaces plays important roles in development and exhibits poorly understood functional alterations in cancer. We reconstituted this intermembrane signaling geometry between live EphA2-expressing human breast cancer cells and supported membranes displaying laterally mobile ephrin-A1. Receptor-ligand binding, clustering, and subsequent lateral transport within this junction were observed. EphA2 transport can be blocked by physical barriers nanofabricated onto the underlying substrate. This physical reorganization of EphA2 alters the cellular response to ephrin-A1, as observed by changes in cytoskeleton morphology and recruitment of a disintegrin and metalloprotease 10. Quantitative analysis of receptor-ligand spatial organization across a library of 26 mammary epithelial cell lines reveals characteristic differences that strongly correlate with invasion potential. These observations reveal a mechanism for spatio-mechanical regulation of EphA2 signaling pathways.	[Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Groves, Jay T.] Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Berkeley, CA 94720 USA; [Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Salaita, Khalid; Nair, Pradeep M.; Petit, Rebecca S.; Groves, Jay T.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Mat Sci, Berkeley, CA 94720 USA; [Neve, Richard M.; Das, Debopriya; Gray, Joe W.] Univ Calif Berkeley, Lawrence Berkeley Lab, Div Life Sci, Berkeley, CA 94720 USA; [Gray, Joe W.] Univ Calif San Francisco, Dept Lab Med & Radiat Oncol, San Francisco, CA 94143 USA; [Groves, Jay T.] Natl Univ Singapore, Res Ctr Excellence Mechanobiol, Singapore 117543, Singapore	Howard Hughes Medical Institute; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California San Francisco; National University of Singapore	Groves, JT (corresponding author), Univ Calif Berkeley, Dept Chem, Howard Hughes Med Inst, Berkeley, CA 94720 USA.	jtgroves@lbl.gov	salaita, khalid/C-4414-2008; Gray, Joe/AAX-9549-2020		Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division; Materials Sciences and Engineering Division; U.S. Department of Energy (DOE) [DE-AC0205CH11231]; Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE [DE-AC02-05CH11231]; U.S. Army Medical Research Acquisition Activity [BC076701, W81XWH-08-1-0677]; National Cancer Institute (NCI) [U54 CA143836]; Office of Science, Office of Biological and Environmental Research, of the DOE [DE-AC02-05CH11231]; NIH [U54 CA 112970]; NCI [P50 CA 58207]; NATIONAL CANCER INSTITUTE [U54CA143836, U54CA112970, P50CA058207] Funding Source: NIH RePORTER	Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division(United States Department of Energy (DOE)); Materials Sciences and Engineering Division(United States Department of Energy (DOE)); U.S. Department of Energy (DOE)(United States Department of Energy (DOE)); Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE(United States Department of Energy (DOE)); U.S. Army Medical Research Acquisition Activity; National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Office of Science, Office of Biological and Environmental Research, of the DOE(United States Department of Energy (DOE)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank N. Bayani for assistance in performing Western blotting, A. Smoligovets and C.-H. Yu for performing transfection and imaging with EGFP-actin-expressing MDA-MB-231 cells, and A. Bershadsky for helpful discussions. This work was supported by the Director, Office of Science, Office of Basic Energy Sciences, Chemical Sciences, Geosciences, and Biosciences Division (K. S., P. M. N.; hybrid synthetic-live cell interfaces) and the Materials Sciences and Engineering Division (R. S. P.; supported membrane substrates) of the U.S. Department of Energy (DOE) under contract no. DE-AC0205CH11231. Patterned substrate fabrication was performed, in part, at the Molecular Foundry, Lawrence Berkeley National Laboratory (LBNL), and was supported by the Office of Science, Office of Basic Energy Sciences, Scientific User Facilities Division, of the U.S. DOE under contract no. DE-AC02-05CH11231. This work was also supported by the Laboratory Directed Research and Development Program of LBNL under U.S. DOE contract no. DE-AC02-05CH11231. Seed support for biomedical aspects of this work was provided by the U.S. Department of Defense Breast Cancer Research Program Concept Award BC076701 under U.S. Army Medical Research Acquisition Activity no. W81XWH-08-1-0677, with follow-on support provided by Award U54 CA143836 from the National Cancer Institute (NCI) beginning in 2009. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NCI or the NIH. J. W. G. acknowledges support from the Director, Office of Science, Office of Biological and Environmental Research, of the DOE under conract no. DE-AC02-05CH11231; the NIH; NCI grant P50 CA 58207; and the NIH NCI Integrative Cancer Biology Program grant number U54 CA 112970 to J. W. G. (bioinformatics and cell lines). The Regents of the University of California have filed a related patent application through LBNL.	Andrews NL, 2008, NAT CELL BIOL, V10, P955, DOI 10.1038/ncb1755; Butcher DT, 2009, NAT REV CANCER, V9, P108, DOI 10.1038/nrc2544; Carter N, 2002, NAT CELL BIOL, V4, P565, DOI 10.1038/ncb823; Chen CS, 2008, J CELL SCI, V121, P3285, DOI 10.1242/jcs.023507; Dalby MJ, 2007, NAT MATER, V6, P997, DOI 10.1038/nmat2013; DAVIS S, 1994, SCIENCE, V266, P816, DOI 10.1126/science.7973638; Day B, 2005, J BIOL CHEM, V280, P26526, DOI 10.1074/jbc.M504972200; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Discher DE, 2005, SCIENCE, V310, P1139, DOI 10.1126/science.1116995; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Galush WJ, 2008, BIOPHYS J, V95, P2512, DOI 10.1529/biophysj.108.131540; Groves JT, 2006, CURR OPIN CHEM BIOL, V10, P544, DOI 10.1016/j.cbpa.2006.10.021; Groves JT, 2002, ACCOUNTS CHEM RES, V35, P149, DOI 10.1021/ar950039m; Groves JT, 1997, SCIENCE, V275, P651, DOI 10.1126/science.275.5300.651; Hartman NC, 2009, P NATL ACAD SCI USA, V106, P12729, DOI 10.1073/pnas.0902621106; Himanen JP, 2004, NAT NEUROSCI, V7, P501, DOI 10.1038/nn1237; Himanen JP, 2001, NATURE, V414, P933, DOI 10.1038/414933a; Humphries JD, 2006, J CELL SCI, V119, P3901, DOI 10.1242/jcs.03098; Hurtley S, 2009, SCIENCE, V326, P1205, DOI 10.1126/science.326.5957.1205; Hynes RO, 2009, SCIENCE, V326, P1216, DOI 10.1126/science.1176009; Janes PW, 2005, CELL, V123, P291, DOI 10.1016/j.cell.2005.08.014; Kullander K, 2002, NAT REV MOL CELL BIO, V3, P475, DOI 10.1038/nrm856; Lackmann M, 2008, SCI SIGNAL, V1, DOI 10.1126/stke.115re2; Macrae M, 2005, CANCER CELL, V8, P111, DOI 10.1016/j.ccr.2005.07.005; Marquardt T, 2005, CELL, V121, P127, DOI 10.1016/j.cell.2005.01.020; Mossman KD, 2005, SCIENCE, V310, P1191, DOI 10.1126/science.1119238; Nam JM, 2006, CHEMBIOCHEM, V7, P436, DOI 10.1002/cbic.200500479; Nelson CM, 2006, SCIENCE, V314, P298, DOI 10.1126/science.1131000; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Ponta H, 2003, NAT REV MOL CELL BIO, V4, P33, DOI 10.1038/nrm1004; Provenzano PP, 2008, BIOPHYS J, V95, P5374, DOI 10.1529/biophysj.108.133116; Qi SY, 2001, P NATL ACAD SCI USA, V98, P6548, DOI 10.1073/pnas.111536798; Scott JD, 2009, SCIENCE, V326, P1220, DOI 10.1126/science.1175668; Taddei ML, 2009, AM J PATHOL, V174, P1492, DOI 10.2353/ajpath.2009.080473; Vargo-Gogola T, 2007, NAT REV CANCER, V7, P659, DOI 10.1038/nrc2193; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; Walker-Daniels J, 2002, MOL CANCER RES, V1, P79	37	252	255	1	73	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1380	1385		10.1126/science.1181729	http://dx.doi.org/10.1126/science.1181729			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223987	Green Submitted, Green Accepted			2022-12-01	WOS:000275418700042
J	Pape, JW; Rouzier, V; Ford, H; Joseph, P; Johnson, WD; Fitzgerald, DW				Pape, Jean William; Rouzier, Vanessa; Ford, Henri; Joseph, Patrice; Johnson, Warren D., Jr.; Fitzgerald, Daniel W.			The GHESKIO Field Hospital and Clinics after the Earthquake in Haiti - Dispatch 3 from Port-au-Prince	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									GHESKIO Ctr, Weill Cornell Med Coll, Port au Prince, Haiti; Ctr Global Hlth, New York, NY USA; Los Angeles Childrens Hosp, Los Angeles, CA USA	Children's Hospital Los Angeles									0	23	24	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMpv1001787	http://dx.doi.org/10.1056/NEJMpv1001787			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	566JM	20164476				2022-12-01	WOS:000275365900035
J	Spence, D				Spence, Des			From the Frontline Bad medicine: type 2 diabetes	BRITISH MEDICAL JOURNAL			English	Editorial Material							DECLINE; DISEASE; COHORT					destwo@yahoo.co.uk						Burrows NR, 2010, DIABETES CARE, V33, P73, DOI 10.2337/dc09-0343; Currie CJ, 2010, LANCET, V375, P481, DOI 10.1016/S0140-6736(09)61969-3; Dale AC, 2008, BRIT MED J, V337, DOI 10.1136/bmj.39582.447998.BE; Fox CS, 2004, JAMA-J AM MED ASSOC, V292, P2495, DOI 10.1001/jama.292.20.2495	4	0	0	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2010	340								c1216	10.1136/bmj.c1216	http://dx.doi.org/10.1136/bmj.c1216			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565FJ	20200060				2022-12-01	WOS:000275274400006
J	Hughes, DA; Ferner, RE				Hughes, Dyfrig A.; Ferner, Robin E.			New drugs for old: disinvestment and NICE	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							COST-EFFECTIVENESS; HEALTH-CARE		[Hughes, Dyfrig A.] Bangor Univ, Inst Med & Social Care Res, Ctr Econ & Policy Hlth, Bangor LL57 1UT, Gwynedd, Wales; [Ferner, Robin E.] City Hosp, W Midlands Ctr Adverse Drug React, Birmingham B18 7QH, W Midlands, England	Bangor University; University of Birmingham	Hughes, DA (corresponding author), Bangor Univ, Inst Med & Social Care Res, Ctr Econ & Policy Hlth, Bangor LL57 1UT, Gwynedd, Wales.	d.a.hughes@bangor.ac.uk	Hughes, Dyfrig/H-5252-2012	Hughes, Dyfrig/0000-0001-8247-7459; Ferner, Robin/0000-0003-3769-1346				*ASS BRIT PHARM IN, PHARM PRIC REG SCHM; Barrett A, 2006, BRIT MED J, V333, P1118, DOI 10.1136/bmj.39008.624051.BE; *DEP HLTH, 2006, SEL CRIT REF TOP NIC; Dowie J, 2004, HEALTH ECON, V13, P453, DOI 10.1002/hec.861; Elshaug AG, 2009, MED J AUSTRALIA, V190, P269, DOI 10.5694/j.1326-5377.2009.tb02394.x; *HOUS COMM HLTH CO, 2006, INFL PHARM IND, V1; Hoyle M, 2008, PHARMACOECONOMICS, V26, P589, DOI 10.2165/00019053-200826070-00006; Hughes D, 2006, PHARMACOECONOMICS, V24, P211, DOI 10.2165/00019053-200624030-00001; *MED HEALTHC PROD, 2008, DRUG SAFETY UPDATE, V2, P7; *NAT I HLTH CLIN E, 2009, CLIN PUBL HLTH DIR P; *NAT I HLTH CLIN E, 2009, COST SAV GUID; *NAT I HLTH CLIN E, 2008, SUPP DIS REINV HLTH; National Institute for Health and Clinical Excellence, 2009, APPR LIF EXT END LIF; Nelson AL, 2009, ANN INTERN MED, V151, P662, DOI 10.7326/0003-4819-151-9-200911030-00011; *NHS INF CTR PRESC, 2009, PRESCR DISP COMM STA; *NHS INF CTR PRESC, 2009, US NICE APPR MED NHS; O'Brien BJ, 2002, HEALTH ECON, V11, P175, DOI 10.1002/hec.655; Pearson Steven, 2007, J Health Serv Res Policy, V12, P160; Walley T, 2000, BRIT MED J, V320, P131, DOI 10.1136/bmj.320.7228.131; 2006, DRUG THER B, V44, P73	20	21	21	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 25	2010	340								c572	10.1136/bmj.c572	http://dx.doi.org/10.1136/bmj.c572			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TH	20185495				2022-12-01	WOS:000275001300013
J	Raman, S; Lange, OF; Rossi, P; Tyka, M; Wang, X; Aramini, J; Liu, GH; Ramelot, TA; Eletsky, A; Szyperski, T; Kennedy, MA; Prestegard, J; Montelione, GT; Baker, D				Raman, Srivatsan; Lange, Oliver F.; Rossi, Paolo; Tyka, Michael; Wang, Xu; Aramini, James; Liu, Gaohua; Ramelot, Theresa A.; Eletsky, Alexander; Szyperski, Thomas; Kennedy, Michael A.; Prestegard, James; Montelione, Gaetano T.; Baker, David			NMR Structure Determination for Larger Proteins Using Backbone-Only Data	SCIENCE			English	Article							RESIDUAL DIPOLAR COUPLINGS; STRUCTURE PREDICTION; AUTOMATED-ANALYSIS; CHEMICAL-SHIFTS; ASSIGNMENTS; ROSETTA	Conventional protein structure determination from nuclear magnetic resonance data relies heavily on side-chain proton-to-proton distances. The necessary side-chain resonance assignment, however, is labor intensive and prone to error. Here we show that structures can be accurately determined without nuclear magnetic resonance (NMR) information on the side chains for proteins up to 25 kilodaltons by incorporating backbone chemical shifts, residual dipolar couplings, and amide proton distances into the Rosetta protein structure modeling methodology. These data, which are too sparse for conventional methods, serve only to guide conformational search toward the lowest-energy conformations in the folding landscape; the details of the computed models are determined by the physical chemistry implicit in the Rosetta all-atom energy function. The new method is not hindered by the deuteration required to suppress nuclear relaxation processes for proteins greater than 15 kilodaltons and should enable routine NMR structure determination for larger proteins.	[Raman, Srivatsan; Lange, Oliver F.; Tyka, Michael; Baker, David] Univ Washington, Dept Biochem, Seattle, WA 98195 USA; [Rossi, Paolo; Aramini, James; Liu, Gaohua; Montelione, Gaetano T.] Rutgers State Univ, Dept Mol Biol & Biochem, Ctr Adv Biotechnol & Med, Piscataway, NJ 08854 USA; [Rossi, Paolo; Aramini, James; Liu, Gaohua; Montelione, Gaetano T.] Rutgers State Univ, NE Struct Genom Consortium, Piscataway, NJ 08854 USA; [Wang, Xu; Prestegard, James] Univ Georgia, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA; [Ramelot, Theresa A.; Kennedy, Michael A.] Miami Univ, Dept Chem & Biochem, Oxford, OH 45056 USA; [Ramelot, Theresa A.; Kennedy, Michael A.] Miami Univ, NE Struct Genom Consortium, Oxford, OH 45056 USA; [Eletsky, Alexander; Szyperski, Thomas] SUNY Buffalo, Dept Chem, Buffalo, NY 14260 USA; [Baker, David] Howard Hughes Med Inst, Seattle, WA 98195 USA	University of Washington; University of Washington Seattle; Rutgers State University New Brunswick; Rutgers State University New Brunswick; University System of Georgia; University of Georgia; University System of Ohio; Miami University; University System of Ohio; Miami University; State University of New York (SUNY) System; State University of New York (SUNY) Buffalo; Howard Hughes Medical Institute	Baker, D (corresponding author), Univ Washington, Dept Biochem, Seattle, WA 98195 USA.	dabaker@u.washington.edu	Lange, Oliver/K-5749-2012; Kennedy, Michael/ABE-6002-2021; Baker, David/K-8941-2012; Lange, Oliver/B-2861-2009; Lange, Oliver/G-1366-2010; Ramelot, Theresa A/V-1413-2017; Kennedy, Michael/M-2578-2019	Lange, Oliver/0000-0002-4018-7020; Baker, David/0000-0001-7896-6217; Ramelot, Theresa A/0000-0002-0335-1573; Tyka, Michael/0000-0003-0108-6558; Montelione, Gaetano/0000-0002-9440-3059	U.S. Department of Energy; Human Frontiers of Science Program; NIH [GM76222]; HHMI; National Institutes of General Medical Science Protein Structure Initiative [U54 GM074958]; Research Resource [RR005351]; Sir Henry Wellcome Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR005351] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM095693, U54GM074958, P20GM076222, P41GM103390, R01GM092802] Funding Source: NIH RePORTER	U.S. Department of Energy(United States Department of Energy (DOE)); Human Frontiers of Science Program(Human Frontier Science Program); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); HHMI(Howard Hughes Medical Institute); National Institutes of General Medical Science Protein Structure Initiative; Research Resource; Sir Henry Wellcome Postdoctoral Fellowship; NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are thankful to the U.S. Department of Energy Innovative and Novel Computational Impact on Theory and Experiment Award for providing access to the Blue Gene/P supercomputer at the Argonne Leadership Computing Facility and to Rosetta@ home participants for their generous contributions of computing power. We thank Y. Shen and A. Bax for fruitful discussions; Y. J. Huang and Y. Tang for their contribution during preliminary studies using sparse NOE constraints with CS-Rosetta; S. Bansal, H.-w. Lee, and Y. Liu for collection of RDC data, A. Lemak for providing the Crystallography and NMR System RDC refinement protocol, and the NESG consortium for access to other unpublished NMR data that has facilitated methods development. S. R., O.F.L., P. R., G. T. M., and D. B. designed research; S. R. designed and tested the CS-RDC-Rosetta protocol; O.F.L. designed and tested the iterative CS-RDC-NOE-Rosetta protocol; M. T. developed the all-atom refinement protocol; S. R., O.F.L. and D. B. designed and performed research for energy based structure validation; X. W and J. P analyzed the ALG13 ensemble; J. A, G. L, T. R, A. E, M. K, and T. S provided blind NMR data sets; and S. R., O.F.L., P. R., G. T. M., and D. B. wrote the manuscript. This work was supported by the Human Frontiers of Science Program (O.F.L.), NIH grant GM76222 (D. B.), the HHMI, the National Institutes of General Medical Science Protein Structure Initiative program grant U54 GM074958 (G. T. M.), and the Research Resource grant RR005351 (J. P.). M. T. holds a Sir Henry Wellcome Postdoctoral Fellowship. RDC and Paramagnetic Relaxation Enhancement data as deposited in the Protein Data Bank (PDB) with accession code 2jzc.	Baran MC, 2004, CHEM REV, V104, P3541, DOI 10.1021/cr030408p; Bartels C, 1997, J COMPUT CHEM, V18, P139, DOI 10.1002/(SICI)1096-987X(19970115)18:1<139::AID-JCC13>3.0.CO;2-H; Berjanskii M, 2009, NUCLEIC ACIDS RES, V37, pW670, DOI 10.1093/nar/gkp280; Bertini I, 2008, DALTON T, P3782, DOI 10.1039/b719526e; Bradley P, 2005, SCIENCE, V309, P1868, DOI 10.1126/science.1113801; Brunette TJ, 2008, PROTEINS, V73, P958, DOI 10.1002/prot.22123; Cavalli A, 2007, P NATL ACAD SCI USA, V104, P9615, DOI 10.1073/pnas.0610313104; Das R, 2008, ANNU REV BIOCHEM, V77, P363, DOI 10.1146/annurev.biochem.77.062906.171838; Gardner KH, 1997, BIOCHEMISTRY-US, V36, P1389, DOI 10.1021/bi9624806; GRZESIEK S, 1993, J BIOMOL NMR, V3, P627; Jung YS, 2004, J BIOMOL NMR, V30, P11, DOI 10.1023/B:JNMR.0000042954.99056.ad; Kontaxis G, 2005, METHOD ENZYMOL, V394, P42, DOI 10.1016/S0076-6879(05)94003-2; Lee W, 2009, BIOINFORMATICS, V25, P2085, DOI 10.1093/bioinformatics/btp345; LEMASTER DM, 1988, BIOCHEMISTRY-US, V27, P142, DOI 10.1021/bi00401a022; Losonczi JA, 1999, J MAGN RESON, V138, P334, DOI 10.1006/jmre.1999.1754; Prestegard JH, 2004, CHEM REV, V104, P3519, DOI 10.1021/cr030419i; Qian B, 2007, NATURE, V450, P259, DOI 10.1038/nature06249; Rohl CA, 2002, J AM CHEM SOC, V124, P2723, DOI 10.1021/ja016880e; Shen Y, 2008, P NATL ACAD SCI USA, V105, P4685, DOI 10.1073/pnas.0800256105; Shen Y, 2009, J BIOMOL NMR, V44, P213, DOI 10.1007/s10858-009-9333-z; Snyder DA, 2005, PROTEINS, V59, P673, DOI 10.1002/prot.20402; van Ingen H, 2009, J PHYS CHEM B, V113, P9968, DOI 10.1021/jp902793y; WAGNER G, 1993, J BIOMOL NMR, V3, P375; Wang X, 2008, STRUCTURE, V16, P965, DOI 10.1016/j.str.2008.03.010; Zemla A, 2003, NUCLEIC ACIDS RES, V31, P3370, DOI 10.1093/nar/gkg571; Zimmerman DE, 1997, J MOL BIOL, V269, P592, DOI 10.1006/jmbi.1997.1052	26	201	217	2	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1014	1018		10.1126/science.1183649	http://dx.doi.org/10.1126/science.1183649			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20133520	Green Accepted			2022-12-01	WOS:000274625800045
J	Beroukhim, R; Mermel, CH; Porter, D; Wei, G; Raychaudhuri, S; Donovan, J; Barretina, J; Boehm, JS; Dobson, J; Urashima, M; Mc Henry, KT; Pinchback, RM; Ligon, AH; Cho, YJ; Haery, L; Greulich, H; Reich, M; Winckler, W; Lawrence, MS; Weir, BA; Tanaka, KE; Chiang, DY; Bass, AJ; Loo, A; Hoffman, C; Prensner, J; Liefeld, T; Gao, Q; Yecies, D; Signoretti, S; Maher, E; Kaye, FJ; Sasaki, H; Tepper, JE; Fletcher, JA; Tabernero, J; Baselga, J; Tsao, MS; Demichelis, F; Rubin, MA; Janne, PA; Daly, MJ; Nucera, C; Levine, RL; Ebert, BL; Gabriel, S; Rustgi, AK; Antonescu, CR; Ladanyi, M; Letai, A; Garraway, LA; Loda, M; Beer, DG; True, LD; Okamoto, A; Pomeroy, SL; Singer, S; Golub, TR; Lander, ES; Getz, G; Sellers, WR; Meyerson, M				Beroukhim, Rameen; Mermel, Craig H.; Porter, Dale; Wei, Guo; Raychaudhuri, Soumya; Donovan, Jerry; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Urashima, Mitsuyoshi; Mc Henry, Kevin T.; Pinchback, Reid M.; Ligon, Azra H.; Cho, Yoon-Jae; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Loo, Alice; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Yecies, Derek; Signoretti, Sabina; Maher, Elizabeth; Kaye, Frederic J.; Sasaki, Hidefumi; Tepper, Joel E.; Fletcher, Jonathan A.; Tabernero, Josep; Baselga, Jose; Tsao, Ming-Sound; Demichelis, Francesca; Rubin, Mark A.; Janne, Pasi A.; Daly, Mark J.; Nucera, Carmelo; Levine, Ross L.; Ebert, Benjamin L.; Gabriel, Stacey; Rustgi, Anil K.; Antonescu, Cristina R.; Ladanyi, Marc; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Beer, David G.; True, Lawrence D.; Okamoto, Aikou; Pomeroy, Scott L.; Singer, Samuel; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Sellers, William R.; Meyerson, Matthew			The landscape of somatic copy-number alteration across human cancers	NATURE			English	Article							ACUTE LYMPHOBLASTIC-LEUKEMIA; EMBRYONIC STEM-CELLS; LUNG-CANCER; CHROMOSOMAL BREAKPOINT; MALIGNANT-MELANOMA; ADAPTER PROTEINS; ARRAY CGH; GENES; GENOME; AMPLIFICATION	A powerful way to discover key genes with causal roles in oncogenesis is to identify genomic regions that undergo frequent alteration in human cancers. Here we present high-resolution analyses of somatic copy-number alterations (SCNAs) from 3,131 cancer specimens, belonging largely to 26 histological types. We identify 158 regions of focal SCNA that are altered at significant frequency across several cancer types, of which 122 cannot be explained by the presence of a known cancer target gene located within these regions. Several gene families are enriched among these regions of focal SCNA, including the BCL2 family of apoptosis regulators and the NF-kappa B pathway. We show that cancer cells containing amplifications surrounding the MCL1 and BCL2L1 anti-apoptotic genes depend on the expression of these genes for survival. Finally, we demonstrate that a large majority of SCNAs identified in individual cancer types are present in several cancer types.	[Beroukhim, Rameen; Mermel, Craig H.; Wei, Guo; Raychaudhuri, Soumya; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Pinchback, Reid M.; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Daly, Mark J.; Ebert, Benjamin L.; Gabriel, Stacey; Garraway, Levi A.; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Meyerson, Matthew] Broad Inst MIT & Harvard, Canc Program, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Beroukhim, Rameen; Mermel, Craig H.; Wei, Guo; Raychaudhuri, Soumya; Barretina, Jordi; Boehm, Jesse S.; Dobson, Jennifer; Pinchback, Reid M.; Haery, Leila; Greulich, Heidi; Reich, Michael; Winckler, Wendy; Lawrence, Michael S.; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Liefeld, Ted; Gao, Qing; Daly, Mark J.; Ebert, Benjamin L.; Gabriel, Stacey; Garraway, Levi A.; Golub, Todd R.; Lander, Eric S.; Getz, Gad; Meyerson, Matthew] Broad Inst MIT & Harvard, Med & Populat Genet Grp, Cambridge Ctr 7, Cambridge, MA 02142 USA; [Lander, Eric S.] Whitehead Inst Biomed Res, Cambridge Ctr 9, Cambridge, MA 02142 USA; [Beroukhim, Rameen; Mermel, Craig H.; Barretina, Jordi; Dobson, Jennifer; Haery, Leila; Greulich, Heidi; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Yecies, Derek; Signoretti, Sabina; Janne, Pasi A.; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Golub, Todd R.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Beroukhim, Rameen; Mermel, Craig H.; Barretina, Jordi; Dobson, Jennifer; Haery, Leila; Greulich, Heidi; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Yecies, Derek; Signoretti, Sabina; Janne, Pasi A.; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Golub, Todd R.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Pediat Oncol, Boston, MA 02115 USA; [Beroukhim, Rameen; Mermel, Craig H.; Barretina, Jordi; Dobson, Jennifer; Haery, Leila; Greulich, Heidi; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Yecies, Derek; Signoretti, Sabina; Janne, Pasi A.; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Golub, Todd R.; Meyerson, Matthew] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Beroukhim, Rameen; Mermel, Craig H.; Barretina, Jordi; Dobson, Jennifer; Haery, Leila; Greulich, Heidi; Weir, Barbara A.; Tanaka, Kumiko E.; Chiang, Derek Y.; Bass, Adam J.; Hoffman, Carter; Prensner, John; Yecies, Derek; Signoretti, Sabina; Janne, Pasi A.; Letai, Anthony; Garraway, Levi A.; Loda, Massimo; Golub, Todd R.; Meyerson, Matthew] Dana Farber Canc Inst, Ctr Canc Genome Discovery, Boston, MA 02115 USA; [Beroukhim, Rameen; Raychaudhuri, Soumya; Ligon, Azra H.; Greulich, Heidi; Bass, Adam J.; Signoretti, Sabina; Fletcher, Jonathan A.; Janne, Pasi A.; Ebert, Benjamin L.; Loda, Massimo] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen; Raychaudhuri, Soumya; Ligon, Azra H.; Greulich, Heidi; Bass, Adam J.; Signoretti, Sabina; Fletcher, Jonathan A.; Janne, Pasi A.; Ebert, Benjamin L.; Loda, Massimo] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Beroukhim, Rameen; Greulich, Heidi; Ebert, Benjamin L.; Lander, Eric S.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Beroukhim, Rameen; Greulich, Heidi; Ebert, Benjamin L.; Lander, Eric S.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Beroukhim, Rameen; Greulich, Heidi; Ebert, Benjamin L.; Lander, Eric S.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Beroukhim, Rameen; Greulich, Heidi; Ebert, Benjamin L.; Lander, Eric S.; Meyerson, Matthew] Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA; [Cho, Yoon-Jae; Pomeroy, Scott L.] Childrens Hosp, Dept Neurol, Boston, MA 02115 USA; [Nucera, Carmelo] Beth Israel Deaconess Med Ctr, Dept Pathol, Boston, MA 02115 USA; [Porter, Dale; Donovan, Jerry; Mc Henry, Kevin T.; Loo, Alice; Sellers, William R.] Novartis Inst BioMed Res, Cambridge, MA 02139 USA; [Urashima, Mitsuyoshi] Jikei Univ, Sch Med, Div Mol Epidemiol, Minato Ku, Tokyo 1058461, Japan; [Maher, Elizabeth] Univ Texas SW Med Ctr Dallas, Dept Internal Med, Dallas, TX 75390 USA; [Kaye, Frederic J.] NCI, Genet Branch, Ctr Canc Res, Bethesda, MD 20889 USA; [Kaye, Frederic J.] Natl Naval Med Ctr, Bethesda, MD 20889 USA; [Sasaki, Hidefumi] Nagoya City Univ, Sch Med, Dept Surg 2, Nagoya, Aichi 4678601, Japan; [Chiang, Derek Y.; Tepper, Joel E.] Univ N Carolina, Sch Med, Lineberger Comprehens Canc Ctr, Dept Genet & Radiat Oncol, Chapel Hill, NC 27599 USA; [Tabernero, Josep; Baselga, Jose] Vall Hebron Univ Hosp, Res Inst, Vall Hebron Inst Oncol, Med Oncol Program, Barcelona 08035, Spain; [Tabernero, Josep; Baselga, Jose] Autonomous Univ Barcelona, E-08035 Barcelona, Spain; [Tsao, Ming-Sound] Princess Margaret Hosp, Univ Hlth Network, Dept Pathol, Toronto, ON M5G 2M9, Canada; [Tsao, Ming-Sound] Princess Margaret Hosp, Univ Hlth Network, Div Appl Mol Oncol, Toronto, ON M5G 2M9, Canada; [Tsao, Ming-Sound] Ontario Canc Inst, Toronto, ON M5G 2M9, Canada; [Demichelis, Francesca; Rubin, Mark A.] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Daly, Mark J.] Massachusetts Gen Hosp, Richard B Simches Res Ctr, Ctr Human Genet Res, Boston, MA 02114 USA; [Levine, Ross L.; Antonescu, Cristina R.; Ladanyi, Marc; Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Med, New York, NY 10065 USA; [Levine, Ross L.; Antonescu, Cristina R.; Ladanyi, Marc; Singer, Samuel] Mem Sloan Kettering Canc Ctr, Dept Pathol, New York, NY 10065 USA; [Rustgi, Anil K.] Univ Penn, Dept Med, GI Div, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Dept Genet, Philadelphia, PA 19104 USA; [Rustgi, Anil K.] Univ Penn, Abramson Canc Ctr, Philadelphia, PA 19104 USA; [Beer, David G.] Univ Michigan, Dept Surg, Thorac Surg Sect, Ann Arbor, MI 48109 USA; [True, Lawrence D.] Univ Washington, Med Ctr, Dept Pathol, Seattle, WA 98195 USA; [Okamoto, Aikou] Jikei Univ, Sch Med, Dept Obstet & Gynecol, Minato Ku, Tokyo 1058461, Japan; [Golub, Todd R.] Howard Hughes Med Inst, Chevy Chase, MD 20815 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Beth Israel Deaconess Medical Center; Novartis; Jikei University; University of Texas System; University of Texas Southwestern Medical Center Dallas; National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); Walter Reed National Military Medical Center; Nagoya City University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina School of Medicine; Autonomous University of Barcelona; Hospital Universitari Vall d'Hebron; Vall d'Hebron Institut de Recerca (VHIR); Vall d'Hebron Institut d'Oncologia (VHIO); Autonomous University of Barcelona; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Princess Margaret Cancer Centre; University of Toronto; University Toronto Affiliates; University Health Network Toronto; Cornell University; Harvard University; Massachusetts General Hospital; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; University of Pennsylvania; University of Pennsylvania; University of Pennsylvania; Pennsylvania Medicine; University of Michigan System; University of Michigan; University of Washington; University of Washington Seattle; Jikei University; Howard Hughes Medical Institute	Lander, ES (corresponding author), Broad Inst MIT & Harvard, Canc Program, Cambridge Ctr 7, Cambridge, MA 02142 USA.	lander@broadinstitute.org; gadgetz@broadinstitute.org; william.sellers@novartis.com; matthew_meyerson@dfci.harvard.edu	Chiang, Derek/L-6452-2019; kaye, frederic/E-2437-2011; Demichelis, Francesca/J-9829-2016; Tsao, Ming-Sound/M-3503-2017; Tsao, Ming Sound/AFQ-7332-2022; Tabernero, Josep/AAG-5026-2019; Daly, Mark J/B-2453-2017; Meyerson, Matthew L/E-7123-2012; Mermel, Craig/AAZ-7322-2020; Teh, Muy-Teck/B-9284-2016; Levine, Rodney L/D-9885-2011; levine, ross/AAE-7658-2019; Ladanyi, Marc/AAG-8585-2019; Lawrence, Michael/AAC-8202-2020; Barretina, Jordi/A-7192-2013	Demichelis, Francesca/0000-0002-8266-8631; Tsao, Ming Sound/0000-0002-9160-5405; Tabernero, Josep/0000-0002-2495-8139; Daly, Mark J/0000-0002-0949-8752; Mermel, Craig/0000-0002-0816-3395; Teh, Muy-Teck/0000-0002-7725-8355; Singer, Samuel/0000-0001-9713-8230; Reich, Michael/0000-0003-4735-5514; Yecies, Derek/0000-0001-8534-4651; Chiang, Derek/0000-0002-1131-6065; Rubin, Mark/0000-0002-8321-9950; Meyerson, Matthew/0000-0002-9133-8108; Barretina, Jordi/0000-0002-3478-4080; Prensner, John/0000-0002-7024-636X; Boehm, Jesse/0000-0002-6795-6336; Hoffman, Carter/0000-0002-4001-7902; Raychaudhuri, Soumya/0000-0002-1901-8265	National Institutes of Health (NIH) [P50CA90578, R01CA109038, R01CA109467, P01CA085859, P01CA 098101, K08CA122833]; Doris Duke Charitable Foundation; Sarah Thomas Monopoli Lung Cancer Research Fund; Seaman Corporation Fund for Lung Cancer Research; Lucas Foundation; NATIONAL CANCER INSTITUTE [P01CA085859, P01CA098101, R01CA109038, U24CA126546, P50CA090578, R01CA109467, K08CA134931, K08CA122833] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003067] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR055688] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [T32GM007753] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Doris Duke Charitable Foundation(Doris Duke Charitable Foundation (DDCF)); Sarah Thomas Monopoli Lung Cancer Research Fund; Seaman Corporation Fund for Lung Cancer Research; Lucas Foundation; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by grants from the National Institutes of Health (NIH) (Dana-Farber/Harvard Cancer Center and Pacific Northwest Prostate Cancer SPOREs, P50CA90578, R01CA109038, R01CA109467, P01CA085859, P01CA 098101 and K08CA122833), the Doris Duke Charitable Foundation, the Sarah Thomas Monopoli Lung Cancer Research Fund, the Seaman Corporation Fund for Lung Cancer Research, and the Lucas Foundation. Medulloblastoma samples were obtained in collaboration with the Children's Oncology Group. N. Vena provided technical assistance with FISH, and I. Mellinghoff, P. S. Mischel, L. Liau and T. F. Cloughesy provided DNA samples. We thank T. Ried, R. Weinberg and B. Vogelstein for critical review of the manuscript and for comments about its context in the field of cancer genetics.	Albertson DG, 2006, TRENDS GENET, V22, P447, DOI 10.1016/j.tig.2006.06.007; Arena V, 2003, GENE CHROMOSOME CANC, V38, P91, DOI 10.1002/gcc.10245; BAKHSHI A, 1985, CELL, V41, P899, DOI 10.1016/S0092-8674(85)80070-2; Barbie DA, 2009, NATURE, V462, P108, DOI 10.1038/nature08460; Baudis M, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-226; Beroukhim R, 2007, P NATL ACAD SCI USA, V104, P20007, DOI 10.1073/pnas.0710052104; Beverly LJ, 2009, ONCOGENE, V28, P1274, DOI 10.1038/onc.2008.466; Boehm JS, 2007, CELL, V129, P1065, DOI 10.1016/j.cell.2007.03.052; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Chitale D, 2009, ONCOGENE, V28, P2773, DOI 10.1038/onc.2009.135; CLEARY ML, 1985, P NATL ACAD SCI USA, V82, P7439, DOI 10.1073/pnas.82.21.7439; DALCIN P, 1993, CANCER GENET CYTOGEN, V68, P85, DOI 10.1016/0165-4608(93)90001-3; Dearth RK, 2007, CELL CYCLE, V6, P705, DOI 10.4161/cc.6.6.4035; Eder AM, 2005, P NATL ACAD SCI USA, V102, P12519, DOI 10.1073/pnas.0505641102; FANIDI A, 1992, NATURE, V359, P554, DOI 10.1038/359554a0; Fukasawa K, 2005, CANCER LETT, V230, P6, DOI 10.1016/j.canlet.2004.12.028; Futreal PA, 2004, NAT REV CANCER, V4, P177, DOI 10.1038/nrc1299; Garraway LA, 2005, NATURE, V436, P117, DOI 10.1038/nature03664; *GLAXOSMITHKLINE, GSK CANC CELL LIN GE; Hupe P, 2004, BIOINFORMATICS, V20, P3413, DOI 10.1093/bioinformatics/bth418; Kendall J, 2007, P NATL ACAD SCI USA, V104, P16663, DOI 10.1073/pnas.0708286104; Lahortiga I, 2007, NAT GENET, V39, P593, DOI 10.1038/ng2025; Lefort N, 2008, NAT BIOTECHNOL, V26, P1364, DOI 10.1038/nbt.1509; Letai AG, 2008, NAT REV CANCER, V8, P121, DOI 10.1038/nrc2297; Lin WM, 2008, CANCER RES, V68, P664, DOI 10.1158/0008-5472.CAN-07-2615; Lundberg AS, 2002, ONCOGENE, V21, P4577, DOI 10.1038/sj.onc.1205550; Luo B, 2008, P NATL ACAD SCI USA, V105, P20380, DOI 10.1073/pnas.0810485105; Mazzarella R, 1998, GENOME RES, V8, P1007, DOI 10.1101/gr.8.10.1007; MITELMAN F, 2009, MITELMAN DATABASE CH, P2093; Mullighan CG, 2008, NATURE, V453, P110, DOI 10.1038/nature06866; Mullighan CG, 2007, NATURE, V446, P758, DOI 10.1038/nature05690; Myllykangas S, 2007, SEMIN CANCER BIOL, V17, P42, DOI 10.1016/j.semcancer.2006.10.005; Nishida K, 2003, CANCER SCI, V94, P1029, DOI 10.1111/j.1349-7006.2003.tb01396.x; Rampino N, 1997, SCIENCE, V275, P967, DOI 10.1126/science.275.5302.967; Raychaudhuri S, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000534; Scholl C, 2009, CELL, V137, P821, DOI 10.1016/j.cell.2009.03.017; Smith DI, 2006, CANCER LETT, V232, P48, DOI 10.1016/j.canlet.2005.06.049; Smith LT, 2006, GENE CHROMOSOME CANC, V45, P957, DOI 10.1002/gcc.20354; Spits C, 2008, NAT BIOTECHNOL, V26, P1361, DOI 10.1038/nbt.1510; Stratton MR, 2009, NATURE, V458, P719, DOI 10.1038/nature07943; Stuart D, 2009, CURR OPIN CELL BIOL, V21, P304, DOI 10.1016/j.ceb.2009.02.001; Tonon G, 2005, P NATL ACAD SCI USA, V102, P9625, DOI 10.1073/pnas.0504126102; TSUJIMOTO Y, 1985, SCIENCE, V229, P1390, DOI 10.1126/science.3929382; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wiedemeyer R, 2008, CANCER CELL, V13, P355, DOI 10.1016/j.ccr.2008.02.010; WU C, 2009, NF KB SIGNALING PATH; Zender L, 2006, CELL, V125, P1253, DOI 10.1016/j.cell.2006.05.030; Zhou P, 2001, BLOOD, V97, P3902, DOI 10.1182/blood.V97.12.3902; 2001, NCI NCBIS SKY M FISH	49	2522	2626	4	264	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					899	905		10.1038/nature08822	http://dx.doi.org/10.1038/nature08822			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164920	Green Accepted, Green Submitted			2022-12-01	WOS:000274582700036
J	Van Cleave, J; Gortmaker, SL; Perrin, JM				Van Cleave, Jeanne; Gortmaker, Steven L.; Perrin, James M.			Dynamics of Obesity and Chronic Health Conditions Among Children and Youth	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; SCHOOL-AGE-CHILDREN; BODY-MASS INDEX; PROSPECTIVE COHORT; CHILDHOOD ASTHMA; CONDUCT DISORDER; MATERNAL OBESITY; PREVALENCE; IMPACT; CARE	Context Rates of obesity and other childhood chronic conditions have increased over recent decades. Patterns of how conditions change over time have not been widely examined. Objective To evaluate change in prevalence of obesity and other chronic conditions in US children, including incidence, remission, and prevalence. Design, Setting, and Participants Prospective study using the National Longitudinal Survey of Youth-Child Cohort (1988-2006) of 3 nationally representative cohorts of children. Children were aged 2 through 8 years at the beginning of each study period, and cohorts were followed up for 6 years, from 1988 to 1994 ( cohort 1, n=2337), 1994 to 2000 ( cohort 2, n=1759), and 2000 to 2006 (n=905). Main Outcome Measures Parent report of a child having a health condition that limited activities or schooling or required medicine, special equipment, or specialized health services and that lasted at least 12 months. Obesity was defined as a body mass index at or above the 95th percentile for age. Chronic conditions were grouped into 4 categories: obesity, asthma, other physical conditions, and behavior/learning problems. Results The end-study prevalence of any chronic health condition was 12.8% (95% confidence interval [CI], 11.2%-14.5%) for cohort 1 in 1994, 25.1% ( 95% CI, 22.7%-27.6%) for cohort 2 in 2000, and 26.6% ( 95% CI, 23.5%-29.9%) for cohort 3 in 2006. There was substantial turnover in chronic conditions: 7.4% ( 95% CI, 6.5%-8.3%) of participants in all cohorts had a chronic condition at the beginning of the study that persisted to the end, 9.3% ( 95% CI, 8.3%-10.3%) reported conditions at the beginning that resolved within 6 years, and 13.4% ( 95% CI, 12.3%-14.6%) had new conditions that arose during the 6-year study period. The prevalence of having a chronic condition during any part of the 6-year study period was highest for cohort 3 (51.5%; 95% CI, 47.3%-55.0%), and there were higher rates among male ( adjusted odds ratio [AOR], 1.24; 95% CI, 1.07-1.42), Hispanic ( AOR, 1.36; 95% CI, 1.11-1.67), and black ( AOR, 1.60; 95% CI, 1.35-1.90) youth. Conclusions Prevalence of chronic conditions among children and youth increased from 1988 to 2006. However, presence of these conditions was dynamic over each 6-year cohort. JAMA. 2010; 303(7):623-630 www.jama.com	[Van Cleave, Jeanne; Perrin, James M.] MassGen Hosp Children, Ctr Child & Adolescent Hlth Policy, Boston, MA 02114 USA; [Van Cleave, Jeanne; Perrin, James M.] Harvard Univ, Sch Med, Dept Pediat, Boston, MA 02115 USA; [Gortmaker, Steven L.] Harvard Univ, Sch Publ Hlth, Dept Soc Human Dev & Hlth, Boston, MA 02115 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard T.H. Chan School of Public Health	Van Cleave, J (corresponding author), MassGen Hosp Children, Ctr Child & Adolescent Hlth Policy, 50 Staniford St 901, Boston, MA 02114 USA.	jvancleave@partners.org		Perrin, James/0000-0002-1810-3708	Robert Wood Johnson Foundation [033659]; Centers for Disease Control and Prevention [U48DP00064]; Maternal and Child Health Bureau [U53MC04773]; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO [U48DP000064] Funding Source: NIH RePORTER	Robert Wood Johnson Foundation(Robert Wood Johnson Foundation (RWJF)); Centers for Disease Control and Prevention(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA); Maternal and Child Health Bureau; NATIONAL CENTER FOR CHRONIC DISEASE PREV AND HEALTH PROMO(United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA)	Preparation of this work was supported by a Robert Wood Johnson Foundation Investigator Award in Health Policy Research (grant 033659), the Centers for Disease Control and Prevention (Prevention Research Centers grant U48DP00064), and a cooperative agreement with the Maternal and Child Health Bureau (U53MC04773). Role of the Sponsor: The funding agencies had no role in the design and conduct of the study; in the collection, analysis, and interpretation of the data; or in the preparation, review, or approval of the manuscript.	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Anderson SE, 2009, ARCH PEDIAT ADOL MED, V163, P344, DOI 10.1001/archpediatrics.2009.18; Baker P. C., 1989, NLSY CHILD HDB 1989; Barbaresi WJ, 2005, ARCH PEDIAT ADOL MED, V159, P37, DOI 10.1001/archpedi.159.1.37; Bethell CD, 2008, MATERN CHILD HLTH J, V12, P1, DOI 10.1007/s10995-007-0220-5; Cederlund M, 2008, J AUTISM DEV DISORD, V38, P72, DOI 10.1007/s10803-007-0364-6; Centers for Disease Control and Prevention, CTR DIS CONTR PREV G; Collins VR, 2008, J PEDIATR-US, V152, P20, DOI 10.1016/j.jpeds.2007.07.045; Costello EJ, 2003, JAMA-J AM MED ASSOC, V290, P2023, DOI 10.1001/jama.290.15.2023; Dietz WH, 2001, ANNU REV PUBL HEALTH, V22, P337, DOI 10.1146/annurev.publhealth.22.1.337; Eisenhower AS, 2009, SOC SCI MED, V68, P89, DOI 10.1016/j.socscimed.2008.09.033; Etzel RA, 2003, PEDIATRICS, V112, P233; Forrest CB, 1997, JAMA-J AM MED ASSOC, V277, P1787, DOI 10.1001/jama.277.22.1787; Freedman DS, 2005, PEDIATRICS, V115, P22, DOI 10.1542/peds.2004-0220; Geenen MM, 2007, JAMA-J AM MED ASSOC, V297, P2705, DOI 10.1001/jama.297.24.2705; Gold DR, 2005, ANNU REV PUBL HEALTH, V26, P89, DOI 10.1146/annurev.publhealth.26.021304.144528; Guerra S, 2004, AM J RESP CRIT CARE, V170, P78, DOI 10.1164/rccm.200309-1224OC; Haberg SE, 2009, PAEDIATR PERINAT EP, V23, P352, DOI 10.1111/j.1365-3016.2009.01034.x; Halfon N, 1999, J AM ACAD CHILD PSY, V38, P600, DOI 10.1097/00004583-199905000-00023; Hesketh K, 2004, PUBLIC HEALTH NUTR, V7, P303, DOI 10.1079/PHN2003537; Howlin P, 2004, J CHILD PSYCHOL PSYC, V45, P212, DOI 10.1111/j.1469-7610.2004.00215.x; JESSOP DJ, 1995, ARCH PEDIAT ADOL MED, V149, P1105, DOI 10.1001/archpedi.1995.02170230059008; Koplan J.P., 2005, PREVENTING CHILDHOOD; LAHEY BB, 1995, J ABNORM PSYCHOL, V104, P83, DOI 10.1037/0021-843X.104.1.83; Law J, 2003, Cochrane Database Syst Rev, pCD004110, DOI 10.1002/14651858.CD004110; Maughan B, 2004, J CHILD PSYCHOL PSYC, V45, P609, DOI 10.1111/j.1469-7610.2004.00250.x; Neff JM, 2006, J AMBUL CARE MANAG, V29, P283, DOI 10.1097/00004479-200610000-00004; Newacheck PW, 2000, ARCH PEDIAT ADOL MED, V154, P287, DOI 10.1001/archpedi.154.3.287; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Pastor PN, 2005, PUBLIC HEALTH REP, V120, P383, DOI 10.1177/003335490512000405; PERRIN EC, 1993, PEDIATRICS, V91, P787; Perrin JM, 2007, JAMA-J AM MED ASSOC, V297, P2755, DOI 10.1001/jama.297.24.2755; Phelan PD, 2002, J ALLERGY CLIN IMMUN, V109, P189, DOI 10.1067/mai.2002.120951; Racine AD, 2001, PEDIATRICS, V108, P1135, DOI 10.1542/peds.108.5.1135; Raina P, 2005, PEDIATRICS, V115, pE626, DOI 10.1542/peds.2004-1689; Reiss J, 2002, PEDIATRICS, V110, P1307; Riethmuller AM, 2009, PEDIATRICS, V124, pE782, DOI 10.1542/peds.2009-0333; Robbins JM, 2007, ARCH PEDIAT ADOL MED, V161, P17, DOI 10.1001/archpedi.161.1.17; Robertson CMT, 2007, JAMA-J AM MED ASSOC, V297, P2733, DOI 10.1001/jama.297.24.2733; Robison LM, 1999, CLIN PEDIATR, V38, P209, DOI 10.1177/000992289903800402; Royston P, 2004, STATA J, V4, P227, DOI 10.1177/1536867X0400400301; Salsberry PJ, 2005, PEDIATRICS, V116, P1329, DOI 10.1542/peds.2004-2583; Sears MR, 2003, NEW ENGL J MED, V349, P1414, DOI 10.1056/NEJMoa022363; Simpson BJ, 2000, PEDIATR INFECT DIS J, V19, P618, DOI 10.1097/00006454-200007000-00007; Spencer TJ, 2007, AMBUL PEDIATR, V7, P73, DOI 10.1016/j.ambp.2006.07.006; Szilagyi PG, 2004, PEDIATRICS, V113, pE395, DOI 10.1542/peds.113.5.e395; Troiano RP, 1998, PEDIATRICS, V101, P497; Watkins ML, 2003, PEDIATRICS, V111, P1152; Whitaker RC, 1997, NEW ENGL J MED, V337, P869, DOI 10.1056/NEJM199709253371301	50	409	413	0	38	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					623	630		10.1001/jama.2010.104	http://dx.doi.org/10.1001/jama.2010.104			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	555NK	20159870	Green Published, Bronze			2022-12-01	WOS:000274518600020
J	Dalziel, K; Shaw, S				Dalziel, Kate; Shaw, Sarah			Easily Missed? Lichen sclerosus	BRITISH MEDICAL JOURNAL			English	Editorial Material							PHIMOSIS; CHILDREN		[Dalziel, Kate] Royal Cornwall Hosp, Truro TR1 3LJ, England; [Shaw, Sarah] Stennack Surg, St Ives, England	Royal Cornwall Hospital	Dalziel, K (corresponding author), Royal Cornwall Hosp, Truro TR1 3LJ, England.	kate.dalziel@rcht.cornwall.nhs.uk						Birenbaum DL, 2007, J REPROD MED, V52, P28; Cooper SM, 2004, ARCH DERMATOL, V140, P702, DOI 10.1001/archderm.140.6.702; DALZIEL KL, 1995, J REPROD MED, V40, P351; Fidel PL, 2000, INFECT IMMUN, V68, P651, DOI 10.1128/IAI.68.2.651-657.2000; JORGENSEN ET, 1993, ACTA DERM-VENEREOL, V73, P55; Lynch PJ, 2007, J REPROD MED, V52, P3; Maronn ML, 2005, PEDIATRICS, V115, pE230, DOI 10.1542/peds.2004-1544; Mattioli G, 2002, PEDIATR SURG INT, V18, P273, DOI 10.1007/s003830100699; Neill SM, 2002, BRIT J DERMATOL, V147, P640, DOI 10.1046/j.1365-2133.2002.05012.x; Powell J, 2001, J AM ACAD DERMATOL, V44, P803, DOI 10.1067/mjd.2001.113474; Powell JJ, 1999, LANCET, V353, P1777, DOI 10.1016/S0140-6736(98)08228-2; Riddell L, 2000, SEX TRANSM INFECT, V76, P311, DOI 10.1136/sti.76.4.311; ZAKI I, 1996, CLIN EXP DERMATOL, V21, P234	13	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 15	2010	340								c731	10.1136/bmj.c731	http://dx.doi.org/10.1136/bmj.c731			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JR	20156913				2022-12-01	WOS:000274738600004
J	Van Bocxlaer, I; Loader, SP; Roelants, K; Biju, SD; Menegon, M; Bossuyt, F				Van Bocxlaer, Ines; Loader, Simon P.; Roelants, Kim; Biju, S. D.; Menegon, Michele; Bossuyt, Franky			Gradual Adaptation Toward a Range-Expansion Phenotype Initiated the Global Radiation of Toads	SCIENCE			English	Article							BUFO-MARINUS; CANE TOAD; EVOLUTION; AMPHIBIANS; DIVERSIFICATION; POPULATION; MORPHOLOGY; BUFONIDAE; FRONT; ANURA	Recent studies have identified range expansion as a potential driver of speciation. Yet it remains poorly understood how, under identical extrinsic settings, differential tendencies for geographic movement of taxa originate and subsequently affect diversification. We identified multiple traits that predict large distributional ranges in extant species of toads (Bufonidae) and used statistical methods to define and phylogenetically reconstruct an optimal range-expansion phenotype. Our results indicate that lineage-specific range-shifting abilities increased through an accumulation of adaptive traits that culminated in such a phenotype. This initiated the episode of global colonization and triggered the major radiation of toads. Evolution toward a range-expansion phenotype might be crucial to understanding both ancient widespread radiations and the evolutionary background of contemporary invasive species such as the cane toad.	[Van Bocxlaer, Ines; Roelants, Kim; Bossuyt, Franky] Vrije Univ Brussels, Dept Biol, Amphibian Evolut Lab, Unit Ecol & Systemat, B-1050 Brussels, Belgium; [Loader, Simon P.] Univ Basel, Sect Biogeog, Dept Environm Sci, CH-4056 Basel, Switzerland; [Biju, S. D.] Univ Delhi, Systemat Lab, CEMDE, Delhi 110007, India; [Menegon, Michele] Museo Tridentino Sci Nat, Sez Zool Vertebrati, I-38100 Trento, Italy	Vrije Universiteit Brussel; University of Basel; University of Delhi	Bossuyt, F (corresponding author), Vrije Univ Brussels, Dept Biol, Amphibian Evolut Lab, Unit Ecol & Systemat, Pleinlaan 2, B-1050 Brussels, Belgium.	fbossuyt@vub.ac.be	Van Bocxlaer, Ines/L-4852-2015; Menegon, Michele/F-9365-2011	Bossuyt, Franky/0000-0001-6804-9271; Roelants, Kim/0000-0001-5367-5958; Loader, Simon/0000-0003-4162-0575	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen [FWO 1.5.039.03N, FWO G.0056.03, FWO G.0307.04, VUB OZR834, ERC 204509]	Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen)(Institute for the Promotion of Innovation by Science and Technology in Flanders (IWT)); Fonds voor Wetenschappelijk Onderzoek-Vlaanderen(FWO)	We thank S. Bogaerts, R. O. de Sa, N. Poyarkov, M. Wilkinson, K. M. Howell, B. Vervust, B. P. Noonan, A. Channing, and J. V. Vindum for tissue samples; R. Verlinde (Vilda), P. Kok, B. Means, and E. Biggi for pictures; R. Ree for advice on Lagrange analyses; and two anonymous reviewers for valuable comments. Supported by the Institute for the Promotion of Innovation through Science and Technology in Flanders (IWT-Vlaanderen; I. V. B.); a postdoctoral fellowship from the Fonds voor Wetenschappelijk Onderzoek-Vlaanderen (F. B., K. R.); and grants FWO 1.5.039.03N, FWO G.0056.03, FWO G.0307.04, VUB OZR834, and ERC 204509 (project TAPAS). Sequences are deposited in GenBank with accession numbers GU183851 to GU183859 and GU226832 to GU226837.	BENTLEY PJ, 1966, SCIENCE, V152, P619, DOI 10.1126/science.152.3722.619; Bossuyt F, 2004, SCIENCE, V306, P479, DOI 10.1126/science.1100167; da Silva HR, 1999, HERPETOLOGICA, V55, P114; Excoffier L, 2008, TRENDS ECOL EVOL, V23, P347, DOI 10.1016/j.tree.2008.04.004; Garnica S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-1; Gavrilets S, 2009, SCIENCE, V323, P732, DOI 10.1126/science.1157966; Hallatschek O, 2007, P NATL ACAD SCI USA, V104, P19926, DOI 10.1073/pnas.0710150104; Leotard G, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005377; Magallon S., 2009, TIMETREE LIFE, P133; Moore BR, 2007, AM NAT, V170, pS28, DOI 10.1086/519460; Moyle RG, 2009, P NATL ACAD SCI USA, V106, P1863, DOI 10.1073/pnas.0809861105; Noonan BP, 2006, AM NAT, V168, P730, DOI 10.1086/509052; Phillips BL, 2009, BIOL LETTERS, V5, P802, DOI 10.1098/rsbl.2009.0367; Phillips BL, 2008, AM NAT, V172, pS34, DOI 10.1086/588255; Phillips BL, 2007, AUSTRAL ECOL, V32, P169, DOI 10.1111/j.1442-9993.2007.01664.x; Phillips BL, 2005, ANIM CONSERV, V8, P407, DOI 10.1017/S1367943005002374; POUNDS JA, 1994, CONSERV BIOL, V8, P72, DOI 10.1046/j.1523-1739.1994.08010072.x; Pramuk JB, 2008, GLOBAL ECOL BIOGEOGR, V17, P72, DOI 10.1111/j.1466-8238.2007.00348.x; Ree RH, 2005, EVOLUTION, V59, P2299; ROFF RA, 2001, DISPERSAL, P191; SCHMID WD, 1965, ECOLOGY, V46, P261, DOI 10.2307/1936329; SZARSKI H, 1972, EVOLUTION GENUS BUFO, P71; THIBAUDEAU G, 1999, TADPOLES BIOL ANURAN, P295; TOLEDO RC, 1993, COMP BIOCHEM PHYS A, V105, P593, DOI 10.1016/0300-9629(93)90259-7; Travis JMJ, 2007, MOL BIOL EVOL, V24, P2334, DOI 10.1093/molbev/msm167; Van Bocxlaer I, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000074	26	184	192	2	68	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					679	682		10.1126/science.1181707	http://dx.doi.org/10.1126/science.1181707			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133569				2022-12-01	WOS:000274251800035
J	Yovel, Y; Falk, B; Moss, CF; Ulanovsky, N				Yovel, Yossi; Falk, Ben; Moss, Cynthia F.; Ulanovsky, Nachum			Optimal Localization by Pointing Off Axis	SCIENCE			English	Article							BAT ROUSETTUS-AEGYPTIACUS; BIG BROWN BAT; ECHOLOCATING BATS; MEGACHIROPTERAN BAT; SOUND LOCALIZATION; EPTESICUS-FUSCUS; ACQUISITION; TRACKING; BEHAVIOR; MAMMALS	Is centering a stimulus in the field of view an optimal strategy to localize and track it? We demonstrated, through experimental and computational studies, that the answer is no. We trained echolocating Egyptian fruit bats to localize a target in complete darkness, and we measured the directional aim of their sonar clicks. The bats did not center the sonar beam on the target, but instead pointed it off axis, accurately directing the maximum slope ("edge") of the beam onto the target. Information-theoretic calculations showed that using the maximum slope is optimal for localizing the target, at the cost of detection. We propose that the tradeoff between detection (optimized at stimulus peak) and localization (optimized at maximum slope) is fundamental to spatial localization and tracking accomplished through hearing, olfaction, and vision.	[Yovel, Yossi; Ulanovsky, Nachum] Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel; [Falk, Ben; Moss, Cynthia F.] Univ Maryland, Dept Psychol, Syst Res Inst, College Pk, MD 20742 USA; [Falk, Ben; Moss, Cynthia F.] Univ Maryland, Neurosci & Cognit Sci Program, College Pk, MD 20742 USA	Weizmann Institute of Science; University System of Maryland; University of Maryland College Park; University System of Maryland; University of Maryland College Park	Ulanovsky, N (corresponding author), Weizmann Inst Sci, Dept Neurobiol, IL-76100 Rehovot, Israel.	nachum.ulanovsky@weizmann.ac.il	; Moss, Cynthia/J-5208-2017	Ulanovsky, Nachum/0000-0001-8598-4667; Yovel, Yossi/0000-0001-5429-9245; Moss, Cynthia/0000-0001-6916-0000	Human Frontiers Science Program; Weizmann Institute	Human Frontiers Science Program(Human Frontier Science Program); Weizmann Institute	We thank N. Sobel, J. Rubin, E. Simoni, A. Rubin, and N. Harper for comments on the manuscript; M. Holderied, I. Couzin, A. Arieli, E. Ahissar, and H.-U. Schnitzler for helpful discussions; and J. Barcelo for technical assistance. This study was funded by a Human Frontiers Science Program grant to N. U. and a Weizmann Institute Postdoctoral Fellowship to Y.Y.	Au WWL, 2003, NATURE, V423, P861, DOI 10.1038/nature01727; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Butts DA, 2006, PLOS BIOL, V4, P639, DOI 10.1371/journal.pbio.0040092; Catania KC, 2006, NATURE, V444, P1024, DOI 10.1038/4441024a; Chiu C, 2008, P NATL ACAD SCI USA, V105, P13116, DOI 10.1073/pnas.0804408105; Dayan P., 2001, THEORETICAL NEUROSCI; Ghose K, 2006, J NEUROSCI, V26, P1704, DOI 10.1523/JNEUROSCI.4315-05.2006; Ghose K, 2003, J ACOUST SOC AM, V114, P1120, DOI 10.1121/1.1589754; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; Heffner RS, 1999, J COMP PSYCHOL, V113, P297, DOI 10.1037/0735-7036.113.3.297; HERBERT H, 1985, Z SAUGETIERKD, V50, P141; Holland RA, 2004, J EXP BIOL, V207, P4361, DOI 10.1242/jeb.01288; Jones G, 2007, P R SOC B, V274, P905, DOI 10.1098/rspb.2006.0200; KALKO EKV, 1993, BEHAV ECOL SOCIOBIOL, V33, P415; Kleinfeld D, 2006, CURR OPIN NEUROBIOL, V16, P435, DOI 10.1016/j.conb.2006.06.009; Louis M, 2008, NAT NEUROSCI, V11, P187, DOI 10.1038/nn2031; MANABE T, 1978, SCIENCE, V200, P339, DOI 10.1126/science.635594; MASTERS WM, 1985, SCIENCE, V228, P1331, DOI 10.1126/science.4001947; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; METZNER W, 1989, NATURE, V341, P529, DOI 10.1038/341529a0; Nelson ME, 2006, J COMP PHYSIOL A, V192, P573, DOI 10.1007/s00359-006-0099-4; Porter J, 2007, NAT NEUROSCI, V10, P27, DOI 10.1038/nn1819; Schnitzler HU, 2003, TRENDS ECOL EVOL, V18, P386, DOI 10.1016/S0169-5347(03)00185-X; SIMMONS JA, 1979, SCIENCE, V203, P16, DOI 10.1126/science.758674; SUGA N, 1989, J EXP BIOL, V146, P277; Surlykke A, 2009, J EXP BIOL, V212, P1011, DOI 10.1242/jeb.024620; Ulanovsky N, 2004, P ROY SOC B-BIOL SCI, V271, P1467, DOI 10.1098/rspb.2004.2750; Ulanovsky N, 2008, P NATL ACAD SCI USA, V105, P8491, DOI 10.1073/pnas.0703550105	28	91	92	0	23	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					701	704		10.1126/science.1183310	http://dx.doi.org/10.1126/science.1183310			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133574				2022-12-01	WOS:000274251800041
J	Solomatin, SV; Greenfeld, M; Chu, S; Herschlag, D				Solomatin, Sergey V.; Greenfeld, Max; Chu, Steven; Herschlag, Daniel			Multiple native states reveal persistent ruggedness of an RNA folding landscape	NATURE			English	Article							TETRAHYMENA RIBOZYME; ENERGY LANDSCAPE; SINGLE-MOLECULE; SUBSTRATE; BINDING; PATHWAYS; DYNAMICS; INTERMEDIATE; CATALYSIS	According to the 'thermodynamic hypothesis', the sequence of a biological macromolecule defines its folded, active (or 'native') structure as a global energy minimum in the folding landscape(1,2). However, the enormous complexity of folding landscapes of large macromolecules raises the question of whether there is in fact a unique global minimum corresponding to a unique native conformation or whether there are deep local minima corresponding to alternative active conformations(3). The folding of many proteins is well described by two-state models, leading to highly simplified representations of protein folding landscapes with a single native conformation(4,5). Nevertheless, accumulating experimental evidence suggests a more complex topology of folding landscapes with multiple active conformations that can take seconds or longer to interconvert(6-8). Here we demonstrate, using single-molecule experiments, that an RNA enzyme folds into multiple distinct native states that interconvert on a timescale much longer than that of catalysis. These data demonstrate that severe ruggedness of RNA folding landscapes extends into conformational space occupied by native conformations.	[Solomatin, Sergey V.; Herschlag, Daniel] Stanford Univ, Dept Biochem, Stanford, CA 94305 USA; [Greenfeld, Max] Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA; [Chu, Steven] Univ Calif Berkeley, Lawrence Berkeley Lab, Berkeley, CA 94720 USA; [Chu, Steven] Univ Calif Berkeley, Dept Phys & Mol & Cell Biol, Berkeley, CA 94720 USA	Stanford University; Stanford University; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; University of California System; University of California Berkeley	Herschlag, D (corresponding author), Stanford Univ, Dept Biochem, Stanford, CA 94305 USA.	herschla@stanford.edu			US National Institutes of Health (NIH) [P01-GM-66275, GM49243]; Stanford Bio-X Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM049243, P01GM066275, R37GM049243] Funding Source: NIH RePORTER	US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Bio-X Program; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank T. H. Lee, B. Cui, H. Kim, W. Zhao and other current and former members of the Chu laboratory, and the Mabuchi laboratory, for technical assistance. We thank members of the Herschlag laboratory for discussions and comments on the manuscript. Financial support for this work was provided by US National Institutes of Health (NIH) programme project grant P01-GM-66275 and NIH grant GM49243, to D. H. We thank the Stanford Bio-X Program for fellowship support to S. V. S.	ANFINSEN CB, 1973, SCIENCE, V181, P223, DOI 10.1126/science.181.4096.223; BEVILACQUA PC, 1992, SCIENCE, V258, P1355, DOI 10.1126/science.1455230; BRYNGELSON JD, 1995, PROTEINS, V21, P167, DOI 10.1002/prot.340210302; Chen SJ, 2000, P NATL ACAD SCI USA, V97, P646, DOI 10.1073/pnas.97.2.646; DILL KA, 1997, NAT STRUCT BIOL, V4, P19, DOI DOI 10.1038/NSB0197-10; Dinner AR, 2000, TRENDS BIOCHEM SCI, V25, P331, DOI 10.1016/S0968-0004(00)01610-8; Ditzler MA, 2008, NUCLEIC ACIDS RES, V36, P7088, DOI 10.1093/nar/gkn871; English BP, 2006, NAT CHEM BIOL, V2, P168, DOI 10.1038/nchembio0306-168; Flomenbom O, 2005, P NATL ACAD SCI USA, V102, P2368, DOI 10.1073/pnas.0409039102; FRIEDEN C, 1979, ANNU REV BIOCHEM, V48, P471, DOI 10.1146/annurev.bi.48.070179.002351; HERSCHLAG D, 1992, BIOCHEMISTRY-US, V31, P1386, DOI 10.1021/bi00120a015; HERSCHLAG D, 1995, J BIOL CHEM, V270, P20871, DOI 10.1074/jbc.270.36.20871; James LC, 2003, TRENDS BIOCHEM SCI, V28, P361, DOI 10.1016/S0968-0004(03)00135-X; JENNINGS PA, 1993, BIOCHEMISTRY-US, V32, P3783, DOI 10.1021/bi00065a034; Kamagata K, 2003, J MOL BIOL, V332, P1143, DOI 10.1016/j.jmb.2003.07.002; Korennykh AV, 2007, BIOCHEMISTRY-US, V46, P12744, DOI 10.1021/bi700931y; LEVINTHAL C, 1968, J CHIM PHYS PCB, V65, P44, DOI 10.1051/jcp/1968650044; LINDAHL T, 1966, P NATL ACAD SCI USA, V55, P941, DOI 10.1073/pnas.55.4.941; Lu HP, 1998, SCIENCE, V282, P1877, DOI 10.1126/science.282.5395.1877; Narlikar GJ, 1999, BIOCHEMISTRY-US, V38, P14192, DOI 10.1021/bi9914309; Pan J, 1997, J MOL BIOL, V273, P7, DOI 10.1006/jmbi.1997.1311; Russell R, 2002, P NATL ACAD SCI USA, V99, P155, DOI 10.1073/pnas.221593598; Russell R, 2001, J MOL BIOL, V308, P839, DOI 10.1006/jmbi.2001.4751; Sattint BD, 2008, J AM CHEM SOC, V130, P6085, DOI 10.1021/ja800919q; SCHMID FX, 1981, EUR J BIOCHEM, V114, P111; Tan E, 2003, P NATL ACAD SCI USA, V100, P9308, DOI 10.1073/pnas.1233536100; Treiber DK, 1999, CURR OPIN STRUC BIOL, V9, P339, DOI 10.1016/S0959-440X(99)80045-1; Zhuang XW, 2002, SCIENCE, V296, P1473, DOI 10.1126/science.1069013; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zwanzig R, 1997, P NATL ACAD SCI USA, V94, P148, DOI 10.1073/pnas.94.1.148	30	155	159	0	37	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					681	U117		10.1038/nature08717	http://dx.doi.org/10.1038/nature08717			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130651	Green Accepted			2022-12-01	WOS:000274193900040
J	Gerstein, HC				Gerstein, Hertzel C.			Does Insulin Therapy Promote, Reduce, or Have a Neutral Effect on Cancers?	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							RISK; WOMEN; MEN		[Gerstein, Hertzel C.] McMaster Univ & Hamilton Hlth Sci, Dept Med, Hamilton, ON L8N 3Z5, Canada; [Gerstein, Hertzel C.] McMaster Univ & Hamilton Hlth Sci, Populat Hlth Res Inst, Hamilton, ON L8N 3Z5, Canada	McMaster University; McMaster University; Population Health Research Institute	Gerstein, HC (corresponding author), McMaster Univ & Hamilton Hlth Sci, Dept Med, Room 3V38,1200 Main St W, Hamilton, ON L8N 3Z5, Canada.	gerstein@mcmaster.ca	Gerstein, Hertzel/ABB-8781-2020; Gerstein, Hertzel C/B-1235-2013	Gerstein, Hertzel/0000-0001-8072-2836; Gerstein, Hertzel C/0000-0001-8072-2836				Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Hemkens LG, 2009, DIABETOLOGIA, V52, P1732, DOI 10.1007/s00125-009-1418-4; Home PD, 2009, DIABETOLOGIA, V52, P2499, DOI 10.1007/s00125-009-1530-5; Jee SH, 2005, JAMA-J AM MED ASSOC, V293, P194, DOI 10.1001/jama.293.2.194; Khaw KT, 2004, CANCER EPIDEM BIOMAR, V13, P915; Rosenstock J, 2009, DIABETOLOGIA, V52, P1971, DOI 10.1007/s00125-009-1452-2; Smith U, 2009, DIABETOLOGIA, V52, P1699, DOI 10.1007/s00125-009-1441-5; Vigneri P, 2009, ENDOCR-RELAT CANCER, V16, P1103, DOI 10.1677/ERC-09-0087; 2009, RES TEAM RESPONDS CO	10	41	42	0	2	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					446	447		10.1001/jama.2010.60	http://dx.doi.org/10.1001/jama.2010.60			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124540				2022-12-01	WOS:000274143600020
J	Renart, A; de la Rocha, J; Bartho, P; Hollender, L; Parga, N; Reyes, A; Harris, KD				Renart, Alfonso; de la Rocha, Jaime; Bartho, Peter; Hollender, Liad; Parga, Nestor; Reyes, Alex; Harris, Kenneth D.			The Asynchronous State in Cortical Circuits	SCIENCE			English	Article							FIRING RATES; NEURONS; DISCHARGE; NETWORKS; SYNCHRONY; DYNAMICS; CORTEX; MOTOR	Correlated spiking is often observed in cortical circuits, but its functional role is controversial. It is believed that correlations are a consequence of shared inputs between nearby neurons and could severely constrain information decoding. Here we show theoretically that recurrent neural networks can generate an asynchronous state characterized by arbitrarily low mean spiking correlations despite substantial amounts of shared input. In this state, spontaneous fluctuations in the activity of excitatory and inhibitory populations accurately track each other, generating negative correlations in synaptic currents which cancel the effect of shared input. Near-zero mean correlations were seen experimentally in recordings from rodent neocortex in vivo. Our results suggest a reexamination of the sources underlying observed correlations and their functional consequences for information processing.	[Renart, Alfonso; de la Rocha, Jaime; Bartho, Peter; Hollender, Liad; Harris, Kenneth D.] Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA; [de la Rocha, Jaime; Reyes, Alex] NYU, Ctr Neural Sci, New York, NY 10003 USA; [Bartho, Peter] Hungarian Acad Sci, Inst Expt Med, H-1083 Budapest, Hungary; [Parga, Nestor] Univ Autonoma Madrid, Dept Fis Teor, E-28049 Madrid, Spain; [Harris, Kenneth D.] NYU, Sch Med, Smilow Res Ctr, New York, NY 10016 USA	Rutgers State University Newark; Rutgers State University New Brunswick; New York University; Hungarian Academy of Sciences; Hungarian Institute of Experimental Medicine; Autonomous University of Madrid; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - UAM - Institut de Fisica Teorica (IFT); New York University	Renart, A (corresponding author), Rutgers State Univ, Ctr Mol & Behav Neurosci, Newark, NJ 07102 USA.	arenart@andromeda.rutgers.edu	de la Rocha, Jaime/I-2119-2015	de la Rocha, Jaime/0000-0002-3314-9384; Renart, Alfonso/0000-0001-7916-9930; Harris, Kenneth/0000-0002-5930-6456	NIH [MH073245, DC009947]; NSF [SBE-0542013]; NSF Science of Learning Center; National Institute on Deafness and Other Communication Disorders, NIH [DC-005787-01A1];  [FIS 2006-09294]; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH073245] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC005787, R01DC009947] Funding Source: NIH RePORTER; Engineering and Physical Sciences Research Council [EP/I005102/1] Funding Source: researchfish; EPSRC [EP/I005102/1] Funding Source: UKRI	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); NSF Science of Learning Center(National Science Foundation (NSF)NSF - Office of the Director (OD)); National Institute on Deafness and Other Communication Disorders, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); ; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); EPSRC(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC))	We thank A. Amarasingham, N. Brunel, G. Buzsaki, B. Doiron, A. Ecker, S. Fijisawa, A. Heimel, A. Kohn, D. Robbe, S. Sakata, E. Stark, and A. Tolias for comments on an earlier version of this manuscript; C. van Vreeswijk for discussions; and A. Compte, S. Ardid, and J. Manrique for sharing their codes. This study was supported by NIH grants MH073245 and DC009947; NSF grant SBE-0542013 to the Temporal Dynamics of Learning Center, an NSF Science of Learning Center; a National Institute on Deafness and Other Communication Disorders, NIH, grant DC-005787-01A1; and a Spanish grant FIS 2006-09294. K. D. H. is an Alfred P. Sloan fellow. We would like to dedicate this work to the memory of D. J. Amit.	Amit DJ, 1997, CEREB CORTEX, V7, P237, DOI 10.1093/cercor/7.3.237; BRITTEN KH, 1992, J NEUROSCI, V12, P4745; Clement EA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002004; Cohen MR, 2008, NEURON, V60, P162, DOI 10.1016/j.neuron.2008.08.007; Ecker AS, 2010, SCIENCE, V327, P584, DOI 10.1126/science.1179867; GAWNE TJ, 1993, J NEUROSCI, V13, P2758; GINZBURG I, 1994, PHYS REV E, V50, P3171, DOI 10.1103/PhysRevE.50.3171; GRAY CM, 1989, P NATL ACAD SCI USA, V86, P1698, DOI 10.1073/pnas.86.5.1698; Holmgren C, 2003, J PHYSIOL-LONDON, V551, P139, DOI 10.1113/jphysiol.2003.044784; Kriener B, 2008, NEURAL COMPUT, V20, P2185, DOI 10.1162/neco.2008.02-07-474; Kumar A, 2008, J NEUROSCI, V28, P5268, DOI 10.1523/JNEUROSCI.2542-07.2008; Lee D, 1998, J NEUROSCI, V18, P1161; Moreno-Bote R, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.028101; Nienborg H, 2009, NATURE, V459, P89, DOI 10.1038/nature07821; Okun M, 2008, NAT NEUROSCI, V11, P535, DOI 10.1038/nn.2105; Riehle A, 1997, SCIENCE, V278, P1950, DOI 10.1126/science.278.5345.1950; Roelfsema PR, 2004, NAT NEUROSCI, V7, P982, DOI 10.1038/nn1304; Shadlen MN, 1998, J NEUROSCI, V18, P3870; Sompolinsky H, 2001, PHYS REV E, V64, DOI 10.1103/PhysRevE.64.051904; STERIADE M, 1999, ELECTROENCEPHALOGRAP; Stern EA, 1998, NATURE, V394, P475, DOI 10.1038/28848; VAADIA E, 1995, NATURE, V373, P515, DOI 10.1038/373515a0; vanVreeswijk C, 1996, SCIENCE, V274, P1724, DOI 10.1126/science.274.5293.1724; Vogels TP, 2005, J NEUROSCI, V25, P10786, DOI 10.1523/JNEUROSCI.3508-05.2005; ZOHARY E, 1994, NATURE, V370, P140, DOI 10.1038/370140a0	25	658	661	4	72	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					587	590		10.1126/science.1179850	http://dx.doi.org/10.1126/science.1179850			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110507	Green Accepted			2022-12-01	WOS:000274020500040
J	Yu, BK; Martins, IRS; Li, PL; Amarasinghe, GK; Umetani, J; Fernandez-Zapico, ME; Billadeau, DD; Machius, M; Tomchick, DR; Rosen, MK				Yu, Bingke; Martins, Ilidio R. S.; Li, Pilong; Amarasinghe, Gaya K.; Umetani, Junko; Fernandez-Zapico, Martin E.; Billadeau, Daniel D.; Machius, Mischa; Tomchick, Diana R.; Rosen, Michael K.			Structural and Energetic Mechanisms of Cooperative Autoinhibition and Activation of Vav1	CELL			English	Article							TYROSINE PHOSPHORYLATION; SH3 DOMAIN; PROTEINS; DYNAMICS; SRC; INTEGRATION; ONCOGENE; SIGNALS; GTPASES; MODEL	Vav proteins are guanine nucleotide exchange factors (GEFs) for Rho family GTPases. They control processes including T cell activation, phagocytosis, and migration of normal and transformed cells. We report the structure and biophysical and cellular analyses of the five-domain autoinhibitory element of Vav1. The catalytic Dbl homology (DH) domain of Vav1 is controlled by two energetically coupled processes. The DH active site is directly, but weakly, inhibited by a helix from the adjacent Acidic domain. This core interaction is strengthened 10-fold by contacts of the calponin homology (CH) domain with the Acidic, pleckstrin homology, and DH domains. This construction enables efficient, step-wise relief of autoinhibition: initial phosphorylation events disrupt the modulatory CH contacts, facilitating phosphorylation of the inhibitory helix and consequent GEF activation. Our findings illustrate how the opposing requirements of strong suppression of activity and rapid kinetics of activation can be achieved in multidomain systems.	[Yu, Bingke; Martins, Ilidio R. S.; Li, Pilong; Amarasinghe, Gaya K.; Umetani, Junko; Machius, Mischa; Tomchick, Diana R.; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Dept Biochem, Dallas, TX 75390 USA; [Yu, Bingke; Martins, Ilidio R. S.; Li, Pilong; Amarasinghe, Gaya K.; Rosen, Michael K.] Univ Texas SW Med Ctr Dallas, Howard Hughes Med Inst, Dallas, TX 75390 USA; [Martins, Ilidio R. S.] Univ Coimbra, Fac Ciencias & Tecnol, Dept Bioquim, P-3001401 Coimbra, Portugal; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Div Oncol Res, Rochester, MN 55905 USA; [Fernandez-Zapico, Martin E.] Mayo Clin, Schulze Ctr Novel Therapeut, Dept Immunol, Rochester, MN 55905 USA	University of Texas System; University of Texas Southwestern Medical Center Dallas; Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas; Universidade de Coimbra; Mayo Clinic; Mayo Clinic	Rosen, MK (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Biochem, 5323 Harry Hines Blvd, Dallas, TX 75390 USA.	michael.rosen@utsouthwestern.edu	, PEP-MX Core/AGV-4051-2022	Tomchick, Diana/0000-0002-7529-4643; Amarasinghe, Gaya/0000-0002-0418-9707	Foundation for Science and Technology (Portugal); Luso- American Development Foundation (Portugal); Cancer Research Institute; NIH [GM066930, AI065474, CA102721, CA136526]; Howard Hughes Medical Institute; U.S. Department of Energy [W-31-109-ENG-38]; NATIONAL CANCER INSTITUTE [R01CA136526, P50CA102701, P20CA102701] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065474] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK084567] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066930] Funding Source: NIH RePORTER	Foundation for Science and Technology (Portugal)(Portuguese Foundation for Science and Technology); Luso- American Development Foundation (Portugal); Cancer Research Institute; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Carlos Amezcua and Chad Brautigam for technical assistance, Lewis Kay for providing NMR pulse sequences, Shae Padrick and Rama Ranganathan for discussion, and Yuh Min Chook for critical reading of the manuscript. I. R. S. M. was supported by fellowships from the Foundation for Science and Technology (Portugal) and the Luso- American Development Foundation (Portugal). G. K. A. was supported by a postdoctoral fellowship from the Cancer Research Institute. This work was supported by NIH grants GM066930 to M. K. R., AI065474 and CA102721 to D. D. B., and CA102721 and CA136526 to M. E. F. and by the Howard Hughes Medical Institute. D. D. B. is a Leukemia and Lymphoma Society Scholar. Use of the Argonne National Laboratory Structural Biology Center beamlines at the Advanced Photon Source was supported by the U.S. Department of Energy, Office of Energy Research, under Contract No. W-31-109-ENG-38.	Abe R, 1999, J BIOL CHEM, V274, P30410, DOI 10.1074/jbc.274.43.30410; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Aghazadeh B, 2000, CELL, V102, P625, DOI 10.1016/S0092-8674(00)00085-4; Amarasinghe GK, 2005, BIOCHEMISTRY-US, V44, P15257, DOI 10.1021/bi051126h; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bustelo XR, 2001, ONCOGENE, V20, P6372, DOI 10.1038/sj.onc.1204780; Chrencik JE, 2008, J MOL BIOL, V380, P828, DOI 10.1016/j.jmb.2008.05.024; Cowan CW, 2005, NEURON, V46, P205, DOI 10.1016/j.neuron.2005.03.019; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; DiNitto JP, 2007, MOL CELL, V28, P569, DOI 10.1016/j.molcel.2007.09.017; Dong ZY, 2006, MOL ENDOCRINOL, V20, P2315, DOI 10.1210/me.2006-0048; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faraldo-Gomez JD, 2007, P NATL ACAD SCI USA, V104, P13643, DOI 10.1073/pnas.0704041104; Hall AB, 2006, IMMUNITY, V24, P305, DOI 10.1016/j.immuni.2006.02.005; Han JW, 1998, SCIENCE, V279, P558, DOI 10.1126/science.279.5350.558; Henzler-Wildman K, 2007, NATURE, V450, P964, DOI 10.1038/nature06522; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; KATZAV S, 1991, MOL CELL BIOL, V11, P1912, DOI 10.1128/MCB.11.4.1912; KATZAV S, 1989, EMBO J, V8, P2283, DOI 10.1002/j.1460-2075.1989.tb08354.x; Katzav S, 2007, CANCER LETT, V255, P241, DOI 10.1016/j.canlet.2007.04.015; Korzhnev DM, 2004, J AM CHEM SOC, V126, P3964, DOI 10.1021/ja039587i; Levinson NM, 2006, PLOS BIOL, V4, P753, DOI 10.1371/journal.pbio.0040144; Li PL, 2008, NAT STRUCT MOL BIOL, V15, P613, DOI 10.1038/nsmb.1428; Llorca O, 2005, EMBO J, V24, P1330, DOI 10.1038/sj.emboj.7600617; Lopez-Lago M, 2000, MOL CELL BIOL, V20, P1678, DOI 10.1128/MCB.20.5.1678-1691.2000; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Miletic AV, 2006, J BIOL CHEM, V281, P38257, DOI 10.1074/jbc.M608913200; Minor W, 2006, ACTA CRYSTALLOGR D, V62, P859, DOI 10.1107/S0907444906019949; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Morris RJ, 2004, J SYNCHROTRON RADIAT, V11, P56, DOI 10.1107/S090904950302394X; Otwinowski Z., 1991, ISOMORPHOUS REPLACEM, P80; Prehoda KE, 2000, SCIENCE, V290, P801, DOI 10.1126/science.290.5492.801; Rapley J, 2008, EMBO REP, V9, P655, DOI 10.1038/embor.2008.80; Sauzeau V, 2006, NAT MED, V12, P841, DOI 10.1038/nm1426; Schindler T, 2000, SCIENCE, V289, P1938, DOI 10.1126/science.289.5486.1938; Schneider TR, 2002, ACTA CRYSTALLOGR D, V58, P1772, DOI 10.1107/S0907444902011678; Sondermann H, 2004, CELL, V119, P393, DOI 10.1016/j.cell.2004.10.005; Tybulewicz VL, 2005, CURR OPIN IMMUNOL, V17, P267, DOI 10.1016/j.coi.2005.04.003; Utomo A, 2006, J IMMUNOL, V177, P6388, DOI 10.4049/jimmunol.177.9.6388; Vajpai N, 2008, J BIOL CHEM, V283, P18292, DOI 10.1074/jbc.M801337200; Vogtherr M, 2006, ANGEW CHEM INT EDIT, V45, P993, DOI 10.1002/anie.200502770; Yohe ME, 2008, BIOCHEMISTRY-US, V47, P6827, DOI 10.1021/bi702543p; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4	43	104	105	0	11	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					246	256		10.1016/j.cell.2009.12.033	http://dx.doi.org/10.1016/j.cell.2009.12.033			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141838	Bronze, Green Accepted			2022-12-01	WOS:000273826500015
J	Hastings, G; Brooks, O; Stead, M; Angus, K; Anker, T; Farrell, T				Hastings, Gerard; Brooks, Oona; Stead, Martine; Angus, Kathryn; Anker, Thomas; Farrell, Tom			Failure of self regulation of UK alcohol advertising	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Hastings, Gerard; Brooks, Oona; Stead, Martine; Angus, Kathryn; Anker, Thomas] Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland; [Farrell, Tom] Open Univ, Milton Keynes MK7 6AA, Bucks, England	University of Stirling; Open University - UK	Hastings, G (corresponding author), Univ Stirling, Inst Social Mkt, Stirling FK9 4LA, Scotland.	gerard.hastings@stir.ac.uk	Anker, Thomas/T-1542-2019	Stead, Martine/0000-0002-3066-4604; Brooks, Oona/0000-0002-8435-322X	Medical Research Council [G0501282] Funding Source: Medline; Economic and Social Research Council [ES/G007489/1] Funding Source: researchfish; MRC [G0501282] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Economic and Social Research Council(UK Research & Innovation (UKRI)Economic & Social Research Council (ESRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Anderson P, 2009, ALCOHOL ALCOHOLISM, V44, P229, DOI 10.1093/alcalc/agn115; Booth A, 2008, INDEPENDENT REV EF A; *CAB OFF, 2003, STRAT UN ALC HARM RE, P129; Cairns G, 2009, EXTENT NATURE EFFECT; Hastings G., 2003, REV RES EFFECTS FOOD; Institute of Medicine, 2006, FOOD MARK CHILDR YOU; Lovato C, 2003, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003439; Smith LA, 2009, BMC PUBLIC HEALTH, V9, DOI 10.1186/1471-2458-9-51	8	70	70	0	12	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 20	2010	340								b5650	10.1136/bmj.b5650	http://dx.doi.org/10.1136/bmj.b5650			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	548HO	20089576	Green Submitted, Green Accepted			2022-12-01	WOS:000273951300004
J	Hayward, RA; Krumholz, HM; Zulman, DM; Timbie, JW; Vijan, S				Hayward, Rodney A.; Krumholz, Harlan M.; Zulman, Donna M.; Timbie, Justin W.; Vijan, Sandeep			Optimizing Statin Treatment for Primary Prevention of Coronary Artery Disease	ANNALS OF INTERNAL MEDICINE			English	Article							DENSITY-LIPOPROTEIN CHOLESTEROL; TISSUE-PLASMINOGEN ACTIVATOR; TYPE-2 DIABETES-MELLITUS; C-REACTIVE PROTEIN; HEART-DISEASE; COST-EFFECTIVENESS; MYOCARDIAL-INFARCTION; CARDIOVASCULAR RISK; INDIVIDUAL PATIENTS; EDUCATION-PROGRAM	Background: Although treating to lipid targets ("treat to target") is widely recommended for coronary artery disease (CAD) prevention, some have advocated administering fixed doses of statins based on a person's estimated net benefit ("tailored treatment"). Objective: To examine how a tailored treatment approach to statin therapy compares with a treat-to-target approach. Design: Simulated model of population-level effects of treat-to-target and tailored treatment approaches to statin therapy. Data Sources: Statin trials from 1994 to 2009 and nationally representative CAD risk factor data. Target Population: U. S. persons aged 30 to 75 years with no history of myocardial infarction. Time Horizon: Lifetime effects of 5 years of treatment. Perspective: Societal and patient. Intervention: Tailored treatment based on a person's 5-year CAD risk (simvastatin, 40 mg, for 5% to 15% CAD risk and atorvastatin, 40 mg, for CAD risk >15%) versus treat-to-target approaches that escalate statin dose per National Cholesterol Education Program [NCEP] III guidelines (including an intensive approach that advances treatment whenever intensification is optional by NCEP III criteria). Outcome Measures: Quality-adjusted life-years (QALYs). Results of Base-Case Analysis: Compared with the standard NCEP III approach, the intensive NCEP III approach treated 15 million more persons and saved 570 000 more QALYs over 5 years. The tailored strategy treated a similar number of persons, as did the intensive NCEP III approach, but saved 500 000 more QALYs and treated fewer persons with high-dose statins. Results of Sensitivity Analysis: No circumstances were found in which a treat-to-target approach was preferable to tailored treatment. Limitation: Model assumptions were based on available clinical data, which included few persons 75 years or older. Conclusion: A tailored treatment strategy prevents more CAD events while treating fewer persons with high-dose statins than low-density lipoprotein cholesterol-based target approaches. Results were robust, even with assumptions favoring a treat-to-target approach.	[Hayward, Rodney A.] Univ Michigan, Sch Med, Robert Wood Johnson Clin Scholars Program, Ann Arbor, MI 48109 USA; Vet Affairs Ann Arbor Healthcare Syst, Ann Arbor, MI USA; Yale Univ, New Haven, CT USA; Yale New Haven Med Ctr, New Haven, CT 06504 USA	University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Ann Arbor Healthcare System; Yale University; Yale University	Hayward, RA (corresponding author), Univ Michigan, Sch Med, Robert Wood Johnson Clin Scholars Program, 6312 Med Sci Bldg 1,1150 W Med Ctr Dr, Ann Arbor, MI 48109 USA.	rhayward@umich.edu	, Harlan/AAI-2875-2020		Department of Veteran Affairs Health Services Research & Development Service's Quality Enhancement Research Initiative [QUERI DIB 98-001]; Measurement Core of the Michigan Diabetes Research & Training Center [P60 DK-20572]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P60DK020572] Funding Source: NIH RePORTER	Department of Veteran Affairs Health Services Research & Development Service's Quality Enhancement Research Initiative; Measurement Core of the Michigan Diabetes Research & Training Center; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	Primary Funding Source: Department of Veteran Affairs Health Services Research & Development Service's Quality Enhancement Research Initiative.; Grant Support: In part by the Department of Veteran Affairs Health Services Research & Development Service's Quality Enhancement Research Initiative (QUERI DIB 98-001). The Measurement Core of the Michigan Diabetes Research & Training Center (National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health [P60 DK-20572]) provided consultative support.	ANDERSON KM, 1991, CIRCULATION, V83, P356, DOI 10.1161/01.CIR.83.1.356; Baigent C, 2005, LANCET, V366, P1267, DOI 10.1016/S0140-6736(05)67394-1; Brunzell JD, 2008, J AM COLL CARDIOL, V51, P1512, DOI 10.1016/j.jacc.2008.02.034; CAREY J, 2008, BUSINESSWEEK    0128; Chan PS, 2007, CIRCULATION, V115, P2398, DOI 10.1161/CIRCULATIONAHA.106.667683; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Glasziou PP, 2008, ANN INTERN MED, V148, P656, DOI 10.7326/0003-4819-148-9-200805060-00005; Gold MR., 1996, COST EFFECTIVENESS H; Gotto AM, 2000, EUR HEART J, V21, P1627, DOI 10.1053/euhj.2000.2288; Grundy Scott M, 2004, J Am Coll Cardiol, V44, P720, DOI 10.1016/j.jacc.2004.07.001; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Grundy SM, 2004, CIRCULATION, V110, P227, DOI 10.1161/01.CIR.0000133317.49796.0E; Hayward RA, 2005, HEALTH AFFAIR, V24, P1571, DOI 10.1377/hlthaff.24.6.1571; Hayward RA, 2007, HEALTH SERV RES, V42, P1718, DOI 10.1111/j.1475-6773.2006.00661.x; Hayward RA, 2007, AM J MANAG CARE, V13, P126; Hayward RA, 2006, ANN INTERN MED, V145, P520, DOI 10.7326/0003-4819-145-7-200610030-00010; Kent DM, 2007, JAMA-J AM MED ASSOC, V298, P1209, DOI 10.1001/jama.298.10.1209; Kent DM, 2002, AM J MED, V113, P104, DOI 10.1016/S0002-9343(02)01160-9; Kravitz RL, 2004, MILBANK Q, V82, P661, DOI 10.1111/j.0887-378X.2004.00327.x; LaRosa JC, 2005, NEW ENGL J MED, V352, P1425, DOI 10.1056/NEJMoa050461; LaRosa JC, 1999, JAMA-J AM MED ASSOC, V282, P2340, DOI 10.1001/jama.282.24.2340; LAW MR, 1994, BMJ-BRIT MED J, V308, P367, DOI 10.1136/bmj.308.6925.367; Law MR, 2003, BRIT MED J, V326, P1423, DOI 10.1136/bmj.326.7404.1423; LEITHA T, 1994, CLIN CARDIOL, V17, P123, DOI 10.1002/clc.4960170305; MARK DB, 1995, NEW ENGL J MED, V332, P1418, DOI 10.1056/NEJM199505253322106; National Center for Health Statistics, 3 NAT HLTH NUTR EX S; National Institute for Health and Clinical Excellence, 2006, STAT PREV CARD EV PA; *NIH, NIH PUBL; Pedersen TR, 2005, JAMA-J AM MED ASSOC, V294, P2437, DOI 10.1001/jama.294.19.2437; Pereira MA, 2004, INT J EPIDEMIOL, V33, P534, DOI 10.1093/ije/dyh057; Pitt B, 2005, NEW ENGL J MED, V352, P1483, DOI 10.1056/NEJMe058052; Pletcher MJ, 2009, ANN INTERN MED, V150, P243, DOI 10.7326/0003-4819-150-4-200902170-00005; Ridker PM, 2008, NEW ENGL J MED, V359, P2195, DOI 10.1056/NEJMoa0807646; Ridker PM, 2008, CIRCULATION, V118, P2243, DOI 10.1161/CIRCULATIONAHA.108.814251; RIND DM, 2009, UPTODATE 17 2; Rothwell PM, 2005, LANCET, V365, P176, DOI 10.1016/S0140-6736(05)17709-5; Rothwell PM, 1999, LANCET, V353, P2105, DOI 10.1016/S0140-6736(98)11415-0; ROTTERDAM EP, 1987, CLIN CHEM, V33, P1913; Sacks FM, 1998, CIRCULATION, V97, P1446; Shepherd J, 2002, LANCET, V359, P2271, DOI 10.1016/S0140-6736(02)09299-1; Snow V, 2004, ANN INTERN MED, V140, P644, DOI 10.7326/0003-4819-140-8-200404200-00012; Ubbink Dirk T, 2008, Patient Prefer Adherence, V2, P315; van Buuren S, 2007, STAT METHODS MED RES, V16, P219, DOI 10.1177/0962280206074463; Vijan S, 2004, ANN INTERN MED, V140, P650, DOI 10.7326/0003-4819-140-8-200404200-00013; Wenger NK, 2007, ANN INTERN MED, V147, P1, DOI 10.7326/0003-4819-147-1-200707030-00002; Wennberg J E, 1991, J Am Board Fam Pract, V4, P365; Whelan T, 2003, J NATL CANCER I, V95, P581, DOI 10.1093/jnci/95.8.581; Wilson PWF, 2008, CIRC-CARDIOVASC QUAL, V1, P92, DOI 10.1161/CIRCOUTCOMES.108.831198; Zulman DM, 2008, MILBANK Q, V86, P557, DOI 10.1111/j.1468-0009.2008.00534.x; UKPDS RISK ENGINE	50	104	107	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					69	+		10.7326/0003-4819-152-2-201001190-00004	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083825				2022-12-01	WOS:000273953000001
J	Blosser, TR; Yang, JG; Stone, MD; Narlikar, GJ; Zhuang, XW				Blosser, Timothy R.; Yang, Janet G.; Stone, Michael D.; Narlikar, Geeta J.; Zhuang, Xiaowei			Dynamics of nucleosome remodelling by individual ACF complexes	NATURE			English	Article							DNA TRANSLOCATION; SINGLE-MOLECULE; HISTONE OCTAMER; ENERGY-TRANSFER; CORE PARTICLE; CHROMATIN; ISWI; SWI/SNF; MECHANISM; CATALYSIS	The ATP-dependent chromatin assembly and remodelling factor (ACF) functions to generate regularly spaced nucleosomes, which are required for heritable gene silencing. The mechanism by which ACF mobilizes nucleosomes remains poorly understood. Here we report a single-molecule FRET study that monitors the remodelling of individual nucleosomes by ACF in real time, revealing previously unknown remodelling intermediates and dynamics. In the presence of ACF and ATP, the nucleosomes exhibit gradual translocation along DNA interrupted by well-defined kinetic pauses that occurred after approximately seven or three to four base pairs of translocation. The binding of ACF, translocation of DNA and exiting of translocation pauses are all ATP-dependent, revealing three distinct functional roles of ATP during remodelling. At equilibrium, a continuously bound ACF complex can move the nucleosome back-and-forth many times before dissociation, indicating that ACF is a highly processive and bidirectional nucleosome translocase.	[Blosser, Timothy R.; Stone, Michael D.; Zhuang, Xiaowei] Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA; [Blosser, Timothy R.] Harvard Univ, Grad Program Biophys, Cambridge, MA 02138 USA; [Yang, Janet G.; Narlikar, Geeta J.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94107 USA; [Stone, Michael D.; Zhuang, Xiaowei] Harvard Univ, Dept Chem & Biol Chem, Cambridge, MA 02138 USA; [Zhuang, Xiaowei] Harvard Univ, Dept Phys, Cambridge, MA 02138 USA	Harvard University; Howard Hughes Medical Institute; Harvard University; University of California System; University of California San Francisco; Harvard University; Harvard University	Zhuang, XW (corresponding author), Harvard Univ, Howard Hughes Med Inst, Cambridge, MA 02138 USA.	geeta.narlikar@ucsf.edu; zhuang@chemistry.harvard.edu	Yang, Janet/P-2003-2015		Howard Hughes Medical Institute; National Institutes of Health [GM073767]; Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM073767] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Widom for providing the plasmid containing the 601 positioning sequence and R. E. Kingston for the plasmids containing the SNF2h and Acf1 genes. We also thank L. Racki and E. Abbondanzieri for helpful discussions, and W. Huang and B. Harada for help with some experiments. This work is supported in part by Howard Hughes Medical Institute ( to X. Z.) and the National Institutes of Health (GM073767) and the Beckman Foundation ( to G. J. N). X. Z. is a Howard Hughes Medical Institute investigator. M. D. S. was a NIH Ruth L. Kirschstein NSRA Fellow, G. J. N is a Leukemia and Lymphoma Society Scholar.	Aalfs JD, 2001, J BIOL CHEM, V276, P34270, DOI 10.1074/jbc.M104163200; Abbondanzieri EA, 2008, NATURE, V453, P184, DOI 10.1038/nature06941; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bochar DA, 2000, P NATL ACAD SCI USA, V97, P1038, DOI 10.1073/pnas.97.3.1038; Cairns BR, 2007, NAT STRUCT MOL BIOL, V14, P989, DOI 10.1038/nsmb1333; Clapier CR, 2009, ANNU REV BIOCHEM, V78, P273, DOI 10.1146/annurev.biochem.77.062706.153223; Dang WW, 2007, MOL CELL BIOL, V27, P8306, DOI 10.1128/MCB.01351-07; Fitzgerald DJ, 2004, EMBO J, V23, P3836, DOI 10.1038/sj.emboj.7600364; Flaus A, 2004, CURR OPIN GENET DEV, V14, P165, DOI 10.1016/j.gde.2004.01.007; Fyodorov DV, 2002, NATURE, V418, P897, DOI 10.1038/nature00929; Gangaraju VK, 2009, MOL CELL, V35, P58, DOI 10.1016/j.molcel.2009.05.013; Ha T, 1996, P NATL ACAD SCI USA, V93, P6264, DOI 10.1073/pnas.93.13.6264; Hamiche A, 1999, CELL, V97, P833, DOI 10.1016/S0092-8674(00)80796-5; He X, 2006, J BIOL CHEM, V281, P28636, DOI 10.1074/jbc.M603008200; Ito T, 1999, GENE DEV, V13, P1529, DOI 10.1101/gad.13.12.1529; Ito T, 1997, CELL, V90, P145, DOI 10.1016/S0092-8674(00)80321-9; Kassabov SR, 2002, MOL CELL BIOL, V22, P7524, DOI 10.1128/MCB.22.21.7524-7534.2002; Langst G, 1999, CELL, V97, P843, DOI 10.1016/S0092-8674(00)80797-7; LeRoy G, 2000, J BIOL CHEM, V275, P14787, DOI 10.1074/jbc.C000093200; Li G, 2005, NAT STRUCT MOL BIOL, V12, P46, DOI 10.1038/nsmb869; Lia G, 2006, MOL CELL, V21, P417, DOI 10.1016/j.molcel.2005.12.013; Lowary PT, 1998, J MOL BIOL, V276, P19, DOI 10.1006/jmbi.1997.1494; Luger K, 1999, METHOD ENZYMOL, V304, P3; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Partensky PD, 2009, J MOL BIOL, V391, P12, DOI 10.1016/j.jmb.2009.04.085; Poot RA, 2000, EMBO J, V19, P3377, DOI 10.1093/emboj/19.13.3377; Rasnik I, 2006, NAT METHODS, V3, P891, DOI 10.1038/NMETH934; Saha A, 2002, GENE DEV, V16, P2120, DOI 10.1101/gad.995002; Schwanbeck R, 2004, J BIOL CHEM, V279, P39933, DOI 10.1074/jbc.M406060200; Shundrovsky A, 2006, NAT STRUCT MOL BIOL, V13, P549, DOI 10.1038/nsmb1102; Smith CL, 2005, CURR TOP DEV BIOL, V65, P115; Stockdale C, 2006, J BIOL CHEM, V281, P16279, DOI 10.1074/jbc.M600682200; Strohner R, 2005, NAT STRUCT MOL BIOL, V12, P683, DOI 10.1038/nsmb966; STRYER L, 1967, P NATL ACAD SCI USA, V58, P719, DOI 10.1073/pnas.58.2.719; Tsukiyama T, 1999, GENE DEV, V13, P686, DOI 10.1101/gad.13.6.686; Whitehouse I, 2003, MOL CELL BIOL, V23, P1935, DOI 10.1128/MCB.23.6.1935-1945.2003; Yang JG, 2006, NAT STRUCT MOL BIOL, V13, P1078, DOI 10.1038/nsmb1170; Zhang YL, 2006, MOL CELL, V24, P559, DOI 10.1016/j.molcel.2006.10.025; Zhuang XW, 2000, SCIENCE, V288, P2048, DOI 10.1126/science.288.5473.2048; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	41	139	141	2	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1022	U79		10.1038/nature08627	http://dx.doi.org/10.1038/nature08627			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033040	Green Accepted, Green Submitted			2022-12-01	WOS:000272996000039
J	Leung, CT; Brugge, JS				Leung, Cheuk T.; Brugge, Joan S.			Tumor Self-Seeding: Bidirectional Flow of Tumor Cells	CELL			English	Editorial Material							BREAST-CANCER METASTASIS; STEM-CELLS; GROWTH		[Leung, Cheuk T.; Brugge, Joan S.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA	Harvard University; Harvard Medical School	Brugge, JS (corresponding author), Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA.	joan_brugge@hms.harvard.edu		Leung, Cheuk/0000-0002-5838-5535				Bos PD, 2009, NATURE, V459, P1005, DOI 10.1038/nature08021; Chambers AF, 2002, NAT REV CANCER, V2, P563, DOI 10.1038/nrc865; Dittma T, 2008, CLIN EXP METASTAS, V25, P11, DOI 10.1007/s10585-007-9095-5; Husemann Y, 2008, CANCER CELL, V13, P58, DOI 10.1016/j.ccr.2007.12.003; Iliopoulos D, 2009, CELL, V139, P693, DOI 10.1016/j.cell.2009.10.014; Karnoub AE, 2007, NATURE, V449, P557, DOI 10.1038/nature06188; McAllister SS, 2008, CELL, V133, P994, DOI 10.1016/j.cell.2008.04.045; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Schafer ZT, 2007, J CLIN INVEST, V117, P3660, DOI 10.1172/JCI34237	9	33	37	0	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1226	1228		10.1016/j.cell.2009.12.013	http://dx.doi.org/10.1016/j.cell.2009.12.013			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064369	Bronze			2022-12-01	WOS:000273048700011
J	Chowdhury, BA; Dal Pan, G				Chowdhury, Badrul A.; Dal Pan, Gerald			The FDA and Safe Use of Long-Acting Beta-Agonists in the Treatment of Asthma.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							RISKS		[Chowdhury, Badrul A.] US FDA, Div Pulm & Allergy Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA; [Dal Pan, Gerald] US FDA, Off Surveillance & Epidemiol, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA); US Food & Drug Administration (FDA)	Chowdhury, BA (corresponding author), US FDA, Div Pulm & Allergy Prod, Off New Drugs, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							*DAILYMED, 2010, PROF DRUG LAB INF; Drazen JM, 2009, NEW ENGL J MED, V360, P1671, DOI 10.1056/NEJMe0902057; Kramer JM, 2009, NEW ENGL J MED, V360, P1592, DOI 10.1056/NEJMp0810561; Martinez FD, 2005, NEW ENGL J MED, V353, P2637, DOI 10.1056/NEJMp058299; National Asthma Education and Prevention Program National Heart Lung and Blood Institute, 2007, NIH PUBL	5	179	189	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1169	1171		10.1056/NEJMp1002074	http://dx.doi.org/10.1056/NEJMp1002074			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	577QQ	20181964				2022-12-01	WOS:000276239500004
J	Tobin, VA; Hashimoto, H; Wacker, DW; Takayanagi, Y; Langnaese, K; Caquineau, C; Noack, J; Landgraf, R; Onaka, T; Leng, G; Meddle, SL; Engelmann, M; Ludwig, M				Tobin, Vicky A.; Hashimoto, Hirofumi; Wacker, Douglas W.; Takayanagi, Yuki; Langnaese, Kristina; Caquineau, Celine; Noack, Julia; Landgraf, Rainer; Onaka, Tatsushi; Leng, Gareth; Meddle, Simone L.; Engelmann, Mario; Ludwig, Mike			An intrinsic vasopressin system in the olfactory bulb is involved in social recognition	NATURE			English	Article							HYPOTHALAMIC MAGNOCELLULAR VASOPRESSIN; NEURONS IN-VIVO; MITRAL CELLS; OXYTOCIN; RECEPTOR; RELEASE; EXPRESSION; RESPONSES; ABLATION; NUCLEUS	Many peptides, when released as chemical messengers within the brain, have powerful influences on complex behaviours. Most strikingly, vasopressin and oxytocin, once thought of as circulating hormones whose actions were confined to peripheral organs, are now known to be released in the brain, where they have fundamentally important roles in social behaviours(1). In humans, disruptions of these peptide systems have been linked to several neurobehavioural disorders, including Prader-Willi syndrome, affective disorders and obsessive-compulsive disorder, and polymorphisms of V1a vasopressin receptor have been linked to autism(2,3). Here we report that the rat olfactory bulb contains a large population of interneurons which express vasopressin, that blocking the actions of vasopressin in the olfactory bulb impairs the social recognition abilities of rats and that vasopressin agonists and antagonists can modulate the processing of information by olfactory bulb neurons. The findings indicate that social information is processed in part by a vasopressin system intrinsic to the olfactory system.	[Tobin, Vicky A.; Hashimoto, Hirofumi; Wacker, Douglas W.; Caquineau, Celine; Leng, Gareth; Meddle, Simone L.; Ludwig, Mike] Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland; [Takayanagi, Yuki; Onaka, Tatsushi] Jichi Med Univ, Dept Physiol, Shimotsuke, Tochigi 3290498, Japan; [Langnaese, Kristina; Noack, Julia; Engelmann, Mario] Otto VonGuericke Univ Magdegurg, Inst Biochem & Cell Biol, D-39120 Magdeburg, Germany; [Noack, Julia] Otto VonGuericke Univ Magdegurg, Ctr Cellular Imaging & Innovat Dis Models, D-39120 Magdeburg, Germany; [Landgraf, Rainer] Max Planck Inst Psychiat, D-80804 Munich, Germany; [Meddle, Simone L.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Meddle, Simone L.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland	University of Edinburgh; Jichi Medical University; Otto von Guericke University; Otto von Guericke University; Max Planck Society; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh	Ludwig, M (corresponding author), Univ Edinburgh, Ctr Integrat Physiol, Edinburgh EH8 9XD, Midlothian, Scotland.	mike.ludwig@ed.ac.uk	Takayanagi, Yuki/S-7998-2018; Leng, Gareth/C-6688-2011; Onaka, Tatsushi/I-7115-2012; Meddle, Simone Louise/C-7748-2013	Takayanagi, Yuki/0000-0003-3788-8229; Leng, Gareth/0000-0002-2388-8466; Meddle, Simone Louise/0000-0002-5629-1332; Hashimoto, Hirofumi/0000-0003-1575-836X; Onaka, Tatsushi/0000-0001-5666-9035	Biotechnology and Biological Sciences Research Council; Japan Ministry of Education, Culture, Sports, Science and Technology; Deutsche Forschungsgemeinschaft; German Academic Exchange Service/Academic Research Collaboration; Japan Society for the Promotion of Science; BBSRC [BB/F019009/1] Funding Source: UKRI; MRC [G0700176] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/F019009/1] Funding Source: researchfish; Medical Research Council [G0700176] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Japan Ministry of Education, Culture, Sports, Science and Technology(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); German Academic Exchange Service/Academic Research Collaboration(Deutscher Akademischer Austausch Dienst (DAAD)); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank V. Bishop, T. Gillespie, K. Richter and R. Murau for technical support; E. Mohr for vectors containing the total vasopressin sequence and a partial sequence; H. Gainer for vasopressin and oxytocin antibodies; Y. Ueta for the vasopressin-eGFP transgenic rats; K. Kohno and E. Kobayashi for the complementary DNA for the diphtheria toxin receptor and support for the production of transgenic rats, respectively; and D. Murphy for the DNA for the vasopressin promoter. This work was supported by grants from the Biotechnology and Biological Sciences Research Council ( M. L., S. L. M.), the Japan Ministry of Education, Culture, Sports, Science and Technology (T.O., Y. T.), the Deutsche Forschungsgemeinschaft ( M. E., J.N.) and the German Academic Exchange Service/Academic Research Collaboration ( M. L., M. E.), and by a fellowship from the Japan Society for the Promotion of Science awarded to H. H.	Bielsky IF, 2005, NEURON, V47, P503, DOI 10.1016/j.neuron.2005.06.031; Brennan PA, 2006, NATURE, V444, P308, DOI 10.1038/nature05404; Brennan PA, 2006, PHILOS T R SOC B, V361, P2061, DOI 10.1098/rstb.2006.1931; Caldwell HK, 2008, PROG NEUROBIOL, V84, P1, DOI 10.1016/j.pneurobio.2007.10.007; Chen HY, 2005, J NEUROCYTOL, V34, P37, DOI 10.1007/s11068-005-5046-8; Debarbieux F, 2003, J NEUROSCI, V23, P5553; DeVito LM, 2009, J NEUROSCI, V29, P2676, DOI 10.1523/JNEUROSCI.5488-08.2009; Dluzen DE, 1998, PEPTIDES, V19, P999, DOI 10.1016/S0196-9781(98)00047-3; Donaldson ZR, 2008, SCIENCE, V322, P900, DOI 10.1126/science.1158668; ENGELMANN M, 1995, PHYSIOL BEHAV, V58, P315, DOI 10.1016/0031-9384(95)00053-L; ENNACEUR A, 1988, BEHAV BRAIN RES, V31, P47, DOI 10.1016/0166-4328(88)90157-X; Ferguson JN, 2000, NAT GENET, V25, P284, DOI 10.1038/77040; Ferguson JN, 2002, FRONT NEUROENDOCRIN, V23, P200, DOI 10.1006/frne.2002.0229; Frank E, 2008, EUR J PHARMACOL, V583, P226, DOI 10.1016/j.ejphar.2007.11.063; Furukawa N, 2006, J BIOCHEM, V140, P831, DOI 10.1093/jb/mvj216; Gouzenes L, 1998, J NEUROSCI, V18, P1879; Hammock EAD, 2006, PHILOS T R SOC B, V361, P2187, DOI 10.1098/rstb.2006.1939; Hassan A, 2005, PHYSIOL GENOMICS, V21, P382, DOI 10.1152/physiolgenomics.00147.2004; Hayar A, 2004, J NEUROSCI, V24, P6676, DOI 10.1523/JNEUROSCI.1367-04.2004; Ikeda K, 2003, J NEUROSCI, V23, P4667; Jiang MR, 1996, J NEUROSCI, V16, P6319; Kosaka Katsuko, 2005, Anatomical Science International, V80, P80, DOI 10.1111/j.1447-073x.2005.00092.x; LEVY F, 1995, BRAIN RES, V669, P197, DOI 10.1016/0006-8993(94)01236-B; Ludwig M, 2006, NAT REV NEUROSCI, V7, P126, DOI 10.1038/nrn1845; Ludwig M, 2002, NATURE, V418, P85, DOI 10.1038/nature00822; Ludwig M, 1997, EUR J NEUROSCI, V9, P2532, DOI 10.1111/j.1460-9568.1997.tb01682.x; Meyer-Lindenberg A, 2009, MOL PSYCHIATR, V14, P968, DOI 10.1038/mp.2008.54; Murphy D, 2003, J NEUROENDOCRINOL, V15, P109, DOI 10.1046/j.1365-2826.2003.00964.x; Orlando GF, 2008, STRESS, V11, P42, DOI 10.1080/10253890701449867; OSTROWSKI NL, 1994, ENDOCRINOLOGY, V135, P1511, DOI 10.1210/en.135.4.1511; Sabatier N, 2004, J PHYSIOL-LONDON, V558, P161, DOI 10.1113/jphysiol.2004.063982; Saito M, 2001, NAT BIOTECHNOL, V19, P746, DOI 10.1038/90795; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tobin VA, 2008, ENDOCRINOLOGY, V149, P6136, DOI 10.1210/en.2008-0178; Ueta Y, 2005, ENDOCRINOLOGY, V146, P406, DOI 10.1210/en.2004-0830; Walum H, 2008, P NATL ACAD SCI USA, V105, P14153, DOI 10.1073/pnas.0803081105; WINSLOW JT, 1993, NATURE, V365, P545, DOI 10.1038/365545a0; YAMAMURA Y, 1991, SCIENCE, V252, P572, DOI 10.1126/science.1850553	38	156	160	0	48	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					413	U110		10.1038/nature08826	http://dx.doi.org/10.1038/nature08826			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20182426	Green Accepted			2022-12-01	WOS:000275657100047
J	Niederhuber, JE				Niederhuber, John E.			Translating Discovery to Patient Care	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							TUMOR MICROENVIRONMENT; CANCER		NCI, Bethesda, MD 20892 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI)	Niederhuber, JE (corresponding author), NCI, 31 Ctr Dr,Room 11A48, Bethesda, MD 20892 USA.	niederj@mail.nih.gov						Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Caussinus Emmanuel, 2007, Prog Mol Subcell Biol, V45, P205; Chin L, 2008, NATURE, V455, P1061, DOI 10.1038/nature07385; Danish M, 2008, CANCER BIOL THER, V7, P331, DOI 10.4161/cbt.7.3.5761; Ischehko I, 2009, SURGERY, V146, P430, DOI 10.1016/j.surg.2009.05.003; Khalil I, 2010, GYNECOL ONCOL, V116, P282, DOI 10.1016/j.ygyno.2009.10.085; Lorusso G, 2008, HISTOCHEM CELL BIOL, V130, P1091, DOI 10.1007/s00418-008-0530-8; Ross JS, 2004, AM J CLIN PATHOL, V122, P598, DOI 10.1309/5CWPU41AFR1VYM3F; Whiteside TL, 2008, ONCOGENE, V27, P5904, DOI 10.1038/onc.2008.271	9	8	8	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1088	1089		10.1001/jama.2010.281	http://dx.doi.org/10.1001/jama.2010.281			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233829				2022-12-01	WOS:000275594100024
J	Hare, S; Gupta, SS; Valkov, E; Engelman, A; Cherepanov, P				Hare, Stephen; Gupta, Saumya Shree; Valkov, Eugene; Engelman, Alan; Cherepanov, Peter			Retroviral intasome assembly and inhibition of DNA strand transfer	NATURE			English	Article							AUTOMATED STRUCTURE SOLUTION; HIV-1 INTEGRASE; CRYSTAL-STRUCTURE; ACTIVE-SITE; TERMINAL DOMAINS; STRUCTURAL BASIS; VIRUS INTEGRASE; BINDING DOMAIN; PROTEIN; MECHANISM	Integrase is an essential retroviral enzyme that binds both termini of linear viral DNA and inserts them into a host cell chromosome. The structure of full-length retroviral integrase, either separately or in complex with DNA, has been lacking. Furthermore, although clinically useful inhibitors of HIV integrase have been developed, their mechanism of action remains speculative. Here we present a crystal structure of full-length integrase from the prototype foamy virus in complex with its cognate DNA. The structure shows the organization of the retroviral intasome comprising an integrase tetramer tightly associated with a pair of viral DNA ends. All three canonical integrase structural domains are involved in extensive protein-DNA and protein-protein interactions. The binding of strand-transfer inhibitors displaces the reactive viral DNA end from the active site, disarming the viral nucleoprotein complex. Our findings define the structural basis of retroviral DNA integration, and will allow modelling of the HIV-1 intasome to aid in the development of antiretroviral drugs.	[Hare, Stephen; Gupta, Saumya Shree; Valkov, Eugene; Cherepanov, Peter] Univ London Imperial Coll Sci Technol & Med, Div Med, London W2 1PG, England; [Engelman, Alan] Dana Farber Canc Inst, Dept Canc Immunol & AIDS, Boston, MA 02115 USA	Imperial College London; Harvard University; Dana-Farber Cancer Institute	Cherepanov, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Div Med, St Marys Campus,Norfolk Pl, London W2 1PG, England.	p.cherepanov@imperial.ac.uk	Valkov, Eugene/AAA-1735-2020; Valkov, Eugene/C-1554-2010; Cherepanov, Peter P/F-6859-2010	Valkov, Eugene/0000-0002-3721-1739; Cherepanov, Peter P/0000-0002-0634-538X; Hare, Stephen/0000-0003-2951-1595	UK Medical Research Council; US National Institutes of Health; MRC [G0900116] Funding Source: UKRI; Medical Research Council [G0900116] Funding Source: researchfish; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070042, P30AI060354] Funding Source: NIH RePORTER	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); US National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank F. Dyda for critical reading of the manuscript, R. Clayton and M. Cummings for the generous gift of InSTIs and helpful discussions, T. Sorensen and the staff of the I02 and I04 beamlines of the Diamond Light Source for assistance with X-ray data collection. P. C. and co-workers are funded by the UK Medical Research Council, and A. E. by the US National Institutes of Health.	Alian A, 2009, P NATL ACAD SCI USA, V106, P8192, DOI 10.1073/pnas.0811919106; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Bujacz G, 1997, J BIOL CHEM, V272, P18161, DOI 10.1074/jbc.272.29.18161; Cai ML, 1997, NAT STRUCT BIOL, V4, P567, DOI 10.1038/nsb0797-567; Chen JCH, 2000, P NATL ACAD SCI USA, V97, P8233, DOI 10.1073/pnas.150220297; Chen ZG, 2000, J MOL BIOL, V296, P521, DOI 10.1006/jmbi.1999.3451; Cherepanov P, 2007, NUCLEIC ACIDS RES, V35, P113, DOI 10.1093/nar/gkl885; Cowtan K, 2006, ACTA CRYSTALLOGR D, V62, P1002, DOI 10.1107/S0907444906022116; Craigie R, 2002, MOBILE DNA, P613; Davies DR, 2000, SCIENCE, V289, P77, DOI 10.1126/science.289.5476.77; Davis IW, 2007, NUCLEIC ACIDS RES, V35, pW375, DOI 10.1093/nar/gkm216; DYDA F, 1994, SCIENCE, V266, P1981, DOI 10.1126/science.7801124; EIJKELENBOOM APAM, 1995, NAT STRUCT BIOL, V2, P807, DOI 10.1038/nsb0995-807; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; ENGELMAN A, 1994, J VIROL, V68, P5911, DOI 10.1128/JVI.68.9.5911-5917.1994; ENGELMAN A, 1991, CELL, V67, P1211, DOI 10.1016/0092-8674(91)90297-C; Espeseth AS, 2000, P NATL ACAD SCI USA, V97, P11244, DOI 10.1073/pnas.200139397; Esposito D, 1998, EMBO J, V17, P5832, DOI 10.1093/emboj/17.19.5832; Gouet P, 2003, NUCLEIC ACIDS RES, V31, P3320, DOI 10.1093/nar/gkg556; Grobler JA, 2008, ANTIVIR THER, V13, pA41; Grobler JA, 2002, P NATL ACAD SCI USA, V99, P6661, DOI 10.1073/pnas.092056199; Hare S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000515; Jaskolski M, 2009, FEBS J, V276, P2926, DOI 10.1111/j.1742-4658.2009.07009.x; Jenkins TM, 1997, EMBO J, V16, P6849, DOI 10.1093/emboj/16.22.6849; Buzon MJ, 2010, AIDS, V24, P17, DOI 10.1097/QAD.0b013e328331c81e; Langley DR, 2008, BIOCHEMISTRY-US, V47, P13481, DOI 10.1021/bi801372d; LEE B, 1971, J MOL BIOL, V55, P379, DOI 10.1016/0022-2836(71)90324-X; Leslie A. G., 1992, JOINT CCP4 ESF EAMCB; Lewinski MK, 2005, ADV GENET, V55, P147, DOI 10.1016/S0065-2660(05)55005-3; Li M, 2006, EMBO J, V25, P1295, DOI 10.1038/sj.emboj.7601005; Luscombe NM, 1997, NUCLEIC ACIDS RES, V25, P4940, DOI 10.1093/nar/25.24.4940; Marchand C, 2009, CURR TOP MED CHEM, V9, P1016, DOI 10.2174/156802609789630910; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Michel F, 2009, EMBO J, V28, P980, DOI 10.1038/emboj.2009.41; MILLER MD, 1995, CURR BIOL, V5, P1047, DOI 10.1016/S0960-9822(95)00209-0; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nowal MG, 2009, VIROLOGY, V389, P141, DOI 10.1016/j.virol.2009.04.014; Nowotny M, 2005, CELL, V121, P1005, DOI 10.1016/j.cell.2005.04.024; Nowotny M, 2009, EMBO REP, V10, P144, DOI 10.1038/embor.2008.256; Richardson JM, 2009, CELL, V138, P1096, DOI 10.1016/j.cell.2009.07.012; Sato M, 2006, J MED CHEM, V49, P1506, DOI 10.1021/jm0600139; Schuttelkopf AW, 2004, ACTA CRYSTALLOGR D, V60, P1355, DOI 10.1107/S0907444904011679; Steiniger-White M, 2004, CURR OPIN STRUC BIOL, V14, P50, DOI 10.1016/j.sbi.2004.01.008; Summa V, 2008, J MED CHEM, V51, P5843, DOI 10.1021/jm800245z; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Valkov E, 2009, NUCLEIC ACIDS RES, V37, P243, DOI 10.1093/nar/gkn938; Wang JY, 2001, EMBO J, V20, P7333, DOI 10.1093/emboj/20.24.7333; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Yang ZN, 2000, J MOL BIOL, V296, P535, DOI 10.1006/jmbi.1999.3463; Zwart Peter H., 2008, V426, P419, DOI 10.1007/978-1-60327-058-8_28	50	521	540	2	62	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					232	U108		10.1038/nature08784	http://dx.doi.org/10.1038/nature08784			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20118915	Green Submitted, Green Accepted			2022-12-01	WOS:000275366100037
J	Lee, JH; Budanov, AV; Park, EJ; Birse, R; Kim, TE; Perkins, GA; Ocorr, K; Ellisman, MH; Bodmer, R; Bier, E; Karin, M				Lee, Jun Hee; Budanov, Andrei V.; Park, Eek Joong; Birse, Ryan; Kim, Teddy E.; Perkins, Guy A.; Ocorr, Karen; Ellisman, Mark H.; Bodmer, Rolf; Bier, Ethan; Karin, Michael			Sestrin as a Feedback Inhibitor of TOR That Prevents Age-Related Pathologies	SCIENCE			English	Article							EXTENDS LIFE-SPAN; DROSOPHILA; AUTOPHAGY; GROWTH; STRESS; TARGET; MTOR; MITOCHONDRIA; RESTRICTION; CONTRIBUTES	Sestrins are conserved proteins that accumulate in cells exposed to stress, potentiate adenosine monophosphate-activated protein kinase (AMPK), and inhibit activation of target of rapamycin (TOR). We show that the abundance of Drosophila sestrin (dSesn) is increased upon chronic TOR activation through accumulation of reactive oxygen species that cause activation of c-Jun amino-terminal kinase and transcription factor Forkhead box O (FoxO). Loss of dSesn resulted in age-associated pathologies including triglyceride accumulation, mitochondrial dysfunction, muscle degeneration, and cardiac malfunction, which were prevented by pharmacological activation of AMPK or inhibition of TOR. Hence, dSesn appears to be a negative feedback regulator of TOR that integrates metabolic and stress inputs and prevents pathologies caused by chronic TOR activation that may result from diminished autophagic clearance of damaged mitochondria, protein aggregates, or lipids.	[Kim, Teddy E.; Bier, Ethan] UCSD, Sect Cell & Dev Biol, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] UCSD, Natl Ctr Microscopy & Imaging Res, La Jolla, CA 92093 USA; [Perkins, Guy A.; Ellisman, Mark H.] UCSD, Dept Neurosci, La Jolla, CA 92093 USA; [Lee, Jun Hee; Budanov, Andrei V.; Park, Eek Joong; Karin, Michael] UCSD, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pharmacol, La Jolla, CA 92093 USA; [Lee, Jun Hee; Budanov, Andrei V.; Park, Eek Joong; Karin, Michael] UCSD, Sch Med, Lab Gene Regulat & Signal Transduct, Dept Pathol, La Jolla, CA 92093 USA; [Birse, Ryan; Ocorr, Karen; Bodmer, Rolf] Sanford Burnham Med Res Inst, Neurosci Aging & Stem Cell Res Ctr, Dev & Aging Program, La Jolla, CA 92037 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; Sanford Burnham Prebys Medical Discovery Institute	Bier, E (corresponding author), UCSD, Sect Cell & Dev Biol, La Jolla, CA 92093 USA.	ebier@ucsd.edu; karinoffice@ucsd.edu		Lee, Jun Hee/0000-0002-2200-6011; Budanov, Andrei/0000-0002-7943-1000; Perkins, Guy/0000-0002-1834-6646	NIH; Superfund Research Program [CA118165, ES006376, P42-ES010337, DK082080, P41RR004050, P30-CA23100, NS29870, AI070654]; NSF [IOS-074462]; Korea Research Foundation [KRF-2007-357-C00096]; Human Frontier Science Program Organization [LT00653/2008-L]; Natural Sciences and Engineering Research Council of Canada; NATIONAL CANCER INSTITUTE [R01CA118165, P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR004050] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI070654, R56AI070654] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K99DK082080] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES010337, R01ES006376] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R56NS029870, R01NS029870] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Superfund Research Program; NSF(National Science Foundation (NSF)); Korea Research Foundation(National Research Foundation of Korea); Human Frontier Science Program Organization(Human Frontier Science Program); Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank W. McGinnis (UCSD), M. Tatar ( Brown Univ.), S. Oldham (Burnham Institute), U. Banerjee ( Univ. of California Los Angeles), I. K. Hariharan ( Univ. of California Berkeley), J. Brenman ( Univ. of North Carolina), O. Puig ( Merck), C. Wilson ( Oxford Univ.), L. Jones ( Salk Institute), M. Miura ( Univ. of Tokyo), Developmental Studies Hybridoma Bank ( Iowa), Drosophila Genomics Resource Center (DGRC) ( Indiana), DGRC ( Japan), Vienna Drosophila RNAi Center ( Austria), Cell Signaling Inc., Santa Cruz Biotechnology, and Bloomington and Harvard stock centers for fly strains, reagents, and access to lab equipment. We acknowledge help from J. Kim, M. Yoon, and R. Anderson in electron microscopy analysis; V. Temkin in ROS analysis; and M. Smelkinson, O. Cook, and A. Guichard in histochemistry. We thank M. Kim for suggestions and constructive criticism. This work was supported by grants and fellowships from the NIH and Superfund Research Program (CA118165, ES006376, and P42-ES010337 to M. K.; DK082080 to A. V. B.; P41RR004050 and P30-CA23100 to M. H. E.; and NS29870 and AI070654 to E. B.), NSF (IOS-074462 to E. B.), Korea Research Foundation (KRF-2007-357-C00096 to J. H. L.), Human Frontier Science Program Organization (LT00653/2008-L to J. H. L), and the Natural Sciences and Engineering Research Council of Canada ( to E. J. P.). M. K. is an American Cancer Society professor.	Bonawitz ND, 2007, CELL METAB, V5, P265, DOI 10.1016/j.cmet.2007.02.009; Budanov AV, 2008, CELL, V134, P451, DOI 10.1016/j.cell.2008.06.028; Budanov AV, 2004, SCIENCE, V304, P596, DOI 10.1126/science.1095569; Budanov AV, 2002, ONCOGENE, V21, P6017, DOI 10.1038/sj.onc.1205877; Chan EY, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.284pe51; Chen C, 2008, J EXP MED, V205, P2397, DOI 10.1084/jem.20081297; Colman RJ, 2009, SCIENCE, V325, P201, DOI 10.1126/science.1173635; Dobrosotskaya IY, 2002, SCIENCE, V296, P879, DOI 10.1126/science.1071124; Greer EL, 2005, ONCOGENE, V24, P7410, DOI 10.1038/sj.onc.1209086; Hara T, 2006, NATURE, V441, P885, DOI 10.1038/nature04724; Harrison DE, 2009, NATURE, V460, P392, DOI 10.1038/nature08221; Harvey KF, 2008, J CELL BIOL, V180, P691, DOI 10.1083/jcb.200710100; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; KAPAHI P, 2004, SCI AGING KNOWLEDGE, pPE34; Kim JH, 2005, BLOOD, V105, P1717, DOI 10.1182/blood-2004-03-0849; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Luong N, 2006, CELL METAB, V4, P133, DOI 10.1016/j.cmet.2006.05.013; Ocorr K, 2007, P NATL ACAD SCI USA, V104, P3943, DOI 10.1073/pnas.0609278104; Oldham S, 2003, TRENDS CELL BIOL, V13, P79, DOI 10.1016/S0962-8924(02)00042-9; Owusu-Ansah E, 2008, NAT GENET, V40, P356, DOI 10.1038/ng.2007.50; Porstmann T, 2008, CELL METAB, V8, P224, DOI 10.1016/j.cmet.2008.07.007; Singh R, 2009, NATURE, V458, P1131, DOI 10.1038/nature07976; TAKAHASHI A, 1970, J GERONTOL, V25, P222, DOI 10.1093/geronj/25.3.222; Towler MC, 2007, CIRC RES, V100, P328, DOI 10.1161/01.RES.0000256090.42690.05; Velasco-Miguel S, 1999, ONCOGENE, V18, P127, DOI 10.1038/sj.onc.1202274; Wessells RJ, 2004, NAT GENET, V36, P1275, DOI 10.1038/ng1476; Wessells R, 2009, AGING CELL, V8, P542, DOI 10.1111/j.1474-9726.2009.00504.x; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Yen WL, 2008, PHYSIOLOGY, V23, P248, DOI 10.1152/physiol.00013.2008; Zhang Y, 2007, AUTOPHAGY, V3, P337, DOI 10.4161/auto.4127; Zid BM, 2009, CELL, V139, P149, DOI 10.1016/j.cell.2009.07.034	31	422	445	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1223	1228		10.1126/science.1182228	http://dx.doi.org/10.1126/science.1182228			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203043	Green Accepted			2022-12-01	WOS:000275162100030
J	Tripp, HJ; Bench, SR; Turk, KA; Foster, RA; Desany, BA; Niazi, F; Affourtit, JP; Zehr, JP				Tripp, H. James; Bench, Shellie R.; Turk, Kendra A.; Foster, Rachel A.; Desany, Brian A.; Niazi, Faheem; Affourtit, Jason P.; Zehr, Jonathan P.			Metabolic streamlining in an open-ocean nitrogen-fixing cyanobacterium	NATURE			English	Article							SUBTROPICAL NORTH PACIFIC; BLUE-GREEN-ALGAE; UNICELLULAR CYANOBACTERIA; N-2-FIXING CYANOBACTERIA; DIVERSITY; FIXATION; DNA; EXPRESSION; GENOMES; SYSTEM	Nitrogen (N-2)-fixing marine cyanobacteria are an important source of fixed inorganic nitrogen that supports oceanic primary productivity and carbon dioxide removal from the atmosphere(1). A globally distributed(2,3), periodically abundant(4) N-2-fixing(5) marine cyanobacterium, UCYN-A, was recently found to lack the oxygen-producing photosystem II complex(6) of the photosynthetic apparatus, indicating a novel metabolism, but remains uncultivated. Here we show, from metabolic reconstructions inferred from the assembly of the complete UCYN-A genome using massively parallel pyro-sequencing of paired-end reads, that UCYN-A has a photofermentative metabolism and is dependent on other organisms for essential compounds. We found that UCYN-A lacks a number of major metabolic pathways including the tricarboxylic acid cycle, but retains sufficient electron transport capacity to generate energy and reducing power from light. Unexpectedly, UCYN-A has a reduced genome (1.44 megabases) that is structurally similar to many chloroplasts and some bacteria, in that it contains inverted repeats of ribosomal RNA operons(7). The lack of biosynthetic pathways for several amino acids and purines suggests that this organism depends on other organisms, either in close association or in symbiosis, for critical nutrients. However, size fractionation experiments using natural populations have so far not provided evidence of a symbiotic association with another microorganism. The UCYN-A cyanobacterium is a paradox in evolution and adaptation to the marine environment, and is an example of the tight metabolic coupling between microorganisms in oligotrophic oceanic microbial communities.	[Tripp, H. James; Bench, Shellie R.; Turk, Kendra A.; Foster, Rachel A.; Zehr, Jonathan P.] Univ Calif Santa Cruz, Ocean Sci Dept, Santa Cruz, CA 95064 USA; [Desany, Brian A.; Niazi, Faheem; Affourtit, Jason P.] Roche Co, Branford, CT 06405 USA	University of California System; University of California Santa Cruz; Roche Holding	Zehr, JP (corresponding author), Univ Calif Santa Cruz, Ocean Sci Dept, 1156 High St, Santa Cruz, CA 95064 USA.	zehrj@ucsc.edu	Bench, Shellie R/E-7679-2010; Zehr, Jonathan P/B-3513-2014	Zehr, Jonathan P/0000-0002-5691-5408; Foster, Rachel/0000-0002-8696-1835	Gordon and Betty Moore Foundation; US National Science Foundation (NSF); NSF Center for Microbial Oceanography: Research and Education	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); US National Science Foundation (NSF)(National Science Foundation (NSF)); NSF Center for Microbial Oceanography: Research and Education(National Science Foundation (NSF))	This work was supported by the Gordon and Betty Moore Foundation, the US National Science Foundation (NSF) and the NSF Center for Microbial Oceanography: Research and Education. 454 Life Sciences, a Roche Company, provided sequencing services. Flow cytometry was done by B. Carter in the Microbial Environmental Genomics Applications: Modelling, Experimentation, and Remote Sensing (MEGAMER) facility of the University of California, Santa Cruz. We thank I. Hewson for sample collection and preliminary metagenomic analysis.	BELKIN S, 1978, ARCH MICROBIOL, V116, P109, DOI 10.1007/BF00408741; Biegala IC, 2008, AQUAT MICROB ECOL, V51, P45, DOI 10.3354/ame01185; Church MJ, 2005, APPL ENVIRON MICROB, V71, P5362, DOI 10.1128/AEM.71.9.5362-5370.2005; Falcon LI, 2002, APPL ENVIRON MICROB, V68, P5760, DOI 10.1128/AEM.68.11.5760-5764.2002; Goebel NL, 2008, J PHYCOL, V44, P1212, DOI 10.1111/j.1529-8817.2008.00581.x; Helm RA, 2003, GENETICS, V165, P951; Janson S, 2002, CYANOBACTERIA IN SYMBIOSIS, P1; Kaneko T, 1996, PLANT MOL BIOL, V31, P193, DOI 10.1007/BF00020621; KIMURA M, 1986, PHILOS T ROY SOC B, V312, P343, DOI 10.1098/rstb.1986.0012; Kotani H, 1995, DNA Res, V2, P133, DOI 10.1093/dnares/2.3.133; Markowitz VM, 2008, NUCLEIC ACIDS RES, V36, pD528, DOI 10.1093/nar/gkm846; Miller JR, 2008, BIOINFORMATICS, V24, P2818, DOI 10.1093/bioinformatics/btn548; Misra HS, 2003, J PLANT PHYSIOL, V160, P33, DOI 10.1078/0176-1617-00846; Morris RM, 2002, NATURE, V420, P806, DOI 10.1038/nature01240; Neuhaus HE, 2000, ANNU REV PLANT PHYS, V51, P111, DOI 10.1146/annurev.arplant.51.1.111; PALMER JD, 1983, NATURE, V301, P92, DOI 10.1038/301092a0; Perez-Brocal V, 2006, SCIENCE, V314, P312, DOI 10.1126/science.1130441; Seshadri R, 2007, PLOS BIOL, V5, P394, DOI 10.1371/journal.pbio.0050075; SMITH AJ, 1967, J BACTERIOL, V94, P972, DOI 10.1128/JB.94.4.972-983.1967; Thauer RK, 2007, SCIENCE, V318, P1732, DOI 10.1126/science.1152209; Turmel M, 1999, P NATL ACAD SCI USA, V96, P10248, DOI 10.1073/pnas.96.18.10248; Turmel M, 2009, MOL BIOL EVOL, V26, P631, DOI 10.1093/molbev/msn285; Urbach E, 1998, LIMNOL OCEANOGR, V43, P1615, DOI 10.4319/lo.1998.43.7.1615; VITOUSEK PM, 1991, BIOGEOCHEMISTRY, V13, P87; Winkler M, 2002, INT J HYDROGEN ENERG, V27, P1431, DOI 10.1016/S0360-3199(02)00095-2; Wunschiers R, 2001, BBA-BIOENERGETICS, V1503, P271, DOI 10.1016/S0005-2728(00)00204-8; Zehr JP, 2008, SCIENCE, V322, P1110, DOI 10.1126/science.1165340; Zehr JP, 2007, P NATL ACAD SCI USA, V104, P17807, DOI 10.1073/pnas.0701017104; Zehr JP, 2007, LIMNOL OCEANOGR, V52, P169, DOI 10.4319/lo.2007.52.1.0169; Zehr JP, 2001, NATURE, V412, P635, DOI 10.1038/35088063	30	210	216	4	132	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					90	94		10.1038/nature08786	http://dx.doi.org/10.1038/nature08786			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20173737				2022-12-01	WOS:000275117500039
J	Lambert, JB; Gurusamy-Thangavelu, SA; Ma, KBA				Lambert, Joseph B.; Gurusamy-Thangavelu, Senthil A.; Ma, Kuangbiao			The Silicate-Mediated Formose Reaction: Bottom-Up Synthesis of Sugar Silicates	SCIENCE			English	Article							MAGNETIC-RESONANCE SPECTRA; PREBIOTIC SYNTHESIS; AQUEOUS-SOLUTION; RNA WORLD; RIBOSE; MINERALS; ORIGIN; MODEL; CHROMATOGRAPHY; FORMALDEHYDE	Understanding the mechanism of sugar formation and stabilization is important for constraining theories on the abiotic origin of complex biomolecules. Although previous studies have produced sugars from small molecules through the formose and related reactions, the product mixtures are complex and unstable. We have demonstrated that simple two-and three-carbon molecules (glycolaldehyde and glyceraldehyde), in the presence of aqueous sodium silicate, spontaneously form silicate complexes of four-and six-carbon sugars, respectively. Silicate selects for sugars with a specific stereochemistry and sequesters them from rapid decomposition. Given the abundance of silicate minerals, these observations suggest that formose-like reactions may provide a feasible pathway for the abiotic formation of biologically important sugars, such as ribose.	[Lambert, Joseph B.; Gurusamy-Thangavelu, Senthil A.; Ma, Kuangbiao] Northwestern Univ, Dept Chem, Evanston, IL 60208 USA	Northwestern University	Lambert, JB (corresponding author), Northwestern Univ, Dept Chem, 2145 Sheridan Rd, Evanston, IL 60208 USA.	jlambert@northwestern.edu	Gurusamy Thangavelu, Senthil/L-7353-2014	Gurusamy Thangavelu, Senthil/0000-0002-7298-0939	National Science Foundation; Dow Corning Corp.; Schlumberger Ltd.	National Science Foundation(National Science Foundation (NSF)); Dow Corning Corp.; Schlumberger Ltd.	This research was supported by the National Science Foundation, Dow Corning Corp., and Schlumberger Ltd.	Arrhenius GO, 2003, HELV CHIM ACTA, V86, P1569, DOI 10.1002/hlca.200390135; BRESLOW R, 1958, J AM CHEM SOC, V80, P3719, DOI 10.1021/ja01547a064; Breslow R., 1959, TETRAHEDRON LETT, V1, P22, DOI DOI 10.1016/S0040-4039(01)99487-0); Butlerow A., 1861, JUSTUS LIEBIGS ANN C, V120, P295; CAIRNSSMITH AG, 1972, J THEOR BIOL, V35, P601, DOI 10.1016/0022-5193(72)90153-1; COLLINS GCS, 1971, J CHEM SOC B, P1352, DOI 10.1039/j29710001352; DECKER P, 1982, J CHROMATOGR, V244, P281, DOI 10.1016/S0021-9673(00)85692-7; GABEL NW, 1967, NATURE, V216, P453, DOI 10.1038/216453a0; Garcia-Jimenez F, 2005, J BRAZIL CHEM SOC, V16, P467, DOI 10.1590/S0103-50532005000300022; Hazen RM, 2003, NAT MATER, V2, P367, DOI 10.1038/nmat879; Holm NG, 2006, GEOCHEM T, V7, DOI 10.1186/1467-4866-7-7; Iqbal MZ, 2009, J CHROMATOGR A, V1216, P5116, DOI 10.1016/j.chroma.2009.04.065; Kastele X, 2005, CHEM-EUR J, V11, P6326, DOI 10.1002/chem.200500147; Kelley DS, 2005, SCIENCE, V307, P1428, DOI 10.1126/science.1102556; Kinrade SD, 2001, J CHEM SOC DALTON, P961, DOI 10.1039/b010111g; KOLB VM, 1994, J MOL EVOL, V38, P549; Krishnamurthy R, 1999, ORIGINS LIFE EVOL B, V29, P139, DOI 10.1023/A:1006540518676; Lambert JB, 2004, J AM CHEM SOC, V126, P9611, DOI 10.1021/ja031748v; LARRALDE R, 1995, P NATL ACAD SCI USA, V92, P8158, DOI 10.1073/pnas.92.18.8158; LOEW O, 1886, J PRAKT CHEM, V34, P51; MATSUMOTO T, 1982, J CHEM SOC PERK T 1, P1975, DOI 10.1039/p19820001975; Orgel LE, 2000, P NATL ACAD SCI USA, V97, P12503, DOI 10.1073/pnas.220406697; Orgel LE, 2004, CRIT REV BIOCHEM MOL, V39, P99, DOI 10.1080/10409230490460765; Pitsch S, 2000, HELV CHIM ACTA, V83, P2398, DOI 10.1002/1522-2675(20000906)83:9<2398::AID-HLCA2398>3.0.CO;2-5; QUE L, 1974, BIOCHEMISTRY-US, V13, P146, DOI 10.1021/bi00698a023; Ricardo A, 2004, SCIENCE, V303, P196, DOI 10.1126/science.1092464; SCHWARTZ AW, 1993, J MOL EVOL, V36, P101, DOI 10.1007/BF00166245; SHAPIRO R, 1988, ORIGINS LIFE EVOL B, V18, P71, DOI 10.1007/BF01808782; SHIGEMASA Y, 1981, J CATAL, V69, P58, DOI 10.1016/0021-9517(81)90128-7; SHIGEMASA Y, 1984, CARBOHYD RES, V134, pC4, DOI 10.1016/0008-6215(84)85034-X; SOCHA RF, 1981, J CATAL, V67, P207, DOI 10.1016/0021-9517(81)90272-4; Springsteen G, 2004, J AM CHEM SOC, V126, P9578, DOI 10.1021/ja0483692; Stumm W., 1996, AQUAT CHEM; Washington J, 2000, ORIGINS LIFE EVOL B, V30, P53, DOI 10.1023/A:1006692606492; Yang XF, 2008, J COLLOID INTERF SCI, V328, P41, DOI 10.1016/j.jcis.2008.08.061	35	111	112	7	85	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					984	986		10.1126/science.1182669	http://dx.doi.org/10.1126/science.1182669			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	556XE	20167782				2022-12-01	WOS:000274625800036
J	Li, W; You, LR; Cooper, J; Schiavon, G; Pepe-Caprio, A; Zhou, L; Ishii, R; Giovannini, M; Hanemann, CO; Long, SB; Erdjument-Bromage, H; Zhou, PB; Tempst, P; Giancotti, FG				Li, Wei; You, Liru; Cooper, Jonathan; Schiavon, Gaia; Pepe-Caprio, Angela; Zhou, Lu; Ishii, Ryohei; Giovannini, Marco; Hanemann, C. Oliver; Long, Stephen B.; Erdjument-Bromage, Hediye; Zhou, Pengbo; Tempst, Paul; Giancotti, Filippo G.			Merlin/NF2 Suppresses Tumorigenesis by Inhibiting the E3 Ubiquitin Ligase CRL4(DCAF1) in the Nucleus	CELL			English	Article							NF2 TUMOR-SUPPRESSOR; CELL-PROLIFERATION; HUMAN SCHWANNOMA; PLASMA-MEMBRANE; NF2/MERLIN; PATHWAY; KINASE; LOCALIZATION; DEGRADATION; GROWTH	Current models imply that the FERM domain protein Merlin, encoded by the tumor suppressor NF2, inhibits mitogenic signaling at or near the plasma membrane. Here, we show that the closed, growth-inhibitory form of Merlin accumulates in the nucleus, binds to the E3 ubiquitin ligase CRL4(DCAF1), and suppresses its activity. Depletion of DCAF1 blocks the promitogenic effect of inactivation of Merlin. Conversely, enforced expression of a Merlin-insensitive mutant of DCAF1 counteracts the antimitogenic effect of Merlin. Re-expression of Merlin and silencing of DCAF1 implement a similar, tumor-suppressive program of gene expression. Tumor-derived mutations invariably disrupt Merlin's ability to interact with or inhibit CRL4(DCAF1). Finally, depletion of DCAF1 inhibits the hyperproliferation of Schwannoma cells from NF2 patients and suppresses the oncogenic potential of Merlin-deficient tumor cell lines. We propose that Merlin suppresses tumorigenesis by translocating to the nucleus to inhibit CRL4(DCAF1).	[Li, Wei; You, Liru; Cooper, Jonathan; Schiavon, Gaia; Pepe-Caprio, Angela; Giancotti, Filippo G.] Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA; [Long, Stephen B.] Mem Sloan Kettering Canc Ctr, Struct Biol Program, New York, NY 10065 USA; [Erdjument-Bromage, Hediye; Tempst, Paul] Mem Sloan Kettering Canc Ctr, Program Mol Biol, New York, NY 10065 USA; [Cooper, Jonathan] Cornell Univ, Sloan Kettering Div, Weill Grad Sch Med Sci, New York, NY 10065 USA; [Zhou, Lu; Hanemann, C. Oliver] Univ Plymouth, Peninsula Coll Med & Dent, Plymouth PL6 8BU, Devon, England; [Ishii, Ryohei; Zhou, Pengbo] Weill Cornell Med Coll, Dept Pathol & Lab Med, New York, NY 10065 USA; [Giovannini, Marco] Ctr Neural Tumor Res, House Ear Inst, Los Angeles, CA 90057 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center; Cornell University; Memorial Sloan Kettering Cancer Center; University of Plymouth; Cornell University; House Research Institute	Giancotti, FG (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol Program, New York, NY 10065 USA.	f-giancotti@ski.mskcc.org	Hanemann, C Oliver/AAV-6257-2020	Hanemann, C Oliver/0000-0002-1951-1025; Ishii, Ryohei/0000-0003-2486-1393; Li, Wei/0000-0001-5696-4309; Cooper, Jonathan/0000-0002-0301-1384; Erdjument-Bromage, Hediye/0000-0003-0224-3594; Tempst, Paul/0000-0002-6680-3987	Baker Street Foundation and National Institutes of Health (NIH) Cancer Center [P30 CA08748]; Children's Tumor Foundation; NIH [R01 CA098210]; NATIONAL CANCER INSTITUTE [R01CA098210, P30CA008748] Funding Source: NIH RePORTER	Baker Street Foundation and National Institutes of Health (NIH) Cancer Center(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Children's Tumor Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank J. Brugge, S. Jhanwar, and D. Lim for cell lines, M. Pagano for constructs, L. Fabrizio and M. Yaneva for help with mass spectrometry, and members of the Giancotti laboratory for discussions. This work was supported by the Baker Street Foundation and National Institutes of Health (NIH) Cancer Center Support Grant P30 CA08748. W. L. is recipient of a Young Investigator Award from the Children's Tumor Foundation. P.Z. was supported by NIH grant R01 CA098210.	Ahronowitz I, 2007, HUM MUTAT, V28, P1, DOI 10.1002/humu.20393; Ammoun S, 2008, CANCER RES, V68, P5236, DOI 10.1158/0008-5472.CAN-07-5849; Bretscher A, 2002, NAT REV MOL CELL BIO, V3, P586, DOI 10.1038/nrm882; Cho E, 2006, NAT GENET, V38, P1142, DOI 10.1038/ng1887; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Curto M, 2007, J CELL BIOL, V177, P893, DOI 10.1083/jcb.200703010; Gascard P, 1999, MOL BIOL CELL, V10, P1783, DOI 10.1091/mbc.10.6.1783; Gutmann DH, 2001, HUM MOL GENET, V10, P1519, DOI 10.1093/hmg/10.14.1519; Hamaratoglu F, 2006, NAT CELL BIOL, V8, P27, DOI 10.1038/ncb1339; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Huang J, 2008, ONCOGENE, V27, P4056, DOI 10.1038/onc.2008.44; James MF, 2009, MOL CELL BIOL, V29, P4250, DOI 10.1128/MCB.01581-08; Jin HC, 2006, NATURE, V442, P576, DOI 10.1038/nature04856; Jin JP, 2006, MOL CELL, V23, P709, DOI 10.1016/j.molcel.2006.08.010; Kaempchen K, 2003, HUM MOL GENET, V12, P1211, DOI 10.1093/hmg/ddg146; Kissil JL, 2003, MOL CELL, V12, P841, DOI 10.1016/S1097-2765(03)00382-4; Kissil JL, 2002, J BIOL CHEM, V277, P10394, DOI 10.1074/jbc.M200083200; Kressel M, 2002, HUM MOL GENET, V11, P2269, DOI 10.1093/hmg/11.19.2269; Lallemand D, 2003, GENE DEV, V17, P1090, DOI 10.1101/gad.1054603; Lallemand D, 2009, ONCOGENE, V28, P854, DOI 10.1038/onc.2008.427; Lee J, 2007, MOL CELL, V26, P775, DOI 10.1016/j.molcel.2007.06.001; Lim ST, 2008, MOL CELL, V29, P9, DOI 10.1016/j.molcel.2007.11.031; Liu LR, 2009, MOL CELL, V34, P451, DOI 10.1016/j.molcel.2009.04.020; Lopez-Lago MA, 2009, MOL CELL BIOL, V29, P4235, DOI 10.1128/MCB.01578-08; Luque CM, 1998, J BIOL CHEM, V273, P11643, DOI 10.1074/jbc.273.19.11643; Maddika S, 2009, NAT CELL BIOL, V11, P409, DOI 10.1038/ncb1848; McCall CM, 2008, MOL CELL BIOL, V28, P5621, DOI 10.1128/MCB.00232-08; McClatchey AI, 2005, GENE DEV, V19, P2265, DOI 10.1101/gad.1335605; McClatchey AI, 2009, TRENDS CELL BIOL, V19, P198, DOI 10.1016/j.tcb.2009.02.006; Muranen T, 2005, ONCOGENE, V24, P1150, DOI 10.1038/sj.onc.1208283; O'Connell BC, 2007, CURR OPIN CELL BIOL, V19, P206, DOI 10.1016/j.ceb.2007.02.014; Okada T, 2005, J CELL BIOL, V171, P361, DOI 10.1083/jcb.200503165; Okada T, 2007, TRENDS CELL BIOL, V17, P222, DOI 10.1016/j.tcb.2007.03.006; Poulikakos PI, 2006, ONCOGENE, V25, P5960, DOI 10.1038/sj.onc.1209587; Pylayeva Y, 2007, METHOD ENZYMOL, V426, P439, DOI 10.1016/S0076-6879(07)26019-7; Rong R, 2004, P NATL ACAD SCI USA, V101, P18200, DOI 10.1073/pnas.0405971102; Schrecengost RS, 2007, CANCER RES, V67, P6174, DOI 10.1158/0008-5472.CAN-06-3455; Shaw RJ, 2001, DEV CELL, V1, P63, DOI 10.1016/S1534-5807(01)00009-0; Shimizu T, 2002, J BIOL CHEM, V277, P10332, DOI 10.1074/jbc.M109979200; Tang XL, 2007, NAT CELL BIOL, V9, P1199, DOI 10.1038/ncb1641; Xiao GH, 2002, J BIOL CHEM, V277, P883, DOI 10.1074/jbc.C100553200	41	219	228	0	21	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 19	2010	140	4					477	490		10.1016/j.cell.2010.01.029	http://dx.doi.org/10.1016/j.cell.2010.01.029			14	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178741	Green Accepted, Bronze			2022-12-01	WOS:000274668400012
J	Wang, QJ; Zhang, YK; Yang, C; Xiong, H; Lin, Y; Yao, J; Li, H; Xie, L; Zhao, W; Yao, YF; Ning, ZB; Zeng, R; Xiong, Y; Guan, KL; Zhao, SM; Zhao, GP				Wang, Qijun; Zhang, Yakun; Yang, Chen; Xiong, Hui; Lin, Yan; Yao, Jun; Li, Hong; Xie, Lu; Zhao, Wei; Yao, Yufeng; Ning, Zhi-Bin; Zeng, Rong; Xiong, Yue; Guan, Kun-Liang; Zhao, Shimin; Zhao, Guo-Ping			Acetylation of Metabolic Enzymes Coordinates Carbon Source Utilization and Metabolic Flux	SCIENCE			English	Article							COA SYNTHETASE; PROTEIN; LYSINE; SIR2	Lysine acetylation regulates many eukaryotic cellular processes, but its function in prokaryotes is largely unknown. We demonstrated that central metabolism enzymes in Salmonella were acetylated extensively and differentially in response to different carbon sources, concomitantly with changes in cell growth and metabolic flux. The relative activities of key enzymes controlling the direction of glycolysis versus gluconeogenesis and the branching between citrate cycle and glyoxylate bypass were all regulated by acetylation. This modulation is mainly controlled by a pair of lysine acetyltransferase and deacetylase, whose expressions are coordinated with growth status. Reversible acetylation of metabolic enzymes ensure that cells respond environmental changes via promptly sensing cellular energy status and flexibly altering reaction rates or directions. It represents a metabolic regulatory mechanism conserved from bacteria to mammals.	[Wang, Qijun; Xiong, Hui; Zhao, Shimin; Zhao, Guo-Ping] Fudan Univ, Sch Life Sci, Dept Microbiol, State Key Lab Genet Engn, Shanghai 200032, Peoples R China; [Lin, Yan; Yao, Jun; Xiong, Yue; Guan, Kun-Liang; Zhao, Shimin] Fudan Univ, Inst Biomed Sci, Mol Cell Biol Lab, Shanghai 200032, Peoples R China; [Zhang, Yakun; Xiong, Hui; Zhao, Guo-Ping] Chinese Natl Human Genome Ctr Shanghai, MOST Shanghai Lab Dis & Hlth Genom, Shanghai 201203, Peoples R China; [Yang, Chen; Li, Hong; Xie, Lu; Zhao, Wei; Ning, Zhi-Bin; Zeng, Rong; Zhao, Guo-Ping] Chinese Acad Sci, Bioinformat Ctr, Key Lab Synthet Biol, Shanghai 200032, Peoples R China; [Yang, Chen; Li, Hong; Xie, Lu; Zhao, Wei; Ning, Zhi-Bin; Zeng, Rong; Zhao, Guo-Ping] Chinese Acad Sci, Lab Syst Biol, Inst Plant Physiol & Ecol, Shanghai Inst Biol Sci, Shanghai 200032, Peoples R China; [Yao, Yufeng] Shanghai Jiao Tong Univ, Lab Human Bacterial Pathogenesis, Dept Med Microbiol & Parasitol, Inst Med Sci,Sch Med, Shanghai 200025, Peoples R China; [Xiong, Yue] Univ N Carolina, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Chapel Hill, NC 27599 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Dept Microbiol, Shatin, Hong Kong, Peoples R China; [Zhao, Guo-Ping] Chinese Univ Hong Kong, Prince Wales Hosp, Li Ka Shing Inst Hlth Sci, Shatin, Hong Kong, Peoples R China	Fudan University; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Shanghai Jiao Tong University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California San Diego; University of California System; University of California San Diego; Chinese University of Hong Kong; Prince of Wales Hospital; Chinese University of Hong Kong; Prince of Wales Hospital	Zhao, SM (corresponding author), Fudan Univ, Sch Life Sci, Dept Microbiol, State Key Lab Genet Engn, Shanghai 200032, Peoples R China.	zhaosm@fudan.edu.cn; gpzhao@sibs.ac.cn	Guan, Kun-Liang/ADK-7088-2022	Zhao, Guo-Ping/0000-0002-7621-6620; Zhao, Wei/0000-0002-2422-8398	state key development programs of basic research of China [2009CB918401, 2006CB806700]; national high technology research and development program of China [2006AA02A308]; National Natural Science Foundation of China [30830002]; Shanghai key basic research project, China [08JC1400900]; NATIONAL CANCER INSTITUTE [R01CA163834, R01CA068377] Funding Source: NIH RePORTER	state key development programs of basic research of China; national high technology research and development program of China(National High Technology Research and Development Program of China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Shanghai key basic research project, China; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank members of Fudan Molecular Cell Biology laboratory for their inputs throughout this work. L. Wang of Nankai University, China, provided the S. Enterica G2466 for this study. This work is supported by state key development programs of basic research of China (2009CB918401 and 2006CB806700), national high technology research and development program of China (2006AA02A308), National Natural Science Foundation of China (30830002), and Shanghai key basic research project, China (08JC1400900).	Bereshchenko OR, 2002, NAT GENET, V32, P606, DOI 10.1038/ng1018; Bitterman KJ, 2002, J BIOL CHEM, V277, P45099, DOI 10.1074/jbc.M205670200; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; Cozzone AJ, 1998, ANNU REV MICROBIOL, V52, P127, DOI 10.1146/annurev.micro.52.1.127; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Hallows WC, 2006, P NATL ACAD SCI USA, V103, P10230, DOI 10.1073/pnas.0604392103; Hua Q, 2003, J BACTERIOL, V185, P7053, DOI 10.1128/JB.185.24.7053-7067.2003; Landry J, 2000, P NATL ACAD SCI USA, V97, P5807, DOI 10.1073/pnas.110148297; Lin YY, 2009, CELL, V136, P1073, DOI 10.1016/j.cell.2009.01.033; Neidhardt F.C., 1996, ESCHERICHIA COLI SAL, Vvol. 1; Starai VJ, 2004, J MOL BIOL, V340, P1005, DOI 10.1016/j.jmb.2004.05.010; Starai VJ, 2002, SCIENCE, V298, P2390, DOI 10.1126/science.1077650; Yang XJ, 2007, ONCOGENE, V26, P5310, DOI 10.1038/sj.onc.1210599; Zamboni N, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-209; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200; Zhao SM, 2010, SCIENCE, V327, P1000, DOI 10.1126/science.1179689	16	756	787	4	305	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1004	1007		10.1126/science.1179687	http://dx.doi.org/10.1126/science.1179687			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167787	Green Published, Green Accepted			2022-12-01	WOS:000274625800042
J	Zhao, SM; Xu, W; Jiang, WQ; Yu, W; Lin, Y; Zhang, TF; Yao, J; Zhou, L; Zeng, YX; Li, H; Li, YX; Shi, J; An, WL; Hancock, SM; He, FC; Qin, LX; Chin, J; Yang, PY; Chen, X; Lei, QY; Xiong, Y; Guan, KL				Zhao, Shimin; Xu, Wei; Jiang, Wenqing; Yu, Wei; Lin, Yan; Zhang, Tengfei; Yao, Jun; Zhou, Li; Zeng, Yaxue; Li, Hong; Li, Yixue; Shi, Jiong; An, Wenlin; Hancock, Susan M.; He, Fuchu; Qin, Lunxiu; Chin, Jason; Yang, Pengyuan; Chen, Xian; Lei, Qunying; Xiong, Yue; Guan, Kun-Liang			Regulation of Cellular Metabolism by Protein Lysine Acetylation	SCIENCE			English	Article							PHOSPHOENOLPYRUVATE CARBOXYKINASE; GLUCONEOGENESIS; DEFICIENCY	Protein lysine acetylation has emerged as a key posttranslational modification in cellular regulation, in particular through the modification of histones and nuclear transcription regulators. We show that lysine acetylation is a prevalent modification in enzymes that catalyze intermediate metabolism. Virtually every enzyme in glycolysis, gluconeogenesis, the tricarboxylic acid (TCA) cycle, the urea cycle, fatty acid metabolism, and glycogen metabolism was found to be acetylated in human liver tissue. The concentration of metabolic fuels, such as glucose, amino acids, and fatty acids, influenced the acetylation status of metabolic enzymes. Acetylation activated enoyl-coenzyme A hydratase/3-hydroxyacyl-coenzyme A dehydrogenase in fatty acid oxidation and malate dehydrogenase in the TCA cycle, inhibited argininosuccinate lyase in the urea cycle, and destabilized phosphoenolpyruvate carboxykinase in gluconeogenesis. Our study reveals that acetylation plays a major role in metabolic regulation.	[Zhao, Shimin; Xu, Wei; Jiang, Wenqing; Yu, Wei; Zhang, Tengfei; Lei, Qunying; Xiong, Yue; Guan, Kun-Liang] Fudan Univ, Sch Life Sci, Shanghai 20032, Peoples R China; [Zhao, Shimin; Xu, Wei; Jiang, Wenqing; Yu, Wei; Lin, Yan; Zhang, Tengfei; Lei, Qunying; Xiong, Yue; Guan, Kun-Liang] Fudan Univ, Mol & Cell Biol Lab, Shanghai 20032, Peoples R China; [Yao, Jun; He, Fuchu; Yang, Pengyuan; Chen, Xian] Fudan Univ, Ctr Prote, Inst Biomed Sci, Shanghai 20032, Peoples R China; [Zhou, Li; Zeng, Yaxue; Chen, Xian; Xiong, Yue] Univ N Carolina, Dept Biochem & Biophys, Lineberger Comprehens Canc Ctr, Chapel Hill, NC 27599 USA; [Li, Hong; Qin, Lunxiu] Fudan Univ, Affiliated Zhongshan Hosp, Shanghai 20032, Peoples R China; [Li, Yixue; Shi, Jiong] Chinese Acad Sci, Shanghai Inst Biol Sci, Bioinformat Ctr, Key Lab Syst Biol, Shanghai 200031, Peoples R China; [An, Wenlin; Hancock, Susan M.; Chin, Jason] MRC, Mol Biol Lab, Cambridge CB2 OQH, England; [Lei, Qunying; Guan, Kun-Liang] Fudan Univ, Dept Biol Chem, Shanghai 20032, Peoples R China; [Guan, Kun-Liang] Univ Calif San Diego, Dept Pharmacol, La Jolla, CA 92093 USA; [Guan, Kun-Liang] Univ Calif San Diego, Moores Canc Ctr, La Jolla, CA 92093 USA	Fudan University; Fudan University; Fudan University; University of North Carolina; University of North Carolina Chapel Hill; Fudan University; Chinese Academy of Sciences; Shanghai Institutes for Biological Sciences, CAS; Fudan University; University of California System; University of California San Diego; University of California System; University of California San Diego	Xiong, Y (corresponding author), Fudan Univ, Sch Life Sci, Shanghai 20032, Peoples R China.	yxiong@email.unc.edu; kuguan@ucsd.edu	Lei, Qun-Ying/J-1390-2017; YU, WEI/C-3822-2012; Guan, Kun-Liang/ADK-7088-2022	Lei, Qun-Ying/0000-0002-8547-8518; He, Fuchu/0000-0002-8571-2351; YU, WEI/0000-0001-9898-4607	Chinese Ministry of Education; state key development programs of basic research of China [2009CB918401, 2006CB806700]; national high technology research and development program of China [2006AA02A308]; Chinese National Science Foundation [30600112, 30871255]; Shanghai key basic research projects [06JC14086, 07PJ14011, 08JC1400900]; NIH [R01GM51586, R01CA108941, R01CA65572]; Medical Research Council [MC_UP_A024_1008, MC_U105181009] Funding Source: researchfish; MRC [MC_U105181009, MC_UP_A024_1008] Funding Source: UKRI; NATIONAL CANCER INSTITUTE [R01CA065572, R01CA108941] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051586] Funding Source: NIH RePORTER	Chinese Ministry of Education(Ministry of Education, China); state key development programs of basic research of China; national high technology research and development program of China(National High Technology Research and Development Program of China); Chinese National Science Foundation(National Natural Science Foundation of China (NSFC)); Shanghai key basic research projects; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank members of Fudan MCB laboratory for their valuable inputs throughout this study and S. Jackson for reading the manuscript. Supported by the 985 program from the Chinese Ministry of Education, state key development programs of basic research of China (grants 2009CB918401 and 2006CB806700), the national high technology research and development program of China (grant 2006AA02A308), Chinese National Science Foundation grants 30600112 and 30871255, Shanghai key basic research projects (grants 06JC14086, 07PJ14011, 08JC1400900), and NIH grants R01GM51586, R01CA108941, and R01CA65572 (K. L. G., X. C., and Y.X.).	ALVARES K, 1994, CANCER RES, V54, P2303; Choudhary C, 2009, SCIENCE, V325, P834, DOI 10.1126/science.1175371; JUNGAS RL, 1992, PHYSIOL REV, V72, P419, DOI 10.1152/physrev.1992.72.2.419; Kim SC, 2006, MOL CELL, V23, P607, DOI 10.1016/j.molcel.2006.06.026; LARDY H, 1984, CURR TOP CELL REGUL, V24, P171; She P, 2000, MOL CELL BIOL, V20, P6508, DOI 10.1128/MCB.20.17.6508-6517.2000; Trevisson E, 2007, HUM MUTAT, V28, P694, DOI 10.1002/humu.20498; WATKINS PA, 1989, J CLIN INVEST, V83, P771, DOI 10.1172/JCI113956; Yang XJ, 2008, MOL CELL, V31, P449, DOI 10.1016/j.molcel.2008.07.002; Yeh CS, 2006, CANCER LETT, V233, P297, DOI 10.1016/j.canlet.2005.03.050; Zhang JM, 2009, MOL CELL PROTEOMICS, V8, P215, DOI 10.1074/mcp.M800187-MCP200	11	1372	1432	10	501	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1000	1004		10.1126/science.1179689	http://dx.doi.org/10.1126/science.1179689			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167786	Green Accepted, Green Submitted			2022-12-01	WOS:000274625800041
J	Bryce, J; Gilroy, K; Jones, G; Hazel, E; Black, RE; Victora, CG				Bryce, Jennifer; Gilroy, Kate; Jones, Gareth; Hazel, Elizabeth; Black, Robert E.; Victora, Cesar G.			The Accelerated Child Survival and Development programme in west Africa: a retrospective evaluation	LANCET			English	Article								Background UNICEF implemented the Accelerated Child Survival and Development (ACSD) programme in 11 west African countries between 2001 and 2005 to reduce child mortality by at least 25% by the end of 2006. We undertook a retrospective evaluation of the programme in Benin, Ghana, and Mali. Methods We used data from Demographic and Health Surveys and Multiple Indicator Cluster Surveys to compare changes in coverage for 14 ACSD interventions, nutritional status (stunting and wasting), and mortality in children younger than 5 years in the ACSD focus districts with those in the remainder of every country (comparison areas), after excluding major metropolitan areas. Findings Mortality in children younger than 5 years decreased in ACSD areas by 13% in Benin (absolute decrease 18 deaths per 1000 livebirths, p=0.12), 20% in Ghana (21 per 1000 livebirths, p=0.10), and 24% in Mali (63 per 1000 livebirths, p<0.0001), but these decreases were not greater than those in comparison areas in Benin (25%; absolute decrease 36 deaths per 1000 livebirths, p=0.15) or Mali (31%; 76 per 1000 livebirths, p=0.30; comparison data not available for Ghana). ACSD districts showed significantly greater increases than did comparison areas in coverage for preventive interventions delivered through outreach and campaign strategies in Ghana and Mali, but not Benin. Coverage in ACSD areas for correct treatment of childhood pneumonia, diarrhoea, and malaria did not differ significantly from before to after programme implementation in Benin and Mali, but decreased significantly in Ghana for malaria (from 78% to 53%, p<0.0001) and diarrhoea (from 39% to 28%, p=0.05). We recorded no significant improvements in nutritional status attributable to ACSD in the three countries. Interpretation The ACSD project did not accelerate child survival in Benin and Mali focus districts relative to comparison areas, probably because coverage for effective treatment interventions for malaria and pneumonia were not accelerated, causes of neonatal deaths and undernutrition were not addressed, and stock shortages of insecticide-treated nets restricted the potential effect of this intervention. Changes in policy and nationwide programme strengthening may have benefited from inputs by UNICEF and other partners, making an acceleration effect in the ACSD focus districts difficult to capture. Funding UNICEF, Canadian International Development Agency, Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (Brazil), and Fulbright Fellowship.	[Bryce, Jennifer; Gilroy, Kate; Jones, Gareth; Hazel, Elizabeth; Black, Robert E.; Victora, Cesar G.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, Baltimore, MD 21205 USA; [Victora, Cesar G.] Univ Fed Pelotas, Pelotas, Brazil	Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Universidade Federal de Pelotas	Bryce, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Inst Int Programs, 615 N Wolfe St, Baltimore, MD 21205 USA.	jbryce@jhsph.edu	Victora, Cesar Gomes/Y-2455-2019; Victora, Cesar G/D-4476-2013	Victora, Cesar Gomes/0000-0002-2465-2180; Victora, Cesar G/0000-0002-2465-2180; Hazel, Elizabeth/0000-0002-9176-3278; Black, Robert/0000-0001-9926-7984	UNICEF; Canadian International Development Agency; Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (Brazil); Fulbright Fellowship	UNICEF; Canadian International Development Agency; Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (Brazil)(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); Fulbright Fellowship	Funding UNICEF, Canadian International Development Agency, Coordenacao de Aperfeicoamento de Pessoal do Nivel Superior (Brazil), and Fulbright Fellowship.; We thank the staff of the Ministries of Health and National Statistics offices in Benin, Ghana, and Mali, and the UNICEF national, regional and headquarters staff and leadership for their active collaboration and participation in this evaluation effort; Easmon Otupiri and Seydou Doumbia who led teams that documented ACSD implementation and contextual factors in Ghana and Mali; Trevor Croft who helped with mortality data processing and analysis; Agbessi Amouzou who helped with mortality and equity analyses; Jeremy Schiefen who helped with administrative coordination; and the staff of Macro, International for assistance with the Supplemental surveys. UNICEF supported the evaluation through funds provided by Canadian CIDA and UNICEF country offices provided financial support for the supplemental surveys and advanced technical assistance from Macro, International.	Aker J.C., 2008, CAN WE AVOID ANOTHER; Arifeen SE, 2009, LANCET, V374, P393, DOI 10.1016/S0140-6736(09)60828-X; Athey S, 2006, ECONOMETRICA, V74, P431, DOI 10.1111/j.1468-0262.2006.00668.x; Black RE, 2008, LANCET, V371, P243, DOI 10.1016/S0140-6736(07)61690-0; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; BRYCE J, 2008, TRACK PROGR MAT NEWB; Bryce J, 2006, LANCET, V368, P1067, DOI 10.1016/S0140-6736(06)69339-2; de Onis M, 2006, ACTA PAEDIATR, V95, P76, DOI 10.1080/08035320500495548; *GHAN HLTH SERV, REG DET HLTH STAT; Ghana Statistical Service. Noguchi Memorial Institute of Medical Research, 2004, GHAN DEM HLTH SURV 2; *J HOPK BLOOMB SCH, LIST EV BAS DEC MAK; Kish L, 1965, SURVEY SAMPLING; *MIN HLTH PLANN ST, 2008, DEM HLTH SURV MAL 20; Quinn VJ, 2005, J HUM LACT, V21, P345, DOI 10.1177/0890334405278383; RAO J, 2005, INTERPLAY SAMPLE SUR; Rutstein S, 2006, GUIDE DHS STAT; *STATACORP, 2005, SURV DAT REF MAN; Tulloch J, 1999, LANCET, V354, pS16; *UN CHILDR FUND, 2004, UNICEF WHO M CHILD S; *UN CHILDR FUND, 2005, ACC CHILD SURV DEV R; United Nations Children's Fund, 2005, MULT IND CLUST SURV; Victora CG, 2009, B WORLD HEALTH ORGAN, V87, P83, DOI 10.2471/BLT.09.062828; Victora CG, 2005, HEALTH POLICY PLANN, V20, pI18, DOI 10.1093/heapol/czi050; Wolter KM, 2007, STAT SOC BEHAV SC, P1, DOI 10.1007/978-0-387-35099-8	24	62	62	0	7	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					572	582		10.1016/S0140-6736(09)62060-2	http://dx.doi.org/10.1016/S0140-6736(09)62060-2			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560YO	20071020				2022-12-01	WOS:000274941900031
J	Gao, X; Zhou, LJ; Jiao, XY; Lu, FR; Yan, CY; Zeng, X; Wang, JW; Shi, YG				Gao, Xiang; Zhou, Lijun; Jiao, Xuyao; Lu, Feiran; Yan, Chuangye; Zeng, Xin; Wang, Jiawei; Shi, Yigong			Mechanism of substrate recognition and transport by an amino acid antiporter	NATURE			English	Article							AGMATINE ANTIPORTER; BACTERIAL HOMOLOG; CRYSTAL-STRUCTURE; RESISTANCE; PUTRESCINE; EXCRETION; ARGININE; SITE; IDENTIFICATION; CADAVERINE	In extremely acidic environments, enteric bacteria such as Escherichia coli rely on the amino acid antiporter AdiC to expel protons by exchanging intracellular agmatine (Agm(2+)) for extracellular arginine (Arg(+))(1-3). AdiC is a representative member of the amino acid-polyamine-organocation (APC) superfamily of membrane transporters(4,5). The structure of substrate-free AdiC revealed a homodimeric assembly, with each protomer containing 12 transmembrane segments and existing in an outward-open conformation(6,7). The overall folding of AdiC is similar to that of the Na+-coupled symporters(8-11). Despite these advances, it remains unclear how the substrate (arginine or agmatine) is recognized and transported by AdiC. Here we report the crystal structure of an E. coli AdiC variant bound to Arg at 3.0 angstrom resolution. The positively charged Arg is enclosed in an acidic binding chamber, with the head groups of Arg hydrogen-bonded to main chain atoms of AdiC and the aliphatic portion of Arg stacked by hydrophobic side chains of highly conserved residues. Arg binding induces pronounced structural rearrangement in transmembrane helix 6 (TM6) and, to a lesser extent, TM2 and TM10, resulting in an occluded conformation. Structural analysis identified three potential gates, involving four aromatic residues and Glu 208, which may work in concert to differentially regulate the upload and release of Arg and Agm.	[Gao, Xiang; Zeng, Xin; Shi, Yigong] Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China; [Zhou, Lijun; Jiao, Xuyao; Lu, Feiran; Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, State Key Lab Biomembrane & Membrane Biotechnol, Struct Biol Ctr, Sch Life Sci, Beijing 100084, Peoples R China; [Zhou, Lijun; Jiao, Xuyao; Lu, Feiran; Yan, Chuangye; Wang, Jiawei] Tsinghua Univ, Sch Med, Beijing 100084, Peoples R China; [Jiao, Xuyao] Shandong Univ, Sch Life Sci, Jinan 250100, Shandong, Peoples R China	Tsinghua University; Tsinghua University; Tsinghua University; Shandong University	Shi, YG (corresponding author), Tsinghua Univ, Minist Educ, Prot Sci Lab, Beijing 100084, Peoples R China.	shi-lab@tsinghua.edu.cn	Wang, Jiawei/D-1144-2010; Yan, Chuangye/AAJ-5832-2021	Wang, Jiawei/0000-0001-9893-8539; Lu, Feiran/0000-0002-1757-2895; Yan, Chuangye/0000-0001-9338-8048; Zhou, Lijun/0000-0002-0393-4787; gao, xiang/0000-0001-6397-5639; Shi, Yigong/0000-0003-2030-168X	Ministry of Science and Technology [2009CB918801]; Tsinghua University; National Natural Science Foundation; Beijing Municipal Commissions of Education and Science and Technology	Ministry of Science and Technology(Ministry of Science, ICT & Future Planning, Republic of Korea); Tsinghua University; National Natural Science Foundation(National Natural Science Foundation of China (NSFC)); Beijing Municipal Commissions of Education and Science and Technology	We thank C. Miller and Y. Xiong for discussion and exchange of information, N. Shimizu, T. Kumasaka and S. Baba at the Spring-8 beamline BL41XU for on-site assistance, and N. Yan for discussion and comments on the manuscript. This work was supported by the Ministry of Science and Technology (grant no. 2009CB918801), Tsinghua University 985 Phase II funds, National Natural Science Foundation, and Beijing Municipal Commissions of Education and Science and Technology.	Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; BAILEY S, 1994, ACTA CRYSTALLOGR D, V50, P760, DOI 10.1107/s0907444994003112; Casagrande F, 2008, J BIOL CHEM, V283, P33240, DOI 10.1074/jbc.M806917200; Castanie-Cornet MP, 1999, J BACTERIOL, V181, P3525, DOI 10.1128/JB.181.11.3525-3535.1999; Cowtan K., 1994, JT CCP4 ESF EACBM NE, V31, P34; Delano W. L., 2002, CCP4 NEWSL PROTEIN C; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Faham S, 2008, SCIENCE, V321, P810, DOI 10.1126/science.1160406; Fang YL, 2007, J BIOL CHEM, V282, P176, DOI 10.1074/jbc.M610075200; Fang YL, 2009, NATURE, V460, P1040, DOI 10.1038/nature08201; Forrest LR, 2008, P NATL ACAD SCI USA, V105, P10338, DOI 10.1073/pnas.0804659105; Foster JW, 2004, NAT REV MICROBIOL, V2, P898, DOI 10.1038/nrmicro1021; Gao X, 2009, SCIENCE, V324, P1565, DOI 10.1126/science.1173654; Gong S, 2003, J BACTERIOL, V185, P4402, DOI 10.1128/JB.185.15.4402-4409.2003; Hersh BM, 1996, J BACTERIOL, V178, P3978, DOI 10.1128/jb.178.13.3978-3981.1996; Iyer R, 2003, J BACTERIOL, V185, P6556, DOI 10.1128/JB.185.22.6556-6561.2003; Jack DL, 2000, MICROBIOL-SGM, V146, P1797, DOI 10.1099/00221287-146-8-1797; Kashiwagi K, 2000, J BIOL CHEM, V275, P36007, DOI 10.1074/jbc.M006083200; Kashiwagi K, 1997, J BIOL CHEM, V272, P6318, DOI 10.1074/jbc.272.10.6318; KASHIWAGI K, 1992, P NATL ACAD SCI USA, V89, P4529, DOI 10.1073/pnas.89.10.4529; Mccoy AJ, 2007, J APPL CRYSTALLOGR, V40, P658, DOI 10.1107/S0021889807021206; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Ressl S, 2009, NATURE, V458, P47, DOI 10.1038/nature07819; Shaffer PL, 2009, SCIENCE, V325, P1010, DOI 10.1126/science.1176088; Singh SK, 2007, NATURE, V448, P952, DOI 10.1038/nature06038; Singh SK, 2008, SCIENCE, V322, P1655, DOI 10.1126/science.1166777; Soksawatmaekhin W, 2004, MOL MICROBIOL, V51, P1401, DOI 10.1046/j.1365-2958.2003.03913.x; Soksawatmaekhin W, 2006, J BIOL CHEM, V281, P29213, DOI 10.1074/jbc.M600754200; Weyand S, 2008, SCIENCE, V322, P709, DOI [10.1126/science.1164440, 10.1126/science.1160058]; Yamashita A, 2005, NATURE, V437, P215, DOI 10.1038/nature03978; Zhou Z, 2007, SCIENCE, V317, P1390, DOI 10.1126/science.1147614	31	156	156	6	137	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					828	U143		10.1038/nature08741	http://dx.doi.org/10.1038/nature08741			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20090677				2022-12-01	WOS:000274394300044
J	Harrison, T				Harrison, Terry			Apes Among the Tangled Branches of Human Origins	SCIENCE			English	Editorial Material							MIOCENE GREAT APE; MIDDLE MIOCENE; ARDIPITHECUS-RAMIDUS; CHIMPANZEE; KENYA		NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA	New York University	Harrison, T (corresponding author), NYU, Dept Anthropol, Ctr Study Human Origins, New York, NY 10003 USA.	terry.harrison@nyu.edu						Agusti J, 2003, J HUM EVOL, V45, P145, DOI 10.1016/S0047-2484(03)00091-5; Andrews Peter, 2005, P103; Begun D. R., 2007, HDB PALAEOANTHROPOLO, V2, P921; Begun David R., 2003, Deinsea (Rotterdam), V10, P23; Gibbons A, 2009, SCIENCE, V326, P1598, DOI 10.1126/science.326.5960.1598-a; Gibbons A, 2009, SCIENCE, V326, P36, DOI 10.1126/science.326_36; Harrison T, 2002, CAM S BIO EVOL ANTHR, V33, P311; HARRISON T, 1989, J HUM EVOL, V18, P537, DOI 10.1016/0047-2484(89)90017-1; Kumar S, 2005, P NATL ACAD SCI USA, V102, P18842, DOI 10.1073/pnas.0509585102; Kunimatsu Y, 2007, P NATL ACAD SCI USA, V104, P19220, DOI 10.1073/pnas.0706190104; McCrossin ML, 1998, PRIMATE LOCOMOTION, P353; Moya-Sola S, 2004, SCIENCE, V306, P1339, DOI 10.1126/science.1103094; Moya-Sola S, 2009, P NATL ACAD SCI USA, V106, P9601, DOI 10.1073/pnas.0811730106; Pickford M, 2005, ANTHROPOL SCI, V113, P95, DOI 10.1537/ase.04S014; Pickford M, 2009, CR PALEVOL, V8, P413, DOI 10.1016/j.crpv.2008.11.003; Stewart CB, 1998, CURR BIOL, V8, pR582, DOI 10.1016/S0960-9822(07)00367-3; Suwa G, 2007, NATURE, V448, P921, DOI 10.1038/nature06113; White TD, 2009, SCIENCE, V326, P75, DOI 10.1126/science.1175802	18	69	71	0	36	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					532	534		10.1126/science.1184703	http://dx.doi.org/10.1126/science.1184703			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	549CT	20110491	Green Submitted			2022-12-01	WOS:000274020500022
J	Boger-Megiddo, I; Heckbert, SR; Weiss, NS; McKnight, B; Furberg, CD; Wiggins, KL; Delaney, JAC; Siscovick, DS; Larson, EB; Lemaitre, RN; Smith, NL; Rice, KM; Glazer, NL; Psaty, BM				Boger-Megiddo, Inbal; Heckbert, Susan R.; Weiss, Noel S.; McKnight, Barbara; Furberg, Curt D.; Wiggins, Kerri L.; Delaney, Joseph A. C.; Siscovick, David S.; Larson, Eric B.; Lemaitre, Rozenn N.; Smith, Nicholas L.; Rice, Kenneth M.; Glazer, Nicole L.; Psaty, Bruce M.			Myocardial infarction and stroke associated with diuretic based two drug antihypertensive regimens: population based case-control study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ANTI HYPERTENSIVE DRUGS; CARDIOVASCULAR MORBIDITY; CALCIUM-ANTAGONISTS; RANDOMIZED-TRIAL; ELDERLY-PATIENTS; HEART-FAILURE; OUTCOMES; AMLODIPINE; MORTALITY; RISK	Objective To examine the association of myocardial infarction and stroke incidence with several commonly used two drug antihypertensive treatment regimens. Design Population based case-control study. Setting Group Health Cooperative, Seattle, WA, USA. Participants Cases (n=353) were aged 30-79 years, had pharmacologically treated hypertension, and were diagnosed with a first fatal or non-fatal myocardial infarction or stroke between 1989 and 2005. Controls (n=952) were a random sample of Group Health members who had pharmacologically treated hypertension. We excluded individuals with heart failure, evidence of coronary heart disease, diabetes, or chronic kidney disease. Exposures One of three common two drug combinations: diuretics plus beta blockers; diuretics plus calcium channel blockers; and diuretics plus angiotensin converting enzyme inhibitors or angiotensin receptor blockers. Main outcome measures Myocardial infarction or stroke. Results Compared with users of diuretics plus beta blockers, users of diuretics plus calcium channel blockers had an increased risk of myocardial infarction (adjusted odds ratio (OR) 1.98, 95% confidence interval 1.37 to 2.87) but not of stroke (OR 1.02, 95% CI 0.63 to 1.64). The risks of myocardial infarction and stroke in users of diuretics plus angiotensin converting enzyme inhibitors or angiotensin receptor blockers were slightly but not significantly lower than in users of diuretics plus beta blockers (myocardial infarction: OR 0.76, 95% CI 0.52 to 1.11; stroke: OR 0.71, 95% CI 0.46 to 1.10). Conclusions In patients with hypertension, diuretics plus calcium channel blockers were associated with a higher risk of myocardial infarction than other common two drug treatment regimens. A large trial of second line antihypertensive treatments in patients already on low dose diuretics is required to provide a solid basis for treatment recommendations.	[Heckbert, Susan R.; Wiggins, Kerri L.; Siscovick, David S.; Lemaitre, Rozenn N.; Smith, Nicholas L.; Glazer, Nicole L.; Psaty, Bruce M.] Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA; [Weiss, Noel S.] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [McKnight, Barbara; Rice, Kenneth M.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Furberg, Curt D.] Wake Forest Univ, Bowman Gray Sch Med, Dept Publ Hlth Sci, Winston Salem, NC 27157 USA; [Larson, Eric B.] Grp Hlth Cooperat Puget Sound, Ctr Hlth Studies, Seattle, WA 98101 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; Wake Forest University; Wake Forest Baptist Medical Center; Group Health Cooperative	Psaty, BM (corresponding author), Univ Washington, Cardiovasc Hlth Res Unit, Seattle, WA 98101 USA.	psaty@u.washington.edu	Delaney, Joseph A/J-8204-2019; Rice, Kenneth M/A-4150-2013	Delaney, Joseph A/0000-0003-1771-1776; Rice, Kenneth M/0000-0001-5779-4495; Glazer, Nicole/0000-0002-6397-609X; Wiggins, Kerri L/0000-0003-2749-1279	National Heart, Lung, and Blood Institute [HL43201, HL40628, HL60739, HL68639, HL68986, HL73410, HL74745, HL085251, HL007902]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL073410, R01HL068986, R01HL074745, R01HL043201, R01HL060739, T32HL007902, R01HL068639, R01HL085251, R01HL040628, R29HL040628] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	This research was supported in part by grants HL43201 (BMP), HL40628 (BMP), HL60739 (BMP), HL68639 (BMP), HL68986 (SRH), HL73410 (NLS), HL74745 (BMP), HL085251 (BMP), and HL007902 (DSS) from the National Heart, Lung, and Blood Institute. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Heart, Lung, and Blood Institute or the National Institutes of Health.	Alderman MH, 2005, HYPERTENSION, V46, P1, DOI 10.1161/01.HYP.0000168924.37091.58; *ALLHAT OFF COORD, 2002, JAMA-J AM MED ASSOC, V288, P2981, DOI DOI 10.1001/JAMA.288.23.2981; BEARD K, 1992, BMJ-BRIT MED J, V304, P412, DOI 10.1136/bmj.304.6824.412; Beckett NS, 2008, NEW ENGL J MED, V358, P1887, DOI 10.1056/NEJMoa0801369; Casas JP, 2005, LANCET, V366, P2026, DOI 10.1016/S0140-6736(05)67814-2; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; Elliott WJ, 2007, LANCET, V369, P201, DOI 10.1016/S0140-6736(07)60108-1; Flather MD, 2000, LANCET, V355, P1575, DOI 10.1016/S0140-6736(00)02212-1; Furberg CD, 2000, JAMA-J AM MED ASSOC, V283, P1967; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Heidenreich PA, 1999, JAMA-J AM MED ASSOC, V281, P1927, DOI 10.1001/jama.281.20.1927; Horton NJ, 2007, AM STAT, V61, P79, DOI 10.1198/000313007X172556; Jamerson K, 2008, NEW ENGL J MED, V359, P2417, DOI 10.1056/NEJMoa0806182; Julius S, 2004, LANCET, V363, P2022, DOI 10.1016/S0140-6736(04)16451-9; Kleinbaum D.G., 2002, LOGISTIC REGRESSION, DOI New York; Laragh J, 2001, AM J HYPERTENS, V14, P491, DOI 10.1016/S0895-7061(01)02097-0; Lechat P, 1998, CIRCULATION, V98, P1184, DOI 10.1161/01.CIR.98.12.1184; Lindholm LH, 2002, LANCET, V359, P1004, DOI 10.1016/S0140-6736(02)08090-X; *NAT COLL CTR CHRO, 2006, HYP MAN AD PRIM CAR; Neal B, 2000, LANCET, V356, P1955; *NIH, 2008, SYST BLOOD PRESS INT; Pepine CJ, 2003, JAMA-J AM MED ASSOC, V290, P2805, DOI 10.1001/jama.290.21.2805; Psaty BM, 2006, JAMA-J AM MED ASSOC, V295, P1704, DOI 10.1001/jama.295.14.1704; PSATY BM, 1995, JAMA-J AM MED ASSOC, V274, P620, DOI 10.1001/jama.274.8.620; Psaty BN, 2003, JAMA-J AM MED ASSOC, V289, P2534, DOI 10.1001/jama.289.19.2534	29	13	15	0	4	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X	1756-1833		BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 25	2010	340								c103	10.1136/bmj.c103	http://dx.doi.org/10.1136/bmj.c103			10	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549XZ	20100777	Green Published, hybrid			2022-12-01	WOS:000274089100001
J	Cohen, SP; Brown, C; Kurihara, C; Plunkett, A; Nguyen, C; Strassels, SA				Cohen, Steven P.; Brown, Charlie; Kurihara, Connie; Plunkett, Anthony; Nguyen, Conner; Strassels, Scott A.			Diagnoses and factors associated with medical evacuation and return to duty for service members participating in Operation Iraqi Freedom or Operation Enduring Freedom: a prospective cohort study	LANCET			English	Article							LOW-BACK-PAIN; NECK PAIN; GULF-WAR; MILITARY; MANAGEMENT; CASUALTIES; DISORDERS; INJURY	Background Anticipation of the types of injuries that occur in modem warfare is essential to plan operations and maintain a healthy military. We aimed to identify the diagnoses that result in most medical evacuations, and ascertain which demographic and clinical variables were associated with return to duty. Methods Demographic and clinical data were prospectively obtained for US military personnel who had been medically evacuated from Operation Iraqi Freedom or Operation Enduring Freedom (January, 2004-December, 2007). Diagnoses were categorised post hoc according to the International Classification of Diseases codes that were recorded at the time of transfer. The primary outcome measure was return to duty within 2 weeks. Findings 34006 personnel were medically evacuated, of whom 89% were men, 91% were enlisted, 82% were in the army, and 86% sustained an injury in Iraq. The most common reasons for medical evacuation were: musculoskeletal and connective tissue disorders (n=8104 service members, 24%), combat injuries (n=4713, 14%), neurological disorders (n=3502, 10%), psychiatric diagnoses (n=3108, 9%), and spinal pain (n=2445, 7%). The factors most strongly associated with return to duty were being a senior officer (adjusted OR 2.01, 95% Cl 1.71-2.35, p<0.0001), having a non-battle-related injury or disease (3.18, 2.77-3.67, p<0.0001), and presenting with chest or abdominal pain (2.48, 1.61-3.81, p<0.0001), a gastrointestinal disorder (non-surgical 2.32, 1.51-3.56, p=0.0001; surgical 2.62, 1.69-4.06, p<0.0001), or a genitourinary disorder (2.19, 1.43-3.36, p=0.0003). Covariates associated with a decreased probability of return to duty were serving in the navy or coast guard (0.59, 0.45-0.78, p=0.0002), or marines (0.86,0.77-0.96, p=0.0083); and presenting with a combat injury (0.27, 0.17-0.44, p<0.0001), a psychiatric disorder (0.28, 0.18-0.43, p<0.0001), musculoskeletal or connective tissue disorder (0.46, 0.30-0.71, p=0.0004), spinal pain (0.41, 0.26-0.63, p=0.0001), or other wound (0.54, 0.34-0.84, p=0.0069). Interpretation Implementation of preventive measures for service members who are at highest risk of evacuation, forward-deployed treatment, and therapeutic interventions could reduce the effect of non-battle-related injuries and disease on military readiness.	[Cohen, Steven P.] Johns Hopkins Sch Med, Pain Management Div, Baltimore, MD USA; [Brown, Charlie] Johns Hopkins Sch Med, Dept Anesthesiol, Baltimore, MD USA; [Cohen, Steven P.; Kurihara, Connie; Plunkett, Anthony] Walter Reed Army Med Ctr, Pain Management Div, Anesthesia Serv, Dept Surg, Washington, DC 20307 USA; [Nguyen, Conner] Landstuhl Reg Med Ctr, Dept Surg, Landstuhl, Germany; [Strassels, Scott A.] Univ Texas Austin, Div Pharm Practice, Austin, TX 78712 USA	Johns Hopkins University; Johns Hopkins Medicine; Johns Hopkins University; Johns Hopkins Medicine; United States Department of Defense; United States Army; Walter Reed National Military Medical Center; Landstuhl Regional Medical Center; University of Texas System; University of Texas Austin	Cohen, SP (corresponding author), 550 North Broadway,Suite 301, Baltimore, MD 21029 USA.	scohen40@jhmi.edu			John P Murtha Neuroscience and Pain Institute, Johnstown, PA, USA; US Army Regional Anesthesia and Pain Management Initiative, Washington, DC, USA	John P Murtha Neuroscience and Pain Institute, Johnstown, PA, USA; US Army Regional Anesthesia and Pain Management Initiative, Washington, DC, USA	Funded by a Congressional grant from the John P Murtha Neuroscience and Pain Institute, Johnstown, PA, USA; and the US Army Regional Anesthesia and Pain Management Initiative, Washington, DC, USA. The opinions or assertions contained herein are the private views of the authors and are not to be construed as official or as reflecting the views of the Department of the Army or the Department of Defense.	[Anonymous], 2014, INT CLASS DIS 9 REV; Ariens GAM, 2001, AM J IND MED, V39, P180, DOI 10.1002/1097-0274(200102)39:2<180::AID-AJIM1005>3.0.CO;2-#; Barrett DH, 2002, PSYCHOSOMATICS, V43, P195, DOI 10.1176/appi.psy.43.3.195; Bellamy RF, 1996, ANESTHESIA PERIOPERA; Carroll LJ, 2008, SPINE, V33, pS93, DOI 10.1097/BRS.0b013e31816445d4; Cohen SP, 2005, ANESTH ANALG, V101, P1098, DOI 10.1213/01.ane.0000169332.45209.cf; COHEN SP, SPINE IN PRESS; Cohen SP, 2009, ARCH INTERN MED, V169, P1916, DOI 10.1001/archinternmed.2009.380; Cohen SP, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2718; Croft AM, 1999, MIL MED, V164, P460, DOI 10.1093/milmed/164.7.460; HOEFFLER DF, 1981, MIL MED, V146, P776; Holcomb JB, 2006, J TRAUMA, V60, P397, DOI 10.1097/01.ta.0000203581.75241.f1; Leclerc A, 1999, SPINE, V24, P1455, DOI 10.1097/00007632-199907150-00011; Peake JB, 2000, AM J PREV MED, V18, P4, DOI 10.1016/S0749-3797(00)00104-5; Pincus Tamar, 2002, Spine (Phila Pa 1976), V27, pE109, DOI 10.1097/00007632-200203010-00017; Pransky G, 2002, SPINE, V27, P864, DOI 10.1097/00007632-200204150-00017; SHANE L, 2005, STARS STRIPES W 1209; SONGTAG D, 2008, NY TIMES NEW YO 0113; TYSON AS, 2006, WASHINGTON POST 1220; *US DEP VET AFF, HOM VET OV HOM; White RL, 2007, ANESTHESIOLOGY, V107, P1003, DOI 10.1097/01.anes.0000290605.55736.e1; Writer JV, 2000, AM J PREV MED, V18, P64, DOI 10.1016/S0749-3797(00)00115-X; Young Richard S K, 2008, Conn Med, V72, P13; ZOROYA G, 2008, US TODAY WASHIN 1020	24	130	140	0	18	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 23	2010	375	9711					301	309		10.1016/S0140-6736(09)61797-9	http://dx.doi.org/10.1016/S0140-6736(09)61797-9			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549QS	20109957				2022-12-01	WOS:000274069300031
J	Bienvenu, F; Jirawatnotai, S; Elias, JE; Meyer, CA; Mizeracka, K; Marson, A; Frampton, GM; Cole, MF; Odom, DT; Odajima, J; Geng, Y; Zagozdzon, A; Jecrois, M; Young, RA; Liu, XS; Cepko, CL; Gygi, SP; Sicinski, P				Bienvenu, Frederic; Jirawatnotai, Siwanon; Elias, Joshua E.; Meyer, Clifford A.; Mizeracka, Karolina; Marson, Alexander; Frampton, Garrett M.; Cole, Megan F.; Odom, Duncan T.; Odajima, Junko; Geng, Yan; Zagozdzon, Agnieszka; Jecrois, Marie; Young, Richard A.; Liu, X. Shirley; Cepko, Constance L.; Gygi, Steven P.; Sicinski, Piotr			Transcriptional role of cyclin D1 in development revealed by a genetic-proteomic screen	NATURE			English	Article							KINASE-INDEPENDENT MECHANISM; CELL-CYCLE; ESTROGEN-RECEPTOR; MOUSE RETINA; BREAST; TRANSFORMATION; RECRUITMENT; EXPRESSION; REPRESSES; CANCER	Cyclin D1 belongs to the core cell cycle machinery, and it is frequently overexpressed in human cancers(1,2). The full repertoire of cyclin D1 functions in normal development and oncogenesis is unclear at present. Here we developed Flag-and haemagglutinin-tagged cyclin D1 knock-in mouse strains that allowed a high-throughput mass spectrometry approach to search for cyclin D1-binding proteins in different mouse organs. In addition to cell cycle partners, we observed several proteins involved in transcription. Genome-wide location analyses (chromatin immunoprecipitation coupled to DNA microarray; ChIP-chip) showed that during mouse development cyclin D1 occupies promoters of abundantly expressed genes. In particular, we found that in developing mouse retinas-an organ that critically requires cyclin D1 function(3,4)-cyclin D1 binds the upstream regulatory region of the Notch1 gene, where it serves to recruit CREB binding protein (CBP) histone acetyltransferase. Genetic ablation of cyclin D1 resulted in decreased CBP recruitment, decreased histone acetylation of the Notch1 promoter region, and led to decreased levels of the Notch1 transcript and protein in cyclin D1-null (Ccnd1(-/-)) retinas. Transduction of an activated allele of Notch1 into Ccnd1(-/-) retinas increased proliferation of retinal progenitor cells, indicating that upregulation of Notch1 signalling alleviates the phenotype of cyclin D1-deficiency. These studies show that in addition to its well-established cell cycle roles, cyclin D1 has an in vivo transcriptional function in mouse development. Our approach, which we term 'genetic-proteomic', can be used to study the in vivo function of essentially any protein.	[Bienvenu, Frederic; Jirawatnotai, Siwanon; Odajima, Junko; Geng, Yan; Zagozdzon, Agnieszka; Jecrois, Marie; Sicinski, Piotr] Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Bienvenu, Frederic; Jirawatnotai, Siwanon; Odajima, Junko; Geng, Yan; Zagozdzon, Agnieszka; Jecrois, Marie; Sicinski, Piotr] Harvard Univ, Sch Med, Dept Pathol, Boston, MA 02115 USA; [Elias, Joshua E.; Gygi, Steven P.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Meyer, Clifford A.; Liu, X. Shirley] Dana Farber Canc Inst, Dept Biostat & Computat Biol, Boston, MA 02115 USA; [Meyer, Clifford A.; Liu, X. Shirley] Harvard Univ, Sch Publ Hlth, Boston, MA 02115 USA; [Mizeracka, Karolina; Cepko, Constance L.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [Jirawatnotai, Siwanon] Mahidol Univ, Inst Mol Biosci, Salaya 73170, Nakhon Prathom, Thailand; [Marson, Alexander; Frampton, Garrett M.; Cole, Megan F.; Young, Richard A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Marson, Alexander; Frampton, Garrett M.; Cole, Megan F.; Young, Richard A.] MIT, Whitehead Inst Biomed Res, Cambridge, MA 02142 USA; [Odom, Duncan T.] Canc Res UK, Cambridge Res Inst, Li Ka Shing Ctr, Cambridge CB2 0RE, England	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Harvard T.H. Chan School of Public Health; Harvard University; Harvard Medical School; Mahidol University; Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT); Whitehead Institute; Cancer Research UK; CRUK Cambridge Institute; University of Cambridge	Sicinski, P (corresponding author), Harvard Univ, Sch Med, Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	Peter_Sicinski@dfci.harvard.edu	Pillay, Nischalan/F-9536-2012; Young, Richard A/F-6495-2012	Young, Richard A/0000-0001-8855-8647; Frampton, Garrett/0000-0002-2361-2750; Odom, Duncan/0000-0001-6201-5599	Cancer Research UK; European Research Council; EMBO Young Investigator Award;  [R01 CA108420];  [P01 CA080111];  [P01 CA109901];  [HG3456];  [R01 EYO9676];  [HG004069]; Cancer Research UK [15603] Funding Source: researchfish; NATIONAL CANCER INSTITUTE [P01CA080111, R01CA108420, P01CA109901] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [R01EY008064, R01EY009676] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003456, R01HG002668, R01HG004069] Funding Source: NIH RePORTER	Cancer Research UK(Cancer Research UK); European Research Council(European Research Council (ERC)European Commission); EMBO Young Investigator Award(European Molecular Biology Organization (EMBO)); ; ; ; ; ; ; Cancer Research UK(Cancer Research UK); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank T. Liu, Y. Ndassa-Colday, J. Marto, R. Bronson, B. Smith, E. Jacobsen, M. Brown and members of the Brown laboratory for help at different stages of the project, M. Ewen for p-Babe-puro-Cyclin D1 and cyclin D1(K112E) plasmids, G. Seigel for R28 cells, T. Volkert, J. Love and E. Fox for help with arrays, P. White and O. Smirnova for help with BCBC arrays. This work was supported by grants R01 CA108420, P01 CA080111 and P01 CA109901 (to P. S.), HG3456 (to S. P. G.), R01 EYO9676 (to C. L. C.), HG004069 (to X. S. L.), Cancer Research UK, European Research Council Starting Grant, and an EMBO Young Investigator Award (all to D. T. O.). P. S. is a Leukemia and Lymphoma Society Scholar.	Adnane J, 1999, ONCOGENE, V18, P239, DOI 10.1038/sj.onc.1202297; Alexson TO, 2006, DEV NEUROSCI-BASEL, V28, P34, DOI 10.1159/000090751; Blackshaw S, 2004, PLOS BIOL, V2, P1411, DOI 10.1371/journal.pbio.0020247; Coqueret O, 2002, GENE, V299, P35, DOI 10.1016/S0378-1119(02)01055-7; Das G, 2009, NEURAL DEV, V4, DOI 10.1186/1749-8104-4-15; FANTL V, 1995, GENE DEV, V9, P2364, DOI 10.1101/gad.9.19.2364; Flora A, 2007, P NATL ACAD SCI USA, V104, P15382, DOI 10.1073/pnas.0707456104; Fu MF, 2005, J BIOL CHEM, V280, P16934, DOI 10.1074/jbc.M500403200; Fu MF, 2005, J BIOL CHEM, V280, P29728, DOI 10.1074/jbc.M503188200; Hatakeyama J, 2004, SEMIN CELL DEV BIOL, V15, P83, DOI 10.1016/j.semcdb.2003.09.005; Heine P, 2008, DEVELOPMENT, V135, P805, DOI 10.1242/dev.012088; Inoue K, 1998, MOL CELL BIOL, V18, P1590, DOI 10.1128/MCB.18.3.1590; Jadhav AR, 2006, DEVELOPMENT, V133, P913, DOI 10.1242/dev.02245; Jadhav AP, 2006, P NATL ACAD SCI USA, V103, P18998, DOI 10.1073/pnas.0608155103; Lindsay J, 2008, CTS-CLIN TRANSL SCI, V1, P107, DOI 10.1111/j.1752-8062.2008.00041.x; Malumbres M, 2009, NAT REV CANCER, V9, P153, DOI 10.1038/nrc2602; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; McMahon C, 1999, P NATL ACAD SCI USA, V96, P5382, DOI 10.1073/pnas.96.10.5382; McManus KJ, 2003, MOL CELL BIOL, V23, P7611, DOI 10.1128/MCB.23.21.7611-7627.2003; Musgrove EA, 2006, GROWTH FACTORS, V24, P13, DOI 10.1080/08977190500361812; Ratineau C, 2002, J BIOL CHEM, V277, P8847, DOI 10.1074/jbc.M110747200; Ronchini C, 2001, MOL CELL BIOL, V21, P5925, DOI 10.1128/MCB.21.17.5925-5934.2001; Saxonov S, 2006, P NATL ACAD SCI USA, V103, P1412, DOI 10.1073/pnas.0510310103; Seigel GM, 1996, IN VITRO CELL DEV-AN, V32, P66; Sherr CJ, 1999, GENE DEV, V13, P1501, DOI 10.1101/gad.13.12.1501; SICINSKI P, 1995, CELL, V82, P621, DOI 10.1016/0092-8674(95)90034-9; Yaron O, 2006, DEVELOPMENT, V133, P1367, DOI 10.1242/dev.02311; Yeung SC, 2005, NEUROREPORT, V16, P673, DOI 10.1097/00001756-200505120-00004; Yu QY, 2001, NATURE, V411, P1017, DOI 10.1038/35082500; Zwijsen RML, 1998, GENE DEV, V12, P3488, DOI 10.1101/gad.12.22.3488	30	211	217	1	43	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					374	378		10.1038/nature08684	http://dx.doi.org/10.1038/nature08684			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090754	Green Submitted, Green Accepted			2022-12-01	WOS:000273748100048
J	Banerjee, A; Hollis, A; Pogge, T				Banerjee, Amitava; Hollis, Aidan; Pogge, Thomas			The Health Impact Fund: incentives for improving access to medicines	LANCET			English	Editorial Material							PATENTS		[Banerjee, Amitava] Univ Oxford, Stroke Prevent Res Unit, Oxford OX3 9DU, England; [Pogge, Thomas] Yale Univ, Dept Philosophy, New Haven, CT USA; [Hollis, Aidan] Univ Calgary, Dept Econ, Calgary, AB T2N 1N4, Canada	University of Oxford; Yale University; University of Calgary	Banerjee, A (corresponding author), Univ Oxford, John Radcliffe Hosp, Stroke Prevent Res Unit, Level 6,West Wing, Oxford OX3 9DU, England.	amitava.banerjee@clneuro.ox.ac.uk	Banerjee, Amitava/D-4381-2014	Banerjee, Amitava/0000-0001-8741-3411; Hollis, Aidan/0000-0001-5125-2193				[Anonymous], 2009, LANCET, V373, P693, DOI 10.1016/S0140-6736(09)60410-4; Attaran A, 2004, HEALTH AFFAIR, V23, P155, DOI 10.1377/hlthaff.23.3.155; Attaran A, 2001, JAMA-J AM MED ASSOC, V286, P1886, DOI 10.1001/jama.286.15.1886; BACIU A, 2007, FUTURE DRUG SAFETY P; CHEN S, 2008, 4703 WPS WORLD BANK; Collins R, 2002, LANCET, V360, P7, DOI 10.1016/S0140-6736(02)09327-3; Garber AM, 2009, NEW ENGL J MED, V360, P1169, DOI 10.1056/NEJMp0808414; Gemmill MC, 2007, HEALTH ECON, V16, P627, DOI 10.1002/hec.1190; HOLLIS A, 2007, WHO PUBL HEAR UNPUB; HOLLIS A, HLTH IMPACT FUND MAK; Horton R, 2002, LANCET, V359, P1605, DOI 10.1016/S0140-6736(02)08523-9; OLIVEIRA MA, 2004, B WORLD HEALTH ORGAN, V82, P8150; PEDERSEN TR, 1994, LANCET, V344, P1383; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; *UN MILL DEV GOALS, GAT UN SYST WORK MDG; von Schirnding Y, 2005, GLOBALIZATION HEALTH, V1, DOI 10.1186/1744-8603-1-8; *WHO, 2005, CHRON DIS REP 2005, pCH2; WHO (World Health Organization), 1988, WORLD DRUG SIT; WITTY A, 2009, BIG PHARMA CATALYST; World Trade Organization, TRAD REL ASP INT PRO; 2000, GLOBAL POVERTY REPOR	21	49	50	0	8	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					166	169		10.1016/S0140-6736(09)61296-4	http://dx.doi.org/10.1016/S0140-6736(09)61296-4			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	20109894				2022-12-01	WOS:000273664500034
J	Zhou, WJ; Ercan, D; Chen, L; Yun, CH; Li, DN; Capelletti, M; Cortot, AB; Chirieac, L; Iacob, RE; Padera, R; Engen, JR; Wong, KK; Eck, MJ; Gray, NS; Janne, PA				Zhou, Wenjun; Ercan, Dalia; Chen, Liang; Yun, Cai-Hong; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Chirieac, Lucian; Iacob, Roxana E.; Padera, Robert; Engen, John R.; Wong, Kwok-Kin; Eck, Michael J.; Gray, Nathanael S.; Jaenne, Pasi A.			Novel mutant-selective EGFR kinase inhibitors against EGFR T790M	NATURE			English	Article							PAN-ERBB INHIBITOR; CELL LUNG-CANCER; TYROSINE KINASE; RESISTANCE; MUTATION; GEFITINIB; SENSITIVITY; NILOTINIB; IMATINIB; HKI-272	The clinical efficacy of epidermal growth factor receptor ( EGFR) kinase inhibitors in EGFR-mutant non-small-cell lung cancer (NSCLC) is limited by the development of drug-resistance mutations, including the gatekeeper T790M mutation(1-3). Strategies targeting EGFR T790M with irreversible inhibitors have had limited success and are associated with toxicity due to concurrent inhibition of wild-type EGFR(4,5). All current EGFR inhibitors possess a structurally related quinazoline-based core scaffold and were identified as ATP-competitive inhibitors of wild-type EGFR. Here we identify a covalent pyrimidine EGFR inhibitor by screening an irreversible kinase inhibitor library specifically against EGFR T790M. These agents are 30- to 100-fold more potent against EGFR T790M, and up to 100-fold less potent against wildtype EGFR, than quinazoline-based EGFR inhibitors in vitro. They are also effective in murine models of lung cancer driven by EGFR T790M. Co-crystallization studies reveal a structural basis for the increased potency and mutant selectivity of these agents. These mutant-selective irreversible EGFR kinase inhibitors may be clinically more effective and better tolerated than quinazoline-based inhibitors. Our findings demonstrate that functional pharmacological screens against clinically important mutant kinases represent a powerful strategy to identify new classes of mutant-selective kinase inhibitors.	[Zhou, Wenjun; Yun, Cai-Hong; Eck, Michael J.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Zhou, Wenjun; Yun, Cai-Hong; Eck, Michael J.; Gray, Nathanael S.] Dana Farber Canc Inst, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Ercan, Dalia; Chen, Liang; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Wong, Kwok-Kin; Jaenne, Pasi A.] Dana Farber Canc Inst, Lowe Ctr Thorac Oncol, Boston, MA 02115 USA; [Ercan, Dalia; Chen, Liang; Li, Danan; Capelletti, Marzia; Cortot, Alexis B.; Wong, Kwok-Kin; Jaenne, Pasi A.] Dana Farber Canc Inst, Dept Med Oncol, Boston, MA 02115 USA; [Chirieac, Lucian; Padera, Robert] Brigham & Womens Hosp, Dept Pathol, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Barnett Inst Chem & Biol Anal, Boston, MA 02115 USA; [Iacob, Roxana E.; Engen, John R.] Northeastern Univ, Dept Chem & Biol Chem, Boston, MA 02115 USA; [Wong, Kwok-Kin; Jaenne, Pasi A.] Brigham & Womens Hosp, Dept Med, Boston, MA 02115 USA; [Wong, Kwok-Kin; Jaenne, Pasi A.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Wong, Kwok-Kin; Jaenne, Pasi A.] Dana Farber Harvard Canc Ctr, Ludwig Ctr, Boston, MA 02115 USA	Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Harvard University; Brigham & Women's Hospital; Northeastern University; Northeastern University; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute	Gray, NS (corresponding author), Dana Farber Canc Inst, Dept Canc Biol, 44 Binney St, Boston, MA 02115 USA.	Nathanael_Gray@dfci.harvard.edu; pjanne@partners.org	云, 彩红/E-1437-2018; Cortot, Alexis B/F-7006-2019; Chirieac, Lucian R./AAD-2030-2019; Capelletti, Marzia/L-6317-2016	Cortot, Alexis B/0000-0003-0098-2238; wong, kwok kin/0000-0001-6323-235X; Capelletti, Marzia/0000-0001-5095-7060; Engen, John R./0000-0002-6918-9476; Chen, Liang/0000-0001-7300-6604	National Institutes of Health [RO1CA11446, R01CA135257, R01CA080942, R01CA130876-02, R01CA116020, R01AG2400401, R01 CA122794, R01GM070590]; National Cancer Institute Lung SPORE [P50CA090578]; Cecily and Robert Harris Foundation; Uniting Against Lung Cancer; Flight Attendant Medical Research Institute; Hazel and Samuel Bellin Research Fund; Damon Runyon Foundation Cancer Innovation Award; NATIONAL CANCER INSTITUTE [R01CA130876, R01CA135257, R01CA122794, P50CA090578, R01CA080942, R01CA116020] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM070590] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute Lung SPORE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Cecily and Robert Harris Foundation; Uniting Against Lung Cancer; Flight Attendant Medical Research Institute; Hazel and Samuel Bellin Research Fund; Damon Runyon Foundation Cancer Innovation Award; NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study is supported by grants from the National Institutes of Health RO1CA11446 ( P. A. J.), R01CA135257 ( P. A. J.), R01CA080942 ( M. J. E.), R01CA130876-02 ( N. S. G.), R01CA116020 ( M. J. E.), R01AG2400401 (K.-K.W.), R01 CA122794 ( K.- K. W.), R01GM070590 ( J. R. E.), National Cancer Institute Lung SPORE P50CA090578 ( P. A. J. and K.- K. W.), the Cecily and Robert Harris Foundation ( K.- K. W.), Uniting Against Lung Cancer ( K.- K. W.), the Flight Attendant Medical Research Institute ( K.- K. W.)., the Hazel and Samuel Bellin Research Fund ( P. A. J.) and the Damon Runyon Foundation Cancer Innovation Award ( N. S. G.). This work is contribution 948 from the Barnett Institute. The authors thank Sai Advantium Pharma for performing the pharmacokinetic studies.	Alam M, 2007, BIOORG MED CHEM LETT, V17, P3463, DOI 10.1016/j.bmcl.2007.03.078; Besse B, 2008, EJC SUPPL, V6, P64, DOI 10.1016/S1359-6349(08)72135-9; Bradeen HA, 2006, BLOOD, V108, P2332, DOI 10.1182/blood-2006-02-004580; Breault GA, 2003, BIOORG MED CHEM LETT, V13, P2961, DOI 10.1016/S0960-894X(03)00203-8; Carey KD, 2006, CANCER RES, V66, P8163, DOI 10.1158/0008-5472.CAN-06-0453; Engelman JA, 2007, CANCER RES, V67, P11924, DOI 10.1158/0008-5472.CAN-07-1885; Engelman JA, 2007, SCIENCE, V316, P1039, DOI 10.1126/science.1141478; Engelman JA, 2006, J CLIN INVEST, V116, P2695, DOI 10.1172/JCI28656; Godin-Heymann N, 2008, MOL CANCER THER, V7, P874, DOI 10.1158/1535-7163.MCT-07-2387; Gontarewicz A, 2008, LEUKEMIA RES, V32, P1857, DOI 10.1016/j.leukres.2008.04.012; Hur W, 2008, BIOORG MED CHEM LETT, V18, P5916, DOI 10.1016/j.bmcl.2008.07.062; Janne PA, 2007, J CLIN ONCOL, V25, P3936, DOI 10.1200/JCO.2007.11.1336; Janne PA, 2008, J CLIN ONCOL, V26; Ji HB, 2006, CANCER CELL, V9, P485, DOI 10.1016/j.ccr.2006.04.022; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Li D, 2008, ONCOGENE, V27, P4702, DOI 10.1038/onc.2008.109; Li DN, 2007, CANCER CELL, V12, P81, DOI 10.1016/j.ccr.2007.06.005; Lietha D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003800; Mok TS, 2009, NEW ENGL J MED, V361, P947, DOI 10.1056/NEJMoa0810699; O'Hare T, 2008, P NATL ACAD SCI USA, V105, P5507, DOI 10.1073/pnas.0800587105; Ogino A, 2007, CANCER RES, V67, P7807, DOI 10.1158/0008-5472.CAN-07-0681; Pao W, 2005, PLOS MED, V2, P57, DOI 10.1371/journal.pmed.0020017; Rosell R, 2009, NEW ENGL J MED, V361, P958, DOI 10.1056/NEJMoa0904554; Tsai J, 2008, P NATL ACAD SCI USA, V105, P3041, DOI 10.1073/pnas.0711741105; Yonesaka K, 2008, CLIN CANCER RES, V14, P6963, DOI 10.1158/1078-0432.CCR-08-0957; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Yuza Y, 2007, CANCER BIOL THER, V6, P661, DOI 10.4161/cbt.6.5.4003	28	757	873	7	180	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	DEC 24	2009	462	7276					1070	1074		10.1038/nature08622	http://dx.doi.org/10.1038/nature08622			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Science & Technology - Other Topics	535UB	20033049	Green Accepted			2022-12-01	WOS:000272996000050
J	Schlereth, A; Moller, B; Liu, WL; Kientz, M; Flipse, J; Rademacher, EH; Schmid, M; Jurgens, G; Weijers, D				Schlereth, Alexandra; Moller, Barbara; Liu, Weilin; Kientz, Marika; Flipse, Jacky; Rademacher, Eike H.; Schmid, Markus; Juergens, Gerd; Weijers, Dolf			MONOPTEROS controls embryonic root initiation by regulating a mobile transcription factor	NATURE			English	Article							AUXIN-RESPONSE FACTORS; LOOP-HELIX PROTEINS; ARABIDOPSIS-THALIANA; GENE-EXPRESSION; FAMILY; EMBRYOGENESIS; ACTIVATION; MUTATION; RECEPTOR; ENCODES	Acquisition of cell identity in plants relies strongly on positional information(1), hence cell-cell communication and inductive signalling are instrumental for developmental patterning. During Arabidopsis embryogenesis, an extra-embryonic cell is specified to become the founder cell of the primary root meristem, hypophysis, in response to signals from adjacent embryonic cells(2). The auxin-dependent transcription factor MONOPTEROS (MP) drives hypophysis specification by promoting transport of the hormone auxin from the embryo to the hypophysis precursor. However, auxin accumulation is not sufficient for hypophysis specification, indicating that additional MP-dependent signals are required(3). Here we describe the microarray-based isolation of MP target genes that mediate signalling from embryo to hypophysis. Of three direct transcriptional target genes, TARGET OF MP5 (TMO5) and TMO7 encode basic helix-loop-helix (bHLH) transcription factors that are expressed in the hypophysis-adjacent embryo cells, and are required and partially sufficient for MP-dependent root initiation. Importantly, the small TMO7 transcription factor moves from its site of synthesis in the embryo to the hypophysis precursor, thus representing a novel MP-dependent intercellular signal in embryonic root specification.	[Schlereth, Alexandra; Kientz, Marika; Juergens, Gerd; Weijers, Dolf] Univ Tubingen, ZMBP, D-72076 Tubingen, Germany; [Moller, Barbara; Liu, Weilin; Flipse, Jacky; Rademacher, Eike H.; Weijers, Dolf] Wageningen Univ, Biochem Lab, NL-6703 HA Wageningen, Netherlands; [Schmid, Markus] Max Planck Inst Dev Biol, Dept Mol Biol, D-72076 Tubingen, Germany	Eberhard Karls University of Tubingen; Wageningen University & Research; Max Planck Society	Jurgens, G (corresponding author), Univ Tubingen, ZMBP, Morgenstelle 3, D-72076 Tubingen, Germany.	gerd.juergens@zmbp.uni-tuebingen.de; dolf.weijers@wur.nl	Weijers, Dolf/A-2076-2010; Weijers, Dolf/ABI-1332-2020; Rademacher, Eike/K-2302-2012; Schmid, Markus/I-4384-2015	Weijers, Dolf/0000-0003-4378-141X; Weijers, Dolf/0000-0003-4378-141X; Schmid, Markus/0000-0002-0068-2967; Flipse, Jacky/0000-0002-2195-5282; Moller, Barbara/0000-0001-6521-4200	Netherlands Organization for Scientific Research (NWO) [VIDI 864.06.012]; Deutsche Forschungsgemeinschaft (DFG) [SFB446]; Netherlands Proteomics Centre (NPC)	Netherlands Organization for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Deutsche Forschungsgemeinschaft (DFG)(German Research Foundation (DFG)); Netherlands Proteomics Centre (NPC)	We acknowledge P. van Oorschot, A. van Haperen and S. Heilbronner for technical assistance, C. Arsene for plant care, S. de Folter and O. Mathieu for advice on ChIP, M. Wunderlich and G. Bijl for help with qPCR, G. Hooiveld for help with statistical analysis of the microarray data and the Nottingham Arabidopsis Stock Centre for mutant and transgenic seeds. We thank P. Maier, S. de Vries, A. Koltunow, A. Lokerse, S. Saiga, V. Willemsen and M. Tsiantis for discussions and comments on the manuscript. This work was supported by grants from the Netherlands Organization for Scientific Research (NWO; VIDI 864.06.012 to D.W.), from the Deutsche Forschungsgemeinschaft (DFG; SFB446 to G.J.) and the Netherlands Proteomics Centre (NPC; D. W., grant awarded to S. de Vries).	Aker J, 2006, J STRUCT BIOL, V156, P62, DOI 10.1016/j.jsb.2006.03.004; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Cole M, 2009, DEVELOPMENT, V136, P1643, DOI 10.1242/dev.032177; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Dharmasiri N, 2005, DEV CELL, V9, P109, DOI 10.1016/j.devcel.2005.05.014; Donner TJ, 2009, DEVELOPMENT, V136, P3235, DOI 10.1242/dev.037028; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; Hamann T, 1999, DEVELOPMENT, V126, P1387; Hamann T, 2002, GENE DEV, V16, P1610, DOI 10.1101/gad.229402; Hardtke CS, 1998, EMBO J, V17, P1405, DOI 10.1093/emboj/17.5.1405; Lauber MH, 1997, J CELL BIOL, V139, P1485, DOI 10.1083/jcb.139.6.1485; Lee S, 2006, PLANT CELL PHYSIOL, V47, P591, DOI 10.1093/pcp/pcj026; Leibfried A, 2005, NATURE, V438, P1172, DOI 10.1038/nature04270; Massari ME, 2000, MOL CELL BIOL, V20, P429, DOI 10.1128/MCB.20.2.429-440.2000; Nakajima K, 2001, NATURE, V413, P307, DOI 10.1038/35095061; Okushima Y, 2005, PLANT CELL, V17, P444, DOI 10.1105/tpc.104.028316; Okushima Y, 2007, PLANT CELL, V19, P118, DOI 10.1105/tpc.106.047761; Rashotte AM, 2006, P NATL ACAD SCI USA, V103, P11081, DOI 10.1073/pnas.0602038103; Riechmann JL, 2000, SCIENCE, V290, P2105, DOI 10.1126/science.290.5499.2105; Sartor MA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-538; Scheres B, 2001, PLANT PHYSIOL, V125, P112, DOI 10.1104/pp.125.1.112; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Smyth G.K., 2004, STAT APPL GENET MOL, V3, pArticl, DOI [10.2202/1544-6115.1027, DOI 10.2202/1544-6115.1027]; Takada S, 2007, DEVELOPMENT, V134, P1141, DOI 10.1242/dev.02803; Tian Q, 2002, PLANT CELL, V14, P301, DOI 10.1105/tpc.010283; Toledo-Ortiz G, 2003, PLANT CELL, V15, P1749, DOI 10.1105/tpc.013839; Ulmasov T, 1999, P NATL ACAD SCI USA, V96, P5844, DOI 10.1073/pnas.96.10.5844; Ulmasov T, 1999, PLANT J, V19, P309, DOI 10.1046/j.1365-313X.1999.00538.x; van den Bosch HM, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-267; Wang H, 2009, PLANT CELL, V21, P3781, DOI 10.1105/tpc.109.072504; Weigel D, 2002, NATURE, V415, P751, DOI 10.1038/415751a; Weijers D, 2006, DEV CELL, V10, P265, DOI 10.1016/j.devcel.2005.12.001; Weijers D, 2005, EMBO J, V24, P1874, DOI 10.1038/sj.emboj.7600659; Weijers D, 2001, DEVELOPMENT, V128, P4289; Wesley SV, 2001, PLANT J, V27, P581, DOI 10.1046/j.1365-313X.2001.01105.x; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683	36	394	420	4	115	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 8	2010	464	7290					913	U128		10.1038/nature08836	http://dx.doi.org/10.1038/nature08836			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	579TM	20220754				2022-12-01	WOS:000276397300042
J	Groffen, AJ; Martens, S; Arazola, RD; Cornelisse, LN; Lozovaya, N; de Jong, APH; Goriounova, NA; Habets, RLP; Takai, Y; Borst, JG; Brose, N; McMahon, HT; Verhage, M				Groffen, Alexander J.; Martens, Sascha; Arazola, Rocio Diez; Cornelisse, L. Niels; Lozovaya, Natalia; de Jong, Arthur P. H.; Goriounova, Natalia A.; Habets, Ron L. P.; Takai, Yoshimi; Borst, J. Gerard; Brose, Nils; McMahon, Harvey T.; Verhage, Matthijs			Doc2b Is a High-Affinity Ca2+ Sensor for Spontaneous Neurotransmitter Release	SCIENCE			English	Article							PRESYNAPTIC CALCIUM STORES; MEMBRANE-FUSION; SYNAPTOTAGMIN-I; PURKINJE-CELL; SYNAPTIC-TRANSMISSION; TRANSMITTER RELEASE; CEREBELLAR CORTEX; NEURONS; PROTEIN; EXOCYTOSIS	Synaptic vesicle fusion in brain synapses occurs in phases that are either tightly coupled to action potentials ( synchronous), immediately following action potentials (asynchronous), or as stochastic events in the absence of action potentials (spontaneous). Synaptotagmin-1, -2, and -9 are vesicle-associated Ca2+ sensors for synchronous release. Here we found that double C2 domain (Doc2) proteins act as Ca2+ sensors to trigger spontaneous release. Although Doc2 proteins are cytosolic, they function analogously to synaptotagmin-1 but with a higher Ca2+ sensitivity. Doc2 proteins bound to N-ethylmaleimide-sensitive factor attachment receptor (SNARE) complexes in competition with synaptotagmin-1. Thus, different classes of multiple C2 domain-containing molecules trigger synchronous versus spontaneous fusion, which suggests a general mechanism for synaptic vesicle fusion triggered by the combined actions of SNAREs and multiple C2 domain-containing proteins.	[Groffen, Alexander J.; Arazola, Rocio Diez; Cornelisse, L. Niels; Lozovaya, Natalia; de Jong, Arthur P. H.; Goriounova, Natalia A.; Verhage, Matthijs] Vrije Univ Amsterdam, CNCR, Dept Funct Genom, NL-1081 HV Amsterdam, Netherlands; [Groffen, Alexander J.; Arazola, Rocio Diez; Cornelisse, L. Niels; Lozovaya, Natalia; de Jong, Arthur P. H.; Goriounova, Natalia A.; Verhage, Matthijs] Vrije Univ Amsterdam Med Ctr, NL-1081 HV Amsterdam, Netherlands; [Martens, Sascha; McMahon, Harvey T.] MRC, Mol Biol Lab, Cambridge CB2 0QH, England; [Lozovaya, Natalia; Goriounova, Natalia A.] Vrije Univ Amsterdam, CNCR, Dept Integrat Neurophysiol, NL-1081 HV Amsterdam, Netherlands; [Lozovaya, Natalia; Borst, J. Gerard] AA Bogomolets Physiol Inst, UA-01024 Kiev, Ukraine; [Habets, Ron L. P.; Takai, Yoshimi] Univ Med Ctr, Erasmus MC, Dept Neurosci, NL-3000 CA Rotterdam, Netherlands; [Brose, Nils] Kobe Univ, Grad Sch Med, Dept Biochem & Mol Biol, Kobe, Hyogo 6500017, Japan; Max Planck Inst Expt Med, Abt Mol Neurobiol, D-37075 Gottingen, Germany	Vrije Universiteit Amsterdam; Vrije Universiteit Amsterdam; VU UNIVERSITY MEDICAL CENTER; MRC Laboratory Molecular Biology; Vrije Universiteit Amsterdam; National Academy of Sciences Ukraine; A.A. Bogomoletz Institute of Physiology; Erasmus University Rotterdam; Erasmus MC; Kobe University; Max Planck Society	Groffen, AJ (corresponding author), Vrije Univ Amsterdam, CNCR, Dept Funct Genom, Neurosci Campus Amsterdam, NL-1081 HV Amsterdam, Netherlands.	sander.groffen@cncr.vu.nl; sascha.martens@univie.ac.at	Goriounova, Natalia/ABE-6759-2020; Groffen, A.J.A./C-1118-2009; Martens, Sascha/C-3693-2011; de Jong, Arthur PH/D-9500-2013	Groffen, A.J.A./0000-0003-0046-4027; Goriounova, Natalia/0000-0002-5917-983X; verhage, matthijs/0000-0002-6085-7503; de Jong, Arthur/0000-0002-7620-2704; Cornelisse, Lennart Niels/0000-0001-9425-2935; Martens, Sascha/0000-0003-3786-8199	EU [019055, F2-2009-241498]; U.K. Medical Research Council; European Molecular Biology Organization; Neuro-Bsik Mouse Phenomics Consortium [BSIK03053]; Medical Research Council [MC_U105178795] Funding Source: researchfish; MRC [MC_U105178795] Funding Source: UKRI	EU(European Commission); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Neuro-Bsik Mouse Phenomics Consortium; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank R. Zalm, D. Schut, I. Saarloos, B. de Vries, C. van der Meer, and M. Schindler for technical assistance. H. Mansvelder and H. Lodder are acknowledged for expert advice and help in neurophysiology. This work was supported by the EU (EUSynapse project 019055 and Eurospin Health-F2-2009-241498 to M. V.), the U.K. Medical Research Council to H. M. M. and S. M., a European Molecular Biology Organization Long-Term Fellowship to S. M., and the Neuro-Bsik Mouse Phenomics Consortium BSIK03053 to M. V. The authors declare no conflicting interests.	Bai JH, 2004, NAT STRUCT MOL BIOL, V11, P36, DOI 10.1038/nsmb709; BERNARD C, 1993, BRAIN RES, V626, P234, DOI 10.1016/0006-8993(93)90584-A; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; CHANPALAY V, 1971, Z ANAT ENTWICKLUNGS, V134, P200, DOI 10.1007/BF00519300; Chicka MC, 2008, NAT STRUCT MOL BIOL, V15, P827, DOI 10.1038/nsmb.1463; Collin T, 2005, CURR OPIN NEUROBIOL, V15, P275, DOI 10.1016/j.conb.2005.05.003; De Crescenzo V, 2004, J NEUROSCI, V24, P1226, DOI 10.1523/JNEUROSCI.4286-03.2004; Duncan RR, 1999, J BIOL CHEM, V274, P27347, DOI 10.1074/jbc.274.39.27347; Emptage NJ, 2001, NEURON, V29, P197, DOI 10.1016/S0896-6273(01)00190-8; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; FOLCH J, 1957, J BIOL CHEM, V226, P497; Friedrich R, 2008, J NEUROSCI, V28, P6794, DOI 10.1523/JNEUROSCI.0538-08.2008; Fukuda N, 2009, DIABETES, V58, P377, DOI 10.2337/db08-0303; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groffen AJA, 2006, J NEUROCHEM, V97, P818, DOI 10.1111/j.1471-4159.2006.03755.x; Groffen AJA, 2004, J BIOL CHEM, V279, P23740, DOI 10.1074/jbc.M400731200; Hori T, 1999, J NEUROSCI, V19, P7262, DOI 10.1523/JNEUROSCI.19-17-07262.1999; Ke B, 2007, J BIOL CHEM, V282, P21786, DOI 10.1074/jbc.M701661200; Kojima T, 1996, J BIOCHEM-TOKYO, V120, P671; Korogod N, 2005, J NEUROSCI, V25, P5127, DOI 10.1523/JNEUROSCI.1295-05.2005; LITTLETON JT, 1993, CELL, V74, P1125, DOI 10.1016/0092-8674(93)90733-7; Liu HS, 2009, J NEUROSCI, V29, P7395, DOI 10.1523/JNEUROSCI.1341-09.2009; Llano I, 2000, NAT NEUROSCI, V3, P1256, DOI 10.1038/81781; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Maximov A, 2007, J CELL BIOL, V176, P113, DOI 10.1083/jcb.200607021; McKay BE, 2005, J PHYSIOL-LONDON, V567, P829, DOI 10.1113/jphysiol.2005.089383; Miyazaki M, 2009, BIOCHEM BIOPH RES CO, V384, P461, DOI 10.1016/j.bbrc.2009.04.133; Orita S, 1997, J BIOL CHEM, V272, P16081, DOI 10.1074/jbc.272.26.16081; ORITA S, 1995, BIOCHEM BIOPH RES CO, V206, P439, DOI 10.1006/bbrc.1995.1062; Otsu Y, 2004, J NEUROSCI, V24, P420, DOI 10.1523/JNEUROSCI.4452-03.2004; Pang ZPP, 2006, J NEUROSCI, V26, P12556, DOI 10.1523/JNEUROSCI.3804-06.2006; Pang ZP, 2006, EMBO J, V25, P2039, DOI 10.1038/sj.emboj.7601103; Sun J, 2007, NATURE, V450, P676, DOI 10.1038/nature06308; Tang J, 2006, CELL, V126, P1175, DOI 10.1016/j.cell.2006.08.030; Tucker WC, 2004, SCIENCE, V304, P435, DOI 10.1126/science.1097196; Verhage M, 1997, NEURON, V18, P453, DOI 10.1016/S0896-6273(00)81245-3; Womack M, 2002, J NEUROSCI, V22, P10603; Xu J, 2007, NEURON, V54, P567, DOI 10.1016/j.neuron.2007.05.004; Xu J, 2009, NAT NEUROSCI, V12, P759, DOI 10.1038/nn.2320; ZENGEL JE, 1994, J PHYSIOL-LONDON, V477, P267, DOI 10.1113/jphysiol.1994.sp020189	42	226	230	0	38	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1614	1618		10.1126/science.1183765	http://dx.doi.org/10.1126/science.1183765			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20150444	Green Accepted			2022-12-01	WOS:000275970600035
J	Boudsocq, M; Willmann, MR; McCormack, M; Lee, H; Shan, LB; He, P; Bush, J; Cheng, SH; Sheen, J				Boudsocq, Marie; Willmann, Matthew R.; McCormack, Matthew; Lee, Horim; Shan, Libo; He, Ping; Bush, Jenifer; Cheng, Shu-Hua; Sheen, Jen			Differential innate immune signalling via Ca2+ sensor protein kinases	NATURE			English	Article							GENE-EXPRESSION ANALYSIS; PLANT DEFENSE; MOLECULAR-PATTERNS; ARABIDOPSIS; CALCIUM; PERCEPTION; RESISTANCE; FLAGELLIN; IDENTIFICATION; TRANSDUCTION	Innate immunity represents the first line of inducible defence against microbial infection in plants and animals(1-3). In both kingdoms, recognition of pathogen- or microbe-associated molecular patterns (PAMPs or MAMPs, respectively), such as flagellin, initiates convergent signalling pathways involving mitogen-activated protein kinase ( MAPK) cascades and global transcriptional changes to boost immunity(1-4). Although Ca2+ has long been recognized as an essential and conserved primary mediator in plant defence responses, how Ca2+ signals are sensed and relayed into early MAMP signalling is unknown(5,6). Using a functional genomic screen and genome-wide gene expression profiling, here we show that four calcium-dependent protein kinases (CDPKs) are Ca2+-sensor protein kinases critical for transcriptional reprogramming in plant innate immune signalling. Unexpectedly, CDPKs and MAPK cascades act differentially in four MAMP-mediated regulatory programs to control early genes involved in the synthesis of defence peptides and metabolites, cell wall modifications and redox signalling. Transcriptome profile comparison suggests that CDPKs are the convergence point of signalling triggered by most MAMPs. Double, triple and quadruple cpk mutant plants display progressively diminished oxidative burst and gene activation induced by the 22-amino-acid peptide flg22, as well as compromised pathogen defence. In contrast to negative roles of calmodulin and a calmodulin-activated transcription factor in plant defence(7,8), the present study reveals Ca2+ signalling complexity and demonstrates key positive roles of specific CDPKs in initial MAMP signalling.	[Boudsocq, Marie; Willmann, Matthew R.; McCormack, Matthew; Lee, Horim; Shan, Libo; He, Ping; Bush, Jenifer; Cheng, Shu-Hua; Sheen, Jen] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02114 USA; [Boudsocq, Marie; Willmann, Matthew R.; McCormack, Matthew; Lee, Horim; Shan, Libo; He, Ping; Bush, Jenifer; Cheng, Shu-Hua; Sheen, Jen] Massachusetts Gen Hosp, Ctr Computat & Integrat Biol, Boston, MA 02114 USA; [Boudsocq, Marie; Willmann, Matthew R.; McCormack, Matthew; Lee, Horim; Shan, Libo; He, Ping; Bush, Jenifer; Cheng, Shu-Hua; Sheen, Jen] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA	Harvard University; Harvard Medical School; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital	Boudsocq, M (corresponding author), CNRS, UPR2355, Inst Sci Vegetal, 1 Ave Terrasse, F-91198 Gif Sur Yvette, France.	boudsocq@molbio.mgh.harvard.edu; willmann@sas.upenn.edu	Lee, Horim/I-6180-2019; poinssot, benoit/B-2569-2009; Boudsocq, Marie/J-6074-2019	poinssot, benoit/0000-0001-5890-4318; Boudsocq, Marie/0000-0001-8945-6773; He, Ping/0000-0002-5926-8349; Willmann, Matthew R./0000-0002-4146-8158	European Community; NSF; National Science Foundation; National Institute of Health; MGH CCIB; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM092893, R01GM070567, R01GM097247, R01GM060493] Funding Source: NIH RePORTER	European Community(European Commission); NSF(National Science Foundation (NSF)); National Science Foundation(National Science Foundation (NSF)); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); MGH CCIB; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank K. H. Liu and E. Baena-Gonzalez for contributing to the CPK clone collection, O.R. Patharkar for initial microarray data analysis, B. Mueller and G. Tena for offering qPCR primers, M. N. Soler and S. Bolte for assistance on confocal microscopy, C. Lauriere for discussions, S. P. Dinesh-Kumar for VIGS vectors, K. Schreiber and D. Desveaux for the seedling pathogen assay, and A. Gust and T. Nurnberger for the original PGN microarray data. Wethank the Salk Institute, Syngenta Biotechnology and A. Sessions for sharing the Arabidopsis T-DNA collections, and the Arabidopsis Biological Resource Center for providing Arabidopsis mutant seeds. This research has been supported by a Marie Curie International fellowship within the 6th European Community Framework Program to M. B., an NSF predoctoral fellowship to M. R. W., and grants from the National Science Foundation and the National Institute of Health, and the MGH CCIB fund to J. S.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alonso JM, 2003, METH MOL B, V236, P177; Asai T, 2002, NATURE, V415, P977, DOI 10.1038/415977a; Baena-Gonzalez E, 2007, NATURE, V448, P938, DOI 10.1038/nature06069; Bednarek P, 2009, SCIENCE, V323, P101, DOI 10.1126/science.1163732; Boller T, 2009, ANNU REV PLANT BIOL, V60, P379, DOI 10.1146/annurev.arplant.57.032905.105346; Boudsocq M, 2004, J BIOL CHEM, V279, P41758, DOI 10.1074/jbc.M405259200; BOUDSOCQ M, 2009, ABIOTIC STRESS ADAPT, pCH4; Burch-Smith TM, 2006, PLANT PHYSIOL, V142, P21, DOI 10.1104/pp.106.084624; Cheng SH, 2002, PLANT PHYSIOL, V129, P469, DOI 10.1104/pp.005645; Chinchilla D, 2007, NATURE, V448, P497, DOI 10.1038/nature05999; Clay NK, 2009, SCIENCE, V323, P95, DOI 10.1126/science.1164627; Du LQ, 2009, NATURE, V457, P1154, DOI 10.1038/nature07612; Felix G, 1999, PLANT J, V18, P265, DOI 10.1046/j.1365-313X.1999.00265.x; Gust AA, 2007, J BIOL CHEM, V282, P32338, DOI 10.1074/jbc.M704886200; Harper JF, 2005, NAT REV MOL CELL BIO, V6, P555, DOI 10.1038/nrm1679; He P, 2006, CELL, V125, P563, DOI 10.1016/j.cell.2006.02.047; Huffaker A, 2007, P NATL ACAD SCI USA, V104, P10732, DOI 10.1073/pnas.0703343104; Kim MC, 2002, NATURE, V416, P447, DOI 10.1038/416447a; Kobayashi M, 2007, PLANT CELL, V19, P1065, DOI 10.1105/tpc.106.048884; Lecourieux D, 2005, CELL CALCIUM, V38, P527, DOI 10.1016/j.ceca.2005.06.036; Lecourieux D, 2006, NEW PHYTOL, V171, P249, DOI 10.1111/j.1469-8137.2006.01777.x; Luan S, 2009, TRENDS PLANT SCI, V14, P37, DOI 10.1016/j.tplants.2008.10.005; Ma W, 2008, PLANT PHYSIOL, V148, P818, DOI 10.1104/pp.108.125104; Ma W, 2007, CELL MICROBIOL, V9, P2571, DOI 10.1111/j.1462-5822.2007.01031.x; Nemhauser JL, 2006, CELL, V126, P467, DOI 10.1016/j.cell.2006.05.050; Nurnberger T, 2004, IMMUNOL REV, V198, P249, DOI 10.1111/j.0105-2896.2004.0119.x; Romeis T, 2000, PLANT CELL, V12, P803, DOI 10.1105/tpc.12.5.803; Romeis T, 2001, EMBO J, V20, P5556, DOI 10.1093/emboj/20.20.5556; Schreiber K, 2008, PLANT J, V54, P522, DOI 10.1111/j.1365-313X.2008.03425.x; Shan LB, 2008, CELL HOST MICROBE, V4, P17, DOI 10.1016/j.chom.2008.05.017; Sheen J, 1996, SCIENCE, V274, P1900, DOI 10.1126/science.274.5294.1900; SHEEN J, 2008, BIOL PLANT MICROBE I, V6, pCH86; Uno YC, 2009, MOL GENET GENOMICS, V281, P375, DOI 10.1007/s00438-008-0419-1; Yoo SD, 2007, NAT PROTOC, V2, P1565, DOI 10.1038/nprot.2007.199; Zhu SY, 2007, PLANT CELL, V19, P3019, DOI 10.1105/tpc.107.050666; Zimmermann P, 2005, TRENDS PLANT SCI, V10, P407, DOI 10.1016/j.tplants.2005.07.003; Zipfel C, 2004, NATURE, V428, P764, DOI 10.1038/nature02485	38	555	583	8	228	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 18	2010	464	7287					418	U116		10.1038/nature08794	http://dx.doi.org/10.1038/nature08794			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20164835	Green Accepted			2022-12-01	WOS:000275657100048
J	Goodman, A				Goodman, Annekathryn			Ministry of Touch -- Reflections on Disaster Work after the Haitian Earthquake.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA	Harvard University; Massachusetts General Hospital	Goodman, A (corresponding author), Massachusetts Gen Hosp, Dept Obstet & Gynecol, Boston, MA 02114 USA.								0	4	4	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11								10.1056/NEJMp1002311	http://dx.doi.org/10.1056/NEJMp1002311			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20200361				2022-12-01	WOS:000275650400005
J	Rothwell, PM; Howard, SC; Dolan, E; O'Brien, E; Dobson, JE; Dahlof, B; Sever, PS; Poulter, NR				Rothwell, Peter M.; Howard, Sally C.; Dolan, Eamon; O'Brien, Eoin; Dobson, Joanna E.; Dahlof, Bjorn; Sever, Peter S.; Poulter, Neil R.			Prognostic significance of visit-to-visit variability, maximum systolic blood pressure, and episodic hypertension	LANCET			English	Article							TRANSIENT ISCHEMIC ATTACK; SOCIETY-OF-HYPERTENSION; CARDIOVASCULAR EVENTS; ANTIHYPERTENSIVE TREATMENT; REGRESSION DILUTION; RISK-FACTOR; STROKE; TRIAL; PREDICTOR; MORTALITY	Background The mechanisms by which hypertension causes vascular events are unclear. Guidelines for diagnosis and treatment focus only on underlying mean blood pressure. We aimed to reliably establish the prognostic significance of visit-to-visit variability in blood pressure, maximum blood pressure reached, untreated episodic hypertension, and residual variability in treated patients. Methods We determined the risk of stroke in relation to visit-to-visit variability in blood pressure (expressed as standard deviation [SDI and parameters independent of mean blood pressure) and maximum blood pressure in patients with previous transient ischaemic attack (TIA; UK-TIA trial and three validation cohorts) and in patients with treated hypertension (Anglo-Scandinavian Cardiac Outcomes Trial Blood Pressure Lowering Arm [ASCOT-BPLA]). In ASCOT-BPLA, 24-h ambulatory blood-pressure monitoring (ABPM) was also studied. Findings In each TIA cohort, visit-to-visit variability in systolic blood pressure (SBP) was a strong predictor of subsequent stroke (eg, top-decile hazard ratio [HR] for SD SBP over seven visits in UK-TIA trial: 6.22, 95% CI 4.16-9.29, p<0.0001), independent of mean S BP, but dependent on precision of measurement (top-decile HR over ten visits: 12.08, 7.40-19.72, p<0.0001). Maximum SBP reached was also a strong predictor of stroke (HR for top-decile over seven visits: 15.01, 6.56-34.38, p<0.0001, after adjustment for mean SBP). In ASCOT-BPLA, residual visit-to-visit variability in SBP on treatment was also a strong predictor of stroke and coronary events (eg, top-decile HR for stroke: 3.25, 2.32-4.54, p<0.0001), independent of mean S BP in clinic or on ABPM. Variability on ABPM was a weaker predictor, but all measures of variability were most predictive in younger patients and at lower (<median) values of mean SBP in every cohort. Interpretation Visit-to-visit variability in SBP and maximum SBP are strong predictors of stroke, independent of mean SBP. Increased residual variability in SBP in patients with treated hypertension is associated with a high risk of vascular events.	[Rothwell, Peter M.; Howard, Sally C.] John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Oxford OX3 9DU, England; [Dolan, Eamon] Connolly Hosp, Stroke & Hypertens Unit, Dublin, Ireland; [O'Brien, Eoin] Univ Coll Dublin, Conway Inst Biomol & Biomed Res, Dublin 2, Ireland; [Dobson, Joanna E.; Sever, Peter S.; Poulter, Neil R.] Univ London Imperial Coll Sci Technol & Med, Int Ctr Circulatory Hlth, London, England; [Dahlof, Bjorn] Univ Gothenburg, Dept Med, Gothenburg, Sweden	University of Oxford; University College Dublin; Imperial College London; University of Gothenburg	Rothwell, PM (corresponding author), John Radcliffe Hosp, Stroke Prevent Res Unit, Univ Dept Clin Neurol, Level 6,West Wing, Oxford OX3 9DU, England.	peter.rothwell@clneuro.ox.ac.uk	Rothwell, Peter/ABE-5913-2020	Rothwell, Peter/0000-0001-9739-9211	UK Medical Research Council; National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, UK; Biomedical Research Centre Award; British Heart Foundation Centre for Excellence Award; Pfizer; Servier Research Group, Paris, France; Medical Research Council [G0500987] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10116] Funding Source: researchfish; MRC [G0500987] Funding Source: UKRI	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, UK(National Institute for Health Research (NIHR)); Biomedical Research Centre Award; British Heart Foundation Centre for Excellence Award; Pfizer(Pfizer); Servier Research Group, Paris, France; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank the investigators of the UK-TIA aspirin trial, the European Stroke Prevention Study (ESPS-1), the Dutch TIA aspirin trial, and the ASCOT-BPLA study. We acknowledge the collaboration of the other ASCOT-BPLA ABPM substudy researchers: Alice V Stanton, Simon Thom, Mark Caulfield, Gordon McInnes, and David Collier. SCH was funded by the UK Medical Research Council and by the National Institute for Health Research (NIHR) Biomedical Research Centre, Oxford, UK. NRP and PSS were supported by a Biomedical Research Centre Award to Imperial College NHS Health Care Trust, are in receipt of a British Heart Foundation Centre for Excellence Award, and along with PMR are recipients of NIHR Senior Investigator Awards. Pfizer was the major funding source of the main ASCOT trial with additional support provided by Servier Research Group, Paris, France.	[Anonymous], 1978, J Chronic Dis, V31, P651; [Anonymous], 1987, LANCET, V2, P1351; ARMITAGE P, 1966, CLIN SCI, V30, P337; Chalmers J, 1996, J HYPERTENS, V14, pS41; Chobanian AV, 2003, HYPERTENSION, V42, P1206, DOI 10.1161/01.HYP.0000107251.49515.c2; COLANDREA MA, 1970, CIRCULATION, V41, P239, DOI 10.1161/01.CIR.41.2.239; CUFFE RL, 2005, CEREBROVASC DIS, V19, P51; Cuffe RL, 2006, STROKE, V37, P2776, DOI 10.1161/01.STR.0000244761.62073.05; Dahlof B, 2005, LANCET, V366, P895, DOI 10.1016/S0140-6736(05)67185-1; Dolan E, 2009, J HYPERTENS, V27, P876, DOI 10.1097/HJH.0b013e328322cd62; FARRELL B, 1991, J NEUROL NEUROSUR PS, V54, P1044, DOI 10.1136/jnnp.54.12.1044; Hata Y, 2002, J HUM HYPERTENS, V16, P141, DOI 10.1038/sj.jhh.1001301; Hata Y, 2000, HYPERTENS RES, V23, P553, DOI 10.1291/hypres.23.553; Havlik RJ, 2002, STROKE, V33, P26, DOI 10.1161/hs0102.101890; Howard SC, 2009, CEREBROVASC DIS, V28, P331, DOI 10.1159/000229551; Howard SC, 2003, J CLIN EPIDEMIOL, V56, P1084, DOI 10.1016/S0895-4356(03)00267-1; JANSEN PAF, 1986, AGE AGEING, V15, P129, DOI 10.1093/ageing/15.3.129; Keenan K, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1492; Kikuya M, 2008, HYPERTENSION, V52, P1045, DOI 10.1161/HYPERTENSIONAHA.107.104620; Klungel OH, 2000, J CLIN EPIDEMIOL, V53, P1158, DOI 10.1016/S0895-4356(00)00228-6; Lawes CMM, 2008, LANCET, V371, P1513, DOI 10.1016/S0140-6736(08)60655-8; Leenen FHH, 2004, CAN J CARDIOL, V20, p77B; Lewington S, 2002, LANCET, V360, P1903, DOI 10.1016/S0140-6736(02)11911-8; MACMAHON S, 1990, LANCET, V335, P765, DOI 10.1016/0140-6736(90)90878-9; Mancia G, 2007, EUR HEART J, V28, P1462, DOI [10.1093/eurheartj/ehm236, 10.1093/eurheartj/eht151]; Marshall T, 2004, BMJ-BRIT MED J, V328, P933, DOI 10.1136/bmj.328.7445.933; O'Brien E, 2005, J HYPERTENS, V23, P697, DOI 10.1097/01.hjh.0000163132.84890.c4; O'Brien E, 2001, J HUM HYPERTENS, V15, pS47, DOI 10.1038/sj.jhh.1001076; OBRIEN E, 1994, J HYPERTENS, V12, P1089; OBRIEN E, 1991, J HYPERTENS, V9, P573, DOI 10.1097/00004872-199106000-00016; Parati G, 2008, J HYPERTENS, V26, P1505, DOI 10.1097/HJH.0b013e328308da66; Pickering TG, 2007, HYPERTENS RES, V30, P479, DOI 10.1291/hypres.30.479; Poulter NR, 2005, LANCET, V366, P907, DOI 10.1016/S0140-6736(05)67186-3; Pringle E, 2003, J HYPERTENS, V21, P2251, DOI 10.1097/00004872-200312000-00012; PROGRESS Collaborat Grp, 2001, LANCET, V358, P1556; Robinson T, 1997, CEREBROVASC DIS, V7, P214, DOI 10.1159/000108194; Rodgers A, 1996, BRIT MED J, V313, P147, DOI 10.1136/bmj.313.7050.147; Rothwell PM, 2010, LANCET, V375, P938, DOI 10.1016/S0140-6736(10)60309-1; Rothwell PM, 2010, LANCET NEUROL, V9, P469, DOI 10.1016/S1474-4422(10)70066-1; Rothwell PM, 2005, LANCET, V366, P1773, DOI 10.1016/S0140-6736(05)67702-1; Toschke AM, 2009, CEREBROVASC DIS, V28, P105, DOI 10.1159/000223434; Tozawa M, 1999, NEPHROL DIAL TRANSPL, V14, P1976, DOI 10.1093/ndt/14.8.1976; Turnbull F, 2008, BMJ-BRIT MED J, V336, P1121, DOI 10.1136/bmj.39548.738368.BE; Turner MJ, 2008, AM J HYPERTENS, V21, P85, DOI 10.1038/ajh.2007.25; VANGIJN J, 1991, NEW ENGL J MED, V325, P1261, DOI 10.1056/NEJM199110313251801; Verdecchia P, 2003, AM J HYPERTENS, V16, P87, DOI 10.1016/S0895-7061(02)03150-3; Warlow C, 2003, LANCET, V362, P1211, DOI 10.1016/S0140-6736(03)14544-8; Webb AJS, 2010, LANCET, V375, P906, DOI 10.1016/S0140-6736(10)60235-8; Whelton P K, 1989, Clin Geriatr Med, V5, P639; Williams B, 2008, LANCET, V371, P2219, DOI 10.1016/S0140-6736(08)60804-1; Zhang ZH, 2000, BRAIN RES, V863, P25, DOI 10.1016/S0006-8993(00)02068-0	51	1199	1359	4	97	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR 13	2010	375	9718					895	905		10.1016/S0140-6736(10)60308-X	http://dx.doi.org/10.1016/S0140-6736(10)60308-X			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	574NA	20226988				2022-12-01	WOS:000275995300029
J	Meer, MV; Kondrashov, AS; Artzy-Randrup, Y; Kondrashov, FA				Meer, Margarita V.; Kondrashov, Alexey S.; Artzy-Randrup, Yael; Kondrashov, Fyodor A.			Compensatory evolution in mitochondrial tRNAs navigates valleys of low fitness	NATURE			English	Article							MOLECULAR PHYLOGENY; SECONDARY STRUCTURES; POPULATION-GENETICS; PROTEIN EVOLUTION; MISSING DATA; MUTATIONS; SELECTION; DIVERGENCE; DROSOPHILA; WHALES	A long-standing controversy in evolutionary biology is whether or not evolving lineages can cross valleys on the fitness landscape that correspond to low-fitness genotypes, which can eventually enable them to reach isolated fitness peaks(1-9). Here we study the fitness landscapes traversed by switches between different AU and GC Watson-Crick nucleotide pairs at complementary sites of mitochondrial transfer RNA stem regions in 83 mammalian species. We find that such Watson-Crick switches occur 30-40 times more slowly than pairs of neutral substitutions, and that alleles corresponding to GU and AC non-Watson-Crick intermediate states segregate within human populations at low frequencies, similar to those of non-synonymous alleles. Substitutions leading to a Watson Crick switch are strongly correlated, especially in mitochondrial tRNAs encoded on the GT-nucleotide-rich strand of the mitochondrial genome. Using these data we estimate that a typical Watson-Crick switch involves crossing a fitness valley of a depth of about 10(-3) or even about 10(-2), with AC intermediates being slightly more deleterious than GU intermediates. This compensatory evolution must proceed through rare intermediate variants that never reach fixation(2). The ubiquitous nature of compensatory evolution in mammalian mitochondrial tRNAs and other molecules(10,11) implies that simultaneous fixation of two alleles that are individually deleterious may be a common phenomenon at the molecular level.	[Meer, Margarita V.; Kondrashov, Fyodor A.] Ctr Genom Regulat, Bioinformat & Genom Programme, Barcelona 08003, Spain; [Kondrashov, Alexey S.; Artzy-Randrup, Yael] Univ Michigan, Inst Life Sci, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 48109 USA; [Artzy-Randrup, Yael] Univ Michigan, Howard Hughes Med Inst, Ann Arbor, MI 49109 USA; [Artzy-Randrup, Yael] Univ Michigan, Dept Ecol & Evolutionary Biol, Ann Arbor, MI 49109 USA	Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG); University of Michigan System; University of Michigan; Howard Hughes Medical Institute; University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Kondrashov, FA (corresponding author), Ctr Genom Regulat, Bioinformat & Genom Programme, C Dr Aiguader 88,Barcelona Biomed Res Pk Bldg, Barcelona 08003, Spain.	fyodor.kondrashov@crg.es	Kondrashov, Fyodor Alexeevich/H-6331-2015	Kondrashov, Fyodor Alexeevich/0000-0001-8243-4694				Agnarsson I, 2008, MOL PHYLOGENET EVOL, V48, P964, DOI 10.1016/j.ympev.2008.05.046; Bazykin GA, 2004, NATURE, V429, P558, DOI 10.1038/nature02601; BERISON DA, 2006, NUCLEIC ACIDS RES, V34, pD16; Chen Y, 2003, P NATL ACAD SCI USA, V100, P11499, DOI 10.1073/pnas.1932834100; Coyne JA, 2000, EVOLUTION, V54, P306, DOI 10.1111/j.0014-3820.2000.tb00033.x; Crow JF, 2008, ANNU REV GENET, V42, P1, DOI 10.1146/annurev.genet.42.110807.091612; Davis AR, 2007, BIOCHEMISTRY-US, V46, P13425, DOI 10.1021/bi701311c; Dobzhansky T, 1936, GENETICS, V21, P113; Donmez N, 2009, GENETICS, V181, P685, DOI 10.1534/genetics.108.097535; Douady CJ, 2002, MOL PHYLOGENET EVOL, V25, P200, DOI 10.1016/S1055-7903(02)00232-4; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Flynn JJ, 2005, SYST BIOL, V54, P317, DOI 10.1080/10635150590923326; Fulton TL, 2006, MOL PHYLOGENET EVOL, V41, P165, DOI 10.1016/j.ympev.2006.05.025; Hatch LT, 2006, MOL PHYLOGENET EVOL, V41, P12, DOI 10.1016/j.ympev.2006.05.023; Horner DS, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-16; Howell N, 2003, AM J HUM GENET, V72, P659, DOI 10.1086/368264; Innan H, 2001, GENETICS, V159, P389; Kelley SO, 2000, NAT STRUCT BIOL, V7, P862, DOI 10.1038/79612; Kern AD, 2004, NAT GENET, V36, P1207, DOI 10.1038/ng1451; Kimura M., 1985, J GENET, V64, P7, DOI [10.1007/BF02923549, DOI 10.1007/BF02923549]; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kondrashov AS, 2002, P NATL ACAD SCI USA, V99, P14878, DOI 10.1073/pnas.232565499; Malyarchuk BA, 2002, HUM GENET, V111, P46, DOI 10.1007/s00439-002-0740-4; Matsui A, 2009, GENE, V441, P53, DOI 10.1016/j.gene.2008.08.024; MCDONALD JH, 1991, NATURE, V351, P652, DOI 10.1038/351652a0; McFarland R, 2004, TRENDS GENET, V20, P591, DOI 10.1016/j.tig.2004.09.014; Muller HJ, 1939, BIOL REV CAMB PHILOS, V14, P261, DOI 10.1111/j.1469-185X.1939.tb00934.x; Murphy WJ, 2001, NATURE, V409, P614, DOI 10.1038/35054550; ORR HA, 1995, GENETICS, V139, P1805; Piskol R, 2008, MOL BIOL EVOL, V25, P2483, DOI 10.1093/molbev/msn195; Poelwijk FJ, 2007, NATURE, V445, P383, DOI 10.1038/nature05451; Popadin KY, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-441; Price SA, 2005, BIOL REV, V80, P445, DOI 10.1017/S1464793105006743; Querouil S, 2001, MOL PHYLOGENET EVOL, V20, P185, DOI 10.1006/mpev.2001.0974; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Schmitz J, 2005, CYTOGENET GENOME RES, V108, P26, DOI 10.1159/000080799; SMITH JM, 1970, NATURE, V225, P563, DOI 10.1038/225563a0; Springer MS, 2001, P NATL ACAD SCI USA, V98, P6241, DOI 10.1073/pnas.111551998; Stewart JB, 2008, PLOS BIOL, V6, P63, DOI 10.1371/journal.pbio.0060010; Sunyaev S, 2001, HUM MOL GENET, V10, P591, DOI 10.1093/hmg/10.6.591; TANAKA M, 1994, GENOMICS, V22, P327, DOI 10.1006/geno.1994.1391; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; WADE MJ, 1991, SCIENCE, V253, P1015, DOI 10.1126/science.1887214; Weinreich DM, 2005, EVOLUTION, V59, P1175; Wittenhagen LM, 2003, TRENDS BIOCHEM SCI, V28, P605, DOI 10.1016/j.tibs.2003.09.006; WRIGHT SEWALL, 1932, PROC SIXTH INTERNAT CONGR GENETICS ITHACA NEW YORK, V1, P356; Xiong Y, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-20; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555	48	65	66	0	25	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					279	U159		10.1038/nature08691	http://dx.doi.org/10.1038/nature08691			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20182427				2022-12-01	WOS:000275366100047
J	Kidder, T				Kidder, Tracy			Recovering from Disaster -- Partners in Health and the Haitian Earthquake.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material																			0	9	10	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9					769	772		10.1056/NEJMp1001705	http://dx.doi.org/10.1056/NEJMp1001705			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563DQ	20164478				2022-12-01	WOS:000275108300001
J	Green, MJ; Myers, KR				Green, Michael J.; Myers, Kimberly R.			Graphic medicine: use of comics in medical education and patient care	BRITISH MEDICAL JOURNAL			English	Editorial Material							BOOKS; ART		[Green, Michael J.; Myers, Kimberly R.] Penn State Coll Med, Dept Humanities & Med, Hershey, PA 17033 USA	Pennsylvania Commonwealth System of Higher Education (PCSHE); Pennsylvania State University; Penn State Health	Green, MJ (corresponding author), Penn State Coll Med, Dept Humanities & Med, 500 Univ Dr, Hershey, PA 17033 USA.	mjg15@psu.edu	Green, Martin A/H-7567-2012	Green, Martin A/0000-0002-8860-396X; Green, Michael/0000-0002-4828-4749				Bitz M, 2004, J ADOLESC ADULT LIT, V47, P574; Carney RN, 2002, EDUC PSYCHOL REV, V14, P5, DOI 10.1023/A:1013176309260; CARTER JB, 2008, TEACHING VISUAL LITE; Dolev JC, 2001, JAMA-J AM MED ASSOC, V286, P1020, DOI 10.1001/jama.286.9.1020; Doxiadis A., 2009, LOGICOMIX EPIC SEARC; FIES B, 2006, MOMS CANC ABRAMS IMA; Fisher Douglas., 2004, ENGL J, V93, P19, DOI [10.2307/4128804, DOI 10.2307/4128804]; Gerde VW, 2008, J BUS ETHICS, V77, P245, DOI 10.1007/s10551-006-9347-3; GILLIES P A, 1990, Health Education Research, V5, P27, DOI 10.1093/her/5.1.27; GREEN MJ, 2009, INT J HEALTHCARE HUM, V3, P1; Hansen B, 2004, B HIST MED, V78, P148, DOI 10.1353/bhm.2004.0018; HARVEY J, 1997, HIV J BIOCOMMUN, V24, P16; Houts PS, 2001, PATIENT EDUC COUNS, V43, P231, DOI 10.1016/S0738-3991(00)00171-3; Johnstone M., 2006, LIVING BLACK DOG HIS; Kakalios J, 2005, PHYS SUPERHEROES; Marchetto MA, 2006, CANC VIXEN TRUE STOR; MAYER RE, 1994, J EDUC PSYCHOL, V86, P389, DOI 10.1037/0022-0663.86.3.389; MCALLISTER MP, 1992, J POP CULT, V26, P1, DOI 10.1111/j.0022-3840.1992.26021.x; McCloud S, 1994, UNDERSTANDING COMICS; Medikidz, MED INF KIDS; Montgomery Hunter K, 1991, DOCTORS STORIES NARR; Naghshineh S, 2008, J GEN INTERN MED, V23, P991, DOI 10.1007/s11606-008-0667-0; Pieper C, 2000, DIABETES RES CLIN PR, V50, P31, DOI DOI 10.1016/S0168-8227(00)81563-6; Sabin Roger, 1996, COMICS COMIX GRAPHIC; Satrapi Marjane, 2003, PERSEPOLIS; Squier SM, 2008, J MED HUMANIT, V29, P71, DOI 10.1007/s10912-008-9057-1; Versaci R., 2001, ENGL J, V91, P61, DOI DOI 10.2307/822347; VERSACI R, 2008, TEACHING VISUAL LITE; COMIC PROBLEMS	29	155	158	5	39	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 3	2010	340								c863	10.1136/bmj.c863	http://dx.doi.org/10.1136/bmj.c863			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	565FJ	20200064				2022-12-01	WOS:000275274400013
J	Guo, JH; Liu, XJ; Zhang, Y; Shen, JL; Han, WX; Zhang, WF; Christie, P; Goulding, KWT; Vitousek, PM; Zhang, FS				Guo, J. H.; Liu, X. J.; Zhang, Y.; Shen, J. L.; Han, W. X.; Zhang, W. F.; Christie, P.; Goulding, K. W. T.; Vitousek, P. M.; Zhang, F. S.			Significant Acidification in Major Chinese Croplands	SCIENCE			English	Article							WINTER-WHEAT; SOIL; BUDGETS; MANAGEMENT; CHEMISTRY; ALUMINUM; SYSTEMS; IMPACT; GRASS	Soil acidification is a major problem in soils of intensive Chinese agricultural systems. We used two nationwide surveys, paired comparisons in numerous individual sites, and several long-term monitoring-field data sets to evaluate changes in soil acidity. Soil pH declined significantly (P < 0.001) from the 1980s to the 2000s in the major Chinese crop-production areas. Processes related to nitrogen cycling released 20 to 221 kilomoles of hydrogen ion (H+) per hectare per year, and base cations uptake contributed a further 15 to 20 kilomoles of H+ per hectare per year to soil acidification in four widespread cropping systems. In comparison, acid deposition (0.4 to 2.0 kilomoles of H+ per hectare per year) made a small contribution to the acidification of agricultural soils across China.	[Guo, J. H.; Liu, X. J.; Zhang, Y.; Shen, J. L.; Han, W. X.; Zhang, W. F.; Christie, P.; Zhang, F. S.] China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China; [Christie, P.] Agri Food & Biosci Inst, Agri Environm Branch, Belfast BT9 5PX, Antrim, North Ireland; [Goulding, K. W. T.] Rothamsted Res, Dept Soil Sci, Harpenden AL5 2JQ, Herts, England; [Vitousek, P. M.] Stanford Univ, Dept Biol, Stanford, CA 94305 USA	China Agricultural University; Agri-Food & Biosciences Institute; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Rothamsted Research; Stanford University	Zhang, FS (corresponding author), China Agr Univ, Coll Resources & Environm Sci, Beijing 100193, Peoples R China.	zhangfs@cau.edu.cn	Shen, Jianlin/G-1820-2014; Liu, Xuejun/AAA-7412-2022; Christie, Peter/B-7919-2008; Han, Wenxuan/B-8791-2016; Zhang, Fusuo/AAV-4517-2021; Goulding, Keith WT/B-2635-2012	Shen, Jianlin/0000-0002-5853-094X; Christie, Peter/0000-0002-1939-7277; Han, Wenxuan/0000-0001-8678-7147; Goulding, Keith WT/0000-0002-6465-1465; zhang, fusuo/0000-0001-8971-0129; Zhang, Ying/0000-0002-9964-9381; Guo, Jingheng/0000-0002-5286-958X	Chinese National Basic Research Program [2009CB118600, 2005CB422206]; NSFC [30821003]; Special Fund for Agricultural Profession [200803030]	Chinese National Basic Research Program(National Basic Research Program of China); NSFC(National Natural Science Foundation of China (NSFC)); Special Fund for Agricultural Profession	We thank X. J. Xiang for data collection, J. Wang for reference correction, and X. Shi and J. Ren for providing soil pH dynamics at two LTMF sites. Financial support for this work was provided by the Chinese National Basic Research Program (2009CB118600 and 2005CB422206), the Innovative Group Grant from NSFC (30821003), and the Special Fund for Agricultural Profession (200803030).	Blake L, 1999, EUR J SOIL SCI, V50, P401, DOI 10.1046/j.1365-2389.1999.00253.x; BLAKE L, 1994, SOIL USE MANAGE, V10, P51, DOI 10.1111/j.1475-2743.1994.tb00458.x; Chadwick OA, 2001, GEODERMA, V100, P321, DOI 10.1016/S0016-7061(01)00027-1; Chen X, 2006, NUTR CYCL AGROECOSYS, V74, P91, DOI 10.1007/s10705-005-1701-9; DELHAIZE E, 1995, PLANT PHYSIOL, V107, P315, DOI 10.1104/pp.107.2.315; Feely RA, 2004, SCIENCE, V305, P362, DOI 10.1126/science.1097329; Fujii K, 2009, PLANT SOIL, V316, P241, DOI 10.1007/s11104-008-9776-0; Goulding K. W. T., 1998, Proceedings - Fertiliser Society; Guo JH, 2007, ENVIRON MONIT ASSESS, V129, P321, DOI 10.1007/s10661-006-9365-8; Hall-Spencer JM, 2008, NATURE, V454, P96, DOI 10.1038/nature07051; Hoegh-Guldberg O, 2007, SCIENCE, V318, P1737, DOI 10.1126/science.1152509; Howarth R W, 2005, ECOSYSTEMS HUMAN WEL, V3, P295; Ju XT, 2007, ENVIRON POLLUT, V145, P497, DOI 10.1016/j.envpol.2006.04.017; Ju XT, 2009, P NATL ACAD SCI USA, V106, P3041, DOI 10.1073/pnas.0813417106; JUO ASR, 1995, PLANT SOIL, V171, P245, DOI 10.1007/BF00010278; Liu XJ, 2003, FIELD CROP RES, V83, P111, DOI 10.1016/S0378-4290(03)00068-6; Matsuyama N, 2005, SOIL SCI PLANT NUTR, V51, P117, DOI 10.1111/j.1747-0765.2005.tb00014.x; Orr JC, 2005, NATURE, V437, P681, DOI 10.1038/nature04095; *SOIL SURV OFF CHI, 1994, CHIN SOIL SPEC, V1; Vitousek PM, 2009, SCIENCE, V324, P1519, DOI 10.1126/science.1170261; Vitousek PM, 1997, ECOL APPL, V7, P737, DOI 10.2307/2269431; VONUEXKULL HR, 1995, PLANT SOIL, V171, P1, DOI 10.1007/BF00009558; WALLACE A, 1994, COMMUN SOIL SCI PLAN, V25, P87, DOI 10.1080/00103629409369010; Wang GH, 2007, AGR SYST, V94, P801, DOI 10.1016/j.agsy.2006.11.006; Xing GX, 2002, BIOGEOCHEMISTRY, V57, P405, DOI 10.1023/A:1016508323200; Zhao Q. G., 2002, MECH TEMPORAL SPATIA, P202; Zhu JH, 2005, AGR ECOSYST ENVIRON, V111, P70, DOI 10.1016/j.agee.2005.04.025; 1982, CHINA AGR YB	28	2207	3008	230	2497	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					1008	1010		10.1126/science.1182570	http://dx.doi.org/10.1126/science.1182570			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20150447	Green Submitted			2022-12-01	WOS:000274625800043
J	Luco, RF; Pan, Q; Tominaga, K; Blencowe, BJ; Pereira-Smith, OM; Misteli, T				Luco, Reini F.; Pan, Qun; Tominaga, Kaoru; Blencowe, Benjamin J.; Pereira-Smith, Olivia M.; Misteli, Tom			Regulation of Alternative Splicing by Histone Modifications	SCIENCE			English	Article							BINDING; EXON; TRANSCRIPTION; RECOGNITION; PTB	Alternative splicing of pre-mRNA is a prominent mechanism to generate protein diversity, yet its regulation is poorly understood. We demonstrated a direct role for histone modifications in alternative splicing. We found distinctive histone modification signatures that correlate with the splicing outcome in a set of human genes, and modulation of histone modifications causes splice site switching. Histone marks affect splicing outcome by influencing the recruitment of splicing regulators via a chromatin-binding protein. These results outline an adaptor system for the reading of histone marks by the pre-mRNA splicing machinery.	[Luco, Reini F.; Misteli, Tom] NCI, NIH, Bethesda, MD 20892 USA; [Pan, Qun; Blencowe, Benjamin J.] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Tominaga, Kaoru; Pereira-Smith, Olivia M.] Univ Texas Hlth Sci Ctr San Antonio, Barshop Inst Longev & Aging Studies, Dept Cellular & Struct Biol, San Antonio, TX 78245 USA	National Institutes of Health (NIH) - USA; NIH National Cancer Institute (NCI); University of Toronto; University of Texas System; University of Texas Health San Antonio	Misteli, T (corresponding author), NCI, NIH, Bethesda, MD 20892 USA.	mistelit@mail.nih.gov	Tominaga, Kaoru/AAL-4250-2020; Pillay, Nischalan/F-9536-2012; Luco, Reini/E-9855-2018	Tominaga, Kaoru/0000-0001-8799-528X; Luco, Reini/0000-0002-9086-6507	NIH; National Cancer Institute; Center for Cancer Research; National Cancer Institute of Canada; Canadian Institutes of Health Research [MOP-67011]; Genome Canada; NIA/NIH [RO1 AGO32134]; American Heart Association [0765084Y]; NATIONAL CANCER INSTITUTE [ZIABC010309] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG032134] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Center for Cancer Research(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Cancer Institute of Canada(Canadian Cancer Society (CCS)); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); Genome Canada(Genome Canada); NIA/NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	We thank J. Patton, D. Skalnik, B. Strahl, J. Steitz, D. Black, M. Garcia-Blanco, and H. Kimura for reagents; P. Scaffidi for discussions; J. Calarco for validations; C. Misquitta for technical assistance; H. Kosucu and Q. Morris for advice on statistical analysis; and E. Tominaga for cell culture. This research was supported by the Intramural Research Program of NIH, the National Cancer Institute, the Center for Cancer Research (T. M.), grants from the National Cancer Institute of Canada, Canadian Institutes of Health Research (grant MOP-67011) and Genome Canada (administered through the Ontario Genomics Institute) to B. B., NIA/NIH grant RO1 AGO32134 (OMPS) to O.P.S., and American Heart Association grant 0765084Y to K. T. Complete RNA deep-sequencing data are available at the Gene Expression Omnibus (accession no. GSE19373).	Allo M, 2009, NAT STRUCT MOL BIOL, V16, P717, DOI 10.1038/nsmb.1620; Andersson R, 2009, GENOME RES, V19, P1732, DOI 10.1101/gr.092353.109; Batsche E, 2006, NAT STRUCT MOL BIOL, V13, P22, DOI 10.1038/nsmb1030; Blencowe BJ, 2006, CELL, V126, P37, DOI 10.1016/j.cell.2006.06.023; Carstens RP, 2000, MOL CELL BIOL, V20, P7388, DOI 10.1128/MCB.20.19.7388-7400.2000; de la Mata M, 2003, MOL CELL, V12, P525, DOI 10.1016/j.molcel.2003.08.001; Hayakawa T, 2007, GENES CELLS, V12, P811, DOI 10.1111/j.1365-2443.2007.01089.x; Kolasinska-Zwierz P, 2009, NAT GENET, V41, P376, DOI 10.1038/ng.322; Kornblihtt AR, 2004, RNA, V10, P1489, DOI 10.1261/rna.7100104; Loomis RJ, 2009, MOL CELL, V33, P450, DOI 10.1016/j.molcel.2009.02.003; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Munoz MJ, 2009, CELL, V137, P708, DOI 10.1016/j.cell.2009.03.010; Nogues G, 2002, J BIOL CHEM, V277, P43110, DOI 10.1074/jbc.M208418200; Pan Q, 2004, MOL CELL, V16, P929, DOI 10.1016/j.molcel.2004.12.004; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Ray D, 2009, NAT BIOTECHNOL, V27, P667, DOI 10.1038/nbt.1550; Robson-Dixon ND, 2004, J BIOL CHEM, V279, P29075, DOI 10.1074/jbc.M312747200; Schor IE, 2009, P NATL ACAD SCI USA, V106, P4325, DOI 10.1073/pnas.0810666106; Schwartz S, 2009, NAT STRUCT MOL BIOL, V16, P990, DOI 10.1038/nsmb.1659; Sims RJ, 2007, MOL CELL, V28, P665, DOI 10.1016/j.molcel.2007.11.010; Spellman R, 2007, MOL CELL, V27, P420, DOI 10.1016/j.molcel.2007.06.016; Spies N, 2009, MOL CELL, V36, P245, DOI 10.1016/j.molcel.2009.10.008; Tilgner H, 2009, NAT STRUCT MOL BIOL, V16, P996, DOI 10.1038/nsmb.1658; Wagner EJ, 2002, MOL CELL, V10, P943, DOI 10.1016/S1097-2765(02)00645-7; WANG ET, 2008, NATURE, V27, P456; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Warzecha CC, 2009, MOL CELL, V33, P591, DOI 10.1016/j.molcel.2009.01.025; Zhang P, 2006, NUCLEIC ACIDS RES, V34, P6621, DOI 10.1093/nar/gkl989	28	729	754	3	145	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 19	2010	327	5968					996	1000		10.1126/science.1184208	http://dx.doi.org/10.1126/science.1184208			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20133523	Green Accepted			2022-12-01	WOS:000274625800040
J	Deng, HX; Doonan, CJ; Furukawa, H; Ferreira, RB; Towne, J; Knobler, CB; Wang, B; Yaghi, OM				Deng, Hexiang; Doonan, Christian J.; Furukawa, Hiroyasu; Ferreira, Ricardo B.; Towne, John; Knobler, Carolyn B.; Wang, Bo; Yaghi, Omar M.			Multiple Functional Groups of Varying Ratios in Metal-Organic Frameworks	SCIENCE			English	Article							ZEOLITIC IMIDAZOLATE FRAMEWORKS; HYDROGEN STORAGE; CARBON-DIOXIDE; PORE-SIZE; CAPTURE; DESIGN	We show that metal-organic frameworks (MOFs) can incorporate a large number of different functionalities on linking groups in a way that mixes the linker, rather than forming separate domains. We made complex MOFs from 1,4-benzenedicarboxylate (denoted by "A" in this work) and its derivatives -NH2, -Br, -(Cl)(2), -NO2, -(CH3)(2), -C4H4, -(OC3H5)(2), and -(OC7H7)(2) (denoted by "B" to "I," respectively) to synthesize 18 multivariate (MTV) MOF-5 type structures that contain up to eight distinct functionalities in one phase. The backbone (zinc oxide and phenylene units) of these structures is ordered, but the distribution of functional groups is disordered. The complex arrangements of several functional groups within the pores can lead to properties that are not simply linear sums of those of the pure components. For example, a member of this series, MTV-MOF-5-EHI, exhibits up to 400% better selectivity for carbon dioxide over carbon monoxide compared with its best same-link counterparts.	[Deng, Hexiang; Doonan, Christian J.; Furukawa, Hiroyasu; Ferreira, Ricardo B.; Towne, John; Knobler, Carolyn B.; Wang, Bo; Yaghi, Omar M.] Univ Calif Los Angeles, Calif Nanosyst Inst, Dept Energy DOE, Inst Genom & Prote,Dept Chem & Biochem, Los Angeles, CA 90095 USA	United States Department of Energy (DOE); University of California System; University of California Los Angeles	Yaghi, OM (corresponding author), Univ Calif Los Angeles, Calif Nanosyst Inst, Dept Energy DOE, Inst Genom & Prote,Dept Chem & Biochem, 607 Charles E Young Dr E, Los Angeles, CA 90095 USA.	yaghi@chem.ucla.edu	Furukawa, Hiroyasu/C-5910-2008; Deng, Hexiang/N-5616-2017; Doonan, christian/ABG-6033-2020; WANG, BO/D-9762-2012; Barroso Ferreira, Ricardo/A-3679-2010; Yaghi, Omar M/C-6749-2013	Furukawa, Hiroyasu/0000-0002-6082-1738; Deng, Hexiang/0000-0002-9398-7996; WANG, BO/0000-0001-9092-3252; Yaghi, Omar/0000-0002-5611-3325	DOE Office of Basic Energy Sciences [DE-FG02-08ER15935]	DOE Office of Basic Energy Sciences(United States Department of Energy (DOE))	This work was supported by DOE Office of Basic Energy Sciences (grant DE-FG02-08ER15935). We thank F. J. Uribe-Romo and R. Taylor for assistance and helpful discussions. MTV-MOF-5-AC and MTV-MOF-5-ACEF have been deposited into the Cambridge Crystallographic Data Centre (CCDC) under deposition numbers CCDC 747004 to 747007.	Banerjee R, 2008, SCIENCE, V319, P939, DOI 10.1126/science.1152516; Banerjee R, 2009, J AM CHEM SOC, V131, P3875, DOI 10.1021/ja809459e; Burrows AD, 2008, ANGEW CHEM INT EDIT, V47, P8482, DOI 10.1002/anie.200802908; Darling SB, 2007, PROG POLYM SCI, V32, P1152, DOI 10.1016/j.progpolymsci.2007.05.004; Eddaoudi M, 2002, SCIENCE, V295, P469, DOI 10.1126/science.1067208; Garibay SJ, 2009, INORG CHEM, V48, P7341, DOI 10.1021/ic900796n; Kaye SS, 2007, J AM CHEM SOC, V129, P14176, DOI 10.1021/ja076877g; Kitaura R, 2002, ANGEW CHEM INT EDIT, V41, P133, DOI 10.1002/1521-3773(20020104)41:1<133::AID-ANIE133>3.0.CO;2-R; Koh K, 2008, ANGEW CHEM INT EDIT, V47, P677, DOI 10.1002/anie.200705020; Kumazawa K, 2003, ANGEW CHEM INT EDIT, V42, P3909, DOI 10.1002/anie.200351797; Li H, 1999, NATURE, V402, P276, DOI 10.1038/46248; Millward AR, 2005, J AM CHEM SOC, V127, P17998, DOI 10.1021/ja0570032; Rosi NL, 2003, SCIENCE, V300, P1127, DOI 10.1126/science.1083440	13	1365	1407	61	1817	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					846	850		10.1126/science.1181761	http://dx.doi.org/10.1126/science.1181761			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150497				2022-12-01	WOS:000274408300056
J	Newman, DK				Newman, Dianne K.			Feasting on Minerals	SCIENCE			English	Editorial Material							PHOTOTROPHIC FE(II) OXIDATION; IRON; BACTERIA; MICROORGANISMS; OPERON		MIT, Dept Biol, Cambridge, MA 02142 USA	Massachusetts Institute of Technology (MIT)	Newman, DK (corresponding author), MIT, Dept Biol, 77 Massachusetts Ave, Cambridge, MA 02142 USA.	dkn@mit.edu			Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		Auernik KS, 2008, APPL ENVIRON MICROB, V74, P7723, DOI 10.1128/AEM.01545-08; Bathe S, 2007, APPL ENVIRON MICROB, V73, P2491, DOI 10.1128/AEM.02589-06; Blothe M, 2009, APPL ENVIRON MICROB, V75, P468, DOI 10.1128/AEM.01817-08; Chan CS, 2004, SCIENCE, V303, P1656, DOI 10.1126/science.1092098; Croal LR, 2007, J BACTERIOL, V189, P1774, DOI 10.1128/JB.01395-06; Crowe SA, 2008, P NATL ACAD SCI USA, V105, P15938, DOI 10.1073/pnas.0805313105; Druschel GK, 2008, GEOCHIM COSMOCHIM AC, V72, P3358, DOI 10.1016/j.gca.2008.04.035; Jerez CA, 2009, SOIL BIOL, V17, P239, DOI 10.1007/978-3-540-89621-0_13; Jiao Y, 2007, J BACTERIOL, V189, P1765, DOI 10.1128/JB.00776-06; Miot J, 2009, APPL ENVIRON MICROB, V75, P5586, DOI 10.1128/AEM.00490-09; Miot J, 2009, GEOCHIM COSMOCHIM AC, V73, P696, DOI 10.1016/j.gca.2008.10.033; Poulain AJ, 2009, APPL ENVIRON MICROB, V75, P6639, DOI 10.1128/AEM.00054-09; Quatrini R, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-394; Shapiro L, 2009, SCIENCE, V326, P1225, DOI 10.1126/science.1175685; Shi L, 2007, MOL MICROBIOL, V65, P12, DOI 10.1111/j.1365-2958.2007.05783.x; Singer SW, 2008, APPL ENVIRON MICROB, V74, P4454, DOI 10.1128/AEM.02799-07; TEMPLE KL, 1951, J BACTERIOL, V62, P605, DOI 10.1128/JB.62.5.605-611.1951; Toner BM, 2009, GEOCHIM COSMOCHIM AC, V73, P388, DOI 10.1016/j.gca.2008.09.035; Weber KA, 2006, NAT REV MICROBIOL, V4, P752, DOI 10.1038/nrmicro1490; Weiss JV, 2007, GEOMICROBIOL J, V24, P559, DOI 10.1080/01490450701670152; Wilmes P, 2009, ISME J, V3, P266, DOI 10.1038/ismej.2008.90	21	16	17	0	32	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					793	794		10.1126/science.1184229	http://dx.doi.org/10.1126/science.1184229			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150475				2022-12-01	WOS:000274408300031
J	Karim, SA; Karim, QA				Karim, Salim Abdool; Karim, Quarraisha Abdool			AIDS research must link to local policy	NATURE			English	Editorial Material									[Karim, Salim Abdool] Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4013 Congella, South Africa; [Karim, Quarraisha Abdool] Columbia Univ, Dept Epidemiol, New York, NY 10032 USA	University of Kwazulu Natal; Columbia University	Karim, SA (corresponding author), Univ KwaZulu Natal, Ctr AIDS Programme Res S Africa, ZA-4013 Congella, South Africa.	caprisa@ukzn.ac.za	Karim, Salim Abdool/AAE-7118-2019; Abdool Karim, Quarraisha/GVS-1160-2022; Karim, Salim Abdool/P-3117-2019; Karim, Salim Safurdeen Abdool/N-5947-2013	Abdool Karim, Quarraisha/0000-0002-0985-477X; Karim, Salim Abdool/0000-0002-4986-2133; Karim, Salim Safurdeen Abdool/0000-0002-4986-2133					0	9	9	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 11	2010	463	7282					733	734		10.1038/463733a	http://dx.doi.org/10.1038/463733a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	553VG	20148015				2022-12-01	WOS:000274394300016
J	Chopra, V; Eagle, KA				Chopra, Vineet; Eagle, Kim A.			Perioperative beta-Blockers for Cardiac Risk Reduction Time for Clarity	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							NONCARDIAC SURGERY		[Chopra, Vineet; Eagle, Kim A.] Univ Michigan Hlth Syst, Div Gen Internal Med, Ann Arbor, MI USA; [Eagle, Kim A.] Univ Michigan Hlth Syst, Div Cardiovasc Med, Ann Arbor, MI USA	University of Michigan System; University of Michigan; University of Michigan System; University of Michigan	Chopra, V (corresponding author), 3119 Taubman Hlth Ctr,1500 E Med Ctr Dr,SPC 5376, Ann Arbor, MI 48104 USA.	vineetc@med.umich.edu		Chopra, Vineet/0000-0001-8670-9376				American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines, 2009, J Am Coll Cardiol, V54, P2102, DOI 10.1016/j.jacc.2009.07.004; Bangalore S, 2008, LANCET, V372, P1962, DOI 10.1016/S0140-6736(08)61560-3; CARDIAC CMS, MEASURES SURG CARE I; Chopra V, 2009, AM J MED, V122, P222, DOI 10.1016/j.amjmed.2008.11.004; Devereaux PJ, 2008, LANCET, V371, P1839, DOI 10.1016/S0140-6736(08)60601-7; Dunkelgrun M, 2009, ANN SURG, V249, P921, DOI 10.1097/SLA.0b013e3181a77d00; Mangano DT, 1996, NEW ENGL J MED, V335, P1713, DOI 10.1056/NEJM199612053352301; Poldermans D, 2001, EUR HEART J, V22, P1353, DOI 10.1053/euhj.2000.2555; Poldermans D, 2009, ANESTHESIOLOGY, V111, P940, DOI 10.1097/ALN.0b013e3181ba3bf4; Zaman AG, 2000, ATHEROSCLEROSIS, V149, P251, DOI 10.1016/S0021-9150(99)00479-7	10	5	6	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					551	552		10.1001/jama.2010.68	http://dx.doi.org/10.1001/jama.2010.68			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145232				2022-12-01	WOS:000274378700027
J	Alcock, F; Clements, A; Webb, C; Lithgow, T				Alcock, Felicity; Clements, Abigail; Webb, Chaille; Lithgow, Trevor			Tinkering Inside the Organelle	SCIENCE			English	Editorial Material							MITOCHONDRIAL; EVOLUTION; PROTEIN; IMPORT; ORIGIN; TRANSLOCASE; EUKARYOTES; MEMBRANE		[Alcock, Felicity; Clements, Abigail; Webb, Chaille; Lithgow, Trevor] Monash Univ, Dept Biochem & Mol Biol, Melbourne, Vic 3800, Australia	Monash University	Alcock, F (corresponding author), Monash Univ, Dept Biochem & Mol Biol, Clayton Campus, Melbourne, Vic 3800, Australia.	trevor.lithgow@med.monash.edu.au	Lithgow, Trevor J/H-5925-2017; Alcock, Felicity/T-4073-2019	Lithgow, Trevor J/0000-0002-0102-7884; Alcock, Felicity/0000-0002-3983-6097; Clements, Abigail/0000-0003-2285-777X				BAKER A, 1987, P NATL ACAD SCI USA, V84, P3117, DOI 10.1073/pnas.84.10.3117; BOORSTEIN WR, 1994, J MOL EVOL, V38, P1; Cavalier-Smith T, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-19; Cavalier-Smith T, 2006, P ROY SOC B-BIOL SCI, V273, P1943, DOI 10.1098/rspb.2006.3531; Clements A, 2009, P NATL ACAD SCI USA, V106, P15791, DOI 10.1073/pnas.0908264106; Dolezal P, 2006, SCIENCE, V313, P314, DOI 10.1126/science.1127895; Gross J, 2009, NAT REV GENET, V10, P495, DOI 10.1038/nrg2610; Haferkamp I, 2002, EUR J BIOCHEM, V269, P3172, DOI 10.1046/j.1432-1033.2002.02991.x; Herrmann JM, 2003, TRENDS MICROBIOL, V11, P74, DOI 10.1016/S0966-842X(02)00033-1; JACOB F, 1977, SCIENCE, V196, P1161, DOI 10.1126/science.860134; Kurland CG, 2000, MICROBIOL MOL BIOL R, V64, P786, DOI 10.1128/MMBR.64.4.786-820.2000; Lucattini R, 2004, MOL BIOL EVOL, V21, P652, DOI 10.1093/molbev/msh058; Mokranjac D, 2003, EMBO J, V22, P4945, DOI 10.1093/emboj/cdg485; Rassow J, 1999, J MOL BIOL, V286, P105, DOI 10.1006/jmbi.1998.2455; Williams BAP, 2008, J MOL BIOL, V375, P1249, DOI 10.1016/j.jmb.2007.11.005; Zimmer C, 2009, SCIENCE, V325, P666, DOI 10.1126/science.325_666	16	36	37	1	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 5	2010	327	5966					649	650		10.1126/science.1182129	http://dx.doi.org/10.1126/science.1182129			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133559				2022-12-01	WOS:000274251800023
J	Bai, F; Branch, RW; Nicolau, DV; Pilizota, T; Steel, BC; Maini, PK; Berry, RM				Bai, Fan; Branch, Richard W.; Nicolau, Dan V., Jr.; Pilizota, Teuta; Steel, Bradley C.; Maini, Philip K.; Berry, Richard M.			Conformational Spread as a Mechanism for Cooperativity in the Bacterial Flagellar Switch	SCIENCE			English	Article							TORQUE-GENERATING UNITS; RESPONSE REGULATOR CHEY; ESCHERICHIA-COLI; ALLOSTERIC MECHANISMS; MOTOR; CHEMOTAXIS; PROTEINS; ROTATION; BINDING; COMPLEX	The bacterial flagellar switch that controls the direction of flagellar rotation during chemotaxis has a highly cooperative response. This has previously been understood in terms of the classic two-state, concerted model of allosteric regulation. Here, we used high-resolution optical microscopy to observe switching of single motors and uncover the stochastic multistate nature of the switch. Our observations are in detailed quantitative agreement with a recent general model of allosteric cooperativity that exhibits conformational spread-the stochastic growth and shrinkage of domains of adjacent subunits sharing a particular conformational state. We expect that conformational spread will be important in explaining cooperativity in other large signaling complexes.	[Bai, Fan; Branch, Richard W.; Pilizota, Teuta; Steel, Bradley C.; Berry, Richard M.] Univ Oxford, Dept Phys, Clarendon Lab, Oxford OX1 3PU, England; [Bai, Fan] Osaka Univ, Grad Sch Frontier Biosci, Nanobiol Labs, Suita, Osaka 5650871, Japan; [Nicolau, Dan V., Jr.; Maini, Philip K.] Univ Oxford, Inst Math, Ctr Math Biol, Oxford OX1 3LB, England; [Nicolau, Dan V., Jr.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94708 USA; [Pilizota, Teuta] Princeton Univ, Carl Icahn Lab, Princeton, NJ 08644 USA; [Maini, Philip K.] Univ Oxford, Dept Biochem, Oxford Ctr Integrat Syst Biol, Oxford OX1 3QU, England	University of Oxford; Osaka University; University of Oxford; University of California System; University of California Berkeley; Princeton University; University of Oxford	Berry, RM (corresponding author), Univ Oxford, Dept Phys, Clarendon Lab, Parks Rd, Oxford OX1 3PU, England.	r.berry1@physics.ox.ac.uk		Bai, Fan/0000-0001-6119-8936; Nicolau, Dan V/0000-0002-9956-0600; Pilizota, Teuta/0000-0002-2156-0221	European Research; European Molecular Biology Organisation; Balliol College; Oxford University; Royal Society; Engineering and Physical Sciences Research Council; Biotechnology and Biological Sciences Research Council [BB/H01991X/1, BB/E00458X/1] Funding Source: researchfish; BBSRC [BB/H01991X/1, BB/E00458X/1] Funding Source: UKRI	European Research(European Research Council (ERC)); European Molecular Biology Organisation; Balliol College; Oxford University; Royal Society(Royal Society of London); Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	Special thanks to T. Duke and I. Graham for introducing the conformational spread model to us. We also thank H. C. Berg and K. Fahrner for the gift of strain KAF 84 and KAF 95. The research of F. B., T. P. and R. M. B. was supported by the European Research Grant NANOMOT (Synthetic Biomimetic Nanoengines: A Modular Platform for Engineering of Nanomechanical Actuator Building Blocks), that of B. C. S. by a fellowship from the European Molecular Biology Organisation, that of D.V.N. by the Devorguilla Scholarship from Balliol College and the Clarendon Scholarship from Oxford University, that of P. K. M. partially by a Royal Society Wolfson Research Merit Award, and that of R. W. B. by the Engineering and Physical Sciences Research Council. F. B. also thanks Y. Zhang for help with the analysis program.	Alon U, 1998, EMBO J, V17, P4238, DOI 10.1093/emboj/17.15.4238; BLOCK SM, 1989, NATURE, V338, P514, DOI 10.1038/338514a0; BLOCK SM, 1983, J BACTERIOL, V154, P312, DOI 10.1128/JB.154.1.312-323.1983; Bray D, 2004, ANNU REV BIOPH BIOM, V33, P53, DOI 10.1146/annurev.biophys.33.110502.132703; Bray D, 2002, P NATL ACAD SCI USA, V99, P7, DOI 10.1073/pnas.022641699; Changeux JP, 2005, SCIENCE, V308, P1424, DOI 10.1126/science.1108595; Cluzel P, 2000, SCIENCE, V287, P1652, DOI 10.1126/science.287.5458.1652; Duke TAJ, 1999, P NATL ACAD SCI USA, V96, P10104, DOI 10.1073/pnas.96.18.10104; Duke TAJ, 2001, J MOL BIOL, V308, P541, DOI 10.1006/jmbi.2001.4610; Dyer CM, 2009, J MOL BIOL, V388, P71, DOI 10.1016/j.jmb.2009.02.004; EIGEN M, 1967, Nobel Symposium, V5, P333; Hilser VJ, 2007, P NATL ACAD SCI USA, V104, P8311, DOI 10.1073/pnas.0700329104; Karpen JW, 2002, TRENDS BIOCHEM SCI, V27, P402, DOI 10.1016/S0968-0004(02)02124-2; Korobkova E, 2004, NATURE, V428, P574, DOI 10.1038/nature02404; Korobkova EA, 2006, PHYS REV LETT, V96, DOI 10.1103/PhysRevLett.96.058105; Koshland DE, 2002, J BIOL CHEM, V277, P46841, DOI 10.1074/jbc.R200014200; KOSHLAND DE, 1966, BIOCHEMISTRY-US, V5, P365, DOI 10.1021/bi00865a047; KUDO S, 1990, NATURE, V346, P677, DOI 10.1038/346677a0; LAPIDUS IR, 1988, J BACTERIOL, V170, P3627, DOI 10.1128/jb.170.8.3627-3632.1988; MONOD J, 1965, J MOL BIOL, V12, P88, DOI 10.1016/S0022-2836(65)80285-6; Park SY, 2006, P NATL ACAD SCI USA, V103, P11886, DOI 10.1073/pnas.0602811103; Pilizota T, 2007, BIOPHYS J, V93, P264, DOI 10.1529/biophysj.106.091074; Reid SW, 2006, P NATL ACAD SCI USA, V103, P8066, DOI 10.1073/pnas.0509932103; Ryu WS, 2000, NATURE, V403, P444, DOI 10.1038/35000233; Sagi Y, 2003, J BIOL CHEM, V278, P25867, DOI 10.1074/jbc.M303201200; Scharf BE, 1998, P NATL ACAD SCI USA, V95, P201, DOI 10.1073/pnas.95.1.201; Sourjik V, 2002, P NATL ACAD SCI USA, V99, P12669, DOI 10.1073/pnas.192463199; Sowa Y, 2005, NATURE, V437, P916, DOI 10.1038/nature04003; Sowa Y, 2008, Q REV BIOPHYS, V41, P103, DOI 10.1017/S0033583508004691; Stryer L., 1999, BIOCHEMISTRY; Tumer L, 1996, BIOPHYS J, V71, P2227, DOI 10.1016/S0006-3495(96)79425-0; van Albada SB, 2009, MOL SYST BIOL, V5, DOI 10.1038/msb.2009.74; Van Way SM, 2004, J BACTERIOL, V186, P3173, DOI 10.1128/JB.186.10.3173-3181.2004; Viappiani C, 2004, P NATL ACAD SCI USA, V101, P14414, DOI 10.1073/pnas.0405987101; Yuan JH, 2009, J MOL BIOL, V390, P394, DOI 10.1016/j.jmb.2009.05.039	35	145	145	1	35	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					685	689		10.1126/science.1182105	http://dx.doi.org/10.1126/science.1182105			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133571	Green Published			2022-12-01	WOS:000274251800037
J	Spitzweck, B; Brankatschk, M; Dickson, BJ				Spitzweck, Bettina; Brankatschk, Marko; Dickson, Barry J.			Distinct Protein Domains and Expression Patterns Confer Divergent Axon Guidance Functions for Drosophila Robo Receptors	CELL			English	Article							LONG-RANGE GUIDANCE; ROUNDABOUT RECEPTOR; COMMISSURAL AXONS; CNS MIDLINE; LATERAL POSITION; GENETIC-ANALYSIS; SLIT; REPULSION; ROLES; RAC	The orthogonal array of axon pathways in the Drosophila CNS is constructed in part under the control of three Robo family axon guidance receptors: Robo1, Robo2 and Robo3. Each of these receptors is responsible for a distinct set of guidance decisions. To determine the molecular basis for these functional specializations, we used homologous recombination to create a series of 9 "robo swap'' alleles: expressing each of the three Robo receptors from each of the three robo loci. We demonstrate that the lateral positioning of longitudinal axon pathways relies primarily on differences in gene regulation, not distinct combinations of Robo proteins as previously thought. In contrast, specific features of the Robo1 and Robo2 proteins contribute to their distinct functions in commissure formation. These specializations allow Robo1 to prevent crossing and Robo2 to promote crossing. These data demonstrate how diversification of expression and structure within a single family of guidance receptors can shape complex patterns of neuronal wiring.	[Spitzweck, Bettina; Brankatschk, Marko; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Dickson, BJ (corresponding author), Res Inst Mol Pathol, Dr Bohr Gasse 7, A-1030 Vienna, Austria.	dickson@imp.ac.at		Brankatschk, Marko/0000-0001-5274-4552; Dickson, Barry/0000-0003-0715-892X	Austrian Science Fund; Boehringer Ingelheim GmbH	Austrian Science Fund(Austrian Science Fund (FWF)); Boehringer Ingelheim GmbH(Boehringer Ingelheim)	We thank Greg Bashaw for communicating unpublished data, Martin Hasemeyer and Carlos Ribeiro for their critical review of the manuscript, and Ruth Fuchs for technical assistance. This work was supported in part by a grant from the Austrian Science Fund. Basic research at the IMP is sponsored by Boehringer Ingelheim GmbH.	Bashaw GJ, 2000, CELL, V101, P703, DOI 10.1016/S0092-8674(00)80883-1; Bonkowsky JL, 1999, NATURE, V402, P540, DOI 10.1038/990122; Brankatschk M, 2006, NAT NEUROSCI, V9, P188, DOI 10.1038/nn1625; Brose K, 1999, CELL, V96, P795, DOI 10.1016/S0092-8674(00)80590-5; Dickson BJ, 2006, ANNU REV CELL DEV BI, V22, P651, DOI 10.1146/annurev.cellbio.21.090704.151234; Dickson BJ, 2002, SCIENCE, V298, P1959, DOI 10.1126/science.1072165; Englund C, 2002, DEVELOPMENT, V129, P4941; Fan XP, 2003, NEURON, V40, P113, DOI 10.1016/S0896-6273(03)00591-9; Goodhill GJ, 2003, NEURAL COMPUT, V15, P549, DOI 10.1162/089976603321192077; GOODMAN CS, 1984, SCI AM, V251, P58, DOI 10.1038/scientificamerican1284-58; Groth AC, 2004, GENETICS, V166, P1775, DOI 10.1534/genetics.166.4.1775; Harris R, 1996, NEURON, V17, P217, DOI 10.1016/S0896-6273(00)80154-3; Hivert B, 2002, MOL CELL NEUROSCI, V21, P534, DOI 10.1006/mcne.2002.1193; Howitt JA, 2004, EMBO J, V23, P4406, DOI 10.1038/sj.emboj.7600446; Hu HL, 2005, P NATL ACAD SCI USA, V102, P4613, DOI 10.1073/pnas.0409325102; Keleman K, 2005, NAT NEUROSCI, V8, P156, DOI 10.1038/nn1388; Keleman K, 2002, CELL, V110, P415, DOI 10.1016/S0092-8674(02)00901-7; Kidd T, 1999, CELL, V96, P785, DOI 10.1016/S0092-8674(00)80589-9; Kidd T, 1998, CELL, V92, P205, DOI 10.1016/S0092-8674(00)80915-0; Kolodziej PA, 1996, CELL, V87, P197, DOI 10.1016/S0092-8674(00)81338-0; LIN DM, 1994, NEURON, V13, P1055, DOI 10.1016/0896-6273(94)90045-0; Lundstrom A, 2004, GENE DEV, V18, P2161, DOI 10.1101/gad.310204; Mitchell KJ, 1996, NEURON, V17, P203, DOI 10.1016/S0896-6273(00)80153-1; Myat A, 2002, NEURON, V35, P447, DOI 10.1016/S0896-6273(02)00795-X; Newsome TP, 2000, DEVELOPMENT, V127, P851; PATEL NH, 1994, DROSOPHILA MELANOGAS, P445; Rajagopalan S, 2000, CELL, V103, P1033, DOI 10.1016/S0092-8674(00)00207-5; Rajagopalan S, 2000, NEURON, V28, P767, DOI 10.1016/S0896-6273(00)00152-5; Rong YS, 2000, SCIENCE, V288, P2013, DOI 10.1126/science.288.5473.2013; Sabatier C, 2004, CELL, V117, P157, DOI 10.1016/S0092-8674(04)00303-4; SEEGER M, 1993, NEURON, V10, P409, DOI 10.1016/0896-6273(93)90330-T; Simpson JH, 2000, CELL, V103, P1019, DOI 10.1016/S0092-8674(00)00206-3; Simpson JH, 2000, NEURON, V28, P753, DOI 10.1016/S0896-6273(00)00151-3; Stein E, 2001, SCIENCE, V291, P1928, DOI 10.1126/science.1058445; TessierLavigne M, 1996, SCIENCE, V274, P1123, DOI 10.1126/science.274.5290.1123; VANVACTOR D, 1993, CELL, V73, P1137, DOI 10.1016/0092-8674(93)90643-5; Yang L, 2006, NEURON, V52, P595, DOI 10.1016/j.neuron.2006.09.039; Yu TW, 2001, NAT NEUROSCI, V4, P1169, DOI 10.1038/nn748	38	76	76	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					409	U158		10.1016/j.cell.2010.01.002	http://dx.doi.org/10.1016/j.cell.2010.01.002			15	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144763	Bronze			2022-12-01	WOS:000274297700018
J	Pomerantz, RT; O'Donnell, M				Pomerantz, Richard T.; O'Donnell, Mike			Direct Restart of a Replication Fork Stalled by a Head-On RNA Polymerase	SCIENCE			English	Article							REPAIR COUPLING FACTOR; DNA-REPLICATION; TRANSCRIPTION; STRAND; COMPLEXES; CONFLICTS; REVEALS; BINDING	In vivo studies suggest that replication forks are arrested by encounters with head-on transcription complexes. Yet, the fate of the replisome and RNA polymerase (RNAP) after a head-on collision is unknown. We found that the Escherichia coli replisome stalls upon collision with a head-on transcription complex, but instead of collapsing, the replication fork remains highly stable and eventually resumes elongation after displacing the RNAP from DNA. We also found that the transcription-repair coupling factor Mfd promotes direct restart of the fork after the collision by facilitating displacement of the RNAP. These findings demonstrate the intrinsic stability of the replication apparatus and a previously unknown role for the transcription-coupled repair pathway in promoting replication past a RNAP block.	[Pomerantz, Richard T.; O'Donnell, Mike] Rockefeller Univ, Howard Hughes Med Inst, New York, NY 10021 USA	Howard Hughes Medical Institute; Rockefeller University	O'Donnell, M (corresponding author), Rockefeller Univ, Howard Hughes Med Inst, 1230 York Ave, New York, NY 10021 USA.	odonnell@mail.rockefeller.edu		O'Donnell, Michael/0000-0001-9002-4214	NIH; Marie-Josee and Henry Kravis Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM038839] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Marie-Josee and Henry Kravis Fellowship; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to S. Darst for providing RNAP and Mfd proteins and expression vectors. We also thank S. Borukhov for providing GreB and D. Zhang for technical support. This work was supported by a grant from the NIH (M. O. D.) and by a Marie-Josee and Henry Kravis Fellowship at the Rockefeller University (R. T. P.).	Bidnenko V, 2002, EMBO J, V21, P3898, DOI 10.1093/emboj/cdf369; Deaconescu AM, 2006, CELL, V124, P507, DOI 10.1016/j.cell.2005.11.045; GEORGE DL, 1974, MOL GEN GENET, V133, P283, DOI 10.1007/BF00332704; HANAWALT PC, 1994, SCIENCE, V266, P1957, DOI 10.1126/science.7801121; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Heller RC, 2006, NATURE, V439, P557, DOI 10.1038/nature04329; HINKLE DC, 1972, J MOL BIOL, V70, P197, DOI 10.1016/0022-2836(72)90533-5; Kaplan DL, 2004, MOL CELL, V15, P453, DOI 10.1016/j.molcel.2004.06.039; Labib K, 2007, EMBO REP, V8, P346, DOI 10.1038/sj.embor.7400940; LIU B, 1995, SCIENCE, V267, P1131, DOI 10.1126/science.7855590; McGlynn P, 2000, CELL, V101, P35, DOI 10.1016/S0092-8674(00)80621-2; McGlynn P, 2008, J MOL BIOL, V381, P249, DOI 10.1016/j.jmb.2008.05.053; Park JS, 2002, CELL, V109, P757, DOI 10.1016/S0092-8674(02)00769-9; Pomerantz RT, 2007, TRENDS MICROBIOL, V15, P156, DOI 10.1016/j.tim.2007.02.007; Pomerantz RT, 2008, NATURE, V456, P762, DOI 10.1038/nature07527; Rudolph CJ, 2007, DNA REPAIR, V6, P981, DOI 10.1016/j.dnarep.2007.02.017; SELBY CP, 1995, J BIOL CHEM, V270, P4882, DOI 10.1074/jbc.270.9.4882; Trautinger BW, 2005, MOL CELL, V19, P247, DOI 10.1016/j.molcel.2005.06.004; Vilette D, 1996, MOL GEN GENET, V252, P398, DOI 10.1007/BF02173004; Yuzhakov A, 1996, CELL, V86, P877, DOI 10.1016/S0092-8674(00)80163-4	20	118	119	0	10	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					590	592		10.1126/science.1179595	http://dx.doi.org/10.1126/science.1179595			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110508	Green Accepted			2022-12-01	WOS:000274020500041
J	Cruciat, CM; Ohkawara, B; Acebron, SP; Karaulanov, E; Reinhard, C; Ingelfinger, D; Boutros, M; Niehrs, C				Cruciat, Cristina-Maria; Ohkawara, Bisei; Acebron, Sergio P.; Karaulanov, Emil; Reinhard, Carmen; Ingelfinger, Dierk; Boutros, Michael; Niehrs, Christof			Requirement of Prorenin Receptor and Vacuolar H+-ATPase-Mediated Acidification for Wnt Signaling	SCIENCE			English	Article							(PRO)RENIN RECEPTOR; ACTIVATION; PROTEIN; LRP6; IDENTIFICATION; MEMBRANE; PATHWAY; COMPLEX; KINASE; GENES	Wnt/beta-catenin signaling is important in stem cell biology, embryonic development, and disease, including cancer. However, the mechanism of Wnt signal transmission, notably how the receptors are activated, remains incompletely understood. We found that the prorenin receptor (PRR) is a component of the Wnt receptor complex. PRR functions in a renin-independent manner as an adaptor between Wnt receptors and the vacuolar H+-adenosine triphosphatase (V-ATPase) complex. Moreover, PRR and V-ATPase were required to mediate Wnt signaling during antero-posterior patterning of Xenopus early central nervous system development. The results reveal an unsuspected role for the prorenin receptor, V-ATPase activity, and acidification during Wnt/beta-catenin signaling.	[Cruciat, Cristina-Maria; Ohkawara, Bisei; Acebron, Sergio P.; Karaulanov, Emil; Reinhard, Carmen; Niehrs, Christof] Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, D-69120 Heidelberg, Germany; [Ingelfinger, Dierk; Boutros, Michael] Deutsch Krebsforschungszentrum, Div Signaling & Funct Genom, D-69120 Heidelberg, Germany; [Ingelfinger, Dierk; Boutros, Michael] Heidelberg Univ, D-69120 Heidelberg, Germany	Helmholtz Association; German Cancer Research Center (DKFZ); Helmholtz Association; German Cancer Research Center (DKFZ); Ruprecht Karls University Heidelberg	Niehrs, C (corresponding author), Deutsch Krebsforschungszentrum, DKFZ ZMBH Alliance, Div Mol Embryol, Neuenheimer Feld 280, D-69120 Heidelberg, Germany.	niehrs@dkfz-heidelberg.de	Boutros, Michael/C-3566-2008	Boutros, Michael/0000-0002-9458-817X; Ohkawara, Bisei/0000-0002-1987-458X	Deutsche Forschungsgemeinschaft; European Commission; Gobierno Vasco	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); European Commission(European CommissionEuropean Commission Joint Research Centre); Gobierno Vasco(Basque Government)	We thank H. Clevers, R. Grosschedl, X. He, R. Moon, J. Nathans, R. Nusse, M. Levin, G. Miesenbock, Y. M. Chan, M. A. Skinner, and M. Lorizate for reagents; Y. L. Huang for confocal microscopy; A. Glinka for recombinant Wnt3a-V5; and T. Buchling and K. Bartscherer for sharing data before publication and discussion. This work was supported by the Deutsche Forschungsgemeinschaft and the European Commission (Endotrack and Marie-Curie Program). S. P. A. is a recipient of a fellowship from Gobierno Vasco.	Amsterdam A, 2004, P NATL ACAD SCI USA, V101, P12792, DOI 10.1073/pnas.0403929101; Beyenbach KW, 2006, J EXP BIOL, V209, P577, DOI 10.1242/jeb.02014; Bilic J, 2007, SCIENCE, V316, P1619, DOI 10.1126/science.1137065; Blitzer JT, 2006, BMC CELL BIOL, V7, DOI 10.1186/1471-2121-7-28; Campbell DJ, 2008, HYPERTENSION, V51, P1259, DOI 10.1161/HYPERTENSIONAHA.108.110924; Clevers H, 2006, CELL, V127, P469, DOI 10.1016/j.cell.2006.10.018; Contrepas A, 2009, AM J PHYSIOL-REG I, V297, pR250, DOI 10.1152/ajpregu.90832.2008; Davidson G, 2005, NATURE, V438, P867, DOI 10.1038/nature04170; Forgac M, 2007, NAT REV MOL CELL BIO, V8, P917, DOI 10.1038/nrm2272; George A, 2007, NEUROBIOL DIS, V26, P125, DOI 10.1016/j.nbd.2006.12.004; Huang Y, 2007, KIDNEY INT, V72, P45, DOI 10.1038/sj.ki.5002243; Kiecker C, 2001, DEVELOPMENT, V128, P4189; Korinek V, 1997, SCIENCE, V275, P1784, DOI 10.1126/science.275.5307.1784; Logan CY, 2004, ANNU REV CELL DEV BI, V20, P781, DOI 10.1146/annurev.cellbio.20.010403.113126; Lu M, 2002, J BIOL CHEM, V277, P38409, DOI 10.1074/jbc.M203521200; Ludwig J, 1998, J BIOL CHEM, V273, P10939, DOI 10.1074/jbc.273.18.10939; Mao JH, 2001, MOL CELL, V7, P801, DOI 10.1016/S1097-2765(01)00224-6; Marshansky V, 2008, CURR OPIN CELL BIOL, V20, P415, DOI 10.1016/j.ceb.2008.03.015; McGrew LL, 1999, MECH DEVELOP, V87, P21, DOI 10.1016/S0925-4773(99)00136-7; MCMAHON AP, 1992, CELL, V69, P581, DOI 10.1016/0092-8674(92)90222-X; Miesenbock G, 1998, NATURE, V394, P192, DOI 10.1038/28190; Moon RT, 2004, NAT REV GENET, V5, P689, DOI 10.1038/nrg1427; Nguyen G, 2002, J CLIN INVEST, V109, P1417, DOI 10.1172/JCI200214276; Polakis P, 2000, GENE DEV, V14, P1837; Ramser J, 2005, HUM MOL GENET, V14, P1019, DOI 10.1093/hmg/ddi094; Sakoda M, 2007, HYPERTENS RES, V30, P1139, DOI 10.1291/hypres.30.1139; Saris JJ, 2006, HYPERTENSION, V48, P564, DOI 10.1161/01.HYP.0000240064.19301.1b; Simons M, 2009, NAT CELL BIOL, V11, P286, DOI 10.1038/ncb1836; Yamamoto H, 2006, DEV CELL, V11, P213, DOI 10.1016/j.devcel.2006.07.003; Zeng X, 2005, NATURE, V438, P873, DOI 10.1038/nature04185; Zeng X, 2008, DEVELOPMENT, V135, P367, DOI 10.1242/dev.013540	31	416	426	0	42	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					459	463		10.1126/science.1179802	http://dx.doi.org/10.1126/science.1179802			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093472				2022-12-01	WOS:000273783100036
J	Rego, AT; Fronzes, R; Waksman, G				Rego, Ana Toste; Fronzes, Remi; Waksman, Gabriel			SnapShot: Bacterial Appendages II	CELL			English	Editorial Material							SECRETION SYSTEM; NEEDLE		[Rego, Ana Toste; Fronzes, Remi; Waksman, Gabriel] Birkbeck & Univ Coll London, Inst Struct Mol Biol, London WC1E 7HX, England	University of London; Birkbeck University London	Rego, AT (corresponding author), Birkbeck & Univ Coll London, Inst Struct Mol Biol, London WC1E 7HX, England.		Fronzes, Remi/T-2578-2019; Fronzes, Rémi/GLS-0406-2022	Toste Rego, Ana/0000-0002-8584-3386; Fronzes, Remi/0000-0003-3031-9824	Medical Research Council [G0800002] Funding Source: Medline; MRC [G0800002] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Chandran V, 2009, NATURE, V462, P1011, DOI 10.1038/nature08588; Deane JE, 2008, MOL MICROBIOL, V69, P267, DOI 10.1111/j.1365-2958.2008.06293.x; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; Derewenda U, 2004, STRUCTURE, V12, P301, DOI 10.1016/j.str.2004.01.010; Fronzes R, 2009, NAT REV MICROBIOL, V7, P703, DOI 10.1038/nrmicro2218; Fronzes R, 2009, SCIENCE, V323, P266, DOI 10.1126/science.1166101; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; Spreter T, 2009, NAT STRUCT MOL BIOL, V16, P468, DOI 10.1038/nsmb.1603; Yip CK, 2005, NATURE, V435, P702, DOI 10.1038/nature03554; Zarivach R, 2007, NAT STRUCT MOL BIOL, V14, P131, DOI 10.1038/nsmb1196	10	1	1	0	5	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 22	2010	140	2							294.e1	10.1016/j.cell.2010.01.006	http://dx.doi.org/10.1016/j.cell.2010.01.006			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141842	Bronze			2022-12-01	WOS:000273826500019
J	Schaer, BA; Schneider, C; Jick, SS; Conen, D; Osswald, S; Meier, CR				Schaer, Beat A.; Schneider, Cornelia; Jick, Susan S.; Conen, David; Osswald, Stefan; Meier, Christoph R.			Risk for Incident Atrial Fibrillation in Patients Who Receive Antihypertensive Drugs A Nested Case-Control Study	ANNALS OF INTERNAL MEDICINE			English	Article							PRACTICE RESEARCH DATABASE; CONVERTING-ENZYME-INHIBITION; LEFT-VENTRICULAR DYSFUNCTION; II RECEPTOR BLOCKADE; GENERAL-PRACTICE; RANDOMIZED-TRIAL; HEART-FAILURE; PREVENTION; HYPERTENSION; REDUCTION	Background: Different antihypertensive drug classes may alter risk for atrial fibrillation. Some studies suggest that drugs that interfere with the renin-angiotensin system may be favorable because of their effect on atrial remodeling. Objective: To assess and compare the relative risk for incident atrial fibrillation among hypertensive patients who receive antihypertensive drugs from different classes. Design: Nested case-control analysis. Setting: The United Kingdom-based General Practice Research Database, a well-validated primary care database comprising approximately 5 million patient records. Patients: 4661 patients with atrial fibrillation and 18 642 matched control participants from a population of 682 993 patients treated for hypertension. Measurements: A comparison of the risk for atrial fibrillation among hypertensive users of angiotensin-converting enzyme (ACE) inhibitors, angiotensin II-receptor blockers (ARBs), or beta-blockers with the reference group of users of calcium-channel blockers. Patients with clinical risk factors for atrial fibrillation were excluded. Results: Current exclusive long-term therapy with ACE inhibitors (odds ratio [OR], 0.75 [95% CI, 0.65 to 0.87]), ARBs (OR, 0.71 [CI, 0.57 to 0.89]), or beta-blockers (OR, 0.78 [CI, 0.67 to 0.92]) was associated with a lower risk for atrial fibrillation than current exclusive therapy with calcium-channel blockers. Limitation: Blood pressure changes during treatment courses could not be evaluated, and risk for bias by indication cannot be fully excluded in an observational study. Conclusion: In hypertensive patients, long-term receipt of ACE inhibitors, ARBs, or beta-blockers reduces the risk for atrial fibrillation compared with receipt of calcium-channel blockers.	[Meier, Christoph R.] Univ Basel Hosp, Hosp Pharm, CH-4031 Basel, Switzerland; Boston Univ, Med Ctr, Lexington, MA USA	University of Basel; Boston University	Meier, CR (corresponding author), Univ Basel Hosp, Hosp Pharm, Spitalstr 26, CH-4031 Basel, Switzerland.	meierch@uhbs.ch	Osswald, Stefan/A-6904-2018	Osswald, Stefan/0000-0002-9240-6731; Jick, Susan/0000-0002-2215-1067; Schneider, Cornelia/0000-0001-9628-691X				Alsheikh-Ali AA, 2004, AM HEART J, V147, P1061, DOI 10.1016/j.ahj.2003.12.033; Boldt A, 2004, HEART, V90, P400, DOI 10.1136/hrt.2003.015347; Burke TA, 2007, PHARMACOEPIDEM DR S, V16, P979, DOI 10.1002/pds.1444; Dorian P, 2008, EUR HEART J SUPPL, V10, pH11, DOI 10.1093/eurheartj/sun033; Ducharme A, 2006, AM HEART J, V152, P86, DOI 10.1016/j.ahj.2005.06.036; Ehrlich JR, 2006, EUR HEART J, V27, P512, DOI 10.1093/eurheartj/ehi668; Epstein AE, 2002, AM HEART J, V143, P991, DOI 10.1067/mhj.2002.122875; FEINBERG WM, 1995, ARCH INTERN MED, V155, P469, DOI 10.1001/archinte.155.5.469; Gasse C, 2005, THROMB HAEMOSTASIS, V94, P537, DOI 10.1160/TH05-03-0166; Go AS, 2001, JAMA-J AM MED ASSOC, V285, P2370, DOI 10.1001/jama.285.18.2370; Hansson L, 1999, LANCET, V353, P611, DOI 10.1016/S0140-6736(98)05012-0; Hansson L, 1999, LANCET, V354, P1751, DOI 10.1016/S0140-6736(99)10327-1; Healey JS, 2005, J AM COLL CARDIOL, V45, P1832, DOI 10.1016/j.jacc.2004.11.070; Jick H, 1997, LANCET, V350, P1045, DOI 10.1016/S0140-6736(05)70451-7; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; Jick SS, 2003, PHARMACOTHERAPY, V23, P686, DOI 10.1592/phco.23.5.686.32205; Kumagai K, 2003, J AM COLL CARDIOL, V41, P2197, DOI 10.1016/S0735-1097(03)00464-9; L'Allier PL, 2004, J AM COLL CARDIOL, V44, P159, DOI 10.1016/j.jacc.2004.03.056; Lawson DH, 1998, QJM-MON J ASSOC PHYS, V91, P445, DOI 10.1093/qjmed/91.6.445; Maggioni AP, 2005, AM HEART J, V149, P548, DOI 10.1016/j.ahj.2004.09.033; Mitchell GF, 2007, JAMA-J AM MED ASSOC, V297, P709, DOI 10.1001/jama.297.7.709; Okazaki H, 2006, HYPERTENS RES, V29, P277, DOI 10.1291/hypres.29.277; Ruigomez A, 2002, J CLIN EPIDEMIOL, V55, P358, DOI 10.1016/S0895-4356(01)00478-4; Ruigomez Ana, 2005, BMC Cardiovasc Disord, V5, P20, DOI 10.1186/1471-2261-5-20; Schauerte P, 2001, J CARDIOVASC ELECTR, V12, P592, DOI 10.1046/j.1540-8167.2001.00592.x; Schlienger RG, 2004, JAMA-J AM MED ASSOC, V292, P1326, DOI 10.1001/jama.292.11.1326; Schmieder RE, 2008, J HYPERTENS, V26, P403, DOI 10.1097/HJH.0b013e3282f35c67; Turnbull F, 2003, LANCET, V362, P1527; Vermes E, 2003, CIRCULATION, V107, P2926, DOI 10.1161/01.CIR.0000072793.81076.D4; Wachtell K, 2005, J AM COLL CARDIOL, V45, P712, DOI 10.1016/j.jacc.2004.10.068; WOLF PA, 1991, STROKE, V22, P983, DOI 10.1161/01.STR.22.8.983; Wood L, 2004, DRUG SAFETY, V27, P871, DOI 10.2165/00002018-200427120-00004; Yusuf S, 2008, NEW ENGL J MED, V358, P1547, DOI 10.1056/NEJMoa0801317	33	77	85	0	3	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	JAN 19	2010	152	2					78	+		10.7326/0003-4819-152-2-201001190-00005	http://dx.doi.org/10.7326/0003-4819-152-2-201001190-00005			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IE	20083826				2022-12-01	WOS:000273953000002
J	Rehwinkel, J; Sousa, CRE				Rehwinkel, Jan; Reis e Sousa, Caetano			RIGorous Detection: Exposing Virus Through RNA Sensing	SCIENCE			English	Editorial Material							DOUBLE-STRANDED-RNA; RIG-I HELICASE; INNATE IMMUNITY; 5'-TRIPHOSPHATE RNA; RECOGNITION; INTERFERON; INDUCTION; RESPONSES; SENSOR	Virus infection in mammals elicits a variety of defense responses that are initiated by signals from virus-sensing receptors expressed by the host. These receptors include the ubiquitously expressed RIG-I-like receptor (RLR) family of RNA helicases. RLRs are cytoplasmic proteins that act in cell-intrinsic antiviral defense by recognizing RNAs indicative of virus presence. Here, we highlight recent progress in understanding how RLRs discriminate between the RNA content of healthy versus virus-infected cells, functioning as accurate sensors of virus invasion.	[Rehwinkel, Jan; Reis e Sousa, Caetano] Canc Res UK, London Res Inst, Immunobiol Lab, London WC2A 3PX, England	Cancer Research UK	Sousa, CRE (corresponding author), Canc Res UK, London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014; Rehwinkel, Jan/CAG-1436-2022	Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Rehwinkel, Jan/0000-0003-3841-835X	Cancer Research UK Funding Source: Medline	Cancer Research UK(Cancer Research UK)		Ablasser A, 2009, NAT IMMUNOL, V10, P1065, DOI 10.1038/ni.1779; Chiu YH, 2009, CELL, V138, P576, DOI 10.1016/j.cell.2009.06.015; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Knipe D. M., 2007, FIELDS VIROLOGY; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Poeck H, 2010, NAT IMMUNOL, V11, P63, DOI 10.1038/ni.1824; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028	20	131	137	3	12	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					284	286		10.1126/science.1185068	http://dx.doi.org/10.1126/science.1185068			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075242				2022-12-01	WOS:000273629700029
J	Woloshin, S; Schwartz, LM				Woloshin, Steven; Schwartz, Lisa M.			The Benefits and Harms of Mammography Screening Understanding the Trade-offs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-CANCER		VA Outcomes Grp, White River Jct, VT USA; Dartmouth Inst Hlth Policy & Clin Practice, Hanover, NH USA	VA Outcomes Group; Dartmouth College	Schwartz, LM (corresponding author), VA Med Ctr, VA Outcomes Grp 111B, White River Jct, VT 05009 USA.	lisa.schwartz@dartmouth.edu						Calonge N, 2009, ANN INTERN MED, V151, P716, DOI 10.7326/0003-4819-151-10-200911170-00008; Elmore G, 1998, NEW ENGL J MED, V338, P1089, DOI 10.1056/NEJM199804163381601; Esserman L, 2009, JAMA-J AM MED ASSOC, V302, P1685, DOI 10.1001/jama.2009.1498; Gotzsche PC, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001877.pub3; Mandelblatt JS, 2009, ANN INTERN MED, V151, P738, DOI 10.7326/0003-4819-151-10-200911170-00010; PEAR R, 2009, NY TIMES        1203; Schwartz LM, 2007, BRIT MED J, V335, P731, DOI 10.1136/bmj.39350.590625.80; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Schwartz LM, 2004, JAMA-J AM MED ASSOC, V291, P71, DOI 10.1001/jama.291.1.71; Zackrisson S, 2006, BRIT MED J, V332, P689, DOI 10.1136/bmj.38764.572569.7C	10	49	50	0	6	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					164	165		10.1001/jama.2009.2007	http://dx.doi.org/10.1001/jama.2009.2007			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068211				2022-12-01	WOS:000273522600028
J	Bongaarts, J; Pelletier, F; Gerland, P				Bongaarts, John; Pelletier, Francois; Gerland, Patrick			How many more AIDS deaths?	LANCET			English	Editorial Material									[Bongaarts, John] Populat Council, New York, NY 10017 USA; [Pelletier, Francois; Gerland, Patrick] UN, Populat Div, New York, NY 10017 USA	Population Council	Bongaarts, J (corresponding author), Populat Council, New York, NY 10017 USA.	jbongaarts@popcouncil.org	Gerland, Patrick/F-7390-2013	Gerland, Patrick/0000-0002-2082-3122				[Anonymous], 2005, UPDATED PROJECTIONS; BONGAARTS J, INT HDB ADU IN PRESS; Mathers CD, 2006, PLOS MED, V3, DOI 10.1371/journal.pmed.0030442; *UNAIDS, 2004, REP GLOB AIDS EP; *UNAIDS, 2008, AIDS EP UPD DEC 2007; *UNAIDS, 2008, 2008 REP GLOB AIDS E; UNAIDS, 2006, REP GLOB AIDS EP; [United Nations Department of Economics and Social Affairs Population division], 2009, WORLD POP PROSP 2008; World Health Organization, 2020, GLOBAL REPORT EPIDEM	9	6	6	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 9	2010	375	9709					103	104		10.1016/S0140-6736(09)61756-6	http://dx.doi.org/10.1016/S0140-6736(09)61756-6			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	20109872				2022-12-01	WOS:000273664500008
J	Ryan, DP; da Silva, MRD; Soong, TW; Fontaine, B; Donaldson, MR; Kung, AWC; Jongjaroenprasert, W; Liang, MC; Khoo, DHC; Cheah, JS; Ho, SC; Bernstein, HS; Maciel, RMB; Brown, RH; Ptacek, LJ				Ryan, Devon P.; da Silva, Magnus R. Dias; Soong, Tuck Wah; Fontaine, Bertrand; Donaldson, Matt R.; Kung, Annie W. C.; Jongjaroenprasert, Wallaya; Liang, Mui Cheng; Khoo, Daphne H. C.; Cheah, Jin Seng; Ho, Su Chin; Bernstein, Harold S.; Maciel, Rui M. B.; Brown, Robert H., Jr.; Ptacek, Louis J.			Mutations in Potassium Channel Kir2.6 Cause Susceptibility to Thyrotoxic Hypokalemic Periodic Paralysis	CELL			English	Article							RECTIFYING K+ CHANNEL; FUNCTIONAL EXPRESSION; CARDIOMYOCYTES; TRAFFICKING; REVEALS; CLONING	Thyrotoxic hypokalemic periodic paralysis (TPP) is characterized by acute attacks of weakness, hypokalemia, and thyrotoxicosis of various etiologies. These transient attacks resemble those of patients with familial hypokalemic periodic paralysis (hypoKPP) and resolve with treatment of the underlying hyperthyroidism. Because of the phenotypic similarity of these conditions, we hypothesized that TPP might also be a channelopathy. While sequencing candidate genes, we identified a previously unreported gene (not present in human sequence databases) that encodes an inwardly rectifying potassium (Kir) channel, Kir2.6. This channel, nearly identical to Kir2.2, is expressed in skeletal muscle and is transcriptionally regulated by thyroid hormone. Expression of Kir2.6 in mammalian cells revealed normal Kir currents in whole-cell and single-channel recordings. Kir2.6 mutations were present in up to 33% of the unrelated TPP patients in our collection. Some of these mutations clearly alter a variety of Kir2.6 properties, all altering muscle membrane excitability leading to paralysis.	[Ryan, Devon P.; Ptacek, Louis J.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA; [Ryan, Devon P.; da Silva, Magnus R. Dias; Donaldson, Matt R.; Ptacek, Louis J.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94158 USA; [Ptacek, Louis J.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Soong, Tuck Wah] Natl Inst Neurosci, Ion Channel & Transporter Lab, Singapore 308433, Singapore; [Fontaine, Bertrand] Univ Paris 06, INSERM, UMRS 546, F-75013 Paris, France; [Fontaine, Bertrand] Grp Hosp Pitie Salpetriere, AP HP, Ctr Reference Canalopathies Musculaires, F-75013 Paris, France; [Kung, Annie W. C.] Univ Hong Kong, Queen Mary Hosp, Dept Med, Hong Kong, Hong Kong, Peoples R China; [Jongjaroenprasert, Wallaya] Mahidol Univ, Ramathibodi Hosp, Dept Med, Bangkok 10400, Thailand; [Soong, Tuck Wah; Liang, Mui Cheng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 308433, Singapore; [Cheah, Jin Seng] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Med, Singapore 308433, Singapore; [Khoo, Daphne H. C.; Ho, Su Chin] Singapore Gen Hosp, Dept Clin Res, Singapore 169608, Singapore; [Bernstein, Harold S.] Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA; [Maciel, Rui M. B.] Univ Fed Sao Paulo, Div Endocrinol, Dept Med, BR-04039032 Sao Paulo, Brazil; [Brown, Robert H., Jr.] Massachusetts Gen Hosp, Charlestown, MA 02129 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; National Neuroscience Institute (NNI); Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Sorbonne Universite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Pitie-Salpetriere - APHP; UDICE-French Research Universities; Sorbonne Universite; University of Hong Kong; Mahidol University; National University of Singapore; National University of Singapore; Singapore General Hospital; University of California System; University of California San Francisco; Universidade Federal de Sao Paulo (UNIFESP); Harvard University; Massachusetts General Hospital	Ptacek, LJ (corresponding author), Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94158 USA.	ljp@ucsf.edu	da Silva, Magnus R. Dias/AAG-7540-2019; Maciel, Rui M. B./A-9826-2013; da Silva, Magnus R Dias/B-9132-2012; da Silva, Magnus R. Dias/AAO-3942-2020	da Silva, Magnus R. Dias/0000-0002-8516-966X; Maciel, Rui M. B./0000-0002-6123-6098; da Silva, Magnus R Dias/0000-0002-8516-966X; da Silva, Magnus R. Dias/0000-0002-8516-966X; Ryan, Devon/0000-0002-8549-0971; Liang, Mui Cheng/0000-0003-1208-0733; Soong, Tuck Wah/0000-0002-0876-0325	Muscular Dystrophy Association; National Institutes of Health [U54 RR19481]; CAPES Foundation [2284/01-4]; FAPESP (Sao Paulo State Research Foundation) [2000/03442-4, 1999/03688-4]; INSERM; AFM; C.B. Day Foundation; NINDS	Muscular Dystrophy Association(Muscular Dystrophy Association); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); CAPES Foundation(Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES)); FAPESP (Sao Paulo State Research Foundation)(Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP)); INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); AFM(Association Francaise contre les Myopathies); C.B. Day Foundation; NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank Lily Jan, Friederike Haas, and Carol Vandenburg for helpful discussions and advice and all the patients for their participation. We also thank Kathleen Giacomini for additional DNA controls. This work was supported by the Muscular Dystrophy Association, National Institutes of Health grant U54 RR19481, CAPES Foundation grant 2284/01-4 (MRDS), and FAPESP (Sao Paulo State Research Foundation) grants 2000/03442-4 (MRDS) and 1999/03688-4 (RMBM). B. F. is supported by INSERM, AFM, and ANR Maladies Rares and acknowledges patient referral and fruitful discussions of members of the clinical and research French network Resocanaux. R. Brown received generous support from the C.B. Day Foundation and the NINDS L.J.P. is an Investigator of the Howard Hughes Medical Institute.	Abraham MR, 1999, FASEB J, V13, P1901; Bailey JA, 2001, GENOME RES, V11, P1005, DOI 10.1101/gr.GR-1871R; Bassett JHD, 2003, MOL CELL ENDOCRINOL, V213, P1, DOI 10.1016/j.mce.2003.10.033; Bulman DE, 1999, NEUROLOGY, V53, P1932, DOI 10.1212/WNL.53.9.1932; Donaldson MR, 2003, NEUROLOGY, V60, P1811, DOI 10.1212/01.WNL.0000072261.14060.47; Eichler EE, 2004, NAT REV GENET, V5, P345, DOI 10.1038/nrg1322; Hugnot JP, 1997, GENOMICS, V39, P113, DOI 10.1006/geno.1996.4450; Karle CA, 2002, CIRCULATION, V106, P1493, DOI 10.1161/01.CIR.0000029747.53262.5C; Kavok NS, 2001, BMC CELL BIOL, V2, DOI 10.1186/1471-2121-2-5; KELLEY DE, 1989, ARCH INTERN MED, V149, P2597, DOI 10.1001/archinte.149.11.2597; Krapivinsky G, 1998, NEURON, V20, P995, DOI 10.1016/S0896-6273(00)80480-8; Kung AWC, 2006, J CLIN ENDOCR METAB, V91, P2490, DOI 10.1210/jc.2006-0356; KUNG AWC, 2002, OXFORD TXB ENDOCRINO, P427; Le Bouter S, 2003, CIRC RES, V92, P234, DOI 10.1161/01.RES.0000053185.75505.8E; Leonoudakis D, 2004, J BIOL CHEM, V279, P22331, DOI 10.1074/jbc.M400285200; Leonoudakis D, 2004, J BIOL CHEM, V279, P19051, DOI 10.1074/jbc.M400284200; Lin HY, 1999, AM J PHYSIOL-CELL PH, V276, pC1014, DOI 10.1152/ajpcell.1999.276.5.C1014; Lopes CMB, 2002, NEURON, V34, P933, DOI 10.1016/S0896-6273(02)00725-0; Lu Z, 2004, ANNU REV PHYSIOL, V66, P103, DOI 10.1146/annurev.physiol.66.032102.150822; Namba N, 1996, FEBS LETT, V386, P211, DOI 10.1016/0014-5793(96)00445-0; Namba N, 1997, CYTOGENET CELL GENET, V79, P85, DOI 10.1159/000134688; NEMZEK JA, 1994, J AM VET MED ASSOC, V205, P65; Nichols CG, 1997, ANNU REV PHYSIOL, V59, P171, DOI 10.1146/annurev.physiol.59.1.171; Plaster NM, 2001, CELL, V105, P511, DOI 10.1016/S0092-8674(01)00342-7; Preisig-Muller R, 2002, P NATL ACAD SCI USA, V99, P7774, DOI 10.1073/pnas.102609499; PTACEK LJ, 1994, CELL, V77, P863; Ryan DP, 2007, MOL GENETIC BASIS NE, P550; Silva Magnus R Dias da, 2004, Arq Bras Endocrinol Metabol, V48, P196; Soom M, 2001, FEBS LETT, V490, P49, DOI 10.1016/S0014-5793(01)02136-6; TAKAHASHI N, 1994, J BIOL CHEM, V269, P23274; Tinker A, 1996, CELL, V87, P857, DOI 10.1016/S0092-8674(00)81993-5; WIBLE BA, 1995, CIRC RES, V76, P343, DOI 10.1161/01.RES.76.3.343; Zaritsky JJ, 2001, J PHYSIOL-LONDON, V533, P697, DOI 10.1111/j.1469-7793.2001.t01-1-00697.x; Zaritsky JJ, 2000, CIRC RES, V87, P160, DOI 10.1161/01.RES.87.2.160; Zobel C, 2003, J PHYSIOL-LONDON, V550, P365, DOI 10.1113/jphysiol.2002.036400	35	172	185	0	13	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					88	98		10.1016/j.cell.2009.12.024	http://dx.doi.org/10.1016/j.cell.2009.12.024			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20074522	Green Accepted, Green Published, Bronze			2022-12-01	WOS:000273391900017
J	Sarewitz, D				Sarewitz, Daniel			Tomorrow never knows	NATURE			English	Editorial Material									Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA	Arizona State University	Sarewitz, D (corresponding author), Arizona State Univ, Consortium Sci Policy & Outcomes, Washington, DC USA.	dsarewitz@gmail.com						PIELKE RA, 1999, APPL BEHAV SCI REV, V7, P83, DOI DOI 10.1016/S1068-8595(00)80012-4; 2008, NATURE, V453, P268	2	7	7	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 7	2010	463	7277					24	24		10.1038/463024a	http://dx.doi.org/10.1038/463024a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	540OV	20054374	Bronze			2022-12-01	WOS:000273344900011
J	Malebranche, LJ				Malebranche, Lionel J.			A Doctor Heads Home to Haiti	ANNALS OF INTERNAL MEDICINE			English	Editorial Material								A second-year medical resident returned to Haiti, his native country, in the aftermath of the 12 January 2010 earthquake. He witnessed the total devastation of Port-au-Prince, the city of his birth, and great human suffering. He describes the emotional and logistical challenges of providing care to the wounded of this impoverished nation.	[Malebranche, Lionel J.] Christiana Care Hlth Syst, Wilmington, DE USA	Christiana Care Health System	Malebranche, LJ (corresponding author), Dept Internal Med, Christiana Care Hlth Serv, 4755 Ogletown Stanton Rd, Newark, DE 19718 USA.								0	1	1	0	1	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAY 18	2010	152	10					677	678		10.7326/0003-4819-152-10-201005180-00211	http://dx.doi.org/10.7326/0003-4819-152-10-201005180-00211			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	598RJ	20167652				2022-12-01	WOS:000277855500008
J	Roach, JC; Glusman, G; Smit, AFA; Huff, CD; Hubley, R; Shannon, PT; Rowen, L; Pant, KP; Goodman, N; Bamshad, M; Shendure, J; Drmanac, R; Jorde, LB; Hood, L; Galas, DJ				Roach, Jared C.; Glusman, Gustavo; Smit, Arian F. A.; Huff, Chad D.; Hubley, Robert; Shannon, Paul T.; Rowen, Lee; Pant, Krishna P.; Goodman, Nathan; Bamshad, Michael; Shendure, Jay; Drmanac, Radoje; Jorde, Lynn B.; Hood, Leroy; Galas, David J.			Analysis of Genetic Inheritance in a Family Quartet by Whole-Genome Sequencing	SCIENCE			English	Article							MIDDLE AWASH; RECOMBINATION; PLEISTOCENE; NUCLEOTIDE; ETHIOPIA; HUMANS; RATES	We analyzed the whole-genome sequences of a family of four, consisting of two siblings and their parents. Family-based sequencing allowed us to delineate recombination sites precisely, identify 70% of the sequencing errors (resulting in > 99.999% accuracy), and identify very rare single-nucleotide polymorphisms. We also directly estimated a human intergeneration mutation rate of similar to 1.1 x 10(-8) per position per haploid genome. Both offspring in this family have two recessive disorders: Miller syndrome, for which the gene was concurrently identified, and primary ciliary dyskinesia, for which causative genes have been previously identified. Family-based genome analysis enabled us to narrow the candidate genes for both of these Mendelian disorders to only four. Our results demonstrate the value of complete genome sequencing in families.	[Roach, Jared C.; Glusman, Gustavo; Smit, Arian F. A.; Huff, Chad D.; Hubley, Robert; Shannon, Paul T.; Rowen, Lee; Goodman, Nathan; Hood, Leroy; Galas, David J.] Inst Syst Biol, Seattle, WA 98103 USA; [Huff, Chad D.; Jorde, Lynn B.] Univ Utah, Eccles Inst Human Genet, Dept Human Genet, Salt Lake City, UT 84109 USA; [Pant, Krishna P.; Drmanac, Radoje] CGI, Mountain View, CA 94043 USA; [Bamshad, Michael] Univ Washington, Dept Pediat, Seattle, WA 98105 USA; [Shendure, Jay] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA	Institute for Systems Biology (ISB); Utah System of Higher Education; University of Utah; University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle	Hood, L (corresponding author), Inst Syst Biol, Seattle, WA 98103 USA.	lhood@systemsbiology.org; dgalas@systemsbiology.org	Shendure, Jay/AAU-3684-2021	Glusman, Gustavo/0000-0001-8060-5955; Shendure, Jay/0000-0002-1516-1865	University of Luxembourg-Institute for Systems Biology Program; NIH, Center for Systems Biology [GM076547, RO1GM081083, R01HL094976, RZ1HG004749, RC2HG005608, R01HD048895]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD048895] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL094976] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [RC2HG005608, R21HG004749, R01HG002939] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547, R01GM081083] Funding Source: NIH RePORTER	University of Luxembourg-Institute for Systems Biology Program; NIH, Center for Systems Biology(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This study was supported by the University of Luxembourg-Institute for Systems Biology Program and by these NIH grants: Center for Systems Biology GM076547 (L. H. and L. R.), RO1GM081083 (A. F. S. and G. G.), R01HL094976 and RZ1HG004749 (J.S.), RC2HG005608 (M. D. and J.S.), and R01HD048895 (M. B.). H. Tabor assisted with ethical review. J. Xing performed the principal components analysis. H. Mefford performed CNV analysis. A. Bigham and K. Buckingham evaluated candidate genes in unrelated individuals. D. Ballinger, A. Sparks, A. Halpern, and G. Nilsen assisted with sequencing and analysis. R. Bressler, S. Dee, and D. Mauldin assisted with bioinformatics. S. Ng and R. Qiu performed the capture array. S. Bloom obtained the resequencing data on the Illumina Genome Analyzer. M. Janer and S. Li performed Sequenom analysis. D. Cox commented on an early version of the manuscript. R. Durbin and D. Altshuler granted permission for our use of 1000 genomes SNP data. CGI employees (R. D. and K. P.) have stock options in the company. J. S. has consulted for CGI. L. H. is a scientific advisor to CGI and holds stock in the company. The dbGAP accessions can be found at www.ncbi.nlm.nih.gov/projects/gap/cgibin/study. cgi?study_id=phs000244.v1.p1 (accession phs000244. v1.p1).	Abecasis GR, 2002, NAT GENET, V30, P97, DOI 10.1038/ng786; BURGESS R, 1979, MOL BIOL EVOL, V25, P2008; Chen FC, 2001, AM J HUM GENET, V68, P444, DOI 10.1086/318206; CHOI M, 2009, P NATL ACAD SCI USA, V106; Deino AL, 2002, J HUM EVOL, V42, P117, DOI 10.1006/jhev.2001.0521; DONNELLY KP, 1983, THEOR POPUL BIOL, V23, P34, DOI 10.1016/0040-5809(83)90004-7; Drmanac R, 2010, SCIENCE, V327, P78, DOI 10.1126/science.1181498; Haile-Selassie Y, 2004, AM J PHYS ANTHROPOL, V123, P1, DOI 10.1002/ajpa.10330; Haile-Selassie Y, 2004, SCIENCE, V303, P1503, DOI 10.1126/science.1092978; Haile-Selassie Y, 2001, NATURE, V412, P178, DOI 10.1038/35084063; Kondrashov AS, 2003, HUM MUTAT, V21, P12, DOI 10.1002/humu.10147; Kruglyak L, 1996, AM J HUM GENET, V58, P1347; Nachman MW, 2000, GENETICS, V156, P297; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; Ng SB, 2009, NATURE, V461, P272, DOI 10.1038/nature08250; Olbrich H, 2002, NAT GENET, V30, P143, DOI 10.1038/ng817; Petkolv PM, 2007, TRENDS GENET, V23, P539, DOI 10.1016/j.tig.2007.08.015; ROACH JC, 1995, GENOMICS, V26, P345, DOI 10.1016/0888-7543(95)80219-C; TAKAHATA N, 1993, JPN J GENET, V68, P539, DOI 10.1266/jjg.68.539; Wall JD, 2003, GENETICS, V163, P395; WATTERSON GA, 1975, THEOR POPUL BIOL, V7, P256, DOI 10.1016/0040-5809(75)90020-9; Xue YL, 2009, CURR BIOL, V19, P1453, DOI 10.1016/j.cub.2009.07.032; 2005, NATURE, V437, P69	23	720	758	2	106	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 30	2010	328	5978					636	639		10.1126/science.1186802	http://dx.doi.org/10.1126/science.1186802			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	589OJ	20220176	Green Submitted, Green Accepted			2022-12-01	WOS:000277159800048
J	Auerbach, PS; Norris, RL; Menon, AS; Brown, IP; Kuah, S; Schwieger, J; Kinyon, J; Helderman, TN; Lawry, L				Auerbach, Paul S.; Norris, Robert L.; Menon, Anil S.; Brown, Ian P.; Kuah, Solomon; Schwieger, Jennifer; Kinyon, Jeffrey; Helderman, Trina N.; Lawry, Lynn			Civil-Military Collaboration in the Initial Medical Response to the Earthquake in Haiti	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Auerbach, Paul S.; Norris, Robert L.; Menon, Anil S.; Brown, Ian P.] Stanford Univ, Sch Med, Dept Surg, Div Emergency Med, Palo Alto, CA 94304 USA; [Kuah, Solomon; Schwieger, Jennifer; Kinyon, Jeffrey] Columbia Univ, Med Ctr, New York Presbyterian Hosp, Dept Emergency Med, New York, NY USA; [Helderman, Trina N.] Lafayette Emergency Care, Lafayette, IN USA; [Lawry, Lynn] Off Assistant Secretary Def Hlth Affairs, Falls Church, VA USA	Stanford University; Columbia University; NewYork-Presbyterian Hospital	Auerbach, PS (corresponding author), Stanford Univ, Sch Med, Dept Surg, Div Emergency Med, Palo Alto, CA 94304 USA.		Lawry, Lynn/ABE-8391-2021	Lawry, Lynn/0000-0001-8229-8768; Brown, Ian/0000-0003-0656-2621					0	24	27	0	9	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 11	2010	362	10								10.1056/NEJMp1001555	http://dx.doi.org/10.1056/NEJMp1001555			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	566JM	20181962				2022-12-01	WOS:000275365900007
J	Thornton, JA; Kercher, JP; Riedel, TP; Wagner, NL; Cozic, J; Holloway, JS; Dube, WP; Wolfe, GM; Quinn, PK; Middlebrook, AM; Alexander, B; Brown, SS				Thornton, Joel A.; Kercher, James P.; Riedel, Theran P.; Wagner, Nicholas L.; Cozic, Julie; Holloway, John S.; Dube, William P.; Wolfe, Glenn M.; Quinn, Patricia K.; Middlebrook, Ann M.; Alexander, Becky; Brown, Steven S.			A large atomic chlorine source inferred from mid-continental reactive nitrogen chemistry	NATURE			English	Article							SEA-SALT AEROSOL; GASEOUS N2O5; CLNO2; CL; PHOTOCHEMISTRY; EMISSIONS; NITRATE; MODEL	Halogen atoms and oxides are highly reactive and can profoundly affect atmospheric composition. Chlorine atoms can decrease the lifetimes of gaseous elemental mercury(1) and hydrocarbons such as the greenhouse gas methane(2). Chlorine atoms also influence cycles that catalytically destroy or produce tropospheric ozone(3), a greenhouse gas potentially toxic to plant and animal life. Conversion of inorganic chloride into gaseous chlorine atom precursors within the troposphere is generally considered a coastal or marine air phenomenon(4). Here we report mid-continental observations of the chlorine atom precursor nitryl chloride at a distance of 1,400km from the nearest coastline. We observe persistent and significant nitryl chloride production relative to the consumption of its nitrogen oxide precursors. Comparison of these findings to model predictions based on aerosol and precipitation composition data from long-term monitoring networks suggests nitryl chloride production in the contiguous USA alone is at a level similar to previous global estimates for coastal and marine regions(5). We also suggest that a significant fraction of tropospheric chlorine atoms(6) may arise directly from anthropogenic pollutants.	[Thornton, Joel A.; Kercher, James P.; Riedel, Theran P.; Wolfe, Glenn M.; Alexander, Becky] Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA; [Riedel, Theran P.; Wolfe, Glenn M.] Univ Washington, Dept Chem, Seattle, WA 98195 USA; [Wagner, Nicholas L.; Cozic, Julie; Holloway, John S.; Dube, William P.; Middlebrook, Ann M.; Brown, Steven S.] NOAA, Earth Syst Res Lab, Boulder, CO 80305 USA; [Cozic, Julie; Holloway, John S.; Dube, William P.] Cooperat Inst Res Environm Studies, Boulder, CO 80309 USA; [Quinn, Patricia K.] NOAA, Pacific Marine Environm Lab, Seattle, WA 98115 USA	University of Washington; University of Washington Seattle; University of Washington; University of Washington Seattle; National Oceanic Atmospheric Admin (NOAA) - USA; National Oceanic Atmospheric Admin (NOAA) - USA	Thornton, JA (corresponding author), Univ Washington, Dept Atmospher Sci, Seattle, WA 98195 USA.	thornton@atmos.washington.edu	Thornton, Joel A/C-1142-2009; Alexander, Becky/N-7048-2013; Wagner, Nicholas L/E-7437-2010; Cozic, Julie/A-5464-2011; Holloway, John S/F-9911-2012; Dube, William/I-1658-2013; Brown, Steven S/I-1762-2013; Wolfe, Glenn/D-5289-2011; Middlebrook, Ann M/E-4831-2011	Thornton, Joel A/0000-0002-5098-4867; Alexander, Becky/0000-0001-9915-4621; Wagner, Nicholas L/0000-0001-9936-1145; Holloway, John S/0000-0002-4585-9594; Dube, William/0000-0003-1286-4087; Middlebrook, Ann M/0000-0002-2984-6304	NSF [ATM-0633897, ATM-0846183]; NOAA Atmospheric Chemistry and Climate Program; Camille and Henry Dreyfus Foundation; National Research Council; Div Atmospheric & Geospace Sciences [0846183] Funding Source: National Science Foundation	NSF(National Science Foundation (NSF)); NOAA Atmospheric Chemistry and Climate Program; Camille and Henry Dreyfus Foundation; National Research Council; Div Atmospheric & Geospace Sciences(National Science Foundation (NSF)NSF - Directorate for Geosciences (GEO))	Funding for the ClNO<INF>2</INF> observations and analysis was provided by NSF grants ATM-0633897 and ATM-0846183 to J. A. T. Boulder field measurements were supported in part by the NOAA Atmospheric Chemistry and Climate Program. J. P. K. thanks the Camille and Henry Dreyfus Foundation for a postdoctoral fellowship in environmental chemistry. N. L. W. thanks the National Research Council for a postdoctoral fellowship.	Abuduwailli J, 2008, J ARID ENVIRON, V72, P1843, DOI 10.1016/j.jaridenv.2008.05.006; Alexander B, 2009, ATMOS CHEM PHYS, V9, P5043, DOI 10.5194/acp-9-5043-2009; Allan W, 2007, J GEOPHYS RES-ATMOS, V112, DOI 10.1029/2006JD007369; Behnke W, 1997, J GEOPHYS RES-ATMOS, V102, P3795, DOI 10.1029/96JD03057; Bertram TH, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040248; Brown SS, 2006, SCIENCE, V311, P67, DOI 10.1126/science.1120120; Donohoue DL, 2005, J PHYS CHEM A, V109, P7732, DOI 10.1021/jp051354l; Erickson DJ, 1999, J GEOPHYS RES-ATMOS, V104, P8347, DOI 10.1029/98JD01384; FINLAYSONPITTS BJ, 1989, NATURE, V337, P241, DOI 10.1038/337241a0; GRAEDEL TE, 1995, GLOBAL BIOGEOCHEM CY, V9, P47, DOI 10.1029/94GB03103; Grannas AM, 2007, ATMOS CHEM PHYS, V7, P4329, DOI 10.5194/acp-7-4329-2007; Keene WC, 1998, GEOPHYS RES LETT, V25, P2181, DOI 10.1029/98GL01591; Kercher JP, 2009, ATMOS MEAS TECH, V2, P193, DOI 10.5194/amt-2-193-2009; Knipping EM, 2003, ENVIRON SCI TECHNOL, V37, P275, DOI 10.1021/es025793z; LOGAN JA, 1981, J GEOPHYS RES-OCEANS, V86, P7210, DOI 10.1029/JC086iC08p07210; MALM WC, 1994, J GEOPHYS RES-ATMOS, V99, P1347, DOI 10.1029/93JD02916; Moffet RC, 2008, ATMOS CHEM PHYS, V8, P4499, DOI 10.5194/acp-8-4499-2008; *NAT ATM DEP PROGR, 2010, NAT ATM DEP PROGR NR; NELSON HH, 1981, J PHYS CHEM-US, V85, P3891, DOI 10.1021/j150625a036; Olivier J., 2001, CLIMATE SYSTEM, P33; Osthoff HD, 2008, NAT GEOSCI, V1, P324, DOI 10.1038/ngeo177; Pechtl S, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029761; Platt U, 2004, ATMOS CHEM PHYS, V4, P2393, DOI 10.5194/acp-4-2393-2004; Roberts JM, 2009, GEOPHYS RES LETT, V36, DOI 10.1029/2009GL040448; Shindell DT, 2009, SCIENCE, V326, P716, DOI 10.1126/science.1174760; SINGH HB, 1981, GEOPHYS RES LETT, V8, P941, DOI 10.1029/GL008i008p00941; Thornton JA, 2003, PHYS CHEM CHEM PHYS, V5, P4593, DOI 10.1039/b307498f; Von Glasow R., 2007, TREATISE GEOCHEMISTR, P21; Wexler AS, 2002, J GEOPHYS RES-ATMOS, V107, DOI 10.1029/2001JD000451; Zhang Q, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029979	30	447	452	9	293	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					271	274		10.1038/nature08905	http://dx.doi.org/10.1038/nature08905			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220847	Green Submitted			2022-12-01	WOS:000275366100045
J	McMahon, HT; Kozlov, MM; Martens, S				McMahon, Harvey T.; Kozlov, Michael M.; Martens, Sascha			Membrane Curvature in Synaptic Vesicle Fusion and Beyond	CELL			English	Article							SYNAPTOTAGMIN-I; MECHANISM; BINDING; RELEASE; DOMAIN; CELLS		[McMahon, Harvey T.; Martens, Sascha] MRC Lab Mol Biol, Cambridge CB0 2QH, England; [Kozlov, Michael M.] Tel Aviv Univ, Sackler Fac Med, Dept Physiol & Pharmacol, IL-69978 Tel Aviv, Israel; [Martens, Sascha] Univ Vienna, Max F Perutz Labs, A-1030 Vienna, Austria	MRC Laboratory Molecular Biology; Tel Aviv University; Sackler Faculty of Medicine; Medical University of Vienna; University of Vienna; Vienna Biocenter (VBC); Max F. Perutz Laboratories (MFPL)	McMahon, HT (corresponding author), MRC Lab Mol Biol, Hills Rd, Cambridge CB0 2QH, England.	hmm@mrc-lmb.cam.ac.uk; michk@post.tau.ac.il; sascha.martens@univie.ac.at	Martens, Sascha/C-3693-2011	Martens, Sascha/0000-0003-3786-8199	Medical Research Council [MC_U105178795] Funding Source: Medline; MRC [MC_U105178795] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Bright NA, 2005, CURR BIOL, V15, P360, DOI 10.1016/j.cub.2005.01.049; Brunecky R, 2005, BIOCHEMISTRY-US, V44, P16064, DOI 10.1021/bi051127+; Campelo F, 2008, BIOPHYS J, V95, P2325, DOI 10.1529/biophysj.108.133173; Chapman ER, 2008, ANNU REV BIOCHEM, V77, P615, DOI 10.1146/annurev.biochem.77.062005.101135; Chernomordik LV, 2008, NAT STRUCT MOL BIOL, V15, P675, DOI 10.1038/nsmb.1455; Fernandez-Chacon R, 2001, NATURE, V410, P41, DOI 10.1038/35065004; Ford MGJ, 2002, NATURE, V419, P361, DOI 10.1038/nature01020; Gallop JL, 2006, EMBO J, V25, P2898, DOI 10.1038/sj.emboj.7601174; GEPPERT M, 1994, CELL, V79, P717, DOI 10.1016/0092-8674(94)90556-8; Groffen AJ, 2010, SCIENCE, V327, P1614, DOI 10.1126/science.1183765; Gu XJ, 1997, PLANT CELL, V9, P157, DOI 10.1105/tpc.9.2.157; Hales KG, 1997, CELL, V90, P121, DOI 10.1016/S0092-8674(00)80319-0; Herrick DZ, 2006, BIOCHEMISTRY-US, V45, P9668, DOI 10.1021/bi060874j; Hu C, 2003, SCIENCE, V300, P1745, DOI 10.1126/science.1084909; Hui EF, 2009, CELL, V138, P709, DOI 10.1016/j.cell.2009.05.049; Jahn R, 2006, NAT REV MOL CELL BIO, V7, P631, DOI 10.1038/nrm2002; Kweon DH, 2006, MOL CELLS, V21, P428; Lee MCS, 2005, CELL, V122, P605, DOI 10.1016/j.cell.2005.07.025; Lynch KL, 2008, MOL BIOL CELL, V19, P5093, DOI 10.1091/mbc.E08-03-0235; Martens S, 2008, NAT REV MOL CELL BIO, V9, P543, DOI 10.1038/nrm2417; Martens S, 2007, SCIENCE, V316, P1205, DOI 10.1126/science.1142614; Ohya T, 2009, NATURE, V459, P1091, DOI 10.1038/nature08107; Orso G, 2009, NATURE, V460, P978, DOI 10.1038/nature08280; Rizo J, 2008, NAT STRUCT MOL BIOL, V15, P665, DOI 10.1038/nsmb.1450; Simonsen A, 1999, J BIOL CHEM, V274, P28857, DOI 10.1074/jbc.274.41.28857; Stein A, 2007, NAT STRUCT MOL BIOL, V14, P904, DOI 10.1038/nsmb1305; Stein A, 2009, NATURE, V460, P525, DOI 10.1038/nature08156; Sudhof TC, 2004, ANNU REV NEUROSCI, V27, P509, DOI 10.1146/annurev.neuro.26.041002.131412; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Xue MS, 2008, NAT STRUCT MOL BIOL, V15, P1160, DOI 10.1038/nsmb.1508	30	154	157	1	44	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					601	605		10.1016/j.cell.2010.02.017	http://dx.doi.org/10.1016/j.cell.2010.02.017			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211126	Bronze			2022-12-01	WOS:000275197400006
J	Di-Poi, N; Montoya-Burgos, JI; Miller, H; Pourquie, O; Milinkovitch, MC; Duboule, D				Di-Poi, Nicolas; Montoya-Burgos, Juan I.; Miller, Hilary; Pourquie, Olivier; Milinkovitch, Michel C.; Duboule, Denis			Changes in Hox genes' structure and function during the evolution of the squamate body plan	NATURE			English	Article							PHYLOGENETIC ANALYSIS; CLUSTERS; SNAKES; EMBRYOS; COMPLEX; GROWTH; MOUSE; CODE	Hox genes are central to the specification of structures along the anterior-posterior body axis(1,2), and modifications in their expression have paralleled the emergence of diversity in vertebrate body plans(3,4). Here we describe the genomic organization of Hox clusters in different reptiles and show that squamates have accumulated unusually large numbers of transposable elements at these loci(5), reflecting extensive genomic rearrangements of coding and non-coding regulatory regions. Comparative expression analyses between two species showing different axial skeletons, the corn snake and the whiptail lizard, revealed major alterations in Hox13 and Hox10 expression features during snake somitogenesis, in line with the expansion of both caudal and thoracic regions. Variations in both protein sequences and regulatory modalities of posterior Hox genes suggest how this genetic system has dealt with its intrinsic collinear constraint to accompany the substantial morphological radiation observed in this group.	[Di-Poi, Nicolas; Montoya-Burgos, Juan I.; Milinkovitch, Michel C.; Duboule, Denis] Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, CH-1211 Geneva 4, Switzerland; [Miller, Hilary] Victoria Univ Wellington, Sch Biol Sci, Wellington 6140, New Zealand; [Pourquie, Olivier] Howard Hughes Med Inst, Kansas City, MO 64110 USA; [Pourquie, Olivier] Stowers Inst Med Res, Kansas City, MO 64110 USA; [Duboule, Denis] Fed Inst Technol EPFL, Sch Life Sci, CH-1015 Lausanne, Switzerland	University of Geneva; Victoria University Wellington; Howard Hughes Medical Institute; Stowers Institute for Medical Research; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne	Duboule, D (corresponding author), Univ Geneva, Dept Zool & Anim Biol, Natl Res Ctr Frontiers Genet, Sci 3, CH-1211 Geneva 4, Switzerland.	denis.duboule@unige.ch	Di-Poi, Nicolas/O-2378-2015; Di-Poi, Nicolas/O-6256-2019; Pourquié, Olivier/CAJ-5443-2022	Di-Poi, Nicolas/0000-0002-3313-3016; Di-Poi, Nicolas/0000-0002-3313-3016; Pourquié, Olivier/0000-0001-5189-1227; Milinkovitch, Michel/0000-0002-2553-0724; duboule, denis/0000-0001-9961-2960; Montoya-Burgos, Juan I./0000-0001-9080-9820	University of Geneva; Federal Institute of Technology in Lausanne; Swiss National Research Fund; National Research Center (NCCR); EU; ERC	University of Geneva; Federal Institute of Technology in Lausanne; Swiss National Research Fund(Swiss National Science Foundation (SNSF)); National Research Center (NCCR)(Swiss National Science Foundation (SNSF)); EU(European Commission); ERC(European Research Council (ERC)European Commission)	We thank A. Schmitz for sharing squamate tissues; A. Debry and F. Chabaud for technical assistance; and members of the Duboule and Milinkovitch laboratories for discussions and reagents. This work was supported by funds from the University of Geneva and the Federal Institute of Technology in Lausanne, the Swiss National Research Fund, the National Research Center (NCCR) 'Frontiers in Genetics', the EU programme 'Crescendo' and the ERC grant SystemsHox.ch (to D. D.).	BURKE AC, 1995, DEVELOPMENT, V121, P333; Carapuco M, 2005, GENE DEV, V19, P2116, DOI 10.1101/gad.338705; Cohn MJ, 1999, NATURE, V399, P474, DOI 10.1038/20944; Deschamps J, 2005, DEVELOPMENT, V132, P2931, DOI 10.1242/dev.01897; Di-Poi N, 2009, GENOME RES, V19, P602, DOI 10.1101/gr.087932.108; Duboule D, 2007, DEVELOPMENT, V134, P2549, DOI 10.1242/dev.001065; Duellman W.E., 1994, BIOL AMPHIBIANS; Feschotte C, 2007, ANNU REV GENET, V41, P331, DOI 10.1146/annurev.genet.40.110405.090448; Garcia-Fernandez J, 2005, NAT REV GENET, V6, P881, DOI 10.1038/nrg1723; GAUNT SJ, 1994, INT J DEV BIOL, V38, P549; Godwin AR, 1998, GENE DEV, V12, P11, DOI 10.1101/gad.12.1.11; Gomez C, 2008, NATURE, V454, P335, DOI 10.1038/nature07020; Herault Y, 1998, DEVELOPMENT, V125, P1669; Hoffstetter R., 1969, P201; Kmita M, 2003, SCIENCE, V301, P331, DOI 10.1126/science.1085753; Kmita M, 2002, DEVELOPMENT, V129, P5521, DOI 10.1242/dev.00151; Kohlsdorf T, 2008, J MOL EVOL, V67, P581, DOI 10.1007/s00239-008-9156-7; Lemons D, 2006, SCIENCE, V313, P1918, DOI 10.1126/science.1132040; Lynch VJ, 2008, P NATL ACAD SCI USA, V105, P14928, DOI 10.1073/pnas.0802355105; Muragaki Y, 1996, SCIENCE, V272, P548, DOI 10.1126/science.272.5261.548; Raynaud A., 1994, Bulletin de la Societe d'Histoire Naturelle de Toulouse, V130, P47; Romer A.S., 1997, OSTEOLOGY REPTILES; Scott V, 2005, J BIOCHEM, V137, P671, DOI 10.1093/jb/mvi086; Suemori H, 2000, DEV BIOL, V220, P333, DOI 10.1006/dbio.2000.9651; Wellik DM, 2003, SCIENCE, V301, P363, DOI 10.1126/science.1085672; Wiens JJ, 2001, EVOLUTION, V55, P2303; Woltering JM, 2009, DEV BIOL, V332, P82, DOI 10.1016/j.ydbio.2009.04.031; Yang ZH, 2007, MOL BIOL EVOL, V24, P1586, DOI 10.1093/molbev/msm088; Young T, 2009, DEV CELL, V17, P516, DOI 10.1016/j.devcel.2009.08.010; Zakany J, 2007, CURR OPIN GENET DEV, V17, P359, DOI 10.1016/j.gde.2007.05.011	30	114	115	0	60	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					99	103		10.1038/nature08789	http://dx.doi.org/10.1038/nature08789			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203609	Green Published			2022-12-01	WOS:000275117500041
J	Foulkes, WD				Foulkes, William D.			Traffic Control for BRCA1	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							SUMOYLATION		[Foulkes, William D.] McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada; [Foulkes, William D.] McGill Univ, Lady Davis Inst, Montreal, PQ, Canada	McGill University; Lady Davis Institute; McGill University	Foulkes, WD (corresponding author), McGill Univ, Dept Oncol, Program Canc Genet, Montreal, PQ, Canada.		Foulkes, William D./AAR-9586-2021	Foulkes, William D./0000-0001-7427-4651				Bergink S, 2009, NATURE, V458, P461, DOI 10.1038/nature07963; Galanty Y, 2009, NATURE, V462, P935, DOI 10.1038/nature08657; Geiss-Friedlander R, 2007, NAT REV MOL CELL BIO, V8, P947, DOI 10.1038/nrm2293; Morris JR, 2009, NATURE, V462, P886, DOI 10.1038/nature08593; Sarge KD, 2009, TRENDS BIOCHEM SCI, V34, P200, DOI 10.1016/j.tibs.2009.01.004	5	8	8	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 25	2010	362	8					755	756		10.1056/NEJMcibr0912412	http://dx.doi.org/10.1056/NEJMcibr0912412			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559SA	20181978				2022-12-01	WOS:000274845600017
J	Shuai, YC; Lu, BY; Hu, Y; Wang, LZ; Sun, K; Zhong, Y				Shuai, Yichun; Lu, Binyan; Hu, Ying; Wang, Lianzhang; Sun, Kan; Zhong, Yi			Forgetting Is Regulated through Rac Activity in Drosophila	CELL			English	Article							RHO-GTPASES; MUSHROOM BODY; ACTIN POLYMERIZATION; OLFACTORY MEMORY; AXON GROWTH; TERM-MEMORY; LIM-KINASE; DISTINCT; COFILIN; PHOSPHORYLATION	Initially acquired memory dissipates rapidly if not consolidated. Such memory decay is thought to result either from the inherently labile nature of newly acquired memories or from interference by subsequently attained information. Here we report that a small G protein Rac-dependent forgetting mechanism contributes to both passive memory decay and interference-induced forgetting in Drosophila. Inhibition of Rac activity leads to slower decay of early memory, extending it from a few hours to more than one day, and to blockade of interference-induced forgetting. Conversely, elevated Rac activity in mushroom body neurons accelerates memory decay. This forgetting mechanism does not affect memory acquisition and is independent of Rutabaga adenylyl cyclase-mediated memory formation mechanisms. Endogenous Rac activation is evoked on different time scales during gradual memory loss in passive decay and during acute memory removal in reversal learning. We suggest that Rac's role in actin cytoskeleton remodeling may contribute to memory erasure.	[Shuai, Yichun; Lu, Binyan; Hu, Ying; Wang, Lianzhang; Sun, Kan; Zhong, Yi] Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China; [Zhong, Yi] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	Tsinghua University; Cold Spring Harbor Laboratory	Zhong, Y (corresponding author), Tsinghua Univ, Dept Biol Sci & Biotechnol, Beijing 100084, Peoples R China.	zhongyi@cshl.edu		Zhong, Yi/0000-0002-7927-5976; LU, BINYAN/0000-0002-1080-0349; Zhong, Yi/0000-0001-7810-9899	973 program [2006CB500806, 2009CB941301]; Beijing Municipal Science & Technology Plan [Z07000200540705]; Tsinghua-Yue-Yuen Medical Sciences Fund	973 program(National Basic Research Program of China); Beijing Municipal Science & Technology Plan(Beijing Municipal Science & Technology Commission); Tsinghua-Yue-Yuen Medical Sciences Fund	We thank L. Luo, H. Tanimoto, A. Chiba, S. Waddell, and the Bloomington Stock Center for fly stocks; F. Sun and T. Xie for sharing equipment; J. Beshel for critical reading of the manuscript; and W. Ma, Y. Wang, Y. Lu, H. Wang, and L. Shao for helpful comments. This work was supported by "973 program'' (2006CB500806 and 2009CB941301), Beijing Municipal Science & Technology Plan (Z07000200540705), and Tsinghua-Yue-Yuen Medical Sciences Fund (all to Y.Z.).	Altmann EM, 2009, TRENDS COGN SCI, V13, P279, DOI 10.1016/j.tics.2009.04.001; ANDERSON JR, 1991, PSYCHOL SCI, V2, P396, DOI 10.1111/j.1467-9280.1991.tb00174.x; Arber S, 1998, NATURE, V393, P805, DOI 10.1038/31729; Aso Y, 2009, J NEUROGENET, V23, P156, DOI 10.1080/01677060802471718; Bamburg JR, 1999, ANNU REV CELL DEV BI, V15, P185, DOI 10.1146/annurev.cellbio.15.1.185; Bjork RA., 1989, VARIETIES MEMORY CON, P309; Blum AL, 2009, CURR BIOL, V19, P1341, DOI 10.1016/j.cub.2009.07.016; BOURNE HR, 1993, CELL, V72, P65, DOI 10.1016/S0092-8674(05)80029-7; BRAND AH, 1993, DEVELOPMENT, V118, P401; Crittenden JR, 1998, LEARN MEMORY, V5, P38; Davis RL, 2005, ANNU REV NEUROSCI, V28, P275, DOI 10.1146/annurev.neuro.28.061604.135651; DEZAZZO J, 1995, TRENDS NEUROSCI, V18, P212, DOI 10.1016/0166-2236(95)93905-D; Dubnau J, 1998, ANNU REV NEUROSCI, V21, P407, DOI 10.1146/annurev.neuro.21.1.407; Edwards DC, 1999, NAT CELL BIOL, V1, P253, DOI 10.1038/12963; Elgersma Y, 1999, CURR OPIN NEUROBIOL, V9, P209, DOI 10.1016/S0959-4388(99)80029-4; Etienne-Manneville S, 2002, NATURE, V420, P629, DOI 10.1038/nature01148; Feig LA, 1999, NAT CELL BIOL, V1, pE25, DOI 10.1038/10018; Fukazawa' Y, 2003, NEURON, V38, P447, DOI 10.1016/S0896-6273(03)00206-X; Genoux D, 2002, NATURE, V418, P970, DOI 10.1038/nature00928; GUNSALUS KC, 1995, J CELL BIOL, V131, P1243, DOI 10.1083/jcb.131.5.1243; Hakeda-Suzuki S, 2002, NATURE, V416, P438, DOI 10.1038/416438a; Han JH, 2007, SCIENCE, V316, P457, DOI [10.1126/science.1139438, 10.1126/science.1134697]; Heisenberg M, 2003, NAT REV NEUROSCI, V4, P266, DOI 10.1038/nrn1074; Johndrow JE, 2004, BIOCHEM CELL BIOL, V82, P643, DOI 10.1139/O04-118; Joneson T, 1996, SCIENCE, V274, P1374, DOI 10.1126/science.274.5291.1374; Jonides J, 2008, ANNU REV PSYCHOL, V59, P193, DOI 10.1146/annurev.psych.59.103006.093615; Kandel ER, 2001, SCIENCE, V294, P1030, DOI 10.1126/science.1067020; Keene AC, 2007, NAT REV NEUROSCI, V8, P341, DOI 10.1038/nrn2098; Kim MD, 2003, DEV BIOL, V262, P282, DOI 10.1016/S0012-1606(03)00393-2; Kraemer PJ, 1997, PSYCHON B REV, V4, P480, DOI 10.3758/BF03214337; Krashes MJ, 2007, NEURON, V53, P103, DOI 10.1016/j.neuron.2006.11.021; Lamarche N, 1996, CELL, V87, P519, DOI 10.1016/S0092-8674(00)81371-9; Lee T, 1999, DEVELOPMENT, V126, P4065; Lewandowsky S, 2009, TRENDS COGN SCI, V13, P120, DOI 10.1016/j.tics.2008.12.003; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Luo LQ, 2000, NAT REV NEUROSCI, V1, P173, DOI 10.1038/35044547; LUO LQ, 1994, GENE DEV, V8, P1787, DOI 10.1101/gad.8.15.1787; Mansuy IM, 2003, BIOCHEM BIOPH RES CO, V311, P1195, DOI 10.1016/j.bbrc.2003.10.046; Margulies C, 2005, CURR BIOL, V15, pR700, DOI 10.1016/j.cub.2005.08.024; McGuire SE, 2003, SCIENCE, V302, P1765, DOI 10.1126/science.1089035; Micheau J, 1999, CELL MOL LIFE SCI, V55, P534, DOI 10.1007/s000180050312; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Ng JL, 2004, NEURON, V44, P779, DOI 10.1016/j.neuron.2004.11.014; Pagani MR, 2009, CELL, V139, P186, DOI 10.1016/j.cell.2009.08.033; QUINN WG, 1976, NATURE, V262, P576, DOI 10.1038/262576a0; QUINN WG, 1974, P NATL ACAD SCI USA, V71, P708, DOI 10.1073/pnas.71.3.708; TULLY T, 1994, CELL, V79, P35, DOI 10.1016/0092-8674(94)90398-0; TULLY T, 1990, COLD SPRING HARB SYM, V55, P203; TULLY T, 1985, J COMP PHYSIOL A, V157, P263, DOI 10.1007/BF01350033; Van Aelst L, 2004, CURR OPIN NEUROBIOL, V14, P297, DOI 10.1016/j.conb.2004.05.012; Wang L, 2007, TRENDS CELL BIOL, V17, P58, DOI 10.1016/j.tcb.2006.11.009; Wixted JT, 2004, ANNU REV PSYCHOL, V55, P235, DOI 10.1146/annurev.psych.55.090902.141555; Yang N, 1998, NATURE, V393, P809, DOI 10.1038/31735; Zars T, 2000, SCIENCE, V288, P672, DOI 10.1126/science.288.5466.672; Zhou Q, 2004, NEURON, V44, P749, DOI 10.1016/j.neuron.2004.11.011	55	148	155	0	54	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					579	589		10.1016/j.cell.2009.12.044	http://dx.doi.org/10.1016/j.cell.2009.12.044			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178749	Bronze			2022-12-01	WOS:000274668400020
J	Woo, HA; Yim, SH; Shin, DH; Kang, D; Yu, DY; Rhee, SG				Woo, Hyun Ae; Yim, Sun Hee; Shin, Dong Hae; Kang, Dongmin; Yu, Dae-Yeul; Rhee, Sue Goo			Inactivation of Peroxiredoxin I by Phosphorylation Allows Localized H2O2 Accumulation for Cell Signaling	CELL			English	Article							CYSTEINE-SULFINIC ACID; HYDROGEN-PEROXIDE; REDOX REGULATION; REACTIVE OXYGEN; TYROSINE PHOSPHORYLATION; MAMMALIAN PEROXIREDOXIN; GROWTH-FACTORS; NADPH OXIDASE; LIPID RAFTS; C-ABL	Despite its toxicity, H2O2 is produced as a signaling molecule that oxidizes critical cysteine residues of effectors such as protein tyrosine phosphatases in response to activation of cell surface receptors. It has remained unclear, however, how H2O2 concentrations above the threshold required to modify effectors are achieved in the presence of the abundant detoxification enzymes peroxiredoxin (Prx) I and II. We now show that PrxI associated with membranes is transiently phosphorylated on tyrosine-194 and thereby inactivated both in cells stimulated via growth factor or immune receptors in vitro and in those at the margin of healing cutaneous wounds in mice. The localized inactivation of PrxI allows for the transient accumulation of H2O2 around membranes, where signaling components are concentrated, while preventing the toxic accumulation of H2O2 elsewhere. In contrast, PrxII was inactivated not by phosphorylation but rather by hyperoxidation of its catalytic cysteine during sustained oxidative stress.	[Woo, Hyun Ae; Yim, Sun Hee; Shin, Dong Hae; Kang, Dongmin; Rhee, Sue Goo] Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea; [Yu, Dae-Yeul] Korea Res Inst Biosci & Biotechnol, Aging Res Ctr, Taejon 305333, South Korea	Ewha Womans University; Korea Research Institute of Bioscience & Biotechnology (KRIBB)	Woo, HA (corresponding author), Ewha Womans Univ, Div Life & Pharmaceut Sci, Seoul 120750, South Korea.	hawoo@ewha.ac.kr; rheesg@ewha.ac.kr	Woo, Hyun Ae/AAT-9586-2021	Kang, Dongmin/0000-0001-5997-625X	National Research Foundation of Korea [2009-0052293, M10642040001-07N4204-00110]	National Research Foundation of Korea(National Research Foundation of Korea)	This study was supported by grants from the National Research Foundation of Korea (National Honor Scientist program grant 2009-0052293 and Bio R&D program grant M10642040001-07N4204-00110 to S. G. R.). We thank K. Matsuno and C. Yabe-Nishimura for providing Nox1-deficent mice.	Bae SH, 2009, ANTIOXID REDOX SIGN, V11, P937, DOI [10.1089/ars.2008.2325, 10.1089/ARS.2008.2325]; Bae YS, 1997, J BIOL CHEM, V272, P217, DOI 10.1074/jbc.272.1.217; Biteau B, 2003, NATURE, V425, P980, DOI 10.1038/nature02075; Carroll M, 1997, BLOOD, V90, P4947, DOI 10.1182/blood.V90.12.4947.4947_4947_4952; Chae HZ, 1999, DIABETES RES CLIN PR, V45, P101, DOI 10.1016/S0168-8227(99)00037-6; Cheng PC, 2001, J IMMUNOL, V166, P3693, DOI 10.4049/jimmunol.166.6.3693; Chiarugi P, 2003, TRENDS BIOCHEM SCI, V28, P509, DOI 10.1016/S0968-0004(03)00174-9; Chiarugi P, 2008, MOL CELLS, V26, P329; Choi MH, 2005, NATURE, V435, P347, DOI 10.1038/nature03587; Clempus RE, 2006, CARDIOVASC RES, V71, P216, DOI 10.1016/j.cardiores.2006.02.033; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Jang HH, 2006, FEBS LETT, V580, P351, DOI 10.1016/j.febslet.2005.12.030; Kang SW, 1998, J BIOL CHEM, V273, P6297, DOI 10.1074/jbc.273.11.6297; Lambeth JD, 2004, NAT REV IMMUNOL, V4, P181, DOI 10.1038/nri1312; Li QA, 2006, MOL CELL BIOL, V26, P140, DOI 10.1128/MCB.26.1.140-154.2006; Li Q, 2008, BIOCHEM J, V411, P531, DOI 10.1042/BJ20071534; Lichti U, 2008, NAT PROTOC, V3, P799, DOI 10.1038/nprot.2008.50; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Matsuno K, 2005, CIRCULATION, V112, P2677, DOI 10.1161/CIRCULATIONAHA.105.573709; Miceli MC, 2001, SEMIN IMMUNOL, V13, P115, DOI 10.1006/smim.2000.0303; Neumann CA, 2003, NATURE, V424, P561, DOI 10.1038/nature01819; Oakley FD, 2009, ANTIOXID REDOX SIGN, V11, P1313, DOI [10.1089/ars.2008.2363, 10.1089/ARS.2008.2363]; Phalen TJ, 2006, J CELL BIOL, V175, P779, DOI 10.1083/jcb.200606005; Plattner R, 1999, GENE DEV, V13, P2400, DOI 10.1101/gad.13.18.2400; PRYWES R, 1986, EMBO J, V5, P2179, DOI 10.1002/j.1460-2075.1986.tb04482.x; Radeva G, 2004, BIOCHEM J, V380, P219, DOI 10.1042/BJ20031348; Rhee SG, 2005, CURR OPIN CELL BIOL, V17, P183, DOI 10.1016/j.ceb.2005.02.004; Rhee SG, 2006, SCIENCE, V312, P1882, DOI 10.1126/science.1130481; Riento K, 2009, J CELL SCI, V122, P912, DOI 10.1242/jcs.039024; Rush J, 2005, NAT BIOTECHNOL, V23, P94, DOI 10.1038/nbt1046; Sen CK, 2008, BBA-GEN SUBJECTS, V1780, P1348, DOI 10.1016/j.bbagen.2008.01.006; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; Stone JR, 2006, ANTIOXID REDOX SIGN, V8, P243, DOI 10.1089/ars.2006.8.243; SUNDARESAN M, 1995, SCIENCE, V270, P296, DOI 10.1126/science.270.5234.296; Tonks NK, 2005, CELL, V121, P667, DOI 10.1016/j.cell.2005.05.016; USHIOFUKAI M, 2006, LOCALIZING NADPH OXI; Valencia A, 2008, J INVEST DERMATOL, V128, P214, DOI 10.1038/sj.jid.5700960; Wen ST, 1997, GENE DEV, V11, P2456, DOI 10.1101/gad.11.19.2456; Woo HA, 2003, J BIOL CHEM, V278, P47361, DOI 10.1074/jbc.C300428200; Woo HA, 2003, SCIENCE, V300, P653, DOI 10.1126/science.1080273; Wood ZA, 2003, SCIENCE, V300, P650, DOI 10.1126/science.1080405; Xu D, 2002, DEV CELL, V2, P251, DOI 10.1016/S1534-5807(02)00132-6	42	465	475	3	62	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 19	2010	140	4					517	528		10.1016/j.cell.2010.01.009	http://dx.doi.org/10.1016/j.cell.2010.01.009			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178744	Bronze			2022-12-01	WOS:000274668400015
J	Rodriguez, J; Jiang, R; Johnson, WC; MacKenzie, BA; Smith, LJ; Barr, RG				Rodriguez, Josanna; Jiang, Rui; Johnson, W. Craig; MacKenzie, Barbara A.; Smith, Lewis J.; Barr, R. Graham			The Association of Pipe and Cigar Use With Cotinine Levels, Lung Function, and Airflow Obstruction A Cross-sectional Study	ANNALS OF INTERNAL MEDICINE			English	Article							PULMONARY-DISEASE; REFERENCE VALUES; PASSIVE SMOKING; MORTALITY; CANCER; ATHEROSCLEROSIS; STANDARDIZATION; DIAGNOSIS; EXPOSURE; SAMPLE	Background: Cigarette smoking is the major cause of chronic obstructive pulmonary disease, but studies on the contribution of other smoking techniques are sparse. Objective: To determine whether pipe and cigar smoking was associated with elevated cotinine levels, decrements in lung function, and increased odds of airflow obstruction. Design: Cross-sectional study. Setting: Population-based sample from 6 U. S. communities. Participants: Men and women aged 48 to 90 years without clinical cardiovascular disease at enrollment who were part of MESA (Multi-Ethnic Study of Atherosclerosis). Measurements: The MESA Lung Study measured spirometry according to American Thoracic Society guidelines and urine cotinine levels by immunoassay on a subsample of MESA. Pipe-years and cigar-years were calculated as years from self-reported age of starting to age of quitting (or to current age in current users) multiplied by pipe-bowls or cigars per day. Results: Of 3528 participants, 9% reported pipe smoking (median, 15 pipe-years), 11% reported cigar smoking (median, 6 cigar-years), and 52% reported cigarette smoking (median, 18 pack-years). Self-reported current pipe and cigar smokers had elevated urine cotinine levels compared with never-smokers. Pipe-years were associated with decrements in FEV1, and cigar-years were associated with decrements in the FEV1-FVC ratio. Participants who smoked pipes or cigars had increased odds of airflow obstruction whether they had also smoked cigarettes (odds ratio, 3.43 [95% CI, 1.75 to 6.71]; P < 0.001) or not (odds ratio, 2.31 [CI, 1.04 to 5.11]; P = 0.039) compared with participants with no smoking history. Limitation: Cross-sectional design. Conclusion: Pipe and cigar smoking increased urine cotinine levels and was associated with decreased lung function and increased odds of airflow obstruction, even in participants who had never smoked cigarettes.	[Barr, R. Graham] Columbia Univ, Med Ctr, New York, NY 10032 USA; Univ Washington, Seattle, WA 98195 USA; NIOSH, Cincinnati, OH 45226 USA; Northwestern Univ, Chicago, IL 60611 USA	Columbia University; University of Washington; University of Washington Seattle; Centers for Disease Control & Prevention - USA; National Institute for Occupational Safety & Health (NIOSH); Northwestern University	Barr, RG (corresponding author), Columbia Univ, Med Ctr, 630 W 168th St,PH 9 E,Room 105, New York, NY 10032 USA.	rgb9@columbia.edu		Smith, Lewis J/0000-0002-4728-1562	National Heart, Lung, and Blood Institute, National Institutes of Health; National Institutes of Health [R01-HL077612, N01-HC95159, HC95169, R01-HL075476]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095159] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL077612, R43HL095169, R21HL095165, R01HL093081, R01HL075476, R44HL095169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [K08AG030235] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute, National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	National Heart, Lung, and Blood Institute, National Institutes of Health.; By the National Institutes of Health (R01-HL077612, N01-HC95159 to HC95169, R01-HL075476).	Baker F, 2000, JAMA-J AM MED ASSOC, V284, P735, DOI 10.1001/jama.284.6.735; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boffetta P, 1999, JNCI-J NATL CANCER I, V91, P697, DOI 10.1093/jnci/91.8.697; CARSTENSEN JM, 1987, J EPIDEMIOL COMMUN H, V41, P166, DOI 10.1136/jech.41.2.166; Centers for Disease Control and Prevention (CDC), 2005, MMWR Morb Mortal Wkly Rep, V54, P509; Chapman KR, 2001, CHEST, V119, P1691, DOI 10.1378/chest.119.6.1691; DAYAL HH, 1994, ENVIRON RES, V65, P161, DOI 10.1006/enrs.1994.1029; FERRIS BG, 1978, AM REV RESPIR DIS, V118, P1; FLINT M, 2005, MMWR SURVEILL SUMM, V54, P297; Funck-Brentano C, 2006, LUNG CANCER, V54, P11, DOI 10.1016/j.lungcan.2006.06.016; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; Henley SJ, 2004, JNCI-J NATL CANCER I, V96, P853, DOI 10.1093/jnci/djh144; Hornung R. W., 1990, APPL OCCUP ENVIRON H, V5, P46, DOI [10.1080/1047322X.1990.10389587, DOI 10.1080/1047322X.1990.10389587, 10.1080/10473]; HOYERT DL, 2001, DHHS PUBLICATION; Iribarren C, 1999, NEW ENGL J MED, V340, P1773, DOI 10.1056/NEJM199906103402301; LANGE P, 1990, THORAX, V45, P22, DOI 10.1136/thx.45.1.22; Lange P, 1991, Ugeskr Laeger, V153, P2742; LEUENBERGER P, 1994, AM J RESP CRIT CARE, V150, P1222, DOI 10.1164/ajrccm.150.5.7952544; McDonald LJ, 2002, J NUCL MED, V43, P1591; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; RUBIN DB, 1976, BIOMETRIKA, V63, P581, DOI 10.2307/2335739; SCHROLL M, 1980, ACTA MED SCAND, V208, P245; Shaper AG, 2003, INT J EPIDEMIOL, V32, P802, DOI 10.1093/ije/dyg206; Streppel MT, 2007, TOB CONTROL, V16, P107, DOI 10.1136/tc.2006.017715; Substance Abuse and Mental Health Services Administration, 2007, NSDUH SER, V32; Substance Abuse and Mental Health Services Administration, 2007, DHHS PUBL; TAGER IB, 1988, AM REV RESPIR DIS, V138, P837, DOI 10.1164/ajrccm/138.4.837; Thorne S. L., 2008, Morbidity and Mortality Weekly Report, V57, P1221; TURNER JAM, 1986, THORAX, V41, P25, DOI 10.1136/thx.41.1.25; *US PHS, 1984, DHHS PUBL; Wald NJ, 1997, BMJ-BRIT MED J, V314, P1860, DOI 10.1136/bmj.314.7098.1860	33	83	83	0	7	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	FEB 16	2010	152	4					201	U17		10.7326/0003-4819-152-4-201002160-00004	http://dx.doi.org/10.7326/0003-4819-152-4-201002160-00004			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	560AF	20157134	Green Accepted			2022-12-01	WOS:000274873300001
J	Currie, CJ; Peters, JR; Tynan, A; Evans, M; Heine, RJ; Bracco, OL; Zagar, T; Poole, CD				Currie, Craig J.; Peters, John R.; Tynan, Aodan; Evans, Marc; Heine, Robert J.; Bracco, Oswaldo L.; Zagar, Tony; Poole, Chris D.			Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study	LANCET			English	Article							GLUCOSE CONTROL; CARDIOVASCULAR EVENTS; RISK; COMPLICATIONS; HYPOGLYCEMIA; ASSOCIATION; THERAPIES; MORTALITY; VETERANS; MELLITUS	Background Results of intervention studies in patients with type 2 diabetes have led to concerns about the safety of aiming for normal blood glucose concentrations. We assessed survival as a function of HbA(1c) in people with type 2 diabetes. Methods Two cohorts of patients aged 50 years and older with type 2 diabetes were generated from the UK General Practice Research Database from November 1986 to November 2008. We identified 27965 patients whose treatment had been intensified from oral monotherapy to combination therapy with oral blood-glucose lowering agents, and 20005 who had changed to regimens that included insulin. Those with diabetes secondary to other causes were excluded. All-cause mortality was the primary outcome. Age, sex, smoking status, cholesterol, cardiovascular risk, and general morbidity were identified as important confounding factors, and Cox survival models were adjusted for these factors accordingly. Findings For combined cohorts, compared with the glycated haemoglobin (HbA(1c)) decile with the lowest hazard (median HbA(1c) 7.5%, IQR 7.5-7.6%), the adjusted hazard ratio (HR) of all-cause mortality in the lowest HbA(1c) decile (6.4%, 6.1-6.6) was 1.52 (95% Cl 1.32-1.76), and in the highest HbA(1c) decile (median 10.5%, IQR 10.1-11.2%) was 1.79 (95% Cl 1.56-2.06). Results showed a general U-shaped association, with the lowest HR at an HbA(1c) of about 7.5%. HR for all-cause mortality in people given insulin-based regimens (2834 deaths) versus those given combination oral agents (2035) was 1.49 (95% Cl 1.39-1.59). Interpretation Low and high mean HbA(1c) values were associated with increased all-cause mortality and cardiac events. If confirmed, diabetes guidelines might need revision to include a minimum HbA(1c) value.	[Currie, Craig J.] Cardiff Univ, Sch Med, Pharma Res Ctr, Cardiff MediCtr,Dept Med, Cardiff CF14 4UJ, S Glam, Wales; [Peters, John R.; Evans, Marc] Univ Wales Hosp, Dept Med, Cardiff CF4 4XW, S Glam, Wales; [Tynan, Aodan; Heine, Robert J.; Bracco, Oswaldo L.; Zagar, Tony] Eli Lilly & Co, Indianapolis, IN 46285 USA; [Poole, Chris D.] Pharmatelligence, Dept Epidemiol, Cardiff, S Glam, Wales	Cardiff University; Cardiff University; Eli Lilly	Currie, CJ (corresponding author), Cardiff Univ, Sch Med, Pharma Res Ctr, Cardiff MediCtr,Dept Med, Cardiff CF14 4UJ, S Glam, Wales.	currie@cardiff.ac.uk			Astellas; Diabetes UK; European Association for the Study of Diabetes; Engineering and Physical Sciences Research Council; Ferring; GSK; Lilly; Medtronic; Medical Research Council; Pfizer; Sanofi-Aventis; National Health Service; Wyeth	Astellas(Astellas Pharmaceuticals); Diabetes UK(Diabetes UK); European Association for the Study of Diabetes; Engineering and Physical Sciences Research Council(UK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC)); Ferring(Ferring Pharmaceuticals); GSK(GlaxoSmithKline); Lilly(Eli Lilly); Medtronic(Medtronic); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Pfizer(Pfizer); Sanofi-Aventis(Sanofi-Aventis); National Health Service; Wyeth(Wyeth)	CJC has received research grants from various health-related organisations, including Astellas, Diabetes UK, the European Association for the Study of Diabetes, the Engineering and Physical Sciences Research Council, Ferring, GSK, Lilly, Medtronic, the Medical Research Council, Pfizer, Sanofi-Aventis, the National Health Service, and Wyeth, and consults for Amylin, Aryx, Astellas, Boeringher Ingelheim. Bristol-Myers Squibb, Diabetes UK, Eisel, Ferring, GSK, Ipsen, Lilly, Medtronic, Merck, Pfizer, Sanofi-Aventis, Takeda, and Wyeth. AT, RJH, OLB, and TZ are employed by Eli Lilly and Company. M E consults for Abbott. Allergan, BMS, GSK, Lilly, Novartis, Novo Nordisk, MSD, Roche, Sanofi-Aventis, and Takeda. CDP consults for Astellas, Ferring, Lilly, Medtronic, Sanofi-Aventis, and Wyeth (pfizer). JRP declares that he has no conflicts of interest.	Abraira C, 1997, ARCH INTERN MED, V157, P181, DOI 10.1001/archinte.157.2.181; American Diabetes Association, 2009, DIABETES CARE, V32, P13; Bowker SL, 2006, DIABETES CARE, V29, P254, DOI 10.2337/diacare.29.02.06.dc05-1558; CHARLSON ME, 1987, J CHRON DIS, V40, P373, DOI 10.1016/0021-9681(87)90171-8; Choi SW, 2008, FREE RADICAL BIO MED, V44, P1217, DOI 10.1016/j.freeradbiomed.2007.12.005; CLAYTON D, 1993, STAT MODELS EPIDEMIO, P307; Currie CJ, 2009, DIABETOLOGIA, V52, P1766, DOI 10.1007/s00125-009-1440-6; Currie CJ, 2006, HEART, V92, P196, DOI 10.1136/hrt.2004.058339; Davies JS, 1998, CLIN ENDOCRINOL, V49, P217, DOI 10.1046/j.1365-2265.1998.00508.x; Deaton C, 2009, EUR J CARDIOVASC NUR, V8, P48, DOI 10.1016/j.ejcnurse.2008.04.003; DONAHOE SM, 2007, JAMA-J AM MED ASSOC, V287, P765; Duckworth W, 2009, NEW ENGL J MED, V360, P129, DOI 10.1056/NEJMoa0808431; *GAN PRACT RES DAT, 1996, INFORM RES, P1; Gerstein HC, 2008, NEW ENGL J MED, V358, P2545, DOI 10.1056/NEJMoa0802743; Giorda CB, 2008, DIABETES CARE, V31, P2154, DOI 10.2337/dc08-1013; Holman RR, 2008, NEW ENGL J MED, V359, P1577, DOI 10.1056/NEJMoa0806470; Home P, 2008, BMJ-BRIT MED J, V336, P458, DOI 10.1136/bmj.39499.514410.80; JICK H, 1991, BRIT MED J, V302, P766, DOI 10.1136/bmj.302.6779.766; KLEINBAUM DG, 2005, SURVIVAL ANAL A SELF, P522; Koenig W, 2007, ARTERIOSCL THROM VAS, V27, P15, DOI 10.1161/01.ATV.0000251503.35795.4f; Mann JFE, 2005, PRESSE MED, V34, P1303, DOI 10.1016/S0755-4982(05)84178-8; Margolis DJ, 2008, PHARMACOEPIDEM DR S, V17, P753, DOI 10.1002/pds.1630; Miller CD, 2001, ARCH INTERN MED, V161, P1653, DOI 10.1001/archinte.161.13.1653; Mulnier HE, 2006, DIABETIC MED, V23, P516, DOI 10.1111/j.1464-5491.2006.01838.x; Nathan DM, 2005, NEW ENGL J MED, V353, P2643, DOI 10.1056/nejmoa052187; Needham DM, 2005, J CRIT CARE, V20, P12, DOI 10.1016/j.jcrc.2004.09.007; Patel A, 2008, NEW ENGL J MED, V358, P2560, DOI 10.1056/NEJMoa0802987; Ray KK, 2009, LANCET, V373, P1765, DOI 10.1016/S0140-6736(09)60697-8; SHAMOON H, 1993, NEW ENGL J MED, V329, P977, DOI 10.1056/nejm199309303291401; Stratton IM, 2000, BMJ-BRIT MED J, V321, P405, DOI 10.1136/bmj.321.7258.405; Turnbull FM, 2009, DIABETOLOGIA, V52, P2288, DOI 10.1007/s00125-009-1470-0; Turner RC, 1998, LANCET, V352, P854, DOI 10.1016/s0140-6736(98)07037-8; Turner RC, 1999, JAMA-J AM MED ASSOC, V281, P2005, DOI 10.1001/jama.281.21.2005; Turner RC, 1998, LANCET, V352, P837, DOI 10.1016/s0140-6736(98)07019-6; Vaag Allan A, 2006, Endocr Pract, V12 Suppl 1, P89; 2009, GEN PRACTICE RES DAT	36	617	633	1	71	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 6	2010	375	9713					481	489		10.1016/S0140-6736(09)61969-3	http://dx.doi.org/10.1016/S0140-6736(09)61969-3			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558PV	20110121				2022-12-01	WOS:000274757900031
J	Ge, P; Tsao, J; Schein, S; Green, TJ; Luo, M; Zhou, ZH				Ge, Peng; Tsao, Jun; Schein, Stan; Green, Todd J.; Luo, Ming; Zhou, Z. Hong			Cryo-EM Model of the Bullet-Shaped Vesicular Stomatitis Virus	SCIENCE			English	Article							MATRIX PROTEIN; CRYSTAL-STRUCTURE; GLYCOPROTEIN-G; DOMAIN; NUCLEOPROTEIN; COMPLEX; CELLS; FORM	Vesicular stomatitis virus (VSV) is a bullet-shaped rhabdovirus and a model system of negative-strand RNA viruses. Through direct visualization by means of cryo-electron microscopy, we show that each virion contains two nested, left-handed helices: an outer helix of matrix protein M and an inner helix of nucleoprotein N and RNA. M has a hub domain with four contact sites that link to neighboring M and N subunits, providing rigidity by clamping adjacent turns of the nucleocapsid. Side-by-side interactions between neighboring N subunits are critical for the nucleocapsid to form a bullet shape, and structure-based mutagenesis results support this description. Together, our data suggest a mechanism of VSV assembly in which the nucleocapsid spirals from the tip to become the helical trunk, both subsequently framed and rigidified by the M layer.	[Ge, Peng; Zhou, Z. Hong] Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA; [Ge, Peng; Schein, Stan; Zhou, Z. Hong] Univ Calif Los Angeles, Calif NanoSyst Inst, Los Angeles, CA 90095 USA; [Ge, Peng; Zhou, Z. Hong] Baylor Coll Med, Struct Computat Biol & Mol Biophys Program, Houston, TX 77030 USA; [Ge, Peng; Zhou, Z. Hong] Univ Texas Med Sch Houston, Dept Pathol & Lab Med, Houston, TX 77030 USA; [Tsao, Jun; Green, Todd J.; Luo, Ming] Univ Alabama, Dept Microbiol, Birmingham, AL 35294 USA; [Schein, Stan] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; Baylor College of Medicine; University of Texas System; University of Texas Health Science Center Houston; University of Alabama System; University of Alabama Birmingham; University of California System; University of California Los Angeles	Zhou, ZH (corresponding author), Univ Calif Los Angeles, Dept Microbiol Immunol & Mol Genet, Los Angeles, CA 90095 USA.	hong.zhou@ucla.edu	Zhou, Z Hong/HDN-0747-2022; Schein, Stan/G-4942-2018	Green, Todd/0000-0003-1158-4710	NIH [AI050066, GM071940, AI069015]; W. M. Keck Foundation through the Keck Center for Virus Imaging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI050066, R01AI069015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071940] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); W. M. Keck Foundation through the Keck Center for Virus Imaging; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. Qiu and Xin Zhang for their technical assistance, Xiaorui Zhang for assistance in graphics, and M. Yang for proofreading the manuscript. This work was supported in part by NIH grants AI050066 (to M. L.), GM071940 (to Z.H.Z.), and AI069015 (to Z.H.Z.). P. G. was supported in part by a training fellowship from the W. M. Keck Foundation to the Gulf Coast Consortia through the Keck Center for Virus Imaging. The first octant of the helical reconstruction map of the virion trunk and its key segmentations have been deposited with the Electron Microscopy Data Bank (accession code EMD-1663). Flexibly fitted coordinates of N into our cryo-EM density have been deposited with PDB (accession code 2WYY).	BLACK BL, 1993, J VIROL, V67, P4814, DOI 10.1128/JVI.67.8.4814-4821.1993; Connor JH, 2006, J VIROL, V80, P3701, DOI 10.1128/JVI.80.8.3701-3711.2006; Ding HT, 2006, J VIROL, V80, P2808, DOI 10.1128/JVI.80.6.2808-2814.2006; Gaudier M, 2002, EMBO J, V21, P2886, DOI 10.1093/emboj/cdf284; GAUDIN Y, 1995, VIROLOGY, V206, P28, DOI 10.1016/S0042-6822(95)80016-6; Gaudin Y, 1997, J MOL BIOL, V274, P816, DOI 10.1006/jmbi.1997.1439; Graham SC, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000251; Green TJ, 2006, SCIENCE, V313, P357, DOI 10.1126/science.1126953; Green TJ, 2009, P NATL ACAD SCI USA, V106, P11713, DOI 10.1073/pnas.0903228106; Lichty BD, 2004, TRENDS MOL MED, V10, P210, DOI 10.1016/j.molmed.2004.03.003; Mebatsion T, 1997, CELL, V90, P841, DOI 10.1016/S0092-8674(00)80349-9; ODENWALD WF, 1986, J VIROL, V57, P922, DOI 10.1128/JVI.57.3.922-932.1986; Roche S, 2007, SCIENCE, V315, P843, DOI 10.1126/science.1135710; Roche S, 2006, SCIENCE, V313, P187, DOI 10.1126/science.1127683; Schnell MJ, 1997, CELL, V90, P849, DOI 10.1016/S0092-8674(00)80350-5; Stojdl DF, 2003, CANCER CELL, V4, P263, DOI 10.1016/S1535-6108(03)00241-1; THOMAS D, 1985, J VIROL, V54, P598, DOI 10.1128/JVI.54.2.598-607.1985; WHITT MA, 1989, J VIROL, V63, P3569, DOI 10.1128/JVI.63.9.3569-3578.1989; Zhang X, 2008, J VIROL, V82, P674, DOI 10.1128/JVI.00935-07; Zhou Y, 1998, VIROLOGY, V246, P83, DOI 10.1006/viro.1998.9169	20	170	176	3	30	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					689	693		10.1126/science.1181766	http://dx.doi.org/10.1126/science.1181766			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133572	Green Accepted			2022-12-01	WOS:000274251800038
J	Rihel, J; Prober, DA; Arvanites, A; Lam, K; Zimmerman, S; Jang, S; Haggarty, SJ; Kokel, D; Rubin, LL; Peterson, RT; Schier, AF				Rihel, Jason; Prober, David A.; Arvanites, Anthony; Lam, Kelvin; Zimmerman, Steven; Jang, Sumin; Haggarty, Stephen J.; Kokel, David; Rubin, Lee L.; Peterson, Randall T.; Schier, Alexander F.			Zebrafish Behavioral Profiling Links Drugs to Biological Targets and Rest/Wake Regulation	SCIENCE			English	Article							SLEEP; STRATEGIES; INHIBITORS; DISORDERS; DISCOVERY; EMBRYOS; HERG; MICE; QT	A major obstacle for the discovery of psychoactive drugs is the inability to predict how small molecules will alter complex behaviors. We report the development and application of a high-throughput, quantitative screen for drugs that alter the behavior of larval zebrafish. We found that the multidimensional nature of observed phenotypes enabled the hierarchical clustering of molecules according to shared behaviors. Behavioral profiling revealed conserved functions of psychotropic molecules and predicted the mechanisms of action of poorly characterized compounds. In addition, behavioral profiling implicated new factors such as ether-a-go-go-related gene ( ERG) potassium channels and immunomodulators in the control of rest and locomotor activity. These results demonstrate the power of high-throughput behavioral profiling in zebrafish to discover and characterize psychotropic drugs and to dissect the pharmacology of complex behaviors.	[Rihel, Jason; Prober, David A.; Zimmerman, Steven; Jang, Sumin; Schier, Alexander F.] Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA; [Arvanites, Anthony; Lam, Kelvin; Rubin, Lee L.; Schier, Alexander F.] Harvard Univ, Harvard Stem Cell Inst, Cambridge, MA 02138 USA; [Haggarty, Stephen J.] Broad Inst MIT & Harvard, Stanley Ctr Psychiat Res, Cambridge, MA 02142 USA; [Haggarty, Stephen J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Boston, MA 02114 USA; [Kokel, David; Peterson, Randall T.] Massachusetts Gen Hosp, Cardiovasc Res Ctr, Dev Biol Lab, Charlestown, MA 02129 USA; [Peterson, Randall T.] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Schier, Alexander F.] Harvard Univ, Sch Med, Div Sleep Med, Boston, MA 02215 USA; [Schier, Alexander F.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University	Rihel, J (corresponding author), Harvard Univ, Dept Mol & Cellular Biol, Cambridge, MA 02138 USA.	rihel@fas.harvard.edu; schier@fas.harvard.edu	Rihel, Jason/G-7106-2011; Haggarty, Stephen J/M-9495-2016; Zebrafish, UCL/A-3125-2009	Haggarty, Stephen J/0000-0002-7872-168X; Rihel, Jason/0000-0003-4067-2066; Peterson, Randall/0000-0003-0727-3469; Rubin, Lee/0000-0002-8658-841X; Schier, Alexander Franz/0000-0001-7645-5325	Life Sciences Research Foundation; Helen Hay Whitney Foundation; NIH [MH086867, MH085205]; Stanley Medical Research Institute; Harvard Stem Cell Institute; McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM085357] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH086867, R21MH085205, K01MH091449] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R00NS060996, K99NS060996] Funding Source: NIH RePORTER	Life Sciences Research Foundation; Helen Hay Whitney Foundation; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanley Medical Research Institute; Harvard Stem Cell Institute; McKnight Endowment Fund for Neuroscience; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank J. Dowling, D. Milan, and G. Vanderlaan for suggestions and reagents and D. Schoppik, G. Uhl, and I. Woods for critical reading of the manuscript. Supported by a Bristol-Myers Squibb postdoctoral fellowship of the Life Sciences Research Foundation (J. R.), a Helen Hay Whitney Foundation postdoctoral fellowship (D. A. P.), a NIH Pathway to Independence grant (D. A. P.), the Stanley Medical Research Institute (S. J. H.), the Harvard Stem Cell Institute (L. L. R.), NIH grants MH086867 and MH085205 (R. T. P.), and grants from NIH and the McKnight Endowment Fund for Neuroscience (A. F. S.). L. L. R. is a founder of iPierian Inc., a biotechnology company, and is a member of its scientific advisory board.	Agid Y, 2007, NAT REV DRUG DISCOV, V6, P189, DOI 10.1038/nrd2217; Bar-Meir E, 2007, CRIT REV TOXICOL, V37, P279, DOI 10.1080/10408440601177855; Cirelli C, 2005, NATURE, V434, P1087, DOI 10.1038/nature03486; Douglas CL, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-42; FOWLER CJ, 1982, BIOCHEM PHARMACOL, V31, P3555, DOI 10.1016/0006-2952(82)90575-5; Imeri L, 2009, NAT REV NEUROSCI, V10, P199, DOI 10.1038/nrn2576; Jacobson KA, 1997, NEUROPHARMACOLOGY, V36, P1157, DOI 10.1016/S0028-3908(97)00104-4; Jorens PG, 1997, HUM EXP TOXICOL, V16, P600, DOI 10.1177/096032719701601008; Langheinrich U, 2003, TOXICOL APPL PHARM, V193, P370, DOI 10.1016/j.taap.2003.07.012; Matteucci A, 2005, EXP BRAIN RES, V167, P641, DOI 10.1007/s00221-005-0068-0; Murphey RD, 2006, CHEM BIOL DRUG DES, V68, P213, DOI 10.1111/j.1747-0285.2006.00439.x; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; North TE, 2009, CELL, V137, P736, DOI 10.1016/j.cell.2009.04.023; Pangalos MN, 2007, NAT REV DRUG DISCOV, V6, P521, DOI 10.1038/nrd2094; Peterson RT, 2004, METHOD CELL BIOL, V76, P569; Prober DA, 2006, J NEUROSCI, V26, P13400, DOI 10.1523/JNEUROSCI.4332-06.2006; Raschi E, 2008, PHARMACOL RES, V57, P181, DOI 10.1016/j.phrs.2008.01.009; Wie MB, 1997, NEUROSCI LETT, V225, P93, DOI 10.1016/S0304-3940(97)00195-X; Yoon BH, 2007, LIFE SCI, V81, P234, DOI 10.1016/j.lfs.2007.05.007	19	509	521	4	99	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 15	2010	327	5963					348	351		10.1126/science.1183090	http://dx.doi.org/10.1126/science.1183090			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075256	Green Accepted			2022-12-01	WOS:000273629700048
J	Huang, JT; Witte, ON				Huang, Jiaoti; Witte, Owen N.			A Seminal Finding for Prostate Cancer?	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CELL		[Huang, Jiaoti; Witte, Owen N.] Univ Calif Los Angeles, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Huang, JT (corresponding author), Univ Calif Los Angeles, Los Angeles, CA 90095 USA.			Huang, Jiaoti/0000-0003-1195-1998				EVANS GS, 1987, PROSTATE, V11, P339, DOI 10.1002/pros.2990110406; Mulholland DJ, 2009, CANCER RES, V69, P8555, DOI 10.1158/0008-5472.CAN-08-4673; OKADA H, 1992, VIRCHOWS ARCH A, V421, P157, DOI 10.1007/BF01607049; Prat A, 2009, NAT MED, V15, P842, DOI 10.1038/nm0809-842; Wang X, 2009, NATURE, V461, P495, DOI 10.1038/nature08361	5	5	7	0	3	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 14	2010	362	2					175	176		10.1056/NEJMcibr0909965	http://dx.doi.org/10.1056/NEJMcibr0909965			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	543FU	20071710				2022-12-01	WOS:000273558500019
J	Ito, T; Woloszyn, M; Mazloff, M				Ito, T.; Woloszyn, M.; Mazloff, M.			Anthropogenic carbon dioxide transport in the Southern Ocean driven by Ekman flow	NATURE			English	Article							RECENT CLIMATE-CHANGE; CO2; CIRCULATION; MODEL; SINK	The Southern Ocean, with its large surface area and vigorous overturning circulation, is potentially a substantial sink of anthropogenic CO(2) (refs 1-4). Despite its importance, the mechanism and pathways of anthropogenic CO(2) uptake and transport are poorly understood. Regulation of the Southern Ocean carbon sink by the wind-driven Ekman flow, mesoscale eddies and their interaction is under debate(5-8). Here we use a high-resolution ocean circulation and carbon cycle model to address the mechanisms controlling the Southern Ocean sink of anthropogenic CO(2). The focus of our study is on the intra-annual variability in anthropogenic CO(2) over a two-year time period. We show that the pattern of carbon uptake is correlated with the oceanic vertical exchange. Zonally integrated carbon uptake peaks at the Antarctic polar front. The carbon is then advected away from the uptake regions by the circulation of the Southern Ocean, which is controlled by the interplay among Ekman flow, ocean eddies and subduction of water masses. Although lateral carbon fluxes are locally dominated by the imprint of mesoscale eddies, the Ekman transport is the primary mechanism for the zonally integrated, cross-frontal transport of anthropogenic CO(2). Intra-annual variability of the cross-frontal transport is dominated by the Ekman flow with little compensation from eddies. A budget analysis in the density coordinate highlights the importance of wind-driven transport across the polar front and subduction at the subtropical front. Our results suggest intimate connections between oceanic carbon uptake and climate variability through the temporal variability of Ekman transport.	[Ito, T.; Woloszyn, M.] Colorado State Univ, Dept Atmospher Sci, Ft Collins, CO 80523 USA; [Mazloff, M.] Univ Calif San Diego, Scripps Inst Oceanog, La Jolla, CA 92093 USA	Colorado State University; University of California System; University of California San Diego; Scripps Institution of Oceanography	Ito, T (corresponding author), Colorado State Univ, Dept Atmospher Sci, 1371 Campus Delivery, Ft Collins, CO 80523 USA.	ito@atmos.colostate.edu	Woloszyn, Mary/T-2186-2019; Mazloff, Matthew/AAG-6463-2019; Ito, Takamitsu/F-3856-2010	Mazloff, Matthew/0000-0002-1650-5850; Ito, Takamitsu/0000-0001-9873-099X; Woloszyn, Molly/0000-0001-7080-757X	US National Aeronautics and Space Administration (NASA) [NNX08AL72G]; US National Oceanic and Atmospheric Administration [NA08OAR4320893]	US National Aeronautics and Space Administration (NASA)(National Aeronautics & Space Administration (NASA)); US National Oceanic and Atmospheric Administration(National Oceanic Atmospheric Admin (NOAA) - USA)	T. I. and M. W. are supported by the US National Aeronautics and Space Administration (NASA) grant NNX08AL72G and the US National Oceanic and Atmospheric Administration grant NA08OAR4320893. The Southern Ocean State Estimate is supported by NASA and US National Oceanographic Partnership Program contracts to the Massachusetts Institute of Technology. The NASA Advanced Supercomputing division and the San Diego Supercomputer Center provided computing and data storage resources. J. L. Sarmiento and N. Lovenduski provided comments that improved the manuscript.	Boning CW, 2008, NAT GEOSCI, V1, P864, DOI 10.1038/ngeo362; Caldeira K, 2000, SCIENCE, V287, P620, DOI 10.1126/science.287.5453.620; Fletcher SEM, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002530; Garcia H.E., 2006, NOAA ATLAS NESDIS, V64, p396 pp; Gruber N, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003349; Ito T, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002103; Key RM, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2004GB002247; Le Quere C, 2007, SCIENCE, V316, P1735, DOI 10.1126/science.1136188; Lovenduski NS, 2008, GLOBAL BIOGEOCHEM CY, V22, DOI 10.1029/2007GB003139; Marinov I, 2006, NATURE, V441, P964, DOI 10.1038/nature04883; Marshall GJ, 2003, J CLIMATE, V16, P4134, DOI 10.1175/1520-0442(2003)016<4134:TITSAM>2.0.CO;2; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5753, DOI 10.1029/96JC02775; Marshall J, 1997, J GEOPHYS RES-OCEANS, V102, P5733, DOI 10.1029/96JC02776; Marshall J, 2006, J PHYS OCEANOGR, V36, P1806, DOI 10.1175/JPO2949.1; Matsumoto K, 2005, GLOBAL BIOGEOCHEM CY, V19, DOI 10.1029/2004GB002397; MAZLOFF M, 2008, THESIS MIT; MAZLOFF MR, J PHYS OCEANOG UNPUB; Miller RL, 2006, J GEOPHYS RES-ATMOS, V111, DOI 10.1029/2005JD006323; Moore JK, 1999, J GEOPHYS RES-OCEANS, V104, P3059, DOI 10.1029/1998JC900032; Najjar RG, 1992, GLOBAL BIOGEOCHEM CY, V6, P45, DOI 10.1029/91GB02718; Orr JC, 2001, GLOBAL BIOGEOCHEM CY, V15, P43, DOI 10.1029/2000GB001273; Russell JL, 2006, J CLIMATE, V19, P6382, DOI 10.1175/JCLI3984.1; Sabine CL, 2004, SCIENCE, V305, P367, DOI 10.1126/science.1097403; Sarmiento JL, 2004, GLOBAL BIOGEOCHEM CY, V18, DOI 10.1029/2003GB002134; SARMIENTO JL, 1992, J GEOPHYS RES-OCEANS, V97, P3621, DOI 10.1029/91JC02849; Sokolov S, 2007, J GEOPHYS RES-OCEANS, V112, DOI 10.1029/2006JC004072; Thompson DWJ, 2002, SCIENCE, V296, P895, DOI 10.1126/science.1069270; TOGGWEILER JR, 1995, DEEP-SEA RES PT I, V42, P477, DOI 10.1016/0967-0637(95)00012-U; WATSON AJ, 2003, CARBON DIOXIDE FLUXE, P123; Wunsch C, 2007, PHYSICA D, V230, P197, DOI 10.1016/j.physd.2006.09.040	30	105	110	2	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 7	2010	463	7277					80	U85		10.1038/nature08687	http://dx.doi.org/10.1038/nature08687			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054394				2022-12-01	WOS:000273344900034
J	Lupski, JR; Reid, JG; Gonzaga-Jauregui, C; Deiros, DR; Chen, DCY; Nazareth, L; Bainbridge, M; Dinh, H; Jing, C; Wheeler, DA; McGuire, AL; Zhang, F; Stankiewicz, P; Halperin, JJ; Yang, CY; Gehman, C; Guo, DW; Irikat, RK; Tom, W; Fantin, NJ; Muzny, DM; Gibbs, RA				Lupski, James R.; Reid, Jeffrey G.; Gonzaga-Jauregui, Claudia; Deiros, David Rio; Chen, David C. Y.; Nazareth, Lynne; Bainbridge, Matthew; Dinh, Huyen; Jing, Chyn; Wheeler, David A.; McGuire, Amy L.; Zhang, Feng; Stankiewicz, Pawel; Halperin, John J.; Yang, Chengyong; Gehman, Curtis; Guo, Danwei; Irikat, Rola K.; Tom, Warren; Fantin, Nick J.; Muzny, Donna M.; Gibbs, Richard A.			Whole-Genome Sequencing in a Patient with Charcot-Marie-Tooth Neuropathy.	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							HEREDITARY NEUROPATHY; STRUCTURAL VARIATION; MISSENSE MUTATIONS; POINT MUTATION; DISEASE; GENE; PROTEIN; SH3TC2; IDENTIFICATION; ASSOCIATION	Background: Whole-genome sequencing may revolutionize medical diagnostics through rapid identification of alleles that cause disease. However, even in cases with simple patterns of inheritance and unambiguous diagnoses, the relationship between disease phenotypes and their corresponding genetic changes can be complicated. Comprehensive diagnostic assays must therefore identify all possible DNA changes in each haplotype and determine which are responsible for the underlying disorder. The high number of rare, heterogeneous mutations present in all humans and the paucity of known functional variants in more than 90% of annotated genes make this challenge particularly difficult. Thus, the identification of the molecular basis of a genetic disease by means of whole-genome sequencing has remained elusive. We therefore aimed to assess the usefulness of human whole-genome sequencing for genetic diagnosis in a patient with Charcot-Marie-Tooth disease. Methods: We identified a family with a recessive form of Charcot-Marie-Tooth disease for which the genetic basis had not been identified. We sequenced the whole genome of the proband, identified all potential functional variants in genes likely to be related to the disease, and genotyped these variants in the affected family members. Results: We identified and validated compound, heterozygous, causative alleles in SH3TC2 (the SH3 domain and tetratricopeptide repeats 2 gene), involving two mutations, in the proband and in family members affected by Charcot-Marie-Tooth disease. Separate subclinical phenotypes segregated independently with each of the two mutations; heterozygous mutations confer susceptibility to neuropathy, including the carpal tunnel syndrome. Conclusions: As shown in this study of a family with Charcot-Marie-Tooth disease, whole-genome sequencing can identify clinically relevant variants and provide diagnostic information to inform the care of patients. N Engl J Med 2010;362:1181-91.	[Lupski, James R.; Reid, Jeffrey G.; Gonzaga-Jauregui, Claudia; Bainbridge, Matthew; Zhang, Feng; Stankiewicz, Pawel; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Dept Mol & Human Genet, Houston, TX 77030 USA; [Reid, Jeffrey G.; Deiros, David Rio; Chen, David C. Y.; Nazareth, Lynne; Bainbridge, Matthew; Dinh, Huyen; Jing, Chyn; Wheeler, David A.; Muzny, Donna M.; Gibbs, Richard A.] Baylor Coll Med, Human Genome Sequencing Ctr, Houston, TX 77030 USA; [McGuire, Amy L.] Baylor Coll Med, Ctr Med Eth & Hlth Policy, Houston, TX 77030 USA; [Lupski, James R.] Baylor Coll Med, Dept Pediat, Houston, TX 77030 USA; [Lupski, James R.] Texas Childrens Hosp, Baylor Coll Med, Houston, TX 77030 USA; [Halperin, John J.] Atlantic Neurosci Inst, Summit, NJ USA; [Halperin, John J.] Mt Sinai Sch Med, New York, NY USA; [Yang, Chengyong; Gehman, Curtis; Guo, Danwei; Irikat, Rola K.; Tom, Warren; Fantin, Nick J.] Life Technol, Carlsbad, CA USA	Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Baylor College of Medicine; Icahn School of Medicine at Mount Sinai; Thermo Fisher Scientific	Gibbs, RA (corresponding author), 1 Baylor Plaza,Mail Stop BCM226, Houston, TX 77030 USA.	agibbs@bcm.edu	Gonzaga-Jauregui, Claudia/H-4752-2019; Zhang, Feng/C-7735-2009; Stankiewicz, Paweł/AAP-7906-2021; Wheeler, David A/M-9740-2018; halperin, john/X-6433-2019	Gonzaga-Jauregui, Claudia/0000-0002-4667-3679; Zhang, Feng/0000-0003-4556-8276; Stankiewicz, Paweł/0000-0002-6456-7490; Wheeler, David A/0000-0002-9056-6299; halperin, john/0000-0003-1170-1710	National Human Genome Research Institute [5 U54 HG003273]; National Institute of Neurological Disorders and Stroke [R01 NS058529]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [U54HG003273] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS058529] Funding Source: NIH RePORTER	National Human Genome Research Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); National Institute of Neurological Disorders and Stroke(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	Supported in part by grants from the National Human Genome Research Institute (5 U54 HG003273, to Dr. Gibbs) and the National Institute of Neurological Disorders and Stroke (R01 NS058529, to Dr. Lupski).	Ahn SM, 2009, GENOME RES, V19, P1622, DOI 10.1101/gr.092197.109; Albert TJ, 2007, NAT METHODS, V4, P903, DOI 10.1038/NMETH1111; Allan W, 1939, ARCH INTERN MED, V63, P1123, DOI 10.1001/archinte.1939.00180230108008; Arnaud E, 2009, P NATL ACAD SCI USA, V106, P17528, DOI 10.1073/pnas.0905523106; Auer-Grumbach M, 2008, NEUROPEDIATRICS, V39, P33, DOI 10.1055/s-2008-1077085; Azzedine H, 2006, NEUROLOGY, V67, P602, DOI 10.1212/01.wnl.0000230225.19797.93; Badano JL, 2002, NAT REV GENET, V3, P779, DOI 10.1038/nrg910; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Chung KW, 2005, NEUROGENETICS, V6, P159, DOI 10.1007/s10048-005-0217-4; Collins FS, 2004, NATURE, V431, P931, DOI 10.1038/nature03001; Del Colle R, 2003, NEUROL SCI, V24, P57, DOI 10.1007/s100720300073; Dipple KM, 2000, AM J HUM GENET, V66, P1729, DOI 10.1086/302938; Dvorakova L, 2001, HUM MUTAT, V18, P52, DOI 10.1002/humu.1149; England JD, 2009, NEUROLOGY, V72, P185, DOI 10.1212/01.wnl.0000336370.51010.a1; Gooding R, 2005, J MED GENET, V42, DOI 10.1136/jmg.2005.034132; Haldane JBS, 1941, J GENET, V41, P149, DOI 10.1007/BF02983018; Hodapp JA, 2006, ARCH NEUROL-CHICAGO, V63, P112, DOI 10.1001/archneur.63.1.112; KAJIWARA K, 1994, SCIENCE, V264, P1604, DOI 10.1126/science.8202715; Katsanis N, 2001, SCIENCE, V293, P2256, DOI 10.1126/science.1063525; Kim JI, 2009, NATURE, V460, P1011, DOI 10.1038/nature08211; Levy S, 2007, PLOS BIOL, V5, P2113, DOI 10.1371/journal.pbio.0050254; Lupo V, 2009, HUM MOL GENET, V18, P4603, DOI 10.1093/hmg/ddp427; Lupski JR, 2007, NEW ENGL J MED, V356, P1169, DOI 10.1056/NEJMcibr067658; LUPSKI JR, 1991, CELL, V66, P219, DOI 10.1016/0092-8674(91)90613-4; McKernan KJ, 2009, GENOME RES, V19, P1527, DOI 10.1101/gr.091868.109; Ng SB, 2010, NAT GENET, V42, P30, DOI 10.1038/ng.499; ROA BB, 1993, NAT GENET, V5, P189, DOI 10.1038/ng1093-189; ROA BB, 1993, NEW ENGL J MED, V329, P96, DOI 10.1056/NEJM199307083290205; Roberts RC, 2010, HUM MOL GENET, V19, P1009, DOI 10.1093/hmg/ddp565; ROMMENS JM, 1989, SCIENCE, V245, P1059, DOI 10.1126/science.2772657; Senderek J, 2003, AM J HUM GENET, V73, P1106, DOI 10.1086/379525; Shy ME, 2006, ANN NEUROL, V59, P358, DOI 10.1002/ana.20777; Verny C, 2004, NEUROLOGY, V63, P1527; WALLACE MR, 1990, SCIENCE, V249, P181, DOI 10.1126/science.2134734; Wang J, 2008, NATURE, V456, P60, DOI 10.1038/nature07484; Wheeler DA, 2008, NATURE, V452, P872, DOI 10.1038/nature06884	36	539	568	2	56	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	APR 1	2010	362	13					1181	1191		10.1056/NEJMoa0908094	http://dx.doi.org/10.1056/NEJMoa0908094			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	577QQ	20220177	Green Accepted			2022-12-01	WOS:000276239500008
J	Rubin, CJ; Zody, MC; Eriksson, J; Meadows, JRS; Sherwood, E; Webster, MT; Jiang, L; Ingman, M; Sharpe, T; Ka, S; Hallbook, F; Besnier, F; Carlborg, O; Bed'hom, B; Tixier-Boichard, M; Jensen, P; Siegel, P; Lindblad-Toh, K; Andersson, L				Rubin, Carl-Johan; Zody, Michael C.; Eriksson, Jonas; Meadows, Jennifer R. S.; Sherwood, Ellen; Webster, Matthew T.; Jiang, Lin; Ingman, Max; Sharpe, Ted; Ka, Sojeong; Hallbook, Finn; Besnier, Francois; Carlborg, Orjan; Bed'hom, Bertrand; Tixier-Boichard, Michele; Jensen, Per; Siegel, Paul; Lindblad-Toh, Kerstin; Andersson, Leif			Whole-genome resequencing reveals loci under selection during chicken domestication	NATURE			English	Article							QUANTITATIVE TRAIT LOCI; BODY-WEIGHT; GENETIC DISSECTION; GROWTH; HORMONE; DIFFERENCE; CONVERSION; EPISTASIS; MUTATION; STRAIN	Domestic animals are excellent models for genetic studies of phenotypic evolution(1-3). They have evolved genetic adaptations to a new environment, the farm, and have been subjected to strong human-driven selection leading to remarkable phenotypic changes in morphology, physiology and behaviour. Identifying the genetic changes underlying these developments provides new insight into general mechanisms by which genetic variation shapes phenotypic diversity. Here we describe the use of massively parallel sequencing to identify selective sweeps of favourable alleles and candidate mutations that have had a prominent role in the domestication of chickens (Gallus gallus domesticus) and their subsequent specialization into broiler (meat-producing) and layer (egg-producing) chickens. We have generated 44.5-fold coverage of the chicken genome using pools of genomic DNA representing eight different populations of domestic chickens as well as red jungle fowl (Gallus gallus), the major wild ancestor(4). We report more than 7,000,000 single nucleotide polymorphisms, almost 1,300 deletions and a number of putative selective sweeps. One of the most striking selective sweeps found in all domestic chickens occurred at the locus for thyroid stimulating hormone receptor (TSHR), which has a pivotal role in metabolic regulation and photoperiod control of reproduction in vertebrates. Several of the selective sweeps detected in broilers overlapped genes associated with growth, appetite and metabolic regulation. We found little evidence that selection for loss-of-function mutations had a prominent role in chicken domestication, but we detected two deletions in coding sequences that we suggest are functionally important. This study has direct application to animal breeding and enhances the importance of the domestic chicken as a model organism for biomedical research.	[Rubin, Carl-Johan; Zody, Michael C.; Eriksson, Jonas; Meadows, Jennifer R. S.; Webster, Matthew T.; Jiang, Lin; Lindblad-Toh, Kerstin; Andersson, Leif] Uppsala Univ, Dept Med Biochem & Microbiol, SE-75123 Uppsala, Sweden; [Zody, Michael C.; Sharpe, Ted; Lindblad-Toh, Kerstin] Harvard Univ, Broad Inst, Cambridge, MA 02142 USA; [Zody, Michael C.; Sharpe, Ted; Lindblad-Toh, Kerstin] MIT, Cambridge, MA 02142 USA; [Sherwood, Ellen] Karolinska Inst, Dept Cell & Mol Biol, SE-17177 Stockholm, Sweden; [Ingman, Max] Uppsala Univ, Rudbeck Lab, Dept Genet & Pathol, SE-75185 Uppsala, Sweden; [Ka, Sojeong; Hallbook, Finn] Uppsala Univ, Dept Neurosci, SE-75124 Uppsala, Sweden; [Besnier, Francois; Carlborg, Orjan; Andersson, Leif] Swedish Univ Agr Sci, Dept Anim Breeding & Genet, SE-75124 Uppsala, Sweden; [Bed'hom, Bertrand; Tixier-Boichard, Michele] INRA, Anim Genet & Integrat Biol UMR1313, F-78350 Jouy En Josas, France; [Jensen, Per] Linkoping Univ, IFM Biol, SE-58183 Linkoping, Sweden; [Siegel, Paul] Virginia Polytech Inst & State Univ, Dept Anim & Poultry Sci, Blacksburg, VA 24061 USA	Uppsala University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Massachusetts Institute of Technology (MIT); Karolinska Institutet; Uppsala University; Uppsala University; Swedish University of Agricultural Sciences; AgroParisTech; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Linkoping University; Virginia Polytechnic Institute & State University	Andersson, L (corresponding author), Uppsala Univ, Dept Med Biochem & Microbiol, Box 582, SE-75123 Uppsala, Sweden.	leif.andersson@imbim.uu.se	Bed'Hom, Bertrand/G-7313-2011	Bed'Hom, Bertrand/0000-0002-0825-0886; Jiang, Lin/0000-0001-9123-5988; Rubin, Carl-Johan/0000-0001-8238-5052; Hallbook, Finn/0000-0001-7552-187X; Meadows, Jennifer/0000-0002-0850-230X; Carlborg, Orjan/0000-0002-2722-5264; Webster, Matthew/0000-0003-1141-2863	Swedish Foundation for Strategic Research; Knut and Alice Wallenberg Foundation; Swedish National Infrastructure for Computing; The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning; European Young Investigator awards	Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Knut and Alice Wallenberg Foundation(Knut & Alice Wallenberg Foundation); Swedish National Infrastructure for Computing; The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning(Swedish Research Council Formas); European Young Investigator awards	Thanks are due to J. Altimiras, J. Dodgson, F. Imsland and S. Kerje for providing genomic DNA samples. We would also like to thank E. Sonnhammar for help with the bioinformatic analysis of the TSHR sequence, the Uppsala Genome Center for SOLiD sequencing and the Uppsala Multidisciplinary Center for Advanced Computational Science for help with data storage and analysis. This work was supported by grants from the Swedish Foundation for Strategic Research, the Knut and Alice Wallenberg Foundation, the Swedish National Infrastructure for Computing and The Swedish Research Council for Environment, Agricultural Sciences and Spatial Planning. K.L.-T. and O.C. are supported by European Young Investigator awards.	AGARWAL SK, 1994, J ENDOCRINOL, V142, P427, DOI 10.1677/joe.0.1420427; Alvarez-Castro JM, 2007, GENETICS, V176, P1151, DOI 10.1534/genetics.106.067348; Ambo M, 2009, ANIM GENET, V40, P200, DOI 10.1111/j.1365-2052.2008.01824.x; Andersson L, 2001, NAT REV GENET, V2, P130, DOI 10.1038/35052563; [Anonymous], 2006, PLOS BIOL, DOI DOI 10.1371/journal.pbio.0040088; Carlborg O, 2006, NAT GENET, V38, P418, DOI 10.1038/ng1761; Chadt A, 2008, NAT GENET, V40, P1354, DOI 10.1038/ng.244; COLE RK, 1966, GENETICS, V53, P1021; Darvasi A, 1998, NAT GENET, V18, P19, DOI 10.1038/ng0198-19; Darwin C, 1859, ORIGINS SPECIES MEAN; Dobney K, 2006, J ZOOL, V269, P261, DOI 10.1111/j.1469-7998.2006.00042.x; Dunnington EA, 1996, POULTRY SCI, V75, P1168, DOI 10.3382/ps.0751168; Eriksson J, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000010; Fairfull R.W, 1990, POULTRY BREEDING GEN, P913; FELSENSTEIN J, 1989, CLADISTICS, V5, P166; Hanon EA, 2008, CURR BIOL, V18, P1147, DOI 10.1016/j.cub.2008.06.076; Havenstein GB, 2003, POULTRY SCI, V82, P1500, DOI 10.1093/ps/82.10.1500; Hillel J, 2003, GENET SEL EVOL, V35, P533, DOI [10.1186/1297-9686-35-6-533, 10.1051/gse:2003038]; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Jacobsson L, 2005, GENET RES, V86, P115, DOI 10.1017/S0016672305007767; Ka S, 2009, RETROVIROLOGY, V6, DOI 10.1186/1742-4690-6-68; Karlsson EK, 2007, NAT GENET, V39, P1321, DOI 10.1038/ng.2007.10; Kerje S, 2003, ANIM GENET, V34, P264, DOI 10.1046/j.1365-2052.2003.01000.x; Le Rouzic A, 2008, EVOL BIOINFORM, V4, P225, DOI 10.4137/EBO.S756; LILJEDAHL LE, 1979, ACTA AGR SCAND, V29, P273, DOI 10.1080/00015127909435238; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lu J, 2006, TRENDS GENET, V22, P126, DOI 10.1016/j.tig.2006.01.004; Messina DN, 2009, BIOINFORMATICS, V25, P1333, DOI 10.1093/bioinformatics/btp153; Nakao N, 2008, NATURE, V452, P317, DOI 10.1038/nature06738; Olson MV, 1999, AM J HUM GENET, V64, P18, DOI 10.1086/302219; Peck GR, 2009, J BIOL CHEM, V284, P30016, DOI 10.1074/jbc.M109.035568; Price E.O., 2002, ANIMAL DOMESTICATION; Ronnegard L, 2008, GENETICS, V178, P2315, DOI 10.1534/genetics.107.083162; Rozen S, 2000, Methods Mol Biol, V132, P365; Sewalem A, 2002, POULTRY SCI, V81, P1775, DOI 10.1093/ps/81.12.1775; Shimada M, 1998, NATURE, V396, P670, DOI 10.1038/25341; Stone S, 2006, HUM MOL GENET, V15, P2709, DOI 10.1093/hmg/ddl204; Tran TS, 2007, ANNU REV CELL DEV BI, V23, P263, DOI 10.1146/annurev.cellbio.22.010605.093554; Wong GKS, 2004, NATURE, V432, P717, DOI 10.1038/nature03156; Yoshimura T, 2003, NATURE, V426, P178, DOI 10.1038/nature02117; Zhou H, 2006, POULTRY SCI, V85, P1700, DOI 10.1093/ps/85.10.1700	41	683	731	5	315	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					587	U145		10.1038/nature08832	http://dx.doi.org/10.1038/nature08832			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20220755	Green Submitted, hybrid, Green Published			2022-12-01	WOS:000275974200047
J	Smith, ZR; Long, JA				Smith, Zachery R.; Long, Jeff A.			Control of Arabidopsis apical-basal embryo polarity by antagonistic transcription factors	NATURE			English	Article							TRANSGENIC PLANTS; AUXIN GRADIENTS; GENE; MERISTEM; SHOOTS; TRANSFORMATION; PHABULOSA; PROTEINS; GROWTH; MUTANT	Plants, similarly to animals, form polarized axes during embryogenesis on which cell differentiation and organ patterning programs are orchestrated. During Arabidopsis embryogenesis, establishment of the shoot and root stem cell populations occurs at opposite ends of an apical-basal axis. Recent work has identified the PLETHORA (PLT) genes as master regulators of basal/root fate(1-3), whereas the master regulators of apical/shoot fate have remained elusive. Here we show that the PLT1 and PLT2 genes are direct targets of the transcriptional co-repressor TOPLESS (TPL) and that PLT1/2 are necessary for the homeotic conversion of shoots to roots in tpl-1 mutants. Using tpl-1 as a genetic tool, we identify the CLASS III HOMEODOMAIN-LEUCINE ZIPPER (HD-ZIP III) transcription factors as master regulators of embryonic apical fate, and show they are sufficient to drive the conversion of the embryonic root pole into a second shoot pole. Furthermore, genetic and misexpression studies show an antagonistic relationship between the PLT and HD-ZIP III genes in specifying the root and shoot poles.	[Smith, Zachery R.; Long, Jeff A.] Univ Calif San Diego, Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA; [Smith, Zachery R.] Univ Calif San Diego, Dept Biol, La Jolla, CA 92037 USA	Salk Institute; University of California System; University of California San Diego; University of California System; University of California San Diego	Long, JA (corresponding author), Univ Calif San Diego, Salk Inst Biol Studies, Plant Biol Lab, La Jolla, CA 92037 USA.	long@salk.edu			Ray Thomas Edwards Foundation Career Development Award; National Institute of Health, NIGMS; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM072764] Funding Source: NIH RePORTER	Ray Thomas Edwards Foundation Career Development Award; National Institute of Health, NIGMS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Sewell for technical assistance with plasmid construction and microscopy; R. Biddick, B. Crawford, Y. Jaillais, N. Krogan, J. Posakony, B. VanSchooten and D. Kelley for discussions and reading of the manuscript; E. York and SIO Unified Laboratory Facility for SEM analysis. This work was supported by a Ray Thomas Edwards Foundation Career Development Award, the National Institute of Health, NIGMS ( J. A. L.), Z.R.S. is a USCD Plant Systems Biology NSF-IGERT Fellow.	Aida M, 2004, CELL, V119, P109, DOI 10.1016/j.cell.2004.09.018; Aoyama T, 1997, PLANT J, V11, P605, DOI 10.1046/j.1365-313X.1997.11030605.x; Blilou I, 2005, NATURE, V433, P39, DOI 10.1038/nature03184; Bowler C, 2004, PLANT J, V39, P776, DOI 10.1111/j.1365-313X.2004.02169.x; Elliott RC, 1996, PLANT CELL, V8, P155, DOI 10.1105/tpc.8.2.155; Emery JF, 2003, CURR BIOL, V13, P1768, DOI 10.1016/j.cub.2003.09.035; Floyd SK, 2004, NATURE, V428, P485, DOI 10.1038/428485a; Friml J, 2002, CELL, V108, P661, DOI 10.1016/S0092-8674(02)00656-6; Friml J, 2003, NATURE, V426, P147, DOI 10.1038/nature02085; Galinha C, 2007, NATURE, V449, P1053, DOI 10.1038/nature06206; GARBARINO JE, 1994, PLANT MOL BIOL, V24, P119, DOI 10.1007/BF00040579; Gray WM, 2001, NATURE, V414, P271, DOI 10.1038/35104500; Grigg SP, 2009, CURR BIOL, V19, P1485, DOI 10.1016/j.cub.2009.06.070; Long JA, 2006, SCIENCE, V312, P1520, DOI 10.1126/science.1123841; Long JA, 2002, DEVELOPMENT, V129, P2797; Mallory AC, 2004, EMBO J, V23, P3356, DOI 10.1038/sj.emboj.7600340; Mayer KFX, 1998, CELL, V95, P805, DOI 10.1016/S0092-8674(00)81703-1; McConnell JR, 1998, DEVELOPMENT, V125, P2935; McConnell JR, 2001, NATURE, V411, P709, DOI 10.1038/35079635; Ochando I, 2006, PLANT PHYSIOL, V141, P607, DOI 10.1104/pp.106.077149; Prigge MJ, 2005, PLANT CELL, V17, P61, DOI 10.1105/tpc.104.026161; Szemenyei H, 2008, SCIENCE, V319, P1384, DOI 10.1126/science.1151461; Tang GL, 2003, GENE DEV, V17, P49, DOI 10.1101/gad.1048103; Zhong RQ, 1999, PLANT PHYSIOL, V120, P53, DOI 10.1104/pp.120.1.53	24	130	147	2	72	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					423	U121		10.1038/nature08843	http://dx.doi.org/10.1038/nature08843			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20190735	Green Accepted, Green Submitted			2022-12-01	WOS:000275657100049
J	Kahn, KL; Adams, JL; Weeks, JC; Chrischilles, EA; Schrag, D; Ayanian, JZ; Kiefe, CI; Ganz, PA; Bhoopalam, N; Potosky, AL; Harrington, DP; Fletcher, RH				Kahn, Katherine L.; Adams, John L.; Weeks, Jane C.; Chrischilles, Elizabeth A.; Schrag, Deborah; Ayanian, John Z.; Kiefe, Catarina I.; Ganz, Patricia A.; Bhoopalam, Nirmala; Potosky, Arnold L.; Harrington, David P.; Fletcher, Robert H.			Adjuvant Chemotherapy Use and Adverse Events Among Older Patients With Stage III Colon Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							MARGINAL STRUCTURAL MODELS; CARE OUTCOMES RESEARCH; COLORECTAL-CANCER; ELDERLY-PATIENTS; CLINICAL-TRIALS; RANDOMIZED-TRIAL; POOLED ANALYSIS; OF-LIFE; FLUOROURACIL; LEUCOVORIN	Context Randomized trials suggest adjuvant chemotherapy is effective for older patients with stage III colon cancer. However, older patients are less likely to receive this therapy than younger patients, perhaps because of concern about adverse effects. Objective To evaluate adjuvant chemotherapy use and outcomes for older patients with stage III colon cancer from well-defined population-based settings and health care systems. Design Observational study of adjuvant chemotherapy use and outcomes by age using Poisson regression to estimate the number of adverse events adjusted for demographic and clinical factors, including comorbid illness and specific elements of chemotherapy regimens documented with clinically detailed medical record reviews and patient and surrogate surveys. Setting Five geographically defined regions (Alabama, Iowa, Los Angeles County, northern California, and North Carolina), 5 integrated health care delivery systems, and 15 Veterans Affairs hospitals. Patients Six hundred seventy-five patients diagnosed with stage III colon cancer from 2003 through 2005 who underwent surgical resection and were followed up for as long as 15 months postdiagnosis. Main Outcome Measures Chemotherapy regimen, dose, duration, and annualized mean number of adverse events stratified by age. Results Of 202 patients aged 75 years and older, 101 (50%) received adjuvant chemotherapy compared with 87% of 473 younger patients (difference, 37%; 95% confidence interval [CI], 30%-45%). Among patients who received adjuvant chemotherapy, 14 patients (14%) aged 75 years and older and 178 younger patients (44%) received a regimen containing oxaliplatin (difference, 30%; 95% CI, 21%-38%). Older patients were less likely to continue treatment, such that by 150 days, 99 patients (40%) aged 65 years and older and 68 younger patients (25%) had discontinued chemotherapy (difference, 15%; 95% CI, 7%-23%). Overall, 162 patients (24%) had at least 1 adverse clinical event, with more events among patients treated with vs without adjuvant chemotherapy (mean, 0.39 vs 0.16; difference, 0.23; 95% CI, 0.11-0.36; P<.001). Among patients receiving adjuvant chemotherapy, adjusted rates of late clinical adverse events were lower for patients 75 years and older (mean, 0.28) vs for younger patients (0.35 for ages 18-54 years, 0.52 for ages 55-64 years, and 0.45 for ages 65-74 years; P=.008 for any age effect). Conclusion Among patients with stage III colon cancer who underwent surgical resection and received adjuvant chemotherapy, older patients in the community received less-toxic and shorter chemotherapy regimens, and those treated had fewer adverse events than younger patients. JAMA. 2010; 303(11): 1037-1045	[Kahn, Katherine L.; Adams, John L.] RAND Corp, Santa Monica, CA 90401 USA; [Kahn, Katherine L.] Univ Calif Los Angeles, Div Gen Internal Med & Hlth Serv Res, Los Angeles, CA USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Div Hematol & Med Oncol, Los Angeles, CA USA; [Kahn, Katherine L.] Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Los Angeles, CA 90095 USA; [Ganz, Patricia A.] Univ Calif Los Angeles, Sch Publ Hlth, Los Angeles, CA 90095 USA; [Weeks, Jane C.] Div Populat Sci, Boston, MA USA; [Harrington, David P.] Dept Biostat & Computat Biol, Boston, MA USA; [Schrag, Deborah] Dana Farber Canc Inst, Boston, MA 02115 USA; [Chrischilles, Elizabeth A.] Univ Iowa, Coll Publ Hlth, Dept Epidemiol, Iowa City, IA USA; [Ayanian, John Z.] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02115 USA; [Ayanian, John Z.] Harvard Univ, Sch Med, Dept Hlth Care Policy, Boston, MA 02115 USA; [Fletcher, Robert H.] Harvard Univ, Sch Med, Dept Populat Med, Boston, MA 02115 USA; [Kiefe, Catarina I.] Univ Massachusetts, Sch Med, Worcester, MA USA; [Bhoopalam, Nirmala] US Dept Vet Affairs, Vet Affairs Edward Hines Jr Hosp, Hines, IL 60141 USA; [Potosky, Arnold L.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Canc Control Program, Washington, DC 20007 USA; [Fletcher, Robert H.] Univ N Carolina, Dept Epidemiol, Chapel Hill, NC USA; [Fletcher, Robert H.] Univ N Carolina, Dept Social Med, Chapel Hill, NC USA	RAND Corporation; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of California System; University of California Los Angeles; Harvard University; Dana-Farber Cancer Institute; University of Iowa; Harvard University; Brigham & Women's Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; University of Massachusetts System; University of Massachusetts Worcester; US Department of Veterans Affairs; Veterans Health Administration (VHA); Edward Hines Jr. VA Hospital; Georgetown University; University of North Carolina; University of North Carolina Chapel Hill; University of North Carolina; University of North Carolina Chapel Hill	Kahn, KL (corresponding author), RAND Corp, 1776 Main St, Santa Monica, CA 90401 USA.	kahn@rand.org	Kahn, Katherine/AAE-2857-2020; Adams, John/ABE-6170-2021	Kahn, Katherine/0000-0002-6605-1455; 	National Cancer Institute (NCI) [U01 CA093344, U01 CA093348]; Harvard Medical School and Northern California Cancer Center [U01 CA093324]; Dana-Farber Cancer Institute and Cancer Research Network [U01 CA093332]; University of Alabama at Birmingham [U01 CA093329]; University of Iowa [U01 CA01013]; University of North Carolina [U01 CA093326]; Department of Veterans Affairs [U01 CDA093344 [MOU], HARQ 03-438MO-03]; NATIONAL CANCER INSTITUTE [U01CA093344, U01CA093324, U01CA093329, U01CA093332, U01CA093326, U01CA093348] Funding Source: NIH RePORTER	National Cancer Institute (NCI)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Harvard Medical School and Northern California Cancer Center; Dana-Farber Cancer Institute and Cancer Research Network; University of Alabama at Birmingham; University of Iowa; University of North Carolina; Department of Veterans Affairs(US Department of Veterans Affairs); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	Funding/Support: The Cancer Care Outcomes Research and Surveillance (CanCORS) Consortium was supported by grants from the National Cancer Institute (NCI) to the statistical coordinating center at the Dana-Farber Cancer Institute (U01 CA093344) and the primary data collection and research centers at RAND Corporation and University of California, Los Angeles (U01 CA093348); Harvard Medical School and Northern California Cancer Center (U01 CA093324); Dana-Farber Cancer Institute and Cancer Research Network (U01 CA093332); University of Alabama at Birmingham (U01 CA093329); University of Iowa (U01 CA01013); and University of North Carolina (U01 CA093326) and by a Department of Veterans Affairs grant to the Durham VA Medical Center (U01 CDA093344 [MOU] and HARQ 03-438MO-03).	American Joint Committee on Cancer, 2006, AJCC CANC STAG ATL; Andre T, 2004, NEW ENGL J MED, V350, P2343, DOI 10.1056/NEJMoa032709; Andre T, 2009, J CLIN ONCOL, V27, P3109, DOI 10.1200/JCO.2008.20.6771; [Anonymous], DEC MAK TOOLS HLTH C; Arias Elizabeth, 2007, Natl Vital Stat Rep, V56, P1; Ayanian JZ, 2004, J CLIN ONCOL, V22, P2992, DOI 10.1200/JCO.2004.06.020; Ayanian JZ, 2003, J CLIN ONCOL, V21, P1293, DOI 10.1200/JCO.2003.06.178; Dencausse Y, 2002, ONKOLOGIE, V25, P426, DOI 10.1159/000067436; Folprecht G, 2004, ANN ONCOL, V15, P1330, DOI 10.1093/annonc/mdh344; Graubard BI, 1999, BIOMETRICS, V55, P652, DOI 10.1111/j.0006-341X.1999.00652.x; Haller DG, 2005, J CLIN ONCOL, V23, P8671, DOI 10.1200/JCO.2004.00.5686; Hernan MA, 2000, EPIDEMIOLOGY, V11, P561, DOI 10.1097/00001648-200009000-00012; Jessup JM, 2005, JAMA-J AM MED ASSOC, V294, P2703, DOI 10.1001/jama.294.21.2703; Kahn KL, 2008, J CLIN ONCOL, V26, P523, DOI 10.1200/JCO.2007.13.1870; Keating NL, 2008, J CLIN ONCOL, V26, P2532, DOI 10.1200/JCO.2007.15.9434; Keating NL, 2010, CANCER-AM CANCER SOC, V116, P998, DOI 10.1002/cncr.24761; Kohne CH, 2008, ONCOLOGIST, V13, P390, DOI 10.1634/theoncologist.2007-0043; Kuebler JP, 2007, J CLIN ONCOL, V25, P2198, DOI 10.1200/JCO.2006.08.2974; LAURIE JA, 1989, J CLIN ONCOL, V7, P1447, DOI 10.1200/JCO.1989.7.10.1447; Malin JL, 2006, SUPPORT CARE CANCER, V14, P837, DOI 10.1007/s00520-005-0902-8; Minino AM, 2007, NATL VITAL STAT REP, V55, P1; MOERTEL CG, 1990, NEW ENGL J MED, V322, P352, DOI 10.1056/NEJM199002083220602; National Cancer Institute, CANC THER EV PROGR C; Neugut AI, 2006, J CLIN ONCOL, V24, P2368, DOI 10.1200/JCO.2005.04.5005; O'Connell MJ, 1998, J CLIN ONCOL, V16, P295, DOI 10.1200/JCO.1998.16.1.295; Piccirillo AF, 2003, J REGISTRY MANAG, V30, P117; Piccirillo JF, 2004, ORL J OTO-RHINO-LARY, V66, P180, DOI 10.1159/000079875; Potosky AL, 2002, J CLIN ONCOL, V20, P1192, DOI 10.1200/JCO.20.5.1192; Robins JM, 2000, EPIDEMIOLOGY, V11, P550, DOI 10.1097/00001648-200009000-00011; ROSENBAUM PR, 1983, BIOMETRIKA, V70, P41, DOI 10.1093/biomet/70.1.41; Sargent D, 2009, J CLIN ONCOL, V27, P872, DOI 10.1200/JCO.2008.19.5362; Sargent DJ, 2001, NEW ENGL J MED, V345, P1091, DOI 10.1056/NEJMoa010957; Schrag D, 2001, J NATL CANCER I, V93, P850, DOI 10.1093/jnci/93.11.850; StataCorp, 2015, STAT STAT SOFTW REL; Sundararajan V, 2002, ANN INTERN MED, V136, P349, DOI 10.7326/0003-4819-136-5-200203050-00007; Townsley CA, 2005, J CLIN ONCOL, V23, P3112, DOI 10.1200/JCO.2005.00.141; Tunis SR, 2003, JAMA-J AM MED ASSOC, V290, P1624, DOI 10.1001/jama.290.12.1624; Zaniboni A, 1998, CANCER, V82, P2135, DOI 10.1002/(SICI)1097-0142(19980601)82:11<2135::AID-CNCR7>3.0.CO;2-U	38	114	119	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1037	1045		10.1001/jama.2010.272	http://dx.doi.org/10.1001/jama.2010.272			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	569KC	20233821	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000275594100016
J	Hinde, CA; Johnstone, RA; Kilner, RM				Hinde, Camilla A.; Johnstone, Rufus A.; Kilner, Rebecca M.			Parent-Offspring Conflict and Coadaptation	SCIENCE			English	Article							MATERNAL TESTOSTERONE; HORMONES; GROWTH; EGGS; ECOLOGY; SIGNALS; BIRDS; YOLK	The evolution of family life has traditionally been studied in parallel by behavioral ecologists and quantitative geneticists. The former focus on parent-offspring conflict and whether parents or offspring control provisioning, whereas the latter concentrate on the coadaptation of parental supply and offspring demand. Here we show how prenatal effects on offspring begging can link the two different approaches. Using theoretical and experimental analyses, we show that when offspring control provisioning, prenatal effects primarily serve the parent's interests: Selection on parents drives coadaptation of parent and offspring traits. In contrast, when parents control provisioning, prenatal effects primarily serve the offspring's interests: Selection on the offspring drives coadaptation of parent and offspring traits. Parent-offspring conflict may thus be responsible for the selective forces that generate parent-offspring coadaptation.	[Hinde, Camilla A.; Johnstone, Rufus A.; Kilner, Rebecca M.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Cambridge	Hinde, CA (corresponding author), Univ Cambridge, Dept Zool, Downing St, Cambridge CB2 3EJ, England.		Kilner, Rebecca/B-2867-2012; Hinde, Camilla/G-4023-2012; Hinde, Camilla/AAF-1597-2019	Kilner, Rebecca/0000-0003-1159-0758; Hinde, Camilla/0000-0001-9376-4023; Hinde, Camilla/0000-0001-9376-4023	Natural Environment Research Council (NERC); Magdalene College Cambridge; Wolfson Foundation; Royal Society; NERC [GR9/02650, GR9/04621, NER/A/S/2002/00776]; Isaac Newton Trust, Cambridge; Newnham College, Cambridge; Natural Environment Research Council [NER/A/S/2002/00776] Funding Source: researchfish	Natural Environment Research Council (NERC)(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Magdalene College Cambridge; Wolfson Foundation; Royal Society(Royal Society of London); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Isaac Newton Trust, Cambridge; Newnham College, Cambridge; Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	R. M. K. was supported by a Natural Environment Research Council (NERC) studentship, then a Junior Research Fellowship at Magdalene College Cambridge, a Royal Society Dorothy Hodgkin Research Fellowship (sponsored by the Wolfson Foundation), and finally a Royal Society University Research Fellowship. The experiments were funded by three NERC grants (GR9/02650, GR9/04621, and NER/A/S/2002/00776), which also supported C. A. H., and a Royal Society Equipment Grant. Additional funding for C. A. H. was provided by the Isaac Newton Trust, Cambridge, and a Junior Research Fellowship at Newnham College, Cambridge. We thank L. Barden, N. Bates, C. Donovan, P. Heavens, P. Hynes, I. Millar, J. Nightingale, and S. Shelton for their help in maintaining the birds and constructing equipment; T. Roberts, M. Wade, and J. Theaker for supplying the birds; and N. Davies, M. Clinchy, L. Zanette, and especially M. Klliker for comments on early drafts of the manuscript. R. M. K. conceived and designed the experiments, collected data, and wrote the paper. C. A. H. analyzed data and co- wrote the paper. R. A. J. contributed the theoretical analysis and co- wrote the paper.	Buchanan KL, 2007, HORM BEHAV, V52, P664, DOI 10.1016/j.yhbeh.2007.08.009; Drummond H, 2008, J AVIAN BIOL, V39, P139, DOI 10.1111/j.0908-8857.2008.04365.x; Falconer DS, 1996, INTRO QUANTITATIVE G; Gebhardt-Henrich S., 1998, AVIAN GROWTH DEV, P324; Gil D, 2008, ADV STUD BEHAV, V38, P337, DOI 10.1016/S0065-3454(08)00007-7; GODFRAY HCJ, 1995, NATURE, V376, P133, DOI 10.1038/376133a0; Groothuis TGG, 2005, NEUROSCI BIOBEHAV R, V29, P329, DOI 10.1016/j.neubiorev.2004.12.002; Hinde CA, 2009, P ROY SOC B-BIOL SCI, V276, P2787, DOI 10.1098/rspb.2009.0375; KILNER R, 1995, P ROY SOC B-BIOL SCI, V260, P343, DOI 10.1098/rspb.1995.0102; Kilner RM, 2008, ADV STUD BEHAV, V38, P283, DOI 10.1016/S0065-3454(08)00006-5; Kilner RM, 2001, P NATL ACAD SCI USA, V98, P11394, DOI 10.1073/pnas.191221798; Kilner RM, 2002, EVOLUTION OF BEGGING: COMPETITION, COOPERATION AND COMMUNICATION, P87, DOI 10.1007/0-306-47660-6_5; Kolliker M, 2005, AM NAT, V166, P506, DOI 10.1086/491687; Lock JE, 2004, AM NAT, V164, P13, DOI 10.1086/421444; Lock JE, 2007, AM NAT, V170, P709, DOI 10.1086/521963; Mock D.W., 1997, EVOLUTION SIBLING RI; Muller W, 2007, AM NAT, V169, pE84, DOI 10.1086/511962; Price T.D., 2007, SPECIATION BIRDS; Royle NJ, 2002, TRENDS ECOL EVOL, V17, P434, DOI 10.1016/S0169-5347(02)02565-X; Schwabl H, 1997, NATURE, V386, P231, DOI 10.1038/386231a0; Schwabl H, 1996, J EXP ZOOL, V276, P157, DOI 10.1002/(SICI)1097-010X(19961001)276:2<157::AID-JEZ9>3.3.CO;2-Y; SCHWABL H, 1993, P NATL ACAD SCI USA, V90, P11446, DOI 10.1073/pnas.90.24.11446; Schwabl H, 1996, COMP BIOCHEM PHYS A, V114, P271, DOI 10.1016/0300-9629(96)00009-6; Smiseth PT, 2008, P ROY SOC B-BIOL SCI, V275, P1823, DOI 10.1098/rspb.2008.0199; TRIVERS RL, 1974, AM ZOOL, V14, P249; Wolf JB, 1998, EVOLUTION, V52, P299, DOI 10.1111/j.1558-5646.1998.tb01632.x	26	109	109	1	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1373	1376		10.1126/science.1186056	http://dx.doi.org/10.1126/science.1186056			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223985				2022-12-01	WOS:000275418700040
J	Omer, SB; Hiremath, GS; Halsey, NA				Omer, Saad B.; Hiremath, Girish S.; Halsey, Neal A.			Respiratory administration of measles vaccine	LANCET			English	Editorial Material							AEROSOL; IMMUNIZATION; CHILDREN		[Omer, Saad B.] Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA; [Omer, Saad B.] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA 30322 USA; [Omer, Saad B.] Emory Vaccine Ctr, Atlanta, GA USA; [Hiremath, Girish S.] INOVA Fairfax Hosp Children, Fairfax, VA USA; [Halsey, Neal A.] Johns Hopkins Bloomberg Sch Publ Hlth, Dept Int Hlth, Baltimore, MD USA; [Halsey, Neal A.] Johns Hopkins Bloomberg Sch Publ Hlth, Inst Vaccine Safety, Baltimore, MD USA	Emory University; Rollins School Public Health; Emory University; Emory University; Inova Fairfax Hospital; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Omer, SB (corresponding author), Emory Univ, Rollins Sch Publ Hlth, Hubert Dept Global Hlth, Atlanta, GA 30322 USA.	somer@emory.edu	Omer, Saad B/K-1182-2012	Omer, Saad B/0000-0002-5383-3474				[Anonymous], MMWR MORB MORTAL WKL; Bellanti JA, 2004, VACCINE, V22, P1214, DOI 10.1016/j.vaccine.2003.09.032; Fernandez-de Castro J, 1997, Salud Publica Mex, V39, P53; Hiremath GS, 2005, HUM VACCINES, V1, P30, DOI 10.4161/hv.1.1.1423; KHANUM S, 1987, LANCET, V1, P150; LiCalsi C, 2001, VACCINE, V19, P2629, DOI 10.1016/S0264-410X(00)00503-X; Low N, 2008, VACCINE, V26, P383, DOI 10.1016/j.vaccine.2007.11.010; SABIN AB, 1983, JAMA-J AM MED ASSOC, V249, P2651, DOI 10.1001/jama.249.19.2651; SABIN AB, 1992, PEDIATRICS, V90, P162; Tosh PK, 2008, MAYO CLIN PROC, V83, P77, DOI 10.4065/83.1.77; *WHO, 2008, OUTC 61 WORLD HLTH A; *WHO, 2009, MEAS AER PROJ; World Health Organization, 2006, IN VACC RES STRAT PL	13	11	11	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 27	2010	375	9716					706	708		10.1016/S0140-6736(09)62028-6	http://dx.doi.org/10.1016/S0140-6736(09)62028-6			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JW	20189011				2022-12-01	WOS:000275211200009
J	Wiseman, RL; Haynes, CM; Ron, D				Wiseman, R. Luke; Haynes, Cole M.; Ron, David			SnapShot: The Unfolded Protein Response	CELL			English	Editorial Material							ATF6; IRE1; RNA		[Wiseman, R. Luke] Scripps Res Inst, La Jolla, CA 92037 USA; [Haynes, Cole M.] Mem Sloan Kettering Canc Ctr, New York, NY 10021 USA; [Ron, David] NYU, Sch Med, New York, NY USA; [Ron, David] Univ Cambridge, Inst Metab Sci, Cambridge, England	Scripps Research Institute; Memorial Sloan Kettering Cancer Center; New York University; University of Cambridge	Wiseman, RL (corresponding author), Scripps Res Inst, La Jolla, CA 92037 USA.			Wiseman, Luke/0000-0001-9287-6840; Ron, David/0000-0002-3014-5636				Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Lee KPK, 2008, CELL, V132, P89, DOI 10.1016/j.cell.2007.10.057; Ron D., 2007, TRANSLATIONAL CONTRO, P345; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Travers KJ, 2000, CELL, V101, P249, DOI 10.1016/S0092-8674(00)80835-1; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2000, MOL CELL BIOL, V20, P6755, DOI 10.1128/MCB.20.18.6755-6767.2000	7	40	42	1	12	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 19	2010	140	4					590	U162	590.e1	10.1016/j.cell.2010.02.006	http://dx.doi.org/10.1016/j.cell.2010.02.006			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178750	Bronze			2022-12-01	WOS:000274668400021
J	Bilham, R				Bilham, Roger			Lessons from the Haiti earthquake	NATURE			English	Editorial Material									Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA	University of Colorado System; University of Colorado Boulder	Bilham, R (corresponding author), Univ Colorado, Dept Geol Sci, Boulder, CO 80309 USA.	roger.bilham@colorado.edu		Bilham, Roger/0000-0002-5547-4102				Ali ST, 2008, GEOPHYS J INT, V174, P904, DOI 10.1111/j.1365-246X.2008.03634.x; BILHAM R, 1989, B SEISMOL SOC AM, V79, P425; Bilham R, 2009, B EARTHQ ENG, V7, P839, DOI 10.1007/s10518-009-9147-0; HOUGH SE, 2006, AFTER EARTH QUAKES; Kerr RA, 2010, SCIENCE, V327, P398, DOI 10.1126/science.327.5964.398; LAURSEN L, 2010, NATURE; Manaker DM, 2008, GEOPHYS J INT, V174, P889, DOI 10.1111/j.1365-246X.2008.03819.x; MCCANN W, 2004, P NSF CAR TSUN WORKS, P43; PRENTICE CS, 1993, GEOLOGY, V21, P49, DOI 10.1130/0091-7613(1993)021<0049:POTNAC>2.3.CO;2; ROSS S. S., 2010, 20101019 USGS; TUCKER B, 2010, ARCHITECTURE AID PRE; [No title captured]	12	118	121	1	55	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 18	2010	463	7283					878	879		10.1038/463878a	http://dx.doi.org/10.1038/463878a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164905				2022-12-01	WOS:000274582700023
J	Fisher, HS; Hoekstra, HE				Fisher, Heidi S.; Hoekstra, Hopi E.			Competition drives cooperation among closely related sperm of deer mice	NATURE			English	Article							NATURAL-POPULATIONS; SWIMMING SPEED; PEROMYSCUS; FERTILITY; VELOCITY; EVOLUTION; RODENT; SIZE; GENE	Among the extraordinary adaptations driven by sperm competition is the cooperative behaviour of spermatozoa(1). By forming cooperative groups, sperm can increase their swimming velocity and thereby gain an advantage in intermale sperm competition(1,2). Accordingly, selection should favour cooperation of the most closely related sperm to maximize fitness(3). Here we show that sperm of deer mice (genus Peromyscus) form motile aggregations, then we use this system to test predictions of sperm cooperation. We find that sperm aggregate more often with conspecific than heterospecific sperm, suggesting that individual sperm can discriminate on the basis of genetic relatedness. Next, we provide evidence that the cooperative behaviour of closely related sperm is driven by sperm competition. In a monogamous species lacking sperm competition, Peromyscus polionotus, sperm indiscriminately group with unrelated conspecific sperm. In contrast, in the highly promiscuous deer mouse, Peromyscus maniculatus, sperm are significantly more likely to aggregate with those obtained from the same male than with sperm from an unrelated conspecific donor. Even when we test sperm from sibling males, we continue to see preferential aggregations of related sperm in P. maniculatus. These results suggest that sperm from promiscuous deer mice discriminate among relatives and thereby cooperate with the most closely related sperm, an adaptation likely to have been driven by sperm competition.	[Fisher, Heidi S.; Hoekstra, Hopi E.] Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA; [Fisher, Heidi S.; Hoekstra, Hopi E.] Harvard Univ, Ctr Brain Sci, Cambridge, MA 02138 USA	Harvard University; Harvard University	Fisher, HS (corresponding author), Harvard Univ, Museum Comparat Zool, Dept Organism & Evolutionary Biol, Cambridge, MA 02138 USA.	hfisher@oeb.harvard.edu	Hoekstra, Hopi E/I-6690-2012	Hoekstra, Hopi E/0000-0003-1431-1769; Fisher, Heidi S./0000-0001-5622-4335	NIH; Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM084719] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arnold and Mabel Beckman Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank M. Manceau and J. Gros for technical assistance and R. Lewontin for statistical advice. S. Immler, K. Foster and D. Haig provided comments and discussion on the manuscript. H. S. F. is supported by an NIH Ruth Kirschstein National Research Service Award. Research was funded by an Arnold and Mabel Beckman Foundation Young Investigator Award to H. E. H.	BIRDSALL DA, 1973, EVOLUTION, V27, P106, DOI 10.1111/j.1558-5646.1973.tb05922.x; Birkhead TR, 1999, P ROY SOC B-BIOL SCI, V266, P1759, DOI 10.1098/rspb.1999.0843; Breed WG, 2005, J MORPHOL, V265, P271, DOI 10.1002/jmor.10357; Burness G, 2004, BEHAV ECOL SOCIOBIOL, V56, P65, DOI 10.1007/s00265-003-0752-7; DAWSON WD, 1965, EVOLUTION, V19, P44, DOI 10.2307/2406294; Dewsbury D.A., 1981, Biologist (Charleston), V63, P138; DEWSBURY DA, 1985, ANIM BEHAV, V33, P1266, DOI 10.1016/S0003-3472(85)80186-X; DEWSBURY DA, 1981, J COMP PHYSIOL PSYCH, V95, P880, DOI 10.1037/h0077842; Donoghue AM, 1999, BIOL REPROD, V61, P422, DOI 10.1095/biolreprod61.2.422; FOLTZ DW, 1981, AM NAT, V117, P665, DOI 10.1086/283751; Gage MJG, 2004, CURR BIOL, V14, P44, DOI 10.1016/j.cub.2003.12.028; Gomendio M, 2008, INT J DEV BIOL, V52, P439, DOI 10.1387/ijdb.082595mg; Holt WV, 2009, REPROD DOMEST ANIM, V44, P31, DOI 10.1111/j.1439-0531.2009.01363.x; HOLT WV, 1989, HUM REPROD, V4, P292, DOI 10.1093/oxfordjournals.humrep.a136891; Howard DJ, 1999, ANNU REV ECOL SYST, V30, P109, DOI 10.1146/annurev.ecolsys.30.1.109; Immler S, 2008, REPRODUCTION, V135, P275, DOI 10.1530/REP-07-0482; Immler S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000170; JD Biggers, 1971, METHODS MAMMALIAN EM; Joseph SB, 2004, TRENDS ECOL EVOL, V19, P592, DOI 10.1016/j.tree.2004.08.004; Linzey A.V., 1974, American Museum Novitates, VNo. 2532, P1; Malo AF, 2005, BIOL REPROD, V72, P822, DOI 10.1095/biolreprod.104.036368; Moore H, 2002, NATURE, V418, P174, DOI 10.1038/nature00832; Moore HDM, 1996, J ANDROL, V17, P50; PARKER GA, 1970, BIOL REV, V45, P525, DOI 10.1111/j.1469-185X.1970.tb01176.x; PARKER GA, 1988, SPERM COMPETITION SE, P3; Pizzari T, 2008, PLOS BIOL, V6, P925, DOI 10.1371/journal.pbio.0060130; Queller DC, 2003, SCIENCE, V299, P105, DOI 10.1126/science.1077742; Ramm SA, 2005, P ROY SOC B-BIOL SCI, V272, P949, DOI 10.1098/rspb.2004.3048; Smukalla S, 2008, CELL, V135, P726, DOI 10.1016/j.cell.2008.09.037; Snook RR, 2005, TRENDS ECOL EVOL, V20, P46, DOI 10.1016/j.tree.2004.10.011; Stickel L. F., 1968, P373	31	88	90	2	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					801	803		10.1038/nature08736	http://dx.doi.org/10.1038/nature08736			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20090679	Green Accepted			2022-12-01	WOS:000274394300038
J	Mook-Kanamori, DO; Steegers, EAP; Eilers, PH; Raat, H; Hofman, A; Jaddoe, VWV				Mook-Kanamori, Dennis O.; Steegers, Eric A. P.; Eilers, Paul H.; Raat, Hein; Hofman, Albert; Jaddoe, Vincent W. V.			Risk Factors and Outcomes Associated With First-Trimester Fetal Growth Restriction	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							LOW-BIRTH-WEIGHT; MATERNAL SMOKING; EARLY-CHILDHOOD; METABOLIC RISK; 1ST TRIMESTER; PREGNANCY; INFANT; LENGTH; COHORT; GAIN	Context Adverse environmental exposures lead to developmental adaptations in fetal life. The influences of maternal physical characteristics and lifestyle habits on first-trimester fetal adaptations and the postnatal consequences are not known. Objective To determine the risk factors and outcomes associated with first-trimester growth restriction. Design, Setting, and Participants Prospective evaluation of the associations of maternal physical characteristics and lifestyle habits with first-trimester fetal crown to rump length in 1631 mothers with a known and reliable first day of their last menstrual period and a regular menstrual cycle. Subsequently, we assessed the associations of first-trimester fetal growth restriction with the risks of adverse birth outcomes and postnatal growth acceleration until the age of 2 years. The study was based in Rotterdam, the Netherlands. Mothers were enrolled between 2001 and 2005. Main Outcome Measures First-trimester fetal growth was measured as fetal crown to rump length by ultrasound between the gestational age of 10 weeks 0 days and 13 weeks 6 days. Main birth outcomes were preterm birth (gestational age <37 weeks), low birth weight (<2500 g), and small size for gestational age (lowest fifth birth centile). Postnatal growth was measured until the age of 2 years. Results In the multivariate analysis, maternal age was positively associated with first-trimester fetal crown to rump length (difference per maternal year of age, 0.79 mm; 95% confidence interval [CI], 0.41 to 1.18 per standard deviation score increase). Higher diastolic blood pressure and higher hematocrit levels were associated with a shorter crown to rump length (differences, -0.40 mm; 95% CI, -0.74 to -0.06 and -0.52 mm; 95% CI, -0.90 to -0.14 per standard deviation increase, respectively). Compared with mothers who were nonsmokers and optimal users of folic acid supplements, those who both smoked and did not use folic acid supplements had shorter fetal crown to rump lengths (difference, -3.84 mm; 95% CI, -5.71 to -1.98). Compared with normal first-trimester fetal growth, first-trimester growth restriction was associated with increased risks of preterm birth (4.0% vs 7.2%; adjusted odds ratio [OR], 2.12; 95% CI, 1.24 to 3.61), low birth weight (3.5% vs 7.5%; adjusted OR, 2.42; 95% CI, 1.41 to 4.16), and small size for gestational age at birth (4.0% vs 10.6%; adjusted OR, 2.64; 95% CI, 1.64 to 4.25). Each standard deviation decrease in first-trimester fetal crown to rump length was associated with a postnatal growth acceleration until the age of 2 years (standard deviation score increase, 0.139 per 2 years; 95% CI, 0.097 to 0.181). Conclusions Maternal physical characteristics and lifestyle habits were independently associated with early fetal growth. First-trimester fetal growth restriction was associated with an increased risk of adverse birth outcomes and growth acceleration in early childhood. JAMA. 2010; 303(6): 527-534	[Mook-Kanamori, Dennis O.; Jaddoe, Vincent W. V.] Erasmus MC, Generat Study Grp R, NL-3000 CA Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.; Hofman, Albert; Jaddoe, Vincent W. V.] Erasmus MC, Dept Epidemiol, NL-3000 CA Rotterdam, Netherlands; [Mook-Kanamori, Dennis O.; Jaddoe, Vincent W. V.] Erasmus MC, Dept Pediat, NL-3000 CA Rotterdam, Netherlands; [Steegers, Eric A. P.] Erasmus MC, Dept Obstet & Gynecol, NL-3000 CA Rotterdam, Netherlands; [Eilers, Paul H.] Erasmus MC, Dept Biostat, NL-3000 CA Rotterdam, Netherlands; [Raat, Hein] Erasmus MC, Dept Publ Hlth, NL-3000 CA Rotterdam, Netherlands	Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC; Erasmus University Rotterdam; Erasmus MC	Jaddoe, VWV (corresponding author), Erasmus MC, Generat Study Grp AE 006 R, POB 2040, NL-3000 CA Rotterdam, Netherlands.	v.jaddoe@erasmusmc.nl			Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research [ZonMw 21000074, ZonMw 90700303]	Erasmus Medical Center, Rotterdam; Erasmus University Rotterdam; Netherlands Organization for Health Research(Netherlands Organization for Health Research and Development)	The Generation R Study is conducted by the Erasmus Medical Center in close collaboration with the School of Law and Faculty of Social Sciences of the Erasmus University Rotterdam, the Municipal Health Service Rotterdam area, the Rotterdam Homecare Foundation, and the Stichting Trombosedienst & Artsenlaboratorium Rijnmond (STAR), Rotterdam, the Netherlands. The first phase of the Generation R Study is made possible by financial support from the Erasmus Medical Center, Rotterdam, the Erasmus University Rotterdam, and the Netherlands Organization for Health Research (ZonMw 21000074). Dr Jaddoe reports receipt of funding from the Netherlands Organization for Health Research (ZonMw 90700303).	Aardenburg R, 2003, BJOG-INT J OBSTET GY, V110, P1001, DOI 10.1111/j.1471-0528.2003.02536.x; Bottomley C, 2009, HUM REPROD, V24, P284, DOI 10.1093/humrep/den389; Breton CV, 2009, AM J RESP CRIT CARE, V180, P462, DOI 10.1164/rccm.200901-0135OC; Bukowski R, 2007, BMJ-BRIT MED J, V334, P836, DOI 10.1136/bmj.39129.637917.AE; Bukowski R, 2007, AM J EPIDEMIOL, V165, P1216, DOI 10.1093/aje/kwm024; Dugoff L, 2004, AM J OBSTET GYNECOL, V191, P1446, DOI 10.1016/j.ajog.2004.06.052; Ekelund U, 2007, J CLIN ENDOCR METAB, V92, P98, DOI 10.1210/jc.2006-1071; Gluckman PD, 2008, NEW ENGL J MED, V359, P61, DOI 10.1056/NEJMra0708473; HADLOCK FP, 1984, RADIOLOGY, V150, P535, DOI 10.1148/radiology.150.2.6691115; Jaddoe VWV, 2007, AM J EPIDEMIOL, V165, P1207, DOI 10.1093/aje/kwm014; Jaddoe VWV, 2008, EUR J EPIDEMIOL, V23, P801, DOI 10.1007/s10654-008-9309-4; Jauniaux E, 2007, AM J OBSTET GYNECOL, V197, DOI 10.1016/j.ajog.2007.02.009; Kirchengast S, 1998, ANN HUM BIOL, V25, P17, DOI 10.1080/03014469800005402; Kuzawa CW, 2005, AM J HUM BIOL, V17, P5, DOI 10.1002/ajhb.20091; Leunissen RWJ, 2009, JAMA-J AM MED ASSOC, V301, P2234, DOI 10.1001/jama.2009.761; Liu Y, 2004, AM J EPIDEMIOL, V160, P131, DOI 10.1093/aje/kwh188; Mukri F, 2008, BJOG-INT J OBSTET GY, V115, P1273, DOI 10.1111/j.1471-0528.2008.01833.x; *NAT COLL CTR WOM, NICE CLIN GUID ANT C; Nohr EA, 2006, EPIDEMIOLOGY, V17, P413, DOI 10.1097/01.ede.0000220549.14177.60; Ong KKL, 2002, PEDIATR RES, V52, P863, DOI 10.1203/01.PDR.0000036602.81878.6D; Poon LCY, 2008, HYPERTENSION, V51, P1027, DOI 10.1161/HYPERTENSIONAHA.107.104646; ROBINSON HP, 1973, BMJ-BRIT MED J, V4, P28, DOI 10.1136/bmj.4.5883.28; *ROYAL COLL OBST G, ULTR SCREEN GUID; Savitz DA, 2002, AM J OBSTET GYNECOL, V187, P1660, DOI 10.1067/mob.2002.127601; Smith GCS, 1998, NEW ENGL J MED, V339, P1817, DOI 10.1056/NEJM199812173392504; Steegers-Theunissen RPM, 2000, BRIT J OBSTET GYNAEC, V107, P1513, DOI 10.1111/j.1471-0528.2000.tb11677.x; Timmermans S, 2009, BRIT J NUTR, V102, P777, DOI 10.1017/S0007114509288994; Troe EJWM, 2007, BJOG-INT J OBSTET GY, V114, P1557, DOI 10.1111/j.1471-0528.2007.01508.x; USHER R, 1969, J PEDIATR-US, V74, P901, DOI 10.1016/S0022-3476(69)80224-6; Verburg BO, 2008, ULTRASOUND OBST GYN, V31, P388, DOI 10.1002/uog.5225; Verburg BO, 2008, PRENATAL DIAG, V28, P323, DOI 10.1002/pd.1972; Zdravkovic T, 2005, PLACENTA, V26, pS81, DOI 10.1016/j.placenta.2005.02.003	32	188	192	0	29	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					527	534		10.1001/jama.2010.78	http://dx.doi.org/10.1001/jama.2010.78			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145229	Green Published, Bronze			2022-12-01	WOS:000274378700024
J	Alderman, MH				Alderman, Michael H.			Reducing Dietary Sodium The Case for Caution	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							CARDIOVASCULAR-DISEASE; FOLLOW-UP; HYPERTENSION		Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Bronx, NY 10461 USA	Yeshiva University; Albert Einstein College of Medicine	Alderman, MH (corresponding author), Yeshiva Univ Albert Einstein Coll Med, Dept Epidemiol & Populat Hlth, Room 1315 Belfer Bldg,1300 Morris Pk Ave, Bronx, NY 10461 USA.	michael.alderman@einstein.yu.edu						Alderman MH, 2007, J HYPERTENS, V25, P903, DOI 10.1097/HJH.0b013e3280c14394; Cohen HW, 2008, J GEN INTERN MED, V23, P1297, DOI 10.1007/s11606-008-0645-6; Cook NR, 2007, BMJ-BRIT MED J, V334, P885, DOI 10.1136/bmj.39147.604896.55; Cook NR, 2009, ARCH INTERN MED, V169, P32, DOI 10.1001/archinternmed.2008.523; Graudal NA, 1998, JAMA-J AM MED ASSOC, V279, P1383, DOI 10.1001/jama.279.17.1383; Jessup M, 2009, CIRCULATION, V119, P1977, DOI 10.1161/CIRCULATIONAHA.109.192064; Marantz PR, 2008, AM J PREV MED, V34, P234, DOI 10.1016/j.amepre.2007.11.017; Paterna S, 2009, AM J CARDIOL, V103, P93, DOI 10.1016/j.amjcard.2008.08.043; Sacco RL, 2006, CIRCULATION, V113, pE409, DOI 10.1161/circ.113.10.e409; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567	10	83	83	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					448	449		10.1001/jama.2010.69	http://dx.doi.org/10.1001/jama.2010.69			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124541				2022-12-01	WOS:000274143600021
J	Harris, SR; Feil, EJ; Holden, MTG; Quail, MA; Nickerson, EK; Chantratita, N; Gardete, S; Tavares, A; Day, N; Lindsay, JA; Edgeworth, JD; de Lencastre, H; Parkhill, J; Peacock, SJ; Bentley, SD				Harris, Simon R.; Feil, Edward J.; Holden, Matthew T. G.; Quail, Michael A.; Nickerson, Emma K.; Chantratita, Narisara; Gardete, Susana; Tavares, Ana; Day, Nick; Lindsay, Jodi A.; Edgeworth, Jonathan D.; de Lencastre, Herminia; Parkhill, Julian; Peacock, Sharon J.; Bentley, Stephen D.			Evolution of MRSA During Hospital Transmission and Intercontinental Spread	SCIENCE			English	Article							RESISTANT STAPHYLOCOCCUS-AUREUS; IDENTIFICATION; CLONES; TRIMETHOPRIM; MUTATION; STRAIN	Current methods for differentiating isolates of predominant lineages of pathogenic bacteria often do not provide sufficient resolution to define precise relationships. Here, we describe a high-throughput genomics approach that provides a high-resolution view of the epidemiology and microevolution of a dominant strain of methicillin-resistant Staphylococcus aureus (MRSA). This approach reveals the global geographic structure within the lineage, its intercontinental transmission through four decades, and the potential to trace person-to-person transmission within a hospital environment. The ability to interrogate and resolve bacterial populations is applicable to a range of infectious diseases, as well as microbial ecology.	[Harris, Simon R.; Holden, Matthew T. G.; Quail, Michael A.; Parkhill, Julian; Bentley, Stephen D.] Wellcome Trust Sanger Inst, Cambridge CB10 15A, England; [Feil, Edward J.] Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England; [Nickerson, Emma K.; Chantratita, Narisara; Day, Nick; Peacock, Sharon J.] Mahidol Univ, Fac Trop Med, Bangkok, Thailand; [Nickerson, Emma K.; Peacock, Sharon J.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Cambridge CB2 0QQ, England; Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Gardete, Susana; Tavares, Ana; de Lencastre, Herminia] Univ Nova Lisboa, Inst Tecnol Quim & Biol, Mol Genet Lab, P-2780156 Oeiras, Portugal; [Gardete, Susana; de Lencastre, Herminia] Rockefeller Univ, Microbiol Lab, New York, NY 10065 USA; [Day, Nick] Univ Oxford, Nuffield Dept Clin Med, Ctr Clin Vaccinol & Trop Med, Oxford OX3 7LJ, England; [Lindsay, Jodi A.] Univ London, Dept Cellular & Mol Med, Ctr Infect, London SW17 0RE, England; [Edgeworth, Jonathan D.] Guys Hosp, Guys Kings & St Thomas Med Sch, Kings Coll London, Dept Infect Dis, London SE1 9RT, England; [Edgeworth, Jonathan D.] Guys & St Thomas Natl Hlth Serv Fdn Trust, Directorate Infect, London SE1 7EH, England	Wellcome Trust Sanger Institute; University of Bath; Mahidol University; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Universidade Nova de Lisboa; Universidade Nova de Lisboa; Rockefeller University; University of Oxford; University of London; Guy's & St Thomas' NHS Foundation Trust; University of London; King's College London; Guy's & St Thomas' NHS Foundation Trust	Bentley, SD (corresponding author), Wellcome Trust Sanger Inst, Wellcome Trust Genome Campus, Cambridge CB10 15A, England.	sdb@sanger.ac.uk	Weinstock, George M/C-6314-2013; Chantratita, Narisara/P-2169-2019; Harris, Simon R/K-1318-2013; Parkhill, Julian/G-4703-2011; Quail, michael/ABE-6131-2020; Peacock, Sharon J/ABE-6331-2020; Lindsay, Jodi/ABH-8205-2020; Lindsay, Jodi/B-9565-2008; Holden, Matthew TG/K-6449-2014	Weinstock, George M/0000-0002-2997-4592; Harris, Simon R/0000-0003-1512-6194; Parkhill, Julian/0000-0002-7069-5958; Lindsay, Jodi/0000-0002-5219-1625; Lindsay, Jodi/0000-0002-5219-1625; Holden, Matthew TG/0000-0002-4958-2166; /0000-0001-6816-8932; Tavares, Ana/0000-0002-2221-4785; Peacock, Sharon/0000-0002-1718-2782	Wellcome Trust; Fundacao para a Ciencia e Tecnologia, Portugal [SFRH/BPD/25403/2005, SFRH/BD/44220/2008]; Guy's and St. Thomas' Charity; Department of Health via the National Institute for Health Research's comprehensive Biomedical Research Centre	Wellcome Trust(Wellcome TrustEuropean Commission); Fundacao para a Ciencia e Tecnologia, Portugal(Portuguese Foundation for Science and Technology); Guy's and St. Thomas' Charity; Department of Health via the National Institute for Health Research's comprehensive Biomedical Research Centre	The Sanger Institute is core funded by the Wellcome Trust. We thank C. Milheirico and J. D. Cockfield for preparation of genomic DNA and G. Dougan and the Sanger Institute Sequencing and Informatics groups for general support. S. G. and A. T. were supported by grants SFRH/BPD/25403/2005 and SFRH/BD/44220/2008, respectively, from Fundacao para a Ciencia e Tecnologia, Portugal. E.K.N., N.C., N.D., and S. J. P. were funded by the Wellcome Trust. Funding for the sequencing of the TW20 genome was provided by Guy's and St. Thomas' Charity. J. D. E. receives funding from the Department of Health via the National Institute for Health Research's comprehensive Biomedical Research Centre award to Guy's and St. Thomas' National Health Service Foundation Trust in partnership with King's College London. The Illumina Genome Analyzer reads are deposited in the Short Read Archive (National Center for Biotechnology Information) under the accession no. ERA000102. The annotated chromosome of TW20 has been submitted to European Molecular Biology Laboratory with the accession number FN433596.	Alp E, 2009, J INFECTION, V58, P433, DOI 10.1016/j.jinf.2009.04.006; Bartels MD, 2008, EUR J CLIN MICROBIOL, V27, P757, DOI 10.1007/s10096-008-0500-z; Besier S, 2003, MOL MICROBIOL, V47, P463, DOI 10.1046/j.1365-2958.2003.03307.x; Dale GE, 1997, J MOL BIOL, V266, P23, DOI 10.1006/jmbi.1996.0770; de Lencastre Herminia, 2008, P333; Edgeworth JD, 2007, CLIN INFECT DIS, V44, P493, DOI 10.1086/511034; Enright MC, 2002, P NATL ACAD SCI USA, V99, P7687, DOI 10.1073/pnas.122108599; Falush D, 2001, P NATL ACAD SCI USA, V98, P15056, DOI 10.1073/pnas.251396098; Feil EJ, 2008, J CLIN MICROBIOL, V46, P1520, DOI 10.1128/JCM.02238-07; Harmsen D, 2003, J CLIN MICROBIOL, V41, P5442, DOI 10.1128/JCM.41.12.5442-5448.2003; Hurdle JG, 2004, J ANTIMICROB CHEMOTH, V53, P102, DOI 10.1093/jac/dkh020; Ko KS, 2005, J CLIN MICROBIOL, V43, P421, DOI 10.1128/JCM.43.1.421-426.2005; Lindsay JA, 2004, TRENDS MICROBIOL, V12, P378, DOI 10.1016/j.tim.2004.06.004; Maiden MCJ, 1998, P NATL ACAD SCI USA, V95, P3140, DOI 10.1073/pnas.95.6.3140; Melter O, 2003, J CLIN MICROBIOL, V41, P4998, DOI 10.1128/JCM.41.11.4998-5005.2003; Moran NA, 2009, SCIENCE, V323, P379, DOI 10.1126/science.1167140; Nubel U, 2008, P NATL ACAD SCI USA, V105, P14130, DOI 10.1073/pnas.0804178105; Ochman H, 1999, P NATL ACAD SCI USA, V96, P12638, DOI 10.1073/pnas.96.22.12638; Oliveira DC, 2001, MICROB DRUG RESIST, V7, P349, DOI 10.1089/10766290152773365; Rocha EPC, 2006, J THEOR BIOL, V239, P226, DOI 10.1016/j.jtbi.2005.08.037; Szczepanik A, 2007, EUR J CLIN MICROBIOL, V26, P29, DOI 10.1007/s10096-006-0237-5; Tanaka M, 2000, J Infect Chemother, V6, P131, DOI 10.1007/s101560070010; Vickers AA, 2009, J ANTIMICROB CHEMOTH, V63, P1112, DOI 10.1093/jac/dkp090; Vivoni AM, 2006, J CLIN MICROBIOL, V44, P1686, DOI 10.1128/JCM.44.5.1686-1691.2006; Wichelhaus TA, 2002, ANTIMICROB AGENTS CH, V46, P3381, DOI 10.1128/AAC.46.11.3381-3385.2002; Xu BL, 2009, J HOSP INFECT, V71, P245, DOI 10.1016/j.jhin.2008.10.029	26	828	861	3	214	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					469	474		10.1126/science.1182395	http://dx.doi.org/10.1126/science.1182395			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093474	Green Accepted			2022-12-01	WOS:000273783100039
J	Unger, EF; Thompson, AM; Blank, MJ; Temple, R				Unger, Ellis F.; Thompson, Aliza M.; Blank, Melanie J.; Temple, Robert			Erythropoiesis-Stimulating Agents - Time for a Reevaluation	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							CHRONIC KIDNEY-DISEASE; EPOETIN; ALPHA		[Unger, Ellis F.; Thompson, Aliza M.; Blank, Melanie J.; Temple, Robert] US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA	US Food & Drug Administration (FDA)	Unger, EF (corresponding author), US FDA, Ctr Drug Evaluat & Res, Silver Spring, MD USA.							Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; *FOOD DRUG ADM, 2007, FDA BRIEF INF JOINT; *FOOD DRUG ADM CTR, 2001, MED OFF CLIN REV DAR; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485	5	195	203	0	7	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					189	192		10.1056/NEJMp0912328	http://dx.doi.org/10.1056/NEJMp0912328			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20054037				2022-12-01	WOS:000273738400001
J	Williams, D; Gutierrez, JM; Harrison, R; Warrell, DA; White, J; Winkel, KD; Gopalakrishnakone, P				Williams, David; Maria Gutierrez, Jose; Harrison, Robert; Warrell, David A.; White, Julian; Winkel, Kenneth D.; Gopalakrishnakone, Ponnampalam		Global Snake Bite Initiative Worki	The Global Snake Bite Initiative: an antidote for snake bite	LANCET			English	Editorial Material							NEGLECTED TROPICAL DISEASES; BURDEN		[Williams, David; Warrell, David A.; Winkel, Kenneth D.] Univ Melbourne, Australian Venom Res Unit, Dept Pharmacol, Parkville, Vic 3010, Australia; [Williams, David] Univ Melbourne, Nossal Inst Global Hlth, Parkville, Vic 3010, Australia; [Maria Gutierrez, Jose] Univ Costa Rica, Inst Clodomiro Picado, San Jose, Costa Rica; [Harrison, Robert] Univ Liverpool, Liverpool Sch Trop Med, Alistair Reid Venom Res Unit, Liverpool L3 5QA, Merseyside, England; [Warrell, David A.] Univ Oxford, John Radcliffe Hosp, Nuffield Dept Clin Med, Oxford OX3 9DU, England; [White, Julian] Womens & Childrens Hosp, Toxinol Dept, Adelaide, SA, Australia; [Gopalakrishnakone, Ponnampalam] Natl Univ Singapore, Yong Loo Lin Sch Med, Singapore 117595, Singapore	University of Melbourne; University of Melbourne; Universidad Costa Rica; Liverpool School of Tropical Medicine; University of Liverpool; University of Oxford; Womens & Childrens Hospital Australia; National University of Singapore	Williams, D (corresponding author), Univ Melbourne, Australian Venom Res Unit, Dept Pharmacol, Grattan St, Parkville, Vic 3010, Australia.	d.williams4@pgrad.unimelb.edu.au	Winkel, Kenneth D./K-8489-2013; Gutiérrez, José/GSJ-1846-2022	Winkel, Kenneth D./0000-0001-8282-6938; Williams, David/0000-0002-6838-4632; Gutierrez, Jose Maria/0000-0001-8385-3081				[Anonymous], 2006, Wkly Epidemiol Rec, V81, P317; [Anonymous], 2008, Wkly Epidemiol Rec, V83, P269; [Anonymous], WORLD HLTH REP 2004; Branche C., 2008, WORLD REPORT CHILD I; Chippaux JP, 1998, B WORLD HEALTH ORGAN, V76, P515; DECOCK KM, 1988, LANCET, V1, P630; GATES W, 2007, COMMUNICATION; Kasturiratne A, 2008, PLOS MED, V5, P1591, DOI 10.1371/journal.pmed.0050218; Mathers CD, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000114; *MELB C MAN, 2008, P 1 GLOB ISS CLIN TO; MION G, 1997, REANIMATION TROPICAL, P349; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; NASIDI A, 1989, T ROY SOC TROP MED H, V83, P401, DOI 10.1016/0035-9203(89)90518-X; SWAROOP S, 1954, Bull World Health Organ, V10, P35; WHO, 2009, GUID PROD CONTR REG; World Health Organization, 2008, Weekly Epidemiological Record, V83, P69	16	220	227	0	23	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 2	2010	375	9708					89	91		10.1016/S0140-6736(09)61159-4	http://dx.doi.org/10.1016/S0140-6736(09)61159-4			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	539BZ	20109867				2022-12-01	WOS:000273229700035
J	Shapira, SD; Gat-Viks, I; Shum, BOV; Dricot, A; de Grace, MM; Wu, LG; Gupta, PB; Hao, T; Silver, SJ; Root, DE; Hill, DE; Regev, A; Hacohen, N				Shapira, Sagi D.; Gat-Viks, Irit; Shum, Bennett O. V.; Dricot, Amelie; de Grace, Marciela M.; Wu, Liguo; Gupta, Piyush B.; Hao, Tong; Silver, Serena J.; Root, David E.; Hill, David E.; Regev, Aviv; Hacohen, Nir			A Physical and Regulatory Map of Host-Influenza Interactions Reveals Pathways in H1N1 Infection	CELL			English	Article							DOUBLE-STRANDED-RNA; VIRUS-INFECTION; NS1 PROTEIN; ANTIVIRAL RESPONSES; GENE-EXPRESSION; RIG-I; REPLICATION; BINDING; SCREEN; ACTIVATION	During the course of a viral infection, viral proteins interact with an array of host proteins and pathways. Here, we present a systematic strategy to elucidate the dynamic interactions between H1N1 influenza and its human host. A combination of yeast two-hybrid analysis and genome-wide expression profiling implicated hundreds of human factors in mediating viral-host interactions. These factors were then examined functionally through depletion analyses in primary lung cells. The resulting data point to potential roles for some unanticipated host and viral proteins in viral infection and the host response, including a network of RNA-binding proteins, components of WNT signaling, and viral polymerase subunits. This multilayered approach provides a comprehensive and unbiased physical and regulatory model of influenza-host interactions and demonstrates a general strategy for uncovering complex host-pathogen relationships.	[Shapira, Sagi D.; Gat-Viks, Irit; Shum, Bennett O. V.; de Grace, Marciela M.; Wu, Liguo; Gupta, Piyush B.; Silver, Serena J.; Root, David E.; Regev, Aviv; Hacohen, Nir] MIT & Harvard, Broad Inst, Cambridge, MA 02142 USA; [Shapira, Sagi D.; de Grace, Marciela M.; Wu, Liguo; Hacohen, Nir] Massachusetts Gen Hosp, Ctr Immunol & Inflammatory Dis, Charlestown, MA 02129 USA; [Shapira, Sagi D.; Wu, Liguo; Hacohen, Nir] Harvard Univ, Sch Med, Dept Med, Boston, MA 02115 USA; [Dricot, Amelie; Hao, Tong; Hill, David E.] Harvard Univ, Sch Med, Dept Genet, Boston, MA 02115 USA; [de Grace, Marciela M.] Harvard Univ, Sch Med, Program Virol, Boston, MA 02115 USA; [Dricot, Amelie; Hao, Tong; Hill, David E.] Dana Farber Canc Inst, Ctr Canc Syst Biol, Boston, MA 02115 USA; [Dricot, Amelie; Hao, Tong; Hill, David E.] Dana Farber Canc Inst, Dept Canc Biol, Boston, MA 02115 USA; [Regev, Aviv] MIT, Howard Hughes Med Inst, Dept Biol, Cambridge, MA 02142 USA	Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School; Harvard University; Dana-Farber Cancer Institute; Harvard University; Dana-Farber Cancer Institute; Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT)	Regev, A (corresponding author), MIT & Harvard, Broad Inst, 7 Cambridge Ctr, Cambridge, MA 02142 USA.	aregev@broad.mit.edu; nhacohen@partners.org	Hill, David E/B-6617-2011	Shapira, Sagi/0000-0002-5425-3682; Shum, Bennett/0000-0001-6150-7233	National Institutes of Health (NIH) [U01 AI074575, R01 HG001715, P50 HG004233]; NIH New Innovator Award; Ford Foundation Predoctoral Fellowship; EMBO Postdoctoral Fellowship; The Ellison Foundation; Howard Hughes Medical Institute; Burroughs Wellcome Fund; NIH Pioneer Award; Sloan Foundation;  [U54 AI057159]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG004233, R01HG001715] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074575, U54AI057159] Funding Source: NIH RePORTER; OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH [DP2OD002230, DP1OD003958] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NIH New Innovator Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ford Foundation Predoctoral Fellowship; EMBO Postdoctoral Fellowship(European Molecular Biology Organization (EMBO)); The Ellison Foundation(Lawrence Ellison Foundation); Howard Hughes Medical Institute(Howard Hughes Medical Institute); Burroughs Wellcome Fund(Burroughs Wellcome Fund); NIH Pioneer Award(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Sloan Foundation(Alfred P. Sloan Foundation); ; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); OFFICE OF THE DIRECTOR, NATIONAL INSTITUTES OF HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)	We thank D. Lieber and K. Maciag for discussions and help with data analysis. We thank C. Shamu and S. Chiang at ICCB (HMS) for the siRNA library and expert advice, S. Gupta and the Broad's Genetic Analysis Platform for microarray processing, H. Le, A. Derr, B. Wong, and the staff at the Broad RNAi Platform for assistance with RNAi studies and analysis, L. Wu for the vRNA reporter plasmid, R. Cadagan and A. Garcia-Sastre for Delta NS1 virus, E. Fodor for PR8 plasmids, R. Lamb for Udorn plasmids, and S. Hart for assistance with artwork. This work was supported by National Institutes of Health (NIH) grant U01 AI074575 (N.H., D.R., and D.H.); U54 AI057159 and the NIH New Innovator Award (N.H.); Ford Foundation Predoctoral Fellowship (M.G.); EMBO Postdoctoral Fellowship (I.G.V.); The Ellison Foundation and NIH grants R01 HG001715 and P50 HG004233 (D.H.); and the Howard Hughes Medical Institute, a Career Award at the Scientific Interface from the Burroughs Wellcome Fund, the NIH Pioneer Award, and the Sloan Foundation (A.R.).	Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bailer SM, 2009, CURR OPIN MICROBIOL, V12, P453, DOI 10.1016/j.mib.2009.06.004; Brander C, 2000, CURR OPIN MICROBIOL, V3, P379, DOI 10.1016/S1369-5274(00)00108-9; Brass AL, 2008, SCIENCE, V319, P921, DOI 10.1126/science.1152725; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Everett RD, 2007, BIOCHIMIE, V89, P819, DOI 10.1016/j.biochi.2007.01.004; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; GARCIA JA, 1992, P NATL ACAD SCI USA, V89, P9372, DOI 10.1073/pnas.89.20.9372; Hale BG, 2008, J GEN VIROL, V89, P2359, DOI 10.1099/vir.0.2008/004606-0; Hao LH, 2008, NATURE, V454, P890, DOI 10.1038/nature07151; Hayward S Diane, 2006, Sci STKE, V2006, pre4; Hiscott J, 2006, ONCOGENE, V25, P6844, DOI 10.1038/sj.onc.1209941; Konig R, 2008, CELL, V135, P49, DOI 10.1016/j.cell.2008.07.032; Krishnan MN, 2008, NATURE, V455, P242, DOI 10.1038/nature07207; Krug RM, 2003, VIROLOGY, V309, P181, DOI 10.1016/S0042-6822(03)00119-3; Lamesch P, 2007, GENOMICS, V89, P307, DOI 10.1016/j.ygeno.2006.11.012; Li QS, 2009, P NATL ACAD SCI USA, V106, P16410, DOI 10.1073/pnas.0907439106; Li SD, 2006, VIROLOGY, V349, P13, DOI 10.1016/j.virol.2006.01.005; Luftig M, 2004, P NATL ACAD SCI USA, V101, P141, DOI 10.1073/pnas.2237183100; Lutz A, 2005, J VIROL METHODS, V126, P13, DOI 10.1016/j.jviromet.2005.01.016; Patel RC, 1999, J BIOL CHEM, V274, P20432, DOI 10.1074/jbc.274.29.20432; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Reichman TW, 2003, J MOL BIOL, V332, P85, DOI 10.1016/S0022-2836(03)00885-4; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sabbah A, 2009, NAT IMMUNOL, V10, P1073, DOI 10.1038/ni.1782; Satterly N, 2007, P NATL ACAD SCI USA, V104, P1853, DOI 10.1073/pnas.0610977104; Segal E, 2003, NAT GENET, V34, P166, DOI 10.1038/ng1165; Staal FJT, 2008, NAT REV IMMUNOL, V8, P581, DOI 10.1038/nri2360; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Takeuchi O, 2009, IMMUNOL REV, V227, P75, DOI 10.1111/j.1600-065X.2008.00737.x; Turpin E, 2005, J VIROL, V79, P8802, DOI 10.1128/JVI.79.14.8802-8811.2005; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Wressnigg N, 2009, J GEN VIROL, V90, P366, DOI 10.1099/vir.0.006122-0	34	490	514	0	55	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1255	1267		10.1016/j.cell.2009.12.018	http://dx.doi.org/10.1016/j.cell.2009.12.018			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064372	Green Accepted, Green Submitted, Bronze			2022-12-01	WOS:000273048700014
J	Montgomery, SB; Sammeth, M; Gutierrez-Arcelus, M; Lach, RP; Ingle, C; Nisbett, J; Guigo, R; Dermitzakis, ET				Montgomery, Stephen B.; Sammeth, Micha; Gutierrez-Arcelus, Maria; Lach, Radoslaw P.; Ingle, Catherine; Nisbett, James; Guigo, Roderic; Dermitzakis, Emmanouil T.			Transcriptome genetics using second generation sequencing in a Caucasian population	NATURE			English	Article							RNA-SEQ; REGULATORY VARIATION; EXPRESSION; GENOME; NUCLEOTIDE; RESOLUTION	Gene expression is an important phenotype that informs about genetic and environmental effects on cellular state. Many studies have previously identified genetic variants for gene expression phenotypes using custom and commercially available microarrays(1-5). Second generation sequencing technologies are now providing unprecedented access to the fine structure of the transcriptome(6-14). We have sequenced the mRNA fraction of the transcriptome in 60 extended HapMap individuals of European descent and have combined these data with genetic variants from the HapMap3 project(15). We have quantified exon abundance based on read depth and have also developed methods to quantify whole transcript abundance. We have found that approximately 10 million reads of sequencing can provide access to the same dynamic range as arrays with better quantification of alternative and highly abundant transcripts. Correlation with SNPs (small nucleotide polymorphisms) leads to a larger discovery of eQTLs (expression quantitative trait loci) than with arrays. We also detect a substantial number of variants that influence the structure of mature transcripts indicating variants responsible for alternative splicing. Finally, measures of allele-specific expression allowed the identification of rare eQTLs and allelic differences in transcript structure. This analysis shows that high throughput sequencing technologies reveal new properties of genetic effects on the transcriptome and allow the exploration of genetic effects in cellular processes.	[Montgomery, Stephen B.; Gutierrez-Arcelus, Maria; Dermitzakis, Emmanouil T.] Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland; [Montgomery, Stephen B.; Lach, Radoslaw P.; Ingle, Catherine; Nisbett, James; Dermitzakis, Emmanouil T.] Wellcome Trust Sanger Inst, Cambridge CB10 1HH, England; [Sammeth, Micha; Guigo, Roderic] Univ Pompeu Fabra, Ctr Genom Regulat, Barcelona 08003, Catalonia, Spain	University of Geneva; Wellcome Trust Sanger Institute; Barcelona Institute of Science & Technology; Pompeu Fabra University; Centre de Regulacio Genomica (CRG)	Dermitzakis, ET (corresponding author), Univ Geneva, Sch Med, Dept Genet Med & Dev, CH-1211 Geneva, Switzerland.	stephen.montgomery@unige.ch; emmanouil.dermitzakis@unige.ch	Dermitzakis, Emmanouil/B-7687-2013; Guigo, Roderic/D-1303-2010; Mustafa, Zafirah/W-9358-2018; Sammeth, Michael/C-1157-2014	Guigo, Roderic/0000-0002-5738-4477; Sammeth, Michael/0000-0002-6528-9883; Montgomery, Stephen/0000-0002-5200-3903	Wellcome Trust; Louis-Jeantet foundation; Swiss National Science Foundation NCCR; Spanish Ministry of Science and Consolider Ingenio	Wellcome Trust(Wellcome TrustEuropean Commission); Louis-Jeantet foundation; Swiss National Science Foundation NCCR(Swiss National Science Foundation (SNSF)); Spanish Ministry of Science and Consolider Ingenio	The authors would like to acknowledge H. Li, S. White, J. O'Brien, S. Searle, M. Quail, S. V. V. Deevi and the Sequencing Core facility at the Wellcome Trust Sanger Institute. We would also like to thank C. Beazley, A. Nica, L. Jostins, K. Morley, J. Barrett and V. Anttila. Funding was provided by the Wellcome Trust, the Louis-Jeantet foundation and the Swiss National Science Foundation NCCR ('Frontiers in Genetics') to E. T. D. and Spanish Ministry of Science and Consolider Ingenio 2010 to R. G.	Ahuja R.K., 1988, NETWORK FLOWS THEORY; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; CORMEN TH, 2001, INTRO ALGORITHMS, P770; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Goring HHH, 2007, NAT GENET, V39, P1208, DOI 10.1038/ng2119; HILLER D, 2009, BIOINFORMATICS, P93901; Hubbard TJP, 2009, NUCLEIC ACIDS RES, V37, pD690, DOI 10.1093/nar/gkn828; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Li H, 2009, BIOINFORMATICS, V25, P2078, DOI 10.1093/bioinformatics/btp352; Maher CA, 2009, NATURE, V458, P97, DOI 10.1038/nature07638; Marchini J, 2007, NAT GENET, V39, P906, DOI 10.1038/ng2088; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Oshlack A, 2009, BIOL DIRECT, V4, DOI 10.1186/1745-6150-4-14; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; PICKRELL JK, 2010, NATURE, V30, P93901; Sabatti C, 2002, GENETICS, V160, P1707; Sammeth M, 2009, J COMPUT BIOL, V16, P1117, DOI 10.1089/cmb.2009.0108; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2007, SCIENCE, V315, P848, DOI 10.1126/science.1136678; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Sultan M, 2008, SCIENCE, V321, P956, DOI 10.1126/science.1160342; t Hoen PAC, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn705; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; Wilhelm BT, 2008, NATURE, V453, P1239, DOI 10.1038/nature07002; Zhang K, 2009, NAT METHODS, V6, P613, DOI 10.1038/nmeth.1357; Zheng SK, 2009, NUCLEIC ACIDS RES, V37, DOI 10.1093/nar/gkp282	34	621	641	1	105	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	APR 1	2010	464	7289					773	U151		10.1038/nature08903	http://dx.doi.org/10.1038/nature08903			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20220756	Green Accepted			2022-12-01	WOS:000276205000048
J	Ray, WA; Murray, KT; Md, MRG; Chung, CP; Smalley, WE; Hall, K; Daugherty, JR; Kaltenbach, LA; Stein, CM				Ray, Wayne A.; Murray, Katherine T.; Md, Marie R. Griffin; Chung, Cecilia P.; Smalley, Walter E.; Hall, Kathi; Daugherty, James R.; Kaltenbach, Lisa A.; Stein, C. Michael			Outcomes With Concurrent Use of Clopidogrel and Proton-Pump Inhibitors A Cohort Study	ANNALS OF INTERNAL MEDICINE			English	Article							NONSTEROIDAL ANTIINFLAMMATORY DRUGS; CORONARY HEART-DISEASE; RISK; OMEPRAZOLE; PHARMACOEPIDEMIOLOGY; PHARMACOKINETICS; RESPONSIVENESS; LANSOPRAZOLE; PANTOPRAZOLE; POLYMORPHISM	Background: Proton-pump inhibitors (PPIs) and clopidogrel are frequently coprescribed, although the benefits and harms of their concurrent use are unclear. Objective: To examine the association between concurrent use of PPIs and clopidogrel and the risks for hospitalizations for gastroduodenal bleeding and serious cardiovascular disease. Design: Retrospective cohort study using automated data to identify patients who received clopidogrel between 1999 through 2005 after hospitalization for coronary heart disease. Setting: Tennessee Medicaid program. Patients: 20 596 patients (including 7593 concurrent users of clopidogrel and PPIs) hospitalized for myocardial infarction, coronary artery revascularization, or unstable angina pectoris. Measurements: Baseline and follow-up drug use was assessed from automated records of dispensed prescriptions. Primary outcomes were hospitalizations for gastroduodenal bleeding and serious cardiovascular disease ( fatal or nonfatal myocardial infarction or sudden cardiac death, stroke, or other cardiovascular death). Results: Pantoprazole and omeprazole accounted for 62% and 9% of concurrent PPI use, respectively. Adjusted incidence of hospitalization for gastroduodenal bleeding in concurrent PPI users was 50% lower than that in nonusers (hazard ratio, 0.50 [95% CI, 0.39 to 0.65]). For patients at highest risk for bleeding, PPI use was associated with an absolute reduction of 28.5 (CI, 11.7 to 36.9) hospitalizations for gastroduodenal bleeding per 1000 person-years. The hazard ratio associated with concurrent PPI use for risk for serious cardiovascular disease was 0.99 (CI, 0.82 to 1.19) for the entire cohort and 1.01 (CI, 0.76 to 1.34) for the subgroup of patients who had percutaneous coronary interventions with stenting during the qualifying hospitalization. Limitations: Unmeasured confounding and misclassification of exposure (no information on adherence or over-the-counter use of drugs) and end points (not confirmed by medical record review) were possible. Because many patients entered the cohort from hospitals with relatively few cohort members, the analysis relied on the assumption that after adjustment for observed covariates, PPI users from one such hospital could be compared with nonusers from a different hospital. Conclusion: In patients with serious coronary heart disease treated with clopidogrel, concurrent PPI use was associated with reduced incidence of hospitalizations for gastroduodenal bleeding. The corresponding point estimate for serious cardiovascular disease was not increased; however, the 95% CI included a clinically important increased risk.	Vanderbilt Univ, Sch Med, Nashville, TN 37212 USA; Vet Affairs Tennessee Valley Healthcare Syst, Nashville, TN USA	Vanderbilt University; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA Tennessee Valley Healthcare System	Ray, WA (corresponding author), Dept Prevent Med, 1500 21st Ave S,Suite 2600, Nashville, TN 37212 USA.	Wayne.Ray@vanderbilt.edu	Chung, Cecilia P/ABE-2177-2021	Chung, Cecilia P/0000-0001-5908-9423	Agency for Healthcare Research and Quality [HS1-16974]; National Heart, Lung, and Blood Institute [HL081707]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL096844, R01HL081707] Funding Source: NIH RePORTER	Agency for Healthcare Research and Quality(United States Department of Health & Human ServicesAgency for Healthcare Research & Quality); National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	Agency for Healthcare Research and Quality and National Heart, Lung, and Blood Institute.; By the Agency for Healthcare Research and Quality Centers for Education and Research on Therapeutics cooperative agreement (HS1-16974) and the National Heart, Lung, and Blood Institute (HL081707).	Altman RD, 2000, ARTHRITIS RHEUM-US, V43, P1905; Arnason T, 2006, THROMB RES, V118, P253, DOI 10.1016/j.thromres.2005.06.015; Bhatt DL, 2008, CIRCULATION, V118, P1894, DOI 10.1161/CIRCULATIONAHA.108.191087; Bhatt DL, 2006, NEW ENGL J MED, V354, P1706, DOI 10.1056/NEJMoa060989; CHAE YK, 2009, JAMA-J AM MED ASSOC, V302, P31; Chae YK, 2009, JAMA-J AM MED ASSOC, V302, P29, DOI 10.1001/jama.2009.896; Chin MWS, 2007, AM J GASTROENTEROL, V102, P2411, DOI 10.1111/j.1572-0241.2007.01460.x; Choma NN, 2009, PHARMACOEPIDEM DR S, V18, P1064, DOI 10.1002/pds.1821; Cryer B, 2005, NEW ENGL J MED, V352, P287, DOI 10.1056/NEJMe048330; Donner A, 2000, DESIGN ANAL CLUSTER; Eshaghian S, 2007, ANN INTERN MED, V146, P434, DOI 10.7326/0003-4819-146-6-200703200-00008; Freedman JE, 2009, NEW ENGL J MED, V360, P411, DOI 10.1056/NEJMe0810513; Gerson LB, 2001, EUR J GASTROEN HEPAT, V13, P611, DOI 10.1097/00042737-200105000-00025; Gilard M, 2008, J AM COLL CARDIOL, V51, P256, DOI 10.1016/j.jacc.2007.06.064; Glynn RJ, 2006, BASIC CLIN PHARMACOL, V98, P253, DOI 10.1111/j.1742-7843.2006.pto_293.x; Gugler R, 1996, BRIT J CLIN PHARMACO, V42, P249, DOI 10.1046/j.1365-2125.1996.40619.x; Gurbel PA, 2008, J AM COLL CARDIOL, V51, P261, DOI 10.1016/j.jacc.2007.07.090; Hernandez-Diaz Sonia, 2001, American Journal of Medicine, V110, p20S; Ho PM, 2009, JAMA-J AM MED ASSOC, V301, P937, DOI 10.1001/jama.2009.261; Hulot JS, 2006, BLOOD, V108, P2244, DOI 10.1182/blood-2006-04-013052; JOHNSON RE, 1991, J AM GERIATR SOC, V39, P1079, DOI 10.1111/j.1532-5415.1991.tb02872.x; JUURLINK DN, 2009, CAN MED ASSOC J, V180, P1; Kahrilas PJ, 2008, NEW ENGL J MED, V359, P1700, DOI 10.1056/NEJMcp0804684; Lanas A, 2007, AM J GASTROENTEROL, V102, P507, DOI 10.1111/j.1572-0241.2006.01062.x; LANDRY JA, 1988, GERONTOLOGIST, V28, P672, DOI 10.1093/geront/28.5.672; Li XQ, 2004, DRUG METAB DISPOS, V32, P821, DOI 10.1124/dmd.32.8.821; Mega JL, 2009, NEW ENGL J MED, V360, P354, DOI 10.1056/NEJMoa0809171; O'Donoghue ML, 2009, LANCET, V374, P989, DOI 10.1016/S0140-6736(09)61525-7; Ray WA, 2002, LANCET, V360, P1071, DOI 10.1016/S0140-6736(02)11131-7; Ray WA, 2003, NEW ENGL J MED, V349, P1592, DOI 10.1056/NEJMp038145; RAY WA, 1989, AM J EPIDEMIOL, V129, P837, DOI 10.1093/oxfordjournals.aje.a115198; Ray WA, 2002, LANCET, V359, P118, DOI 10.1016/S0140-6736(02)07370-1; Ray WA, 2007, GASTROENTEROLOGY, V133, P790, DOI 10.1053/j.gastro.2007.06.058; Ray WA, 2009, NEW ENGL J MED, V360, P225, DOI 10.1056/NEJMoa0806994; Rournie CL, 2008, PHARMACOEPIDEM DR S, V17, P20, DOI 10.1002/pds.1518; Schneider-Lindner V, 2009, JAMA-J AM MED ASSOC, V302, P29, DOI 10.1001/jama.2009.897; SCHNEIDERLINDNE.V, 2009, JAMA-J AM MED ASSOC, V302, P31, DOI DOI 10.1001/JAMA.2009.897; Shahi CN, 2001, AM HEART J, V142, P263, DOI 10.1067/mhj.2001.116477; Siller-Matula JM, 2009, AM HEART J, V157, P148, DOI 10.1016/j.ahj.2008.09.017; Simon T, 2009, NEW ENGL J MED, V360, P363, DOI 10.1056/NEJMoa0808227; Small DS, 2008, J CLIN PHARMACOL, V48, P475, DOI 10.1177/0091270008315310; WEST SL, 1995, AM J EPIDEMIOL, V142, P1103, DOI 10.1093/oxfordjournals.aje.a117563; Wiviott SD, 2007, NEW ENGL J MED, V357, P2001, DOI 10.1056/NEJMoa0706482; Yu KS, 2001, CLIN PHARMACOL THER, V69, P266, DOI 10.1067/mcp.2001.114231	44	183	200	0	14	AMER COLL PHYSICIANS	PHILADELPHIA	INDEPENDENCE MALL WEST 6TH AND RACE ST, PHILADELPHIA, PA 19106-1572 USA	0003-4819	1539-3704		ANN INTERN MED	Ann. Intern. Med.	MAR 16	2010	152	6					337	+		10.7326/0003-4819-152-6-201003160-00003	http://dx.doi.org/10.7326/0003-4819-152-6-201003160-00003			18	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573IF	20231564	Green Accepted			2022-12-01	WOS:000275905200001
J	Ravasi, T; Suzuki, H; Cannistraci, CV; Katayama, S; Bajic, VB; Tan, K; Akalin, A; Schmeier, S; Kanamori-Katayama, M; Bertin, N; Carninci, P; Daub, CO; Forrest, ARR; Gough, J; Grimmond, S; Han, JH; Hashimoto, T; Hide, W; Hofmann, O; Kawaji, H; Kubosaki, A; Lassmann, T; van Nimwegen, E; Ogawa, C; Teasdale, RD; Tegner, J; Lenhard, B; Teichmann, SA; Arakawa, T; Ninomiya, N; Murakami, K; Tagami, M; Fukuda, S; Imamura, K; Kai, C; Ishihara, R; Kitazume, Y; Kawai, J; Hume, DA; Ideker, T; Hayashizaki, Y				Ravasi, Timothy; Suzuki, Harukazu; Cannistraci, Carlo Vittorio; Katayama, Shintaro; Bajic, Vladimir B.; Tan, Kai; Akalin, Altuna; Schmeier, Sebastian; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Gough, Julian; Grimmond, Sean; Han, Jung-Hoon; Hashimoto, Takehiro; Hide, Winston; Hofmann, Oliver; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; van Nimwegen, Erik; Ogawa, Chihiro; Teasdale, Rohan D.; Tegner, Jesper; Lenhard, Boris; Teichmann, Sarah A.; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hume, David A.; Ideker, Trey; Hayashizaki, Yoshihide			An Atlas of Combinatorial Transcriptional Regulation in Mouse and Man	CELL			English	Article							EMBRYONIC STEM-CELLS; PROTEIN INTERACTIONS; GENE-EXPRESSION; NETWORKS; DNA; BINDING; FAMILY; YEAST; LIPOPOLYSACCHARIDE; DIFFERENTIATION	Combinatorial interactions among transcription factors are critical to directing tissue-specific gene expression. To build a global atlas of these combinations, we have screened for physical interactions among the majority of human and mouse DNA-binding transcription factors (TFs). The complete networks contain 762 human and 877 mouse interactions. Analysis of the networks reveals that highly connected TFs are broadly expressed across tissues, and that roughly half of the measured interactions are conserved between mouse and human. The data highlight the importance of TF combinations for determining cell fate, and they lead to the identification of a SMAD3/FLI1 complex expressed during development of immunity. The availability of large TF combinatorial networks in both human and mouse will provide many opportunities to study gene regulation, tissue differentiation, and mammalian evolution.	[Ravasi, Timothy; Suzuki, Harukazu; Cannistraci, Carlo Vittorio; Katayama, Shintaro; Bajic, Vladimir B.; Tan, Kai; Akalin, Altuna; Schmeier, Sebastian; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Gough, Julian; Grimmond, Sean; Han, Jung-Hoon; Hashimoto, Takehiro; Hide, Winston; Hofmann, Oliver; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; van Nimwegen, Erik; Ogawa, Chihiro; Teasdale, Rohan D.; Tegner, Jesper; Lenhard, Boris; Teichmann, Sarah A.; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hume, David A.; Ideker, Trey; Hayashizaki, Yoshihide] Univ Calif San Diego, FANTOM Consortium, La Jolla, CA 92093 USA; [Suzuki, Harukazu; Katayama, Shintaro; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Hashimoto, Takehiro; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; Ogawa, Chihiro; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hayashizaki, Yoshihide] Univ Calif San Diego, RIKEN Om Sci Ctr, La Jolla, CA 92093 USA; [Ravasi, Timothy; Cannistraci, Carlo Vittorio; Tan, Kai; Ideker, Trey] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Ravasi, Timothy; Cannistraci, Carlo Vittorio; Tan, Kai; Ideker, Trey] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Ravasi, Timothy; Cannistraci, Carlo Vittorio; Bajic, Vladimir B.; Han, Jung-Hoon] King Abdullah Univ Sci & Technol, Computat Biosci Res Ctr, Div Chem & Life Sci & Engn, Red Sea Integrat Syst Biol Lab, Jeddah, Saudi Arabia; [Suzuki, Harukazu; Katayama, Shintaro; Kanamori-Katayama, Mutsumi; Bertin, Nicolas; Carninci, Piero; Daub, Carsten O.; Forrest, Alistair R. R.; Hashimoto, Takehiro; Kawaji, Hideya; Kubosaki, Atsutaka; Lassmann, Timo; Ogawa, Chihiro; Arakawa, Takahiro; Ninomiya, Noriko; Murakami, Kayoko; Tagami, Michihira; Fukuda, Shiro; Imamura, Kengo; Kai, Chikatoshi; Ishihara, Ryoko; Kitazume, Yayoi; Kawai, Jun; Hayashizaki, Yoshihide] RIKEN Yokohama Inst, RIKEN Om Sci Ctr, Tsurumi Ku, Kanagawa 2300045, Japan; [Cannistraci, Carlo Vittorio] Politecn Torino, Dept Mech, I-10129 Turin, Italy; [Cannistraci, Carlo Vittorio] Ist Sci San Raffaele, I-20132 Milan, Italy; [Cannistraci, Carlo Vittorio] Politecn Torino, CMP Grp Microsoft Res, I-10129 Turin, Italy; [Bajic, Vladimir B.; Schmeier, Sebastian; Hide, Winston; Hofmann, Oliver] Univ Western Cape, S African Natl Bioinformat Inst, ZA-7535 Bellville, South Africa; [Akalin, Altuna; Lenhard, Boris] Bergen Ctr Computat Sci, N-5008 Bergen, Norway; [Forrest, Alistair R. R.] Griffith Univ, Eskitis Inst Cell & Mol Therapies, Griffith, Qld 4111, Australia; [Gough, Julian] Univ Bristol, Dept Comp Sci, Bristol BS8 1UB, Avon, England; [Grimmond, Sean; Teasdale, Rohan D.] Univ Queensland, Inst Mol Biosci, Australian Res Council, Special Res Ctr Funct & Appl Genom, St Lucia, Qld 4072, Australia; [Han, Jung-Hoon; Teichmann, Sarah A.] MRC Lab Mol Biol, Cambridge CB2 0QH, England; [Hide, Winston] Harvard Univ, Sch Publ Hlth, Dept Biostat, Boston, MA 02115 USA; [van Nimwegen, Erik] Univ Basel, Biozentrum, CH-4056 Basel, Switzerland; [van Nimwegen, Erik] Swiss Inst Bioinformat, CH-4056 Basel, Switzerland; [Tegner, Jesper] Karolinska Univ Hosp Solna, Karolinska Inst, Dept Med, Atherosclerosis Res Unit,Ctr Mol Med,Computat Med, SE-17176 Stockholm, Sweden; [Tegner, Jesper] Linkoping Univ, Dept Phys Chem & Biol, SE-58183 Linkoping, Sweden; [Hume, David A.] Univ Edinburgh, Roslin Inst, Roslin EH25 9PS, Midlothian, Scotland; [Hume, David A.] Univ Edinburgh, Royal Dick Sch Vet Studies, Roslin EH25 9PS, Midlothian, Scotland; [Ideker, Trey] Univ Calif San Diego, Inst Genom Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; King Abdullah University of Science & Technology; RIKEN; Polytechnic University of Turin; Vita-Salute San Raffaele University; IRCCS Ospedale San Raffaele; Polytechnic University of Turin; South African National Biodiversity Institute; University of the Western Cape; Griffith University; University of Bristol; University of Queensland; MRC Laboratory Molecular Biology; Harvard University; Harvard T.H. Chan School of Public Health; University of Basel; Swiss Institute of Bioinformatics; Karolinska Institutet; Karolinska University Hospital; Linkoping University; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); Roslin Institute; University of Edinburgh; University of Edinburgh; University of California System; University of California San Diego	Ideker, T (corresponding author), Univ Calif San Diego, FANTOM Consortium, 9500 Gilman Dr, La Jolla, CA 92093 USA.	tideker@ucsd.edu; yosihide@gsc.riken.jp	Lassmann, Timo/HCH-4313-2022; Hayashizaki, Yoshihide/N-6590-2015; Bertin, Nicolas/O-9602-2019; Carninci, Piero/K-1568-2014; van Nimwegen, Erik/ABF-1085-2021; Grimmond, Sean/K-3246-2019; Hide, Winston/R-3815-2019; Lassmann, Timo/A-8271-2008; Suzuki, Harukazu/N-9553-2015; Grimmond, Sean M/J-5304-2016; Califano, Andrea/F-7239-2012; Kawaji, Hideya/N-5116-2015; Forrest, Alistair/A-6597-2008; Daub, Carsten O/A-7436-2010; Hume, David A/C-7695-2013; Hofmann, Oliver M/F-1800-2013; Teasdale, Rohan D/B-2538-2009; Hide, Winston Hide/C-7217-2009; Teasdale, Rohan/AAD-6698-2019; Kawai, Jun/A-6451-2016; Ravasi, Timothy/B-8777-2008; Schmeier, Sebastian/D-4731-2011; AKALIN, ALTUNA/A-4424-2012; Cannistraci, Carlo Vittorio/G-1710-2014; Hide, Winston A/V-2727-2017; Tomic, Nevena/AAA-2135-2021; Radovanovic, Aleksandar/M-3687-2019; Radovanovic, Aleksandar/D-1313-2012; Katayama, Shintaro/F-2958-2010; tegner, jesper N/R-5095-2017; Kaur, Mandeep/N-4550-2015; Bertin, Nicolas/C-3025-2008; Bajic, Vladimir/D-2810-2009	Lassmann, Timo/0000-0002-0138-2691; Carninci, Piero/0000-0001-7202-7243; van Nimwegen, Erik/0000-0001-6338-1312; Grimmond, Sean/0000-0002-8102-7998; Hide, Winston/0000-0002-8621-3271; Lassmann, Timo/0000-0002-0138-2691; Suzuki, Harukazu/0000-0002-8087-0836; Grimmond, Sean M/0000-0002-8102-7998; Kawaji, Hideya/0000-0002-0575-0308; Forrest, Alistair/0000-0003-4543-1675; Daub, Carsten O/0000-0002-3295-8729; Hofmann, Oliver M/0000-0002-7738-1513; Teasdale, Rohan D/0000-0001-7455-5269; Hide, Winston Hide/0000-0002-8621-3271; Teasdale, Rohan/0000-0001-7455-5269; Schmeier, Sebastian/0000-0002-3947-8226; AKALIN, ALTUNA/0000-0002-0468-0117; Cannistraci, Carlo Vittorio/0000-0003-0100-8410; Hide, Winston A/0000-0002-8621-3271; Radovanovic, Aleksandar/0000-0002-8749-7608; Radovanovic, Aleksandar/0000-0002-8749-7608; Katayama, Shintaro/0000-0001-7581-5157; tegner, jesper N/0000-0002-9568-5588; Kaur, Mandeep/0000-0002-9757-4048; Fukuda, Shiro/0000-0002-0065-662X; Teichmann, Sarah/0000-0002-6294-6366; Hume, David/0000-0002-2615-1478; Bertin, Nicolas/0000-0002-9835-9606; Bajic, Vladimir/0000-0001-5435-4750; Ideker, Trey/0000-0002-1708-8454; Ravasi, Timothy/0000-0002-9950-465X; MacPherson, Cameron/0000-0002-8945-9736; Lenhard, Boris/0000-0002-1114-1509; Tan, Kai/0000-0002-9104-5567	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT); US National Institute of Mental Health [MH062261]; King Abdullah University of Science and Technology; Max Planck Society for the Advancement of Science; SA National Bioinformatics Network; Claude Leon Foundation; Australian NHMRC; Scuola Interpolitecnica di Dottorato; NATIONAL INSTITUTE OF MENTAL HEALTH [P30MH062261] Funding Source: NIH RePORTER; Biotechnology and Biological Sciences Research Council [BB/G022771/1] Funding Source: researchfish; Medical Research Council [G9900991B, MC_U105161047] Funding Source: researchfish; BBSRC [BB/G022771/1] Funding Source: UKRI; MRC [MC_U105161047] Funding Source: UKRI	Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT)(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)); US National Institute of Mental Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); King Abdullah University of Science and Technology(King Abdullah University of Science & Technology); Max Planck Society for the Advancement of Science(Max Planck SocietyEuropean Commission); SA National Bioinformatics Network; Claude Leon Foundation; Australian NHMRC(National Health and Medical Research Council (NHMRC) of Australia); Scuola Interpolitecnica di Dottorato; NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	The work for the RIKEN Omics Science Center was supported by grants from the Japanese Ministry of Education, Culture, Sports, Science and Technology (MEXT) through the Genome Network Project and for the RIKEN Omics Science Center (YH, Principal Investigator). Members of the FANTOM Consortium were supported by grant MH062261 from the US National Institute of Mental Health (TR, KT, TI), the King Abdullah University of Science and Technology (TR, VBB), the Max Planck Society for the Advancement of Science (AK), the SA National Bioinformatics Network (SS, AR, VBB, WAH), the Claude Leon Foundation (MK), a CJ Martin Fellowship from the Australian NHMRC (ARRF), and the Scuola Interpolitecnica di Dottorato (CVC). The authors gratefully acknowledge S. Choi for critical feedback on the manuscript.	Ameyar M, 2003, BIOCHIMIE, V85, P747, DOI 10.1016/j.biochi.2003.09.006; Ban J, 2008, CANCER RES, V68, P7100, DOI 10.1158/0008-5472.CAN-07-6145; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Cole MF, 2008, GENE DEV, V22, P746, DOI 10.1101/gad.1642408; Davidson EH, 2002, SCIENCE, V295, P1669, DOI 10.1126/science.1069883; Duverger O, 2008, J CELL PHYSIOL, V216, P337, DOI 10.1002/jcp.21491; Fedorova E, 2008, BBA-MOL CELL RES, V1783, P2174, DOI 10.1016/j.bbamcr.2008.07.018; Grigoryan G, 2009, NATURE, V458, P859, DOI 10.1038/nature07885; Jaenisch R, 2009, J THROMB HAEMOST, V7, P21, DOI 10.1111/j.1538-7836.2009.03418.x; Jin GX, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001207; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Kalaev M, 2008, BIOINFORMATICS, V24, P594, DOI 10.1093/bioinformatics/btm630; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Luscombe NM, 2004, NATURE, V431, P308, DOI 10.1038/nature02782; Marson A, 2007, NATURE, V445, P931, DOI 10.1038/nature05478; Mathur D, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r126; Meran S, 2008, J BIOL CHEM, V283, P6530, DOI 10.1074/jbc.M704819200; Muller FJ, 2008, NATURE, V455, P401, DOI 10.1038/nature07213; Naef F, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni104; O'Brien KP, 2005, NUCLEIC ACIDS RES, V33, pD476, DOI 10.1093/nar/gki107; Park DU, 2005, BIOINFORMATICS, V21, P3234, DOI 10.1093/bioinformatics/bti512; Roach JC, 2007, P NATL ACAD SCI USA, V104, P16245, DOI 10.1073/pnas.0707757104; Roguev A, 2008, SCIENCE, V322, P405, DOI 10.1126/science.1162609; Schreiber J, 2006, P NATL ACAD SCI USA, V103, P5899, DOI 10.1073/pnas.0510996103; Shachaf CM, 2008, CANCER RES, V68, P5132, DOI 10.1158/0008-5472.CAN-07-6192; Suzuki H, 2001, GENOME RES, V11, P1758, DOI 10.1101/gr.180101; Suzuki H, 2004, BIOTECHNIQUES, V37, P918, DOI 10.2144/04376BM06; Suzuki H, 2009, NAT GENET, V41, P553, DOI 10.1038/ng.375; Tan K, 2008, P NATL ACAD SCI USA, V105, P2934, DOI 10.1073/pnas.0708670105; Tan K, 2008, GENOMICS, V91, P219, DOI 10.1016/j.ygeno.2007.11.005; Taylor IW, 2009, NAT BIOTECHNOL, V27, P199, DOI 10.1038/nbt.1522; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Usui K, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r98; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Walhout AJM, 2006, GENOME RES, V16, P1445, DOI 10.1101/gr.5321506; Wen XL, 1998, P NATL ACAD SCI USA, V95, P334, DOI 10.1073/pnas.95.1.334; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yu XP, 2006, NUCLEIC ACIDS RES, V34, P4925, DOI 10.1093/nar/gkl595; Zhang Wen, 2004, J Biol, V3, P21, DOI 10.1186/jbiol16; Zhou LQ, 2008, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-54	41	518	532	1	50	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					744	752		10.1016/j.cell.2010.01.044	http://dx.doi.org/10.1016/j.cell.2010.01.044			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211142	Green Published, Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000275197400022
J	Cusimano, MD; Kwok, J				Cusimano, Michael D.; Kwok, Judith			Skiers, Snowboarders, and Safety Helmets	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							INJURIES; HEAD		[Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Toronto, ON M5W 1W8, Canada; [Cusimano, Michael D.; Kwok, Judith] St Michaels Hosp, Injury Prevent Res Off, Toronto, ON M5W 1W8, Canada; [Cusimano, Michael D.; Kwok, Judith] Univ Toronto, Toronto, ON, Canada	University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto; University Toronto Affiliates; Saint Michaels Hospital Toronto; University of Toronto	Cusimano, MD (corresponding author), St Michaels Hosp, Div Neurosurg, 30 Bond St, Toronto, ON M5W 1W8, Canada.	injuryprevention@smh.toronto.on.ca	Cusimano, Michael/X-4059-2019; Cusimano, Michael/GWR-1025-2022	Cusimano, Michael/0000-0002-9989-0650				Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Evans B, 2009, INT J INJ CONTROL SA, V16, P9, DOI 10.1080/17457300902732045; Jlrgensen U, 1998, Knee Surg Sports Traumatol Arthrosc, V6, P194; Kronisch RL, 2002, SPORTS MED, V32, P523, DOI 10.2165/00007256-200232080-00004; Lawrence L, 2008, PEDIATR EMERG CARE, V24, P219, DOI 10.1097/PEC.0b013e31816a9f0a; Mueller BA, 2008, EPIDEMIOLOGY, V19, P270, DOI 10.1097/EDE.0b013e318163567c; *NAT SKI AR ASS, NSAA MED CTR CURR RE; *OCC SAF HLTH ADM, QUICK TIPS SKI RES W; *OH DEP HLTH, OH REC FED FUND SAF; Rivara FP, 1998, ANNU REV PUBL HEALTH, V19, P293, DOI 10.1146/annurev.publhealth.19.1.293	10	12	12	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					661	662		10.1001/jama.2010.147	http://dx.doi.org/10.1001/jama.2010.147			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555NK	20159875				2022-12-01	WOS:000274518600026
J	Doceul, V; Hollinshead, M; van der Linden, L; Smith, GL				Doceul, Virginie; Hollinshead, Michael; van der Linden, Lonneke; Smith, Geoffrey L.			Repulsion of Superinfecting Virions: A Mechanism for Rapid Virus Spread	SCIENCE			English	Article							EXTRACELLULAR ENVELOPED VIRUS; ACTIN TAIL FORMATION; TO-CELL SPREAD; VACCINIA VIRUS; SEQUENCE-ANALYSIS; A36R PROTEIN; A33R PROTEIN; GENE; FUSION; LOCALIZATION	Viruses are thought to spread across susceptible cells through an iterative process of infection, replication, and release, so that the rate of spread is limited by replication kinetics. Here, we show that vaccinia virus spreads across one cell every 75 minutes, fourfold faster than its replication cycle would permit. To explain this phenomenon, we found that newly infected cells express two surface proteins that mark cells as infected and, via exploitation of cellular machinery, induce the repulsion of superinfecting virions away toward uninfected cells. Mechanistically, early expression of proteins A33 and A36 was critical for virion repulsion and rapid spread, and cells expressing these proteins repelled exogenous virions rapidly. Additional spreading mechanisms may exist for other viruses that also spread faster than predicted by replication kinetics.	[Doceul, Virginie; Hollinshead, Michael; van der Linden, Lonneke; Smith, Geoffrey L.] Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Virol, London W2 1PG, England	Imperial College London	Smith, GL (corresponding author), Univ London Imperial Coll Sci Technol & Med, Fac Med, Dept Virol, St Marys Campus,Norfolk Pl, London W2 1PG, England.	geoffrey.l.smith@imperial.ac.uk	Smith, Geoffrey L/G-2894-2012	Smith, Geoffrey L/0000-0002-3730-9955	UK Medical Research Council; MRC [G0501257] Funding Source: UKRI; Medical Research Council [G0501257] Funding Source: researchfish	UK Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	We thank Professor Rick E. Randall, University of St. Andrews for the lentivirus vectors. GLS is a Wellcome Trust Principal Research Fellow. This work was supported by the UK Medical Research Council.	BLASCO R, 1991, J VIROL, V65, P4598, DOI 10.1128/JVI.65.9.4598-4608.1991; Carter GC, 2003, J GEN VIROL, V84, P2443, DOI 10.1099/vir.0.19271-0; Condit RC, 2006, ADV VIRUS RES, V66, P31, DOI 10.1016/S0065-3527(06)66002-8; CUDMORE S, 1995, NATURE, V378, P636, DOI 10.1038/378636a0; DULBECCO R, 1952, P NATL ACAD SCI USA, V38, P747, DOI 10.1073/pnas.38.8.747; Elliott G, 1999, J VIROL, V73, P4110, DOI 10.1128/JVI.73.5.4110-4119.1999; ENGELSTAD M, 1993, VIROLOGY, V194, P627, DOI 10.1006/viro.1993.1302; HILLER G, 1979, VIROLOGY, V98, P142, DOI 10.1016/0042-6822(79)90533-6; LAW KM, 1992, J GEN VIROL, V73, P549, DOI 10.1099/0022-1317-73-3-549; Law M, 2002, J GEN VIROL, V83, P209, DOI 10.1099/0022-1317-83-1-209; Lorenzo MM, 2000, J VIROL, V74, P10535, DOI 10.1128/JVI.74.22.10535-10550.2000; McIntosh AAG, 1996, J VIROL, V70, P272, DOI 10.1128/JVI.70.1.272-281.1996; Moss B., 2007, FIELDS VIROLOGY, V2, P2905; PARKINSON JE, 1994, VIROLOGY, V204, P376, DOI 10.1006/viro.1994.1542; PAYNE LG, 1979, J VIROL, V32, P614, DOI 10.1128/JVI.32.2.614-622.1979; Perdiguero B, 2006, J VIROL, V80, P8763, DOI 10.1128/JVI.00598-06; Roberts KL, 2008, TRENDS MICROBIOL, V16, P472, DOI 10.1016/j.tim.2008.07.009; Roper RL, 1998, J VIROL, V72, P4192, DOI 10.1128/JVI.72.5.4192-4204.1998; Roper RL, 1996, J VIROL, V70, P3753, DOI 10.1128/JVI.70.6.3753-3762.1996; ROSEL J, 1985, J VIROL, V56, P830, DOI 10.1128/JVI.56.3.830-838.1985; Rottger S, 1999, J VIROL, V73, P2863; Sanderson CM, 1998, J VIROL, V72, P1235, DOI 10.1128/JVI.72.2.1235-1243.1998; Smith GL, 2002, J GEN VIROL, V83, P2915, DOI 10.1099/0022-1317-83-12-2915; STOKES GV, 1976, J VIROL, V18, P636, DOI 10.1128/JVI.18.2.636-643.1976; Turner PC, 2008, VIROLOGY, V380, P226, DOI 10.1016/j.virol.2008.07.020; van Eijl H, 2000, VIROLOGY, V271, P26, DOI 10.1006/viro.2000.0260; Wagenaar TR, 2007, J VIROL, V81, P6286, DOI 10.1128/JVI.00274-07; Wagenaar TR, 2009, J VIROL, V83, P1546, DOI 10.1128/JVI.01684-08; Wolffe EJ, 2001, J VIROL, V75, P303, DOI 10.1128/JVI.75.1.303-310.2001; Zhang WH, 2000, J VIROL, V74, P11654, DOI 10.1128/JVI.74.24.11654-11662.2000	30	154	159	1	27	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					873	876		10.1126/science.1183173	http://dx.doi.org/10.1126/science.1183173			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20093437	Green Accepted			2022-12-01	WOS:000274408300064
J	Li, JL; Browning, S; Mahal, SP; Oelschlegel, AM; Weissmann, C				Li, Jiali; Browning, Shawn; Mahal, Sukhvir P.; Oelschlegel, Anja M.; Weissmann, Charles			Darwinian Evolution of Prions in Cell Culture	SCIENCE			English	Article							CREUTZFELDT-JAKOB-DISEASE; MOUSE SCRAPIE; PROTEIN; STRAINS; ASSAY; CONFORMATION; HAMSTERS; AGENT	Prions are infectious proteins consisting mainly of PrPSc, a beta sheet-rich conformer of the normal host protein PrPC, and occur in different strains. Strain identity is thought to be encoded by PrPSc conformation. We found that biologically cloned prion populations gradually became heterogeneous by accumulating "mutants," and selective pressures resulted in the emergence of different mutants as major constituents of the evolving population. Thus, when transferred from brain to cultured cells, "cell-adapted" prions outcompeted their "brain-adapted" counterparts, and the opposite occurred when prions were returned from cells to brain. Similarly, the inhibitor swainsonine selected for a resistant substrain, whereas, in its absence, the susceptible substrain outgrew its resistant counterpart. Prions, albeit devoid of a nucleic acid genome, are thus subject to mutation and selective amplification.	[Li, Jiali; Browning, Shawn; Mahal, Sukhvir P.; Oelschlegel, Anja M.; Weissmann, Charles] Scripps Florida, Dept Infectol, Jupiter, FL 33458 USA	State University System of Florida; University of Florida	Weissmann, C (corresponding author), Scripps Florida, Dept Infectol, 130 Scripps Way, Jupiter, FL 33458 USA.	charlesw@scripps.edu	li, jiali/C-8811-2011		NIH [NSO59543]; Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS067214, R01NS059543] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Alafi Family Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank C. A. Demczyk for assistance with cell culture, E. Smith for assistance with the SSCA, I. Suponitsky-Kroyter for the proteolytic digestion analyses, and A. Sherman for histochemistry and animal work. We thank T. Bartfai, G. Joyce, and C. Lasmezas for critical reading of the manuscript and valuable suggestions. The project was supported by an R01 grant (# NSO59543) from the NIH and by a generous donation from the Alafi Family Foundation to C.	Arima K, 2005, J VIROL, V79, P7104, DOI 10.1128/JVI.79.11.7104-7112.2005; Arjona A, 2004, P NATL ACAD SCI USA, V101, P8768, DOI 10.1073/pnas.0400158101; Barria MA, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000421; BESSEN RA, 1992, J VIROL, V66, P2096, DOI 10.1128/JVI.66.4.2096-2101.1992; Bruce M E, 1991, Curr Top Microbiol Immunol, V172, P125; BRUCE ME, 1992, E H S NEURO, P497; BRUCE ME, 1987, J GEN VIROL, V68, P79, DOI 10.1099/0022-1317-68-1-79; Caughey B, 1999, MOL BIOTECHNOL, V13, P45, DOI 10.1385/MB:13:1:45; Collinge J, 1996, NATURE, V383, P685, DOI 10.1038/383685a0; Collinge J, 2007, SCIENCE, V318, P930, DOI 10.1126/science.1138718; Eigen M, 1996, TRENDS MICROBIOL, V4, P216, DOI 10.1016/0966-842X(96)20011-3; EPSTEIN IR, 1979, BIOPHYS CHEM, V10, P153, DOI 10.1016/0301-4622(79)85035-8; FRASER H, 1992, PRION DIS HUMANS ANI, P59; Ghaemmaghami S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000673; Hilton DA, 1998, LANCET, V352, P703, DOI 10.1016/S0140-6736(98)24035-9; JARRETT JT, 1993, CELL, V73, P1055, DOI 10.1016/0092-8674(93)90635-4; Kellershohn N, 1998, BIOCHEM J, V334, P539, DOI 10.1042/bj3340539; KIMBERLIN RH, 1987, J GEN VIROL, V68, P1875, DOI 10.1099/0022-1317-68-7-1875; KIMBERLIN RH, 1989, J GEN VIROL, V70, P2017, DOI 10.1099/0022-1317-70-8-2017; Klohn PC, 2003, P NATL ACAD SCI USA, V100, P11666, DOI 10.1073/pnas.1834432100; Kuczius T, 1999, MOL MED, V5, P406, DOI 10.1007/BF03402129; Legname G, 2006, P NATL ACAD SCI USA, V103, P19105, DOI 10.1073/pnas.0608970103; Mahal SP, 2007, P NATL ACAD SCI USA, V104, P20908, DOI 10.1073/pnas.0710054104; MCCONNELL I, COMMUNICATION; Owen JP, 2007, J VIROL, V81, P10532, DOI 10.1128/JVI.00640-07; Peretz D, 2002, NEURON, V34, P921, DOI 10.1016/S0896-6273(02)00726-2; Peretz D, 2001, PROTEIN SCI, V10, P854, DOI 10.1110/ps.39201; Saborio GP, 2001, NATURE, V411, P810, DOI 10.1038/35081095; Telling GC, 1996, SCIENCE, V274, P2079, DOI 10.1126/science.274.5295.2079; TULSIANI DRP, 1983, J BIOL CHEM, V258, P7578; Wadsworth JDF, 2001, LANCET, V358, P171, DOI 10.1016/S0140-6736(01)05403-4	31	299	304	2	50	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					869	872		10.1126/science.1183218	http://dx.doi.org/10.1126/science.1183218			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044542	Green Accepted			2022-12-01	WOS:000274408300063
J	Lishko, PV; Botchkina, IL; Fedorenko, A; Kirichok, Y				Lishko, Polina V.; Botchkina, Inna L.; Fedorenko, Andriy; Kirichok, Yuriy			Acid Extrusion from Human Spermatozoa Is Mediated by Flagellar Voltage-Gated Proton Channel	CELL			English	Article							INTRACELLULAR PH; SPERM MOTILITY; BOVINE SPERM; HYPERACTIVATED MOTILITY; NA+/H+ EXCHANGER; MAMMALIAN SPERM; MALE-FERTILITY; BULL SPERM; CA2+; ZINC	Human spermatozoa are quiescent in the male reproductive system and must undergo activation once introduced into the female reproductive tract. This process is known to require alkalinization of sperm cytoplasm, but the mechanism responsible for transmembrane proton extrusion has remained unknown because of the inability to measure membrane conductance in human sperm. Here, by successfully patch clamping human spermatozoa, we show that proton channel Hv1 is their dominant proton conductance. Hv1 is confined to the principal piece of the sperm flagellum, where it is expressed at unusually high density. Robust flagellar Hv1-dependent proton conductance is activated by membrane depolarization, an alkaline extracellular environment, endocannabinoid anandamide, and removal of extracellular zinc, a potent Hv1 blocker. Hv1 allows only outward transport of protons and is therefore dedicated to inducing intracellular alkalinization and activating spermatozoa. The importance of Hv1 for sperm activation makes it an attractive target for controlling male fertility.	[Lishko, Polina V.; Botchkina, Inna L.; Fedorenko, Andriy; Kirichok, Yuriy] Univ Calif San Francisco, Dept Physiol, San Francisco, CA 94158 USA	University of California System; University of California San Francisco	Kirichok, Y (corresponding author), Univ Calif San Francisco, Dept Physiol, UCSF Mail Code 2140,Genentech Hall,Room N272F,600, San Francisco, CA 94158 USA.	yuriy.kirichok@ucsf.edu	Lishko, Polina/L-1191-2017; Lishko, Polina/GQH-9569-2022		UCSF	UCSF	We thank David Clapham, Kenton Swartz, and Elena Grachova for their advice. Some images were acquired at the Nikon Imaging Center at UCSF/QB3. This work was funded by UCSF Program for Breakthrough Biomedical Research. P.V.L. and Y.K. conceived the project, designed the experiments, and wrote the manuscript. P.V.L. performed most of the electrophysiological and biochemical experiments. Y. K. and A. F. obtained some electrophysiological data. P.V.L. and I.L.B. performed immunocytochemistry and biochemistry experiments. All authors discussed the results and commented on the manuscript.	ACOTT TS, 1984, BIOL REPROD, V30, P926, DOI 10.1095/biolreprod30.4.926; Alabi AA, 2007, NATURE, V450, P370, DOI 10.1038/nature06266; BABCOCK DF, 1983, P NATL ACAD SCI-BIOL, V80, P1327, DOI 10.1073/pnas.80.5.1327; Carlson AE, 2003, P NATL ACAD SCI USA, V100, P14864, DOI 10.1073/pnas.2536658100; CARR DW, 1989, BIOL REPROD, V41, P907, DOI 10.1095/biolreprod41.5.907; CARR DW, 1985, BIOL REPROD, V33, P588, DOI 10.1095/biolreprod33.3.588; Cooper TG, 2005, HUM REPROD, V20, P9, DOI 10.1093/humrep/deh555; Darszon A, 2006, REPRODUCTION, V131, P977, DOI 10.1530/rep.1.00612; DASGUPTA S, 1993, J REPROD FERTIL, V99, P135; DeCoursey TE, 2008, CELL MOL LIFE SCI, V65, P2554, DOI 10.1007/s00018-008-8056-8; Decoursey TE, 2003, PHYSIOL REV, V83, P475, DOI 10.1152/physrev.00028.2002; DeCoursey TE, 2008, J PHYSIOL-LONDON, V586, P5305, DOI 10.1113/jphysiol.2008.161703; EHRENWALD E, 1990, MOL REPROD DEV, V25, P195, DOI 10.1002/mrd.1080250213; El-Talatini MR, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004579; FLORMAN HM, 1989, DEV BIOL, V135, P133, DOI 10.1016/0012-1606(89)90164-4; Garcia MA, 1999, MOL REPROD DEV, V52, P189, DOI 10.1002/(SICI)1098-2795(199902)52:2<189::AID-MRD10>3.0.CO;2-D; GIROUXWIDEMANN V, 1991, MOL REPROD DEV, V29, P157, DOI 10.1002/mrd.1080290211; GOLTZ JS, 1988, BIOL REPROD, V39, P1129, DOI 10.1095/biolreprod39.5.1129; GUNN SA, 1958, AM J PHYSIOL, V193, P505, DOI 10.1152/ajplegacy.1958.193.3.505; Hamamah S, 1998, HUM REPROD, V13, P20, DOI 10.1093/humrep/13.suppl_4.20; Hamamah S, 1996, MOL HUM REPROD, V2, P219, DOI 10.1093/molehr/2.4.219; Ho HC, 2002, DEV BIOL, V250, P208, DOI 10.1006/dbio.2002.0797; Ishii T, 2004, J NEUROCYTOL, V33, P657, DOI 10.1007/s11068-005-3334-y; Jimenez-Gonzalez MC, 2007, J CELL PHYSIOL, V213, P801, DOI 10.1002/jcp.21153; Jones JM, 2000, J ANDROL, V21, P616; Kaupp UB, 2008, ANNU REV PHYSIOL, V70, P93, DOI 10.1146/annurev.physiol.70.113006.100654; Kirichok Y, 2006, NATURE, V439, P737, DOI 10.1038/nature04417; Koch HP, 2008, P NATL ACAD SCI USA, V105, P9111, DOI 10.1073/pnas.0801553105; Lee SY, 2008, P NATL ACAD SCI USA, V105, P7692, DOI 10.1073/pnas.0803277105; Lu J, 2008, BIOCHEM SOC T, V36, P1317, DOI 10.1042/BST0361317; Marquez B, 2007, BIOL REPROD, V76, P660, DOI 10.1095/biolreprod.106.055038; Navarro B, 2008, INT J DEV BIOL, V52, P607, DOI 10.1387/ijdb.072554bn; Navarro B, 2007, P NATL ACAD SCI USA, V104, P7688, DOI 10.1073/pnas.0702018104; Okochi Y, 2009, BIOCHEM BIOPH RES CO, V382, P274, DOI 10.1016/j.bbrc.2009.03.036; PARRISH JJ, 1989, BIOL REPROD, V41, P683, DOI 10.1095/biolreprod41.4.683; Platts AE, 2007, HUM MOL GENET, V16, P763, DOI 10.1093/hmg/ddm012; Publicover S, 2007, NAT CELL BIOL, V9, P235, DOI 10.1038/ncb0307-235; Qi HY, 2007, P NATL ACAD SCI USA, V104, P1219, DOI 10.1073/pnas.0610286104; Quill TA, 2001, P NATL ACAD SCI USA, V98, P12527, DOI 10.1073/pnas.221454998; Ramsey IS, 2009, P NATL ACAD SCI USA, V106, P7642, DOI 10.1073/pnas.0902761106; Ramsey IS, 2006, NATURE, V440, P1213, DOI 10.1038/nature04700; Ren DJ, 2001, NATURE, V413, P603, DOI 10.1038/35098027; RIFFO M, 1992, INT J ANDROL, V15, P229, DOI 10.1111/j.1365-2605.1992.tb01343.x; SAARANEN M, 1987, HUM REPROD, V2, P475, DOI 10.1093/oxfordjournals.humrep.a136573; Santi CM, 1998, J GEN PHYSIOL, V112, P33, DOI 10.1085/jgp.112.1.33; Sasaki M, 2006, SCIENCE, V312, P589, DOI 10.1126/science.1122352; SCHACKMANN RW, 1986, J BIOL CHEM, V261, P8719; Schuel H, 2005, BIOL REPROD, V73, P1078, DOI 10.1095/biolreprod.105.043273; Suarez SS, 2006, HUM REPROD UPDATE, V12, P23, DOI 10.1093/humupd/dmi047; Suarez SS, 2008, HUM REPROD UPDATE, V14, P647, DOI 10.1093/humupd/dmn029; TAJIMA Y, 1990, BIOCHIM BIOPHYS ACTA, V1034, P326, DOI 10.1016/0304-4165(90)90059-6; Tombola F, 2008, NEURON, V58, P546, DOI 10.1016/j.neuron.2008.03.026; Woo AL, 2002, MOL REPROD DEV, V62, P348, DOI 10.1002/mrd.90002; Zeng Y, 1996, DEV BIOL, V173, P510, DOI 10.1006/dbio.1996.0044	54	264	268	1	27	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					327	U23		10.1016/j.cell.2009.12.053	http://dx.doi.org/10.1016/j.cell.2009.12.053			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144758	Bronze			2022-12-01	WOS:000274297700011
J	Rehwinkel, J; Tan, CP; Goubau, D; Schulz, O; Pichlmair, A; Bier, K; Robb, N; Vreede, F; Barclay, W; Fodor, E; Sousa, CRE				Rehwinkel, Jan; Tan, Choon Ping; Goubau, Delphine; Schulz, Oliver; Pichlmair, Andreas; Bier, Katja; Robb, Nicole; Vreede, Frank; Barclay, Wendy; Fodor, Ervin; Reis e Sousa, Caetano			RIG-I Detects Viral Genomic RNA during Negative-Strand RNA Virus Infection	CELL			English	Article							INFLUENZA-A VIRUS; INDUCIBLE GENE-I; NS1 PROTEIN; INNATE IMMUNITY; 5'-TRIPHOSPHATE RNA; BETA-INTERFERON; VIRION RNA; PA SUBUNIT; RECOGNITION; BINDING	RIG-I is a key mediator of antiviral immunity, able to couple detection of infection by RNA viruses to the induction of interferons. Natural RIG-I stimulatory RNAs have variously been proposed to correspond to virus genomes, virus replication intermediates, viral transcripts, or self-RNA cleaved by RNase L. However, the relative contribution of each of these RNA species to RIG-I activation and interferon induction in virus-infected cells is not known. Here, we use three approaches to identify physiological RIG-I agonists in cells infected with influenza A virus or Sendai virus. We show that RIG-I agonists are exclusively generated by the process of virus replication and correspond to full-length virus genomes. Therefore, nongenomic viral transcripts, short replication intermediates, and cleaved self-RNA do not contribute substantially to interferon induction in cells infected with these negative strand RNA viruses. Rather, single-stranded RNA viral genomes bearing 50-triphosphates constitute the natural RIG-I agonists that trigger cell-intrinsic innate immune responses during infection.	[Rehwinkel, Jan; Tan, Choon Ping; Goubau, Delphine; Schulz, Oliver; Pichlmair, Andreas; Reis e Sousa, Caetano] Canc Res UK London Res Inst, Immunobiol Lab, London WC2A 3PX, England; [Tan, Choon Ping; Bier, Katja; Robb, Nicole; Vreede, Frank; Fodor, Ervin] Univ Oxford, Sir William Dunn Sch Pathol, Oxford OX1 3RE, England; [Barclay, Wendy] Univ London Imperial Coll Sci Technol & Med, Dept Virol, London W2 1PG, England	Cancer Research UK; University of Oxford; Imperial College London	Sousa, CRE (corresponding author), Canc Res UK London Res Inst, Immunobiol Lab, 44 Lincolns Inn Fields, London WC2A 3PX, England.	caetano@cancer.org.uk	Rehwinkel, Jan/CAG-1436-2022; Reis e Sousa, Caetano/ABD-7322-2021; Reis e Sousa, Caetano/O-1657-2014	Rehwinkel, Jan/0000-0003-3841-835X; Reis e Sousa, Caetano/0000-0001-7392-2119; Reis e Sousa, Caetano/0000-0001-7392-2119; Vreede, Frank/0000-0001-9935-2337; Fodor, Ervin/0000-0003-3249-196X; Schulz, Oliver/0000-0002-1493-3341; Barclay, Wendy/0000-0002-3948-0895	FEBS; Human Frontier Science Program; Baxter and Alma Ricard Foundation; Biotechnology and Biological Sciences Research Council; MRC; Wellcome Trust; European Union (FLUINNATE); Cancer Research UK; Medical Research Council [G0700848] Funding Source: researchfish; MRC [G0700848] Funding Source: UKRI	FEBS; Human Frontier Science Program(Human Frontier Science Program); Baxter and Alma Ricard Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome TrustEuropean Commission); European Union (FLUINNATE)(European CommissionEuropean Commission Joint Research Centre); Cancer Research UK(Cancer Research UK); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank Peter Palese and Shizuo Akira for reagents and George Brownlee and all members of the Immunobiology laboratory for advice and critical discussions. J.R. is a recipient of FEBS and Human Frontier Science Program long-term fellowships. D. G. is a recipient of a Baxter and Alma Ricard Foundation scholarship. K. B. is a recipient of a Biotechnology and Biological Sciences Research Council studentship. E. F. is supported by grants from the MRC, Wellcome Trust, and the European Union (FLUINNATE). Work in the C. R. S. laboratory is funded by Cancer Research UK and a prize from Fondation Bettencourt-Schueller.	Bitko V, 2008, J VIROL, V82, P7977, DOI 10.1128/JVI.02762-07; Collins SE, 2004, J VIROL, V78, P1706, DOI 10.1128/JVI.78.4.1706-1717.2004; Cui S, 2008, MOL CELL, V29, P169, DOI 10.1016/j.molcel.2007.10.032; Donelan NR, 2003, J VIROL, V77, P13257, DOI 10.1128/JVI.77.24.13257-13266.2003; DUESBERG PH, 1969, J MOL BIOL, V42, P485, DOI 10.1016/0022-2836(69)90237-X; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; FODOR E, 1994, J VIROL, V68, P4092, DOI 10.1128/JVI.68.6.4092-4096.1994; Gack MU, 2009, CELL HOST MICROBE, V5, P439, DOI 10.1016/j.chom.2009.04.006; Gitlin L, 2006, P NATL ACAD SCI USA, V103, P8459, DOI 10.1073/pnas.0603082103; GRUNBERGMANAGO M, 1955, SCIENCE, V122, P907, DOI 10.1126/science.122.3176.907; Guo Z, 2007, AM J RESP CELL MOL, V36, P263, DOI 10.1165/rcmb.2006-0283RC; Habjan M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002032; Hara K, 2006, J VIROL, V80, P7789, DOI 10.1128/JVI.00600-06; HATADA E, 1992, J GEN VIROL, V73, P3325, DOI 10.1099/0022-1317-73-12-3325; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hornung V, 2006, SCIENCE, V314, P994, DOI 10.1126/science.1132505; ISAACS A, 1957, PROC R SOC SER B-BIO, V147, P258, DOI 10.1098/rspb.1957.0048; JACKSON DA, 1982, NATURE, V296, P366, DOI 10.1038/296366a0; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kato H, 2008, J EXP MED, V205, P1601, DOI 10.1084/jem.20080091; Kilbourne ED, 2006, EMERG INFECT DIS, V12, P9, DOI 10.3201/eid1201.051254; Knipe D. M., 2007, FIELDS VIROLOGY; KRUG RM, 1987, COLD SPRING HARB SYM, V52, P353, DOI 10.1101/SQB.1987.052.01.040; Kumar H, 2006, J EXP MED, V203, P1795, DOI 10.1084/jem.20060792; Maines TR, 2008, IMMUNOL REV, V225, P68, DOI 10.1111/j.1600-065X.2008.00690.x; Malathi K, 2007, NATURE, V448, P816, DOI 10.1038/nature06042; Marques JT, 2006, NAT BIOTECHNOL, V24, P559, DOI 10.1038/nbt1205; Mibayashi M, 2007, J VIROL, V81, P514, DOI 10.1128/JVI.01265-06; Myong S, 2009, SCIENCE, V323, P1070, DOI 10.1126/science.1168352; Opitz B, 2007, CELL MICROBIOL, V9, P930, DOI 10.1111/j.1462-5822.2006.00841.x; Pichlmair A, 2007, IMMUNITY, V27, P370, DOI 10.1016/j.immuni.2007.08.012; Pichlmair A, 2006, SCIENCE, V314, P997, DOI 10.1126/science.1132998; Pichlmair A, 2009, J VIROL, V83, P10761, DOI 10.1128/JVI.00770-09; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Plumet S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000279; Ranjith-Kumar CT, 2009, J BIOL CHEM, V284, P1155, DOI 10.1074/jbc.M806219200; Robb NC, 2009, J GEN VIROL, V90, P1398, DOI 10.1099/vir.0.009639-0; Saito T, 2008, NATURE, V454, P523, DOI 10.1038/nature07106; Samanta M, 2006, EMBO J, V25, P4207, DOI 10.1038/sj.emboj.7601314; Samuel CE, 2001, CLIN MICROBIOL REV, V14, P778, DOI 10.1128/CMR.14.4.778-809.2001; Schlee M, 2009, IMMUNITY, V31, P25, DOI 10.1016/j.immuni.2009.05.008; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schmidt A, 2009, P NATL ACAD SCI USA, V106, P12067, DOI 10.1073/pnas.0900971106; Takahasi K, 2008, MOL CELL, V29, P428, DOI 10.1016/j.molcel.2007.11.028; TILEY LS, 1994, J VIROL, V68, P5108, DOI 10.1128/JVI.68.8.5108-5116.1994; Uzri D, 2009, J VIROL, V83, P4174, DOI 10.1128/JVI.02449-08; Wang XY, 2000, J VIROL, V74, P11566, DOI 10.1128/JVI.74.24.11566-11573.2000; WRESCHNER DH, 1981, NATURE, V289, P414, DOI 10.1038/289414a0; Yoneyama M, 2009, IMMUNOL REV, V227, P54, DOI 10.1111/j.1600-065X.2008.00727.x	49	427	445	2	33	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					397	U143		10.1016/j.cell.2010.01.020	http://dx.doi.org/10.1016/j.cell.2010.01.020			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144762	Bronze			2022-12-01	WOS:000274297700017
J	Collini, E; Wong, CY; Wilk, KE; Curmi, PMG; Brumer, P; Scholes, GD				Collini, Elisabetta; Wong, Cathy Y.; Wilk, Krystyna E.; Curmi, Paul M. G.; Brumer, Paul; Scholes, Gregory D.			Coherently wired light-harvesting in photosynthetic marine algae at ambient temperature	NATURE			English	Article							RESONANCE ENERGY-TRANSFER; DYNAMICS; MOLECULES; EXCITONS; PROTEIN	Photosynthesis makes use of sunlight to convert carbon dioxide into useful biomass and is vital for life on Earth. Crucial components for the photosynthetic process are antenna proteins, which absorb light and transmit the resultant excitation energy between molecules to a reaction centre. The efficiency of these electronic energy transfers has inspired much work on antenna proteins isolated from photosynthetic organisms to uncover the basic mechanisms at play(1-5). Intriguingly, recent work has documented(6-8) that light-absorbing molecules in some photosynthetic proteins capture and transfer energy according to quantum-mechanical probability laws instead of classical laws(9) at temperatures up to 180 K. This contrasts with the long-held view that long-range quantum coherence between molecules cannot be sustained in complex biological systems, even at low temperatures. Here we present two-dimensional photon echo spectroscopy(10-13) measurements on two evolutionarily related light-harvesting proteins isolated from marine cryptophyte algae, which reveal exceptionally long-lasting excitation oscillations with distinct correlations and anti-correlations even at ambient temperature. These observations provide compelling evidence for quantum-coherent sharing of electronic excitation across the 5-nm-wide proteins under biologically relevant conditions, suggesting that distant molecules within the photosynthetic proteins are 'wired' together by quantum coherence for more efficient light-harvesting in cryptophyte marine algae.	[Collini, Elisabetta; Wong, Cathy Y.; Brumer, Paul; Scholes, Gregory D.] Univ Toronto, Dept Chem, Inst Opt Sci, Toronto, ON M5S 3H6, Canada; [Collini, Elisabetta; Wong, Cathy Y.; Brumer, Paul; Scholes, Gregory D.] Univ Toronto, Ctr Quantum Informat & Quantum Control, Toronto, ON M5S 3H6, Canada; [Wilk, Krystyna E.; Curmi, Paul M. G.] Univ New S Wales, Sch Phys, Sydney, NSW 2052, Australia; [Wilk, Krystyna E.; Curmi, Paul M. G.] Univ New S Wales, St Vincents Hosp, Ctr Appl Med Res, Sydney, NSW 2052, Australia	University of Toronto; University of Toronto; University of New South Wales Sydney; St Vincents Hospital Sydney; University of New South Wales Sydney	Scholes, GD (corresponding author), Univ Toronto, Dept Chem, Inst Opt Sci, 80 St George St, Toronto, ON M5S 3H6, Canada.	gscholes@chem.utoronto.ca	Collini, Elisabetta/F-1668-2010; Curmi, Paul/G-7185-2011	Collini, Elisabetta/0000-0002-1019-9100; Curmi, Paul/0000-0001-5762-7638	Natural Sciences and Engineering Research Council of Canada; Australian Research Council; EWR	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Australian Research Council(Australian Research Council); EWR	This work was supported by the Natural Sciences and Engineering Research Council of Canada and the Australian Research Council. G.D.S. acknowledges the support of an EWR Steacie Memorial Fellowship.	Abramavicius D, 2009, CHEM REV, V109, P2350, DOI 10.1021/cr800268n; Beljonne D, 2009, J PHYS CHEM B, V113, P6583, DOI 10.1021/jp900708f; Brixner T, 2004, J CHEM PHYS, V121, P4221, DOI 10.1063/1.1776112; Cheng YC, 2008, J PHYS CHEM A, V112, P4254, DOI 10.1021/jp7107889; Cheng YC, 2009, ANNU REV PHYS CHEM, V60, P241, DOI 10.1146/annurev.physchem.040808.090259; Cho MH, 2008, CHEM REV, V108, P1331, DOI 10.1021/cr078377b; Collini E, 2009, SCIENCE, V323, P369, DOI 10.1126/science.1164016; Doust AB, 2004, J MOL BIOL, V344, P135, DOI 10.1016/j.jmb.2004.09.044; Engel GS, 2007, NATURE, V446, P782, DOI 10.1038/nature05678; FEYNMAN RP, 1948, REV MOD PHYS, V20, P367, DOI 10.1103/RevModPhys.20.367; Franco I, 2008, J CHEM PHYS, V128, DOI 10.1063/1.2940789; Green B. R., 2003, LIGHT HARVESTING ANT; Hwang H, 2004, J PHYS CHEM B, V108, P6723, DOI 10.1021/jp037031b; Jang S, 2007, J PHYS CHEM B, V111, P6807, DOI 10.1021/jp070111l; Jang S, 2009, J CHEM PHYS, V131, DOI 10.1063/1.3247899; Jonas DM, 2003, ANNU REV PHYS CHEM, V54, P425, DOI 10.1146/annurev.physchem.54.011002.103907; LANGHOFF CA, 1974, CHEM PHYS, V6, P34, DOI 10.1016/0301-0104(74)80032-7; Lee H, 2007, SCIENCE, V316, P1462, DOI 10.1126/science.1142188; Mercer IP, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.057402; Mirkovic T, 2007, PHOTOCH PHOTOBIO SCI, V6, P964, DOI 10.1039/b704962e; RACKOVSKY S, 1973, MOL PHYS, V25, P61, DOI 10.1080/00268977300100081; RHODES W, 1969, J CHEM PHYS, V50, P2885, DOI 10.1063/1.1671480; Scholes GD, 2003, ANNU REV PHYS CHEM, V54, P57, DOI 10.1146/annurev.physchem.54.011002.103746; Scholes GD, 2007, J PHYS CHEM B, V111, P6978, DOI 10.1021/jp072540p; Scholes GD, 2006, NAT MATER, V5, P683, DOI 10.1038/nmat1714; SPEARBERNSTEIN L, 1989, J PHYCOL, V25, P412, DOI 10.1111/j.1529-8817.1989.tb00245.x; van der Weij-De Wit CD, 2008, BIOPHYS J, V94, P2423, DOI 10.1529/biophysj.107.113993; van Grondelle R, 2006, PHYS CHEM CHEM PHYS, V8, P793, DOI 10.1039/b514032c; WEDEMAYER GJ, 1992, J BIOL CHEM, V267, P7315; Wilk KE, 1999, P NATL ACAD SCI USA, V96, P8901, DOI 10.1073/pnas.96.16.8901	30	1226	1249	15	518	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					644	U69		10.1038/nature08811	http://dx.doi.org/10.1038/nature08811			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130647				2022-12-01	WOS:000274193900032
J	Coleman, J; Spurling, G				Coleman, Justin; Spurling, Geoffrey			Easily missed? Constipation in people with learning disability	BRITISH MEDICAL JOURNAL			English	Editorial Material							INTELLECTUAL DISABILITIES; CHILDREN; MANAGEMENT		[Coleman, Justin; Spurling, Geoffrey] Inala Indigenous Hlth, Discipline Gen Practice, Inala, Qld 4077, Australia		Coleman, J (corresponding author), Inala Indigenous Hlth, Discipline Gen Practice, 64 Wirraway Parade, Inala, Qld 4077, Australia.	colross@tpg.com.au	Spurling, Geoffrey K/F-1783-2010	Spurling, Geoffrey K/0000-0002-3525-4663				Bohmer CJM, 2001, J INTELL DISABIL RES, V45, P212, DOI 10.1046/j.1365-2788.2001.00300.x; Carr E., 1995, MENTAL RETARDATION D, V1, P94, DOI DOI 10.1002/MRDD.1410010204; Del Giudice E, 1999, BRAIN DEV-JPN, V21, P307, DOI 10.1016/S0387-7604(99)00025-X; Elawad MA, 2001, DEV MED CHILD NEUROL, V43, P829, DOI 10.1017/S0012162201001505; JANCAR J, 1994, J INTELL DISABIL RES, V38, P413; Kamm MA, 2003, BMJ-BRIT MED J, V327, P459, DOI 10.1136/bmj.327.7413.459; Lantman-de Valk HMJV, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a2507; MARSH L, 2008, BR J NURS, V17, P11; Pare P, 2001, AM J GASTROENTEROL, V96, P3130, DOI 10.1111/j.1572-0241.2001.05259.x; Ramkumar D, 2005, AM J GASTROENTEROL, V100, P936, DOI 10.1111/j.1572-0241.2005.40925.x; Rubin G, 2006, BMJ-BRIT MED J, V333, P1051, DOI 10.1136/bmj.39007.760174.47; Staiano A, 2000, J PEDIATR-US, V136, P41, DOI 10.1016/S0022-3476(00)90047-7; Starr JM, 2008, J INTELL DISABIL RES, V52, P483, DOI 10.1111/j.1365-2788.2008.01051.x; Sullivan PB, 2008, DEV DISABIL RES REV, V14, P128, DOI 10.1002/ddrr.18; 2004, DIRECTED ENHANCED SE	15	10	10	0	6	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 26	2010	340								c222	10.1136/bmj.c222	http://dx.doi.org/10.1136/bmj.c222			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YA	20103526				2022-12-01	WOS:000274089200002
J	Murchison, EP; Tovar, C; Hsu, A; Bender, HS; Kheradpour, P; Rebbeck, CA; Obendorf, D; Conlan, C; Bahlo, M; Blizzard, CA; Pyecroft, S; Kreiss, A; Kellis, M; Stark, A; Harkins, TT; Graves, JAM; Woods, GM; Hannon, GJ; Papenfuss, AT				Murchison, Elizabeth P.; Tovar, Cesar; Hsu, Arthur; Bender, Hannah S.; Kheradpour, Pouya; Rebbeck, Clare A.; Obendorf, David; Conlan, Carly; Bahlo, Melanie; Blizzard, Catherine A.; Pyecroft, Stephen; Kreiss, Alexandre; Kellis, Manolis; Stark, Alexander; Harkins, Timothy T.; Graves, Jennifer A. Marshall; Woods, Gregory M.; Hannon, Gregory J.; Papenfuss, Anthony T.			The Tasmanian Devil Transcriptome Reveals Schwann Cell Origins of a Clonally Transmissible Cancer	SCIENCE			English	Article							FACIAL-TUMOR DISEASE; SARCOPHILUS-HARRISII; IMMUNOHISTOCHEMICAL CHARACTERIZATION; VENEREAL TUMOR; MICRORNAS; DIVERSITY; NEOPLASMS; EVOLUTION; PROTEIN; SYSTEM	The Tasmanian devil, a marsupial carnivore, is endangered because of the emergence of a transmissible cancer known as devil facial tumor disease (DFTD). This fatal cancer is clonally derived and is an allograft transmitted between devils by biting. We performed a large-scale genetic analysis of DFTD with microsatellite genotyping, a mitochondrial genome analysis, and deep sequencing of the DFTD transcriptome and microRNAs. These studies confirm that DFTD is a monophyletic clonally transmissible tumor and suggest that the disease is of Schwann cell origin. On the basis of these results, we have generated a diagnostic marker for DFTD and identify a suite of genes relevant to DFTD pathology and transmission. We provide a genomic data set for the Tasmanian devil that is applicable to cancer diagnosis, disease evolution, and conservation biology.	[Murchison, Elizabeth P.; Bender, Hannah S.; Rebbeck, Clare A.; Conlan, Carly; Hannon, Gregory J.] Cold Spring Harbor Lab, Howard Hughes Med Inst, Watson Sch Biol Sci, Cold Spring Harbor, NY 11724 USA; [Murchison, Elizabeth P.; Bender, Hannah S.; Graves, Jennifer A. Marshall] Australian Natl Univ, Res Sch Biol, Canberra, ACT 0200, Australia; [Murchison, Elizabeth P.; Bender, Hannah S.; Graves, Jennifer A. Marshall] Australian Natl Univ, ARC Ctr Excellence Kangaroo Genom, Canberra, ACT 0200, Australia; [Tovar, Cesar; Obendorf, David; Blizzard, Catherine A.; Kreiss, Alexandre; Woods, Gregory M.] Univ Tasmania, Menzies Res Inst, Hobart, Tas 7000, Australia; [Hsu, Arthur; Bahlo, Melanie; Papenfuss, Anthony T.] Walter & Eliza Hall Inst Med Res, Bioinformat Div, Melbourne, Vic 3052, Australia; [Kheradpour, Pouya; Kellis, Manolis; Stark, Alexander] MIT, Comp Sci & Artificial Intelligence Lab, Cambridge, MA 02139 USA; [Pyecroft, Stephen] Dept Primary Ind & Water, Mt Pleasant Anim Hlth Labs, Kings Meadows, Tas 7249, Australia; [Kellis, Manolis; Stark, Alexander] MIT, Broad Inst, Cambridge, MA 02141 USA; [Kellis, Manolis; Stark, Alexander] Harvard Univ, Cambridge, MA 02141 USA; [Harkins, Timothy T.] Roche Appl Sci, Indianapolis, IN 46250 USA	Cold Spring Harbor Laboratory; Howard Hughes Medical Institute; Australian National University; Australian National University; University of Tasmania; Menzies Institute for Medical Research; Walter & Eliza Hall Institute; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Harvard University; Roche Holding	Murchison, EP (corresponding author), Wellcome Trust Sanger Inst, Canc Genome Project, Cambridge CB10 1SA, England.	elizabeth.murchison@sanger.ac.uk	Hannon, Gregory/AAB-3568-2019; Papenfuss, Anthony T/C-6297-2008; Stark, Alexander/D-1473-2012; Woods, Greg/J-7533-2014; Kellis, Manolis/ABE-7385-2020	Papenfuss, Anthony T/0000-0002-1102-8506; Stark, Alexander/0000-0003-2611-0841; Woods, Greg/0000-0001-8421-7917; Kellis, Manolis/0000-0001-7113-9630; Murchison, Elizabeth Proby/0000-0001-7462-8907; Tovar Lopez, Cesar Dario/0000-0001-9555-2489; rebbeck, clare/0000-0002-2502-9622; Blizzard, Catherine/0000-0002-8683-2937; Graves, Jennifer/0000-0001-6480-7856; Hsu, Arthur/0000-0001-8308-1106; Bender, Hannah/0000-0001-9458-4964	NATIONAL CANCER INSTITUTE [P01CA013106] Funding Source: NIH RePORTER; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG004037] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM062534] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [P01 CA013106-38, P01 CA013106] Funding Source: Medline; NHGRI NIH HHS [R01 HG004037] Funding Source: Medline; NIGMS NIH HHS [R01 GM062534-10, R01 GM062534] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		CANFIELD PJ, 1993, J ZOO WILDLIFE MED, V24, P158; CLARK HB, 1985, AM J PATHOL, V121, P96; COOPER HL, 1964, J NATL CANCER I, V33, P691; Dahlin LB, 2008, SCAND J SURG, V97, P310, DOI 10.1177/145749690809700407; Gold R, 1999, BRAIN PATHOL, V9, P343; GRECO D, 1997, TXB VET PHYSL; Gregory PA, 2008, CELL CYCLE, V7, P3112, DOI 10.4161/cc.7.20.6851; GRINER LA, 1979, J NATL CANCER I, V62, P589, DOI 10.1093/jnci/62.3.589; Hawkins CE, 2006, BIOL CONSERV, V131, P307, DOI 10.1016/j.biocon.2006.04.010; Jones ME, 2004, MOL ECOL, V13, P2197, DOI 10.1111/j.1365-294X.2004.02239.x; Lachish S, 2007, J ANIM ECOL, V76, P926, DOI 10.1111/j.1365-2656.2007.01272.x; Loh R, 2006, VET PATHOL, V43, P896, DOI 10.1354/vp.43-6-896; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Marchal T, 1997, VET IMMUNOL IMMUNOP, V57, P1, DOI 10.1016/S0165-2427(96)05757-1; McCallum H, 2008, TRENDS ECOL EVOL, V23, P631, DOI 10.1016/j.tree.2008.07.001; McCallum H, 2007, ECOHEALTH, V4, P318, DOI 10.1007/s10393-007-0118-0; Mozos E, 1996, VET PATHOL, V33, P257, DOI 10.1177/030098589603300301; Murgia C, 2006, CELL, V126, P477, DOI 10.1016/j.cell.2006.05.051; Pearse AM, 2006, NATURE, V439, P549, DOI 10.1038/439549a; Rebbeck CA, 2009, EVOLUTION, V63, P2340, DOI 10.1111/j.1558-5646.2009.00724.x; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Siddle HV, 2007, P NATL ACAD SCI USA, V104, P16221, DOI 10.1073/pnas.0704580104; Svaren J, 2008, GLIA, V56, P1541, DOI 10.1002/glia.20767; Ueda R, 2009, P NATL ACAD SCI USA, V106, P10746, DOI 10.1073/pnas.0811817106; Verrier JD, 2009, GLIA, V57, P1265, DOI 10.1002/glia.20846	25	156	225	1	133	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 1	2010	327	5961					84	87		10.1126/science.1180616	http://dx.doi.org/10.1126/science.1180616			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044575	Green Accepted, Green Submitted			2022-12-01	WOS:000273395400036
J	Loarie, SR; Duffy, PB; Hamilton, H; Asner, GP; Field, CB; Ackerly, DD				Loarie, Scott R.; Duffy, Philip B.; Hamilton, Healy; Asner, Gregory P.; Field, Christopher B.; Ackerly, David D.			The velocity of climate change	NATURE			English	Article							MIGRATION CAPACITY; PROTECTED AREAS; CHANGE IMPACTS; DISPERSAL; MOUNTAIN; SYSTEMS; FOREST; SHIFTS; BIRDS; USA	The ranges of plants and animals are moving in response to recent changes in climate(1). As temperatures rise, ecosystems with 'nowhere to go', such as mountains, are considered to be more threatened(2,3). However, species survival may depend as much on keeping pace with moving climates as the climate's ultimate persistence(4,5). Here we present a new index of the velocity of temperature change (km yr(-1)), derived from spatial gradients (degrees C km(-1)) and multimodel ensemble forecasts of rates of temperature increase (degrees C yr(-1)) in the twenty-first century. This index represents the instantaneous local velocity along Earth's surface needed to maintain constant temperatures, and has a global mean of 0.42 km yr(-1) (A1B emission scenario). Owing to topographic effects, the velocity of temperature change is lowest in mountainous biomes such as tropical and subtropical coniferous forests (0.08 km yr(-1)), temperate coniferous forest, and montane grasslands. Velocities are highest in flooded grasslands (1.26 km yr(-1)), mangroves and deserts. High velocities suggest that the climates of only 8% of global protected areas have residence times exceeding 100 years. Small protected areas exacerbate the problem in Mediterranean-type and temperate coniferous forest biomes. Large protected areas may mitigate the problem in desert biomes. These results indicate management strategies for minimizing biodiversity loss from climate change. Montane landscapes may effectively shelter many species into the next century. Elsewhere, reduced emissions, a much expanded network of protected areas(6), or efforts to increase species movement may be necessary(7).	[Loarie, Scott R.; Duffy, Philip B.; Asner, Gregory P.; Field, Christopher B.] Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA; [Duffy, Philip B.] Climate Cent Inc, Palo Alto, CA 94301 USA; [Hamilton, Healy] Calif Acad Sci, Ctr Appl Biodivers Informat, San Francisco, CA 94118 USA; [Ackerly, David D.] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA	Carnegie Institution for Science; California Academy of Sciences; University of California System; University of California Berkeley	Loarie, SR (corresponding author), Carnegie Inst Sci, Dept Global Ecol, Stanford, CA 94305 USA.	loarie@stanford.edu	Asner, Gregory/G-9268-2013; Ackerly, David/A-1247-2009	Asner, Gregory/0000-0001-7893-6421; Ackerly, David/0000-0002-1847-7398	Gordon and Betty Moore Foundation; Stanford University Global Climate and Energy Project	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); Stanford University Global Climate and Energy Project	This work was made possible through the support of the Gordon and Betty Moore Foundation and the Stanford University Global Climate and Energy Project.	Beckage B, 2008, P NATL ACAD SCI USA, V105, P4197, DOI 10.1073/pnas.0708921105; Burrough P.A., 1998, PRINCIPLES GEOGRAPHI, P190; Clark JS, 1998, BIOSCIENCE, V48, P13, DOI 10.2307/1313224; Clark JS, 1998, AM NAT, V152, P204, DOI 10.1086/286162; Colwell RK, 2008, SCIENCE, V322, P258, DOI 10.1126/science.1162547; Daly C, 2008, INT J CLIMATOL, V28, P2031, DOI 10.1002/joc.1688; Damschen EI, 2006, SCIENCE, V313, P1284, DOI 10.1126/science.1130098; Hannah L, 2008, ANN NY ACAD SCI, V1134, P201, DOI 10.1196/annals.1439.009; Hijmans RJ, 2005, INT J CLIMATOL, V25, P1965, DOI 10.1002/joc.1276; Hoegh-Guldberg O, 2008, SCIENCE, V321, P345, DOI 10.1126/science.1157897; Joppa LN, 2008, P NATL ACAD SCI USA, V105, P6673, DOI 10.1073/pnas.0802471105; Kelly AE, 2008, P NATL ACAD SCI USA, V105, P11823, DOI 10.1073/pnas.0802891105; Lenoir J, 2008, SCIENCE, V320, P1768, DOI 10.1126/science.1156831; Loarie SR, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002502; Malcolm JR, 2002, J BIOGEOGR, V29, P835, DOI 10.1046/j.1365-2699.2002.00702.x; Maurer EP, 2009, HYDROL EARTH SYST SC, V13, P183, DOI 10.5194/hess-13-183-2009; McLachlan JS, 2005, ECOLOGY, V86, P2088, DOI 10.1890/04-1036; Moritz C, 2008, SCIENCE, V322, P261, DOI 10.1126/science.1163428; Murphy JM, 2004, NATURE, V430, P768, DOI 10.1038/nature02771; Nogues-Bravo D, 2007, GLOBAL ENVIRON CHANG, V17, P420, DOI 10.1016/j.gloenvcha.2006.11.007; Olson DM, 2001, BIOSCIENCE, V51, P933, DOI 10.1641/0006-3568(2001)051[0933:TEOTWA]2.0.CO;2; Parmesan C, 2003, NATURE, V421, P37, DOI 10.1038/nature01286; Parmesan C, 2006, ANNU REV ECOL EVOL S, V37, P637, DOI 10.1146/annurev.ecolsys.37.091305.110100; Pearson RG, 2006, TRENDS ECOL EVOL, V21, P111, DOI 10.1016/j.tree.2005.11.022; Peterson AT, 2003, GLOBAL CHANGE BIOL, V9, P647, DOI 10.1046/j.1365-2486.2003.00616.x; Peterson DL, 1997, GLOBAL ECOL BIOGEOGR, V6, P7, DOI 10.2307/2997523; Thuiller W, 2005, P NATL ACAD SCI USA, V102, P8245, DOI 10.1073/pnas.0409902102; Trivedi MR, 2008, GLOBAL CHANGE BIOL, V14, P1089, DOI 10.1111/j.1365-2486.2008.01553.x; Van Houtan KS, 2007, ECOL LETT, V10, P219, DOI 10.1111/j.1461-0248.2007.01004.x; WEISS SB, 1988, ECOLOGY, V69, P1486, DOI 10.2307/1941646; Williams JW, 2007, P NATL ACAD SCI USA, V104, P5738, DOI 10.1073/pnas.0606292104	31	1439	1488	37	1297	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	DEC 24	2009	462	7276					1052	U111		10.1038/nature08649	http://dx.doi.org/10.1038/nature08649			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	535UB	20033047				2022-12-01	WOS:000272996000046
J	Merin, O; Ash, N; Levy, G; Schwaber, MJ; Kreiss, Y				Merin, Ofer; Ash, Nachman; Levy, Gad; Schwaber, Mitchell J.; Kreiss, Yitshak			The Israeli Field Hospital in Haiti -- Ethical Dilemmas in Early Disaster Response.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Merin, Ofer] Shaare Zedek Med Ctr, Trauma Unit, Jerusalem, Israel; [Merin, Ofer] Shaare Zedek Med Ctr, Dept Cardiothorac Surg, Jerusalem, Israel; [Merin, Ofer] Hebrew Univ Jerusalem, Fac Med, Jerusalem, Israel; [Merin, Ofer; Levy, Gad; Schwaber, Mitchell J.; Kreiss, Yitshak] Israel Def Forces Med Corps Field Hosp, Tel Hashomer, Israel; [Ash, Nachman] Israel Def Forces Off Surg Gen, Tel Hashomer, Israel; [Levy, Gad] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Radiol, IL-69978 Tel Aviv, Israel; [Schwaber, Mitchell J.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Dept Consultat Med, IL-69978 Tel Aviv, Israel; [Schwaber, Mitchell J.] Tel Aviv Univ, Tel Aviv Sourasky Med Ctr, Div Epidemiol & Prevent Med, IL-69978 Tel Aviv, Israel; [Schwaber, Mitchell J.] Israel Minist Hlth, Natl Ctr Infect Control, Tel Aviv, Israel	Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Shaare Zedek Medical Center; Hebrew University of Jerusalem; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center; Tel Aviv University; Sackler Faculty of Medicine; Tel Aviv Sourasky Medical Center	Merin, O (corresponding author), Shaare Zedek Med Ctr, Trauma Unit, Jerusalem, Israel.		Ash, Nachman/ABC-2961-2020; Schwaber, Mitchell/AAI-2486-2019						0	88	89	1	10	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	MAR 18	2010	362	11								10.1056/NEJMp1001693	http://dx.doi.org/10.1056/NEJMp1001693			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570CY	20200362				2022-12-01	WOS:000275650400006
J	Carel, H; Johnson, S; Gamble, L				Carel, Havi; Johnson, Simon; Gamble, Liz			A Patient's Journey Living with lymphangioleiomyomatosis	BRITISH MEDICAL JOURNAL			English	Editorial Material							TUBEROUS SCLEROSIS COMPLEX; SIROLIMUS		[Carel, Havi] Univ W England, Fac Humanities & Social Sci, Bristol BS16 1QY, Avon, England; [Johnson, Simon] Univ Nottingham, Queens Med Ctr, Div Therapeut & Mol Med, Nottingham NG7 2RD, England; [Gamble, Liz] Bristol Royal Infirm & Gen Hosp, Dept Resp Med, Bristol, Avon, England	University of West England; University of Nottingham; Bristol Royal Infirmary	Carel, H (corresponding author), Univ W England, Fac Humanities & Social Sci, Bristol BS16 1QY, Avon, England.	havi.Carel@uwe.ac.uk; simon.johnson@nottingham.ac.uk; liz.gamble@UHBristol.nhs.uk		Johnson, Simon/0000-0002-9837-2763; Carel, Havi/0000-0002-1260-2362				Avila NA, 2000, RADIOLOGY, V216, P147, DOI 10.1148/radiology.216.1.r00jl42147; Bissler JJ, 2008, NEW ENGL J MED, V358, P140, DOI 10.1056/NEJMoa063564; Davies DM, 2008, NEW ENGL J MED, V358, P200, DOI 10.1056/NEJMc072500; Goncharova EA, 2002, J BIOL CHEM, V277, P30958, DOI 10.1074/jbc.M202678200; Henske EP, 2003, GENE CHROMOSOME CANC, V38, P376, DOI 10.1002/gcc.10252; Johnson SR, 2010, EUR RESPIR J, V35, P14, DOI 10.1183/09031936.00076209; Johnson SR, 2004, THORAX, V59, P800, DOI 10.1136/thx.2004.023283; Johnson SR, 2006, EUR RESPIR J, V27, P1056, DOI 10.1183/09031936.06.00113303	8	3	4	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 12	2010	340								c848	10.1136/bmj.c848	http://dx.doi.org/10.1136/bmj.c848			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	570FF	20228149				2022-12-01	WOS:000275657000011
J	Schnorrer, F; Schonbauer, C; Langer, CCH; Dietzl, G; Novatchkova, M; Schernhuber, K; Fellner, M; Azaryan, A; Radolf, M; Stark, A; Keleman, K; Dickson, BJ				Schnorrer, Frank; Schoenbauer, Cornelia; Langer, Christoph C. H.; Dietzl, Georg; Novatchkova, Maria; Schernhuber, Katharina; Fellner, Michaela; Azaryan, Anna; Radolf, Martin; Stark, Alexander; Keleman, Krystyna; Dickson, Barry J.			Systematic genetic analysis of muscle morphogenesis and function in Drosophila	NATURE			English	Article							MELANOGASTER; ENCODES; PROTEIN; CELLS; VERTEBRATES; EXPRESSION; MUTANTS	Systematic genetic approaches have provided deep insight into the molecular and cellular mechanisms that operate in simple unicellular organisms. For multicellular organisms, however, the pleiotropy of gene function has largely restricted such approaches to the study of early embryogenesis. With the availability of genome-wide transgenic RNA interference (RNAi) libraries in Drosophila(1,2), it is now possible to perform a systematic genetic dissection of any cell or tissue type at any stage of the lifespan. Here we apply these methods to define the genetic basis for formation and function of the Drosophila muscle. We identify a role inmuscle for 2,785 genes, many of which we assign to specific functions in the organization of muscles, myofibrils or sarcomeres. Many of these genes are phylogenetically conserved, including genes implicated in mammalian sarcomere organization and human muscle diseases.	[Schnorrer, Frank; Schoenbauer, Cornelia; Langer, Christoph C. H.] Max Planck Inst Biochem, D-82152 Martinsried, Germany; [Schnorrer, Frank; Dietzl, Georg; Novatchkova, Maria; Schernhuber, Katharina; Fellner, Michaela; Azaryan, Anna; Radolf, Martin; Stark, Alexander; Keleman, Krystyna; Dickson, Barry J.] Res Inst Mol Pathol, A-1030 Vienna, Austria	Max Planck Society; Vienna Biocenter (VBC); Research Institute of Molecular Pathology (IMP)	Schnorrer, F (corresponding author), Max Planck Inst Biochem, Klopferspitz 18, D-82152 Martinsried, Germany.	schnorrer@biochem.mpg.de; dickson@imp.ac.at	Schnorrer, Frank/AIE-3578-2022; Stark, Alexander/D-1473-2012; Dickson, Barry/AAE-7632-2019	Schnorrer, Frank/0000-0002-9518-7263; Stark, Alexander/0000-0003-2611-0841; Dickson, Barry/0000-0003-0715-892X; Langer, Christoph C. H./0000-0001-8751-1564	Boehringer Ingelheim GmbH; Max-Planck Society; Human Frontier Science Program; European Union; Austrian Ministry for Science and Research	Boehringer Ingelheim GmbH(Boehringer Ingelheim); Max-Planck Society(Max Planck SocietyFoundation CELLEX); Human Frontier Science Program(Human Frontier Science Program); European Union(European Commission); Austrian Ministry for Science and Research	We thank the Vienna Drosophila RNAi Center for transgenic RNAi lines, and H. Bellen, B. Bullard, J. Saide and T. Volk for their gifts of various antibodies. This work was supported by Boehringer Ingelheim GmbH, the Max-Planck Society and a postdoctoral fellowship to F. S. from the Human Frontier Science Program. Generation of a second set of RNAi lines was supported by a grant from the European Union 7th Framework Programme. A. S. and M. N. were supported by the Austrian Ministry for Science and Research (GEN-AU Bioinformatics Integration Network).	Arbeitman MN, 2002, SCIENCE, V297, P2270, DOI 10.1126/science.1072152; AYMESOUTHGATE A, 1991, P NATL ACAD SCI USA, V88, P7973, DOI 10.1073/pnas.88.18.7973; BATE M, 1993, DEV DROSOPHILA METAN, V2, P1013; Besse F, 2007, J CELL BIOL, V177, P843, DOI 10.1083/jcb.200701111; Beuchle D, 2007, MECH DEVELOP, V124, P390, DOI 10.1016/j.mod.2007.01.006; Buckingham M, 2006, CURR OPIN GENET DEV, V16, P525, DOI 10.1016/j.gde.2006.08.008; Butler MJ, 2003, DEVELOPMENT, V130, P659, DOI 10.1242/dev.00293; CAMPBELL HD, 1993, P NATL ACAD SCI USA, V90, P11386, DOI 10.1073/pnas.90.23.11386; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Fong KSK, 1999, GENOMICS, V58, P146, DOI 10.1006/geno.1999.5817; Hartenstein V, 2006, MOL B INT U, P8, DOI 10.1007/0-387-32963-3_2; HOMYK T, 1977, GENETICS, V87, P95; Lamb RS, 1998, MOL BIOL CELL, V9, P3505, DOI 10.1091/mbc.9.12.3505; Matsumoto A, 2007, GENE DEV, V21, P1687, DOI 10.1101/gad.1552207; Nongthomba U, 2007, GENETICS, V177, P295, DOI 10.1534/genetics.106.056812; North KN, 1997, J MED GENET, V34, P705, DOI 10.1136/jmg.34.9.705; Park J, 2006, NATURE, V441, P1157, DOI 10.1038/nature04788; Quinones-Coello AT, 2007, GENETICS, V175, P1089, DOI 10.1534/genetics.106.065995; Reddy KL, 2000, DEV BIOL, V224, P401, DOI 10.1006/dbio.2000.9797; Reedy MC, 2000, J CELL BIOL, V151, P1483, DOI 10.1083/jcb.151.7.1483; Ren N, 2007, GENETICS, V176, P2223, DOI 10.1534/genetics.107.072959; Sandmann T, 2006, DEV CELL, V10, P797, DOI 10.1016/j.devcel.2006.04.009; Schnorrer F, 2004, DEV CELL, V7, P9, DOI 10.1016/j.devcel.2004.06.010; Taylor MV, 2006, MOL B INT U, P169, DOI 10.1007/0-387-32963-3_14; Vigoreaux JO, 2006, MOL B INT U, P143, DOI 10.1007/0-387-32963-3_12; Vigoreaux JO, 2001, BIOESSAYS, V23, P1047, DOI 10.1002/bies.1150; Zaffran S, 1997, DEVELOPMENT, V124, P2087	27	180	182	0	26	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2010	464	7286					287	291		10.1038/nature08799	http://dx.doi.org/10.1038/nature08799			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220848				2022-12-01	WOS:000275366100049
J	Balsari, S; Lemery, J; Williams, TP; Nelson, BD				Balsari, Satchit; Lemery, Jay; Williams, Timothy P.; Nelson, Brett D.			Protecting the Children of Haiti.	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Balsari, Satchit; Lemery, Jay; Williams, Timothy P.; Nelson, Brett D.] Harvard Univ, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA; [Nelson, Brett D.] Harvard Univ, Sch Med, Boston, MA 02115 USA; [Balsari, Satchit; Lemery, Jay] Weill Cornell Med Coll, Div Emergency Med, New York, NY USA	Harvard University; Harvard University; Harvard Medical School; Cornell University	Balsari, S (corresponding author), Harvard Univ, Francois Xavier Bagnoud Ctr Hlth & Human Rights, Boston, MA 02115 USA.		Nelson, Brett D/I-4218-2014; Nelson, Brett/L-2686-2019	Nelson, Brett D/0000-0002-5049-1798; Nelson, Brett/0000-0002-5049-1798				LEDERER E, 2010, ASS PRESS       0209; Panter-Brick Catherine, 2000, ABANDONED CHILDREN; SEQUERA V, 2010, ASS PRESS       0127; Shahinian G, 2009, REPORT SPECIAL RAPPO	4	24	24	0	1	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9								10.1056/NEJMp1001820	http://dx.doi.org/10.1056/NEJMp1001820			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	563DQ	20164477	Bronze, Green Submitted, Green Published			2022-12-01	WOS:000275108300004
J	Brookhart, MA; Schneeweiss, S; Avorn, J; Bradbury, BD; Liu, J; Winkelmayer, WC				Brookhart, M. Alan; Schneeweiss, Sebastian; Avorn, Jerry; Bradbury, Brian D.; Liu, Jun; Winkelmayer, Wolfgang C.			Comparative Mortality Risk of Anemia Management Practices in Incident Hemodialysis Patients	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							RECOMBINANT-HUMAN-ERYTHROPOIETIN; INTRAVENOUS IRON THERAPY; STAGE RENAL-DISEASE; EPOETIN-ALPHA; HEMATOCRIT VALUES; HEMOGLOBIN LEVELS; SURVIVAL; HOSPITALIZATION; RESPONSIVENESS; AMELIORATION	Context Controversy exists about optimal management of anemia in end-stage renal disease. Objective To compare the mortality risk of different dialysis center-level patterns of anemia management. Design, Setting, and Patients Using data from Medicare's end-stage renal disease program (1999-2007), we characterized each US dialysis center's annual anemia management practice by estimating its typical use of erythropoiesis-stimulating agents (ESAs) and intravenous iron in hemodialysis patients within 4 hematocrit categories. We used Cox proportional hazards regression to correlate center-level patterns of ESA and iron use with 1-year mortality risk in 269 717 incident hemodialysis patients. Main Outcome Measure One-year all-cause mortality. Results Monthly mortality rates were highest in patients with hematocrit less than 30% (mortality, 2.1%) and lowest for those with hematocrit of 36% or higher (mortality, 0.7%). After adjustment for baseline case-mix differences, dialysis centers that used larger ESA doses in patients with hematocrit less than 30% had lower mortality rates than centers that used smaller doses (highest vs lowest dose group: hazard ratio [HR], 0.94; 95% confidence interval [ CI], 0.90-0.97). Centers that administered iron more frequently to patients with hematocrit less than 33% also had lower mortality rates (highest vs lowest quintile, HR, 0.95; 95% CI, 0.91-0.98). However, centers that used larger ESA doses in patients with hematocrit between 33% and 35.9% had higher mortality rates ( highest vs lowest quintile, HR, 1.07; 95% CI, 1.03-1.12). More intensive use of both ESAs and iron was associated with increased mortality risk in patients with hematocrit of 36% or higher. These findings persisted across a range of secondary analyses. Conclusions Greater ESA and iron use were associated with decreased mortality risk at lower hematocrit levels, in which mortality rates are the highest. Although the overall mortality rate was lower at higher hematocrit levels, elevated mortality risk was associated with greater use of ESAs and iron in these patients. JAMA. 2010;303(9):857-864 www.jama.com	[Winkelmayer, Wolfgang C.] Stanford Univ, Sch Med, Div Nephrol, Palo Alto, CA 94304 USA; [Brookhart, M. Alan] Univ N Carolina, Dept Epidemiol, Gillings Sch Global Publ Hlth, Chapel Hill, NC USA; [Brookhart, M. Alan; Schneeweiss, Sebastian; Avorn, Jerry; Liu, Jun; Winkelmayer, Wolfgang C.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Pharmacoepidemiol & Pharmacoecon,Dept Med, Boston, MA 02115 USA; [Bradbury, Brian D.] Amgen Inc, Dept Biostat & Epidemiol, Thousand Oaks, CA 91320 USA	Stanford University; University of North Carolina; University of North Carolina Chapel Hill; Harvard University; Brigham & Women's Hospital; Harvard Medical School; Amgen	Winkelmayer, WC (corresponding author), Stanford Univ, Sch Med, Div Nephrol, 780 Welch Rd,Ste 106, Palo Alto, CA 94304 USA.	wcw1@stanford.edu	Schneeweiss, Sebastian/C-2125-2013	Schneeweiss, Sebastian/0000-0003-2575-467X	National Institute on Aging [AG-027400]; American Heart Association; Satellite Healthcare Inc; National Institutes of Health; NATIONAL INSTITUTE ON AGING [K25AG027400] Funding Source: NIH RePORTER	National Institute on Aging(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); American Heart Association(American Heart Association); Satellite Healthcare Inc; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by an investigator-initiated contract from Amgen to Brigham and Women's Hospital that placed no restrictions on publications. Dr Brookhart is supported by a career development award from the National Institute on Aging (grant AG-027400). Dr Winkelmayer has received support including a Scientist Development Grant from the American Heart Association, a Norman S. Coplon Extramural Research Program Award from Satellite Healthcare Inc, support from the National Institutes of Health for unrelated projects.	Berliner JA, 1996, FREE RADICAL BIO MED, V20, P707, DOI 10.1016/0891-5849(95)02173-6; Besarab A, 1998, NEW ENGL J MED, V339, P584, DOI 10.1056/NEJM199808273390903; Bradbury BD, 2008, AM J KIDNEY DIS, V51, P62, DOI 10.1053/j.ajkd.2007.09.015; Bradbury BD, 2009, PHARMACOEPIDEM DR S, V18, P932, DOI 10.1002/pds.1799; Bradbury BD, 2009, AM J KIDNEY DIS, V54, P554, DOI 10.1053/j.ajkd.2009.05.010; Bradbury BD, 2009, CLIN J AM SOC NEPHRO, V4, P630, DOI 10.2215/CJN.03580708; Bradbury BD, 2009, NEPHROL DIAL TRANSPL, V24, P919, DOI 10.1093/ndt/gfn543; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brewster UC, 2004, SEMIN DIALYSIS, V17, P57; Brewster UC, 2006, SEMIN DIALYSIS, V19, P285, DOI 10.1111/j.1525-139X.2006.00174.x; Brookhart MA, 2006, EPIDEMIOLOGY, V17, P268, DOI 10.1097/01.ede.0000193606.58671.c5; Bullen JJ, 2005, FEMS IMMUNOL MED MIC, V43, P325, DOI 10.1016/j.femsim.2004.11.010; CANNELLA G, 1991, NEPHROL DIAL TRANSPL, V6, P31, DOI 10.1093/ndt/6.1.31; Collins AJ, 2001, J AM SOC NEPHROL, V12, P2465, DOI 10.1681/ASN.V12112465; Collins AJ, 1998, J AM SOC NEPHROL, V9, P2108; D'Agostino RB, 2007, JAMA-J AM MED ASSOC, V297, P314, DOI 10.1001/jama.297.3.314; ESCHBACH JW, 1989, ANN INTERN MED, V111, P992, DOI 10.7326/0003-4819-111-12-992; Faich G, 1999, AM J KIDNEY DIS, V33, P464, DOI 10.1016/S0272-6386(99)70183-6; Feldman HI, 2004, J AM SOC NEPHROL, V15, P1623, DOI 10.1097/01.ASN.0000128009.69594.BE; Feldman HI, 2002, J AM SOC NEPHROL, V13, DOI 10.1681/ASN.V133734; Fletes R, 2001, AM J KIDNEY DIS, V37, P743, DOI 10.1016/S0272-6386(01)80123-2; Himmelfarb J, 2002, KIDNEY INT, V62, P1524, DOI 10.1046/j.1523-1755.2002.00600.x; Johnston SC, 2000, J CLIN EPIDEMIOL, V53, P1236, DOI 10.1016/S0895-4356(00)00251-1; Kalantar-Zadeh K, 2005, J AM SOC NEPHROL, V16, P3070, DOI 10.1681/ASN.2005040423; KAUPKE CJ, 1993, J AM SOC NEPHROL, V3, P1672; Kilpatrick RD, 2008, CLIN J AM SOC NEPHRO, V3, P1077, DOI 10.2215/CJN.04601007; LIN DY, 1989, J AM STAT ASSOC, V84, P1074, DOI 10.2307/2290085; Ma JZ, 1999, J AM SOC NEPHROL, V10, P610; MACDOUGALL IC, 1990, LANCET, V335, P489, DOI 10.1016/0140-6736(90)90733-L; Ofsthun N, 2003, KIDNEY INT, V63, P1908, DOI 10.1046/j.1523-1755.2003.00937.x; Pfeffer MA, 2009, NEW ENGL J MED, V361, P2019, DOI 10.1056/NEJMoa0907845; Reddan DN, 2003, NEPHROL DIAL TRANSPL, V18, P147, DOI 10.1093/ndt/18.1.147; Schneeweiss S, 2008, NEW ENGL J MED, V358, P771, DOI 10.1056/NEJMoa0707571; Singh Ajay K, 2007, Nephrol News Issues, V21, P55; Singh AK, 2006, NEW ENGL J MED, V355, P2085, DOI 10.1056/NEJMoa065485; Singh AK, 2010, J AM SOC NEPHROL, V21, P2, DOI 10.1681/ASN.2009111127; SINGH AK, 2007, NEPHROL NEWS ISSUES, V21, P58; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Tentori F, 2009, NEPHROL DIAL TRANSPL, V24, P963, DOI 10.1093/ndt/gfn592; Thamer M, 2007, JAMA-J AM MED ASSOC, V297, P1667, DOI 10.1001/jama.297.15.1667; Unger EF, 2010, NEW ENGL J MED, V362, P189, DOI 10.1056/NEJMp0912328; United States Food and Drug Administration, FDA PUBL HLTH ADV ER; *US REN DAT SYST, 2007, 2004 ANN DAT REP ATL; Vaziri ND, 1999, AM J KIDNEY DIS, V33, P821, DOI 10.1016/S0272-6386(99)70413-0; Vaziri ND, 2001, CURR OPIN NEPHROL HY, V10, P633, DOI 10.1097/00041552-200109000-00013; Wang PS, 2005, NEW ENGL J MED, V353, P2335, DOI 10.1056/NEJMoa052827; WIZEMANN V, 1992, NEPHRON, V62, P161, DOI 10.1159/000187026; Wolfe RA, 2005, AM J KIDNEY DIS, V45, P127, DOI 10.1053/j.ajkd.2004.09.023; Xia H, 1999, J AM SOC NEPHROL, V10, P1309; Zhang Y, 2004, AM J KIDNEY DIS, V44, P866, DOI 10.1053/j.ajkd.2004.08.002; Zhang Y, 2009, CLIN J AM SOC NEPHRO, V4, P638, DOI 10.2215/CJN.05071008; Zhou XJ, 2002, NEPHROL DIAL TRANSPL, V17, P992, DOI 10.1093/ndt/17.6.992	52	85	88	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					857	864		10.1001/jama.2010.206	http://dx.doi.org/10.1001/jama.2010.206			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197532	Bronze			2022-12-01	WOS:000275059500019
J	Breslow, DK; Collins, SR; Bodenmiller, B; Aebersold, R; Simons, K; Shevchenko, A; Ejsing, CS; Weissman, JS				Breslow, David K.; Collins, Sean R.; Bodenmiller, Bernd; Aebersold, Ruedi; Simons, Kai; Shevchenko, Andrej; Ejsing, Christer S.; Weissman, Jonathan S.			Orm family proteins mediate sphingolipid homeostasis	NATURE			English	Article							GENOME-WIDE ASSOCIATION; SERINE PALMITOYLTRANSFERASE; SACCHAROMYCES-CEREVISIAE; YEAST; ASTHMA; METABOLISM; CERAMIDE; SPHINGOSINE-1-PHOSPHATE; ENZYME; GENE	Despite the essential roles of sphingolipids both as structural components of membranes and critical signalling molecules, we have a limited understanding of how cells sense and regulate their levels. Here we reveal the function in sphingolipid metabolism of the ORM genes (known as ORMDL genes in humans)-a conserved gene family that includes ORMDL3, which has recently been identified as a potential risk factor for childhood asthma. Starting from an unbiased functional genomic approach in Saccharomyces cerevisiae, we identify Orm proteins as negative regulators of sphingolipid synthesis that form a conserved complex with serine palmitoyltransferase, the first and rate-limiting enzyme in sphingolipid production. We also define a regulatory pathway in which phosphorylation of Orm proteins relieves their inhibitory activity when sphingolipid production is disrupted. Changes in ORM gene expression or mutations to their phosphorylation sites cause dysregulation of sphingolipid metabolism. Our work identifies the Orm proteins as critical mediators of sphingolipid homeostasis and raises the possibility that sphingolipid misregulation contributes to the development of childhood asthma.	[Breslow, David K.; Collins, Sean R.; Weissman, Jonathan S.] Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, San Francisco, CA 94158 USA; [Breslow, David K.; Collins, Sean R.; Weissman, Jonathan S.] Univ Calif San Francisco, Howard Hughes Med Inst, San Francisco, CA 94158 USA; [Breslow, David K.] Univ Calif San Francisco, Grad Program Chem & Chem Biol, San Francisco, CA 94158 USA; [Breslow, David K.; Collins, Sean R.; Weissman, Jonathan S.] Univ Calif San Francisco, Calif Inst Quantitat Biomed Res, San Francisco, CA 94158 USA; [Bodenmiller, Bernd; Aebersold, Ruedi] ETH, Inst Mol Syst Biol, CH-8093 Zurich, Switzerland; [Aebersold, Ruedi] Inst Syst Biol, Seattle, WA 98103 USA; [Aebersold, Ruedi] Univ Zurich, Fac Sci, CH-8057 Zurich, Switzerland; [Simons, Kai; Shevchenko, Andrej; Ejsing, Christer S.] Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Ejsing, Christer S.] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark	University of California System; University of California San Francisco; Howard Hughes Medical Institute; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; Swiss Federal Institutes of Technology Domain; ETH Zurich; Institute for Systems Biology (ISB); University of Zurich; Max Planck Society; University of Southern Denmark	Weissman, JS (corresponding author), Univ Calif San Francisco, Dept Mol & Cellular Pharmacol, 1700 4th St, San Francisco, CA 94158 USA.	weissman@cmp.ucsf.edu	Ejsing, Christer S/R-5922-2016	Ejsing, Christer S./0000-0003-4963-0276; Breslow, David/0000-0003-0245-3348; Collins, Sean/0000-0002-4276-5840; Simons, Kai/0000-0002-9231-9996; Weissman, Jonathan/0000-0003-2445-670X	Deutsche Forschungsgemeinschaft [SFB/TR 13, A1, D1]; EUFP6 PRISM; ETH Zurich; National Heart, Lung, and Blood Institute, National Institute of Health [N01-HV-28179]; SystemsX.ch; Swiss initiative for systems biology; Boehringer Ingelheim Fonds; Swiss National Science Foundation; Howard Hughes Medical Institute; University of California, San Francisco Strategic Asthma Basic Research Center; National Science Foundation; Fannie and John Hertz Foundation; DIVISION OF HEART AND VASCULAR DISEASES [N01HV028179] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM073210] Funding Source: NIH RePORTER	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EUFP6 PRISM(European Commission); ETH Zurich(ETH Zurich); National Heart, Lung, and Blood Institute, National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); SystemsX.ch; Swiss initiative for systems biology; Boehringer Ingelheim Fonds(Boehringer Ingelheim); Swiss National Science Foundation(Swiss National Science Foundation (SNSF)European Commission); Howard Hughes Medical Institute(Howard Hughes Medical Institute); University of California, San Francisco Strategic Asthma Basic Research Center(University of California System); National Science Foundation(National Science Foundation (NSF)); Fannie and John Hertz Foundation; DIVISION OF HEART AND VASCULAR DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge A. Falick, S. Zhou and D. King for identification of proteins by mass spectrometry; M. Schuldiner and S. Wang for E- MAP data collection; D. Fiedler and K. Shokat for providing the phosphate-binding acrylamide reagent; E. Griffis and M. D'Ambrosio for assistance with fluorescence microscopy; N. Ingolia for a codon-optimized mCherry-tagging plasmid; E. Burchard and J. Galanter for discussions of asthma genetics; I. Poser and A. Hyman for advice and providing the HeLa-Kyoto cell line; and M. Bassik, G. Brar, V. Denic, A. Frost, N. Ingolia, E. Quan, B. Toyama and other members of the Weissman laboratory for discussions. This work was supported by funding from Deutsche Forschungsgemeinschaft SFB/TR 13 projects A1 ( K. S.) and D1 ( A. S.), EUFP6 PRISM ( K. S.), ETH Zurich ( R. A.), the National Heart, Lung, and Blood Institute, National Institute of Health (N01-HV-28179) ( R. A.), SystemsX.ch, the Swiss initiative for systems biology ( R. A.), the Boehringer Ingelheim Fonds and the Swiss National Science Foundation (B. B.), the Howard Hughes Medical Institute (J. S. W.), the University of California, San Francisco Strategic Asthma Basic Research Center ( J. S. W.), the National Science Foundation Graduate Research Fellowship Program ( D. K. B.) and the Fannie and John Hertz Foundation ( D. K. B.).	Akinbami LJ, 2009, PEDIATRICS, V123, pS131, DOI 10.1542/peds.2008-2233C; Ammit AJ, 2001, FASEB J, V15, P1212, DOI 10.1096/fj.00-0742fje; Aronova S, 2008, CELL METAB, V7, P148, DOI 10.1016/j.cmet.2007.11.015; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Barrett JC, 2009, NAT GENET, V41, P703, DOI 10.1038/ng.381; Beeler T, 1998, J BIOL CHEM, V273, P30688, DOI 10.1074/jbc.273.46.30688; Blagoveshchenskaya A, 2009, MOL BIOSYST, V5, P36, DOI 10.1039/b810979f; Bouzigon E, 2008, NEW ENGL J MED, V359, P1985, DOI 10.1056/NEJMoa0806604; Brice SE, 2009, J BIOL CHEM, V284, P7588, DOI 10.1074/jbc.M808325200; Brown MS, 2009, J LIPID RES, V50, pS15, DOI 10.1194/jlr.R800054-JLR200; Burg JS, 2008, CELL METAB, V8, P522, DOI 10.1016/j.cmet.2008.09.004; Cowart LA, 2007, BBA-MOL CELL BIOL L, V1771, P421, DOI 10.1016/j.bbalip.2006.08.005; D'Angelo G, 2007, NATURE, V449, P62, DOI 10.1038/nature06097; Delgado A, 2006, BBA-BIOMEMBRANES, V1758, P1957, DOI 10.1016/j.bbamem.2006.08.017; Dickson RC, 2006, PROG LIPID RES, V45, P447, DOI 10.1016/j.plipres.2006.03.004; Ejsing CS, 2009, P NATL ACAD SCI USA, V106, P2136, DOI 10.1073/pnas.0811700106; Fischer J, 2007, NAT GENET, V39, P28, DOI 10.1038/ng1951; Gable K, 2000, J BIOL CHEM, V275, P7597, DOI 10.1074/jbc.275.11.7597; Galanter J, 2008, AM J RESP CRIT CARE, V177, P1194, DOI 10.1164/rccm.200711-1644OC; Hampton RY, 2009, CHEM REV, V109, P1561, DOI 10.1021/cr800544v; Hanada K, 2003, NATURE, V426, P803, DOI 10.1038/nature02188; Hanada K, 2003, BBA-MOL CELL BIOL L, V1632, P16, DOI 10.1016/S1388-1981(03)00059-3; Hannun YA, 2008, NAT REV MOL CELL BIO, V9, P139, DOI 10.1038/nrm2329; Hirschfield GM, 2009, NEW ENGL J MED, V360, P2544, DOI 10.1056/NEJMoa0810440; Hjelmqvist L, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-6-research0027; Hornemann T, 2007, BIOCHEM J, V405, P157, DOI 10.1042/BJ20070025; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Idzko M, 2006, J CLIN INVEST, V116, P2935, DOI 10.1172/JCI28295; JIMENEZ CR, 1998, CURRENT PROTOCOLS PR; Kearns BG, 1997, NATURE, V387, P101, DOI 10.1038/387101a0; Kinoshita E, 2006, MOL CELL PROTEOMICS, V5, P749, DOI 10.1074/mcp.T500024-MCP200; Klemm RW, 2009, J CELL BIOL, V185, P601, DOI 10.1083/jcb.200901145; Kumagai K, 2007, J BIOL CHEM, V282, P17758, DOI 10.1074/jbc.M702291200; Kurat CF, 2009, MOL CELL, V33, P53, DOI 10.1016/j.molcel.2008.12.019; Lebman DA, 2008, J LIPID RES, V49, P1388, DOI 10.1194/jlr.R800008-JLR200; Lester RL, 2001, ANAL BIOCHEM, V298, P283, DOI 10.1006/abio.2001.5368; Loewen CJR, 2004, SCIENCE, V304, P1644, DOI 10.1126/science.1096083; Martin CE, 2007, BBA-MOL CELL BIOL L, V1771, P271, DOI 10.1016/j.bbalip.2006.06.010; Masini E, 2008, J PHARMACOL EXP THER, V324, P548, DOI 10.1124/jpet.107.131565; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Rivera J, 2008, NAT REV IMMUNOL, V8, P753, DOI 10.1038/nri2400; Ryan JJ, 2008, DRUG NEWS PERSPECT, V21, P89, DOI 10.1358/dnp.2008.21.2.1188195; Schuldiner M, 2005, CELL, V123, P507, DOI 10.1016/j.cell.2005.08.031; Strahl T, 2007, BBA-MOL CELL BIOL L, V1771, P353, DOI 10.1016/j.bbalip.2007.01.015; Tabuchi M, 2006, MOL CELL BIOL, V26, P5861, DOI 10.1128/MCB.02403-05; Tavendale R, 2008, J ALLERGY CLIN IMMUN, V121, P860, DOI 10.1016/j.jaci.2008.01.015; Vacaru AM, 2009, J CELL BIOL, V185, P1013, DOI 10.1083/jcb.200903152; Vercelli D, 2008, NAT REV IMMUNOL, V8, P169, DOI 10.1038/nri2257; Verlaan DJ, 2009, AM J HUM GENET, V85, P377, DOI 10.1016/j.ajhg.2009.08.007; Wu H, 2009, ALLERGY, V64, P629, DOI 10.1111/j.1398-9995.2008.01912.x	50	408	431	2	57	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1048	U65		10.1038/nature08787	http://dx.doi.org/10.1038/nature08787			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182505	Green Accepted, Green Submitted			2022-12-01	WOS:000275108400029
J	Bingol, B; Wang, CF; Arnott, D; Cheng, DM; Peng, JM; Sheng, M				Bingol, Baris; Wang, Chi-Fong; Arnott, David; Cheng, Dongmei; Peng, Junmin; Sheng, Morgan			Autophosphorylated CaMKII alpha Acts as a Scaffold to Recruit Proteasomes to Dendritic Spines	CELL			English	Article							PROTEIN-KINASE-II; LONG-TERM POTENTIATION; INTERACTING PROTEINS; HIPPOCAMPAL-NEURONS; TERNARY COMPLEX; DEGRADATION; PLASTICITY; MEMORY; UBIQUITINATION; MAINTENANCE	The molecular mechanisms regulating the ubiquitin proteasome system (UPS) at synapses are poorly understood. We report that CaMKII alpha-an abundant postsynaptic protein kinase-mediates the activity-dependent recruitment of proteasomes to dendritic spines in hippocampal neurons. CaMKII alpha is biochemically associated with proteasomes in the brain. CaMKII alpha translocation to synapses is required for activity-induced proteasome accumulation in spines, and is sufficient to redistribute proteasomes to postsynaptic sites. CaMKII alpha autophosphorylation enhances its binding to proteasomes and promotes proteasome recruitment to spines. In addition to this structural role, CaMKII alpha stimulates proteasome activity by phosphorylating proteasome subunit Rpt6 on Serine 120. However, CaMKII alpha translocation, but not its kinase activity, is required for activity-dependent degradation of polyubiquitinated proteins in spines. Our findings reveal a scaffolding role of postsynaptic CaMKII alpha in activity-dependent proteasome redistribution, which is commensurate with the great abundance of CaMKII alpha in synapses.	[Bingol, Baris; Wang, Chi-Fong; Sheng, Morgan] MIT, Dept Brain & Cognit Sci & Biol, Picower Inst Learning & Memory, Cambridge, MA 02139 USA; [Bingol, Baris; Sheng, Morgan] Genentech Inc, Dept Neurosci, San Francisco, CA 94080 USA; [Arnott, David] Genentech Inc, Dept Prot Chem, San Francisco, CA 94080 USA; [Cheng, Dongmei; Peng, Junmin] Emory Univ, Sch Med, Dept Human Genet, Ctr Neurodegenerat Dis, Atlanta, GA 30322 USA	Massachusetts Institute of Technology (MIT); Northwell Health; Roche Holding; Genentech; Roche Holding; Genentech; Emory University	Sheng, M (corresponding author), MIT, Dept Brain & Cognit Sci & Biol, Picower Inst Learning & Memory, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	msheng@mit.edu	Peng, Junmin/N-2614-2018	Peng, Junmin/0000-0003-0472-7648; Sheng, Morgan/0000-0002-8703-5366				Banaszynski LA, 2005, J AM CHEM SOC, V127, P4715, DOI 10.1021/ja043277y; Bayer KU, 2001, NATURE, V411, P801, DOI 10.1038/35081080; Bingol B, 2005, CURR OPIN NEUROBIOL, V15, P536, DOI 10.1016/j.conb.2005.08.016; Bingol B, 2006, NATURE, V441, P1144, DOI 10.1038/nature04769; Bousquet-Dubouch MP, 2009, MOL CELL PROTEOMICS, V8, P1150, DOI 10.1074/mcp.M800193-MCP200; Brocke L, 1999, J BIOL CHEM, V274, P22713, DOI 10.1074/jbc.274.32.22713; Cheng DM, 2006, MOL CELL PROTEOMICS, V5, P1158, DOI 10.1074/mcp.D500009-MCP200; Choe EA, 2007, J NEUROSCI, V27, P9503, DOI 10.1523/JNEUROSCI.1408-07.2007; Colledge M, 2003, NEURON, V40, P595, DOI 10.1016/S0896-6273(03)00687-1; Djakovic SN, 2009, J BIOL CHEM, V284, P26655, DOI 10.1074/jbc.M109.021956; Ehlers MD, 2003, NAT NEUROSCI, V6, P231, DOI 10.1038/nn1013; Elgersma Y, 2002, NEURON, V36, P493, DOI 10.1016/S0896-6273(02)01007-3; Fink CC, 2003, NEURON, V39, P283, DOI 10.1016/S0896-6273(03)00428-8; Fonseca R, 2006, NEURON, V52, P239, DOI 10.1016/j.neuron.2006.08.015; Glickman MH, 2005, FEBS LETT, V579, P3214, DOI 10.1016/j.febslet.2005.04.048; Glickman MH, 1998, MOL CELL BIOL, V18, P3149, DOI 10.1128/MCB.18.6.3149; Goh Amanda M., 2008, BMC Biochemistry, V9, P4, DOI 10.1186/1471-2091-9-4; Hinds HL, 2003, P NATL ACAD SCI USA, V100, P4275, DOI 10.1073/pnas.0530202100; Karpova A, 2006, J NEUROSCI, V26, P4949, DOI 10.1523/JNEUROSCI.4573-05.2006; KOLB SJ, 1995, J NEUROCHEM, V64, P2147; Lee SH, 2008, SCIENCE, V319, P1253, DOI 10.1126/science.1150541; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Lopez-Salon M, 2001, EUR J NEUROSCI, V14, P1820, DOI 10.1046/j.0953-816x.2001.01806.x; Lu WY, 2001, NEURON, V29, P243, DOI 10.1016/S0896-6273(01)00194-5; Newton K, 2008, CELL, V134, P668, DOI 10.1016/j.cell.2008.07.039; Okamoto KI, 2007, P NATL ACAD SCI USA, V104, P6418, DOI 10.1073/pnas.0701656104; Otmakhov N, 2004, J NEUROSCI, V24, P9324, DOI 10.1523/JNEUROSCI.2350-04.2004; Scanlon TC, 2009, EXP CELL RES, V315, P176, DOI 10.1016/j.yexcr.2008.10.027; Schauber C, 1998, NATURE, V391, P715, DOI 10.1038/35661; Seeburg DP, 2008, NEURON, V58, P571, DOI 10.1016/j.neuron.2008.03.021; Shen H, 2007, J NEUROSCI, V27, P8903, DOI 10.1523/JNEUROSCI.1571-07.2007; Shen K, 1999, SCIENCE, V284, P162, DOI 10.1126/science.284.5411.162; Tao-Cheng JH, 2006, BRAIN CELL BIOL, V35, P117, DOI 10.1007/s11068-007-9012-5; Thiagarajan TC, 2002, NEURON, V36, P1103, DOI 10.1016/S0896-6273(02)01049-8; Verma R, 2000, MOL BIOL CELL, V11, P3425, DOI 10.1091/mbc.11.10.3425; Walikonis RS, 2001, J NEUROSCI, V21, P423, DOI 10.1523/JNEUROSCI.21-02-00423.2001; Wang XR, 2008, MOL CELL PROTEOMICS, V7, P46, DOI 10.1074/mcp.M700261-MCP200; Wu GY, 1998, SCIENCE, V279, P222, DOI 10.1126/science.279.5348.222; Yao I, 2007, CELL, V130, P943, DOI 10.1016/j.cell.2007.06.052	39	210	213	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 19	2010	140	4					567	578		10.1016/j.cell.2010.01.024	http://dx.doi.org/10.1016/j.cell.2010.01.024			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	557KQ	20178748	Green Published, Bronze			2022-12-01	WOS:000274668400019
J	Macdonald, H				Macdonald, Helen			Military Medicine Long road to recovery	BRITISH MEDICAL JOURNAL			English	Editorial Material									BMJ, London WC1H 9JR, England		Macdonald, H (corresponding author), BMJ, London WC1H 9JR, England.	hmacdonald@bmj.com						Defence Analytical Services and Advice, 2010, EST PROP PRIS ENGL W; Napo, 2009, ARM FORC CRIM JUST S; National Audit Office, 2010, MIN DEF TREAT INJ IL	3	2	2	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	FEB 18	2010	340								c647	10.1136/bmj.c647	http://dx.doi.org/10.1136/bmj.c647			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JV	20167648				2022-12-01	WOS:000274739000004
J	Paynter, NP; Chasman, DI; Pare, G; Buring, JE; Cook, NR; Miletich, JP; Ridker, PM				Paynter, Nina P.; Chasman, Daniel I.; Pare, Guillaume; Buring, Julie E.; Cook, Nancy R.; Miletich, Joseph P.; Ridker, Paul M.			Association Between a Literature-Based Genetic Risk Score and Cardiovascular Events in Women	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENOME-WIDE ASSOCIATION; HEART-DISEASE RISK; ATHEROSCLEROSIS RISK; PREDICTION; RECLASSIFICATION; GENOTYPE; LOCUS	Context While multiple genetic markers associated with cardiovascular disease have been identified by genome-wide association studies, their aggregate effect on risk beyond traditional factors is uncertain, particularly among women. Objective To test the predictive ability of a literature-based genetic risk score for cardiovascular disease. Design, Setting, and Participants Prospective cohort of 19 313 initially healthy white women in the Women's Genome Health Study followed up over a median of 12.3 years (interquartile range, 11.6-12.8 years). Genetic risk scores were constructed from the National Human Genome Research Institute's catalog of genome-wide association study results published between 2005 and June 2009. Main Outcome Measure Incident myocardial infarction, stroke, arterial revascularization, and cardiovascular death. Results A total of 101 single nucleotide polymorphisms reported to be associated with cardiovascular disease or at least 1 intermediate cardiovascular disease phenotype at a published P value of less than 10(-7) were identified and risk alleles were added to create a genetic risk score. During follow-up, 777 cardiovascular disease events occurred (199 myocardial infarctions, 203 strokes, 63 cardiovascular deaths, 312 revascularizations). After adjustment for age, the genetic risk score had a hazard ratio (HR) for cardiovascular disease of 1.02 per risk allele (95% confidence interval [CI], 1.00-1.03/risk allele; P=.006). This corresponds to an absolute cardiovascular disease risk of 3% over 10 years in the lowest tertile of genetic risk (73-99 risk alleles) and 3.7% in the highest tertile (106-125 risk alleles). However, after adjustment for traditional factors, the genetic risk score did not improve discrimination or reclassification (change in c index from Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults [ATP III] risk score, 0; net reclassification improvement, 0.5%; [P=.24]). The genetic risk score was not associated with cardiovascular disease risk (ATP III-adjusted HR/allele, 1.00; 95% CI, 0.99-1.01). In contrast, self-reported family history remained significantly associated with cardiovascular disease in multivariable models. Conclusion After adjustment for traditional cardiovascular risk factors, a genetic risk score comprising 101 single nucleotide polymorphisms was not significantly associated with the incidence of total cardiovascular disease. JAMA. 2010;303(7):631-637 www.jama.com	[Paynter, Nina P.; Chasman, Daniel I.; Pare, Guillaume; Buring, Julie E.; Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Div Prevent Med, Boston, MA 02215 USA; [Paynter, Nina P.; Chasman, Daniel I.; Pare, Guillaume; Buring, Julie E.; Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Ctr Cardiovasc Dis Prevent, Boston, MA 02215 USA; [Paynter, Nina P.; Chasman, Daniel I.; Pare, Guillaume; Buring, Julie E.; Cook, Nancy R.; Ridker, Paul M.] Brigham & Womens Hosp, Div Cardiovasc Dis, Boston, MA 02215 USA; [Pare, Guillaume] McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada; [Pare, Guillaume] McMaster Univ, Dept Clin Epidemiol & Biostat, Hamilton, ON, Canada; [Miletich, Joseph P.] Amgen Inc, Thousand Oaks, CA 91320 USA	Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; McMaster University; McMaster University; Amgen	Paynter, NP (corresponding author), Brigham & Womens Hosp, Div Prevent Med, 900 Commonwealth Ave E, Boston, MA 02215 USA.	npaynter@partners.org		Venkatasubramanian, Siddharth/0000-0002-5860-0768	National Heart, Lung, and Blood Institute [HL 043851, HL 080467]; National Cancer Institute [CA 047988]; Donald W. Reynolds Foundation; Leducq Foundation; NATIONAL CANCER INSTITUTE [R01CA047988] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL080467, R01HL043851] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Donald W. Reynolds Foundation; Leducq Foundation(Leducq Foundation); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))	The Women's Genome Health Study is supported by funds from the National Heart, Lung, and Blood Institute (grants HL 043851 and HL 080467), the National Cancer Institute (grant CA 047988), the Donald W. Reynolds Foundation, and the Leducq Foundation. Genotyping was performed by Amgen Inc. Additional support for DNA extraction, reagents, and data analysis was provided by Roche Diagnostics and Amgen Inc.	BARANY F, 1991, P NATL ACAD SCI USA, V88, P189, DOI 10.1073/pnas.88.1.189; Brautbar A, 2009, CIRC-CARDIOVASC GENE, V2, P279, DOI 10.1161/CIRCGENETICS.108.817338; Cook NR, 2009, ANN INTERN MED, V150, P795, DOI 10.7326/0003-4819-150-11-200906020-00007; Dunbar SA, 2006, CLIN CHIM ACTA, V363, P71, DOI 10.1016/j.cccn.2005.06.023; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Grundy SM, 2002, CIRCULATION, V106, P3143, DOI 10.1161/circ.106.25.3143; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; HINDORFF JA, CATALOG PUBLISHED GE; Ioannidis JPA, 2009, CIRC-CARDIOVASC GENE, V2, P7, DOI 10.1161/CIRCGENETICS.108.833392; Kathiresan S, 2008, NEW ENGL J MED, V358, P1240, DOI 10.1056/NEJMoa0706728; LEMESHOW S, 1982, AM J EPIDEMIOL, V115, P92, DOI 10.1093/oxfordjournals.aje.a113284; Li Y., 2006, AM J HUM GENET S, V79, P2290; McCarthy MI, 2008, NAT REV GENET, V9, P356, DOI 10.1038/nrg2344; Morrison AC, 2007, AM J EPIDEMIOL, V166, P28, DOI 10.1093/aje/kwm060; Paynter NP, 2009, ANN INTERN MED, V150, P65, DOI 10.7326/0003-4819-150-2-200901200-00003; Pei YF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003551; Pencina MJ, 2008, STAT MED, V27, P157, DOI 10.1002/sim.2929; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rexrode KM, 2000, J WOMEN HEALTH GEN-B, V9, P19, DOI 10.1089/152460900318911; Ridker PM, 2008, CLIN CHEM, V54, P249, DOI 10.1373/clinchem.2007.099366; Ridker PM, 2007, JAMA-J AM MED ASSOC, V297, P611, DOI 10.1001/jama.297.6.611; Talmud PJ, 2008, CLIN CHEM, V54, P467, DOI 10.1373/clinchem.2007.095489	22	262	276	0	10	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 17	2010	303	7					631	637		10.1001/jama.2010.119	http://dx.doi.org/10.1001/jama.2010.119			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555NK	20159871	Green Accepted			2022-12-01	WOS:000274518600021
J	Myers, S; Bowden, R; Tumian, A; Bontrop, RE; Freeman, C; MacFie, TS; McVean, G; Donnelly, P				Myers, Simon; Bowden, Rory; Tumian, Afidalina; Bontrop, Ronald E.; Freeman, Colin; MacFie, Tammie S.; McVean, Gil; Donnelly, Peter			Drive Against Hotspot Motifs in Primates Implicates the PRDM9 Gene in Meiotic Recombination	SCIENCE			English	Article							YEAST SACCHAROMYCES-CEREVISIAE; HISTONE H3 METHYLTRANSFERASE; HUMAN GENOME; EVOLUTION; CONVERSION; INITIATION; HUMANS; MOUSE; CHIMPANZEES	Although present in both humans and chimpanzees, recombination hotspots, at which meiotic crossover events cluster, differ markedly in their genomic location between the species. We report that a 13-base pair sequence motif previously associated with the activity of 40% of human hotspots does not function in chimpanzees and is being removed by self-destructive drive in the human lineage. Multiple lines of evidence suggest that the rapidly evolving zinc-finger protein PRDM9 binds to this motif and that sequence changes in the protein may be responsible for hotspot differences between species. The involvement of PRDM9, which causes histone H3 lysine 4 trimethylation, implies that there is a common mechanism for recombination hotspots in eukaryotes but raises questions about what forces have driven such rapid change.	[Myers, Simon; Bowden, Rory; Tumian, Afidalina; McVean, Gil; Donnelly, Peter] Univ Oxford, Dept Stat, Oxford OX1 3TG, England; [Myers, Simon; Bowden, Rory; Freeman, Colin; McVean, Gil; Donnelly, Peter] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Bontrop, Ronald E.] Biomed Primate Res Ctr, Dept Comparat Genet & Refinement, NL-2288 GJ Rijswijk, Netherlands; [MacFie, Tammie S.] Univ Cambridge, Dept Zool, Cambridge CB2 3EJ, England	University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; University of Cambridge	Myers, S (corresponding author), Univ Oxford, Dept Stat, 1 S Parks Rd, Oxford OX1 3TG, England.	myers@stats.ox.ac.uk	Myers, Simon R/A-6792-2015; Bontrop, Ronald E./D-4844-2011; Bontrop, Ronald E/J-3628-2012; Tumian, Afidalina/J-4404-2014	Myers, Simon R/0000-0002-2585-9626; Bontrop, Ronald E/0000-0003-0874-6467; Tumian, Afidalina/0000-0003-2763-6677; Donnelly, Peter/0000-0001-9495-3408	Leverhulme Trust; Royal Society; Wellcome Trust	Leverhulme Trust(Leverhulme Trust); Royal Society(Royal Society of London); Wellcome Trust(Wellcome Trust)	We thank N. Mundy for advice and provision of chimpanzee samples and C. Mitchell and E. Nerrienet for assisting in chimpanzee sample collection. We thank D. Falush and G. Coop for helpful conversations. Part of the work was completed while S. M. was a fellow at the Broad Institute. We would like to acknowledge funding from the Leverhulme Trust (to G. M.), the Royal Society (to P. D.), and the Wellcome Trust (to S. M., C. F., G. M., and P. D.). The chimpanzee genotype data for 22 hotspot candidate regions generated is available online with the SOM as Database S1.	Baudat F, 2010, SCIENCE, V327, P836, DOI 10.1126/science.1183439; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Coop G, 2007, PLOS GENET, V3, P377, DOI 10.1371/journal.pgen.0030035; Gerton JL, 2000, P NATL ACAD SCI USA, V97, P11383, DOI 10.1073/pnas.97.21.11383; Gibbs RA, 2007, SCIENCE, V316, P222, DOI 10.1126/science.1139247; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mets DG, 2009, CELL, V139, P73, DOI 10.1016/j.cell.2009.07.035; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; NAGYLAKI T, 1983, P NATL ACAD SCI-BIOL, V80, P6278, DOI 10.1073/pnas.80.20.6278; NICOLAS A, 1989, NATURE, V338, P35, DOI 10.1038/338035a0; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Persikov AV, 2009, BIOINFORMATICS, V25, P22, DOI 10.1093/bioinformatics/btn580; Presgraves DC, 2007, BIOESSAYS, V29, P386, DOI 10.1002/bies.20555; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Schimenti J, 2000, TRENDS GENET, V16, P240, DOI 10.1016/S0168-9525(00)02020-5; Webb AJ, 2008, P NATL ACAD SCI USA, V105, P10471, DOI 10.1073/pnas.0804933105; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Wyckoff GJ, 2000, NATURE, V403, P304, DOI 10.1038/35002070	26	432	438	0	47	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					876	879		10.1126/science.1182363	http://dx.doi.org/10.1126/science.1182363			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044541	Green Accepted			2022-12-01	WOS:000274408300065
J	Smith, MD; Roheim, CA; Crowder, LB; Halpern, BS; Turnipseed, M; Anderson, JL; Asche, F; Bourillon, L; Guttormsen, AG; Khan, A; Liguori, LA; McNevin, A; O'Connor, MI; Squires, D; Tyedmers, P; Brownstein, C; Carden, K; Klinger, DH; Sagarin, R; Selkoe, KA				Smith, Martin D.; Roheim, Cathy A.; Crowder, Larry B.; Halpern, Benjamin S.; Turnipseed, Mary; Anderson, James L.; Asche, Frank; Bourillon, Luis; Guttormsen, Atle G.; Khan, Ahmed; Liguori, Lisa A.; McNevin, Aaron; O'Connor, Mary I.; Squires, Dale; Tyedmers, Peter; Brownstein, Carrie; Carden, Kristin; Klinger, Dane H.; Sagarin, Raphael; Selkoe, Kimberly A.			Sustainability and Global Seafood	SCIENCE			English	Editorial Material							COMMONS; TRADE; FISH		[Smith, Martin D.; Turnipseed, Mary] Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA; [Smith, Martin D.] Duke Univ, Dept Econ, Durham, NC 27708 USA; [Roheim, Cathy A.; Anderson, James L.] Univ Rhode Isl, Dept Environm & Nat Resource Econ, Kingston, RI 02881 USA; [Crowder, Larry B.] Duke Univ, Nicholas Sch Environm, Ctr Marine Conservat, Beaufort, NC 28516 USA; [Halpern, Benjamin S.; O'Connor, Mary I.; Selkoe, Kimberly A.] Univ Calif Santa Barbara, Natl Ctr Ecol Anal & Synth, Santa Barbara, CA 93101 USA; [Asche, Frank] Univ Stavanger, Dept Ind Econ, N-4036 Stavanger, Norway; [Bourillon, Luis] Comunidad & Biodiversidad AC COBI, Guaymas 85420, Sonora, Mexico; [Guttormsen, Atle G.] Norwegian Univ Life Sci, Dept Econ & Resource Management, N-1432 As, Norway; [Khan, Ahmed] Mem Univ Newfoundland, Dept Geog, Int Coastal Network, St John, NF A1B 3X9, Canada; [Liguori, Lisa A.] Univ Georgia, Marine Extens Serv, Brunswick, GA 31520 USA; [McNevin, Aaron] World Wildlife Fund, Washington, DC 20037 USA; [Squires, Dale] SW Fisheries Sci Ctr, La Jolla, CA 92037 USA; [Tyedmers, Peter] Dalhousie Univ, Sch Resource & Environm Studies, Halifax, NS B3H 3J5, Canada; [Brownstein, Carrie] Whole Foods Market, Austin, TX 78703 USA; [Carden, Kristin] Univ Calif Santa Barbara, Dept Ecol Evolut & Marine Biol, Santa Barbara, CA 93106 USA; [Klinger, Dane H.] Stanford Univ, Emmett Interdisciplinary Program Environm & Resou, Stanford, CA 94305 USA; [Sagarin, Raphael] Univ Arizona, Inst Environm, Tucson, AZ 85719 USA; [Selkoe, Kimberly A.] Hawaii Inst Marine Biol, Kaneohe, HI 96744 USA	Duke University; Duke University; University of Rhode Island; Duke University; National Center for Ecological Analysis & Synthesis; University of California System; University of California Santa Barbara; Universitetet i Stavanger; Norwegian University of Life Sciences; Memorial University Newfoundland; University System of Georgia; University of Georgia; World Wildlife Fund; National Oceanic Atmospheric Admin (NOAA) - USA; Dalhousie University; University of California System; University of California Santa Barbara; Stanford University; University of Arizona	Smith, MD (corresponding author), Duke Univ, Nicholas Sch Environm, Durham, NC 27708 USA.	marsmith@duke.edu	O'Connor, Mary I/F-2275-2010; Asche, Frank/AAG-9920-2020; Guttormsen, Atle/GZG-2356-2022; Smith, Martin D/D-9168-2016; O'Connor, Mary/R-2933-2019; Tyedmers, Peter H/I-7490-2012; Tyedmers, Peter/N-1334-2019	O'Connor, Mary I/0000-0001-9583-1592; Asche, Frank/0000-0002-1540-9728; Smith, Martin D/0000-0002-4714-463X; Tyedmers, Peter H/0000-0002-5150-0756; Tyedmers, Peter/0000-0002-5150-0756; Anderson, James L./0000-0003-2942-8345				Anderson J. L., 2002, Marine Resource Economics, V17, P133; Arrow K, 2004, J ECON PERSPECT, V18, P147, DOI 10.1257/0895330042162377; Asche F, 2009, MAR RESOUR ECON, V24, P405, DOI 10.1086/mre.24.4.42629664; Asche F, 2008, MAR RESOUR ECON, V23, P527, DOI 10.1086/mre.23.4.42629678; Bourillon L., 2009, BIODIVERSITAS, V86, P7; Brander JA, 1998, J INT ECON, V44, P181, DOI 10.1016/S0022-1996(97)00029-9; Cinner JE, 2007, BIOL CONSERV, V140, P201, DOI 10.1016/j.biocon.2007.08.008; Copeland BR, 2009, AM ECON REV, V99, P725, DOI 10.1257/aer.99.3.725; COPES P, 1970, SCOT J POLIT ECON, V17, P69, DOI 10.1111/j.1467-9485.1970.tb00487.x; Dietz T, 2003, SCIENCE, V302, P1907, DOI 10.1126/science.1091015; FAO, 2009, FISHSTAT PLUS; FAO (Food and Agriculture Organization of the United Nations), 2008, PREV UND TOT POP; Food and Agriculture Organization of the United Nations, 2009, STAT WORLD FISH AQ 2; Gordon HS, 1954, J POLIT ECON, V62, P124, DOI 10.1086/257497; Halpern BS, 2008, SCIENCE, V319, P948, DOI 10.1126/science.1149345; Hibbeln JR, 2007, LANCET, V369, P578, DOI 10.1016/S0140-6736(07)60277-3; Kaufman Daniel, 2009, 4978 WORLD BANK; Naylor RL, 2000, NATURE, V405, P1017, DOI 10.1038/35016500; Ostrom E., 1992, CRAFTING I SELF GOVE; Ostrom E, 2009, SCIENCE, V325, P419, DOI 10.1126/science.1172133; Pauly D, 1998, SCIENCE, V279, P860, DOI 10.1126/science.279.5352.860; Roos N, 2007, J NUTR, V137, P1106, DOI 10.1093/jn/137.4.1106	22	314	319	4	151	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 12	2010	327	5967					784	786		10.1126/science.1185345	http://dx.doi.org/10.1126/science.1185345			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	554AQ	20150469				2022-12-01	WOS:000274408300025
J	van Leeuwen, MT; Webster, AC; McCredie, MRE; Stewart, JH; McDonald, SP; Amin, J; Kaldor, JM; Chapman, JR; Vajdic, CM; Grulich, AE				van Leeuwen, Marina T.; Webster, Angela C.; McCredie, Margaret R. E.; Stewart, John H.; McDonald, Stephen P.; Amin, Janaki; Kaldor, John M.; Chapman, Jeremy R.; Vajdic, Claire M.; Grulich, Andrew E.			Effect of reduced immunosuppression after kidney transplant failure on risk of cancer: population based retrospective cohort study	BMJ-BRITISH MEDICAL JOURNAL			English	Article							ACTIVE ANTIRETROVIRAL THERAPY; SWISS HIV COHORT; NON-HODGKIN-LYMPHOMA; KAPOSI-SARCOMA; THYROID-CANCER; DISEASE; ASSOCIATION; RECIPIENTS; END	Objective To compare cancer incidence in kidney transplant recipients during periods of transplant function (and immunosuppression) and after transplant failure (when immunosuppression is ceased or reduced). Design, setting, and participants Nationwide, population based retrospective cohort study of 8173 Australian kidney transplant recipients registered on the Australia and New Zealand Dialysis and Transplant Registry who first received a transplant during 1982-2003. Incident cancers were ascertained using linkage with national cancer registry records. Main outcome measures Cancer-specific standardised incidence ratios for periods of transplant function and for dialysis after transplant failure. Incidence was compared between periods using multivariate incidence rate ratios adjusted for current age, sex, and duration of transplantation. Results All cases of Kaposi's sarcoma occurred during transplant function. Standardised incidence ratios were significantly elevated during transplant function, but not during dialysis after transplant failure, for non-Hodgkin's lymphoma, lip cancer, and melanoma. For each of these cancers, incidence was significantly lower during dialysis after transplant failure in multivariate analysis ( incidence rate ratios 0.20 (95% CI 0.06 to 0.65) for non-Hodgkin's lymphoma, 0.04 (0.01 to 0.31) for lip cancer, and 0.16 (0.04 to 0.64) for melanoma). In contrast, standardised incidence ratios during dialysis after transplant failure remained significantly elevated for leukaemia and lung cancer, and cancers related to end stage kidney disease ( kidney, urinary tract, and thyroid cancers), with thyroid cancer incidence significantly higher during dialysis after transplant failure ( incidence rate ratio 6.77 (2.64 to 17.39)). There was no significant difference in incidence by transplant function for other cancers. Conclusions The effect of immunosuppression on cancer risk is rapidly reversible for some, but not all, cancer types. Risk reversal was mainly observed for cancers with a confirmed infectious cause. Risk of other cancers, especially those related to end stage kidney disease, remained significantly increased after reduction of immunosuppression.	[van Leeuwen, Marina T.; Amin, Janaki; Kaldor, John M.; Grulich, Andrew E.] Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, Sydney, NSW 2010, Australia; [van Leeuwen, Marina T.] Univ New S Wales, Sch Publ Hlth & Community Med, Sydney, NSW 2052, Australia; [Webster, Angela C.; McDonald, Stephen P.] Queen Elizabeth Hosp, Australia & New Zealand Dialysis & Transplant Reg, Woodville, SA 5011, Australia; [Webster, Angela C.] Univ Sydney, Sch Publ Hlth, Sydney, NSW 2006, Australia; [Webster, Angela C.; Chapman, Jeremy R.] Univ Sydney, Westmead Hosp, Westmead Millennium Inst, Ctr Transplant & Renal Res, Westmead, NSW 2145, Australia; [McCredie, Margaret R. E.; Stewart, John H.] Univ Otago, Dept Prevent & Social Med, Dunedin 9054, New Zealand; [McDonald, Stephen P.] Univ Adelaide, Discipline Med, Adelaide, SA 5005, Australia; [McDonald, Stephen P.] Univ Adelaide, Discipline Publ Hlth, Adelaide, SA 5005, Australia; [Vajdic, Claire M.] Univ New S Wales, Prince Wales Clin Sch, Canc Res Ctr, Sydney, NSW 2052, Australia	University of New South Wales Sydney; Kirby Institute; University of New South Wales Sydney; University of Sydney; University of Sydney; Westmead Institute for Medical Research; University of Otago; University of Adelaide; University of Adelaide; University of New South Wales Sydney	Grulich, AE (corresponding author), Univ New S Wales, Natl Ctr HIV Epidemiol & Clin Res, 376 Victoria St, Sydney, NSW 2010, Australia.	agrulich@nchecr.unsw.edu.au	Webster, Angela/J-2186-2012; van Leeuwen, Marina T/AAQ-5339-2021; McDonald, Stephen/G-4010-2013; Kaldor, John M/D-4545-2011; Vajdic, Claire/AAP-5940-2020	Webster, Angela/0000-0001-7509-0512; van Leeuwen, Marina T/0000-0002-1570-2852; McDonald, Stephen/0000-0001-6103-1386; Amin, Janaki/0000-0003-2161-9366; Vajdic, Claire/0000-0002-3612-8298	Cancer Council New South Wales [RG 47/03]; National Health and Medical Research Council [ID 510346, ID 401131]; Cancer Institute New South Wales [07/CDF/1-38, 06/RSA/1/28]; Australian Government Department of Health and Ageing; New Zealand Ministry of Health; Kidney Health Australia	Cancer Council New South Wales(Cancer Council New South Wales); National Health and Medical Research Council(National Health and Medical Research Council (NHMRC) of Australia); Cancer Institute New South Wales; Australian Government Department of Health and Ageing(Australian GovernmentDepartment of Health & Ageing); New Zealand Ministry of Health; Kidney Health Australia	This work was supported by the Cancer Council New South Wales (RG 47/03); the National Health and Medical Research Council ( ID 510346 to CMV, ID 401131 to MTvL); and the Cancer Institute New South Wales (07/CDF/1-38 to CMV, 06/RSA/1/28 to MTvL). The ANZDATA Registry administrative office is supported by funding from the Australian Government Department of Health and Ageing, the New Zealand Ministry of Health, and Kidney Health Australia; data collection costs were borne by contributing renal units. The National Centre in HIV Epidemiology and Clinical Research is funded by the Australian Government Department of Health and Ageing and is affiliated with the Faculty of Medicine, University of New South Wales. The funders had no role in the design and conduct of the study; collection, management, analysis, and interpretation of the data; or preparation, review, or approval of the manuscript.	Australian Institute of Health and Welfare (AIHW) and Australasian Association of Cancer Registries (AACR), 2008, CANC AUSTR OV 2008; Barozzi P, 2008, TRANSPLANTATION, V86, P738, DOI 10.1097/TP.0b013e318184112c; Bouvard V, 2009, LANCET ONCOL, V10, P321, DOI 10.1016/S1470-2045(09)70096-8; Breslow NE, 1987, STAT METHODS CANC RE, VII; Clifford GM, 2005, JNCI-J NATL CANCER I, V97, P425, DOI 10.1093/jnci/dji072; Franceschi S, 2008, BRIT J CANCER, V99, P800, DOI 10.1038/sj.bjc.6604520; GLATTRE E, 1989, INT J EPIDEMIOL, V18, P45, DOI 10.1093/ije/18.1.45; Grulich AE, 2007, LANCET, V370, P59, DOI 10.1016/S0140-6736(07)61050-2; Hessol NA, 2007, AM J EPIDEMIOL, V165, P1143, DOI 10.1093/aje/kwm017; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; HIRJI KF, 1989, AM STAT, V43, P7, DOI 10.2307/2685158; *IARC, 1997, IARC MON EV CARC RIS, V8; *INT AG RES CANC, 2007, IARC MON EV CARC RIS; Klyachkin ML, 2001, AM SURGEON, V67, P397; Lebbe Celeste, 2008, Transplant Rev (Orlando), V22, P252, DOI 10.1016/j.trre.2008.05.004; Marcen Roberto, 2008, Transplant Rev (Orlando), V22, P62, DOI 10.1016/j.trre.2007.09.005; McDonald SP, 2002, AM J KIDNEY DIS, V40, P1122, DOI 10.1053/ajkd.2002.36943; Patel P, 2008, ANN INTERN MED, V148, P728, DOI 10.7326/0003-4819-148-10-200805200-00005; PENN I, 1994, CANCER DETECT PREV, V18, P241; Penn I, 1998, SPRINGER SEMIN IMMUN, V20, P343, DOI 10.1007/BF00838048; Piaserico S, 2006, J AM ACAD DERMATOL, V54, P338, DOI 10.1016/j.jaad.2005.06.023; Polesel J, 2008, AIDS, V22, P301, DOI 10.1097/QAD.0b013e3282f2705d; STARZL TE, 1984, LANCET, V1, P583; Vajdic CM, 2006, JAMA-J AM MED ASSOC, V296, P2823, DOI 10.1001/jama.296.23.2823; Vajdic CM, 2009, CANCER EPIDEM BIOMAR, V18, P2297, DOI 10.1158/1055-9965.EPI-09-0278; Vamvakas S, 1998, AM J NEPHROL, V18, P89, DOI 10.1159/000013314; van Leeuwen MT, 2009, BLOOD, V114, P630, DOI 10.1182/blood-2009-02-202507; van Leeuwen MT, 2009, CANCER EPIDEM BIOMAR, V18, P561, DOI 10.1158/1055-9965.EPI-08-0919; YOUNG L, 1989, NEW ENGL J MED, V321, P1080, DOI 10.1056/NEJM198910193211604	29	104	105	0	5	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2010	340								c570	10.1136/bmj.c570	http://dx.doi.org/10.1136/bmj.c570			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZV	20150194	Green Submitted, hybrid, Green Published			2022-12-01	WOS:000274477200003
J	Nakamura, T; Furuhashi, M; Li, P; Cao, HM; Tuncman, G; Sonenberg, N; Gorgun, CZ; Hotamisligil, GS				Nakamura, Takahisa; Furuhashi, Masato; Li, Ping; Cao, Haiming; Tuncman, Gurol; Sonenberg, Nahum; Gorgun, Cem Z.; Hotamisligil, Goekhan S.			Double-Stranded RNA-Dependent Protein Kinase Links Pathogen Sensing with Stress and Metabolic Homeostasis	CELL			English	Article							ENDOPLASMIC-RETICULUM STRESS; INDUCED INSULIN-RESISTANCE; P38 MAPK ACTIVATION; DS RNA; PKR; MICE; BINDING; OBESITY; ALPHA; JNK	As chronic inflammation is a hallmark of obesity, pathways that integrate nutrient- and pathogen sensing pathways are of great interest in understanding the mechanisms of insulin resistance, type 2 diabetes, and other chronic metabolic pathologies. Here, we provide evidence that double-stranded RNA-dependent protein kinase (PKR) can respond to nutrient signals as well as endoplasmic reticulum (ER) stress and coordinate the activity of other critical inflammatory kinases such as the c-Jun N-terminal kinase (JNK) to regulate insulin action and metabolism. PKR also directly targets and modifies insulin receptor substrate and hence integrates nutrients and insulin action with a defined pathogen response system. Dietary and genetic obesity features marked activation of PKR in adipose and liver tissues and absence of PKR alleviates metabolic deterioration due to nutrient or energy excess in mice. These findings demonstrate PKR as a critical component of an inflammatory complex that responds to nutrients and organelle dysfunction.	[Nakamura, Takahisa; Furuhashi, Masato; Li, Ping; Cao, Haiming; Tuncman, Gurol; Gorgun, Cem Z.; Hotamisligil, Goekhan S.] Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA; [Sonenberg, Nahum] McGill Univ, Dept Biochem, Montreal, PQ H3G 1Y6, Canada; [Hotamisligil, Goekhan S.] Harvard MIT Broad Inst, Cambridge, MA 02142 USA	Harvard University; Harvard T.H. Chan School of Public Health; McGill University; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute	Hotamisligil, GS (corresponding author), Harvard Univ, Sch Publ Hlth, Dept Genet & Complex Dis, Boston, MA 02115 USA.	ghotamis@hsph.harvard.edu	Furuhashi, Masato/AAT-5518-2021; Longo, Kenneth A/A-5631-2010; Cao, Haiming/P-4634-2016	Furuhashi, Masato/0000-0002-0145-3541; Nakamura, Takahisa/0000-0003-4922-4569	National Institutes of Health; International Human Frontier Science Program; Uehara Memorial Foundation; Japan Society for the Promotion of Science; American Diabetes Association; NIH [DK71507-04]; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071507, P30DK040561, R01DK052539] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); International Human Frontier Science Program(Human Frontier Science Program); Uehara Memorial Foundation(Uehara Memorial Foundation); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science); American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank all members of the Hotamisligil lab for their scientific input and contributions, especially Brenna Baccaro, Sara Vallerie, Margaret F. Gregor, and Ling Yang for support and discussions and Kristen Gilbert, Rebecca Foote, and Julie Gound for administrative assistance. We are grateful to Jun Eguchi and Atsuo Sasaki for helpful discussions. This study is supported by a grant from the National Institutes of Health (to G. S. H.). T. N. is supported by fellowships from the International Human Frontier Science Program and the Uehara Memorial Foundation. M. F. is supported by fellowships from the Japan Society for the Promotion of Science and the American Diabetes Association. H. C. is supported by a NIH Roadmap Fellowship (DK71507-04) and the American Diabetes Association. G. S. H. is a share owner and on the Scientific Advisory Board of Syndexa Pharmaceuticals.	Abraham N, 1999, J BIOL CHEM, V274, P5953, DOI 10.1074/jbc.274.9.5953; Antonelli A, 2009, NAT CLIN PRACT ENDOC, V5, P26, DOI 10.1038/ncpendmet1027; Bahtiyar Gul, 2004, Curr Diab Rep, V4, P194, DOI 10.1007/s11892-004-0023-7; Baltzis D, 2002, J BIOL CHEM, V277, P38364, DOI 10.1074/jbc.M203564200; Bonnet MC, 2000, MOL CELL BIOL, V20, P4532, DOI 10.1128/MCB.20.13.4532-4542.2000; Chakrabarti A, 2008, J BIOL CHEM, V283, P25132, DOI 10.1074/jbc.M804770200; Delhem N, 2001, ONCOGENE, V20, P5836, DOI 10.1038/sj.onc.1204744; Eizirik DL, 2008, ENDOCR REV, V29, P42, DOI 10.1210/er.2007-0015; Furuhashi M, 2007, NATURE, V447, P959, DOI 10.1038/nature05844; Gao ZG, 2004, MOL ENDOCRINOL, V18, P2024, DOI 10.1210/me.2003-0383; Garcia MA, 2006, MICROBIOL MOL BIOL R, V70, P1032, DOI 10.1128/MMBR.00027-06; Goh KC, 2000, EMBO J, V19, P4292, DOI 10.1093/emboj/19.16.4292; Gregor MF, 2007, J LIPID RES, V48, P1905, DOI 10.1194/jlr.R700007-JLR200; Gregor MF, 2009, DIABETES, V58, P693, DOI 10.2337/db08-1220; GUSELLA GL, 1995, J IMMUNOL, V154, P345; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Holcik M, 2005, NAT REV MOL CELL BIO, V6, P318, DOI 10.1038/nrm1618; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hotamisligil GS, 2008, NAT REV IMMUNOL, V8, P923, DOI 10.1038/nri2449; Hotamisligil GS, 1996, SCIENCE, V271, P665, DOI 10.1126/science.271.5249.665; Kim JK, 2004, J CLIN INVEST, V114, P823, DOI 10.1172/JCI200422230; MCCORMACK SJ, 1994, VIROLOGY, V198, P92, DOI 10.1006/viro.1994.1011; Ozcan U, 2004, SCIENCE, V306, P457, DOI 10.1126/science.1103160; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; SAMUEL CE, 1993, J BIOL CHEM, V268, P7603; Scarim AL, 2001, AM J PATHOL, V159, P273, DOI 10.1016/S0002-9440(10)61693-8; Shi H, 2006, J CLIN INVEST, V116, P3015, DOI 10.1172/JCI28898; Takada Y, 2007, ONCOGENE, V26, P1201, DOI 10.1038/sj.onc.1209906; Tokumoto Y, 2007, J MED VIROL, V79, P1120, DOI 10.1002/jmv.20902; Urano F, 2000, SCIENCE, V287, P664, DOI 10.1126/science.287.5453.664; von Herrath M, 2009, DIABETES, V58, P2, DOI 10.2337/db08-9027; Williams B R, 2001, Sci STKE, V2001, pre2, DOI 10.1126/stke.2001.89.re2; Wu SY, 1996, J BIOL CHEM, V271, P1756, DOI 10.1074/jbc.271.3.1756; Yang YL, 1995, EMBO J, V14, P6095, DOI 10.1002/j.1460-2075.1995.tb00300.x	34	375	398	0	36	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					338	U41		10.1016/j.cell.2010.01.001	http://dx.doi.org/10.1016/j.cell.2010.01.001			18	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144759	Bronze, Green Submitted, Green Accepted			2022-12-01	WOS:000274297700012
J	Cady, SD; Schmidt-Rohr, K; Wang, J; Soto, CS; DeGrado, WF; Hong, M				Cady, Sarah D.; Schmidt-Rohr, Klaus; Wang, Jun; Soto, Cinque S.; DeGrado, William F.; Hong, Mei			Structure of the amantadine binding site of influenza M2 proton channels in lipid bilayers	NATURE			English	Article							SOLID-STATE NMR; ANTIVIRAL DRUG AMANTADINE; SIDE-CHAIN CONFORMATION; SELECTIVE ION-CHANNEL; A VIRUS; TRANSMEMBRANE PEPTIDE; DISTANCE MEASUREMENTS; PROTEIN; INHIBITION; DOMAIN	The M2 protein of influenza A virus is a membrane-spanning tetrameric proton channel targeted by the antiviral drugs amantadine and rimantadine(1). Resistance to these drugs has compromised their effectiveness against many influenza strains, including pandemic H1N1. A recent crystal structure of M2(22-46) showed electron densities attributed to a single amantadine in the amino-terminal half of the pore(2), indicating a physical occlusion mechanism for inhibition. However, a solution NMR structure of M2(18-60) showed four rimantadines bound to the carboxy-terminal lipid-facing surface of the helices(3), suggesting an allosteric mechanism. Here we show by solid-state NMR spectroscopy that two amantadine-binding sites exist in M2 in phospholipid bilayers. The high-affinity site, occupied by a single amantadine, is located in the N-terminal channel lumen, surrounded by residues mutated in amantadine-resistant viruses. Quantification of the protein-amantadine distances resulted in a 0.3 angstrom-resolution structure of the high-affinity binding site. The second, low-affinity, site was observed on the C-terminal protein surface, but only when the drug reaches high concentrations in the bilayer. The orientation and dynamics of the drug are distinct in the two sites, as shown by H-2 NMR. These results indicate that amantadine physically occludes the M2 channel, thus paving the way for developing new antiviral drugs against influenza viruses. The study demonstrates the ability of solid-state NMR to elucidate small-molecule interactions with membrane proteins and determine high-resolution structures of their complexes.	[Cady, Sarah D.; Schmidt-Rohr, Klaus; Hong, Mei] Iowa State Univ, Dept Chem, Ames, IA 50011 USA; [Wang, Jun; Soto, Cinque S.; DeGrado, William F.] Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA; [Wang, Jun; Soto, Cinque S.; DeGrado, William F.] Univ Penn, Dept Chem, Philadelphia, PA 19104 USA	Iowa State University; University of Pennsylvania; University of Pennsylvania	Hong, M (corresponding author), Iowa State Univ, Dept Chem, Ames, IA 50011 USA.	mhong@iastate.edu	Wang, Jun/G-6504-2010; Cady, Sarah D./AAL-8810-2020	Wang, Jun/0000-0002-4845-4621; Cady, Sarah D./0000-0002-8310-7422; Hong, Mei/0000-0001-5255-5858	NSF [MCB-0543473]; NIH [GM088204, GM56423, AI74571]; Iowa State University Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI074571] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM088204, R01GM056423] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Iowa State University Foundation; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work was supported by a NSF grant MCB-0543473 and an NIH grant GM088204 to M. H., the Iowa State University Foundation, and NIH grants GM56423 and AI74571 to W. F. D.	Cady SD, 2008, P NATL ACAD SCI USA, V105, P1483, DOI 10.1073/pnas.0711500105; Cady SD, 2009, BIOCHEMISTRY-US, V48, P7356, DOI 10.1021/bi9008837; Cady SD, 2009, J MOL BIOL, V385, P1127, DOI 10.1016/j.jmb.2008.11.022; Chen HN, 2007, BIOPHYS J, V93, P3470, DOI 10.1529/biophysj.107.105742; Cristian L, 2003, P NATL ACAD SCI USA, V100, P14772, DOI 10.1073/pnas.2536751100; GULLION T, 1989, J MAGN RESON, V81, P196, DOI 10.1016/0022-2364(89)90280-1; Gullion T, 2000, J MAGN RESON, V146, P220, DOI 10.1006/jmre.2000.2164; HOLSINGER LJ, 1994, J VIROL, V68, P1551, DOI 10.1128/JVI.68.3.1551-1563.1994; Hong M, 2009, J AM CHEM SOC, V131, P7806, DOI 10.1021/ja901550q; Hu J, 2007, BIOPHYS J, V92, P4335, DOI 10.1529/biophysj.106.090183; Hu J, 2007, BIOPHYS J, V93, P276, DOI 10.1529/biophysj.106.102103; Jaroniec CP, 2001, J AM CHEM SOC, V123, P3507, DOI 10.1021/ja003266e; Jing XH, 2008, P NATL ACAD SCI USA, V105, P10967, DOI 10.1073/pnas.0804958105; Li C, 2008, BIOPHYS J, V94, P1295, DOI 10.1529/biophysj.107.112482; Li C, 2007, BBA-BIOMEMBRANES, V1768, P3162, DOI 10.1016/j.bbamem.2007.08.025; Lin TI, 1997, J GEN VIROL, V78, P767, DOI 10.1099/0022-1317-78-4-767; Luo WB, 2007, J PHYS CHEM B, V111, P10825, DOI 10.1021/jp073823k; Luo W, 2006, J AM CHEM SOC, V128, P7242, DOI 10.1021/ja0603406; Luo WB, 2009, BIOCHEMISTRY-US, V48, P6361, DOI 10.1021/bi900716s; Ma CL, 2009, P NATL ACAD SCI USA, V106, P12283, DOI 10.1073/pnas.0905726106; Pinto LH, 2006, J BIOL CHEM, V281, P8997, DOI 10.1074/jbc.R500020200; Sack I, 1999, J MAGN RESON, V138, P54, DOI 10.1006/jmre.1999.1710; Salom D, 2000, BIOCHEMISTRY-US, V39, P14160, DOI 10.1021/bi001799u; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Stouffer AL, 2008, STRUCTURE, V16, P1067, DOI 10.1016/j.str.2008.04.011; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Tang YJ, 2002, J BIOL CHEM, V277, P39880, DOI 10.1074/jbc.M206582200; WANG C, 1993, J VIROL, V67, P5585, DOI 10.1128/JVI.67.9.5585-5594.1993; Wang J, 2009, J AM CHEM SOC, V131, P8066, DOI 10.1021/ja900063s; Yi M, 2008, J PHYS CHEM B, V112, P7977, DOI 10.1021/jp800171m	30	502	505	7	212	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					689	U127		10.1038/nature08722	http://dx.doi.org/10.1038/nature08722			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130653	Green Accepted, Green Submitted			2022-12-01	WOS:000274193900042
J	Walters, RG; Jacquemont, S; Valsesia, A; de Smith, AJ; Martinet, D; Andersson, J; Falchi, M; Chen, F; Andrieux, J; Lobbens, S; Delobel, B; Stutzmann, F; Moustafa, JSES; Chevre, JC; Lecoeur, C; Vatin, V; Bouquillon, S; Buxton, JL; Boute, O; Holder-Espinasse, M; Cuisset, JM; Lemaitre, MP; Ambresin, AE; Brioschi, A; Gaillard, M; Giusti, V; Fellmann, F; Ferrarini, A; Hadjikhani, N; Campion, D; Guilmatre, A; Goldenberg, A; Calmels, N; Mandel, JL; Le Caignec, C; David, A; Isidor, B; Cordier, MP; Dupuis-Girod, S; Labalme, A; Sanlaville, D; Beri-Dexheimer, M; Jonveaux, P; Leheup, B; Ounap, K; Bochukova, EG; Henning, E; Keogh, J; Ellis, RJ; MacDermot, KD; van Haelst, MM; Vincent-Delorme, C; Plessis, G; Touraine, R; Philippe, A; Malan, V; Mathieu-Dramard, M; Chiesa, J; Blaumeiser, B; Kooy, RF; Caiazzo, R; Pigeyre, M; Balkau, B; Sladek, R; Bergmann, S; Mooser, V; Waterworth, D; Reymond, A; Vollenweider, P; Waeber, G; Kurg, A; Palta, P; Esko, T; Metspalu, A; Nelis, M; Elliott, P; Hartikainen, AL; McCarthy, MI; Peltonen, L; Carlsson, L; Jacobson, P; Sjostrom, L; Huang, N; Hurles, ME; O'Rahilly, S; Farooqi, IS; Mannik, K; Jarvelin, MR; Pattou, F; Meyre, D; Walley, AJ; Coin, LJM; Blakemore, AIF; Froguel, P; Beckmann, JS				Walters, R. G.; Jacquemont, S.; Valsesia, A.; de Smith, A. J.; Martinet, D.; Andersson, J.; Falchi, M.; Chen, F.; Andrieux, J.; Lobbens, S.; Delobel, B.; Stutzmann, F.; Moustafa, J. S. El-Sayed; Chevre, J. -C.; Lecoeur, C.; Vatin, V.; Bouquillon, S.; Buxton, J. L.; Boute, O.; Holder-Espinasse, M.; Cuisset, J. -M.; Lemaitre, M. -P.; Ambresin, A. -E.; Brioschi, A.; Gaillard, M.; Giusti, V.; Fellmann, F.; Ferrarini, A.; Hadjikhani, N.; Campion, D.; Guilmatre, A.; Goldenberg, A.; Calmels, N.; Mandel, J. -L.; Le Caignec, C.; David, A.; Isidor, B.; Cordier, M. -P.; Dupuis-Girod, S.; Labalme, A.; Sanlaville, D.; Beri-Dexheimer, M.; Jonveaux, P.; Leheup, B.; Ounap, K.; Bochukova, E. G.; Henning, E.; Keogh, J.; Ellis, R. J.; MacDermot, K. D.; van Haelst, M. M.; Vincent-Delorme, C.; Plessis, G.; Touraine, R.; Philippe, A.; Malan, V.; Mathieu-Dramard, M.; Chiesa, J.; Blaumeiser, B.; Kooy, R. F.; Caiazzo, R.; Pigeyre, M.; Balkau, B.; Sladek, R.; Bergmann, S.; Mooser, V.; Waterworth, D.; Reymond, A.; Vollenweider, P.; Waeber, G.; Kurg, A.; Palta, P.; Esko, T.; Metspalu, A.; Nelis, M.; Elliott, P.; Hartikainen, A. -L.; McCarthy, M. I.; Peltonen, L.; Carlsson, L.; Jacobson, P.; Sjostrom, L.; Huang, N.; Hurles, M. E.; O'Rahilly, S.; Farooqi, I. S.; Maennik, K.; Jarvelin, M. -R.; Pattou, F.; Meyre, D.; Walley, A. J.; Coin, L. J. M.; Blakemore, A. I. F.; Froguel, P.; Beckmann, J. S.			A new highly penetrant form of obesity due to deletions on chromosome 16p11.2	NATURE			English	Article							GENOME-WIDE ASSOCIATION; CIRCULAR BINARY SEGMENTATION; COPY NUMBER VARIATION; FRAMESHIFT MUTATION; RISK LOCI; MICRODELETION; AUTISM; SAMPLE; BIRTH; MC4R	Obesity has become a major worldwide challenge to public health, owing to an interaction between the Western 'obesogenic' environment and a strong genetic contribution(1). Recent extensive genome-wide association studies (GWASs) have identified numerous single nucleotide polymorphisms associated with obesity, but these loci together account for only a small fraction of the known heritable component(1). Thus, the 'common disease, common variant' hypothesis is increasingly coming under challenge(2). Here we report a highly penetrant form of obesity, initially observed in 31 subjects who were heterozygous for deletions of at least 593 kilobases at 16p11.2 and whose ascertainment included cognitive deficits. Nineteen similar deletions were identified from GWAS data in 16,053 individuals from eight European cohorts. These deletions were absent from healthy non-obese controls and accounted for 0.7% of our morbid obesity cases (body mass index (BMI) >= 40 kg m(-2) or BMI standard deviation score >= 4; P = 6.43 x 10(-8), odds ratio 43.0), demonstrating the potential importance in common disease of rare variants with strong effects. This highlights a promising strategy for identifying missing heritability in obesity and other complex traits: cohorts with extreme phenotypes are likely to be enriched for rare variants, thereby improving power for their discovery. Subsequent analysis of the loci so identified may well reveal additional rare variants that further contribute to the missing heritability, as recently reported for SIM1 (ref. 3). The most productive approach may therefore be to combine the 'power of the extreme'(4) in small, well-phenotyped cohorts, with targeted follow-up in case-control and population cohorts.	[Walters, R. G.; de Smith, A. J.; Andersson, J.; Falchi, M.; Moustafa, J. S. El-Sayed; Buxton, J. L.; Walley, A. J.; Blakemore, A. I. F.; Froguel, P.] Univ London Imperial Coll Sci Technol & Med, Sect Genom Med, London W12 0NN, England; [Walters, R. G.; Elliott, P.; Jarvelin, M. -R.; Coin, L. J. M.] Univ London Imperial Coll Sci Technol & Med, Dept Epidemiol & Publ Hlth, London W2 1PG, England; [Jacquemont, S.; Martinet, D.; Gaillard, M.; Fellmann, F.; Ferrarini, A.; Beckmann, J. S.] CHU Vaudois, Serv Genet Med, CH-1011 Lausanne, Switzerland; [Valsesia, A.; Bergmann, S.; Beckmann, J. S.] Univ Lausanne, Dept Med Genet, CH-1015 Lausanne, Switzerland; [Valsesia, A.] Univ Lausanne, Ludwig Inst Canc Res, CH-1015 Lausanne, Switzerland; [Valsesia, A.; Bergmann, S.] Swiss Inst Bioinformat, CH-1015 Lausanne, Switzerland; [Chen, F.; Hadjikhani, N.] Ecole Polytech Fed Lausanne, Brain Mind Inst, CH-1015 Lausanne, Switzerland; [Andrieux, J.; Bouquillon, S.] Ctr Hosp Reg Univ, Med Genet Lab, F-59000 Lille, France; [Lobbens, S.; Stutzmann, F.; Chevre, J. -C.; Lecoeur, C.; Vatin, V.; Meyre, D.; Froguel, P.] Inst Pasteur, Inst Biol 8090, CNRS, F-59800 Lille, France; [Delobel, B.] Hop St Vincent de Paul, Ctr Genet Chromosom, GHICL, F-59020 Lille, France; [Boute, O.; Holder-Espinasse, M.] CHU Lille, Serv Genet Clin, Hop Jeanne Flandre, F-59000 Lille, France; [Cuisset, J. -M.; Lemaitre, M. -P.] Ctr Hosp Reg Univ, Serv Neuropediat, F-59000 Lille, France; [Ambresin, A. -E.] CHU Vaudois, Unite Multidisciplinaire Sante Adolescents, CH-1011 Lausanne, Switzerland; [Brioschi, A.] CHU Vaudois, Serv Neuropsychol & Neurorehabil, CH-1011 Lausanne, Switzerland; [Giusti, V.] CHU Vaudois, Serv Endocrinol, CH-1011 Lausanne, Switzerland; [Hadjikhani, N.] Harvard Univ, Sch Med, Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Campion, D.; Guilmatre, A.] Fac Med, INSERM, U614, F-76183 Rouen, France; [Goldenberg, A.] CHU Rouen, Serv Genet, F-76031 Rouen, France; [Calmels, N.; Mandel, J. -L.] Nouvel Hop Civil, Lab Diagnost Genet, F-67091 Strasbourg, France; [Le Caignec, C.; David, A.; Isidor, B.] CHU Nantes, Serv Genet Med, F-44093 Nantes, France; [Le Caignec, C.] Inst Thorax, UMR915, INSERM, F-44007 Nantes, France; [Cordier, M. -P.; Dupuis-Girod, S.; Labalme, A.; Sanlaville, D.] Hop Hotel Dieu, Hosp Civils Lyon, Serv Genet, F-69288 Lyon, France; [Sanlaville, D.] Univ Lyon 1, EA 4171, F-69622 Villeurbanne, France; [Beri-Dexheimer, M.; Jonveaux, P.; Leheup, B.] Nancy Univ, Ctr Hosp Univ, Genet Lab, F-54511 Vandoeuvre Les Nancy, France; [Leheup, B.] Univ Henri Poincare, Med Sch Nancy EA4368, F-54003 Nancy, France; [Ounap, K.] Univ Tartu, Childrens Hosp, United Labs, Dept Genet, EE-50406 Tartu, Estonia; [Bochukova, E. G.; Henning, E.; Keogh, J.; O'Rahilly, S.; Farooqi, I. S.] Univ Cambridge, Metab Res Labs, Inst Metab Sci, Addenbrookes Hosp, Cambridge CB2 0QQ, England; [Ellis, R. J.; MacDermot, K. D.; van Haelst, M. M.] Northwick Pk & St Marks Hosp, NW Thames Reg Genet Serv, Harrow HA1 3UJ, Middx, England; [Vincent-Delorme, C.] Ctr Hosp Arras, F-62000 Arras, France; [Plessis, G.] Ctr Hosp Univ Clemenceau, Serv Genet Med, F-14033 Caen, France; [Touraine, R.] Ctr Hosp Univ Hop Nord, Serv Genet, F-42055 St Etienne, France; [Philippe, A.; Malan, V.] Univ Paris 05, Hop Necker Enfants Malad, Dept Genet, F-75015 Paris, France; [Philippe, A.; Malan, V.] Univ Paris 05, Hop Necker Enfants Malad, INSERM, U781, F-75015 Paris, France; [Mathieu-Dramard, M.] Ctr Hosp Univ, Serv Genet Clin, F-80054 Amiens, France; [Chiesa, J.] Ctr Hosp Univ Caremeau, Lab Cytogenet, F-30029 Nimes, France; [Blaumeiser, B.; Kooy, R. F.] Univ Hosp & Univ Antwerp, Dept Med Genet, B-2650 Edegem, Belgium; [Caiazzo, R.; Pattou, F.] INSERM, U859, F-59045 Lille, France; [Caiazzo, R.; Pigeyre, M.; Pattou, F.] Univ Lille Nord France, CHU Lille, F-59037 Lille, France; [Balkau, B.] INSERM, U780, IFR69, F-94807 Villejuif, France; [Sladek, R.] McGill Univ, Montreal, PQ H3A 1A4, Canada; [Sladek, R.] Genome Quebec Innovat Ctr, Montreal, PQ H3A 1A4, Canada; [Sladek, R.] McGill Univ, Dept Med & Human Genet, Montreal, PQ H3A 1B1, Canada; [Mooser, V.; Waterworth, D.] GlaxoSmithKline, Div Genet, Philadelphia, PA 19101 USA; [Reymond, A.] Univ Lausanne, Ctr Integrat Genom, CH-1015 Lausanne, Switzerland; [Vollenweider, P.; Waeber, G.] CHU Vaudois, Dept Med, CH-1011 Lausanne, Switzerland; [Kurg, A.; Palta, P.; Maennik, K.] Univ Tartu, Inst Mol & Cell Biol, EE-51010 Tartu, Estonia; [Esko, T.; Metspalu, A.; Nelis, M.] Univ Tartu, Estonian Genome Project, EE-50410 Tartu, Estonia; [Esko, T.; Metspalu, A.; Nelis, M.] Estonian Bioctr, EE-51010 Tartu, Estonia; [Hartikainen, A. -L.] Univ Oulu, Dept Obstet & Gynaecol, SF-90220 Oulu, Finland; [McCarthy, M. I.] Univ Oxford, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England; [McCarthy, M. I.] Univ Oxford, Wellcome Trust Ctr Human Genet, Oxford OX3 7BN, England; [Peltonen, L.; Huang, N.; Hurles, M. E.] Wellcome Trust Sanger Inst, Hinxton CB10 1SA, Cambs, England; [Peltonen, L.] Biomedicum, Inst Mol Med, Helsinki 00290, Finland; [Peltonen, L.] MIT, Broad Inst, Cambridge, MA 02142 USA; [Carlsson, L.; Jacobson, P.; Sjostrom, L.] Sahlgrens Acad, Dept Mol & Clin Med, S-41345 Gothenburg, Sweden; [Carlsson, L.; Jacobson, P.; Sjostrom, L.] Sahlgrens Acad, Ctr Cardiovasc & Metab Res, S-41345 Gothenburg, Sweden; [Jarvelin, M. -R.] Natl Publ Hlth Inst, Dept Child & Adolescent Hlth, Oulu 90101, Finland; [Jarvelin, M. -R.] Univ Oulu, Inst Hlth Sci, SF-90220 Oulu, Finland; [Jarvelin, M. -R.] Univ Oulu, Bioctr Oulu, SF-90220 Oulu, Finland	Imperial College London; Imperial College London; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Ludwig Institute for Cancer Research; University of Lausanne; Swiss Institute of Bioinformatics; Swiss Federal Institutes of Technology Domain; Ecole Polytechnique Federale de Lausanne; Universite de Lille - ISITE; CHU Lille; Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Universite de Lille - ISITE; Institut Pasteur Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille - ISITE; CHU Lille; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); Harvard University; Massachusetts General Hospital; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Franche-Comte; CHU de Rouen; CHU Strasbourg; Nantes Universite; CHU de Nantes; Institut National de la Sante et de la Recherche Medicale (Inserm); Nantes Universite; CHU de Nantes; CHU Lyon; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU de Nancy; Universite de Lorraine; Universite de Lorraine; University of Tartu; Cambridge University Hospitals NHS Foundation Trust; Addenbrooke's Hospital; University of Cambridge; Imperial College London; CHU de Caen NORMANDIE; CHU de St Etienne; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; UDICE-French Research Universities; Universite Paris Cite; Assistance Publique Hopitaux Paris (APHP); Hopital Universitaire Necker-Enfants Malades - APHP; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite Paris Cite; Picardie Universites; Universite de Picardie Jules Verne (UPJV); CHU Amiens; Universite de Montpellier; CHU de Nimes; Institut National de la Sante et de la Recherche Medicale (Inserm); Universite de Lille - ISITE; Universite de Lille; Universite de Lille - ISITE; CHU Lille; Universite de Lille; Institut National de la Sante et de la Recherche Medicale (Inserm); McGill University; McGill University; GlaxoSmithKline; University of Lausanne; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Tartu; University of Tartu; Estonian Biocentre; University of Oulu; University of Oxford; University of Oxford; Wellcome Centre for Human Genetics; Wellcome Trust Sanger Institute; University of Helsinki; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; University of Gothenburg; University of Gothenburg; Finland National Institute for Health & Welfare; University of Oulu; University of Oulu	Froguel, P (corresponding author), Univ London Imperial Coll Sci Technol & Med, Sect Genom Med, London W12 0NN, England.	p.froguel@imperial.ac.uk; jacques.beckmann@chuv.ch	Buxton, Jessica/L-9849-2019; Meyre, David/D-7315-2011; Walters, Robin G/E-6069-2010; Falchi, Mario/F-5956-2013; Pattou, Francois/O-6151-2017; Hadjikhani, Nouchine/C-2018-2008; caiazzo, robert/Y-9692-2019; Le Caignec, Cedric/K-8467-2015; Jacquemont, Sebastien/AAS-5060-2021; Coin, Lachlan/O-4976-2019; Andersson-Assarsson, Johanna/M-2524-2019; Beckmann, Jacques Simon/A-9772-2008; Sanlaville, Damien/M-4716-2014; Colaus, PsyColaus/K-6607-2013; Palta, Priit/W-2477-2019; Caiazzo, Robert/D-1958-2013; Isidor, Bertrand/AAJ-3456-2021; Kurg, Ants/AAM-1292-2020; Walley, Andrew J/D-2573-2009; Chèvre, Jean-Claude/C-3943-2015; O'Rahilly, Stephen/ABF-6509-2020; Coin, Lachlan JM/A-9001-2014; FROGUEL, Philippe/O-6799-2017; Touraine, Renaud/AAV-1605-2020; Valsesia, Armand/F-1724-2010; Dupuis-Girod, Sophie/D-6268-2014; Kurg, Ants/J-2616-2015; Ounap, Katrin/Q-1103-2016; Sladek, Robert/R-2391-2019; Malan, Valerie/H-7423-2017; Nelis, Mari/ABG-7775-2020; Kooy, Frank/F-5276-2014; Buxton, Jessica L/I-4033-2014; Farooqi, Ismaa Sadaf/AAZ-3046-2020; Blakemore, Alexandra I F/D-2253-2009; Carlsson, Lena/F-7570-2018; Isidor, Bertrand/L-2435-2015; Philippe, Anne/E-5587-2017; Mandel, Jean Louis/Q-2668-2016; McCarthy, Mark/M-3763-2015	Meyre, David/0000-0003-4850-7444; Walters, Robin G/0000-0002-9179-0321; Pattou, Francois/0000-0001-8388-3766; Hadjikhani, Nouchine/0000-0003-4075-3106; caiazzo, robert/0000-0001-5383-0540; Le Caignec, Cedric/0000-0002-0598-653X; Jacquemont, Sebastien/0000-0001-6838-8767; Coin, Lachlan/0000-0002-4300-455X; Andersson-Assarsson, Johanna/0000-0001-9082-8589; Beckmann, Jacques Simon/0000-0002-9741-1900; Sanlaville, Damien/0000-0001-9939-2849; Palta, Priit/0000-0001-9320-7008; Isidor, Bertrand/0000-0001-6480-126X; Kurg, Ants/0000-0002-0829-1987; Walley, Andrew J/0000-0001-7707-7549; Chèvre, Jean-Claude/0000-0002-5329-5231; O'Rahilly, Stephen/0000-0003-2199-4449; Coin, Lachlan JM/0000-0002-4300-455X; FROGUEL, Philippe/0000-0003-2972-0784; Ounap, Katrin/0000-0002-4594-6364; Sladek, Robert/0000-0002-2730-1204; Malan, Valerie/0000-0002-3450-4958; Nelis, Mari/0000-0001-9748-1020; Kooy, Frank/0000-0003-2024-0485; Buxton, Jessica L/0000-0002-0918-9335; Blakemore, Alexandra I F/0000-0003-0661-564X; Carlsson, Lena/0000-0003-4145-6242; Isidor, Bertrand/0000-0001-6480-126X; Elliott, Paul/0000-0002-7511-5684; Dupuis-Girod, Sophie/0000-0002-8834-5526; Waeber, Gerard/0000-0003-4193-788X; de Smith, Adam/0000-0003-4880-7543; CHEN, Fei/0000-0003-2077-3812; CALMELS, Nadege/0000-0001-8516-8184; Farooqi, Sadaf/0000-0001-7609-3504; Fellmann, Florence/0000-0003-3156-4768; Jarvelin, Marjo-Riitta/0000-0002-2149-0630; Falchi, Mario/0000-0002-5646-1004; Reymond, Alexandre/0000-0003-1030-8327; Bergmann, Sven/0000-0002-6785-9034; Ambresin, Anne-emmanuelle/0000-0001-8386-4231; El-Sayed Moustafa, Julia Sarah/0000-0001-6963-6654; Jacobson, Peter/0000-0002-1769-1827; Mandel, Jean Louis/0000-0002-0535-6589; McCarthy, Mark/0000-0002-4393-0510; Pigeyre, Marie/0000-0003-2984-8366; PHILIPPE, Anne/0000-0001-8746-0576; Bochukova, Elena/0000-0003-0275-1548; Valsesia, Armand/0000-0003-0746-9664	Wellcome Trust; Medical Research Council (MRC) [G0500539]; Swiss National Foundation [310000-112552, 33CSCO-122661]; RCUK; Swiss National Fund [320030_122674]; Synapsis Foundation; University of Lausanne; Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; le Conseil Regional Nord Pas de Calais/FEDER; GlaxoSmithKline; Faculty of Biology and Medicine of Lausanne; Estonian Government [SF0180142s08]; EU; FP7 [201413 ENGAGE, 212111 BBMRI]; ECOGENE [205419]; Genome Canada; Genome Quebec; Swedish Research Council [K2008-65X-20753-01-4, K2007-55X-11285-13, 529-2002-6671]; Swedish Foundation for Strategic Research; Swedish Diabetes Foundation; Ake Wiberg Foundation; Foundations of the National Board of Health and Welfare; Jeansson Foundations; Magn Bergvall Foundation; Tore Nilson Foundation; Royal Physiographic Society; INNOVA-VINNMER; Swedish federal government; INSERM; CNAMTS; Lilly; Novartis Pharma; Sanofi-Aventis; Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France; ALFEDIAM; ONIVINS; Ardix Medical, Bayer Diagnostics; Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk; Pierre Fabre; Roche and Topcon; Academy of Finland [104781, 120315]; University Hospital Oulu; Biocenter, University of Oulu, Finland; European Commission [QLG1-CT-2000-01643]; NHLBI [5R01HL087679-02, 1RL1MH083268-01]; NIH/NIMH [5R01MH63706: 02]; ENGAGE [HEALTH-F4-2007-201413];  [SF0180026s09]; MRC [G0900554, G0600331] Funding Source: UKRI; Medical Research Council [G0900554, G0600331] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL087679] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063706, RL1MH083268] Funding Source: NIH RePORTER	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (MRC)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Swiss National Foundation(Swiss National Science Foundation (SNSF)); RCUK(UK Research & Innovation (UKRI)); Swiss National Fund(Swiss National Science Foundation (SNSF)); Synapsis Foundation; University of Lausanne; Ludwig Institute for Cancer Research; Swiss Institute of Bioinformatics; le Conseil Regional Nord Pas de Calais/FEDER(Region Hauts-de-FranceEuropean Commission); GlaxoSmithKline(GlaxoSmithKline); Faculty of Biology and Medicine of Lausanne; Estonian Government; EU(European Commission); FP7; ECOGENE; Genome Canada(Genome Canada); Genome Quebec; Swedish Research Council(Swedish Research CouncilEuropean Commission); Swedish Foundation for Strategic Research(Swedish Foundation for Strategic Research); Swedish Diabetes Foundation; Ake Wiberg Foundation; Foundations of the National Board of Health and Welfare; Jeansson Foundations; Magn Bergvall Foundation; Tore Nilson Foundation; Royal Physiographic Society; INNOVA-VINNMER; Swedish federal government; INSERM(Institut National de la Sante et de la Recherche Medicale (Inserm)European Commission); CNAMTS; Lilly(Eli Lilly); Novartis Pharma; Sanofi-Aventis(Sanofi-Aventis); Association Diabete Risque Vasculaire; Federation Francaise de Cardiologie; La Fondation de France(Fondation de France); ALFEDIAM; ONIVINS; Ardix Medical, Bayer Diagnostics(Bayer AG); Becton Dickinson; Cardionics; Merck Sante; Novo Nordisk(Novo Nordisk); Pierre Fabre; Roche and Topcon; Academy of Finland(Academy of Finland); University Hospital Oulu; Biocenter, University of Oulu, Finland; European Commission(European CommissionEuropean Commission Joint Research Centre); NHLBI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIH/NIMH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); ENGAGE; ; MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	A.J.W., A. I. F. B. and P. F. are supported by grants from the Wellcome Trust and the Medical Research Council (MRC). J.S.B. is supported by a grant from the Swiss National Foundation (310000-112552). L.J.M.C. is supported by an RCUK Fellowship. S.J. is funded by Swiss National Fund 320030_122674 and the Synapsis Foundation, University of Lausanne. A. V. is funded by the Ludwig Institute for Cancer Research. S. B. is supported by the Swiss Institute of Bioinformatics. I. S. F. and M. E. H. are funded by the Wellcome Trust and the MRC. We thank the DHOS (Direction de l'Hospitalisation et de l'Organisation des Soins) from the French Ministry of Health for their support in the development of several array CGH platforms in France. We thank le Conseil Regional Nord Pas de Calais/FEDER' for their financial support. Part of the CoLaus computation was performed at the Vital-IT center for high-performance computing of the Swiss Institute of Bioinformatics. The CoLaus authors thank Y. Barreau, M. Firmann, V. Mayor, A.-L. Bastian, B. Ramic, M. Moranville, M. Baumer, M. Sagette, J. Ecoffey and S. Mermoud for data collection. The CoLaus study was supported by grants from GlaxoSmithKline, the Faculty of Biology and Medicine of Lausanne and by the Swiss National Foundation (33CSCO-122661). K. M., A. K., T. E., M.N. and A. M. received support from targeted financing from Estonian Government SF0180142s08, and P. P. from SF0180026s09; and from the EU through the European Regional Development Fund. T. E., M.N. and A. M. received support from FP7 grants (201413 ENGAGE, 212111 BBMRI, ECOGENE (no. 205419, EBC)). The genotyping of the Estonian Genome Project samples were performed in the Estonian Biocentre Genotyping Core Facility. The EGPUT authors thank V. Soo for technical help in genotyping. The Northwick Park authors acknowledge support from the NIHR Biomedical Research Centre Scheme and the Hammersmith Hospital Charity Trustees. Genome Canada and Genome Quebec funded the genotyping of DESIR subjects. Work on the SOS sib pair cohort was supported by grants from the Swedish Research Council (K2008-65X-20753-01-4, K2007-55X-11285-13, 529-2002-6671), the Swedish Foundation for Strategic Research to Sahlgrenska Center for Cardiovascular and Metabolic Research, the Swedish Diabetes Foundation, the Ake Wiberg Foundation, Foundations of the National Board of Health and Welfare, the Jeansson Foundations, the Magn Bergvall Foundation, the Tore Nilson Foundation, the Royal Physiographic Society (Nilsson-Ehle Foundation), VINNOVA-VINNMER, and the Swedish federal government under the LUA/ALF agreement. The DESIR study has been supported by INSERM, CNAMTS, Lilly, Novartis Pharma and Sanofi-Aventis, by INSERM (Reseaux en Sante Publique, Interactions entre les determinants de la sante), by the Association Diabete Risque Vasculaire, the Federation Francaise de Cardiologie, La Fondation de France, ALFEDIAM, ONIVINS, Ardix Medical, Bayer Diagnostics, Becton Dickinson, Cardionics, Merck Sante, Novo Nordisk, Pierre Fabre, Roche and Topcon. Northern Finland Birth Cohort 1966 (NFBC1966) was supported by the Academy of Finland (project grants 104781, 120315 and Center of Excellence in Complex Disease Genetics), University Hospital Oulu, Biocenter, University of Oulu, Finland, the European Commission (EURO-BLCS, Framework 5 award QLG1-CT-2000-01643), NHLBI grant 5R01HL087679-02 through the STAMPEED program (1RL1MH083268-01), NIH/NIMH (5R01MH63706: 02), the ENGAGE project and grant agreement HEALTH-F4-2007-201413, and the MRC (studentship grant G0500539).; The NFBC authors than P. Rantakallio for the launch of NFBC1966 and initial data collection, S. Vaara for data collection, T. Ylitalo for administration, M. Koiranen for data management, and O. Tornwall and M. Jussila for DNA biobanking.	Balkau B, 1997, DIABETES METAB, V23, P428; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; Bengtsson H., 2008, 745 U CAL DEP STAT; Bengtsson H, 2009, BIOINFORMATICS, V25, P861, DOI 10.1093/bioinformatics/btp074; Bijlsma EK, 2009, EUR J MED GENET, V52, P77, DOI 10.1016/j.ejmg.2009.03.006; Boeka AG, 2008, ARCH CLIN NEUROPSYCH, V23, P467, DOI 10.1016/j.acn.2008.03.003; Chen AY, 2010, OBESITY, V18, P210, DOI 10.1038/oby.2009.185; Colella S, 2007, NUCLEIC ACIDS RES, V35, P2013, DOI 10.1093/nar/gkm076; CONRAD DF, 2009, NATURE          1007, DOI DOI 10.1038/NATURE08516; Farooqi IS, 2000, ARCH DIS CHILD, V83, P31, DOI 10.1136/adc.83.1.31; Fernandez BA, 2010, J MED GENET, V47, P195, DOI 10.1136/jmg.2009.069369; Fisher RA, 1922, J R STAT SOC, V85, P87, DOI 10.2307/2340521; Froguel P, 2008, NEW ENGL J MED, V359, P891, DOI 10.1056/NEJMp0805396; Ghebranious N, 2007, AM J MED GENET A, V143A, P1462, DOI 10.1002/ajmg.a.31837; Huang Jing, 2004, Human Genomics, V1, P287; Jernas M, 2009, BIOCHEM BIOPH RES CO, V383, P63, DOI 10.1016/j.bbrc.2009.03.120; Korn JM, 2008, NAT GENET, V40, P1253, DOI 10.1038/ng.237; Kumar RA, 2008, HUM MOL GENET, V17, P628, DOI 10.1093/hmg/ddm376; Manolio TA, 2009, NATURE, V461, P747, DOI 10.1038/nature08494; Marioni JC, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-10-r228; Marques-Vidal P, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-330; Marshall CR, 2008, AM J HUM GENET, V82, P477, DOI 10.1016/j.ajhg.2007.12.009; McCarthy SE, 2009, NAT GENET, V41, P1223, DOI 10.1038/ng.474; Meyre D, 2009, NAT GENET, V41, P157, DOI 10.1038/ng.301; Nelis M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005472; Olshen AB, 2004, BIOSTATISTICS, V5, P557, DOI 10.1093/biostatistics/kxh008; POSKITT EME, 1995, ACTA PAEDIATR, V84, P961, DOI 10.1111/j.1651-2227.1995.tb13806.x; ROLLANDCACHERA MF, 1991, EUR J CLIN NUTR, V45, P13; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Schouten JP, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/gnf056; Shimojima K, 2009, EUR J MED GENET, V52, P433, DOI 10.1016/j.ejmg.2009.09.007; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Stutzmann F, 2009, DIABETOLOGIA, V52, pS104; Vaisse C, 1998, NAT GENET, V20, P113, DOI 10.1038/2407; Venkatraman ES, 2007, BIOINFORMATICS, V23, P657, DOI 10.1093/bioinformatics/btl646; Walley AJ, 2009, NAT REV GENET, V10, P431, DOI 10.1038/nrg2594; Wang K, 2007, GENOME RES, V17, P1665, DOI 10.1101/gr.6861907; Weiss LA, 2008, NEW ENGL J MED, V358, P667, DOI 10.1056/NEJMoa075974; Willer CJ, 2009, NAT GENET, V41, P25, DOI 10.1038/ng.287; WOOLF B, 1955, ANN HUM GENET, V19, P251, DOI 10.1111/j.1469-1809.1955.tb01348.x; Yeo GSH, 1998, NAT GENET, V20, P111, DOI 10.1038/2404	41	354	374	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					671	U104		10.1038/nature08727	http://dx.doi.org/10.1038/nature08727			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130649	Green Accepted, Green Submitted			2022-12-01	WOS:000274193900038
J	Boilard, E; Nigrovic, PA; Larabee, K; Watts, GFM; Coblyn, JS; Weinblatt, ME; Massarotti, EM; Remold-O'Donnell, E; Farndale, RW; Ware, J; Lee, DM				Boilard, Eric; Nigrovic, Peter A.; Larabee, Katherine; Watts, Gerald F. M.; Coblyn, Jonathan S.; Weinblatt, Michael E.; Massarotti, Elena M.; Remold-O'Donnell, Eileen; Farndale, Richard W.; Ware, Jerry; Lee, David M.			Platelets Amplify Inflammation in Arthritis via Collagen-Dependent Microparticle Production	SCIENCE			English	Article							RHEUMATOID-ARTHRITIS; GLYCOPROTEIN-VI; ACTIVATION; DISEASE; COMPLEXES; MECHANISM; RECEPTOR; PLASMA; CHAIN	In addition to their pivotal role in thrombosis and wound repair, platelets participate in inflammatory responses. We investigated the role of platelets in the autoimmune disease rheumatoid arthritis. We identified platelet microparticles-submicrometer vesicles elaborated by activated platelets-in joint fluid from patients with rheumatoid arthritis and other forms of inflammatory arthritis, but not in joint fluid from patients with osteoarthritis. Platelet microparticles were proinflammatory, eliciting cytokine responses from synovial fibroblasts via interleukin-1. Consistent with these findings, depletion of platelets attenuated murine inflammatory arthritis. Using both pharmacologic and genetic approaches, we identified the collagen receptor glycoprotein VI as a key trigger for platelet microparticle generation in arthritis pathophysiology. Thus, these findings demonstrate a previously unappreciated role for platelets and their activation-induced microparticles in inflammatory joint diseases.	[Boilard, Eric; Nigrovic, Peter A.; Larabee, Katherine; Watts, Gerald F. M.; Coblyn, Jonathan S.; Weinblatt, Michael E.; Massarotti, Elena M.; Lee, David M.] Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA; [Nigrovic, Peter A.] Childrens Hosp Boston, Div Immunol, Boston, MA 02115 USA; [Remold-O'Donnell, Eileen] Harvard Univ, Sch Med, Immune Dis Inst, Boston, MA 02115 USA; [Farndale, Richard W.] Univ Cambridge, Dept Biochem, Cambridge CB2 1QW, England; [Ware, Jerry] Univ Arkansas Med Sci, Little Rock, AR 72205 USA	Harvard University; Brigham & Women's Hospital; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard Medical School; University of Cambridge; University of Arkansas System; University of Arkansas Medical Sciences	Lee, DM (corresponding author), Harvard Univ, Brigham & Womens Hosp, Sch Med, Div Rheumatol Immunol & Allergy, Boston, MA 02115 USA.	dlee@rics.bwh.harvard.edu		Watts, Gerald/0000-0003-2276-1524	NIH [P01 AI065858, K08AR051321, HL091269]; Arthritis Foundation; Cogan Family Foundation; British Heart Foundation and Medical Research Council, UK; National Heart, Lung, and Blood Institute [HL50545]; MRC [G0500707] Funding Source: UKRI; British Heart Foundation [RG/09/003/27122] Funding Source: researchfish; Medical Research Council [G0500707] Funding Source: researchfish; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL050545, R21HL091269] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [P01AI065858] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K08AR051321] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Arthritis Foundation; Cogan Family Foundation; British Heart Foundation and Medical Research Council, UK; National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); British Heart Foundation(British Heart Foundation); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))	Financial support for this work was provided by NIH grant P01 AI065858, an Arthritis Foundation Investigator Award, and the Cogan Family Foundation (D. M. L.); an Arthritis Foundation Postdoctoral Fellowship Award (E. B.); NIH grants K08AR051321 (P. A. N.) and HL091269 (E. R.-O.); the British Heart Foundation and Medical Research Council, UK (R. W. F.); and National Heart, Lung, and Blood Institute grant HL50545 (J. W.). D. M. L., E. B., and J. W. have filed a provisional patent application for glycoprotein VI as a target for treatment for inflammatory arthritis.	Berckmans RJ, 2002, ARTHRITIS RHEUM-US, V46, P2857, DOI 10.1002/art.10587; Binstadt BA, 2006, NAT IMMUNOL, V7, P284, DOI 10.1038/ni1306; Chen M, 2008, ARTHRITIS RHEUM, V58, P1354, DOI 10.1002/art.23453; Davi G, 2007, NEW ENGL J MED, V357, P2482, DOI 10.1056/NEJMra071014; FARR M, 1983, ANN RHEUM DIS, V42, P545, DOI 10.1136/ard.42.5.545; GARTNER LP, 2006, BRS CELL BIOL HISTOL; George JN, 2000, LANCET, V355, P1531, DOI 10.1016/S0140-6736(00)02175-9; GINSBERG MH, 1978, ARTHRITIS RHEUM, V21, P994, DOI 10.1002/art.1780210825; Helmick CG, 2008, ARTHRITIS RHEUM-US, V58, P15, DOI 10.1002/art.23177; Iannacone M, 2005, NAT MED, V11, P1167, DOI 10.1038/nm1317; Joseph JE, 2001, BRIT J HAEMATOL, V115, P451, DOI 10.1046/j.1365-2141.2001.03101.x; Knijff-Dutmer EAJ, 2002, ARTHRITIS RHEUM-US, V46, P1498, DOI 10.1002/art.10312; Kyburz D, 2003, SPRINGER SEMIN IMMUN, V25, P79, DOI 10.1007/s00281-003-0131-5; Lee DM, 2007, SCIENCE, V315, P1006, DOI 10.1126/science.1137306; Lee DM, 2001, LANCET, V358, P903, DOI 10.1016/S0140-6736(01)06075-5; LEE DM, 2004, KELLEY TXB RHEUMATOL, P175; LEVENE RB, 1986, BLOOD, V67, P207; Lindemann S, 2001, J CELL BIOL, V154, P485, DOI 10.1083/jcb.200105058; Mertens M, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD005121.pub3; Moroi M, 2004, THROMB RES, V114, P221, DOI 10.1016/j.thromres.2004.06.046; Nieswandt B, 2000, J BIOL CHEM, V275, P23998, DOI 10.1074/jbc.M003803200; Nieswandt B, 2003, BLOOD, V102, P449, DOI 10.1182/blood-2002-12-3882; Pastakia KB, 1996, J CLIN PATHOL-CL MOL, V49, pM17; Perez-Pujol S, 2007, CYTOM PART A, V71A, P38, DOI 10.1002/cyto.a.20354; Poduval P, 2007, ARTHRITIS RHEUM, V56, P3959, DOI 10.1002/art.23072; SCHUMACHER H R JR, 1975, Annals of Clinical and Laboratory Science, V5, P489; Shin K, 2009, J IMMUNOL, V182, P647, DOI 10.4049/jimmunol.182.1.647; Smethurst PA, 2007, J BIOL CHEM, V282, P1296, DOI 10.1074/jbc.M606479200; THIAGARAJAN P, 1991, J BIOL CHEM, V266, P24302; Valant PA, 1998, BRIT J HAEMATOL, V100, P24, DOI 10.1046/j.1365-2141.1998.00526.x; WOLF P, 1967, BRIT J HAEMATOL, V13, P269, DOI 10.1111/j.1365-2141.1967.tb08741.x	31	773	827	2	126	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 29	2010	327	5965					580	583		10.1126/science.1181928	http://dx.doi.org/10.1126/science.1181928			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	549CT	20110505	Green Accepted			2022-12-01	WOS:000274020500038
J	Lieberman, DE; Venkadesan, M; Werbel, WA; Daoud, AI; D'Andrea, S; Davis, IS; Mang'Eni, RO; Pitsiladis, Y				Lieberman, Daniel E.; Venkadesan, Madhusudhan; Werbel, William A.; Daoud, Adam I.; D'Andrea, Susan; Davis, Irene S.; Mang'Eni, Robert Ojiambo; Pitsiladis, Yannis			Foot strike patterns and collision forces in habitually barefoot versus shod runners	NATURE			English	Article							RUNNING INJURIES; FEMALE RUNNERS; STANCE PHASE; EVOLUTION; WALKING; HOMO; MASS	Humans have engaged in endurance running for millions of years(1), but the modern running shoe was not invented until the 1970s. For most of human evolutionary history, runners were either barefoot or wore minimal footwear such as sandals or moccasins with smaller heels and little cushioning relative to modern running shoes. We wondered how runners coped with the impact caused by the foot colliding with the ground before the invention of the modern shoe. Here we show that habitually barefoot endurance runners often land on the fore-foot (fore-foot strike) before bringing down the heel, but they sometimes land with a flat foot (mid-foot strike) or, less often, on the heel (rear-foot strike). In contrast, habitually shod runners mostly rear-foot strike, facilitated by the elevated and cushioned heel of the modern running shoe. Kinematic and kinetic analyses show that even on hard surfaces, barefoot runners who fore-foot strike generate smaller collision forces than shod rear-foot strikers. This difference results primarily from a more plantarflexed foot at landing and more ankle compliance during impact, decreasing the effective mass of the body that collides with the ground. Fore-foot-and mid-foot-strike gaits were probably more common when humans ran barefoot or in minimal shoes, and may protect the feet and lower limbs from some of the impact-related injuries now experienced by a high percentage of runners.	[Lieberman, Daniel E.; Venkadesan, Madhusudhan; Daoud, Adam I.] Harvard Univ, Dept Human Evolutionary Biol, Cambridge, MA 02138 USA; [Venkadesan, Madhusudhan] Harvard Univ, Sch Engn & Appl Sci, Cambridge, MA 02138 USA; [Werbel, William A.] Univ Michigan, Sch Med, Ann Arbor, MI 48109 USA; [D'Andrea, Susan] Providence Vet Affairs Med Ctr, Ctr Restorat & Regenerat Med, Providence, RI 02906 USA; [Davis, Irene S.] Univ Delaware, Dept Phys Therapy, Newark, DE 19716 USA; [Mang'Eni, Robert Ojiambo; Pitsiladis, Yannis] Moi Univ, Sch Med, Dept Med Physiol, Eldoret 30100, Kenya; [Mang'Eni, Robert Ojiambo; Pitsiladis, Yannis] Univ Glasgow, Fac Biomed Life Sci, Glasgow G12 8QQ, Lanark, Scotland	Harvard University; Harvard University; University of Michigan System; University of Michigan; US Department of Veterans Affairs; Veterans Health Administration (VHA); Providence VA Medical Center; University of Delaware; Moi University; University of Glasgow	Lieberman, DE (corresponding author), Harvard Univ, Dept Human Evolutionary Biol, 11 Divin Ave, Cambridge, MA 02138 USA.	danlieb@fas.harvard.edu	Daoud-Gray, Adam I/O-3183-2015; Venkadesan, Madhusudhan/B-4697-2008	Daoud-Gray, Adam I/0000-0003-3792-7881; Venkadesan, Madhusudhan/0000-0001-5754-7478; Pitsiladis, Yannis/0000-0001-6210-2449	US National Science Foundation; American School of Prehistoric Research; Goelet Fund; Harvard University; Vibram USA	US National Science Foundation(National Science Foundation (NSF)); American School of Prehistoric Research; Goelet Fund; Harvard University; Vibram USA	We are grateful to the many volunteer runners who donated their time and patience. For help in Kenya, we thank M. Sang; E. Anjilla; Moi University Medical School; E. Maritim; and the students and teachers of Pemja, Union and AIC Chebisaas schools, in Kenya. For laboratory assistance in Cambridge, we thank A. Biewener, S. Chester, C. M. Eng, K. Duncan, C. Moreno, P. Mulvaney, N. T. Roach, C. P. Rolian, I. Ros, K. Whitcome and S. Wright. We are grateful to A. Biewener, D. Bramble, J. Hamill, H. Herr, L. Mahadevan and D. Raichlen for discussions and comments. Funding was provided by the US National Science Foundation, the American School of Prehistoric Research, The Goelet Fund, Harvard University and Vibram USA.	BOBBERT MF, 1991, J BIOMECH, V24, P1095, DOI 10.1016/0021-9290(91)90002-5; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; Chatterjee A, 2000, DYNAM STABIL SYST, V15, P139, DOI 10.1080/02681110050032128; Chi KJ, 2005, J BIOMECH, V38, P1387, DOI 10.1016/j.jbiomech.2004.06.020; De Wit B, 2000, J BIOMECH, V33, P269, DOI 10.1016/S0021-9290(99)00192-X; DECLERCQ D, 1994, J BIOMECH, V27, P1213, DOI 10.1016/0021-9290(94)90275-5; DEMPSTER WT, 1955, 55159 WADC US AIR FO; DICKINSON JA, 1985, J BIOMECH, V18, P415, DOI 10.1016/0021-9290(85)90276-3; Divert C, 2008, INT J SPORTS MED, V29, P512, DOI 10.1055/s-2007-989233; Divert C, 2005, INT J SPORTS MED, V26, P593, DOI 10.1055/s-2004-821327; Dixon SJ, 2000, MED SCI SPORT EXER, V32, P1919, DOI 10.1097/00005768-200011000-00016; Eslami M, 2007, CLIN BIOMECH, V22, P74, DOI 10.1016/j.clinbiomech.2006.08.002; Hasegawa H, 2007, J STRENGTH COND RES, V21, P888, DOI 10.1519/R-22096.1; Jungers WL, 2009, NATURE, V459, P81, DOI 10.1038/nature07989; Ker R F, 1989, Proc Inst Mech Eng H, V203, P191, DOI 10.1243/PIME_PROC_1989_203_038_01; KER RF, 1987, NATURE, V325, P147, DOI 10.1038/325147a0; Kerr BA, 1983, P INT S BIOM ASP SPO, P135; LATIMER B, 1989, AM J PHYS ANTHROPOL, V78, P369, DOI 10.1002/ajpa.1330780306; Laughton CA, 2003, J APPL BIOMECH, V19, P153, DOI 10.1123/jab.19.2.153; MARTI B, 1989, SHOE SPORT, P256; Milner CE, 2006, MED SCI SPORT EXER, V38, P323, DOI 10.1249/01.mss.0000183477.75808.92; Nigg B.M., 1986, BIOMECHANICS RUNNING; Onywera VO, 2006, J SPORT SCI, V24, P415, DOI 10.1080/02640410500189033; Pohl MB, 2009, CLIN J SPORT MED, V19, P372, DOI 10.1097/JSM.0b013e3181b8c270; Richards CE, 2009, BRIT J SPORT MED, V43, P159, DOI 10.1136/bjsm.2008.046680; ROBBINS SE, 1987, MED SCI SPORT EXER, V19, P148; Squadrone R, 2009, J SPORT MED PHYS FIT, V49, P6; van Gent RN, 2007, BRIT J SPORT MED, V41, P469, DOI 10.1136/bjsm.2006.033548; VANMECHELEN W, 1992, SPORTS MED, V14, P320, DOI 10.2165/00007256-199214050-00004; Williams DS, 2000, J APPL BIOMECH, V16, P210, DOI 10.1123/jab.16.2.210	30	808	845	20	640	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					531	U149		10.1038/nature08723	http://dx.doi.org/10.1038/nature08723			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20111000				2022-12-01	WOS:000273981100049
J	Hill, J; Treasure, T				Hill, Jennifer; Treasure, Tom		Natl Clinical Guideline Ctr Acute	Guidelines Reducing the risk of venous thromboembolism in patients admitted to hospital: summary of NICE guidance	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							HIP		[Hill, Jennifer] Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, London NW1 4LE, England; [Treasure, Tom] UCL, Clin Operat Res Unit, Guideline Dev Grp, London WC1H 0BT, England	Royal College of Physicians; University of London; University College London	Hill, J (corresponding author), Royal Coll Physicians, Natl Clin Guideline Ctr Acute & Chron Condit, London NW1 4LE, England.	tom.treasure@gmail.com		Stansby, Gerard/0000-0001-5539-3049; Wonderling, David/0000-0003-0315-6273	National Institute for Health and Clinical Excellence	National Institute for Health and Clinical Excellence	The National Clinical Guideline Centre for Acute and Chronic Conditions was commissioned and funded by the National Institute for Health and Clinical Excellence to write this summary.	Choudhry NK, 2006, BMJ-BRIT MED J, V332, P141, DOI 10.1136/bmj.38698.709572.55; Cohen AT, 2007, THROMB HAEMOSTASIS, V98, P756, DOI 10.1160/TH07-03-0212; Department of Health, 2007, REP IND EXP WORK GRO; Department of Health, RISK ASS VEN THROMB; Eikelboom JW, 2009, CHEST, V135, P513, DOI 10.1378/chest.08-2655; Geerts WH, 2008, CHEST, V133, p381S, DOI 10.1378/chest.08-0656; Haas SB, 2008, J BONE JOINT SURG AM, V90A, P2764; Hill J, 2007, BMJ-BRIT MED J, V334, P1053, DOI 10.1136/bmj.39174.678032.AD; House of Commons Health Select Committee, 2005, PREV VEN THROMB HOSP; Hunt BJ, 2008, ARTERIOSCL THROM VAS, V28, P398, DOI 10.1161/ATVBAHA.108.162586; *NAT I HLTH CLIN E, 2008, STROK DIAGN MAN AC S; Sharrock NE, 2008, CLIN ORTHOP RELAT R, V466, P714, DOI 10.1007/s11999-007-0092-4	12	56	71	0	6	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 27	2010	340								c95	10.1136/bmj.c95	http://dx.doi.org/10.1136/bmj.c95			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	549YB	20106897				2022-12-01	WOS:000274089300016
J	Epsztein, J; Lee, AK; Chorev, E; Brecht, M				Epsztein, Jerome; Lee, Albert K.; Chorev, Edith; Brecht, Michael			Impact of Spikelets on Hippocampal CA1 Pyramidal Cell Activity During Spatial Exploration	SCIENCE			English	Article							FIELD BURST ACTIVITY; FREELY MOVING RATS; PLACE CELLS; IN-VITRO; FREQUENCY OSCILLATIONS; ELECTRICAL SYNAPSES; FAST PREPOTENTIALS; ECTOPIC SPIKES; GAP-JUNCTIONS; NEURONS	In vivo intracellular recordings of hippocampal neurons reveal the occurrence of fast events of small amplitude called spikelets or fast prepotentials. Because intracellular recordings have been restricted to anesthetized or head-fixed animals, it is not known how spikelet activity contributes to hippocampal spatial representations. We addressed this question in CA1 pyramidal cells by using in vivo whole-cell recording in freely moving rats. We observed a high incidence of spikelets that occurred either in isolation or in bursts and could drive spiking as fast prepotentials of action potentials. Spikelets strongly contributed to spiking activity, driving similar to 30% of all action potentials. CA1 pyramidal cell firing and spikelet activity were comodulated as a function of the animal's location in the environment. We conclude that spikelets have a major impact on hippocampal activity during spatial exploration.	[Epsztein, Jerome; Lee, Albert K.; Chorev, Edith; Brecht, Michael] Humboldt Univ, Bernstein Ctr Computat Neurosci, D-10115 Berlin, Germany	Humboldt University of Berlin	Epsztein, J (corresponding author), INSERM, Inst Neurobiol Mediterranee, U801, Parc Sci & Technol Luminy,Boite Postale 13, F-13273 Marseille 9, France.	epsztein@inmed.univ-mrs.fr	Epsztein, Jerome/O-7922-2016	Epsztein, Jerome/0000-0002-5344-3986; Chorev, Edith/0000-0002-7170-8327; Brecht, Michael/0000-0002-5387-0953	Neurocure, Bernstein Center for Computational Neuroscience (BMBF), Humboldt University; Neuro-behavior European Research Council; European Molecular Biology Organization; Human Frontier Science Program	Neurocure, Bernstein Center for Computational Neuroscience (BMBF), Humboldt University(Federal Ministry of Education & Research (BMBF)); Neuro-behavior European Research Council; European Molecular Biology Organization(European Molecular Biology Organization (EMBO)); Human Frontier Science Program(Human Frontier Science Program)	We would like to thank B. Geue, R. Karpinski, and A. Stern at Humboldt University for technical assistance and D. Schmitz for comments on the manuscript. This work was supported by Neurocure, Bernstein Center for Computational Neuroscience (BMBF), Humboldt University, and Neuro-behavior European Research Council grants (M. B.), a European Molecular Biology Organization Long Term Fellowship (A. K. L.), and a Human Frontier Science Program Long Term Fellowship (J.E.).	Avoli M, 1998, EUR J NEUROSCI, V10, P2714, DOI 10.1046/j.1460-9568.1998.t01-1-00275.x; Crochet S, 2004, CEREB CORTEX, V14, P1110, DOI 10.1093/cercor/bhh071; Draguhn A, 1998, NATURE, V394, P189, DOI 10.1038/28184; Dugue GP, 2009, NEURON, V61, P126, DOI 10.1016/j.neuron.2008.11.028; EPSZTEIN J, 2008, SOC NEUR ABSTR; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Hamzei-Sichani F, 2007, P NATL ACAD SCI USA, V104, P12548, DOI 10.1073/pnas.0705281104; Harvey CD, 2009, NATURE, V461, P941, DOI 10.1038/nature08499; JEFFERYS JGR, 1982, NATURE, V300, P448, DOI 10.1038/300448a0; Landisman CE, 2002, J NEUROSCI, V22, P1002, DOI 10.1523/JNEUROSCI.22-03-01002.2002; LEE AK, 2008, SOC NEUR ABSTR; Lee AK, 2006, NEURON, V51, P399, DOI 10.1016/j.neuron.2006.07.004; Lee AK, 2009, NAT PROTOC, V4, P385, DOI 10.1038/nprot.2009.5; LLINAS R, 1974, J NEUROPHYSIOL, V37, P560, DOI 10.1152/jn.1974.37.3.560; MACVICAR BA, 1981, SCIENCE, V213, P782, DOI 10.1126/science.6266013; Mann-Metzer P, 1999, J NEUROSCI, V19, P3298; Mercer A, 2006, BRAIN CELL BIOL, V35, P13, DOI 10.1007/s11068-006-9005-9; Muller R, 1996, NEURON, V17, P813, DOI 10.1016/S0896-6273(00)80214-7; OKEEFE J, 1971, BRAIN RES, V34, P171, DOI 10.1016/0006-8993(71)90358-1; PEREZVELAZQUEZ JL, 1994, J NEUROSCI, V14, P4308; Schmitz D, 2001, NEURON, V31, P831, DOI 10.1016/S0896-6273(01)00410-X; Simon A, 2005, J NEUROSCI, V25, P6278, DOI 10.1523/JNEUROSCI.1431-05.2005; SPENCER WA, 1961, J NEUROPHYSIOL, V24, P272, DOI 10.1152/jn.1961.24.3.272; STASHEFF SF, 1993, J NEUROPHYSIOL, V70, P961, DOI 10.1152/jn.1993.70.3.961; Tamas G, 2000, NAT NEUROSCI, V3, P366, DOI 10.1038/73936; TAYLOR CP, 1982, SCIENCE, V218, P810, DOI 10.1126/science.7134978; THOMPSON LT, 1989, J NEUROSCI, V9, P2382; Traub RD, 2001, J NEUROPHYSIOL, V85, P1246, DOI 10.1152/jn.2001.85.3.1246; TRAUB RD, 1995, J PHYSIOL-LONDON, V489, P127, DOI 10.1113/jphysiol.1995.sp021036; VALIANTE TA, 1995, J NEUROSCI, V15, P6946; Zsiros V, 2005, J NEUROSCI, V25, P8686, DOI 10.1523/JNEUROSCI.2810-05.2005	32	84	86	0	20	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					474	477		10.1126/science.1182773	http://dx.doi.org/10.1126/science.1182773			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093475				2022-12-01	WOS:000273783100040
J	Liu, BD; Larsson, L; Caballero, A; Hao, XX; Oling, D; Grantham, J; Nystrom, T				Liu, Beidong; Larsson, Lisa; Caballero, Antonio; Hao, Xinxin; Oling, David; Grantham, Julie; Nystrom, Thomas			The Polarisome Is Required for Segregation and Retrograde Transport of Protein Aggregates	CELL			English	Article							CELL-CYCLE PROGRESSION; ACTIN CYTOSKELETON; LIFE-SPAN; SACCHAROMYCES-CEREVISIAE; ASYMMETRIC SEGREGATION; GENETIC INTERACTIONS; DAMAGED PROTEINS; CHAPERONIN CCT; YEAST; SIR2	The paradigm sirtuin, Sir2p, of budding yeast is required for establishing cellular age asymmetry, which includes the retention of damaged and aggregated proteins in mother cells. By establishing the global genetic interaction network of SIR2 we identified the polarisome, the formin Bni1p, and myosin motor protein Myo2p as essential components of the machinery segregating protein aggregates during mitotic cytokinesis. Moreover, we found that daughter cells can clear themselves of damage by a polarisome- and tropomyosin-dependent polarized flow of aggregates into the mother cell compartment. The role of Sir2p in cytoskeletal functions and polarity is linked to the CCT chaperonin in sir2D cells being compromised in folding actin. We discuss the findings in view of recent models hypothesizing that polarity may have evolved to avoid clonal senescence by establishing an aging (soma-like) and rejuvenated (germ-like) lineage.	[Liu, Beidong; Larsson, Lisa; Caballero, Antonio; Hao, Xinxin; Oling, David; Grantham, Julie; Nystrom, Thomas] Gothenburg Univ, Dept Cell & Mol Biol, S-41390 Gothenburg, Sweden	University of Gothenburg	Liu, BD (corresponding author), Gothenburg Univ, Dept Cell & Mol Biol, Medicinaregatan 9C, S-41390 Gothenburg, Sweden.	beidong.liu@cmb.gu.se; thomas.nystrom@cmb.gu.se	Caballero, Antonio/I-8510-2014; Liu, Beidong/L-2485-2015; Grantham, Julie/A-5002-2009	Caballero, Antonio/0000-0001-6042-9245; Liu, Beidong/0000-0001-6052-8411; 	Swedish Natural Research Council; Wallenberg scholar; Foundation for Strategic Research in Sweden; Goran Gustafsson Foundation; EC	Swedish Natural Research Council(Swedish Research Council); Wallenberg scholar; Foundation for Strategic Research in Sweden; Goran Gustafsson Foundation; EC(European CommissionEuropean Commission Joint Research Centre)	The authors would like to thank Charles Boone for providing strains, software support for the SGA analysis, and helpful suggestions throughout this work. The epsilon AD2 antibody was a kind gift from Keith Willison, and David Sinclair provided useful information on reagents and antibodies. This work was supported by grants from the Swedish Natural Research Council (VR), the Wallenberg scholar award, the Foundation for Strategic Research in Sweden (SSF-BioX program), the Goran Gustafsson Foundation, and the EC (Acronyms: Mimage & Proteomage).	Ackermann M, 2003, SCIENCE, V300, P1920, DOI 10.1126/science.1083532; Ackermann M, 2007, AGING CELL, V6, P235, DOI 10.1111/j.1474-9726.2007.00281.x; Aguilaniu H, 2003, SCIENCE, V299, P1751, DOI 10.1126/science.1080418; Barker MG, 1999, YEAST, V15, P1511, DOI 10.1002/(SICI)1097-0061(199910)15:14<1511::AID-YEA482>3.3.CO;2-P; Boone C, 2007, NAT REV GENET, V8, P437, DOI 10.1038/nrg2085; Brackley KI, 2009, CELL STRESS CHAPERON, V14, P23, DOI 10.1007/s12192-008-0057-x; Dang WW, 2009, NATURE, V459, P802, DOI 10.1038/nature08085; Defossez PA, 1999, MOL CELL, V3, P447, DOI 10.1016/S1097-2765(00)80472-4; Dong YQ, 2003, J CELL BIOL, V161, P1081, DOI 10.1083/jcb.200212040; Erjavec N, 2008, P NATL ACAD SCI USA, V105, P18764, DOI 10.1073/pnas.0804550105; Erjavec N, 2007, GENE DEV, V21, P2410, DOI 10.1101/gad.439307; Erjavec N, 2007, P NATL ACAD SCI USA, V104, P10877, DOI 10.1073/pnas.0701634104; Ganusova EE, 2006, MOL CELL BIOL, V26, P617, DOI 10.1128/MCB.26.2.617-629.2006; Girao H, 2008, FEBS LETT, V582, P2112, DOI 10.1016/j.febslet.2008.04.011; Grantham J, 2006, EXP CELL RES, V312, P2309, DOI 10.1016/j.yexcr.2006.03.028; Guarente L, 2000, GENE DEV, V14, P1021; Howitz KT, 2003, NATURE, V425, P191, DOI 10.1038/nature01960; Imai S, 2000, NATURE, V403, P795, DOI 10.1038/35001622; Jin H, 2000, MOL BIOL CELL, V11, P647, DOI 10.1091/mbc.11.2.647; Johnston JA, 1998, J CELL BIOL, V143, P1883, DOI 10.1083/jcb.143.7.1883; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kaeberlein M, 2007, PLOS GENET, V3, P655, DOI 10.1371/journal.pgen.0030084; Kawaguchi Y, 2003, CELL, V115, P727, DOI 10.1016/S0092-8674(03)00939-5; Kelley R, 2005, NAT BIOTECHNOL, V23, P561, DOI 10.1038/nbt1096; KIRKWOOD TBL, 1979, PROC R SOC SER B-BIO, V205, P531, DOI 10.1098/rspb.1979.0083; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; KIRKWOOD TBL, 1981, REPAIR ITS EVOLUTION; Lai CY, 2002, GENETICS, V162, P73; Lamming DW, 2005, SCIENCE, V309, P1861, DOI 10.1126/science.1113611; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Llorca O, 1999, NATURE, V402, P693, DOI 10.1038/45294; Macara IG, 2008, CELL, V135, P801, DOI 10.1016/j.cell.2008.11.006; McLaughlin S, 2002, ANNU REV BIOPH BIOM, V31, P151, DOI 10.1146/annurev.biophys.31.082901.134259; Moazed D, 2001, CURR OPIN CELL BIOL, V13, P232, DOI 10.1016/S0955-0674(00)00202-7; Moseley JB, 2006, MICROBIOL MOL BIOL R, V70, P605, DOI 10.1128/MMBR.00013-06; Nystrom T, 2007, PLOS GENET, V3, P2355, DOI 10.1371/journal.pgen.0030224; Pappenberger G, 2006, J MOL BIOL, V360, P484, DOI 10.1016/j.jmb.2006.05.003; PARTRIDGE L, 1993, NATURE, V362, P305, DOI 10.1038/362305a0; Perrod S, 2001, EMBO J, V20, P197, DOI 10.1093/emboj/20.1.197; Pruyne D, 2002, SCIENCE, V297, P612, DOI 10.1126/science.1072309; RAYMENT I, 1993, SCIENCE, V261, P58, DOI 10.1126/science.8316858; Rogina B, 2004, P NATL ACAD SCI USA, V101, P15998, DOI 10.1073/pnas.0404184101; Sagot I, 2002, NAT CELL BIOL, V4, P626, DOI 10.1038/ncb834; Schott D, 1999, J CELL BIOL, V147, P791, DOI 10.1083/jcb.147.4.791; Shcheprova Z, 2008, NATURE, V454, P728, DOI 10.1038/nature07212; Shimon L, 2008, J MOL BIOL, V377, P469, DOI 10.1016/j.jmb.2008.01.011; Sinclair DA, 1997, CELL, V91, P1033, DOI 10.1016/S0092-8674(00)80493-6; Sinclair DA, 2002, MECH AGEING DEV, V123, P857, DOI 10.1016/S0047-6374(02)00023-4; Smeal T, 1996, CELL, V84, P633, DOI 10.1016/S0092-8674(00)81038-7; SMITH MG, 1995, MOL BIOL CELL, V6, P1381, DOI 10.1091/mbc.6.10.1381; Soderberg O, 2006, NAT METHODS, V3, P995, DOI 10.1038/nmeth947; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Tessarz P, 2009, MOL CELL BIOL, V29, P3738, DOI 10.1128/MCB.00201-09; Tissenbaum HA, 2001, NATURE, V410, P227, DOI 10.1038/35065638; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Veatch JR, 2009, CELL, V137, P1247, DOI 10.1016/j.cell.2009.04.014; VINH DBN, 1994, P NATL ACAD SCI USA, V91, P9116, DOI 10.1073/pnas.91.19.9116; Wang YS, 2009, J EUR ACAD DERMATOL, V23, P451, DOI 10.1111/j.1468-3083.2008.02895.x; Warringer J, 2003, P NATL ACAD SCI USA, V100, P15724, DOI 10.1073/pnas.2435976100; Weismann A., 1889, ESSAYS HEREDITY KIND; WERTMAN KF, 1992, GENETICS, V132, P337; Yang HC, 2002, P NATL ACAD SCI USA, V99, P751, DOI 10.1073/pnas.022462899	63	240	241	3	30	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					257	267		10.1016/j.cell.2009.12.031	http://dx.doi.org/10.1016/j.cell.2009.12.031			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141839	Bronze			2022-12-01	WOS:000273826500016
J	Smits, P; Bolton, AD; Funari, V; Hong, M; Boyden, ED; Lu, L; Manning, DK; Dwyer, ND; Moran, JL; Prysak, M; Merriman, B; Nelson, SF; Bonafe, L; Superti-Furga, A; Ikegawa, S; Krakow, D; Cohn, DH; Kirchhausen, T; Warman, ML; Beier, DR				Smits, Patrick; Bolton, Andrew D.; Funari, Vincent; Hong, Minh; Boyden, Eric D.; Lu, Lei; Manning, Danielle K.; Dwyer, Noelle D.; Moran, Jennifer L.; Prysak, Mary; Merriman, Barry; Nelson, Stanley F.; Bonafe, Luisa; Superti-Furga, Andrea; Ikegawa, Shiro; Krakow, Deborah; Cohn, Daniel H.; Kirchhausen, Tom; Warman, Matthew L.; Beier, David R.			Lethal Skeletal Dysplasia in Mice and Humans Lacking the Golgin GMAP-210	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							THYROID-HORMONE RECEPTOR; RIBBON FORMATION; ER STRESS; PROTEIN; APPARATUS; MOUSE; MECHANISMS; MUTATIONS; PHENOTYPE; CARTILAGE	BACKGROUND Establishing the genetic basis of phenotypes such as skeletal dysplasia in model organisms can provide insights into biologic processes and their role in human disease. METHODS We screened mutagenized mice and observed a neonatal lethal skeletal dysplasia with an autosomal recessive pattern of inheritance. Through genetic mapping and positional cloning, we identified the causative mutation. RESULTS Affected mice had a nonsense mutation in the thyroid hormone receptor interactor 11 gene (Trip11), which encodes the Golgi microtubule-associated protein 210 (GMAP-210); the affected mice lacked this protein. Golgi architecture was disturbed in multiple tissues, including cartilage. Skeletal development was severely impaired, with chondrocytes showing swelling and stress in the endoplasmic reticulum, abnormal cellular differentiation, and increased cell death. Golgi-mediated glycosylation events were altered in fibroblasts and chondrocytes lacking GMAP-210, and these chondrocytes had intracellular accumulation of perlecan, an extracellular matrix protein, but not of type II collagen or aggrecan, two other extracellular matrix proteins. The similarities between the skeletal and cellular phenotypes in these mice and those in patients with achondrogenesis type 1A, a neonatal lethal form of skeletal dysplasia in humans, suggested that achondrogenesis type 1A may be caused by GMAP-210 deficiency. Sequence analysis revealed loss-of-function mutations in the 10 unrelated patients with achondrogenesis type 1A whom we studied. CONCLUSIONS GMAP-210 is required for the efficient glycosylation and cellular transport of multiple proteins. The identification of a mutation affecting GMAP-210 in mice, and then in humans, as the cause of a lethal skeletal dysplasia underscores the value of screening for abnormal phenotypes in model organisms and identifying the causative mutations.	[Smits, Patrick; Hong, Minh; Boyden, Eric D.; Warman, Matthew L.] Childrens Hosp, Dept Orthoped Surg, Orthoped Res Labs, Boston, MA 02115 USA; [Warman, Matthew L.] Childrens Hosp, Howard Hughes Med Inst, Boston, MA 02115 USA; [Lu, Lei; Kirchhausen, Tom] Childrens Hosp, Program Cellular & Mol Med, Boston, MA 02115 USA; [Bolton, Andrew D.; Manning, Danielle K.; Dwyer, Noelle D.; Moran, Jennifer L.; Prysak, Mary; Beier, David R.] Brigham & Womens Hosp, Div Genet, Boston, MA 02115 USA; [Lu, Lei; Kirchhausen, Tom] Brigham & Womens Hosp, Immune Dis Inst, Boston, MA 02115 USA; [Lu, Lei; Kirchhausen, Tom] Brigham & Womens Hosp, Dept Cell Biol, Boston, MA 02115 USA; [Warman, Matthew L.] Brigham & Womens Hosp, Dept Genet, Boston, MA 02115 USA; [Funari, Vincent; Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, Cedars Sinai Med Ctr, Inst Med Genet, Los Angeles, CA 90048 USA; [Funari, Vincent; Merriman, Barry; Nelson, Stanley F.; Krakow, Deborah; Cohn, Daniel H.] Univ Calif Los Angeles, David Geffen Sch Med, Los Angeles, CA 90048 USA; [Bonafe, Luisa] Univ Lausanne, CHU Vaudois, Div Mol Pediat, Lausanne, Switzerland; [Superti-Furga, Andrea] Univ Freiburg, Dept Pediat, D-7800 Freiburg, Germany; [Ikegawa, Shiro] RIKEN, Ctr Genom Med, Tokyo, Japan	Harvard University; Boston Children's Hospital; Harvard University; Boston Children's Hospital; Howard Hughes Medical Institute; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Harvard University; Brigham & Women's Hospital; Harvard University; Boston Children's Hospital; Program in Cellular & Molecular Medicine (PCMM); Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Harvard University; Brigham & Women's Hospital; Cedars Sinai Medical Center; University of California System; University of California Los Angeles; University of California System; University of California Los Angeles; University of California Los Angeles Medical Center; David Geffen School of Medicine at UCLA; University of Lausanne; Centre Hospitalier Universitaire Vaudois (CHUV); University of Freiburg; RIKEN	Warman, ML (corresponding author), Childrens Hosp, Dept Orthoped Surg, Orthoped Res Labs, Enders 907-2,320 Longwood Ave, Boston, MA 02115 USA.	matthew.warman@childrens.harvard.edu	Nelson, Stanley F/D-4771-2009; superti-furga, andrea/E-9162-2015; Ikegawa, Shiro/N-6895-2015; Lu, Lei/A-2225-2011; Krakow, Deborah/B-5778-2009	Nelson, Stanley F/0000-0002-2082-3114; superti-furga, andrea/0000-0002-3543-7531; Ikegawa, Shiro/0000-0003-0316-2147; Lu, Lei/0000-0002-8192-1471; Krakow, Deborah/0000-0001-9906-4968; Dwyer, Noelle/0000-0002-1995-7203; Moran, Jennifer/0000-0002-5664-4716	National Institutes of Health [HD36404, UO1 HD43430, GM075252, A1063430, AR050180]; Swiss National Research Foundation [320000-116506]; Arthritis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD036404] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD043430] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR050180] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM075252] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Swiss National Research Foundation(Swiss National Science Foundation (SNSF)); Arthritis Foundation; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health (HD36404 and UO1 HD43430, to Dr. Beier; GM075252 and A1063430, to Dr. Kirchhausen; and AR050180, to Dr. Warman) and the Swiss National Research Foundation (320000-116506, to Dr. Bonafe) and by an Arthritis Foundation Investigator Award to Dr. Smits.	Aigner T, 2007, PEDIATR DEVEL PATHOL, V10, P328, DOI 10.2350/06-07-0134.1; Aszodi A, 2000, CELL STRUCT FUNCT, V25, P73, DOI 10.1247/csf.25.73; Barr FA, 2003, CURR OPIN CELL BIOL, V15, P405, DOI 10.1016/S0955-0674(03)00054-1; Beischlag TV, 2004, J BIOL CHEM, V279, P54620, DOI 10.1074/jbc.M410456200; Boyadjiev SA, 2006, NAT GENET, V38, P1192, DOI 10.1038/ng1876; Chang KH, 1997, P NATL ACAD SCI USA, V94, P9040, DOI 10.1073/pnas.94.17.9040; DALTON AJ, 1954, AM J ANAT, V94, P171, DOI 10.1002/aja.1000940202; Diao A, 2003, J CELL BIOL, V160, P201, DOI 10.1083/jcb.200207045; Dimitrov A, 2009, HUM MOL GENET, V18, P440, DOI 10.1093/hmg/ddn371; Feng Y, 2003, P NATL ACAD SCI USA, V100, P6469, DOI 10.1073/pnas.0631766100; Follit JA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000315; Fromme JC, 2007, DEV CELL, V13, P623, DOI 10.1016/j.devcel.2007.10.005; Gedeon AK, 2001, AM J HUM GENET, V68, P1386, DOI 10.1086/320592; Golgi C, 1898, B SOC MED CHIR PA, V13, P3; Gudbjartsson DF, 2008, NAT GENET, V40, P609, DOI 10.1038/ng.122; Haycraft CJ, 2008, CURR TOP DEV BIOL, V85, P303, DOI 10.1016/S0070-2153(08)00811-9; HEINEGARD D, 1985, BIOCHEM J, V225, P95, DOI 10.1042/bj2250095; Herron BJ, 2002, NAT GENET, V30, P185, DOI 10.1038/ng812; Hsia CCW, 2004, AM J RESP CRIT CARE, V170, P319, DOI 10.1164/rccm.200209-1062ST; Lang MR, 2006, NAT GENET, V38, P1198, DOI 10.1038/ng1880; LEE JW, 1995, MOL ENDOCRINOL, V9, P243; Lettre G, 2008, NAT GENET, V40, P584, DOI 10.1038/ng.125; Lieu ZZ, 2008, P NATL ACAD SCI USA, V105, P3351, DOI 10.1073/pnas.0800137105; Lisse TS, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.0040007; Lock JG, 2005, TRAFFIC, V6, P1142, DOI 10.1111/j.1600-0854.2005.00349.x; Marra P, 2007, MOL BIOL CELL, V18, P1595, DOI 10.1091/mbc.E06-10-0886; MOLZ G, 1980, EUR J PEDIATR, V134, P69, DOI 10.1007/BF00442406; Moran JL, 2006, GENOME RES, V16, P436, DOI 10.1101/gr.4563306; Osipovich AB, 2008, P NATL ACAD SCI USA, V105, P16171, DOI 10.1073/pnas.0804259105; Pfeffer SR, 2007, ANNU REV BIOCHEM, V76, P629, DOI 10.1146/annurev.biochem.76.061705.130002; Pirog-Garcia KA, 2007, HUM MOL GENET, V16, P2072, DOI 10.1093/hmg/ddm155; Puthenveedu MA, 2006, NAT CELL BIOL, V8, P238, DOI 10.1038/ncb1366; Rios RM, 2004, CELL, V118, P323; Schroder M, 2005, MUTAT RES-FUND MOL M, V569, P29, DOI 10.1016/j.mrfmmm.2004.06.056; Seegmiller RE, 2008, J HISTOCHEM CYTOCHEM, V56, P1003, DOI 10.1369/jhc.2008.951673; SupertiFurga A, 1996, NAT GENET, V12, P100, DOI 10.1038/ng0196-100; SUZAKI E, 1992, J HISTOCHEM CYTOCHEM, V40, P379, DOI 10.1177/40.3.1552177; Sztul E, 2006, AM J PHYSIOL-CELL PH, V290, pC11, DOI 10.1152/ajpcell.00293.2005; Tsang KY, 2007, PLOS BIOL, V5, P568, DOI 10.1371/journal.pbio.0050044; Wong SY, 2008, CURR TOP DEV BIOL, V85, P225, DOI 10.1016/S0070-2153(08)00809-0	40	99	104	0	13	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					206	216		10.1056/NEJMoa0900158	http://dx.doi.org/10.1056/NEJMoa0900158			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089971	Green Accepted			2022-12-01	WOS:000273738400007
J	Raoult, D				Raoult, Didier			The post-Darwinist rhizome of life	LANCET			English	Editorial Material									URMITE CNRS IRD, UMR 6236, Fac Med, Unite Rickettsies, F-13385 Marseille, France	UDICE-French Research Universities; Aix-Marseille Universite; Centre National de la Recherche Scientifique (CNRS); Institut National de la Sante et de la Recherche Medicale (Inserm); Institut de Recherche pour le Developpement (IRD); Universite de Franche-Comte	Raoult, D (corresponding author), URMITE CNRS IRD, UMR 6236, Fac Med, Unite Rickettsies, F-13385 Marseille, France.	didier.raoult@gmail.com	RAOULT, Didier/A-8434-2008	RAOULT, Didier/0000-0002-0633-5974				[Anonymous], 1976, RHIZOME INTRO; Callaway E, 2007, NATURE, V449, P6, DOI 10.1038/449006b; Darwin C., 1859, ORIGIN SPECIES MEANS; Dawkins R, 2006, SELFISH GENE, V30th; Doolittle WF, 2007, P NATL ACAD SCI USA, V104, P2043, DOI 10.1073/pnas.0610699104; Fraser CM, 2000, NATURE, V406, P799, DOI 10.1038/35021244; Koonin EV, 2009, NUCLEIC ACIDS RES, V37, P1011, DOI 10.1093/nar/gkp089; Raoult D, 2008, NAT REV MICROBIOL, V6, P315, DOI 10.1038/nrmicro1858	8	64	67	0	4	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	JAN 9	2010	375	9709					104	105		10.1016/S0140-6736(09)61958-9	http://dx.doi.org/10.1016/S0140-6736(09)61958-9			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	544NM	20109873				2022-12-01	WOS:000273664500009
J	Kiessling, W; Simpson, C; Foote, M				Kiessling, Wolfgang; Simpson, Carl; Foote, Michael			Reefs as Cradles of Evolution and Sources of Biodiversity in the Phanerozoic	SCIENCE			English	Article							MARINE FOSSIL RECORD; LATITUDINAL GRADIENTS; HABITAT COMPLEXITY; DIVERSITY; DYNAMICS; CORALS; COMMUNITIES; PATTERNS; DIVERSIFICATION; ORIGINATION	Large-scale biodiversity gradients among environments and habitats are usually attributed to a complex array of ecological and evolutionary factors. We tested the evolutionary component of such gradients by compiling the environments of the geologically oldest occurrences of marine genera and using sampling standardization to assess if originations tended to be clustered in particular environments. Shallow, tropical environments and carbonate substrates all tend to have harbored high origination rates. Diversity within these environments tended to be preferentially generated in reefs, probably because of their habitat complexity. Reefs were also prolific at exporting diversity to other environments, which might be a consequence of low-diversity habitats being more susceptible to invasions.	[Kiessling, Wolfgang; Simpson, Carl] Humboldt Univ, Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, D-10115 Berlin, Germany; [Foote, Michael] Univ Chicago, Dept Geophys Sci, Chicago, IL 60637 USA	Humboldt University of Berlin; Leibniz Institut fur Evolutions und Biodiversitatsforschung; University of Chicago	Kiessling, W (corresponding author), Humboldt Univ, Leibniz Inst Res Evolut & Biodivers, Museum Nat Kunde, D-10115 Berlin, Germany.	wolfgang.kiessling@mfn-berlin.de	Kiessling, Wolfgang/E-2259-2015; Simpson, Carl/E-7140-2010	Kiessling, Wolfgang/0000-0002-1088-2014; Simpson, Carl/0000-0003-0719-4437	Deutsche Forschungsgemeinschaft [KI 806/5-1]; VolkswagenStiftung	Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); VolkswagenStiftung(Volkswagen)	This work was supported by the Deutsche Forschungsgemeinschaft (grant KI 806/5-1) and the VolkswagenStiftung. We thank U. Merkel for contributing substantially to the reef occurrence data. This is Paleobiology Database publication # 105.	Alfaro ME, 2007, EVOLUTION, V61, P2104, DOI 10.1111/j.1558-5646.2007.00182.x; Alroy J, 2008, P NATL ACAD SCI USA, V105, P11536, DOI 10.1073/pnas.0802597105; Bellwood DR, 1996, CORAL REEFS, V15, P11, DOI 10.1007/BF01626074; Briggs JC, 2005, J BIOGEOGR, V32, P1517, DOI 10.1111/j.1365-2699.2005.01266.x; Glynn PW, 2004, ECOSYSTEMS, V7, P358, DOI 10.1007/s10021-004-0184-x; Gratwicke B, 2005, MAR ECOL PROG SER, V292, P301, DOI 10.3354/meps292301; Jablonski D, 2005, J EXP ZOOL PART B, V304B, P504, DOI 10.1002/jez.b.21075; JABLONSKI D, 1983, SCIENCE, V222, P1123, DOI 10.1126/science.222.4628.1123; Jablonski D, 2006, SCIENCE, V314, P102, DOI 10.1126/science.1130880; Kiessling W, 2005, NATURE, V433, P410, DOI 10.1038/nature03152; Kiessling W, 2007, PALEOBIOLOGY, V33, P414, DOI 10.1666/06069.1; KNOWLTON FG, 1994, SYST ZOOL, V9, P7; Kohn AJ, 1997, MARINE BIODIVERSITY-BOOK, P201, DOI 10.1017/CBO9780511752360.010; Levine JM, 1999, OIKOS, V87, P15, DOI 10.2307/3546992; Lindner A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002429; Lingo ME, 2006, ENVIRON BIOL FISH, V76, P71, DOI 10.1007/s10641-006-9009-4; McPeek MA, 2008, AM NAT, V172, pE270, DOI 10.1086/593137; PANDOLFI JM, 1992, J BIOGEOGR, V19, P593, DOI 10.2307/2845703; RAUP DM, 1982, SCIENCE, V215, P1501, DOI 10.1126/science.215.4539.1501; Reaka-Kudla M. L., 1997, BIODIVERSITY, P83; Rosen B. R., 1984, FOSSILS CLIMATE, P201; Shea K, 2002, TRENDS ECOL EVOL, V17, P170, DOI 10.1016/S0169-5347(02)02495-3; STEHLI FG, 1971, SYST ZOOL, V20, P115, DOI 10.2307/2412052; Valentine JW, 2008, PALEOBIOLOGY, V34, P169, DOI 10.1666/0094-8373(2008)034[0169:IDALG]2.0.CO;2; Wagner PJ, 2007, P ROY SOC B-BIOL SCI, V274, P439, DOI 10.1098/rspb.2006.3742; Wallace CC, 2006, P ROY SOC B-BIOL SCI, V273, P975, DOI 10.1098/rspb.2005.3307; Williams ST, 2004, EVOLUTION, V58, P2227; Willig MR, 2003, ANNU REV ECOL EVOL S, V34, P273, DOI 10.1146/annurev.ecolsys.34.012103.144032	28	121	128	3	61	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					196	198		10.1126/science.1182241	http://dx.doi.org/10.1126/science.1182241			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056888	Green Submitted			2022-12-01	WOS:000273394000033
J	Woo, CJ; Kharchenko, PV; Daheron, L; Park, PJ; Kingston, RE				Woo, Caroline J.; Kharchenko, Peter V.; Daheron, Laurence; Park, Peter J.; Kingston, Robert E.			A Region of the Human HOXD Cluster that Confers Polycomb-Group Responsiveness	CELL			English	Article							EMBRYONIC STEM-CELLS; POLYCOMB/TRITHORAX RESPONSE ELEMENTS; TRANSCRIPTION FACTOR YY1; DNA-BINDING PROTEIN; DROSOPHILA-MELANOGASTER; DEVELOPMENTAL REGULATORS; PCG PROTEINS; GROUP GENES; IN-VIVO; COMPLEXES	Polycomb group (PcG) proteins are essential for accurate axial body patterning during embryonic development. PcG-mediated repression is conserved in metazoans and is targeted in Drosophila by Polycomb response elements (PREs). However, targeting sequences in humans have not been described. While analyzing chromatin architecture in the context of human embryonic stem cell (hESC) differentiation, we discovered a 1.8kb region between HOXD11 and HOXD12(D11.12) that is associated with PcG proteins, becomes nuclease hypersensitive, and then shows alteration in nuclease sensitivity as hESCs differentiate. The D11.12 element repressed luciferase expression from a reporter construct and full repression required a highly conserved region and YY1 binding sites. Furthermore, repression was dependent on the PcG proteins BMI1 and EED and a YY1-interacting partner, RYBP. We conclude that D11.12 is a Polycomb-dependent regulatory region with similarities to Drosophila PREs, indicating conservation in the mechanisms that target PcG function in mammals and flies.	[Woo, Caroline J.; Kingston, Robert E.] Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA; [Kharchenko, Peter V.; Park, Peter J.] Harvard Univ, Sch Med, Ctr Biomed Informat, Boston, MA 02115 USA; [Kharchenko, Peter V.; Park, Peter J.] Childrens Hosp, Informat Program, Boston, MA 02115 USA; [Daheron, Laurence] Harvard Univ, Massachusetts Gen Hosp, Sch Med, Ctr Regenerat Med, Boston, MA 02114 USA; [Daheron, Laurence] Harvard Stem Cell Inst, Cambridge, MA 02138 USA	Harvard University; Massachusetts General Hospital; Harvard University; Harvard Medical School; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School; Massachusetts General Hospital; Harvard University	Kingston, RE (corresponding author), Massachusetts Gen Hosp, Dept Mol Biol, Boston, MA 02114 USA.	kingston@molbio.mgh.harvard.edu		Park, Peter/0000-0001-9378-960X	NIH [GM43901, HG003141, GM082798]; NRSA [GM072265]; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003141] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM048405, R01GM082798, F32GM072265, R01GM043901] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NRSA(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank S. K. Bowman and M. D. Simon for discussions and critical reading of the manuscript. Funding for this work for R. E. K. and C. J. W. was provided by NIH (GM43901 and HG003141). C. J. W. was supported by NRSA GM072265. P. J. K. and P. V. K. were supported by NIH grant GM082798.	Atchison L, 2003, EMBO J, V22, P1347, DOI 10.1093/emboj/cdg124; Barberi T, 2005, PLOS MED, V2, P554, DOI 10.1371/journal.pmed.0020161; Beckers J, 1998, DEV DYNAM, V213, P1; Bejarano F, 2005, MECH DEVELOP, V122, P1118, DOI 10.1016/j.mod.2005.06.001; Beuchle D, 2001, DEVELOPMENT, V128, P993; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Bracken AP, 2006, GENE DEV, V20, P1123, DOI 10.1101/gad.381706; Brown JL, 2003, DEVELOPMENT, V130, P285, DOI 10.1242/dev.00204; Brown JL, 1998, MOL CELL, V1, P1057, DOI 10.1016/S1097-2765(00)80106-9; Bruggeman SWM, 2005, GENE DEV, V19, P1438, DOI 10.1101/gad.1299305; Cao R, 2005, MOL CELL, V20, P845, DOI 10.1016/j.molcel.2005.12.002; Cavalli G, 1998, CELL, V93, P505, DOI 10.1016/S0092-8674(00)81181-2; Dejardin J, 2005, NATURE, V434, P533, DOI 10.1038/nature03386; Dennis JH, 2007, GENOME RES, V17, P928, DOI 10.1101/gr.5636607; Francis NJ, 2004, SCIENCE, V306, P1574, DOI 10.1126/science.1100576; Garcia E, 1999, EMBO J, V18, P3404, DOI 10.1093/emboj/18.12.3404; Grimaud C, 2006, CHROMOSOME RES, V14, P363, DOI 10.1007/s10577-006-1069-y; Hanson RD, 1999, P NATL ACAD SCI USA, V96, P14372, DOI 10.1073/pnas.96.25.14372; Henikoff S, 2009, GENOME RES, V19, P460, DOI 10.1101/gr.087619.108; Kahn TG, 2006, J BIOL CHEM, V281, P29064, DOI 10.1074/jbc.M605430200; Kallin EM, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000506; Kharchenko PV, 2008, GENOME RES, V18, P1554, DOI 10.1101/gr.075952.107; Kim SY, 2006, DEVELOPMENT, V133, P4957, DOI 10.1242/dev.02677; Ku M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000242; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Lessard J, 1999, GENE DEV, V13, P2691, DOI 10.1101/gad.13.20.2691; Mishra RK, 2001, MOL CELL BIOL, V21, P1311, DOI 10.1128/MCB.21.4.1311-1318.2001; Mito Y, 2007, SCIENCE, V315, P1408, DOI 10.1126/science.1134004; Mohd-Sarip A, 2006, MOL CELL, V24, P91, DOI 10.1016/j.molcel.2006.08.007; Muller J, 2006, CURR OPIN GENET DEV, V16, P476, DOI 10.1016/j.gde.2006.08.005; Negre N, 2006, PLOS BIOL, V4, P917, DOI 10.1371/journal.pbio.0040170; Oktaba K, 2008, DEV CELL, V15, P877, DOI 10.1016/j.devcel.2008.10.005; Papp B, 2006, GENE DEV, V20, P2041, DOI 10.1101/gad.388706; Ramirez-Carrozzi VR, 2009, CELL, V138, P114, DOI 10.1016/j.cell.2009.04.020; Ringrose L, 2004, MOL CELL, V16, P641, DOI 10.1016/j.molcel.2004.10.015; Ringrose L, 2003, DEV CELL, V5, P759, DOI 10.1016/S1534-5807(03)00337-X; Ringrose L, 2007, DEVELOPMENT, V134, P223, DOI 10.1242/dev.02723; Schmitt S, 2005, GENE DEV, V19, P697, DOI 10.1101/gad.326205; Schmitt S, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-218; Schwartz YB, 2007, NAT REV GENET, V8, P9, DOI 10.1038/nrg1981; Schwartz YB, 2006, NAT GENET, V38, P700, DOI 10.1038/ng1817; Sengupta AK, 2004, DEVELOPMENT, V131, P1959, DOI 10.1242/dev.01084; Simon JA, 2009, NAT REV MOL CELL BIO, V10, P697, DOI 10.1038/nrm2763; Sing A, 2009, CELL, V138, P885, DOI 10.1016/j.cell.2009.08.020; Soshnikova N, 2009, SCIENCE, V324, P1320, DOI 10.1126/science.1171468; Squazzo SL, 2006, GENOME RES, V16, P890, DOI 10.1101/gr.5306606; Srinivasan L, 2005, J CELL BIOCHEM, V96, P689, DOI 10.1002/jcb.20562; Stock JK, 2007, NAT CELL BIOL, V9, P1428, DOI 10.1038/ncb1663; Tigli RS, 2009, J TISSUE ENG REGEN M, V3, P348, DOI 10.1002/term.169; Tiwari VK, 2008, GENOME RES, V18, P1171, DOI 10.1101/gr.073452.107; Tolhuis B, 2006, NAT GENET, V38, P694, DOI 10.1038/ng1792; vanderLugt NMT, 1996, MECH DEVELOP, V58, P153, DOI 10.1016/S0925-4773(96)00570-9; Wang L, 2004, MOL CELL, V14, P637, DOI 10.1016/j.molcel.2004.05.009	53	244	259	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 8	2010	140	1					99	110		10.1016/j.cell.2009.12.022	http://dx.doi.org/10.1016/j.cell.2009.12.022			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085705	Bronze, Green Accepted			2022-12-01	WOS:000273391900018
J	Pickrell, JK; Marioni, JC; Pai, AA; Degner, JF; Engelhardt, BE; Nkadori, E; Veyrieras, JB; Stephens, M; Gilad, Y; Pritchard, JK				Pickrell, Joseph K.; Marioni, John C.; Pai, Athma A.; Degner, Jacob F.; Engelhardt, Barbara E.; Nkadori, Everlyne; Veyrieras, Jean-Baptiste; Stephens, Matthew; Gilad, Yoav; Pritchard, Jonathan K.			Understanding mechanisms underlying human gene expression variation with RNA sequencing	NATURE			English	Article							GENOME; CELLS; SEQ; CONTRIBUTE; DISCOVERY; VARIANTS	Understanding the genetic mechanisms underlying natural variation in gene expression is a central goal of both medical and evolutionary genetics, and studies of expression quantitative trait loci (eQTLs) have become an important tool for achieving this goal(1). Although all eQTL studies so far have assayed messenger RNA levels using expression microarrays, recent advances in RNA sequencing enable the analysis of transcript variation at unprecedented resolution. We sequenced RNA from 69 lymphoblastoid cell lines derived from unrelated Nigerian individuals that have been extensively genotyped by the International HapMap Project(2). By pooling data from all individuals, we generated a map of the transcriptional landscape of these cells, identifying extensive use of unannotated untranslated regions and more than 100 new putative protein-coding exons. Using the genotypes from the HapMap project, we identified more than a thousand genes at which genetic variation influences overall expression levels or splicing. We demonstrate that eQTLs near genes generally act by a mechanism involving allele-specific expression, and that variation that influences the inclusion of an exon is enriched within and near the consensus splice sites. Our results illustrate the power of high-throughput sequencing for the joint analysis of variation in transcription, splicing and allele-specific expression across individuals.	[Pickrell, Joseph K.; Marioni, John C.; Pai, Athma A.; Degner, Jacob F.; Nkadori, Everlyne; Veyrieras, Jean-Baptiste; Stephens, Matthew; Gilad, Yoav; Pritchard, Jonathan K.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Engelhardt, Barbara E.] Univ Chicago, Dept Comp Sci, Chicago, IL 60637 USA; [Nkadori, Everlyne; Pritchard, Jonathan K.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Stephens, Matthew] Univ Chicago, Dept Stat, Chicago, IL 60637 USA	University of Chicago; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of Chicago	Pickrell, JK (corresponding author), Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA.	pickrell@uchicago.edu; gilad@uchicago.edu; pritch@uchicago.edu		Edsall, Lee Elizabeth/0000-0002-0326-2829; Engelhardt, Barbara/0000-0002-6139-7334; Marioni, John/0000-0001-9092-0852; Pai, Athma/0000-0002-7995-9948	HHMI; NIH [MH084703-01, GM077959]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077959] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH084703] Funding Source: NIH RePORTER	HHMI(Howard Hughes Medical Institute); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))	We thank D. Gaffney, J. Bell, K. Bullaughey, Y. Guan and other members of the Pritchard, M. Przeworski and Stephens laboratory groups for helpful discussions, M. Domanus and P. Zumbo for sequencing support, and J. Zekos for computational assistance. J. F. D. and A. A. P. are supported by an NIH Training Grant to the University of Chicago. This work was supported by the HHMI and by NIH grants MH084703-01 to J. K. Pritchard and GM077959 to Y. G.	Cheung VG, 2005, NATURE, V437, P1365, DOI 10.1038/nature04244; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Choy E, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000287; Cloonan N, 2008, NAT METHODS, V5, P613, DOI 10.1038/nmeth.1223; Degner JF, 2009, BIOINFORMATICS, V25, P3207, DOI 10.1093/bioinformatics/btp579; Fraser HB, 2009, GENOME RES, V19, P567, DOI 10.1101/gr.083477.108; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Ge B, 2009, NAT GENET, V41, P1216, DOI 10.1038/ng.473; Guan YT, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000279; Huang RS, 2007, P NATL ACAD SCI USA, V104, P9758, DOI 10.1073/pnas.0703736104; Kang HM, 2008, GENETICS, V180, P1909, DOI 10.1534/genetics.108.094201; Kwan T, 2007, GENOME RES, V17, P1210, DOI 10.1101/gr.6281007; Li H, 2008, GENOME RES, V18, P1851, DOI 10.1101/gr.078212.108; Marioni JC, 2008, GENOME RES, V18, P1509, DOI 10.1101/gr.079558.108; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Miller W, 2007, GENOME RES, V17, P1797, DOI 10.1101/gr.6761107; Moffatt MF, 2007, NATURE, V448, P470, DOI 10.1038/nature06014; Mortazavi A, 2008, NAT METHODS, V5, P621, DOI 10.1038/nmeth.1226; Rockman MV, 2006, NAT REV GENET, V7, P862, DOI 10.1038/nrg1964; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Stranger BE, 2007, NAT GENET, V39, P1217, DOI 10.1038/ng2142; Stranger BE, 2005, PLOS GENET, V1, P695, DOI 10.1371/journal.pgen.0010078; Verlaan DJ, 2009, GENOME RES, V19, P118, DOI 10.1101/gr.084798.108; Veyrieras JB, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000214; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang Z, 2009, NAT REV GENET, V10, P57, DOI 10.1038/nrg2484; WATSON J, 2008, MOL BIOL GENE, pCH13; Xie XH, 2005, NATURE, V434, P338, DOI 10.1038/nature03441; Zhao J, 1999, MICROBIOL MOL BIOL R, V63, P405, DOI 10.1128/MMBR.63.2.405-445.1999	29	892	914	1	172	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					768	772		10.1038/nature08872	http://dx.doi.org/10.1038/nature08872			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20220758	Green Accepted			2022-12-01	WOS:000276205000047
J	Nikolaev, VO; Moshkov, A; Lyon, AR; Miragoli, M; Novak, P; Paur, H; Lohse, MJ; Korchev, YE; Harding, SE; Gorelik, J				Nikolaev, Viacheslav O.; Moshkov, Alexey; Lyon, Alexander R.; Miragoli, Michele; Novak, Pavel; Paur, Helen; Lohse, Martin J.; Korchev, Yuri E.; Harding, Sian E.; Gorelik, Julia			beta(2)-Adrenergic Receptor Redistribution in Heart Failure Changes cAMP Compartmentation	SCIENCE			English	Article							PROTEIN-KINASE-A; ADULT CARDIAC MYOCYTES; TRANSGENIC MICE; CYCLIC-AMP; PHOSPHORYLATION; CELL; MICRODOMAINS; HYPERTROPHY; PROPAGATION; SURFACE	The beta(1)- and beta(2)-adrenergic receptors (beta ARs) on the surface of cardiomyocytes mediate distinct effects on cardiac function and the development of heart failure by regulating production of the second messenger cyclic adenosine monophosphate (cAMP). The spatial localization in cardiomyocytes of these bARs, which are coupled to heterotrimeric guanine nucleotide-binding proteins (G proteins), and the functional implications of their localization have been unclear. We combined nanoscale live-cell scanning ion conductance and fluorescence resonance energy transfer microscopy techniques and found that, in cardiomyocytes from healthy adult rats and mice, spatially confined beta(2)AR-induced cAMP signals are localized exclusively to the deep transverse tubules, whereas functional beta(1)ARs are distributed across the entire cell surface. In cardiomyocytes derived from a rat model of chronic heart failure, beta(2)ARs were redistributed from the transverse tubules to the cell crest, which led to diffuse receptor-mediated cAMP signaling. Thus, the redistribution of beta(2)ARs in heart failure changes compartmentation of cAMP and might contribute to the failing myocardial phenotype.	[Nikolaev, Viacheslav O.; Moshkov, Alexey; Lyon, Alexander R.; Miragoli, Michele; Novak, Pavel; Paur, Helen; Harding, Sian E.; Gorelik, Julia] Univ London Imperial Coll Sci Technol & Med, Dept Cardiac Med, Natl Heart & Lung Inst, London SW3 6LY, England; [Nikolaev, Viacheslav O.; Lohse, Martin J.] Univ Wurzburg, Inst Pharmacol & Toxicol, D-97078 Wurzburg, Germany; [Nikolaev, Viacheslav O.; Lohse, Martin J.] Univ Wurzburg, Rudolf Virchow Ctr, D-97078 Wurzburg, Germany; [Novak, Pavel; Korchev, Yuri E.] Univ London Imperial Coll Sci Technol & Med, Div Med, London W12 0NN, England	Imperial College London; University of Wurzburg; University of Wurzburg; Imperial College London	Gorelik, J (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Cardiac Med, Natl Heart & Lung Inst, Dovehouse St, London SW3 6LY, England.	j.gorelik@imperial.ac.uk	Moshkov, Alexey/AAO-9902-2020; Nikolaev, Vyacheslav/AAT-7746-2020; Novak, Pavel/J-4264-2012; Miragoli, Michele/AAN-7116-2020; Miragoli, Michele/K-6418-2016; Moshkov, Alexey/C-2825-2014; Lohse, Martin J/A-7160-2012; Novak, Pavel/P-8154-2019	Moshkov, Alexey/0000-0002-1858-6738; Novak, Pavel/0000-0002-5461-0344; Miragoli, Michele/0000-0002-4058-4368; Miragoli, Michele/0000-0002-4058-4368; Moshkov, Alexey/0000-0002-1858-6738; Lohse, Martin J/0000-0002-0599-3510; Novak, Pavel/0000-0002-5461-0344; Nikolaev, Viacheslav/0000-0002-7529-5179; Harding, Sian/0000-0002-3651-6354; Gorelik, Julia/0000-0003-1148-9158; Korchev, Yuri/0000-0002-4872-8696	Wellcome Trust [WTN 084064]; Action Medical Research; U.K. Biotechnology and Biological Sciences Research Council; U.K. Medical Research Council; Leducq Foundation; Biotechnology and Biological Sciences Research Council [BB/E52708X/1, BB/D020875/1] Funding Source: researchfish; Medical Research Council [G0500373] Funding Source: researchfish; BBSRC [BB/E52708X/1, BB/D020875/1] Funding Source: UKRI; MRC [G0500373] Funding Source: UKRI	Wellcome Trust(Wellcome TrustEuropean Commission); Action Medical Research; U.K. Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); U.K. Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Leducq Foundation(Leducq Foundation); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))	We thank P. O'Gara for cardiomyocyte isolation; C. Dees for receptor binding assays; and L. Jaffe, F. Klauschen, and S. Gambaryan for critical reading of the manuscript. This study was supported by the Wellcome Trust (WTN 084064 to J.G.), Action Medical Research Grant ( to J.G.), a U.K. Biotechnology and Biological Sciences Research Council grant ( to Y.E.K.), a U.K. Medical Research Council grant ( to J.G. and Y.E.K.) and a grant from Leducq Foundation ( to S. E. H. and M.J.L.). Y.E.K. is a shareholder of, and P.N. has a consultancy agreement with, Ionscope Ltd., a company that sells scanning ion conductance microscopes. The cAMP sensor Epac2-camps used in this study is covered by a patent belonging to the University of Wurzburg. It is being provided at no cost, but with a material transfer agreement, to nonprofit research institutes and universities.	BUXTON ILO, 1983, J BIOL CHEM, V258, P233; Calaghan S, 2008, J MOL CELL CARDIOL, V45, P88, DOI 10.1016/j.yjmcc.2008.04.004; Communal C, 1999, CIRCULATION, V100, P2210, DOI 10.1161/01.CIR.100.22.2210; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; DELMONTE F, 1993, CIRCULATION, V88, P854, DOI 10.1161/01.CIR.88.3.854; DeSantiago J, 2008, CIRC RES, V102, P1389, DOI 10.1161/CIRCRESAHA.107.169011; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P6400, DOI 10.1073/pnas.96.11.6400; Engelhardt S, 1999, P NATL ACAD SCI USA, V96, P7059, DOI 10.1073/pnas.96.12.7059; Fink MA, 2001, CIRC RES, V88, P291, DOI 10.1161/01.RES.88.3.291; Fischmeister R, 2006, CIRC RES, V99, P816, DOI 10.1161/01.RES.0000246118.98832.04; HANSMA PK, 1989, SCIENCE, V243, P641, DOI 10.1126/science.2464851; Head BP, 2005, J BIOL CHEM, V280, P31036, DOI 10.1074/jbc.M502540200; Kaumann A, 1999, CIRCULATION, V99, P65, DOI 10.1161/01.CIR.99.1.65; Korchev YE, 2000, NAT CELL BIOL, V2, P616, DOI 10.1038/35023563; Lohse MJ, 2003, CIRC RES, V93, P896, DOI 10.1161/01.RES.0000102042.83024.CA; Lyon AR, 2009, P NATL ACAD SCI USA, V106, P6854, DOI 10.1073/pnas.0809777106; MILANO CA, 1994, SCIENCE, V264, P582, DOI 10.1126/science.8160017; Mongillo M, 2006, CIRC RES, V98, P226, DOI 10.1161/01.RES.0000200178.34179.93; Nikolaev VO, 2006, CIRC RES, V99, P1084, DOI 10.1161/01.RES.0000250046.69918.d5; Nikolaev VO, 2004, J BIOL CHEM, V279, P37215, DOI 10.1074/jbc.C400302200; Novak P, 2009, NAT METHODS, V6, P279, DOI [10.1038/NMETH.1306, 10.1038/nmeth.1306]; Saucerman JJ, 2006, P NATL ACAD SCI USA, V103, P12923, DOI 10.1073/pnas.0600137103; Soto D, 2009, CIRC RES, V104, P770, DOI 10.1161/CIRCRESAHA.108.187880; Xiang Y, 2003, SCIENCE, V300, P1530, DOI 10.1126/science.1079206; Xiao R P, 2001, Sci STKE, V2001, pre15, DOI 10.1126/stke.2001.104.re15; XIAO RP, 1995, MOL PHARMACOL, V47, P322; Zaccolo M, 2002, SCIENCE, V295, P1711, DOI 10.1126/science.1069982; Zakhary DR, 2000, CIRCULATION, V101, P1459, DOI 10.1161/01.CIR.101.12.1459; Zhu WZ, 2001, P NATL ACAD SCI USA, V98, P1607, DOI 10.1073/pnas.98.4.1607	29	396	411	1	78	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 26	2010	327	5973					1653	1657		10.1126/science.1185988	http://dx.doi.org/10.1126/science.1185988			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20185685				2022-12-01	WOS:000275970600047
J	Salazar-Ciudad, I; Jernvall, J				Salazar-Ciudad, Isaac; Jernvall, Jukka			A computational model of teeth and the developmental origins of morphological variation	NATURE			English	Article							EXPRESSION PATTERNS; MAMMALIAN TEETH; EVOLUTION; SIMULATION; MORPHOGENESIS; DYNAMICS; ONTOGENY	The relationship between the genotype and the phenotype, or the genotype-phenotype map, is generally approached with the tools of multivariate quantitative genetics and morphometrics(1-4). Whereas studies of development(5-7) and mathematical models of development(4,8-12) may offer new insights into the genotype-phenotype map, the challenge is to make them useful at the level of microevolution. Here we report a computational model of mammalian tooth development that combines parameters of genetic and cellular interactions to produce a three-dimensional tooth from a simple tooth primordia. We systematically tinkered with each of the model parameters to generate phenotypic variation and used geometric morphometric analyses to identify, or developmentally ordinate, parameters best explaining population-level variation of real teeth. To model the full range of developmentally possible morphologies, we used a population sample of ringed seals (Phoca hispida ladogensis)(13). Seal dentitions show a high degree of variation, typically linked to the lack of exact occlusion(13-16). Our model suggests that despite the complexity of development and teeth, there may be a simple basis for dental variation. Changes in single parameters regulating signalling during cusp development may explain shape variation among individuals, whereas a parameter regulating epithelial growth may explain serial, tooth-to-tooth variation along the jaw. Our study provides a step towards integrating the genotype, development and the phenotype.	[Salazar-Ciudad, Isaac] Univ Autonoma Barcelona, Dept Genet & Microbiol, Fac Biociencies, E-08193 Barcelona, Spain; [Salazar-Ciudad, Isaac; Jernvall, Jukka] Univ Helsinki, Inst Biotechnol, Dev Biol Program, FIN-00014 Helsinki, Finland; [Jernvall, Jukka] SUNY Stony Brook, Dept Ecol & Evolut, Stony Brook, NY 11794 USA	Autonomous University of Barcelona; University of Helsinki; State University of New York (SUNY) System; SUNY Community College; State University of New York (SUNY) Stony Brook	Salazar-Ciudad, I (corresponding author), Univ Autonoma Barcelona, Dept Genet & Microbiol, Fac Biociencies, E-08193 Barcelona, Spain.	isaac.salazar@uab.cat; jernvall@fastmail.fm	Salazar-Ciudad, Isaac/R-2238-2018	Salazar Ciudad, Isaac/0000-0003-1607-0962	Ramon y Cajal Program [RYC-2007-00149]; Academy of Finland	Ramon y Cajal Program(Spanish Government); Academy of Finland(Academy of Finland)	We thank I. Corfe, A. R. Evans, J. Fierst, M. Fortelius, B. Julia, S. Sova, J. Hakanen, E. Harjunmaa, N. Navarro, I. Thesleff, P. C. Wright and S. Zohdy for comments, discussions, and support on this work, A. Kangas for help in data collection, and M. Hilden and I. Hanski (Finnish Museum of Natural History) for access to collections. This study was supported by the Ramon y Cajal Program (RYC-2007-00149) and the Academy of Finland.	Aberg T, 1997, DEV DYNAM, V210, P383, DOI 10.1002/(SICI)1097-0177(199712)210:4<383::AID-AJA3>3.0.CO;2-C; Buchanan AV, 2009, BIOESSAYS, V31, P198, DOI 10.1002/bies.200800133; BUTLER PM, 1956, BIOL REV, V31, P30, DOI 10.1111/j.1469-185X.1956.tb01551.x; Cruwys L, 2006, POLAR REC, V42, P83, DOI 10.1017/S0032247405004869; Darwin C., 1859, ORIGIN SPECIES MEANS; Evans TM, 2006, EVOL DEV, V8, P273, DOI 10.1111/j.1525-142X.2006.00098.x; Forgacs G, 2005, BIOLOGICAL PHYSICS OF THE DEVELOPING EMBRYO, P1, DOI 10.1017/CBO9780511755576; Fraser GJ, 2009, PLOS BIOL, V7, P233, DOI 10.1371/journal.pbio.1000031; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Hammer O, 2005, LETHAIA, V38, P111, DOI 10.1080/00241160510013222; Harris MP, 2005, P NATL ACAD SCI USA, V102, P11734, DOI 10.1073/pnas.0500781102; Honda H, 2008, DEVELOPMENT, V135, P1407, DOI 10.1242/dev.014555; Jaeger J, 2004, NATURE, V430, P368, DOI 10.1038/nature02678; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P2641, DOI 10.1073/pnas.050586297; Jernvall J, 2000, P NATL ACAD SCI USA, V97, P14444, DOI 10.1073/pnas.97.26.14444; Jernvall Jukka, 1995, Acta Zoologica Fennica, V198, P1; Kassai Y, 2005, SCIENCE, V309, P2067, DOI 10.1126/science.1116848; Kavanagh KD, 2007, NATURE, V449, P427, DOI 10.1038/nature06153; Keller R, 2006, DEVELOPMENT, V133, P2291, DOI 10.1242/dev.02406; Kettunen P, 2000, DEV DYNAM, V219, P322, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1062>3.0.CO;2-J; Lecuit T, 2007, NAT REV MOL CELL BIO, V8, P633, DOI 10.1038/nrm2222; LONNBERG E, 1923, FAUNA FLORA, V18, P116; Luo ZX, 2007, NATURE, V450, P1011, DOI 10.1038/nature06277; McGregor AP, 2007, NATURE, V448, P587, DOI 10.1038/nature05988; Miller CT, 2007, CELL, V131, P1179, DOI 10.1016/j.cell.2007.10.055; Miller EH, 2007, J MAMMAL, V88, P1325, DOI 10.1644/06-MAMM-A-243R.1; Nahmad M, 2008, EVOL DEV, V10, P360, DOI 10.1111/j.1525-142X.2008.00244.x; Newman TJ, 2005, MATH BIOSCI ENG, V2, P613, DOI 10.3934/mbe.2005.2.613; Osborn JW, 2008, J THEOR BIOL, V255, P338, DOI 10.1016/j.jtbi.2008.09.008; Polly PD, 2008, EVOL BIOL, V35, P83, DOI 10.1007/s11692-008-9020-0; Prud'homme B, 2007, P NATL ACAD SCI USA, V104, P8605, DOI 10.1073/pnas.0700488104; Roff DA, 2007, EVOLUTION, V61, P1017, DOI 10.1111/j.1558-5646.2007.00100.x; Rybczynski N, 2009, NATURE, V458, P1021, DOI 10.1038/nature07985; Salazar-Ciudad I, 2000, J THEOR BIOL, V205, P587, DOI 10.1006/jtbi.2000.2092; Salazar-Ciudad I, 2002, P NATL ACAD SCI USA, V99, P8116, DOI 10.1073/pnas.132069499; Salazar-Ciudad I, 2001, EVOL DEV, V3, P84, DOI 10.1046/j.1525-142x.2001.003002084.x; Stewart BE, 1998, MAR MAMMAL SCI, V14, P221, DOI 10.1111/j.1748-7692.1998.tb00712.x; Wagner GP, 2008, NATURE, V452, P470, DOI 10.1038/nature06756; Zeng ZB, 2005, GENETICA, V123, P25, DOI 10.1007/s10709-004-2705-0	39	221	223	1	59	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					583	U138		10.1038/nature08838	http://dx.doi.org/10.1038/nature08838			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20220757				2022-12-01	WOS:000275974200046
J	Barton, AD; Dutkiewicz, S; Flierl, G; Bragg, J; Follows, MJ				Barton, Andrew D.; Dutkiewicz, Stephanie; Flierl, Glenn; Bragg, Jason; Follows, Michael J.			Patterns of Diversity in Marine Phytoplankton	SCIENCE			English	Article							RESOURCE COMPETITION; BIOGEOGRAPHY; GRADIENT; OCEAN; MODEL; COMMUNITIES; SPECIATION	Spatial diversity gradients are a pervasive feature of life on Earth. We examined a global ocean circulation, biogeochemistry, and ecosystem model that indicated a decrease in phytoplankton diversity with increasing latitude, consistent with observations of many marine and terrestrial taxa. In the modeled subpolar oceans, seasonal variability of the environment led to competitive exclusion of phytoplankton with slower growth rates and lower diversity. The relatively weak seasonality of the stable subtropical and tropical oceans in the global model enabled long exclusion time scales and prolonged coexistence of multiple phytoplankton with comparable fitness. Superimposed on the decline in diversity seen from equator to pole were "hot spots" of enhanced diversity in some regions of energetic ocean circulation, which reflected lateral dispersal.	[Barton, Andrew D.; Dutkiewicz, Stephanie; Flierl, Glenn; Follows, Michael J.] MIT, Dept Earth Atmospher & Planetary Sci, Cambridge, MA 02139 USA; [Bragg, Jason] MIT, Dept Civil & Environm Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT); Massachusetts Institute of Technology (MIT)	Barton, AD (corresponding author), MIT, Dept Earth Atmospher & Planetary Sci, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	adbarton@mit.edu	Bragg, Jason/R-5611-2016; Bragg, Jason G/A-4473-2012; Follows, Michael/G-9824-2011; Bragg, Jason/P-7675-2019	Bragg, Jason/0000-0002-7621-7295; Bragg, Jason G/0000-0003-0093-4981; Bragg, Jason/0000-0002-7621-7295; Barton, Andrew/0000-0002-6480-4433	Gordon and Betty Moore Foundation; NASA; NOAA	Gordon and Betty Moore Foundation(Gordon and Betty Moore Foundation); NASA(National Aeronautics & Space Administration (NASA)); NOAA(National Oceanic Atmospheric Admin (NOAA) - USA)	A. D. B., S. D., J.B., and M.J.F. are grateful for support from the Gordon and Betty Moore Foundation's Marine Microbiology Initiative. M.J.F. and S. D. are also grateful for support from NASA and NOAA.	Allen AP, 2006, P NATL ACAD SCI USA, V103, P9130, DOI 10.1073/pnas.0603587103; Cavender-Bares KK, 2001, DEEP-SEA RES PT I, V48, P2373, DOI 10.1016/S0967-0637(01)00027-9; Cermeno P, 2008, P NATL ACAD SCI USA, V105, P20344, DOI 10.1073/pnas.0811302106; Cermeno P, 2008, LIMNOL OCEANOGR, V53, P312, DOI 10.4319/lo.2008.53.1.0312; CURRIE DJ, 1991, AM NAT, V137, P27, DOI 10.1086/285144; Dutkiewicz S, 2009, GLOBAL BIOGEOCHEM CY, V23, DOI 10.1029/2008GB003405; Falkowski PG, 2007, NAT REV MICROBIOL, V5, P813, DOI 10.1038/nrmicro1751; Follows MJ, 2007, SCIENCE, V315, P1843, DOI 10.1126/science.1138544; Fuhrman JA, 2008, P NATL ACAD SCI USA, V105, P7774, DOI 10.1073/pnas.0803070105; GROVER JP, 1990, AM NAT, V136, P771, DOI 10.1086/285131; HANSEN SR, 1980, SCIENCE, V207, P1491; Hillebrand H, 2004, AM NAT, V163, P192, DOI 10.1086/381004; HONJO S, 1974, Micropaleontology (New York), V20, P209, DOI 10.2307/1485061; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1959, AM NAT, V93, P145, DOI 10.1086/282070; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; MAC ARTHUR ROBERT H., 1967; Martiny AC, 2009, ENVIRON MICROBIOL, V11, P823, DOI 10.1111/j.1462-2920.2008.01803.x; Martiny JBH, 2006, NAT REV MICROBIOL, V4, P102, DOI 10.1038/nrmicro1341; Mittelbach GG, 2007, ECOL LETT, V10, P315, DOI 10.1111/j.1461-0248.2007.01020.x; Pommier T, 2007, MOL ECOL, V16, P867, DOI 10.1111/j.1365-294X.2006.03189.x; Ptacnik R, 2008, P NATL ACAD SCI USA, V105, P5134, DOI 10.1073/pnas.0708328105; STEWART FM, 1973, AM NAT, V107, P171, DOI 10.1086/282825; TILMAN D, 1981, ECOLOGY, V62, P802, DOI 10.2307/1937747	25	230	234	10	175	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 19	2010	327	5972					1509	1511		10.1126/science.1184961	http://dx.doi.org/10.1126/science.1184961			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570YQ	20185684	Green Published			2022-12-01	WOS:000275715200048
J	Collinet, C; Stoter, M; Bradshaw, CR; Samusik, N; Rink, JC; Kenski, D; Habermann, B; Buchholz, F; Henschel, R; Mueller, MS; Nagel, WE; Fava, E; Kalaidzidis, Y; Zerial, M				Collinet, Claudio; Stoeter, Martin; Bradshaw, Charles R.; Samusik, Nikolay; Rink, Jochen C.; Kenski, Denise; Habermann, Bianca; Buchholz, Frank; Henschel, Robert; Mueller, Matthias S.; Nagel, Wolfgang E.; Fava, Eugenio; Kalaidzidis, Yannis; Zerial, Marino			Systems survey of endocytosis by multiparametric image analysis	NATURE			English	Article							MEDIATED ENDOCYTOSIS; SIGNAL-TRANSDUCTION; CELL BIOLOGY; ENDOSOMES; CYTOKINESIS; SPECIFICITY; MECHANISMS; PROTEINS; GRADIENT; SCREEN	Endocytosis is a complex process fulfilling many cellular and developmental functions. Understanding how it is regulated and integrated with other cellular processes requires a comprehensive analysis of its molecular constituents and general design principles. Here, we developed a new strategy to phenotypically profile the human genome with respect to transferrin (TF) and epidermal growth factor (EGF) endocytosis by combining RNA interference, automated high-resolution confocal microscopy, quantitative multiparametric image analysis and high-performance computing. We identified several novel components of endocytic trafficking, including genes implicated in human diseases. We found that signalling pathways such as Wnt, integrin/cell adhesion, transforming growth factor (TGF)-beta and Notch regulate the endocytic system, and identified new genes involved in cargo sorting to a subset of signalling endosomes. A systems analysis by Bayesian networks further showed that the number, size, concentration of cargo and intracellular position of endosomes are not determined randomly but are subject to specific regulation, thus uncovering novel properties of the endocytic system.	[Collinet, Claudio; Bradshaw, Charles R.; Samusik, Nikolay; Habermann, Bianca; Buchholz, Frank; Kalaidzidis, Yannis; Zerial, Marino] MPI CBG, Max Planck Inst Mol Cell Biol & Genet, D-01307 Dresden, Germany; [Henschel, Robert; Mueller, Matthias S.; Nagel, Wolfgang E.] Tech Univ Dresden, Ctr Informat Serv & High Performance Comp ZIH, D-01062 Dresden, Germany; [Kalaidzidis, Yannis] Moscow MV Lomonosov State Univ, Belozersky Inst Physicochem Biol, Moscow 119899, Russia	Max Planck Society; Technische Universitat Dresden; Lomonosov Moscow State University	Zerial, M (corresponding author), MPI CBG, Max Planck Inst Mol Cell Biol & Genet, Pfotenhauerstr 108, D-01307 Dresden, Germany.	zerial@mpi-cbg.de	Habermann, Bianca/N-4886-2016; Buchholz, Frank/B-4700-2017; Kalaidzidis, Yannis/H-3094-2016	Habermann, Bianca/0000-0002-2457-7504; Buchholz, Frank/0000-0002-4577-3344; Kalaidzidis, Yannis/0000-0002-6137-1193; Collinet, Claudio/0000-0002-8532-2601; Fava, Eugenio/0000-0002-3737-0334; Bradshaw, Charles/0000-0002-3528-458X	Max Planck Society (MPG); HepatoSys of the German Ministry for Education and Research BMBF; DFG; Gottlieb Daimler und Karl Benz Stiftung; European Community	Max Planck Society (MPG)(Max Planck Society); HepatoSys of the German Ministry for Education and Research BMBF(Federal Ministry of Education & Research (BMBF)); DFG(German Research Foundation (DFG)); Gottlieb Daimler und Karl Benz Stiftung; European Community(European Commission)	We acknowledge T. Galvez and G. Marsico, members of the Zerial group for discussions and scientific support. We are particularly indebted to K. Korn who developed transfection protocols and organized various preparatory steps and logistics before the screen and E. Krausz for the management of the HT-TDS, the MPI-CBG screening facility. We thank J. Schmitt, A. Lohmann, S. Christ, N. Tomschke, A. Niederlein, J. Wagner, M. Gierth, E. Krausz for technical, robotics and computational assistance, and M. Boes and J. Oegema for IT support that made the large-scale computational analysis possible. We acknowledge I. C. Baines, T. Galvez, J. Howard, T. Hyman, M. McShane, G. O'Sullivan and P. Tomancak for comments on themanuscript. This work was financially supported by the Max Planck Society (MPG) and by the systems biology network HepatoSys of the German Ministry for Education and Research BMBF, the DFG and the Gottlieb Daimler und Karl Benz Stiftung. This work is also part of the project 'Endotrack', which received research funding from the European Community's Sixth Framework Programme.	Baluska F, 2006, DEV BIOL, V294, P1, DOI 10.1016/j.ydbio.2006.02.047; Baskys A, 2007, ANN NY ACAD SCI, V1122, P313, DOI 10.1196/annals.1403.023; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Blank U, 2008, BLOOD, V111, P492, DOI 10.1182/blood-2007-07-075168; Burgdorf S, 2008, CURR OPIN IMMUNOL, V20, P89, DOI 10.1016/j.coi.2007.12.002; Carlton JG, 2007, SCIENCE, V316, P1908, DOI 10.1126/science.1143422; Cullen BR, 2006, NAT METHODS, V3, P677, DOI 10.1038/NMETH913; Dudu V, 2004, CURR OPIN CELL BIOL, V16, P407, DOI 10.1016/j.ceb.2004.06.008; Echeverri CJ, 2006, NAT METHODS, V3, P777, DOI 10.1038/nmeth1006-777; Entchev EV, 2002, TRAFFIC, V3, P98, DOI 10.1034/j.1600-0854.2002.030203.x; Friedman A, 2006, NATURE, V444, P230, DOI 10.1038/nature05280; FUKUNAGA K, 1975, IEEE T INFORM THEORY, V21, P32, DOI 10.1109/TIT.1975.1055330; Gagliardi M, 2008, TRAFFIC, V9, P1, DOI 10.1111/j.1600-0854.2007.00662.x; Galvez T, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r142; Gruenberg J, 2006, NAT REV MOL CELL BIO, V7, P495, DOI 10.1038/nrm1959; Habermann B, 2004, EMBO REP, V5, P250, DOI 10.1038/sj.embor.7400105; Hayakawa A, 2007, BIOCHEM SOC SYMP, V74, P95, DOI 10.1042/BSS2007c09; Heldin CH, 2009, CURR OPIN CELL BIOL, V21, P166, DOI 10.1016/j.ceb.2009.01.021; Hill E, 2000, EMBO J, V19, P5711, DOI 10.1093/emboj/19.21.5711; Huang SS, 2005, J CELL BIOCHEM, V96, P447, DOI 10.1002/jcb.20558; Kermorgant S, 2008, J CELL BIOL, V182, P855, DOI 10.1083/jcb.200806076; Kittler R, 2007, NAT METHODS, V4, P337, DOI 10.1038/NMETH1025; Konig R, 2007, NAT METHODS, V4, P847, DOI 10.1038/NMETH1089; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Le Borgne R, 2006, CURR OPIN CELL BIOL, V18, P213, DOI 10.1016/j.ceb.2006.02.011; Marsh M, 1999, SCIENCE, V285, P215, DOI 10.1126/science.285.5425.215; Miaczynska M, 2004, CURR OPIN CELL BIOL, V16, P400, DOI 10.1016/j.ceb.2004.06.005; Miaczynska M, 2004, CELL, V116, P445, DOI 10.1016/S0092-8674(04)00117-5; Motley A, 2003, J CELL BIOL, V162, P909, DOI 10.1083/jcb.200305145; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; Pagano RE, 2000, TRAFFIC, V1, P807, DOI 10.1034/j.1600-0854.2000.011101.x; Pearl J., 1988, PROBABILISTIC REASON, DOI [10.1016/C2009-0-27609-4, DOI 10.1016/C2009-0-27609-4, 10.1016/B978-0-08-051489-5.50008-4]; Pelkmans L, 2005, NATURE, V436, P78, DOI 10.1038/nature03571; Perrimon N, 2007, GENETICS, V175, P7, DOI 10.1534/genetics.106.069963; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Piper RC, 2007, ANNU REV CELL DEV BI, V23, P519, DOI 10.1146/annurev.cellbio.23.090506.123319; Polo S, 2006, CELL, V124, P897, DOI 10.1016/j.cell.2006.02.025; Rink J, 2005, CELL, V122, P735, DOI 10.1016/j.cell.2005.06.043; Santos SDM, 2007, NAT CELL BIOL, V9, P324, DOI 10.1038/ncb1543; Schenck A, 2008, CELL, V133, P486, DOI 10.1016/j.cell.2008.02.044; Schnatwinkel C, 2004, PLOS BIOL, V2, P1363, DOI 10.1371/journal.pbio.0020261; Sigismund S, 2005, P NATL ACAD SCI USA, V102, P2760, DOI 10.1073/pnas.0409817102; Stenmark H, 2009, NAT REV MOL CELL BIO, V10, P513, DOI 10.1038/nrm2728; Weinmaster G, 2000, CURR OPIN GENET DEV, V10, P363, DOI 10.1016/S0959-437X(00)00097-6	44	317	327	1	52	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					243	U123		10.1038/nature08779	http://dx.doi.org/10.1038/nature08779			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20190736				2022-12-01	WOS:000275366100039
J	Bertrand, JY; Chi, NC; Santoso, B; Teng, ST; Stainier, DYR; Traver, D				Bertrand, Julien Y.; Chi, Neil C.; Santoso, Buyung; Teng, Shutian; Stainier, Didier Y. R.; Traver, David			Haematopoietic stem cells derive directly from aortic endothelium during development	NATURE			English	Article							ZEBRAFISH; EXPRESSION; ADULT; BLOOD	A major goal of regenerative medicine is to instruct formation of multipotent, tissue-specific stem cells from induced pluripotent stem cells (iPSCs) for cell replacement therapies. Generation of haematopoietic stem cells (HSCs) from iPSCs or embryonic stem cells (ESCs) is not currently possible, however, necessitating a better understanding of how HSCs normally arise during embryonic development. We previously showed that haematopoiesis occurs through four distinct waves during zebrafish development, with HSCs arising in the final wave in close association with the dorsal aorta. Recent reports have suggested that murine HSCs derive from haemogenic endothelial cells (ECs) lining the aortic floor(1,2). Additional in vitro studies have similarly indicated that the haematopoietic progeny of ESCs arise through intermediates with endothelial potential(3,4). Here we have used the unique strengths of the zebrafish embryo to image directly the generation of HSCs from the ventral wall of the dorsal aorta. Using combinations of fluorescent reporter transgenes, confocal time-lapse microscopy and flow cytometry, we have identified and isolated the stepwise intermediates as aortic haemogenic endothelium transitions to nascent HSCs. Finally, using a permanent lineage tracing strategy, we demonstrate that the HSCs generated from haemogenic endothelium are the lineal founders of the adult haematopoietic system.	[Bertrand, Julien Y.; Santoso, Buyung; Teng, Shutian; Traver, David] Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92093 USA; [Bertrand, Julien Y.; Santoso, Buyung; Teng, Shutian; Traver, David] Univ Calif San Diego, Sect Cell & Dev Biol, San Diego, CA 92093 USA; [Chi, Neil C.] Univ Calif San Diego, Dept Med, San Diego, CA 92093 USA; [Chi, Neil C.; Stainier, Didier Y. R.] Univ Calif San Francisco, Dept Biochem & Biophys, San Francisco, CA 94158 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Francisco	Traver, D (corresponding author), Univ Calif San Diego, Dept Cellular & Mol Med, San Diego, CA 92093 USA.	dtraver@ucsd.edu	BERTRAND, Julien/O-3655-2019	BERTRAND, Julien/0000-0001-6570-4082; Stainier, Didier/0000-0002-0382-0026	Cancer Research Institute; California Institute for Regenerative Medicine (CIRM); National Institutes of Health (NIH) [HL074891, F32DK752433, HL54737, DK074482]; GlaxoSmithKline; American Heart Association; Packard Foundation; American Society of Hematology; CIRM; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K08HL074891, R01HL054737] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074482] Funding Source: NIH RePORTER	Cancer Research Institute; California Institute for Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); GlaxoSmithKline(GlaxoSmithKline); American Heart Association(American Heart Association); Packard Foundation(The David & Lucile Packard Foundation); American Society of Hematology; CIRM(California Institute for Regenerative Medicine); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))	We thank S. Lin for providing kdrl: RFP animals. J.Y.B. was supported by the Irvington program of the Cancer Research Institute and by the California Institute for Regenerative Medicine (CIRM), N.C.C. by National Institutes of Health (NIH) HL074891, a Research and Education Foundation Award from GlaxoSmithKline and a Beginning Grant in Aid Award from the American Heart Association, B. S. by NIH F32DK752433, D.Y.R.S. by the Packard Foundation and NIH HL54737, and D. T. by a Scholar Award from the American Society of Hematology, a New Investigator Award from CIRM, and NIH DK074482.	Beis D, 2005, DEVELOPMENT, V132, P4193, DOI 10.1242/dev.01970; Bertrand JY, 2008, DEVELOPMENT, V135, P1853, DOI 10.1242/dev.015297; Bertrand JY, 2005, P NATL ACAD SCI USA, V102, P134, DOI 10.1073/pnas.0402270102; Bussmann J, 2007, PLOS GENET, V3, P1425, DOI 10.1371/journal.pgen.0030140; Chen MJ, 2009, NATURE, V457, P887, DOI 10.1038/nature07619; Chi NC, 2008, GENE DEV, V22, P734, DOI 10.1101/gad.1629408; Choi J, 2007, DEV BIOL, V304, P735, DOI 10.1016/j.ydbio.2007.01.023; Ciau-Uitz A, 2000, CELL, V102, P787, DOI 10.1016/S0092-8674(00)00067-2; Cumano A, 2007, ANNU REV IMMUNOL, V25, P745, DOI 10.1146/annurev.immunol.25.022106.141538; de Bruijn MFTR, 2000, EMBO J, V19, P2465, DOI 10.1093/emboj/19.11.2465; Dzierzak E, 2008, NAT IMMUNOL, V9, P129, DOI 10.1038/ni1560; Eilken HM, 2009, NATURE, V457, P896, DOI 10.1038/nature07760; Feng H, 2007, BRIT J HAEMATOL, V138, P169, DOI 10.1111/j.1365-2141.2007.06625.x; Huang HG, 2005, BMC DEV BIOL, V5, DOI 10.1186/1471-213X-5-7; Jaffredo T, 1998, DEVELOPMENT, V125, P4575; Kawakami K, 2004, DEV CELL, V7, P133, DOI 10.1016/j.devcel.2004.06.005; Kissa K, 2008, BLOOD, V111, P1147, DOI 10.1182/blood-2007-07-099499; Lancrin C, 2009, NATURE, V457, P892, DOI 10.1038/nature07679; Liao W, 1997, DEVELOPMENT, V124, P381; MacPherson D, 2004, GENE DEV, V18, P1681, DOI 10.1101/gad.1203304; Mikkola HKA, 2003, BLOOD, V101, P508, DOI 10.1182/blood-2002-06-1699; Murry CE, 2008, CELL, V132, P661, DOI 10.1016/j.cell.2008.02.008; North TE, 2007, NATURE, V447, P1007, DOI 10.1038/nature05883; Rozen S, 2000, Methods Mol Biol, V132, P365; Traver D, 2003, NAT IMMUNOL, V4, P1238, DOI 10.1038/ni1007; Westerfield M, 1994, ZEBRAFISH BOOK GUIDE; Zovein AC, 2008, CELL STEM CELL, V3, P625, DOI 10.1016/j.stem.2008.09.018	27	688	708	3	91	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					108	U120		10.1038/nature08738	http://dx.doi.org/10.1038/nature08738			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20154733	Green Accepted			2022-12-01	WOS:000275117500043
J	Green, SM; Mason, KP				Green, Steven M.; Mason, Keira P.			Reformulation of the Sedation Continuum	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PROCEDURAL SEDATION; ANALGESIA		[Green, Steven M.] Loma Linda Univ, Med Ctr, Dept Emergency Med, Loma Linda, CA 92354 USA; [Green, Steven M.] Childrens Hosp, Loma Linda, CA USA; [Mason, Keira P.] Childrens Hosp, Dept Anesthesiol, Boston, MA 02115 USA; [Mason, Keira P.] Harvard Univ, Sch Med, Boston, MA USA	Loma Linda University; Children's Hospital Los Angeles; Harvard University; Boston Children's Hospital; Harvard University; Harvard Medical School	Green, SM (corresponding author), Loma Linda Univ, Med Ctr, Dept Emergency Med, A-108,11234 Anderson St, Loma Linda, CA 92354 USA.	steve@viridissimo.com	Mason, Keira/AAS-4734-2020; Mason, Keira/GZN-2525-2022	Mason, Keira/0000-0002-9375-7816; 				[Anonymous], 1985, PEDIATRICS, V76, P317; BERNSTEIN MJ, 1985, JAMA-J AM MED ASSOC, V254, P1073; Casamassimo P, 2006, PEDIATRICS, V118, P2587, DOI 10.1542/peds.2006-2780; Cravero JP, 2004, ANESTH ANALG, V99, P1355, DOI 10.1213/01.ANE.0000134810.60270.E8; Green SM, 2008, ANN EMERG MED, V52, P392, DOI 10.1016/j.annemergmed.2007.12.002; Green SM, 2008, ANN EMERG MED, V52, P9, DOI 10.1016/j.annemergmed.2007.12.001; Gross JB, 2002, ANESTHESIOLOGY, V96, P1004; *JOINT COMM, SED AN CAR STAND; Krauss B, 2008, PEDIATR ANESTH, V18, P30, DOI 10.1111/j.1460-9592.2007.02406.x; Krauss B, 2007, ANN EMERG MED, V50, P172, DOI 10.1016/j.annemergmed.2006.10.016	10	20	21	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 3	2010	303	9					876	877		10.1001/jama.2010.217	http://dx.doi.org/10.1001/jama.2010.217			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	562NU	20197535				2022-12-01	WOS:000275059500022
J	Clark, JS				Clark, James S.			Individuals and the Variation Needed for High Species Diversity in Forest Trees	SCIENCE			English	Article							LONG-TERM; COEXISTENCE; COMPETITION; NEUTRALITY; NICHE; MECHANISMS; TRADEOFFS; STABILITY	In the past, explanations for high species diversity have been sought at the species level. Theory shows that coexistence requires substantial differences between species, but species-level data rarely provide evidence for such differences. Using data from forests in the southeastern United States, I show here that variation evident at the individual level provides for coexistence of large numbers of competitors. Variation among individuals within populations allows species to differ in their distributions of responses to the environment, despite the fact that the populations to which they belong do not differ, on average. Results are consistent with theory predicting that coexistence depends on competition being stronger within than between species, shown here by analysis of individual-level responses to environmental fluctuation.	[Clark, James S.] Duke Univ, Nicholas Sch Environm, Dept Biol, Durham, NC 27708 USA; [Clark, James S.] Duke Univ, Dept Stat Sci, Durham, NC 27708 USA	Duke University; Duke University	Clark, JS (corresponding author), Duke Univ, Nicholas Sch Environm, Dept Biol, Durham, NC 27708 USA.	jimclark@duke.edu	Clark, James S./G-6331-2011					Adler PB, 2006, P NATL ACAD SCI USA, V103, P12793, DOI 10.1073/pnas.0600599103; Angert AL, 2009, P NATL ACAD SCI USA, V106, P11641, DOI 10.1073/pnas.0904512106; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; Clark JS, 2007, ECOL LETT, V10, P647, DOI 10.1111/j.1461-0248.2007.01041.x; Clark JS, 2004, ECOL MONOGR, V74, P415, DOI 10.1890/02-4093; Clark JS, 2003, NATURE, V423, P635, DOI 10.1038/nature01632; CLARK JS, 2010, HDB BAYESIAN ANAL, P431; Condit R, 2006, SCIENCE, V313, P98, DOI 10.1126/science.1124712; CONNELL J H, 1971, P298; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; HUTCHINSON GE, 1961, AM NAT, V95, P137, DOI 10.1086/282171; JANZEN DH, 1970, AM NAT, V104, P501, DOI 10.1086/282687; LEVIN SA, 1970, AM NAT, V104, P413, DOI 10.1086/282676; LEVINS R, 1979, AM NAT, V114, P765, DOI 10.1086/283527; MACARTHUR RH, 1964, P NATL ACAD SCI USA, V51, P1207, DOI 10.1073/pnas.51.6.1207; McDowell N, 2008, NEW PHYTOL, V178, P719, DOI 10.1111/j.1469-8137.2008.02436.x; Mohan JE, 2007, ECOL APPL, V17, P1198, DOI 10.1890/05-1690; Rees M, 2001, SCIENCE, V293, P650, DOI 10.1126/science.1062586; Silvertown J, 2004, TRENDS ECOL EVOL, V19, P605, DOI 10.1016/j.tree.2004.09.003; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; TILMAN D, 1988; Zillio T, 2007, OIKOS, V116, P931, DOI 10.1111/j.2007.0030-1299.15662.x	24	249	260	6	168	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1129	1132		10.1126/science.1183506	http://dx.doi.org/10.1126/science.1183506			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185724				2022-12-01	WOS:000274901100036
J	Herrero, M; Thornton, PK; Notenbaert, AM; Wood, S; Msangi, S; Freeman, HA; Bossio, D; Dixon, J; Peters, M; van de Steeg, J; Lynam, J; Rao, PP; Macmillan, S; Gerard, B; McDermott, J; Sere, C; Rosegrant, M				Herrero, M.; Thornton, P. K.; Notenbaert, A. M.; Wood, S.; Msangi, S.; Freeman, H. A.; Bossio, D.; Dixon, J.; Peters, M.; van de Steeg, J.; Lynam, J.; Rao, P. Parthasarathy; Macmillan, S.; Gerard, B.; McDermott, J.; Sere, C.; Rosegrant, M.			Smart Investments in Sustainable Food Production: Revisiting Mixed Crop-Livestock Systems	SCIENCE			English	Editorial Material							INTENSIFICATION; SCIENCE	Farmers in mixed crop-livestock systems produce about half of the world's food. In small holdings around the world, livestock are reared mostly on grass, browse, and nonfood biomass from maize, millet, rice, and sorghum crops and in their turn supply manure and traction for future crops. Animals act as insurance against hard times, and supply farmers with a source of regular income from sales of milk, eggs, and other products. Thus, faced with population growth and climate change, small-holder farmers should be the first target for policies to intensify production by carefully managed inputs of fertilizer, water, and feed to minimize waste and environmental impact, supported by improved access to markets, new varieties, and technologies.	[Herrero, M.; Thornton, P. K.; Notenbaert, A. M.; van de Steeg, J.; Macmillan, S.; McDermott, J.; Sere, C.] ILRI, Nairobi, Kenya; [Wood, S.; Msangi, S.; Rosegrant, M.] IFPRI, Washington, DC 20006 USA; [Freeman, H. A.] Int Finance Corp, World Bank Grp, Washington, DC 20433 USA; [Bossio, D.] IWMI, Colombo, Sri Lanka; [Dixon, J.] Australian Ctr Int Agr Res, Canberra, ACT, Australia; [Peters, M.] CIAT, Cali, Colombia; [Rao, P. Parthasarathy] Int Crops Res Inst Semi Arid Trop, Hyderabad, Andhra Pradesh, India; [Gerard, B.] CGIAR Syst Wide Livestock Programme, Addis Ababa, Ethiopia	CGIAR; International Livestock Research Institute (ILRI); CGIAR; International Food Policy Research Institute (IFPRI); The World Bank; CGIAR; International Water Management Institute (IWMI); Alliance; International Center for Tropical Agriculture - CIAT; CGIAR; International Crops Research Institute for the Semi-Arid-Tropics (ICRISAT); CGIAR	Herrero, M (corresponding author), ILRI, POB 30709, Nairobi, Kenya.	m.herrero@cgiar.org	Gerard, Bruno/AAG-6592-2019; Herrero, Mario/A-6678-2015; Thornton, Philip/AAB-8806-2020	Gerard, Bruno/0000-0002-1079-7493; Herrero, Mario/0000-0002-7741-5090; Thornton, Philip/0000-0002-1854-0182; Notenbaert, An Maria Omer/0000-0002-6266-2240	CGIAR Systemwide Livestock Programme; Canadian International Development Agency; World Bank; Swiss Agency for Development and Cooperation	CGIAR Systemwide Livestock Programme(CGIAR); Canadian International Development Agency; World Bank(The World Bank India); Swiss Agency for Development and Cooperation	This work was funded by the CGIAR Systemwide Livestock Programme. We acknowledge support from the Canadian International Development Agency, the World Bank, and the Swiss Agency for Development and Cooperation. We also thank M. Blummel, W. Thorpe, S. Staal, and S. Tarawali for useful discussions on the topic.	[Anonymous], 2008, INT TRADE CLIMATE CH; Blummel M., 2006, Journal of SAT Agricultural Research, V2, P1; Carpenter SR, 2009, P NATL ACAD SCI USA, V106, P1305, DOI 10.1073/pnas.0808772106; Conant RT, 2002, GLOBAL BIOGEOCHEM CY, V16, DOI 10.1029/2001GB001661; Delgado C., 1999, 28 IFPRIFAOILRI; DIXON J, 2009, FEED FOOD FUEL COMPE; Dixon J, 2009, DRIVERS CHANGE CROP; EEA, 2009, ANN EUR COMM GREENH; Fan SG, 2001, AM J AGR ECON, V83, P1217, DOI 10.1111/0002-9092.00270; FAO, 2007, STAT FOOD AGR PAYING; Gerber P, 2005, BIORESOURCE TECHNOL, V96, P263, DOI 10.1016/j.biortech.2004.05.016; *IEG, 2007, WORLD BANK ASS AGR S; Immerzeel W, 2008, AGR SYST, V96, P52, DOI 10.1016/j.agsy.2007.05.005; *INT ASS AGR SCI T, 2009, GLOB REP; Kiers ET, 2008, SCIENCE, V320, P320, DOI 10.1126/science.1158390; Lal R, 2004, SCIENCE, V304, P1623, DOI 10.1126/science.1097396; Matson PA, 1997, SCIENCE, V277, P504, DOI 10.1126/science.277.5325.504; Millennium Ecosystem Assessment, 2005, EC HUM WELL BEING SC, V2; Molden D, 2007, WATER FOOD WATER LIF; Morton DC, 2006, P NATL ACAD SCI USA, V103, P14637, DOI 10.1073/pnas.0606377103; Parry M.L., 2007, CONTRIBUTION WORKING; Perry B, 2007, SCIENCE, V315, P333, DOI 10.1126/science.1138614; ROSEGRANT M, 2009, AGR CROSSROADS; Steinfeld H., 2006, LIVESTOCKS LONG SHAD, DOI [10.1890/1540-9295(2007)5[4:D]2.0.CO;2, DOI 10.1890/1540-9295(2007)5[4:D]2.0.CO;2]; The Royal Society, 2009, 1109 RS; Tittonell P, 2009, AGR SYST, V101, P1, DOI 10.1016/j.agsy.2009.02.003; United Nations Environment Programme, 2007, GLOB ENV OUTL; Waithaka MM, 2006, AGR SYST, V90, P243, DOI 10.1016/j.agsy.2005.12.007; Wani S.P., 2009, RAINFED AGR UNLOCKIN	29	482	500	15	316	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					822	825		10.1126/science.1183725	http://dx.doi.org/10.1126/science.1183725			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20150490	Green Accepted			2022-12-01	WOS:000274408300047
J	Malekpour, M; Esfandbod, M				Malekpour, Mahdi; Esfandbod, Mohsen			Cutaneous Leishmaniasis	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									[Malekpour, Mahdi; Esfandbod, Mohsen] Univ Tehran Med Sci, Tehran, Iran	Tehran University of Medical Sciences	Malekpour, M (corresponding author), Univ Tehran Med Sci, Tehran, Iran.	sfandbod@sina.tums.ac.ir	Malekpour, Mahdi/B-6174-2009	Malekpour, Mahdi/0000-0002-7337-3479; Esfandbod, Mohsen/0000-0002-6497-2306					0	2	2	0	0	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					E15	E15		10.1056/NEJMicm0808917	http://dx.doi.org/10.1056/NEJMicm0808917			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147710				2022-12-01	WOS:000274397200012
J	Mostertz, W; Stevenson, M; Acharya, C; Chan, I; Walters, K; Lamlertthon, W; Barry, W; Crawford, J; Nevins, J; Potti, A				Mostertz, William; Stevenson, Marvaretta; Acharya, Chaitanya; Chan, Isaac; Walters, Kelli; Lamlertthon, Wisut; Barry, William; Crawford, Jeffrey; Nevins, Joseph; Potti, Anil			Age- and Sex-Specific Genomic Profiles in Non-Small Cell Lung Cancer	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							GENE-EXPRESSION PROFILES; BREAST-CANCER; ADENOCARCINOMA; SIGNATURES; SURVIVAL; WOMEN; EPIDEMIOLOGY; PROGNOSIS; THERAPY; CLASSIFICATION	Context Gene expression profiling may be useful in examining differences underlying age- and sex-specific outcomes in non-small cell lung cancer (NSCLC). Objective To describe clinically relevant differences in the underlying biology of NSCLC based on patient age and sex. Design, Setting, and Patients Retrospective analysis of 787 patients with predominantly early stage NSCLC performed at Duke University, Durham, North Carolina, from July 2008 to June 2009. Lung tumor samples with corresponding microarray and clinical data were used. All patients were divided into subgroups based on age (<70 vs >= 70 years old) or sex. Gene expression signatures representing oncogenic pathway activation and tumor biology/microenvironment status were applied to these samples to obtain patterns of activation/deregulation. Main Outcome Measures Patterns of oncogenic and molecular signaling pathway activation that are reproducible and correlate with 5-year recurrence-free patient survival. Results Low-and high-risk patient clusters/cohorts were identified with the longest and shortest 5-year recurrence-free survival, respectively, within the age and sex NSCLC subgroups. These cohorts of NSCLC demonstrate similar patterns of pathway activation. In patients younger than 70 years, high-risk patients, with the shortest recurrence-free survival, demonstrated increased activation of the Src (25% vs 6%; P<.001) and tumor necrosis factor (76% vs 42%; P<.001) pathways compared with low-risk patients. High-risk patients aged 70 years or older demonstrated increased activation of the wound healing (40% vs 24%; P=.02) and invasiveness (64% vs 20%; P<.001) pathways compared with low-risk patients. In women, high-risk patients demonstrated increased activation of the invasiveness (99% vs 2%; P<.001) and STAT3 (72% vs 35%; P<.001) pathways while high-risk men demonstrated increased activation of the STAT3 (87% vs 18%; P<.001), tumor necrosis factor (90% vs 46%; P<.001), EGFR (13% vs 2%; P=.003), and wound healing (50% vs 22%; P<.001) pathways. Multivariate analyses confirmed the independent clinical relevance of the pathway-based subphenotypes in women (hazard ratio [HR], 2.02; 95% confidence interval [CI], 1.34-3.03; P<.001) and patients younger than 70 years (HR, 1.83; 95% CI, 1.24-2.71; P=.003). All observations were reproducible in split sample analyses. Conclusions Among a cohort of patients with NSCLC, subgroups defined by oncogenic pathway activation profiles were associated with recurrence-free survival. These findings require validation in independent patient data sets. JAMA. 2010; 303(6): 535-543	[Mostertz, William; Stevenson, Marvaretta; Acharya, Chaitanya; Chan, Isaac; Walters, Kelli; Lamlertthon, Wisut; Nevins, Joseph; Potti, Anil] Duke Univ, Inst Genome Sci & Policy, Durham, NC 27708 USA; [Stevenson, Marvaretta; Crawford, Jeffrey; Potti, Anil] Duke Univ, Div Oncol, Dept Med, Durham, NC 27708 USA; [Barry, William] Duke Univ, Dept Computat Biol & Bioinformat, Durham, NC 27708 USA	Duke University; Duke University; Duke University	Potti, A (corresponding author), Duke Univ, Inst Genome Sci & Policy, Box 3382,101 Sci Dr, Durham, NC 27708 USA.	anil.potti@duke.edu	Acharya, Chaitanya/T-3510-2019	Chan, Isaac/0000-0003-2623-3163	Emilene Brown Cancer Research Fund; Harold and Linda Chapman Lung Cancer Fund; Jimmy V Foundation; American Cancer Society; National Cancer Institute	Emilene Brown Cancer Research Fund; Harold and Linda Chapman Lung Cancer Fund; Jimmy V Foundation; American Cancer Society(American Cancer Society); National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	This study was supported by research grants from the Emilene Brown Cancer Research Fund, the Harold and Linda Chapman Lung Cancer Fund, the Jimmy V Foundation, the American Cancer Society, and the National Cancer Institute.	Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Beer DG, 2002, NAT MED, V8, P816, DOI 10.1038/nm733; Bhattacharjee A, 2001, P NATL ACAD SCI USA, V98, P13790, DOI 10.1073/pnas.191502998; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bild AH, 2006, NAT REV CANCER, V6, P735, DOI 10.1038/nrc1976; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; Carter SL, 2006, NAT GENET, V38, P1043, DOI 10.1038/ng1861; Cerfolio RJ, 2006, CHEST, V130, P1796, DOI 10.1378/chest.130.6.1796; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chang JT, 2009, MOL CELL, V34, P104, DOI 10.1016/j.molcel.2009.02.030; Chen HY, 2007, NEW ENGL J MED, V356, P11, DOI 10.1056/NEJMoa060096; de Perrot M, 2000, J THORAC CARDIOV SUR, V119, P21, DOI 10.1016/S0022-5223(00)70213-3; Ding L, 2008, NATURE, V455, P1069, DOI 10.1038/nature07423; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fu JB, 2005, CHEST, V127, P768, DOI 10.1378/chest.127.3.768; GARST JDM, 2008, AM SOC CLIN ONC ANN; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Golub TR, 1999, SCIENCE, V286, P531, DOI 10.1126/science.286.5439.531; Ihaka R., 1996, J COMPUTATIONAL GRAP, V5, P299, DOI DOI 10.2307/1390807; Jemal A, 2008, JNCI-J NATL CANCER I, V100, P1672, DOI 10.1093/jnci/djn389; Johnson DG, 2006, CURR MOL MED, V6, P731; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Liu R, 2007, NEW ENGL J MED, V356, P217, DOI 10.1056/NEJMoa063994; Minna JD, 2004, SCIENCE, V304, P1458, DOI 10.1126/science.1099578; Molina JR, 2008, MAYO CLIN PROC, V83, P584, DOI 10.4065/83.5.584; Pauk N, 2005, LUNG CANCER, V48, P1, DOI 10.1016/j.lungcan.2004.10.009; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Potti A, 2006, NEW ENGL J MED, V355, P570, DOI 10.1056/NEJMoa060467; Raponi M, 2006, CANCER RES, V66, P7466, DOI 10.1158/0008-5472.CAN-06-1191; Ries LA, 2006, SEER CANC STAT REV 1; Shedden K, 2008, NAT MED, V14, P822, DOI 10.1038/nm.1790; Thomas L, 2005, CHEST, V128, P370, DOI 10.1378/chest.128.1.370; Viemann D, 2006, J LEUKOCYTE BIOL, V80, P174, DOI 10.1189/jlb.0905530; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; West M, 2001, P NATL ACAD SCI USA, V98, P11462, DOI 10.1073/pnas.201162998; Widschwendter M, 2007, NAT GENET, V39, P157, DOI 10.1038/ng1941	38	41	42	1	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					535	543		10.1001/jama.2010.80	http://dx.doi.org/10.1001/jama.2010.80			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145230	Bronze			2022-12-01	WOS:000274378700025
J	Ratner, TJ				Ratner, Terry J.			The Changing of the Seasons	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												tjrwriter@aol.com							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 10	2010	303	6					493	494		10.1001/jama.2010.84	http://dx.doi.org/10.1001/jama.2010.84			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553PG	20145216				2022-12-01	WOS:000274378700001
J	Bezemer, ID; Bare, LA; Arellano, AR; Reitsma, PH; Rosendaal, FR				Bezemer, Irene D.; Bare, Lance A.; Arellano, Andre R.; Reitsma, Pieter H.; Rosendaal, Frits R.			Updated Analysis of Gene Variants Associated With Deep Vein Thrombosis	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Letter									[Bezemer, Irene D.; Rosendaal, Frits R.] Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands; [Reitsma, Pieter H.] Leiden Univ, Med Ctr, Einthoven Lab Expt Vasc Med, Leiden, Netherlands; [Bare, Lance A.; Arellano, Andre R.] Celera, Alameda, CA USA	Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC; Leiden University; Leiden University Medical Center (LUMC); Leiden University - Excl LUMC	Bezemer, ID (corresponding author), Leiden Univ, Med Ctr, Dept Clin Epidemiol, Leiden, Netherlands.	f.r.rosendaal@lumc.nl	Rosendaal, Frits/Q-3842-2017	Rosendaal, Frits/0000-0003-2558-7496				Bezemer ID, 2008, JAMA-J AM MED ASSOC, V299, P1306, DOI 10.1001/jama.299.11.1306; Bezemer ID, 2009, HAEMATOL-HEMATOL J, V94, P693, DOI 10.3324/haematol.2008.003020; Smith NL, 2007, JAMA-J AM MED ASSOC, V297, P489, DOI 10.1001/jama.297.5.489	3	20	20	2	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 3	2010	303	5					421	422		10.1001/jama.2010.57	http://dx.doi.org/10.1001/jama.2010.57			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	550QR	20124536	Bronze			2022-12-01	WOS:000274143600013
J	Wu, M; Pastor-Pareja, JC; Xu, T				Wu, Ming; Pastor-Pareja, Jose Carlos; Xu, Tian			Interaction between Ras(V12) and scribbled clones induces tumour growth and invasion	NATURE			English	Article							DROSOPHILA JAK/STAT PATHWAY; SIGNALING PATHWAY; CELL POLARITY; JNK; CANCER; ACTIVATION; RAS; OVERGROWTH; EXPRESSION; TISSUES	Human tumours have a large degree of cellular and genetic heterogeneity(1). Complex cell interactions in the tumour and its microenvironment are thought to have an important role in tumorigenesis and cancer progression(2). Furthermore, cooperation between oncogenic genetic lesions is required for tumour development(3); however, it is not known how cell interactions contribute to oncogenic cooperation. The genetic techniques available in the fruitfly Drosophila melanogaster allow analysis of the behaviour of cells with distinct mutations(4), making this the ideal model organism with which to study cell interactions and oncogenic cooperation. In Drosophila eye-antennal discs, cooperation between the oncogenic protein Ras(V12) (ref.5) and loss-of-function mutations in the conserved tumour suppressor scribbled (scrib)(6,7) gives rise to metastatic tumours that display many characteristics observed in human cancers(8-11). Here we show that clones of cells bearing different mutations can cooperate to promote tumour growth and invasion in Drosophila. We found that the Ras(V12) and scrib(-) mutations can also cause tumours when they affect different adjacent epithelial cells. We show that this interaction between Ras(V12) and scrib(-) clones involves JNK signalling propagation and JNK-induced upregulation of JAK/STAT-activating cytokines, a compensatory growth mechanism for tissue homeostasis. The development of Ras(V12) tumours can also be triggered by tissue damage, a stress condition that activates JNK signalling. Given the conservation of the pathways examined here, similar cooperative mechanisms could have a role in the development of human cancers.	[Wu, Ming; Pastor-Pareja, Jose Carlos; Xu, Tian] Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, New Haven, CT 06519 USA; [Xu, Tian] Fudan Univ, Sch Life Sci, Inst Dev Biol & Mol Med, Fudan Yale Biomed Res Ctr, Shanghai 20043, Peoples R China	Howard Hughes Medical Institute; Yale University; Fudan University	Xu, T (corresponding author), Yale Univ, Sch Med, Dept Genet, Howard Hughes Med Inst, 295 Congress Ave, New Haven, CT 06519 USA.	tian.xu@yale.edu	Pastor-Pareja, Jose Carlos/ABE-6917-2021	Pastor-Pareja, Jose Carlos/0000-0002-3823-4473; Wu, Ming/0000-0002-2193-8271	Spanish Ministry of Education; NIH/NCI; NATIONAL CANCER INSTITUTE [R01CA069408] Funding Source: NIH RePORTER	Spanish Ministry of Education(Spanish Government); NIH/NCI(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank E. Bach, D. Harrison, J. Castelli-Gair Hombria, M. Zeidler, T. Adachi-Yamada, M. Mlodzik, E. Matunis, D. Montell, H. Agaisse, the Bloomington Stock Center and the National Institute of Genetics (Kyoto) for fly strains, and T. Ni, S. Landrette and M. Rojas for comments. R. Pagliarini and S. Landrette helped with microarray analysis and RT-PCR. We thank T. Igaki for discussing the manuscript and providing FRT82B, tub-Gal80, scrib 1/TM6B flies. M. W. is a Yale predoctoral fellow. J. C. P.-P. was funded by a Spanish Ministry of Education postdoctoral fellowship. This work was supported by a grant from NIH/NCI to T. X. T. X. is a Howard Hughes Medical Institute Investigator.	Agaisse H, 2003, DEV CELL, V5, P441, DOI 10.1016/S1534-5807(03)00244-2; Bach EA, 2007, GENE EXPR PATTERNS, V7, P323, DOI 10.1016/j.modgep.2006.08.003; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; BARBACID M, 1987, ANNU REV BIOCHEM, V56, P779, DOI 10.1146/annurev.bi.56.070187.004023; Bilder D, 2000, NATURE, V403, P676, DOI 10.1038/35001108; Bosch M, 2005, DEV BIOL, V280, P73, DOI 10.1016/j.ydbio.2005.01.002; Brown S, 2001, CURR BIOL, V11, P1700, DOI 10.1016/S0960-9822(01)00524-3; Brumby AM, 2003, EMBO J, V22, P5769, DOI 10.1093/emboj/cdg548; de Visser KE, 2006, NAT REV CANCER, V6, P24, DOI 10.1038/nrc1782; DVORAK HF, 1986, NEW ENGL J MED, V315, P1650; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Harrison DA, 1998, GENE DEV, V12, P3252, DOI 10.1101/gad.12.20.3252; HEPPNER GH, 1984, CANCER RES, V44, P2259; Hombria JCG, 2005, DEV BIOL, V288, P420, DOI 10.1016/j.ydbio.2005.09.040; Igaki T, 2006, CURR BIOL, V16, P1139, DOI 10.1016/j.cub.2006.04.042; Igaki T, 2009, DEV CELL, V16, P458, DOI 10.1016/j.devcel.2009.01.002; Karim FD, 1998, DEVELOPMENT, V125, P1; Kinzler KW, 1996, CELL, V87, P159, DOI 10.1016/S0092-8674(00)81333-1; Martin FA, 2009, INT J DEV BIOL, V53, P1341, DOI 10.1387/ijdb.072447fm; Martin-Blanco E, 1998, GENE DEV, V12, P557, DOI 10.1101/gad.12.4.557; Pagliarini RA, 2003, SCIENCE, V302, P1227, DOI 10.1126/science.1088474; Pastor-Pareja JC, 2008, DIS MODEL MECH, V1, P144, DOI 10.1242/dmm.000950; Ryoo HD, 2004, DEV CELL, V7, P491, DOI 10.1016/j.devcel.2004.08.019; Srivastava A, 2007, P NATL ACAD SCI USA, V104, P2721, DOI 10.1073/pnas.0611666104; Uhlirova M, 2005, P NATL ACAD SCI USA, V102, P13123, DOI 10.1073/pnas.0504170102; Uhlirova M, 2006, EMBO J, V25, P5294, DOI 10.1038/sj.emboj.7601401; XU T, 1993, DEVELOPMENT, V117, P1223; Zeidler MP, 2000, ONCOGENE, V19, P2598, DOI 10.1038/sj.onc.1203482; Zhan LX, 2008, CELL, V135, P865, DOI 10.1016/j.cell.2008.09.045	30	267	270	2	44	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 28	2010	463	7280					545	U165		10.1038/nature08702	http://dx.doi.org/10.1038/nature08702			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20072127	Green Accepted, Green Submitted			2022-12-01	WOS:000273981100052
J	Tu, WH; Xu, X; Peng, LS; Zhong, XF; Zhang, WF; Soundarapandian, MM; Balel, C; Wang, MQ; Jia, NL; Zhang, W; Lew, F; Chan, SL; Chen, YF; Lu, YM				Tu, Weihong; Xu, Xin; Peng, Lisheng; Zhong, Xiaofen; Zhang, Wenfeng; Soundarapandian, Mangala M.; Balel, Cherine; Wang, Manqi; Jia, Nali; Zhang, Wen; Lew, Frank; Chan, Sic Lung; Chen, Yanfang; Lu, Youming			DAPK1 Interaction with NMDA Receptor NR2B Subunits Mediates Brain Damage in Stroke	CELL			English	Article							PROTEIN-KINASE-II; CELL-DEATH; IN-VIVO; HIPPOCAMPAL-NEURONS; FOREBRAIN ISCHEMIA; GLUTAMATE RELEASE; ION CHANNELS; ACTIVATION; NEURODEGENERATION; CALMODULIN	N-methyl-D-aspartate (NMDA) receptors constitute a major subtype of glutamate receptors at extra-synaptic sites that link multiple intracellular catabolic processes responsible for irreversible neuronal death. Here, we report that cerebral ischemia recruits death-associated protein kinase 1 (DAPK1) into the NMDA receptor NR2B protein complex in the cortex of adult mice. DAPK1 directly binds with the NMDA receptor NR2B C-terminal tail consisting of amino acid 1292-1304 (NR2BCT). A constitutively active DAPK1 phosphorylates NR2B subunit at Ser-1303 and in turn enhances the NR1/NR2B receptor channel conductance. Genetic deletion of DAPK1 or administration of NR2BCT that uncouples an activated DAPK1 from an NMDA receptor NR2B subunit in vivo in mice blocks injurious Ca2+ influx through NMDA receptor channels at extrasynaptic sites and protects neurons against cerebral ischemic insults. Thus, DAPK1 physically and functionally interacts with the NMDA receptor NR2B subunit at extrasynaptic sites and this interaction acts as a central mediator for stroke damage.	[Tu, Weihong; Xu, Xin; Peng, Lisheng; Zhong, Xiaofen; Wang, Manqi; Jia, Nali; Zhang, Wen; Lu, Youming] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Neurol, New Orleans, LA 70112 USA; [Tu, Weihong; Xu, Xin; Peng, Lisheng; Zhong, Xiaofen; Wang, Manqi; Jia, Nali; Zhang, Wen; Lu, Youming] Louisiana State Univ, Hlth Sci Ctr, Sch Med, Ctr Neurosci, New Orleans, LA 70112 USA; [Tu, Weihong; Soundarapandian, Mangala M.; Balel, Cherine; Lew, Frank; Chan, Sic Lung; Lu, Youming] Univ Cent Florida, Coll Med, Burnett Sch Biomed Sci, Biomed Sci Ctr, Orlando, FL 32816 USA; [Zhang, Wenfeng; Chen, Yanfang] Wright State Univ, Sch Med, Dept Pharmacol & Toxicol, Dayton, OH 45435 USA	Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; Louisiana State University System; Louisiana State University Health Sciences Center New Orleans; State University System of Florida; University of Central Florida; University System of Ohio; Wright State University Dayton	Lu, YM (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Sch Med, Dept Neurol, New Orleans, LA 70112 USA.	ylu1@lsuhsc.edu	Zhang, Wen/B-2671-2009; Zhang, Wen/O-4354-2019; Xu, Xin/E-2076-2014	Zhang, Wen/0000-0001-5166-0736; Zhang, Wen/0000-0001-5166-0736; 	American Heart Association [05553413YL, 0535201YC, 0625532 XZ]; National Institute of Health [R01NS5051383YL, R01AG033282YL]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS051383] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG033282] Funding Source: NIH RePORTER	American Heart Association(American Heart Association); National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))	This work was supported by the American Heart Association (05553413YL; 0535201YC; and 0625532 XZ), National Institute of Health (NIH/NINDS, R01NS5051383YL and NIH/NIA R01AG033282YL). We thank Ryan Labadens at the Neuroscience Center of Excellence, Louisiana State University School of Medicine Health Sciences Center, and for assistance in manuscript preparation and discussion.	Aarts M, 2003, CELL, V115, P863, DOI 10.1016/S0092-8674(03)01017-1; Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Bano D, 2005, CELL, V120, P275, DOI 10.1016/j.cell.2004.11.049; Bialik S, 2006, ANNU REV BIOCHEM, V75, P189, DOI 10.1146/annurev.biochem.75.103004.142615; Brickley SG, 2003, J NEUROSCI, V23, P4958; Chatterton JE, 2002, NATURE, V415, P793, DOI 10.1038/nature715; DREJER J, 1985, J NEUROCHEM, V45, P145, DOI 10.1111/j.1471-4159.1985.tb05486.x; El-Husseini AE, 2002, CELL, V108, P849, DOI 10.1016/S0092-8674(02)00683-9; Eliasson MJL, 1999, J NEUROSCI, V19, P5910, DOI 10.1523/JNEUROSCI.19-14-05910.1999; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fiskum G, 1999, J CEREBR BLOOD F MET, V19, P351, DOI 10.1097/00004647-199904000-00001; Gardoni F, 2002, EUR J NEUROSCI, V16, P777, DOI 10.1046/j.1460-9568.2002.02141.x; Ghosh A, 2002, SCIENCE, V295, P449, DOI 10.1126/science.1069391; Greengard P, 2001, SCIENCE, V294, P1024, DOI 10.1126/science.294.5544.1024; HANSON SK, 1994, STROKE, V25, P466, DOI 10.1161/01.STR.25.2.466; Hardingham GE, 2002, NAT NEUROSCI, V5, P405, DOI 10.1038/nn835; Khanna S, 2007, J BIOL CHEM, V282, P23482, DOI 10.1074/jbc.M611269200; KINOUCHI H, 1991, P NATL ACAD SCI USA, V88, P11158, DOI 10.1073/pnas.88.24.11158; Krajewski S, 1999, P NATL ACAD SCI USA, V96, P5752, DOI 10.1073/pnas.96.10.5752; Krupp JJ, 1999, J NEUROSCI, V19, P1165; Lipton SA, 2006, NAT REV DRUG DISCOV, V5, P160, DOI 10.1038/nrd1958; Lisman J, 2002, NAT REV NEUROSCI, V3, P175, DOI 10.1038/nrn753; Liu SH, 2004, NEURON, V43, P43, DOI 10.1016/j.neuron.2004.06.017; Liu YT, 2007, J NEUROSCI, V27, P2846, DOI 10.1523/JNEUROSCI.0116-07.2007; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Mabuchi T, 2001, J NEUROSCI, V21, P9204, DOI 10.1523/JNEUROSCI.21-23-09204.2001; Madden DR, 2002, NAT REV NEUROSCI, V3, P91, DOI 10.1038/nrn725; Marshall J, 2003, NEURON, V39, P625, DOI 10.1016/S0896-6273(03)00496-3; Omkumar RV, 1996, J BIOL CHEM, V271, P31670, DOI 10.1074/jbc.271.49.31670; PellegriniGiampietro DE, 1997, TRENDS NEUROSCI, V20, P464, DOI 10.1016/S0166-2236(97)01100-4; Peng PL, 2006, NEURON, V49, P719, DOI 10.1016/j.neuron.2006.01.025; Petersen JD, 2003, J NEUROSCI, V23, P11270; Rossi DJ, 2000, NATURE, V403, P316, DOI 10.1038/35002090; Salter MW, 2004, NAT REV NEUROSCI, V5, P317, DOI 10.1038/nrn1368; Schumacher AM, 2004, BIOCHEMISTRY-US, V43, P8116, DOI 10.1021/bi049589v; Shohat G, 2001, J BIOL CHEM, V276, P47460, DOI 10.1074/jbc.M105133200; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; Simpkins KL, 2003, J NEUROSCI, V23, P11322; Sprengel R, 1998, CELL, V92, P279, DOI 10.1016/S0092-8674(00)80921-6; Sun MK, 2008, P NATL ACAD SCI USA, V105, P13620, DOI 10.1073/pnas.0805952105; Takasu MA, 2002, SCIENCE, V295, P491, DOI 10.1126/science.1065983; Thomas CG, 2006, J NEUROPHYSIOL, V95, P1727, DOI 10.1152/jn.00771.2005; Tovar KR, 1999, J NEUROSCI, V19, P4180; Uehara T, 2006, NATURE, V441, P513, DOI 10.1038/nature04782; Van Eldik LJ, 2002, TRENDS PHARMACOL SCI, V23, P302, DOI 10.1016/S0165-6147(02)02049-7; Velentza AV, 2001, J BIOL CHEM, V276, P38956, DOI 10.1074/jbc.M104273200; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang J, 2003, NAT NEUROSCI, V6, P1039, DOI 10.1038/nn1119; Wang J, 2003, J NEUROSCI, V23, P826; Waxham MN, 1996, J CEREBR BLOOD F MET, V16, P1, DOI 10.1097/00004647-199601000-00001; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026	51	338	366	3	69	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					222	234		10.1016/j.cell.2009.12.055	http://dx.doi.org/10.1016/j.cell.2009.12.055			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141836	Green Accepted, Bronze			2022-12-01	WOS:000273826500013
J	Gornall, J				Gornall, Jonathan			Medical Research A very public break-up	BRITISH MEDICAL JOURNAL			English	Editorial Material							PATENT FORAMEN OVALE; MIGRAINE INTERVENTION; DECOMPRESSION ILLNESS; CLOSURE; HEADACHE; DEVICE; TRIAL					Jgornall@mac.com						Carroll JD, 2008, CIRCULATION, V117, P1358, DOI 10.1161/CIRCULATIONAHA.107.758748; Carroll JD, 2009, CIRC-CARDIOVASC INTE, V2, P475, DOI 10.1161/CIRCINTERVENTIONS.109.860031; Dowson, 2009, CIRCULATION, V120, pE71, DOI 10.1161/CIRCULATIONAHA.109.192626; Dowson A, 2008, CIRCULATION, V117, P1397, DOI 10.1161/CIRCULATIONAHA.107.727271; HAGEN PT, 1984, MAYO CLIN PROC, V59, P17, DOI 10.1016/S0025-6196(12)60336-X; *HEALTHWATCH, HEALTHWATCH AW 2003; Nugent AW, 2006, J AM COLL CARDIOL, V48, P538, DOI 10.1016/j.jacc.2006.03.049; Reisman M, 2005, J AM COLL CARDIOL, V45, P493, DOI 10.1016/j.jacc.2004.10.055; Schwerzmann M, 2004, NEUROLOGY, V62, P1399, DOI 10.1212/01.WNL.0000120677.64217.A9; Wilmshurst P, 1996, LANCET, V348, P752, DOI 10.1016/S0140-6736(05)65638-3; Wilmshurst PT, 2000, LANCET, V356, P1648, DOI 10.1016/S0140-6736(00)03160-3; WILMSHURST PT, 1986, BRIT MED J, V293, P1277, DOI 10.1136/bmj.293.6557.1277	12	5	5	1	3	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	JAN 18	2010	340								c110	10.1136/bmj.c110	http://dx.doi.org/10.1136/bmj.c110			7	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548HM	20083545				2022-12-01	WOS:000273951100002
J	Mahtani, KR; Rose, PW; van Someren, N				Mahtani, Kamal R.; Rose, Peter W.; van Someren, Niall			Case report Microscopic colitis in primary care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							IRRITABLE-BOWEL-SYNDROME; COLLAGENOUS COLITIS; LYMPHOCYTIC COLITIS; DISEASE; BUDESONIDE; DIARRHEA; RISK		[Rose, Peter W.] Univ Oxford, Dept Primary Hlth Care, Oxford OX3 7LF, England; [van Someren, Niall] Chase Farm Hosp, Dept Med, Enfield EN2 8JL, Middx, England	University of Oxford; University of London; University College London; Royal Free London NHS Foundation Trust		kamal.mahtani@dphpc.ox.ac.uk			National Institute for Health Research [ACF-2008-13-014] Funding Source: researchfish	National Institute for Health Research(National Institute for Health Research (NIHR))		Chande N, 2005, SCAND J GASTROENTERO, V40, P343, DOI 10.1080/00365520510011623; Chande N, 2009, AM J GASTROENTEROL, V104, P235, DOI 10.1038/ajg.2008.16; Chiba M, 2009, WORLD J GASTROENTERO, V15, P2166, DOI 10.3748/wjg.15.2166; *DEP HLTH, 2000, GUID URG REF PAT SUP; Fernandez-Banares F, 1999, AM J GASTROENTEROL, V94, P418, DOI 10.1111/j.1572-0241.1999.00870.x; Fernandez-Banares F, 2007, AM J GASTROENTEROL, V102, P324, DOI 10.1111/j.1572-0241.2006.00902.x; Ford AC, 2008, JAMA-J AM MED ASSOC, V300, P1793, DOI 10.1001/jama.300.15.1793; Jones R, 2009, BMJ-BRIT MED J, V338, DOI 10.1136/bmj.b1877; Kao KT, 2009, WORLD J GASTROENTERO, V15, P3122, DOI 10.3748/wjg.15.3122; Limsui D, 2007, INFLAMM BOWEL DIS, V13, P175, DOI 10.1002/ibd.20059; McKeage K, 2002, DRUGS, V62, P2263, DOI 10.2165/00003495-200262150-00015; Miehlke S, 2009, GASTROENTEROLOGY, V136, P2092, DOI 10.1053/j.gastro.2009.02.078; Nielsen OH, 2004, LANCET, V364, P2055, DOI 10.1016/S0140-6736(04)17518-1; Olesen M, 2004, GUT, V53, P346, DOI 10.1136/gut.2003.014431; Pardi DS, 2007, GUT, V56, P504, DOI 10.1136/gut.2006.105890; RIDDELL RH, 1992, GUT, V33, P683, DOI 10.1136/gut.33.5.683; TALLEY NJ, 1992, AM J EPIDEMIOL, V136, P165, DOI 10.1093/oxfordjournals.aje.a116483; Thielman NM, 2004, NEW ENGL J MED, V350, P38, DOI 10.1056/NEJMcp031534; Thomas PD, 2003, GUT, V52, P1; Thomson RD, 2002, AM J GASTROENTEROL, V97, P2908; Williams JJ, 2008, CLIN GASTROENTEROL H, V6, P35, DOI 10.1016/j.cgh.2007.10.031	21	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN 6	2010	340								b5520	10.1136/bmj.b5520	http://dx.doi.org/10.1136/bmj.b5520			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542IE	20053827				2022-12-01	WOS:000273485500007
J	Skelhorn, J; Rowland, HM; Speed, MP; Ruxton, GD				Skelhorn, John; Rowland, Hannah M.; Speed, Michael P.; Ruxton, Graeme D.			Masquerade: Camouflage Without Crypsis	SCIENCE			English	Article							MIMICRY		[Skelhorn, John; Ruxton, Graeme D.] Univ Glasgow, Fac Biomed & Life Sci, Div Ecol & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland; [Rowland, Hannah M.; Speed, Michael P.] Univ Liverpool, Sch Biol Sci, Div Populat & Evolutionary Biol, Liverpool L69 7ZB, Merseyside, England	University of Glasgow; University of Liverpool	Ruxton, GD (corresponding author), Univ Glasgow, Fac Biomed & Life Sci, Div Ecol & Evolutionary Biol, Glasgow G12 8QQ, Lanark, Scotland.	G.Ruxton@bio.gla.ac.uk	Rowland, Hannah/D-8114-2012	Rowland, Hannah/0000-0002-1040-555X; Ruxton, Graeme/0000-0001-8943-6609	Natural Environment Research Council [NE/F002653/1] Funding Source: researchfish; NERC [NE/F002653/1] Funding Source: UKRI	Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ALLEN JA, 1985, J BIOL EDUC, V19, P268, DOI 10.1080/00219266.1985.9654747; ENDLER JA, 1981, BIOL J LINN SOC, V16, P25, DOI 10.1111/j.1095-8312.1981.tb01840.x; Mappes J, 2005, TRENDS ECOL EVOL, V20, P598, DOI 10.1016/j.tree.2005.07.011; SPEED MP, 1993, ANIM BEHAV, V46, P1246, DOI 10.1006/anbe.1993.1321; Stevens M, 2009, PHILOS T R SOC B, V364, P423, DOI 10.1098/rstb.2008.0217; [No title captured]	6	155	160	5	174	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					51	51		10.1126/science.1181931	http://dx.doi.org/10.1126/science.1181931			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044568				2022-12-01	WOS:000273395400026
J	Li, QG; Gao, KQ; Vinther, J; Shawkey, MD; Clarke, JA; D'Alba, L; Meng, QJ; Briggs, DEG; Prum, RO				Li, Quanguo; Gao, Ke-Qin; Vinther, Jakob; Shawkey, Matthew D.; Clarke, Julia A.; D'Alba, Liliana; Meng, Qingjin; Briggs, Derek E. G.; Prum, Richard O.			Plumage Color Patterns of an Extinct Dinosaur	SCIENCE			English	Article							FEATHERS	For as long as dinosaurs have been known to exist, there has been speculation about their appearance. Fossil feathers can preserve the morphology of color-imparting melanosomes, which allow color patterns in feathered dinosaurs to be reconstructed. Here, we have mapped feather color patterns in a Late Jurassic basal paravian theropod dinosaur. Quantitative comparisons with melanosome shape and density in extant feathers indicate that the body was gray and dark and the face had rufous speckles. The crown was rufous, and the long limb feathers were white with distal black spangles. The evolution of melanin-based within-feather pigmentation patterns may coincide with that of elongate pennaceous feathers in the common ancestor of Maniraptora, before active powered flight. Feathers may thus have played a role in sexual selection or other communication.	[Vinther, Jakob; Briggs, Derek E. G.] Yale Univ, Dept Geol & Geophys, New Haven, CT 06511 USA; [Li, Quanguo; Meng, Qingjin] Beijing Museum Nat Hist, Beijing 100050, Peoples R China; [Gao, Ke-Qin] Peking Univ, Sch Earth & Space Sci, Beijing 100871, Peoples R China; [Vinther, Jakob; Briggs, Derek E. G.; Prum, Richard O.] Yale Univ, Peabody Museum Nat Hist, New Haven, CT 06511 USA; [Shawkey, Matthew D.; D'Alba, Liliana] Univ Akron, Dept Biol, Akron, OH 44325 USA; [Shawkey, Matthew D.; D'Alba, Liliana] Univ Akron, Integrated Biosci Program, Akron, OH 44325 USA; [Clarke, Julia A.] Univ Texas Austin, Dept Geol Sci, Austin, TX 78712 USA; [Prum, Richard O.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06511 USA	Yale University; Peking University; Yale University; University System of Ohio; University of Akron; University System of Ohio; University of Akron; University of Texas System; University of Texas Austin; Yale University	Vinther, J (corresponding author), Yale Univ, Dept Geol & Geophys, POB 6666, New Haven, CT 06511 USA.	jakob.vinther@yale.edu	Vinther, Jakob/GZG-4679-2022; Li, Quanguo/ABE-9756-2021; /B-4978-2011; D'Alba, Liliana/AAC-4969-2022; Meng, Q./GSI-6185-2022	/0000-0003-2218-2637; D'Alba, Liliana/0000-0002-2478-3455; Shawkey, Matthew/0000-0002-5131-8209; Prum, Richard/0000-0002-4741-7132; Vinther, Jakob/0000-0002-3584-9616	NSF [EAR-0720062, EAR-0719758]; Air Force Office of Scientific Research [FA9550-09-10159]; University of Akron; National Geographic Society; Yale University	NSF(National Science Foundation (NSF)); Air Force Office of Scientific Research(United States Department of DefenseAir Force Office of Scientific Research (AFOSR)); University of Akron; National Geographic Society(National Geographic Society); Yale University	E. Champion and S. Nesbitt helped produce the figures. N. Vitek, J. A. Cundiff, and C. L. Canter made initial investigations of modern feathers. The research was funded by NSF (EAR-0720062 and EAR-0719758), the Air Force Office of Scientific Research (FA9550-09-10159), University of Akron startup funds, the National Geographic Society, and the Yale University W. R. Coe Fund. K. J. McGraw and R. J. Safran provided modern feather samples. The studied specimen is accessioned at Beijing Museum of Natural History (BMNHC). The color plate in Fig. 4 was painted by M. D. DiGiorgio.	Bortolotti G. R., 2006, BIRD COLORATION, V2, P3, DOI DOI 10.2307/J.CTV22JNR8K.4; Burtt E.H. Jr, 1979, P75; Hill G.E., 2006, BIRD COLORATION, V2; Hu DY, 2009, NATURE, V461, P640, DOI 10.1038/nature08322; Jablonski PG, 1999, BEHAV ECOL, V10, P7, DOI 10.1093/beheco/10.1.7; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; JI Q, 1996, CHIN GEOL, V23, P30; Mumme RL, 2002, AUK, V119, P1024, DOI 10.1642/0004-8038(2002)119[1024:STIANW]2.0.CO;2; Norell MA, 2005, ANNU REV EARTH PL SC, V33, P277, DOI 10.1146/annurev.earth.33.092203.122511; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Vinther J, 2010, BIOL LETTERS, V6, P128, DOI 10.1098/rsbl.2009.0524; Willson SK., 2004, ORNITHOL MONOGR, V55, P1, DOI 10.2307/40166802; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 2009, CHINESE SCI BULL, V54, P430, DOI 10.1007/s11434-009-0009-6; Xu Xing, 2009, Vertebrata Palasiatica, V47, P311; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhang FC, 2010, NATURE, V463, P1075, DOI 10.1038/nature08740; Zhou Z, 2000, VERTEBRAT PALASIATIC, V38, P113; Zhou Zhong-He, 2000, Vertebrata Palasiatica, V38, P241	20	175	180	1	164	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1369	1372		10.1126/science.1186290	http://dx.doi.org/10.1126/science.1186290			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20133521	Green Published			2022-12-01	WOS:000275418700039
J	Shinar, G; Feinberg, M				Shinar, Guy; Feinberg, Martin			Structural Sources of Robustness in Biochemical Reaction Networks	SCIENCE			English	Article							CHEMICAL-REACTION NETWORKS; BACTERIAL CHEMOTAXIS; PHOSPHATASE-ACTIVITY; PHOSPHORYLATION; DEPHOSPHORYLATION; ADAPTATION; GRADIENT; SENSOR; ENVZ	In vivo variations in the concentrations of biomolecular species are inevitable. These variations in turn propagate along networks of chemical reactions and modify the concentrations of still other species, which influence biological activity. Because excessive variations in the amounts of certain active species might hamper cell function, regulation systems have evolved that act to maintain concentrations within tight bounds. We identify simple yet subtle structural attributes that impart concentration robustness to any mass-action network possessing them. We thereby describe a large class of robustness-inducing networks that already embraces two quite different biochemical modules for which concentration robustness has been observed experimentally: the Escherichia coli osmoregulation system EnvZ-OmpR and the glyoxylate bypass control system isocitrate dehydrogenase kinase-phosphatase-isocitrate dehydrogenase. The structural attributes identified here might confer robustness far more broadly.	[Feinberg, Martin] Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Koffolt Labs 125, Columbus, OH 43210 USA; [Shinar, Guy] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Feinberg, Martin] Ohio State Univ, Dept Math, Koffolt Labs 125, Columbus, OH 43210 USA	University System of Ohio; Ohio State University; Weizmann Institute of Science; University System of Ohio; Ohio State University	Feinberg, M (corresponding author), Ohio State Univ, William G Lowrie Dept Chem & Biomol Engn, Koffolt Labs 125, 140 W 19th Ave, Columbus, OH 43210 USA.	feinberg@chbmeng.ohio-state.edu			NSF [BES-0425459]; NIH [1R01GM086881-01]; Kahn Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM086881] Funding Source: NIH RePORTER	NSF(National Science Foundation (NSF)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Kahn Family Foundation; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We are grateful to U. Alon for comments, insight, and support; E. Eden for writing the software implementation of the theorem; and A. Cohen, G. Enciso, R. Kishony, D. Koster, M. Laub, A. Mayo, R. Milo, and J. Rabinowitz for their help. Supported by NSF grant BES-0425459, NIH grant 1R01GM086881-01, and the Kahn Family Foundation.	Alon U, 1999, NATURE, V397, P168, DOI 10.1038/16483; Barkai N, 1997, NATURE, V387, P913, DOI 10.1038/43199; Batchelor E, 2003, P NATL ACAD SCI USA, V100, P691, DOI 10.1073/pnas.0234782100; Craciun G, 2006, P NATL ACAD SCI USA, V103, P8697, DOI 10.1073/pnas.0602767103; Csikasz-Nagy A, 2008, J R SOC INTERFACE, V5, pS41, DOI 10.1098/rsif.2008.0099.focus; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; EDEN E, 2009, REACTION NETWORK ANA; Eldar A, 2002, NATURE, V419, P304, DOI 10.1038/nature01061; FEINBERG M, 1987, CHEM ENG SCI, V42, P2229, DOI 10.1016/0009-2509(87)80099-4; Feinberg M, 1995, ARCH RATION MECH AN, V132, P311, DOI 10.1007/BF00375614; Hsing WH, 1997, J BACTERIOL, V179, P3729, DOI 10.1128/jb.179.11.3729-3735.1997; IGO MM, 1989, GENE DEV, V3, P1725, DOI 10.1101/gad.3.11.1725; Kollmann M, 2005, NATURE, V438, P504, DOI 10.1038/nature04228; LAPORTE DC, 1985, J BIOL CHEM, V260, P563; Levchenko A, 2002, BIOPHYS J, V82, P50, DOI 10.1016/S0006-3495(02)75373-3; Pratt L., 1995, 2 COMPONENT SIGNAL T, P105; Sanowar S, 2005, BIOCHEM J, V390, P769, DOI 10.1042/BJ20050060; Shinar G, 2007, P NATL ACAD SCI USA, V104, P19931, DOI 10.1073/pnas.0706792104; Shinar G, 2009, SIAM J APPL MATH, V69, P977, DOI 10.1137/080719820; Shinar G, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000297; Stock AM, 2000, ANNU REV BIOCHEM, V69, P183, DOI 10.1146/annurev.biochem.69.1.183; Yi TM, 2000, P NATL ACAD SCI USA, V97, P4649, DOI 10.1073/pnas.97.9.4649; Zhu Y, 2000, P NATL ACAD SCI USA, V97, P7808, DOI 10.1073/pnas.97.14.7808; [No title captured]	24	236	238	1	55	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1389	1391		10.1126/science.1183372	http://dx.doi.org/10.1126/science.1183372			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223989				2022-12-01	WOS:000275418700044
J	Ranu, H; Holden, E; Madden, B				Ranu, Harpreet; Holden, Emma; Madden, Brendan			Case report A pain in the leg and breathlessness	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material							THROMBOEMBOLIC PULMONARY-HYPERTENSION; RISK STRATIFICATION; PROGNOSTIC-SIGNIFICANCE; EMBOLISM; THERAPY; ANTICOAGULATION; BIOMARKERS; SILDENAFIL; TROPONINS; BENEFIT		[Ranu, Harpreet; Holden, Emma; Madden, Brendan] St George Hosp, Dept Cardiothorac Med, London SW17 0QT, England	St Georges University London	Madden, B (corresponding author), St George Hosp, Dept Cardiothorac Med, London SW17 0QT, England.	Brendan.Madden@stgeorges.nhs.uk						Becattini C, 2007, CIRCULATION, V116, P427, DOI 10.1161/CIRCULATIONAHA.106.680421; Bresser Paul, 2006, Proc Am Thorac Soc, V3, P594, DOI 10.1513/pats.200605-115LR; Chapman TH, 2009, VASC PHARMACOL, V51, P90, DOI 10.1016/j.vph.2009.04.002; Douketis JD, 2005, J THROMB HAEMOST, V3, P508, DOI 10.1111/j.1538-7836.2005.01189.x; Elsharawy M, 2002, EUR J VASC ENDOVASC, V24, P209, DOI 10.1053/ejvs.2002.1665; Fekrazad MH, 2009, J THROMB THROMBOLYS, V28, P270, DOI 10.1007/s11239-009-0374-7; Fengler BT, 2009, AM J EMERG MED, V27, P84, DOI 10.1016/j.ajem.2007.10.021; Giannitsis E, 2005, CIRCULATION, V112, P1520, DOI 10.1161/CIRCULATIONAHA.105.566182; Gibson NS, 2008, CHEST, V134, P789, DOI 10.1378/chest.08-0344; Goldhaber SZ, 1999, LANCET, V353, P1386, DOI 10.1016/S0140-6736(98)07534-5; Hoeper MM, 2006, CIRCULATION, V113, P2011, DOI 10.1161/CIRCULATIONAHA.105.602565; Hughes RJ, 2006, EUR RESPIR J, V28, P138, DOI 10.1183/09031936.06.00135905; Jimenez D, 2009, CHEST, V136, P974, DOI 10.1378/chest.09-0608; Kahn SR, 2002, BLOOD REV, V16, P155, DOI 10.1016/S0268-960X(02)00008-5; Kearon C, 1999, NEW ENGL J MED, V340, P901, DOI 10.1056/NEJM199903253401201; Kearon C, 2008, CHEST, V133, p454S, DOI 10.1378/chest.08-0658; KLOK FA, 2009, AM J RESP CRIT CARE; Konstantinides S, 2002, CIRCULATION, V106, P1263, DOI 10.1161/01.CIR.0000028422.51668.A2; Kucher N, 2006, CIRCULATION, V113, P577, DOI 10.1161/CIRCULATIONAHA.105.592592; Kucher N, 2003, CIRCULATION, V108, P2191, DOI 10.1161/01.CIR.0000100687.99687.CE; MOSER KM, 1993, CHEST, V103, P685, DOI 10.1378/chest.103.3.685; Pengo V, 2004, NEW ENGL J MED, V350, P2257, DOI 10.1056/NEJMoa032274; Quinlan DJ, 2004, ANN INTERN MED, V140, P175, DOI 10.7326/0003-4819-140-3-200402030-00008; Scridon T, 2005, AM J CARDIOL, V96, P303, DOI 10.1016/j.amjcard.2005.03.062; Sheth A, 2005, VASC PHARMACOL, V42, P41, DOI 10.1016/j.vph.2004.11.005; Todd JL, 2009, CHEST, V135, P1321, DOI 10.1378/chest.08-2125	26	0	0	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	MAR 10	2010	340								c925	10.1136/bmj.c925	http://dx.doi.org/10.1136/bmj.c925			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	570FD	20219821				2022-12-01	WOS:000275656800034
J	Miller, E; Hoschler, K; Hardelid, P; Stanford, E; Andrews, N; Zambon, M				Miller, Elizabeth; Hoschler, Katja; Hardelid, Pia; Stanford, Elaine; Andrews, Nick; Zambon, Maria			Incidence of 2009 pandemic influenza A H1N1 infection in England: a cross-sectional serological study	LANCET			English	Article							ANTIBODY	Background Knowledge of the age-specific prevalence of immunity from, and incidence of infection with, 2009 pandemic influenza A H1N1 virus is essential for modelling the future burden of disease and the effectiveness of interventions such as vaccination. Methods In this cross-sectional serological survey, we obtained 1403 serum samples taken in 2008 (before the first wave of H1N1 infection) and 1954 serum samples taken in August and September, 2009 (after the first wave of infection) as part of the annual collection for the Health Protection Agency seroepidemiology programme from patients accessing health care in England. Antibody titres were measured by use of haemagglutination inhibition and microneutralisation assays. We calculated the proportion of samples with antibodies to pandemic H1N1 virus in 2008 by age group and compared the proportion of samples with haemagglutination inhibition titre 1:32 or more (deemed a protective response) before the first wave of infection with the proportion after the first wave. Findings In the baseline serum samples from 2008, haemagglutination inhibition and microneutralisation antibody titres increased significantly with age (F test p<0.0001). The proportion of samples with haemagglutination inhibition litre 1:32 or more ranged from 1.8% (three of 171; 95% CI 0.6-5.0) in children aged 0-4 years to 31.3% (52 of 166; 24.8-38.7) in adults aged 80 years or older. In London and the West Midlands, the difference in the proportion of samples with haemagglutination inhibition titre equal to or above 1:32 between baseline and September, 2009, was 21.3% (95% CI 8.8-40.3) for children younger than 5 years of age, 42.0% (26.3-58.2) for 5-14-year-olds, and 20.6% (1.6-42.4) for 15-24-year-olds, with no difference between baseline and September in older age groups. In other regions, only children younger than 15 years showed a significant increase from baseline (6.3%, 1.8-12.9). Interpretation Around one child in every three was infected with 2009 pandemic H1N1 in the first wave of infection in regions with a high incidence, ten times more than estimated from clinical surveillance. Pre-existing antibody in older age groups protects against infection. Children have an important role in transmission of influenza and would be a key target group for vaccination both for their protection and for the protection of others through herd immunity.	[Miller, Elizabeth] Hlth Protect Agcy Ctr Infect, Immunisat Hepatitis & Blood Safety Dept, London NW9 6BT, England; [Hoschler, Katja; Zambon, Maria] Hlth Protect Agcy Ctr Infect, Resp Virus Unit, London NW9 6BT, England; [Hardelid, Pia; Andrews, Nick] Hlth Protect Agcy Ctr Infect, Stat Unit, London NW9 6BT, England; [Stanford, Elaine] Manchester Royal Infirm, Hlth Protect Agcy, Vaccine Evaluat Seroepidemiol Unit, Manchester M13 9WL, Lancs, England	Health Protection Agency; Health Protection Agency; Health Protection Agency; Health Protection Agency; University of Manchester	Miller, E (corresponding author), Hlth Protect Agcy Ctr Infect, Immunisat Hepatitis & Blood Safety Dept, 61 Colindale Ave, London NW9 6BT, England.	liz.miller@hpa.org.uk	Hardelid, Pia/B-3575-2011; Hardelid, Pia/K-3353-2013	Hardelid, Pia/0000-0002-0154-1306	Novartis; Sanofi Pasteur; Baxter; CSL Australia; National Institute for Health Research Health Technology [09/95/01]	Novartis(Novartis); Sanofi Pasteur; Baxter; CSL Australia; National Institute for Health Research Health Technology	MZ and KH have received research grants from Novartis, Sanofi Pasteur, Baxter, and CSL Australia. KH has received travel expenses from Sanofi Pasteur. All other authors declare that they have no conflicts of interest.; We thank Pauline Kaye for collation for data on serological responses in confirmed cases, Albert Jan Van Hoek and Stefan Flasche for their assistance in data analysis and presentation, and the HPA and National Health Service laboratories that collect samples for the HPA seroepidemiology programme. We also thank the chemical pathology laboratories in the participating regions for their collaboration in the collection of the August and September seroincidence samples and the Royal College of Pathologists and HPA regional epidemiologists for their support in recruitment of these laboratories. This study was funded by a grant to the Health Protection Agency from the National Institute for Health Research Health Technology Assessment Programme (09/95/01) under its Pandemic Influenza call.	BAGUELIN M, VACCINE IN PRESS; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Clark TW, 2009, NEW ENGL J MED, V361, P2424, DOI 10.1056/NEJMoa0907650; Dietz K, 1993, Stat Methods Med Res, V2, P23, DOI 10.1177/096228029300200103; Ellis J, 2009, EUROSURVEILLANCE, V14; *FLUS, UK FLU SURV; Hall IM, 2007, EPIDEMIOL INFECT, V135, P372, DOI 10.1017/S0950268806007084; Hancock K, 2009, NEW ENGL J MED, V361, P1945, DOI 10.1056/NEJMoa0906453; Health Protection Agency, SER PROGR; Health Protection Agency, 2009, HPA WEEKL NAT INFL R; *HLTH PROT AG, METH US EST NEW PAND; *HLTH PROT AG, 2009, WEEKL INT SUMM; HOBSON D, 1972, J HYG-CAMBRIDGE, V70, P767, DOI 10.1017/S0022172400022610; Johnson BF, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007671; Mossong J, 2008, PLOS MED, V5, P381, DOI 10.1371/journal.pmed.0050074; Office for National Statistics, POP EST UK ENGL WAL; Osborne K, 2000, INT J EPIDEMIOL, V29, P362, DOI 10.1093/ije/29.2.362; Rowe T, 1999, J CLIN MICROBIOL, V37, P937, DOI 10.1128/JCM.37.4.937-943.1999	18	581	592	0	66	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	MAR-APR	2010	375	9720					1100	1108		10.1016/S0140-6736(09)62126-7	http://dx.doi.org/10.1016/S0140-6736(09)62126-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	578ZB	20096450				2022-12-01	WOS:000276334600033
J	Zhang, FC; Kearns, SL; Orr, PJ; Benton, MJ; Zhou, ZH; Johnson, D; Xu, X; Wang, XL				Zhang, Fucheng; Kearns, Stuart L.; Orr, Patrick J.; Benton, Michael J.; Zhou, Zhonghe; Johnson, Diane; Xu, Xing; Wang, Xiaolin			Fossilized melanosomes and the colour of Cretaceous dinosaurs and birds	NATURE			English	Article							INTEGUMENTARY STRUCTURES; FEATHERED DINOSAURS; THEROPOD DINOSAUR; YIXIAN FORMATION; COLLAGEN-FIBERS; CHINA; EVOLUTION; ORIGIN; PROTOFEATHERS	Spectacular fossils from the Early Cretaceous Jehol Group(1,2) of northeastern China have greatly expanded our knowledge of the diversity and palaeobiology of dinosaurs and early birds, and contributed to our understanding of the origin of birds, of flight, and of feathers. Pennaceous (vaned) feathers and integumentary filaments are preserved in birds(3-5) and non-avian theropod dinosaurs(6-12), but little is known of their microstructure. Here we report that melanosomes (colour-bearing organelles) are not only preserved in the pennaceous feathers of early birds, but also in an identical manner in integumentary filaments of non-avian dinosaurs, thus refuting recent claims(13-16) that the filaments are partially decayed dermal collagen fibres. Examples of both eumelanosomes and phaeomelanosomes have been identified, and they are often preserved in life position within the structure of partially degraded feathers and filaments. Furthermore, the data here provide empirical evidence for reconstructing the colours and colour patterning of these extinct birds and theropod dinosaurs: for example, the dark-coloured stripes on the tail of the theropod dinosaur Sinosauropteryx can reasonably be inferred to have exhibited chestnut to reddish-brown tones.	[Kearns, Stuart L.; Benton, Michael J.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Zhang, Fucheng; Zhou, Zhonghe; Xu, Xing; Wang, Xiaolin] Chinese Acad Sci, Inst Vertebrate Paleontol & Paleoanthropol, Key Lab Evolutionary Systemat Vertebrates, Beijing 100044, Peoples R China; [Orr, Patrick J.] Univ Coll Dublin, Sch Geol Sci, Dublin 4, Ireland; [Johnson, Diane] Open Univ, Planetary & Space Sci Res Inst, Milton Keynes MK7 6AA, Bucks, England	University of Bristol; Chinese Academy of Sciences; Institute of Vertebrate Paleontology & Paleoanthropology, CAS; University College Dublin; Open University - UK	Benton, MJ (corresponding author), Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England.	mike.benton@bristol.ac.uk; zhonghe@yeah.net	Benton, Michael J/A-5639-2008	Benton, Michael J/0000-0002-4323-1824; Orr, Patrick/0000-0002-6740-1656	NERC; MST of China; National Natural Science Foundation of China; NERC [NE/E011055/1] Funding Source: UKRI; Natural Environment Research Council [NE/E011055/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); MST of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	We thank M. McNamara (University College Dublin), R. Prum (Yale University) and J. Simon (Duke University) for comments, and L. Leonard and N. Monaghan (National Museum of Ireland) for materials. This work was supported by the NERC, the Major Basic Research Projects of MST of China, and the National Natural Science Foundation of China.	Benton MJ, 2008, P GEOLOGIST ASSOC, V119, P209, DOI 10.1016/S0016-7878(08)80302-1; Chen PJ, 1998, NATURE, V391, P147, DOI 10.1038/34356; DURRER H, 1986, BIOL INTEGUMENT, V2, P239; Feduccia A, 2005, J MORPHOL, V266, P125, DOI 10.1002/jmor.10382; Ji Q, 1998, NATURE, V393, P753, DOI 10.1038/31635; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P563, DOI 10.1007/s00114-003-0483-7; Lingham-Soliar T, 2003, NATURWISSENSCHAFTEN, V90, P428, DOI 10.1007/s00114-003-0448-x; Lingham-Soliar T, 2007, P ROY SOC B-BIOL SCI, V274, P1823, DOI 10.1098/rspb.2007.0352; McGraw KJ., 2006, BIRD COLORATION, P243; Ortolani-Machado CF, 2009, TISSUE CELL, V41, P239, DOI 10.1016/j.tice.2008.11.005; Prum RO, 2005, J EXP ZOOL PART B, V304B, P570, DOI 10.1002/jez.b.21073; Prum RO, 2003, J EXP BIOL, V206, P2409, DOI 10.1242/jeb.00431; Prum RO, 2002, Q REV BIOL, V77, P261, DOI 10.1086/341993; Prum RO, 2002, P ROY SOC B-BIOL SCI, V269, P781, DOI 10.1098/rspb.2001.1896; Prum RO, 2006, BIRD COLORATION, V1, P295; Sawyer RH, 2003, J EXP ZOOL PART B, V297B, P27, DOI 10.1002/jez.b.00017; Vinther J, 2008, BIOL LETTERS, V4, P522, DOI 10.1098/rsbl.2008.0302; Vinther J, 2010, BIOL LETTERS, V6, P128, DOI 10.1098/rsbl.2009.0524; WUTTKE M, 1983, Senckenbergiana Lethaea, V64, P509; Xu X, 2003, NATURE, V421, P335, DOI 10.1038/nature01342; Xu X, 1999, NATURE, V401, P262, DOI 10.1038/45769; Xu X, 2005, NATURWISSENSCHAFTEN, V92, P173, DOI 10.1007/s00114-004-0604-y; Xu Xing, 2003, Vertebrata Palasiatica, V41, P195; Xu X, 2009, P NATL ACAD SCI USA, V106, P832, DOI 10.1073/pnas.0810055106; Zhang FC, 2000, SCIENCE, V290, P1955, DOI 10.1126/science.290.5498.1955; Zhang FC, 2004, NATURE, V431, P925, DOI 10.1038/431925a; Zhang FC, 2008, SCI CHINA SER D, V51, P625, DOI 10.1007/s11430-008-0050-3; Zhang FC, 2006, GEOL J, V41, P395, DOI 10.1002/gj.1057; Zheng XT, 2009, NATURE, V458, P333, DOI 10.1038/nature07856; Zhou ZH, 2003, NATURE, V421, P807, DOI 10.1038/nature01420	30	177	192	2	181	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1075	1078		10.1038/nature08740	http://dx.doi.org/10.1038/nature08740			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20107440	Green Accepted			2022-12-01	WOS:000275108400035
J	Marx, FG; Uhen, MD				Marx, Felix G.; Uhen, Mark D.			Climate, Critters, and Cetaceans: Cenozoic Drivers of the Evolution of Modern Whales	SCIENCE			English	Article							ANTARCTIC CIRCUMPOLAR CURRENT; SOUTHERN-OCEAN; DYNAMICS; NUTRIENT	Modern cetaceans, a poster child of evolution, play an important role in the ocean ecosystem as apex predators and nutrient distributors, as well as evolutionary "stepping stones" for the deep sea biota. Recent discussions on the impact of climate change and marine exploitation on current cetacean populations may benefit from insights into what factors have influenced cetacean diversity in the past. Previous studies suggested that the rise of diatoms as dominant marine primary producers and global temperature change were key factors in the evolution of modern whales. Based on a comprehensive diversity data set, we show that much of observed cetacean paleodiversity can indeed be explained by diatom diversity in conjunction with variations in climate as indicated by oxygen stable isotope records (delta(18)O).	[Marx, Felix G.] Univ Otago, Dept Geol, Dunedin 9016, Otago, New Zealand; [Marx, Felix G.] Univ Bristol, Dept Earth Sci, Bristol BS8 1RJ, Avon, England; [Uhen, Mark D.] George Mason Univ, Dept Atmospher Ocean & Earth Sci, Fairfax, VA 22030 USA	University of Otago; University of Bristol; George Mason University	Marx, FG (corresponding author), Univ Otago, Dept Geol, 360 Leith Walk,POB 56, Dunedin 9016, Otago, New Zealand.	f.g.marx@bristol.ac.uk	Uhen, Mark D/AAZ-3158-2020; Marx, Felix Georg/AAI-3480-2021	Uhen, Mark D/0000-0002-2689-0801; Marx, Felix Georg/0000-0002-1029-4001	University of Otago	University of Otago	We thank three referees for their comments, as well as G. Hunt for advice and help with R programming and M. Katz for the provision of data. L. Kavalieris, I. Jolliffe, M. Carrano, D. Thomas, M. Benton, and the participants of the August 2009 Encyclopedia of Life synthesis meeting on marine tetrapod evolution at the Field Museum, Chicago, provided advice and helpful discussions about earlier versions of this work and related topics. F. M. was supported by a University of Otago Postgraduate Scholarship. This is Paleobiology Database publication 108.	Bannister J.L., 2008, ENCY MARINE MAMMALS, V2nd, P80; Barker PF, 2007, DEEP-SEA RES PT II, V54, P2388, DOI 10.1016/j.dsr2.2007.07.028; Barker PF, 2004, EARTH-SCI REV, V66, P143, DOI 10.1016/j.earscirev.2003.10.003; BARRETT PM, 2009, R SOC B, V276, P2667; Berger WH, 2007, DEEP-SEA RES PT II, V54, P2399, DOI 10.1016/j.dsr2.2007.07.024; Burnham KP, 2001, MODEL SELECTION MULT; Crampton JS, 2003, SCIENCE, V301, P358, DOI 10.1126/science.1085075; Fordyce RE, 2003, J VERTEBR PALEONTOL, V23, p50A; FORDYCE RE, 1977, PALAEOGEOGR PALAEOCL, V21, P265; FORDYCE RE, 1980, PALAEOGEOGR PALAEOCL, V31, P319, DOI 10.1016/0031-0182(80)90024-3; FORDYCE RE, 2003, EOCENE OLIGOCENE TRA, P154; HAECKEL E, 1899, KUNSTFORMEN NATUR; Le Quere C, 2005, GLOBAL CHANGE BIOL, V11, P2016, DOI 10.1111/j.1365-2468.2005.01004.x; LIPPS J H, 1976, Paleobiology, V2, P147; Maddala G. S., 1986, LTD DEPENDENT QUALIT; MITCHELL ED, 1989, CAN J FISH AQUAT SCI, V46, P2219, DOI 10.1139/f89-273; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Peters SE, 2005, P NATL ACAD SCI USA, V102, P12326, DOI 10.1073/pnas.0502616102; Peters SE, 2001, PALEOBIOLOGY, V27, P583, DOI 10.1666/0094-8373(2001)027<0583:BITPAR>2.0.CO;2; Pondaven P, 1999, DEEP-SEA RES PT I, V46, P1923, DOI 10.1016/S0967-0637(99)00033-3; RYTHER JH, 1969, SCIENCE, V166, P72, DOI 10.1126/science.166.3901.72; Sarmiento JL, 2004, NATURE, V427, P56, DOI 10.1038/nature02127; Smith AB, 2007, PALAEONTOLOGY, V50, P765, DOI 10.1111/j.1475-4983.2007.00693.x; Spencer-Cervato Cinzia, 1999, Palaeontologia Electronica, V2, pUnpaginated; SUGIURA N, 1978, COMMUN STAT A-THEOR, V7, P13, DOI 10.1080/03610927808827599; Whitehead H, 2008, ECOL LETT, V11, P1198, DOI 10.1111/j.1461-0248.2008.01234.x; Zachos JC, 2008, NATURE, V451, P279, DOI 10.1038/nature06588	27	144	148	1	109	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	FEB 19	2010	327	5968					993	996		10.1126/science.1185581	http://dx.doi.org/10.1126/science.1185581			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556XE	20167785	Green Published			2022-12-01	WOS:000274625800039
J	Cals, JWL; Francis, NA				Cals, Jochen W. L.; Francis, Nick A.			10-Minute Consultation Acute cough in adults	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Cals, Jochen W. L.] Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, NL-6200 MD Maastricht, Netherlands; [Francis, Nick A.] Cardiff Univ, Sch Med, Dept Publ Hlth & Primary Care, Cardiff CF14 4XN, S Glam, Wales	Maastricht University; Cardiff University	Cals, JWL (corresponding author), Maastricht Univ, CAPHRI Sch Publ Hlth & Primary Care, Dept Gen Practice, POB 616, NL-6200 MD Maastricht, Netherlands.	j.cals@hag.unimaas.nl	Cals, Jochen WL/A-1262-2007; Francis, Nick/B-7413-2009	Cals, Jochen WL/0000-0001-9550-5674; Francis, Nick/0000-0001-8939-7312	Netherlands Organisation for Health Research and Development (ZonMW)	Netherlands Organisation for Health Research and Development (ZonMW)(Netherlands Organization for Health Research and Development)	JWLC is supported by a grant of the Netherlands Organisation for Health Research and Development (ZonMW) as an MD medical research trainee.		0	3	3	0	4	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 12	2010	340								c574	10.1136/bmj.c574	http://dx.doi.org/10.1136/bmj.c574			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	555AB	20154050	Green Accepted			2022-12-01	WOS:000274477800002
J	Ide, S; Miyazaki, T; Maki, H; Kobayashi, T				Ide, Satoru; Miyazaki, Takaaki; Maki, Hisaji; Kobayashi, Takehiko			Abundance of Ribosomal RNA Gene Copies Maintains Genome Integrity	SCIENCE			English	Article							BUDDING YEAST CHROMOSOMES; SISTER-CHROMATID COHESION; SACCHAROMYCES-CEREVISIAE; DNA-DAMAGE; CONDENSIN; REPLICATION; TRANSCRIPTION; SEGREGATION; MUTANTS; REVEALS	The ribosomal RNA (rDNA) gene repeats are essential housekeeping genes found in all organisms. A gene amplification system maintains large cluster(s) of tandemly repeated copies in the chromosome, with each species having a specific number of copies. Yeast has many untranscribed rDNA copies (extra copies), and we found that when they are lost, the cells become sensitive to DNA damage induced by mutagens. We show that this sensitivity is dependent on rDNA transcriptional activity, which interferes with cohesion between rDNA loci of sister chromatids. The extra rDNA copies facilitate condensin association and sister-chromatid cohesion, thereby facilitating recombinational repair. These results suggest that high concentrations of heavily transcribed genes are toxic to the cells, and therefore amplified genes, such as rDNA, have evolved.	[Ide, Satoru; Miyazaki, Takaaki; Kobayashi, Takehiko] Natl Inst Genet, Mishima, Shizuoka 4118540, Japan; [Miyazaki, Takaaki; Kobayashi, Takehiko] Grad Univ Adv Studies, Mishima, Shizuoka 4118540, Japan; [Maki, Hisaji] Nara Inst Sci & Technol, Dept Mol Biol, Grad Sch Biol Sci, Nara 6300101, Japan	Research Organization of Information & Systems (ROIS); National Institute of Genetics (NIG) - Japan; Graduate University for Advanced Studies - Japan; Nara Institute of Science & Technology	Kobayashi, T (corresponding author), Natl Inst Genet, 1111 Yata, Mishima, Shizuoka 4118540, Japan.	takobaya@lab.nig.ac.jp			Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan [17080010, 21247003, 17370065]	Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT))	We thank M. Nomura (University of California, Irvine), H. Araki National Institute of Genetics, Japan (NIG), A. Murray (Harvard University), and K. Shimada (Friedrich Miescher Institute, Switzerland) for kindly providing plasmids and strains. We thank A. R. D. Ganley (Massey University) and T. Iida (NIG) for critical reading and comments on the manuscript. This work was supported in part by grants-in-aid for Scientific Research (17080010, 21247003, and 17370065 to T. K.) from the Ministry of Education, Culture, Sports, Science, and Technology (MEXT), Japan.	Aono N, 2002, NATURE, V417, P197, DOI 10.1038/417197a; Bhalla N, 2002, MOL BIOL CELL, V13, P632, DOI 10.1091/mbc.01-05-0264; BREWER BJ, 1987, CELL, V51, P463, DOI 10.1016/0092-8674(87)90642-8; Chang M, 2002, P NATL ACAD SCI USA, V99, P16934, DOI 10.1073/pnas.262669299; Cortes-Ledesma F, 2006, EMBO REP, V7, P919, DOI 10.1038/sj.embor.7400774; D'Ambrosio C, 2008, GENE DEV, V22, P2215, DOI 10.1101/gad.1675708; French SL, 2003, MOL CELL BIOL, V23, P1558, DOI 10.1128/MCB.23.5.1558-1568.2003; Ide S, 2007, MOL CELL BIOL, V27, P568, DOI 10.1128/MCB.00731-06; Johzuka K, 2007, GENES CELLS, V12, P759, DOI 10.1111/j.1365-2443.2007.01085.x; Kobayashi T, 2005, SCIENCE, V309, P1581, DOI 10.1126/science.1116102; Lacefield S, 2007, NAT GENET, V39, P1273, DOI 10.1038/ng2120; Lam WW, 2006, GENE DEV, V20, P2973, DOI 10.1101/gad.1468806; NOMURA M, 1977, ANNU REV GENET, V11, P297, DOI 10.1146/annurev.ge.11.120177.001501; Sjogren C, 2001, CURR BIOL, V11, P991, DOI 10.1016/S0960-9822(01)00271-8; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Unal E, 2004, MOL CELL, V16, P991, DOI 10.1016/j.molcel.2004.11.027; Wang BD, 2006, CELL CYCLE, V5, P2260, DOI 10.4161/cc.5.19.3292; Warner JR, 1999, TRENDS BIOCHEM SCI, V24, P437, DOI 10.1016/S0968-0004(99)01460-7; Zou H, 1997, CELL, V90, P87, DOI 10.1016/S0092-8674(00)80316-5	20	210	214	0	26	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 5	2010	327	5966					693	696		10.1126/science.1179044	http://dx.doi.org/10.1126/science.1179044			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551ZD	20133573				2022-12-01	WOS:000274251800039
J	Draghi, JA; Parsons, TL; Wagner, GP; Plotkin, JB				Draghi, Jeremy A.; Parsons, Todd L.; Wagner, Guenter P.; Plotkin, Joshua B.			Mutational robustness can facilitate adaptation	NATURE			English	Article							GENE NETWORKS; PROMOTES EVOLVABILITY; DIGITAL ORGANISMS; EVOLUTION; INNOVATION; SELECTION; RNA	Robustness seems to be the opposite of evolvability. If phenotypes are robust against mutation, we might expect that a population will have difficulty adapting to an environmental change, as several studies have suggested(1-4). However, other studies contend that robust organisms are more adaptable(5-8). A quantitative understanding of the relationship between robustness and evolvability will help resolve these conflicting reports and will clarify outstanding problems in molecular and experimental evolution, evolutionary developmental biology and protein engineering. Here we demonstrate, using a general population genetics model, that mutational robustness can either impede or facilitate adaptation, depending on the population size, the mutation rate and the structure of the fitness landscape. In particular, neutral diversity in a robust population can accelerate adaptation as long as the number of phenotypes accessible to an individual by mutation is smaller than the total number of phenotypes in the fitness landscape. These results provide a quantitative resolution to a significant ambiguity in evolutionary theory.	[Draghi, Jeremy A.; Parsons, Todd L.; Plotkin, Joshua B.] Univ Penn, Dept Biol, Philadelphia, PA 19104 USA; [Plotkin, Joshua B.] Univ Penn, Program Appl Math & Computat Sci, Philadelphia, PA 19104 USA; [Wagner, Guenter P.] Yale Univ, Dept Ecol & Evolutionary Biol, New Haven, CT 06520 USA	University of Pennsylvania; University of Pennsylvania; Yale University	Plotkin, JB (corresponding author), Univ Penn, Dept Biol, Philadelphia, PA 19104 USA.	jplotkin@sas.upenn.edu	Plotkin, Joshua B/E-6947-2013	Wagner, Gunter/0000-0002-3097-002X	Burroughs Wellcome Fund; David and Lucile Packard Foundation; James S. McDonnell Foundation; Alfred P. Sloan Foundation; Defense Advanced Research Projects Agency [HR0011-05-1-0057]; US National Institute of Allergy and Infectious Diseases [2U54AI057168]; John Templeton Foundation; Perinatology Research Branch of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057168] Funding Source: NIH RePORTER	Burroughs Wellcome Fund(Burroughs Wellcome Fund); David and Lucile Packard Foundation(The David & Lucile Packard Foundation); James S. McDonnell Foundation; Alfred P. Sloan Foundation(Alfred P. Sloan Foundation); Defense Advanced Research Projects Agency(United States Department of DefenseDefense Advanced Research Projects Agency (DARPA)); US National Institute of Allergy and Infectious Diseases(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); John Templeton Foundation; Perinatology Research Branch of the US National Institutes of Health; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	We thank P. Turner and members of the Plotkin laboratory for advice and feedback. J.B.P. acknowledges funding from the Burroughs Wellcome Fund, the David and Lucile Packard Foundation, the James S. McDonnell Foundation, the Alfred P. Sloan Foundation, the Defense Advanced Research Projects Agency (HR0011-05-1-0057) and the US National Institute of Allergy and Infectious Diseases (2U54AI057168). G. P. W. acknowledges funding from the John Templeton Foundation and the Perinatology Research Branch of the US National Institutes of Health.	Aldana M, 2007, J THEOR BIOL, V245, P433, DOI 10.1016/j.jtbi.2006.10.027; Ancel LW, 2000, J EXP ZOOL, V288, P242, DOI 10.1002/1097-010X(20001015)288:3<242::AID-JEZ5>3.0.CO;2-O; Bergman A, 2003, NATURE, V424, P549, DOI 10.1038/nature01765; Bloom JD, 2006, P NATL ACAD SCI USA, V103, P5869, DOI 10.1073/pnas.0510098103; Blount ZD, 2008, P NATL ACAD SCI USA, V105, P7899, DOI 10.1073/pnas.0803151105; Cambray G, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000256; Carter AJR, 2005, THEOR POPUL BIOL, V68, P179, DOI 10.1016/j.tpb.2005.05.002; Ciliberti S, 2007, P NATL ACAD SCI USA, V104, P13591, DOI 10.1073/pnas.0705396104; Cowperthwaite MC, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000110; Daniels BC, 2008, CURR OPIN BIOTECH, V19, P389, DOI 10.1016/j.copbio.2008.06.008; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Elena SF, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-284; Fontana W, 1998, SCIENCE, V280, P1451, DOI 10.1126/science.280.5368.1451; Forster R, 2006, J THEOR BIOL, V243, P181, DOI 10.1016/j.jtbi.2006.06.020; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Kirschner M, 2005, PLAUSIBILITY LIFE RE; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Krakauer DC, 2002, P NATL ACAD SCI USA, V99, P1405, DOI 10.1073/pnas.032668599; Lenski RE, 2006, PLOS BIOL, V4, P2190, DOI 10.1371/journal.pbio.0040428; McBride RC, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-231; Meyers LA, 2005, PLOS COMPUT BIOL, V1, P236, DOI 10.1371/journal.pcbi.0010032; Parter M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000206; Rutherford SL, 1998, NATURE, V396, P336, DOI 10.1038/24550; Sumedha, 2007, BIOSYSTEMS, V90, P475, DOI 10.1016/j.biosystems.2006.11.007; van Nimwegen E, 1999, P NATL ACAD SCI USA, V96, P9716, DOI 10.1073/pnas.96.17.9716; van Nimwegen E, 2006, SCIENCE, V314, P1884, DOI 10.1126/science.1137300; Wagner A., 2005, ROBUSTNESS EVOLVABIL; Wagner A, 2008, P ROY SOC B-BIOL SCI, V275, P91, DOI 10.1098/rspb.2007.1137; Wilds R, 2008, CHAOS, V18, DOI 10.1063/1.2962223; Wilke CO, 2001, NATURE, V412, P331, DOI 10.1038/35085569	30	225	228	0	56	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					353	355		10.1038/nature08694	http://dx.doi.org/10.1038/nature08694			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090752	Green Accepted			2022-12-01	WOS:000273748100043
J	Conteh, L; Engels, T; Molyneux, DH				Conteh, Lesong; Engels, Thomas; Molyneux, David H.			Neglected Tropical Diseases 4 Socioeconomic aspects of neglected tropical diseases	LANCET			English	Review							COMMUNITY-DIRECTED TREATMENT; SCHOOL DEWORMING PROGRAM; COST-EFFECTIVENESS; ONCHOCERCIASIS CONTROL; HEMORRHAGIC-FEVER; INCOME COUNTRIES; AFRICAN PROGRAM; ECONOMIC-IMPACT; BURULI ULCER; HEALTH	Although many examples of highly cost-effective interventions to control neglected tropical diseases exist, our understanding of the full economic effect that these diseases have on individuals, households, and nations needs to be improved to target interventions more effectively and equitably. We review data for the effect of neglected tropical diseases on a population's health and economy. We also present evidence on the costs, cost-effectiveness, and financing of strategies to monitor, control, or reduce morbidity and mortality associated with these diseases. We explore the potential for economies of scale and scope in terms of the costs and benefits of successfully delivering large-scale and integrated interventions. The low cost of neglected tropical disease control is driven by four factors: the commitment of pharmaceutical companies to provide free drugs; the scale of programmes; the opportunities for synergising delivery modes; and the often non-remunerated volunteer contribution of communities and teachers in drug distribution. Finally, we make suggestions for future economic research.	[Conteh, Lesong] Univ London London Sch Hyg & Trop Med, London WC1E 7HT, England; [Engels, Thomas] Int Consulting, Brussels, Belgium; [Molyneux, David H.] Univ Liverpool, Liverpool Sch Trop Med, Liverpool L3 5QA, Merseyside, England	University of London; London School of Hygiene & Tropical Medicine; Liverpool School of Tropical Medicine; University of Liverpool	Conteh, L (corresponding author), Univ London London Sch Hyg & Trop Med, Keppel St, London WC1E 7HT, England.	lesong.conteh@lshtm.ac.uk	Conteh, Lesong/ABE-9550-2020	Conteh, Lesong/0000-0002-0719-3672	GlaxoSmithKline	GlaxoSmithKline(GlaxoSmithKline)	DHM is the executive secretary of the Global Alliance to Eliminate Lymphatic Filariasis. Since 2000, he has received grants from the UK Department for International Development, which includes a 25% contribution from GlaxoSmithKline to the Liverpool School of Tropical Medicine. He attends meetings of the Mectizan Donation Program and is supported by GlaxoSmithKline and Merck to provide independent scientific advice to programmes. The other authors declare that they have no conflicts of interest.	Alvar J, 2006, TRENDS PARASITOL, V22, P552, DOI 10.1016/j.pt.2006.09.004; Amazigo U, 2008, ANN TROP MED PARASIT, V102, P1, DOI 10.1179/136485908X311885; Amazigo U, 2007, SOC SCI MED, V64, P2070, DOI 10.1016/j.socscimed.2007.01.018; *APOC, 2006, ONCH CONTR PARTN M S; *APOC, 2006, 11 SESS JOINT ACT FO; Blackburn BG, 2006, AM J TROP MED HYG, V75, P650, DOI 10.4269/ajtmh.2006.75.650; Blas B. L., 2006, Southeast Asian Journal of Tropical Medicine and Public Health, V37, P26; Bleakley H, 2007, Q J ECON, V122, P73, DOI 10.1162/qjec.121.1.73; BOATIN BA, 2006, ADV PARASIT, P349; Brady MA, 2006, TRENDS PARASITOL, V22, P285, DOI 10.1016/j.pt.2006.05.007; Brooker S, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000291; Brooker S, 2008, HEALTH POLICY PLANN, V23, P24, DOI 10.1093/heapol/czm041; Brooker S, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-99; Budke CM, 2005, AM J TROP MED HYG, V73, P2, DOI 10.4269/ajtmh.2005.73.2; Bundy DAP, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000362; Canning D, 2006, T ROY SOC TROP MED H, V100, P499, DOI 10.1016/j.trstmh.2006.02.001; CARABIN H, MONETARY BURDEN TAEN; Castillo-Riquelme M, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000336; Clark DV, 2005, AM J TROP MED HYG, V72, P786, DOI 10.4269/ajtmh.2005.72.786; Clarke SE, 2008, LANCET, V372, P127, DOI 10.1016/S0140-6736(08)61034-X; CROMPTON D, DFID SUPPORT CONTROL; *DEP CONTR NEGL TR, 2006, NEGL TROP DIS PREV T; Dixon S, 2002, BRIT MED J, V324, P232, DOI 10.1136/bmj.324.7331.232; Engels D, 2006, TRENDS PARASITOL, V22, P363, DOI 10.1016/j.pt.2006.06.004; Fenwick A, 2005, LANCET, V365, P1029, DOI 10.1016/s0140-6736(05)71134-x; Fevre EM, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-96; Frick KD, 2003, AM J TROP MED HYG, V69, P1; Gallup JL, 2001, AM J TROP MED HYG, V64, P85, DOI 10.4269/ajtmh.2001.64.85; Garg P, 2008, T ROY SOC TROP MED H, V102, P570, DOI 10.1016/j.trstmh.2008.02.015; Gilgen D, 2001, TROP MED INT HEALTH, V6, P449, DOI 10.1046/j.1365-3156.2001.00729.x; Goldman AS, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000067; Grietens KP, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000321; Guinness Lorna, 2007, Cost Eff Resour Alloc, V5, P13, DOI 10.1186/1478-7547-5-13; Guyatt HL, 2001, B WORLD HEALTH ORGAN, V79, P695; HADDIX A, 1999, JOINT SESS HAG DEC 8; Harving ML, 2007, DAN MED BULL, V54, P170; Hodgkin C, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000074; Homeida M, 2002, ANN TROP MED PARASIT, V96, P93, DOI 10.1179/000349802125000673; Hotez P, 2006, LANCET, V367, P563, DOI 10.1016/S0140-6736(06)68213-5; Hotez PJ, 2007, NEW ENGL J MED, V357, P1018, DOI 10.1056/NEJMra064142; Hotez PJ, 2006, VACCINE, V24, P5787, DOI 10.1016/j.vaccine.2006.05.008; Hotez PJ, 2006, PLOS MED, V3, P576, DOI 10.1371/journal.pmed.0030102; Hotez PJ, 2009, LANCET, V373, P1570, DOI 10.1016/S0140-6736(09)60233-6; Hotez PJ, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000430; Hotez PJ, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000230; International Monetary Fund, WORLD EC OUTL DAT; Jamison DT, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P3, DOI 10.1596/978-0-8213-6179-5/Chpt-1; Jha P, 2002, SCIENCE, V295, P2036, DOI 10.1126/science.295.5562.2036; Kabatereine NB, 2006, TRENDS PARASITOL, V22, P332, DOI 10.1016/j.pt.2006.05.001; Kamel M. I., 2001, Journal of the Egyptian Society of Parasitology, V31, P153; King CH, 2005, LANCET, V365, P1561, DOI 10.1016/S0140-6736(05)66457-4; King CH, 2008, CHRONIC ILLN, V4, P65, DOI 10.1177/1742395307084407; Kirigia J M, 2000, Afr J Health Sci, V7, P55; Kumaranayake L, 2000, HEALTH POLICY PLANN, V15, P230, DOI 10.1093/heapol/15.2.230; Laxminarayan R, 2006, LANCET, V367, P1193, DOI 10.1016/S0140-6736(06)68440-7; Laxminarayan R, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P35; MAUMMA GA, 2006, ANN M WHO GLOB BUR U; MCFARLAND DA, COST EVALUATION CDTI; Miguel E, 2004, ECONOMETRICA, V72, P159, DOI 10.1111/j.1468-0262.2004.00481.x; Molyneux DH, 2008, T ROY SOC TROP MED H, V102, P509, DOI 10.1016/j.trstmh.2008.02.024; Molyneux DH, 2009, LANCET, V373, P296, DOI 10.1016/S0140-6736(09)60089-1; Molyneux DH, 2005, PLOS MED, V2, P1064, DOI 10.1371/journal.pmed.0020336; Molyneux DH, 2005, EYE, V19, P1050, DOI 10.1038/sj.eye.6701961; Molyneux DH, 2004, LANCET, V364, P380, DOI 10.1016/S0140-6736(04)16728-7; Montresor A, 2007, T ROY SOC TROP MED H, V101, P461, DOI 10.1016/j.trstmh.2006.07.008; Morel CM, 2005, BMJ-BRIT MED J, V331, P1299, DOI 10.1136/bmj.38639.702384.AE; Mulder AA, 2008, T ROY SOC TROP MED H, V102, P912, DOI 10.1016/j.trstmh.2008.05.026; MURRAY CJL, 1996, GLOBAL BURDEN DIS AX; Ndhlovu P, 2007, T ROY SOC TROP MED H, V101, P433, DOI 10.1016/j.trstmh.2006.08.008; Ottesen EA, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000317; OVER M, 1992, HLTH ADULTS DEV WORL, P161; Perera M, 2007, PLOS NEGLECT TROP D, V1, DOI 10.1371/journal.pntd.0000128; Phommasack B, 2008, T ROY SOC TROP MED H, V102, P1201, DOI 10.1016/j.trstmh.2008.04.036; Ramzy Reda M R, 2005, Filaria J, V4, P7, DOI 10.1186/1475-2883-4-7; Raso G, 2004, INT J EPIDEMIOL, V33, P1092, DOI 10.1093/ije/dyh241; Remme JHF, 2006, DISEASE CONTROL PRIORITIES IN DEVELOPING COUNTRIES, 2ND EDITION, P433; Rheingans Richard D, 2004, Filaria J, V3, P2, DOI 10.1186/1475-2883-3-2; Sachs JD, 2006, SCIENCE, V311, P1521, DOI 10.1126/science.1126851; Sakti H, 1999, TROP MED INT HEALTH, V4, P322, DOI 10.1046/j.1365-3156.1999.00410.x; Sauerborn R, 1996, SOC SCI MED, V43, P291, DOI 10.1016/0277-9536(95)00375-4; Seketeli A., 2002, Annals of Tropical Medicine and Parasitology, V96, pS15, DOI 10.1179/000349802125000628; Shillcutt SD, 2009, PHARMACOECONOMICS, V27, P903, DOI 10.2165/10899580-000000000-00000; Sinuon M, 2005, T ROY SOC TROP MED H, V99, P664, DOI 10.1016/j.trstmh.2004.12.004; Smith RD, 2005, J HEALTH ECON, V24, P1055, DOI 10.1016/j.jhealeco.2005.02.003; *STAT BOL, CPI INFL CALC; Stoever K, 2009, LANCET, V373, P2025, DOI 10.1016/S0140-6736(09)61111-9; STROSBERG AM, 2007, CHAGAS DIS LATIN AM, P1; TAN-TORRES TE, 2003, MAKING CHOICES HLTH; Teklehaimanot A, 2007, LANCET, V369, P2143, DOI 10.1016/S0140-6736(07)60951-9; Torgerson PR, 2003, ACTA TROP, V85, P113, DOI 10.1016/S0001-706X(02)00228-0; Valdmanis V, 2003, INT J TECHNOL ASSESS, V19, P692, DOI 10.1017/S0266462303000655; Wang LD, 2008, LANCET, V372, P1793, DOI 10.1016/S0140-6736(08)61358-6; Waters HR, 2004, TROP MED INT HEALTH, V9, pA16, DOI 10.1111/j.1365-3156.2004.01210.x; Weiss MG, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000237; Whitehead M, 2001, LANCET, V358, P833, DOI 10.1016/S0140-6736(01)05975-X; *WHO, FIN CRIS GLOB HLTH; *WHO, COMM DIR INT MAJ HLT; World Health Organization, 2007, GLOB PLAN COMB NEGL; World Health Organization, 2006, PREV CHEM HUM HELM C; Xu K, 2003, LANCET, V362, P111, DOI 10.1016/S0140-6736(03)13861-5; INT DRUG PRICE INDIC	101	169	173	0	41	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	JAN 16	2010	375	9710					239	247		10.1016/S0140-6736(09)61422-7	http://dx.doi.org/10.1016/S0140-6736(09)61422-7			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	546ZH	20109925				2022-12-01	WOS:000273853800034
J	England, J				England, John			Canada needs a polar policy	NATURE			English	Editorial Material									Univ Alberta, Edmonton, AB T6G 2E3, Canada	University of Alberta	England, J (corresponding author), Univ Alberta, Edmonton, AB T6G 2E3, Canada.	john.england@ualberta.ca							0	5	5	0	6	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	JAN 14	2010	463	7278					159	159		10.1038/463159a	http://dx.doi.org/10.1038/463159a			1	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075900	Bronze			2022-12-01	WOS:000273582700017
J	Moldovan, GL; D'Andrea, AD				Moldovan, George-Lucian; D'Andrea, Alan D.			FANCD2 Hurdles the DNA Interstrand Crosslink	CELL			English	Editorial Material							FANCONI-ANEMIA; REPAIR		[Moldovan, George-Lucian; D'Andrea, Alan D.] Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Radiat Oncol, Boston, MA 02215 USA	Harvard University; Dana-Farber Cancer Institute; Harvard Medical School	D'Andrea, AD (corresponding author), Harvard Univ, Dana Farber Canc Inst, Sch Med, Dept Radiat Oncol, 44 Binney St, Boston, MA 02215 USA.	alan_dandrea@dfci.harvard.edu	Classen, Scott/AAY-8176-2020	George-Lucian, Moldovan/0000-0003-3825-149X	NATIONAL CANCER INSTITUTE [P01CA092584] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL052725, R37HL052725] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI067751] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043889] Funding Source: NIH RePORTER; NCI NIH HHS [P01CA092584, P01 CA092584, P01 CA092584-09] Funding Source: Medline; NHLBI NIH HHS [R37 HL052725, R01 HL052725, R37 HL052725-16] Funding Source: Medline; NIAID NIH HHS [U19 AI067751-05, U19 AI067751] Funding Source: Medline; NIDDK NIH HHS [R01 DK043889, R01 DK043889-17] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ben-Yehoyada M, 2009, MOL CELL, V35, P704, DOI 10.1016/j.molcel.2009.08.014; Bienko M, 2005, SCIENCE, V310, P1821, DOI 10.1126/science.1120615; Howlett NG, 2002, SCIENCE, V297, P606, DOI 10.1126/science.1073834; KNIPSCHEER P, 2009, SCIENCE         1112, DOI DOI 10.1126/SCIENCE.1182372; Mirchandani KD, 2008, DNA REPAIR, V7, P902, DOI 10.1016/j.dnarep.2008.03.001; Moldovan GL, 2009, ANNU REV GENET, V43, P223, DOI 10.1146/annurev-genet-102108-134222; Niedzwiedz W, 2004, MOL CELL, V15, P607, DOI 10.1016/j.molcel.2004.08.009; Patel KJ, 2007, DNA REPAIR, V6, P885, DOI 10.1016/j.dnarep.2007.02.002; Raschle M, 2008, CELL, V134, P969, DOI 10.1016/j.cell.2008.08.030	9	18	18	0	2	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	DEC 24	2009	139	7					1222	1224		10.1016/j.cell.2009.12.006	http://dx.doi.org/10.1016/j.cell.2009.12.006			4	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064367	Bronze, Green Accepted			2022-12-01	WOS:000273048700009
J	Olmedo-Monfil, V; Duran-Figueroa, N; Arteaga-Vazquez, M; Demesa-Arevalo, E; Autran, D; Grimanelli, D; Slotkin, RK; Martienssen, RA; Vielle-Calzada, JP				Olmedo-Monfil, Vianey; Duran-Figueroa, Noe; Arteaga-Vazquez, Mario; Demesa-Arevalo, Edgar; Autran, Daphne; Grimanelli, Daniel; Slotkin, R. Keith; Martienssen, Robert A.; Vielle-Calzada, Jean-Philippe			Control of female gamete formation by a small RNA pathway in Arabidopsis	NATURE			English	Article							TRANS-ACTING SIRNAS; GENE; BIOGENESIS; EXPRESSION; GENOME	In the ovules of most sexual flowering plants female gametogenesis is initiated from a single surviving gametic cell, the functional megaspore, formed after meiosis of the somatically derived megaspore mother cell (MMC)(1,2). Because some mutants and certain sexual species exhibit more than one MMC2-4, and many others are able to form gametes without meiosis (by apomixis)(5), it has been suggested that somatic cells in the ovule are competent to respond to a local signal likely to have an important function in determination(6). Here we show that the Arabidopsis protein ARGONAUTE 9 (AGO9) controls female gamete formation by restricting the specification of gameto-phyte precursors in a dosage-dependent, non-cell-autonomous manner. Mutations in AGO9 lead to the differentiation of multiple gametic cells that are able to initiate gametogenesis. The AGO9 protein is not expressed in the gamete lineage; instead, it is expressed in cytoplasmic foci of somatic companion cells. Mutations in SUPPRESSOR OF GENE SILENCING 3 and RNA-DEPENDENT RNA POLYMERASE 6 exhibit an identical defect to ago9 mutants, indicating that the movement of small RNA (sRNAs) silencing out of somatic companion cells is necessary for controlling the specification of gametic cells. AGO9 preferentially interacts with 24-nucleotide sRNAs derived from transposable elements (TEs), and its activity is necessary to silence TEs in female gametes and their accessory cells. Our results show that AGO9-dependent sRNA silencing is crucial to specify cell fate in the Arabidopsis ovule, and that epigenetic reprogramming in companion cells is necessary for sRNA-dependent silencing in plant gametes.	[Olmedo-Monfil, Vianey; Duran-Figueroa, Noe; Arteaga-Vazquez, Mario; Demesa-Arevalo, Edgar; Vielle-Calzada, Jean-Philippe] Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Grp Desarrollo Reprod & Apomixis, Guanajuato 36500, Mexico; [Olmedo-Monfil, Vianey; Duran-Figueroa, Noe; Arteaga-Vazquez, Mario; Demesa-Arevalo, Edgar; Vielle-Calzada, Jean-Philippe] Cinvestav Irapuato, Dept Ingn Genet Plantas, Guanajuato 36500, Mexico; [Autran, Daphne; Grimanelli, Daniel] Inst Rech Dev, UMR 5096, F-34394 Montpellier, France; [Slotkin, R. Keith; Martienssen, Robert A.] Cold Spring Harbor Lab, Cold Spring Harbor, NY 11724 USA	CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; CINVESTAV - Centro de Investigacion y de Estudios Avanzados del Instituto Politecnico Nacional; Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); Universite Perpignan Via Domitia; Institut de Recherche pour le Developpement (IRD); Universite de Montpellier; Cold Spring Harbor Laboratory	Vielle-Calzada, JP (corresponding author), Cinvestav Irapuato, Lab Nacl Genom Biodiversidad, Grp Desarrollo Reprod & Apomixis, Guanajuato 36500, Mexico.	vielle@ira.cinvestav.mx	Duran, Francisco/A-5373-2011; Slotkin, R. Keith/H-6965-2013; Vielle-Calzada, Jean-Philippe/AAG-4036-2019; Autran, Daphné/AAV-4792-2021; Grimanelli, Daniel/ABE-4777-2020; Demesa-Arevalo, Edgar/AAX-8477-2020; Autran, Daphné/D-4846-2009; Arteaga-Vazquez, Mario/M-1545-2019; Arteaga-Vazquez, Mario Alberto/AAB-7979-2022	Slotkin, R. Keith/0000-0001-9582-3533; Autran, Daphné/0000-0002-5227-8966; Demesa-Arevalo, Edgar/0000-0002-2793-5928; Autran, Daphné/0000-0002-5227-8966; Arteaga-Vazquez, Mario Alberto/0000-0002-9435-0049; Grimanelli, Daniel/0000-0001-5424-114X; DURAN-FIGUEROA, NOE/0000-0002-2830-7325	IRD-France; ANR; NIH; NSF; Consejo Nacional de Ciencia y Tecnologia; Consejo Estatal de Ciencia y Tecnologia de Guanajuato; Howard Hughes Medical Institute; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM067014] Funding Source: NIH RePORTER	IRD-France; ANR(French National Research Agency (ANR)); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NSF(National Science Foundation (NSF)); Consejo Nacional de Ciencia y Tecnologia(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); Consejo Estatal de Ciencia y Tecnologia de Guanajuato; Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank N. Sanchez for sharing the pFM2 marker, E. Demunck for technical assistance during cloning and sequencing, S. Poethig, J. Carrington, T. Lagrange and the Arabidopsis Stock Center for providing mutants, J. Mendiola and C. Alvarez for help with genetic and bioinformatic analysis, and R. Jorgensen for critically reading the manuscript. This work was supported by IRD-France and ANR ( D. A. and D. G.), NIH and NSF (R. K. S. and R. A. M), Consejo Nacional de Ciencia y Tecnologia ( V.O.-M., N.D.-F., M.A.-V., E.D.-A. and J.-P. V.-C.), Consejo Estatal de Ciencia y Tecnologia de Guanajuato (J.-P.V.-C.), and the Howard Hughes Medical Institute (J.-P.V.-C.).	Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Bass HW, 2000, J CELL SCI, V113, P1033; Baumberger N, 2005, P NATL ACAD SCI USA, V102, P11928, DOI 10.1073/pnas.0505461102; Bicknell RA, 2004, PLANT CELL, V16, pS228, DOI 10.1105/tpc.017921; Chen XM, 2009, ANNU REV CELL DEV BI, V25, P21, DOI 10.1146/annurev.cellbio.042308.113417; Chitwood DH, 2009, GENE DEV, V23, P549, DOI 10.1101/gad.1770009; Garcia-Aguilar M, 2005, PLANT MOL BIOL REP, V23, P279, DOI 10.1007/BF02772758; Grossniklaus U, 1998, SEMIN CELL DEV BIOL, V9, P227, DOI 10.1006/scdb.1997.0214; Himber C, 2003, EMBO J, V22, P4523, DOI 10.1093/emboj/cdg431; Huanca-Mamani W, 2005, P NATL ACAD SCI USA, V102, P17231, DOI 10.1073/pnas.0508186102; Kasahara RD, 2005, PLANT CELL, V17, P2981, DOI 10.1105/tpc.105.034603; Klattenhoff C, 2008, DEVELOPMENT, V135, P3, DOI 10.1242/dev.006486; Maheswari P., 1950, INTRO EMBRYOLOGY ANG; Mosher RA, 2009, NATURE, V460, P283, DOI 10.1038/nature08084; Nonomura KI, 2003, PLANT CELL, V15, P1728, DOI 10.1105/tpc.012401; Peragine A, 2004, GENE DEV, V18, P2368, DOI 10.1101/gad.1231804; Pham JW, 2004, CELL, V117, P83, DOI 10.1016/S0092-8674(04)00258-2; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Schwab R, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005980; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Sheridan WF, 1996, GENETICS, V142, P1009; Siddiqi I, 2000, DEVELOPMENT, V127, P197; Slotkin RK, 2009, CELL, V136, P461, DOI 10.1016/j.cell.2008.12.038; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Vielle-Calzada JP, 2000, NATURE, V404, P91, DOI 10.1038/35003595; Vielle-Calzada JP, 1999, GENE DEV, V13, P2971, DOI 10.1101/gad.13.22.2971; Voinnet O, 2005, FEBS LETT, V579, P5858, DOI 10.1016/j.febslet.2005.09.039; Walbot V, 2003, NAT REV GENET, V4, P369, DOI 10.1038/nrg1064; WEBB MC, 1990, SEX PLANT REPROD, V3, P244, DOI 10.1007/BF00202882; Wu MF, 2006, DEVELOPMENT, V133, P4211, DOI 10.1242/dev.02602; Xie ZX, 2005, P NATL ACAD SCI USA, V102, P12984, DOI 10.1073/pnas.0506426102; Xie ZX, 2004, PLOS BIOL, V2, P642, DOI 10.1371/journal.pbio.0020104; Yoshikawa M, 2005, GENE DEV, V19, P2164, DOI 10.1101/gad.1352605	33	388	406	2	118	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					628	U200		10.1038/nature08828	http://dx.doi.org/10.1038/nature08828			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20208518	Green Accepted, Green Published			2022-12-01	WOS:000275974200056
J	Elkin, EB; Bach, PB				Elkin, Elena B.; Bach, Peter B.			Cancer's Next Frontier Addressing High and Increasing Costs	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							REIMBURSEMENT; MEDICARE		[Elkin, Elena B.; Bach, Peter B.] Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center	Bach, PB (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Epidemiol & Biostat, Hlth Outcomes Res Grp, 1275 York Ave,Box 44, New York, NY 10065 USA.	bachp@mskcc.org			NATIONAL CANCER INSTITUTE [K07CA118189] Funding Source: NIH RePORTER; NCI NIH HHS [K07 CA118189, K07 CA118189-04] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Brown ML, 2001, ANNU REV PUBL HEALTH, V22, P91, DOI 10.1146/annurev.publhealth.22.1.91; Fisher ES, 2009, HEALTH AFFAIR, V28, pW219, DOI 10.1377/hlthaff.28.2.w219; Goldman DP, 2006, HEALTH AFFAIR, V25, P1319, DOI 10.1377/hlthaff.25.5.1319; Jacobson M, 2006, HEALTH AFFAIR, V25, P437, DOI 10.1377/hlthaff.25.2.437; National Heart Lung and Blood Institute, 2008, NHLBI FACT BOOK FISC; Neumann PJ, 2010, HEALTH AFFAIR, V29, P196, DOI 10.1377/hlthaff.2009.0077; The Kaiser Family Foundation, 2009, US TOD KAIS FAM FDN; Warren JL, 2008, J NATL CANCER I, V100, P888, DOI 10.1093/jnci/djn175; Weight CJ, 2008, CANCER-AM CANCER SOC, V112, P2195, DOI 10.1002/cncr.23421	9	110	114	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 17	2010	303	11					1086	1087		10.1001/jama.2010.283	http://dx.doi.org/10.1001/jama.2010.283			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	569KC	20233828	Green Accepted			2022-12-01	WOS:000275594100023
J	Hochman, M; McCormick, D				Hochman, Michael; McCormick, Danny			Characteristics of Published Comparative Effectiveness Studies of Medications	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							PLACEBO-CONTROLLED TRIALS; RANDOMIZED-TRIALS; CLINICAL-TRIALS; SYSTEMATIC REVIEWS; NONINFERIORITY; SAFETY; EQUIVALENCE; ASSOCIATION; DRUG; CONCLUSIONS	Context Policy makers and physician organizations have recently called for more comparative effectiveness (CE) research, yet little is known about existing CE studies. Objective To describe the characteristics of recently published CE studies evaluating medications. Design, Setting, and Participants Analysis of all randomized trials, observational studies, and meta-analyses involving medications published in the 6 general medicine and internal medicine journals with the highest impact factor between June 1, 2008, and September 30, 2009. Main Outcome Measures The prevalence and characteristics of CE studies (those comparing existing, active treatments) and non-CE studies (those involving novel therapies or those using an inactive control). Results We identified 328 studies evaluating medications, 104 of which were CE studies. Among the CE studies, 45 (43%; 95% confidence interval [CI], 34%-53%) compared different medications, 11 (11%; 95% CI, 5%-18%) compared medications with nonpharmacologic interventions, 32 (31%; 95% CI, 22%-41%) compared different pharmacologic strategies, and 16 (15%; 95% CI, 9%-24%) compared different medication dosing schedules. Twenty (19%; 95% CI, 12%-28%) CE studies focused on safety and 2 (2%; 95% CI, 0%-7%) included cost-effectiveness analyses. Comparative effectiveness studies were less likely than non-CE studies to have been exclusively commercially funded: 13% (95% CI, 8%-22%) vs 45% (95% CI, 38%-52%), respectively (P < .001). In total, 90 (87%; 95% CI, 78%-92%) of the CE studies received noncommercial funding, including 66 that received government funding (63%; 95% CI, 53%-73%). Of 212 randomized trials, 97 (46%; 95% CI, 39%-63%) used an active comparator; the rest used an inactive control. Active-comparator trials were less likely than trials with inactive controls to report positive results: 44% (95% CI, 33%-55%) vs 66% (95% CI, 57%-75%), respectively (P=.002). Conclusions In these high-impact general medicine journals, approximately one-third of studies evaluating medications were CE studies. Of these studies, only a minority compared pharmacologic and nonpharmacologic therapies, few focused on safety or cost, and most were funded by noncommercial funding sources. JAMA. 2010;303(10):951-958	Cambridge Hlth Alliance, Dept Med, Cambridge, MA USA; Harvard Univ, Sch Med, Boston, MA USA	Harvard University; Cambridge Health Alliance; Harvard University; Harvard Medical School	Hochman, M (corresponding author), Univ So Calif, Dept Med, Keck Sch Med, 1975 Zonal Ave,KAM 500, Los Angeles, CA 90089 USA.	mhochman@usc.edu						Als-Nielsen B, 2003, JAMA-J AM MED ASSOC, V290, P921, DOI 10.1001/jama.290.7.921; *AM COLL PHYS, 2008, IMPR AV COMP EFF INF; BACIU A, 2006, FUTURE DRUG SAFETY P; Bekelman JE, 2003, JAMA-J AM MED ASSOC, V289, P454, DOI 10.1001/jama.289.4.454; Bhandari M, 2004, CAN MED ASSOC J, V170, P477; Chan AW, 2004, CAN MED ASSOC J, V171, P735, DOI 10.1503/cmaj.1041086; Clement FM, 2009, JAMA-J AM MED ASSOC, V302, P1437, DOI 10.1001/jama.2009.1409; Djulbegovic B, 2000, LANCET, V356, P635, DOI 10.1016/S0140-6736(00)02605-2; Emanuel EJ, 2001, NEW ENGL J MED, V345, P915, DOI 10.1056/NEJM200109203451211; Ernst E, 2001, BRIT MED J, V323, P546, DOI 10.1136/bmj.323.7312.546; Ernst E, 2001, ARCH INTERN MED, V161, P125, DOI 10.1001/archinte.161.1.125-a; Fontanarosa PB, 2004, JAMA-J AM MED ASSOC, V292, P2647, DOI 10.1001/jama.292.21.2647; Gomberg-Maitland M, 2003, AM HEART J, V146, P398, DOI 10.1016/S0002-8703(03)00324-7; Goodman DC, 2005, PEDIATRICS, V116, P493, DOI 10.1542/peds.2005-1231; Greene CJ, 2008, J TRAUMA STRESS, V21, P433, DOI 10.1002/jts.20367; *I MED, KNOW WHAT WORKS HEAL; *I MED ROUNDT EV B, 2007, LEARN WHAT WORKS BES; Institute of Medicine, 2009, IN NAT PRIOR COMP EF; Ioannidis John P A, 2008, Philos Ethics Humanit Med, V3, P14, DOI 10.1186/1747-5341-3-14; JACOBSON GA, 2007, CRS REPORT C COMP CL; Katz KA, 2006, J AM ACAD DERMATOL, V55, P814, DOI 10.1016/j.jaad.2006.07.005; Kirschner N, 2008, ANN INTERN MED, V148, P956, DOI 10.7326/0003-4819-148-12-200806170-00222; Kjaergard LL, 2002, BMJ-BRIT MED J, V325, P249, DOI 10.1136/bmj.325.7358.249; LEWIS TR, 2007, CASE PUBLIC FUNDING, V4; Misbin RI, 2001, DIABETES CARE, V24, P773, DOI 10.2337/diacare.24.4.773; Papanikolaou PN, 2004, AM J PSYCHIAT, V161, P1692, DOI 10.1176/appi.ajp.161.9.1692; Piaggio G, 2006, JAMA-J AM MED ASSOC, V295, P1152, DOI 10.1001/jama.295.10.1152; Pitrou I, 2009, ARCH INTERN MED, V169, P1756, DOI 10.1001/archinternmed.2009.306; Ridker PM, 2006, JAMA-J AM MED ASSOC, V295, P2270, DOI 10.1001/jama.295.19.2270; Sox HC, 2009, ANN INTERN MED, V151, P203, DOI 10.7326/0003-4819-151-3-200908040-00125; Stafford RS, 2009, NEW ENGL J MED, V361, P1230, DOI 10.1056/NEJMp0906490; StataCorp, 2009, STAT STAT SOFTW REL; *THOMS REUT, SCI J CIT REP ISI SU; Tuma RS, 2007, J NATL CANCER I, V99, P1746, DOI 10.1093/jnci/djm258; *US C BUDG OFF, 2007, RES COMP EFF MED TRE; *US DEP HHS, COMP EFF RES FUND FE; *US FDA, 2001, REG INF CHOIC CONTR; VANDENBROUKE JP, 2008, JAMA-J AM MED ASSOC, V3, P2417; Vitiello B, 2004, BIOL PSYCHIAT, V56, P3, DOI 10.1016/j.biopsych.2004.03.011; Vlahakes GJ, 2006, NEW ENGL J MED, V354, P413, DOI 10.1056/NEJMe058272; Vlopp KG, 2009, NEW ENGL J MED, V361, P331, DOI 10.1056/NEJMp0903496	41	62	64	0	5	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	MAR 10	2010	303	10					951	958		10.1001/jama.2010.240	http://dx.doi.org/10.1001/jama.2010.240			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565UC	20215609	Bronze			2022-12-01	WOS:000275319300022
J	Pape, JW; Deschamps, MM; Ford, H; Joseph, P; Johnson, WD; Fitzgerald, DW				Pape, Jean William; Deschamps, Marie Marcelle; Ford, Henri; Joseph, Patrice; Johnson, Warren D., Jr.; Fitzgerald, Daniel W.			The GHESKIO Refugee Camp after the earthquake in Haiti - Dispatch 2 from Port-au-Prince	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material									GHESKIO Ctr, Weill Cornell Med Coll, Port au Prince, Haiti; Los Angeles Childrens Hosp, Los Angeles, CA USA; Ctr Global Hlth, New York, NY USA	Children's Hospital Los Angeles									0	9	9	0	5	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	MAR 4	2010	362	9								10.1056/NEJMpv1001785	http://dx.doi.org/10.1056/NEJMpv1001785			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	563DQ	20154302				2022-12-01	WOS:000275108300032
J	Dauwerse, L; Abma, TA; Wolbers, JG				Dauwerse, Linda; Abma, T. A.; Wolbers, John G.			A Patient's Journey The war in my head: coping with arteriovenous malformation after a brain haemorrhage	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Dauwerse, Linda; Abma, T. A.] Vrije Univ Amsterdam, Med Ctr, Dept Med Humanities, NL-1007 MB Amsterdam, Netherlands; [Wolbers, John G.] Erasmus Univ, Med Ctr, Dept Neurosurg, NL-3000 CA Rotterdam, Netherlands	Vrije Universiteit Amsterdam; Erasmus University Rotterdam; Erasmus MC	Dauwerse, L (corresponding author), Vrije Univ Amsterdam, Med Ctr, Dept Med Humanities, POB 7057, NL-1007 MB Amsterdam, Netherlands.	l.dauwerse@vumc.nl	Abma, Tineke/AER-4580-2022	Abma, Tineke/0000-0002-8902-322X					0	2	2	0	2	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 26	2010	340								b5400	10.1136/bmj.b5400	http://dx.doi.org/10.1136/bmj.b5400			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	561TI	20189968	Green Submitted			2022-12-01	WOS:000275001400001
J	Vierbuchen, T; Ostermeier, A; Pang, ZP; Kokubu, Y; Sudhof, TC; Wernig, M				Vierbuchen, Thomas; Ostermeier, Austin; Pang, Zhiping P.; Kokubu, Yuko; Suedhof, Thomas C.; Wernig, Marius			Direct conversion of fibroblasts to functional neurons by defined factors	NATURE			English	Article							EMBRYONIC STEM-CELLS; SOMATIC-CELLS; MATURE B; NUCLEAR TRANSFER; PLURIPOTENCY; EXPRESSION; PROTEINS; TRANSPLANTATION; PROGENITORS; GENERATION	Cellular differentiation and lineage commitment are considered to be robust and irreversible processes during development. Recent work has shown that mouse and human fibroblasts can be reprogrammed to a pluripotent state with a combination of four transcription factors. This raised the question of whether transcription factors could directly induce other defined somatic cell fates, and not only an undifferentiated state. We hypothesized that combinatorial expression of neural-lineage-specific transcription factors could directly convert fibroblasts into neurons. Starting from a pool of nineteen candidate genes, we identified a combination of only three factors, Ascl1, Brn2 ( also called Pou3f2) and Myt1l, that suffice to rapidly and efficiently convert mouse embryonic and postnatal fibroblasts into functional neurons in vitro. These induced neuronal (iN) cells express multiple neuron-specific proteins, generate action potentials and form functional synapses. Generation of iN cells from non-neural lineages could have important implications for studies of neural development, neurological disease modelling and regenerative medicine.	[Vierbuchen, Thomas; Ostermeier, Austin; Kokubu, Yuko; Wernig, Marius] Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, Palo Alto, CA 94304 USA; [Vierbuchen, Thomas; Ostermeier, Austin; Wernig, Marius] Stanford Univ, Sch Med, Program Canc Biol, Palo Alto, CA 94304 USA; [Pang, Zhiping P.; Suedhof, Thomas C.] Stanford Univ, Sch Med, Dept Cellular & Mol Physiol, Palo Alto, CA 94304 USA; [Suedhof, Thomas C.] Stanford Univ, Sch Med, Howard Hughes Med Inst, Palo Alto, CA 94304 USA	Stanford University; Stanford University; Stanford University; Howard Hughes Medical Institute; Stanford University	Wernig, M (corresponding author), Stanford Univ, Sch Med, Inst Stem Cell Biol & Regenerat Med, Dept Pathol, 1050 Arastradero Rd, Palo Alto, CA 94304 USA.	wernig@stanford.edu	Wilson, Matthew H/K-3193-2013; Pang, Zhiping/AAF-5757-2020	Pang, Zhiping/0000-0002-6183-1233; Vierbuchen, Thomas/0000-0002-5690-5680	Institute for Stem Cell Biology and Regenerative Medicine at Stanford; Donald E. and Delia B. Baxter Foundation; William Stinehart Jr and the Reed Foundation; National Institute of Health [1018438-142-PABCA]; Ruth and Robert Halperin Stanford Graduate Fellowship; NARSAD; NIH/NINDS [5T32NS007280]; NATIONAL CANCER INSTITUTE [T32CA009302] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [U01HL100397] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [T32NS007280] Funding Source: NIH RePORTER	Institute for Stem Cell Biology and Regenerative Medicine at Stanford; Donald E. and Delia B. Baxter Foundation; William Stinehart Jr and the Reed Foundation; National Institute of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Ruth and Robert Halperin Stanford Graduate Fellowship; NARSAD(NARSAD); NIH/NINDS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank S. Marro and P. Lovelace for help with FACS sorting, S. Hafeez and Y. Huh for assistance with molecular cloning and mouse husbandry, and K. Jann for assistance with the diagram in Fig. 1. We would also like to thank I. Graef, R. Bajpai, J. Wysocka, J.-R. Lin and J.-Y. Chen for contributing reagents and help with analysis. This work was supported by start-up funds from the Institute for Stem Cell Biology and Regenerative Medicine at Stanford ( M. W.), the Donald E. and Delia B. Baxter Foundation ( M. W.), an award from William Stinehart Jr and the Reed Foundation ( M. W.), the National Institute of Health Training Grant 1018438-142-PABCA (A.O.) and the Ruth and Robert Halperin Stanford Graduate Fellowship ( T. V.). Z.P.P. is supported by NARSAD Young Investigator Award and NIH/NINDS Epilepsy Training Grant 5T32NS007280.	Beard C, 2006, GENESIS, V44, P23, DOI 10.1002/gene.20180; Bernstein BE, 2007, CELL, V128, P669, DOI 10.1016/j.cell.2007.01.033; BLAU HM, 1989, TRENDS GENET, V5, P268, DOI 10.1016/0168-9525(89)90100-5; BRIGGS R, 1952, P NATL ACAD SCI USA, V38, P455, DOI 10.1073/pnas.38.5.455; Bussmann LH, 2009, CELL STEM CELL, V5, P554, DOI 10.1016/j.stem.2009.10.004; Campbell KHS, 1996, NATURE, V380, P64, DOI 10.1038/380064a0; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Cobaleda C, 2007, NATURE, V449, P473, DOI 10.1038/nature06159; Cowan CA, 2005, SCIENCE, V309, P1369, DOI 10.1126/science.1116447; DAVIS RL, 1987, CELL, V51, P987, DOI 10.1016/0092-8674(87)90585-X; Do JT, 2004, STEM CELLS, V22, P941, DOI 10.1634/stemcells.22-6-941; ESCURAT M, 1990, J NEUROSCI, V10, P764; Farah MH, 2000, DEVELOPMENT, V127, P693; Feng R, 2008, P NATL ACAD SCI USA, V105, P6057, DOI 10.1073/pnas.0711961105; GUILLEMOT F, 1993, CELL, V75, P463, DOI 10.1016/0092-8674(93)90381-Y; Guillemot F, 2005, CURR OPIN CELL BIOL, V17, P639, DOI 10.1016/j.ceb.2005.09.006; GURDON JB, 1958, NATURE, V182, P64, DOI 10.1038/182064a0; Hanna J, 2008, CELL, V133, P250, DOI 10.1016/j.cell.2008.03.028; Hochedlinger K, 2002, NATURE, V415, P1035, DOI 10.1038/nature718; Jaenisch R, 2008, CELL, V132, P567, DOI 10.1016/j.cell.2008.01.015; Jenuwein T, 2001, SCIENCE, V293, P1074, DOI 10.1126/science.1063127; Kondo M, 2000, NATURE, V407, P383, DOI 10.1038/35030112; LEE JE, 1995, SCIENCE, V268, P836, DOI 10.1126/science.7754368; Maximov A, 2005, NEURON, V48, P547, DOI 10.1016/j.neuron.2005.09.006; Maximov A, 2007, J NEUROSCI METH, V161, P75, DOI 10.1016/j.jneumeth.2006.10.009; SCHAFER BW, 1990, NATURE, V344, P454, DOI 10.1038/344454a0; Silva J, 2008, CELL, V132, P532, DOI 10.1016/j.cell.2008.02.006; Tada M, 2001, CURR BIOL, V11, P1553, DOI 10.1016/S0960-9822(01)00459-6; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tucker KL, 2001, NAT NEUROSCI, V4, P29, DOI 10.1038/82868; Wernig M, 2002, J NEUROSCI RES, V69, P918, DOI 10.1002/jnr.10395; Wernig M, 2008, NAT BIOTECHNOL, V26, P916, DOI 10.1038/nbt1483; Wu H, 2007, P NATL ACAD SCI USA, V104, P13821, DOI 10.1073/pnas.0706199104; Xie HF, 2004, CELL, V117, P663, DOI 10.1016/S0092-8674(04)00419-2; Yamanaka S, 2009, NATURE, V460, P49, DOI 10.1038/nature08180; Zhou Q, 2008, CELL STEM CELL, V3, P382, DOI 10.1016/j.stem.2008.09.015; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	37	2073	2270	5	409	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1035	U50		10.1038/nature08797	http://dx.doi.org/10.1038/nature08797			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20107439	Green Accepted			2022-12-01	WOS:000275108400027
J	Sidibe, M; Buse, K				Sidibe, Michel; Buse, Kent			Fomenting a prevention revolution for HIV	LANCET			English	Editorial Material									[Sidibe, Michel; Buse, Kent] Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland	UNAIDS	Buse, K (corresponding author), Joint United Nations Programme HIV AIDS UNAIDS, CH-1211 Geneva 27, Switzerland.	busek@unaids.org	Buse, Kent/AAK-6688-2020	Buse, Kent/0000-0002-5485-0110				England R, 2009, LANCET, V374, P1674, DOI 10.1016/S0140-6736(09)61984-X; FEUER C, 2009, ADAPTING REALITIES T; Jaffar S, 2009, LANCET, V374, P2080, DOI 10.1016/S0140-6736(09)61674-3; Kaoma Kapya, 2009, GLOBALIZING CULTURE; Ottosson Daniel, 2009, STATE SPONSORED HOMO; Piot P, 2008, LANCET, V372, P845, DOI 10.1016/S0140-6736(08)60888-0; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; SIDIBE M, 2009, COMMUNICATION    DEC; Starrs AM, 2009, LANCET, V374, P1674, DOI 10.1016/S0140-6736(09)61985-1; *UNAIDS, 2009, AIDS EP UPD; UNAIDS, 2009, JOINT ACT RES UNAIDS; UNAIDS, 2009, MAPP RESTR ENTR STAY; United Nations General Assembly, 2001, DECL COMM HIV AIDS; WHO, 2009, UN ACC SCAL PRIOR HI; WHO, 2008, REP EXP CONS POS SYN; 2008, LANCET INFECT DIS, V8, P457	16	3	3	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	FEB 13	2010	375	9714					533	535		10.1016/S0140-6736(10)60138-9	http://dx.doi.org/10.1016/S0140-6736(10)60138-9			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	560YO	20159276				2022-12-01	WOS:000274941900008
J	Lister, S				Lister, Sam			Social Care No quick fix for long term care	BMJ-BRITISH MEDICAL JOURNAL			English	Editorial Material									Times, London, England		Lister, S (corresponding author), Times, London, England.	Sam.Lister@thetimes.co.uk						CUTHBERT M, 2010, PUBLIC FINANCE  0122; Department of Health, 2000, NHS PLAN GOV RESP RO; FERGUSON T, 1948, LANCET, V254, P417; LISTER S, 2009, TIMES           1120; Royal Commission on Long Term Care, 1999, RESP OLD AG LONG TER; 1954, BMJ, V1, P1425	6	1	1	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	FEB 11	2010	340								c814	10.1136/bmj.c814	http://dx.doi.org/10.1136/bmj.c814			3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	554ZV	20150195				2022-12-01	WOS:000274477200006
J	Vogel, JP; Garvin, DF; Mockler, TC; Schmutz, J; Rokhsar, D; Bevan, MW; Barry, K; Lucas, S; Harmon-Smith, M; Lail, K; Tice, H; Grimwood, J; McKenzie, N; Huo, NX; Gu, YQ; Lazo, GR; Anderson, OD; You, FM; Luo, MC; Dvorak, J; Wright, J; Febrer, M; Idziak, D; Hasterok, R; Lindquist, E; Wang, M; Fox, SE; Priest, HD; Filichkin, SA; Givan, SA; Bryant, DW; Chang, JH; Wu, HY; Wu, W; Hsia, AP; Schnable, PS; Kalyanaraman, A; Barbazuk, B; Michael, TP; Hazen, SP; Bragg, JN; Laudencia-Chingcuanco, D; Weng, YQ; Haberer, G; Spannagl, M; Mayer, K; Rattei, T; Mitros, T; Lee, SJ; Rose, JKC; Mueller, LA; York, TL; Wicker, T; Buchmann, JP; Tanskanen, J; Schulman, AH; Gundlach, H; de Oliveira, AC; Maia, LD; Belknap, W; Jiang, N; Lai, JS; Zhu, LC; Ma, JX; Sun, C; Pritham, E; Salse, J; Murat, F; Abrouk, M; Bruggmann, R; Messing, J; Fahlgren, N; Sullivan, CM; Carrington, JC; Chapman, EJ; May, GD; Zhai, JX; Ganssmann, M; Gurazada, SGR; German, M; Meyers, BC; Green, PJ; Tyler, L; Wu, JJ; Thomson, J; Chen, S; Scheller, HV; Harholt, J; Ulvskov, P; Kimbrel, JA; Bartley, LE; Cao, PJ; Jung, KH; Sharma, MK; Vega-Sanchez, M; Ronald, P; Dardick, CD; De Bodt, S; Verelst, W; Inze, D; Heese, M; Schnittger, A; Yang, XH; Kalluri, UC; Tuskan, GA; Hua, ZH; Vierstra, RD; Cui, Y; Ouyang, SH; Sun, QX; Liu, ZY; Yilmaz, A; Grotewold, E; Sibout, R; Hematy, K; Mouille, G; Hofte, H; Pelloux, J; O'Connor, D; Schnable, J; Rowe, S; Harmon, F; Cass, CL; Sedbrook, JC; Byrne, ME; Walsh, S; Higgins, J; Li, PH; Brutnell, T; Unver, T; Budak, H; Belcram, H; Charles, M; Chalhoub, B; Baxter, I				Vogel, John P.; Garvin, David F.; Mockler, Todd C.; Schmutz, Jeremy; Rokhsar, Dan; Bevan, Michael W.; Barry, Kerrie; Lucas, Susan; Harmon-Smoth, Miranda; Lail, Kathleen; Tice, Hope; Grimwood, Jane; McKenzie, Neil; Huo, Naxin; Gu, Yong Q; Lazo, Gerard R.; Anderson, Olin D.; You, Frank M.; Luo, Ming-Cheng; Dvorak, Jan; Wright, Jan; Febrer, Melanie; Idziak, Dominika; Hasterok, Robert; Lindquist, Erika; Wang, Mei; Fox, Samuel E.; Priest, Henry D.; Filichkin, Sergei A.; Givan, Scott A.; Bryant, Douglas W.; Chang, Jeff H.; Wu, Haiyan; Wu, Wei; Hsia, An-Ping; Schnable, Patrick S.; Kalyanaraman, Anantharaman; Baarbazuk, Brad; Michael, Todd P.; Hazen, Samuel P.; Bragg, Jennifer N.; Laudencia-Chingcuanco, Debbie; Weng, Yiqun; Haberer, Georg; Spannagl, Mianuel; Mayer, Klaus; Rattei, Thomas; Mitros, Therese; Lee, Sang-Jik; Rose, Jocelyn K. C.; Mueller, Lukas A.; York, Thomas L.; Wicker, Thomas; Buchmann, Jan P.; Tanskanen, Jaakko; Schulman, Alan H.; Gundlach, Heidrun; de Oliveira, Antonio Costa; Maia, Luciano da C.; Belknap, William; Jiang, Ning; Lai, Jinsheng; Zhu, Liucun; Ma, Jianxin; Sun, Cheng; Pritham, Ellen; Salse, Jerome; Murat, Florent; Abrouk, Michael; Bruggmann, Remy; Messing, Joachim; Fahlgren, Noah; Sullivan, Christopher M.; Carrington, James C.; Chapman, Elisabeth J.; May, Greg D.; Zhai, Jixian; Ganssmann, Matthias; Gurazada, Sai Guna Ranjan; German, Marcelo; Meyers, Blake C.; Green, Pamela J.; Tyler, Ludmila; Wu, Jiajie; Thomson, James; Chen, Shan; Scheller, Henrik V.; Harholt, Jesper; Ulvskov, Peter; Kimbrel, Jeffrey A.; Bartley, Laura E.; Cao, Peijian; Jung, Ki-Hong; Sharma, Manoj K.; Vega-Sanchez, Miguel; Ronald, Pamela; Dardick, Christopher D.; De Bodt, Stefanie; Verelst, Wim; Inze, Dirk; Heese, Maren; Schnittger, Arp; Yang, Xiaohan; Kalluri, Udaya C.; Tuskan, Gerald A.; Hua, Zhihua; Vierstra, Richard D.; Cui, Yu; Ouyang, Shuhong; Sun, Qixin; Liu, Zhiyong; Yilmaz, Alper; Grotewold, Erich; Sibout, Richard; Hematy, Kian; Mouille, Gregory; Hoefte, Herman; Pelloux, Jerome; O'Connor, Devin; Schbnable, James; Rowe, Scott; Harmon, Frank; Cass, Cynthia L.; Sedbrook, John C.; Byrne, Mary E.; Walsh, Sean; Higgins, Janet; Li, Pinghua; Brutnell, Thomas; Unver, Turgay; Budak, Hikmet; Belcram, Harry; Charles, Mathieu; Chalhoub, Boulos; Baxter, Ivan		Int Brachypodium Initiative	Genome sequencing and analysis of the model grass Brachypodium distachyon	NATURE			English	Article							AGROBACTERIUM-MEDIATED TRANSFORMATION; INTRASPECIES DIVERSITY; RICE; EVOLUTION; DIVERGENCE; WHEAT; MAP; IDENTIFICATION; TRITICEAE; DYNAMICS	Three subfamilies of grasses, the Ehrhartoideae, Panicoideae and Pooideae, provide the bulk of human nutrition and are poised to become major sources of renewable energy. Here we describe the genome sequence of the wild grass Brachypodium distachyon (Brachypodium), which is, to our knowledge, the first member of the Pooideae subfamily to be sequenced. Comparison of the Brachypodium, rice and sorghum genomes shows a precise history of genome evolution across a broad diversity of the grasses, and establishes a template for analysis of the large genomes of economically important pooid grasses such as wheat. The high-quality genome sequence, coupled with ease of cultivation and transformation, small size and rapid life cycle, will help Brachypodium reach its potential as an important model system for developing new energy and food crops.	[Vogel, John P.; Huo, Naxin; Gu, Yong Q; Lazo, Gerard R.; Anderson, Olin D.; Bragg, Jennifer N.; Laudencia-Chingcuanco, Debbie; Belknap, William; Tyler, Ludmila; Wu, Jiajie; Thomson, James] USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA; [Garvin, David F.] USDA ARS, Plant Sci Res Unit, St Paul, MN 55108 USA; [Garvin, David F.] Univ Minnesota, St Paul, MN 55108 USA; [Mockler, Todd C.; Fox, Samuel E.; Priest, Henry D.; Filichkin, Sergei A.; Givan, Scott A.; Bryant, Douglas W.; Chang, Jeff H.; Fahlgren, Noah; Sullivan, Christopher M.; Carrington, James C.; Chapman, Elisabeth J.; Kimbrel, Jeffrey A.] Oregon State Univ, Corvallis, OR 97331 USA; [Schmutz, Jeremy; Grimwood, Jane] HudsonAlpha Inst, Huntsville, AL 35806 USA; [Rokhsar, Dan; Barry, Kerrie; Lucas, Susan; Harmon-Smoth, Miranda; Lail, Kathleen; Tice, Hope; Febrer, Melanie; Lindquist, Erika; Wang, Mei] US DOE, Joint Genome Inst, Walnut Creek, CA 94598 USA; [Rokhsar, Dan; Mitros, Therese; Tyler, Ludmila] Univ Calif Berkeley, Berkeley, CA 94720 USA; [Bevan, Michael W.; McKenzie, Neil; Wright, Jan; Byrne, Mary E.; Walsh, Sean; Higgins, Janet] John Innes Ctr, Norwich NR4 7UJ, Norfolk, England; [You, Frank M.; Luo, Ming-Cheng; Dvorak, Jan; Wu, Jiajie; Bartley, Laura E.; Cao, Peijian; Jung, Ki-Hong; Sharma, Manoj K.; Vega-Sanchez, Miguel; Ronald, Pamela] Univ Calif Davis, Davis, CA 95616 USA; [Idziak, Dominika; Hasterok, Robert] Univ Silesia, Katowice, Poland; [Wu, Haiyan; Wu, Wei; Hsia, An-Ping; Schnable, Patrick S.] Iowa State Univ, Ames, IA 50011 USA; [Kalyanaraman, Anantharaman] Washington State Univ, Pullman, WA 99163 USA; [Baarbazuk, Brad] Univ Florida, Gainesville, FL 32611 USA; [Michael, Todd P.; Bruggmann, Remy; Messing, Joachim] Rutgers State Univ, Piscataway, NJ 08855 USA; [Hazen, Samuel P.; Chen, Shan] Univ Massachusetts, Amherst, MA 01003 USA; [Weng, Yiqun] Univ Wisconsin, USDA ARS, Vegetable Crops Res Unit, Dept Hort, Madison, WI 53706 USA; [Haberer, Georg; Spannagl, Mianuel; Mayer, Klaus; Gundlach, Heidrun] Helmholtz Zentrum Munchen, D-85764 Neuherberg, Germany; [Rattei, Thomas] Tech Univ Munich, D-80333 Munich, Germany; [Lee, Sang-Jik; Rose, Jocelyn K. C.] Cornell Univ, Ithaca, NY 14853 USA; [Mueller, Lukas A.; York, Thomas L.; Li, Pinghua; Brutnell, Thomas] Boyce Thompson Inst Plant Res, Ithaca, NY 14853 USA; [Wicker, Thomas; Buchmann, Jan P.] Univ Zurich, CH-8008 Zurich, Switzerland; [Tanskanen, Jaakko; Schulman, Alan H.] MTT Agrifood Res, FIN-00014 Helsinki, Finland; [Tanskanen, Jaakko; Schulman, Alan H.] Univ Helsinki, FIN-00014 Helsinki, Finland; [de Oliveira, Antonio Costa; Maia, Luciano da C.] Univ Fed Pelotas, BR-96001970 Pelotas, RS, Brazil; [Jiang, Ning] Michigan State Univ, E Lansing, MI 48824 USA; [Wu, Haiyan; Schnable, Patrick S.; Lai, Jinsheng; Cui, Yu; Ouyang, Shuhong; Sun, Qixin; Liu, Zhiyong] China Agr Univ, Beijing 10094, Peoples R China; [Zhu, Liucun; Ma, Jianxin] Purdue Univ, W Lafayette, IN 47907 USA; [Sun, Cheng; Pritham, Ellen] Univ Texas, Arlington, TX 76019 USA; [Salse, Jerome; Murat, Florent; Abrouk, Michael] INRA, UMR 1095, F-63100 Clermont Ferrand, France; [Chapman, Elisabeth J.] Univ Calif San Diego, La Jolla, CA 92093 USA; [May, Greg D.] Natl Ctr Genome Resources, Santa Fe, NM 87505 USA; [Zhai, Jixian; Ganssmann, Matthias; Gurazada, Sai Guna Ranjan; German, Marcelo; Meyers, Blake C.; Green, Pamela J.] Univ Delaware, Newark, DE 19716 USA; [Scheller, Henrik V.; Bartley, Laura E.; Cao, Peijian; Jung, Ki-Hong; Sharma, Manoj K.; Vega-Sanchez, Miguel; Ronald, Pamela] Joint Bioenergy Inst, Emeryville, CA 94720 USA; [Harholt, Jesper; Ulvskov, Peter] Univ Copenhagen, DK-1871 Frederiksberg, Denmark; [Dardick, Christopher D.] USDA ARS, Appalachian Fruit Res Stn, Kearneysville, WV 25430 USA; [De Bodt, Stefanie; Verelst, Wim; Inze, Dirk] VIB, VIB Dept Plant Syst Biol, B-9052 Ghent, Belgium; [De Bodt, Stefanie; Verelst, Wim; Inze, Dirk] Univ Ghent, Dept Plant Biotechnol & Genet, B-9052 Ghent, Belgium; [Heese, Maren; Schnittger, Arp] CNRS, Inst Biol Mol Plantes, F-67084 Strasbourg, France; [Yang, Xiaohan; Kalluri, Udaya C.; Tuskan, Gerald A.] BioEnergy Sci Ctr, Oak Ridge, TN 37831 USA; [Yang, Xiaohan; Kalluri, Udaya C.; Tuskan, Gerald A.] Oak Ridge Natl Lab, Oak Ridge, TN 37831 USA; [Hua, Zhihua; Vierstra, Richard D.] Univ Wisconsin, Madison, WI 53706 USA; [Yilmaz, Alper; Grotewold, Erich] Ohio State Univ, Columbus, OH 43210 USA; [Sibout, Richard; Hematy, Kian; Mouille, Gregory; Hoefte, Herman] INRA, Inst Jean Pierre Bourgin, UMR1318, F-78026 Versailles, France; [Pelloux, Jerome] Univ Picardie, F-80039 Amiens, France; [O'Connor, Devin; Schbnable, James; Rowe, Scott; Harmon, Frank] Univ Calif Berkeley, Plant Gene Express Ctr, Albany, CA 94710 USA; [Cass, Cynthia L.; Sedbrook, John C.] Illinois State Univ, Normal, IL 61790 USA; [Cass, Cynthia L.; Sedbrook, John C.] DOE, Great Lakes Bioenergy Res Ctr, Normal, IL 61790 USA; [Unver, Turgay; Budak, Hikmet] Sabanci Univ, T-34956 Istanbul, Turkey; [Belcram, Harry; Charles, Mathieu; Chalhoub, Boulos] INRA CNRS UEVE, Unite Rech Genomique Vegetale, F-91057 Evry, France; [Baxter, Ivan] USDA ARS, Donald Danforth Plant Sci Ctr, St Louis, MO 63130 USA	United States Department of Agriculture (USDA); United States Department of Agriculture (USDA); University of Minnesota System; University of Minnesota Twin Cities; Oregon State University; HudsonAlpha Institute for Biotechnology; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; Joint Genome Institute - JGI; University of California System; University of California Berkeley; UK Research & Innovation (UKRI); Biotechnology and Biological Sciences Research Council (BBSRC); John Innes Center; University of California System; University of California Davis; University of Silesia in Katowice; Iowa State University; Washington State University; State University System of Florida; University of Florida; Rutgers State University New Brunswick; University of Massachusetts System; University of Massachusetts Amherst; United States Department of Agriculture (USDA); University of Wisconsin System; University of Wisconsin Madison; Helmholtz Association; Helmholtz-Center Munich - German Research Center for Environmental Health; Technical University of Munich; Cornell University; Cornell University; Boyce Thompson Institute for Plant Research; University of Zurich; Natural Resources Institute Finland (Luke); University of Helsinki; Universidade Federal de Pelotas; Michigan State University; China Agricultural University; Purdue University System; Purdue University; Purdue University West Lafayette Campus; University of Texas System; University of Texas Arlington; INRAE; University of California System; University of California San Diego; National Center for Genome Resources (NCGR); University of Delaware; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI; University of Copenhagen; United States Department of Agriculture (USDA); Flanders Institute for Biotechnology (VIB); Ghent University; Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universites de Strasbourg Etablissements Associes; Universite de Strasbourg; United States Department of Energy (DOE); Oak Ridge National Laboratory; BioEnergy Science Center (BESC); United States Department of Energy (DOE); Oak Ridge National Laboratory; University of Wisconsin System; University of Wisconsin Madison; University System of Ohio; Ohio State University; INRAE; UDICE-French Research Universities; Universite Paris Saclay; Picardie Universites; Universite de Picardie Jules Verne (UPJV); University of California System; University of California Berkeley; Illinois State University; United States Department of Energy (DOE); Sabanci University; INRAE; Donald Danforth Plant Science Center; United States Department of Agriculture (USDA)	Vogel, JP (corresponding author), USDA ARS, Western Reg Res Ctr, Albany, CA 94710 USA.		Li, Ping/GYV-4914-2022; Yang, Xiaohan/AAM-2449-2020; Ulvskov, Peter/I-1228-2014; Yilmaz, Alper/R-1830-2019; Cass, Carol E/F-5861-2010; Baxter, Ivan R/A-1052-2009; Harholt, Jesper/F-6865-2014; Scheller, Henrik/AAH-4770-2020; Budak, Hikmet/F-4708-2010; Oliveira, Antonio/K-5923-2019; Vega-Sanchez, Miguel/K-3072-2012; Bartley, Laura/AAF-2217-2020; Mueller, Lukas A/E-8840-2011; Brutnell, Thomas/M-2840-2013; Harholt, Jesper/F-3760-2011; Maia, Luciano C./G-4005-2016; Fahlgren, Noah/D-4404-2011; Hua, Zhihua/AAD-1146-2021; Scheller, Henrik V/A-8106-2008; Kimbrel, Jeff/S-9638-2019; Inzé, Dirk/AAW-6381-2021; Ronald, Pamela/AAK-7664-2020; Luo, Ming-Cheng/C-5600-2011; Yilmaz, Alper/C-7075-2014; Schmutz, Jeremy/N-3173-2013; KALLURI, UDAYA/A-6218-2011; Budak, Hikmet/S-5835-2017; Lazo, Gerard/A-8900-2009; Schulman, Alan/A-9322-2011; Oliveira, Antonio/F-7508-2012; Zhai, Jixian/HCH-9272-2022; Jiang, Ning/G-6546-2012; Carrington, James C/A-4656-2012; Schnittger, Arp/F-8989-2010; Unver, Turgay/B-4819-2009; Hasterok, Robert/A-1629-2008; Mayer, Klaus FX/M-7941-2015; Hématy, Kian/AAD-8989-2021; Budak, Hikmet/U-8517-2019; Barry, Kerrie Whitelaw/AAA-5500-2020; Jung, Ki Hong/L-5570-2019; Grimwood, Jane/ABD-5737-2021; Tuskan, Gerald/A-6225-2011; Hua, Zhihua/B-8835-2012; Higgins, Janet/A-5002-2011; Meyers, Blake C/B-6535-2012; Abrouk, Michael/F-8516-2014; Buchmann, Jan Piotr/S-1727-2019; Yang, Xiaohan/A-6975-2011; Abrouk, Michael/W-1972-2017; Rattei, Thomas/F-1366-2011; Cao, Peijian/U-6776-2019; Sun, Cheng/AAW-7354-2021; Mockler, Todd C/L-2609-2013; Wicker, Thomas/Z-1978-2019; Schnittger, Arp/AAO-6920-2020	Yang, Xiaohan/0000-0001-5207-4210; Ulvskov, Peter/0000-0003-3776-818X; Yilmaz, Alper/0000-0002-8827-4887; Baxter, Ivan R/0000-0001-6680-1722; Harholt, Jesper/0000-0002-7984-0066; Scheller, Henrik/0000-0002-6702-3560; Budak, Hikmet/0000-0002-2556-2478; Oliveira, Antonio/0000-0001-8835-8071; Vega-Sanchez, Miguel/0000-0003-0128-2743; Bartley, Laura/0000-0001-8610-7551; Brutnell, Thomas/0000-0002-3581-8211; Maia, Luciano C./0000-0002-4371-261X; Fahlgren, Noah/0000-0002-5597-4537; Scheller, Henrik V/0000-0002-6702-3560; Inzé, Dirk/0000-0002-3217-8407; Luo, Ming-Cheng/0000-0002-9744-5887; Yilmaz, Alper/0000-0002-8827-4887; Schmutz, Jeremy/0000-0001-8062-9172; Budak, Hikmet/0000-0002-2556-2478; Lazo, Gerard/0000-0002-9160-2052; Schulman, Alan/0000-0002-4126-6177; Oliveira, Antonio/0000-0001-8835-8071; Carrington, James C/0000-0003-3572-129X; Schnittger, Arp/0000-0001-7067-0091; Unver, Turgay/0000-0001-6760-443X; Mayer, Klaus FX/0000-0001-6484-1077; Budak, Hikmet/0000-0002-2556-2478; Barry, Kerrie Whitelaw/0000-0002-8999-6785; Jung, Ki Hong/0000-0003-0427-5901; Tuskan, Gerald/0000-0003-0106-1289; Meyers, Blake C/0000-0003-3436-6097; Abrouk, Michael/0000-0001-9082-1432; Buchmann, Jan Piotr/0000-0002-6842-1229; Yang, Xiaohan/0000-0001-5207-4210; Abrouk, Michael/0000-0001-9082-1432; Rattei, Thomas/0000-0002-0592-7791; Sun, Cheng/0000-0001-7476-9224; Mockler, Todd C/0000-0002-0462-5775; Schnittger, Arp/0000-0001-7067-0091; Rokhsar, Daniel/0000-0002-8704-2224; Kimbrel, Jeffrey/0000-0001-7213-9392; Hasterok, Robert/0000-0001-6667-2721; York, Thomas/0000-0002-6829-5816; Hazen, Samuel/0000-0001-9131-8994; Grotewold, Erich/0000-0002-4720-7290; Spannagl, Manuel/0000-0003-0701-7035; KALLURI, UDAYA/0000-0002-5963-8370; Gundlach, Heidrun/0000-0002-6757-0943; Liu liu, Zhiyong zhi yong/0000-0002-6958-5233; Laudencia-Chingcuanco, Debbie/0000-0002-9192-8255; Bruggmann, Remy/0000-0001-5629-6363; Michael, Todd/0000-0001-6272-2875; Byrne, Mary/0000-0003-4309-3086; Givan, Scott/0000-0002-0630-8589; Sharma, Manoj K./0000-0002-4768-8733; Schnable, James/0000-0001-6739-5527; Chang, Jeff/0000-0002-1833-0695; Pelloux, Jerome/0000-0002-9371-1711; O'Connor, Devin/0000-0003-4071-8626; Vogel, John/0000-0003-1786-2689; Rowe, Scott C/0000-0001-5691-079X; Schnable, Patrick/0000-0001-9169-5204; , Thomas/0000-0002-6777-7135; Messing, Joachim/0000-0001-8260-2643; Haberer, Georg/0000-0002-6612-6939; Hematy, Kian/0000-0002-3933-3852; Zhai, Jixian/0000-0002-0217-0666; Idziak-Helmcke, Dominika/0000-0002-0713-2466; zhu, liucun/0000-0002-8334-0216; Murat, Florent/0000-0003-2116-2511; Mouille, Gregory/0000-0002-5493-754X	US Department of Energy Joint Genome Institute; BBSRC; EU; GABI Barlex; Oregon State Agricultural Research Foundation; Biotechnology and Biological Sciences Research Council [BB/E004725/1] Funding Source: researchfish; BBSRC [BB/E004725/1] Funding Source: UKRI	US Department of Energy Joint Genome Institute(United States Department of Energy (DOE)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); EU(European Commission); GABI Barlex; Oregon State Agricultural Research Foundation; Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))	We acknowledge the contributions of the late M. Gale, who identified the importance of conserved gene order in grass genomes. This work was mainly supported by the US Department of Energy Joint Genome Institute Community Sequencing Program project with J.P.V., D. F. G., T. C. M. and M. W. B., a BBSRC grant to M. W. B., an EU Contract Agronomics grant to M. W. B. and K. F. X. M., and GABI Barlex grant to K. F. X. M. Illumina transcriptome sequencing was supported by a DOE Plant Feedstock Genomics for Bioenergy grant and an Oregon State Agricultural Research Foundation grant to T. C. M.; small RNA research was supported by the DOE Plant Feedstock Genomics for Bioenergy grants to P.J.G. and T. C. M.; annotation was supported by a DOE Plant Feedstocks for Genomics Bioenergy grant to J.P.V. A full list of support and acknowledgements is in the Supplementary Information.	Barker NP, 2001, ANN MO BOT GARD, V88, P373, DOI 10.2307/3298585; Bennett MD, 2005, ANN BOT-LONDON, V95, P45, DOI 10.1093/aob/mci003; Bennetzen JL, 1997, PLANT CELL, V9, P1509, DOI 10.1105/tpc.9.9.1509; Bossolini E, 2007, PLANT J, V49, P704, DOI 10.1111/j.1365-313X.2006.02991.x; Charles M, 2009, MOL BIOL EVOL, V26, P1651, DOI 10.1093/molbev/msp076; Draper J, 2001, PLANT PHYSIOL, V127, P1539, DOI 10.1104/pp.010196; Filiz E, 2009, GENOME, V52, P876, DOI [10.1139/g09-062, 10.1139/G09-062]; Fox S, 2009, METHODS MOL BIOL, V553, P79, DOI 10.1007/978-1-60327-563-7_5; Garvin DF, 2008, CROP SCI, V48, pS69, DOI 10.2135/cropsci2007.06.0332tpg; Garvin DF, 2010, GENOME, V53, P1, DOI [10.1139/G09-079, 10.1139/g09-079]; Gaut BS, 2002, NEW PHYTOL, V154, P15, DOI 10.1046/j.1469-8137.2002.00352.x; Global Perspective Studies Unit-Food and Agriculture Organization of the United Nation, 2006, WORLD AGR 2030 2050; Gray J, 2009, PLANT PHYSIOL, V149, P4, DOI 10.1104/pp.108.128504; Gu YQ, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-496; Huo NX, 2008, FUNCT INTEGR GENOMIC, V8, P135, DOI 10.1007/s10142-007-0062-7; Huo NX, 2006, GENOME, V49, P1099, DOI 10.1139/G06-087; Jiang N, 2004, NATURE, V431, P569, DOI 10.1038/nature02953; Kellogg EA, 2001, PLANT PHYSIOL, V125, P1198, DOI 10.1104/pp.125.3.1198; Luo MC, 2009, P NATL ACAD SCI USA, V106, P15780, DOI 10.1073/pnas.0908195106; Ma JX, 2004, P NATL ACAD SCI USA, V101, P12404, DOI 10.1073/pnas.0403715101; Matsumoto T, 2005, NATURE, V436, P793, DOI 10.1038/nature03895; McCarthy EM, 2003, BIOINFORMATICS, V19, P362, DOI 10.1093/bioinformatics/btf878; Meyers BC, 2003, PLANT CELL, V15, P809, DOI 10.1105/tpc.009308; MOORE G, 1995, CURR BIOL, V5, P737, DOI 10.1016/S0960-9822(95)00148-5; Morgante M, 2005, NAT GENET, V37, P997, DOI 10.1038/ng1615; Paterson AH, 2004, P NATL ACAD SCI USA, V101, P9903, DOI 10.1073/pnas.0307901101; Paterson AH, 2009, NATURE, V457, P551, DOI 10.1038/nature07723; Qi LL, 2004, GENETICS, V168, P701, DOI 10.1534/genetics.104.034868; Rajagopalan R, 2006, GENE DEV, V20, P3407, DOI 10.1101/gad.1476406; Salamini F, 2002, NAT REV GENET, V3, P429, DOI 10.1038/nrg817; Salse J, 2008, PLANT CELL, V20, P11, DOI 10.1105/tpc.107.056309; Somerville C, 2006, SCIENCE, V312, P1277, DOI 10.1126/science.1130034; Srinivasachary, 2007, THEOR APPL GENET, V115, P489, DOI 10.1007/s00122-007-0582-5; Stein N, 2007, THEOR APPL GENET, V114, P823, DOI 10.1007/s00122-006-0480-2; Tanaka T, 2008, NUCLEIC ACIDS RES, V36, pD1028, DOI 10.1093/nar/gkm978; US-DOE, 2006, BREAK BIOL BARR CELL; Vain P, 2008, PLANT BIOTECHNOL J, V6, P236, DOI 10.1111/j.1467-7652.2007.00308.x; Vicient CM, 2005, J MOL EVOL, V61, P275, DOI 10.1007/s00239-004-0168-7; Vogel J, 2008, CURR OPIN PLANT BIOL, V11, P301, DOI 10.1016/j.pbi.2008.03.002; Vogel J, 2008, PLANT CELL REP, V27, P471, DOI 10.1007/s00299-007-0472-y; Vogel JP, 2009, BMC PLANT BIOL, V9, DOI 10.1186/1471-2229-9-88; Vogel JP, 2006, THEOR APPL GENET, V113, P186, DOI 10.1007/s00122-006-0285-3; Vogel JP, 2006, PLANT CELL TISS ORG, V84, P199, DOI 10.1007/s11240-005-9023-9; Wei F, 2007, PLOS GENET, V3, P1254, DOI 10.1371/journal.pgen.0030123; Wicker T, 2009, PLANT PHYSIOL, V149, P258, DOI 10.1104/pp.108.129734; Wicker T, 2007, GENOME RES, V17, P1072, DOI 10.1101/gr.6214107	46	1316	1366	11	389	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 11	2010	463	7282					763	768		10.1038/nature08747	http://dx.doi.org/10.1038/nature08747			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	553VG	20148030	Green Published, Bronze			2022-12-01	WOS:000274394300030
J	Zheng, YM; Bai, H; Huang, ZB; Tian, XL; Nie, FQ; Zhao, Y; Zhai, J; Jiang, L				Zheng, Yongmei; Bai, Hao; Huang, Zhongbing; Tian, Xuelin; Nie, Fu-Qiang; Zhao, Yong; Zhai, Jin; Jiang, Lei			Directional water collection on wetted spider silk	NATURE			English	Article							MECHANICAL-PROPERTIES; SURFACES; CAPTURE; DROPLET; MOTION	Many biological surfaces in both the plant and animal kingdom possess unusual structural features at the micro-and nanometre-scale that control their interaction with water and hence wettability(1-5). An intriguing example is provided by desert beetles, which use micrometre-sized patterns of hydrophobic and hydrophilic regions on their backs to capture water from humid air(6). As anyone who has admired spider webs adorned with dew drops will appreciate, spider silk is also capable of efficiently collecting water from air. Here we show that the water-collecting ability of the capture silk of the cribellate spider Uloborus walckenaerius is the result of a unique fibre structure that forms after wetting, with the 'wet-rebuilt' fibres characterized by periodic spindle-knots made of random nanofibrils and separated by joints made of aligned nanofibrils. These structural features result in a surface energy gradient between the spindle-knots and the joints and also in a difference in Laplace pressure, with both factors acting together to achieve continuous condensation and directional collection of water drops around spindle-knots. Submillimetre-sized liquid drops have been driven by surface energy gradients(7-9) or a difference in Laplace pressure(10), but until now neither force on its own has been used to overcome the larger hysteresis effects that make the movement of micrometre-sized drops more difficult. By tapping into both driving forces, spider silk achieves this task. Inspired by this finding, we designed artificial fibres that mimic the structural features of silk and exhibit its directional water-collecting ability.	[Huang, Zhongbing; Tian, Xuelin; Nie, Fu-Qiang; Zhao, Yong; Jiang, Lei] Chinese Acad Sci, Inst Chem, BNLMS, Beijing 100190, Peoples R China; [Zheng, Yongmei; Zhai, Jin] Beijing Univ Aeronaut & Astronaut, Sch Chem & Environm, Beijing 100083, Peoples R China; [Bai, Hao] Natl Ctr Nanosci & Technol, Beijing 100190, Peoples R China	Chinese Academy of Sciences; Institute of Chemistry, CAS; Beihang University; Chinese Academy of Sciences; National Center for Nanoscience & Technology - China	Jiang, L (corresponding author), Chinese Acad Sci, Inst Chem, BNLMS, Beijing 100190, Peoples R China.	zhaoyong@iccas.ac.cn; jianglei@iccas.ac.cn	Bai, Hao/D-1713-2017; Jiang, Lei/B-1066-2011; jiang, lei/E-8437-2010; , 许永傲/AAC-2581-2019; Tian, Xuelin/C-3424-2008; Zhao, Yong/D-4523-2009; Bai, Hao/J-5255-2012	Bai, Hao/0000-0002-3348-6129; Tian, Xuelin/0000-0001-6178-2067; Zhao, Yong/0000-0002-2545-1620; Bai, Hao/0000-0002-1707-4976	State Basic Research Program of China [2007CB936403]; Key Program in the National Natural Science Foundation of China [119030601101]; Knowledge Innovation Program in the Chinese Academy of Sciences [2A200522222200301]	State Basic Research Program of China(National Basic Research Program of China); Key Program in the National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC)); Knowledge Innovation Program in the Chinese Academy of Sciences(Knowledge Innovation Program of the Chinese Academy of Sciences)	We thank the State Basic Research Program of China (2007CB936403), the Key Program in the National Natural Science Foundation of China (119030601101), and the Knowledge Innovation Program in the Chinese Academy of Sciences (2A200522222200301).	Becker N, 2003, NAT MATER, V2, P278, DOI 10.1038/nmat858; Blossey R, 2003, NAT MATER, V2, P301, DOI 10.1038/nmat856; CHAUDHURY MK, 1992, SCIENCE, V256, P1539, DOI 10.1126/science.256.5063.1539; Daniel S, 2004, LANGMUIR, V20, P4085, DOI 10.1021/la036221a; Daniel S, 2001, SCIENCE, V291, P633, DOI 10.1126/science.291.5504.633; EDMONDS DT, 1992, P ROY SOC B-BIOL SCI, V248, P145, DOI 10.1098/rspb.1992.0055; Emile O, 2006, NATURE, V440, P621, DOI 10.1038/440621a; Fang GP, 2008, LANGMUIR, V24, P11651, DOI 10.1021/la802033q; Feng L, 2002, ADV MATER, V14, P1857, DOI 10.1002/adma.200290020; Gao XF, 2004, NATURE, V432, P36, DOI 10.1038/432036a; Gau H, 1999, SCIENCE, V283, P46, DOI 10.1126/science.283.5398.46; Li XM, 2007, CHEM SOC REV, V36, P1350, DOI 10.1039/b602486f; Liu Y, 2005, NAT MATER, V4, P901, DOI 10.1038/nmat1534; Lorenceau E, 2004, J FLUID MECH, V510, P29, DOI 10.1017/S0022112004009152; Parker AR, 2001, NATURE, V414, P33, DOI 10.1038/35102108; PETERS HM, 1984, ZOOMORPHOLOGY, V104, P96, DOI 10.1007/BF00312023; Porter D, 2007, NANO TODAY, V2, P6, DOI 10.1016/S1748-0132(07)70071-3; Quere D, 2008, ANNU REV MATER RES, V38, P71, DOI 10.1146/annurev.matsci.38.060407.132434; Sun TL, 2005, ACCOUNTS CHEM RES, V38, P644, DOI 10.1021/ar040224c; VOLLRATH F, 1990, NATURE, V345, P526, DOI 10.1038/345526a0; Vollrath F, 2000, J Biotechnol, V74, P67; VOLLRATH F, 1989, NATURE, V340, P305, DOI 10.1038/340305a0; Vollrath F, 2006, SOFT MATTER, V2, P377, DOI 10.1039/b600098n; Wenzel RN, 1936, IND ENG CHEM, V28, P988, DOI 10.1021/ie50320a024; Yang JT, 2008, LANGMUIR, V24, P9889, DOI 10.1021/la8004695; Yoshimitsu Z, 2002, LANGMUIR, V18, P5818, DOI 10.1021/la020088p; Zheng YM, 2007, SOFT MATTER, V3, P178, DOI 10.1039/b612667g	27	1356	1432	125	2623	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					640	643		10.1038/nature08729	http://dx.doi.org/10.1038/nature08729			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130646				2022-12-01	WOS:000274193900031
J	Park, EJ; Lee, JH; Yu, GY; He, GB; Ali, SR; Holzer, RG; Osterreicher, CH; Takahashi, H; Karin, M				Park, Eek Joong; Lee, Jun Hee; Yu, Guann-Yi; He, Guobin; Ali, Syed Raza; Holzer, Ryan G.; Oesterreicher, Christoph H.; Takahashi, Hiroyuki; Karin, Michael			Dietary and Genetic Obesity Promote Liver Inflammation and Tumorigenesis by Enhancing IL-6 and TNF Expression	CELL			English	Article							INDUCED INSULIN-RESISTANCE; SUBCUTANEOUS ADIPOSE-TISSUE; HEPATOCELLULAR-CARCINOMA; KAPPA-B; CHEMICAL HEPATOCARCINOGENESIS; COMPENSATORY PROLIFERATION; CANCER DEVELOPMENT; INTERLEUKIN-6; CELLS; SERUM	Epidemiological studies indicate that overweight and obesity are associated with increased cancer risk. To study how obesity augments cancer risk and development, we focused on hepatocellular carcinoma (HCC), the common form of liver cancer whose occurrence and progression are the most strongly affected by obesity among all cancers. We now demonstrate that either dietary or genetic obesity is a potent bona fide liver tumor promoter in mice. Obesity-promoted HCC development was dependent on enhanced production of the tumor-promoting cytokines IL-6 and TNF, which cause hepatic inflammation and activation of the oncogenic transcription factor STAT3. The chronic inflammatory response caused by obesity and enhanced production of IL-6 and TNF may also increase the risk of other cancers.	[Park, Eek Joong; Lee, Jun Hee; Yu, Guann-Yi; He, Guobin; Ali, Syed Raza; Holzer, Ryan G.; Oesterreicher, Christoph H.; Takahashi, Hiroyuki; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Park, Eek Joong; Lee, Jun Hee; Yu, Guann-Yi; He, Guobin; Ali, Syed Raza; Holzer, Ryan G.; Oesterreicher, Christoph H.; Takahashi, Hiroyuki; Karin, Michael] Univ Calif San Diego, Sch Med, Dept Pathol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA; [Oesterreicher, Christoph H.] Univ Calif San Diego, Sch Med, Dept Med, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Karin, M (corresponding author), Univ Calif San Diego, Sch Med, Dept Pharmacol, Lab Gene Regulat & Signal Transduct, La Jolla, CA 92093 USA.	karinoffice@ucsd.edu	ali, syed/J-6124-2014; Ali, Syed/M-7418-2013; Yu, Guann-Yi/O-5139-2019	Yu, Guann-Yi/0000-0002-0580-8282; Lee, Jun Hee/0000-0002-2200-6011	Natural Sciences and Engineering Research Council of Canada; Korean Research Foundation; Philip Morris Foundation; American Diabetes Association; NIH [ES006376, CA118165]; Superfund Research [P42-ES010337]; Wellcome Trust [WT086755]; NATIONAL CANCER INSTITUTE [R01CA118165] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES006376, P42ES010337] Funding Source: NIH RePORTER	Natural Sciences and Engineering Research Council of Canada(Natural Sciences and Engineering Research Council of Canada (NSERC)CGIAR); Korean Research Foundation(National Research Foundation of Korea); Philip Morris Foundation; American Diabetes Association(American Diabetes Association); NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Superfund Research; Wellcome Trust(Wellcome TrustEuropean Commission); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))	We thank David Brenner and the anonymous reviewers for their critical comments and Giovanni Solinas for his advice on metabolic measurements. We also thank Soo Young Lee, Helen Tran, and Katsumi Miyai for technical assistance and advice on liver pathology. E.J.P. and J.H.L. were supported in part by postdoctoral fellowships from the Natural Sciences and Engineering Research Council of Canada and Korean Research Foundation, respectively. S.R.A. received a postdoctoral fellowship from the Philip Morris Foundation and G.Y.Y. was supported by an American Diabetes Association postdoctoral research grant to M. K. Work was supported by grants from the NIH (ES006376 and CA118165), the Superfund Research Program (P42-ES010337), and the Wellcome Trust (WT086755) to M.K., who is an American Cancer Society Research Professor.	Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Bastard JP, 2000, J CLIN ENDOCR METAB, V85, P3338, DOI 10.1210/jc.85.9.3338; Bianchini F, 2002, LANCET ONCOL, V3, P565, DOI 10.1016/S1470-2045(02)00849-5; Bisgaard HC, 1996, CLIN LAB MED, V16, P325, DOI 10.1016/S0272-2712(18)30272-5; Bromberg J, 2009, CANCER CELL, V15, P79, DOI 10.1016/j.ccr.2009.01.009; Caldwell SH, 2004, GASTROENTEROLOGY, V127, pS97, DOI 10.1053/j.gastro.2004.09.021; Calle EE, 2003, NEW ENGL J MED, V348, P1625, DOI 10.1056/NEJMoa021423; Calle EE, 2004, NAT REV CANCER, V4, P579, DOI 10.1038/nrc1408; Calvisi DF, 2006, GASTROENTEROLOGY, V130, P1117, DOI 10.1053/j.gastro.2006.01.006; Di Gregorio GB, 2004, AM J PHYSIOL-ENDOC M, V287, pE799, DOI 10.1152/ajpendo.00155.2004; El-Serag HB, 2007, GASTROENTEROLOGY, V132, P2557, DOI 10.1053/j.gastro.2007.04.061; Eriksen KW, 2001, LEUKEMIA, V15, P787, DOI 10.1038/sj.leu.2402093; Fausto N, 1999, SEMIN LIVER DIS, V19, P243, DOI 10.1055/s-2007-1007114; FOLCH J, 1957, J BIOL CHEM, V226, P497; Fried SK, 1998, J CLIN ENDOCR METAB, V83, P847, DOI 10.1210/jc.83.3.847; FRIEDMAN JM, 1991, GENOMICS, V11, P1054, DOI 10.1016/0888-7543(91)90032-A; Grivennikov S, 2009, CANCER CELL, V15, P103, DOI 10.1016/j.ccr.2009.01.001; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; HE G, 2010, CANC CELL IN PRESS; Hirosumi J, 2002, NATURE, V420, P333, DOI 10.1038/nature01137; Hotamisligil GS, 2006, NATURE, V444, P860, DOI 10.1038/nature05485; Hui LJ, 2007, NAT GENET, V39, P741, DOI 10.1038/ng2033; Johansson M, 2008, IMMUNOL REV, V222, P145, DOI 10.1111/j.1600-065X.2008.00600.x; Kamimura D, 2004, REV PHYSIOL BIOCH P, V149, P1, DOI 10.1007/s10254-003-0012-2; Karin M, 2006, NATURE, V441, P431, DOI 10.1038/nature04870; Li SS, 2009, VIROLOGY, V391, P257, DOI 10.1016/j.virol.2009.06.039; Lin WW, 2007, J CLIN INVEST, V117, P1175, DOI 10.1172/JCI31537; Luedde T, 2007, CANCER CELL, V11, P119, DOI 10.1016/j.ccr.2006.12.016; Maeda S, 2005, CELL, V121, P977, DOI 10.1016/j.cell.2005.04.014; Mantovani A, 2008, NATURE, V454, P436, DOI 10.1038/nature07205; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Nakagawa H, 2009, INT J CANCER, V125, P2264, DOI 10.1002/ijc.24720; Naugler WE, 2007, SCIENCE, V317, P121, DOI 10.1126/science.1140485; NONOGAKI K, 1995, ENDOCRINOLOGY, V136, P2143, DOI 10.1210/en.136.5.2143; Parekh S, 2007, GASTROENTEROLOGY, V132, P2191, DOI 10.1053/j.gastro.2007.03.055; PELLEYMOUNTER MA, 1995, SCIENCE, V269, P540, DOI 10.1126/science.7624776; Rebouissou S, 2009, NATURE, V457, P200, DOI 10.1038/nature07475; Sakurai T, 2008, CANCER CELL, V14, P156, DOI 10.1016/j.ccr.2008.06.016; Sakurai T, 2006, P NATL ACAD SCI USA, V103, P10544, DOI 10.1073/pnas.0603499103; Sheweita SA, 2003, CURR DRUG METAB, V4, P45, DOI 10.2174/1389200033336919; Shoelson SE, 2007, GASTROENTEROLOGY, V132, P2169, DOI 10.1053/j.gastro.2007.03.059; Solinas G, 2007, CELL METAB, V6, P386, DOI 10.1016/j.cmet.2007.09.011; TILG H, 1992, GASTROENTEROLOGY, V103, P264, DOI 10.1016/0016-5085(92)91122-K; Tremblay F, 2007, P NATL ACAD SCI USA, V104, P14056, DOI 10.1073/pnas.0706517104; Trikha M, 2003, CLIN CANCER RES, V9, P4653; Um SH, 2004, NATURE, V431, P200, DOI 10.1038/nature02866; VESSELINOVITCH SD, 1983, CANCER RES, V43, P4253; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Wang D, 2006, IEEE AERO EL SYS MAG, V21, P3, DOI 10.1109/MAES.2006.1705163; Wang Y, 2009, INT J CANCER, V124, P540, DOI 10.1002/ijc.23995; WARD JM, 1986, ENVIRON HEALTH PERSP, V65, P279, DOI 10.2307/3430195; Wong VWS, 2009, INT J CANCER, V124, P2766, DOI 10.1002/ijc.24281; Wunderlich FT, 2008, P NATL ACAD SCI USA, V105, P1297, DOI 10.1073/pnas.0707849104	53	1189	1228	10	163	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	JAN 22	2010	140	2					197	208		10.1016/j.cell.2009.12.052	http://dx.doi.org/10.1016/j.cell.2009.12.052			12	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141834	Bronze, Green Accepted			2022-12-01	WOS:000273826500011
J	Rotenberg, E; Yakir, D				Rotenberg, Eyal; Yakir, Dan			Contribution of Semi-Arid Forests to the Climate System	SCIENCE			English	Article							DROUGHT; BOREAL; DESERTIFICATION; EFFICIENCY; FEEDBACKS	Forests both take up CO2 and enhance absorption of solar radiation, with contrasting effects on global temperature. Based on a 9-year study in the forests' dry timberline, we show that substantial carbon sequestration (cooling effect) is maintained in the large dry transition zone (precipitation from 200 to 600 millimeters) by shifts in peak photosynthetic activities from summer to early spring, and this is counteracted by longwave radiation (L) suppression (warming effect), doubling the forestation shortwave (S) albedo effect. Several decades of carbon accumulation are required to balance the twofold S + L effect. Desertification over the past several decades, however, contributed negative forcing at Earth's surface equivalent to similar to 20% of the global anthropogenic CO2 effect over the same period, moderating warming trends.	[Rotenberg, Eyal; Yakir, Dan] Weizmann Inst Sci, IL-76100 Rehovot, Israel	Weizmann Institute of Science	Yakir, D (corresponding author), Weizmann Inst Sci, IL-76100 Rehovot, Israel.	dan.yakir@weizmann.ac.il	Yakir, Dan/K-1500-2012		Israel Science Foundation; Minerva-Avron Center; Weizmann Institute	Israel Science Foundation(Israel Science Foundation); Minerva-Avron Center; Weizmann Institute	We thank the students, postdocs, and technicians of the Yatir team for making this project possible. The long-term operation of the Yatir Forest Research Field Site is supported by the Cathy Wills and Robert Lewis Program in Environmental Science. Financial support from the Israel Science Foundation, Global Change and the Hydrological Cycle-Jordan River (GLOWA-JR), Keren Kayemet L'Israel (KKL), Jewish National Fund (JNF), the Minerva-Avron Center, and the Weizmann Institute is gratefully acknowledged.	AFIK T, 2009, THESIS HEBREW U JERU; [Anonymous], 4 IPCC; Asner GP, 2003, GLOBAL ECOL BIOGEOGR, V12, P191, DOI 10.1046/j.1466-822X.2003.00026.x; Aubinet M, 2000, ADV ECOL RES, V30, P113, DOI 10.1016/S0065-2504(08)60018-5; Bala G, 2007, P NATL ACAD SCI USA, V104, P6550, DOI 10.1073/pnas.0608998104; Baldocchi D, 2001, B AM METEOROL SOC, V82, P2415, DOI 10.1175/1520-0477(2001)082<2415:FANTTS>2.3.CO;2; Bar Massada A, 2006, CAN J FOREST RES, V36, P2585, DOI 10.1139/X06-152; Betts RA, 2000, NATURE, V408, P187, DOI 10.1038/35041545; Bonan GB, 2008, SCIENCE, V320, P1444, DOI 10.1126/science.1155121; Bowman DMJS, 2009, SCIENCE, V324, P481, DOI 10.1126/science.1163886; Campbell Gaylon S., 1998; Canadell JG, 2007, P NATL ACAD SCI USA, V104, P18866, DOI 10.1073/pnas.0702737104; CHARNEY J, 1977, J ATMOS SCI, V34, P1366, DOI 10.1175/1520-0469(1977)034<1366:ACSOTE>2.0.CO;2; CHARNEY JG, 1975, Q J ROY METEOR SOC, V101, P193, DOI 10.1002/qj.49710142802; Ciais P, 2005, NATURE, V437, P529, DOI 10.1038/nature03972; Claussen M, 2001, GEOPHYS RES LETT, V28, P1011, DOI 10.1029/2000GL012471; Davin EL, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL029678; *FAO, 2004, WORLD SOILS RES REP, V102; Helliker BR, 2008, NATURE, V454, P511, DOI 10.1038/nature07031; Knorr W, 2001, GEOPHYS RES LETT, V28, P3489, DOI 10.1029/2001GL013283; Lal R, 2004, ENVIRON MANAGE, V33, P528, DOI 10.1007/s00267-003-9110-9; LeHouerou HN, 1996, J ARID ENVIRON, V34, P133, DOI 10.1006/jare.1996.0099; Luyssaert S, 2007, GLOBAL CHANGE BIOL, V13, P2509, DOI 10.1111/j.1365-2486.2007.01439.x; Maseyk K, 2008, GLOBAL CHANGE BIOL, V14, P1553, DOI 10.1111/j.1365-2486.2008.01604.x; Maseyk KS, 2008, NEW PHYTOL, V178, P603, DOI 10.1111/j.1469-8137.2008.02391.x; Masson V, 2003, J CLIMATE, V16, P1261, DOI 10.1175/1520-0442-16.9.1261; Myhre G, 1998, GEOPHYS RES LETT, V25, P2715, DOI 10.1029/98GL01908; *NAT CLIM DAT CTR, 1964, MEAN DAIL SOL RAD MO; OTTERMAN J, 1974, SCIENCE, V186, P531, DOI 10.1126/science.186.4163.531; Pacala S, 2004, SCIENCE, V305, P968, DOI 10.1126/science.1100103; Peixoto J., 1992, PHYS CLIMATE, P520, DOI DOI 10.1063/1.2809772; Penuelas J, 2003, GLOBAL CHANGE BIOL, V9, P131, DOI 10.1046/j.1365-2486.2003.00566.x; Reynolds JF, 2007, SCIENCE, V316, P847, DOI 10.1126/science.1131634; Schaeffer M, 2006, GLOBAL BIOGEOCHEM CY, V20, DOI 10.1029/2005GB002581; SHAW RH, 1982, AGR METEOROL, V26, P51, DOI 10.1016/0002-1571(82)90057-7; SHUTTLEWORTH WJ, 1984, Q J ROY METEOR SOC, V110, P1163, DOI 10.1002/qj.49711046623; Smith GL, 2002, J CLIMATE, V15, P1175, DOI [10.1175/1520-0442(2002)015<1175:SRBACC>2.0.CO;2, 10.1175/1520-0442(2002)015&lt;1175:SRBACC&gt;2.0.CO;2]; Warner T.T., 2004, DESERT METEOROLOGY, DOI [10.1017/CBO9780511535789, DOI 10.1017/CBO9780511535789]; Xue YK, 1997, Q J ROY METEOR SOC, V123, P1483, DOI 10.1002/qj.49712354203	39	336	357	14	191	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					451	454		10.1126/science.1179998	http://dx.doi.org/10.1126/science.1179998			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093470				2022-12-01	WOS:000273783100034
J	Tero, A; Takagi, S; Saigusa, T; Ito, K; Bebber, DP; Fricker, MD; Yumiki, K; Kobayashi, R; Nakagaki, T				Tero, Atsushi; Takagi, Seiji; Saigusa, Tetsu; Ito, Kentaro; Bebber, Dan P.; Fricker, Mark D.; Yumiki, Kenji; Kobayashi, Ryo; Nakagaki, Toshiyuki			Rules for Biologically Inspired Adaptive Network Design	SCIENCE			English	Article							TRANSPORT NETWORK; PHYSARUM; SHAPE	Transport networks are ubiquitous in both social and biological systems. Robust network performance involves a complex trade-off involving cost, transport efficiency, and fault tolerance. Biological networks have been honed by many cycles of evolutionary selection pressure and are likely to yield reasonable solutions to such combinatorial optimization problems. Furthermore, they develop without centralized control and may represent a readily scalable solution for growing networks in general. We show that the slime mold Physarum polycephalum forms networks with comparable efficiency, fault tolerance, and cost to those of real-world infrastructure networks-in this case, the Tokyo rail system. The core mechanisms needed for adaptive network formation can be captured in a biologically inspired mathematical model that may be useful to guide network construction in other domains.	[Tero, Atsushi; Takagi, Seiji; Ito, Kentaro; Nakagaki, Toshiyuki] Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan; [Tero, Atsushi] JST, PRESTO, Saitama, Japan; [Saigusa, Tetsu] Hokkaido Univ, Grad Sch Engn, Sapporo, Hokkaido 0608628, Japan; [Bebber, Dan P.; Fricker, Mark D.] Univ Oxford, Dept Plant Sci, Oxford OX1 3RB, England; [Yumiki, Kenji; Kobayashi, Ryo] Hiroshima Univ, Dept Math & Life Sci, Higashihiroshima 7398526, Japan; [Kobayashi, Ryo; Nakagaki, Toshiyuki] JST, CREST, Chiyoda Ku, Tokyo 1020075, Japan	Hokkaido University; Japan Science & Technology Agency (JST); Hokkaido University; University of Oxford; Hiroshima University; Japan Science & Technology Agency (JST)	Nakagaki, T (corresponding author), Hokkaido Univ, Res Inst Elect Sci, Sapporo, Hokkaido 0600812, Japan.	nakagaki@es.hokudai.ac.jp	Fricker, Mark/AAX-9245-2020; Kobayashi, Ryo/G-8714-2019; Fricker, Mark D/L-6627-2014; Nakagaki, Toshiyuki/L-3049-2013	Kobayashi, Ryo/0000-0003-0750-5848; Fricker, Mark D/0000-0002-8942-6897; Nakagaki, Toshiyuki/0000-0002-3446-4888	MEXT KAKENHI [18650054, 20300105]; Human Frontier Science Program [RGP51/2007]; EU [12999]; NERC [A/S/882]; Natural Environment Research Council [NER/A/S/2002/00882] Funding Source: researchfish	MEXT KAKENHI(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of ScienceGrants-in-Aid for Scientific Research (KAKENHI)); Human Frontier Science Program(Human Frontier Science Program); EU(European Commission); NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))	Supported by MEXT KAKENHI grants 18650054 and 20300105, Human Frontier Science Program grant RGP51/2007, EU Framework 6 contract 12999 (NEST), and NERC grant A/S/882.	Akyildiz IF, 2005, COMPUT NETW, V47, P445, DOI 10.1016/j.comnet.2004.12.001; Albert R, 2004, PHYS REV E, V69, DOI 10.1103/PhysRevE.69.025103; Albert R, 2000, NATURE, V406, P378, DOI 10.1038/35019019; Bebber DP, 2007, P ROY SOC B-BIOL SCI, V274, P2307, DOI 10.1098/rspb.2007.0459; Buhl J, 2009, BEHAV ECOL SOCIOBIOL, V63, P451, DOI 10.1007/s00265-008-0680-7; Colorni A., 1996, International Transactions in Operational Research, V3, P1, DOI 10.1111/j.1475-3995.1996.tb00032.x; *IND INV BOARD OFF, 2006, TRAIN DER HATF; KAMBHU J, 2007, FEDERAL RESERVE BANK, V13, P1; May RM, 2008, NATURE, V451, P893, DOI 10.1038/451893a; Nakagaki T, 2000, NATURE, V407, P470, DOI 10.1038/35035159; Nakagaki T, 2000, BIOPHYS CHEM, V84, P195, DOI 10.1016/S0301-4622(00)00108-3; Nakagaki T, 2004, P ROY SOC B-BIOL SCI, V271, P2305, DOI 10.1098/rspb.2004.2856; Nakagaki T, 2004, BIOPHYS CHEM, V107, P1, DOI 10.1016/S0301-4622(03)00189-3; Nakagaki T, 2001, BIOPHYS CHEM, V92, P47, DOI 10.1016/S0301-4622(01)00179-X; NAKAGAKI T, 2007, TOPOLOGICAL ASPECTS, P94; Nakagaki T, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.068104; Sole RV, 2008, PHYS REV E, V77, DOI 10.1103/PhysRevE.77.026102; Takamatsu A, 2009, J THEOR BIOL, V256, P29, DOI 10.1016/j.jtbi.2008.09.010; Tero A, 2006, PHYSICA A, V363, P115, DOI 10.1016/j.physa.2006.01.053; Tero A, 2008, THEOR BIOSCI, V127, P89, DOI 10.1007/s12064-008-0037-9; Tero A, 2007, J THEOR BIOL, V244, P553, DOI 10.1016/j.jtbi.2006.07.015	21	497	517	15	370	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					439	442		10.1126/science.1177894	http://dx.doi.org/10.1126/science.1177894			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093467	Green Submitted			2022-12-01	WOS:000273783100030
J	Graham, IA; Besser, K; Blumer, S; Branigan, CA; Czechowski, T; Elias, L; Guterman, I; Harvey, D; Isaac, PG; Khan, AM; Larson, TR; Li, Y; Pawson, T; Penfield, T; Rae, AM; Rathbone, DA; Reid, S; Ross, J; Smallwood, MF; Segura, V; Townsend, T; Vyas, D; Winzer, T; Bowles, D				Graham, Ian A.; Besser, Katrin; Blumer, Susan; Branigan, Caroline A.; Czechowski, Tomasz; Elias, Luisa; Guterman, Inna; Harvey, David; Isaac, Peter G.; Khan, Awais M.; Larson, Tony R.; Li, Yi; Pawson, Tanya; Penfield, Teresa; Rae, Anne M.; Rathbone, Deborah A.; Reid, Sonja; Ross, Joe; Smallwood, Margaret F.; Segura, Vincent; Townsend, Theresa; Vyas, Darshna; Winzer, Thilo; Bowles, Dianna			The Genetic Map of Artemisia annua L. Identifies Loci Affecting Yield of the Antimalarial Drug Artemisinin	SCIENCE			English	Article							BIOSYNTHESIS; ASTERACEAE; CLONING	Artemisinin is a plant natural product produced by Artemisia annua and the active ingredient in the most effective treatment for malaria. Efforts to eradicate malaria are increasing demand for an affordable, high-quality, robust supply of artemisinin. We performed deep sequencing on the transcriptome of A. annua to identify genes and markers for fast-track breeding. Extensive genetic variation enabled us to build a detailed genetic map with nine linkage groups. Replicated field trials resulted in a quantitative trait loci (QTL) map that accounts for a significant amount of the variation in key traits controlling artemisinin yield. Enrichment for positive QTLs in parents of new high-yielding hybrids confirms that the knowledge and tools to convert A. annua into a robust crop are now available.	[Graham, Ian A.; Besser, Katrin; Blumer, Susan; Branigan, Caroline A.; Czechowski, Tomasz; Elias, Luisa; Guterman, Inna; Harvey, David; Khan, Awais M.; Larson, Tony R.; Li, Yi; Pawson, Tanya; Penfield, Teresa; Rae, Anne M.; Rathbone, Deborah A.; Reid, Sonja; Ross, Joe; Smallwood, Margaret F.; Segura, Vincent; Townsend, Theresa; Vyas, Darshna; Winzer, Thilo; Bowles, Dianna] Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5YW, N Yorkshire, England; [Isaac, Peter G.] IDna Genet Ltd, Norwich NR4 7UH, Norfolk, England	University of York - UK	Graham, IA (corresponding author), Univ York, Dept Biol, Ctr Novel Agr Prod, York YO10 5YW, N Yorkshire, England.	iag1@york.ac.uk; djb32@york.ac.uk	Segura, Vincent/B-4656-2013; Larson, Tony/AAI-4782-2020	Segura, Vincent/0000-0003-1860-2256; Larson, Tony/0000-0003-1337-3482; Khan, Muhammad Awais/0000-0002-0424-7727	Bill and Melinda Gates Foundation; Medicines for Malaria Venture; Garfield Weston Foundation for the Centre for Novel Agricultural Products	Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Medicines for Malaria Venture; Garfield Weston Foundation for the Centre for Novel Agricultural Products	We thank L. Doucet, H. Martin, N. Nattriss, M. Segura, and A. Czechowska for horticulture assistance; G. Chigeza for horticulture management; S. Graham, S. Heywood, B. Kowalik, S. Pandey, R. Simister, and C. Whitehead for laboratory assistance; C. Calvert, P. Dickes, W. Lawley, and D. Rotherham for project management; E. Bartlet for communications advice; and P. Roberts for graphic design. We thank T. Brewer, H. Klee, and K. Stuart for insightful advice on this project. We thank X. Simonnet and Mediplant for access to the Artemis pedigree. We acknowledge financial support for this project from The Bill and Melinda Gates Foundation and Medicines for Malaria Venture, as well as from The Garfield Weston Foundation for the Centre for Novel Agricultural Products.	Bertea CM, 2006, ARCH BIOCHEM BIOPHYS, V448, P3, DOI 10.1016/j.abb.2006.02.026; Bertea CM, 2005, PLANTA MED, V71, P40, DOI 10.1055/s-2005-837749; Chang MCY, 2007, NAT CHEM BIOL, V3, P274, DOI 10.1038/nchembio875; Covello PS, 2008, PHYTOCHEMISTRY, V69, P2881, DOI 10.1016/j.phytochem.2008.10.001; Delabays N, 2001, CURR MED CHEM, V8, P1795, DOI 10.2174/0929867013371635; Dondorp AM, 2009, NEW ENGL J MED, V361, P455, DOI 10.1056/NEJMoa0808859; DUKE MV, 1994, INT J PLANT SCI, V155, P365, DOI 10.1086/297173; FERREIRA JFS, 1995, INT J PLANT SCI, V156, P807, DOI 10.1086/297304; *NAT AC SCI, 2004, SAV LIV BUYING TIM E; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Teoh KH, 2006, FEBS LETT, V580, P1411, DOI 10.1016/j.febslet.2006.01.065; TEOH KH, 2009, CAN J BOT, V87, P635; Torrell M, 2001, GENOME, V44, P231, DOI 10.1139/gen-44-2-231; WORLDHEALTH ORGANIZATION (WHO), 2008, WORLD MAL REP 2008; Zhang Y, 2008, J BIOL CHEM, V283, P21501, DOI 10.1074/jbc.M803090200	15	253	306	2	146	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					328	331		10.1126/science.1182612	http://dx.doi.org/10.1126/science.1182612			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	544CM	20075252				2022-12-01	WOS:000273629700042
J	Liang, BA; Mackey, T				Liang, Bryan A.; Mackey, Tim			Reforming Off-Label Promotion to Enhance Orphan Disease Treatment	SCIENCE			English	Editorial Material							DRUGS; FDA		[Liang, Bryan A.; Mackey, Tim] Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA 92101 USA; [Liang, Bryan A.] Univ Calif San Diego, San Diego Sch Med, San Diego Ctr Patient Safety, Dept Anesthesiol, San Diego, CA 92103 USA	University of California System; University of California San Diego	Liang, BA (corresponding author), Calif Western Sch Law, Inst Hlth Law Studies, San Diego, CA 92101 USA.	baliang@alum.mit.edu	Mackey, Tim/H-9156-2013	Mackey, Tim/0000-0002-2191-7833				ABELSON R, 2009, NY TIMES        0127, pA22, DOI DOI 10.1007/S00228-005-0981-Y; Berenson Alex, 2006, N Y Times Web, pC2; Boos J, 2003, ANN ONCOL, V14, P1, DOI 10.1093/annonc/mdg035; Brewer GJ, 2009, TRANSL RES, V154, P314, DOI 10.1016/j.trsl.2009.03.008; Canadian Organization for Rare Disorders, 2005, CAN ORPH DRUG POL LE; *DHHS, 2001, OEI090000380 DHHS; FDA, 2009, GOOD REPR PRACT DIST; Hampton T, 2007, JAMA-J AM MED ASSOC, V297, P683, DOI 10.1001/jama.297.7.683; Krammer MG, 2003, NATL ORG RARE DISORD; Liang BA, 2007, HARVARD J LEGIS, V44, P363; Mello MM, 2009, NEW ENGL J MED, V360, P1557, DOI 10.1056/NEJMhle0807695; POLLACK A, 1990, NY TIMES        0116, pD1; Psaty BM, 2008, JAMA-J AM MED ASSOC, V299, P1949, DOI 10.1001/jama.299.16.1949; Radley DC, 2006, ARCH INTERN MED, V166, P1021, DOI 10.1001/archinte.166.9.1021; *RAR CANC FOR, 2009, OFF LIM INV NHS ORG; Richey EA, 2009, J CLIN ONCOL, V27, P4398, DOI 10.1200/JCO.2008.21.1961; SALBU SR, 1999, FLA L REV, V51, P181, DOI DOI 10.1377/HLTHAFF.2010.1032; Schlander M, 2009, CURR MED RES OPIN, V25, P1285, DOI [10.1185/03007990902892633, 10.1185/03007990902892633 ]; Stafford RS, 2008, NEW ENGL J MED, V358, P1427, DOI 10.1056/NEJMp0802107; 2008, NIH NEWS; 1997, FED REG, V62, P64073; 1996, FED REG, V61, P52800	22	24	24	0	2	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 15	2010	327	5963					273	274		10.1126/science.1181567	http://dx.doi.org/10.1126/science.1181567			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	544CM	20075234				2022-12-01	WOS:000273629700021
J	Henneberger, C; Papouin, T; Oliet, SHR; Rusakov, DA				Henneberger, Christian; Papouin, Thomas; Oliet, Stephane H. R.; Rusakov, Dmitri A.			Long-term potentiation depends on release of D-serine from astrocytes	NATURE			English	Article							GLUTAMATE RELEASE; SYNAPTIC-TRANSMISSION; TRANSPORTER CURRENTS; RECEPTOR ACTIVATION; GLYCINE SITE; IN-SITU; CALCIUM; HIPPOCAMPUS; SYNAPSES; BRAIN	Long-term potentiation (LTP) of synaptic transmission provides an experimental model for studying mechanisms of memory(1). The classical form of LTP relies on N-methyl-D-aspartate receptors (NMDARs), and it has been shown that astroglia can regulate their activation through Ca2+-dependent release of the NMDAR co-agonist D-serine(2-4). Release of D-serine from glia enables LTP in cultures(5) and explains a correlation between glial coverage of synapses and LTP in the supraoptic nucleus(4). However, increases in Ca2+ concentration in astroglia can also release other signalling molecules, most prominently glutamate(6-8), ATP(9) and tumour necrosis factor-alpha(10,11), whereas neurons themselves can synthesize and supply D-serine(12,13). Furthermore, loading an astrocyte with exogenous Ca2+ buffers does not suppress LTP in hippocampal area CA1 (refs 14-16), and the physiological relevance of experiments in cultures or strong exogenous stimuli applied to astrocytes has been questioned(17,18). The involvement of glia in LTP induction therefore remains controversial. Here we show that clamping internal Ca2+ in individual CA1 astrocytes blocks LTP induction at nearby excitatory synapses by decreasing the occupancy of the NMDAR co-agonist sites. This LTP blockade can be reversed by exogenous D-serine or glycine, whereas depletion of D-serine or disruption of exocytosis in an individual astrocyte blocks local LTP. We therefore demonstrate that Ca2+-dependent release of D-serine from an astrocyte controls NMDAR-dependent plasticity in many thousands of excitatory synapses nearby.	[Henneberger, Christian; Rusakov, Dmitri A.] UCL, UCL Inst Neurol, London WC1N 3BG, England; [Papouin, Thomas; Oliet, Stephane H. R.] INSERM, U862, Neuroctr Magendie, F-33077 Bordeaux, France; [Papouin, Thomas; Oliet, Stephane H. R.] Univ Bordeaux, F-33077 Bordeaux, France	University of London; University College London; Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Universite de Bordeaux; UDICE-French Research Universities; Universite de Bordeaux	Rusakov, DA (corresponding author), UCL, UCL Inst Neurol, London WC1N 3BG, England.	stephane.oliet@inserm.fr; d.rusakov@ion.ucl.ac.uk	Rusakov, Dmitri/AAH-4529-2021; Rusakov, Dmitri A/E-1987-2011; Henneberger, Christian/C-1557-2008; Papouin, Thomas/W-2769-2019	Rusakov, Dmitri/0000-0001-9539-9947; Rusakov, Dmitri A/0000-0001-9539-9947; Henneberger, Christian/0000-0002-5391-7387; Papouin, Thomas/0000-0001-5288-1944; Oliet, Stephane/0000-0003-0595-9029	Human Frontier Science Programme; Wellcome Trust; Medical Research Council (UK); European Union (Promemoria), INSERM, Universite de Bordeaux; Fondation pour la Recherche Medicale; French Ministry of Research; MRC [G0900613, G0802216, G0600368] Funding Source: UKRI; Medical Research Council [G0900613, G0600368, G0802216] Funding Source: researchfish	Human Frontier Science Programme(Human Frontier Science Program); Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council (UK)(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Union (Promemoria), INSERM, Universite de Bordeaux(Institut National de la Sante et de la Recherche Medicale (Inserm)); Fondation pour la Recherche Medicale(Fondation pour la Recherche Medicale); French Ministry of Research(Ministry of Research, FranceEuropean Commission); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)	Acknowledgements We thank D. Kullmann, J. Diamond, T. Bliss and K. Volynski for comments and suggestions. This work was supported by the Human Frontier Science Programme (D. A. R. and S.H.R.O.), the Wellcome Trust (Senior Fellowship to D. A. R.), the Medical Research Council (UK), the European Union (Promemoria), INSERM, Universite de Bordeaux, the Fondation pour la Recherche Medicale (Equipe FRM, to S.H.R.O.), National Alliance for Research on Schizophrenia and Depression (NARSAD; Independent Investigator, SHRO), Agence National de la Recherche, Federation pour la Recherche sur le Cerveau, Conseil Regional d'Aquitaine and a studentship from the French Ministry of Research to T. P.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; BAKER PF, 1985, CELL CALCIUM, V6, P5, DOI 10.1016/0143-4160(85)90030-2; Bergles DE, 1998, J NEUROSCI, V18, P7709; Bezzi P, 2001, NAT NEUROSCI, V4, P702, DOI 10.1038/89490; Bezzi P, 1998, NATURE, V391, P281, DOI 10.1038/34651; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Bushong EA, 2002, J NEUROSCI, V22, P183, DOI 10.1523/JNEUROSCI.22-01-00183.2002; Cummings JA, 1996, NEURON, V16, P825, DOI 10.1016/S0896-6273(00)80102-6; Diamond JS, 1998, NEURON, V21, P425, DOI 10.1016/S0896-6273(00)80551-6; Duffy S, 2008, NEUROPSYCHOPHARMACOL, V33, P1004, DOI 10.1038/sj.npp.1301486; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fellin T, 2009, P NATL ACAD SCI USA, V106, P15037, DOI 10.1073/pnas.0906419106; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Ge WP, 2007, J NEUROPHYSIOL, V97, P2564, DOI 10.1152/jn.00146.2006; Kartvelishvily E, 2006, J BIOL CHEM, V281, P14151, DOI 10.1074/jbc.M512927200; Li Y, 2009, J NEUROPHYSIOL, V102, P578, DOI 10.1152/jn.91342.2008; Luscher C, 1998, NEURON, V21, P435, DOI 10.1016/S0896-6273(00)80552-8; Martineau M, 2008, GLIA, V56, P1271, DOI 10.1002/glia.20696; Miya K, 2008, J COMP NEUROL, V510, P641, DOI 10.1002/cne.21822; Mothet JP, 2005, P NATL ACAD SCI USA, V102, P5606, DOI 10.1073/pnas.0408483102; Mothet JP, 2000, P NATL ACAD SCI USA, V97, P4926, DOI 10.1073/pnas.97.9.4926; Oertner TG, 2002, NAT NEUROSCI, V5, P657, DOI 10.1038/nn867; Panatier A, 2006, CELL, V125, P775, DOI 10.1016/j.cell.2006.02.051; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Porter JT, 1996, J NEUROSCI, V16, P5073; Rouach N, 2008, SCIENCE, V322, P1551, DOI 10.1126/science.1164022; Rusakov DA, 2003, NEURON, V37, P287, DOI 10.1016/S0896-6273(03)00025-4; Rusakov DA, 1998, J NEUROSCI, V18, P3158; SCHELL MJ, 1995, P NATL ACAD SCI USA, V92, P3948, DOI 10.1073/pnas.92.9.3948; Scott R, 2008, J NEUROSCI, V28, P7765, DOI 10.1523/JNEUROSCI.1296-08.2008; Stellwagen D, 2006, NATURE, V440, P1054, DOI 10.1038/nature04671; Strisovsky K, 2005, BIOCHEMISTRY-US, V44, P13091, DOI 10.1021/bi051201o; SZERB JC, 1987, BRAIN RES, V410, P116, DOI 10.1016/S0006-8993(87)80030-6; Volterra A, 2005, NAT REV NEUROSCI, V6, P626, DOI 10.1038/nrn1722; Xu T, 1998, NAT NEUROSCI, V1, P192, DOI 10.1038/642; Yang YL, 2003, P NATL ACAD SCI USA, V100, P15194, DOI 10.1073/pnas.2431073100	37	914	936	5	169	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 14	2010	463	7278					232	U120		10.1038/nature08673	http://dx.doi.org/10.1038/nature08673			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	543MQ	20075918	Green Accepted			2022-12-01	WOS:000273582700036
J	Berg, WA				Berg, Wendie A.			Benefits of Screening Mammography	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							BREAST-CANCER; MORTALITY; WOMEN		Amer Radiol Serv, Lutherville Timonium, MD 21093 USA		Berg, WA (corresponding author), Amer Radiol Serv, Lutherville Timonium, MD 21093 USA.	wendieberg@gmail.com			NCI NIH HHS [U01 CA89008, U01 CA079778] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA079778] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		[Anonymous], FREQUENTLY ASKED QUE; Bancej C, 2003, J MED SCREEN, V10, P16, DOI 10.1258/096914103321610761; Berg WA, 2009, AM J ROENTGENOL, V192, P390, DOI 10.2214/AJR.08.1706; Coldman A, 2007, INT J CANCER, V120, P1076, DOI 10.1002/ijc.22249; National Academies/National Research Council, 2006, HLTH RISKS EXP LOW L; Nelson HD, 2009, ANN INTERN MED, V151, P727, DOI 10.7326/0003-4819-151-10-200911170-00009; Schwartz LM, 2000, BMJ-BRIT MED J, V320, P1635, DOI 10.1136/bmj.320.7250.1635; Shapiro S, 1988, PERIODIC SCREENING B; Tabar L, 1996, INT J CANCER, V68, P693; Tabar L, 2003, LANCET, V361, P1405, DOI 10.1016/S0140-6736(03)13143-1	10	33	33	0	4	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 13	2010	303	2					168	169		10.1001/jama.2009.1993	http://dx.doi.org/10.1001/jama.2009.1993			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	542UI	20068213	Green Accepted, Green Submitted			2022-12-01	WOS:000273522600030
J	Humbard, MA; Miranda, HV; Lim, JM; Krause, DJ; Pritz, JR; Zhou, GY; Chen, SX; Wells, L; Maupin-Furlow, JA				Humbard, Matthew A.; Miranda, Hugo V.; Lim, Jae-Min; Krause, David J.; Pritz, Jonathan R.; Zhou, Guangyin; Chen, Sixue; Wells, Lance; Maupin-Furlow, Julie A.			Ubiquitin-like small archaeal modifier proteins (SAMPs) in Haloferax volcanii	NATURE			English	Article							PROTEASOME-ACTIVATING NUCLEOTIDASE; RHODANESE-LIKE PROTEIN; MOLYBDENUM COFACTOR; DEPENDENT DEGRADATION; SULFUR CARRIER; SYSTEM; CHAINS; PUP; DEUBIQUITINATION; METALLOPROTEASE	Archaea, one of three major evolutionary lineages of life, encode proteasomes highly related to those of eukaryotes. In contrast, archaeal ubiquitin-like proteins are less conserved and not known to function in protein conjugation. This has complicated our understanding of the origins of ubiquitination and its connection to proteasomes. Here we report two small archaeal modifier proteins, SAMP1 and SAMP2, with a beta-grasp fold and carboxy-terminal diglycine motif similar to ubiquitin, that form protein conjugates in the archaeon Haloferax volcanii. The levels of SAMP-conjugates were altered by nitrogen-limitation and proteasomal gene knockout and spanned various functions including components of the Urm1 pathway. LC-MS/MS-based collision-induced dissociation demonstrated isopeptide bonds between the C-terminal glycine of SAMP2 and the epsilon-amino group of lysines from a number of protein targets and Lys58 of SAMP2 itself, revealing poly-SAMP chains. The widespread distribution and diversity of pathways modified by SAMPylation suggest that this type of protein conjugation is central to the archaeal lineage.	[Humbard, Matthew A.; Miranda, Hugo V.; Krause, David J.; Pritz, Jonathan R.; Zhou, Guangyin; Maupin-Furlow, Julie A.] Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA; [Chen, Sixue] Univ Florida, Dept Biol, Gainesville, FL 32611 USA; [Chen, Sixue] Univ Florida, Interdisciplinary Ctr Biotechnol Res, Gainesville, FL 32611 USA; [Lim, Jae-Min; Wells, Lance] Univ Georgia, Dept Biochem & Mol Biol, Complex Carbohydrate Res Ctr, Athens, GA 30602 USA	State University System of Florida; University of Florida; State University System of Florida; University of Florida; State University System of Florida; University of Florida; University System of Georgia; University of Georgia	Maupin-Furlow, JA (corresponding author), Univ Florida, Dept Microbiol & Cell Sci, Gainesville, FL 32611 USA.	jmaupin@ufl.edu	Maupin-Furlow, Julie/AAW-4035-2020; CHEN, SI/GZL-4800-2022; Wells, Lance/H-3118-2013	Maupin-Furlow, Julie/0000-0001-6105-0923; Wells, Lance/0000-0003-4956-5363	NIH [1S10 RR025418-01, NCRR P41 RR018502, R01 GM057498]; DOE [DE-FG02-05ER15650]; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR025418, P41RR018502] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057498] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE(United States Department of Energy (DOE)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank the staff at UF ICBR including C. Diaz and R. Zheng for MS and S. Shanker for DNA sequencing. Thanks to M. Terns and F. Aydemir for advice on purification of SAMP conjugates from anti-Flag agarose, N. Furlow for plasmid DNA preparations and J. Foster for other advice. We thank also T. Allers, M. Mevarech, M. Dyall-Smith and M. Danson labs for H. volcanii strains and plasmids. This work was funded in part by NIH 1S10 RR025418-01 to SC, Integrated Technology Resource for Biomedical Glycomics at UGA (supported by NIH/NCRR P41 RR018502, L. W. senior investigator) and NIH R01 GM057498 and DOE DE-FG02-05ER15650 to J.A.M.-F.	Albuquerque CP, 2008, MOL CELL PROTEOMICS, V7, P1389, DOI 10.1074/mcp.M700468-MCP200; Borden KLB, 1998, BIOCHEM CELL BIOL, V76, P351, DOI 10.1139/bcb-76-2-3-351; Burns KE, 2009, J BIOL CHEM, V284, P3069, DOI 10.1074/jbc.M808032200; Burroughs AM, 2007, BIOL DIRECT, V2, DOI 10.1186/1745-6150-2-4; Burroughs AM, 2009, PROTEINS, V75, P895, DOI 10.1002/prot.22298; Chen X, 2009, J MOL BIOL, V392, P208, DOI 10.1016/j.jmb.2009.07.018; Ciechanover A, 2004, TRENDS CELL BIOL, V14, P103, DOI 10.1016/j.tcb.2004.01.004; Colnaghi R, 2001, FEBS LETT, V500, P153, DOI 10.1016/S0014-5793(01)02610-2; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dyall-Smith M.L., 2008, HALOHANDBOOK PROTOCO; Furukawa K, 2000, J BIOL CHEM, V275, P7462, DOI 10.1074/jbc.275.11.7462; Goehring AS, 2003, EUKARYOT CELL, V2, P930, DOI 10.1128/EC.2.5.930-936.2003; GONEN H, 1994, P NATL ACAD SCI USA, V91, P7648, DOI 10.1073/pnas.91.16.7648; Gonen H, 1996, ADV EXP MED BIOL, V389, P209; Hochstrasser M, 2009, NATURE, V458, P422, DOI 10.1038/nature07958; Hoeller D, 2007, MOL CELL, V26, P891, DOI 10.1016/j.molcel.2007.05.014; Humbard MA, 2006, J BACTERIOL, V188, P7521, DOI 10.1128/JB.00943-06; Ikeda F, 2008, EMBO REP, V9, P536, DOI 10.1038/embor.2008.93; Iyer LM, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-7-r60; Kaczowka SJ, 2003, J BACTERIOL, V185, P165, DOI 10.1128/JB.185.1.165-174.2003; Kessler D, 2006, FEMS MICROBIOL REV, V30, P825, DOI 10.1111/j.1574-6976.2006.00036.x; Kirkland PA, 2008, J BACTERIOL, V190, P193, DOI 10.1128/JB.01196-07; Kirkland PA, 2007, MICROBIOL-SGM, V153, P2271, DOI 10.1099/mic.0.2007/005769-0; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Leimkuhler S, 2003, J BIOL CHEM, V278, P26127, DOI 10.1074/jbc.M303092200; Liao SH, 2009, BIOCHEM J, V422, P207, DOI 10.1042/BJ20090738; Matthies A, 2004, P NATL ACAD SCI USA, V101, P5946, DOI 10.1073/pnas.0308191101; Maupin-Furlow JA, 2000, FRONT BIOSCI-LANDMRK, V5, pD837, DOI 10.2741/furlow; McLuskey K, 2003, J BIOL CHEM, V278, P23706, DOI 10.1074/jbc.M301485200; Noma A, 2009, NUCLEIC ACIDS RES, V37, P1335, DOI 10.1093/nar/gkn1023; Pearce MJ, 2008, SCIENCE, V322, P1104, DOI 10.1126/science.1163885; Perkins DN, 1999, ELECTROPHORESIS, V20, P3551, DOI 10.1002/(SICI)1522-2683(19991201)20:18<3551::AID-ELPS3551>3.0.CO;2-2; Pickart CM, 2004, CURR OPIN CHEM BIOL, V8, P610, DOI 10.1016/j.cbpa.2004.09.009; Reuter CJ, 2004, J BACTERIOL, V186, P7763, DOI 10.1128/JB.186.22.7763-7772.2004; Schlieker CD, 2008, P NATL ACAD SCI USA, V105, P18255, DOI 10.1073/pnas.0808756105; Schmitz J, 2008, BIOCHEMISTRY-US, V47, P6479, DOI 10.1021/bi800477u; Schulman BA, 2009, NAT REV MOL CELL BIO, V10, P319, DOI 10.1038/nrm2673; Spallarossa A, 2004, J MOL BIOL, V335, P583, DOI 10.1016/j.jmb.2003.10.072; Striebel F, 2009, NAT STRUCT MOL BIOL, V16, P647, DOI 10.1038/nsmb.1597; Tarasov VY, 2008, MOL MICROBIOL, V67, P772, DOI 10.1111/j.1365-2958.2007.06081.x; Verma R, 2002, SCIENCE, V298, P611, DOI 10.1126/science.1075898; Xu P, 2009, CELL, V137, P133, DOI 10.1016/j.cell.2009.01.041; Yao TT, 2002, NATURE, V419, P403, DOI 10.1038/nature01071; Zhou GY, 2008, J BACTERIOL, V190, P8096, DOI 10.1128/JB.01180-08	44	142	157	1	31	NATURE PORTFOLIO	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					54	U60		10.1038/nature08659	http://dx.doi.org/10.1038/nature08659			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054389	Green Accepted			2022-12-01	WOS:000273344900028
J	Cox, RM; Calsbeek, R				Cox, Robert M.; Calsbeek, Ryan			Cryptic Sex-Ratio Bias Provides Indirect Genetic Benefits Despite Sexual Conflict	SCIENCE			English	Article							SIZE DIMORPHISM; MATE CHOICE; SELECTION; FITNESS; EVOLUTION; ANOLIS; LINKAGE	When selection favors sexual dimorphism, high-fitness parents often produce low-fitness progeny of the opposite sex. This sexual conflict is thought to overwhelm the genetic benefits of mate choice because preferred males incur a cost through the production of low-fitness daughters. We provide a counterpoint in a lizard (Anolis sagrei) that exhibits sexual conflict over body size. By using mate-choice experiments, we show that female brown anoles produce more sons than daughters via large sires but more daughters than sons via small sires. Measures of progeny fitness in the wild suggest that maximal fitness payoffs can be achieved by shifting offspring production from daughters to sons as sire size increases. These results illustrate how the resolution of sexual conflict can restore the genetic benefits of mate choice.	[Cox, Robert M.; Calsbeek, Ryan] Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA	Dartmouth College	Cox, RM (corresponding author), Dartmouth Coll, Dept Biol Sci, Hanover, NH 03755 USA.	robert.m.cox@dartmouth.edu		Calsbeek, Ryan/0000-0002-9236-4092	NSF [DEB 0816862]; Dartmouth College	NSF(National Science Foundation (NSF)); Dartmouth College	We thank M. C. Duryea and M. Najarro for genotyping samples and conducting paternity analyses and M. Callahan, D. Cheney, and L. Symes for assistance with mating trails and animal care. M. C. Duryea, S. Kuchta, M. Logan, M. Najarro, and D. Urbach provided comments on the manuscript. Research was conducted under permits from the Bahamas Ministry of Agriculture and approval from the Dartmouth College Institutional Animal Care and Use Committee (protocol 07-02-03). An award from NSF (DEB 0816862 to R. Calsbeek) and funding from Dartmouth College provided financial support.	ARNQVIST G, 2000, MONOGRAPHS BEHAV ECO; Bedhomme Stephanie, 2007, P185; Bonduriansky R, 2005, EVOLUTION, V59, P1965; Calsbeek R, 2004, J EVOLUTION BIOL, V17, P464, DOI 10.1046/j.1420-9101.2003.00665.x; Calsbeek R, 2008, EVOLUTION, V62, P1137, DOI 10.1111/j.1558-5646.2008.00356.x; Chapman T, 2003, TRENDS ECOL EVOL, V18, P41, DOI 10.1016/S0169-5347(02)00004-6; Chippindale AK, 2001, P NATL ACAD SCI USA, V98, P1671, DOI 10.1073/pnas.041378098; Connallon T, 2009, EVOLUTION, V63, P2179, DOI 10.1111/j.1558-5646.2009.00692.x; Cox RM, 2009, J EVOLUTION BIOL, V22, P1586, DOI 10.1111/j.1420-9101.2009.01772.x; Cox RM, 2010, EVOLUTION, V64, P798, DOI 10.1111/j.1558-5646.2009.00851.x; Cox RM, 2009, AM NAT, V173, P176, DOI 10.1086/595841; DELPH LF, 1936, EVOLUTION, V58, P2004; Fairbairn DJ, 2006, HEREDITY, V97, P319, DOI 10.1038/sj.hdy.6800895; Fedorka KM, 2004, NATURE, V429, P65, DOI 10.1038/nature02492; Foerster K, 2007, NATURE, V447, P1107, DOI 10.1038/nature05912; Gibson JR, 2002, P ROY SOC B-BIOL SCI, V269, P499, DOI 10.1098/rspb.2001.1863; GORMAN GC, 1966, AM NAT, V100, P579, DOI 10.1086/282451; Janzen FJ, 2006, J EVOLUTION BIOL, V19, P1775, DOI 10.1111/j.1420-9101.2006.01138.x; Kirkpatrick M, 2004, EVOLUTION, V58, P683; LANDE R, 1980, EVOLUTION, V34, P292, DOI [10.2307/2407393, 10.1111/j.1558-5646.1980.tb04817.x]; Pischedda A, 2006, PLOS BIOL, V4, P2099, DOI 10.1371/journal.pbio.0040356; Poissant J, 2010, EVOLUTION, V64, P97, DOI 10.1111/j.1558-5646.2009.00793.x; Pryke SR, 2009, SCIENCE, V323, P1605, DOI 10.1126/science.1168928; Rice W.R., 2001, J EVOLUTIONARY BIOL, V14, P865; RICE WR, 1984, EVOLUTION, V38, P735, DOI [10.1111/j.1558-5646.1984.tb00346.x, 10.2307/2408385]; Svensson EI, 2009, EVOLUTION, V63, P3124, DOI 10.1111/j.1558-5646.2009.00782.x; Tokarz RR, 1998, HERPETOLOGICA, V54, P388; TRIVERS RL, 1976, EVOLUTION, V30, P253, DOI 10.1111/j.1558-5646.1976.tb00908.x	28	55	55	1	40	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	APR 2	2010	328	5974					92	94		10.1126/science.1185550	http://dx.doi.org/10.1126/science.1185550			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577DR	20203012				2022-12-01	WOS:000276202200042
J	Metzger, E; Imhof, A; Patel, D; Kahl, P; Hoffmeyer, K; Friedrichs, N; Muller, JM; Greschik, H; Kirfel, J; Ji, S; Kunowska, N; Beisenherz-Huss, C; Gunther, T; Buettner, R; Schule, R				Metzger, Eric; Imhof, Axel; Patel, Dharmeshkumar; Kahl, Philip; Hoffmeyer, Katrin; Friedrichs, Nicolaus; Mueller, Judith M.; Greschik, Holger; Kirfel, Jutta; Ji, Sujuan; Kunowska, Natalia; Beisenherz-Huss, Christian; Guenther, Thomas; Buettner, Reinhard; Schuele, Roland			Phosphorylation of histone H3T6 by PKC beta(I) controls demethylation at histone H3K4	NATURE			English	Article							DOMAIN-CONTAINING PROTEINS; ANDROGEN-RECEPTOR; PROSTATE-CANCER; TRANSCRIPTIONAL REGULATION; STRUCTURAL BASIS; LSD1; COMPLEX; GENE	Demethylation at distinct lysine residues in histone H3 by lysine-specific demethylase 1 (LSD1) causes either gene repression or activation(1,2). As a component of co-repressor complexes, LSD1 contributes to target gene repression by removing mono-and dimethyl marks from lysine 4 of histone H3 (H3K4)(1,3). In contrast, during androgen receptor (AR)-activated gene expression, LSD1 removes mono-and dimethyl marks from lysine 9 of histone H3 (H3K9)(2). Yet, the mechanisms that control this dual specificity of demethylation are unknown. Here we show that phosphorylation of histone H3 at threonine 6 (H3T6) by protein kinase C beta I (PKC beta(I), also known as PRKCb beta) is the key event that prevents LSD1 from demethylating H3K4 during AR-dependent gene activation. In vitro, histone H3 peptides methylated at lysine 4 and phosphorylated at threonine 6 are no longer LSD1 substrates. In vivo, PKC beta(I) co-localizes with AR and LSD1 on target gene promoters and phosphorylates H3T6 after androgen-induced gene expression. RNA interference (RNAi)-mediated knockdown of PKC beta(I) abrogates H3T6 phosphorylation, enhances demethylation at H3K4, and inhibits AR-dependent transcription. Activation of PKC beta(I) requires androgen-dependent recruitment of the gatekeeper kinase protein kinase C (PKC)-related kinase 1 (PRK1)(4). Notably, increased levels of PKC beta(I) and phosphorylated H3T6 (H3T6ph) positively correlate with high Gleason scores of prostate carcinomas, and inhibition of PKC beta(I) blocks AR-induced tumour cell proliferation in vitro and cancer progression of tumour xeno-grafts in vivo. Together, our data establish that androgen-dependent kinase signalling leads to the writing of the new chromatin mark H3T6ph, which in consequence prevents removal of active methyl marks from H3K4 during AR-stimulated gene expression.	[Metzger, Eric; Patel, Dharmeshkumar; Hoffmeyer, Katrin; Friedrichs, Nicolaus; Mueller, Judith M.; Greschik, Holger; Ji, Sujuan; Kunowska, Natalia; Guenther, Thomas; Schuele, Roland] Univ Freiburg Klinikum, Urol Klin, Frauenklin, D-79106 Freiburg, Germany; [Metzger, Eric; Patel, Dharmeshkumar; Hoffmeyer, Katrin; Friedrichs, Nicolaus; Mueller, Judith M.; Greschik, Holger; Ji, Sujuan; Kunowska, Natalia; Guenther, Thomas; Schuele, Roland] Univ Freiburg Klinikum, Zent Klin Forsch, D-79106 Freiburg, Germany; [Beisenherz-Huss, Christian] ProQinase, D-79106 Freiburg, Germany; [Imhof, Axel] Univ Munich, Adolf Butenandt Inst, D-80336 Munich, Germany; [Imhof, Axel] Univ Munich, Munich CIPS, D-80336 Munich, Germany; [Kahl, Philip; Kirfel, Jutta; Buettner, Reinhard] Univ Klinikum Bonn, Inst Pathol, D-53127 Bonn, Germany	University of Freiburg; University of Freiburg; University of Munich; University of Munich; University of Bonn	Schule, R (corresponding author), Univ Freiburg Klinikum, Urol Klin, Frauenklin, Breisacherstr 66, D-79106 Freiburg, Germany.	roland.schuele@uniklinik-freiburg.de	Imhof, Axel/AAU-5313-2021	Imhof, Axel/0000-0003-2993-8249; Gunther, Thomas/0000-0003-3903-9490	Deutsche Krebshilfe; Deutsche Forschungsgemeinschaft [SFB 746/P2, Schu 688/9-1, SFB 832/Z1]	Deutsche Krebshilfe(Deutsche Krebshilfe); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG))	We thank U. Elsasser-Beile, K. Alt, U. Wetterauer, W. Schulze-Seelmann, R. Schneider, T. Waldmann, L. Heukamp, J. M. G. Higgins and N. Potier for providing reagents. We are obliged to A. Rieder, F. Pfefferle, L. Walz, L. Spady and J. Lauterwasser for technical assistance. This work was supported by grants of the Deutsche Krebshilfe and the Deutsche Forschungsgemeinschaft (Reinhart Koselleck-Projekt, SFB 746/P2, Schu 688/9-1, Dr. Hans Messner Stiftung, Dr. Oetker-Stiftung and SFB 832/Z1) to R. S. and R. B.	Forneris F, 2007, J BIOL CHEM, V282, P20070, DOI 10.1074/jbc.C700100200; Hsing AW, 2000, INT J CANCER, V85, P60, DOI 10.1002/(SICI)1097-0215(20000101)85:1&lt;60::AID-IJC11&gt;3.0.CO;2-B; Jensen Mette Munk, 2008, BMC Med Imaging, V8, P16, DOI 10.1186/1471-2342-8-16; Kahl P, 2006, CANCER RES, V66, P11341, DOI 10.1158/0008-5472.CAN-06-1570; Kang ZG, 2004, MOL ENDOCRINOL, V18, P2633, DOI 10.1210/me.2004-0245; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Keranen LM, 1995, CURR BIOL, V5, P1394, DOI 10.1016/S0960-9822(95)00277-6; Klose RJ, 2006, NAT REV GENET, V7, P715, DOI 10.1038/nrg1945; Kononen J, 1998, NAT MED, V4, P844, DOI 10.1038/nm0798-844; Magee JA, 2006, ENDOCRINOLOGY, V147, P590, DOI 10.1210/en.2005-1001; Makkonen H, 2008, ONCOGENE, V27, P4865, DOI 10.1038/onc.2008.125; Metzger E, 2005, NATURE, V437, P436, DOI 10.1038/nature04020; Metzger E, 2008, NAT CELL BIOL, V10, P53, DOI 10.1038/ncb1668; Metzger E, 2007, NAT STRUCT MOL BIOL, V14, P252, DOI 10.1038/nsmb0407-252; ONEILL TE, 1992, J MOL BIOL, V223, P67, DOI 10.1016/0022-2836(92)90716-W; SCHRODER FH, 1992, PROSTATE, P129; Shi YJ, 2004, CELL, V119, P941, DOI 10.1016/j.cell.2004.12.012; Tsukada Y, 2006, NATURE, V439, P811, DOI 10.1038/nature04433; Wang QB, 2007, MOL CELL, V27, P380, DOI 10.1016/j.molcel.2007.05.041; Wang Y, 2009, CELL, V138, P660, DOI 10.1016/j.cell.2009.05.050; Wissmann M, 2007, NAT CELL BIOL, V9, P347, DOI 10.1038/ncb1546; Wiznerowicz M, 2003, J VIROL, V77, P8957, DOI 10.1128/JVI.77.16.8957-8951.2003; Yang MJ, 2007, NAT STRUCT MOL BIOL, V14, P535, DOI 10.1038/nsmb1255	23	208	222	1	28	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	APR 1	2010	464	7289					792	U175		10.1038/nature08839	http://dx.doi.org/10.1038/nature08839			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	577EO	20228790				2022-12-01	WOS:000276205000052
J	Kumar, S; Molina-Cruz, A; Gupta, L; Rodrigues, J; Barillas-Mury, C				Kumar, Sanjeev; Molina-Cruz, Alvaro; Gupta, Lalita; Rodrigues, Janneth; Barillas-Mury, Carolina			A Peroxidase/Dual Oxidase System Modulates Midgut Epithelial Immunity in Anopheles gambiae	SCIENCE			English	Article							PERITROPHIC MATRIX PROTEIN; DROSOPHILA GUT IMMUNITY; DUAL OXIDASE; PLASMODIUM; INFECTION; PATHWAY; DUOX	Extracellular matrices in diverse biological systems are cross-linked by dityrosine covalent bonds catalyzed by the peroxidase/oxidase system. We show that a peroxidase, secreted by the Anopheles gambiae midgut, and dual oxidase form a dityrosine network that decreases gut permeability to immune elicitors. This network protects the microbiota by preventing activation of epithelial immunity. It also provides a suitable environment for malaria parasites to develop within the midgut lumen without inducing nitric oxide synthase expression. Disruption of this barrier results in strong and effective pathogen-specific immune responses.	[Kumar, Sanjeev; Molina-Cruz, Alvaro; Gupta, Lalita; Rodrigues, Janneth; Barillas-Mury, Carolina] NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA	National Institutes of Health (NIH) - USA; NIH National Institute of Allergy & Infectious Diseases (NIAID)	Barillas-Mury, C (corresponding author), NIAID, Lab Malaria & Vector Res, NIH, Rockville, MD 20852 USA.	cbarillas@niaid.nih.gov	Gupta, Lalita/R-1111-2019	Rodrigues, Janneth/0000-0001-9693-1958; GUPTA, LALITA/0000-0002-0712-8512; Kumar, Sanjeev/0000-0003-3866-4593	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [ZIAAI000947] Funding Source: NIH RePORTER	Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by the Intramural Research Program of the Division of Intramural Research, National Institute of Allergy and Infectious Diseases, NIH. We thank A. Laughinghouse, K. Lee, T. Lehman, and R. Gwadz for insectary support; J. Kabat for assistance with confocal imaging; J. Ribeiro and J. Valenzuela for their comments and insight; and B. Marshall for editorial assistance. The complete data set for this microarray experiment has been submitted to the National Center for Biotechnology Information Gene Expression Omnibus database with accession number GSE20204.	Devenport M, 2004, INSECT MOL BIOL, V13, P349, DOI 10.1111/j.0962-1075.2004.00488.x; Dong YM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000423; Edens WA, 2001, J CELL BIOL, V154, P879, DOI 10.1083/jcb.200103132; Gupta L, 2009, CELL HOST MICROBE, V5, P498, DOI 10.1016/j.chom.2009.04.003; Ha EM, 2005, SCIENCE, V310, P847, DOI 10.1126/science.1117311; Ha EM, 2005, DEV CELL, V8, P125, DOI 10.1016/j.devcel.2004.11.007; Ha EM, 2009, NAT IMMUNOL, V10, P949, DOI 10.1038/ni.1765; Ha EM, 2009, DEV CELL, V16, P386, DOI 10.1016/j.devcel.2008.12.015; Kumar S, 2004, J BIOL CHEM, V279, P53475, DOI 10.1074/jbc.M409905200; Lim JH, 2005, INFECT IMMUN, V73, P2778, DOI 10.1128/IAI.73.5.2778-2789.2005; Meitzler JL, 2009, J BIOL CHEM, V284, P18634, DOI 10.1074/jbc.M109.013581; Shen ZC, 1999, P NATL ACAD SCI USA, V96, P5610, DOI 10.1073/pnas.96.10.5610; Shen ZC, 1998, J BIOL CHEM, V273, P17665, DOI 10.1074/jbc.273.28.17665; Wong JL, 2004, DEV CELL, V7, P801, DOI 10.1016/j.devcel.2004.10.014; Zaidman-Remy A, 2006, IMMUNITY, V24, P463, DOI 10.1016/j.immuni.2006.02.012	15	220	230	3	69	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 26	2010	327	5973					1644	1648		10.1126/science.1184008	http://dx.doi.org/10.1126/science.1184008			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574ED	20223948	Green Accepted			2022-12-01	WOS:000275970600044
J	Hansen, DV; Lui, JH; Parker, PRL; Kriegstein, AR				Hansen, David V.; Lui, Jan H.; Parker, Philip R. L.; Kriegstein, Arnold R.			Neurogenic radial glia in the outer subventricular zone of human neocortex	NATURE			English	Article							GABAERGIC NEURONS; CELLS; PAX6; DIFFERENTIATION; TELENCEPHALON; EVOLUTION; DIVISION; ORIGIN; CORTEX; ARISE	Neurons in the developing rodent cortex are generated from radial glial cells that function as neural stem cells. These epithelial cells line the cerebral ventricles and generate intermediate progenitor cells that migrate into the subventricular zone (SVZ) and proliferate to increase neuronal number. The developing human SVZ has a massively expanded outer region (OSVZ) thought to contribute to cortical size and complexity. However, OSVZ progenitor cell types and their contribution to neurogenesis are not well understood. Here we show that large numbers of radial glia-like cells and intermediate progenitor cells populate the human OSVZ. We find that OSVZ radial glia-like cells have a long basal process but, surprisingly, are non-epithelial as they lack contact with the ventricular surface. Using real-time imaging and clonal analysis, we demonstrate that these cells can undergo proliferative divisions and self-renewing asymmetric divisions to generate neuronal progenitor cells that can proliferate further. We also show that inhibition of Notch signalling in OSVZ progenitor cells induces their neuronal differentiation. The establishment of non-ventricular radial glia-like cells may have been a critical evolutionary advance underlying increased cortical size and complexity in the human brain.	[Hansen, David V.; Lui, Jan H.; Parker, Philip R. L.; Kriegstein, Arnold R.] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, San Francisco, CA 94143 USA; [Hansen, David V.; Lui, Jan H.; Parker, Philip R. L.; Kriegstein, Arnold R.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA 94143 USA; [Lui, Jan H.] Univ Calif San Francisco, Biomed Sci Grad Program, San Francisco, CA 94143 USA; [Parker, Philip R. L.] Univ Calif San Francisco, Grad Program Neurosci, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco; University of California System; University of California San Francisco	Kriegstein, AR (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, 513 Parnassus Ave, San Francisco, CA 94143 USA.	KriegsteinA@stemcell.ucsf.edu		Parker, Philip R. L./0000-0002-6224-9747; Hansen, David/0000-0001-9679-7189	California Institute for Regenerative Medicine; Bernard Osher Foundation; CIRM	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); Bernard Osher Foundation; CIRM(California Institute for Regenerative Medicine)	We thank A. Alvarez-Buylla, D. Rowitch and Kriegstein laboratory members for ideas arising from discussions and for critical reading of the manuscript. We thank A. Javaherian for help setting up the conditions for dye electroporation, T. Weissman for advice on 'DiOlistics', Z. Mirzadeh for expertise with whole-mount staining, C. Harwell for retroviral production, and W. Walantus, J. Agudelo, L. Fuentealba, O. Genbacev, M. Donne and S. Kaing for other technical support. We thank R. Kageyama for his gift of the HES1 antibody<SUP>35</SUP>, and F. Gage for GFP-retrovirus reagents. We thank the staff at San Francisco General Hospital for providing access to donated fetal tissue. Artwork in Fig. 5e is by K. X. Probst (Xavier Studio). This work was supported by grants from the California Institute for Regenerative Medicine and the Bernard Osher Foundation. J. H. L. is funded by a CIRM Predoctoral Fellowship.	Abdel-Mannan O, 2008, BRAIN RES BULL, V75, P398, DOI 10.1016/j.brainresbull.2007.10.047; Baek JH, 2006, DEVELOPMENT, V133, P2467, DOI 10.1242/dev.02403; Bayatti N, 2008, CEREB CORTEX, V18, P1536, DOI 10.1093/cercor/bhm184; Chenn A, 1998, MOL CELL NEUROSCI, V11, P183, DOI 10.1006/mcne.1998.0680; CHOI BH, 1986, J NEUROPATH EXP NEUR, V45, P408, DOI 10.1097/00005072-198607000-00003; Englund C, 2005, J NEUROSCI, V25, P247, DOI 10.1523/JNEUROSCI.2899-04.2005; Fish JL, 2008, J CELL SCI, V121, P2783, DOI 10.1242/jcs.023465; Gaiano N, 2000, NEURON, V26, P395, DOI 10.1016/S0896-6273(00)81172-1; Gan WB, 2000, NEURON, V27, P219, DOI 10.1016/S0896-6273(00)00031-3; Gotz M, 1998, NEURON, V21, P1031, DOI 10.1016/S0896-6273(00)80621-2; Gotz M, 2005, NAT REV MOL CELL BIO, V6, P777, DOI 10.1038/nrm1739; Haas K, 2001, NEURON, V29, P583, DOI 10.1016/S0896-6273(01)00235-5; Haubensak W, 2004, P NATL ACAD SCI USA, V101, P3196, DOI 10.1073/pnas.0308600100; Kowalczyk T, 2009, CEREB CORTEX, V19, P2439, DOI 10.1093/cercor/bhn260; Kriegstein A, 2006, NAT REV NEUROSCI, V7, P883, DOI 10.1038/nrn2008; Letinic K, 2002, NATURE, V417, P645, DOI 10.1038/nature00779; Lukaszewicz A, 2005, NEURON, V47, P353, DOI 10.1016/j.neuron.2005.06.032; Malatesta P, 2000, DEVELOPMENT, V127, P5253; Miyata T, 2001, NEURON, V31, P727, DOI 10.1016/S0896-6273(01)00420-2; Mo ZC, 2008, CEREB CORTEX, V18, P1455, DOI 10.1093/cercor/bhm181; Noctor SC, 2001, NATURE, V409, P714, DOI 10.1038/35055553; Noctor SC, 2004, NAT NEUROSCI, V7, P136, DOI 10.1038/nn1172; Petanjek Z, 2009, CEREB CORTEX, V19, P249, DOI 10.1093/cercor/bhn078; RAKIC P, 1988, SCIENCE, V241, P170, DOI 10.1126/science.3291116; RAKIC P, 1974, SCIENCE, V183, P425, DOI 10.1126/science.183.4123.425; Rakic P, 2003, CEREB CORTEX, V13, P541, DOI 10.1093/cercor/13.6.541; RAKIC P, 1968, J NEUROPATH EXP NEUR, V27, P246; SCHMECHEL DE, 1979, ANAT EMBRYOL, V156, P115, DOI 10.1007/BF00300010; SCHMECHEL DE, 1979, NATURE, V277, P303, DOI 10.1038/277303a0; Sessa A, 2008, NEURON, V60, P56, DOI 10.1016/j.neuron.2008.09.028; Shimojo H, 2008, NEURON, V58, P52, DOI 10.1016/j.neuron.2008.02.014; SMART IHM, 1973, J ANAT, V116, P67; Smart IHM, 2002, CEREB CORTEX, V12, P37, DOI 10.1093/cercor/12.1.37; Weissman T, 2003, CEREB CORTEX, V13, P550, DOI 10.1093/cercor/13.6.550; Zecevic N, 2005, J COMP NEUROL, V491, P109, DOI 10.1002/cne.20714	35	805	820	6	66	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 25	2010	464	7288					554	U110		10.1038/nature08845	http://dx.doi.org/10.1038/nature08845			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	574FL	20154730				2022-12-01	WOS:000275974200040
J	Barrett-Connor, E; Nielson, CM; Orwoll, E; Bauer, DC; Cauley, JA				Barrett-Connor, Elizabeth; Nielson, Carrie M.; Orwoll, Eric; Bauer, Douglas C.; Cauley, Jane A.		Osteoporotic Fractures Men MrOS St	Epidemiology of rib fractures in older men: Osteoporotic Fractures in Men (MrOS) prospective cohort study	BRITISH MEDICAL JOURNAL			English	Article							HIGH-TRAUMA FRACTURES; BONE-MINERAL DENSITY; WOMEN	Objective To study the causes and consequences of radiologically confirmed rib fractures (seldom considered in the context of osteoporosis) in community dwelling older men. Design Prospective cohort study (Osteoporotic Fractures in Men (MrOS) Study). Setting and participants 5995 men aged 65 or over recruited in 2000-2 from six US sites; 99% answered mailed questionnaires about falls and fractures every four months for a mean 6.2 (SD 1.3) year follow-up. Main outcome measures New fractures validated by radiology reports; multivariate Cox proportional hazard ratios were used to evaluate factors independently associated with time to incident rib fracture; associations between baseline rib fracture and incident hip and wrist fracture were also evaluated. Results The incidence of rib fracture was 3.5/1000 person years, and 24% (126/522) of all incident non-spine fractures were rib fractures. Nearly half of new rib fractures (48%; n=61) followed falling from standing height or lower. Independent risk factors for an incident rib fracture were age 80 or above, low bone density, difficulty with instrumental activities of daily living, and a baseline history of rib/chest fracture. Men with a history of rib/chest fracture had at least a twofold increased risk of an incident rib fracture (adjusted hazard ratio 2.71, 95% confidence interval 1.86 to 3.95), hip fracture (2.05, 1.33 to 3.15), and wrist fracture (2.06, 1.14 to 3.70). Only 14/82 of men reported being treated with bone specific drugs after their incident rib fracture. Conclusions Rib fracture, the most common incident clinical fracture in men, was associated with classic risk markers for osteoporosis, including old age, low hip bone mineral density, and history of fracture. A history of rib fracture predicted a more than twofold increased risk of future fracture of the rib, hip, or wrist, independent of bone density and other covariates. Rib fractures should be considered to be osteoporotic fractures in the evaluation of older men for treatment to prevent future fracture.	[Barrett-Connor, Elizabeth] Univ Calif San Diego, Dept Family & Prevent Med, La Jolla, CA 92093 USA; [Nielson, Carrie M.; Orwoll, Eric] Oregon Hlth & Sci Univ, Bone & Mineral Unit, Portland, OR 97201 USA; [Bauer, Douglas C.] Univ Calif San Francisco, San Francisco, CA 94107 USA; [Cauley, Jane A.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA 15241 USA	University of California System; University of California San Diego; Oregon Health & Science University; University of California System; University of California San Francisco; Pennsylvania Commonwealth System of Higher Education (PCSHE); University of Pittsburgh	Barrett-Connor, E (corresponding author), Univ Calif San Diego, Dept Family & Prevent Med, 9500 Gilman Dr, La Jolla, CA 92093 USA.	ebarrettconnor@ucsd.edu		Cauley, Jane A/0000-0003-0752-4408; Orwoll, Eric/0000-0002-8520-7355	National Institutes of Health [U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, UL1 RR024140]; National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS); National Institute on Aging (NIA); National Center for Research Resources (NCRR)	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); National Institute on Aging (NIA)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); National Center for Research Resources (NCRR)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))	The Osteoporotic Fractures in Men (MrOS) Study is supported by National Institutes of Health funding. The National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), the National Institute on Aging (NIA), the National Center for Research Resources (NCRR), and NIH Roadmap for Medical Research provide support under the following grant numbers: U01 AR45580, U01 AR45614, U01 AR45632, U01 AR45647, U01 AR45654, U01 AR45583, U01 AG18197, U01-AG027810, and UL1 RR024140.	Adler NE, 2000, HEALTH PSYCHOL, V19, P586, DOI 10.1037/0278-6133.19.6.586; Barnea Y, 2002, CAN J SURG, V45, P43; Blank JB, 2005, CONTEMP CLIN TRIALS, V26, P557, DOI 10.1016/j.cct.2005.05.005; Block G, 1990, Epidemiology, V1, P58, DOI 10.1097/00001648-199001000-00013; COOPER C, 1992, TRENDS ENDOCRIN MET, V3, P224, DOI 10.1016/1043-2760(92)90032-V; Davie MWJ, 1996, J ORTHOP RHEUMATOL, V9, P41; HONKANEN R, 1995, J CLIN EPIDEMIOL, V48, P881, DOI 10.1016/0895-4356(94)00220-K; Ismail AA, 2006, OSTEOPOROSIS INT, V17, P41, DOI 10.1007/s00198-005-1887-3; JONES G, 1994, OSTEOPOROSIS INT, V4, P277, DOI 10.1007/BF01623352; Kanis JA, 2008, OSTEOPOROSIS INT, V19, P385, DOI 10.1007/s00198-007-0543-5; Mackey DC, 2007, JAMA-J AM MED ASSOC, V298, P2381, DOI 10.1001/jama.298.20.2381; Marcus R, 2008, OSTEOPOROSIS, VOLS I AND II, 3RD EDITION, P1; NEVITT M, 1992, P INT S FALLS ELD MA; NEVITT MC, 1992, AM J EPIDEMIOL, V135, P490, DOI 10.1093/oxfordjournals.aje.a116315; NEVITT MC, 1991, P INT S FALLS ELD MA; Orwoll E, 2005, CONTEMP CLIN TRIALS, V26, P569, DOI 10.1016/j.cct.2005.05.006; PAHOR M, 1994, EUR J EPIDEMIOL, V10, P405, DOI 10.1007/BF01719664; Palvanen M, 2004, OSTEOPOROSIS INT, V15, P649, DOI 10.1007/s00198-003-1585-y; Sanders KM, 1998, J BONE MINER RES, V13, P1337, DOI 10.1359/jbmr.1998.13.8.1337; WASHBURN RA, 1993, J CLIN EPIDEMIOL, V46, P153, DOI 10.1016/0895-4356(93)90053-4	20	47	47	0	1	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BRIT MED J	Br. Med. J.	MAR 15	2010	340								c1069	10.1136/bmj.c1069	http://dx.doi.org/10.1136/bmj.c1069			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	573RA	20231246	hybrid, Green Published, Green Submitted			2022-12-01	WOS:000275931100001
J	Roch, S				Roch, Sebastien			Toward Extracting All Phylogenetic Information from Matrices of Evolutionary Distances	SCIENCE			English	Article							GENERALIZED LEAST-SQUARES; SEQUENCE DATA; TREES; RECONSTRUCTION; MODEL; PERFORMANCE	The matrix of evolutionary distances is a model-based statistic, derived from molecular sequences, summarizing the pairwise phylogenetic relations between a collection of species. Phylogenetic tree reconstruction methods relying on this matrix are relatively fast and thus widely used in molecular systematics. However, because of their intrinsic reliance on summary statistics, distance-matrix methods are assumed to be less accurate than likelihood-based approaches. In this paper, pairwise sequence comparisons are shown to be more powerful than previously hypothesized. A statistical analysis of certain distance-based techniques indicates that their data requirement for large evolutionary trees essentially matches the conjectured performance of maximum likelihood methods-challenging the idea that summary statistics lead to suboptimal analyses. On the basis of a connection between ancestral state reconstruction and distance averaging, the critical role played by the covariances of the distance matrix is identified.	Univ Calif Los Angeles, Dept Math, Los Angeles, CA 90095 USA	University of California System; University of California Los Angeles	Roch, S (corresponding author), Univ Calif Los Angeles, Dept Math, 520 Portola Plaza, Los Angeles, CA 90095 USA.	roch@math.ucla.edu						Atteson K, 1999, ALGORITHMICA, V25, P251, DOI 10.1007/PL00008277; Bruno WJ, 2000, MOL BIOL EVOL, V17, P189, DOI 10.1093/oxfordjournals.molbev.a026231; BULMER M, 1991, MOL BIOL EVOL, V8, P868; Chor B, 2006, J ACM, V53, P722, DOI 10.1145/1183907.1183909; Daskalakis C., 2006, STOC'06. Proceedings of the 38th Annual ACM Symposium on Theory of Computing, P159, DOI 10.1145/1132516.1132540; Daskalakis C, 2011, PROBAB THEORY REL, V149, P149, DOI 10.1007/s00440-009-0246-2; Desper R, 2002, J COMPUT BIOL, V9, P687, DOI 10.1089/106652702761034136; Erdos PL, 1999, RANDOM STRUCT ALGOR, V14, P153, DOI 10.1002/(SICI)1098-2418(199903)14:2<153::AID-RSA3>3.0.CO;2-R; Evans W, 2000, ANN APPL PROBAB, V10, P410; Felsenstein J., 2004, INFERRING PHYLOGENIE; Gascuel O, 1997, MOL BIOL EVOL, V14, P685, DOI 10.1093/oxfordjournals.molbev.a025808; GRAHAM RL, 1982, MATH BIOSCI, V60, P133, DOI 10.1016/0025-5564(82)90125-0; HUSON DH, 1999, WAE 99, P271; Janson S, 2004, ANN PROBAB, V32, P2630, DOI 10.1214/0091179040000000153; Kim J, 1998, SYST BIOL, V47, P43, DOI 10.1080/106351598261021; Lacey MR, 2006, MATH BIOSCI, V199, P188, DOI 10.1016/j.mbs.2005.11.003; MIHAESCU R, 2008, THESIS U CALIFORNIA; Mihaescu R, 2008, P NATL ACAD SCI USA, V105, P13206, DOI 10.1073/pnas.0802089105; Mossel E, 2004, T AM MATH SOC, V356, P2379, DOI 10.1090/S0002-9947-03-03382-8; Mossel E, 2003, ANN APPL PROBAB, V13, P817; Mossel E, 2001, ANN APPL PROBAB, V11, P285, DOI 10.1214/aoap/998926994; MOSSEL E, COMMUNICATION; Roch S., 2008, FOCS, P729; Rzhetsky A, 1996, MOL BIOL EVOL, V13, P1255, DOI 10.1093/oxfordjournals.molbev.a025691; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Schervish M J., 1995, THEORY STAT; SNEATH P. H. A., 1973, NUMERICAL TAXONOMY; SOKAL ROBERT R., 1958, UNIV KANSAS SCI BULL, V38, P1409; Sokal RR, 1963, PRINCIPLES NUMERICAL; Steel MA, 2002, SIAM J DISCRETE MATH, V15, P562, DOI 10.1137/S089548010138790X; STEEL MA, 1988, NATURE, V336, P118, DOI 10.1038/336118a0; Steel M, 2009, J THEOR BIOL, V256, P467, DOI 10.1016/j.jtbi.2008.10.010; Susko E, 2003, MOL BIOL EVOL, V20, P862, DOI 10.1093/molbev/msg093; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023	34	35	36	1	7	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	MAR 12	2010	327	5971					1376	1379		10.1126/science.1182300	http://dx.doi.org/10.1126/science.1182300			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223986				2022-12-01	WOS:000275418700041
J	Geva-Zatorsky, N; Dekel, E; Cohen, AA; Danon, T; Cohen, L; Alon, U				Geva-Zatorsky, Naama; Dekel, Erez; Cohen, Ariel A.; Danon, Tamar; Cohen, Lydia; Alon, Uri			Protein Dynamics in Drug Combinations: a Linear Superposition of Individual-Drug Responses	CELL			English	Article							GENE NETWORKS; HUMAN-CELLS; SYSTEMS; PROTEOMICS; THERAPY; SYNERGY	Drugs and drug combinations have complex biological effects on cells and organisms. Little is known about how drugs affect protein dynamics that determine these effects. Here, we use a dynamic proteomics approach to accurately follow 15 protein levels in human cells in response to 13 different drugs. We find that protein dynamics in response to combinations of drugs are described accurately by a linear superposition ( weighted sum) of their response to individual drugs. The weights in this superposition describe the relative impact of each drug on each protein. Using these weights, we show that one can predict the dynamics in a three-drug or four-drug combination on the basis of the dynamics in drug pairs. Our approach might eliminate the need to increase the number of experiments exponentially with the number of drugs and suggests that it might be possible to rationally control protein dynamics with specific drug combinations.	[Geva-Zatorsky, Naama; Dekel, Erez; Cohen, Ariel A.; Danon, Tamar; Cohen, Lydia; Alon, Uri] Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel; [Geva-Zatorsky, Naama; Dekel, Erez; Cohen, Ariel A.; Danon, Tamar; Cohen, Lydia; Alon, Uri] Weizmann Inst Sci, Dept Phys Complex Syst, IL-76100 Rehovot, Israel	Weizmann Institute of Science; Weizmann Institute of Science	Alon, U (corresponding author), Weizmann Inst Sci, Dept Mol Cell Biol, IL-76100 Rehovot, Israel.	urialon@weizmann.ac.il	Geva-Zatorsky, Naama/AAP-9176-2021	Geva-Zatorsky, Naama/0000-0002-7303-854X	Kahn Family Foundation; Keren Isra-Pa'amei Tikva	Kahn Family Foundation; Keren Isra-Pa'amei Tikva	This work was supported by the Kahn Family Foundation and by Keren Isra-Pa'amei Tikva. We thank Pierre Choukroun for assistance with the computer cluster. We thank J. Lehar, W. Koestler, J. Bar, I. Glinert, Y. Aylon, and all members of the Alon laboratory for fruitful discussions, comments, and technical help.	Alon U, 2006, INTRO SYSTEMS BIOL D; BERENBAUM MC, 1989, PHARMACOL REV, V41, P93; Bliss CI, 1939, ANN APPL BIOL, V26, P585, DOI 10.1111/j.1744-7348.1939.tb06990.x; Cohen AA, 2008, SCIENCE, V322, P1511, DOI 10.1126/science.1160165; di Bernardo D, 2005, NAT BIOTECHNOL, V23, P377, DOI 10.1038/nbt1075; Fitzgerald JB, 2006, NAT CHEM BIOL, V2, P458, DOI 10.1038/nchembio817; Garman KS, 2007, HUM MOL GENET, V16, pR226, DOI 10.1093/hmg/ddm184; GRECO WR, 1995, PHARMACOL REV, V47, P331; Jolliffe I.T., 2002, PRINCIPLE COMPONENT, V2nd ed.; Jonker DM, 2005, PHARMACOL THERAPEUT, V106, P1, DOI 10.1016/j.pharmthera.2004.10.014; Keith CT, 2005, NAT REV DRUG DISCOV, V4, P71, DOI 10.1038/nrd1609; Lehar J, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100116; LOEWE S, 1953, ARZNEIMITTEL-FORSCH, V3, P285; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Pearson K, 1901, PHILOS MAG, V2, P559, DOI 10.1080/14786440109462720; Potti A, 2006, NAT MED, V12, P1294, DOI 10.1038/nm1491; Prill RJ, 2005, PLOS BIOL, V3, P1881, DOI 10.1371/journal.pbio.0030343; Sigal A, 2007, NAT PROTOC, V2, P1515, DOI 10.1038/nprot.2007.197; Sigal A, 2006, NAT METHODS, V3, P525, DOI 10.1038/NMETH892; Strogatz SH., 1994, STUDIES NONLINEARITY, P1; Tegner J, 2003, P NATL ACAD SCI USA, V100, P5944, DOI 10.1073/pnas.0933416100; Thattai M, 2001, P NATL ACAD SCI USA, V98, P8614, DOI 10.1073/pnas.151588598; Yeh P, 2006, NAT GENET, V38, P489, DOI 10.1038/ng1755; ZHANG SZ, 1990, CELL BIOL TOXICOL, V6, P219	24	80	80	1	12	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					643	651		10.1016/j.cell.2010.02.011	http://dx.doi.org/10.1016/j.cell.2010.02.011			9	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211134	Bronze			2022-12-01	WOS:000275197400014
J	Low, K; Harding, T; Jardine, P				Low, Karen; Harding, Teresa; Jardine, Philip			A Patient's Journey Dopa responsive dystonia	BRITISH MEDICAL JOURNAL			English	Editorial Material									[Low, Karen] Bristol Royal Hosp Children, Bristol BS2 8BJ, Avon, England; [Jardine, Philip] Frenchay Hosp, Bristol BS16 1LE, Avon, England	Bristol Royal Hospital For Children	Harding, T (corresponding author), 42 Braikenridge Close, Clevedon, England.	harding@blueyonder.co.uk							0	2	2	0	0	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	MAR 4	2010	340								c668	10.1136/bmj.c668	http://dx.doi.org/10.1136/bmj.c668			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	565FK	20203076				2022-12-01	WOS:000275274500005
J	Nielsen, LP; Risgaard-Petersen, N; Fossing, H; Christensen, PB; Sayama, M				Nielsen, Lars Peter; Risgaard-Petersen, Nils; Fossing, Henrik; Christensen, Peter Bondo; Sayama, Mikio			Electric currents couple spatially separated biogeochemical processes in marine sediment	NATURE			English	Article							PORPHYRY SULFIDE MINERALIZATION; ORGANIC-CARBON; WATER; MODEL; ELECTROCHEMISTRY; COMMUNITIES; DIFFUSION; REDUCTION; TRANSPORT	Some bacteria are capable of extracellular electron transfer, thereby enabling them to use electron acceptors and donors without direct cell contact(1-4). Beyond the micrometre scale, however, no firm evidence has previously existed that spatially segregated biogeochemical processes can be coupled by electric currents in nature. Here we provide evidence that electric currents running through defaunated sediment couple oxygen consumption at the sediment surface to oxidation of hydrogen sulphide and organic carbon deep within the sediment. Altering the oxygen concentration in the sea water overlying the sediment resulted in a rapid (<1-h) change in the hydrogen sulphide concentration within the sediment more than 12 mm below the oxic zone, a change explicable by transmission of electrons but not by diffusion of molecules. Mass balances indicated that more than 40% of total oxygen consumption in the sediment was driven by electrons conducted from the anoxic zone. A distinct pH peak in the oxic zone could be explained by electrochemical oxygen reduction, but not by any conventional sets of aerobic sediment processes. We suggest that the electric current was conducted by bacterial nanowires combined with pyrite, soluble electron shuttles and outer-membrane cytochromes. Electrical communication between distant chemical and biological processes in nature adds a new dimension to our understanding of biogeochemistry and microbial ecology.	[Nielsen, Lars Peter] Aarhus Univ, Dept Biol Sci, DK-8000 Aarhus C, Denmark; [Risgaard-Petersen, Nils] Aarhus Univ, Ctr Geomicrobiol, DK-8000 Aarhus C, Denmark; [Fossing, Henrik; Christensen, Peter Bondo] Aarhus Univ, Natl Environm Res Inst, Dept Marine Ecol, DK-8600 Silkeborg, Denmark; [Sayama, Mikio] Natl Inst Adv Ind Sci & Technol, Tsukuba, Ibaraki 3058569, Japan	Aarhus University; Aarhus University; Aarhus University; National Institute of Advanced Industrial Science & Technology (AIST)	Nielsen, LP (corresponding author), Aarhus Univ, Dept Biol Sci, Ny Munkegade 114, DK-8000 Aarhus C, Denmark.	biolpn@biology.au.dk	Fossing, Henrik/J-5646-2013; Nielsen, Lars Peter/AAL-6274-2021; Nielsen, Lars Peter/J-7401-2013; Risgaard-Petersen, Nils/J-2479-2013; Risgaard-Petersen, Nils/AAX-6747-2021	Nielsen, Lars Peter/0000-0002-7269-4860; Nielsen, Lars Peter/0000-0002-7269-4860; Risgaard-Petersen, Nils/0000-0002-2767-2080; Risgaard-Petersen, Nils/0000-0002-2767-2080; Fossing, Henrik/0000-0001-5193-176X	Aarhus University Research Foundation; Danish National Research Foundation; Max Planck Society; Japan Society for the Promotion of Science	Aarhus University Research Foundation; Danish National Research Foundation(Danmarks Grundforskningsfond); Max Planck Society(Max Planck Society); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	This research was financially supported by the Aarhus University Research Foundation, the Danish National Research Foundation (N.R.-P.), the Max Planck Society (N.R.-P.) and the Japan Society for the Promotion of Science ( M. S.).	Berg P, 1998, LIMNOL OCEANOGR, V43, P1500, DOI 10.4319/lo.1998.43.7.1500; Bigalke J, 1997, ELECTROCHIM ACTA, V42, P3443, DOI 10.1016/S0013-4686(97)00053-4; CANFIELD DE, 1993, MAR GEOL, V113, P27, DOI 10.1016/0025-3227(93)90147-N; CORRY CE, 1985, GEOPHYSICS, V50, P1020, DOI 10.1190/1.1441967; Crank J., 1967, MATH DIFFUSION, P18; FOSSING H, 1989, BIOGEOCHEMISTRY, V8, P205; Glud RN, 1996, MAR ECOL PROG SER, V141, P303, DOI 10.3354/meps141303; Glud RN, 1999, MAR ECOL PROG SER, V186, P87, DOI 10.3354/meps186087; Glud RN, 2008, MAR BIOL RES, V4, P243, DOI 10.1080/17451000801888726; Jeroschewski P, 1996, ANAL CHEM, V68, P4351, DOI 10.1021/ac960091b; Leang C, 2003, J BACTERIOL, V185, P2096, DOI 10.1128/JB.185.7.2096-2103.2003; LENEY GW, 1986, GEOPHYSICS, V51, P1153; LI YH, 1974, GEOCHIM COSMOCHIM AC, V38, P703; Lovley DR, 1996, NATURE, V382, P445, DOI 10.1038/382445a0; Naudet V, 2005, GEOPHYS RES LETT, V32, DOI 10.1029/2005GL022735; Ntarlagiannis D, 2007, GEOPHYS RES LETT, V34, DOI 10.1029/2007GL030426; Rabaey K, 2007, ISME J, V1, P9, DOI 10.1038/ismej.2007.4; Reguera G, 2005, NATURE, V435, P1098, DOI 10.1038/nature03661; Reimers CE, 2001, ENVIRON SCI TECHNOL, V35, P192, DOI 10.1021/es001223s; Risgaard-Petersen N, 2006, NATURE, V443, P93, DOI 10.1038/nature05070; Ryckelynck N, 2005, BIOGEOCHEMISTRY, V76, P113, DOI 10.1007/s10533-005-2671-3; Sato M, 1960, GEOPHYSICS, V25, P226, DOI DOI 10.1190/1.1438689; Sayama M, 2005, APPL ENVIRON MICROB, V71, P7575, DOI 10.1128/AEM.71.11.7575-7577.2005; Soetaert K, 2007, MAR CHEM, V105, P30, DOI 10.1016/j.marchem.2006.12.012; STOOKEY LL, 1970, ANAL CHEM, V42, P779, DOI 10.1021/ac60289a016; Stumm W, 1981, AQUAT CHEM, P179; Torres CI, 2008, ENVIRON SCI TECHNOL, V42, P6593, DOI 10.1021/es800970w; TROMP TK, 1995, GEOCHIM COSMOCHIM AC, V59, P1259, DOI 10.1016/0016-7037(95)00042-X; ULLMAN WJ, 1982, LIMNOL OCEANOGR, V27, P552, DOI 10.4319/lo.1982.27.3.0552; Williams KH, 2007, J GEOPHYS RES-BIOGEO, V112, DOI 10.1029/2007JG000440	30	342	372	21	367	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 25	2010	463	7284					1071	1074		10.1038/nature08790	http://dx.doi.org/10.1038/nature08790			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563DR	20182510				2022-12-01	WOS:000275108400034
J	Roberts, TF; Tschida, KA; Klein, ME; Mooney, R				Roberts, Todd F.; Tschida, Katherine A.; Klein, Marguerita E.; Mooney, Richard			Rapid spine stabilization and synaptic enhancement at the onset of behavioural learning	NATURE			English	Article							LONG-TERM POTENTIATION; DENDRITIC SPINES; IN-VIVO; ZEBRA FINCH; SONG; NEURONS; CORTEX; PLASTICITY; DEPRIVATION; INTEGRATION	Behavioural learning depends on the brain's capacity to respond to instructive experience and is often enhanced during a juvenile sensitive period. How instructive experience acts on the juvenile brain to trigger behavioural learning remains unknown. In vitro studies show that forms of synaptic strengthening thought to underlie learning are accompanied by an increase in the stability, number and size of dendritic spines, which are the major sites of excitatory synaptic transmission in the vertebrate brain(1-7). In vivo imaging studies in sensory cortical regions reveal that these structural features can be affected by disrupting sensory experience and that spine turnover increases during sensitive periods for sensory map formation(8-12). These observations support two hypotheses: first, the increased capacity for behavioural learning during a sensitive period is associated with enhanced spine dynamics on sensorimotor neurons important for the learned behaviour; second, instructive experience rapidly stabilizes and strengthens these dynamic spines. Here we report a test of these hypotheses using two-photon in vivo imaging to measure spine dynamics in zebra finches, which learn to sing by imitating a tutor song during a juvenile sensitive period(13,14). Spine dynamics were measured in the forebrain nucleus HVC, the proximal site where auditory information merges with an explicit song motor representation(15-19), immediately before and after juvenile finches first experienced tutor song(20). Higher levels of spine turnover before tutoring correlated with a greater capacity for subsequent song imitation. In juveniles with high levels of spine turnover, hearing a tutor song led to the rapid (similar to 24-h) stabilization, accumulation and enlargement of dendritic spines in HVC. Moreover, in vivo intracellular recordings made immediately before and after the first day of tutoring revealed robust enhancement of synaptic activity in HVC. These findings suggest that behavioural learning results when instructive experience is able to rapidly stabilize and strengthen synapses on sensorimotor neurons important for the control of the learned behaviour.	[Roberts, Todd F.; Tschida, Katherine A.; Klein, Marguerita E.; Mooney, Richard] Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA	Duke University	Mooney, R (corresponding author), Duke Univ, Med Ctr, Dept Neurobiol, Durham, NC 27710 USA.	mooney@neuro.duke.edu		Mooney, Richard/0000-0002-3308-1367; Tschida, Katherine/0000-0002-8171-1722	US National Science Foundation (NSF); US National Institutes of Health (NIH); Howard Hughes Medical Institute; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC002524] Funding Source: NIH RePORTER	US National Science Foundation (NSF)(National Science Foundation (NSF)); US National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank M. Ehlers and L. Katz for access to the two-photon microscope and support in making lentivirus, K. Hamaguchi for peak detection and analysis software and D. Kloetzer for animal husbandry and laboratory support. D. Fitzpatrick, D. Purves and M. Ehlers provided comments on the manuscript. This work was supported by grants from the US National Science Foundation (NSF) and the US National Institutes of Health (NIH) (R. M.). T. F. R. was supported by a National Research Service Award from the NIH, K. A. T. was supported by a pre-doctoral award from the NSF and M. E. K. was supported by the Howard Hughes Medical Institute (Investigator, M. Ehlers).	Alvarez VA, 2007, ANNU REV NEUROSCI, V30, P79, DOI 10.1146/annurev.neuro.30.051606.094222; Bauer EE, 2008, J NEUROSCI, V28, P1509, DOI 10.1523/JNEUROSCI.3838-07.2008; Chklovskii DB, 2004, NATURE, V431, P782, DOI 10.1038/nature03012; De Roo M, 2008, PLOS BIOL, V6, P1850, DOI 10.1371/journal.pbio.0060219; Deregnaucourt S, 2005, NATURE, V433, P710, DOI 10.1038/nature03275; Dittgen T, 2004, P NATL ACAD SCI USA, V101, P18206, DOI 10.1073/pnas.0407976101; EALES LA, 1985, ANIM BEHAV, V33, P1293, DOI 10.1016/S0003-3472(85)80189-5; Engert F, 1999, NATURE, V399, P66, DOI 10.1038/19978; Hahnloser RHR, 2002, NATURE, V419, P65, DOI 10.1038/nature00974; Hofer SB, 2009, NATURE, V457, P313, DOI 10.1038/nature07487; Holtmaat AJGD, 2005, NEURON, V45, P279, DOI 10.1016/j.neuron.2005.01.003; Holtmaat A, 2006, NATURE, V441, P979, DOI 10.1038/nature04783; Immelmann K., 1969, P61; Kopec CD, 2006, J NEUROSCI, V26, P2000, DOI 10.1523/JNEUROSCI.3918-05.2006; Majewska A, 2003, P NATL ACAD SCI USA, V100, P16024, DOI 10.1073/pnas.2636949100; Maletic-Savatic M, 1999, SCIENCE, V283, P1923, DOI 10.1126/science.283.5409.1923; Matsuzaki M, 2004, NATURE, V429, P761, DOI 10.1038/nature02617; MCCASLAND JS, 1981, P NATL ACAD SCI-BIOL, V78, P7815, DOI 10.1073/pnas.78.12.7815; Mooney R, 2000, J NEUROSCI, V20, P5420, DOI 10.1523/JNEUROSCI.20-14-05420.2000; NOTTEBOHM F, 1976, J COMP NEUROL, V165, P457, DOI 10.1002/cne.901650405; Prather JF, 2008, NATURE, V451, P305, DOI 10.1038/nature06492; Roberts TF, 2008, J NEUROSCI, V28, P3479, DOI 10.1523/JNEUROSCI.0177-08.2008; Scharff C, 2000, NEURON, V25, P481, DOI 10.1016/S0896-6273(00)80910-1; Shank SS, 2009, NATURE, V458, P73, DOI 10.1038/nature07615; Tchernichovski O, 2001, SCIENCE, V291, P2564, DOI 10.1126/science.1058522; Trachtenberg JT, 2002, NATURE, V420, P788, DOI 10.1038/nature01273; Zito K, 2009, NEURON, V61, P247, DOI 10.1016/j.neuron.2008.10.054; Zuo Y, 2005, NATURE, V436, P261, DOI 10.1038/nature03715; Zuo Y, 2005, NEURON, V46, P181, DOI 10.1016/j.neuron.2005.04.001	29	209	211	0	22	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 18	2010	463	7283					948	U123		10.1038/nature08759	http://dx.doi.org/10.1038/nature08759			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	556HZ	20164928	Green Accepted			2022-12-01	WOS:000274582700046
J	Baudat, F; Buard, J; Grey, C; Fledel-Alon, A; Ober, C; Przeworski, M; Coop, G; de Massy, B				Baudat, F.; Buard, J.; Grey, C.; Fledel-Alon, A.; Ober, C.; Przeworski, M.; Coop, G.; de Massy, B.			PRDM9 Is a Major Determinant of Meiotic Recombination Hotspots in Humans and Mice	SCIENCE			English	Article							HISTONE H3 METHYLTRANSFERASE; ZINC FINGERS; HUMAN GENOME; HOT-SPOTS; RATES; CHIMPANZEES; INITIATION; PATTERNS; MEIOSIS; SITES	Meiotic recombination events cluster into narrow segments of the genome, defined as hotspots. Here, we demonstrate that a major player for hotspot specification is the Prdm9 gene. First, two mouse strains that differ in hotspot usage are polymorphic for the zinc finger DNA binding array of PRDM9. Second, the human consensus PRDM9 allele is predicted to recognize the 13-mer motif enriched at human hotspots; this DNA binding specificity is verified by in vitro studies. Third, allelic variants of PRDM9 zinc fingers are significantly associated with variability in genome-wide hotspot usage among humans. Our results provide a molecular basis for the distribution of meiotic recombination in mammals, in which the binding of PRDM9 to specific DNA sequences targets the initiation of recombination at specific locations in the genome.	[Baudat, F.; Buard, J.; Grey, C.; de Massy, B.] CNRS, UPR1142, Inst Genet Humaine, Montpellier, France; [Fledel-Alon, A.; Ober, C.; Przeworski, M.] Univ Chicago, Dept Human Genet, Chicago, IL 60637 USA; [Przeworski, M.] Univ Chicago, Howard Hughes Med Inst, Chicago, IL 60637 USA; [Coop, G.] Univ Calif Davis, Dept Ecol & Evolut, Davis, CA 95616 USA; [Coop, G.] Univ Calif Davis, Ctr Populat Biol, Davis, CA 95616 USA	Centre National de la Recherche Scientifique (CNRS); Universite de Montpellier; University of Chicago; Howard Hughes Medical Institute; University of Chicago; University of California System; University of California Davis; University of California System; University of California Davis	de Massy, B (corresponding author), CNRS, UPR1142, Inst Genet Humaine, Montpellier, France.	bernard.de-massy@igh.cnrs.fr		Baudat, Frederic/0000-0003-2415-8366; Ober, Carole/0000-0003-4626-9809; Coop, Graham/0000-0001-8431-0302	CNRS; Association pour la Recherche sur le Cancer [ARC 3939]; Fondation Jer me Lejeune; Agence Nationale de la Recherche [ANR-06-BLAN-0160-01, ANR-09-BLAN-0269-01]; Electricite de France; NIH [HD21244, HL085197, GM83098]; American Recovery and Reinvestment Act [03S1]; Howard Hughes Medical Institute; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD021244] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL085197] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083098] Funding Source: NIH RePORTER	CNRS(Centre National de la Recherche Scientifique (CNRS)); Association pour la Recherche sur le Cancer(Fondation ARC pour la Recherche sur le CancerAustralian Research Council); Fondation Jer me Lejeune; Agence Nationale de la Recherche(French National Research Agency (ANR)); Electricite de France; NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); American Recovery and Reinvestment Act; Howard Hughes Medical Institute(Howard Hughes Medical Institute); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank all members of our laboratories for discussions, J. Pritchard for comments on an earlier version of the manuscript, R. Hernandez and E. Leffler for their help with bioinformatics, E. Leffler for generating fig. S7, E. Brun for technical assistance on PRDM9 in vitro assays, and D. Haddou and F. Arnal for mouse facility service. This study was supported by a grant from CNRS; the Association pour la Recherche sur le Cancer (grant ARC 3939); the Fondation Jer me Lejeune and the Agence Nationale de la Recherche (grants ANR-06-BLAN-0160-01 and ANR-09-BLAN-0269-01) to B.d.M. C. G. was supported by a grant from Electricite de France. This research was further was supported by NIH grants HD21244 and HL085197 to C.O., a Sloan Foundation Fellowship to G. C., NIH grant GM83098, American Recovery and Reinvestment Act supplement 03S1, and a Howard Hughes Medical Institute Early Career Scientist Award to M. P. Sequences generated for this study are deposited in GenBank with the following accession numbers: GU216222, GU216223, GU216224, GU216225, GU216226, GU216227, GU216228, GU216229, and GU216230.	Arnheim N, 2007, ANNU REV GENET, V41, P369, DOI 10.1146/annurev.genet.41.110306.130301; Borde V, 2009, EMBO J, V28, P99, DOI 10.1038/emboj.2008.257; Boulton A, 1997, P NATL ACAD SCI USA, V94, P8058, DOI 10.1073/pnas.94.15.8058; Buard J, 2007, TRENDS GENET, V23, P301, DOI 10.1016/j.tig.2007.03.014; Buard J, 2009, EMBO J, V28, P2616, DOI 10.1038/emboj.2009.207; Coop G, 2008, SCIENCE, V319, P1395, DOI 10.1126/science.1151851; Coop G, 2007, NAT REV GENET, V8, P23, DOI 10.1038/nrg1947; de Massy B, 2003, TRENDS GENET, V19, P514, DOI 10.1016/S0168-9525(03)00201-4; Fu F, 2009, NUCLEIC ACIDS RES, V37, pD279, DOI 10.1093/nar/gkn606; Grey C, 2009, PLOS BIOL, V7, P327, DOI 10.1371/journal.pbio.1000035; Hayashi K, 2005, NATURE, V438, P374, DOI 10.1038/nature04112; HUNTER N, 2007, MOL GENETICS RECOMBI, P381; Jeffreys AJ, 2005, HUM MOL GENET, V14, P2277, DOI 10.1093/hmg/ddi232; Jeffreys AJ, 2001, NAT GENET, V29, P217, DOI 10.1038/ng1001-217; Jeffreys AJ, 2002, NAT GENET, V31, P267, DOI 10.1038/ng910; Keeney Scott, 2008, V2, P81, DOI 10.1007/7050_2007_026; McVean GAT, 2004, SCIENCE, V304, P581, DOI 10.1126/science.1092500; Mihola O, 2009, SCIENCE, V323, P373, DOI 10.1126/science.1163601; Myers S, 2005, SCIENCE, V310, P321, DOI 10.1126/science.1117196; Myers S, 2008, NAT GENET, V40, P1124, DOI 10.1038/ng.213; Myers S, 2010, SCIENCE, V327, P876, DOI 10.1126/science.1182363; Oliver PL, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000753; Pabo CO, 2001, ANNU REV BIOCHEM, V70, P313, DOI 10.1146/annurev.biochem.70.1.313; Paigen K, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000119; Parvanov ED, 2009, PLOS BIOL, V7, P340, DOI 10.1371/journal.pbio.1000036; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Ptak SE, 2005, NAT GENET, V37, P429, DOI 10.1038/ng1529; Ramirez CL, 2008, NAT METHODS, V5, P374, DOI 10.1038/nmeth0508-374; Winckler W, 2005, SCIENCE, V308, P107, DOI 10.1126/science.1105322; Wolfe SA, 2001, STRUCTURE, V9, P717, DOI 10.1016/S0969-2126(01)00632-3	30	639	651	2	103	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 12	2010	327	5967					836	840		10.1126/science.1183439	http://dx.doi.org/10.1126/science.1183439			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	554AQ	20044539	Green Accepted			2022-12-01	WOS:000274408300053
J	Guatelli, J				Guatelli, John			How Innate Immunity Can Inhibit the Release of HIV-1 from Infected Cells	NEW ENGLAND JOURNAL OF MEDICINE			English	Editorial Material							VPU PROTEIN		[Guatelli, John] Univ Calif San Diego, San Diego, CA 92103 USA; [Guatelli, John] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA	University of California System; University of California San Diego; US Department of Veterans Affairs; Veterans Health Administration (VHA); VA San Diego Healthcare System	Guatelli, J (corresponding author), Univ Calif San Diego, San Diego, CA 92103 USA.				NIAID NIH HHS [R01 AI081668] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI081668] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Neil SJD, 2008, NATURE, V451, P425, DOI 10.1038/nature06553; Neil SJD, 2007, CELL HOST MICROBE, V2, P193, DOI 10.1016/j.chom.2007.08.001; Perez-Caballero D, 2009, CELL, V139, P499, DOI 10.1016/j.cell.2009.08.039; Tokarev A, 2009, AIDS RES HUM RETROV, V25, P1197, DOI 10.1089/aid.2009.0253; Van Damme N, 2008, CELL HOST MICROBE, V3, P245, DOI 10.1016/j.chom.2008.03.001	5	1	1	0	2	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	FEB 11	2010	362	6					553	554		10.1056/NEJMcibr0911557	http://dx.doi.org/10.1056/NEJMcibr0911557			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	553WJ	20147723				2022-12-01	WOS:000274397200017
J	Sun, LJ; Liu, SQ; Chen, ZJJ				Sun, Lijun; Liu, Siqi; Chen, Zhijian J.			SnapShot: Pathways of Antiviral Innate Immunity	CELL			English	Editorial Material									[Sun, Lijun; Liu, Siqi; Chen, Zhijian J.] Univ Texas SW Med Ctr Dallas, Dept Mol Biol, HHMI, Dallas, TX 75390 USA	Howard Hughes Medical Institute; University of Texas System; University of Texas Southwestern Medical Center Dallas	Sun, LJ (corresponding author), Univ Texas SW Med Ctr Dallas, Dept Mol Biol, HHMI, Dallas, TX 75390 USA.		Sun, Lijun/ABD-4470-2021; Liu, Siqi/D-9325-2014; Chen, Zhijian/C-6039-2012	Liu, Siqi/0000-0002-2767-641X; Chen, Zhijian/0000-0002-8475-8251	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM063692] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM063692-08, R01 GM063692] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Bhoj VG, 2009, NATURE, V458, P430, DOI 10.1038/nature07959; Fujita T, 2009, IMMUNITY, V31, P4, DOI 10.1016/j.immuni.2009.06.014; Kim YM, 2008, NATURE, V452, P234, DOI 10.1038/nature06726; Schroder K, 2009, CURR BIOL, V19, pR262, DOI 10.1016/j.cub.2009.02.011; Sun SC, 2008, NAT REV IMMUNOL, V8, P501, DOI 10.1038/nri2337; Tabeta K, 2006, NAT IMMUNOL, V7, P156, DOI 10.1038/ni1297; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087	8	54	55	3	17	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	FEB 5	2010	140	3					436	U182		10.1016/j.cell.2010.01.041	http://dx.doi.org/10.1016/j.cell.2010.01.041			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144765	Green Accepted, Bronze			2022-12-01	WOS:000274297700020
J	Russo, I; Babbitt, S; Muralidharan, V; Butler, T; Oksman, A; Goldberg, DE				Russo, Ilaria; Babbitt, Shalon; Muralidharan, Vasant; Butler, Tamira; Oksman, Anna; Goldberg, Daniel E.			Plasmepsin V licenses Plasmodium proteins for export into the host erythrocyte	NATURE			English	Article							ENDOPLASMIC-RETICULUM; PARASITE PROTEINS; FOOD VACUOLE; FALCIPARUM; TRAFFICKING; VIRULENCE; CALPAIN; REVEALS	During their intraerythrocytic development, malaria parasites export hundreds of proteins to remodel their host cell. Nutrient acquisition, cytoadherence and antigenic variation are among the key virulence functions effected by this erythrocyte takeover. Proteins destined for export are synthesized in the endoplasmic reticulum (ER) and cleaved at a conserved (PEXEL) motif, which allows translocation into the host cell via an ATP-driven translocon called the PTEX complex. We report that plasmepsin V, an ER aspartic protease with distant homology to the mammalian processing enzyme BACE, recognizes the PEXEL motif and cleaves it at the correct site. This enzyme is essential for parasite viability and ER residence is essential for its function. We propose that plasmepsin V is the PEXEL protease and is an attractive enzyme for antimalarial drug development.	[Goldberg, Daniel E.] Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA; Washington Univ, Sch Med, Dept Med, St Louis, MO 63110 USA	Howard Hughes Medical Institute; Washington University (WUSTL); Washington University (WUSTL)	Goldberg, DE (corresponding author), Washington Univ, Sch Med, Howard Hughes Med Inst, Dept Mol Microbiol, St Louis, MO 63110 USA.	Goldberg@borcim.wustl.edu	russo, ilaria/D-4674-2014; Russo, Ilaria/GNP-2328-2022	russo, ilaria/0000-0002-2269-7078; Russo, Ilaria/0000-0002-2269-7078; Muralidharan, Vasant/0000-0001-6367-6284	NIH [AI-047798]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI047798] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))	This work was supported by NIH grant AI-047798. We thank A. Cowman, B. Crabb and S. Lindquist for suggestions, J. Adams and ATCC (MR4) for BiP antibody, D. Taylor for HRPII antibody, R. Anders for RESA antibody, A. Miller and M. Ndonwi for HRPII protein, P. Hruz for HIV protease inhibitors, J. Tang and S. Romeo for BACE inhibitors, W. Beatty for fluorescence analysis, S. Beverley for fluorimeter access, B. Vaupel for technical assistance and J. Turk for mass spectrometer access. Proteomics analysis was carried out at the 'Fingerprints' Proteomics Facility, College of Life Sciences, University of Dundee.	Bhattacharjee Souvik, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020050; Boddey JA, 2009, TRAFFIC, V10, P285, DOI 10.1111/j.1600-0854.2008.00864.x; Chang HH, 2008, MOL BIOCHEM PARASIT, V160, P107, DOI 10.1016/j.molbiopara.2008.04.011; de Koning-Ward TF, 2009, NATURE, V459, P945, DOI 10.1038/nature08104; Drew ME, 2008, J BIOL CHEM, V283, P12870, DOI 10.1074/jbc.M708949200; Haldar K, 2007, CURR OPIN HEMATOL, V14, P203, DOI 10.1097/MOH.0b013e3280f31b2d; Hiller NL, 2004, SCIENCE, V306, P1934, DOI 10.1126/science.1102737; Kim JH, 1998, P NATL ACAD SCI USA, V95, P2997, DOI 10.1073/pnas.95.6.2997; Klemba M, 2004, J CELL BIOL, V164, P47, DOI 10.1083/jcb200307147; Klemba M, 2005, MOL BIOCHEM PARASIT, V143, P183, DOI 10.1016/j.molbiopara.2005.05.015; Klemba M, 2004, J BIOL CHEM, V279, P43000, DOI 10.1074/jbc.M408123200; Maier AG, 2008, CELL, V134, P48, DOI 10.1016/j.cell.2008.04.051; Maier AG, 2009, NAT REV MICROBIOL, V7, P341, DOI 10.1038/nrmicro2110; Marti M, 2004, SCIENCE, V306, P1930, DOI 10.1126/science.1102452; Parikh S, 2005, ANTIMICROB AGENTS CH, V49, P2983, DOI 10.1128/AAC.49.7.2983-2985.2005; Russo I, 2009, P NATL ACAD SCI USA, V106, P1554, DOI 10.1073/pnas.0806926106; Russo I, 2009, MOL MICROBIOL, V72, P229, DOI 10.1111/j.1365-2958.2009.06639.x; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Skinner-Adams TS, 2004, J INFECT DIS, V190, P1998, DOI 10.1086/425584; Sullivan DJ, 1996, SCIENCE, V271, P219, DOI 10.1126/science.271.5246.219; TANG J, 2004, HDB PROTEOLYTIC ENZY, V1, pCH13; van Ooij C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000084	23	213	218	0	27	NATURE RESEARCH	BERLIN	HEIDELBERGER PLATZ 3, BERLIN, 14197, GERMANY	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					632	636		10.1038/nature08726	http://dx.doi.org/10.1038/nature08726			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20130644	Green Accepted			2022-12-01	WOS:000274193900029
J	Spence, D				Spence, Des			From the Frontline Bad medicine: osteoporosis	BRITISH MEDICAL JOURNAL			English	Editorial Material												destwo@yahoo.co.uk							0	1	1	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 3	2010	340								c643	10.1136/bmj.c643	http://dx.doi.org/10.1136/bmj.c643			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	553CV	20130012				2022-12-01	WOS:000274343500004
J	Hughes, JF; Skaletsky, H; Pyntikova, T; Graves, TA; van Daalen, SKM; Minx, PJ; Fulton, RS; McGrath, SD; Locke, DP; Friedman, C; Trask, BJ; Mardis, ER; Warren, WC; Repping, S; Rozen, S; Wilson, RK; Page, DC				Hughes, Jennifer F.; Skaletsky, Helen; Pyntikova, Tatyana; Graves, Tina A.; van Daalen, Saskia K. M.; Minx, Patrick J.; Fulton, Robert S.; McGrath, Sean D.; Locke, Devin P.; Friedman, Cynthia; Trask, Barbara J.; Mardis, Elaine R.; Warren, Wesley C.; Repping, Sjoerd; Rozen, Steve; Wilson, Richard K.; Page, David C.			Chimpanzee and human Y chromosomes are remarkably divergent in structure and gene content	NATURE			English	Article							SEX-CHROMOSOME; X-CHROMOSOME; HUMAN GENOME; EVOLUTION; SEQUENCE; PALINDROMES; REGION; RECOMBINATION; DEGENERATION; POLYMORPHISM	The human Y chromosome began to evolve from an autosome hundreds of millions of years ago, acquiring a sex-determining function and undergoing a series of inversions that suppressed crossing over with the X chromosome(1,2). Little is known about the recent evolution of the Y chromosome because only the human Y chromosome has been fully sequenced. Prevailing theories hold that Y chromosomes evolve by gene loss, the pace of which slows over time, eventually leading to a paucity of genes, and stasis(3,4). These theories have been buttressed by partial sequence data from newly emergent plant and animal Y chromosomes(5-8), but they have not been tested in older, highly evolved Y chromosomes such as that of humans. Here we finished sequencing of the male-specific region of the Y chromosome (MSY) in our closest living relative, the chimpanzee, achieving levels of accuracy and completion previously reached for the human MSY. By comparing the MSYs of the two species we show that they differ radically in sequence structure and gene content, indicating rapid evolution during the past 6 million years. The chimpanzee MSY contains twice as many massive palindromes as the human MSY, yet it has lost large fractions of the MSY protein-coding genes and gene families present in the last common ancestor. We suggest that the extraordinary divergence of the chimpanzee and human MSYs was driven by four synergistic factors: the prominent role of the MSY in sperm production, 'genetic hitchhiking' effects in the absence of meiotic crossing over, frequent ectopic recombination within the MSY, and species differences in mating behaviour. Although genetic decay may be the principal dynamic in the evolution of newly emergent Y chromosomes, wholesale renovation is the paramount theme in the continuing evolution of chimpanzee, human and perhaps other older MSYs.	[Hughes, Jennifer F.; Skaletsky, Helen; Pyntikova, Tatyana; Rozen, Steve; Page, David C.] Whitehead Inst, Howard Hughes Med Inst, Cambridge, MA 02142 USA; [Hughes, Jennifer F.; Skaletsky, Helen; Pyntikova, Tatyana; Rozen, Steve; Page, David C.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Graves, Tina A.; Minx, Patrick J.; Fulton, Robert S.; McGrath, Sean D.; Locke, Devin P.; Mardis, Elaine R.; Warren, Wesley C.; Wilson, Richard K.] Washington Univ, Sch Med, Genome Ctr, St Louis, MO 63108 USA; [van Daalen, Saskia K. M.; Repping, Sjoerd] Univ Amsterdam, Acad Med Ctr, Dept Obstet & Gynecol, Ctr Reprod Med, NL-1105 AZ Amsterdam, Netherlands; [Friedman, Cynthia; Trask, Barbara J.] Fred Hutchinson Canc Res Ctr, Div Human Biol, Seattle, WA 98109 USA	Howard Hughes Medical Institute; Massachusetts Institute of Technology (MIT); Whitehead Institute; Massachusetts Institute of Technology (MIT); Washington University (WUSTL); University of Amsterdam; Academic Medical Center Amsterdam; Fred Hutchinson Cancer Center	Page, DC (corresponding author), Whitehead Inst, Howard Hughes Med Inst, 9 Cambridge Ctr, Cambridge, MA 02142 USA.	dcpage@wi.mit.edu	Wilson, Richard K./AAF-4139-2019; McGrath, Sean David/AAT-3540-2020; Mardis, Elaine/W-2202-2019; Rozen, Steven G./J-5939-2013	Wilson, Richard K./0000-0002-1992-1358; McGrath, Sean David/0000-0001-9064-8449; Locke, Devin/0000-0002-2527-0475; Rozen, Steven G./0000-0002-4288-0056; Repping, Sjoerd/0000-0002-6959-149X	National Institutes of Health; Howard Hughes Medical Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG000257] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank L. Brown, V. Frazzoni, G. Rogers and A. Berger for technical assistance, and L. Brown, M. Carmell, G. Dokshin, M. Gill, J. Mueller, K. Romer and Y. Soh for comments on the manuscript. This work was supported by the National Institutes of Health and the Howard Hughes Medical Institute.	Bachtrog D, 2002, NATURE, V416, P323, DOI 10.1038/416323a; Bachtrog D, 2008, GENETICS, V179, P1513, DOI 10.1534/genetics.107.084012; CHARLESWORTH B, 1991, SCIENCE, V251, P1030, DOI 10.1126/science.1998119; Charlesworth B, 2000, PHILOS T R SOC B, V355, P1563, DOI 10.1098/rstb.2000.0717; *CHIMP SEQ AN CONS, 2005, NATURE, V0437; DIXSON AF, 1998, PRIMATE SEXUALITY CO, P37; Filatov DA, 2000, NATURE, V404, P388, DOI 10.1038/35006057; Hillier LW, 2004, NATURE, V432, P695, DOI 10.1038/nature03154; Hughes JF, 2006, NAT GENET, V38, P853, DOI 10.1038/ng0806-853b; Hughes JF, 2005, NATURE, V437, P101, DOI 10.1038/nature04101; Kawaguchi TK, 2001, NAT GENET, V29, P279, DOI 10.1038/ng757; Kuroki Y, 2006, NAT GENET, V38, P158, DOI 10.1038/ng1729; Lahn BT, 1999, SCIENCE, V286, P964, DOI 10.1126/science.286.5441.964; Lange J, 2009, CELL, V138, P855, DOI 10.1016/j.cell.2009.07.042; Liu ZY, 2004, NATURE, V427, P348, DOI 10.1038/nature02228; Mefford HC, 2001, HUM MOL GENET, V10, P2363, DOI 10.1093/hmg/10.21.2363; Murphy WJ, 2006, PLOS GENET, V2, P353, DOI 10.1371/journal.pgen.0020043; PAGE DC, 1984, NATURE, V311, P119, DOI 10.1038/311119a0; Peichel CL, 2004, CURR BIOL, V14, P1416, DOI 10.1016/j.cub.2004.08.030; Repping S, 2002, AM J HUM GENET, V71, P906, DOI 10.1086/342928; Repping S, 2006, NAT GENET, V38, P463, DOI 10.1038/ng1754; Repping S, 2003, NAT GENET, V35, P247, DOI 10.1038/ng1250; Rice WR, 1996, BIOSCIENCE, V46, P331, DOI 10.2307/1312947; Rozen S, 2003, NATURE, V423, P873, DOI 10.1038/nature01723; Saxena R, 2000, GENOMICS, V67, P256, DOI 10.1006/geno.2000.6260; Skaletsky H, 2003, NATURE, V423, P825, DOI 10.1038/nature01722; Steinemann S, 2005, CYTOGENET GENOME RES, V110, P134, DOI 10.1159/000084945; Watanabe H, 2004, NATURE, V429, P382, DOI 10.1038/nature02564; Yeh RF, 2001, GENOME RES, V11, P803, DOI 10.1101/gr.175701; Yohn CT, 2005, PLOS BIOL, V3, P577, DOI 10.1371/journal.pbio.0030110	30	264	271	1	82	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					536	539		10.1038/nature08700	http://dx.doi.org/10.1038/nature08700			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20072128	Green Accepted, Green Submitted			2022-12-01	WOS:000273981100050
J	Kirkegaard, T; Roth, AG; Petersen, NHT; Mahalka, AK; Olsen, OD; Moilanen, I; Zylicz, A; Knudsen, J; Sandhoff, K; Arenz, C; Kinnunen, PKJ; Nylandsted, J; Jaattela, M				Kirkegaard, Thomas; Roth, Anke G.; Petersen, Nikolaj H. T.; Mahalka, Ajay K.; Olsen, Ole Dines; Moilanen, Irina; Zylicz, Alicja; Knudsen, Jens; Sandhoff, Konrad; Arenz, Christoph; Kinnunen, Paavo K. J.; Nylandsted, Jesper; Jaattela, Marja			Hsp70 stabilizes lysosomes and reverts Niemann-Pick disease-associated lysosomal pathology	NATURE			English	Article							ACID SPHINGOMYELINASE; HEAT-SHOCK-PROTEIN-70 FAMILY; CELL-DEATH; STIMULATION; INVOLVEMENT; ACTIVATION; CATHEPSINS; APOPTOSIS; MEMBRANES; PROTEINS	Heat shock protein 70 (Hsp70) is an evolutionarily highly conserved molecular chaperone that promotes the survival of stressed cells by inhibiting lysosomal membrane permeabilization(1-5), a hallmark of stress-induced cell death(6-10). Clues to its molecular mechanism of action may lay in the recently reported stress-and cancer-associated translocation of a small portion of Hsp70 to the lysosomal compartment(1,11). Here we show that Hsp70 stabilizes lysosomes by binding to an endolysosomal anionic phospholipid bis(monoacylglycero) phosphate (BMP), an essential co-factor for lysosomal sphingomyelin metabolism(12-14). In acidic environments Hsp70 binds with high affinity and specificity to BMP, thereby facilitating the BMP binding and activity of acid sphingomyelinase (ASM). The inhibition of the Hsp70-BMP interaction by BMP antibodies or a point mutation in Hsp70 (Trp90Phe), as well as the pharmacological and genetic inhibition of ASM, effectively revert the Hsp70-mediated stabilization of lysosomes. Notably, the reduced ASM activity in cells from patients with Niemann-Pick disease (NPD) A and B-severe lysosomal storage disorders caused by mutations in the sphingomyelin phosphodiesterase 1 gene (SMPD1) encoding for ASM(15)-is also associated with a marked decrease in lysosomal stability, and this phenotype can be effectively corrected by treatment with recombinant Hsp70. Taken together, these data open exciting possibilities for the development of new treatments for lysosomal storage disorders and cancer with compounds that enter the lysosomal lumen by the endocytic delivery pathway.	[Kirkegaard, Thomas; Petersen, Nikolaj H. T.; Olsen, Ole Dines; Nylandsted, Jesper; Jaattela, Marja] Danish Canc Soc, Inst Canc Biol, Apoptosis Dept, DK-2100 Copenhagen, Denmark; [Kirkegaard, Thomas; Petersen, Nikolaj H. T.; Olsen, Ole Dines; Nylandsted, Jesper; Jaattela, Marja] Danish Canc Soc, Inst Canc Biol, Ctr Genotox Stress Res, DK-2100 Copenhagen, Denmark; [Roth, Anke G.; Arenz, Christoph] Humboldt Univ, Inst Chem, D-10099 Berlin, Germany; [Mahalka, Ajay K.; Moilanen, Irina; Kinnunen, Paavo K. J.] Univ Helsinki, Inst Biomed, Helsinki Biophys & Biomembrane Grp, FIN-00014 Helsinki, Finland; [Olsen, Ole Dines; Knudsen, Jens] Univ So Denmark, Dept Biochem & Mol Biol, DK-5230 Odense, Denmark; [Zylicz, Alicja] Int Inst Mol & Cell Biol, PL-02109 Warsaw, Poland; [Sandhoff, Konrad] Univ Bonn, Kekule Inst Organ Chem & Biochem, LIMES, D-53121 Bonn, Germany	Danish Cancer Society; Danish Cancer Society; Humboldt University of Berlin; University of Helsinki; University of Southern Denmark; Miedzynarodowy Instytut Biologii Molekularnej i Komorkowej; University of Bonn	Jaattela, M (corresponding author), Danish Canc Soc, Inst Canc Biol, Apoptosis Dept, DK-2100 Copenhagen, Denmark.	mj@cancer.dk	Arenz, Christoph/D-1841-2010; Nylandsted, Jesper/ABE-7192-2021; Sander-Effron, Samuel/AAX-2231-2020; Mahalka, Ajay/K-3993-2015; Mahalka, Ajay Kumar/G-6875-2012; Jäättelä, Marja/AAT-7932-2021; Resource Center, NINDS Human Genetics/AGF-2474-2022	Mahalka, Ajay Kumar/0000-0002-0716-9947; Jäättelä, Marja/0000-0001-5950-7111; Nylandsted, Jesper/0000-0001-6474-5093; Arenz, Christoph/0000-0001-7613-9437; Zylicz, Alicja/0000-0003-4174-3073	Danish Cancer Society; Danish National Research Foundation; Danish Medical Research Council; European Commission; Meyer Foundation; Novo Nordisk Foundation; Association for International Cancer Research; Finnish Academy; Sigrid Juselius Foundation; Volkswagenstiftung; Deutsche Forschungsgemeinschaft [SFB 645, SPP 1267]; EU; Polish Ministry of Science and High Education	Danish Cancer Society(Danish Cancer Society); Danish National Research Foundation(Danmarks Grundforskningsfond); Danish Medical Research Council(Danish Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)); European Commission(European CommissionEuropean Commission Joint Research Centre); Meyer Foundation; Novo Nordisk Foundation(Novo Nordisk FoundationNovocure Limited); Association for International Cancer Research; Finnish Academy(Academy of Finland); Sigrid Juselius Foundation(Sigrid Juselius Foundation); Volkswagenstiftung(Volkswagen); Deutsche Forschungsgemeinschaft(German Research Foundation (DFG)); EU(European Commission); Polish Ministry of Science and High Education(Ministry of Science and Higher Education, Poland)	We thank E. Gulbins and A. Riehle for the NPD A (no. 2) cells, the Charite Berlin and the Johannes Gutenberg-Universitat Mainz for the NPD B fibroblasts, C. Ejsing and H. Schulze for advice, and J. Gruenberg, B. Margulis and the Developmental Studies Hybridoma Bank for antibodies. This work was supported by grants from the Danish Cancer Society, the Danish National Research Foundation, the Danish Medical Research Council, the European Commission FP7 (APO-SYS), the Meyer Foundation, the Novo Nordisk Foundation, and the Association for International Cancer Research for M. J., the Finnish Academy and the Sigrid Juselius Foundation for P. K. J. K., Volkswagenstiftung for A. G. R. and C. A., Deutsche Forschungsgemeinschaft (SFB 645, SPP 1267) and EU (LipidomicNet) for K. S., and the Polish Ministry of Science and High Education for A.Z.	Bivik C, 2007, CARCINOGENESIS, V28, P537, DOI 10.1093/carcin/bgl152; BLIGH EG, 1959, CAN J BIOCHEM PHYS, V37, P911; Brunk UT, 1997, FREE RADICAL BIO MED, V23, P616, DOI 10.1016/S0891-5849(97)00007-5; Brunk UT, 2001, REDOX REP, V6, P91, DOI 10.1179/135100001101536094; Daugaard M, 2007, FEBS LETT, V581, P3702, DOI [10.1016/j.febslet.2007.05.039, 10.1016/j.febsiet.2007.05.039]; Doulias PT, 2007, FREE RADICAL BIO MED, V42, P567, DOI 10.1016/j.freeradbiomed.2006.11.022; FERLINZ K, 1991, BIOCHEM BIOPH RES CO, V179, P1187, DOI 10.1016/0006-291X(91)91697-B; Flerov MA, 2003, B EXP BIOL MED+, V136, P120, DOI 10.1023/A:1026394218471; Goni FM, 2002, FEBS LETT, V531, P38, DOI 10.1016/S0014-5793(02)03482-8; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guicciardi ME, 2004, ONCOGENE, V23, P2881, DOI 10.1038/sj.onc.1207512; Gyrd-Hansen M, 2006, MOL CELL BIOL, V26, P7880, DOI 10.1128/MCB.00716-06; Holopainen JM, 2000, EUR J BIOCHEM, V267, P6231, DOI 10.1046/j.1432-1327.2000.01708.x; Holopainen JM, 1998, BIOCHEMISTRY-US, V37, P17562, DOI 10.1021/bi980915e; Hwang JH, 2005, PANCREAS, V31, P332, DOI 10.1097/01.mpa.0000183377.04295.c3; Kirkegaard T, 2009, BBA-MOL CELL RES, V1793, P746, DOI 10.1016/j.bbamcr.2008.09.008; Kobayashi T, 1998, NATURE, V392, P193, DOI 10.1038/32440; Kolter T, 2005, ANNU REV CELL DEV BI, V21, P81, DOI 10.1146/annurev.cellbio.21.122303.120013; Kolzer M, 2004, FEBS LETT, V559, P96, DOI 10.1016/S0014-5793(04)00033-X; Leist M, 2001, NAT REV MOL CELL BIO, V2, P589, DOI 10.1038/35085008; Linke T, 2001, BIOL CHEM, V382, P283, DOI 10.1515/BC.2001.035; Mambula SS, 2006, J IMMUNOL, V177, P7849, DOI 10.4049/jimmunol.177.11.7849; Morshauser RC, 1999, J MOL BIOL, V289, P1387, DOI 10.1006/jmbi.1999.2776; Nylandsted J, 2004, J EXP MED, V200, P425, DOI 10.1084/jem.20040531; QUINTERN LE, 1987, BIOCHIM BIOPHYS ACTA, V922, P323, DOI 10.1016/0005-2760(87)90055-5; Rohde M, 2005, GENE DEV, V19, P570, DOI 10.1101/gad.305405; Smith EL, 2008, FASEB J, V22, P3419, DOI 10.1096/fj.08-108043; Sriram M, 1997, STRUCTURE, V5, P403, DOI 10.1016/S0969-2126(97)00197-4; Stoka V, 2007, BIOL CHEM, V388, P555, DOI 10.1515/BC.2007.064; Tidwell JL, 2004, CELL STRESS CHAPERON, V9, P88, DOI 10.1379/CSC-9R.1; Utermohlen O, 2008, IMMUNOBIOLOGY, V213, P307, DOI 10.1016/j.imbio.2007.10.016; Yu Q, 2001, MOL VIS, V7, P48; Zhao HX, 2002, J BIOL CHEM, V277, P25170, DOI 10.1074/jbc.M203186200	33	343	358	6	67	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					549	U171		10.1038/nature08710	http://dx.doi.org/10.1038/nature08710			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20111001				2022-12-01	WOS:000273981100053
J	Li, WK; Schulman, S; Dutton, RJ; Boyd, D; Beckwith, J; Rapoport, TA				Li, Weikai; Schulman, Sol; Dutton, Rachel J.; Boyd, Dana; Beckwith, Jon; Rapoport, Tom A.			Structure of a bacterial homologue of vitamin K epoxide reductase	NATURE			English	Article							DISULFIDE BOND FORMATION; ACTIVE-SITE; VKORC1; DSBB; MODEL; RESISTANCE; CONVERSION; MUTATIONS; MECHANISM; CYCLE	Vitamin K epoxide reductase (VKOR) generates vitamin K hydroquinone to sustain c-carboxylation of many blood coagulation factors. Here, we report the 3.6 angstrom crystal structure of a bacterial homologue of VKOR from Synechococcus sp. The structure shows VKOR in complex with its naturally fused redox partner, a thioredoxin-like domain, and corresponds to an arrested state of electron transfer. The catalytic core of VKOR is a four transmembrane helix bundle that surrounds a quinone, connected through an additional transmembrane segment with the periplasmic thioredoxin-like domain. We propose a pathway for how VKOR uses electrons from cysteines of newly synthesized proteins to reduce a quinone, a mechanism confirmed by in vitro reconstitution of vitamin K-dependent disulphide bridge formation. Our results have implications for the mechanism of the mammalian VKOR and explain how mutations can cause resistance to the VKOR inhibitor warfarin, the most commonly used oral anticoagulant.	[Li, Weikai; Schulman, Sol; Rapoport, Tom A.] Harvard Univ, Sch Med, Howard Hughes Med Inst, Boston, MA 02115 USA; [Li, Weikai; Schulman, Sol; Rapoport, Tom A.] Harvard Univ, Sch Med, Dept Cell Biol, Boston, MA 02115 USA; [Dutton, Rachel J.; Boyd, Dana; Beckwith, Jon] Harvard Univ, Sch Med, Dept Microbiol & Mol Genet, Boston, MA 02115 USA	Harvard University; Harvard Medical School; Howard Hughes Medical Institute; Harvard University; Harvard Medical School; Harvard University; Harvard Medical School	Rapoport, TA (corresponding author), Harvard Univ, Sch Med, Howard Hughes Med Inst, 240 Longwood Ave, Boston, MA 02115 USA.	weikai@crystal.harvard.edu; tom_rapoport@hms.harvard.edu		schulman, sol/0000-0002-5229-3592	NIH; National Institute of General Medical Sciences [GMO41883]; Charles King Trust; National Heart, Lung, and Blood Institute (NIH) [K99, 1K99HL097083]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R00HL097083, K99HL097083] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM041883, T32GM007753] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Charles King Trust; National Heart, Lung, and Blood Institute (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank C. Jao for help with mass spectroscopy, S. Harrison for insightful comments on the structure, B. Furie, B. C. Furie and Y. Yu. for discussion, A. Osborne, B. van den Berg, J. Zimmer, and Y. Chen for critical reading of the manuscript, R. Zhang for help with the figures, the staff at Advanced Photon Source beamline ID-24C, and the SBGrid consortium at Harvard Medical School. S. S. is supported by an NIH Medical Scientist Training Program fellowship. J. B. is supported by grant GMO41883 from the National Institute of General Medical Sciences. W. L. is supported by a Charles King Trust fellowship and K99 grant 1K99HL097083 from the National Heart, Lung, and Blood Institute (NIH). T. A. R. is an HHMI investigator.	Bader M, 1998, J BIOL CHEM, V273, P10302, DOI 10.1074/jbc.273.17.10302; BARDWELL JCA, 1993, P NATL ACAD SCI USA, V90, P1038, DOI 10.1073/pnas.90.3.1038; Chu PH, 2006, P NATL ACAD SCI USA, V103, P19308, DOI 10.1073/pnas.0609401103; Cowtan KD, 1996, ACTA CRYSTALLOGR D, V52, P43, DOI 10.1107/S090744499500761X; D'Ambrosio RL, 2007, J THROMB HAEMOST, V5, P191, DOI 10.1111/j.1538-7836.2006.02261.x; Dutton RJ, 2008, P NATL ACAD SCI USA, V105, P11933, DOI 10.1073/pnas.0804621105; Dutton RJ, 2010, P NATL ACAD SCI USA, V107, P297, DOI 10.1073/pnas.0912952107; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Furie B, 1999, BLOOD, V93, P1798, DOI 10.1182/blood.V93.6.1798.406k22_1798_1808; Gebauer M, 2007, BIOORGAN MED CHEM, V15, P2414, DOI 10.1016/j.bmc.2007.01.014; Goodstadt L, 2004, TRENDS BIOCHEM SCI, V29, P289, DOI 10.1016/j.tibs.2004.04.004; Gross E, 2004, CELL, V117, P601, DOI 10.1016/S0092-8674(04)00418-0; Gross E, 2002, NAT STRUCT BIOL, V9, P61, DOI 10.1038/nsb740; Inaba K, 2004, J BIOL CHEM, V279, P6761, DOI 10.1074/jbc.M310765200; Inaba K, 2006, CELL, V127, P789, DOI 10.1016/j.cell.2006.10.034; Inaba K, 2009, EMBO J, V28, P779, DOI 10.1038/emboj.2009.21; Jin DY, 2007, BIOCHEMISTRY-US, V46, P7279, DOI 10.1021/bi700527j; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; KISHIGAMI S, 1995, J BIOL CHEM, V270, P17072, DOI 10.1074/jbc.270.29.17072; Klein TE, 2009, NEW ENGL J MED, V360, P753, DOI 10.1056/NEJMoa0809329; Langer G, 2008, NAT PROTOC, V3, P1171, DOI 10.1038/nprot.2008.91; Malojcic G, 2008, FEBS LETT, V582, P3301, DOI 10.1016/j.febslet.2008.07.063; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oldenburg J, 2008, VITAM HORM, V78, P35, DOI 10.1016/S0083-6729(07)00003-9; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Pelz HJ, 2005, GENETICS, V170, P1839, DOI 10.1534/genetics.104.040360; Regeimbal J, 2003, P NATL ACAD SCI USA, V100, P13779, DOI 10.1073/pnas.1935988100; Rost S, 2005, THROMB HAEMOSTASIS, V94, P780, DOI 10.1160/TH05-02-0082; Rost S, 2004, NATURE, V427, P537, DOI 10.1038/nature02214; Rost S, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-4; Sheldrick GM, 2008, ACTA CRYSTALLOGR A, V64, P112, DOI 10.1107/S0108767307043930; SILVERMAN RB, 1981, J AM CHEM SOC, V103, P5939, DOI 10.1021/ja00409a068; Singh AK, 2008, J BIOL CHEM, V283, P15762, DOI 10.1074/jbc.M800982200; SOUTE BAM, 1992, BIOCHEM J, V281, P255, DOI 10.1042/bj2810255; STENFLO J, 1977, ANNU REV BIOCHEM, V46, P157, DOI 10.1146/annurev.bi.46.070177.001105; Terwilliger TC, 1999, ACTA CRYSTALLOGR D, V55, P849, DOI 10.1107/S0907444999000839; Tie JK, 2008, VITAM HORM, V78, P103, DOI 10.1016/S0083-6729(07)00006-4; Tie JK, 2005, J BIOL CHEM, V280, P16410, DOI 10.1074/jbc.M500765200; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Wajih N, 2007, J BIOL CHEM, V282, P2626, DOI 10.1074/jbc.M608954200; Winn MD, 2001, ACTA CRYSTALLOGR D, V57, P122, DOI 10.1107/S0907444900014736; Zhang KYJ, 1997, METHOD ENZYMOL, V277, P53, DOI 10.1016/S0076-6879(97)77006-X; Zhou YP, 2008, MOL CELL, V31, P896, DOI 10.1016/j.molcel.2008.08.028	43	149	153	1	32	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 28	2010	463	7280					507	U123		10.1038/nature08720	http://dx.doi.org/10.1038/nature08720			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	548QK	20110994	Green Accepted			2022-12-01	WOS:000273981100043
J	Costanzo, M; Baryshnikova, A; Bellay, J; Kim, Y; Spear, ED; Sevier, CS; Ding, HM; Koh, JLY; Toufighi, K; Mostafavi, S; Prinz, J; Onge, RPS; VanderSluis, B; Makhnevych, T; Vizeacoumar, FJ; Alizadeh, S; Bahr, S; Brost, RL; Chen, YQ; Cokol, M; Deshpande, R; Li, ZJ; Lin, ZY; Liang, WD; Marback, M; Paw, J; Luis, BJS; Shuteriqi, E; Tong, AHY; van Dyk, N; Wallace, IM; Whitney, JA; Weirauch, MT; Zhong, GQ; Zhu, HW; Houry, WA; Brudno, M; Ragibizadeh, S; Papp, B; Pal, C; Roth, FP; Giaever, G; Nislow, C; Troyanskaya, OG; Bussey, H; Bader, GD; Gingras, AC; Morris, QD; Kim, PM; Kaiser, CA; Myers, CL; Andrews, BJ; Boone, C				Costanzo, Michael; Baryshnikova, Anastasia; Bellay, Jeremy; Kim, Yungil; Spear, Eric D.; Sevier, Carolyn S.; Ding, Huiming; Koh, Judice L. Y.; Toufighi, Kiana; Mostafavi, Sara; Prinz, Jeany; Onge, Robert P. St.; VanderSluis, Benjamin; Makhnevych, Taras; Vizeacoumar, Franco J.; Alizadeh, Solmaz; Bahr, Sondra; Brost, Renee L.; Chen, Yiqun; Cokol, Murat; Deshpande, Raamesh; Li, Zhijian; Lin, Zhen-Yuan; Liang, Wendy; Marback, Michaela; Paw, Jadine; Luis, Bryan-Joseph San; Shuteriqi, Ermira; Tong, Amy Hin Yan; van Dyk, Nydia; Wallace, Iain M.; Whitney, Joseph A.; Weirauch, Matthew T.; Zhong, Guoqing; Zhu, Hongwei; Houry, Walid A.; Brudno, Michael; Ragibizadeh, Sasan; Papp, Balazs; Pal, Csaba; Roth, Frederick P.; Giaever, Guri; Nislow, Corey; Troyanskaya, Olga G.; Bussey, Howard; Bader, Gary D.; Gingras, Anne-Claude; Morris, Quaid D.; Kim, Philip M.; Kaiser, Chris A.; Myers, Chad L.; Andrews, Brenda J.; Boone, Charles			The Genetic Landscape of a Cell	SCIENCE			English	Article							SACCHAROMYCES-CEREVISIAE; INTERACTION NETWORKS; TRANSFER-RNA; PROTEIN; EVOLUTION; INTERACTOME; EXOCYTOSIS; PATHWAYS; REVEALS; MAP	A genome-scale genetic interaction map was constructed by examining 5.4 million gene-gene pairs for synthetic genetic interactions, generating quantitative genetic interaction profiles for similar to 75% of all genes in the budding yeast, Saccharomyces cerevisiae. A network based on genetic interaction profiles reveals a functional map of the cell in which genes of similar biological processes cluster together in coherent subsets, and highly correlated profiles delineate specific pathways to define gene function. The global network identifies functional cross-connections between all bioprocesses, mapping a cellular wiring diagram of pleiotropy. Genetic interaction degree correlated with a number of different gene attributes, which may be informative about genetic network hubs in other organisms. We also demonstrate that extensive and unbiased mapping of the genetic landscape provides a key for interpretation of chemical-genetic interactions and drug target identification.	[Bellay, Jeremy; Kim, Yungil; Deshpande, Raamesh; Myers, Chad L.] Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA; [Costanzo, Michael; Baryshnikova, Anastasia; Ding, Huiming; Koh, Judice L. Y.; Toufighi, Kiana; Prinz, Jeany; Vizeacoumar, Franco J.; Alizadeh, Solmaz; Bahr, Sondra; Brost, Renee L.; Chen, Yiqun; Li, Zhijian; Liang, Wendy; Marback, Michaela; Paw, Jadine; Luis, Bryan-Joseph San; Shuteriqi, Ermira; Tong, Amy Hin Yan; van Dyk, Nydia; Wallace, Iain M.; Zhong, Guoqing; Zhu, Hongwei; Giaever, Guri; Nislow, Corey; Bader, Gary D.; Morris, Quaid D.; Kim, Philip M.; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Dept Mol Genet, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Costanzo, Michael; Baryshnikova, Anastasia; Ding, Huiming; Koh, Judice L. Y.; Toufighi, Kiana; Mostafavi, Sara; Prinz, Jeany; Vizeacoumar, Franco J.; Alizadeh, Solmaz; Bahr, Sondra; Brost, Renee L.; Chen, Yiqun; Li, Zhijian; Liang, Wendy; Marback, Michaela; Paw, Jadine; Luis, Bryan-Joseph San; Shuteriqi, Ermira; Tong, Amy Hin Yan; van Dyk, Nydia; Wallace, Iain M.; Whitney, Joseph A.; Zhong, Guoqing; Zhu, Hongwei; Brudno, Michael; Nislow, Corey; Bader, Gary D.; Morris, Quaid D.; Kim, Philip M.; Andrews, Brenda J.; Boone, Charles] Univ Toronto, Banting & Best Dept Med Res, Terrence Donnelly Ctr Cellular & Biomol Res, Toronto, ON M5S 3E1, Canada; [Spear, Eric D.; Sevier, Carolyn S.; Kaiser, Chris A.] MIT, Dept Biol, Cambridge, MA 02142 USA; [Mostafavi, Sara; Whitney, Joseph A.; Brudno, Michael; Morris, Quaid D.] Univ Toronto, Dept Comp Sci, Toronto, ON M5S 2E4, Canada; [Onge, Robert P. St.] Stanford Univ, Dept Biochem, Stanford Genome Technol Ctr, Palo Alto, CA 94304 USA; [Makhnevych, Taras] Univ Toronto, Dept Biochem, Toronto, ON M5S 1A8, Canada; [Cokol, Murat; Roth, Frederick P.] Harvard Univ, Sch Med, Dept Biol Chem & Mol Pharmacol, Boston, MA 02115 USA; [Lin, Zhen-Yuan; Gingras, Anne-Claude] Mt Sinai Hosp, Samuel Lunenfeld Res Inst, Toronto, ON M5G 1X5, Canada; [Wallace, Iain M.; Giaever, Guri] Univ Toronto, Dept Pharm, Toronto, ON M5S 3E1, Canada; [Weirauch, Matthew T.] Univ Calif Santa Cruz, Dept Biomol Engn, Santa Cruz, CA 95064 USA; [Ragibizadeh, Sasan] S&P Robot Inc, N York, ON M3J 2V8, Canada; [Papp, Balazs; Pal, Csaba] Biol Res Ctr, Inst Biochem, H-6701 Szeged, Hungary; [Troyanskaya, Olga G.] Princeton Univ, Dept Comp Sci, Lewis Sigler Inst Integrat Genom, Carl Icahn Lab, Princeton, NJ 08544 USA; [Bussey, Howard] McGill Univ, Dept Biol, Montreal, PQ H3A 1B1, Canada	University of Minnesota System; University of Minnesota Twin Cities; University of Toronto; University of Toronto; Massachusetts Institute of Technology (MIT); University of Toronto; Stanford University; University of Toronto; Harvard University; Harvard Medical School; University of Toronto; University Toronto Affiliates; Sinai Health System Toronto; Lunenfeld Tanenbaum Research Institute; University of Toronto; University of California System; University of California Santa Cruz; Hungarian Academy of Sciences; Hungarian Biological Research Center; Princeton University; McGill University	Myers, CL (corresponding author), Univ Minnesota, Dept Comp Sci & Engn, Minneapolis, MN 55455 USA.	cmyers@cs.umn.edu; brenda.andrews@utoronto.ca; charlie.boone@utoronto.ca	Troyanskaya, Olga G/B-1968-2010; Roth, Frederick P/H-6308-2011; Morris, Quaid/ABE-8343-2020; Vizeacoumar, Franco/GLS-7161-2022; Califano, Andrea/F-7239-2012; Weirauch, Matthew/M-5459-2019; Gingras, Anne-Claude/E-9982-2010; Bader, Gary/C-1176-2009; Gingras, Anne-Claude/ABA-8341-2020; Wallace, Iain/B-9464-2009	Gingras, Anne-Claude/0000-0002-6090-4437; Bader, Gary/0000-0003-0185-8861; Gingras, Anne-Claude/0000-0002-6090-4437; Wallace, Iain/0000-0002-9491-7025; Sevier, Carolyn/0000-0003-3245-6988; Papp, Balazs/0000-0003-3093-8852; Troyanskaya, Olga/0000-0002-5676-5737; Morris, Quaid/0000-0002-2760-6999; Roth, Frederick/0000-0002-6628-649X	Genome Canada through the Ontario Genomics Institute [2004-OGI-3-01]; Canadian Institutes of Health Research [GSP-41567]; University of Minnesota; Minnesota Supercomputing Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R01HG003224] Funding Source: NIH RePORTER	Genome Canada through the Ontario Genomics Institute(Genome Canada); Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR)); University of Minnesota(University of Minnesota System); Minnesota Supercomputing Institute; NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))	We thank S. Dixon, T. Hughes, P. Jorgensen, and M. Tyers for critical comments. Supported by Genome Canada through the Ontario Genomics Institute (2004-OGI-3-01) and the Canadian Institutes of Health Research (GSP-41567) (C. B., B. A.), the University of Minnesota Biomedical Informatics and Computational Biology program (J.B., R. D.), and a seed grant from the Minnesota Supercomputing Institute (J.B., B. V.).	Chen EJ, 2003, J CELL BIOL, V161, P333, DOI 10.1083/jcb.200210141; de Visser JAGM, 2003, EVOLUTION, V57, P1959, DOI 10.1554/02-750R; Dixon SJ, 2009, ANNU REV GENET, V43, P601, DOI 10.1146/annurev.genet.39.073003.114751; Dunham MJ, 2002, P NATL ACAD SCI USA, V99, P16144, DOI 10.1073/pnas.242624799; Esberg A, 2006, MOL CELL, V24, P139, DOI 10.1016/j.molcel.2006.07.031; Fong PC, 2009, NEW ENGL J MED, V361, P123, DOI 10.1056/NEJMoa0900212; Fraser HB, 2003, BMC EVOL BIOL, V3, DOI 10.1186/1471-2148-3-11; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731; Huber A, 2009, GENE DEV, V23, P1929, DOI 10.1101/gad.532109; Johansen LD, 2008, J CELL SCI, V121, P854, DOI 10.1242/jcs.013722; Jonikas MC, 2009, SCIENCE, V323, P1693, DOI 10.1126/science.1167983; Kim PM, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.16; Kim PM, 2006, SCIENCE, V314, P1938, DOI 10.1126/science.1136174; Krogan NJ, 2006, NATURE, V440, P637, DOI 10.1038/nature04670; Lehar J, 2008, NAT CHEM BIOL, V4, P674, DOI 10.1038/nchembio.120; Lehner B, 2006, NAT GENET, V38, P896, DOI 10.1038/ng1844; Leidel S, 2009, NATURE, V458, P228, DOI 10.1038/nature07643; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Mani R, 2008, P NATL ACAD SCI USA, V105, P3461, DOI 10.1073/pnas.0712255105; Meiklejohn CD, 2002, TRENDS ECOL EVOL, V17, P468, DOI 10.1016/S0169-5347(02)02596-X; Metzger MB, 2009, MOL BIOL CELL, V20, P1006, DOI 10.1091/mbc.E08-02-0140; Naumanen T, 2008, CELL ADHES MIGR, V2, P236, DOI 10.4161/cam.2.4.6630; Pal C, 2001, GENETICS, V158, P927; Parsons AB, 2004, NAT BIOTECHNOL, V22, P62, DOI 10.1038/nbt919; Rahl PB, 2005, MOL CELL, V17, P841, DOI 10.1016/j.molcel.2005.02.018; Segre D, 2005, NAT GENET, V37, P77, DOI 10.1038/ng1489; Sevier CS, 2007, CELL, V129, P333, DOI 10.1016/j.cell.2007.02.039; St Onge RP, 2007, NAT GENET, V39, P199, DOI 10.1038/ng1948; Tarassov K, 2008, SCIENCE, V320, P1465, DOI 10.1126/science.1153878; Tong AHY, 2004, SCIENCE, V303, P808, DOI 10.1126/science.1091317; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Waddington C.H., 1957, STRATEGY GENE; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684	34	1522	1563	1	265	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 22	2010	327	5964					425	431		10.1126/science.1180823	http://dx.doi.org/10.1126/science.1180823			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	546BS	20093466	Green Accepted			2022-12-01	WOS:000273783100027
J	Roberts, RG; Brook, BW				Roberts, Richard G.; Brook, Barry W.			And Then There Were None?	SCIENCE			English	Editorial Material							PLEISTOCENE AUSTRALIA; MEGAFAUNA; EXTINCTION; COLLAPSE; HUMANS		[Roberts, Richard G.] Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia; [Brook, Barry W.] Univ Adelaide, Sch Earth & Environm Sci, Inst Environm, Adelaide, SA 5005, Australia	University of Wollongong; University of Adelaide	Roberts, RG (corresponding author), Univ Wollongong, Sch Earth & Environm Sci, Ctr Archaeol Sci, Wollongong, NSW 2522, Australia.	rgrob@uow.edu.au; barry.brook@adelaide.edu.au	Brook, Barry W./G-2686-2011; Roberts, Richard Graham/B-8245-2013	Brook, Barry W./0000-0002-2491-1517; Roberts, Richard Graham/0000-0002-0128-4119				Ayliffe LK, 2008, QUATERNARY SCI REV, V27, P1784, DOI 10.1016/j.quascirev.2008.07.008; Brook B. W., 2006, ALCHERINGA, V1, P39; Field J, 2008, EARTH-SCI REV, V89, P97, DOI 10.1016/j.earscirev.2008.04.006; Fillios M, 2010, QUATERN INT, V211, P123, DOI 10.1016/j.quaint.2009.04.003; Gill JL, 2009, SCIENCE, V326, P1100, DOI 10.1126/science.1179504; Gillespie R, 2006, ARCHAEOL OCEAN, V41, P1; Grun R, 2010, QUATERNARY SCI REV, V29, P596, DOI 10.1016/j.quascirev.2009.11.004; Grun R, 2008, AUST J EARTH SCI, V55, P917, DOI 10.1080/08120090802097419; Haile J, 2009, P NATL ACAD SCI USA, V106, P22352, DOI 10.1073/pnas.0912510106; Miller GH, 1999, SCIENCE, V283, P205, DOI 10.1126/science.283.5399.205; Miller GH, 2005, SCIENCE, V309, P287, DOI 10.1126/science.1111288; Prideaux GJ, 2007, GEOLOGY, V35, P33, DOI 10.1130/G23070A.1; Prideaux GJ, 2009, P NATL ACAD SCI USA, V106, P11646, DOI 10.1073/pnas.0900956106; Roberts RG, 2001, SCIENCE, V292, P1888, DOI 10.1126/science.1060264; Trueman CNG, 2005, P NATL ACAD SCI USA, V102, P8381, DOI 10.1073/pnas.0408975102; Turney CSM, 2008, P NATL ACAD SCI USA, V105, P12150, DOI 10.1073/pnas.0801360105	16	14	14	1	28	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 22	2010	327	5964					420	422		10.1126/science.1185517	http://dx.doi.org/10.1126/science.1185517			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	546BS	20093463				2022-12-01	WOS:000273783100024
J	Royou, A; Gagou, ME; Karess, R; Sullivan, W				Royou, Anne; Gagou, Mary E.; Karess, Roger; Sullivan, William			BubR1-and Polo-Coated DNA Tethers Facilitate Poleward Segregation of Acentric Chromatids	CELL			English	Article							SPINDLE-ASSEMBLY CHECKPOINT; DROSOPHILA-MELANOGASTER; GENOMIC INSTABILITY; CENTROMERE; DAMAGE; ANAPHASE; TELOMERES; MITOSIS; ARREST; YEAST	The mechanisms that safeguard cells against chromosomal instability (CIN) are of great interest, as CIN contributes to tumorigenesis. To gain insight into these mechanisms, we studied the behavior of cells entering mitosis with damaged chromosomes. We used the endonuclease I-CreI to generate acentric chromosomes in Drosophila larvae. While I-CreI expression produces acentric chromosomes in the majority of neuronal stem cells, remarkably, it has no effect on adult survival. Our live studies reveal that acentric chromatids segregate efficiently to opposite poles. The acentric chromatid poleward movement is mediated through DNA tethers decorated with BubR1, Polo, INCENP, and Aurora-B. Reduced BubR1 or Polo function results in abnormal segregation of acentric chromatids, a decrease in acentric chromosome tethering, and a great reduction in adult survival. We propose that BubR1 and Polo facilitate the accurate segregation of acentric chromatids by maintaining the integrity of the tethers that connect acentric chromosomes to their centric partners.	[Gagou, Mary E.; Karess, Roger] Univ Paris 07, Inst Jacques Monod, F-75205 Paris 13, France; [Royou, Anne; Sullivan, William] Univ Calif Santa Cruz, Dept Mol Cell & Dev Biol, Santa Cruz, CA 95064 USA	UDICE-French Research Universities; Universite Paris Cite; University of California System; University of California Santa Cruz	Royou, A (corresponding author), Univ Paris 07, Inst Jacques Monod, 4 Rue Marie Andree Lagroua Weill Halle, F-75205 Paris 13, France.	royou@biology.ucsc.edu		Karess, Roger/0000-0002-7299-0600	California Institute for Regenerative Medicine; National Institutes of Health [GM046409]; European Union; Centre National de la Recherche Scientifique; Agence Nationale de la Recherche [ANR-08-BLAN-0006-01]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM046409, R29GM046409] Funding Source: NIH RePORTER	California Institute for Regenerative Medicine(California Institute for Regenerative Medicine); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); European Union(European Commission); Centre National de la Recherche Scientifique(Centre National de la Recherche Scientifique (CNRS)); Agence Nationale de la Recherche(French National Research Agency (ANR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank Kent Golic (University of Utah, UT), Kim McKim (Rutgers University, NJ), Claudio Sunkel (University of Porto, Portugal) and William Earnshaw (University of Edinburgh, UK) for sharing reagents, the Sullivan lab members and Derek McCusker (Institut Europeen de Chimie et Biochimie, Bordeaux, France) for critical reading of the manuscript. We also thank Alfredo Villasante (Universidad Autonoma de Madrid, Spain) for sharing unpublished data. A. R. and W. S. were supported by grants from the California Institute for Regenerative Medicine and the National Institutes of Health (GM046409), respectively. M. E. G. was supported by a training and mobility grant from the Research Training Network program of the European Union. R. K. was supported by the Centre National de la Recherche Scientifique and the Agence Nationale de la Recherche (ANR-08-BLAN-0006-01).	Basu J, 1999, J CELL BIOL, V146, P13, DOI 10.1083/jcb.146.1.13; Baumann C, 2007, CELL, V128, P101, DOI 10.1016/j.cell.2006.11.041; Blower MD, 2001, NAT CELL BIOL, V3, P730, DOI 10.1038/35087045; Buffin E, 2005, CURR BIOL, V15, P856, DOI 10.1016/j.cub.2005.03.052; Buffin E, 2007, NAT CELL BIOL, V9, P565, DOI 10.1038/ncb1570; Burton JL, 2007, GENE DEV, V21, P655, DOI 10.1101/gad.1511107; Chan KL, 2009, NAT CELL BIOL, V11, P753, DOI 10.1038/ncb1882; Clarkson M, 1999, DNA CELL BIOL, V18, P457, DOI 10.1089/104454999315178; Davenport J, 2006, EXP CELL RES, V312, P1831, DOI 10.1016/j.yexcr.2006.02.018; Donaldson MM, 2001, J CELL BIOL, V153, P663, DOI 10.1083/jcb.153.4.663; Elowe S, 2007, GENE DEV, V21, P2205, DOI 10.1101/gad.436007; Galgoczy DJ, 2001, MOL CELL BIOL, V21, P1710, DOI 10.1128/MCB.21.5.1710-1718.2001; Hartl TA, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000228; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; Ishii K, 2008, SCIENCE, V321, P1088, DOI 10.1126/science.1158699; Kanda T, 2001, J CELL SCI, V114, P49; Kaye JA, 2004, CURR BIOL, V14, P2096, DOI 10.1016/j.cub.2004.10.051; King EMJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000342; LaFountain JR, 2002, J CELL SCI, V115, P1541; LLAMAZARES S, 1991, GENE DEV, V5, P2153, DOI 10.1101/gad.5.12a.2153; Logarinho E, 2004, J CELL SCI, V117, P1757, DOI 10.1242/jcs.01033; Malkova A, 1996, P NATL ACAD SCI USA, V93, P7131, DOI 10.1073/pnas.93.14.7131; Malureanu LA, 2009, DEV CELL, V16, P118, DOI 10.1016/j.devcel.2008.11.004; Melo JA, 2001, GENE DEV, V15, P2809; Moutinho-Santos T, 1999, BIOL CELL, V91, P585, DOI 10.1016/S0248-4900(00)88523-8; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Musaro M, 2008, NAT GENET, V40, P362, DOI 10.1038/ng.2007.64; Platero JS, 1999, MOL CELL, V4, P995, DOI 10.1016/S1097-2765(00)80228-2; Rahmani Z, 2009, J CELL BIOL, V187, P597, DOI 10.1083/jcb.200905026; Rong YKS, 2002, GENE DEV, V16, P1568, DOI 10.1101/gad.986602; Royou A, 2005, CURR BIOL, V15, P334, DOI 10.1016/j.cub.2005.02.026; SANDELL LL, 1993, CELL, V75, P729, DOI 10.1016/0092-8674(93)90493-A; Schuh M, 2007, CURR BIOL, V17, P237, DOI 10.1016/j.cub.2006.11.051; Sczaniecka M, 2008, J BIOL CHEM, V283, P23039, DOI 10.1074/jbc.M803594200; Su TT, 2006, ANNU REV GENET, V40, P187, DOI 10.1146/annurev.genet.40.110405.090428; Titen SWA, 2008, GENETICS, V180, P1821, DOI 10.1534/genetics.108.093625; Tusell L, 2008, CYTOGENET GENOME RES, V122, P315, DOI 10.1159/000167818; Vidanes GM, 2005, CELL, V121, P973, DOI 10.1016/j.cell.2005.06.013; Wang LHC, 2008, CHROMOSOMA, V117, P123, DOI 10.1007/s00412-007-0131-7; Warren WD, 2000, CURR BIOL, V10, P1463, DOI 10.1016/S0960-9822(00)00806-X; WILLIAMS BC, 1994, J CELL SCI, V107, P785; Wong OK, 2007, J CELL BIOL, V179, P611, DOI 10.1083/jcb.200708044; Zachos G, 2007, DEV CELL, V12, P247, DOI 10.1016/j.devcel.2007.01.003	43	54	54	0	4	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 22	2010	140	2					235	245		10.1016/j.cell.2009.12.043	http://dx.doi.org/10.1016/j.cell.2009.12.043			11	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	546QX	20141837	Green Accepted, Bronze			2022-12-01	WOS:000273826500014
J	Danino, T; Mondragon-Palomino, O; Tsimring, L; Hasty, J				Danino, Tal; Mondragon-Palomino, Octavio; Tsimring, Lev; Hasty, Jeff			A synchronized quorum of genetic clocks	NATURE			English	Article							BACILLUS-THURINGIENSIS; QUENCHING LACTONASE; CELL COMMUNICATION; ESCHERICHIA-COLI; TOGGLE SWITCH; EXPRESSION; NETWORK; BEHAVIOR; OSCILLATORS; RHYTHMS	The engineering of genetic circuits with predictive functionality in living cells represents a defining focus of the expanding field of synthetic biology. This focus was elegantly set in motion a decade ago with the design and construction of a genetic toggle switch and an oscillator, with subsequent highlights that have included circuits capable of pattern generation, noise shaping, edge detection and event counting. Here we describe an engineered gene network with global intercellular coupling that is capable of generating synchronized oscillations in a growing population of cells. Using microfluidic devices tailored for cellular populations at differing length scales, we investigate the collective synchronization properties along with spatiotemporal waves occurring at millimetre scales. We use computational modelling to describe quantitatively the observed dependence of the period and amplitude of the bulk oscillations on the flow rate. The synchronized genetic clock sets the stage for the use of microbes in the creation of a macroscopic biosensor with an oscillatory output. Furthermore, it provides a specific model system for the generation of a mechanistic description of emergent coordinated behaviour at the colony level.	[Danino, Tal; Mondragon-Palomino, Octavio; Hasty, Jeff] Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA; [Tsimring, Lev; Hasty, Jeff] Univ Calif San Diego, BioCircuits Inst, La Jolla, CA 92093 USA; [Hasty, Jeff] Univ Calif, Div Biol Sci, Mol Biol Sect, La Jolla, CA 92093 USA	University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego	Hasty, J (corresponding author), Univ Calif San Diego, Dept Bioengn, La Jolla, CA 92093 USA.	hasty@bioeng.ucsd.edu		Tsimring, Lev/0000-0003-0709-3548	National Institutes of Health and General Medicine [GM69811]; DOE CSGF; CONACyT (Mexico) [184646]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM069811] Funding Source: NIH RePORTER	National Institutes of Health and General Medicine(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); DOE CSGF(United States Department of Energy (DOE)); CONACyT (Mexico)(Consejo Nacional de Ciencia y Tecnologia (CONACyT)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank J. Stricker for helpful discussions on plasmid construction, and M. Bennett, K. Wiesenfeld and J. Collins for stimulating discussions during the preparation of the manuscript. This work was supported by the National Institutes of Health and General Medicine (GM69811), the DOE CSGF fellowship (to T. D.), and CONACyT (Mexico, grant 184646, to O. M.-P.).	Alon U, 2007, NAT REV GENET, V8, P450, DOI 10.1038/nrg2102; Atkinson MR, 2003, CELL, V113, P597, DOI 10.1016/S0092-8674(03)00346-5; Austin DW, 2006, NATURE, V439, P608, DOI 10.1038/nature04194; Basu S, 2005, NATURE, V434, P1130, DOI 10.1038/nature03461; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Cookson NA, 2009, FEBS LETT, V583, P3931, DOI 10.1016/j.febslet.2009.10.089; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; DUNLAP PV, 1985, J BACTERIOL, V164, P45, DOI 10.1128/JB.164.1.45-50.1985; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Elson RC, 1998, PHYS REV LETT, V81, P5692, DOI 10.1103/PhysRevLett.81.5692; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Friedland AE, 2009, SCIENCE, V324, P1199, DOI 10.1126/science.1172005; Fung E, 2005, NATURE, V435, P118, DOI 10.1038/nature03508; Garcia-Ojalvo J, 2004, P NATL ACAD SCI USA, V101, P10955, DOI 10.1073/pnas.0307095101; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Glass L, 2001, NATURE, V410, P277, DOI 10.1038/35065745; Glossop NRJ, 1999, SCIENCE, V286, P766, DOI 10.1126/science.286.5440.766; Grenier F, 2003, J NEUROPHYSIOL, V89, P841, DOI 10.1152/jn.00420.2002; Hasty J, 2002, NATURE, V420, P224, DOI 10.1038/nature01257; Huygens C., 1932, OEUVRES COMPLETES CH, V17; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Jiang YJ, 2000, NATURE, V408, P475, DOI 10.1038/35044091; Kerckhoffs RCP, 2009, MED IMAGE ANAL, V13, P362, DOI 10.1016/j.media.2008.06.013; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Lakin-Thomas PL, 2004, ANNU REV MICROBIOL, V58, P489, DOI 10.1146/annurev.micro.58.030603.123744; Lewandowski W, 1999, P IEEE, V87, P163, DOI 10.1109/5.736348; Li D, 2002, IEEE SIGNAL PROC MAG, V19, P17, DOI 10.1109/79.985674; Liu D, 2008, BIOCHEMISTRY-US, V47, P7706, DOI 10.1021/bi800368y; Lutz R, 1997, NUCLEIC ACIDS RES, V25, P1203, DOI 10.1093/nar/25.6.1203; Mather W, 2009, PHYS REV LETT, V102, DOI 10.1103/PhysRevLett.102.068105; McMillen D, 2002, P NATL ACAD SCI USA, V99, P679, DOI 10.1073/pnas.022642299; MIROLLO RE, 1990, SIAM J APPL MATH, V50, P1645, DOI 10.1137/0150098; Ozbudak EM, 2002, NAT GENET, V31, P69, DOI 10.1038/ng869; Pikovsky A., 2003, SYNCHRONIZATION UNIV; Reading NC, 2006, FEMS MICROBIOL LETT, V254, P1, DOI 10.1111/j.1574-6968.2005.00001.x; Stricker J, 2008, NATURE, V456, P516, DOI 10.1038/nature07389; Strogatz S. H., 2004, SYNC; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Thomas PW, 2005, BIOCHEMISTRY-US, V44, P7559, DOI 10.1021/bi050050m; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Vladimirov AG, 2003, EUROPHYS LETT, V61, P613, DOI 10.1209/epl/i2003-00115-8; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Wiesenfeld K, 1996, PHYS REV LETT, V76, P404, DOI 10.1103/PhysRevLett.76.404; WINFREE AT, 1967, J THEOR BIOL, V16, P15, DOI 10.1016/0022-5193(67)90051-3; You LC, 2004, NATURE, V428, P868, DOI 10.1038/nature02491; Young MW, 2001, NAT REV GENET, V2, P702, DOI 10.1038/35088576	49	688	723	14	310	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					326	330		10.1038/nature08753	http://dx.doi.org/10.1038/nature08753			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090747	Green Accepted, Green Submitted			2022-12-01	WOS:000273748100037
J	Gay, EB				Gay, Elizabeth B.			Insight	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												eg3d@hscmail.mcc.virginia.edu							0	0	0	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					205	205		10.1001/jama.2009.2026	http://dx.doi.org/10.1001/jama.2009.2026			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20085944				2022-12-01	WOS:000273690600001
J	Lessler, J; Reich, NG; Cummings, DAT				Lessler, Justin; Reich, Nicholas G.; Cummings, Derek A. T.		New York City Dept Hlth; Mental Hyg Swine Influenza Invest	Outbreak of 2009 Pandemic Influenza A (H1N1) at a New York City School	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							COMMUNITY TRANSMISSION; INFECTIONS; HOUSEHOLD; DISTRIBUTIONS; CHILDREN; VIRUS	BACKGROUND In April 2009, an outbreak of novel swine-origin influenza A ( 2009 H1N1 influenza) occurred at a high school in Queens, New York. We describe the outbreak and characterize the clinical and epidemiologic aspects of this novel virus. METHODS The New York City Department of Health and Mental Hygiene characterized the outbreak through laboratory confirmation of the presence of the 2009 H1N1 virus in nasopharyngeal and oropharyngeal specimens and through information obtained from an online survey. Detailed information on exposure and the onset of symptoms was used to estimate the incubation period, generation time, and within-school reproductive number associated with 2009 H1N1 influenza, with the use of established techniques. RESULTS From April 24 through May 8, infection with the 2009 H1N1 virus was confirmed in 124 high-school students and employees. In responses to the online questionnaire, more than 800 students and employees (35% of student respondents and 10% of employee respondents) reported having an influenza-like illness during this period. No persons with confirmed 2009 H1N1 influenza or with influenza-like illness had severe symptoms. A linkage with travel to Mexico was identified. The estimated median incubation period for confirmed 2009 H1N1 influenza was 1.4 days (95% confidence interval [CI], 1.0 to 1.8), with symptoms developing in 95% of cases by 2.2 days (95% CI, 1.7 to 2.6). The estimated median generation time was 2.7 days (95% CI, 2.0 to 3.5). We estimate that the within-school reproductive number was 3.3. CONCLUSIONS The findings from this investigation suggest that 2009 H1N1 influenza in the high school was widespread but did not cause severe illness. The reasons for the rapid and extensive spread of influenza-like illnesses are unknown. The natural history and transmission of the 2009 H1N1 influenza virus appear to be similar to those of previously observed circulating pandemic and interpandemic influenza viruses.	[Lessler, Justin; Cummings, Derek A. T.] Johns Hopkins Univ, Dept Epidemiol, Baltimore, MD USA; [Reich, Nicholas G.] Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Biostat, Baltimore, MD USA	Johns Hopkins University; Johns Hopkins University; Johns Hopkins Bloomberg School of Public Health	Lessler, J (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Epidemiol, 615 N Wolfe St,E6545, Baltimore, MD 21205 USA.	jlessler@jhsph.edu	Reich, Nicholas/L-1168-2019; Tsoi, Benjamin/T-2766-2018	Reich, Nicholas/0000-0003-3503-9899; Marx, Melissa/0000-0001-9735-6342; Tsoi, Benjamin/0000-0003-2927-6687; Lessler, Justin/0000-0002-9741-8109; DiGrande, Laura/0000-0002-7742-0164	National Institutes of Health [1 R01 TW008246-01, 1U01-GM070708]; Bill and Melinda Gates Foundation; U. S. Department of Homeland Security [N00014-06-1-0991]; Burroughs Wellcome Fund; FOGARTY INTERNATIONAL CENTER [R01TW008246] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [U01GM070708] Funding Source: NIH RePORTER	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); U. S. Department of Homeland Security(United States Department of Homeland Security (DHS)); Burroughs Wellcome Fund(Burroughs Wellcome Fund); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by grants from the National Institutes of Health (1 R01 TW008246-01, to Drs. Lessler and Cummings; and 1U01-GM070708, to Dr. Cummings), the Bill and Melinda Gates Foundation ( to Drs. Lessler and Cummings), and the U. S. Department of Homeland Security (N00014-06-1-0991, to Mr. Reich). Dr. Cummings is the recipient of a Career Award at the Scientific Interface from the Burroughs Wellcome Fund.	[Anonymous], MMWR MORB MORTAL WKL; BECKER NG, 1989, ANAL INFECT DIS DATA; Brownstein JS, 2005, AM J EPIDEMIOL, V162, P686, DOI 10.1093/aje/kwi257; Carrat F, 2008, AM J EPIDEMIOL, V167, P775, DOI 10.1093/aje/kwm375; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cowling BJ, 2009, EPIDEMIOLOGY, V20, P344, DOI 10.1097/EDE.0b013e31819d1092; Fraser C, 2009, SCIENCE, V324, P1557, DOI 10.1126/science.1176062; Klein J, 1992, SURVIVAL ANAL STATE; Lessler J, 2007, J R SOC INTERFACE, V4, P755, DOI 10.1098/rsif.2007.0228; Lessler J, 2009, LANCET INFECT DIS, V9, P291, DOI 10.1016/S1473-3099(09)70069-6; Longini IM, 2005, AM J EPIDEMIOL, V161, P303, DOI 10.1093/aje/kwi053; LONGINI IM, 1982, BIOMETRICS, V38, P115, DOI 10.2307/2530294; MACKENZIE D, 2009, DEADLY NEW FLU VIRUS; Mills CE, 2004, NATURE, V432, P904, DOI 10.1038/nature03063; Nishiura H, 2009, EUROSURVEILLANCE, V14; Nishiura Hiroshi, 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P1075; Reich NG, 2009, STAT MED, V28, P2769, DOI 10.1002/sim.3659; Wallinga J, 2007, P ROY SOC B-BIOL SCI, V274, P599, DOI 10.1098/rspb.2006.3754; 2009, MMWR MORB MORTAL WKL, V58, P470	19	236	242	0	19	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793			NEW ENGL J MED	N. Engl. J. Med.	DEC 31	2009	361	27					2628	2636		10.1056/NEJMoa0906089	http://dx.doi.org/10.1056/NEJMoa0906089			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	538JV	20042754				2022-12-01	WOS:000273181300010
J	Todo, Y; Kato, H; Kaneuchi, M; Watari, H; Takeda, M; Sakuragi, N				Todo, Yukiharu; Kato, Hidenori; Kaneuchi, Masanori; Watari, Hidemichi; Takeda, Mahito; Sakuragi, Noriaki			Survival effect of para-aortic lymphadenectomy in endometrial cancer (SEPAL study): a retrospective cohort analysis	LANCET			English	Article							PHASE-III TRIAL; THERAPEUTIC ROLE; STAGE-I; CARCINOMA; CHEMOTHERAPY; RISK; ADENOCARCINOMA; RADIOTHERAPY; CORPUS	Background In response to findings that pelvic lymphadenectomy does not have any therapeutic benefit for endometrial cancer, we aimed to establish whether complete, systematic lymphadenectomy, including the para-aortic lymph nodes, should be part of surgical therapy for patients at intermediate and high risk of recurrence. Methods We selected 671 patients with endometrial carcinoma who had been treated with complete, systematic pelvic lymphadenectomy (n=325 patients) or combined pelvic and para-aortic lymphadenectomy (n=346) at two tertiary centres in Japan (January, 1986 June, 2004). Patients at intermediate or high risk of recurrence were offered adjuvant radiotherapy or chemotherapy. The primary outcome measure was overall survival. Findings Overall survival was significantly longer in the pelvic and para-aortic lymphadenectomy group than in the pelvic lymphadenectomy group (HR 0.53, 95% CI 0.38-0.76; p=0.0005). This association was also recorded in 407 patients at intermediate or high risk (p=0.0009), but overall survival was not related to lymphadenectorny type in low-risk patients. Multivariate analysis of prognostic factors showed that in patients with intermediate or high risk of recurrence, pelvic and para-aortic lymphadenectomy reduced the risk of death compared with pelvic lymphadenectomy (0.44, 0.30-0.64; p<0.0001). Analysis of 328 patients with intermediate or high risk who were treated with adjuvant radiotherapy or chemotherapy showed that patient survival improved with pelvic and para-aortic lymphadenectomy (0.48, 0.29-0.83; p=0.0049) and with adjuvant chemotherapy (0.59, 0.37-1.00; p=0.0465) independently of one another. Interpretation Combined pelvic and para-aortic lymphadenectomy is recommended as treatment for patients with endometrial carcinoma of intermediate or high risk of recurrence. If a prospective randomised or comparative cohort study is planned to validate the therapeutic effect of lymphadenectomy, it should include both pelvic and para-aortic lymphadenectomy in patients of intermediate or high risk of recurrence.	[Sakuragi, Noriaki] Hokkaido Univ, Grad Sch Med, Dept Gynaecol, Kita Ku, Sapporo, Hokkaido 0608638, Japan; [Kaneuchi, Masanori; Watari, Hidemichi; Takeda, Mahito; Sakuragi, Noriaki] Hokkaido Univ Hosp, Dept Gynaecol, Sapporo, Hokkaido 060, Japan; [Todo, Yukiharu; Kato, Hidenori] Hokkaido Canc Ctr, Natl Hosp Org, Div Gynaecol Oncol, Sapporo, Hokkaido, Japan	Hokkaido University; Hokkaido University	Sakuragi, N (corresponding author), Hokkaido Univ, Grad Sch Med, Dept Gynaecol, Kita Ku, N15,W7, Sapporo, Hokkaido 0608638, Japan.	sakuragi@med.hokudai.ac.jp	Sakuragi, Noriaki/D-6507-2012		Japanese Foundation for Multidisciplinary Treatment of Cancer; Japan Society for the Promotion of Science	Japanese Foundation for Multidisciplinary Treatment of Cancer(Japanese Foundation for Multidisciplinary Treatment of Cancer); Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	We thank Sharon Hanley. Japanese Red Cross Hokkaido College of Nursing, for English editing of the report. This study was partly supported by grants-in-aid for scientific research from the Japanese Foundation for Multidisciplinary Treatment of Cancer, and the Japan Society for the Promotion of Science.	Chan JK, 2007, LANCET ONCOL, V8, P831, DOI 10.1016/S1470-2045(07)70275-9; Chan JK, 2006, CANCER, V107, P1823, DOI 10.1002/cncr.22185; Cragun JM, 2005, J CLIN ONCOL, V23, P3668, DOI 10.1200/JCO.2005.04.144; CREASMAN WT, 1987, CANCER, V60, P2035, DOI 10.1002/1097-0142(19901015)60:8+<2035::AID-CNCR2820601515>3.0.CO;2-8; Frederick PJ, 2009, CANCER CONTROL, V16, P23, DOI 10.1177/107327480901600104; Fujimoto T, 2007, GYNECOL ONCOL, V107, P253, DOI 10.1016/j.ygyno.2007.06.009; GRIGSBY PW, 1992, INT J RADIAT ONCOL, V22, P905, DOI 10.1016/0360-3016(92)90786-H; Kitchener H, 2009, LANCET, V373, P125, DOI 10.1016/S0140-6736(08)61766-3; Lutman CV, 2006, GYNECOL ONCOL, V102, P92, DOI 10.1016/j.ygyno.2005.11.032; Maggi R, 2006, BRIT J CANCER, V95, P266, DOI 10.1038/sj.bjc.6603279; Mariani A, 2000, GYNECOL ONCOL, V76, P348, DOI 10.1006/gyno.1999.5688; Mariani A, 2008, GYNECOL ONCOL, V109, P11, DOI 10.1016/j.ygyno.2008.01.023; Niikura H, 2004, GYNECOL ONCOL, V92, P669, DOI 10.1016/j.ygyno.2003.10.039; Nishiya M, 1998, INT J CANCER, V79, P521; Panici PB, 2008, JNCI-J NATL CANCER I, V100, P1707, DOI 10.1093/jnci/djn397; Randall ME, 2006, J CLIN ONCOL, V24, P36, DOI 10.1200/JCO.2004.00.7617; Roland PY, 2004, GYNECOL ONCOL, V93, P125, DOI 10.1016/j.ygyno.2003.12.018; Sakuragi N, 2000, ACTA OBSTET GYN SCAN, V79, P311, DOI 10.1034/j.1600-0412.2000.079004311.x; Susumu N, 2008, GYNECOL ONCOL, V108, P226, DOI 10.1016/j.ygyno.2007.09.029; von Elm E, 2008, J CLIN EPIDEMIOL, V61, P344, DOI [10.1016/j.jclinepi.2007.11.008, 10.2471/BLT.07.045120]; Watanabe Y, 2007, GYNECOL ONCOL, V105, P325, DOI 10.1016/j.ygyno.2006.12.015; WITTEKIND C, 2005, TNM ATLAS ILLUSTRATE, P250; Yaegashi N, 2007, INT J CLIN ONCOL, V12, P176, DOI 10.1007/s10147-006-0621-2; Yokoyama Y, 1997, GYNECOL ONCOL, V64, P411, DOI 10.1006/gyno.1996.4573	24	529	556	0	32	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0140-6736	1474-547X		LANCET	Lancet	APR 3	2010	375	9721					1165	1172		10.1016/S0140-6736(09)62002-X	http://dx.doi.org/10.1016/S0140-6736(09)62002-X			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	585VL	20188410				2022-12-01	WOS:000276858200028
J	Sotillo, R; Schvartzman, JM; Socci, ND; Benezra, R				Sotillo, Rocio; Schvartzman, Juan-Manuel; Socci, Nicholas D.; Benezra, Robert			Mad2-induced chromosome instability leads to lung tumour relapse after oncogene withdrawal	NATURE			English	Article							MITOTIC CHECKPOINT; CLONAL EVOLUTION; CANCER; MICE; ADENOCARCINOMAS; TUMORIGENESIS; MECHANISMS; RESISTANCE; MISSEGREGATION; REGRESSION	Inhibition of an initiating oncogene often leads to extensive tumour cell death, a phenomenon known as oncogene addiction(1). This has led to the search for compounds that specifically target and inhibit oncogenes as anticancer agents. However, there has been no systematic exploration of whether chromosomal instability generated as a result of deregulation of the mitotic checkpoint pathway(2,3), a frequent characteristic of solid tumours, has any effect on oncogene addiction. Here we show that induction of chromosome instability by overexpression of the mitotic checkpoint gene Mad2 in mice does not affect the regression of Kras-driven lung tumours when Kras is inhibited. However, tumours that experience transient Mad2 overexpression and consequent chromosome instability recur at markedly elevated rates. The recurrent tumours are highly aneuploid and have varied activation of pro-proliferative pathways. Thus, early chromosomal instability may be responsible for tumour relapse after seemingly effective anticancer treatments.	[Sotillo, Rocio; Schvartzman, Juan-Manuel; Benezra, Robert] Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA; [Socci, Nicholas D.] Mem Sloan Kettering Canc Ctr, Computat Biol Ctr, New York, NY 10065 USA	Memorial Sloan Kettering Cancer Center; Memorial Sloan Kettering Cancer Center	Benezra, R (corresponding author), Mem Sloan Kettering Canc Ctr, Canc Biol & Genet Program, New York, NY 10065 USA.	r-benezra@ski.mskcc.org		Sotillo, Rocio/0000-0002-0855-7917; Schvartzman, Juan Manuel/0000-0002-8036-1361	Charles H. Revson Foundation; US Department of Defense; National Institutes of Health; NATIONAL CANCER INSTITUTE [R01CA124378] Funding Source: NIH RePORTER	Charles H. Revson Foundation; US Department of Defense(United States Department of Defense); National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))	We thank H. Varmus and W. Pao for the CCSP-rtTA and TetO-Kras mice; K. Politi, K. Podsypanina and M. Jechlinger for reagents, discussions and critical reading of the manuscript; C. Le and M. Lupu for MR imaging; M. Leversha, C. Kalyani and J. McGuire for FISH staining; K. M. D. La Perle, M. Jiao and M. Squatrito for immunohistochemistry and pathological analysis; A. Viale for CGH and Affymetrix; and Y. Chin, S. Curelariu and C. Coker for excellent technical assistance. Support was provided to R. S. by the Charles H. Revson Foundation, to J. M. S. by a Breast Cancer Research Program (BCRP) Predoctoral Traineeship Award from the US Department of Defense (Congressionally Directed Medical Research Programs) and to R. B. by the National Institutes of Health.	Baker DJ, 2005, CURR OPIN CELL BIOL, V17, P583, DOI 10.1016/j.ceb.2005.09.011; Boxer RB, 2004, CANCER CELL, V6, P577, DOI 10.1016/j.ccr.2004.10.013; Chang S, 2001, SEMIN CANCER BIOL, V11, P227, DOI 10.1006/scbi.2000.0374; Chin L, 1999, NATURE, V400, P468, DOI 10.1038/22788; Cortes J, 2004, HEMATOL ONCOL CLIN N, V18, P671, DOI 10.1016/j.hoc.2004.03.012; Dobles M, 2000, CELL, V101, P635, DOI 10.1016/S0092-8674(00)80875-2; DRUKER BJ, 2001, NEW ENGL J MED, V344, P1037; Felsher DW, 1999, MOL CELL, V4, P199, DOI 10.1016/S1097-2765(00)80367-6; Fisher GH, 2001, GENE DEV, V15, P3249, DOI 10.1101/gad.947701; Giuriato S, 2003, CELL CYCLE, V2, P329, DOI 10.4161/cc.2.4.415; Gorre ME, 2001, SCIENCE, V293, P876, DOI 10.1126/science.1062538; Hernando E, 2004, NATURE, V430, P797, DOI 10.1038/nature02820; Hochhaus A, 2002, LEUKEMIA, V16, P2190, DOI 10.1038/sj.leu.2402741; Jeganathan K, 2007, J CELL BIOL, V179, P255, DOI 10.1083/jcb.200706015; Kobayashi S, 2005, NEW ENGL J MED, V352, P786, DOI 10.1056/NEJMoa044238; Kwon M, 2008, GENE DEV, V22, P2189, DOI 10.1101/gad.1700908; Li M, 2007, MOL CELL BIOL, V27, P3481, DOI 10.1128/MCB.02088-06; O'Dwyer ME, 2002, BLOOD, V100, P1628, DOI 10.1182/blood-2002-03-0777; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Perez de Castro I, 2007, CARCINOGENESIS, V28, P899, DOI 10.1093/carcin/bgm019; Politi K, 2006, GENE DEV, V20, P1496, DOI 10.1101/gad.1417406; Rao CV, 2005, P NATL ACAD SCI USA, V102, P4365, DOI 10.1073/pnas.0407822102; Ricke RM, 2008, TRENDS GENET, V24, P457, DOI 10.1016/j.tig.2008.07.002; Schvartzman JM, 2010, NAT REV CANCER, V10, P102, DOI 10.1038/nrc2781; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Tichelaar JW, 2000, J BIOL CHEM, V275, P11858, DOI 10.1074/jbc.275.16.11858; Weaver BAA, 2007, CANCER CELL, V11, P25, DOI 10.1016/j.ccr.2006.12.003; Weinstein IB, 2006, NAT CLIN PRACT ONCOL, V3, P448, DOI 10.1038/ncponc0558	28	195	199	0	20	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 18	2010	464	7287					436	U138		10.1038/nature08803	http://dx.doi.org/10.1038/nature08803			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	570FG	20173739	Green Accepted			2022-12-01	WOS:000275657100052
J	Chandrashekar, J; Kuhn, C; Oka, Y; Yarmolinsky, DA; Hummler, E; Ryba, NJP; Zuker, CS				Chandrashekar, Jayaram; Kuhn, Christina; Oka, Yuki; Yarmolinsky, David A.; Hummler, Edith; Ryba, Nicholas J. P.; Zuker, Charles S.			The cells and peripheral representation of sodium taste in mice	NATURE			English	Article							SINGLE CHORDA TYMPANI; GLOSSOPHARYNGEAL NERVE; RECEPTOR-CELLS; BITTER TASTE; SALT TASTE; AMILORIDE; CHANNEL; MOUSE; NACL; RAT	Salt taste in mammals can trigger two divergent behavioural responses. In general, concentrated saline solutions elicit robust behavioural aversion, whereas low concentrations of NaCl are typically attractive, particularly after sodium depletion(1-5). Notably, the attractive salt pathway is selectively responsive to sodium and inhibited by amiloride, whereas the aversive one functions as a nonselective detector for a wide range of salts(1-3,6-9). Because amiloride is a potent inhibitor of the epithelial sodium channel (ENaC), ENaC has been proposed to function as a component of the salt-taste-receptor system(1,3,6-14). Previously, we showed that four of the five basic taste qualities-sweet, sour, bitter and umami-are mediated by separate taste-receptor cells (TRCs) each tuned to a single taste modality, and wired to elicit stereotypical behavioural responses(5,15-18). Here we show that sodium sensing is also mediated by a dedicated population of TRCs. These taste cells express the epithelial sodium channel ENaC19,20, and mediate behavioural attraction to NaCl. We genetically engineered mice lacking ENaC alpha in TRCs, and produced animals exhibiting a complete loss of salt attraction and sodium taste responses. Together, these studies substantiate independent cellular substrates for all five basic taste qualities, and validate the essential role of ENaC for sodium taste in mice.	[Chandrashekar, Jayaram; Oka, Yuki; Yarmolinsky, David A.; Zuker, Charles S.] Univ Calif San Diego, Howard Hughes Med Inst, La Jolla, CA 92093 USA; [Chandrashekar, Jayaram; Oka, Yuki; Yarmolinsky, David A.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurobiol, La Jolla, CA 92093 USA; [Chandrashekar, Jayaram; Oka, Yuki; Yarmolinsky, David A.; Zuker, Charles S.] Univ Calif San Diego, Dept Neurosci, La Jolla, CA 92093 USA; [Kuhn, Christina; Ryba, Nicholas J. P.] Natl Inst Dent & Craniofacial Res, NIH, Bethesda, MD 20892 USA; [Hummler, Edith] Univ Lausanne, Fac Biol & Med, Dept Pharmacol & Toxicol, CH-1005 Lausanne, Switzerland	Howard Hughes Medical Institute; University of California System; University of California San Diego; University of California System; University of California San Diego; University of California System; University of California San Diego; National Institutes of Health (NIH) - USA; NIH National Institute of Dental & Craniofacial Research (NIDCR); University of Lausanne	Zuker, CS (corresponding author), Columbia Univ, Columbia Coll Phys & Surg, Howard Hughes Med Inst, Dept Biochem, New York, NY 10032 USA.	cz2195@columbia.edu		Ryba, Nicholas/0000-0002-2060-8393; Chandrashekar, jayaram/0000-0001-6412-0114; Oka, Yuki/0000-0003-2686-0677	NIH, NIDCR; NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH [ZIADE000561] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC003160] Funding Source: NIH RePORTER	NIH, NIDCR(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE OF DENTAL & CRANIOFACIAL RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Dental & Craniofacial Research (NIDCR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))	We thank W. Guo and A. Becker for generation and maintenance of mouse lines, and K. Scott and members of our laboratories for valuable comments. This research was supported in part by the intramural research program of the NIH, NIDCR (N.J.P.R.). C.S.Z. is an investigator of the Howard Hughes Medical Institute.	BEAUCHAMP GK, 1990, AM J CLIN NUTR, V51, P881, DOI 10.1093/ajcn/51.5.881; CANESSA CM, 1994, NATURE, V367, P463, DOI 10.1038/367463a0; Chandrashekar J, 2009, SCIENCE, V326, P443, DOI 10.1126/science.1174601; Contreras RJ, 1989, NEURAL MECHANISMS TA, P119; DETHIER VG, 1977, AM SCI, V65, P744; Doolin RE, 1996, J GEN PHYSIOL, V107, P545, DOI 10.1085/jgp.107.4.545; DUNCAN C. J., 1962, PHYSIOL ZOOL, V35, P120; Eylam S, 2005, AM J PHYSIOL-REG I, V288, pR1361, DOI 10.1152/ajpregu.00796.2004; FRANK ME, 1991, J NEUROPHYSIOL, V65, P1452, DOI 10.1152/jn.1991.65.6.1452; Halpern BP, 1998, NEUROSCI BIOBEHAV R, V23, P5, DOI 10.1016/S0149-7634(97)00063-8; HECK GL, 1984, SCIENCE, V223, P403, DOI 10.1126/science.6691151; Hellekant G, 1997, J NEUROPHYSIOL, V77, P978, DOI 10.1152/jn.1997.77.2.978; HELLEKANT G, 1994, PHYSIOL BEHAV, V56, P1185, DOI 10.1016/0031-9384(94)90364-6; HETTINGER TP, 1990, BRAIN RES, V513, P24, DOI 10.1016/0006-8993(90)91085-U; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; Hummler E, 2000, J AM SOC NEPHROL, V11, pS129; Hummler E, 2002, GENESIS, V32, P169, DOI 10.1002/gene.10041; Kretz O, 1999, J HISTOCHEM CYTOCHEM, V47, P51, DOI 10.1177/002215549904700106; Lindemann B, 2001, NATURE, V413, P219, DOI 10.1038/35093032; Mueller KL, 2005, NATURE, V434, P225, DOI 10.1038/nature03352; Nelson G, 2002, NATURE, V416, P199, DOI 10.1038/nature726; Ninomiya Y, 1998, P NATL ACAD SCI USA, V95, P5347, DOI 10.1073/pnas.95.9.5347; Oka Y, 2006, NEURON, V52, P857, DOI 10.1016/j.neuron.2006.10.019; SCHIFFMAN SS, 1983, P NATL ACAD SCI-BIOL, V80, P6136, DOI 10.1073/pnas.80.19.6136; Strazzullo P, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b4567; Vandenbeuch A, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-1; Yarmolinsky DA, 2009, CELL, V139, P234, DOI 10.1016/j.cell.2009.10.001; Yoshida R, 2009, NEUROSCIENCE, V159, P795, DOI 10.1016/j.neuroscience.2008.12.052; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0; Zhao GQ, 2003, CELL, V115, P255, DOI 10.1016/S0092-8674(03)00844-4	30	405	424	11	190	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					297	U182		10.1038/nature08783	http://dx.doi.org/10.1038/nature08783			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20107438	Green Accepted			2022-12-01	WOS:000275366100051
J	Koff, WC				Koff, Wayne C.			Accelerating HIV vaccine development	NATURE			English	Editorial Material							PROTECTION; CHALLENGE; DESIGN; GP120; BROAD		Int AIDS Vaccine Initiat, New York, NY 10038 USA	International AIDS Vaccine Initiative	Koff, WC (corresponding author), Int AIDS Vaccine Initiat, 110 William St,27th Floor, New York, NY 10038 USA.	wkoff@iavi.org						Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Haase AT, 2010, NATURE, V464, P217, DOI 10.1038/nature08757; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; *HIV VACC MICR RES, 2009, AD REAL TRENDS HIV P; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; KOSMRLJ A, NATURE IN PRESS; Miura T, 2009, J VIROL, V83, P3407, DOI 10.1128/JVI.02459-08; Pancera M, 2010, P NATL ACAD SCI USA, V107, P1166, DOI 10.1073/pnas.0911004107; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Simek MD, 2009, J VIROL, V83, P7337, DOI 10.1128/JVI.00110-09; Stamatatos L, 2009, NAT MED, V15, P866, DOI 10.1038/nm.1949; Virgin HW, 2010, NATURE, V464, P224, DOI 10.1038/nature08898; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746	15	22	25	0	0	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	MAR 11	2010	464	7286					161	162		10.1038/464161a	http://dx.doi.org/10.1038/464161a			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	566JO	20220821				2022-12-01	WOS:000275366100017
J	Virgin, HW; Walker, BD				Virgin, Herbert W.; Walker, Bruce D.			Immunology and the elusive AIDS vaccine	NATURE			English	Article							SIMIAN IMMUNODEFICIENCY VIRUS; T-CELL RESPONSES; HIV-1 INFECTION; NEUTRALIZING ANTIBODIES; LYMPHOCYTE ESCAPE; IMMUNE CONTROL; MACAQUE MODEL; B-CELLS; REPLICATION; PROTECTION	Developing a human immunodeficiency virus (HIV) vaccine is critical to end the global acquired immunodeficiency syndrome (AIDS) epidemic, but many question whether this goal is achievable. Natural immunity is not protective, and despite immunogenicity of HIV vaccine candidates, human trials have exclusively yielded disappointing results. Nevertheless, there is an indication that success may be possible, but this will be dependent on understanding the antiviral immune response in unprecedented depth to identify and engineer the types of immunity required. Here we outline fundamental immunological questions that need to be answered to develop a protective HIV vaccine, and the immediate need to harness a much broader scientific community to achieve this goal.	[Virgin, Herbert W.] Washington Univ, Sch Med, St Louis, MO 63110 USA; [Virgin, Herbert W.] Washington Univ, Midwest Reg Ctr Excellence Biodef & Emerging Infe, St Louis, MO 63110 USA; [Walker, Bruce D.] Massachusetts Gen Hosp, MIT, Ragon Inst, Charlestown, MA 02129 USA; [Walker, Bruce D.] Harvard Univ, Howard Hughes Med Inst, Charlestown, MA 02129 USA	Washington University (WUSTL); Washington University (WUSTL); Harvard University; Massachusetts General Hospital; Massachusetts Institute of Technology (MIT); Ragon Institute; Harvard University; Howard Hughes Medical Institute	Virgin, HW (corresponding author), Washington Univ, Sch Med, Campus Box 8118,660 S Euclid Ave, St Louis, MO 63110 USA.	virgin@wustl.edu; bwalker@partners.org		Virgin, Herbert/0000-0001-8580-7628	National Institutes of Health; Bill and Melinda Gates Foundation; Mark and Lisa Schwartz Foundation	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Bill and Melinda Gates Foundation(Bill & Melinda Gates Foundation); Mark and Lisa Schwartz Foundation	We would like to acknowledge, while accepting full responsibility for the content and opinions expressed, open discussions and correspondence with: M. Altfeld, D. Brooks, D. Burton, M. Colonna, L. Corey, B. Beutler, D. Barouch, A. Chakraborty, F. Chisari, R. Desrosiers, M. Diamond, A. Garcia-Sastre, L. Glimcher, P. Goulder, H. Greenberg, A. Haase, K. Hasenkrug, B. Haynes, M. Hirsch, S. Abdool-Karim, W. Koff, B. Lamb, J. Lifson, J. Loh, R. Medzhitov, J. Moore, M. Nussenzweig, M. Oldstone, L. Picker, B. Roizman, R. Siliciano, G. Silvestri, S. Wain-Hobson, D. Watkins, R. Weiss, J. Wherry and O. Yang. This work was supported by grants from the National Institutes of Health (H. W. V. and B. D. W.), the Bill and Melinda Gates Foundation (B. D. W.), and a gift from the Mark and Lisa Schwartz Foundation (B. D. W.).	Allen TM, 2004, J VIROL, V78, P7069, DOI 10.1128/JVI.78.13.7069-7078.2004; Altfeld M, 2002, NATURE, V420, P434, DOI 10.1038/nature01200; Araki K, 2009, NATURE, V460, P108, DOI 10.1038/nature08155; Barber DL, 2006, NATURE, V439, P682, DOI 10.1038/nature04444; Barton ES, 2007, NATURE, V447, P326, DOI 10.1038/nature05762; Blazkova J, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000554; Brenchley JM, 2006, NAT MED, V12, P1365, DOI 10.1038/nm1511; Brooks DG, 2008, J EXP MED, V205, P533, DOI 10.1084/jem.20071948; Brooks DG, 2008, P NATL ACAD SCI USA, V105, P20428, DOI 10.1073/pnas.0811139106; Brumme ZL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006687; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; Bushman FD, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000437; Chachu KA, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000236; Chen H, 2009, J VIROL, V83, P3138, DOI 10.1128/JVI.02073-08; Chen L, 2009, SCIENCE, V326, P1123, DOI 10.1126/science.1175868; Chung C, 2007, J VIROL, V81, P1517, DOI 10.1128/JVI.01780-06; Cohen MS, 2008, J CLIN INVEST, V118, P1244, DOI 10.1172/JCI34706; Day CL, 2006, NATURE, V443, P350, DOI 10.1038/nature05115; Deeks SG, 2007, IMMUNITY, V27, P406, DOI 10.1016/j.immuni.2007.08.010; Derdeyn CA, 2004, SCIENCE, V303, P2019, DOI 10.1126/science.1093137; Dinoso JB, 2009, J VIROL, V83, P9247, DOI 10.1128/JVI.00840-09; Douek DC, 2002, NATURE, V417, P95, DOI 10.1038/417095a; Draenert R, 2006, J EXP MED, V203, P529, DOI 10.1084/jem.20052116; Duvall MG, 2006, J IMMUNOL, V176, P6973, DOI 10.4049/jimmunol.176.11.6973; Elsaesser H, 2009, SCIENCE, V324, P1569, DOI 10.1126/science.1174182; Fauci AS, 2008, SCIENCE, V321, P530, DOI 10.1126/science.1161000; FIELDS BN, 1994, NATURE, V369, P95, DOI 10.1038/369095a0; Finkbeiner SR, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000011; Fischer W, 2007, NAT MED, V13, P100, DOI 10.1038/nm1461; Fowke KR, 1996, LANCET, V348, P1347, DOI 10.1016/S0140-6736(95)12269-2; Frohlich A, 2009, SCIENCE, V324, P1576, DOI 10.1126/science.1172815; Gebhardt T, 2009, NAT IMMUNOL, V10, P524, DOI 10.1038/ni.1718; Gilbert PB, 2005, J INFECT DIS, V191, P666, DOI 10.1086/428405; Goepfert PA, 2008, J EXP MED, V205, P1009, DOI 10.1084/jem.20072457; Goonetilleke N, 2009, J EXP MED, V206, P1253, DOI 10.1084/jem.20090365; Ha SJ, 2008, J EXP MED, V205, P543, DOI 10.1084/jem.20071949; Hansen SG, 2009, NAT MED, V15, P293, DOI 10.1038/nm.1935; HASENKRUG KJ, 1995, P NATL ACAD SCI USA, V92, P10492, DOI 10.1073/pnas.92.23.10492; Hasenkrug KJ, 1998, J VIROL, V72, P6559, DOI 10.1128/JVI.72.8.6559-6564.1998; Hatziioannou T, 2009, P NATL ACAD SCI USA, V106, P4425, DOI 10.1073/pnas.0812587106; Hessell AJ, 2007, NATURE, V449, P101, DOI 10.1038/nature06106; Hessell AJ, 2009, NAT MED, V15, P951, DOI 10.1038/nm.1974; Hessell AJ, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000433; Hubner W, 2009, SCIENCE, V323, P1743, DOI 10.1126/science.1167525; Ivanov II, 2009, CELL, V139, P485, DOI 10.1016/j.cell.2009.09.033; Johnson PR, 2009, NAT MED, V15, P901, DOI 10.1038/nm.1967; Kaufman DR, 2008, J IMMUNOL, V181, P4188, DOI 10.4049/jimmunol.181.6.4188; Kaufmann DE, 2007, NAT IMMUNOL, V8, P1246, DOI 10.1038/ni1515; Keele BF, 2008, P NATL ACAD SCI USA, V105, P7552, DOI 10.1073/pnas.0802203105; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Klatt NR, 2008, J CLIN INVEST, V118, P2039, DOI 10.1172/JCI33814; Korber BT, 2009, J VIROL, V83, P8300, DOI 10.1128/JVI.00114-09; KRONER BL, 1994, J ACQ IMMUN DEF SYND, V7, P279; Kwong PD, 2009, NAT IMMUNOL, V10, P573, DOI 10.1038/ni.1746; Liu JY, 2009, NATURE, V457, P87, DOI 10.1038/nature07469; Lu W, 2004, NAT MED, V10, P1359, DOI 10.1038/nm1147; Lund JM, 2008, SCIENCE, V320, P1220, DOI 10.1126/science.1155209; Martin MP, 2007, NAT GENET, V39, P733, DOI 10.1038/ng2035; MATLOUBIAN M, 1994, J VIROL, V68, P8056, DOI 10.1128/JVI.68.12.8056-8063.1994; McClellan KB, 2006, PLOS PATHOG, V2, P578, DOI 10.1371/journal.ppat.0020058; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; McKenna P, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040020; Mehlhop E, 2005, J VIROL, V79, P7466, DOI 10.1128/JVI.79.12.7466-7477.2005; Messer RJ, 2004, P NATL ACAD SCI USA, V101, P12260, DOI 10.1073/pnas.0404769101; Miura T, 2009, J VIROL, V83, P2743, DOI 10.1128/JVI.02265-08; Moir S, 2008, J EXP MED, V205, P1797, DOI 10.1084/jem.20072683; Moir S, 2009, NAT REV IMMUNOL, V9, P235, DOI 10.1038/nri2524; Moore CB, 2002, SCIENCE, V296, P1439, DOI 10.1126/science.1069660; Nakanishi Y, 2009, NATURE, V462, P510, DOI 10.1038/nature08511; Neil S, 2009, J INTERF CYTOK RES, V29, P569, DOI 10.1089/jir.2009.0077; Nelson S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000060; Nix WA, 2008, J CLIN MICROBIOL, V46, P2874, DOI 10.1128/JCM.00074-08; Okoye A, 2009, J EXP MED, V206, P1575, DOI 10.1084/jem.20090356; Paovonen J, 2009, LANCET, V374, P301, DOI 10.1016/S0140-6736(09)61248-4; Petrovas C, 2006, J EXP MED, V203, P2281, DOI 10.1084/jem.20061496; Pike R, 2009, J VIROL, V83, P11211, DOI 10.1128/JVI.01225-09; Querec TD, 2009, NAT IMMUNOL, V10, P116, DOI 10.1038/ni.1688; Rerks-Ngarm S, 2009, NEW ENGL J MED, V361, P2209, DOI 10.1056/NEJMoa0908492; Salazar-Gonzalez JF, 2009, J EXP MED, V206, P1273, DOI 10.1084/jem.20090378; Santiago ML, 2008, SCIENCE, V321, P1343, DOI 10.1126/science.1161121; Scheid JF, 2009, NATURE, V458, P636, DOI 10.1038/nature07930; Schneidewind A, 2008, J VIROL, V82, P5594, DOI 10.1128/JVI.02356-07; Schneidewind A, 2009, J VIROL, V83, P3993, DOI 10.1128/JVI.01108-08; Sheehy AM, 2003, NAT MED, V9, P1404, DOI 10.1038/nm945; Sheehy AM, 2002, NATURE, V418, P646, DOI 10.1038/nature00939; Slack E, 2009, SCIENCE, V325, P617, DOI 10.1126/science.1172747; Sodora DL, 2009, NAT MED, V15, P861, DOI 10.1038/nm.2013; Tibbetts SA, 2002, J VIROL, V76, P7125, DOI 10.1128/JVI.76.14.7125-7132.2002; Tinoco R, 2009, IMMUNITY, V31, P145, DOI 10.1016/j.immuni.2009.06.015; Trautmann L, 2006, NAT MED, V12, P1198, DOI 10.1038/nm1482; Troyer RM, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000365; TYLER KL, 1993, J VIROL, V67, P3446, DOI 10.1128/JVI.67.6.3446-3453.1993; Velu V, 2009, NATURE, V458, P206, DOI 10.1038/nature07662; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Virgin HW, 2009, CELL, V138, P30, DOI 10.1016/j.cell.2009.06.036; Walker LM, 2009, SCIENCE, V326, P285, DOI 10.1126/science.1178746; Wilson NA, 2009, J VIROL, V83, P6508, DOI 10.1128/JVI.00272-09; Wyand MS, 1999, J VIROL, V73, P8356, DOI 10.1128/JVI.73.10.8356-8363.1999; Yi JS, 2009, SCIENCE, V324, P1572, DOI 10.1126/science.1175194; Zhang JX, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002035; Zhu J, 2007, J EXP MED, V204, P595, DOI 10.1084/jem.20061792	101	133	136	0	12	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 11	2010	464	7286					224	231		10.1038/nature08898	http://dx.doi.org/10.1038/nature08898			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	566JO	20220841				2022-12-01	WOS:000275366100036
J	Wang, D; Griffitts, J; Starker, C; Fedorova, E; Limpens, E; Ivanov, S; Bisseling, T; Long, SR				Wang, Dong; Griffitts, Joel; Starker, Colby; Fedorova, Elena; Limpens, Erik; Ivanov, Sergey; Bisseling, Ton; Long, Sharon			A Nodule-Specific Protein Secretory Pathway Required for Nitrogen-Fixing Symbiosis	SCIENCE			English	Article							SIGNAL PEPTIDASE ACTIVITY; MEDICAGO-TRUNCATULA; ROOT-NODULES; ENDOPLASMIC-RETICULUM; GENE-EXPRESSION; MEMBRANE; FIXATION; MUTANTS; DEFINE; PLANT	The nitrogen-fixing symbiosis between Sinorhizobium meliloti and its leguminous host plant Medicago truncatula occurs in a specialized root organ called the nodule. Bacteria that are released into plant cells are surrounded by a unique plant membrane compartment termed a symbiosome. We found that in the symbiosis-defective dnf1 mutant of M. truncatula, bacteroid and symbiosome development are blocked. We identified the DNF1 gene as encoding a subunit of a signal peptidase complex that is highly expressed in nodules. By analyzing data from whole-genome expression analysis, we propose that correct symbiosome development in M. truncatula requires the orderly secretion of protein constituents through coordinated up-regulation of a nodule-specific pathway exemplified by DNF1.	[Wang, Dong; Griffitts, Joel; Starker, Colby; Long, Sharon] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Fedorova, Elena; Limpens, Erik; Ivanov, Sergey; Bisseling, Ton] Wageningen Univ, Grad Sch Expt Plant Sci, Mol Biol Lab, NL-6708 PB Wageningen, Netherlands; [Fedorova, Elena; Ivanov, Sergey] Russian Acad Sci, KA Timiryazev Plant Physiol Inst, Moscow 127392, Russia	Stanford University; Wageningen University & Research; Russian Academy of Sciences; Timiryazev Institute of Plant Physiology	Long, SR (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	SRL@stanford.edu	Bisseling, Ton/A-2421-2013; Fedorova, Elena Erika/U-1069-2017	Ivanov, Sergey/0000-0002-4191-3928; Starker, Colby/0000-0002-6774-7227; Fedorova, Elena/0000-0003-3953-1282	Helen Hay Whitney Foundation; National Institutes of Health; Netherlands Organisation for Scientific Research (NWO); Hoover Circle fund; Howard Hughes Medical Institute; U.S. Department of Energy [DE-FG03-90ER20010]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM093628] Funding Source: NIH RePORTER	Helen Hay Whitney Foundation; National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Netherlands Organisation for Scientific Research (NWO)(Netherlands Organization for Scientific Research (NWO)); Hoover Circle fund; Howard Hughes Medical Institute(Howard Hughes Medical Institute); U.S. Department of Energy(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We thank D. Ehrhardt for assistance with confocal microscope and E. Kondorosi, P. Mergaert, and W. Van de Velde for critical reviews of the manuscript and for sharing unpublished results. This work was supported by the Helen Hay Whitney Foundation (to J.G.), a National Institutes of Health training grant (to C. S.), The Netherlands Organisation for Scientific Research (NWO, to E. L., S. I., E. F., and T. B.), the Hoover Circle fund, and prior support from the Howard Hughes Medical Institute and the U.S. Department of Energy grant no. DE-FG03-90ER20010 (to S. R. L.).	Benedito VA, 2008, PLANT J, V55, P504, DOI 10.1111/j.1365-313X.2008.03519.x; Catalano CM, 2007, PLANTA, V225, P541, DOI 10.1007/s00425-006-0369-y; Catalano CM, 2004, ELECTROPHORESIS, V25, P519, DOI 10.1002/elps.200305711; Coque L, 2008, MOL PLANT MICROBE IN, V21, P404, DOI 10.1094/MPMI-21-4-0404; Dalbey RE, 1997, PROTEIN SCI, V6, P1129, DOI 10.1002/pro.5560060601; de Graaf BHJ, 2005, PLANT CELL, V17, P2564, DOI 10.1105/tpc.105.033183; Du YR, 2004, J CELL SCI, V117, P2871, DOI 10.1242/jcs.01286; El Yahyaoui F, 2004, PLANT PHYSIOL, V136, P3159, DOI 10.1104/pp.104.043612; Fang H, 1997, J BIOL CHEM, V272, P13152, DOI 10.1074/jbc.272.20.13152; Limpens E, 2009, PLANT CELL, V21, P2811, DOI 10.1105/tpc.108.064410; Manthey K, 2004, MOL PLANT MICROBE IN, V17, P1063, DOI 10.1094/MPMI.2004.17.10.1063; Mergaert P, 2003, PLANT PHYSIOL, V132, P161, DOI 10.1104/pp.102.018192; Meyer HA, 1997, J BIOL CHEM, V272, P13159, DOI 10.1074/jbc.272.20.13159; Mitra RM, 2004, P NATL ACAD SCI USA, V101, P4701, DOI 10.1073/pnas.0400595101; Mitra RM, 2004, PLANT PHYSIOL, V134, P595, DOI 10.1104/pp.103.031518; Paetzel M, 2002, CHEM REV, V102, P4549, DOI 10.1021/cr010166y; RAIKHEL N, 2000, BIOCH MOL BIOL PLANT, P160; Starker CG, 2006, PLANT PHYSIOL, V140, P671, DOI 10.1104/pp.105.072132; Thompson AR, 2005, CURR OPIN PLANT BIOL, V8, P165, DOI 10.1016/j.pbi.2005.01.013; VASSE J, 1990, J BACTERIOL, V172, P4295, DOI 10.1128/jb.172.8.4295-4306.1990	20	179	191	4	67	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1126	1129		10.1126/science.1184096	http://dx.doi.org/10.1126/science.1184096			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185723	Green Accepted			2022-12-01	WOS:000274901100035
J	Kapur, NA				Kapur, Nitin Agrawal			Doppelganger	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material												nitin.kapur@yale.edu							0	1	1	0	0	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	FEB 24	2010	303	8					711	712		10.1001/jama.2010.173	http://dx.doi.org/10.1001/jama.2010.173			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	559DD	20179274				2022-12-01	WOS:000274800000001
J	Horton, R				Horton, Richard			Offline: AIDS is not zero sum	LANCET			English	Editorial Material									The Lancet, London NW1 7BY, England		Horton, R (corresponding author), The Lancet, London NW1 7BY, England.								0	0	0	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	0140-6736			LANCET	Lancet	FEB 20	2010	375	9715					624	624		10.1016/S0140-6736(10)60244-9	http://dx.doi.org/10.1016/S0140-6736(10)60244-9			1	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	564JT	20171387				2022-12-01	WOS:000275210900011
J	Macdonald, H				Macdonald, Helen			Emergency Medicine Doctors on the front line	BRITISH MEDICAL JOURNAL			English	News Item												hmacdonald@bmj.com						[Anonymous], TRAUM WHO CAR	1	2	2	0	1	B M J PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0959-535X			BRIT MED J	Br. Med. J.	FEB 18	2010	340								c379	10.1136/bmj.c379	http://dx.doi.org/10.1136/bmj.c379			4	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	558JV	20167646				2022-12-01	WOS:000274739000002
J	Barr, RG; Bluemke, DA; Ahmed, FS; Carr, JJ; Enright, PL; Hoffman, EA; Jiang, R; Kawut, SM; Kronmal, RA; Lima, JAC; Shahar, E; Smith, LJ; Watson, KE				Barr, R. Graham; Bluemke, David A.; Ahmed, Firas S.; Carr, J. Jeffery; Enright, Paul L.; Hoffman, Eric A.; Jiang, Rui; Kawut, Steven M.; Kronmal, Richard A.; Lima, Joao A. C.; Shahar, Eyal; Smith, Lewis J.; Watson, Karol E.			Percent Emphysema, Airflow Obstruction, and Impaired Left Ventricular Filling	NEW ENGLAND JOURNAL OF MEDICINE			English	Article							PULMONARY BLOOD-FLOW; CHRONIC COR-PULMONALE; RAY CT IMAGES; ATHEROSCLEROSIS MESA; MYOCARDIAL MASS; LUNG-DISEASE; CARDIAC CT; MILD COPD; HYPERTENSION; SMOKERS	BACKGROUND Very severe chronic obstructive pulmonary disease causes cor pulmonale with elevated pulmonary vascular resistance and secondary reductions in left ventricular filling, stroke volume, and cardiac output. We hypothesized that emphysema, as detected on computed tomography (CT), and airflow obstruction are inversely related to left ventricular end-diastolic volume, stroke volume, and cardiac output among persons without very severe lung disease. METHODS We measured left ventricular structure and function with the use of magnetic resonance imaging in 2816 persons who were 45 to 84 years of age. The extent of emphysema (expressed as percent emphysema) was defined as the percentage of voxels below -910 Hounsfield units in the lung windows on cardiac computed tomographic scans. Spirometry was performed according to American Thoracic Society guidelines. Generalized additive models were used to test for threshold effects. RESULTS Of the study participants, 13% were current smokers, 38% were former smokers, and 49% had never smoked. A 10-point increase in percent emphysema was linearly related to reductions in left ventricular end-diastolic volume (-4.1 ml; 95% confidence interval [CI], -3.3 to -4.9; P<0.001), stroke volume (-2.7 ml; 95% CI, -2.2 to -3.3; P<0.001), and cardiac output (-0.19 liters per minute; 95% CI, -0.14 to -0.23; P<0.001). These associations were of greater magnitude among current smokers than among former smokers and those who had never smoked. The extent of airflow obstruction was similarly associated with left ventricular structure and function, and smoking status had similar modifying effects on these associations. Percent emphysema and airflow obstruction were not associated with the left ventricular ejection fraction. CONCLUSIONS In a population-based study, a greater extent of emphysema on CT scanning and more severe airflow obstruction were linearly related to impaired left ventricular filling, reduced stroke volume, and lower cardiac output without changes in the ejection fraction.	[Barr, R. Graham; Ahmed, Firas S.; Jiang, Rui] Columbia Univ, Dept Med, Coll Phys & Surg, New York, NY 10032 USA; [Barr, R. Graham; Jiang, Rui] Columbia Univ, Mailman Sch Publ Hlth, Dept Epidemiol, New York, NY 10032 USA; [Bluemke, David A.] NIH, Dept Radiol & Imaging Sci, Ctr Clin, Bethesda, MD 20892 USA; [Carr, J. Jeffery] Wake Forest Univ, Dept Radiol, Winston Salem, NC 27109 USA; [Enright, Paul L.; Shahar, Eyal] Univ Arizona, Div Epidemiol & Biostat, Tucson, AZ USA; [Hoffman, Eric A.] Univ Iowa, Dept Radiol, Iowa City, IA 52242 USA; [Kawut, Steven M.] Univ Penn, Sch Med, Penn Cardiovasc Inst, Ctr Clin Epidemiol & Biostat, Philadelphia, PA 19104 USA; [Kawut, Steven M.] Univ Penn, Sch Med, Dept Med, Philadelphia, PA 19104 USA; [Kronmal, Richard A.] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Lima, Joao A. C.] Johns Hopkins Univ, Dept Med, Baltimore, MD USA; [Lima, Joao A. C.] Johns Hopkins Univ, Dept Radiol, Baltimore, MD USA; [Smith, Lewis J.] Northwestern Univ, Dept Med, Chicago, IL 60611 USA; [Watson, Karol E.] Univ Calif Los Angeles, Dept Med, Los Angeles, CA 90024 USA	Columbia University; Columbia University; National Institutes of Health (NIH) - USA; NIH Clinical Center (CC); Wake Forest University; University of Arizona; University of Iowa; University of Pennsylvania; Pennsylvania Medicine; University of Pennsylvania; University of Washington; University of Washington Seattle; Johns Hopkins University; Johns Hopkins University; Northwestern University; University of California System; University of California Los Angeles	Barr, RG (corresponding author), Columbia Univ, Med Ctr, Div Gen Med, 630 W 168th St,PH 9 E,Rm 105, New York, NY 10032 USA.	rgb9@columbia.edu	Carr, John Jeffrey/A-1938-2012; Watson, Karol/ABD-7425-2021; Carr, John/AAN-7531-2021; Bluemke, David/GYU-8169-2022	Carr, John Jeffrey/0000-0002-4398-8237; Carr, John/0000-0002-4398-8237; Bluemke, David/0000-0002-8323-8086; Smith, Lewis J/0000-0002-4728-1562; Hoffman, Eric/0000-0001-8456-9437	National Heart, Lung, and Blood Institute [N01-HC95159, N01HC95169]; Pfizer; Toshiba Medical Systems and General Electric;  [R01-HL077612];  [R01-HL075476];  [R01-HL093081];  [UL1-RR02415]; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS [N01HC095169, N01HC095166, N01HC095163, N01HC095164, N01HC095165, N01HC095162, N01HC095161, N01HC095167, N01HC095160, N01HC095168, N01HC095159] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR002415] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R43HL095169, R01HL075476, R01HL077612, R01HL093081, R44HL095169, R01HL086719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [ZIAEB000072] Funding Source: NIH RePORTER; CLINICAL CENTER [ZIACL090019] Funding Source: NIH RePORTER	National Heart, Lung, and Blood Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); Pfizer(Pfizer); Toshiba Medical Systems and General Electric(General Electric); ; ; ; ; DIVISION OF EPIDEMIOLOGY AND CLINICAL APPLICATIONS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); CLINICAL CENTER	Supported by grants (R01-HL077612, R01-HL075476, and R01-HL093081) and contracts (N01-HC95159 through N01HC95169) from the National Heart, Lung, and Blood Institute, with additional support from UL1-RR02415.; Dr. Enright reports receiving consulting fees from Pfizer and Gilead; Dr. Hoffman, having equity ownership in and being a founder of VIDA Diagnostics and receiving lecture fees from Sanofi-Aventis, AstraZeneca, and Chiesi Pharmaceuticals; Dr. Kawut, receiving grant support from Pfizer; Dr. Lima, receiving grant support from Toshiba Medical Systems and General Electric; and Dr. Smith, receiving consulting fees from Merck and KarmelSonix. No other potential conflict of interest relevant to this article was reported.	[Anonymous], 2008, MESA MAN OP FIELD CT; BARBERA JA, 1994, AM J RESP CRIT CARE, V149, P423, DOI 10.1164/ajrccm.149.2.8306040; Barbera JA, 2003, EUR RESPIR J, V21, P892, DOI 10.1183/09031936.03.00115402; Barr RG, 2007, AM J RESP CRIT CARE, V176, P1200, DOI 10.1164/rccm.200707-980OC; BAUM GL, 1971, NEW ENGL J MED, V285, P361, DOI 10.1056/NEJM197108122850701; Bertoni AG, 2009, AM J EPIDEMIOL, V169, P444, DOI 10.1093/aje/kwn350; Bild DE, 2002, AM J EPIDEMIOL, V156, P871, DOI 10.1093/aje/kwf113; Boussuges A, 2000, AM J RESP CRIT CARE, V162, P670, DOI 10.1164/ajrccm.162.2.9908056; Bristow J D, 1966, Prog Cardiovasc Dis, V9, P239, DOI 10.1016/S0033-0620(66)80026-9; BUDA AJ, 1979, NEW ENGL J MED, V301, P453, DOI 10.1056/NEJM197908303010901; BURROWS B, 1972, NEW ENGL J MED, V286, P912, DOI 10.1056/NEJM197204272861703; CABANES LR, 1989, NEW ENGL J MED, V320, P1317, DOI 10.1056/NEJM198905183202005; Capderou A, 2000, AM J RESP CRIT CARE, V162, P2073, DOI 10.1164/ajrccm.162.6.2005077; Carmo M M, 1994, Rev Port Cardiol, V13, P763; Carr JJ, 2005, RADIOLOGY, V234, P35, DOI 10.1148/radiol.2341040439; Celli BR, 2004, EUR RESPIR J, V23, P932, DOI 10.1183/09031936.04.00014304; Chaouat A, 2005, AM J RESP CRIT CARE, V172, P189, DOI 10.1164/rccm.200401-006OC; COXSON HO, 1995, J APPL PHYSIOL, V79, P1525, DOI 10.1152/jappl.1995.79.5.1525; Demedts IK, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-53; FAGGIANO P, 1993, CARDIOLOGY, V83, P30, DOI 10.1159/000175944; FISHMAN AP, 1976, AM REV RESPIR DIS, V114, P775; FRANK MJ, 1973, CIRCULATION, V47, P798, DOI 10.1161/01.CIR.47.4.798; Gan CTJ, 2006, AM J PHYSIOL-HEART C, V290, pH1528, DOI 10.1152/ajpheart.01031.2005; GLENNY RW, 1991, J APPL PHYSIOL, V71, P620, DOI 10.1152/jappl.1991.71.2.620; Guo J, 2002, 2002 IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING, PROCEEDINGS, P871, DOI 10.1109/ISBI.2002.1029398; HAKIM TS, 1987, J APPL PHYSIOL, V63, P1114, DOI 10.1152/jappl.1987.63.3.1114; Hankinson JL, 1999, AM J RESP CRIT CARE, V159, P179, DOI 10.1164/ajrccm.159.1.9712108; Hankinson JL, 2010, CHEST, V137, P138, DOI 10.1378/chest.09-0919; HARVEY RM, 1951, AM J MED, V10, P719, DOI 10.1016/0002-9343(51)90340-3; Heckbert SR, 2006, J AM COLL CARDIOL, V48, P2285, DOI 10.1016/j.jacc.2006.03.072; Hoffman EA, 2009, ACAD RADIOL, V16, P689, DOI 10.1016/j.acra.2008.12.024; Hu SY, 2001, IEEE T MED IMAGING, V20, P490, DOI 10.1109/42.929615; Jemal A, 2005, JAMA-J AM MED ASSOC, V294, P1255, DOI 10.1001/jama.294.10.1255; Jiang R, 2008, AM J EPIDEMIOL, V168, P602, DOI 10.1093/aje/kwn174; Jorgensen K, 2007, CHEST, V131, P1050, DOI 10.1378/chest.06-2245; Kasahara Y, 2001, AM J RESP CRIT CARE, V163, P737, DOI 10.1164/ajrccm.163.3.2002117; KATZ J, 1988, RADIOLOGY, V169, P495, DOI 10.1148/radiology.169.2.2971985; KELLER AM, 1986, J AM COLL CARDIOL, V8, P113, DOI 10.1016/S0735-1097(86)80100-0; KLINE LE, 1977, CHEST, V72, P558, DOI 10.1378/chest.72.5.558; Lichodziejewska B, 2007, CHEST, V131, P1142, DOI 10.1378/chest.06-2056; LIEBOW AA, 1959, AM REV RESPIR DIS, V80, P67; Macklem PT, 2006, EUR RESPIR REV, V15, P80, DOI 10.1183/09059180.00010005; MACNEE W, 1994, AM J RESP CRIT CARE, V150, P833, DOI 10.1164/ajrccm.150.3.8087359; MARZLUF BA, 2007, EUR RESPIR J, V30, pS608; Miller MR, 2005, EUR RESPIR J, V26, P319, DOI 10.1183/09031936.05.00034805; Natori S, 2006, AM J ROENTGENOL, V186, pS357, DOI 10.2214/AJR.04.1868; Noordegraaf AV, 1997, CHEST, V112, P640, DOI 10.1378/chest.112.3.640; Peinado VI, 1998, AM J PHYSIOL-LUNG C, V274, pL908, DOI 10.1152/ajplung.1998.274.6.L908; Petrache I, 2005, NAT MED, V11, P491, DOI 10.1038/nm1238; Rabe KF, 2007, AM J RESP CRIT CARE, V176, P532, DOI 10.1164/rccm.200703-456SO; Santos S, 2002, EUR RESPIR J, V19, P632, DOI 10.1183/09031936.02.00245902; Scharf SM, 2002, AM J RESP CRIT CARE, V166, P314, DOI 10.1164/rccm.2107027; STEELE P, 1975, AM J MED, V59, P21, DOI 10.1016/0002-9343(75)90317-4; Thabut G, 2005, CHEST, V127, P1531, DOI 10.1378/chest.127.5.1531; Tschirren J, 2005, IEEE T MED IMAGING, V24, P1540, DOI 10.1109/TMI.2005.857653; Vonk-Noordegraaf A, 2005, CHEST, V127, P1898, DOI 10.1378/chest.127.6.1898; Zhang L, 2006, IEEE T MED IMAGING, V25, P1, DOI 10.1109/TMI.2005.859209	57	388	401	0	26	MASSACHUSETTS MEDICAL SOC	WALTHAM	WALTHAM WOODS CENTER, 860 WINTER ST,, WALTHAM, MA 02451-1413 USA	0028-4793	1533-4406		NEW ENGL J MED	N. Engl. J. Med.	JAN 21	2010	362	3					217	227		10.1056/NEJMoa0808836	http://dx.doi.org/10.1056/NEJMoa0808836			11	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	545NE	20089972	Green Accepted			2022-12-01	WOS:000273738400008
J	Zhang, JJ; Baker, ML; Schroder, GF; Douglas, NR; Reissmann, S; Jakana, J; Dougherty, M; Fu, CJ; Levitt, M; Ludtke, SJ; Frydman, J; Chiu, W				Zhang, Junjie; Baker, Matthew L.; Schroeder, Gunnar F.; Douglas, Nicholai R.; Reissmann, Stefanie; Jakana, Joanita; Dougherty, Matthew; Fu, Caroline J.; Levitt, Michael; Ludtke, Steven J.; Frydman, Judith; Chiu, Wah			Mechanism of folding chamber closure in a group II chaperonin	NATURE			English	Article							PARTICLE ELECTRON CRYOMICROSCOPY; CRYSTAL-STRUCTURE; ARCHAEAL CHAPERONIN; MOLECULAR CHAPERONES; GROEL; RESOLUTION; PROTEIN; RECONSTRUCTION; AGGREGATION; STATE	Group II chaperonins are essential mediators of cellular protein folding in eukaryotes and archaea. These oligomeric protein machines, similar to 1 megadalton, consist of two back-to-back rings encompassing a central cavity that accommodates polypeptide substrates(1-3). Chaperonin-mediated protein folding is critically dependent on the closure of a built-in lid(4,5), which is triggered by ATP hydrolysis(6). The structural rearrangements and molecular events leading to lid closure are still unknown. Here we report four single particle cryo-electron microscopy (cryo-EM) structures of Mm-cpn, an archaeal group II chaperonin(5,7), in the nucleotide-free (open) and nucleotide-induced (closed) states. The 4.3 angstrom resolution of the closed conformation allowed building of the first ever atomic model directly from the single particle cryo-EM density map, in which we were able to visualize the nucleotide and more than 70% of the side chains. The model of the open conformation was obtained by using the deformable elastic network modelling with the 8 angstrom resolution open-state cryo-EM density restraints. Together, the open and closed structures show how local conformational changes triggered by ATP hydrolysis lead to an alteration of intersubunit contacts within and across the rings, ultimately causing a rocking motion that closes the ring. Our analyses show that there is an intricate and unforeseen set of interactions controlling allosteric communication and inter-ring signalling, driving the conformational cycle of group II chaperonins. Beyond this, we anticipate that our methodology of combining single particle cryo-EM and computational modelling will become a powerful tool in the determination of atomic details involved in the dynamic processes of macromolecular machines in solution.	[Zhang, Junjie; Ludtke, Steven J.; Chiu, Wah] Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA; [Zhang, Junjie; Baker, Matthew L.; Jakana, Joanita; Dougherty, Matthew; Fu, Caroline J.; Ludtke, Steven J.; Chiu, Wah] Baylor Coll Med, Natl Ctr Macromol Imaging, Verna & Marrs McLean Dept Biochem & Mol Biol, Houston, TX 77030 USA; [Schroeder, Gunnar F.; Levitt, Michael] Stanford Univ, Dept Biol Struct, Stanford, CA 94305 USA; [Douglas, Nicholai R.; Reissmann, Stefanie; Frydman, Judith] Stanford Univ, Dept Biol, Stanford, CA 94305 USA; [Douglas, Nicholai R.; Reissmann, Stefanie; Frydman, Judith] Stanford Univ, BioX Program, Stanford, CA 94305 USA	Baylor College of Medicine; Baylor College of Medicine; Stanford University; Stanford University; Stanford University	Chiu, W (corresponding author), Baylor Coll Med, Grad Program Struct & Computat Biol & Mol Biophys, Houston, TX 77030 USA.	jfrydman@stanford.edu; wah@bcm.edu	Zhang, Junjie/V-3855-2019; Schröder, Gunnar F/H-5261-2013; Levitt, Michael/E-4582-2012; Ludtke, Steven/A-4478-2008	Zhang, Junjie/0000-0002-7912-0819; Schröder, Gunnar F/0000-0003-1803-5431; Levitt, Michael/0000-0002-8414-7397; , judith/0000-0003-2302-6943; Ludtke, Steven/0000-0002-1903-1574; /0000-0003-3905-8085	National Institutes of Health through the Nanomedicine Development Center Roadmap Initiative; Biomedical Technology Research Center for Structural Biology in National Center for Research Resources; Nanobiology Training Fellowship; National Science Foundation; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR002250] Funding Source: NIH RePORTER; NATIONAL EYE INSTITUTE [PN2EY016525] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R90DK071504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM080139, R01GM079429, R01GM063817, T32GM007276] Funding Source: NIH RePORTER	National Institutes of Health through the Nanomedicine Development Center Roadmap Initiative(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Biomedical Technology Research Center for Structural Biology in National Center for Research Resources; Nanobiology Training Fellowship; National Science Foundation(National Science Foundation (NSF)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	We acknowledge the support of grants from the National Institutes of Health through the Nanomedicine Development Center Roadmap Initiative, Biomedical Technology Research Center for Structural Biology in National Center for Research Resources, Nanobiology Training Fellowship administered by the Keck Center of the Gulf Coast Consortia and the National Science Foundation.	Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Balch WE, 2008, SCIENCE, V319, P916, DOI 10.1126/science.1141448; Blow D, 2002, OUTLINE CRYSTALLOGRA; Boisvert DC, 1996, NAT STRUCT BIOL, V3, P170, DOI 10.1038/nsb0296-170; Booth CR, 2008, NAT STRUCT MOL BIOL, V15, P746, DOI 10.1038/nsmb.1436; BRAIG K, 1994, NATURE, V371, P578, DOI 10.1038/371578a0; BRAIG K, 1995, NAT STRUCT BIOL, V2, P1083, DOI 10.1038/nsb1295-1083; Bukau B, 1998, CELL, V92, P351, DOI 10.1016/S0092-8674(00)80928-9; Clare DK, 2008, STRUCTURE, V16, P528, DOI 10.1016/j.str.2008.01.016; Ditzel L, 1998, CELL, V93, P125, DOI 10.1016/S0092-8674(00)81152-6; Dobson CM, 2004, SEMIN CELL DEV BIOL, V15, P3, DOI 10.1016/j.semcdb.2003.12.008; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fernandez JJ, 2008, J STRUCT BIOL, V164, P170, DOI 10.1016/j.jsb.2008.05.010; Frydman J, 2001, ANNU REV BIOCHEM, V70, P603, DOI 10.1146/annurev.biochem.70.1.603; HARAUZ G, 1986, OPTIK, V73, P146; Hartl FU, 2002, SCIENCE, V295, P1852, DOI 10.1126/science.1068408; Jiang W, 2008, NATURE, V451, P1130, DOI 10.1038/nature06665; Kitamura A, 2006, NAT CELL BIOL, V8, P1163, DOI 10.1038/ncb1478; Kusmierczyk AR, 2003, FEBS LETT, V547, P201, DOI 10.1016/S0014-5793(03)00722-1; Kusmierczyk AR, 2003, BIOCHEM J, V371, P669, DOI 10.1042/BJ20030230; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Ludtke SJ, 1999, J STRUCT BIOL, V128, P82, DOI 10.1006/jsbi.1999.4174; Ludtke SJ, 2001, J MOL BIOL, V314, P253, DOI 10.1006/jmbi.2001.5133; Ludtke SJ, 2008, STRUCTURE, V16, P441, DOI 10.1016/j.str.2008.02.007; Meyer AS, 2003, CELL, V113, P369, DOI 10.1016/S0092-8674(03)00307-6; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Reissmann S, 2007, NAT STRUCT MOL BIOL, V14, P432, DOI 10.1038/nsmb1236; Rosenthal PB, 2003, J MOL BIOL, V333, P721, DOI 10.1016/j.jmb.2003.07.013; SAIBIL HR, 1993, CURR BIOL, V3, P265, DOI 10.1016/0960-9822(93)90176-O; Schoehn G, 2000, J MOL BIOL, V301, P323, DOI 10.1006/jmbi.2000.3952; Schroder GF, 2007, STRUCTURE, V15, P1630, DOI 10.1016/j.str.2007.09.021; Suzuki M, 2008, J BIOL CHEM, V283, P23931, DOI 10.1074/jbc.M804090200; Tam S, 2006, NAT CELL BIOL, V8, P1155, DOI 10.1038/ncb1477; Tang YC, 2006, CELL, V125, P903, DOI 10.1016/j.cell.2006.04.027; Xu ZH, 1997, NATURE, V388, P741, DOI 10.1038/41944; Yam AY, 2008, NAT STRUCT MOL BIOL, V15, P1255, DOI 10.1038/nsmb.1515; Yang C, 2009, J MICROSC-OXFORD, V233, P391, DOI 10.1111/j.1365-2818.2009.03137.x; Yu XK, 2008, NATURE, V453, P415, DOI 10.1038/nature06893; Zhang X, 2008, P NATL ACAD SCI USA, V105, P1867, DOI 10.1073/pnas.0711623105	39	161	163	1	36	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					379	U130		10.1038/nature08701	http://dx.doi.org/10.1038/nature08701			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090755	Green Accepted			2022-12-01	WOS:000273748100049
J	Gaston, KJ				Gaston, Kevin J.			Valuing Common Species	SCIENCE			English	Editorial Material							ECOSYSTEM FUNCTION; BIODIVERSITY; HEALTH		Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England	University of Sheffield	Gaston, KJ (corresponding author), Univ Sheffield, Dept Anim & Plant Sci, Biodivers & Macroecol Grp, Sheffield S10 2TN, S Yorkshire, England.	k.j.gaston@sheffield.ac.uk						Bell JF, 2008, AM J PREV MED, V35, P547, DOI 10.1016/j.amepre.2008.07.006; Bunker DE, 2005, SCIENCE, V310, P1029, DOI 10.1126/science.1117682; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Gaston KJ, 2008, J BIOGEOGR, V35, P483, DOI 10.1111/j.1365-2699.2007.01772.x; Gaston KJ, 2008, TRENDS ECOL EVOL, V23, P14, DOI 10.1016/j.tree.2007.11.001; Gaston KJ, 2007, P ROY SOC B-BIOL SCI, V274, P1567, DOI 10.1098/rspb.2007.0236; Grime JP, 1998, J ECOL, V86, P902, DOI 10.1046/j.1365-2745.1998.00306.x; Hooper DU, 2005, ECOL MONOGR, V75, P3, DOI 10.1890/04-0922; Jablonski D, 2006, AM NAT, V168, P556, DOI 10.1086/507994; LEOPOLD LB, 1953, ROUND RIVER J A LEOP; Mitchell R, 2007, J EPIDEMIOL COMMUN H, V61, P681, DOI 10.1136/jech.2006.053553; Nielsen TS, 2007, HEALTH PLACE, V13, P839, DOI 10.1016/j.healthplace.2007.02.001; Sizling AL, 2009, AM NAT, V174, P82, DOI 10.1086/599305; Smith MD, 2003, ECOL LETT, V6, P509, DOI 10.1046/j.1461-0248.2003.00454.x; Solan M, 2004, SCIENCE, V306, P1177, DOI 10.1126/science.1103960; Taylor BW, 2006, SCIENCE, V313, P833, DOI 10.1126/science.1128223	16	233	239	5	120	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075			SCIENCE	Science	JAN 8	2010	327	5962					154	155		10.1126/science.1182818	http://dx.doi.org/10.1126/science.1182818			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	541DQ	20056880				2022-12-01	WOS:000273394000022
J	Holtz, WJ; Keasling, JD				Holtz, William J.; Keasling, Jay D.			Engineering Static and Dynamic Control of Synthetic Pathways	CELL			English	Article							ESCHERICHIA-COLI; MEVALONATE PATHWAY; MESSENGER-RNA; GENE NETWORKS; OPTIMIZATION; EXPRESSION; BIOSYNTHESIS; METABOLISM; FRAMEWORK; TARGETS		[Keasling, Jay D.] Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Dept Bioengn, Berkeley, CA 94720 USA; [Holtz, William J.] Univ Calif Berkeley, Dept Elect Engn & Comp Sci, Berkeley, CA 94720 USA; [Keasling, Jay D.] Univ Calif Berkeley, Lawrence Berkeley Lab, Phys Biosci Div, Berkeley, CA 94720 USA; [Holtz, William J.; Keasling, Jay D.] Synthet Biol Engn Res Ctr, Emeryville, CA 94608 USA; [Keasling, Jay D.] Joint BioEnergy Inst, Emeryville, CA 94608 USA	University of California System; University of California Berkeley; University of California System; University of California Berkeley; University of California System; University of California Berkeley; United States Department of Energy (DOE); Lawrence Berkeley National Laboratory; University of California System; University of California Berkeley; United States Department of Energy (DOE); Joint BioEnergy Institute - JBEI	Keasling, JD (corresponding author), Univ Calif Berkeley, Dept Chem Engn, Berkeley, CA 94720 USA.	keasling@berkeley.edu	Keasling, Jay D/J-9162-2012	Keasling, Jay D/0000-0003-4170-6088				Alper H, 2005, METAB ENG, V7, P155, DOI 10.1016/j.ymben.2004.12.003; Alper H, 2005, NAT BIOTECHNOL, V23, P612, DOI 10.1038/nbt1083; Amanullah A., 2004, HDB IND MIXING SCI P, P1071, DOI [10.1002/0471451452.ch18., DOI 10.1002/0471451452.CH18]; Anesiadis N, 2008, METAB ENG, V10, P255, DOI 10.1016/j.ymben.2008.06.004; Becskei A, 2000, NATURE, V405, P590, DOI 10.1038/35014651; Burgard AP, 2003, BIOTECHNOL BIOENG, V84, P647, DOI 10.1002/bit.10803; Chin CS, 2008, PLOS BIOL, V6, P1343, DOI 10.1371/journal.pbio.0060146; Dueber JE, 2009, NAT BIOTECHNOL, V27, P753, DOI 10.1038/nbt.1557; Farmer WR, 2000, NAT BIOTECHNOL, V18, P533, DOI 10.1038/75398; Gadkar KG, 2005, BIOTECHNOL BIOENG, V89, P243, DOI 10.1002/bit.20349; Grant GA, 1996, PROTEIN SCI, V5, P34; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Kimura S, 2005, J BIOCHEM, V137, P523, DOI 10.1093/jb/mvi065; Kobayashi H, 2004, P NATL ACAD SCI USA, V101, P8414, DOI 10.1073/pnas.0402940101; Llaneras F, 2008, J BIOSCI BIOENG, V105, P1, DOI 10.1263/jbb.105.1; Martin VJJ, 2003, NAT BIOTECHNOL, V21, P796, DOI 10.1038/nbt833; Nakamura CE, 2003, CURR OPIN BIOTECH, V14, P454, DOI 10.1016/j.copbio.2003.08.005; Pharkya P, 2006, METAB ENG, V8, P1, DOI 10.1016/j.ymben.2005.08.003; Ro DK, 2006, NATURE, V440, P940, DOI 10.1038/nature04640; Salis HM, 2009, NAT BIOTECHNOL, V27, P946, DOI 10.1038/nbt.1568; Schmidt FR, 2005, APPL MICROBIOL BIOT, V68, P425, DOI 10.1007/s00253-005-0003-0; SCHONER BE, 1986, P NATL ACAD SCI USA, V83, P8506, DOI 10.1073/pnas.83.22.8506; Yoon SH, 2009, J BIOTECHNOL, V140, P218, DOI 10.1016/j.jbiotec.2009.01.008; Zhang KC, 2008, P NATL ACAD SCI USA, V105, P20653, DOI 10.1073/pnas.0807157106	24	170	182	3	71	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	JAN 8	2010	140	1					19	23		10.1016/j.cell.2009.12.029	http://dx.doi.org/10.1016/j.cell.2009.12.029			5	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	541CY	20085699	Bronze			2022-12-01	WOS:000273391900008
J	Palmer, MA; Bernhardt, ES; Schlesinger, WH; Eshleman, KN; Foufoula-Georgiou, E; Hendryx, MS; Lemly, AD; Likens, GE; Loucks, OL; Power, ME; White, PS; Wilcock, PR				Palmer, M. A.; Bernhardt, E. S.; Schlesinger, W. H.; Eshleman, K. N.; Foufoula-Georgiou, E.; Hendryx, M. S.; Lemly, A. D.; Likens, G. E.; Loucks, O. L.; Power, M. E.; White, P. S.; Wilcock, P. R.			Mountaintop Mining Consequences	SCIENCE			English	Editorial Material							LAND-USE; COAL		[Palmer, M. A.; Eshleman, K. N.] Univ Maryland, Ctr Environm Sci, Cambridge, MD 21613 USA; [Palmer, M. A.] Univ Maryland, College Pk, MD 20742 USA; [Bernhardt, E. S.] Duke Univ, Durham, NC 27708 USA; [Schlesinger, W. H.; Likens, G. E.] Cary Inst Ecosyst Studies, Millbrook, NY 12545 USA; [Foufoula-Georgiou, E.] Univ Minnesota, Minneapolis, MN 55414 USA; [Hendryx, M. S.] W Virginia Univ, Morgantown, WV 26506 USA; [Lemly, A. D.] Wake Forest Univ, Winston Salem, NC 27109 USA; [Loucks, O. L.] Miami Univ, Oxford, OH 45056 USA; [Power, M. E.] Univ Calif Berkeley, Berkeley, CA 94720 USA; [White, P. S.] Univ N Carolina, Chapel Hill, NC 27599 USA; [Wilcock, P. R.] Johns Hopkins Univ, Baltimore, MD 21218 USA	University System of Maryland; University of Maryland Center for Environmental Science; University System of Maryland; University of Maryland College Park; Duke University; Cary Institute of Ecosystem Studies; University of Minnesota System; University of Minnesota Twin Cities; West Virginia University; Wake Forest University; University System of Ohio; Miami University; University of California System; University of California Berkeley; University of North Carolina; University of North Carolina Chapel Hill; Johns Hopkins University	Palmer, MA (corresponding author), Univ Maryland, Ctr Environm Sci, Cambridge, MD 21613 USA.	mpalmer@umd.edu	Palmer, Margaret A/F-9648-2013; Bernhardt, Emily S/D-9940-2011; Bernhardt, Emily/B-4541-2010; Eshleman, Keith N/J-6531-2015	Palmer, Margaret A/0000-0003-1468-7993; Bernhardt, Emily S/0000-0003-3031-621X; Eshleman, Keith N/0000-0002-8274-450X; Hendryx, Michael/0000-0002-2764-387X; Foufoula-Georgiou, Efi/0000-0003-1078-231X				Allan JD, 2004, ANNU REV ECOL EVOL S, V35, P257, DOI 10.1146/annurev.ecolsys.35.120202.110122; Amichev BY, 2008, FOREST ECOL MANAG, V256, P1949, DOI 10.1016/j.foreco.2008.07.020; CARACO NF, 1989, NATURE, V341, P316, DOI 10.1038/341316a0; Chikkatur AP, 2009, ENERGY, V34, P942, DOI 10.1016/j.energy.2008.12.014; Conley JM, 2009, ENVIRON SCI TECHNOL, V43, P7952, DOI 10.1021/es9016377; Emerson R, 2009, J ENVIRON QUAL, V38, P1821, DOI 10.2134/jeq2008.0479; *EPA, 2005, MOUNT MIN VF FIN PRO; *EPA, 2002, STREAM CHEM REP 2; Ferrari JR, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007109; Ghose MK, 2007, ENVIRON MONIT ASSESS, V130, P17, DOI 10.1007/s10661-006-9448-6; Hartman KJ, 2005, HYDROBIOLOGIA, V532, P91, DOI 10.1007/s10750-004-9019-1; Hendryx M, 2009, PUBLIC HEALTH REP, V124, P541, DOI 10.1177/003335490912400411; JOYE SB, 1995, SCIENCE, V270, P623, DOI 10.1126/science.270.5236.623; Lemly AD, 2002, SPR S ENV M; MCAULEY S, 2006, 5059 USGS; McCormick BC, 2009, WATER RESOUR RES, V45, DOI 10.1029/2008WR007594; Meyer JL, 2007, J AM WATER RESOUR AS, V43, P86, DOI 10.1111/j.1752-1688.2007.00008.x; Negley TL, 2006, HYDROL PROCESS, V20, P3467, DOI 10.1002/hyp.6148; Paybins KS, 2000, 1204 USGS; Pond GJ, 2008, J N AM BENTHOL SOC, V27, P717, DOI 10.1899/08-015.1; SAMS JI, 2000, 994208 USGS; Saylor KL, 2008, LAND COVER TRENDS CE; Simmons JA, 2008, ECOL APPL, V18, P104, DOI 10.1890/07-1117.1; Townsend PA, 2009, REMOTE SENS ENVIRON, V113, P62, DOI 10.1016/j.rse.2008.08.012; van der Welle MEW, 2008, SCI TOTAL ENVIRON, V406, P426, DOI 10.1016/j.scitotenv.2008.05.056; 2008, FED REG, V73, P10	26	394	404	3	242	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					148	149		10.1126/science.1180543	http://dx.doi.org/10.1126/science.1180543			2	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056876				2022-12-01	WOS:000273394000018
J	Jensen, LMR; Sanishvili, R; Davidson, VL; Wilmot, CM				Jensen, Lyndal M. R.; Sanishvili, Ruslan; Davidson, Victor L.; Wilmot, Carrie M.			In Crystallo Posttranslational Modification Within a MauG/Pre-Methylamine Dehydrogenase Complex	SCIENCE			English	Article							TRYPTOPHAN TRYPTOPHYLQUINONE; OXYGEN ACTIVATION; COFACTOR; MECHANISM	MauG is a diheme enzyme responsible for the posttranslational modification of two tryptophan residues to form the tryptophan tryptophylquinone (TTQ) cofactor of methylamine dehydrogenase (MADH). MauG converts preMADH, containing monohydroxylated beta Trp(57), to fully functional MADH by catalyzing the insertion of a second oxygen atom into the indole ring and covalently linking beta Trp(57) to beta Trp(108). We have solved the x-ray crystal structure of MauG complexed with preMADH to 2.1 angstroms. The c-type heme irons and the nascent TTQ site are separated by long distances over which electron transfer must occur to achieve catalysis. In addition, one of the hemes has an atypical His-Tyr axial ligation. The crystalline protein complex is catalytically competent; upon addition of hydrogen peroxide, MauG-dependent TTQ synthesis occurs.	[Jensen, Lyndal M. R.; Wilmot, Carrie M.] Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Biosci Div, Collaborat Access Team, Gen Med Inst, Argonne, IL 60439 USA; [Sanishvili, Ruslan] Argonne Natl Lab, Biosci Div, Collaborat Access Team, Inst Canc, Argonne, IL 60439 USA; [Davidson, Victor L.] Univ Mississippi, Med Ctr, Dept Biochem, Jackson, MS 39216 USA	University of Minnesota System; University of Minnesota Twin Cities; United States Department of Energy (DOE); Argonne National Laboratory; United States Department of Energy (DOE); Argonne National Laboratory; University of Mississippi; University of Mississippi Medical Center	Wilmot, CM (corresponding author), Univ Minnesota, Dept Biochem Mol Biol & Biophys, Minneapolis, MN 55455 USA.	wilmo004@umn.edu		Davidson, Victor/0000-0002-1966-7302; Wilmot, Carrie/0000-0002-8706-0000	NIH [GM66569, GM41574]; Minnesota Partnership for Biotechnology and Medical Genomics [SPAP-05-0013-P-FY06]; National Cancer Institute [Y1-CO-1020]; National Institute of General Medical Sciences [Y1-GM-1104]; U.S. Department of Energy, Basic Energy Sciences, Office of Science [DE-AC02-06CH11357]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM066569, R37GM041574, R01GM041574] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Minnesota Partnership for Biotechnology and Medical Genomics; National Cancer Institute(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); U.S. Department of Energy, Basic Energy Sciences, Office of Science(United States Department of Energy (DOE)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	Supported by NIH grants GM66569 (C. M. W.) and GM41574 (V. L. D.) and Minnesota Partnership for Biotechnology and Medical Genomics grant SPAP-05-0013-P-FY06. Computer resources were provided by the Basic Sciences Computing Laboratory of the University of Minnesota Supercomputing Institute, and we thank C. Ergenekan for his support. X-ray data were collected at the Kahlert Structural Biology Laboratory (KSBL) at the University of Minnesota and GM/CA-CAT at the Advanced Photon Source (APS), Argonne National Laboratory, Argonne, IL. GM/CA-CAT is funded by National Cancer Institute grant Y1-CO-1020 and National Institute of General Medical Sciences grant Y1-GM-1104. Use of the Advanced Photon Source was supported by the U.S. Department of Energy, Basic Energy Sciences, Office of Science, under contract DE-AC02-06CH11357. We thank E. Hoeffner for KSBL support and the staff at Sector 23, APS, for their support, especially M. Becker, S. Corcoran, V. Nagarajan, and D. Yoder. We thank S. Shin for performing the experiment shown in fig. S4. Coordinates and structure factors have been deposited in the Protein Data Bank with acquisition codes 3L4M (MauG-preMADH complex) and 3L4O (MauG-preMADH complex treated with H<INF>2</INF>O<INF>2</INF>).	Chen LY, 1998, J MOL BIOL, V276, P131, DOI 10.1006/jmbi.1997.1511; Davidson VL, 2007, BIOCHEMISTRY-US, V46, P5283, DOI 10.1021/bi700468t; Davidson VL, 2001, ADV PROTEIN CHEM, V58, P95; Denisov IG, 2005, CHEM REV, V105, P2253, DOI 10.1021/cr0307143; Fulop V, 2001, ADV INORG CHEM, V51, P163; Hersleth HP, 2006, J INORG BIOCHEM, V100, P460, DOI 10.1016/j.jinorgbio.2006.01.018; Kovaleva EG, 2007, ACCOUNTS CHEM RES, V40, P475, DOI 10.1021/ar700052v; Lee SY, 2009, BIOCHEMISTRY-US, V48, P2442, DOI 10.1021/bi802166c; Li XH, 2006, BIOCHEMISTRY-US, V45, P821, DOI 10.1021/bi052000n; Li XH, 2008, P NATL ACAD SCI USA, V105, P8597, DOI 10.1073/pnas.0801643105; Li XH, 2006, BIOCHEMISTRY-US, V45, P13276, DOI 10.1021/bi061497d; Makris TM, 2002, DRUG METAB REV, V34, P691, DOI 10.1081/DMR-120015691; MCINTIRE WS, 1991, SCIENCE, V252, P817, DOI 10.1126/science.2028257; Pearson AR, 2004, BIOCHEMISTRY-US, V43, P5494, DOI 10.1021/bi049863l; Pearson AR, 2006, J AM CHEM SOC, V128, P12416, DOI 10.1021/ja064466e; Pettigrew GW, 2006, J INORG BIOCHEM, V100, P551, DOI 10.1016/j.jinorgbio.2005.12.008; RAAG R, 1991, BIOCHEMISTRY-US, V30, P2674, DOI 10.1021/bi00224a016; Wang YT, 2005, J AM CHEM SOC, V127, P8258, DOI 10.1021/ja051734k; Wang YT, 2003, BIOCHEMISTRY-US, V42, P7318, DOI 10.1021/bi034243q	19	100	101	0	17	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 12	2010	327	5971					1392	1394		10.1126/science.1182492	http://dx.doi.org/10.1126/science.1182492			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	567CA	20223990	Green Accepted			2022-12-01	WOS:000275418700045
J	Agulhon, C; Fiacco, TA; McCarthy, KD				Agulhon, Cendra; Fiacco, Todd A.; McCarthy, Ken D.			Hippocampal Short- and Long-Term Plasticity Are Not Modulated by Astrocyte Ca2+ Signaling	SCIENCE			English	Article							IN-SITU; INWARD CURRENTS; GLUTAMATE; CALCIUM; STIMULATION; DEPOTENTIATION; POTENTIATION; ACTIVATION; FREQUENCY; RELEASE	The concept that astrocytes release neuroactive molecules (gliotransmitters) to affect synaptic transmission has been a paradigm shift in neuroscience research over the past decade. This concept suggests that astrocytes, together with pre- and postsynaptic neuronal elements, make up a functional synapse. Astrocyte release of gliotransmitters (for example, glutamate and adenosine triphosphate) is generally accepted to be a Ca2+-dependent process. We used two mouse lines to either selectively increase or obliterate astrocytic G(q) G protein-coupled receptor Ca2+ signaling to further test the hypothesis that astrocytes release gliotransmitters in a Ca2+-dependent manner to affect synaptic transmission. Neither increasing nor obliterating astrocytic Ca2+ fluxes affects spontaneous and evoked excitatory synaptic transmission or synaptic plasticity. Our findings suggest that, at least in the hippocampus, the mechanisms of gliotransmission need to be reconsidered.	[Agulhon, Cendra; McCarthy, Ken D.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC 27599 USA; [Fiacco, Todd A.] Univ Calif Riverside, Dept Cell Biol & Neurosci, Riverside, CA 92521 USA	University of North Carolina; University of North Carolina Chapel Hill; University of California System; University of California Riverside	Agulhon, C (corresponding author), Univ N Carolina, Dept Pharmacol, Genet Med Bldg,CB 7365, Chapel Hill, NC 27599 USA.	cendra_agulhon@med.unc.edu		Agulhon, Cendra/0000-0001-7508-6978	NIH [NS033938, NS020212]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS033938, R01NS020212] Funding Source: NIH RePORTER	NIH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We thank K. Casper for making MrgA1<SUP>+</SUP> mice; J. Chen for providing IP<INF>3</INF>R2 KO mice; and B. Djukic, B. Philpot, A. Roberts, and J. de Marchena for valuable help and discussions. This work was supported by NIH grants NS033938 and NS020212.	Agulhon C, 2008, NEURON, V59, P932, DOI 10.1016/j.neuron.2008.09.004; Andersson M, 2007, J PHYSIOL-LONDON, V585, P843, DOI 10.1113/jphysiol.2007.142737; Angulo MC, 2004, J NEUROSCI, V24, P6920, DOI 10.1523/JNEUROSCI.0473-04.2004; Chung HJ, 2009, P NATL ACAD SCI USA, V106, P635, DOI 10.1073/pnas.0811685106; Fellin T, 2004, NEURON, V43, P729, DOI 10.1016/j.neuron.2004.08.011; Fiacco TA, 2004, J NEUROSCI, V24, P722, DOI 10.1523/JNEUROSCI.2859-03.2004; Fiacco TA, 2007, NEURON, V54, P611, DOI 10.1016/j.neuron.2007.04.032; Fiacco TA, 2009, ANNU REV PHARMACOL, V49, P151, DOI 10.1146/annurev.pharmtox.011008.145602; Huang CC, 2001, J BIOL CHEM, V276, P48108, DOI 10.1074/jbc.M106388200; Izumi Y, 2008, J NEUROSCI, V28, P9557, DOI 10.1523/JNEUROSCI.3346-08.2008; Lee CJ, 2007, J PHYSIOL-LONDON, V581, P1057, DOI 10.1113/jphysiol.2007.130377; Li R, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-55; Li XD, 2005, CIRC RES, V96, P1274, DOI 10.1161/01.RES.0000172556.05576.4c; Mannaioni G, 2001, J NEUROSCI, V21, P5925, DOI 10.1523/JNEUROSCI.21-16-05925.2001; Navarrete M, 2008, NEURON, V57, P883, DOI 10.1016/j.neuron.2008.01.029; Pascual O, 2005, SCIENCE, V310, P113, DOI 10.1126/science.1116916; Pasti L, 1997, J NEUROSCI, V17, P7817; Perea G, 2005, J NEUROSCI, V25, P2192, DOI 10.1523/JNEUROSCI.3965-04.2005; Perea G, 2007, SCIENCE, V317, P1083, DOI 10.1126/science.1144640; Petravicz J, 2008, J NEUROSCI, V28, P4967, DOI 10.1523/JNEUROSCI.5572-07.2008; Porter JT, 1996, J NEUROSCI, V16, P5073; Rae MG, 2004, NEUROPHARMACOLOGY, V46, P1057, DOI 10.1016/j.neuropharm.2004.02.002; Sasaki Y, 1997, J NEUROCHEM, V68, P2194; Serrano A, 2006, J NEUROSCI, V26, P5370, DOI 10.1523/JNEUROSCI.5255-05.2006; Shigetomi E, 2008, J NEUROSCI, V28, P6659, DOI 10.1523/JNEUROSCI.1717-08.2008; Tritsch NX, 2007, NEURON, V54, P497, DOI 10.1016/j.neuron.2007.05.008; Wang XH, 2006, NAT NEUROSCI, V9, P816, DOI 10.1038/nn1703; Zho WM, 2002, J NEUROSCI, V22, P8838; Zucker RS, 1996, NEURON, V17, P1049, DOI 10.1016/S0896-6273(00)80238-X	29	314	321	1	64	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	MAR 5	2010	327	5970					1250	1254		10.1126/science.1184821	http://dx.doi.org/10.1126/science.1184821			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563VD	20203048				2022-12-01	WOS:000275162100038
J	Guo, CX; Tang, TS; Friedberg, EC				Guo, Caixia; Tang, Tie-Shan; Friedberg, Errol C.			SnapShot: Nucleotide Excision Repair	CELL			English	Editorial Material									[Guo, Caixia] Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China; [Tang, Tie-Shan] Chinese Acad Sci, Inst Zool, SKLBMB, Beijing 100101, Peoples R China; [Guo, Caixia; Friedberg, Errol C.] Univ Texas SW Med Ctr Dallas, Dallas, TX 75390 USA	Chinese Academy of Sciences; Beijing Institute of Genomics, CAS; Chinese Academy of Sciences; Institute of Zoology, CAS; University of Texas System; University of Texas Southwestern Medical Center Dallas	Guo, CX (corresponding author), Chinese Acad Sci, Beijing Inst Genom, Beijing 100101, Peoples R China.				NIEHS NIH HHS [ES11344] Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R01ES011344] Funding Source: NIH RePORTER	NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Coin F, 2008, MOL CELL, V31, P9, DOI 10.1016/j.molcel.2008.04.024; Friedberg EC, 2005, DNA REPAIR MUTAGENES; Hanawalt PC, 2008, NAT REV MOL CELL BIO, V9, P958, DOI 10.1038/nrm2549; Nouspikel T, 2009, CELL MOL LIFE SCI, V66, P994, DOI 10.1007/s00018-009-8737-y; SELBY CP, 1993, SCIENCE, V260, P53, DOI 10.1126/science.8465200; Sugasawa K, 2005, CELL, V121, P387, DOI 10.1016/j.cell.2005.02.035; Svejstrup JQ, 2002, NAT REV MOL CELL BIO, V3, P21, DOI 10.1038/nrm703; Truglio JJ, 2006, CHEM REV, V106, P233, DOI 10.1021/cr040471u; Volker M, 2001, MOL CELL, V8, P213, DOI 10.1016/S1097-2765(01)00281-7	9	8	10	0	16	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	MAR 5	2010	140	5					754	U169	754.e1	10.1016/j.cell.2010.02.033	http://dx.doi.org/10.1016/j.cell.2010.02.033			2	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	564EZ	20211143	Bronze			2022-12-01	WOS:000275197400024
J	Zhang, Q; Raoof, M; Chen, Y; Sumi, Y; Sursal, T; Junger, W; Brohi, K; Itagaki, K; Hauser, CJ				Zhang, Qin; Raoof, Mustafa; Chen, Yu; Sumi, Yuka; Sursal, Tolga; Junger, Wolfgang; Brohi, Karim; Itagaki, Kiyoshi; Hauser, Carl J.			Circulating mitochondrial DAMPs cause inflammatory responses to injury	NATURE			English	Article							OPERATED CALCIUM INFLUX; HUMAN NEUTROPHILS; TRAUMA; SHOCK; MOBILIZATION; CHEMOTAXIS; RECEPTORS; PEPTIDES; MODELS; SIRS	Injury causes a systemic inflammatory response syndrome (SIRS) that is clinically much like sepsis(1). Microbial pathogen-associated molecular patterns (PAMPs) activate innate immunocytes through pattern recognition receptors(2). Similarly, cellular injury can release endogenous 'damage'-associated molecular patterns (DAMPs) that activate innate immunity(3). Mitochondria are evolutionary endosymbionts that were derived from bacteria(4) and so might bear bacterial molecular motifs. Here we show that injury releases mitochondrial DAMPs (MTDs) into the circulation with functionally important immune consequences. MTDs include formyl peptides and mitochondrial DNA. These activate human polymorphonuclear neutrophils (PMNs) through formyl peptide receptor-1 and Toll-like receptor (TLR) 9, respectively. MTDs promote PMN Ca2+ flux and phosphorylation of mitogen-activated protein (MAP) kinases, thus leading to PMN migration and degranulation in vitro and in vivo. Circulating MTDs can elicit neutrophil-mediated organ injury. Cellular disruption by trauma releases mitochondrial DAMPs with evolutionarily conserved similarities to bacterial PAMPs into the circulation. These signal through innate immune pathways identical to those activated in sepsis to create a sepsis-like state. The release of such mitochondrial 'enemies within' by cellular injury is a key link between trauma, inflammation and SIRS.	[Zhang, Qin; Raoof, Mustafa; Chen, Yu; Sumi, Yuka; Sursal, Tolga; Junger, Wolfgang; Itagaki, Kiyoshi; Hauser, Carl J.] Beth Israel Deaconess Med Ctr, Dept Surg, Div Trauma, Boston, MA 02215 USA; [Zhang, Qin; Raoof, Mustafa; Chen, Yu; Sumi, Yuka; Sursal, Tolga; Junger, Wolfgang; Itagaki, Kiyoshi; Hauser, Carl J.] Harvard Univ, Sch Med, Boston, MA 02215 USA; [Brohi, Karim] Univ London, Barts & London Sch Med & Dent, Trauma Clin Acad Unit, London E1 1BB, England	Harvard University; Beth Israel Deaconess Medical Center; Harvard University; Harvard Medical School; University of London; Queen Mary University London	Hauser, CJ (corresponding author), Beth Israel Deaconess Med Ctr, Dept Surg, Div Trauma, 330 Brookline Ave, Boston, MA 02215 USA.	cjhauser@bidmc.harvard.edu	Hauser, Carl J./Y-1189-2019; Junger, Wolfgang G/I-1932-2013; Itagaki, Kiyoshi/M-5501-2015; Sursal, Tolga/AAN-8585-2021; Raoof, Mustafa/D-1664-2012	Junger, Wolfgang G/0000-0003-3350-8452; Itagaki, Kiyoshi/0000-0002-6033-1122; Hauser, Carl/0000-0003-3167-1846	National Institute of General Medical Sciences; Department of Defense; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM051477, R01GM059179] Funding Source: NIH RePORTER	National Institute of General Medical Sciences(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); Department of Defense(United States Department of Defense); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))	This work is supported by a National Institute of General Medical Sciences grant and a Department of Defense CDMRP/DRMRP hypothesis development award (to C.J.H.).	Abraham E, 2003, CRIT CARE MED, V31, pS195, DOI 10.1097/01.CCM.0000057843.47705.E8; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; BONE RC, 1992, JAMA-J AM MED ASSOC, V268, P3452, DOI 10.1001/jama.268.24.3452; CARDON LR, 1994, P NATL ACAD SCI USA, V91, P3799, DOI 10.1073/pnas.91.9.3799; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Collins LV, 2004, J LEUKOCYTE BIOL, V75, P995, DOI 10.1189/jlb.0703328; Deitch EA, 2006, FRONT BIOSCI-LANDMRK, V11, P520, DOI 10.2741/1816; Fekete Z, 2001, SHOCK, V16, P15, DOI 10.1097/00024382-200116010-00003; FINE J, 1959, NEW ENGL J MED, V260, P214, DOI 10.1056/NEJM195901292600505; Hauser CJ, 2005, SHOCK, V24, P24, DOI 10.1097/01.shk.0000191387.18818.43; Hauser CJ, 2000, J TRAUMA, V48, P592, DOI 10.1097/00005373-200004000-00003; Hauser CJ, 2001, J LEUKOCYTE BIOL, V69, P63; Hayashi F, 2003, BLOOD, V102, P2660, DOI 10.1182/blood-2003-04-1078; JANEWAY CA, 1989, COLD SPRING HARB SYM, V54, P1; Lee SH, 2007, BIOCHEM BIOPH RES CO, V364, P996, DOI 10.1016/j.bbrc.2007.10.111; MARCKER K, 1964, J MOL BIOL, V8, P835, DOI 10.1016/S0022-2836(64)80164-9; MATZINGER P, 1994, ANNU REV IMMUNOL, V12, P991, DOI 10.1146/annurev.iy.12.040194.005015; MOORE FA, 1991, J TRAUMA, V31, P629, DOI 10.1097/00005373-199105000-00006; MOORE FA, 1991, J TRAUMA, V31, P636, DOI DOI 10.1097/00005373-199105000-00006]; Rabiet MJ, 2005, EUR J IMMUNOL, V35, P2486, DOI 10.1002/eji.200526338; Sagan L, 1967, J Theor Biol, V14, P255; Sasser Scott M., 2009, Morbidity and Mortality Weekly Report, V58, P1; SCHIFFMANN E, 1975, P NATL ACAD SCI USA, V72, P1059, DOI 10.1073/pnas.72.3.1059; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Simms HH, 2000, J TRAUMA, V48, P597; Taanman JW, 1999, BBA-BIOENERGETICS, V1410, P103, DOI 10.1016/S0005-2728(98)00161-3; Tarlowe MH, 2003, J IMMUNOL, V171, P2066, DOI 10.4049/jimmunol.171.4.2066; UCHIDA K, 1993, P NATL ACAD SCI USA, V90, P8742, DOI 10.1073/pnas.90.18.8742; Van Lint P, 2006, CYTOKINE GROWTH F R, V17, P217, DOI 10.1016/j.cytogfr.2006.04.001; WENZELSEIFERT K, 1993, J IMMUNOL, V150, P4591; West MA, 2007, J TRAUMA, V62, P805, DOI 10.1097/01.ta.0000259267.74789.9b; Zhang Q, 2005, LIFE SCI, V77, P3068, DOI 10.1016/j.lfs.2005.02.034	32	2310	2416	25	352	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	MAR 4	2010	464	7285					104	U115		10.1038/nature08780	http://dx.doi.org/10.1038/nature08780			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	563GZ	20203610	Green Accepted			2022-12-01	WOS:000275117500042
J	To, TL; Maheshri, N				To, Tsz-Leung; Maheshri, Narendra			Noise Can Induce Bimodality in Positive Transcriptional Feedback Loops Without Bistability	SCIENCE			English	Article							GENE-EXPRESSION; CELL; MEMORY; MODULE	Transcriptional positive-feedback loops are widely associated with bistability, characterized by two stable expression states that allow cells to respond to analog signals in a digital manner. Using a synthetic system in budding yeast, we show that positive feedback involving a promoter with multiple transcription factor (TF) binding sites can induce a steady-state bimodal response without cooperative binding of the TF. Deterministic models of this system do not predict bistability. Rather, the bimodal response requires a short-lived TF and stochastic fluctuations in the TF's expression. Multiple binding sites provide these fluctuations. Because many promoters possess multiple binding sites and many TFs are unstable, positive-feedback loops in gene regulatory networks may exhibit bimodal responses, but not necessarily because of deterministic bistability, as is commonly thought.	[To, Tsz-Leung; Maheshri, Narendra] MIT, Dept Chem Engn, Cambridge, MA 02139 USA	Massachusetts Institute of Technology (MIT)	Maheshri, N (corresponding author), MIT, Dept Chem Engn, Cambridge, MA 02139 USA.	narendra@mit.edu			NSF; Human Frontiers Science Program [RGY2007]; Massachusetts Institute of Technology	NSF(National Science Foundation (NSF)); Human Frontiers Science Program(Human Frontier Science Program); Massachusetts Institute of Technology	We thank A. Raj for technical assistance with FISH, and C. J. Zopf, H. Kim, A. Raj, J. Gore, and K. Verstrepen for comments on the manuscript. This work was funded by an NSF Graduate Fellowship (to T.-L. T.), the Human Frontiers Science Program RGY2007 (to N.M.), and Massachusetts Institute of Technology startup funds (to N.M.)	Acar M, 2005, NATURE, V435, P228, DOI 10.1038/nature03524; Ajo-Franklin CM, 2007, GENE DEV, V21, P2271, DOI 10.1101/gad.1586107; Alon U, 2006, INTRO SYSTEMS BIOL D; Altschuler SJ, 2008, NATURE, V454, P886, DOI 10.1038/nature07119; Becskei A, 2004, NAT CELL BIOL, V6, P451, DOI 10.1038/ncb1124; Becskei A, 2001, EMBO J, V20, P2528, DOI 10.1093/emboj/20.10.2528; Belle A, 2006, P NATL ACAD SCI USA, V103, P13004, DOI 10.1073/pnas.0605420103; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Friedman N, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.168302; Gari E, 1997, YEAST, V13, P837, DOI 10.1002/(SICI)1097-0061(199707)13:9<837::AID-YEA145>3.0.CO;2-T; Ingolia NT, 2007, CURR BIOL, V17, P668, DOI 10.1016/j.cub.2007.03.016; Isaacs FJ, 2003, P NATL ACAD SCI USA, V100, P7714, DOI 10.1073/pnas.1332628100; Karmakar R, 2007, PHYS BIOL, V4, P29, DOI 10.1088/1478-3975/4/1/004; KELLER AD, 1995, J THEOR BIOL, V172, P169, DOI 10.1006/jtbi.1995.0014; Maheshri N, 2007, ANNU REV BIOPH BIOM, V36, P413, DOI 10.1146/annurev.biophys.36.040306.132705; Miller JA, 2003, MOL CELL BIOL, V23, P1623, DOI 10.1128/MCB.23.5.1623-1632.2003; Raj A, 2008, NAT METHODS, V5, P877, DOI 10.1038/NMETH.1253; Raj A, 2006, PLOS BIOL, V4, P1707, DOI 10.1371/journal.pbio.0040309; Salghetti SE, 2001, SCIENCE, V293, P1651, DOI 10.1126/science.1062079; Samoilov M, 2005, P NATL ACAD SCI USA, V102, P2310, DOI 10.1073/pnas.0406841102; Xiong W, 2003, NATURE, V426, P460, DOI 10.1038/nature02089	21	201	203	1	44	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	FEB 26	2010	327	5969					1142	1145		10.1126/science.1178962	http://dx.doi.org/10.1126/science.1178962			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	560KJ	20185727				2022-12-01	WOS:000274901100040
J	Hulme, M; Zorita, E; Stocker, TF; Price, J; Christy, JR				Hulme, Mike; Zorita, Eduardo; Stocker, Thomas F.; Price, Jeff; Christy, John R.			IPCC: cherish it, tweak it or scrap it?	NATURE			English	Editorial Material									[Hulme, Mike] Univ E Anglia, Norwich NR4 7TJ, Norfolk, England; [Zorita, Eduardo] GKSS Forschungszentrum Geesthacht GmbH, Geesthacht, Germany; [Stocker, Thomas F.] Univ Bern, CH-3012 Bern, Switzerland; [Christy, John R.] Univ Alabama, Huntsville, AL 35899 USA	University of East Anglia; Helmholtz Association; Helmholtz-Zentrum Geesthacht - Zentrum fur Material- und Kustenforschung; University of Bern; University of Alabama System; University of Alabama Huntsville	Hulme, M (corresponding author), Univ E Anglia, Norwich NR4 7TJ, Norfolk, England.		Stocker, Thomas/B-1273-2013; Hulme, Mike/F-9012-2010	Hulme, Mike/0000-0002-1273-7662					0	43	43	1	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836			NATURE	Nature	FEB 11	2010	463	7282					730	732		10.1038/463730a	http://dx.doi.org/10.1038/463730a			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	553VG	20148014				2022-12-01	WOS:000274394300015
J	Kalverda, B; Pickersgill, H; Shloma, VV; Fornerod, M				Kalverda, Bernike; Pickersgill, Helen; Shloma, Victor V.; Fornerod, Maarten			Nucleoporins Directly Stimulate Expression of Developmental and Cell-Cycle Genes Inside the Nucleoplasm	CELL			English	Article							NUCLEAR-PORE COMPONENTS; SPATIAL-ORGANIZATION; PROTEIN; TRANSCRIPTION; GENOME; CHROMOSOMES; COMPLEXES; PHOSPHORYLATION; IDENTIFICATION; METHYLATION	Nuclear pore complexes (NPCs) mediate transport across the nuclear envelope. In yeast, they also interact with active genes, attracting or retaining them at the nuclear periphery. In higher eukaryotes, some NPC components (nucleoporins) are also found in the nucleoplasm, with a so far unknown function. We have functionally characterized nucleoporin-chromatin interactions specifically at the NPC or within the nucleoplasm in Drosophila. We analyzed genomic interactions of full-length nucleoporins Nup98, Nup50, and Nup62 and nucleoplasmic and NPC-tethered forms of Nup98. We found that nucleoporins predominantly interacted with transcriptionally active genes inside the nucleoplasm, in particular those involved in developmental regulation and the cell cycle. A smaller set of nonactive genes interacted with the NPC. Genes strongly interacting with nucleoplasmic Nup98 were downregulated upon Nup98 depletion and activated on nucleoplasmic Nup98 overexpression. Thus, nucleoporins stimulate developmental and cell-cycle gene expression away from the NPC by interacting with these genes inside the nucleoplasm.	[Kalverda, Bernike; Pickersgill, Helen; Fornerod, Maarten] Netherlands Canc Inst, Div Gene Regulat, NL-1066 CX Amsterdam, Netherlands; [Shloma, Victor V.] Russian Acad Sci, Dept Mol & Cell Biol, Inst Chem Biol & Fundamental Med, Novosibirsk 630090, Russia	Netherlands Cancer Institute; Institute of Chemical Biology & Fundamental Medicine, Siberian Branch of the RAS; Russian Academy of Sciences	Fornerod, M (corresponding author), Netherlands Canc Inst, Div Gene Regulat, Plesmanlaan 121, NL-1066 CX Amsterdam, Netherlands.	m.fornerod@nki.nl	Fornerod, Maarten/A-7503-2010; Shloma, Victor/N-7979-2015; Kalverda, Bernike/A-7691-2010	Fornerod, Maarten/0000-0002-6166-3030	Dutch Cancer Society [NKI-2004-3080]; Marie Curie European fellowship; Russian Foundation for Basic Research [08-04-01105a]; Program of Presidium RAS "Molecular and Cellular Biology'' [N22.4]; SB RAS [N37]; Science Schools [5104.2008.4]	Dutch Cancer Society(KWF Kankerbestrijding); Marie Curie European fellowship(European Commission); Russian Foundation for Basic Research(Russian Foundation for Basic Research (RFBR)); Program of Presidium RAS "Molecular and Cellular Biology''; SB RAS(Russian Academy of Sciences); Science Schools	We thank M. Hetzer and M. Capelson for Drosophila Nup98 antibody; J. Gro beta hans for Nup50 antibody; M. Roling for help with FISH experiments; N. Xylourgidis for help with scoring of FISH images; U. Braunschweig for the pCASPERGW-MycDam vector; L. Pagie and W. Meuleman for gene end alignment scripts; J. Delrow for providing cDNA microarrays; the NKI microarray facility for help with microarray experiments; A. Olszak, A. de Jong, M. Vogel, L. Oomen, and L. Brocks for technical help and advice; B. van Steensel for intellectual input and support; M. Hetzer and A. Akhtar for sharing unpublished data; F. v. Leeuwen, and N. Xylourgidis for critically reading the manuscript; and J. van Deursen and R. Wolthuis and members of the Fornerod and van Steensel labs for helpful discussions. This work was supported by the Dutch Cancer Society grant NKI-2004-3080. H. P. was funded by a Marie Curie European fellowship. V. V. S. was supported by the Russian Foundation for Basic Research grant N 08-04-01105a, Program of Presidium RAS "Molecular and Cellular Biology'' N22.4, Interdisciplinary integration project of SB RAS N37, and Science Schools grant 5104.2008.4.	Ahn SH, 2004, MOL CELL, V13, P67, DOI 10.1016/S1097-2765(03)00492-1; Argiropoulos B, 2007, ONCOGENE, V26, P6766, DOI 10.1038/sj.onc.1210760; Bai XT, 2006, CANCER RES, V66, P4584, DOI 10.1158/0008-5472.CAN-05-3101; BEERMANN W, 1952, CHROMOSOMA, V5, P139; BLOBEL G, 1985, P NATL ACAD SCI USA, V82, P8527, DOI 10.1073/pnas.82.24.8527; Brandt A, 2006, CURR BIOL, V16, P543, DOI 10.1016/j.cub.2006.01.051; Brickner JH, 2004, PLOS BIOL, V2, P1843, DOI 10.1371/journal.pbio.0020342; Bridges CB, 1935, J HERED, V26, P60, DOI 10.1093/oxfordjournals.jhered.a104022; Brown CR, 2008, GENE DEV, V22, P627, DOI 10.1101/gad.1632708; Capelson M, 2010, CELL, V140, P372, DOI 10.1016/j.cell.2009.12.054; Casolari JM, 2005, GENE DEV, V19, P1188, DOI 10.1101/gad.1307205; Casolari JM, 2004, CELL, V117, P427, DOI 10.1016/S0092-8674(04)00448-9; Choksi SP, 2006, DEV CELL, V11, P775, DOI 10.1016/j.devcel.2006.09.015; Chubb JR, 2002, CURR BIOL, V12, P439, DOI 10.1016/S0960-9822(02)00695-4; Daigle N, 2001, J CELL BIOL, V154, P71, DOI 10.1083/jcb.200101089; DAVIS LI, 1986, CELL, V45, P699, DOI 10.1016/0092-8674(86)90784-1; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; ECHALIER G, 1997, DROSOPHILA CELLS CUL, P393; Enninga J, 2002, SCIENCE, V295, P1523, DOI 10.1126/science.1067861; Finlan LE, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000039; Glinsky GV, 2006, CELL CYCLE, V5, P1208, DOI 10.4161/cc.5.11.2796; Glinsky GV, 2005, J CLIN INVEST, V115, P1503, DOI 10.1172/JCI23412; Greil F, 2003, GENE DEV, V17, P2825, DOI 10.1101/gad.281503; Greil F, 2006, METHOD ENZYMOL, V410, P342, DOI 10.1016/S0076-6879(06)10016-6; Griffis ER, 2002, MOL BIOL CELL, V13, P1282, DOI 10.1091/mbc.01-11-0538; Guelen L, 2008, NATURE, V453, P948, DOI 10.1038/nature06947; Heessen S, 2007, EMBO REP, V8, P914, DOI 10.1038/sj.embor.7401075; HOCHSTRASSER M, 1986, J CELL BIOL, V102, P112, DOI 10.1083/jcb.102.1.112; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Kasper LH, 1999, MOL CELL BIOL, V19, P764; KLADDE MP, 1994, P NATL ACAD SCI USA, V91, P1361, DOI 10.1073/pnas.91.4.1361; Kroon E, 2001, EMBO J, V20, P350, DOI 10.1093/emboj/20.3.350; Lam DH, 2001, LEUKEMIA, V15, P1689, DOI 10.1038/sj.leu.2402269; Lindsay ME, 2002, CELL, V110, P349, DOI 10.1016/S0092-8674(02)00836-X; Marshall WF, 2002, CURR BIOL, V12, pR185, DOI 10.1016/S0960-9822(02)00724-8; Marshall WF, 1997, CURR BIOL, V7, P930, DOI 10.1016/S0960-9822(06)00412-X; Mendjan S, 2006, MOL CELL, V21, P811, DOI 10.1016/j.molcel.2006.02.007; Mito Y, 2005, NAT GENET, V37, P1090, DOI 10.1038/ng1637; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pineault N, 2003, BLOOD, V101, P4529, DOI 10.1182/blood-2002-08-2484; POWERS MA, 1995, J CELL BIOL, V128, P721, DOI 10.1083/jcb.128.5.721; Rabut G, 2004, NAT CELL BIOL, V6, P1114, DOI 10.1038/ncb1184; Reddy KL, 2008, NATURE, V452, P243, DOI 10.1038/nature06727; Schubeler D, 2004, GENE DEV, V18, P1263, DOI 10.1101/gad.1198204; Shevelyov YY, 2009, P NATL ACAD SCI USA, V106, P3282, DOI 10.1073/pnas.0811933106; Smitherman M, 2000, MOL CELL BIOL, V20, P5631, DOI 10.1128/MCB.20.15.5631-5642.2000; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Stavru F, 2006, J CELL BIOL, V173, P509, DOI 10.1083/jcb.200601001; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; STUURMAN N, 1995, J CELL SCI, V108, P3137; Taddei A, 2006, NATURE, V441, P774, DOI 10.1038/nature04845; Tran EJ, 2006, CELL, V125, P1041, DOI 10.1016/j.cell.2006.05.027; van Steensel B, 2000, NAT BIOTECHNOL, V18, P424, DOI 10.1038/74487; van Steensel B, 2001, NAT GENET, V27, P304, DOI 10.1038/85871; Wang GG, 2007, NAT CELL BIOL, V9, P804, DOI 10.1038/ncb1608; Yao J, 2007, MOL CELL, V28, P978, DOI 10.1016/j.molcel.2007.10.017; Zimowska G, 1997, J CELL SCI, V110, P927	58	313	320	0	42	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0092-8674	1097-4172		CELL	Cell	FEB 5	2010	140	3					360	U81		10.1016/j.cell.2010.01.011	http://dx.doi.org/10.1016/j.cell.2010.01.011			22	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	552ND	20144760	Bronze			2022-12-01	WOS:000274297700014
J	Melton, C; Judson, RL; Blelloch, R				Melton, Collin; Judson, Robert L.; Blelloch, Robert			Opposing microRNA families regulate self-renewal in mouse embryonic stem cells	NATURE			English	Article							TRANSCRIPTIONAL NETWORK; DNA METHYLATION; C-MYC; PLURIPOTENCY; RNA; DIFFERENTIATION; EXPRESSION; LIN-28; NANOG; URIDYLATION	When embryonic stem cells (ESCs) differentiate, they must both silence the ESC self-renewal program and activate new tissue-specific programs. In the absence of DGCR8 (Dgcr8(-/-)), a protein required for microRNA (miRNA) biogenesis, mouse ESCs are unable to silence self-renewal. Here we show that the introduction of let-7 miRNAs-a family of miRNAs highly expressed in somatic cells-can suppress self-renewal in Dgcr8(-/-) but not wild-type ESCs. Introduction of ESC cell cycle regulating (ESCC) miRNAs into the Dgcr8(-/-) ESCs blocks the capacity of let-7 to suppress self-renewal. Profiling and bioinformatic analyses show that let-7 inhibits whereas ESCC miRNAs indirectly activate numerous self-renewal genes. Furthermore, inhibition of the let-7 family promotes de-differentiation of somatic cells to induced pluripotent stem cells. Together, these findings show how the ESCC and let-7 miRNAs act through common pathways to alternatively stabilize the self-renewing versus differentiated cell fates.	[Melton, Collin; Judson, Robert L.; Blelloch, Robert] Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Biomed Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA; [Melton, Collin; Judson, Robert L.; Blelloch, Robert] Univ Calif San Francisco, Dept Urol, San Francisco, CA 94143 USA	University of California System; University of California San Francisco; University of California System; University of California San Francisco	Blelloch, R (corresponding author), Univ Calif San Francisco, Eli & Edythe Broad Ctr Regenerat Med & Stem Cell, Program Biomed Sci, Ctr Reprod Sci, San Francisco, CA 94143 USA.	blellochr@stemcell.ucsf.edu			National Institutes of Health (NIH) [K08 NS48118, R01 NS057221]; California Institute of Regenerative Medicine (CIRM) [RS1-00161, RN2-00906]; American Health Assistance Foundation; Pew Charitable Trust; National Science Foundation (NSF); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [K08NS048118, R01NS057221] Funding Source: NIH RePORTER	National Institutes of Health (NIH)(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); California Institute of Regenerative Medicine (CIRM)(California Institute for Regenerative Medicine); American Health Assistance Foundation(BrightFocus Foundation); Pew Charitable Trust; National Science Foundation (NSF)(National Science Foundation (NSF)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))	We would like to thank M. Ramalho-Santos, S. Fisher, M. Conti and members of the Blelloch laboratory for critical reading of the manuscript. We would like to thank A. Amiet for let-7 and control inhibitors, M. Bishop for c-Myc floxed mice and A. Shenoy for ESC-derived neural progenitor cells cultures. Furthermore, we would like to acknowledge A. Olshen and R. Roy for their helpful advice concerning our statistical methods. This work was supported by funds to R. B. from the National Institutes of Health (NIH; K08 NS48118 and R01 NS057221), California Institute of Regenerative Medicine (CIRM; Seed Grant RS1-00161, New Faculty Award RN2-00906), the American Health Assistance Foundation (formerly Stem Cell Research Foundation), and the Pew Charitable Trust. C. M. and R.L.J. are supported by the National Science Foundation (NSF) graduate research fellowships.	Babiarz J. E., 2009, STEMBOOK, P1, DOI [10.3824/stembook.1.47.1, DOI 10.3824/STEMBOOK.1.47.1]; Benetti R, 2008, NAT STRUCT MOL BIOL, V15, P268, DOI 10.1038/nsmb.1399; Blelloch R, 2007, CELL STEM CELL, V1, P245, DOI 10.1016/j.stem.2007.08.008; Brambrink T, 2008, CELL STEM CELL, V2, P151, DOI 10.1016/j.stem.2008.01.004; Buehr M, 2003, PHILOS T R SOC B, V358, P1397, DOI 10.1098/rstb.2003.1327; Bussing I, 2008, TRENDS MOL MED, V14, P400, DOI 10.1016/j.molmed.2008.07.001; Calabrese JM, 2007, P NATL ACAD SCI USA, V104, P18097, DOI 10.1073/pnas.0709193104; Cartwright P, 2005, DEVELOPMENT, V132, P885, DOI 10.1242/dev.01670; Chen CF, 2007, MAMM GENOME, V18, P316, DOI 10.1007/s00335-007-9032-6; Chen X, 2008, CELL, V133, P1106, DOI 10.1016/j.cell.2008.04.043; Heo I, 2008, MOL CELL, V32, P276, DOI 10.1016/j.molcel.2008.09.014; Heo I, 2009, CELL, V138, P696, DOI 10.1016/j.cell.2009.08.002; Hochedlinger K, 2009, DEVELOPMENT, V136, P509, DOI 10.1242/dev.020867; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Jones MR, 2009, NAT CELL BIOL, V11, P1157, DOI 10.1038/ncb1931; Judson RL, 2009, NAT BIOTECHNOL, V27, P459, DOI 10.1038/nbt.1535; Kanellopoulou C, 2005, GENE DEV, V19, P489, DOI 10.1101/gad.1248505; Kim JW, 2008, CELL, V132, P1049, DOI 10.1016/j.cell.2008.02.039; Kumar MS, 2007, NAT GENET, V39, P673, DOI 10.1038/ng2003; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim CY, 2008, CELL STEM CELL, V3, P543, DOI 10.1016/j.stem.2008.08.004; Marson A, 2008, CELL, V134, P521, DOI 10.1016/j.cell.2008.07.020; Mendell JT, 2008, CELL, V133, P217, DOI 10.1016/j.cell.2008.04.001; Murchison EP, 2005, P NATL ACAD SCI USA, V102, P12135, DOI 10.1073/pnas.0505479102; Nakagawa M, 2008, NAT BIOTECHNOL, V26, P101, DOI 10.1038/nbt1374; Newman MA, 2008, RNA, V14, P1539, DOI 10.1261/rna.1155108; Okabe S, 1996, MECH DEVELOP, V59, P89, DOI 10.1016/0925-4773(96)00572-2; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Polesskaya A, 2007, GENE DEV, V21, P1125, DOI 10.1101/gad.415007; Ramalho-Santos M, 2002, SCIENCE, V298, P597, DOI 10.1126/science.1072530; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Shi R, 2005, BIOTECHNIQUES, V39, P519, DOI 10.2144/000112010; Sinkkonen L, 2008, NAT STRUCT MOL BIOL, V15, P259, DOI 10.1038/nsmb.1391; Stadtfeld M, 2008, CELL STEM CELL, V2, P230, DOI 10.1016/j.stem.2008.02.001; Takahashi K, 2006, CELL, V126, P663, DOI 10.1016/j.cell.2006.07.024; Tay Y, 2008, NATURE, V455, P1124, DOI 10.1038/nature07299; Tay YMS, 2008, STEM CELLS, V26, P17, DOI 10.1634/stemcells.2007-0295; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Trumpp A, 2001, NATURE, V414, P768, DOI 10.1038/414768a; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Wang YM, 2007, NAT GENET, V39, P380, DOI 10.1038/ng1969; Wang Y, 2008, NAT GENET, V40, P1478, DOI 10.1038/ng.250; Wernig M, 2008, CELL STEM CELL, V2, P10, DOI 10.1016/j.stem.2007.12.001; Wu Q, 2006, J BIOL CHEM, V281, P24090, DOI 10.1074/jbc.C600122200; Xu BS, 2009, RNA, V15, P357, DOI 10.1261/rna.1368009; Xu N, 2009, CELL, V137, P647, DOI 10.1016/j.cell.2009.02.038; Yu JY, 2007, SCIENCE, V318, P1917, DOI 10.1126/science.1151526; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481	49	520	558	1	85	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	FEB 4	2010	463	7281					621	U45		10.1038/nature08725	http://dx.doi.org/10.1038/nature08725			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	551GB	20054295	Green Submitted, Green Accepted			2022-12-01	WOS:000274193900027
J	Snyderman, R; Dinan, MA				Snyderman, Ralph; Dinan, Michaela A.			Improving Health by Taking It Personally	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Editorial Material							PRIMARY-CARE; MEDICINE; TRANSFORMATION; SUPPORT		[Snyderman, Ralph; Dinan, Michaela A.] Duke Univ, Med Ctr, Ctr Res Prospect Hlth Care, Durham, NC 27710 USA	Duke University	Snyderman, R (corresponding author), Duke Univ, Med Ctr, Ctr Res Prospect Hlth Care, DUMC 3059, Durham, NC 27710 USA.	ralph.snyderman@duke.edu						*DUK PROSP HLTH, DUK PROSP HLTH PROGR; Goroll AH, 2007, J GEN INTERN MED, V22, P410, DOI 10.1007/s11606-006-0083-2; Plomin R, 2009, NAT REV GENET, V10, P872, DOI 10.1038/nrg2670; Rosenthal TC, 2008, J AM BOARD FAM MED, V21, P427, DOI 10.3122/jabfm.2008.05.070287; Schoen C, 2007, HEALTH AFFAIR, V26, pW717, DOI 10.1377/hlthaff.26.6.w717; Snyderman R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-104; Snyderman R, 2003, ACAD MED, V78, P1079, DOI 10.1097/00001888-200311000-00002; Whellan DJ, 2001, ARCH INTERN MED, V161, P2223, DOI 10.1001/archinte.161.18.2223; Williams RS, 2003, SCIENCE, V300, P549, DOI 10.1126/science.300.5619.549; Yoediono Z, 2008, PERS MED, V5, P47, DOI 10.2217/17410541.5.1.47	10	19	20	0	3	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 27	2010	303	4					363	364		10.1001/jama.2010.34	http://dx.doi.org/10.1001/jama.2010.34			2	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	548IC	20103762				2022-12-01	WOS:000273952800027
J	Dalgliesh, GL; Furge, K; Greenman, C; Chen, LN; Bignell, G; Butler, A; Davies, H; Edkins, S; Hardy, C; Latimer, C; Teague, J; Andrews, J; Barthorpe, S; Beare, D; Buck, G; Campbell, PJ; Forbes, S; Jia, MM; Jones, D; Knott, H; Kok, CY; Lau, KW; Leroy, C; Lin, ML; McBride, DJ; Maddison, M; Maguire, S; McLay, K; Menzies, A; Mironenko, T; Mulderrig, L; Mudie, L; O'Meara, S; Pleasance, E; Rajasingham, A; Shepherd, R; Smith, R; Stebbings, L; Stephens, P; Tang, G; Tarpey, PS; Turrell, K; Dykema, KJ; Khoo, SK; Petillo, D; Wondergem, B; Anema, J; Kahnoski, RJ; Teh, B; Stratton, MR; Futreal, PA				Dalgliesh, Gillian L.; Furge, Kyle; Greenman, Chris; Chen, Lina; Bignell, Graham; Butler, Adam; Davies, Helen; Edkins, Sarah; Hardy, Claire; Latimer, Calli; Teague, Jon; Andrews, Jenny; Barthorpe, Syd; Beare, Dave; Buck, Gemma; Campbell, Peter J.; Forbes, Simon; Jia, Mingming; Jones, David; Knott, Henry; Kok, Chai Yin; Lau, King Wai; Leroy, Catherine; Lin, Meng-Lay; McBride, David J.; Maddison, Mark; Maguire, Simon; McLay, Kirsten; Menzies, Andrew; Mironenko, Tatiana; Mulderrig, Lee; Mudie, Laura; O'Meara, Sarah; Pleasance, Erin; Rajasingham, Arjunan; Shepherd, Rebecca; Smith, Raffaella; Stebbings, Lucy; Stephens, Philip; Tang, Gurpreet; Tarpey, Patrick S.; Turrell, Kelly; Dykema, Karl J.; Khoo, Sok Kean; Petillo, David; Wondergem, Bill; Anema, John; Kahnoski, Richard J.; Teh, Bin Tean; Stratton, Michael R.; Futreal, P. Andrew			Systematic sequencing of renal carcinoma reveals inactivation of histone modifying genes	NATURE			English	Article							CELL CARCINOMA; PROGNOSTIC-SIGNIFICANCE; SOMATIC MUTATIONS; CANCER GENOMES; P600	Clear cell renal cell carcinoma (ccRCC) is the most common form of adult kidney cancer, characterized by the presence of inactivating mutations in the VHL gene in most cases(1,2), and by infrequent somatic mutations in known cancer genes. To determine further the genetics of ccRCC, we have sequenced 101 cases through 3,544 protein-coding genes. Here we report the identification of inactivating mutations in two genes encoding enzymes involved in histone modification-SETD2, a histone H3 lysine 36 methyltransferase, and JARID1C (also known as KDM5C), a histone H3 lysine 4 demethylase-as well as mutations in the histone H3 lysine 27 demethylase, UTX (KMD6A), that we recently reported(3). The results highlight the role of mutations in components of the chromatin modification machinery in human cancer. Furthermore, NF2 mutations were found in non-VHL mutated ccRCC, and several other probable cancer genes were identified. These results indicate that substantial genetic heterogeneity exists in a cancer type dominated by mutations in a single gene, and that systematic screens will be key to fully determining the somatic genetic architecture of cancer.	[Khoo, Sok Kean; Petillo, David; Teh, Bin Tean] Van Andel Res Inst, Lab Canc Genert, Grand Rapids, MI 49503 USA; [Anema, John; Kahnoski, Richard J.] Spectrum Hlth Hosp, Dept Urol, Grand Rapids, MI 49503 USA; [Teh, Bin Tean] Natl Canc Ctr, NCCS VARI Translat Canc Res Lab, Singapore 169610, Singapore; [Stratton, Michael R.] Inst Canc Res, Sutton SM2 5NG, Surrey, England; [Furge, Kyle; Dykema, Karl J.; Wondergem, Bill] Van Andel Res Inst, Lab Computat Biol, Grand Rapids, MI 49503 USA; [Dalgliesh, Gillian L.; Greenman, Chris; Chen, Lina; Bignell, Graham; Butler, Adam; Davies, Helen; Edkins, Sarah; Hardy, Claire; Latimer, Calli; Teague, Jon; Andrews, Jenny; Barthorpe, Syd; Beare, Dave; Buck, Gemma; Campbell, Peter J.; Forbes, Simon; Jia, Mingming; Jones, David; Knott, Henry; Kok, Chai Yin; Lau, King Wai; Leroy, Catherine; Lin, Meng-Lay; McBride, David J.; Maddison, Mark; Maguire, Simon; McLay, Kirsten; Menzies, Andrew; Mironenko, Tatiana; Mulderrig, Lee; Mudie, Laura; O'Meara, Sarah; Pleasance, Erin; Rajasingham, Arjunan; Shepherd, Rebecca; Smith, Raffaella; Stebbings, Lucy; Stephens, Philip; Tang, Gurpreet; Tarpey, Patrick S.; Turrell, Kelly; Stratton, Michael R.; Futreal, P. Andrew] Wellcome Trust Sanger Inst, Canc Genome Project, Hinxton CB10 1SA, England	Van Andel Institute; National Cancer Centre Singapore (NCCS); University of London; Institute of Cancer Research - UK; Van Andel Institute; Wellcome Trust Sanger Institute	Teh, B (corresponding author), Van Andel Res Inst, Lab Canc Genert, Grand Rapids, MI 49503 USA.	Bin.Teh@vai.org; mrs@sanger.ac.uk; paf@sanger.ac.uk	; Dalgliesh, Gillian/B-7799-2008	Teh, Bin Tean/0000-0003-1514-1124; Edkins, Sarah/0000-0003-0717-1972; Buck, Gemma/0000-0001-5289-1050; Dalgliesh, Gillian/0000-0001-8526-5064	Wellcome Trust [077012/Z/05/Z]; Hauenstein and Gerber Foundations	Wellcome Trust(Wellcome TrustEuropean Commission); Hauenstein and Gerber Foundations	We would like to acknowledge the Wellcome Trust for support under grant reference 077012/Z/05/Z and the Hauenstein and Gerber Foundations for support for the microarray expression work. We also thank S. Martin, W. McLaughlin and S. Noyes for administrative support and F. Brasseur for providing the matched-pair ccRCC cell lines.	Banks RE, 2006, CANCER RES, V66, P2000, DOI 10.1158/0008-5472.CAN-05-3074; Bommi-Reddy A, 2008, P NATL ACAD SCI USA, V105, P16484, DOI 10.1073/pnas.0806574105; Chi JT, 2006, PLOS MED, V3, P395, DOI 10.1371/journal.pmed.0030047; DeMasi J, 2005, P NATL ACAD SCI USA, V102, P11486, DOI 10.1073/pnas.0505322102; Demuth I, 2007, ONCOGENE, V26, P7792, DOI 10.1038/sj.onc.1210876; Dicks E, 2007, BIOINFORMATICS, V23, P1689, DOI 10.1093/bioinformatics/btm152; Eble JN, 2004, PATHOLOGY GENETICS T; Edge S. B., 2009, AJCC CANC STAGING MA; Ferner RE, 2007, LANCET NEUROL, V6, P340, DOI 10.1016/S1474-4422(07)70075-3; FUHRMAN SA, 1982, AM J SURG PATHOL, V6, P655, DOI 10.1097/00000478-198210000-00007; Gordan JD, 2007, CANCER CELL, V11, P335, DOI 10.1016/j.ccr.2007.02.006; Greenman C, 2006, GENETICS, V173, P2187, DOI 10.1534/genetics.105.044677; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Huh KW, 2005, P NATL ACAD SCI USA, V102, P11492, DOI 10.1073/pnas.0505337102; Issaeva I, 2007, MOL CELL BIOL, V27, P1889, DOI 10.1128/MCB.01506-06; Iwase S, 2007, CELL, V128, P1077, DOI 10.1016/j.cell.2007.02.017; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; Kudlow BA, 2007, NAT REV MOL CELL BIO, V8, P394, DOI 10.1038/nrm2161; Lee MG, 2007, SCIENCE, V318, P447, DOI 10.1126/science.1149042; Mandriota SJ, 2002, CANCER CELL, V1, P459, DOI 10.1016/S1535-6108(02)00071-5; McKinnon PJ, 2007, ANNU REV GENOM HUM G, V8, P37, DOI 10.1146/annurev.genom.7.080505.115648; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Rini BI, 2009, LANCET, V373, P1119, DOI 10.1016/S0140-6736(09)60229-4; Sun XJ, 2005, J BIOL CHEM, V280, P35261, DOI 10.1074/jbc.M504012200; van Haaften G, 2009, NAT GENET, V41, P521, DOI 10.1038/ng.349; Young AP, 2008, NAT CELL BIOL, V10, P361, DOI 10.1038/ncb1699; Zhang HF, 2007, CANCER CELL, V11, P407, DOI 10.1016/j.ccr.2007.04.001	27	874	905	0	86	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					360	363		10.1038/nature08672	http://dx.doi.org/10.1038/nature08672			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20054297	Green Accepted			2022-12-01	WOS:000273748100045
J	Wang, Q; Mynar, JL; Yoshida, M; Lee, E; Lee, M; Okuro, K; Kinbara, K; Aida, T				Wang, Qigang; Mynar, Justin L.; Yoshida, Masaru; Lee, Eunji; Lee, Myongsoo; Okuro, Kou; Kinbara, Kazushi; Aida, Takuzo			High-water-content mouldable hydrogels by mixing clay and a dendritic molecular binder	NATURE			English	Article							NANOCOMPOSITE HYDROGELS; MEDICINE; POLYMER	With the world's focus on reducing our dependency on fossil-fuel energy, the scientific community can investigate new plastic materials that are much less dependent on petroleum than are conventional plastics. Given increasing environmental issues, the idea of replacing plastics with water-based gels, so-called hydrogels, seems reasonable. Here we report that water and clay (2-3 per cent by mass), when mixed with a very small proportion (<0.4 per cent by mass) of organic components, quickly form a transparent hydrogel. This material can be moulded into shape-persistent, free-standing objects owing to its exceptionally great mechanical strength, and rapidly and completely self-heals when damaged. Furthermore, it preserves biologically active proteins for catalysis. So far(1) no other hydrogels, including conventional ones formed by mixing polymeric cations and anions(2,3) or polysaccharides and borax(4), have been reported to possess all these features. Notably, this material is formed only by non-covalent forces resulting from the specific design of a telechelic dendritic macromolecule with multiple adhesive termini for binding to clay.	[Wang, Qigang; Mynar, Justin L.; Okuro, Kou; Kinbara, Kazushi; Aida, Takuzo] Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, Tokyo 1138656, Japan; [Mynar, Justin L.; Aida, Takuzo] Natl Museum Emerging Sci & Innovat, Japan Sci & Technol Agcy, ERATO SORST Nanospace Project, Koto Ku, Tokyo 1350064, Japan; [Yoshida, Masaru] Natl Inst Adv Ind Sci & Technol, Nanotechnol Res Inst, Tsukuba, Ibaraki 3058565, Japan; [Lee, Eunji; Lee, Myongsoo] Seoul Natl Univ, Dept Chem, Seoul 151747, South Korea; [Lee, Eunji; Lee, Myongsoo] Seoul Natl Univ, Ctr Supramol Nanoassembly, Seoul 151747, South Korea	University of Tokyo; Japan Science & Technology Agency (JST); National Institute of Advanced Industrial Science & Technology (AIST); Seoul National University (SNU); Seoul National University (SNU)	Aida, T (corresponding author), Univ Tokyo, Sch Engn, Dept Chem & Biotechnol, Bunkyo Ku, 7-3-1 Hongo, Tokyo 1138656, Japan.	jmynar@berkeley.edu; aida@macro.t.u-tokyo.ac.jp	Aida, Takuzo/I-9117-2012; Lee, Myongsoo/A-8106-2011; Kinbara, Kazushi/E-6347-2017; Wang, Qigang/G-1124-2010; Lee, Eunji/H-1301-2011; Yoshida, Masaru/B-7380-2018	Kinbara, Kazushi/0000-0002-5945-9612; Wang, Qigang/0000-0002-4026-3337; Lee, Eunji/0000-0001-7494-1776; Yoshida, Masaru/0000-0002-9220-4312; Okuro, Kou/0000-0003-0445-6358	Japan Society for the Promotion of Science	Japan Society for the Promotion of Science(Ministry of Education, Culture, Sports, Science and Technology, Japan (MEXT)Japan Society for the Promotion of Science)	Q. W. thanks the Japan Society for the Promotion of Science postdoctoral fellowship for foreign researchers. We thank Y. Arakawa for his support for the synthesis of PEG-G3-dendron.	Carnahan MA, 2002, J AM CHEM SOC, V124, P5291, DOI 10.1021/ja025576y; Crompton KE, 2007, BIOMATERIALS, V28, P441, DOI 10.1016/j.biomaterials.2006.08.044; Das AK, 2008, SMALL, V4, P279, DOI 10.1002/smll.200700889; Dong L, 2006, NATURE, V442, P551, DOI 10.1038/nature05024; Gong JP, 2003, ADV MATER, V15, P1155, DOI 10.1002/adma.200304907; Haraguchi K, 2002, ADV MATER, V14, P1120, DOI 10.1002/1521-4095(20020816)14:16<1120::AID-ADMA1120>3.0.CO;2-9; Hirst AR, 2008, ANGEW CHEM INT EDIT, V47, P8002, DOI 10.1002/anie.200800022; Ihre H, 2001, J AM CHEM SOC, V123, P5908, DOI 10.1021/ja010524e; Jayawarna V, 2006, ADV MATER, V18, P611, DOI 10.1002/adma.200501522; Kiyonaka S, 2004, NAT MATER, V3, P58, DOI 10.1038/nmat1034; Ladet S, 2008, NATURE, V452, P76, DOI 10.1038/nature06619; Li P, 2009, J APPL POLYM SCI, V111, P1786, DOI 10.1002/app.29061; Liu Y, 2006, POLYMER, V47, P1, DOI 10.1016/j.polymer.2005.11.030; Marsich E, 2008, J BIOMED MATER RES A, V84A, P364, DOI 10.1002/jbm.a.31307; Nowak AP, 2002, NATURE, V417, P424, DOI 10.1038/417424a; Okada A, 2006, MACROMOL MATER ENG, V291, P1449, DOI 10.1002/mame.200600260; Okay O, 2007, MACROMOLECULES, V40, P3378, DOI 10.1021/ma062929v; Okuro K, 2009, J AM CHEM SOC, V131, P1626, DOI 10.1021/ja800491v; Peppas NA, 2000, ANNU REV BIOMED ENG, V2, P9, DOI 10.1146/annurev.bioeng.2.1.9; PEZRON E, 1988, MACROMOLECULES, V21, P1121, DOI 10.1021/ma00182a045; *ROCKW ADD LTD, 1990, L21101G ROCKW ADD LT; Rokita B, 2009, MACROMOLECULES, V42, P3269, DOI 10.1021/ma802565p; Schnepp ZAC, 2006, ADV MATER, V18, P1869, DOI 10.1002/adma.200502545; Sijbesma RP, 1997, SCIENCE, V278, P1601, DOI 10.1126/science.278.5343.1601; Silva GA, 2004, SCIENCE, V303, P1352, DOI 10.1126/science.1093783; Sreenivasachary N, 2005, P NATL ACAD SCI USA, V102, P5938, DOI 10.1073/pnas.0501663102; Wang QG, 2007, CHEM COMMUN, P1032, DOI 10.1039/b615223f; Wathier M, 2004, J AM CHEM SOC, V126, P12744, DOI 10.1021/ja045870l; Xing BG, 2002, J AM CHEM SOC, V124, P14846, DOI 10.1021/ja028539f; Yoshida M, 2007, J AM CHEM SOC, V129, P11039, DOI 10.1021/ja0738677	30	1272	1324	50	1937	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 21	2010	463	7279					339	343		10.1038/nature08693	http://dx.doi.org/10.1038/nature08693			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	545PM	20090750				2022-12-01	WOS:000273748100040
J	Ogden, CL; Carroll, MD; Curtin, LR; Lamb, MM; Flegal, KM				Ogden, Cynthia L.; Carroll, Margaret D.; Curtin, Lester R.; Lamb, Molly M.; Flegal, Katherine M.			Prevalence of High Body Mass Index in US Children and Adolescents, 2007-2008	JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION			English	Article							OVERWEIGHT; OBESITY; ADULTS	Context The prevalence of high body mass index (BMI) among children and adolescents in the United States appeared to plateau between 1999 and 2006. Objectives To provide the most recent estimates of high BMI among children and adolescents and high weight for recumbent length among infants and toddlers and to analyze trends in prevalence between 1999 and 2008. Design, Setting, and Participants The National Health and Nutrition Examination Survey 2007-2008, a representative sample of the US population with measured heights and weights on 3281 children and adolescents (2 through 19 years of age) and 719 infants and toddlers (birth to 2 years of age). Main Outcome Measures Prevalence of high weight for recumbent length (>= 95th percentile of the Centers for Disease Control and Prevention growth charts) among infants and toddlers. Prevalence of high BMI among children and adolescents defined at 3 levels: BMI for age at or above the 97th percentile, at or above the 95th percentile, and at or above the 85th percentile of the BMI-for-age growth charts. Analyses of trends by age, sex, and race/ethnicity from 1999-2000 to 2007-2008. Results In 2007-2008, 9.5% of infants and toddlers (95% confidence interval [CI], 7.3%-11.7%) were at or above the 95th percentile of the weight-for-recumbent-length growth charts. Among children and adolescents aged 2 through 19 years, 11.9% (95% CI, 9.8%-13.9%) were at or above the 97th percentile of the BMI-for-age growth charts; 16.9% (95% CI, 14.1%-19.6%) were at or above the 95th percentile; and 31.7% (95% CI, 29.2%-34.1%) were at or above the 85th percentile of BMI for age. Prevalence estimates differed by age and by race/ethnic group. Trend analyses indicate no significant trend between 1999-2000 and 2007-2008 except at the highest BMI cut point (BMI for age >= 97th percentile) among all 6-through 19-year-old boys (odds ratio [OR], 1.52; 95% CI, 1.17-2.01) and among non-Hispanic white boys of the same age (OR, 1.87; 95% CI, 1.22-2.94). Conclusion No statistically significant linear trends in high weight for recumbent length or high BMI were found over the time periods 1999-2000, 2001-2002, 2003-2004, 2005-2006, and 2007-2008 among girls and boys except among the very heaviest 6-through 19-year-old boys. JAMA. 2010;303(3):242-249	[Ogden, Cynthia L.; Carroll, Margaret D.; Curtin, Lester R.; Lamb, Molly M.; Flegal, Katherine M.] Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, Hyattsville, MD 20782 USA	Centers for Disease Control & Prevention - USA; CDC National Center for Health Statistics (NCHS)	Ogden, CL (corresponding author), Ctr Dis Control & Prevent, Natl Ctr Hlth Stat, 3311 Toledo Rd,Room 4414, Hyattsville, MD 20782 USA.	cogden@cdc.gov	Fruyt, Sofie/F-6843-2011; Flegal, Katherine M/A-4608-2013	Flegal, Katherine/0000-0002-0838-469X; Lamb, Molly/0000-0002-2331-2555				Barlow SE, 1998, PEDIATRICS, V102, DOI 10.1542/peds.102.3.e29; *COMM PREV SERV, OB PREV BEH INT RED; Eaton Danice K., 2008, Morbidity and Mortality Weekly Report, V57, P1; Flegal KM, 2006, HEALTH EDUC RES, V21, P755, DOI 10.1093/her/cyl128; Freedman DS, 2008, OBESITY, V16, P1105, DOI 10.1038/oby.2008.30; Freedman DS, 2007, J PEDIATR-US, V150, P12, DOI 10.1016/j.jpeds.2006.08.042; Hedley AA, 2004, JAMA-J AM MED ASSOC, V291, P2847, DOI 10.1001/jama.291.23.2847; HIMES JH, 1994, AM J CLIN NUTR, V59, P307, DOI 10.1093/ajcn/59.2.307; Krebs NF, 2007, PEDIATRICS, V120, pS193, DOI 10.1542/peds.2007-2329D; Kuczmarski RJ., 2000, CDC GROWTH CHARTS US; *NAT CTR HLTH STAT, PREV OV INF CHILDR L; National Health and Nutrition Examination Survey, QUEST DAT REL DOC; *NHS INF CTR LIF S, 2009, STAT OB PHYS ACT DIE; Ogden CL, 2002, JAMA-J AM MED ASSOC, V288, P1728, DOI 10.1001/jama.288.14.1728; Ogden CL, 2006, JAMA-J AM MED ASSOC, V295, P1549, DOI 10.1001/jama.295.13.1549; OGDEN CL, 2009, EPIDEMIOLOGY OBESITY; Ogden CL, 2008, JAMA-J AM MED ASSOC, V299, P2401, DOI 10.1001/jama.299.20.2401; Ogden Cynthia L, 2007, NCHS Data Brief, P1; Pi-Sunyer FX, 1998, OBES RES, V6, p51S; SERDULA MK, 1993, PREV MED, V22, P167, DOI 10.1006/pmed.1993.1014; Sharma A. J., 2009, Morbidity and Mortality Weekly Report, V58, P769; Story M, 2009, J ADOLESCENT HEALTH, V45, pS1, DOI 10.1016/j.jadohealth.2009.06.022; Sundblom E, 2008, INT J OBESITY, V32, P1525, DOI 10.1038/ijo.2008.104; Velleman P.F., 1981, APPL BASICS COMPUTIN; YOUTH ONLINE COMPREH	25	2182	2211	2	146	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	0098-7484	1538-3598		JAMA-J AM MED ASSOC	JAMA-J. Am. Med. Assoc.	JAN 20	2010	303	3					242	249		10.1001/jama.2009.2012	http://dx.doi.org/10.1001/jama.2009.2012			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	544WM	20071470	Bronze			2022-12-01	WOS:000273690600020
J	Maze, I; Covington, HE; Dietz, DM; LaPlant, Q; Renthal, W; Russo, SJ; Mechanic, M; Mouzon, E; Neve, RL; Haggarty, SJ; Ren, YH; Sampath, SC; Hurd, YL; Greengard, P; Tarakhovsky, A; Schaefer, A; Nestler, EJ				Maze, Ian; Covington, Herbert E., III; Dietz, David M.; LaPlant, Quincey; Renthal, William; Russo, Scott J.; Mechanic, Max; Mouzon, Ezekiell; Neve, Rachael L.; Haggarty, Stephen J.; Ren, Yanhua; Sampath, Srihari C.; Hurd, Yasmin L.; Greengard, Paul; Tarakhovsky, Alexander; Schaefer, Anne; Nestler, Eric J.			Essential Role of the Histone Methyltransferase G9a in Cocaine-Induced Plasticity	SCIENCE			English	Article							NUCLEUS-ACCUMBENS; DELTA-FOSB; GENE-EXPRESSION; EXPOSURE; PROTEIN; NEURONS; REWARD; AMPHETAMINE; MECHANISMS; ADDICTION	Cocaine-induced alterations in gene expression cause changes in neuronal morphology and behavior that may underlie cocaine addiction. In mice, we identified an essential role for histone 3 lysine 9 (H3K9) dimethylation and the lysine dimethyltransferase G9a in cocaine-induced structural and behavioral plasticity. Repeated cocaine administration reduced global levels of H3K9 dimethylation in the nucleus accumbens. This reduction in histone methylation was mediated through the repression of G9a in this brain region, which was regulated by the cocaine-induced transcription factor Delta FosB. Using conditional mutagenesis and viral-mediated gene transfer, we found that G9a down-regulation increased the dendritic spine plasticity of nucleus accumbens neurons and enhanced the preference for cocaine, thereby establishing a crucial role for histone methylation in the long-term actions of cocaine.	[Maze, Ian; Covington, Herbert E., III; Dietz, David M.; LaPlant, Quincey; Russo, Scott J.; Mouzon, Ezekiell; Ren, Yanhua; Hurd, Yasmin L.; Nestler, Eric J.] Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA; [LaPlant, Quincey; Renthal, William; Mechanic, Max] Univ Texas SW Med Ctr Dallas, Dept Psychiat, Dallas, TX 75390 USA; [LaPlant, Quincey; Renthal, William; Mechanic, Max] Univ Texas SW Med Ctr Dallas, Dept Neurosci, Dallas, TX 75390 USA; [Neve, Rachael L.] MIT, Dept Brain & Cognit Sci, Cambridge, MA 02139 USA; [Haggarty, Stephen J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Psychiat & Neurodev Genet Unit, Boston, MA 02114 USA; [Haggarty, Stephen J.] Massachusetts Gen Hosp, Ctr Human Genet Res, Mol Neurogenet Unit, Boston, MA 02114 USA; [Haggarty, Stephen J.] Harvard & Massachusetts Inst Technol, Broad Inst, Stanley Ctr Psychiat Res, Cambridge, MA USA; [Sampath, Srihari C.; Tarakhovsky, Alexander] Rockefeller Univ, Lab Lymphocyte Signaling, New York, NY 10021 USA; [Greengard, Paul; Schaefer, Anne] Rockefeller Univ, Mol & Cellular Neurosci Lab, New York, NY 10021 USA	Icahn School of Medicine at Mount Sinai; University of Texas System; University of Texas Southwestern Medical Center Dallas; University of Texas System; University of Texas Southwestern Medical Center Dallas; Massachusetts Institute of Technology (MIT); Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts General Hospital; Harvard University; Massachusetts Institute of Technology (MIT); Broad Institute; Rockefeller University; Rockefeller University	Nestler, EJ (corresponding author), Mt Sinai Sch Med, Fishberg Dept Neurosci, New York, NY 10029 USA.	eric.nestler@mssm.edu	Maze, Ian/P-8077-2018; Dietz, David/J-9458-2015; Dietz, David/AAW-4574-2021; Haggarty, Stephen J/M-9495-2016; Russo, Scott/R-7107-2019	Dietz, David/0000-0002-6927-9236; Dietz, David/0000-0002-6927-9236; Haggarty, Stephen J/0000-0002-7872-168X; Russo, Scott/0000-0002-6470-1805; Renthal, William/0000-0003-0206-2101; Maze, Ian/0000-0003-1490-7781	National Institute on Drug Abuse [P01 DA08227, R01 DA07359, P0110044]; NATIONAL INSTITUTE ON DRUG ABUSE [P01DA008227, P01DA010044, R01DA014133, R01DA007359] Funding Source: NIH RePORTER	National Institute on Drug Abuse(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)	This work was supported by grants from the National Institute on Drug Abuse: P01 DA08227 and R01 DA07359 (E. J. N.) and P0110044 (P. G.). E. J. N. certifies that none of the materials included in the manuscript have been previously published or are under consideration elsewhere, including on the Internet. All work involving the use of animals was conducted in accordance with institutional and Institutional Animal Care and Use Committee guidelines at both the University of Texas Southwestern Medical Center and Mount Sinai School of Medicine.	Bibb JA, 2001, NATURE, V410, P376, DOI 10.1038/35066591; Borrelli E, 2008, NEURON, V60, P961, DOI 10.1016/j.neuron.2008.10.012; Brami-Cherrier K, 2009, J NEUROCHEM, V108, P1323, DOI 10.1111/j.1471-4159.2009.05879.x; Chang YQ, 2009, NAT STRUCT MOL BIOL, V16, P312, DOI 10.1038/nsmb.1560; Graham DL, 2007, NAT NEUROSCI, V10, P1029, DOI 10.1038/nn1929; Hyman SE, 2006, ANNU REV NEUROSCI, V29, P565, DOI 10.1146/annurev.neuro.29.051605.113009; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; Kubicek S, 2007, MOL CELL, V25, P473, DOI 10.1016/j.molcel.2007.01.017; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Lee KW, 2006, P NATL ACAD SCI USA, V103, P3399, DOI 10.1073/pnas.0511244103; McClung CA, 2003, NAT NEUROSCI, V6, P1208, DOI 10.1038/nn1143; Nestler EJ, 2008, PHILOS T R SOC B, V363, P3245, DOI 10.1098/rstb.2008.0067; Norrholm SD, 2003, NEUROSCIENCE, V116, P19, DOI 10.1016/S0306-4522(02)00560-2; Pulipparacharuvil S, 2008, NEURON, V59, P621, DOI 10.1016/j.neuron.2008.06.020; Renthal W, 2008, J NEUROSCI, V28, P7344, DOI 10.1523/JNEUROSCI.1043-08.2008; Renthal W, 2007, NEURON, V56, P517, DOI 10.1016/j.neuron.2007.09.032; Renthal W, 2009, NEURON, V62, P335, DOI 10.1016/j.neuron.2009.03.026; Robinson TE, 1997, J NEUROSCI, V17, P8491; Robinson TE, 2004, NEUROPHARMACOLOGY, V47, P33, DOI 10.1016/j.neuropharm.2004.06.025; Russo SJ, 2009, J NEUROSCI, V29, P3529, DOI 10.1523/JNEUROSCI.6173-08.2009; Sampath SC, 2007, MOL CELL, V27, P596, DOI 10.1016/j.molcel.2007.06.026; Stipanovich A, 2008, NATURE, V453, P879, DOI 10.1038/nature06994; Tachibana M, 2001, J BIOL CHEM, V276, P25309, DOI 10.1074/jbc.M101914200; Thomas MJ, 2003, PHILOS T ROY SOC B, V358, P815, DOI 10.1098/rstb.2002.1236; Toda S, 2006, J NEUROSCI, V26, P1579, DOI 10.1523/JNEUROSCI.4132-05.2006; Ujike H, 2002, ANN NY ACAD SCI, V965, P55; Ungless MA, 2001, NATURE, V411, P583, DOI 10.1038/35079077	27	474	492	0	57	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 8	2010	327	5962					213	216		10.1126/science.1179438	http://dx.doi.org/10.1126/science.1179438			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DQ	20056891	Green Accepted			2022-12-01	WOS:000273394000038
J	Bokoch, MP; Zou, YZ; Rasmussen, SGF; Liu, CW; Nygaard, R; Rosenbaum, DM; Fung, JJ; Choi, HJ; Thian, FS; Kobilka, TS; Puglisi, JD; Weis, WI; Pardo, L; Prosser, RS; Mueller, L; Kobilka, BK				Bokoch, Michael P.; Zou, Yaozhong; Rasmussen, Soren G. F.; Liu, Corey W.; Nygaard, Rie; Rosenbaum, Daniel M.; Fung, Juan Jose; Choi, Hee-Jung; Thian, Foon Sun; Kobilka, Tong Sun; Puglisi, Joseph D.; Weis, William I.; Pardo, Leonardo; Prosser, R. Scott; Mueller, Luciano; Kobilka, Brian K.			Ligand-specific regulation of the extracellular surface of a G-protein-coupled receptor	NATURE			English	Article							TOGGLE SWITCH MODEL; CRYSTAL-STRUCTURE; BINDING-SITE; BETA(2)-ADRENERGIC RECEPTOR; ADRENERGIC-RECEPTOR; LYSINE RESIDUES; HELIX MOVEMENT; ACTIVATION; RHODOPSIN; RECOGNITION	G-protein-coupled receptors (GPCRs) are seven-transmembrane proteins that mediate most cellular responses to hormones and neurotransmitters. They are the largest group of therapeutic targets for a broad spectrum of diseases. Recent crystal structures of GPCRs(1-5) have revealed structural conservation extending from the orthosteric ligand-binding site in the transmembrane core to the cytoplasmic G-protein-coupling domains. In contrast, the extracellular surface (ECS) of GPCRs is remarkably diverse and is therefore an ideal target for the discovery of subtype-selective drugs. However, little is known about the functional role of the ECS in receptor activation, or about conformational coupling of this surface to the native ligand-binding pocket. Here we use NMR spectroscopy to investigate ligand-specific conformational changes around a central structural feature in the ECS of the beta(2) adrenergic receptor: a salt bridge linking extracellular loops 2 and 3. Small-molecule drugs that bind within the transmembrane core and exhibit different efficacies towards G-protein activation (agonist, neutral antagonist and inverse agonist) also stabilize distinct conformations of the ECS. We thereby demonstrate conformational coupling between the ECS and the orthosteric binding site, showing that drugs targeting this diverse surface could function as allosteric modulators with high subtype selectivity. Moreover, these studies provide a new insight into the dynamic behaviour of GPCRs not addressable by static, inactive-state crystal structures.	[Bokoch, Michael P.; Zou, Yaozhong; Rasmussen, Soren G. F.; Nygaard, Rie; Rosenbaum, Daniel M.; Fung, Juan Jose; Choi, Hee-Jung; Thian, Foon Sun; Kobilka, Tong Sun; Weis, William I.; Kobilka, Brian K.] Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA; [Liu, Corey W.; Puglisi, Joseph D.] Stanford Univ, Stanford Magnet Resonance Lab, Sch Med, Stanford, CA 94305 USA; [Choi, Hee-Jung; Puglisi, Joseph D.; Weis, William I.] Stanford Univ, Dept Biol Struct, Sch Med, Stanford, CA 94305 USA; [Pardo, Leonardo] Univ Autonoma Barcelona, Lab Med Computac, Unitat Bioestadist, E-08193 Barcelona, Spain; [Prosser, R. Scott] Univ Toronto, UTM, Dept Chem, Mississauga, ON L5L 1C6, Canada; [Mueller, Luciano] Bristol Myers Squibb Co, Pharmaceut Res Inst, Princeton, NJ 08543 USA	Stanford University; Stanford University; Stanford University; Autonomous University of Barcelona; University of Toronto; University Toronto Mississauga; Bristol-Myers Squibb	Kobilka, BK (corresponding author), Stanford Univ, Dept Mol & Cellular Physiol, Sch Med, Stanford, CA 94305 USA.	kobilka@stanford.edu	Nygaard, Rie/B-7351-2013; FUNG, John Julian/A-2679-2012; Weis, William I/G-1437-2011; Bokoch, Michael P./J-2637-2019	FUNG, John Julian/0000-0002-3038-0441; Weis, William I/0000-0002-5583-6150; Bokoch, Michael P./0000-0003-1387-9547; Kobilka, Brian/0000-0001-5958-3990; Choi, Hee-Jung/0000-0002-1167-1526; Rasmussen, Soren/0000-0002-1853-1841; Pardo, Leonardo/0000-0003-1778-7420	National Institutes of Health [NS028471, GM56169]; Stanford Medical Scientist Training Program; Lundbeck Foundation; University of Copenhagen and 7TM Pharma; Instituto de Salud Carlos III; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM056169] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH082313] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R37NS028471, R01NS028471] Funding Source: NIH RePORTER; Lundbeck Foundation [R19-2008-2113, R37-2009-3457] Funding Source: researchfish	National Institutes of Health(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Stanford Medical Scientist Training Program; Lundbeck Foundation(Lundbeckfonden); University of Copenhagen and 7TM Pharma; Instituto de Salud Carlos III(Instituto de Salud Carlos IIIEuropean Commission); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); Lundbeck Foundation(Lundbeckfonden)	We acknowledge support from National Institutes of Health, grants NS028471 (B. K. K.) and GM56169 (W. I. W.), the Stanford Medical Scientist Training Program (M. P. B.), the Lundbeck Foundation (S. G. F. R.), the University of Copenhagen and 7TM Pharma (R.N.), and the Instituto de Salud Carlos III (L. P.).	Abraham SJ, 2008, J BIOMOL NMR, V42, P143, DOI 10.1007/s10858-008-9274-y; Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Ahuja S, 2009, NAT STRUCT MOL BIOL, V16, P168, DOI 10.1038/nsmb.1549; Altenbach C, 2008, P NATL ACAD SCI USA, V105, P7439, DOI 10.1073/pnas.0802515105; Baker JG, 2005, BRIT J PHARMACOL, V144, P317, DOI 10.1038/sj.bjp.0706048; Ballesteros J. A., 1995, RECEPTOR MOL BIOL, V25, P366, DOI DOI 10.1016/S1043-9471(05)80049-7; Baneres JL, 2005, J BIOL CHEM, V280, P20253, DOI 10.1074/jbc.M412009200; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cherezov V, 2007, SCIENCE, V318, P1258, DOI 10.1126/science.1150577; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Elling CE, 2006, J BIOL CHEM, V281, P17337, DOI 10.1074/jbc.M512510200; Farrens DL, 1996, SCIENCE, V274, P768, DOI 10.1126/science.274.5288.768; GERKEN TA, 1982, J BIOL CHEM, V257, P2894; Ghanouni P, 2001, J BIOL CHEM, V276, P24433, DOI 10.1074/jbc.C100162200; Hanson MA, 2008, STRUCTURE, V16, P897, DOI 10.1016/j.str.2008.05.001; HUBBARD SJ, 1991, J MOL BIOL, V220, P507, DOI 10.1016/0022-2836(91)90027-4; Jaakola VP, 2008, SCIENCE, V322, P1211, DOI 10.1126/science.1164772; JENTOFT JE, 1979, J BIOL CHEM, V254, P4366; KOBILKA BK, 1995, ANAL BIOCHEM, V231, P269, DOI 10.1006/abio.1995.1533; Kobilka BK, 2007, TRENDS PHARMACOL SCI, V28, P397, DOI 10.1016/j.tips.2007.06.003; Kumar S, 2002, BIOPHYS J, V83, P1595, DOI 10.1016/S0006-3495(02)73929-5; Nygaard R, 2009, TRENDS PHARMACOL SCI, V30, P249, DOI 10.1016/j.tips.2009.02.006; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Park JH, 2008, NATURE, V454, P183, DOI 10.1038/nature07063; Rasmussen SGF, 2007, NATURE, V450, P383, DOI 10.1038/nature06325; Rosenbaum DM, 2007, SCIENCE, V318, P1266, DOI 10.1126/science.1150609; Scheerer P, 2008, NATURE, V455, P497, DOI 10.1038/nature07330; Schwartz TW, 2006, ANNU REV PHARMACOL, V46, P481, DOI 10.1146/annurev.pharmtox.46.120604.141218; SHERRY AD, 1983, J BIOL CHEM, V258, P8663; Swaminath G, 2005, J BIOL CHEM, V280, P22165, DOI 10.1074/jbc.M502352200; TOTA MR, 1990, J BIOL CHEM, V265, P16891; Tugarinov V, 2003, J AM CHEM SOC, V125, P10420, DOI 10.1021/ja030153x; Warne T, 2008, NATURE, V454, P486, DOI 10.1038/nature07101; Wieland K, 1996, P NATL ACAD SCI USA, V93, P9276, DOI 10.1073/pnas.93.17.9276; Yao XJ, 2009, P NATL ACAD SCI USA, V106, P9501, DOI 10.1073/pnas.0811437106; Yao XJ, 2006, NAT CHEM BIOL, V2, P417, DOI 10.1038/nchembio801; ZHANG MJ, 1993, J BIOL CHEM, V268, P22420	37	387	400	1	123	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	0028-0836	1476-4687		NATURE	Nature	JAN 7	2010	463	7277					108	U121		10.1038/nature08650	http://dx.doi.org/10.1038/nature08650			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	540OV	20054398	Green Accepted			2022-12-01	WOS:000273344900040
J	Liu, HT; He, J; Tang, JY; Liu, H; Pang, P; Cao, D; Krstic, P; Joseph, S; Lindsay, S; Nuckolls, C				Liu, Haitao; He, Jin; Tang, Jinyao; Liu, Hao; Pang, Pei; Cao, Di; Krstic, Predrag; Joseph, Sony; Lindsay, Stuart; Nuckolls, Colin			Translocation of Single-Stranded DNA Through Single-Walled Carbon Nanotubes	SCIENCE			English	Article							SOLID-STATE NANOPORES; TRANSPORT; MOLECULES; CHANNEL; FABRICATION; MEMBRANES; ACID	We report the fabrication of devices in which one single-walled carbon nanotube spans a barrier between two fluid reservoirs, enabling direct electrical measurement of ion transport through the tube. A fraction of the tubes pass anomalously high ionic currents. Electrophoretic transport of small single-stranded DNA oligomers through these tubes is marked by large transient increases in ion current and was confirmed by polymerase chain reaction analysis. Each current pulse contains about 10(7) charges, an enormous amplification of the translocated charge. Carbon nanotubes simplify the construction of nanopores, permit new types of electrical measurements, and may open avenues for control of DNA translocation.	[He, Jin; Liu, Hao; Pang, Pei; Cao, Di; Lindsay, Stuart] Biodesign Inst, Tempe, AZ 85287 USA; [Liu, Haitao; Tang, Jinyao; Nuckolls, Colin] Columbia Univ, Dept Chem, New York, NY 10027 USA; [Liu, Hao; Lindsay, Stuart] Dept Chem & Biochem, Tempe, AZ 85287 USA; [Pang, Pei; Cao, Di; Lindsay, Stuart] Arizona State Univ, Dept Phys, Tempe, AZ 85287 USA; [Krstic, Predrag; Joseph, Sony] Oak Ridge Natl Lab, Div Phys, Oak Ridge, TN 37831 USA	Columbia University; Arizona State University; Arizona State University-Tempe; United States Department of Energy (DOE); Oak Ridge National Laboratory	Lindsay, S (corresponding author), Biodesign Inst, Tempe, AZ 85287 USA.	Stuart.Lindsay@asu.edu; cn37@columbia.edu	he, jin/AAV-8045-2021; Tang, Jinyao/I-3851-2012; he, jin/C-6256-2009	he, jin/0000-0002-2633-9809; 	NATIONAL HUMAN GENOME RESEARCH INSTITUTE [R21HG004770] Funding Source: NIH RePORTER; NHGRI NIH HHS [R21 HG004770, R21 HG004770-01] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI))		Akeson M, 1999, BIOPHYS J, V77, P3227, DOI 10.1016/S0006-3495(99)77153-5; Branton D, 2008, NAT BIOTECHNOL, V26, P1146, DOI 10.1038/nbt.1495; Chang H, 2006, APPL PHYS LETT, V88, DOI 10.1063/1.2179131; Chow KF, 2008, J AM CHEM SOC, V130, P7544, DOI 10.1021/ja802013q; Dekker C, 2007, NAT NANOTECHNOL, V2, P209, DOI 10.1038/nnano.2007.27; Fan R, 2005, NANO LETT, V5, P1633, DOI 10.1021/nl0509677; Guo XF, 2006, SCIENCE, V311, P356, DOI 10.1126/science.1120986; Hinds BJ, 2004, SCIENCE, V303, P62, DOI 10.1126/science.1092048; Holt JK, 2006, SCIENCE, V312, P1034, DOI 10.1126/science.1126298; Ito T, 2003, CHEM COMMUN, P1482, DOI 10.1039/b302511j; Jin XZ, 2007, LANGMUIR, V23, P13209, DOI 10.1021/la702326v; Joseph S, 2003, NANO LETT, V3, P1399, DOI 10.1021/nl0346326; Joseph S, 2008, NANO LETT, V8, P452, DOI 10.1021/nl072385q; Kasianowicz JJ, 1996, P NATL ACAD SCI USA, V93, P13770, DOI 10.1073/pnas.93.24.13770; Kasianowicz JJ, 2001, ANAL CHEM, V73, P2268, DOI 10.1021/ac000958c; Kim MJ, 2006, ADV MATER, V18, P3149, DOI 10.1002/adma.200601191; Li J, 2001, NATURE, V412, P166, DOI 10.1038/35084037; Liang XG, 2008, NANO LETT, V8, P1472, DOI 10.1021/nl080473k; Meller A, 2002, ELECTROPHORESIS, V23, P2583, DOI 10.1002/1522-2683(200208)23:16<2583::AID-ELPS2583>3.0.CO;2-H; Rhee M, 2007, TRENDS BIOTECHNOL, V25, P174, DOI 10.1016/j.tibtech.2007.02.008; Stein D, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.035901; Storm AJ, 2003, NAT MATER, V2, P537, DOI 10.1038/nmat941; Tu XM, 2009, NATURE, V460, P250, DOI 10.1038/nature08116; Warakulwit C, 2008, NANO LETT, V8, P500, DOI 10.1021/nl072652s; Xie YH, 2007, J CHEM PHYS, V127, DOI 10.1063/1.2799989; Yeh IC, 2004, P NATL ACAD SCI USA, V101, P12177, DOI 10.1073/pnas.0402699101	26	254	268	5	204	AMER ASSOC ADVANCEMENT SCIENCE	WASHINGTON	1200 NEW YORK AVE, NW, WASHINGTON, DC 20005 USA	0036-8075	1095-9203		SCIENCE	Science	JAN 1	2010	327	5961					64	67		10.1126/science.1181799	http://dx.doi.org/10.1126/science.1181799			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	541DZ	20044570	Green Accepted			2022-12-01	WOS:000273395400030
J	Selivanova, G; Ivaska, J				Selivanova, Galina; Ivaska, Johanna			Integrins and Mutant p53 on the Road to Metastasis	CELL			English	Editorial Material									[Ivaska, Johanna] Univ Turku, Turku Ctr Biotechnol, FIN-20500 Turku, Finland; [Ivaska, Johanna] Univ Turku, Dept Biochem & Food Chem, FIN-20500 Turku, Finland; [Ivaska, Johanna] VTT Tech Res Ctr Finland, FIN-20500 Turku, Finland; [Selivanova, Galina] Karolinska Inst, Dept Microbiol Tumor & Cell Biol, S-17177 Stockholm, Sweden	University of Turku; University of Turku; VTT Technical Research Center Finland; Karolinska Institutet	Ivaska, J (corresponding author), Univ Turku, Turku Ctr Biotechnol, FIN-20500 Turku, Finland.	johanna.ivaska@vtt.fi		Selivanova, Galina/0000-0002-8698-4332; Ivaska, Johanna/0000-0002-6295-6556				Bon G, 2009, CANCER RES, V69, P5978, DOI 10.1158/0008-5472.CAN-09-0244; Brosh R, 2009, NAT REV CANCER, V9, P701, DOI 10.1038/nrc2693; Carroll DK, 2006, NAT CELL BIOL, V8, P551, DOI 10.1038/ncb1420; Caswell PT, 2009, NAT REV MOL CELL BIO, V10, P843, DOI 10.1038/nrm2799; Chiang AC, 2008, NEW ENGL J MED, V359, P2814, DOI 10.1056/NEJMra0805239; Kaur S, 2009, AM J PATHOL, V175, P2184, DOI 10.2353/ajpath.2009.090028; Selivanova G, 2007, ONCOGENE, V26, P2243, DOI 10.1038/sj.onc.1210295	7	19	22	0	7	CELL PRESS	CAMBRIDGE	600 TECHNOLOGY SQUARE, 5TH FLOOR, CAMBRIDGE, MA 02139 USA	0092-8674			CELL	Cell	DEC 24	2009	139	7					1220	1222		10.1016/j.cell.2009.12.016	http://dx.doi.org/10.1016/j.cell.2009.12.016			3	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	536MO	20064366	Bronze			2022-12-01	WOS:000273048700008
